PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Al Safadi, R; Amor, S; Hery-Arnaud, G; Spellerberg, B; Lanotte, P; Mereghetti, L; Gannier, F; Quentin, R; Rosenau, A				Al Safadi, Rim; Amor, Souheila; Hery-Arnaud, Genevieve; Spellerberg, Barbara; Lanotte, Philippe; Mereghetti, Laurent; Gannier, Francois; Quentin, Roland; Rosenau, Agnes			Enhanced Expression of lmb Gene Encoding Laminin-Binding Protein in Streptococcus agalactiae Strains Harboring IS1548 in scpB-lmb Intergenic Region	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; INVASIVE NEONATAL DISEASE; MICROVASCULAR ENDOTHELIAL-CELLS; GROUP-II INTRON; C5A PEPTIDASE; MOLECULAR CHARACTERIZATION; INSERTIONAL ACTIVATION; POPULATION-STRUCTURE; BIOFILM FORMATION; EPITHELIAL-CELLS	Group B streptococcus (GBS) is the main cause of neonatal sepsis and meningitis. Bacterial surface proteins play a major role in GBS binding to and invasion of different host surfaces. The scpB and lmb genes, coding for fibronectin-binding and laminin-binding surface proteins, are present in almost all human GBS isolates. The scpB-lmb intergenic region is a hot spot for integration of two mobile genetic elements (MGEs): the insertion element IS1548 or the group II intron GBSi1. We studied the structure of scpB-lmb intergenic region in 111 GBS isolates belonging to the intraspecies major clonal complexes (CCs). IS1548 was mostly found (72.2%) in CC19 serotype III strains recovered more specifically (92.3%) from neonatal meningitis. GBSi1 was principally found (70.6%) in CC17 strains, mostly (94.4%) of serotype III, but also (15.7%) in CC19 strains, mostly (87.5%) of serotype II. No MGE was found in most strains of the other CCs (76.0%), notably CC23, CC10 and CC1. Twenty-six strains representing these three genetic configurations were selected to investigate the transcription and expression levels of scpB and lmb genes. Quantitative RT-PCR showed that lmb transcripts were 5.0- to 9.6-fold higher in the group of strains with IS1548 than in the other two groups of strains (P<0.001). Accordingly, the binding ability to laminin was 3.8- to 6.6-fold higher in these strains (P <= 0.001). Moreover, Lmb amount expressed on the cell surface was 2.4- to 2.7-fold greater in these strains (P<0.001). By contrast, scpB transcript levels and fibronectin binding ability were similar in the three groups of strains. Deletion of the IS1548 sequence between scpB and lmb genes in a CC19 serotype III GBS strain substantially reduced the transcription of lmb gene (13.5-fold), the binding ability to laminin (6.2-fold), and the expression of Lmb protein (5.0-fold). These data highlight the importance of MGEs in bacterial virulence and demonstrate the up-regulation of lmb gene by IS1548; the increased lmb gene expression observed in CC19 serotype III strains with IS1548 may play a role in their ability to cause neonatal meningitis and endocarditis.	[Al Safadi, Rim; Amor, Souheila; Hery-Arnaud, Genevieve; Lanotte, Philippe; Mereghetti, Laurent; Quentin, Roland; Rosenau, Agnes] Univ Tours, UFR Med, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Federatif Rech Agents Transmissibles & Infec, Tours, France; [Spellerberg, Barbara] Univ Ulm Klinikum, Inst Med Mikrobiol & Hyg, Ulm, Germany; [Gannier, Francois] Univ Tours, UFR Sci, UMR CNRS FRE Physiol Cellules Cardiaques & Vasc 3, Tours, France; [Quentin, Roland] CHRU Tours, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; Ulm University; Universite de Tours; CHU Tours	Al Safadi, R (corresponding author), Univ Tours, UFR Med, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Federatif Rech Agents Transmissibles & Infec, Tours, France.	rosenau@univ-tours.fr	Spellerberg, Barbara/D-3443-2011; Gannier, François/P-5036-2016; Gannier, François/AAD-7372-2020	Spellerberg, Barbara/0000-0001-7552-8764; Gannier, François/0000-0001-9383-7229; 	Region Centre, France [200700025461]	Region Centre, France(Region Centre-Val de Loire)	Funding: This work was supported by grant no. 200700025461 from the Region Centre, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bidet P, 2003, J INFECT DIS, V188, P1132, DOI 10.1086/378517; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bohnsack JF, 2004, EMERG INFECT DIS, V10, P1412, DOI 10.3201/eid1008.030917; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Broker G, 2004, INT J MED MICROBIOL, V294, P169, DOI 10.1016/j.ijmm.2004.06.018; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Davies HD, 2004, J INFECT DIS, V189, P1097, DOI 10.1086/382087; deFelipe FL, 1996, MOL GEN GENET, V250, P428, DOI 10.1007/s004380050095; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dmitriev A, 2004, ACTA VET BRNO, V73, P215, DOI 10.2754/avb200473020215; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gleich-Theurer U, 2009, INFECT IMMUN, V77, P3817, DOI 10.1128/IAI.00826-08; Granlund M, 1998, J INFECT DIS, V177, P967, DOI 10.1086/515233; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Hery-Arnaud G, 2005, J BACTERIOL, V187, P6248, DOI 10.1128/JB.187.17.6248-6252.2005; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kling DE, 1999, BIOTECHNIQUES, V27, P24, DOI 10.2144/99271bm03; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Luan SL, 2003, GENE, V312, P305, DOI 10.1016/S0378-1119(03)00634-6; MOREILLON P, 1999, INFECT DIS MOSBY, P501; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; PREISSNER KT, 2005, CELLULAR MICROBIOLOG, P87; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; ROGERS MB, 1994, J BACTERIOL, V176, P4376, DOI 10.1128/jb.176.14.4376-4384.1994; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; RUBENS CE, 1989, J BACTERIOL, V171, P5531, DOI 10.1128/jb.171.10.5531-5535.1989; Sambrook J., 2002, MOL CLONING LAB MANU; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Takahashi S, 2002, J INFECT DIS, V186, P1034, DOI 10.1086/342950; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Terao Y, 2002, INFECT IMMUN, V70, P993; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; YILIRIM AO, 2002, RES VET SCI, V2, P131	53	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10794	10.1371/journal.pone.0010794	http://dx.doi.org/10.1371/journal.pone.0010794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520730	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600018
J	Olsen, AW; Theisen, M; Christensen, D; Follmann, F; Andersen, P				Olsen, Anja Weinreich; Theisen, Michael; Christensen, Dennis; Follmann, Frank; Andersen, Peter			Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CD8(+) T-CELLS; OBLIGATE INTRACELLULAR PATHOGEN; TRACHOMATIS INFECTION; MYCOBACTERIUM-TUBERCULOSIS; TRACT REINFECTION; EXPRESSION LIBRARY; GAMMA-INTERFERON; IMMUNE-RESPONSE; CD4(+)	Background: The chlamydial proteins CT443 (OmcB) and CT521 (rl16) have previously been identified as human B and/or T cell targets during a chlamydial infection in humans. Here we compare the protective effector mechanism promoted by a fusion protein composed of CT521 and CT443 (CTH1) with a primary intranasal Chlamydia muridarum infection known to provide high levels of protection against a genital chlamydial challenge. Methodology/Principal Findings: The fusion protein CTH1, adjuvanted with a strong Th1 inducing cationic adjuvant (CAF01), significantly reduced the bacterial shedding compared to a control group in both a C. trachomatis Serovar D and C. muridarum challenge model. The CTH1/CAF01 vaccine was found to induce polyfunctional T cells consisting of TNF alpha/IL-2 and TNF alpha/IL-2/IFN-gamma positive cells and high titers of CTH1 specific IgG2a and IgG1. By depletion experiments the protection in the C. muridarum challenge model was demonstrated to be mediated solely by CD4(+) T cells. In comparison, an intranasal infection with C. muridarum induced a T cell response that consisted predominantly of TNF alpha/IFN-gamma co-expressing effector CD4(+) T cells and an antibody response consisting of C. muridarum specific IgG1, IgG2a but also IgA. This response was associated with a high level of protection against challenge-a protection that was only partially dependent on CD4(+) T cells. Furthermore, whereas the antibody response induced by intranasal infection was strongly reactive against the native antigens displayed in the chlamydial elementary body, only low levels of antibodies against this preparation were found after CTH1/CAF01 immunization. Conclusions/Significance: Our data demonstrate that CTH1 vaccination promotes a CD4(+) T cell dependent protective response but compared with intranasal C. muridarum infection lacks a CD4 independent protective mechanism for complete protection.	[Olsen, Anja Weinreich; Theisen, Michael; Christensen, Dennis; Follmann, Frank; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Olsen, AW (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	aol@ssi.dk; pa@ssi.dk	Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551; Follmann, Frank/0000-0002-8373-7774	Statens Serum Institut	Statens Serum Institut	The study was funded by Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; ALLEN JE, 1989, J BACTERIOL, V171, P285, DOI 10.1128/jb.171.1.285-291.1989; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Boom WH, 2003, TUBERCULOSIS, V83, P98, DOI 10.1016/S1472-9792(02)00054-9; Brandt L, 1996, J IMMUNOL, V157, P3527; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; BRUNHAM RC, 1994, INFECT AGENT DIS, V3, P218; Champion CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005409; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dooms H, 2004, J IMMUNOL, V172, P5973, DOI 10.4049/jimmunol.172.10.5973; ECDC, 2008, ANN EP REP COMM DIS; Fadel S, 2007, J MED MICROBIOL, V56, P15, DOI 10.1099/jmm.0.46801-0; Follmann F, 2008, J INFECT DIS, V197, P897, DOI 10.1086/528378; Goodall JC, 2001, EUR J IMMUNOL, V31, P1513, DOI 10.1002/1521-4141(200105)31:5<1513::AID-IMMU1513>3.0.CO;2-U; GRAYSTON JT, 1964, ARCH ENVIRON HEALTH, V8, P518, DOI 10.1080/00039896.1964.10663711; Hafner LM, 2008, FUTURE MICROBIOL, V3, P67, DOI 10.2217/17460913.3.1.67; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; IGIETSEME JU, 1994, INFECT IMMUN, V62, P5195, DOI 10.1128/IAI.62.11.5195-5197.1994; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Moore T, 2002, IMMUNOLOGY, V105, P213, DOI 10.1046/j.0019-2805.2001.01354.x; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Morrison SG, 2005, INFECT IMMUN, V73, P6183, DOI 10.1128/IAI.73.9.6183-6186.2005; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Morrison SG, 2001, INFECT IMMUN, V69, P2643, DOI 10.1128/IAI.69.4.2643-2649.2001; Murphey C, 2006, CELL IMMUNOL, V242, P110, DOI 10.1016/j.cellimm.2006.10.002; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Murthy AK, 2009, FEMS IMMUNOL MED MIC, V55, P271, DOI 10.1111/j.1574-695X.2008.00517.x; Olsen AW, 2006, J INFECT DIS, V194, P1258, DOI 10.1086/508203; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; PAL S, 1994, INFECT IMMUN, V62, P3354, DOI 10.1128/IAI.62.8.3354-3362.1994; Pal S, 2001, INFECT IMMUN, V69, P6240, DOI 10.1128/IAI.69.10.6240-6247.2001; Perry LL, 1997, J IMMUNOL, V158, P3344; Portig I, 2003, CLIN DIAGN LAB IMMUN, V10, P103, DOI 10.1128/CDLI.10.1.103-107.2003; RANK RG, 1992, INFECT IMMUN, V60, P4427, DOI 10.1128/IAI.60.10.4427-4429.1992; RANK RG, 1989, INFECT IMMUN, V57, P299, DOI 10.1128/IAI.57.1.299-301.1989; Rank RG, 1999, CHLAMYDIA, P239; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 1998, INFECT IMMUN, V66, P3618, DOI 10.1128/IAI.66.8.3618-3625.1998; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; SUN G, 2009, VACCINE; WAGAR EA, 1990, J INFECT DIS, V162, P922, DOI 10.1093/infdis/162.4.922; WANG SP, 1967, AM J OPHTHALMOL, V63, P1615, DOI 10.1016/0002-9394(67)94155-4; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Williams DM, 1996, INFECT IMMUN, V64, P3916, DOI 10.1128/IAI.64.9.3916-3919.1996; Yu H, 2009, J IMMUNOL, V182, P1602, DOI 10.4049/jimmunol.182.3.1602	58	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10768	10.1371/journal.pone.0010768	http://dx.doi.org/10.1371/journal.pone.0010768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505822	gold, Green Submitted, Green Published			2022-12-27	WOS:000278017400025
J	Hagglof, C; Hammarsten, P; Josefsson, A; Stattin, P; Paulsson, J; Bergh, A; Ostman, A				Hagglof, Christina; Hammarsten, Peter; Josefsson, Andreas; Stattin, Par; Paulsson, Janna; Bergh, Anders; Ostman, Arne			Stromal PDGFR beta Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; INHIBITION; CARCINOMA; MICROENVIRONMENT; HETEROGENEITY; CHEMOTHERAPY; TARGETS; MARKERS	Background: The identification of new prognostic markers for prostate cancer is highly warranted, since it is difficult to identify patients requiring curative treatment. Data from both experimental models and clinical samples have identified important functions of PDGFR beta on pericytes and fibroblasts in the tumor stroma. Methodology/Principal Findings: In this study the prognostic significance of PDGFRb in prostate cancer stroma, and in matched non-malignant tissue, was evaluated with immunohistochemistry. PDGFRb expression was analyzed in normal and tumor stroma from more than 300 prostate cancer patients. High PDGFR beta expression in tumor stroma was associated with large tumor size, advanced stage, high Gleason score and high vessel density. Perivascular PDGFR beta staining in tumors was also correlated with high Gleason score. Correlations were also observed between PDGFR beta status in tumor stroma and nonmalignant stroma. Similarly, high PDGFR beta expression in adjacent non-malignant tissue stroma correlated with large tumor size, advanced stage, high Gleason score and proliferation in non-malignant epithelium. Interestingly, high levels of PDGFR beta in the stroma of tumor and non-malignant tissue were associated with shorter cancer specific survival in prostate cancer patients. Conclusions/Significance: The study revealed a number of novel associations between stromal PDGFR beta expression in prostate tumors and several important clinical characteristics, including survival.	[Hagglof, Christina; Paulsson, Janna; Ostman, Arne] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hammarsten, Peter; Josefsson, Andreas; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Perioperat Sci Urol & Androl, Umea, Sweden	Karolinska Institutet; Umea University; Umea University; Umea University	Hagglof, C (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	arne.ostman@ki.se	Josefsson, Andreas/T-2311-2019	Josefsson, Andreas/0000-0002-2013-0887	Swedish Research Council; Swedish Cancer Society; Konung Gustaf V.s Jubileumsfond	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Konung Gustaf V.s Jubileumsfond	This study was funded by unrestricted grants from a Linna grant to the STARGET network from the Swedish Research Council and grants from Swedish Cancer Society and Konung Gustaf V.s Jubileumsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Fleischmann A, 2009, PROSTATE, V69, P976, DOI 10.1002/pros.20948; FORSBERG K, 1993, P NATL ACAD SCI USA, V90, P393, DOI 10.1073/pnas.90.2.393; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Johansson A, 2007, PROSTATE, V67, P1664, DOI 10.1002/pros.20657; Josefsson A, 2005, EUR UROL, V48, P577, DOI 10.1016/j.eururo.2005.05.016; Karja V, 2005, ANTICANCER RES, V25, P4435; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lissbrant IF, 2001, SCAND J UROL NEPHROL, V35, P437; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mathew P, 2009, J UROLOGY, V181, P81, DOI 10.1016/j.juro.2008.09.006; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Nupponen NN, 2008, MODERN PATHOL, V21, P265, DOI 10.1038/modpathol.3800989; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yanagisawa N, 2007, HUM PATHOL, V38, P1611, DOI 10.1016/j.humpath.2007.04.008	28	77	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10747	10.1371/journal.pone.0010747	http://dx.doi.org/10.1371/journal.pone.0010747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505768	Green Submitted, Green Published, gold			2022-12-27	WOS:000278017300018
J	Conversi, A; Umani, SF; Peluso, T; Molinero, JC; Santojanni, A; Edwards, M				Conversi, Alessandra; Umani, Serena Fonda; Peluso, Tiziana; Molinero, Juan Carlos; Santojanni, Alberto; Edwards, Martin			The Mediterranean Sea Regime Shift at the End of the 1980s, and Intriguing Parallelisms with Other European Basins	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CONTINUOUS PLANKTON RECORDS; DEEP-WATER FORMATION; LONG-TERM CHANGES; CALANUS-FINMARCHICUS; MNEMIOPSIS-LEIDYI; MARINE ECOSYSTEMS; CLIMATE INDEXES; ADRIATIC SEA; AEGEAN SEA	Background: Regime shifts are abrupt changes encompassing a multitude of physical properties and ecosystem variables, which lead to new regime conditions. Recent investigations focus on the changes in ecosystem diversity and functioning associated to such shifts. Of particular interest, because of the implication on climate drivers, are shifts that occur synchronously in separated basins. Principal Findings: In this work we analyze and review long-term records of Mediterranean ecological and hydro-climate variables and find that all point to a synchronous change in the late 1980s. A quantitative synthesis of the literature (including observed oceanic data, models and satellite analyses) shows that these years mark a major change in Mediterranean hydrographic properties, surface circulation, and deep water convection (the Eastern Mediterranean Transient). We provide novel analyses that link local, regional and basin scale hydrological properties with two major indicators of large scale climate, the North Atlantic Oscillation index and the Northern Hemisphere Temperature index, suggesting that the Mediterranean shift is part of a large scale change in the Northern Hemisphere. We provide a simplified scheme of the different effects of climate vs. temperature on pelagic ecosystems. Conclusions: Our results show that the Mediterranean Sea underwent a major change at the end of the 1980s that encompassed atmospheric, hydrological, and ecological systems, for which it can be considered a regime shift. We further provide evidence that the local hydrography is linked to the larger scale, northern hemisphere climate. These results suggest that the shifts that affected the North, Baltic, Black and Mediterranean (this work) Seas at the end of the 1980s, that have been so far only partly associated, are likely linked as part a northern hemisphere change. These findings bear wide implications for the development of climate change scenarios, as synchronous shifts may provide the key for distinguishing local (i.e., basin) anthropogenic drivers, such as eutrophication or fishing, from larger scale (hemispheric) climate drivers.	[Conversi, Alessandra; Peluso, Tiziana] Italian Natl Res Council CNR, Marine Sci Inst ISMAR, La Spezia, Italy; [Conversi, Alessandra; Edwards, Martin] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Umani, Serena Fonda] Univ Trieste, Dept Life Sci, Trieste, Italy; [Molinero, Juan Carlos] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Santojanni, Alberto] Italian Natl Res Council CNR, Marine Sci Inst ISMAR, Ancona, Italy; [Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci SAHFOS, Plymouth, Devon, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Plymouth; University of Trieste; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Istituto di Scienze Marine (ISMAR-CNR)	Conversi, A (corresponding author), Italian Natl Res Council CNR, Marine Sci Inst ISMAR, La Spezia, Italy.	a.conversi@ismar.cnr.it	Conversi, Alessandra/G-3899-2011; Fonda, Serena/H-6753-2012; CNR, Ismar/P-1247-2014	Conversi, Alessandra/0000-0002-8566-8282; CNR, Ismar/0000-0001-5351-1486; Edwards, Martin/0000-0002-5716-4714; SANTOJANNI, ALBERTO/0000-0003-4947-3004	Italian Ministry of University and Research; NERC [SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001] Funding Source: researchfish	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been supported by the Project VECTOR (VulnErability of the Italian Coastal area and marine ecosystems to climaTic changes and their rOle in the Mediterranean caRbon cycles; http://vector-conisma.geo.unimib.it/), funded by the Italian Ministry of University and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Artegiani A., 1985, NOVA THALASSIA, V7, P137; Azam F, 1999, Ann Ist Super Sanita, V35, P411; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; BEAUGRAND G, 2009, GLOBAL CHANGE BIOL, DOI DOI 10.1111/J.1365-2486.2009.01848X; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Bethoux JP, 1999, PROG OCEANOGR, V44, P131, DOI 10.1016/S0079-6611(99)00023-3; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Borzelli GLE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039261; CATALETTO B, 1995, ICES J MAR SCI, V52, P669, DOI 10.1016/1054-3139(95)80080-8; CHELTON DB, 1982, J MAR RES, V40, P1095; *CIESM, 2001, CIESM WORKSH MON, V14; COLEBROOK JM, 1984, MAR BIOL, V83, P313, DOI 10.1007/BF00397464; COLEBROOK JM, 1982, OCEANOL ACTA, V5, P473; Coll M, 2009, MAR ECOL PROG SER, V381, P17, DOI 10.3354/meps07944; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Conversi A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004763; Conversi A, 2001, DEEP-SEA RES PT II, V48, P519, DOI 10.1016/S0967-0645(00)00088-6; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; DEGOBBIS D, 1995, SCI TOTAL ENVIRON, V165, P43, DOI 10.1016/0048-9697(95)04542-9; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Demirov E, 2002, J MARINE SYST, V33, P23, DOI 10.1016/S0924-7963(02)00051-9; Demirov EK, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2005JC003174; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dippner JW, 2000, J MARINE SYST, V25, P23, DOI 10.1016/S0924-7963(00)00006-3; Drinkwater K.F., 2003, GEOPHYS MONOGR SER, V134, P211; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Fonda Umani Serena, 2008, CIESM Workshop Monographs, V35, P59; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Gertman I, 2006, J PHYS OCEANOGR, V36, P1841, DOI 10.1175/JPO2940.1; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Grbec B, 2002, CLIMATE RES, V20, P241, DOI 10.3354/cr020241; Greene CH, 2003, PROG OCEANOGR, V58, P301, DOI 10.1016/j.pocean.2003.08.009; Greene CH, 2009, SCIENCE, V324, P733, DOI 10.1126/science.1173951; Gucu AC, 2002, ESTUAR COAST SHELF S, V54, P439, DOI 10.1006/ecss.2000.0657; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hinrichsen HH, 2002, CAN J FISH AQUAT SCI, V59, P1858, DOI 10.1139/F02-149; IBANEZ F, 1993, CR ACAD SCI III-VIE, V316, P745; Josey SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001778; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; Kirby RR, 2007, MAR ECOL PROG SER, V330, P31, DOI 10.3354/meps330031; Klanjscek J, 2007, ECOL MODEL, V201, P312, DOI 10.1016/j.ecolmodel.2006.09.020; Klein B, 1999, DEEP-SEA RES PT I, V46, P371, DOI 10.1016/S0967-0637(98)00075-2; Koeller P, 2009, SCIENCE, V324, P791, DOI 10.1126/science.1170987; Korres G, 2000, J CLIMATE, V13, P732, DOI 10.1175/1520-0442(2000)013<0732:TORTLF>2.0.CO;2; Lascaratos A, 1999, PROG OCEANOGR, V44, P5, DOI 10.1016/S0079-6611(99)00019-1; Legendre P., 2012, NUMERICAL ECOLOGY; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Malanotte-Rizzoli P, 1999, DYNAM ATMOS OCEANS, V29, P365, DOI 10.1016/S0377-0265(99)00011-1; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; MedCLIVAR, 2004, WHIT PAP MED CLIM VA; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Molinero JC, 2005, LIMNOL OCEANOGR, V50, P1213, DOI 10.4319/lo.2005.50.4.1213; Molinero JC, 2008, LIMNOL OCEANOGR, V53, P1456, DOI 10.4319/lo.2008.53.4.1456; Molinero JC, 2008, GLOBAL CHANGE BIOL, V14, P11, DOI 10.1111/j.1365-2486.2007.01469.x; Niermann U., 1999, NATO Science Series Partnership Sub-Series 2 Environmental Security, V56, P147; Oguz T, 2008, J PLANKTON RES, V30, P1385, DOI 10.1093/plankt/fbn094; Oguz T, 2007, DEEP-SEA RES PT I, V54, P220, DOI 10.1016/j.dsr.2006.09.010; Oguz T, 2006, J MARINE SYST, V60, P235, DOI 10.1016/j.jmarsys.2005.11.011; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Pinardi N, 1997, GEOPHYS RES LETT, V24, P425, DOI 10.1029/96GL03952; PINARDI N, 2005, FLOODING ENV CHALLEN, P41; Precali R, 2005, SCI TOTAL ENVIRON, V353, P10, DOI 10.1016/j.scitotenv.2005.09.066; Pujol MI, 2005, J MARINE SYST, V58, P121, DOI 10.1016/j.jmarsys.2005.07.005; Quadrelli R, 2001, CLIM DYNAM, V17, P457, DOI 10.1007/s003820000121; Regner S, 1996, SCI MAR, V60, P167; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; REID PC, 2002, CHANGING STATES LARG, P27; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Rodionov S, 2005, ICES J MAR SCI, V62, P328, DOI 10.1016/j.icesjms.2005.01.013; Rodionov S., 2005, BRIEF OVERVIEW REGIM, P17, DOI DOI 10.1016/J.JDEVECO.2014.10.003; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Roether W, 1996, SCIENCE, V271, P333, DOI 10.1126/science.271.5247.333; Roether W, 2007, PROG OCEANOGR, V74, P540, DOI 10.1016/j.pocean.2007.03.001; SAMUEL SL, 1999, J GEOPHYS RES, V104, P5191; Santojanni A, 2006, CLIM RES, V31, P181, DOI 10.3354/cr031181; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tsimplis MN, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015870; Umani SF, 2007, AQUAT MICROB ECOL, V46, P163; Umani SF, 1996, SCI MAR, V60, P65; UMANI SF, 1989, GLI EPISODI MARE SPO, P3; Vignudelli S, 1999, GEOPHYS RES LETT, V26, P623, DOI 10.1029/1999GL900038; Wasmund N, 1998, J PLANKTON RES, V20, P1099, DOI 10.1093/plankt/20.6.1099; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; [No title captured]	94	131	132	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10633	10.1371/journal.pone.0010633	http://dx.doi.org/10.1371/journal.pone.0010633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502704	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400002
J	Horner, V; Proctor, D; Bonnie, KE; Whiten, A; de Waal, FBM				Horner, Victoria; Proctor, Darby; Bonnie, Kristin E.; Whiten, Andrew; de Waal, Frans B. M.			Prestige Affects Cultural Learning in Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES; WILD CHIMPANZEES; TOOL USE; TRANSMISSION; RANK; INNOVATION; STRATEGIES; BEHAVIOR; CHILDREN; SKILLS	Humans follow the example of prestigious, high-status individuals much more readily than that of others, such as when we copy the behavior of village elders, community leaders, or celebrities. This tendency has been declared uniquely human, yet remains untested in other species. Experimental studies of animal learning have typically focused on the learning mechanism rather than on social issues, such as who learns from whom. The latter, however, is essential to understanding how habits spread. Here we report that when given opportunities to watch alternative solutions to a foraging problem performed by two different models of their own species, chimpanzees preferentially copy the method shown by the older, higher-ranking individual with a prior track-record of success. Since both solutions were equally difficult, shown an equal number of times by each model and resulted in equal rewards, we interpret this outcome as evidence that the preferred model in each of the two groups tested enjoyed a significant degree of prestige in terms of whose example other chimpanzees chose to follow. Such prestige-based cultural transmission is a phenomenon shared with our own species. If similar biases operate in wild animal populations, the adoption of culturally transmitted innovations may be significantly shaped by the characteristics of performers.	[Horner, Victoria; Proctor, Darby; de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Lawrenceville, GA USA; [Bonnie, Kristin E.] Beloit Coll, Dept Psychol, Beloit, WI 53511 USA; [Whiten, Andrew] Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9AJ, Fife, Scotland	Emory University; Beloit College; University of St Andrews	Horner, V (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Lawrenceville, GA USA.	vhorner@emory.edu	Proctor, Darby/AAB-2749-2019	Proctor, Darby/0000-0002-5465-6705; Whiten, Andrew/0000-0003-2426-5890	Living Links Center of Emory University; Emory University's College of Arts Sciences; National Institutes of Health [RR-00165]; Royal Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Living Links Center of Emory University; Emory University's College of Arts Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Living Links Center of Emory University, Emory University's College of Arts & Sciences, and by a base grant from the National Institutes of Health (RR-00165) to Yerkes National Primate Research Center (YNPRC). A. Whiten was supported by a Royal Society Leverhulme Trust Senior Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKOW JH, 1975, CURR ANTHROPOL, V16, P553, DOI 10.1086/201619; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; BOESCH C, 1995, INT J PRIMATOL, V16, P1, DOI 10.1007/BF02700150; Boesch C, 1998, CURR ANTHROPOL, V39, P591, DOI 10.1086/204785; Boesch C, 2007, J COMP PSYCHOL, V121, P227, DOI 10.1037/0735-7036.121.3.227; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; de Waal FBM, 2001, APE SUSHI MASTER; De Waal FBM, 2008, SCIENCE, V319, P569, DOI 10.1126/science.319.5863.569c; Durham WH., 1991, COEVOLUTION GENES CU; Goodall J., 1963, S ZOOL SOC LOND, V10, P39; GOODALL J, 1973, PRECULTURAL PRIMATE, V1; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Horner V, 2010, MIND CHIMPANZEE; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Laland KN, 2004, LEARN BEHAV, V32, P4; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; MENZEL EWJ, 1973, PRECULTURAL PRIMATE; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; Ottoni EB, 2005, ANIM COGN, V8, P215, DOI 10.1007/s10071-004-0245-8; Pongracz P, 2008, ANIM COGN, V11, P75, DOI 10.1007/s10071-007-0090-7; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	34	113	113	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10625	10.1371/journal.pone.0010625	http://dx.doi.org/10.1371/journal.pone.0010625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502702	gold, Green Published, Green Submitted			2022-12-27	WOS:000277845400001
J	Li, J; Ribeiro, JMC; Yan, GY				Li, Jun; Ribeiro, Jose M. C.; Yan, Guiyun			Allelic Gene Structure Variations in Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE SURVEY; MESSENGER-RNA; AB-INITIO; SEQUENCE; PREDICTION; EXON; REFRACTORINESS; IDENTIFICATION; ISOFORMS	Background: Allelic gene structure variations and alternative splicing are responsible for transcript structure variations. More than 75% of human genes have structural isoforms of transcripts, but to date few studies have been conducted to verify the alternative splicing systematically. Methodology/Principal Findings: The present study used expressed sequence tags (ESTs) and EST tagged SNP patterns to examine the transcript structure variations resulting from allelic gene structure variations in the major human malaria vector, Anopheles gambiae. About 80% of 236,004 available A. gambiae ESTs were successfully aligned to A. gambiae reference genomes. More than 2,340 transcript structure variation events were detected. Because the current A. gambiae annotation is incomplete, we re-annotated the A. gambiae genome with an A. gambiae-specific gene model so that the effect of variations on gene coding could be better evaluated. A total of 15,962 genes were predicted. Among them, 3,873 were novel genes and 12,089 were previously identified genes. The gene completion rate improved from 60% to 84%. Based on EST support, 82.5% of gene structures were predicted correctly. In light of the new annotation, we found that similar to 78% of transcript structure variations were located within the coding sequence (CDS) regions, and >65% of variations in the CDS regions have the same open-reading-frame. The association between transcript structure isoforms and SNPs indicated that more than 28% of transcript structure variation events were contributed by different gene alleles in A. gambiae. Conclusions/Significance: We successfully expanded the A. gambiae genome annotation. We predicted and analyzed transcript structure variations in A. gambiae and found that allelic gene structure variation plays a major role in transcript diversity in this important human malaria vector.	[Li, Jun] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Ribeiro, Jose M. C.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine	Li, J (corresponding author), Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA.	junli@umn.edu		Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health [R56AI081829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, R56AI081829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by a grant from the National Institutes of Health (R56AI081829 to Jun Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; ESTES PA, 1992, J BIOL CHEM, V267, P14902; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Gorman MJ, 1997, GENETICS, V146, P965; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kriventseva EV, 2005, GENOME RES, V15, P893, DOI 10.1101/gr.3756405; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Malko DB, 2006, GENOME RES, V16, P505, DOI 10.1101/gr.4236606; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Menge DM, 2006, GENETICS, V173, P235, DOI 10.1534/genetics.105.055129; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RIBEIRO JMC, 2007, ANOGOLD; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; Schlueter SD, 2003, NUCLEIC ACIDS RES, V31, P3597, DOI 10.1093/nar/gkg533; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Swart EC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-8; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; WANG Z, 2008, SPLICING REGULATION; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	41	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10699	10.1371/journal.pone.0010699	http://dx.doi.org/10.1371/journal.pone.0010699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502664	gold, Green Published, Green Submitted			2022-12-27	WOS:000277845400009
J	Bhaskaran, MD; Smith, BN				Bhaskaran, Muthu D.; Smith, Bret N.			Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							CA1 PYRAMIDAL CELLS; KAINIC ACID; HIPPOCAMPAL SLICES; MOSSY FIBERS; SYNAPTIC REORGANIZATION; GABAERGIC INTERNEURONS; SPONTANEOUS SEIZURES; NEUROPEPTIDE-Y; GRANULE CELLS; RECEPTOR	Temporal lobe epilepsy (TLE) is a neurological condition associated with neuron loss, axon sprouting, and hippocampal sclerosis, which results in modified synaptic circuitry. Cannabinoids appear to be anti-convulsive in patients and animal models of TLE, but the mechanisms of this effect are not known. A pilocarpine-induced status epilepticus mouse model of TLE was used to study the effect of cannabinoid agonists on recurrent excitatory circuits of the dentate gyrus using electrophysiological recordings in hippocampal slices isolated from control mice and mice with TLE. Cannabinoid agonists WIN 55,212-2, anandamide (AEA), or 2-arachydonoylglycerol (2-AG) reduced the frequency of spontaneous and tetrodotoxin-resistant excitatory postsynaptic currents (EPSCs) in mice with TLE, but not in controls. WIN 55,212-2 also reduced the frequency of EPSCs evoked by glutamate-photolysis activation of other granule cells in epileptic mice. Secondary population discharges evoked after antidromic electrical stimulation of mossy fibers in the hilus were also attenuated by cannabinoid agonists. Agonist effects were blocked by the cannabinoid type 1 receptor (CB1R) antagonist AM251. No change in glutamate release was observed in slices from mice that did not undergo status epilepticus. Western blot analysis suggested an up-regulation of CB1R in the dentate gyrus of animals with TLE. These findings indicate that activation of CB1R present on nerve terminals can suppress recurrent excitation in the dentate gyrus of mice with TLE. This suggests a mechanism for the anti-convulsive role of cannabinoids aimed at modulating receptors on synaptic terminals expressed de novo after epileptogenesis.	[Bhaskaran, Muthu D.; Smith, Bret N.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Bhaskaran, Muthu D.; Smith, Bret N.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	University of Kentucky; Tulane University	Bhaskaran, MD (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	bret.smith@uky.edu			National Institutes of Health [R21 NS052302]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from National Institutes of Health (R21 NS052302) and the Epilepsy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baker D, 2003, EXPERT OPIN INV DRUG, V12, P561; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BHASKARAN M, 2010, EXP NEUROL; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Braakman H, 2009, EPILEPSIA, V50, P129; BUCKMASTER PS, 1992, HIPPOCAMPUS, V2, P349, DOI 10.1002/hipo.450020403; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chen J, 2007, SHOCK, V27, P58; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; CRONIN J, 1988, BRAIN RES, V474, P181, DOI 10.1016/0006-8993(88)90681-6; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; Epsztein J, 2005, J NEUROSCI, V25, P8229, DOI 10.1523/JNEUROSCI.1469-05.2005; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; HOUSER CR, 1990, J NEUROSCI, V10, P267; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lynch M, 2000, J NEUROPHYSIOL, V83, P693, DOI 10.1152/jn.2000.83.2.693; Magloczky Z, 2000, NEUROSCIENCE, V96, P7, DOI 10.1016/S0306-4522(99)00474-1; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATHERN GW, 1995, J NEUROSCI, V15, P3990; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; NADLER JV, 1980, BRAIN RES, V182, P1; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nakajima S, 1991, Hippocampus, V1, P67, DOI 10.1002/hipo.450010107; Patrylo PR, 1998, J NEUROPHYSIOL, V79, P418, DOI 10.1152/jn.1998.79.1.418; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Smith BN, 1997, NEUROSCI LETT, V222, P1, DOI 10.1016/S0304-3940(97)13326-2; Smith BN, 2002, J NEUROPHYSIOL, V87, P1655, DOI 10.1152/jn.00581.2001; Smith BN, 2001, J NEUROPHYSIOL, V85, P1, DOI 10.1152/jn.2001.85.1.1; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Tu B, 2005, J NEUROSCI, V25, P1718, DOI 10.1523/JNEUROSCI.4835-04.2005; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Winokur RS, 2004, EPILEPSY RES, V58, P93, DOI 10.1016/j.eplepsyres.2004.01.002; Wuarin JP, 1996, J NEUROSCI, V16, P4438; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Zhu ZQ, 1997, J NEUROPATH EXP NEUR, V56, P988, DOI 10.1097/00005072-199709000-00004	64	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10683	10.1371/journal.pone.0010683	http://dx.doi.org/10.1371/journal.pone.0010683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498848	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700019
J	Tolimieri, N; Anderson, MJ				Tolimieri, Nick; Anderson, Marti J.			Taxonomic Distinctness of Demersal Fishes of the California Current: Moving Beyond Simple Measures of Diversity for Marine Ecosystem-Based Management	PLOS ONE			English	Article							LARGE-SCALE PATTERNS; GROUNDFISH ASSEMBLAGES; SPECIES-DIVERSITY; COMMUNITY DIVERSITY; BIODIVERSITY; SEA; HABITATS; RICHNESS; HOTSPOTS; AREAS	Background: Large-scale patterns or trends in species diversity have long interested ecologists. The classic pattern is for diversity (e. g., species richness) to decrease with increasing latitude. Taxonomic distinctness is a diversity measure based on the relatedness of the species within a sample. Here we examined patterns of taxonomic distinctness in relation to latitude (ca. 32-48 degrees N) and depth (ca. 50-1220 m) for demersal fishes on the continental shelf and slope of the US Pacific coast. Methodology/Principal Findings: Both average taxonomic distinctness (AvTD) and variation in taxonomic distinctness (VarTD) changed with latitude and depth. AvTD was highest at approximately 500 m and lowest at around 200 m bottom depth. Latitudinal trends in AvTD were somewhat weaker and were depth-specific. AvTD increased with latitude on the shelf (50-150 m) but tended to decrease with latitude at deeper depths. Variation in taxonomic distinctness (VarTD) was highest around 300 m. As with AvTD, latitudinal trends in VarTD were depth-specific. On the shelf (50-150 m), VarTD increased with latitude, while in deeper areas the patterns were more complex. Closer inspection of the data showed that the number and distribution of species within the class Chondrichthyes were the primary drivers of the overall patterns seen in AvTD and VarTD, while the relatedness and distribution of species in the order Scorpaeniformes appeared to cause the relatively low observed values of AvTD at around 200 m. Conclusions/Significance: These trends contrast to some extent the patterns seen in earlier studies for species richness and evenness in demersal fishes along this coast and add to our understanding of diversity of the demersal fishes of the California Current.	[Tolimieri, Nick] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [Anderson, Marti J.] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand	National Oceanic Atmospheric Admin (NOAA) - USA; Massey University	Tolimieri, N (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA USA.	nick.tolimieri@noaa.gov	Anderson, Marti J./AAQ-9038-2021	Anderson, Marti J./0000-0002-4018-4049	NOAA Fisheries (Northwest Fisheries Science Center); Royal Society of New Zealand Marsden [MAU0713]	NOAA Fisheries (Northwest Fisheries Science Center)(National Oceanic Atmospheric Admin (NOAA) - USA); Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported in part by NOAA Fisheries (Northwest Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M.J. Anderson was partially supported by a Royal Society of New Zealand Marsden Grant, no. MAU0713 and also by a Research Associateship from the US National Research Council, through C. Jordan at NOAA.	Arvanitidis C, 2009, MAR ECOL PROG SER, V382, P265, DOI 10.3354/meps07955; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Builder-Ramsey T, 2002, NMFSNWFSC55 NOAA US; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cowling RM, 1995, BIODIVERSITY LETT, V2, P127; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAITH DP, 1994, PHILOS T R SOC B, V345, P45, DOI 10.1098/rstb.1994.0085; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gorley C.K., 2006, GETTING STARTED PRIM; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; Guo Y, 2001, J MAR BIOL ASSOC UK, V81, P755, DOI 10.1017/S0025315401004568; Hastie T., 1999, GEN ADDITIVE MODELS; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HORN MH, 1978, J BIOGEOGR, V5, P23, DOI 10.2307/3038105; Horn MH, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P3; Jagielo T, 2003, FISH B-NOAA, V101, P545; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2007, 2003 US W COAST BOTT; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Levin PS, 2002, AM SCI, V90, P6, DOI 10.1511/2002.1.6; Love M. S., 2002, ROCKFISHES NE PACIFI; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; MERRETT NR, 1994, ENVIRON BIOL FISH, V41, P207, DOI 10.1007/BF02197846; MURRAY SN, 1981, J BIOGEOGR, V8, P339, DOI 10.2307/2844755; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NEWELL IRWIN M., 1948, PROC AMER PHIL SOC, V92, P155; PEARCY W G, 1982, Biological Oceanography, V1, P375; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rogers SI, 1999, J ANIM ECOL, V68, P769, DOI 10.1046/j.1365-2656.1999.00327.x; Rogers SI, 2008, MAR POLLUT BULL, V56, P880, DOI 10.1016/j.marpolbul.2008.01.035; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Somerfield PJ, 2008, ICES J MAR SCI, V65, P1462, DOI 10.1093/icesjms/fsn118; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wildsmith MD, 2009, MAR POLLUT BULL, V58, P1250, DOI 10.1016/j.marpolbul.2009.06.008; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WILLIG RM, 2000, ENCY BIODIVERSITY, P701; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	73	51	55	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10653	10.1371/journal.pone.0010653	http://dx.doi.org/10.1371/journal.pone.0010653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498727	gold, Green Submitted, Green Published			2022-12-27	WOS:000277773700006
J	Yu, JJ; Fu, PF; Pink, JJ; Dawson, D; Wasman, J; Orem, J; Mwanda, WO; Zhu, HL; Liang, XB; Guo, Y; Petros, WP; Mitsuyasu, RT; Wabinga, H; Remick, SC				Yu, Jing Jie; Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay; Orem, Jackson; Mwanda, Walter O.; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Mitsuyasu, Ronald T.; Wabinga, Henry; Remick, Scot C.			HPV Infection and EGFR Activation/Alteration in HIV-Infected East African Patients with Conjunctival Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS TYPE-16; GROWTH-FACTOR RECEPTOR; CERVICAL-CANCER; LUNG-CANCER; E5 GENE; EXPRESSION; UGANDA; HEAD; NECK	Background: There has been substantial growth in the numbers of patients with conjunctival squamous cell carcinoma infected with HIV in East Africa. The natural history of the conjunctival squamous cell carcinoma appears to be unique in this region of the world, but the etiologic mechanism unclear and therapeutic options limited. This research was carried out to determine if conjunctival squamous cell carcinoma harbors human papillomavirus DNA and is associated with activation of the EGFR signaling pathway. Positive findings would identify etiologic causes and provide clinical guidance to improve treatment. Methods/Findings: Expression of p-MAPK/MAPK, p-Akt/Akt and p-EGFR/EGFR in cell nuclei and cytoplasm of 38 FFPE specimens were assessed by immunohistochemistry; HPV genotype was detected by qPCR assay; EGFR mutation was assessed by DNA sequencing analysis; and EGFR mRNA expression was measured using relative qPCR. Statistical analyses included two-sided Fisher exact test or chi-square test, Spearman correlation coefficient and ANOVA. HPV 18 was found in 61% of samples, with HPV 16 double-genotype in 6 patients (16%). Immunohistochemistry and qPCR data suggest that activation and expression of the EGFR signaling pathway is related to disease progression of conjunctival cancer. The associations between cytoplasmic p-MAPK, cytoplasmic p-Akt and tumor invasiveness were significant (p = 0.05 or 0.028). Nuclear p-EGFR appeared only in invasive tumors. A significant positive association between EGFR expression and disease invasiveness was observed (p = 0.01). A SNP in 10 patients and one missense mutation were found within EGFR tyrosine kinase domain. Statistical analysis indicates that patients with measurable EGFR expression more likely harbor EGFR mutations, compared to those with negative EGFR expression 935.3% vs. 0%). Conclusions/Significance: We conclude that HPV types 16/18 infection is frequent in East African patients with AIDS-associated squamous cell carcinoma of the conjunctiva. EGFR activation/alteration may contribute to and sustain the high prevalence of this cancer. Our findings hint that adoption of HPV vaccination strategies may impact the incidence of conjunctival carcinoma. Agents that target the EGFR pathway may have potential therapeutic benefit.	[Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Pharm, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mol Med Core Facil, Sch Med, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Yu, Jing Jie; Zhu, Honglan; Liang, Xiaobing; Guo, Yi; Petros, William P.; Remick, Scot C.] W Virginia Univ, Mol Med Core Facil, Sch Pharm, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Med, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Ctr AIDS Res, Dept Pathol, Cleveland, OH 44106 USA; [Fu, Pingfu; Pink, John J.; Dawson, Dawn; Wasman, Jay] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Orem, Jackson] Makerere Univ, Uganda Canc Inst, Sch Med, Kampala, Uganda; [Wabinga, Henry] Makerere Univ, Dept Pathol, Sch Med, Kampala, Uganda; [Mwanda, Walter O.] Univ Nairobi, Kenyatta Natl Hosp, Dept Pathol, Nairobi, Kenya; [Mitsuyasu, Ronald T.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Makerere University; Kenyatta National Hospital; University of Nairobi; University of California System; University of California Los Angeles	Yu, JJ (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA.	jyu@hsc.wvu.edu	Fu, Pingfu/O-5415-2019	Fu, Pingfu/0000-0002-2334-5218	National Institutes of Health [CA70091, CA43703, CA70081, CA121947, P30 CA43703]; NATIONAL CANCER INSTITUTE [T32CA070091, P30CA043703, U01CA070081, U01CA121947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA70091, CA43703, CA70081, CA121947 and P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar LV, 2006, SEX TRANSM INFECT, V82, P31, DOI 10.1136/sti.2005.015131; ATEENYIAGABA C, 1995, LANCET, V345, P695, DOI 10.1016/S0140-6736(95)90870-6; Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690; Bertelsen BI, 2006, VIRCHOWS ARCH, V449, P141, DOI 10.1007/s00428-006-0232-3; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cheng YH, 2007, COMM COM INF SC, V2, P1; de Koning Maurits Nc, 2008, Infect Agent Cancer, V3, P12, DOI 10.1186/1750-9378-3-12; Ferenczy A, 2002, LANCET ONCOL, V3, P11, DOI 10.1016/S1470-2045(01)00617-9; Gillison ML, 2006, J CLIN ONCOL, V24, P5623, DOI 10.1200/JCO.2006.07.1829; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Grunwald V, 2003, JNCI-J NATL CANCER I, V95, P851, DOI 10.1093/jnci/95.12.851; GU ZM, 1995, J VIROL, V69, P8051, DOI 10.1128/JVI.69.12.8051-8056.1995; Ha PK, 2002, CLIN CANCER RES, V8, P1203; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kenny D, 2002, J HISTOCHEM CYTOCHEM, V50, P1219, DOI 10.1177/002215540205000909; Kohrenhagen N, 2008, J OBSTET GYNAECOL RE, V34, P293, DOI 10.1111/j.1447-0756.2008.00749.x; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Moubayed P, 2004, AM J CLIN PATHOL, V122, P938, DOI [10.1309/T189UWWVB71M9VRC, 10.1309/T189UwVVVB71M9VRC]; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Newton R, 2002, BRIT J CANCER, V87, P301, DOI 10.1038/sj.bjc.6600451; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PIM D, 1992, ONCOGENE, V7, P27; Sanclemente G, 2002, J EUR ACAD DERMATOL, V16, P231, DOI 10.1046/j.1473-2165.2002.00419.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shepler TR, 2006, OPHTHAL PLAST RECONS, V22, P113, DOI 10.1097/01.iop.0000202609.92772.c3; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; Waddell KM, 1996, BRIT J OPHTHALMOL, V80, P503, DOI 10.1136/bjo.80.6.503; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	31	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10477	10.1371/journal.pone.0010477	http://dx.doi.org/10.1371/journal.pone.0010477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498858	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700001
J	Cohen, J; Dibner, MS; Wilson, A				Cohen, Joshua; Dibner, Maria Staroselsky; Wilson, Andrew			Development of and Access to Products for Neglected Diseases	PLOS ONE			English	Article							DRUG DEVELOPMENT; MARKET	Introduction: Prior research on neglected disease drug development suggested inadequate funding was responsible for relatively few new approvals. In response, significantly more resources have been allocated towards development of drugs targeting neglected diseases. Our objective was to reassess drug development between1975 and 1999, evaluate progress in neglected disease drug development since 2000, and explain how increased numbers of approvals are a necessary but insufficient condition to improving access. Methods: To assess numbers of approvals targeting neglected diseases, we employed two distinct methodologies: First, to revisit numbers published in Trouiller et al. (2002) we used their method to count marketed new chemical entities (NCEs) between 1975 and 1999. Second, using the G-Finder report as a benchmark, we identified which diseases are currently considered "neglected'' to tally approvals in the 1975-1999 and 2000-2009 periods. Searching PharmaProjects and IMS R&D Focus databases as well as websites from numerous drug regulatory agencies, we identified new drug approvals and indications. Also, we examined the World Health Organization's (WHO) Essential Drug List (EDL) to see which drugs and indications were on the list. Findings: Upon recount, using Trouiller et al. methodology, we found that between 1975 and 1999 more NCEs (n = 32) targeting tropical diseases and tuberculosis were approved than reported in Trouiller et al. (n = 16). Using the G-Finder method of defining neglected diseases, we found 46 new drug approvals between 1975 and 1999. WHO included 85% of these drugs on the EDL. In the period 2000 to May 2009, despite much greater funding, only 26 new drugs and vaccines for neglected diseases were marketed. Of these, WHO placed 50% on the EDL. Conclusions: Product approvals for neglected diseases have increased, though progress has been uneven, with malaria appearing to benefit most in the short run from increased funding, while less success has been booked in other disease categories. Uneven progress suggests funding could be better targeted, particularly with regard to neglected diseases that have hitherto received scant attention. In addition, policymakers should focus on other aspects related to access. Besides drug development, there are the issues of EDL listing, architecture, availability, affordability, and adoption.	[Cohen, Joshua; Wilson, Andrew] Tufts Univ, Ctr Study Drug Dev, Boston, MA 02111 USA; [Dibner, Maria Staroselsky] Lahey Clin Fdn, Dept Med, Burlington, MA USA	Tufts University; Lahey Hospital & Medical Center	Cohen, J (corresponding author), Tufts Univ, Ctr Study Drug Dev, Boston, MA 02111 USA.	joshua.cohen@tufts.edu						Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Dentzer S, 2009, HEALTH AFFAIR, V28, pW411, DOI 10.1377/hlthaff.28.3.w411; Fehr A, 2006, TROP MED INT HEALTH, V11, P1335, DOI 10.1111/j.1365-3156.2006.01714.x; Frost LJ, 2009, HEALTH AFFAIR, V28, P962, DOI 10.1377/hlthaff.28.4.962; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; REICH M, 2008, ACCESS DO GOOD TECHN; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Trouiller P, 2001, TROP MED INT HEALTH, V6, P945, DOI 10.1046/j.1365-3156.2001.00803.x; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; WHO Model List of Essential Medicines, 2007, WHO MOD LIST ESS MED; REVISED PROCEDURES U; ENSURING SUCCESS TAR; 2009, ECONOMIST       0515	15	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10610	10.1371/journal.pone.0010610	http://dx.doi.org/10.1371/journal.pone.0010610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485552	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563400015
J	Wada, M; Higo, N; Moizumi, S; Kitazawa, S				Wada, Makoto; Higo, Noriyuki; Moizumi, Shunjiro; Kitazawa, Shigeru			c-Fos Expression during Temporal Order Judgment in Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; MEDIAL PREFRONTAL CORTEX; IN-SITU HYBRIDIZATION; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; MESSENGER-RNAS; TRANSCRIPTION FACTORS; SELF-STIMULATION; TIME PERCEPTION; MACAQUE MONKEY	The neuronal mechanisms for ordering sensory signals in time still need to be clarified despite a long history of research. To address this issue, we recently developed a behavioral task of temporal order judgment in mice. In the present study, we examined the expression of c-Fos, a marker of neural activation, in mice just after they carried out the temporal order judgment task. The expression of c-Fos was examined in C57BL/6N mice (male, n = 5) that were trained to judge the order of two air-puff stimuli delivered bilaterally to the right and left whiskers with stimulation intervals of 50-750 ms. The mice were rewarded with a food pellet when they responded by orienting their head toward the first stimulus (n = 2) or toward the second stimulus (n = 3) after a visual "go'' signal. c-Fos-stained cell densities of these mice (test group) were compared with those of two control groups in coronal brain sections prepared at bregma -2, -1, 0, +1, and +2 mm by applying statistical parametric mapping to the c-Fos immuno-stained sections. The expression of c-Fos was significantly higher in the test group than in the other groups in the bilateral barrel fields of the primary somatosensory cortex, the left secondary somatosensory cortex, the dorsal part of the right secondary auditory cortex. Laminar analyses in the primary somatosensory cortex revealed that c-Fos expression in the test group was most evident in layers II and III, where callosal fibers project. The results suggest that temporal order judgment involves processing bilateral somatosensory signals through the supragranular layers of the primary sensory cortex and in the multimodal sensory areas, including marginal zone between the primary somatosensory cortex and the secondary sensory cortex.	[Wada, Makoto; Moizumi, Shunjiro; Kitazawa, Shigeru] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Wada, Makoto; Kitazawa, Shigeru] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Wada, Makoto; Higo, Noriyuki; Kitazawa, Shigeru] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan; [Wada, Makoto] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Sensory Funct, Cognit Funct Sect, Tokorozawa, Saitama, Japan	Juntendo University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Wada, M (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan.	m-wada@juntendo.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Japan Society for the Promotion of Science [18200024, 21240029]; Industry-University Joint Research from Agency of Japan Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Industry-University Joint Research from Agency of Japan Science and Technology	This study was supported in part by Grants-in-Aid for Scientific Research (A) (#18200024; #21240029) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to S. K. and Industry-University Joint Research from Agency of Japan Science and Technology (http://www.jst.go.jp/EN/index.html) to M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitogiannis A, 2000, BEHAV BRAIN RES, V107, P123, DOI 10.1016/S0166-4328(99)00120-5; Boguszewski P, 2005, ACTA NEUROBIOL EXP, V65, P191; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brown CE, 2005, J COMP NEUROL, V486, P48, DOI 10.1002/cne.20522; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; DENNET DC, 1992, BEHAV BRAIN SCI, P183; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2005, NAT NEUROSCI, V8, P850, DOI 10.1038/nn0705-850; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; Filipkowski RK, 2000, LEARN MEMORY, V7, P116, DOI 10.1101/lm.7.2.116; HAMLIN AJ, 1994, AM J PSYCHOL, P564; Higo N, 2003, J COMP NEUROL, V467, P135, DOI 10.1002/cne.10850; Higo N, 1998, HIPPOCAMPUS, V8, P533, DOI 10.1002/(SICI)1098-1063(1998)8:5<533::AID-HIPO11>3.0.CO;2-#; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Hirokawa J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003266; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; Hu ZL, 2003, J NEUROSCI, V23, P10963; Hunt GE, 1998, NEUROSCIENCE, V83, P501, DOI 10.1016/S0306-4522(97)00409-0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; INNOCENTI GM, 1984, CEREB CORTEX, P291; JONES EG, 1994, J NEUROSCI, V14, P611; Lee YI, 1998, NEUROREPORT, V9, P2733, DOI 10.1097/00001756-199808240-00009; MACK KJ, 1992, MOL BRAIN RES, V12, P141, DOI 10.1016/0169-328X(92)90077-O; Mead AN, 1999, EUR J NEUROSCI, V11, P4089, DOI 10.1046/j.1460-9568.1999.00828.x; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Melzer P, 1997, J COMP NEUROL, V380, P145, DOI 10.1002/(SICI)1096-9861(19970331)380:1<145::AID-CNE11>3.0.CO;2-Z; MENZEL RR, 2005, CEREB CORTEX; MEUNIER M, 1991, BEHAV BRAIN RES, V44, P133, DOI 10.1016/S0166-4328(05)80018-X; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nagahara AH, 1997, NEUROBIOL AGING, V18, P45, DOI 10.1016/S0197-4580(96)00166-2; Nicholls M E, 1996, Laterality, V1, P97; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Nordquist RE, 2003, BEHAV BRAIN RES, V146, P65, DOI 10.1016/j.bbr.2003.09.014; Panagis G, 1997, NEUROSCIENCE, V77, P175, DOI 10.1016/S0306-4522(96)00471-X; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sakata S, 2002, EUR J NEUROSCI, V15, P735, DOI 10.1046/j.1460-9568.2002.01905.x; Schochet TL, 2005, NEUROSCIENCE, V135, P285, DOI 10.1016/j.neuroscience.2005.05.057; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shibuya S, 2007, EXP BRAIN RES, V179, P709, DOI 10.1007/s00221-006-0829-4; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Wada M, 2005, BEHAV BRAIN RES, V157, P167, DOI 10.1016/j.bbr.2004.06.026; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; WADA M, 2004, SOC NEUR ABST; WADA M, 2009, BEHAV BRAIN RES; Wada M, 2006, NEUROSCI RES, V56, P96, DOI 10.1016/j.neures.2006.05.013; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wedzony K, 2003, N-S ARCH PHARMACOL, V368, P331, DOI 10.1007/s00210-003-0811-7; Yamamoto S, 2005, J NEUROPHYSIOL, V93, P2856, DOI 10.1152/jn.01015.2004; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Yamamoto S, 2001, NAT NEUROSCI, V4, P979, DOI 10.1038/nn721	59	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10483	10.1371/journal.pone.0010483	http://dx.doi.org/10.1371/journal.pone.0010483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463958	gold, Green Submitted, Green Published			2022-12-27	WOS:000277379400019
J	Bergstad, OA; Gjelsvik, G; Schander, C; Hoines, AS				Bergstad, Odd Aksel; Gjelsvik, Guro; Schander, Christoffer; Hoines, Age S.			Feeding Ecology of Coryphaenoides rupestris from the Mid-Atlantic Ridge	PLOS ONE			English	Article							MIDOCEAN RIDGE; FISHES; DEEP; PREY; STRATEGIES; PATTERNS	The Macrourid fish roundnose grenadier, Coryphaenoides rupestris, is one of the most common benthopelagic fishes on the northern mid-Atlantic Ridge. The ecology of the species is comparatively well studied in continental slope waters of the North Atlantic, but not on the mid-Atlantic Ridge, which is a central mid-ocean area of its distribution. In total, 166 specimens from the RV G.O. Sars cruise in July 2004 were examined. The diet mainly comprised cephalopods, pelagic shrimps and fish. Pelagic and benthopelagic copepods were the most numerous prey, but did not contribute much on a weight basis. Cephalopods were by far the most important prey of the small grenadiers, while shrimps and fish became increasingly significant with increasing size. Previous studies from other areas have also found pelagic prey to be important, but in contrast to this study, cephalopods were generally of less importance. The study was an element of more wide-ranging food-web studies of the mid-Atlantic Ridge macro-and megafauna communities within the international MAR-ECO project.	[Bergstad, Odd Aksel] Inst Marine Res, Arendal, Norway; [Gjelsvik, Guro] Norwegian Directorate Fisheries, Bergen, Norway; [Schander, Christoffer] Univ Bergen, Dept Biol, Bergen, Norway; [Schander, Christoffer] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Hoines, Age S.] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; University of Bergen; University of Bergen; Institute of Marine Research - Norway	Bergstad, OA (corresponding author), Inst Marine Res, Arendal, Norway.	oddaksel@imr.no		Bergstad, Odd Aksel/0000-0002-4096-0896	Institute of Marine Research, University of Bergen	Institute of Marine Research, University of Bergen	The study was funded by the institutions with which the senior authors are affiliated (Institute of Marine Research, University of Bergen). The institutions provided facilities and salaries, but were otherwise not involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad O. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P165; BERGSTAD OA, 1990, NETH J SEA RES, V25, P237, DOI 10.1016/0077-7579(90)90025-C; Bergstad OA, 2002, OCEANOL ACTA, V25, P219, DOI 10.1016/S0399-1784(02)01203-3; Bergstad OA, 2008, AM FISH S S, V63, P65; Clarke M.R, 1986, HDB IDENTIFICATION C; GARRISON T, 2002, OCEANOGRAPHY INVITAT; GEISTDOERFER P, 1986, FISHES N E ATLANTIC, V1, P644; HAEDRICH RL, 1988, J NAT HIST, V22, P1325, DOI 10.1080/00222938800770811; HAEDRICH RL, 1974, DEEP-SEA RES, V21, P977, DOI 10.1016/0011-7471(74)90030-8; JORGENSEN O, 1991, 50 NW ATL FISH ORG; Jorgensen Ole A., 1996, Journal of Northwest Atlantic Fishery Science, V18, P7; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MAUCHLINE J, 1984, MAR BIOL, V81, P107, DOI 10.1007/BF00393109; MCLELLAN T, 1977, DEEP-SEA RES, V24, P1019, DOI 10.1016/0146-6291(77)90572-0; PECHENICK LN, 1977, 5977 ISR PROGR SCI T; PODRAZHANSKAYA SG, 1971, 7189 INT COMM NW ATL; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TROYANOVSKY FM, 1995, NATO ASI SERIES E, V296, P357; Vecchione M, 2010, MAR BIOL RES, V6, P25, DOI 10.1080/17451000902810751; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017	24	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10453	10.1371/journal.pone.0010453	http://dx.doi.org/10.1371/journal.pone.0010453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454674	Green Published, Green Accepted, gold			2022-12-27	WOS:000277240300024
J	Bradshaw, CJA; Giam, X; Sodhi, NS				Bradshaw, Corey J. A.; Giam, Xingli; Sodhi, Navjot S.			Evaluating the Relative Environmental Impact of Countries	PLOS ONE			English	Article							BIODIVERSITY; MARINE; CARBON; SUSTAINABILITY; DEFORESTATION; DEMOCRACY; FORESTS; CRISIS; FORCES; EXTENT	Environmental protection is critical to maintain ecosystem services essential for human well-being. It is important to be able to rank countries by their environmental impact so that poor performers as well as policy 'models' can be identified. We provide novel metrics of country-specific environmental impact ranks - one proportional to total resource availability per country and an absolute (total) measure of impact - that explicitly avoid incorporating confounding human health or economic indicators. Our rankings are based on natural forest loss, habitat conversion, marine captures, fertilizer use, water pollution, carbon emissions and species threat, although many other variables were excluded due to a lack of country-specific data. Of 228 countries considered, 179 (proportional) and 171 (absolute) had sufficient data for correlations. The proportional index ranked Singapore, Korea, Qatar, Kuwait, Japan, Thailand, Bahrain, Malaysia, Philippines and Netherlands as having the highest proportional environmental impact, whereas Brazil, USA, China, Indonesia, Japan, Mexico, India, Russia, Australia and Peru had the highest absolute impact (i.e., total resource use, emissions and species threatened). Proportional and absolute environmental impact ranks were correlated, with mainly Asian countries having both high proportional and absolute impact. Despite weak concordance among the drivers of environmental impact, countries often perform poorly for different reasons. We found no evidence to support the environmental Kuznets curve hypothesis of a non-linear relationship between impact and per capita wealth, although there was a weak reduction in environmental impact as per capita wealth increases. Using structural equation models to account for cross-correlation, we found that increasing wealth was the most important driver of environmental impact. Our results show that the global community not only has to encourage better environmental performance in less-developed countries, especially those in Asia, there is also a requirement to focus on the development of environmentally friendly practices in wealthier countries.	[Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Giam, Xingli; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Giam, Xingli] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sodhi, Navjot S.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Adelaide; University of Adelaide; National University of Singapore; Princeton University; Harvard University	Bradshaw, CJA (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	corey.bradshaw@adelaide.edu.au	Bradshaw, Corey J.A./A-1311-2008	Bradshaw, Corey J.A./0000-0002-5328-7741; Giam, Xingli/0000-0002-5239-9477	Sarah and Daniel Hrdy Fellowship; National University of Singapore	Sarah and Daniel Hrdy Fellowship; National University of Singapore(National University of Singapore)	N.S.S. thanks the Sarah and Daniel Hrdy Fellowship for support while the manuscript was being prepared. The National University of Singapore provided additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABED, 2002, GOVERNANCE CORRUPTIO; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2008, WORLD DEV IND 2008; [Anonymous], 1997, NATURES SERVICES; Barbier EB, 2001, J ECON SURV, V15, P413, DOI 10.1111/1467-6419.00144; Bawa KS, 1997, NATURE, V386, P562, DOI 10.1038/386562a0; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Didia DO, 1997, GLOBAL ENVIRON CHANG, V7, P63, DOI 10.1016/S0959-3780(96)00024-6; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; *EUR COMM JOINT RE, 2002, GLC 2000 GLOB LAND C; Ewers RM, 2006, GLOBAL ENVIRON CHANG, V16, P161, DOI 10.1016/j.gloenvcha.2005.12.001; *FAO, 2007, FISHSTAT PLUS UN SOF; *FAO, 2009, AQUASTAT GLOB INF SY; FOSTER JR, 1992, LITHIUM, V3, P77; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Ghertner DA, 2007, ECOL ECON, V63, P563, DOI 10.1016/j.ecolecon.2006.12.010; GIAM X, 2010, BIOL CONSER IN PRESS; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HIJMANS R, 2008, GLOBAL ADM AREAS VER; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffmann JP, 2004, SOCIOL PERSPECT, V47, P79, DOI 10.1525/sop.2004.47.1.79; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Kaufmann D., 2007, GOVERNANCE MATTERS 6; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Li Q, 2006, INT STUD QUART, V50, P935, DOI 10.1111/j.1468-2478.2006.00432.x; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Morse S, 2006, ECOL SOC, V11; Naidoo R, 2001, CONSERV BIOL, V15, P1021, DOI 10.1046/j.1523-1739.2001.0150041021.x; Olsthoorn X, 2001, J AIR TRANSP MANAG, V7, P87, DOI 10.1016/S0969-6997(00)00031-4; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scrieciu SS, 2007, ECOL ECON, V62, P603, DOI 10.1016/j.ecolecon.2006.07.028; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Stern DI, 1996, WORLD DEV, V24, P1151, DOI 10.1016/0305-750X(96)00032-0; STRASSBURG BBN, 2010, CONSERVATION LETT, V3, DOI DOI 10.1111/J.1755-1263X.2009.00092.X; Transparency International, 2002, CORR PERC IND 2002; *UN, 2004, SESS NAT RES GOV CON; *US BUR CENS, 2008, INT DAT BAS IDB; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vohringer F., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P217, DOI 10.1023/B:MITI.0000029918.24860.3e; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769; [No title captured]	63	112	114	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10440	10.1371/journal.pone.0010440	http://dx.doi.org/10.1371/journal.pone.0010440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PW	20454670	gold, Green Published			2022-12-27	WOS:000277240300016
J	Fan, HC; Quake, SR				Fan, H. Christina; Quake, Stephen R.			Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics	PLOS ONE			English	Article							DIAGNOSIS; DNA; GENOME; SERUM	We recently demonstrated noninvasive detection of fetal aneuploidy by shotgun sequencing cell-free DNA in maternal plasma using next-generation high throughput sequencer. However, GC bias introduced by the sequencer placed a practical limit on the sensitivity of aneuploidy detection. In this study, we describe a method to computationally remove GC bias in short read sequencing data by applying weight to each sequenced read based on local genomic GC content. We show that sensitivity is limited only by counting statistics and that sensitivity can be increased to arbitrary precision in sample containing arbitrarily small fraction of fetal DNA simply by sequencing more DNA molecules. High throughput shotgun sequencing of maternal plasma DNA should therefore enable noninvasive diagnosis of any type of fetal aneuploidy.	[Fan, H. Christina] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute	Fan, HC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu			Wallace H. Coulter Foundation; National Institutes of Health	Wallace H. Coulter Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the Wallace H. Coulter Foundation (http://www.whcf.org/) and the National Institutes of Health Director's Pioneer Award (http://nihroadmap.nih.gov/pioneer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; CHIU RW, 2009, CLIN CHEM; Chu TJ, 2009, BIOINFORMATICS, V25, P1244, DOI 10.1093/bioinformatics/btp156; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X	11	104	189	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10439	10.1371/journal.pone.0010439	http://dx.doi.org/10.1371/journal.pone.0010439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454671	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300015
J	Langenheder, S; Bulling, MT; Solan, M; Prosser, JI				Langenheder, Silke; Bulling, Mark T.; Solan, Martin; Prosser, James I.			Bacterial Biodiversity-Ecosystem Functioning Relations Are Modified by Environmental Complexity	PLOS ONE			English	Article							SPECIES-DIVERSITY; HETEROGENEITY; BIOMASS; COMPLEMENTARITY; ASSEMBLAGES; SELECTION; CONSUMER; RATHER	Background: With the recognition that environmental change resulting from anthropogenic activities is causing a global decline in biodiversity, much attention has been devoted to understanding how changes in biodiversity may alter levels of ecosystem functioning. Although environmental complexity has long been recognised as a major driving force in evolutionary processes, it has only recently been incorporated into biodiversity-ecosystem functioning investigations. Environmental complexity is expected to strengthen the positive effect of species richness on ecosystem functioning, mainly because it leads to stronger complementarity effects, such as resource partitioning and facilitative interactions among species when the number of available resource increases. Methodology/Principal Findings: Here we implemented an experiment to test the combined effect of species richness and environmental complexity, more specifically, resource richness on ecosystem functioning over time. We show, using all possible combinations of species within a bacterial community consisting of six species, and all possible combinations of three substrates, that diversity-functioning (metabolic activity) relationships change over time from linear to saturated. This was probably caused by a combination of limited complementarity effects and negative interactions among competing species as the experiment progressed. Even though species richness and resource richness both enhanced ecosystem functioning, they did so independently from each other. Instead there were complex interactions between particular species and substrate combinations. Conclusions/Significance: Our study shows clearly that both species richness and environmental complexity increase ecosystem functioning. The finding that there was no direct interaction between these two factors, but that instead rather complex interactions between combinations of certain species and resources underlie positive biodiversity ecosystem functioning relationships, suggests that detailed knowledge of how individual species interact with complex natural environments will be required in order to make reliable predictions about how altered levels of biodiversity will most likely affect ecosystem functioning.	[Langenheder, Silke; Prosser, James I.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Bulling, Mark T.; Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Scotland	University of Aberdeen; University of Aberdeen	Langenheder, S (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	silke.langenheder@ebc.uu.se	Solan, Martin/E-9338-2012; Langenheder, Silke/C-9614-2017; Prosser, Jim/F-5280-2010	Solan, Martin/0000-0001-9924-5574; Langenheder, Silke/0000-0002-5245-9935; Prosser, Jim/0000-0003-1757-5102; Bulling, Mark/0000-0002-0742-256X	Marie Curie Fellowship [MEIF-CT-2005-23826]; Natural Environment Research Council [NE/E006795/1]; Natural Environment Research Council [NE/H017445/1] Funding Source: researchfish; NERC [NE/H017445/1, NE/E006795/1] Funding Source: UKRI	Marie Curie Fellowship(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Marie Curie Fellowship (Contract MEIF-CT-2005-23826) and by the Natural Environment Research Council (Grant NE/E006795/1), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Eriksson BK, 2006, ECOLOGY, V87, P246, DOI 10.1890/05-0090; Godbold JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007423; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; GOTTSCHAL JC, 1986, BACTERIA NATURE, V2; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MacLean R. Craig, 2005, Ecology Letters, V8, P38; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Orwin KH, 2006, ECOLOGY, V87, P580, DOI 10.1890/05-0383; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pinheiro J., 2006, NLME R PACKAGE FITTI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Replansky T, 2009, OIKOS, V118, P233, DOI 10.1111/j.1600-0706.2008.16948.x; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1997, SCIENCE, V278, P1866; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tokeshi M., 1999, SPECIES COEXSISTENCE; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; West B. T., 2007, LINEAR MIXED MODELS; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zuur Alain F., 2009, P1	48	111	111	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10834	10.1371/journal.pone.0010834	http://dx.doi.org/10.1371/journal.pone.0010834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520808	gold, Green Published			2022-12-27	WOS:000278221500020
J	Deribew, A; Alemseged, F; Tessema, F; Sena, L; Birhanu, Z; Zeynudin, A; Sudhakar, M; Abdo, N; Deribe, K; Biadgilign, S				Deribew, Amare; Alemseged, Fessehaye; Tessema, Fasil; Sena, Lelisa; Birhanu, Zewdie; Zeynudin, Ahmed; Sudhakar, Morankar; Abdo, Nasir; Deribe, Kebede; Biadgilign, Sibhatu			Malaria and Under-Nutrition: A Community Based Study Among Under-Five Children at Risk of Malaria, South-West Ethiopia	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; AFRICAN CHILDREN; IRON STATUS; MALNUTRITION; MORBIDITY; DETERMINANTS; MORTALITY; PROVINCE; REGION	Background: The interaction between malaria and under-nutrition is not well elucidated in Ethiopia. The objective of this study was to assess the magnitude of under-nutrition and its correlation with malaria among under-five children in southwest Ethiopia. Methods: This cross-sectional study was undertaken during March-February, 2009 as part of the baseline assessment of a cluster randomized trial around Gilgel Gibe Hydroelectric dam, south-west Ethiopia. A total of 2410 under-five children were included for anthropometric measurement and blood investigation for the diagnosis of malaria and anemia. The nutritional status of children was determined using the International Reference Population defined by the U.S National Center for Health Statistics (NCHS). Blood film was used to identify malaria parasite and haemoglobin concentration was determined by Hemo Cue analyzer (HemoCue Hb 301, Sweden). Results: Significant proportion (40.4%) of under-five children were stunted (height-for-age <-22SD). The prevalence of under-weight was 34.2%. One third and one tenth of the children had anemia and malaria parasite respectively. Older children were more likely to have under-nutrition. There was no association between malaria and under-nutrition. Children who had malaria parasite were 1.5 times more likely to become anaemic compare to children who had no malaria parasite, [OR = 1.5, (95% CI: 1.1-2.0)]. Conclusion: In this study, there is no association between malaria and under-nutrition. Children who have malaria are more likely to be anaemic. Malaria prevention and control program should consider nutrition interventions particularly anemia.	[Deribew, Amare; Alemseged, Fessehaye; Tessema, Fasil; Sena, Lelisa] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Birhanu, Zewdie; Sudhakar, Morankar] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Zeynudin, Ahmed] Jimma Univ, Dept Lab Med & Pathol, Jimma, Ethiopia; [Abdo, Nasir] Jimma Zone Hlth Dept, Jimma, Ethiopia; [Deribe, Kebede] Fayyaa Integrated Dev Assoc NCMI, Addis Ababa, Ethiopia; [Biadgilign, Sibhatu] Johns Hopkins Univ, Tech Support Ethiopian HIV AIDS ART Initiat, Addis Ababa, Ethiopia	Jimma University; Jimma University; Jimma University	Deribew, A (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.	amare_deribew@yahoo.com	Dadi, Lelisa Sena/AAC-5641-2019; Deribe, Kebede/I-5422-2019; Birhanu, Zewdie/L-5983-2019; Deribe, Kebede/K-7055-2019	Dadi, Lelisa Sena/0000-0002-5232-3771; Deribe, Kebede/0000-0002-8526-6996; Deribew, Amare/0000-0003-2031-6080; Kasim, Ahmed Zeynudin/0000-0002-0552-1783; Biadgilign, Sibhatu/0000-0002-7582-5977	UNICEF/UNDP/WorldBank/WHO	UNICEF/UNDP/WorldBank/WHO(World Health Organization)	The study is funded by the UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breman JG, 2001, AM J TROP MED HYG, V64, P1; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deen JL, 2002, J TROP PEDIATRICS, V48, P78, DOI 10.1093/tropej/48.2.78; DERIBEW A, 2009, EFFECT TRAI IN PRESS; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Genton B, 1998, AM J CLIN NUTR, V68, P734, DOI 10.1093/ajcn/68.3.734; Hadley C, 2008, J EPIDEMIOL COMMUN H, V62, P980, DOI 10.1136/jech.2007.068460; HENDRICKSE RG, 1971, ANN TROP MED PARASIT, V65, P1; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; MEDHIN G, BMC PUBLIC HLTH, V10, P27; MURRAY MJ, 1975, LANCET, V1, P653; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Phengxay M, 2007, PEDIATR INT, V49, P260, DOI 10.1111/j.1442-200X.2007.02354.x; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; SNOW RW, 1991, T ROY SOC TROP MED H, V85, P584, DOI 10.1016/0035-9203(91)90351-X; Snow RW, 1997, ACTA TROP, V65, P1, DOI 10.1016/S0001-706X(96)00601-8; Wamani H., 2007, BMC Pediatrics, V7; *WHO, 2008, WHOHTMGMP20081; WOLDEGEBRIEL Z, 1993, BRIT J NUTR, V70, P593, DOI 10.1079/BJN19930151; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	28	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10775	10.1371/journal.pone.0010775	http://dx.doi.org/10.1371/journal.pone.0010775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505829	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400022
J	Lacerda, SMSN; Batlouni, SR; Costa, GMJ; Segatelli, TM; Quirino, BR; Queiroz, BM; Kalapothakis, E; Franca, LR				Lacerda, Samyra M. S. N.; Batlouni, Sergio R.; Costa, Guilherme M. J.; Segatelli, Tania M.; Quirino, Bruno R.; Queiroz, Bruno M.; Kalapothakis, Evanguedes; Franca, Luiz R.			A New and Fast Technique to Generate Offspring after Germ Cells Transplantation in Adult Fish: The Nile Tilapia (Oreochromis niloticus) Model	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; LINE CHIMERAS; RAINBOW-TROUT; SPERMATOGENESIS; PROLIFERATION; COLONIZATION; ZEBRAFISH; CULTURE; TESTIS; MOUSE	Background: Germ cell transplantation results in fertile recipients and is the only available approach to functionally investigate the spermatogonial stem cell biology in mammals and probably in other vertebrates. In the current study, we describe a novel non-surgical methodology for efficient spermatogonial transplantation into the testes of adult tilapia (O. niloticus), in which endogenous spermatogenesis had been depleted with the cytostatic drug busulfan. Methodology/Principal Findings: Using two different tilapia strains, the production of fertile spermatozoa with donor characteristics was demonstrated in adult recipient, which also sired progeny with the donor genotype. Also, after cryopreservation tilapia spermatogonial cells were able to differentiate to spermatozoa in the testes of recipient fishes. These findings indicate that injecting germ cells directly into adult testis facilitates and enable fast generation of donor spermatogenesis and offspring compared to previously described methods. Conclusion: Therefore, a new suitable methodology for biotechnological investigations in aquaculture was established, with a high potential to improve the production of commercially valuable fish, generate transgenic animals and preserve endangered fish species.	[Lacerda, Samyra M. S. N.; Batlouni, Sergio R.; Costa, Guilherme M. J.; Segatelli, Tania M.; Quirino, Bruno R.; Franca, Luiz R.] Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Batlouni, Sergio R.] Sao Paulo State Univ, Aquaculture Ctr CAUNESP, Sao Paulo, Brazil; [Queiroz, Bruno M.] GM Alevinos LTDA, Contagem, MG, Brazil; [Kalapothakis, Evanguedes] Univ Fed Minas Gerais, Dept Gen Biol, Lab Biotechnol & Mol Markers, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Lacerda, SMSN (corresponding author), Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil.	lrfranca@icb.ufmg.br	Lacerda, Samyra/A-7756-2016; Batlouni, Sergio r/F-6357-2010; Lacerda, Samyra/AAG-8948-2021; Mattos Jardim Costa, Guilherme/A-7369-2016; Batlouni, Sergio r/D-2324-2017; Nassif, Samyra/AAR-5947-2020; DE FRANCA, LUIZ/AAA-6923-2021	Lacerda, Samyra/0000-0003-4577-6243; Batlouni, Sergio r/0000-0003-3579-2530; Lacerda, Samyra/0000-0003-4577-6243; Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Batlouni, Sergio r/0000-0003-3579-2530; 	Brazilian National Council for Research (CNPq); Minas Gerais State Foundation (FAPEMIG); Coordination for the Improvement of Higher Level Personnel (CAPES)	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support was provided by the Brazilian National Council for Research (CNPq); Minas Gerais State Foundation (FAPEMIG); Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; De Rooij DG, 2000, J ANDROL, V21, P776; Dobrinski I, 2008, REPROD DOMEST ANIM, V43, P288, DOI 10.1111/j.1439-0531.2008.01176.x; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; FAO, 2007, CULT AQ SPEC INF PRO; Herrid M, 2006, REPRODUCTION, V132, P617, DOI 10.1530/rep.1.01125; Herrid M, 2009, REPROD FERT DEVELOP, V21, P393, DOI 10.1071/RD08129; Hilsdorf AWS, 2002, PIGM CELL RES, V15, P57, DOI 10.1034/j.1600-0749.2002.00058.x; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Horan P K, 1990, Methods Cell Biol, V33, P469; Hussain M.G., 1994, Asian Fisheries Science, V7, P215; Kobayashi T, 2007, MOL REPROD DEV, V74, P207, DOI 10.1002/mrd.20577; Lacerda S. M. S. N., 2006, Animal Reproduction, V3, P146; LIN S, 1992, P NATL ACAD SCI USA, V89, P4519, DOI 10.1073/pnas.89.10.4519; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; Melo DC, 2006, ARQ BRAS MED VET ZOO, V58, P87, DOI 10.1590/S0102-09352006000100013; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; REICH L, 1990, GENETICA, V80, P195, DOI 10.1007/BF00137326; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Shikina S, 2008, MOL REPROD DEV, V75, P529, DOI 10.1002/mrd.20771; STICKNEY RR, 2000, ENCY AQUACULTURE, P934; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Takeuchi Y, 2001, MOL REPROD DEV, V59, P380, DOI 10.1002/mrd.1044; Takeuchi Y, 2009, BIOL REPROD, V81, P1055, DOI 10.1095/biolreprod.109.077701; VANBEEK MEAB, 1990, CELL TISSUE KINET, V23, P1; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782	42	95	103	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10740	10.1371/journal.pone.0010740	http://dx.doi.org/10.1371/journal.pone.0010740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505774	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017300013
J	Xu, YH; Sun, Y; Barnes, S; Grabowski, GA				Xu, You-Hai; Sun, Ying; Barnes, Sonya; Grabowski, Gregory A.			Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model	PLOS ONE			English	Article							ACID-BETA-GLUCOSIDASE; ENZYME-REPLACEMENT THERAPY; MACROPHAGE-TARGETED GLUCOCEREBROSIDASE; MANNOSE-TERMINATED GLUCOCEREBROSIDASE; POTENT INHIBITOR; TYPE-1; EFFICACY; INTERNALIZATION; ALGLUCERASE; FIBROBLASTS	Gaucher disease type 1 is caused by the defective activity of the lysosomal enzyme, acid beta-glucosidase (GCase). Regular infusions of purified recombinant GCase are the standard of care for reversing hematologic, hepatic, splenic, and bony manifestations. Here, similar in vitro enzymatic properties, and in vivo pharmacokinetics and pharmacodynamics (PK/PD) and therapeutic efficacy of GCase were found with two human GCases, recombinant GCase (CHO cell, imiglucerase, Imig) and gene-activated GCase (human fibrosarcoma cells, velaglucerase alfa, Vela), in a Gaucher mouse, D409V/null. About 80+% of either enzyme localized to the liver interstitial cells and <5% was recovered in spleens and lungs after bolus i.v. injections. Glucosylceramide (GC) levels and storage cell numbers were reduced in a dose (5, 15 or 60 U/kg/wk) dependent manner in livers (60-95%) and in spleens (similar to 10-30%). Compared to Vela, Imig (60 U/kg/wk) had lesser effects at reducing hepatic GC (p = 0.0199) by 4 wks; this difference disappeared by 8 wks when nearly WT levels were achieved by Imig. Anti-GCase IgG was detected in GCase treated mice at 60 U/kg/wk, and IgE mediated acute hypersensitivity and death occurred after several injections of 60 U/kg/wk (21% with Vela and 34% with Imig). The responses of GC levels and storage cell numbers in Vela- and Imig-treated Gaucher mice at various doses provide a backdrop for clinical applications and decisions.	[Xu, You-Hai; Sun, Ying; Barnes, Sonya; Grabowski, Gregory A.] Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Xu, YH (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA.	greg.grabowski@cchmc.org			National Institutes of Health [DK 36729]; Shire Human Genetic Therapies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shire Human Genetic Therapies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by grants to G. A. G. from the National Institutes of Health (DK 36729) and from Shire Human Genetic Therapies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BERGMANN JE, 1989, AM J HUM GENET, V44, P741; BEUTLER E, 1991, BLOOD, V78, P1183; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bijsterbosch MK, 1996, EUR J BIOCHEM, V237, P344, DOI 10.1111/j.1432-1033.1996.00344.x; BOVE KE, 1995, HUM PATHOL, V26, P1040, DOI 10.1016/0046-8177(95)90097-7; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; CHANEY W, 1986, J BIOL CHEM, V261, P551; Charrow J, 2007, CLIN GENET, V71, P205, DOI 10.1111/j.1399-0004.2007.00769.x; Charrow J, 2004, J PEDIATR-US, V144, P112, DOI 10.1016/j.jpeds.2003.10.067; DEDUVE C, 1964, FED PROC, V23, P1045; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Du H, 2005, AM J HUM GENET, V77, P1061, DOI 10.1086/498652; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; FABBRO D, 1987, AM J HUM GENET, V40, P15; FALLET S, 1992, PEDIATR RES, V31, P496, DOI 10.1203/00006450-199205000-00018; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Friedman BA, 1999, BLOOD, V93, P2807; FURBISH FS, 1981, BIOCHIM BIOPHYS ACTA, V673, P425, DOI 10.1016/0304-4165(81)90474-8; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 2009, GENET MED, V11, P92, DOI 10.1097/GIM.0b013e31818e2c19; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Hollak CEM, 2009, EXPERT OPIN PHARMACO, V10, P2641, DOI 10.1517/14656560903270520; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kaplan P, 1996, J PEDIATR-US, V129, P149, DOI 10.1016/S0022-3476(96)70203-2; Lee R E, 1982, Prog Clin Biol Res, V95, P177; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Olszewski MA, 2000, J IMMUNOL, V165, P6429, DOI 10.4049/jimmunol.165.11.6429; PARWARESCH MR, 1986, AM J PATHOL, V125, P141; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; PASTORES GM, 1993, BLOOD, V82, P408; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; QI XY, 1994, J BIOL CHEM, V269, P16746; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; ROSENTHAL DI, 1995, PEDIATRICS, V96, P629; SATO Y, 1993, J CLIN INVEST, V91, P1909, DOI 10.1172/JCI116409; SLUITER W, 1984, J IMMUNOL METHODS, V73, P221, DOI 10.1016/0022-1759(84)90046-2; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; TSUJI S, 1986, J BIOL CHEM, V261, P50; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2004, BLOOD, V104, P1253, DOI 10.1182/blood-2003-11-3854; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; ZIMRAN A, 1995, LANCET, V345, P1479, DOI 10.1016/S0140-6736(95)91038-7	50	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10750	10.1371/journal.pone.0010750	http://dx.doi.org/10.1371/journal.pone.0010750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505772	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017300021
J	Elsaba, TMA; Martinez-Pomares, L; Robins, AR; Crook, S; Seth, R; Jackson, D; McCart, A; Silver, AR; Tomlinson, IPM; Ilyas, M				Elsaba, Tarek M. A.; Martinez-Pomares, Luisa; Robins, Adrian R.; Crook, Simon; Seth, Rashmi; Jackson, Darryl; McCart, Amy; Silver, Andrew R.; Tomlinson, Ian P. M.; Ilyas, Mohammad			The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer	PLOS ONE			English	Article							IDENTIFICATION; ANTIGEN; TUMORS	CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal cancer (CRC). In this study, we sought to clarify the expression and role of CD133 in CRC. Initially the size of the CD133-expressing (CD133+) population in eight well-described CRC cell lines was measured by flow cytometry and was found to range from 0% to >95%. The cell line HT29 has a CD133+ population of >95% and was chosen for functional evaluation of CD133 after gene knockdown by RNA interference. A time course assay showed that CD133 inhibition had no significant effect on cell proliferation or apoptosis. However, CD133 knockdown did result in greater susceptibility to staurosporine-induced apoptosis (p = 0.01) and reduction in cell motility (p<0.04). Since gene knockdown may cause "off-target" effects, the cell line SW480 (which has a CD133+ population of 40%) was sorted into pure CD133+ and CD133- populations to allow functional comparison of isogenic populations separated only by CD133 expression. In concordance with the knockdown experiments, a time course assay showed no significant proliferative differences between the CD133+/CD133- populations. Also greater resistance to staurosporine-induced apoptosis (p = 0.008), greater cell motility (p = 0.03) and greater colony forming efficiency was seen in the CD133+ population than the CD133- population in both 2D and 3D culture (p<0.0001 and p<0.003 respectively). Finally, the plasticity of CD133 expression in tumour cells was tested. Quantitative PCR analysis showed there was transcriptional repression in the CD133- population of SW480. Prolonged culture of a pure CD133- population resulted in re-emergence of CD133+ cells. We conclude that CD133 expression in CRCs is associated with some features attributable to stemness and that there is plasticity of CD133 expression. Further studies are necessary to delineate the mechanistic basis of these features.	[Elsaba, Tarek M. A.; Crook, Simon; Seth, Rashmi; Jackson, Darryl; Ilyas, Mohammad] Univ Nottingham, Queens Med Ctr, Div Pathol, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Elsaba, Tarek M. A.] Assiut Univ, S Egypt Canc Inst, Dept Pathol, Assiut, Egypt; [Martinez-Pomares, Luisa; Robins, Adrian R.] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham, England; [McCart, Amy; Silver, Andrew R.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Acad Surg, London, England; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ilyas, Mohammad] Queens Med Ctr, Nottingham Digest Dis Ctr, Biol Res Unit, Nottingham NG7 2UH, England	University of Nottingham; Egyptian Knowledge Bank (EKB); Assiut University; University of Nottingham; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Nottingham	Elsaba, TMA (corresponding author), Univ Nottingham, Queens Med Ctr, Div Pathol, Sch Mol Med Sci, Nottingham NG7 2RD, England.	Mohammad.Ilyas@nottingham.ac.uk	Jackson, Darryl/GVS-2243-2022; Reed, Amy E McCart/C-6192-2011; Elsaba, Tarek/AAF-1286-2021	Reed, Amy E McCart/0000-0001-5387-2791; Elsaba, Tarek/0000-0001-5670-7038; Martinez-Pomares, Luisa/0000-0002-2331-127X	University of Nottingham; CR-UK; Egyptian government	University of Nottingham; CR-UK(Cancer Research UK); Egyptian government	This work was funded by the University of Nottingham and CR-UK. Tarek Elsaba is a recipient of a PhD scholarship which has been provided by the Egyptian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKADER A, 2009, C TERMINAL TENSIN LI, P57; ADDLA SK, 2008, CHARACTERIZATION HOE, pF680; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; Arango M, 2005, Dermatol Online J, V11, P2; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DAVID H, 2009, J PATHOL, V219, P427; GERMANA R, 2008, STEM CELL ASS ANTIGE, P3008; GIEBEL B, 2004, SEGREGATION LIPID RA, P2332; HADAS DS, 2007, SUPPRESSION GASTRIC, P188; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; LI C, 2007, IDENTIFICATION PANCR, P1030; LIU G, 2006, ANAL GENE EXPRESSION, P67; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; MIRAGLIA S, 1997, NOVEL 5 TRANSMEMBRAN, P5013; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; OLIVER MH, 1989, RAPID CONVENIENT ASS, P513; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Rasband W.S., 1997, IMAGE J; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TETSUHIRO C, 2006, SIDE POPULATION PURI, P240; WRIGHT M, 2008, BRCAL BREAST TUMORS, pR10; YI JM, 2008, ABNORMAL DNA METHYLA, P8094; YIN AH, 1997, AC133 NOVEL MARKER H, P5002; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	33	72	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10714	10.1371/journal.pone.0010714	http://dx.doi.org/10.1371/journal.pone.0010714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502714	gold, Green Published, Green Submitted			2022-12-27	WOS:000277845400016
J	Landsverk, ML; Weiser, DC; Hannibal, MC; Kimelman, D				Landsverk, Megan L.; Weiser, Douglas C.; Hannibal, Mark C.; Kimelman, David			Alternative Splicing of sept9a and sept9b in Zebrafish Produces Multiple mRNA Transcripts Expressed Throughout Development	PLOS ONE			English	Article							HEREDITARY NEURALGIC AMYOTROPHY; MAMMALIAN SEPTIN; MSF-A; GENE; MICROTUBULES; ISOFORMS; DISEASE; TUMORS; CELLS	Background: Septins are involved in a number of cellular processes including cytokinesis and organization of the cytoskeleton. Alterations in human septin-9 (SEPT9) levels have been linked to multiple cancers, whereas mutations in SEPT9 cause the episodic neuropathy, hereditary neuralgic amyotrophy (HNA). Despite its important function in human health, the in vivo role of SEPT9 is unknown. Methodology/Principal Findings: Here we utilize zebrafish to study the role of SEPT9 in early development. We show that zebrafish possess two genes, sept9a and sept9b that, like humans, express multiple transcripts. Knockdown or overexpression of sept9a transcripts results in specific developmental alterations including circulation defects and aberrant epidermal development. Conclusions/Significance: Our work demonstrates that sept9 plays an important role in zebrafish development, and establishes zebrafish as a valuable model organism for the study of SEPT9.	[Landsverk, Megan L.; Hannibal, Mark C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Weiser, Douglas C.; Kimelman, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Landsverk, Megan L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weiser, Douglas C.] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of the Pacific	Landsverk, ML (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	kimelman@uw.edu		Hannibal, Mark/0000-0002-9077-3837	NIH [GM079203, NS38181]; NRSA [F32HD053189]; University of the Pacific Start-up funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038181] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of the Pacific Start-up funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant (GM079203) to D. K. and NIH grant (NS38181) to Phillip Chance and an NRSA fellowship (F32HD053189) and University of the Pacific Start-up funds to D. C. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Kiener TK, 2008, DEV BIOL, V316, P36, DOI 10.1016/j.ydbio.2007.12.047; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Landsverk ML, 2009, HUM MOL GENET, V18, P1200, DOI 10.1093/hmg/ddp014; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Robertson C, 2004, J PATHOL, V203, P519, DOI 10.1002/path.1551; Russell SEH, 2000, CANCER RES, V60, P4729; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Webb AE, 2008, DEV DYNAM, V237, P1153, DOI 10.1002/dvdy.21509; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10712	10.1371/journal.pone.0010712	http://dx.doi.org/10.1371/journal.pone.0010712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502708	gold, Green Submitted, Green Published			2022-12-27	WOS:000277845400015
J	Yang, M; Gao, CH; Wang, Y; Zhang, H; He, ZG				Yang, Min; Gao, Chunhui; Wang, Yi; Zhang, Hua; He, Zheng-Guo			Characterization of the Interaction and Cross-Regulation of Three Mycobacterium tuberculosis RelBE Modules	PLOS ONE			English	Article							TOXIN-ANTITOXIN MODULES; ESCHERICHIA-COLI; DNA-POLYMERASE; PLASMID; PROKARYOTES; SYSTEMS; STRESS; GROWTH; CELLS; LOCI	RelBE represents a typical bacterial toxin-antitoxin (TA) system. Mycobacterium tuberculosis H37Rv, the pathogen responsible for human tuberculosis, contains three RelBE-like modules, RelBE, RelFG, and RelJK, which are at least partly expressed in human macrophages during infection. RelBE modules appear to be autoregulated in an atypical manner compared to other TA systems; however, the molecular mechanisms and potential interactions between different RelBE modules remain to be elucidated. In the present study, we characterized the interaction and cross-regulation of these Rel toxin-antitoxin modules from this unique pathogen. The physical interactions between the three pairs of RelBE proteins were confirmed and the DNA-binding domain recognized by three RelBE-like pairs and domain structure characteristics were described. The three RelE-like proteins physically interacted with the same RelB-like protein, and could conditionally regulate its binding with promoter DNA. The RelBE-like modules exerted complex cross-regulation effects on mycobacterial growth. The relB antitoxin gene could replace relF in cross-neutralizing the relG toxin gene. Conversely, relF enhanced the toxicity of the relE toxin gene, while relB increased the toxicity of relK. This is the first report of interactions between different pairs of RelBE modules of M. tuberculosis.	[Yang, Min; Gao, Chunhui; Wang, Yi; Zhang, Hua; He, Zheng-Guo] Huazhong Agr Univ, Ctr Prote Res, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Ctr Prote Res, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	Gao, Chun-Hui/B-3667-2016; He, Zheng-Guo/P-3647-2014; Gao, Chun-Hui/B-4111-2008	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	973 Program [2006CB504402]; National Natural Science Foundation of China [30930003]; National Special Key Project of China on Major Infectious Diseases [2008ZX10003-005, 2008ZX10003-006]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Key Project of China on Major Infectious Diseases	This work was supported by 973 Program (2006CB504402), the National Natural Science Foundation of China (30930003) and the National Special Key Project of China on Major Infectious Diseases (2008ZX10003-005 and 2008ZX10003-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gronlund H, 1999, J MOL BIOL, V285, P1401, DOI 10.1006/jmbi.1998.2416; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; JAFFE A, 1985, J BACTERIOL, V163, P841; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Wang J, 2007, BIOCHEM BIOPH RES CO, V363, P63, DOI 10.1016/j.bbrc.2007.08.125; WHO, 2009, GLOB TUB CONTR 2009; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	28	62	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10672	10.1371/journal.pone.0010672	http://dx.doi.org/10.1371/journal.pone.0010672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498855	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700015
J	Lari, M; Rizzi, E; Milani, L; Corti, G; Balsamo, C; Vai, S; Catalano, G; Pilli, E; Longo, L; Condemi, S; Giunti, P; Hanni, C; De Bellis, G; Orlando, L; Barbujani, G; Caramelli, D				Lari, Martina; Rizzi, Ermanno; Milani, Lucio; Corti, Giorgio; Balsamo, Carlotta; Vai, Stefania; Catalano, Giulio; Pilli, Elena; Longo, Laura; Condemi, Silvana; Giunti, Paolo; Haenni, Catherine; De Bellis, Gianluca; Orlando, Ludovic; Barbujani, Guido; Caramelli, David			The Microcephalin Ancestral Allele in a Neanderthal Individual	PLOS ONE			English	Article							REGULATING BRAIN SIZE; X-CHROMOSOME; POPULATION-STRUCTURE; GENETIC DIVERSITY; MODERN HUMANS; HOMO-SAPIENS; DNA; EVOLUTION; SEQUENCE; SELECTION	Background: The high frequency (around 0.70 worlwide) and the relatively young age (between 14,000 and 62,000 years) of a derived group of haplotypes, haplogroup D, at the microcephalin (MCPH1) locus led to the proposal that haplogroup D originated in a human lineage that separated from modern humans>1 million years ago, evolved under strong positive selection, and passed into the human gene pool by an episode of admixture circa 37,000 years ago. The geographic distribution of haplogroup D, with marked differences between Africa and Eurasia, suggested that the archaic human form admixing with anatomically modern humans might have been Neanderthal. Methodology/Principal Findings: Here we report the first PCR amplification and high-throughput sequencing of nuclear DNA at the microcephalin (MCPH1) locus from Neanderthal individual from Mezzena Rockshelter (Monti Lessini, Italy). We show that a well-preserved Neanderthal fossil dated at approximately 50,000 years B. P., was homozygous for the ancestral, non-D, allele. The high yield of Neanderthal mtDNA sequences of the studied specimen, the pattern of nucleotide misincorporation among sequences consistent with post-mortem DNA damage and an accurate control of the MCPH1 alleles in all personnel that manipulated the sample, make it extremely unlikely that this result might reflect modern DNA contamination. Conclusions/Significance: The MCPH1 genotype of the Monti Lessini (MLS) Neanderthal does not prove that there was no interbreeding between anatomically archaic and modern humans in Europe, but certainly shows that speculations on a possible Neanderthal origin of what is now the most common MCPH1 haplogroup are not supported by empirical evidence from ancient DNA.	[Lari, Martina; Milani, Lucio; Balsamo, Carlotta; Vai, Stefania; Catalano, Giulio; Pilli, Elena; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy; [Rizzi, Ermanno; Corti, Giorgio; De Bellis, Gianluca] CNR, ITB, Segrate, MI, Italy; [Longo, Laura] Univ Siena, Dipartimento Sci Ambientali G Sarfatti, UR Ecol Preistor, I-53100 Siena, Italy; [Longo, Laura; Giunti, Paolo] Museo Storia Nat Verona, Sez Preistoria, Verona, Italy; [Condemi, Silvana] Univ Mediterranee, CNRS EFS, Lab Anthropol Bioculturelle, UMR6578, Marseille, France; [Haenni, Catherine; Orlando, Ludovic] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,INRA, F-69365 Lyon, France; [Barbujani, Guido] Univ Ferrara, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Siena; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Ferrara	Lari, M (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy.	david.caramelli@unifi.it	De Bellis, Gianluca/H-9725-2013; Longo, Laura/G-2797-2011; Orlando, Ludovic/A-8932-2013; Condemi, Silvana/ABE-2701-2021; Rizzi, Ermanno/J-7448-2012; rizzi, ermanno/Q-3399-2016; Catalano, Giulio/AAT-2749-2020; Lari, Martina/A-4085-2009; Barbujani, Guido/ABE-9998-2020	De Bellis, Gianluca/0000-0002-1622-4477; Longo, Laura/0000-0001-6562-3047; Orlando, Ludovic/0000-0003-3936-1850; Condemi, Silvana/0000-0002-6516-0879; rizzi, ermanno/0000-0002-9898-2326; Catalano, Giulio/0000-0002-2564-5775; Barbujani, Guido/0000-0001-7854-6669; Corti, Giorgio/0000-0001-6379-4117; Caramelli, David/0000-0001-6468-1675; VAI, STEFANIA/0000-0003-3844-5147; Pilli, Elena/0000-0002-3150-5082	Italian Ministry of Universities (MIUR); PRIN; FIRB [n RBLA03ER38]	Italian Ministry of Universities (MIUR)(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by the Italian Ministry of Universities (MIUR http://www.miur.it) PRIN funds to G. B. and D. C. Grant FIRB (http://firb.miur.it/) n RBLA03ER38 funds to E. R., G. D. B. and G. Corti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Coop G, 2008, MOL BIOL EVOL, V25, P1257, DOI 10.1093/molbev/msn091; Cox MP, 2008, GENETICS, V178, P427, DOI 10.1534/genetics.107.080432; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert M Thomas P, 2006, Med Secoli, V18, P701; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Giunti Paolo, 2008, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V32, P39; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hawks J, 2008, TRENDS GENET, V24, P19, DOI 10.1016/j.tig.2007.10.003; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lalueza-Fox C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-342; Linderholm A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002316; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Marth G, 2003, P NATL ACAD SCI USA, V100, P376, DOI 10.1073/pnas.222673099; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Sabater-Lleal M, 2006, HUM GENET, V118, P741, DOI 10.1007/s00439-005-0045-5; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	50	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10648	10.1371/journal.pone.0010648	http://dx.doi.org/10.1371/journal.pone.0010648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498832	gold, Green Published, Green Submitted			2022-12-27	WOS:000277771600012
J	Slater, M; Spanlang, B; Sanchez-Vives, MV; Blanke, O				Slater, Mel; Spanlang, Bernhard; Sanchez-Vives, Maria V.; Blanke, Olaf			First Person Experience of Body Transfer in Virtual Reality	PLOS ONE			English	Article							PERCEPTUAL ILLUSION; SELF-CONSCIOUSNESS; RUBBER HAND; LIMB; SUM; REPRESENTATIONS; RECOGNITION; OWNERSHIP; ONLINE; TOUCH	Background: Altering the normal association between touch and its visual correlate can result in the illusory perception of a fake limb as part of our own body. Thus, when touch is seen to be applied to a rubber hand while felt synchronously on the corresponding hidden real hand, an illusion of ownership of the rubber hand usually occurs. The illusion has also been demonstrated using visuomotor correlation between the movements of the hidden real hand and the seen fake hand. This type of paradigm has been used with respect to the whole body generating out-of-the-body and body substitution illusions. However, such studies have only ever manipulated a single factor and although they used a form of virtual reality have not exploited the power of immersive virtual reality (IVR) to produce radical transformations in body ownership. Principal Findings: Here we show that a first person perspective of a life-sized virtual human female body that appears to substitute the male subjects' own bodies was sufficient to generate a body transfer illusion. This was demonstrated subjectively by questionnaire and physiologically through heart-rate deceleration in response to a threat to the virtual body. This finding is in contrast to earlier experimental studies that assume visuotactile synchrony to be the critical contributory factor in ownership illusions. Our finding was possible because IVR allowed us to use a novel experimental design for this type of problem with three independent binary factors: (i) perspective position (first or third), (ii) synchronous or asynchronous mirror reflections and (iii) synchrony or asynchrony between felt and seen touch. Conclusions: The results support the notion that bottom-up perceptual mechanisms can temporarily override top down knowledge resulting in a radical illusion of transfer of body ownership. The research also illustrates immersive virtual reality as a powerful tool in the study of body representation and experience, since it supports experimental manipulations that would otherwise be infeasible, with the technology being mature enough to represent human bodies and their motion.	[Slater, Mel; Sanchez-Vives, Maria V.] Univ Barcelona, ICREA, Barcelona, Spain; [Slater, Mel; Spanlang, Bernhard] Univ Barcelona, Fac Psicol, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England; [Spanlang, Bernhard] Univ Politecn Cataluna, Dept LSI, Barcelona, Spain; [Sanchez-Vives, Maria V.] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland	ICREA; University of Barcelona; University of Barcelona; University of London; University College London; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Slater, M (corresponding author), Univ Barcelona, ICREA, Barcelona, Spain.	melslater@gmail.com	Sanchez-Vives, Maria/J-8526-2014; Slater, Mel/M-5210-2014	Sanchez-Vives, Maria/0000-0002-8437-9083; Slater, Mel/0000-0002-6223-0050; Spanlang, Bernhard/0000-0002-9659-635X	European Union; Future and Emerging Technologies (FET) [27731]; MS's European Research Council [227985]; ICREA Funding Source: Custom	European Union(European Commission); Future and Emerging Technologies (FET)(European Commission); MS's European Research Council; ICREA(ICREA)	This research was supported by the Integrated Project PRESENCCIA funded under the European Union's Sixth Framework Program, Future and Emerging Technologies (FET), Contract Number 27731. http://cordis.europa.eu/ist/fet/pr.htm. The work was also partially supported by MS's European Research Council grant TRAVERSE (227985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; Carruthers G, 2008, CONSCIOUS COGN, V17, P1321, DOI 10.1016/j.concog.2008.07.008; Carruthers G, 2008, CONSCIOUS COGN, V17, P1302, DOI 10.1016/j.concog.2008.02.001; DEVINSKY O, 1989, ARCH NEUROL-CHICAGO, V46, P1080, DOI 10.1001/archneur.1989.00520460060015; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; McCullagh P, 1989, GEN LINEAR MODELS; Noe A, 2004, ACTION PERCEPTION BR; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; SCHAEFER M, 2009, HUMAN BRAIN MAPPING, V30; Schaefer M, 2007, NEUROIMAGE, V36, P700, DOI 10.1016/j.neuroimage.2007.03.046; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; SLATER M, 2008, DIGITAL BODY VIRTUAL; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, CONSCIOUS COGN, V17, P1317, DOI 10.1016/j.concog.2008.06.012; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	38	523	527	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10564	10.1371/journal.pone.0010564	http://dx.doi.org/10.1371/journal.pone.0010564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485681	Green Published, gold			2022-12-27	WOS:000277563400003
J	Unni, VK; Weissman, TA; Rockenstein, E; Masliah, E; McLean, PJ; Hyman, BT				Unni, Vivek K.; Weissman, Tamily A.; Rockenstein, Edward; Masliah, Eliezer; McLean, Pamela J.; Hyman, Bradley T.			In Vivo Imaging of alpha-Synuclein in Mouse Cortex Demonstrates Stable Expression and Differential Subcellular Compartment Mobility	PLOS ONE			English	Article							CELL-DEATH; LONG-TERM; ACCUMULATION; AGGREGATION; DEGRADATION; APPEARANCE; DOPAMINE; DYNAMICS; PLAQUES; MODELS	Background: Regulation of alpha-synuclein levels within cells is thought to play a critical role in Parkinson's Disease (PD) pathogenesis and in other related synucleinopathies. These processes have been studied primarily in reduced preparations, including cell culture. We now develop methods to measure alpha-synuclein levels in the living mammalian brain to study in vivo protein mobility, turnover and degradation with subcellular specificity. Methodology/Principal Findings: We have developed a system using enhanced Green Fluorescent Protein (GFP)-tagged human alpha-synuclein (Syn-GFP) transgenic mice and in vivo multiphoton imaging to measure alpha-synuclein levels with subcellular resolution. This new experimental paradigm allows individual Syn-GFP-expressing neurons and presynaptic terminals to be imaged in the living mouse brain over a period of months. We find that Syn-GFP is stably expressed by neurons and presynaptic terminals over this time frame and further find that different presynaptic terminals can express widely differing levels of Syn-GFP. Using the fluorescence recovery after photobleaching (FRAP) technique in vivo we provide evidence that at least two pools of Syn-GFP exist in terminals with lower levels of mobility than measured previously. These results demonstrate that multiphoton imaging in Syn-GFP mice is an excellent new strategy for exploring the biology of alpha-synuclein and related mechanisms of neurodegeneration. Conclusions/Significance: In vivo multiphoton imaging in Syn-GFP transgenic mice demonstrates stable alpha-synuclein expression and differential subcellular compartment mobility within cortical neurons. This opens new avenues for studying alpha-synuclein biology in the living brain and testing new therapeutics for PD and related disorders.	[Unni, Vivek K.; McLean, Pamela J.; Hyman, Bradley T.] MGH Harvard Med Sch, Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA; [Weissman, Tamily A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Weissman, Tamily A.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Harvard University; University of California System; University of California San Diego	Unni, VK (corresponding author), MGH Harvard Med Sch, Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA.	bhyman@partners.org		Weissman, Tamily/0000-0001-9361-6071; McLean, Pamela/0000-0003-4870-5715	National Institutes of Health [NS038372, NS063963, T32AG000222, T32NS048005, AG18440, AG022074]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963, T32NS048005, P50NS038372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG018440, R01AG018440, T32AG000222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants NS038372, NS063963, T32AG000222, T32NS048005, AG18440 and AG022074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; DECALIGNON A, 2010, NATURE IN PRESS; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; George JM, 2002, GENOME BIOL, V3; Gomez-Santos C, 2005, BRAIN RES BULL, V65, P87, DOI 10.1016/j.brainresbull.2004.11.008; Grutzendler Jaime, 2006, NeuroRx, V3, P489, DOI 10.1016/j.nurx.2006.07.005; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lee IH, 2008, NEUROCHEM RES, V33, P1393, DOI 10.1007/s11064-008-9598-8; Liang TB, 2006, J NEUROCHEM, V99, P470, DOI 10.1111/j.1471-4159.2006.04111.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Schwach G, 2010, J MOL NEUROSCI, V41, P80, DOI 10.1007/s12031-009-9289-1; Skoch Jesse, 2004, V299, P349; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48	36	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10589	10.1371/journal.pone.0010589	http://dx.doi.org/10.1371/journal.pone.0010589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485674	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200020
J	Dubielecka, PM; Cui, P; Xiong, XL; Hossain, S; Heck, S; Angelov, L; Kotula, L				Dubielecka, Patrycja M.; Cui, Ping; Xiong, Xiaoling; Hossain, Sajjad; Heck, Susanne; Angelov, Lyudmil; Kotula, Leszek			Differential Regulation of Macropinocytosis by Abi1/Hssh3bp1 Isoforms	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; BINDING PROTEIN RAC; GROWTH-FACTOR; DENDRITIC CELLS; 3T3 CELLS; ACTIVATION; DISTINCT; EPS8; GTP; PINOCYTOSIS	Background: Macropinocytosis, which is a constitutive cellular process of fluid and macromolecule uptake, is regulated by actin cytoskeleton rearrangements near the plasma membrane. Activation of Rac1, which is proposed to act upstream of the actin polymerization regulatory Wave 2 complex, has been found to correlate with enhanced macropinocytosis. One of the components of the Wave 2 complex is Abi1. Multiple, alternatively spliced isoforms of Abi1 are expressed in mammalian cells, but the functional significance of the various isoforms is unknown. Principal Findings: Here, using flow cytometric assay analysis for Alexa Fluor 647, we demonstrate that Abi1 isoforms 2 and 3 differentially regulate macropinocytosis. LNCaP cells expressing isoform 3 had increased macropinocytic uptake that correlated with enhanced cell spreading and higher Rac1 activation in comparison to cells expressing isoform 2. Isoform 2 expressing cells had decreased macropinocytic uptake, but demonstrated greater sensitivity to Rac1 activation. Moreover, more isoform 2 was localized within the cytoplasm in comparison to isoform 3, which was more associated with the plasma membrane. Activated Rac1 was found to specifically bind to a site in exon 10 of isoform 2 in vitro. Because of alternative mRNA splicing, exon 10 is absent from isoform 3, precluding similar binding of activated Rac1. Both isoforms, however, bound to inactive Rac1 through the same non-exon 10 site. Thus, Abi1 isoform 3-containing Wave 2 complex exhibited a differential binding to activated vs. inactive Rac1, whereas isoform 2-containing Wave 2 complex bound activated or inactive Rac1 comparably. Conclusion: Based on these observations, we postulate that Abi1 isoforms differentially regulate macropinocytosis as a consequence of their different relative affinities for activated Rac1 in Wave 2 complex. These findings also raise the possibility that isoform-specific roles occur in other Abi1 functions.	[Dubielecka, Patrycja M.; Cui, Ping; Xiong, Xiaoling; Hossain, Sajjad; Kotula, Leszek] New York Blood Ctr, Lab Cell Signaling, New York, NY 10021 USA; [Angelov, Lyudmil] New York Blood Ctr, Confocal Microscopy Lab, New York, NY 10021 USA	New York Blood Center; New York Blood Center	Dubielecka, PM (corresponding author), New York Blood Ctr, Lab Cell Signaling, New York, NY 10021 USA.	lkotula@nybloodcenter.org	Dubielecka, Patrycja/AAF-8128-2019	Kotula, Leszek/0000-0002-7977-7124	National Institutes of Health [R01 NS044968]; Department of Defense [W81XWH-08-1-0320]; F. M. Kirby Foundation, Inc., Morristown, New Jersey; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); F. M. Kirby Foundation, Inc., Morristown, New Jersey; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R01 NS044968 (National Institutes of Health) and W81XWH-08-1-0320 (Department of Defense) (L. K.). Xiaoling Xiong and Sajjad Hossain were supported in part by a grant (L. K.) from the F. M. Kirby Foundation, Inc., Morristown, New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyere M, 2002, INT J MED MICROBIOL, V291, P487; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; DAVIES PF, 1978, J CELL BIOL, V79, P663, DOI 10.1083/jcb.79.3.663; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Goi T, 1999, MOL CELL BIOL, V19, P1731; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Ibarra N, 2005, BIOCHEM SOC T, V33, P1243, DOI 10.1042/BST0331243; Ikeguchi A, 2001, ONCOGENE, V20, P4926, DOI 10.1038/sj.onc.1204502; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Macoska JA, 2001, NEOPLASIA, V3, P99, DOI 10.1038/sj.neo.7900145; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Ohmori T, 2001, BIOCHEMISTRY-US, V40, P12992, DOI 10.1021/bi0109459; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Watts C., 1989, COLD SPRING HARB SYM, V1, P345; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028; Xu JL, 2000, J CELL SCI, V113, P3805; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Ziemnicka-Kotula D, 1998, J BIOL CHEM, V273, P13681, DOI 10.1074/jbc.273.22.13681	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10430	10.1371/journal.pone.0010430	http://dx.doi.org/10.1371/journal.pone.0010430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479892	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467900001
J	Busch, MSA; Sedano, A; Simonson, T				Busch, Marcel Schmidt Am; Sedano, Audrey; Simonson, Thomas			Computational Protein Design: Validation and Possible Relevance as a Tool for Homology Searching and Fold Recognition	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; STRUCTURAL GENOMICS; ENERGY FUNCTIONS; SCOP DATABASE; PSI-BLAST; SEQUENCE; STABILITY; PFAM; ALIGNMENTS; PREDICTION	Background: Protein fold recognition usually relies on a statistical model of each fold; each model is constructed from an ensemble of natural sequences belonging to that fold. A complementary strategy may be to employ sequence ensembles produced by computational protein design. Designed sequences can be more diverse than natural sequences, possibly avoiding some limitations of experimental databases. Methodology/Principal Findings: We explore this strategy for four SCOP families: Small Kunitz-type inhibitors (SKIs), Interleukin-8 chemokines, PDZ domains, and large Caspase catalytic subunits, represented by 43 structures. An automated procedure is used to redesign the 43 proteins. We use the experimental backbones as fixed templates in the folded state and a molecular mechanics model to compute the interaction energies between sidechain and backbone groups. Calculations are done with the Proteins@Home volunteer computing platform. A heuristic algorithm is used to scan the sequence and conformational space, yielding 200,000-300,000 sequences per backbone template. The results confirm and generalize our earlier study of SH2 and SH3 domains. The designed sequences ressemble moderately-distant, natural homologues of the initial templates; e. g., the SUPERFAMILY, profile Hidden-Markov Model library recognizes 85% of the low-energy sequences as native-like. Conversely, Position Specific Scoring Matrices derived from the sequences can be used to detect natural homologues within the SwissProt database: 60% of known PDZ domains are detected and around 90% of known SKIs and chemokines. Energy components and inter-residue correlations are analyzed and ways to improve the method are discussed. Conclusions/Significance: For some families, designed sequences can be a useful complement to experimental ones for homologue searching. However, improved tools are needed to extract more information from the designed profiles before the method can be of general use.	[Busch, Marcel Schmidt Am; Sedano, Audrey; Simonson, Thomas] Ecole Polytech, Biochim Lab, CNRS, Dept Biol,UMR7654, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Busch, MSA (corresponding author), Ecole Polytech, Biochim Lab, CNRS, Dept Biol,UMR7654, F-91128 Palaiseau, France.	thomas.simonson@polytechnique.fr		Simonson, Thomas/0000-0002-5117-7338	ANR (Agence Nationale de la Recherche)	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	The project was supported by the ANR (Agence Nationale de la Recherche) High Performance Computing program (PROTEUS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson David P., 2004, 5 IEEE ACM INT WORKS; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Busch MSA, 2008, J COMPUT CHEM, V29, P1092, DOI 10.1002/jcc.20870; Busch MSA, 2009, PROTEINS, V77, P139, DOI 10.1002/prot.22426; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chowdry AB, 2007, J COMPUT CHEM, V28, P2378, DOI 10.1002/jcc.20727; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Durbin R., 2002, BIOL SEQUENCE ANAL; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; Hubner IA, 2006, P NATL ACAD SCI USA, V103, P17747, DOI 10.1073/pnas.0605580103; Jaramillo A, 2002, P NATL ACAD SCI USA, V99, P13554, DOI 10.1073/pnas.212068599; Kang SG, 2007, CURR OPIN CHEM BIOL, V11, P329, DOI 10.1016/j.cbpa.2007.05.006; Karplus K, 1999, PROTEINS, P121; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; Koehl P, 1999, J MOL BIOL, V293, P1183, DOI 10.1006/jmbi.1999.3212; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larson SM, 2003, J MOL BIOL, V332, P275, DOI 10.1016/S0022-2836(03)00832-5; Larson SM, 2003, PROTEINS, V51, P390, DOI 10.1002/prot.10346; Larson SM, 2002, PROTEIN SCI, V11, P2804, DOI 10.1110/ps.0203902; Launay G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-270; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lopes A, 2007, PROTEINS, V67, P853, DOI 10.1002/prot.21379; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marin A, 2002, PROTEINS, V49, P493, DOI 10.1002/prot.10231; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Murphy LR, 2000, PROTEIN ENG, V13, P149, DOI 10.1093/protein/13.3.149; Panchenko AR, 2002, PROTEIN SCI, V11, P361, DOI 10.1110/ps.19902; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Pokala N, 2004, PROTEIN SCI, V13, P925, DOI 10.1110/ps.03486104; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Saunders CT, 2005, J MOL BIOL, V346, P631, DOI 10.1016/j.jmb.2004.11.062; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmidt am Busch M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-148; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Sillitoe I, 2005, PROTEIN SCI, V14, P1800, DOI 10.1110/ps.041056105; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Street AG, 1998, FOLD DES, V3, P253, DOI 10.1016/S1359-0278(98)00036-4; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Todd AE, 2005, J MOL BIOL, V348, P1235, DOI 10.1016/j.jmb.2005.03.037; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882; Venclovas C, 2001, PROTEINS, P47; Ventura S, 2004, PROTEINS, V56, P1, DOI 10.1002/prot.20142; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212; Wernisch L, 2000, J MOL BIOL, V301, P713, DOI 10.1006/jmbi.2000.3984; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; Wollacott AM, 2007, PROTEIN SCI, V16, P165, DOI 10.1110/ps.062270707; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	86	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10410	10.1371/journal.pone.0010410	http://dx.doi.org/10.1371/journal.pone.0010410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463972	Green Published, gold			2022-12-27	WOS:000277379400004
J	Janssen, PJ; Van Houdt, R; Moors, H; Monsieurs, P; Morin, N; Michaux, A; Benotmane, MA; Leys, N; Vallaeys, T; Lapidus, A; Monchy, B; Medigue, C; Taghavi, S; McCorkle, S; Dunn, J; van der Lelie, D; Mergeay, M				Janssen, Paul J.; Van Houdt, Rob; Moors, Hugo; Monsieurs, Pieter; Morin, Nicolas; Michaux, Arlette; Benotmane, Mohammed A.; Leys, Natalie; Vallaeys, Tatiana; Lapidus, Alla; Monchy, Bastien; Medigue, Claudine; Taghavi, Safiyh; McCorkle, Sean; Dunn, John; van der Lelie, Daniel; Mergeay, Max			The Complete Genome Sequence of Cupriavidus metallidurans Strain CH34, a Master Survivalist in Harsh and Anthropogenic Environments	PLOS ONE			English	Article							ALCALIGENES-EUTROPHUS CH34; HEAVY-METAL RESISTANCE; INTRACELLULAR 3-HYDROXYBUTYRATE-OLIGOMER HYDROLASE; TRANSPORTER CLASSIFICATION DATABASE; MICROBIAL SIGNAL-TRANSDUCTION; COMPLETE NUCLEOTIDE-SEQUENCE; 2 CAPSULAR POLYSACCHARIDES; COPPER-BINDING PROTEIN; COENZYME-A REDUCTASE; RALSTONIA-EUTROPHA	Many bacteria in the environment have adapted to the presence of toxic heavy metals. Over the last 30 years, this heavy metal tolerance was the subject of extensive research. The bacterium Cupriavidus metallidurans strain CH34, originally isolated by us in 1976 from a metal processing factory, is considered a major model organism in this field because it withstands milli-molar range concentrations of over 20 different heavy metal ions. This tolerance is mostly achieved by rapid ion efflux but also by metal-complexation and -reduction. We present here the full genome sequence of strain CH34 and the manual annotation of all its genes. The genome of C. metallidurans CH34 is composed of two large circular chromosomes CHR1 and CHR2 of, respectively, 3,928,089 bp and 2,580,084 bp, and two megaplasmids pMOL28 and pMOL30 of, respectively, 171,459 bp and 233,720 bp in size. At least 25 loci for heavy-metal resistance (HMR) are distributed over the four replicons. Approximately 67% of the 6,717 coding sequences (CDSs) present in the CH34 genome could be assigned a putative function, and 9.1% (611 genes) appear to be unique to this strain. One out of five proteins is associated with either transport or transcription while the relay of environmental stimuli is governed by more than 600 signal transduction systems. The CH34 genome is most similar to the genomes of other Cupriavidus strains by correspondence between the respective CHR1 replicons but also displays similarity to the genomes of more distantly related species as a result of gene transfer and through the presence of large genomic islands. The presence of at least 57 IS elements and 19 transposons and the ability to take in and express foreign genes indicates a very dynamic and complex genome shaped by evolutionary forces. The genome data show that C. metallidurans CH34 is particularly well equipped to live in extreme conditions and anthropogenic environments that are rich in metals.	[Janssen, Paul J.; Van Houdt, Rob; Moors, Hugo; Monsieurs, Pieter; Morin, Nicolas; Michaux, Arlette; Benotmane, Mohammed A.; Leys, Natalie; Mergeay, Max] Belgian Nucl Res Ctr SCK CEN, Mol, Belgium; [Vallaeys, Tatiana] Univ Montpellier 2, Lab Ecosyst Lagunaires ECOLAG, CNRS, UMR 5119, Montpellier, France; [Lapidus, Alla] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA; [Monchy, Bastien] Univ Blaise Pascal, LMGE, CNRS, UMR 6023, Aubiere, France; [Medigue, Claudine] CNRS, UMR8030, Lab Anal Bioinformat Genom & Metab LABGeM, Evry, France; [Medigue, Claudine] CEA DSV IG Genoscope, Evry, France; [Taghavi, Safiyh; McCorkle, Sean; Dunn, John; van der Lelie, Daniel] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Belgian Nuclear Research Centre (SCK-CEN); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Brookhaven National Laboratory	Janssen, PJ (corresponding author), Belgian Nucl Res Ctr SCK CEN, Mol, Belgium.	pjanssen@sckcen.be	Mergeay, Max/H-2003-2011; Monsieurs, Pieter/A-2917-2009; Vallaeys, Tatiana/AAE-5508-2019; Van Houdt, Rob/B-8599-2011; Janssen, Paul/V-8575-2019; Leys, Natalie M.E.J./P-2761-2017; Lapidus, Alla L/I-4348-2013; Monsieurs, Pieter/W-3916-2019	Van Houdt, Rob/0000-0002-7459-496X; Janssen, Paul/0000-0002-7877-0270; Lapidus, Alla L/0000-0003-0427-8731; Monsieurs, Pieter/0000-0003-2214-6652; MONCHY, Sebastien/0000-0001-5808-4700; McCorkle, Sean/0000-0003-1126-4071; Benotmane, Rafi/0000-0002-8985-1578	SCK/CEN; European Space Agency [90037, 90094]; Brookhaven and Lawrence Berkeley National Laboratories [LDRD09-005]; United States Department of Energy, Office of Science, Biological and Environmental Research (BER) [KP1102010, DE-AC02-98CH10886]; U.S. Department of Energy	SCK/CEN; European Space Agency(European Space AgencyEuropean Commission); Brookhaven and Lawrence Berkeley National Laboratories; United States Department of Energy, Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The work was partially supported by internal funds of SCK/CEN, by the European Space Agency through the MESSAGE contracts (PRODEX agreements No. 90037 and 90094), and by Laboratory Directed Research and Development funds at the Brookhaven and Lawrence Berkeley National Laboratories. JD, SMcC, ST and DvdL acknowledge support by the United States Department of Energy, Office of Science, Biological and Environmental Research (BER), project number KP1102010 under contract DE-AC02-98CH10886, and by Laboratory Directed Research and Development funds (LDRD09-005) at the Brookhaven National Laboratory under contract with the U.S. Department of Energy. SM and NM acknowledge the support via a SCK/CEN PhD grant (AWM-programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; Antoine R, 2000, INT J MED MICROBIOL, V290, P301; Arrecubieta C, 2001, J BIOL CHEM, V276, P4245, DOI 10.1074/jbc.M008183200; Atomi H, 2002, J BIOSCI BIOENG, V94, P497, DOI 10.1016/S1389-1723(02)80186-4; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bersch B, 2008, J MOL BIOL, V380, P386, DOI 10.1016/j.jmb.2008.05.017; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Boyd JM, 2004, J BIOL CHEM, V279, P46644, DOI 10.1074/jbc.M407177200; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; Brickman TJ, 1996, J BACTERIOL, V178, P54, DOI 10.1128/jb.178.1.54-60.1996; BROWN NL, 1995, MOL MICROBIOL, V17, P1153, DOI 10.1111/j.1365-2958.1995.mmi_17061153.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Clarke BR, 1999, J BACTERIOL, V181, P2279, DOI 10.1128/JB.181.7.2279-2285.1999; Clough SJ, 1997, APPL ENVIRON MICROB, V63, P844, DOI 10.1128/AEM.63.3.844-850.1997; Coenye T, 2005, J CLIN MICROBIOL, V43, P3463, DOI 10.1128/JCM.43.7.3463-3466.2005; COLLARD JM, 1994, FEMS MICROBIOL REV, V14, P405, DOI 10.1016/0168-6445(94)90059-0; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; De Gelder J, 2009, MICROGRAVITY SCI TEC, V21, P217, DOI 10.1007/s12217-008-9037-0; Defrance M, 2008, NAT PROTOC, V3, P1589, DOI 10.1038/nprot.2008.98; Denger K, 1997, ARCH MICROBIOL, V168, P297, DOI 10.1007/s002030050502; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; DERORE H, 1994, FEMS MICROBIOL ECOL, V14, P263, DOI 10.1111/j.1574-6941.1994.tb00112.x; DIELS L, 1995, J IND MICROBIOL, V14, P142, DOI 10.1007/BF01569896; DIELS L, 1985, ARCH INT PHYSIOL BIO, V93, pB27; DIELS L, 1993, SCI TOTAL ENVIRON, V140, P471, DOI 10.1016/0048-9697(93)90044-7; Diels L, 2009, ANTON LEEUW INT J G, V96, P247, DOI 10.1007/s10482-009-9361-4; DONG Q, 1992, J BACTERIOL, V174, P8133, DOI 10.1128/JB.174.24.8133-8138.1992; DONG QH, 1994, MOL MICROBIOL, V14, P185, DOI 10.1111/j.1365-2958.1994.tb01278.x; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Fergusson JE, 1990, HEAVY ELEMENTS CHEM; FEULNER G, 1990, J BACTERIOL, V172, P446, DOI 10.1128/JB.172.1.446-456.1990; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Fricke WF, 2009, J MOL MICROB BIOTECH, V16, P124, DOI 10.1159/000142899; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fry NK, 2005, EMERG INFECT DIS, V11, P1131, DOI 10.3201/eid1107.050046; Galperin MY, 2005, ASM NEWS, V71, P326; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Garg RP, 2000, MOL MICROBIOL, V38, P359, DOI 10.1046/j.1365-2958.2000.02131.x; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gibson JL, 1997, J BACTERIOL, V179, P663, DOI 10.1128/jb.179.3.663-669.1997; Gilis A, 1998, J IND MICROBIOL BIOT, V20, P61, DOI 10.1038/sj.jim.2900478; Gilis A, 1996, J BACTERIOL, V178, P5499, DOI 10.1128/jb.178.18.5499-5507.1996; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2001, INT J SYST EVOL MICR, V51, P1773, DOI 10.1099/00207713-51-5-1773; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Grosse C, 1999, J BACTERIOL, V181, P2385; Grosse C, 2007, J MOL MICROB BIOTECH, V12, P227, DOI 10.1159/000099644; Guine V, 2006, ENVIRON SCI TECHNOL, V40, P1806, DOI 10.1021/es050981l; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; Harrison FH, 2005, MICROBIOL-SGM, V151, P727, DOI 10.1099/mic.0.27731-0; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Hassan MET, 1999, GENE, V238, P417, DOI 10.1016/S0378-1119(99)00349-2; Herrou J, 2007, J MOL BIOL, V373, P954, DOI 10.1016/j.jmb.2007.08.006; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Huvent I, 2006, J MOL BIOL, V356, P1014, DOI 10.1016/j.jmb.2005.11.096; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; JENDROSSEK D, 1990, J BACTERIOL, V172, P4844, DOI 10.1128/jb.172.9.4844-4851.1990; Jian X, 2009, J AM CHEM SOC, V131, P10869, DOI 10.1021/ja904279n; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; Kageyama C, 2005, ARCH MICROBIOL, V183, P56, DOI 10.1007/s00203-004-0746-5; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Kitada M, 2000, EXTREMOPHILES, V4, P253, DOI 10.1007/s007920070010; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kobayashi T, 2005, J BACTERIOL, V187, P5129, DOI 10.1128/JB.187.15.5129-5135.2005; Kobayashi T, 2003, J BACTERIOL, V185, P3485, DOI 10.1128/JB.185.12.3485-3490.2003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Leedjarv A, 2008, J BACTERIOL, V190, P2680, DOI 10.1128/JB.01494-07; Legatzki A, 2003, J BACTERIOL, V185, P4354, DOI 10.1128/JB.185.15.4354-4361.2003; LEJEUNE P, 1983, J BACTERIOL, V155, P1015, DOI 10.1128/JB.155.3.1015-1026.1983; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Leys N, 2009, ANTON LEEUW INT J G, V96, P227, DOI 10.1007/s10482-009-9360-5; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; LIESEGANG H, 1993, J BACTERIOL, V175, P767, DOI 10.1128/JB.175.3.767-778.1993; Lorite MJ, 2000, APPL ENVIRON MICROB, V66, P1871, DOI 10.1128/AEM.66.5.1871-1876.2000; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lutke-Eversloh T, 1999, FEMS MICROBIOL LETT, V181, P63; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MERGEAY M, 1978, ARCH INT PHYSIOL BIO, V86, P440; Mergeay M, 2000, BACTERIAL STRESS RESPONSES, P403; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; MERGEAY M, 1987, MOL GEN GENET, V209, P61, DOI 10.1007/BF00329837; MERGEAY M, 1987, ARCH INT PHYSIOL BIO, V95, pB36; Mergeay Max, 2009, V11, P209, DOI 10.1007/7171_2008_19; Merlin C, 1999, PLASMID, V41, P40, DOI 10.1006/plas.1998.1375; Merlin C, 1997, MOL GEN GENET, V253, P499; Mikolay A, 2009, ANTON LEEUW INT J G, V96, P183, DOI 10.1007/s10482-008-9303-6; Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x; Monchy S, 2006, INT J ENVIRON AN CH, V86, P677, DOI 10.1080/03067310600583824; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Monchy S, 2006, MICROBIOL-SGM, V152, P1765, DOI 10.1099/mic.0.28593-0; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Munzinger M, 1999, Z NATURFORSCH C, V54, P867; Nicholson TL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-220; NIES A, 1989, J BACTERIOL, V171, P5065, DOI 10.1128/jb.171.9.5065-5070.1989; NIES A, 1990, J BIOL CHEM, V265, P5648; NIES D, 1987, J BACTERIOL, V169, P4865, DOI 10.1128/jb.169.10.4865-4868.1987; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Nies DH, 2004, ARCH MICROBIOL, V181, P255, DOI 10.1007/s00203-004-0658-4; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NIES DH, 1989, J BACTERIOL, V171, P896, DOI 10.1128/jb.171.2.896-900.1989; Nies DH, 2006, J MOL MICROB BIOTECH, V11, P82, DOI 10.1159/000092820; Noel-Georis I, 2004, PROTEOMICS, V4, P151, DOI 10.1002/pmic.200300551; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Pompidor G, 2009, ANTON LEEUW INT J G, V96, P141, DOI 10.1007/s10482-008-9283-6; Promponas VJ, 2000, BIOINFORMATICS, V16, P915, DOI 10.1093/bioinformatics/16.10.915; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rosch V, 2008, ARCH MICROBIOL, V190, P11, DOI 10.1007/s00203-008-0357-7; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Roux M, 2001, APPL ENVIRON MICROB, V67, P769, DOI 10.1128/AEM.67.2.769-773.2001; Russo TA, 1998, J BACTERIOL, V180, P338, DOI 10.1128/JB.180.2.338-349.1998; Ryan MP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-242; SADOUK A, 1993, MOL GEN GENET, V240, P181, DOI 10.1007/BF00277055; Saegusa H, 2002, J BIOSCI BIOENG, V94, P106, DOI 10.1263/jbb.94.106; SAIER MH, 1994, MOL MICROBIOL, V11, P841, DOI 10.1111/j.1365-2958.1994.tb00362.x; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sakakibara Yasubumi, 2007, Nihon Hansenbyo Gakkai Zasshi, V76, P251; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sarro MI, 2005, INT MICROBIOL, V8, P223; Sato Y, 2006, INT J SYST EVOL MICR, V56, P973, DOI 10.1099/ijs.0.63922-0; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schleheck D, 2004, APPL ENVIRON MICROB, V70, P4053, DOI 10.1128/AEM.70.7.4053-4063.2004; Schmalenberger A, 2007, ENVIRON MICROBIOL, V9, P535, DOI 10.1111/j.1462-2920.2006.01172.x; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Sendra V, 2006, BIOCHEMISTRY-US, V45, P5557, DOI 10.1021/bi060328q; Siedow A, 1999, J BACTERIOL, V181, P4919, DOI 10.1128/JB.181.16.4919-4928.1999; Siegele DA, 2005, J BACTERIOL, V187, P6253, DOI 10.1128/JB.187.18.6253-6254.2005; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SILVER S, 1988, ANNU REV MICROBIOL, V42, P717, DOI 10.1146/annurev.mi.42.100188.003441; Sluis MK, 2002, J BACTERIOL, V184, P2969, DOI 10.1128/JB.184.11.2969-2977.2002; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Springer N, 1996, FEMS MICROBIOL LETT, V135, P333; Stark D, 2007, J MED MICROBIOL, V56, P435, DOI 10.1099/jmm.0.46976-0; Stokes HW, 2007, ANTIMICROB AGENTS CH, V51, P1827, DOI 10.1128/AAC.01279-06; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Sugiyama A, 2004, CURR MICROBIOL, V48, P424, DOI 10.1007/s00284-003-4227-x; SUMMERS AO, 1972, J BACTERIOL, V112, P1228, DOI 10.1128/JB.112.3.1228-1236.1972; TABITA FR, 1992, FEMS MICROBIOL LETT, V99, P107; Taghavi S, 1997, PLASMID, V37, P22, DOI 10.1006/plas.1996.1274; TAGHAVI S, 1994, APPL ENVIRON MICROB, V60, P3585, DOI 10.1128/AEM.60.10.3585-3591.1994; Taghavi S, 1996, MOL GEN GENET, V250, P169, DOI 10.1007/BF02174176; Taghavi S, 2009, ANTON LEEUW INT J G, V96, P171, DOI 10.1007/s10482-008-9289-0; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tauch A, 2002, MICROBIOL-SGM, V148, P1637, DOI 10.1099/00221287-148-6-1637; Tibazarwa C, 2000, J BACTERIOL, V182, P1399, DOI 10.1128/JB.182.5.1399-1409.2000; TOP E, 1994, APPL ENVIRON MICROB, V60, P831, DOI 10.1128/AEM.60.3.831-839.1994; TOP E, 1990, APPL ENVIRON MICROB, V56, P2471, DOI 10.1128/AEM.56.8.2471-2479.1990; TOP EM, 1995, FEMS MICROBIOL ECOL, V18, P191, DOI 10.1016/0168-6496(95)00054-7; Toussaint A, 2003, APPL ENVIRON MICROB, V69, P4837, DOI 10.1128/AEM.69.8.4837-4845.2003; Tseng SP, 2007, ANTIMICROB AGENTS CH, V51, P4187, DOI 10.1128/AAC.00542-07; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Van der Auwera GA, 2009, ANTON LEEUW INT J G, V96, P193, DOI 10.1007/s10482-009-9316-9; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Van Houdt R, 2009, ANTON LEEUW INT J G, V96, P205, DOI 10.1007/s10482-009-9345-4; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; VANGIJSEGEM F, 1982, PLASMID, V7, P30, DOI 10.1016/0147-619X(82)90024-5; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; von Rozycki T, 2005, COMP FUNCT GENOM, V6, P17, DOI 10.1002/cfg.454; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5; von Wintzingerode F, 2001, INT J SYST EVOL MICR, V51, P1257, DOI 10.1099/00207713-51-4-1257; Wang F, 2007, CHEMOSPHERE, V67, P896, DOI 10.1016/j.chemosphere.2006.11.019; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wrighton KC, 2009, MICROBE, V4, P281; York GM, 2003, J BACTERIOL, V185, P3788, DOI 10.1128/JB.185.13.3788-3794.2003; Zhang YB, 2009, ANTON LEEUW INT J G, V96, P161, DOI 10.1007/s10482-009-9313-z; Zoropogui A, 2008, BIOCHEM BIOPH RES CO, V365, P735, DOI 10.1016/j.bbrc.2007.11.030	226	202	454	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10433	10.1371/journal.pone.0010433	http://dx.doi.org/10.1371/journal.pone.0010433			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463976	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400008
J	Knapp, S				Knapp, Sandra			Four New Vining Species of Solanum (Dulcamaroid Clade) from Montane Habitats in Tropical America	PLOS ONE			English	Article								Background: Solanum (Solanaceae), with approximately 1500 species, is one of the largest genera of flowering plants, and has a centre of diversity in the New World tropics. The genus is divided into 13 major clades, of which two, the Dulcamaroid clade and the "African Non-Spiny'' clade, exhibit vine morphology with twining petioles. I am currently preparing a worldwide monograph of these two groups, comprising some 70 species. Methods: I formally describe here four new species of Solanum from montane Mexico and South America all belonging to the Dulcamaroid clade (including the traditionally recognised section Jasminosolanum Bitter). Descriptions, discussions of closely related species and preliminary conservation assessments are provided for all species; all species are illustrated. This paper is also a test case for the electronic publication of new names in flowering plants. Conclusions: These new species are all relatively rare, but not currently of conservation concern. Solanum aspersum sp. nov. is distributed in Colombia and Ecuador, S. luculentum sp. nov. in Colombia and Venezuela, S. sanchez-vegae sp. nov. is endemic to northern Peru and S. sousae sp. nov. to southern Mexico. Solanum luculentum has the morphology of a dioecious species; this is the first report of this breeding system in the Dulcamaroid clade.	Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945	National Science Foundation [DEB-0316614]	National Science Foundation(National Science Foundation (NSF))	Financial support for this work came from the National Science Foundation Planetary Biodiversity Inventory (award DEB-0316614, "PBI Solanum-A Worldwide Treatment'') (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohs L., 2005, SYST BOT, V104, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Candolle, 1852, PRODROMUS SYSTEMATIS, V13, P1, DOI [10.5962/bhl.title.286, DOI 10.5962/BHL.TITLE.286]; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Knapp S, 2006, TAXON, V55, P2, DOI 10.2307/25065662; Knapp S, 1998, PLANT SYST EVOL, V210, P113, DOI 10.1007/BF00984731; Knapp S., 1989, B BRIT MUS NAT HIST, V19, p63 ; KNAPP S, 2010, SYSTEMA NATURAE, V250, P83, DOI DOI 10.1201/EBK1420095012-C8; Knapp S, 2002, FLORA NEOTROPICA, V84, P1; Knapp S, 2008, ANN MO BOT GARD, V95, P405, DOI 10.3417/2006159; Knapp S, 2007, NATURE, V446, P261, DOI 10.1038/446261a; McNeill J., 2006, V146, P1; Mentz Lilian Auler, 2004, Pesquisas Botanica, V54, P1; Nee M., 1999, SOLANACEAE, VIV, P285; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671	14	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10502	10.1371/journal.pone.0010502	http://dx.doi.org/10.1371/journal.pone.0010502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463921	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400035
J	Parsons, MH; Blumstein, DT				Parsons, Michael H.; Blumstein, Daniel T.			Familiarity Breeds Contempt: Kangaroos Persistently Avoid Areas with Experimentally Deployed Dingo Scents	PLOS ONE			English	Article							PREDATOR RECOGNITION; BEHAVIOR; CUES; HABITUATION; ODOR; RESPONSES; MARKING; FEAR; REPELLENTS; WALLABIES	Background: Whether or not animals habituate to repeated exposure to predator scents may depend upon whether there are predators associated with the cues. Understanding the contexts of habituation is theoretically important and has profound implication for the application of predator-based herbivore deterrents. We repeatedly exposed a mixed mob of macropod marsupials to olfactory scents (urine, feces) from a sympatric predator (Canis lupus dingo), along with a control (water). If these predator cues were alarming, we expected that over time, some red kangaroos (Macropus rufous), western grey kangaroos (Macropus fuliginosus) and agile wallabies (Macropus agilis) would elect to not participate in cafeteria trials because the scents provided information about the riskiness of the area. Methodology/Principal Findings: We evaluated the effects of urine and feces independently and expected that urine would elicit a stronger reaction because it contains a broader class of infochemicals (pheromones, kairomones). Finally, we scored non-invasive indicators (flight and alarm stomps) to determine whether fear or altered palatability was responsible for the response. Repeated exposure reduced macropodid foraging on food associated with 40 ml of dingo urine, X = 986.75+/-3.97 g food remained as compared to the tap water control, X = 209.0+/-107.0 g (P<0.001). Macropodids fled more when encountering a urine treatment, X = 4.50+/-2.08 flights, as compared to the control, X = 0 flights (P< 0.001). There was no difference in effect between urine or feces treatments (P>0.5). Macropodids did not habituate to repeated exposure to predator scents, rather they avoided the entire experimental area after 10 days of trials (R-2 = 83.8; P<0.001). Conclusions/Significance: Responses to urine and feces were indistinguishable; both elicited fear-based responses and deterred foraging. Despite repeated exposure to predator-related cues in the absence of a predator, macropodids persistently avoided an area of highly palatable food. Area avoidance is consistent with that observed from other species following repeated anti-predator conditioning, However, this is the first time this response has been experimentally observed among medium or large vertebrates 2 where a local response is observed spatially and an area effect is revealed over time.	[Parsons, Michael H.] Curtin Univ Technol, Dept Environm Biol, CEDD, Perth, WA, Australia; [Parsons, Michael H.] Murdoch Univ, Sch Vet Biol & Biomed Sci, Murdoch, WA 6150, Australia; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Curtin University; Murdoch University; University of California System; University of California Los Angeles	Parsons, MH (corresponding author), Curtin Univ Technol, Dept Environm Biol, CEDD, Perth, WA, Australia.	M.Parsons@Murdoch.edu.au	Blumstein, Daniel T./B-6199-2012	Blumstein, Daniel T./0000-0001-5793-9244	Australian Research Council [LPO776652]; Rural Industries Research and Development Corporation (RIRDC) [PRJ000676]; Minerals and Energy Resources Institute of Western Australia (MERIWA) [M394]; Barrick Gold, Iluka Resources; WA Chemistry Centre	Australian Research Council(Australian Research Council); Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp); Minerals and Energy Resources Institute of Western Australia (MERIWA); Barrick Gold, Iluka Resources; WA Chemistry Centre	This research was part-supported by the Australian Research Council (LPO776652; http://www.arc.gov.au), the Rural Industries Research and Development Corporation (RIRDC PRJ000676; http://www.rirdc.gov.au), and the Minerals and Energy Resources Institute of Western Australia (MERIWA M394; http://www.doir.wa.gov.au/meriwa) sponsored by Barrick Gold, Iluka Resources and the WA Chemistry Centre. Except as described, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN G, 1989, ANIM BEHAV, V37, P11, DOI 10.1016/0003-3472(89)90002-X; [Anonymous], 2014, PHEROMONES ANIMAL BE; Arnould C, 1998, J CHEM ECOL, V24, P559, DOI 10.1023/A:1022321104758; ARNOULD C, 1993, J CHEM ECOL, V19, P225, DOI 10.1007/BF00993691; Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Belton LE, 2007, AFR ZOOL, V42, P135, DOI 10.3377/1562-7020(2007)42[135:DCGSXI]2.0.CO;2; BENDER H, 2005, THESIS U MELBOURNE M; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2002, ANIM CONSERV, V5, P87, DOI 10.1017/S1367943002002123; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Cohen J., 1998, STAT POWER ANAL BEHA; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; EPPLE G, 1995, ECOL APPL, V5, P1163, DOI 10.2307/2269363; Erhard HW, 2006, APPL ANIM BEHAV SCI, V99, P132, DOI 10.1016/j.applanim.2005.10.008; ERLINGE S, 1982, ANIM BEHAV, V30, P811, DOI 10.1016/S0003-3472(82)80154-1; EVANS JP, 2007, BEHAV ECO SOCIOBIOL, V61, P340; Gelperin A, 2008, J CHEM ECOL, V34, P928, DOI 10.1007/s10886-008-9483-6; Godard RD, 2007, J AVIAN BIOL, V38, P128, DOI 10.1111/j.2007.0908-8857.03788.x; Gonzalo A, 2007, ANIM BEHAV, V74, P447, DOI 10.1016/j.anbehav.2006.11.032; Gorman M.L., 1989, P57; Hazlett BA, 1999, BEHAVIOUR, V136, P161, DOI 10.1163/156853999501261; HOLLEN LL, 2007, ETHOL, V113; HOLOMUZKI JR, 1994, FRESHWATER BIOL, V32, P585, DOI 10.1111/j.1365-2427.1994.tb01149.x; Hunt M, 1999, PHYSIOL BEHAV, V67, P365, DOI 10.1016/S0031-9384(99)00084-0; JEDRZEJEWSKI W, 1990, CAN J ZOOL, V68, P660, DOI 10.1139/z90-096; Jones M, 2000, J CHEM ECOL, V26, P455, DOI 10.1023/A:1005417707588; Kesavaraju B, 2007, ETHOLOGY, V113, P199, DOI 10.1111/j.1439-0310.2006.01317.x; KIMBALL BA, 2006, ADV VERTEBR PEST MAN, V4, P59; Masini CV, 2005, BEHAV NEUROSCI, V119, P280, DOI 10.1037/0735-7044.119.1.280; MILLS MGL, 1980, S AFR J ZOOL, V15, P240; Monclus R, 2006, CHEMOECOLOGY, V16, P25, DOI 10.1007/s00049-005-0324-6; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; MURRAY PJ, 2006, AGRIC, V47, P851; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Parsons MH, 2007, J WILDLIFE MANAGE, V71, P1225, DOI 10.2193/2006-096; Pyare S, 2003, BIOL CONSERV, V113, P63, DOI 10.1016/S0006-3207(02)00350-6; Rameshkumar K, 2008, ZOOL SCI, V25, P349, DOI 10.2108/zsj.25.349; Rosell F, 1998, J CHEM ECOL, V24, P207, DOI 10.1023/A:1022524223435; Rosell F, 2000, WILDLIFE BIOL, V6, P13, DOI 10.2981/wlb.2000.033; SANKAR R, 2008, ANIM SCI, V103; Schultz CJ, 2000, DIABETIC MED, V17, P7, DOI 10.1046/j.1464-5491.2000.00200.x; Seamans TW, 2002, INT J PEST MANAGE, V48, P301, DOI 10.1080/09670870210149853; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; Sprague AJ, 2008, AVIAN CONSERV ECOL, V3; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SULLIVAN TP, 1986, J CHEM ECOL, V12, P729, DOI 10.1007/BF01012105; Vilhunen S, 2006, J FISH BIOL, V68, P25, DOI 10.1111/j.0022-1112.2006.00873.x; Wilton AN, 1999, J HERED, V90, P108, DOI 10.1093/jhered/90.1.108; Ylonen H, 2006, BEHAV ECOL SOCIOBIOL, V60, P350, DOI 10.1007/s00265-006-0171-7	51	56	59	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10403	10.1371/journal.pone.0010403	http://dx.doi.org/10.1371/journal.pone.0010403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463952	gold, Green Published			2022-12-27	WOS:000277379400003
J	Boni, MF; de Jong, MD; van Doorn, HR; Holmes, EC				Boni, Maciej F.; de Jong, Menno D.; van Doorn, H. Rogier; Holmes, Edward C.			Guidelines for Identifying Homologous Recombination Events in Influenza A Virus	PLOS ONE			English	Article							HEMAGGLUTININ GENE; ANTIGENIC DRIFT; GENOME ANALYSIS; EVOLUTION; RESISTANCE; SEQUENCE; SURVEILLANCE; REASSORTMENT; SELECTION; ALIGNMENT	The rapid evolution of influenza viruses occurs both clonally and non-clonally through a variety of genetic mechanisms and selection pressures. The non-clonal evolution of influenza viruses comprises relatively frequent reassortment among gene segments and a more rarely reported process of non-homologous RNA recombination. Homologous RNA recombination within segments has been proposed as a third such mechanism, but to date the evidence for the existence of this process among influenza viruses has been both weak and controversial. As homologous recombination has not yet been demonstrated in the laboratory, supporting evidence, if it exists, may come primarily from patterns of phylogenetic incongruence observed in gene sequence data. Here, we review the necessary criteria related to laboratory procedures and sample handling, bioinformatic analysis, and the known ecology and evolution of influenza viruses that need to be met in order to confirm that a homologous recombination event occurred in the history of a set of sequences. To determine if these criteria have an effect on recombination analysis, we gathered 8307 publicly available full-length sequences of influenza A segments and divided them into those that were sequenced via the National Institutes of Health Influenza Genome Sequencing Project (IGSP) and those that were not. As sample handling and sequencing are executed to a very high standard in the IGSP, these sequences should be less likely to be exposed to contamination by other samples or by laboratory strains, and thus should not exhibit laboratory-generated signals of homologous recombination. Our analysis shows that the IGSP data set contains only two phylogenetically-supported single recombinant sequences and no recombinant clades. In marked contrast, the non-IGSP data show a very large amount of potential recombination. We conclude that the presence of false positive signals in the non-IGSP data is more likely than false negatives in the IGSP data, and that given the evidence to date, homologous recombination seems to play little or no role in the evolution of influenza A viruses.	[Boni, Maciej F.; de Jong, Menno D.; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Boni, Maciej F.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Boni, Maciej F.; van Doorn, H. Rogier] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Holmes, Edward C.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, State Coll, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Oxford; University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Boni, MF (corresponding author), Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.	mboni@oucru.org	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; van Doorn, H. Rogier/H-3080-2019	Holmes, Edward/0000-0001-9596-3552; van Doorn, H. Rogier/0000-0002-9807-1821	United Kingdom Medical Research Council [G0600718]; University of Amsterdam; Wellcome Trust [081613/Z/06/Z, 077078/Z/05/Z]; National Institutes of Health [GM080533]; MRC [G0600718] Funding Source: UKRI; Medical Research Council [G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080533] Funding Source: NIH RePORTER	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Amsterdam; Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MFB is supported by United Kingdom Medical Research Council grant G0600718. MDdJ is supported by the University of Amsterdam. HRvD is supported by Wellcome Trust grants 081613/Z/06/Z and 077078/Z/05/Z. ECH is supported by National Institutes of Health grant GM080533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 2007, ANTIVIR THER, V12, P603; Boni MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123; Daly JM, 1996, J GEN VIROL, V77, P661, DOI 10.1099/0022-1317-77-4-661; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Gollin D, 2009, LIVEST SCI, V120, P248, DOI 10.1016/j.livsci.2008.07.017; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; Han GZ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-65; He CQ, 2008, VIROLOGY, V380, P12, DOI 10.1016/j.virol.2008.07.014; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; HOGAN ML, 1986, ADV APPL MATH, V7, P2, DOI 10.1016/0196-8858(86)90003-5; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; NELSON M, 2008, PLOS PATHOG, V4; ORLICH M, 1994, VIROLOGY, V204, P462, DOI 10.1006/viro.1994.1555; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r33; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Unitied Nations, 2010, UN COMM TRAD STAT DA; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Worobey M, 2002, SCIENCE, V296; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07	49	60	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10434	10.1371/journal.pone.0010434	http://dx.doi.org/10.1371/journal.pone.0010434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454662	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300010
J	Ghoshal, K; Motiwala, T; Claus, R; Yan, P; Kutay, H; Datta, J; Majumder, S; Bai, SM; Majumder, A; Huang, T; Plass, C; Jacob, ST				Ghoshal, Kalpana; Motiwala, Tasneem; Claus, Rainer; Yan, Pearlly; Kutay, Huban; Datta, Jharna; Majumder, Sarmila; Bai, Shoumei; Majumder, Arnab; Huang, Tim; Plass, Christoph; Jacob, Samson T.			HOXB13, a Target of DNMT3B, Is Methylated at an Upstream CpG Island, and Functions as a Tumor Suppressor in Primary Colorectal Tumors	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 3B; DE-NOVO METHYLATION; COLON-CANCER; PROMOTER METHYLATION; GENE-EXPRESSION; CELL CARCINOMA; BREAST-CANCER; PC12 CELLS; 3A; HYPERMETHYLATION	Background: A hallmark of cancer cells is hypermethylation of CpG islands (CGIs), which probably arises from upregulation of one or more DNA methyltransferases. The purpose of this study was to identify the targets of DNMT3B, an essential DNA methyltransferase in mammals, in colon cancer. Methodology/Principal Findings: Chromatin immunoprecipitation with DNMT3B specific antibody followed by CGI microarray identified genes with or without CGIs, repeat elements and genomic contigs in RKO cells. ChIP-Chop analysis showed that the majority of the target genes including P16, DCC, DISC1, SLIT1, CAVEOLIN1, GNA11, TBX5, TBX18, HOXB13 and some histone variants, that harbor CGI in their promoters, were methylated in multiple colon cancer cell lines but not in normal colon epithelial cells. Further, these genes were reactivated in RKO cells after treatment with 5-aza-2'-deoxycytidine, a DNA hypomethylating agent. COBRA showed that the CGIs encompassing the promoter and/or coding region of DCC, TBX5, TBX18, SLIT1 were methylated in primary colorectal tumors but not in matching normal colon tissues whereas GNA11 was methylated in both. MassARRAY analysis demonstrated that the CGI located similar to 4.5 kb upstream of HOXB13 + 1 site was tumor-specifically hypermethylated in primary colorectal cancers and cancer cell lines. HOXB13 upstream CGI was partially hypomethylated in DNMT1(-/-) HCT cells but was almost methylation free in cells lacking both DNMT1 and DNMT3B. Analysis of tumor suppressor properties of two aberrantly methylated transcription factors, HOXB13 and TBX18, revealed that both inhibited growth and clonogenic survival of colon cancer cells in vitro, but only HOXB13 abolished tumor growth in nude mice. Conclusions/Significance: This is the first report that identifies several important tumor suppressors and transcription factors as direct DNMT3B targets in colon cancer and as potential biomarkers for this cancer. Further, this study shows that methylation at an upstream CGI of HOXB13 is unique to colon cancer.	[Ghoshal, Kalpana; Motiwala, Tasneem; Kutay, Huban; Datta, Jharna; Majumder, Sarmila; Bai, Shoumei; Majumder, Arnab; Jacob, Samson T.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Ghoshal, Kalpana; Yan, Pearlly; Majumder, Sarmila; Huang, Tim; Jacob, Samson T.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Claus, Rainer; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-6900 Heidelberg, Germany; [Yan, Pearlly; Huang, Tim] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Helmholtz Association; German Cancer Research Center (DKFZ); University System of Ohio; Ohio State University	Ghoshal, K (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	kalpana.ghoshal@osumc.edu; samson.jacob@osumc.edu	Claus, Rainer/AAZ-5606-2020; Yan, Pearlly S/E-4339-2011; Jacob, Samson/H-3135-2011; Motiwala, Tasneem/AAB-9067-2021; Plass, Christoph/H-7192-2014	Claus, Rainer/0000-0003-2617-8766; Yan, Pearlly S/0000-0003-1965-4920; 	National Institutes of Health [CA086978, CA101956]; NATIONAL CANCER INSTITUTE [P01CA101956, R01CA086978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by grants CA086978 and CA101956 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI S, 2009, J BIOL CHEM; Bai SM, 2006, J BIOL CHEM, V281, P13604, DOI 10.1074/jbc.M513278200; Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Baylin Stephen B, 2004, Novartis Found Symp, V259, P226; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Chen HM, 2004, SER REMOTE SENS, V3, P3, DOI 10.1142/9789812702630_0001; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; Datta J, 2003, J CELL BIOCHEM, V88, P855, DOI 10.1002/jcb.10457; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Dias RR, 2007, INT J CARDIOL, V114, P98, DOI 10.1016/j.ijcard.2005.09.056; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Farin HF, 2008, J BIOL CHEM, V283, P25372, DOI 10.1074/jbc.M802723200; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Ghoshal K, 2002, METHOD ENZYMOL, V353, P476; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Girault I, 2003, CLIN CANCER RES, V9, P4415; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; JIN B, 2009, CANC RES; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jung C, 2005, BRIT J CANCER, V92, P2233, DOI 10.1038/sj.bjc.6602631; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kim MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006555; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin SY, 2004, ANTICANCER RES, V24, P1645; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Miao J, 2007, P NATL ACAD SCI USA, V104, P17093, DOI 10.1073/pnas.0707938104; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okuda H, 2006, ONCOGENE, V25, P1733, DOI 10.1038/sj.onc.1209200; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Plass C, 2006, CURR TOP MICROBIOL, V310, P179; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rodriguez BAT, 2008, CARCINOGENESIS, V29, P1459, DOI 10.1093/carcin/bgn115; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wu JJ, 2006, CANCER RES, V66, P6899, DOI 10.1158/0008-5472.CAN-06-0276; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhao YW, 2005, ONCOL REP, V13, P721	65	56	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10338	10.1371/journal.pone.0010338	http://dx.doi.org/10.1371/journal.pone.0010338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454457	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100002
J	Chen, SG; Owens, GC; Makarenkova, H; Edelman, DB				Chen, Sigeng; Owens, Geoffrey C.; Makarenkova, Helen; Edelman, David B.			HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons	PLOS ONE			English	Article							KINESIN-HEAVY-CHAIN; AXONAL-TRANSPORT; MICROTUBULE ACETYLATION; ALZHEIMERS-DISEASE; TUBULIN; DEACETYLASE; BINDING; INTERACTS; PARKIN; MILTON	Background: Tubulin is a major substrate of the cytoplasmic class II histone deacetylase HDAC6. Inhibition of HDAC6 results in higher levels of acetylated tubulin and enhanced binding of the motor protein kinesin-1 to tubulin, which promotes transport of cargoes along microtubules. Microtubule-dependent intracellular trafficking may therefore be regulated by modulating the activity of HDAC6. We have shown previously that the neuromodulator serotonin increases mitochondrial movement in hippocampal neurons via the Akt-GSK3 beta signaling pathway. Here, we demonstrate a role for HDAC6 in this signaling pathway. Methodology/Principal Findings: We found that the presence of tubacin, a specific HDAC6 inhibitor, dramatically enhanced mitochondrial movement in hippocampal neurons, whereas niltubacin, an inactive tubacin analog, had no effect. Compared to control cultures, higher levels of acetylated tubulin were found in neurons treated with tubacin, and more kinesin-1 was associated with mitochondria isolated from these neurons. Inhibition of GSK3 beta decreased cytoplasmic deacetylase activity and increased tubulin acetylation, whereas blockade of Akt, which phosphorylates and down-regulates GSK3 beta, increased cytoplasmic deacetylase activity and decreased tubulin acetylation. Concordantly, the administration of 5-HT, 8-OH-DPAT (a specific 5-HT1A receptor agonist), or fluoxetine (a 5-HT reuptake inhibitor) increased tubulin acetylation. GSK3 beta was found to co-localize with HDAC6 in hippocampal neurons, and inhibition of GSK3 beta resulted in decreased binding of antibody to phosphoserine-22, a potential GSK3 beta phosphorylation site in HDAC6. GSK3 beta may therefore regulate HDAC6 activity by phosphorylation. Conclusions/Significance: This study demonstrates that HDAC6 plays an important role in the modulation of mitochondrial transport. The link between HDAC6 and GSK3 beta, established here, has important implications for our understanding of neurodegenerative disorders. In particular, abnormal mitochondrial transport, which has been observed in such disorders as Alzheimer's disease and Parkinson's disease, could result from the misregulation of HDAC6 by GSK3 beta. HDAC6 may therefore constitute an attractive target in the treatment of these disorders.	[Chen, Sigeng; Owens, Geoffrey C.; Makarenkova, Helen; Edelman, David B.] Inst Neurosci, San Diego, CA USA		Chen, SG (corresponding author), Inst Neurosci, San Diego, CA USA.	schen@nsi.edu	Chen, Sigeng/G-1678-2014		Neurosciences Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	Neurosciences Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the Neurosciences Research Foundation. The Neurosciences Research Foundation did not have any role in study design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Beal M Flint, 2007, Novartis Found Symp, V287, P183; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chen J, 2008, GENOME RES, V18, P123, DOI 10.1101/gr.6940108; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; DING H, 2008, J NEUROCHEM; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Pigino G, 2003, J NEUROSCI, V23, P4499; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Schlager MA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-25; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Trejo HE, 2010, FASEB J, V24, P374, DOI 10.1096/fj.09-137802; Trimmer PA, 2005, ANTIOXID REDOX SIGN, V7, P1101, DOI 10.1089/ars.2005.7.1101; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	43	271	280	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10848	10.1371/journal.pone.0010848	http://dx.doi.org/10.1371/journal.pone.0010848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520769	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500033
J	Cohen, H; Voss, P; Lepore, F; Scherzer, P				Cohen, Henri; Voss, Patrice; Lepore, Franco; Scherzer, Peter			The Nature of Working Memory for Braille	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EARLY VISUAL-CORTEX; TACTILE ACUITY; LATE BLIND; CONGENITALLY BLIND; ADAPTIVE-CHANGES; DISCRIMINATION; RECOGNITION; PERFORMANCE; ACTIVATION	Blind individuals have been shown on multiple occasions to compensate for their loss of sight by developing exceptional abilities in their remaining senses. While most research has been focused on perceptual abilities per se in the auditory and tactile modalities, recent work has also investigated higher-order processes involving memory and language functions. Here we examined tactile working memory for Braille in two groups of visually challenged individuals (completely blind subjects, CBS; blind with residual vision, BRV). In a first experimental procedure both groups were given a Braille tactile memory span task with and without articulatory suppression, while the BRV and a sighted group performed a visual version of the task. It was shown that the Braille tactile working memory (BrWM) of CBS individuals under articulatory suppression is as efficient as that of sighted individuals' visual working memory in the same condition. Moreover, the results suggest that BrWM may be more robust in the CBS than in the BRV subjects, thus pointing to the potential role of visual experience in shaping tactile working memory. A second experiment designed to assess the nature (spatial vs. verbal) of this working memory was then carried out with two new CBS and BRV groups having to perform the Braille task concurrently with a mental arithmetic task or a mental displacement of blocks task. We show that the disruption of memory was greatest when concurrently carrying out the mental displacement of blocks, indicating that the Braille tactile subsystem of working memory is likely spatial in nature in CBS. The results also point to the multimodal nature of working memory and show how experience can shape the development of its subcomponents.	[Cohen, Henri] Univ Paris 05, CNRS, Lab Psychol & Neuropsychol Cognit, FRE 3292, Boulogne Billancourt, France; [Cohen, Henri; Scherzer, Peter] Univ Quebec, Inst Cognit Sci, Montreal, PQ H3C 3P8, Canada; [Cohen, Henri] Clin St Anne, Quebec Memory & Motor Skills Disorders Res Ctr, Quebec City, PQ, Canada; [Voss, Patrice; Lepore, Franco] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Montreal; Universite de Montreal	Cohen, H (corresponding author), Univ Paris 05, CNRS, Lab Psychol & Neuropsychol Cognit, FRE 3292, Boulogne Billancourt, France.	henri.cohen@parisdescartes.fr	voss, patrice/I-7026-2019	voss, patrice/0000-0001-8698-7130	FQRSC (Fonds de recherche sur la societe et la culture) (Quebec)	FQRSC (Fonds de recherche sur la societe et la culture) (Quebec)	This study was aided in part by a grant from FQRSC (Fonds de recherche sur la societe et la culture) (Quebec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2008, EXP BRAIN RES, V187, P587, DOI 10.1007/s00221-008-1327-7; Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; AXELROD S, 1959, RES SERIES AM FDN BL, V7; BADDELEY A, 1992, Q J EXP PSYCHOL-A, V44, P1, DOI 10.1080/14640749208401281; Baddeley A. D, 1986, WORKING MEMORY; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Bliss I, 2004, COGNITIVE BRAIN RES, V18, P273, DOI 10.1016/j.cogbrainres.2003.10.012; BORINO D, 2008, ARCH ITAL BIOL, V146, P133; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Cornoldi C., 2003, VISUO SPATIAL WORKIN; D'Angiulli A, 2002, INT J REHABIL RES, V25, P143, DOI 10.1097/00004356-200206000-00008; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; GILSON EQ, 1969, Q J EXP PSYCHOL, V21, P180, DOI 10.1080/14640746908400211; Goldreich D, 2003, J NEUROSCI, V23, P3439; JONES B, 1975, BRIT J PSYCHOL, V66, P461, DOI 10.1111/j.2044-8295.1975.tb01481.x; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; LOGIE RH, 1990, ACTA PSYCHOL, V75, P55, DOI 10.1016/0001-6918(90)90066-O; Mahrer P, 2002, MEMORY, V10, P7, DOI 10.1080/09658210143000128; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Miles C, 1996, MEMORY, V4, P655, DOI 10.1080/741940995; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; RICE C, 1970, AM F BLIND RES B, V22, P1, DOI DOI 10.3758/S13414-011-0160-4; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Roder B, 2000, NEUROPSYCHOLOGIA, V38, P1482, DOI 10.1016/S0028-3932(00)00057-9; Roder B, 2003, INT J PSYCHOPHYSIOL, V50, P27, DOI 10.1016/S0167-8760(03)00122-3; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Roder B, 2001, COGNITIVE BRAIN RES, V11, P289, DOI 10.1016/S0926-6410(01)00002-7; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saito DN, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-79; SULLIVAN EV, 1972, Q J EXP PSYCHOL, V24, P253, DOI 10.1080/14640747208400278; Theoret H, 2004, J PHYSIOL-PARIS, V98, P221, DOI 10.1016/j.jphysparis.2004.03.009; Vecchi T, 2004, NEUROREPORT, V15, P2787; Vecchi T, 1998, MEMORY, V6, P91, DOI 10.1080/741941601; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; VOSS P, 2010, WILEY INTER IN PRESS; Zhou YD, 1997, EXP BRAIN RES, V116, P551, DOI 10.1007/PL00005783; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10833	10.1371/journal.pone.0010833	http://dx.doi.org/10.1371/journal.pone.0010833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603PW	20520807	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500019
J	Safdar, A; Hamadeh, MJ; Kaczor, JJ; Raha, S; Debeer, J; Tarnopolsky, MA				Safdar, Adeel; Hamadeh, Mazen J.; Kaczor, Jan J.; Raha, Sandeep; deBeer, Justin; Tarnopolsky, Mark A.			Aberrant Mitochondrial Homeostasis in the Skeletal Muscle of Sedentary Older Adults	PLOS ONE			English	Article							DNA-DELETION MUTATIONS; CONJUGATED LINOLEIC-ACID; C-REACTIVE PROTEIN; NITRIC-OXIDE; RESISTANCE EXERCISE; PHYSICAL-ACTIVITY; OXIDATIVE DAMAGE; CREATINE MONOHYDRATE; SUPEROXIDE-DISMUTASE; INFLAMMATORY MARKERS	The role of mitochondrial dysfunction and oxidative stress has been extensively characterized in the aetiology of sarcopenia (aging-associated loss of muscle mass) and muscle wasting as a result of muscle disuse. What remains less clear is whether the decline in skeletal muscle mitochondrial oxidative capacity is purely a function of the aging process or if the sedentary lifestyle of older adult subjects has confounded previous reports. The objective of the present study was to investigate if a recreationally active lifestyle in older adults can conserve skeletal muscle strength and functionality, chronic systemic inflammation, mitochondrial biogenesis and oxidative capacity, and cellular antioxidant capacity. To that end, muscle biopsies were taken from the vastus lateralis of young and age-matched recreationally active older and sedentary older men and women (N = 10/group; R female = male). We show that a physically active lifestyle is associated with the partial compensatory preservation of mitochondrial biogenesis, and cellular oxidative and antioxidant capacity in skeletal muscle of older adults. Conversely a sedentary lifestyle, associated with osteoarthritis-mediated physical inactivity, is associated with reduced mitochondrial function, dysregulation of cellular redox status and chronic systemic inflammation that renders the skeletal muscle intracellular environment prone to reactive oxygen species-mediated toxicity. We propose that an active lifestyle is an important determinant of quality of life and molecular progression of aging in skeletal muscle of the elderly, and is a viable therapy for attenuating and/or reversing skeletal muscle strength declines and mitochondrial abnormalities associated with aging.	[Safdar, Adeel] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Safdar, Adeel; Hamadeh, Mazen J.; Kaczor, Jan J.; Raha, Sandeep; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [deBeer, Justin] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Hamadeh, Mazen J.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; York University - Canada	Safdar, A (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Raha, Sandeep/AAF-3655-2020; Kaczor, Jan/A-1990-2008; Kaczor, Jan/AAH-5078-2021; Kaczor, Jan/ABC-6283-2021	Raha, Sandeep/0000-0001-7307-3292; Kaczor, Jan/0000-0002-6370-2160; Safdar, Adeel/0000-0003-2469-0467; Hamadeh, Mazen/0000-0002-3511-4345; Safdar, Adeel/0000-0002-7453-7770	Canadian Institute of Health Research (CIHR); Physician Services Incorporated; CIHR - Institute of Aging	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Physician Services Incorporated; CIHR - Institute of Aging(Canadian Institutes of Health Research (CIHR))	Funding: Funding for this work was primarily from grants to MAT from the Canadian Institute of Health Research (CIHR), the Physician Services Incorporated, and a donation from Mr. Warren Lammert and Family. AS was funded by CIHR - Institute of Aging Doctoral Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x; Albert MA, 2004, AM J CARDIOL, V93, P221, DOI 10.1016/j.amjcard.2003.09.046; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839; Bauer JM, 2008, EXP GERONTOL, V43, P674, DOI 10.1016/j.exger.2008.03.007; Berk DR, 2006, J GERONTOL A-BIOL, V61, P97, DOI 10.1093/gerona/61.1.97; Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bosomworth NJ, 2009, CAN FAM PHYSICIAN, V55, P871; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; BUFORD TW, J GERONTOL A; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Capasso M, 2008, MUSCLE NERVE, V37, P196, DOI 10.1002/mus.20907; CARDELLACH F, 1989, LANCET, V2, P44; Cesari M, 2006, AM J CLIN NUTR, V83, P1142, DOI 10.1093/ajcn/83.5.1142; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; Chokshi NK, 2008, SEMIN PERINATOL, V32, P92, DOI 10.1053/j.semperi.2008.01.002; Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Fakhrzadeh L, 2008, TOXICOL APPL PHARM, V227, P380, DOI 10.1016/j.taap.2007.11.012; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Franceschi C, 2001, AGING-CLIN EXP RES, V13, P163, DOI 10.1007/BF03351475; FRANSEN M, OSTEOARTHRITIS CARTI; Frontera WR, 2008, J APPL PHYSIOL, V105, P637, DOI 10.1152/japplphysiol.90332.2008; Frontera WR, 2003, MUSCLE NERVE, V28, P601, DOI 10.1002/mus.10480; Frontera WR, 2001, INT J SPORT NUTR EXE, V11, pS16, DOI 10.1123/ijsnem.11.s1.s16; Frontera WR, 2000, AM J PHYSIOL-CELL PH, V279, pC611, DOI 10.1152/ajpcell.2000.279.3.C611; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Hepple Russell T, 2003, Sci Aging Knowledge Environ, V2003, ppe31; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9; HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009; Hubbard RE, 2008, J AM GERIATR SOC, V56, P279, DOI 10.1111/j.1532-5415.2007.01548.x; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184; Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee HC, 1997, J FORMOS MED ASSOC, V96, P770; Leeuwenburgh C, 2006, ANTIOXID REDOX SIGN, V8, P503, DOI 10.1089/ars.2006.8.503; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001; Leveille SG, 1999, AM J EPIDEMIOL, V149, P654; LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Mahler D A, 1986, Clin Geriatr Med, V2, P433; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Melton L J 3rd, 2000, Mayo Clin Proc, V75 Suppl, pS10; Melton LJ, 2000, MAYO CLIN P S, V75, pS12, DOI DOI 10.1016/S0025-6196(19)30635-4; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195; Rooyackers OE, 1997, MUSCLE NERVE, pS93; Roy BD, 2005, ARCH PHYS MED REHAB, V86, P1293, DOI 10.1016/j.apmr.2005.01.005; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Safdar A, 2008, PHYSIOL GENOMICS, V32, P219, DOI 10.1152/physiolgenomics.00157.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Shi X, 2007, FREE RADICAL RES, V41, P1313, DOI 10.1080/10715760701687117; Sohal RS, 1997, FASEB J, V11, P1269, DOI 10.1096/fasebj.11.14.9409545; SONG R, J ALTERN COMPLEMENT, V16, P227; Spector TD, 1997, ARTHRITIS RHEUM, V40, P723, DOI 10.1002/art.1780400419; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Strawbridge WJ, 1996, AM J EPIDEMIOL, V144, P135, DOI 10.1093/oxfordjournals.aje.a008900; Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P213, DOI 10.1139/H07-142; THOMAS NE, 2008, SCAND J MED SCI SPOR; THOMPSON LV, 2008, EXP GERONTOL; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Trappe SW, 1996, J APPL PHYSIOL, V80, P285, DOI 10.1152/jappl.1996.80.1.285; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; TSENG BS, 1995, J GERONTOL A-BIOL, V50, P113; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wilkie R, 2007, ARTHRIT RHEUM-ARTHR, V57, P1381, DOI 10.1002/art.23083; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zucchini C, 1995, BIOCHEM MOL BIOL INT, V37, P607	98	130	131	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10778	10.1371/journal.pone.0010778	http://dx.doi.org/10.1371/journal.pone.0010778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520725	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600009
J	Love, W; Dobbs, N; Tabor, L; Simecka, JW				Love, Wees; Dobbs, Nicole; Tabor, Leslie; Simecka, Jerry W.			Toll-Like Receptor 2 (TLR2) Plays a Major Role in Innate Resistance in the Lung against Murine Mycoplasma	PLOS ONE			English	Article							NF-KAPPA-B; ALVEOLAR MACROPHAGES; RESPIRATORY-INFECTIONS; GAMMA-INTERFERON; IMMUNE-RESPONSE; CUTTING EDGE; HOST-DEFENSE; PNEUMONIAE; EXPRESSION; PULMONIS	Mycoplasma lipoproteins are recognized by Toll-like receptors (TLR), but TLRs' role in responses to infection are unknown. Mycoplasma pulmonis is a naturally occurring respiratory pathogen in mice. In the current study, we used TLR-transfected HEK cells and TLR2(-/-) bone marrow-derived dendritic cells to demonstrate TLR2-mediated events are important in the initial host-mycoplasma interactions promoting cytokine responses. As we found alveolar macrophages expressed TLR1, TLR2 and TLR6 mRNAs, a role for TLR2 in innate immune clearance in lungs was examined. Three days post-infection, TLR2(-/-) mice had higher M. pulmonis numbers in lungs, but not in nasal passages. However, TLR2(-/-) mice had higher lung cytokine levels, indicating TLR2-independent mechanisms are also involved in host responses. Thus, TLR2 plays a critical role in the ability of innate immunity to determine M. pulmonis numbers in the lung, and it is likely that early after respiratory infection that TLR2 recognition of M. pulmonis triggers initial cytokine responses of host cells.	[Love, Wees; Dobbs, Nicole; Tabor, Leslie; Simecka, Jerry W.] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Love, W (corresponding author), Univ N Texas Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX USA.	jsimecka@hsc.unt.edu			Public Health Service [1R01HL069431]; National Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069431] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Grant 1R01HL069431 (to J.W.S.). Wees Love, Ph. D. was supported by National Heart Institute Minority Research Supplement for this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CASSELL GH, 1982, REV INFECT DIS, V4, pS18; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; DAVIDSON MK, 1988, INFECT IMMUN, V56, P2163, DOI 10.1128/IAI.56.8.2163-2168.1988; DAVIS JK, 1992, AM REV RESPIR DIS, V145, P406, DOI 10.1164/ajrccm/145.2_Pt_1.406; DAVIS JK, 1980, INFECT IMMUN, V29, P590; Davison P. A., 1991, Seed Science Research, V1, P29; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Echchannaoui H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-25; ERB P, 1979, INFECT IMMUN, V25, P11, DOI 10.1128/IAI.25.1.11-15.1979; FAULKNER CB, 1995, INFECT IMMUN, V63, P4084, DOI 10.1128/IAI.63.10.4084-4090.1995; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; FOY HM, 1979, J INFECT DIS, V139, P681, DOI 10.1093/infdis/139.6.681; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Fuse ET, 2007, J MED MICROBIOL, V56, P305, DOI 10.1099/jmm.0.46913-0; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; HickmanDavis JM, 1997, INFECT IMMUN, V65, P2278, DOI 10.1128/IAI.65.6.2278-2282.1997; HICKMANDAVIS JM, 1998, AM J PHYSL LUNG CELL, V18; Hodge LM, 2002, J INFECT DIS, V186, P290, DOI 10.1086/341280; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Isaacs D, 2002, MED J AUSTRALIA, V177, pS50; Jones HP, 2003, FRONT BIOSCI-LANDMRK, V8, pD930, DOI 10.2741/1098; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Kraft M, 2006, J ALLERGY CLIN IMMUN, V117, P1197, DOI 10.1016/j.jaci.2006.03.001; KRAUSE DC, 1993, MYCOPLASMAS MOL BIOL, P417; KRUISBEEK A, 1999, CURRENT PROTOCOLS IM; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mitsunari M, 2006, J REPROD IMMUNOL, V72, P46, DOI 10.1016/j.jri.2006.02.003; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Powell Jonathan D, 2004, Clin Dev Immunol, V11, P77, DOI 10.1080/10446670410001670535; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sato M, 1999, IMMUNOL LETT, V67, P63, DOI 10.1016/S0165-2478(98)00186-2; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2004, IMMUNOLOGY, V113, P121, DOI 10.1111/j.1365-2567.2004.01937.x; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Simecka Jerry W., 1992, P391; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Weinberger M, 2004, DRUG DISCOV TODAY, V9, P831, DOI 10.1016/S1359-6446(04)03239-8; Woolard MD, 2005, INFECT IMMUN, V73, P6742, DOI 10.1128/IAI.73.10.6742-6751.2005; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wu Q, 2008, AM J RESP CRIT CARE, V177, P720, DOI 10.1164/rccm.200709-1387OC; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	50	30	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10739	10.1371/journal.pone.0010739	http://dx.doi.org/10.1371/journal.pone.0010739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505832	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300012
J	Denney, L; Aitken, C; Li, CKF; Wilson-Davies, E; Kok, WL; Clelland, C; Rooney, K; Young, D; Dong, T; McMichael, AJ; Carman, WF; Ho, LP				Denney, Laura; Aitken, Celia; Li, Chris Ka-Fai; Wilson-Davies, Eleri; Kok, Wai Ling; Clelland, Colin; Rooney, Kevin; Young, Duncan; Dong, Tao; McMichael, Andrew J.; Carman, William F.; Ho, Ling-Pei			Reduction of Natural Killer but Not Effector CD8 T Lymphoyctes in Three Consecutive Cases of Severe/Lethal H1N1/09 Influenza A Virus Infection	PLOS ONE			English	Article							HUMAN NK CELLS; HUMAN-PREGNANCY; RESPONSES; HLA; RECOGNITION; PATHOLOGY; ANTIGENS; MITOGENS; ABSENCE; GENES	Background: The cause of severe disease in some patients infected with pandemic influenza A virus is unclear. Methodology/Principal Findings: We present the cellular immunology profile in the blood, and detailed clinical (and postmortem) findings of three patients with rapidly progressive infection, including a pregnant patient who died. The striking finding is of reduction in natural killer (NK) cells but preservation of activated effector CD8 T lymphocytes; with viraemia in the patient who had no NK cells. Comparison with control groups suggests that the reduction of NK cells is unique to these severely ill patients. Conclusion/Significance: Our report shows markedly reduced NK cells in the three patients that we sampled and raises the hypothesis that NK may have a more significant role than T lymphocytes in controlling viral burden when the host is confronted with a new influenza A virus subtype.	[Denney, Laura; Li, Chris Ka-Fai; Kok, Wai Ling; Dong, Tao; McMichael, Andrew J.; Ho, Ling-Pei] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford, England; [Aitken, Celia; Wilson-Davies, Eleri; Carman, William F.] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland; [Clelland, Colin] John Radcliffe Hosp, Dept Pathol, Oxford OX3 9DU, England; [Young, Duncan] John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England; [Rooney, Kevin] Royal Alexandra Hosp, Intens Care Unit, Paisley, Renfrew, Scotland; [Ho, Ling-Pei] Oxford Radcliffe NHS Trust, Oxford Ctr Resp Med, Oxford, England	University of Oxford; Gartnavel Royal Hospital; University of Oxford; University of Oxford	Denney, L (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford, England.	Ling-pei.ho@imm.ox.ac.uk	Ho, Ling-Pei/AAL-4776-2021; LI, chris/HDO-6232-2022	Dong, Tao/0000-0003-3545-3758; Ho, Ling Pei/0000-0001-8319-301X; Young, John Duncan/0000-0002-6838-4835	Medical Research Council (UK); Medical Research Council [G1000800a, G1001046, G0600520, G0600371] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68] Funding Source: researchfish; MRC [G1001046, G0600371, G0600520] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BIRKELAND SA, 1980, SCAND J IMMUNOL, V11, P321, DOI 10.1111/j.1365-3083.1980.tb00240.x; Carr MJ, 2009, J CLIN VIROL, V45, P196, DOI 10.1016/j.jcv.2009.06.001; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; ELLWART JW, 1990, CYTOMETRY, V11, P239, DOI 10.1002/cyto.990110204; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GEHRZ RC, 1981, AM J OBSTET GYNECOL, V140, P665, DOI 10.1016/0002-9378(81)90201-5; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; *HLTH PROT AG HLTH, 2009, EUROSURVEILLANCE, V14, P19232; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Ho LP, 2005, LANCET, V365, P1062, DOI 10.1016/S0140-6736(05)71143-0; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Le Bouteiller P, 2008, AM J REPROD IMMUNOL, V59, P401, DOI 10.1111/j.1600-0897.2008.00597.x; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Manaster I, 2008, PLACENTA, V29, pS60, DOI 10.1016/j.placenta.2007.10.006; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Shu YL, 2010, J INFECT DIS, V201, P1173, DOI 10.1086/651457; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; THONG YH, 1973, NEW ENGL J MED, V289, P604, DOI 10.1056/NEJM197309202891203; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582	36	55	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10675	10.1371/journal.pone.0010675	http://dx.doi.org/10.1371/journal.pone.0010675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502691	gold, Green Submitted, Green Published			2022-12-27	WOS:000277776500001
J	MacNeil, LG; Melov, S; Hubbard, AE; Baker, SK; Tarnopolsky, MA				MacNeil, Lauren G.; Melov, Simon; Hubbard, Alan E.; Baker, Steven K.; Tarnopolsky, Mark A.			Eccentric Exercise Activates Novel Transcriptional Regulation of Hypertrophic Signaling Pathways Not Affected by Hormone Changes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SERUM RESPONSE FACTOR; ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; RHO-GTPASES; SATELLITE CELLS; RESISTANCE EXERCISE; GENDER-DIFFERENCES; SEX-DIFFERENCES	Unaccustomed eccentric exercise damages skeletal muscle tissue, activating mechanisms of recovery and remodeling that may be influenced by the female sex hormone 17 beta-estradiol (E2). Using high density oligonucleotide based microarrays, we screened for differences in mRNA expression caused by E2 and eccentric exercise. After random assignment to 8 days of either placebo (CON) or E2 (EXP), eighteen men performed 150 single-leg eccentric contractions. Muscle biopsies were collected at baseline (BL), following supplementation (PS), +3 hours (3H) and +48 hours (48H) after exercise. Serum E2 concentrations increased significantly with supplementation (P<0.001) but did not affect microarray results. Exercise led to early transcriptional changes in striated muscle activator of Rho signaling (STARS), Rho family GTPase 3 (RND3), mitogen activated protein kinase (MAPK) regulation and the downstream transcription factor FOS. Targeted RT-PCR analysis identified concurrent induction of negative regulators of calcineurin signaling RCAN (P<0.001) and HMOX1 (P=0.009). Protein contents were elevated for RND3 at 3H (P=0.02) and FOS at 48H (P<0.05). These findings indicate that early RhoA and NFAT signaling and regulation are altered following exercise for muscle remodeling and repair, but are not affected by E2.	[MacNeil, Lauren G.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Melov, Simon] Buck Inst Age Res, Novato, CA USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Baker, Steven K.; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; Buck Institute for Research on Aging; University of California System; University of California Berkeley; McMaster University; McMaster University	MacNeil, LG (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	Natural Sciences and Engineering Council of Canada (NSERC) [183817-07]; Glenn foundation for Medical Research	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Glenn foundation for Medical Research	This study was supported by a grant in aid from the Natural Sciences and Engineering Council of Canada (NSERC) to M. T.(183817-07). S. M. was supported by financial assistance from the Glenn foundation for Medical Research. L. M. was supported by a graduate scholarship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMELINK GJ, 1986, J NEUROL SCI, V76, P61, DOI 10.1016/0022-510X(86)90142-5; AMELINK GJ, 1988, PFLUG ARCH EUR J PHY, V412, P417, DOI 10.1007/BF01907561; AMELINK GJ, 1990, ACTA PHYSIOL SCAND, V138, P115, DOI 10.1111/j.1748-1716.1990.tb08823.x; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Arnett MG, 2000, CAN J APPL PHYSIOL, V25, P419, DOI 10.1139/h00-027; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Beaton LJ, 2002, MED SCI SPORT EXER, V34, P798, DOI 10.1097/00005768-200205000-00012; Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Clarkson PM, 2001, CURR OPIN CLIN NUTR, V4, P527, DOI 10.1097/00075197-200111000-00011; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Devries MC, 2005, J CLIN ENDOCR METAB, V90, P6218, DOI 10.1210/jc.2005-0926; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Enns DL, 2008, J APPL PHYSIOL, V104, P347, DOI 10.1152/japplphysiol.00128.2007; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fiedler B, 2004, CARDIOVASC RES, V63, P450, DOI 10.1016/j.cardiores.2004.04.002; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; FRIDEN J, 1984, INT J SPORTS MED, V5, P15, DOI 10.1055/s-2008-1025873; Gao GX, 2009, BIOCHEM BIOPH RES CO, V385, P439, DOI 10.1016/j.bbrc.2009.05.090; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOUSH DJ, 1995, MED SCI SPORT EXER, V27, P784; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JONES DA, 1989, J PHYSIOL-LONDON, V412, P415, DOI 10.1113/jphysiol.1989.sp017624; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; Katzenellenbogen BS, 2000, J STEROID BIOCHEM, V74, P279, DOI 10.1016/S0960-0760(00)00104-7; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Komulainen J, 1999, ACTA PHYSIOL SCAND, V165, P57; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; Leinwand LA, 2001, P NATL ACAD SCI USA, V98, P2947, DOI 10.1073/pnas.051033698; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mahadeva H, 2002, FEBS LETT, V521, P100, DOI 10.1016/S0014-5793(02)02833-8; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Mendez P, 2005, J ENDOCRINOL, V185, P11, DOI 10.1677/joe.1.06058; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; NEWHAM DJ, 1983, J NEUROL SCI, V61, P109, DOI 10.1016/0022-510X(83)90058-8; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Papa I, 1999, J MUSCLE RES CELL M, V20, P187, DOI 10.1023/A:1005489319058; Persky AM, 2000, P SOC EXP BIOL MED, V223, P59, DOI 10.1046/j.1525-1373.2000.22308.x; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Puntschart A, 1998, AM J PHYSIOL-CELL PH, V274, pC129, DOI 10.1152/ajpcell.1998.274.1.C129; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Santalucia T, 2003, CARDIOVASC RES, V59, P639, DOI 10.1016/S0008-6363(03)00472-3; SASAI N, 2009, MUSCLE NERVE; Schneider BS, 1999, RES NURS HEALTH, V22, P243, DOI 10.1002/(SICI)1098-240X(199906)22:3<243::AID-NUR6>3.0.CO;2-X; Sribnick EA, 2004, NEUROCHEM RES, V29, P2007, DOI 10.1007/s11064-004-6874-0; Stupka N, 2001, J APPL PHYSIOL, V91, P1828, DOI 10.1152/jappl.2001.91.4.1828; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Stupka N, 2001, J APPL PHYSIOL, V91, P1669, DOI 10.1152/jappl.2001.91.4.1669; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Tarnopolsky MA, 2001, MUSCLE NERVE, V24, P682, DOI 10.1002/mus.1055; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tiidus PM, 2009, J APPL PHYSIOL, V106, P1010, DOI 10.1152/japplphysiol.90848.2008; Tiidus PM, 2005, BRIT J SPORT MED, V39, P251, DOI 10.1136/bjsm.2005.016881; Tiidus PM, 2005, ACTA PHYSIOL SCAND, V184, P67, DOI 10.1111/j.1365-201X.2005.01427.x; TIIDUS PM, 1995, CAN J APPL PHYSIOL, V20, P26, DOI 10.1139/h95-002; Tiidus PM, 2001, CAN J PHYSIOL PHARM, V79, P400, DOI 10.1139/cjpp-79-5-400; Tongers J, 2004, CARDIOVASC RES, V63, P545, DOI 10.1016/j.cardiores.2004.04.015; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wiik A, 2003, ACTA PHYSIOL SCAND, V179, P381, DOI 10.1046/j.0001-6772.2003.01186.x; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wright DC, 2007, APPL PHYSIOL NUTR ME, V32, P840, DOI 10.1139/H07-062; XAVIER CP, 2009, J MOL BIOL; Xie Y, 2008, J CELL SCI, V121, P514, DOI 10.1242/jcs.013557; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	106	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10695	10.1371/journal.pone.0010695	http://dx.doi.org/10.1371/journal.pone.0010695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502695	Green Published, gold, Green Submitted			2022-12-27	WOS:000277776500012
J	Tun, HW; Marlow, LA; von Roemeling, CA; Cooper, SJ; Kreinest, P; Wu, K; Luxon, BA; Sinha, M; Anastasiadis, PZ; Copland, JA				Tun, Han W.; Marlow, Laura A.; von Roemeling, Christina A.; Cooper, Simon J.; Kreinest, Pamela; Wu, Kevin; Luxon, Bruce A.; Sinha, Mala; Anastasiadis, Panos Z.; Copland, John A.			Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; TRANSCRIPTION FACTORS; OXIDATIVE-PHOSPHORYLATION; CANCER; KIDNEY; RECEPTOR-4; PROTEIN; CXCR4; DMRT2; TUMOR	Background: Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. The purpose of this study is to define a biological pathway signature and a cellular differentiation program in ccRCC. Methodology: We performed gene expression profiling of early-stage ccRCC and patient-matched normal renal tissue using Affymetrix HG-U133a and HG-U133b GeneChips combined with a comprehensive bioinformatic analyses, including pathway analysis. The results were validated by real time PCR and IHC on two independent sample sets. Cellular differentiation experiments were performed on ccRCC cell lines and their matched normal renal epithelial cells, in differentiation media, to determine their mesenchymal differentiation potential. Principal Findings: We identified a unique pathway signature with three major biological alterations-loss of normal renal function, down-regulated metabolism, and immune activation-which revealed an adipogenic gene expression signature linked to the hallmark lipid-laden clear cell morphology of ccRCC. Culturing normal renal and ccRCC cells in differentiation media showed that only ccRCC cells were induced to undergo adipogenic and, surprisingly, osteogenic differentiation. A gene expression signature consistent with epithelial mesenchymal transition (EMT) was identified for ccRCC. We revealed significant down-regulation of four developmental transcription factors (GATA3, TFCP2L1, TFAP2B, DMRT2) that are important for normal renal development. Conclusions: ccRCC is characterized by a lack of epithelial differentiation, mesenchymal/adipogenic transdifferentiation, and pluripotent mesenchymal stem cell-like differentiation capacity in vitro. We suggest that down-regulation of developmental transcription factors may mediate the aberrant differentiation in ccRCC. We propose a model in which normal renal epithelial cells undergo dedifferentiation, EMT, and adipogenic transdifferentiation, resulting in ccRCC. Because ccRCC cells grown in adipogenic media regain the characteristic ccRCC phenotype, we have indentified a new in vitro ccRCC cell model more resembling ccRCC tumor morphology.	[Tun, Han W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA; [Marlow, Laura A.; von Roemeling, Christina A.; Cooper, Simon J.; Kreinest, Pamela; Anastasiadis, Panos Z.; Copland, John A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Wu, Kevin] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Luxon, Bruce A.; Sinha, Mala] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Luxon, Bruce A.; Sinha, Mala] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Tun, HW (corresponding author), Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA.	copland.john@mayo.edu	Luxon, Bruce A/C-9140-2012	Marlow, Laura/0000-0002-4726-9889; von Roemeling, Christina/0000-0002-3754-5544	Sarah and James Kennedy Career Development Award [CA104505, CA125807, CA104505-05S1]; Scheidel Foundation; David and Lois Stulberg Endowed Fund for Kidney Cancer; NATIONAL CANCER INSTITUTE [R44CA125807, R01CA104505, R43CA125807] Funding Source: NIH RePORTER	Sarah and James Kennedy Career Development Award; Scheidel Foundation; David and Lois Stulberg Endowed Fund for Kidney Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by a Sarah and James Kennedy Career Development Award (H. W. T.), CA104505 (J.A.C.), CA125807 (J.A.C.), CA104505-05S1 (J.A.C.), a generous gift from Susan A. Olde, OBE (J.A.C.), The Scheidel Foundation (J.A.C.) and the David and Lois Stulberg Endowed Fund for Kidney Cancer (J.A.C.). The parties who provided these funds had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2005, LIFE SCI, V76, P2559, DOI 10.1016/j.lfs.2004.10.054; Amato RJ, 2000, SEMIN ONCOL, V27, P177; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; BEHAM A, 1992, VIRCHOWS ARCH A, V421, P209, DOI 10.1007/BF01611177; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; COOPER SJ, 2010, ONCOGENE; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; DONHUIJSEN K, 1989, PATHOL RES PRACT, V184, P287, DOI 10.1016/S0344-0338(89)80088-3; EBLE J, 2004, TUMORS KIDNEY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferraris S, 2009, AM J MED GENET A, V149A, P770, DOI 10.1002/ajmg.a.32689; Gmeiner WH, 2008, ONCOL REP, V19, P245; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He Z, 2004, CANCER GENET CYTOGEN, V152, P89, DOI 10.1016/j.cancergencyto.2003.11.001; Hervouet E, 2008, CARCINOGENESIS, V29, P1528, DOI 10.1093/carcin/bgn125; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Krambeck AE, 2007, CLIN CANCER RES, V13, P1749, DOI 10.1158/1078-0432.CCR-06-2129; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; LOHI J, 1995, INT J CANCER, V63, P442; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morikawa T, 2007, CLIN CANCER RES, V13, P5703, DOI 10.1158/1078-0432.CCR-07-0603; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ottolenghi C, 2000, GENOMICS, V64, P179, DOI 10.1006/geno.2000.6120; Ounap K, 2004, AM J MED GENET A, V130A, P415, DOI 10.1002/ajmg.a.30269; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rezende RB, 1999, AM J SURG PATHOL, V23, P1532, DOI 10.1097/00000478-199912000-00011; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rosen ED, 2000, GENE DEV, V14, P1293; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schuetz AN, 2005, J MOL DIAGN, V7, P206, DOI 10.1016/S1525-1578(10)60547-8; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Seo KW, 2007, COMPARATIVE MED, V57, P460; Taichman RS, 2002, CANCER RES, V62, P1832; Takahashi M, 2006, J MED INVESTIG, V53, P9, DOI 10.2152/jmi.53.9; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; UNIPROT T, 2009, NUCLEIC ACIDS RES, V37, pD169; Upton MP, 2005, J IMMUNOTHER, V28, P488, DOI 10.1097/01.cji.0000170357.14962.9b; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zhao HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006039	69	132	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10696	10.1371/journal.pone.0010696	http://dx.doi.org/10.1371/journal.pone.0010696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502531	Green Published, gold			2022-12-27	WOS:000277776500013
J	Crowder, CD; Matthews, HE; Schutzer, S; Rounds, MA; Luft, BJ; Nolte, O; Campbell, SR; Phillipson, CA; Li, F; Sampath, R; Ecker, DJ; Eshoo, MW				Crowder, Chris D.; Matthews, Heather E.; Schutzer, Steven; Rounds, Megan A.; Luft, Benjamin J.; Nolte, Oliver; Campbell, Scott R.; Phillipson, Curtis A.; Li, Feng; Sampath, Ranga; Ecker, David J.; Eshoo, Mark W.			Genotypic Variation and Mixtures of Lyme Borrelia in Ixodes Ticks from North America and Europe	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; GENETIC DIVERSITY; MULTILOCUS PCR; BURGDORFERI; DISEASE; SCAPULARIS; INFECTION; OSPC; IDENTIFICATION; POPULATION	Background: Lyme disease, caused by various species of Borrelia, is transmitted by Ixodes ticks in North America and Europe. Studies have shown the genotype of Borrelia burgdorferi sensu stricto (s.s.) or the species of B. burgdorferi sensu lato (s.l.) affects the ability of the bacteria to cause local or disseminated infection in humans. Methodology/Principal Findings: We used a multilocus PCR electrospray mass spectrometry assay to determine the species and genotype Borrelia from ticks collected in New York, Connecticut, Indiana, Southern Germany, and California and characterized isolates from parts of the United States and Europe. These analyses identified 53 distinct genotypes of B. burgdorferi sensu stricto with higher resolution than ospC typing. Genotypes of other members of the B. burgdorferi sensu lato complex were also identified and genotyped including B. afzelii, B. garinii, B. lusitaniae, B. spielmanii, and B. valaisiana. While each site in North America had genotypes unique to that location, we found genotypes shared between individual regions and two genotypes found across the United States. Significant B. burgdorferi s.s. genotypic diversity was observed between North America and Europe: only 6.6% of US genotypes (3 of 45) were found in Europe and 27% of the European genotypes (3 of 11) were observed in the US. Interestingly, 39% of adult Ixodes scapularis ticks from North America were infected with more than one genotype of B. burgdorferi s.s. and 22.2% of Ixodes ricinus ticks from Germany were infected with more than one genotype of B. burgdorferi s.l. Conclusions/Significance: The presence of multiple Borrelia genotypes in ticks increases the probability that a person will be infected with more than one genotype of B. burgdorferi, potentially increasing the risks of disseminated Lyme disease. Our study indicates that the genotypic diversity of Borrelia in ticks in both North America and Europe is higher then previously reported and can have potential clinical consequences.	[Crowder, Chris D.; Matthews, Heather E.; Rounds, Megan A.; Phillipson, Curtis A.; Li, Feng; Sampath, Ranga; Ecker, David J.; Eshoo, Mark W.] Ibis Biosci, Carlsbad, CA USA; [Campbell, Scott R.] Suffolk Cty Dept Hlth Serv, Yaphank, NY USA; [Luft, Benjamin J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Nolte, Oliver] Lab Dr Brunner, Constance, Germany; [Schutzer, Steven] Univ Med & Dent New Jersey, Dept Med, Newark, NJ 07103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University Medical Center	Crowder, CD (corresponding author), Ibis Biosci, Carlsbad, CA USA.	meshoo@ibisbio.com	Nolte, Oliver/AAW-9016-2020	Nolte, Oliver/0000-0002-1761-0812; Ecker, David/0000-0003-4350-9037; Luft, Benjamin/0000-0001-9008-7004	Lyme Disease Association; Tami Fund; National Institute of Allergy and Infectious Diseases [1R43AI077156-01, AI47553]; CDC [200-2008-M-27504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI077156, R44AI047553] Funding Source: NIH RePORTER	Lyme Disease Association; Tami Fund; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Lyme Disease Association, the Tami Fund, National Institute of Allergy and Infectious Diseases (grant # 1R43AI077156-01 and AI47553) and the CDC (contract 200-2008-M-27504) for financial support for this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyn LB, 2008, J CLIN MICROBIOL, V46, P644, DOI 10.1128/JCM.00801-07; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Coyle P K, 1990, Infect Dis Clin North Am, V4, P731; Coyle PK, 2002, MED CLIN N AM, V86, P261, DOI 10.1016/S0025-7125(03)00086-5; COYLE PK, 1993, NEUROLOGY, V43, P1093, DOI 10.1212/WNL.43.6.1093; CROWDER CD, 2009, J MED ENTOM IN PRESS; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; ESHOO MW, 2009, J CLIN MICROBIOL; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Farlow J, 2002, J CLIN MICROBIOL, V40, P4612, DOI 10.1128/JCM.40.12.4612-4618.2002; Fikrig E, 2004, J CLIN MICROBIOL, V42, P1243, DOI 10.1128/JCM.42.3.1243-1246.2004; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hannis JC, 2008, J CLIN MICROBIOL, V46, P1220, DOI 10.1128/JCM.02158-07; HOEN AG, 2009, P NATL ACAD SCI US; Hulinska D, 2007, FOLIA MICROBIOL, V52, P315, DOI 10.1007/BF02932085; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Norris DE, 1997, J CLIN MICROBIOL, V35, P2359, DOI 10.1128/JCM.35.9.2359-2364.1997; Qiu WG, 2008, EMERG INFECT DIS, V14, P1097, DOI 10.3201/eid/1407.070880; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Qiu WG, 2002, GENETICS, V160, P833; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Schutzer SE, 1997, J CLIN INVEST, V100, P763, DOI 10.1172/JCI119589; SCHUTZER SE, 1994, HOSP PRACT, V29, P8, DOI 10.1080/21548331.1994.11443039; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; TOKARZ R, 2009, VECTOR BORNE ZOONOTI; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Vitorino LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004002; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	38	62	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10650	10.1371/journal.pone.0010650	http://dx.doi.org/10.1371/journal.pone.0010650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498837	Green Published, Green Submitted, gold			2022-12-27	WOS:000277771600014
J	Scantlebury, N; Zhao, XL; Moncalvo, VGR; Camiletti, A; Zahanova, S; Dineen, A; Xin, JH; Campos, AR				Scantlebury, Nadia; Zhao, Xiao Li; Moncalvo, Veronica G. Rodriguez; Camiletti, Alison; Zahanova, Stacy; Dineen, Aidan; Xin, Ji-Hou; Campos, Ana Regina			The Drosophila Gene RanBPM Functions in the Mushroom Body to Regulate Larval Behavior	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; SHORT NEUROPEPTIDE-F; K+ CHANNEL MUTANTS; BINDING-PROTEIN; NERVOUS-SYSTEM; FEEDING-BEHAVIOR; MORPHOMETRIC DESCRIPTION; WANDERING BEHAVIOR; SYNAPTIC STRUCTURE; AMINO-ACIDS	Background: In vertebrates, Ran-Binding Protein in the Microtubule Organizing Center (RanBPM) appears to function as a scaffolding protein in a variety of signal transduction pathways. In Drosophila, RanBPM is implicated in the regulation of germ line stem cell (GSC) niche organization in the ovary. Here, we addressed the role of RanBPM in nervous system function in the context of Drosophila larval behavior. Methodology/Principal Findings: We report that in Drosophila, RanBPM is required for larval feeding, light-induced changes in locomotion, and viability. RanBPM is highly expressed in the Kenyon cells of the larval mushroom body (MB), a structure well studied for its role in associative learning in Drosophila and other insects. RanBPM mutants do not display major disruption in nervous system morphology besides reduced proliferation. Expression of the RanBPM gene in the Kenyon cells is sufficient to rescue all behavioral phenotypes. Through genetic epistasis experiments, we demonstrate that RanBPM participates with the Drosophila orthologue of the Fragile X Mental Retardation Protein (FMRP) in the development of neuromuscular junction (NMJ). Conclusions/Significance: We demonstrate that the RanBPM gene functions in the MB neurons for larval behavior. Our results suggest a role for this gene in an FMRP-dependent process. Taken together our findings point to a novel role for the MB in larval behavior.	[Scantlebury, Nadia; Zhao, Xiao Li; Moncalvo, Veronica G. Rodriguez; Camiletti, Alison; Zahanova, Stacy; Dineen, Aidan; Xin, Ji-Hou; Campos, Ana Regina] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Scantlebury, N (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	camposa@mcmaster.ca			Canadian Institutes of Health Research (CIHR) [MOP 12700]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Work funded by a Canadian Institutes of Health Research (CIHR) grant (MOP 12700) to Ana Regina Campos. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Busto M, 1999, J NEUROSCI, V19, P3337; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; DINEEN A, 2009, THESIS MCMASTER U HA; Gasque G, 2006, J CELL PHYSIOL, V209, P1046, DOI 10.1002/jcp.20764; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAASE A, 2008, J NEUROCHEM; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Kaspar M, 2008, DEV BIOL, V324, P177, DOI 10.1016/j.ydbio.2008.08.031; Kim T, 2009, BIOCHEM BIOPH RES CO, V378, P15, DOI 10.1016/j.bbrc.2008.09.034; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li YJ, 2008, BBA-GENE REGUL MECH, V1779, P702, DOI 10.1016/j.bbagrm.2008.07.003; LILLY M, 1990, GENETICS, V124, P293; Martin JR, 1998, LEARN MEMORY, V5, P179; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Migeon JC, 1999, MOL BIOL CELL, V10, P1733, DOI 10.1091/mbc.10.6.1733; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; MONCALVO VGR, 2009, SEROTONERGIC NEURONS; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; SCANTLEBURY N, 2007, DROSOPHILA LARVAL RE; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schulz RA, 1996, ONCOGENE, V12, P1827; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Siomi H, 2004, MENT RETARD DEV D R, V10, P68, DOI 10.1002/mrdd.20011; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang JW, 2002, J NEUROGENET, V16, P45, DOI 10.1080/01677060213106; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zinke I, 1999, DEVELOPMENT, V126, P5275	77	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10652	10.1371/journal.pone.0010652	http://dx.doi.org/10.1371/journal.pone.0010652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498842	Green Published, Green Submitted, gold			2022-12-27	WOS:000277771600016
J	Van der Burg, E; Cass, J; Olivers, CNL; Theeuwes, J; Alais, D				Van der Burg, Erik; Cass, John; Olivers, Christian N. L.; Theeuwes, Jan; Alais, David			Efficient Visual Search from Synchronized Auditory Signals Requires Transient Audiovisual Events	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; STIMULI; VISION; INPUTS; TIME; TOP	Background: A prevailing view is that audiovisual integration requires temporally coincident signals. However, a recent study failed to find any evidence for audiovisual integration in visual search even when using synchronized audiovisual events. An important question is what information is critical to observe audiovisual integration. Methodology/Principal Findings: Here we demonstrate that temporal coincidence (i.e., synchrony) of auditory and visual components can trigger audiovisual interaction in cluttered displays and consequently produce very fast and efficient target identification. In visual search experiments, subjects found a modulating visual target vastly more efficiently when it was paired with a synchronous auditory signal. By manipulating the kind of temporal modulation (sine wave vs. square wave vs. difference wave; harmonic sine-wave synthesis; gradient of onset/offset ramps) we show that abrupt visual events are required for this search efficiency to occur, and that sinusoidal audiovisual modulations do not support efficient search. Conclusions/Significance: Thus, audiovisual temporal alignment will only lead to benefits in visual search if the changes in the component signals are both synchronized and transient. We propose that transient signals are necessary in synchrony-driven binding to avoid spurious interactions with unrelated signals when these occur close together in time.	[Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Cass, John] Univ Western Sydney, Sch Psychol, Sydney, NSW, Australia; [Cass, John] Univ Western Sydney, MARCS Auditory Res Labs, Sydney, NSW, Australia; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Vrije Universiteit Amsterdam; Western Sydney University; Western Sydney University; University of Sydney	Van der Burg, E (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	e.van.der.burg@psy.vu.nl	Theeuwes, Jan/B-6862-2008; Cass, John/AAC-7505-2021; Theeuwes, Jan/ABF-3771-2020; Van der Burg, Erik/E-3013-2010	Olivers, Christian/0000-0001-7470-5378; Theeuwes, Jan/0000-0002-5849-7721	Dutch Technology Foundation [07079]; NWO-VIDI [452-06-007]; Australian Research Council [JC: DP0774697, DA: DP0770299]	Dutch Technology Foundation(Technologiestichting STW); NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Australian Research Council(Australian Research Council)	J. Theeuwes was supported by a Dutch Technology Foundation STW grant (07079), and C. Olivers by a NWO-VIDI grant 452-06-007. J. Cass and D. Alais were supported by Discovery Projects awarded by the Australian Research Council (JC: DP0774697; DA: DP0770299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Mottonen R, 2006, NEUROIMAGE, V30, P563, DOI 10.1016/j.neuroimage.2005.10.002; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Olivers CNL, 2008, BRAIN RES, V1242, P191, DOI 10.1016/j.brainres.2008.01.070; Roseboom W, 2009, J VISION, V9, DOI 10.1167/9.12.4; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Thomas GJ, 1941, J EXP PSYCHOL, V28, P163, DOI 10.1037/h0055183; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Atteveldt NM, 2007, CEREB CORTEX, V17, P962, DOI 10.1093/cercor/bhl007; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; VANDERBURG E, 2008, HUMAN PERCEPTION PER, V34, P1053; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2001, PERCEPT PSYCHOPHYS, V63, P651, DOI 10.3758/BF03194427; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	40	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10664	10.1371/journal.pone.0010664	http://dx.doi.org/10.1371/journal.pone.0010664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597PU	20498844	Green Published, gold			2022-12-27	WOS:000277771600023
J	Sousa-Neves, R; Rosas, A				Sousa-Neves, Rui; Rosas, Alexandre			An Analysis of Genetic Changes during the Divergence of Drosophila Species	PLOS ONE			English	Article							HYBRID LETHAL SYSTEMS; MELANOGASTER; SIMULANS; INVIABILITY; COMPLEX; CHROMOSOMES; MAURITIANA; EVOLUTION; STERILITY; SECHELLIA	Background: It has been long appreciated that speciation involves changes in body plans and establishes genetic, reproductive, developmental and behavioral incompatibilities between populations. However, little is still known about the genetic components involved in these changes or the sequence and scale of events that lead to the differentiation of species. Principal Findings: In this paper, we investigated the genetic changes in three closely related species of Drosophila by making pair-wise comparisons of their genomes. We focused our analysis on the modern relatives of the alleles likely to be segregating in pre-historic populations at the time or after the ancestor of D. simulans became separated from the ancestor of D. melanogaster. Some of these genes were previously implicated in the genetics of reproduction and behavior while the biological functions of others are not yet clear. Conclusions: Together these results identify different classes of genes that might have participated in the beginning of segregation of these species millions of years ago in Africa.	[Sousa-Neves, Rui] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Rosas, Alexandre] Univ Fed Paraiba, CCEN, Dept Fis, BR-58059900 Joao Pessoa, Paraiba, Brazil	Case Western Reserve University; Universidade Federal da Paraiba	Sousa-Neves, R (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	rui.sousaneves@case.edu	Rosas, Alexandre/F-7412-2010	Rosas, Alexandre/0000-0001-7983-358X				Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; BAKER BS, 1972, GENETICS, V71, P255; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Galindo K, 2001, GENETICS, V159, P1059; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hadorn E., 1961, Revue Suisse de Zoologie, V68, P197; Horton IH, 1939, GENETICS, V24, P234; HUTTER P, 1990, GENETICS, V124, P909; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Orr HA, 1997, GENETICS, V145, P1031; Podemski L, 2001, CHROMOSOMA, V110, P305, DOI 10.1007/s004120100151; SANCHEZ L, 1983, ROUX ARCH DEV BIOL, V192, P48, DOI 10.1007/BF00848770; SAWAMURA K, 1993, GENETICS, V133, P307; Sawamura K, 2004, GENETICA, V120, P253, DOI 10.1023/B:GENE.0000017646.11191.b0; SAWAMURA K, 1993, GENETICS, V133, P299; SEILER T, 1974, EXPERIENTIA, V30, P709; STURTEVANT AH, 1929, PUBL CARNEG I WASH, V399, P1; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tomaru M, 2000, EVOLUTION, V54, P1286, DOI 10.1111/j.0014-3820.2000.tb00561.x; WATANABE TK, 1979, SCIENCE, V205, P906, DOI 10.1126/science.205.4409.906; WATANABE TK, 1979, JAPANESE J GENETICS, P325; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P825, DOI 10.1016/S0965-1748(97)00056-8; Wu CJ, 2008, GENETICS, V180, P61, DOI 10.1534/genetics.108.091140	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10485	10.1371/journal.pone.0010485	http://dx.doi.org/10.1371/journal.pone.0010485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463966	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400021
J	Gullo, C; Koh, LK; Pang, WL; Ho, KT; Tan, SH; Schwarz, H				Gullo, Charles; Koh, Liang Kai; Pang, Wan Lu; Ho, Kian Tong; Tan, Shi Hao; Schwarz, Herbert			Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; BONE-MARROW; B-CELLS; MONOCLONAL-ANTIBODY; MONOCYTE ACTIVATION; RECEPTOR FAMILY; GROWTH-FACTOR; 4-1BB; DIFFERENTIATION; INTERLEUKIN-6	Background: Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the second most prevalent blood cancer. At present there is no cure for MM, and the average prognosis is only three to five years. Current treatments such as chemotherapy are able to prolong a patient's life but rarely prevent relapse of the disease. Even hematopoietic stem cell transplants and novel drug combinations are often not curative, underscoring the need for a continued search for novel therapeutics. CD137 and its ligand are members of the Tumor Necrosis Factor (TNF) receptor and TNF superfamilies, respectively. Since CD137 ligand cross-linking enhances proliferation and survival of healthy B cells we hypothesized that it would also act as a growth stimulus for B cell cancers. Methodology/Principal Findings: Proliferation and survival of B cell lymphoma cell lines were not affected or slightly enhanced by CD137 ligand agonists in vitro. But surprisingly, they had the opposite effects on MM cells, where CD137 ligand signals inhibited proliferation and induced cell death by apoptosis. Furthermore, secretion of the pro-inflammatory cytokines, IL-6 and IL-8 were also enhanced in MM but not in non-MM cell lines in response to CD137 ligand agonists. The secretion of these cytokines in response to CD137 ligand signaling was consistent with the observed activation of the classical NF-kappa B pathway. We hypothesize that the induction of this pathway results in activation-induced cell death, and that this is the underlying mechanism of CD137-induced MM cell death and growth arrest. Conclusions/Significance: These data point to a hitherto unrecognized role of CD137 and CD137 ligand in MM cell biology. The selective inhibition of proliferation and induction of cell death in MM cells by CD137 ligand agonists may also warrant a closer evaluation of their therapeutic potential.	[Gullo, Charles; Ho, Kian Tong] Singapore Gen Hosp, Dept Clin Res, Canc Immunol Lab, Singapore 0316, Singapore; [Koh, Liang Kai; Pang, Wan Lu; Tan, Shi Hao; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Singapore General Hospital; National University of Singapore	Gullo, C (corresponding author), Singapore Gen Hosp, Dept Clin Res, Canc Immunol Lab, Singapore 0316, Singapore.	phssh@nus.edu.sg	Gullo, Charles A/X-9938-2019	Gullo, Charles A/0000-0002-4221-0087; Koh, Liang Kai/0000-0002-0687-3510	National Medical Research Council, Singapore [NMRC/1175/2008]; Singapore Cancer Syndicate	National Medical Research Council, Singapore(National Medical Research Council, Singapore); Singapore Cancer Syndicate	This work was supported by a grant (NMRC/1175/2008) from the National Medical Research Council, Singapore (https://www.nmrc.gov.sg/) to HS, and a grant (SCSBS0074) from the Singapore Cancer Syndicate (www.scs.a-star.edu.sg) to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bensinger William I, 2004, Clin Adv Hematol Oncol, V2, P46; Berard M, 1999, IMMUNOLOGY, V98, P47; Bringhen S, 2006, EXPERT OPIN INV DRUG, V15, P1565, DOI 10.1517/13543784.15.12.1565; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Daniel PT, 1997, EUR J IMMUNOL, V27, P1029, DOI 10.1002/eji.1830270433; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; FUNAKOSHI S, 1994, BLOOD, V83, P2787, DOI 10.1182/blood.V83.10.2787.2787; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hwang WYK, 2006, LEUKEMIA, V20, P715, DOI 10.1038/sj.leu.2404099; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Ju SW, 2003, HYBRIDOMA HYBRIDOM, V22, P333, DOI 10.1089/153685903322538872; Jung HW, 2004, EXP MOL MED, V36, P13, DOI 10.1038/emm.2004.2; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KAWANO MM, 1995, BLOOD, V85, P487; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kline M, 2007, LEUKEMIA RES, V31, P591, DOI 10.1016/j.leukres.2006.06.012; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lauta VM, 2003, CANCER, V97, P2440, DOI 10.1002/cncr.11072; Law CL, 2005, CANCER RES, V65, P8331, DOI 10.1158/0008-5472.CAN-05-0095; Lindstedt M, 2003, SCAND J IMMUNOL, V57, P305, DOI 10.1046/j.1365-3083.2003.01217.x; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Podar K, 2004, BLOOD, V103, P3474, DOI 10.1182/blood-2003-10-3527; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; Rajkumar SV, 2005, MAYO CLIN PROC, V80, P1371, DOI 10.4065/80.10.1371; REIBNEGGER G, 1991, CANCER RES, V51, P6250; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; SELINA SK, 2003, IMMUNOL REV, V194, P5; Sica G, 2000, ADV EXP MED BIOL, V465, P355; Szocinski JL, 2002, BLOOD, V100, P217, DOI 10.1182/blood.V100.1.217; Tai YT, 2004, CANCER RES, V64, P2846, DOI 10.1158/0008-5472.CAN-03-3630; Vallet S, 2008, LEUKEMIA LYMPHOMA, V49, P1238, DOI 10.1080/10428190802005191; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; ZHOU Z, 1995, IMMUNOL LETT, V45, P67, DOI 10.1016/0165-2478(94)00227-I	49	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10845	10.1371/journal.pone.0010845	http://dx.doi.org/10.1371/journal.pone.0010845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520765	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221500030
J	Rizzi, M; Knoth, R; Hampe, CS; Lorenz, P; Gougeon, ML; Lemercier, B; Venhoff, N; Ferrera, F; Salzer, U; Thiesen, HJ; Peter, HH; Walker, UA; Eibel, H				Rizzi, Marta; Knoth, Rolf; Hampe, Christiane S.; Lorenz, Peter; Gougeon, Marie-Lise; Lemercier, Brigitte; Venhoff, Nils; Ferrera, Francesca; Salzer, Ulrich; Thiesen, Hans-Juergen; Peter, Hans-Hartmut; Walker, Ulrich A.; Eibel, Hermann			Long-Lived Plasma Cells and Memory B Cells Produce Pathogenic Anti-GAD65 Autoantibodies in Stiff Person Syndrome	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; HUMAN MONOCLONAL-ANTIBODIES; SYNDROME TYPE-I; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; AUTOIMMUNE-THYROIDITIS; CEREBROSPINAL-FLUID; DIABETES-MELLITUS; DEPLETION THERAPY; ENZYME-ACTIVITY	Stiff person syndrome (SPS) is a rare, neurological disorder characterized by sudden cramps and spasms. High titers of enzyme-inhibiting IgG autoantibodies against the 65 kD isoform of glutamic acid decarboxylase (GAD65) are a hallmark of SPS, implicating an autoimmune component in the pathology of the syndrome. Studying the B cell compartment and the anti-GAD65 B cell response in two monozygotic twins suffering from SPS, who were treated with the B cell-depleting monoclonal anti-CD20 antibody rituximab, we found that the humoral autoimmune response in SPS is composed of a rituximab-sensitive part that is rapidly cleared after treatment, and a rituximab-resistant component, which persists and acts as a reservoir for autoantibodies inhibiting GAD65 enzyme activity. Our data show that these potentially pathogenic anti-GAD65 autoantibodies are secreted by long-lived plasma cells, which may either be persistent or develop from rituximab-resistant memory B lymphocytes. Both subsets represent only a fraction of anti-GAD65 autoantibody secreting cells. Therefore, the identification and targeting of this compartment is a key factor for successful treatment planning of SPS and of similar autoimmune diseases.	[Rizzi, Marta; Venhoff, Nils; Salzer, Ulrich; Peter, Hans-Hartmut; Eibel, Hermann] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Rizzi, Marta; Venhoff, Nils; Salzer, Ulrich; Peter, Hans-Hartmut; Eibel, Hermann] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Rizzi, Marta; Eibel, Hermann] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany; [Knoth, Rolf] Univ Med Ctr Freiburg, Inst Pathol, Dept Neuropathol, Freiburg, Germany; [Hampe, Christiane S.] Univ Washington, Dept Med, Seattle, WA USA; [Lorenz, Peter; Thiesen, Hans-Juergen] Univ Rostock, Inst Immunol, Rostock, Germany; [Gougeon, Marie-Lise; Lemercier, Brigitte] Inst Pasteur, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Ferrera, Francesca] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Walker, Ulrich A.] Univ Basel, Dept Rheumatol, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Washington; University of Washington Seattle; University of Rostock; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Genoa; University of Basel	Rizzi, M (corresponding author), Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany.	hermann.eibel@uniklinik-freiburg.de	Hampe, Christiane Susanne/GSD-7679-2022; Rizzi, Marta/ABE-7264-2020	Rizzi, Marta/0000-0002-5153-6089; Lorenz, Peter A./0000-0001-7925-1002; Salzer, Ulrich/0000-0002-1769-1157; Hampe, Christiane/0000-0001-9111-6671	European Community [LSHM-CT-2004-G05264]; EUROPAD-net [HEALTH-F2-2008-201549]	European Community(European Commission); EUROPAD-net	This work was supported through the European Community funded project Autorome (LSHM-CT-2004-G05264) to HE, PL, MLG, and HJT, and EUROPAD-net (HEALTH-F2-2008-201549) to HE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BJORK E, 1994, DIABETES, V43, P161, DOI 10.2337/diabetes.43.1.161; BRASHEAR HR, 1991, NEUROLOGY, V41, P1588, DOI 10.1212/WNL.41.10.1588; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Dalakas MC, 2005, J NEUROL, V252, P19, DOI 10.1007/s00415-005-1105-4; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Dalakas MC, 2001, NEUROLOGY, V57, P780, DOI 10.1212/WNL.57.5.780; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; El Fassi D, 2007, J CLIN ENDOCR METAB, V92, P1769, DOI 10.1210/jc.2006-2388; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Ferrera F, 2007, CLIN IMMUNOL, V122, P13, DOI 10.1016/j.clim.2006.09.013; Foreman AL, 2008, AUTOIMMUNITY, V41, P80, DOI 10.1080/08916930701619656; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hampe CS, 2001, FEBS LETT, V488, P185, DOI 10.1016/S0014-5793(00)02429-7; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; Iwasaki H, 2001, ENDOCR J, V48, P261, DOI 10.1507/endocrj.48.261; Jaume JC, 2002, J IMMUNOL, V169, P665, DOI 10.4049/jimmunol.169.2.665; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Levy LM, 2005, ARCH NEUROL-CHICAGO, V62, P970, DOI 10.1001/archneur.62.6.970; Levy Lucien M., 1999, Annals of Internal Medicine, V131, P522; Lim A, 2008, INT IMMUNOL, V20, P105, DOI 10.1093/intimm/dxm125; Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18; Madec AM, 1996, J IMMUNOL, V156, P3541; Moller B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2686; Monson NL, 2005, ARCH NEUROL-CHICAGO, V62, P258, DOI 10.1001/archneur.62.2.258; Mouquet H, 2008, J INVEST DERMATOL, V128, P2859, DOI 10.1038/jid.2008.178; Nakou M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2798; NOSSAL GJV, 1964, J EXP MED, V119, P485, DOI 10.1084/jem.119.3.485; Nyholt DR, 2006, TWIN RES HUM GENET, V9, P194, DOI 10.1375/twin.9.2.194; Padoa CJ, 2003, DIABETES, V52, P2689, DOI 10.2337/diabetes.52.11.2689; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Petereit HF, 2009, MULT SCLER J, V15, P189, DOI 10.1177/1352458508098268; Plesner A, 2001, AUTOIMMUNITY, V34, P221, DOI 10.3109/08916930109014691; Presciuttini S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-23; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Raju R, 2008, INT REV IMMUNOL, V27, P79, DOI 10.1080/08830180701883240; Rehnberg M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2789; RICHTER W, 1992, P NATL ACAD SCI USA, V89, P8467, DOI 10.1073/pnas.89.18.8467; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Ruige JB, 1997, DIABETES CARE, V20, P1108, DOI 10.2337/diacare.20.7.1108; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Shaw PJ, 1999, LANCET, V353, P86, DOI 10.1016/S0140-6736(05)76151-1; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Teng YKO, 2007, ARTHRITIS RHEUM-US, V56, P3909, DOI 10.1002/art.22967; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Tremble J, 1997, J CLIN ENDOCR METAB, V82, P2664, DOI 10.1210/jc.82.8.2664; Tuomi T, 1996, J CLIN ENDOCR METAB, V81, P1488, DOI 10.1210/jc.81.4.1488; Venhoff N, 2009, ANN RHEUM DIS, V68, P1506, DOI 10.1136/ard.2008.103721; VICARI AM, 1989, NEW ENGL J MED, V320, P1498; Wasserman RL, 2009, EUR J PHARM SCI, V37, P272, DOI 10.1016/j.ejps.2009.02.014	64	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10838	10.1371/journal.pone.0010838	http://dx.doi.org/10.1371/journal.pone.0010838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520773	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500024
J	Tyagi, N; Anamika, K; Srinivasan, N				Tyagi, Nidhi; Anamika, Krishanpal; Srinivasan, Narayanaswamy			A Framework for Classification of Prokaryotic Protein Kinases	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SIGNAL-TRANSDUCTION PATHWAYS; SERINE THREONINE KINASE; MYCOBACTERIUM-TUBERCULOSIS; EUKARYOTIC-TYPE; MYXOCOCCUS-XANTHUS; TYROSINE KINASE; SER/THR KINASE; SERINE/THREONINE KINASE; CHLAMYDIA-TRACHOMATIS	Background: Overwhelming majority of the Serine/Threonine protein kinases identified by gleaning archaeal and eubacterial genomes could not be classified into any of the well known Hanks and Hunter subfamilies of protein kinases. This is owing to the development of Hanks and Hunter classification scheme based on eukaryotic protein kinases which are highly divergent from their prokaryotic homologues. A large dataset of prokaryotic Serine/Threonine protein kinases recognized from genomes of prokaryotes have been used to develop a classification framework for prokaryotic Ser/Thr protein kinases. Methodology/Principal Findings: We have used traditional sequence alignment and phylogenetic approaches and clustered the prokaryotic kinases which represent 72 subfamilies with at least 4 members in each. Such a clustering enables classification of prokaryotic Ser/Thr kinases and it can be used as a framework to classify newly identified prokaryotic Ser/Thr kinases. After series of searches in a comprehensive sequence database we recognized that 38 subfamilies of prokaryotic protein kinases are associated to a specific taxonomic level. For example 4, 6 and 3 subfamilies have been identified that are currently specific to phylum proteobacteria, cyanobacteria and actinobacteria respectively. Similarly subfamilies which are specific to an order, sub-order, class, family and genus have also been identified. In addition to these, we also identify organism-diverse subfamilies. Members of these clusters are from organisms of different taxonomic levels, such as archaea, bacteria, eukaryotes and viruses. Conclusion/Significance: Interestingly, occurrence of several taxonomic level specific subfamilies of prokaryotic kinases contrasts with classification of eukaryotic protein kinases in which most of the popular subfamilies of eukaryotic protein kinases occur diversely in several eukaryotes. Many prokaryotic Ser/Thr kinases exhibit a wide variety of modular organization which indicates a degree of complexity and protein-protein interactions in the signaling pathways in these microbes.	[Tyagi, Nidhi; Anamika, Krishanpal; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Tyagi, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		Tyagi, Nidhi/0000-0002-2065-9051	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India; Microsoft Corporation	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Microsoft Corporation(Microsoft)	This research is supported by Department of Biotechnology, Government of India and also by the Mathematical Biology initiative supported by the Department of Science and Technology, Government of India. N.T. is supported by a grant from Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2004, COMP FUNCT GENOM, V5, P2, DOI 10.1002/cfg.358; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Anamika K, 2007, PROTEIN PEPTIDE LETT, V14, P509; Anamika K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-625; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bakal CJ, 2000, TRENDS CELL BIOL, V10, P32, DOI 10.1016/S0962-8924(99)01681-5; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; BENTLEY SD, 2002, NATURE, V3, P417; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; BOURRET RB, 1989, J BIOL CHEM, V264, P7085; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Souza M, 2000, NUCLEIC ACIDS RES, V28, P335, DOI 10.1093/nar/28.1.335; D'Souza M, 2007, NUCLEIC ACIDS RES, V35, pD271, DOI 10.1093/nar/gkl949; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Frasch SC, 1996, J BACTERIOL, V178, P4084, DOI 10.1128/jb.178.14.4084-4088.1996; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gowri VS, 2006, NUCLEIC ACIDS RES, V34, pD243, DOI 10.1093/nar/gkj043; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Han GN, 2001, FEMS MICROBIOL LETT, V200, P79, DOI 10.1016/S0378-1097(01)00206-3; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Iyer LM, 2004, PROTEINS, V55, P977, DOI 10.1002/prot.20076; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kamei A, 2003, CURR MICROBIOL, V46, P296, DOI 10.1007/s00284-002-3887-2; Kamei A, 2002, DNA RES, V9, P71, DOI 10.1093/dnares/9.3.71; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; KUNZE B, 1985, J ANTIBIOT, V38, P1649, DOI 10.7164/antibiotics.38.1649; KUNZE B, 1984, J ANTIBIOT, V37, P454, DOI 10.7164/antibiotics.37.454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lower BH, 2004, J BACTERIOL, V186, P463, DOI 10.1128/JB.186.2.463-472.2004; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Makemson JC, 1997, INT J SYST BACTERIOL, V47, P1034, DOI 10.1099/00207713-47-4-1034; Maltsev N, 2002, NUCLEIC ACIDS RES, V30, P349, DOI 10.1093/nar/30.1.349; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; MATSUMOTO A, 1994, GENE, V146, P47; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; MUNOZDORADO J, 1993, J CELL BIOCHEM, V51, P29, DOI 10.1002/jcb.240510107; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neu JM, 2002, MOL MICROBIOL, V44, P417, DOI 10.1046/j.1365-2958.2002.02879.x; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Oren A, 2004, INT J SYST EVOL MICR, V54, P1895, DOI 10.1099/ijs.0.03008-0; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Petrickova K, 2003, MICROBIOL-SGM, V149, P1609, DOI 10.1099/mic.0.26275-0; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; REIZER J, 1988, CRC CR REV MICROBIOL, V15, P297, DOI 10.3109/10408418809104461; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sensen CW, 1998, EXTREMOPHILES, V2, P305, DOI 10.1007/s007920050073; SHAKIR SM, 2009, J BACTERIOL; SKORKO R, 1984, EUR J BIOCHEM, V145, P617, DOI 10.1111/j.1432-1033.1984.tb08601.x; SMITH RF, 1995, PROTEIN SCI, V4, P126; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SOUTH SL, 1994, MOL MICROBIOL, V12, P903, DOI 10.1111/j.1365-2958.1994.tb01078.x; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009; Thomasson B, 2002, MOL MICROBIOL, V46, P1399, DOI 10.1046/j.1365-2958.2002.03258.x; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; UDO H, 1995, GENE DEV, V9, P972, DOI 10.1101/gad.9.8.972; Ueda K, 1996, GENE, V169, P91, DOI 10.1016/0378-1119(95)00771-7; Umeyama T, 2002, APPL MICROBIOL BIOT, V59, P419, DOI 10.1007/s00253-002-1045-1; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; WARNER KM, 1994, PLANT PHYSIOL, V105, P629, DOI 10.1104/pp.105.2.629; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHANG CC, 1993, P NATL ACAD SCI USA, V90, P11840, DOI 10.1073/pnas.90.24.11840; Zhang CC, 1998, NUCLEIC ACIDS RES, V26, P3619, DOI 10.1093/nar/26.16.3619; Zhang WD, 1996, MOL MICROBIOL, V20, P435, DOI 10.1111/j.1365-2958.1996.tb02630.x; ZHANG WD, 1992, J BACTERIOL, V174, P5450, DOI 10.1128/JB.174.16.5450-5453.1992; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003	125	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10608	10.1371/journal.pone.0010608	http://dx.doi.org/10.1371/journal.pone.0010608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520783	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000278221500001
J	Beaume, M; Hernandez, D; Farinelli, L; Deluen, C; Linder, P; Gaspin, C; Romby, P; Schrenzel, J; Francois, P				Beaume, Marie; Hernandez, David; Farinelli, Laurent; Deluen, Cecile; Linder, Patrick; Gaspin, Christine; Romby, Pascale; Schrenzel, Jacques; Francois, Patrice			Cartography of Methicillin-Resistant S. aureus Transcripts: Detection, Orientation and Temporal Expression during Growth Phase and Stress Conditions	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTISENSE TRANSCRIPTION; REDUCED SUSCEPTIBILITY; LOCUS; REGULATOR; VANCOMYCIN; STRAINS; GENOME; AGR; IDENTIFICATION	Background: Staphylococcus aureus is a versatile bacterial opportunist responsible for a wide spectrum of infections. The severity of these infections is highly variable and depends on multiple parameters including the genome content of the bacterium as well as the condition of the infected host. Clinically and epidemiologically, S. aureus shows a particular capacity to survive and adapt to drastic environmental changes including the presence of numerous antimicrobial agents. Mechanisms triggering this adaptation remain largely unknown despite important research efforts. Most studies evaluating gene content have so far neglected to analyze the so-called intergenic regions as well as potential antisense RNA molecules. Principal Findings: Using high-throughput sequencing technology, we performed an inventory of the whole transcriptome of S. aureus strain N315. In addition to the annotated transcription units, we identified more than 195 small transcribed regions, in the chromosome and the plasmid of S. aureus strain N315. The coding strand of each transcript was identified and structural analysis enabled classification of all discovered transcripts. RNA purified at four time-points during the growth phase of the bacterium allowed us to define the temporal expression of such transcripts. A selection of 26 transcripts of interest dispersed along the intergenic regions was assessed for expression changes in the presence of various stress conditions including pH, temperature, oxidative shocks and growth in a stringent medium. Most of these transcripts showed expression patterns specific for the defined stress conditions that we tested. Conclusions: These RNA molecules potentially represent important effectors of S. aureus adaptation and more generally could support some of the epidemiological characteristics of the bacterium.	[Beaume, Marie; Hernandez, David; Schrenzel, Jacques; Francois, Patrice] Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland; [Farinelli, Laurent; Deluen, Cecile] Fasteris SA, Plan Les Ouates, Switzerland; [Linder, Patrick] Ctr Med Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Gaspin, Christine] UBIA & Plateforme GenoToul Bioinfo, INRA, UR 875, F-31326 Castanet Tolosan, France; [Romby, Pascale] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France	University of Geneva; University of Geneva; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beaume, M (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland.	marie.beaume@genomic.ch	francois, patrice/AAL-5583-2020; ROMBY, Pascale/AGP-3328-2022; Schrenzel, Jacques/P-8525-2017; Gaspin, Christine/B-6756-2015; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Gaspin, Christine/0000-0003-0304-5186; francois, patrice/0000-0002-0540-750X	Swiss National Science Foundation [3100A0 112370/1, 3100A0-116075, 31003A-118309]; Infectigen CGR [75298]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen CGR	This work was supported by grants from the Swiss National Science Foundation 3100A0 112370/1 (to JS), 3100A0-116075 (to PF), 31003A-118309 (to PL) and Infectigen CGR 75298 (to PF). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. However, the funders (LF, CD) appear as co-authors because they performed some experiments.	ABUQATOUSEH LF, 2010, J MOL MED; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2009, J BACTERIOL, V191, P1180, DOI 10.1128/JB.01058-08; Balbontin R, 2008, J BACTERIOL, V190, P4075, DOI 10.1128/JB.00220-08; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; BEAUME M, 2009, INT J MED MICROBIOL; Borg MA, 2005, CLIN MICROBIOL INFEC, V11, P405, DOI 10.1111/j.1469-0691.2005.01110.x; BOYCE JM, 1992, INFECT CONT HOSP EP, V13, P725; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Chesneau O, 1999, FEMS MICROBIOL LETT, V177, P93, DOI 10.1016/S0378-1097(99)00296-7; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; CHEVALIER C, 2010, PLOSPATHOGE IN PRESS; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; CROS MJ, 2007, NATURE PROTOCOLS; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Entenza JM, 2005, INFECT IMMUN, V73, P990, DOI 10.1128/IAI.73.2.990-998.2005; Ferraz V, 2000, S AFR MED J, V90, P1113; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FOZO EM, 2010, NUCL ACIDS RES; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Gordon JJ, 2006, BIOINFORMATICS, V22, P142, DOI 10.1093/bioinformatics/bti771; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Jones ME, 2002, ANTIMICROB AGENTS CH, V46, P3104, DOI 10.1128/AAC.46.9.3104-3105.2002; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lulitanond A, 2009, J CLIN MICROBIOL, V47, P2311, DOI 10.1128/JCM.01749-08; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; *NCBI, 2009, NCBI GEN PROJ; NI ED, 1998, MOL MICROBIOL, V30, P245; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Puskas LG, 2002, BIOTECHNIQUES, V32, P1330, DOI 10.2144/02326mt04; Reyes-Lopez M, 2003, NUCLEIC ACIDS RES, V31, P779, DOI 10.1093/nar/gkg132; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Rosenblad MA, 2009, RNA BIOL, V6, P508, DOI 10.4161/rna.6.5.9753; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Sng LH, 2005, INT J ANTIMICROB AG, V25, P177, DOI 10.1016/j.ijantimicag.2004.11.001; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sridhar Jayavel, 2007, In Silico Biology, V7, P601; Steckelberg JM, 2000, INFECT ASS INDWELLIN; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wagner EGH, 2002, ADV GENET, V46, P361; WANG J, 2010, NUCL ACIDS RES; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WURTZEL O, 2009, GENOME RES; Xiong YQ, 2004, INFECT IMMUN, V72, P1832, DOI 10.1128/IAI.72.3.1832-1836.2004; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	91	105	107	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10725	10.1371/journal.pone.0010725	http://dx.doi.org/10.1371/journal.pone.0010725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505759	Green Published, gold			2022-12-27	WOS:000278017300005
J	Dahdul, WM; Balhoff, JP; Engeman, J; Grande, T; Hilton, EJ; Kothari, C; Lapp, H; Lundberg, JG; Midford, PE; Vision, TJ; Westerfield, M; Mabee, PM				Dahdul, Wasila M.; Balhoff, James P.; Engeman, Jeffrey; Grande, Terry; Hilton, Eric J.; Kothari, Cartik; Lapp, Hilmar; Lundberg, John G.; Midford, Peter E.; Vision, Todd J.; Westerfield, Monte; Mabee, Paula M.			Evolutionary Characters, Phenotypes and Ontologies: Curating Data from the Systematic Biology Literature	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OSTARIOPHYSI; SILURIFORMES; TELEOSTEI; CHARACIFORMES; OSTEICHTHYES; LORICARIIDAE; GENOMICS; SUPPORT; PISCES	Background: The wealth of phenotypic descriptions documented in the published articles, monographs, and dissertations of phylogenetic systematics is traditionally reported in a free-text format, and it is therefore largely inaccessible for linkage to biological databases for genetics, development, and phenotypes, and difficult to manage for large-scale integrative work. The Phenoscape project aims to represent these complex and detailed descriptions with rich and formal semantics that are amenable to computation and integration with phenotype data from other fields of biology. This entails reconceptualizing the traditional free-text characters into the computable Entity-Quality (EQ) formalism using ontologies. Methodology/Principal Findings: We used ontologies and the EQ formalism to curate a collection of 47 phylogenetic studies on ostariophysan fishes (including catfishes, characins, minnows, knifefishes) and their relatives with the goal of integrating these complex phenotype descriptions with information from an existing model organism database (zebrafish, http://zfin.org). We developed a curation workflow for the collection of character, taxonomic and specimen data from these publications. A total of 4,617 phenotypic characters (10,512 states) for 3,449 taxa, primarily species, were curated into EQ formalism (for a total of 12,861 EQ statements) using anatomical and taxonomic terms from teleost-specific ontologies (Teleost Anatomy Ontology and Teleost Taxonomy Ontology) in combination with terms from a quality ontology (Phenotype and Trait Ontology). Standards and guidelines for consistently and accurately representing phenotypes were developed in response to the challenges that were evident from two annotation experiments and from feedback from curators. Conclusions/Significance: The challenges we encountered and many of the curation standards and methods for improving consistency that we developed are generally applicable to any effort to represent phenotypes using ontologies. This is because an ontological representation of the detailed variations in phenotype, whether between mutant or wildtype, among individual humans, or across the diversity of species, requires a process by which a precise combination of terms from domain ontologies are selected and organized according to logical relations. The efficiencies that we have developed in this process will be useful for any attempt to annotate complex phenotypic descriptions using ontologies. We also discuss some ramifications of EQ representation for the domain of systematics.	[Dahdul, Wasila M.; Engeman, Jeffrey; Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Dahdul, Wasila M.; Balhoff, James P.; Kothari, Cartik; Lapp, Hilmar; Midford, Peter E.; Vision, Todd J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.; Kothari, Cartik; Vision, Todd J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Grande, Terry] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Hilton, Eric J.] Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries Sci, Gloucester Point, VA 23062 USA; [Lundberg, John G.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of South Dakota; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; Loyola University Chicago; William & Mary; Virginia Institute of Marine Science; Drexel University; University of Oregon	Dahdul, WM (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	wasila.dahdul@usd.edu; pmabee@usd.edu	Lapp, Hilmar/A-8275-2009; Midford, Peter E./B-5946-2008; Vision, Todd/B-4867-2010	Midford, Peter E./0000-0001-6512-3296; Vision, Todd/0000-0002-6133-2581; Dahdul, Wasila/0000-0003-3162-7490; Balhoff, James/0000-0002-8688-6599; Lapp, Hilmar/0000-0001-9107-0714; Mabee, Paula/0000-0002-8455-3213	National Science Foundation [DBI 0641025]; National Institutes of Health [HG002659]; National Evolutionary Synthesis Center, NSF [EF-0423641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG002659] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062542] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center, NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank National Science Foundation (DBI 0641025), National Institutes of Health (HG002659), and the National Evolutionary Synthesis Center (NSF EF-0423641) for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JS, 2001, MISCELLANEOUS PUBLIC, V190; [Anonymous], 1991, ANATOMY RELATIONSHIP; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], MOUSE GENOME INFORM; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Arratia Gloria, 1999, P265; BAGILS RZ, 2004, MESOZOIC FISHES, V3, P391; BALHOFF JP, 2010, PLOS ONE IN PRESS; BOCKMANN FA, 1998, ANALISE FILOGENETICA; BORNBUSCH AH, 1995, ZOOL J LINN SOC-LOND, V115, P1; Britto MR, 2003, P ACAD NAT SCI PHILA, V153, P119, DOI 10.1635/0097-3157(2003)153[0119:POTSCH]2.0.CO;2; Buckup Paulo Andreas, 1998, P123; Cavender T.M., 1993, P293; Chang MM, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)404<0001:ROEBAD>2.0.CO;2; CHEN XP, 1994, PHYLOGENETIC STUDIES; Clarke JA, 2009, ZOOL J LINN SOC-LOND, V157, P586, DOI 10.1111/j.1096-3642.2009.00550.x; COBURN MM, 1992, HIST ECOLOGY N AM FR; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; de Pinna M.C.C., 1993, HIGHER LEVEL PHYLOGE; De Pinna MCC, 2007, ZOOL J LINN SOC-LOND, V150, P755, DOI 10.1111/j.1096-3642.2007.00306.x; DEPINNA MCC, 1996, FIELDIANA ZOOLOGY, V84; DIDARIO F, 1999, FILOGENIA PRISTIGAST; Eschmeyer W. N., 2010, CATALOG FISHES ELECT; Fang F, 2003, COPEIA, P714; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; FRICKE R., 2010, GUIDE FISH COLLECTIO; Friel J.P., 1994, PHYLOGENETIC STUDY N; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande T, 2004, COPEIA, P743; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; GRANDE T, 2008, REEVALUATION GONORYN, P295; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kailola Patricia J., 2004, Beagle, V20, P87; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Lucena Carlos A.S., 1998, P261; Lundberg J.G., 1993, P392; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maddison WP, 2019, MESQUITE MODULAR SYS; Malabarba Luiz R., 1998, P193; Mayden R. L., 1989, MISC PUBL MUS NAT HI, V80, P1, DOI DOI 10.5962/BHL.TITLE.5480; Miko I, 2009, ZOOKEYS, P127, DOI 10.3897/zookeys.20.119; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; MUNGALL C, 2007, REPRESENTING PHENOTY; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; *PHEN, PHEN GUID CHAR ANN; *PHEN, PHEN CUR MAIL LIST; Poyato-Ariza F. J., 1996, PALEOICHTHYOLOGICA, V6, P1; ROYERO R, 1999, STUDIES SYSTEMATICS; Sanger TJ, 2002, ZOOL J LINN SOC-LOND, V135, P529, DOI 10.1046/j.1096-3642.2002.00014.x; SANTAGATA S, 2009, ZOOLOGICAL J LINNEAN, V157; SAWADA Y, 1982, Memoirs of the Faculty of Fisheries Hokkaido University, V28, P65; SCHAEFER S A, 1987, Contributions in Science (Los Angeles), P1; SCHAEFER SA, 1991, ZOOL J LINN SOC-LOND, V102, P1, DOI 10.1111/j.1096-3642.1991.tb01535.x; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; SHIBATTA OA, 1998, SISTEMATICA EVOLUCAO; Sidlauskas BL, 2008, ZOOL J LINN SOC-LOND, V154, P70, DOI 10.1111/j.1096-3642.2008.00407.x; SIEBERT DH, 1987, INTERRELATIONSHIPS F; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith G.R., 1993, P778; Soares-Porto Luisa Maria, 1998, P331; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Toledo-Piza M, 2007, ZOOL J LINN SOC-LOND, V151, P691, DOI 10.1111/j.1096-3642.2007.00355.x; Toledo-Piza Monica, 2000, American Museum Novitates, V3286, P1, DOI 10.1206/0003-0082(2000)286<0001:TNFSCT>2.0.CO;2; Vari R.P., 1995, SMITHSONIAN CONTRIBU, V564, P1, DOI [10.5479/si.00810282.564, DOI 10.5479/SI.00810282.564]; Vari RP, 2001, SMITHSONIAN CONTRIBU, V613; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Weitzman Stanley H., 1998, P171; Zanata AM, 2005, ZOOL J LINN SOC-LOND, V145, P1, DOI 10.1111/j.1096-3642.2005.00183.x; OBOPHENOTYPE MAILING; OBODISCUSS MAILING L; EVIDENCE CODES ONTOL; TELEOST ANATOMY ONTO; TELEOST TAXONOMY ONT; TELEOST DISCUSS MAIL	78	62	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10708	10.1371/journal.pone.0010708	http://dx.doi.org/10.1371/journal.pone.0010708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505755	Green Published, gold			2022-12-27	WOS:000278017300003
J	Shah, JY; Phadtare, A; Rajgor, D; Vaghasia, M; Pradhan, S; Zelko, H; Pietrobon, R				Shah, Jatin Y.; Phadtare, Amruta; Rajgor, Dimple; Vaghasia, Meenakshi; Pradhan, Shreyasee; Zelko, Hilary; Pietrobon, Ricardo			What Leads Indians to Participate in Clinical Trials? A Meta-Analysis of Qualitative Studies	PLOS ONE			English	Article							HIV VACCINE TRIALS; AFRICAN-AMERICAN PARTICIPATION; SOUTH ASIAN PATIENTS; RIO-DE-JANEIRO; MEDICAL-RESEARCH; PREVENTION TRIALS; INFORMED-CONSENT; RANDOMIZED-TRIAL; CANCER-PATIENTS; HIGH-RISK	Background: With the globalization of clinical trials, large developing nations have substantially increased their participation in multi-site studies. This participation has raised ethical concerns, among them the fear that local customs, habits and culture are not respected while asking potential participants to take part in study. This knowledge gap is particularly noticeable among Indian subjects, since despite the large number of participants, little is known regarding what factors affect their willingness to participate in clinical trials. Methods: We conducted a meta-analysis of all studies evaluating the factors and barriers, from the perspective of potential Indian participants, contributing to their participation in clinical trials. We searched both international as well as Indian-specific bibliographic databases, including Pubmed, Cochrane, Openjgate, MedInd, Scirus and Medknow, also performing hand searches and communicating with authors to obtain additional references. We enrolled studies dealing exclusively with the participation of Indians in clinical trials. Data extraction was conducted by three researchers, with disagreement being resolved by consensus. Results: Six qualitative studies and one survey were found evaluating the main themes affecting the participation of Indian subjects. Themes included Personal health benefits, Altruism, Trust in physicians, Source of extra income, Detailed knowledge, Methods for motivating participants as factors favoring, while Mistrust on trial organizations, Concerns about efficacy and safety of trials, Psychological reasons, Trial burden, Loss of confidentiality, Dependency issues, Language as the barriers. Conclusion: We identified factors that facilitated and barriers that have negative implications on trial participation decisions in Indian subjects. Due consideration and weightage should be assigned to these factors while planning future trials in India.	[Shah, Jatin Y.; Rajgor, Dimple; Pradhan, Shreyasee; Pietrobon, Ricardo] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Shah, Jatin Y.; Phadtare, Amruta; Rajgor, Dimple; Vaghasia, Meenakshi; Pradhan, Shreyasee; Zelko, Hilary; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA; [Phadtare, Amruta; Vaghasia, Meenakshi] Kalpavriksha Healthcare & Res, Thana, India; [Zelko, Hilary; Pietrobon, Ricardo] Duke Univ, Dept Surg, Durham, NC USA	National University of Singapore; Duke University; Duke University	Shah, JY (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore.	rpietro@duke.edu	Shah, Jatin/B-6039-2011; Rajgor, Dimple/C-7317-2015	Shah, Jatin/0000-0002-2457-491X; Rajgor, Dimple/0000-0002-6940-7656; Pietrobon, Ricardo/0000-0003-2996-2193				Avis NE, 2006, J CLIN ONCOL, V24, P1860, DOI 10.1200/JCO.2005.03.8976; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Buchwald D, 2006, J GEN INTERN MED, V21, P648, DOI 10.1111/j.1525-1497.2006.00449.x; Cambron JA, 2001, J MANIP PHYSIOL THER, V24, P79, DOI 10.1067/mmt.2001.112567; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Catania C, 2008, ONCOLOGY-BASEL, V74, P177, DOI 10.1159/000151365; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Coyne CA, 2004, J CANCER EDUC, V19, P165, DOI 10.1207/s15430154jce1903_11; Crawley LM, 2001, J NATL MED ASSOC, V93, p14S; Diaz VA, 2008, FAM MED, V40, P46; DON M, CLIN TRIALS SAFETY R; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; DWORKIN G, 1982, MAKING HLTH CARE DEC, P63; Ellington L, 2006, PSYCHO-ONCOL, V15, P273, DOI 10.1002/pon.943; Gitanjali B, 2003, J Postgrad Med, V49, P109; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Grady Christine, 2001, American Journal of Bioethics, V1, P40, DOI 10.1162/152651601300169031; HAHN RA, 1982, MAKING HLTH CARE DEC, P37; Halpern SD, 2003, AM HEART J, V146, P985, DOI 10.1016/S0002-8703(03)00507-6; Harrison LH, 1999, J ACQ IMMUN DEF SYND, V21, P408; Homer C, 2000, MIDWIFERY, V16, P252, DOI 10.1054/midw.2000.0230; HOROWITZ HS, 1978, J PUBLIC HEALTH DENT, V38, P35, DOI 10.1111/j.1752-7325.1978.tb03714.x; Hussain-Gambles M, 2004, FAM PRACT, V21, P636, DOI 10.1093/fampra/cmh611; Hussain-Gambles M, 2004, HEALTH TECHNOL ASSES, V8, P1; Hussain-Gambles M, 2006, HEALTH POLICY, V77, P149, DOI 10.1016/j.healthpol.2005.07.022; Jones JM, 2006, J CANCER EDUC, V21, P237; Joseph J, 2008, CONTEMP CLIN TRIALS, V29, P311, DOI 10.1016/j.cct.2007.10.006; Kennedy Betty M, 2007, J Cult Divers, V14, P141; Khaliq Waseem, 2003, Minn Med, V86, P39; Kimmick GG, 2005, J CLIN ONCOL, V23, P2201, DOI 10.1200/JCO.2005.01.222; King WD, 2007, AIDS PATIENT CARE ST, V21, P551, DOI 10.1089/apc.2006.0173; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; LARA PN, 2001, OFFICIAL J AM SOC CL, V19, P1728; LaVallie DL, 2008, ETHNIC DIS, V18, P210; Lee SJ, 2005, J RHEUMATOL, V32, P2317; MARSHALL SL, 1994, J ADV NURS, V19, P566, DOI 10.1111/j.1365-2648.1994.tb01122.x; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.2521; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; MYNATT CR, 1978, Q J EXP PSYCHOL, V30, P395, DOI 10.1080/00335557843000007; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nundy S, 2005, NEW ENGL J MED, V352, P1633, DOI 10.1056/NEJMp048361; Nyamathi AM, 2007, AIDS BEHAV, V11, P619, DOI 10.1007/s10461-006-9173-8; O'Connell JM, 2002, JAIDS-J ACQ IMM DEF, V31, P521, DOI 10.1097/00126334-200212150-00010; Palmas W, 2006, TELEMED J E-HEALTH, V12, P601, DOI 10.1089/tmj.2006.12.601; Pentz RD, 2002, J CLIN ONCOL, V20, P3785, DOI 10.1200/JCO.2002.04.084; Perisse AR, 2000, J ACQ IMMUN DEF SYND, V25, P459, DOI 10.1097/00126334-200012150-00012; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B; Rojavin MA, 2006, CONTEMP CLIN TRIALS, V27, P103, DOI 10.1016/j.cct.2005.11.014; Russell KM, 2008, APPL NURS RES, V21, P90, DOI 10.1016/j.apnr.2006.05.001; Sahay S, 2005, VACCINE, V23, P1351, DOI 10.1016/j.vaccine.2004.09.032; Schutta K M, 2000, Oncol Nurs Forum, V27, P1435; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Shaw PH, 2007, J PEDIAT HEMATOL ONC, V29, P811, DOI 10.1097/MPH.0b013e31815814f3; Suhadev M, 2006, INDIAN J MED RES, V124, P631; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; TOMLINSON H, 2004, DRUGS GIANT MOVES TR; Townsley CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-34; Tu SP, 2005, CANCER-AM CANCER SOC, V104, P2999, DOI 10.1002/cncr.21524; Umutyan A, 2008, CANCER-AM CANCER SOC, V112, P212, DOI 10.1002/cncr.23170; Unson CG, 2004, J AGING HEALTH, V16, P426, DOI 10.1177/0898264304264211; Wallace K, 2006, J CLIN ONCOL, V24, P4158, DOI 10.1200/JCO.2006.06.3875; Wasan AD, 2009, PAIN MED, V10, P111, DOI 10.1111/j.1526-4637.2008.00481.x; Wendler D, 2008, ARCH INTERN MED, V168, P1294, DOI 10.1001/archinte.168.12.1294; WILBUR W, 2005, MED INFORM KNOWLEDGE, P277; Wong ML, 2004, COMMUNITY GENET, V7, P44, DOI 10.1159/000080303; Wood CG, 2006, AM J CLIN ONCOL-CANC, V29, P593, DOI 10.1097/01.coc.0000236213.61427.84; 2005, HEALTHCARE NEWS, V5; CYBERLAW CANDICE PLA	75	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10730	10.1371/journal.pone.0010730	http://dx.doi.org/10.1371/journal.pone.0010730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	600VP	20505754	Green Published, gold			2022-12-27	WOS:000278017300006
J	Crawford, BE; Garner, OB; Bishop, JR; Zhang, DY; Bush, KT; Nigam, SK; Esko, JD				Crawford, Brett E.; Garner, Omai B.; Bishop, Joseph R.; Zhang, David Y.; Bush, Kevin T.; Nigam, Sanjay K.; Esko, Jeffrey D.			Loss of the Heparan Sulfate Sulfotransferase, Ndst1, in Mammary Epithelial Cells Selectively Blocks Lobuloalveolar Development in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GLAND DEVELOPMENT; BRANCHING MORPHOGENESIS; CONDITIONAL KNOCKOUT; TARGETED DISRUPTION; TEMPORAL EXPRESSION; BASAL LAMINA; GENE; DEFECTS; PROTEOGLYCANS	Background: Considerable evidence indicates that heparan sulfate is essential for the development of tissues consisting of branching ducts and tubules. However, there are few examples where specific sulfate residues regulate a specific stage in the formation of such tissues. Methodology/Principal Findings: We examined the role of heparan sulfation in mammary gland branching morphogenesis, lactation and lobuloalveolar development by inactivation of heparan sulfate GlcNAc N-deacetylase/N-sulfotransferase genes (Ndst) in mammary epithelial cells using the Cre-loxP system. Ndst1 deficiency resulted in an overall reduction in glucosamine N-sulfation and decreased binding of FGF to mammary epithelial cells in vitro and in vivo. Mammary epithelia lacking Ndst1 underwent branching morphogenesis, filling the gland with ductal tissue by sexual maturity to the same extent as wildtype epithelia. However, lobuloalveolar expansion did not occur in Ndst1-deficient animals, resulting in insufficient milk production to nurture newly born pups. Lactational differentiation of isolated mammary epithelial cells occurred appropriately via stat5 activation, further supporting the notion that the lack of milk production was due to lack of expansion of the lobuloalveoli. Conclusions/Significance: These findings demonstrate a selective, highly penetrant, cell autonomous effect of Ndst1-mediated sulfation on lobuloalveolar development.	[Crawford, Brett E.; Garner, Omai B.; Bishop, Joseph R.; Zhang, David Y.; Nigam, Sanjay K.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crawford, Brett E.; Garner, Omai B.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Crawford, BE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	snigam@ucsd.edu; jesko@ucsd.edu		Zhang, David/0000-0001-5809-0027	National Institutes of Health [CA67754, AI58916, AI52692, GM33063, HL57345]; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI058916, F32AI052692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by training grant CA67754 (B. E. C), NRSA Minority Predoctoral Fellowship AI58916 (O.B.G.), NRSA Fellowship AI52692 (J.R.B) and GM33063 and HL57345 (J.D.E) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brisken C, 2000, GENE DEV, V14, P650; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Delehedde M, 2001, J MAMMARY GLAND BIOL, V6, P253, DOI 10.1023/A:1011367423085; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dunbar ME, 2001, J ENDOCRINOL, V171, P403, DOI 10.1677/joe.0.1710403; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GORDON JR, 1980, DEV BIOL, V74, P118, DOI 10.1016/0012-1606(80)90056-1; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Humphreys RC, 1997, MOL ENDOCRINOL, V11, P801, DOI 10.1210/me.11.6.801; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Ishiguro K, 2001, LAB INVEST, V81, P509, DOI 10.1038/labinvest.3780259; Jackson D, 1997, J CELL SCI, V110, P1261; Joseph H, 1999, MOL BIOL CELL, V10, P1221, DOI 10.1091/mbc.10.4.1221; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; LI M, 2000, METHODS MAMMARY GLAN, P233; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Paguirigan A, 2006, EUR J CANCER, V42, P1225, DOI 10.1016/j.ejca.2006.01.048; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pullan Shirley E., 1996, P97; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Robinson GW, 1997, DEVELOPMENT, V124, P2701; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; Shah MM, 2010, DEV BIOL, V339, P354, DOI 10.1016/j.ydbio.2009.12.033; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SILBERSTEIN GB, 1982, DEV BIOL, V90, P215, DOI 10.1016/0012-1606(82)90228-7; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Steer DL, 2004, DEV BIOL, V272, P310, DOI 10.1016/j.ydbio.2004.04.029; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wei G, 2000, J BIOL CHEM, V275, P27733; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Xie W, 1997, MOL ENDOCRINOL, V11, P1766, DOI 10.1210/me.11.12.1766; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	76	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10691	10.1371/journal.pone.0010691	http://dx.doi.org/10.1371/journal.pone.0010691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502530	Green Published, Green Submitted, gold			2022-12-27	WOS:000277776500008
J	Liao, JY; Ma, LM; Guo, YH; Zhang, YC; Zhou, H; Shao, P; Chen, YQ; Qu, LH				Liao, Jian-You; Ma, Li-Ming; Guo, Yan-Hua; Zhang, Yu-Chan; Zhou, Hui; Shao, Peng; Chen, Yue-Qin; Qu, Liang-Hu			Deep Sequencing of Human Nuclear and Cytoplasmic Small RNAs Reveals an Unexpectedly Complex Subcellular Distribution of miRNAs and tRNA 3 ' Trailers	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; GENE; IDENTIFICATION; BIOGENESIS; DISCOVERY; TRANSCRIPTS; PROTEINS; SNORNA; SIRNAS	Background: MicroRNAs (miRNAs) are similar to 22-nt small non-coding regulatory RNAs that have generally been considered to regulate gene expression at the post-transcriptional level in the cytoplasm. However, recent studies have reported that some miRNAs localize to and function in the nucleus. Methodology/Principal Findings: To determine the number of miRNAs localized to the nucleus, we systematically investigated the subcellular distribution of small RNAs (sRNAs) by independent deep sequencing sequenced of the nuclear and cytoplasmic pools of 18- to 30-nucleotide sRNAs from human cells. We identified 339 nuclear and 324 cytoplasmic known miRNAs, 300 of which overlap, suggesting that the majority of miRNAs are imported into the nucleus. With the exception of a few miRNAs evidently enriched in the nuclear pool, such as the mir-29b, the ratio of miRNA abundances in the nuclear fraction versus in the cytoplasmic fraction vary to some extent. Moreover, our results revealed that a large number of tRNA 3'trailers are exported from the nucleus and accumulate in the cytoplasm. These tRNA 3' trailers accumulate in a variety of cell types, implying that the biogenesis of tRNA 3' trailers is conserved and that they have a potential functional role in vertebrate cells. Conclusion/Significance: Our results provide the first comprehensive view of the subcellular distribution of diverse sRNAs and new insights into the roles of miRNAs and tRNA 39 trailers in the cell.	[Liao, Jian-You; Ma, Li-Ming; Guo, Yan-Hua; Zhang, Yu-Chan; Zhou, Hui; Shao, Peng; Chen, Yue-Qin; Qu, Liang-Hu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liao, JY (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	Shao, Peng/AAN-4606-2020; Shao, Peng/M-5172-2019; Shao, Peng/A-6122-2019	Shao, Peng/0000-0002-8453-6480; Zhou, Hui/0000-0001-9157-3792; Ma, Liming/0000-0001-9319-5828; Qu, Liang-Hu/0000-0003-3657-2863	National Natural Science Foundation of China [30830066, 30771151, 30870530]; National High-Tech Program [2008AA02Z106]; Sun Yat-sen University [2009-33000-3161051]; Ministry of Science and Technology of China [2005CB724600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program; Sun Yat-sen University; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (No. 30830066, 30771151 and 30870530), funds from National High-Tech Program (No. 2008AA02Z106), the Young Teacher Training Program of Sun Yat-sen University (2009-33000-3161051) and the National Basic Research Program (No. 2005CB724600) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Greenberg Michael E, 2007, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0410s78; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HAGENBUCHLE O, 1979, CELL, V18, P1217, DOI 10.1016/0092-8674(79)90234-4; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KOSKI RA, 1982, J BIOL CHEM, V257, P4514; Kruszka K, 2003, EMBO J, V22, P621, DOI 10.1093/emboj/cdg040; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li J, 2010, CANCER GENET CYTOGEN, V196, P23, DOI 10.1016/j.cancergencyto.2009.08.004; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	62	220	254	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10563	10.1371/journal.pone.0010563	http://dx.doi.org/10.1371/journal.pone.0010563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498841	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600001
J	van den Berg, BHJ; McCarthy, FM; Lamont, SJ; Burgess, SC				van den Berg, Bart H. J.; McCarthy, Fiona M.; Lamont, Susan J.; Burgess, Shane C.			Re-Annotation Is an Essential Step in Systems Biology Modeling of Functional Genomics Data	PLOS ONE			English	Article							INDUCIBLE COSTIMULATOR; GENE-EXPRESSION; T-CELLS; DNA MICROARRAYS; CHICKEN GENOME; NK-LYSIN; CD28; REANNOTATION; SEQUENCE; ONTOLOGY	One motivation of systems biology research is to understand gene functions and interactions from functional genomics data such as that derived from microarrays. Up-to-date structural and functional annotations of genes are an essential foundation of systems biology modeling. We propose that the first essential step in any systems biology modeling of functional genomics data, especially for species with recently sequenced genomes, is gene structural and functional re-annotation. To demonstrate the impact of such re-annotation, we structurally and functionally re-annotated a microarray developed, and previously used, as a tool for disease research. We quantified the impact of this re-annotation on the array based on the total numbers of structural- and functional-annotations, the Gene Annotation Quality (GAQ) score, and canonical pathway coverage. We next quantified the impact of re-annotation on systems biology modeling using a previously published experiment that used this microarray. We show that re-annotation improves the quantity and quality of structural- and functional-annotations, allows a more comprehensive Gene Ontology based modeling, and improves pathway coverage for both the whole array and a differentially expressed mRNA subset. Our results also demonstrate that re-annotation can result in a different knowledge outcome derived from previous published research findings. We propose that, because of this, re-annotation should be considered to be an essential first step for deriving value from functional genomics data.	[van den Berg, Bart H. J.; McCarthy, Fiona M.; Burgess, Shane C.] Mississippi State Univ, Dept Basic Sci, Coll Vet Med, Starkville, MS USA; [van den Berg, Bart H. J.; McCarthy, Fiona M.; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Starkville, MS USA; [Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi Agr & Forestry Expt Stn, Starkville, MS USA; [McCarthy, Fiona M.] Mississippi State Univ, AgBase Databases, Starkville, MS USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Lamont, Susan J.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Iowa State University; Iowa State University	van den Berg, BHJ (corresponding author), Mississippi State Univ, Dept Basic Sci, Coll Vet Med, Starkville, MS USA.	bvandenberg@cvm.msstate.edu			National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2004-34481-14513, 2004-35204-14829, 2006-35204-16549, 2007-35205-17941]	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant numbers 2004-34481-14513, 2004-35204-14829, 2006-35204-16549 and 2007-35205-17941. The URL of the funding agency is http://www.nifa.usda.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1995, EMBO J, V14, P1615, DOI 10.1002/j.1460-2075.1995.tb07150.x; Andersson M, 1999, INFECT IMMUN, V67, P201, DOI 10.1128/IAI.67.1.201-205.1999; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Barrett T, 2008, NAT METHODS, V5, P117, DOI 10.1038/nmeth0208-117b; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Braga-Neto UM, 2006, PLOS COMPUT BIOL, V2, P651, DOI 10.1371/journal.pcbi.0020081; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Burnside J, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-13; Buza TJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-425; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chen LL, 2008, FEBS J, V275, P198, DOI 10.1111/j.1742-4658.2007.06190.x; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; de Jong YP, 2004, INT IMMUNOL, V16, P205, DOI 10.1093/intimm/dxh019; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eyras E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-131; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Gupta N, 2008, CANCER RES, V68, P808, DOI 10.1158/0008-5472.CAN-07-3169; Harel A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-348; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kim KM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn485; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Neerincx Pieter B T, 2009, BMC Proc, V3 Suppl 4, pS4, DOI 10.1186/1753-6561-3-S4-S4; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Ouzounis CA, 2002, GENOME BIOL, V3; Pruess M, 2003, NUCLEIC ACIDS RES, V31, P414, DOI 10.1093/nar/gkg105; Richardson MK, 2007, CYTOGENET GENOME RES, V117, P110, DOI 10.1159/000103171; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sellheyer K, 2004, J AM ACAD DERMATOL, V51, P681, DOI 10.1016/j.jaad.2004.03.038; Shilling RA, 2006, CLIN IMMUNOL, V121, P13, DOI 10.1016/j.clim.2006.04.574; SMITH C, 2006, GENE EXPRESSION ANAL; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; van Berkel MEAT, 2006, IMMUNOL LETT, V105, P115, DOI 10.1016/j.imlet.2006.02.007; van den Berg BHJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-30; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Wall Dennis P., 2007, V396, P95; Wang XQ, 2006, VIRAL IMMUNOL, V19, P768, DOI 10.1089/vim.2006.19.768; Washietl S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-55; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zhou H, 2007, CYTOGENET GENOME RES, V117, P131, DOI 10.1159/000103173	55	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10642	10.1371/journal.pone.0010642	http://dx.doi.org/10.1371/journal.pone.0010642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498845	gold, Green Published, Green Submitted			2022-12-27	WOS:000277771600008
J	Chia, R; Tattum, MH; Jones, S; Collinge, J; Fisher, EMC; Jackson, GS				Chia, Ruth; Tattum, M. Howard; Jones, Samantha; Collinge, John; Fisher, Elizabeth M. C.; Jackson, Graham S.			Superoxide Dismutase 1 and tgSOD1(G93A) Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; BODY-LIKE INCLUSIONS; TRANSGENIC MICE; FAMILIAL ALS; INTRANUCLEAR INCLUSIONS; DISEASE PROGRESSION; SOD1; MUTATIONS; AGGREGATION; MUTANTS	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that specifically affects motor neurons and leads to a progressive and ultimately fatal loss of function, resulting in death typically within 3 to 5 years of diagnosis. The disease starts with a focal centre of weakness, such as one limb, and appears to spread to other parts of the body. Mutations in superoxide dismutase 1 (SOD1) are known to cause disease and it is generally accepted they lead to pathology not by loss of enzymatic activity but by gain of some unknown toxic function(s). Although different mutations lead to varying tendencies of SOD1 to aggregate, we suggest abnormal proteins share a common misfolding pathway that leads to the formation of amyloid fibrils. Methodology/Principal Findings: Here we demonstrate that misfolding of superoxide dismutase 1 leads to the formation of amyloid fibrils associated with seeding activity, which can accelerate the formation of new fibrils in an autocatalytic cascade. The time limiting event is nucleation to form a stable protein "seed" before a rapid linear polymerisation results in amyloid fibrils analogous to other protein misfolding disorders. This phenomenon was not confined to fibrils of recombinant protein as here we show, for the first time, that spinal cord homogenates obtained from a transgenic mouse model that overexpresses mutant human superoxide dismutase 1 (the TgSOD1(G93A) mouse) also contain amyloid seeds that accelerate the formation of new fibrils in both wildtype and mutant SOD1 protein in vitro. Conclusions/Significance: These findings provide new insights into ALS disease mechanism and in particular a mechanism that could account for the spread of pathology throughout the nervous system. This model of disease spread, which has analogies to other protein misfolding disorders such as prion disease, also suggests it may be possible to design assays for therapeutics that can inhibit fibril propagation and hence, possibly, disease progression.	[Chia, Ruth; Collinge, John; Fisher, Elizabeth M. C.] Univ Coll London Inst Neurol, Dept Neurodegenerat Dis, London, England; [Tattum, M. Howard; Jones, Samantha; Collinge, John; Jackson, Graham S.] Univ Coll London Inst Neurol, MRC Prion Unit, London, England	University of London; University College London; University of London; University College London	Chia, R (corresponding author), Univ Coll London Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011	Brain Research Trust; UK Medical Research Council; MRC [MC_U123170362, G0500288, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123170362, G0500288] Funding Source: researchfish	Brain Research Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Brain Research Trust and the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Andersen PM, 2004, ANN NEUROL, V55, P298, DOI 10.1002/ana.10850; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bowen S, 2007, EUR J NEUROSCI, V25, P2947, DOI 10.1111/j.1460-9568.2007.05554.x; Brown RH, 1998, NAT MED, V4, P1362, DOI 10.1038/3945; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NILSSON KM, 2007, AM SOC NEUR M; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Santillo M, 2007, J NEUROCHEM, V102, P679, DOI 10.1111/j.1471-4159.2007.04538.x; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	60	101	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10627	10.1371/journal.pone.0010627	http://dx.doi.org/10.1371/journal.pone.0010627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498711	Green Submitted, Green Published, gold			2022-12-27	WOS:000277633500015
J	Yu, PC; Calderaro, D; Gualandro, DM; Marques, AC; Pastana, AF; Prandini, JC; Caramelli, B				Yu, Pai Ching; Calderaro, Daniela; Gualandro, Danielle Menosi; Marques, Andre Coelho; Pastana, Adriana Feio; Prandini, Joao Carlos; Caramelli, Bruno			Non-Cardiac Surgery in Developing Countries: Epidemiological Aspects and Economical Opportunities - The Case of Brazil	PLOS ONE			English	Article							VASCULAR-SURGERY; PERIOPERATIVE MORTALITY; MYOCARDIAL-INFARCTION; CARDIAC TROPONIN; TRIAL; RISK; ASSOCIATION; GUIDELINES; METOPROLOL; MORBIDITY	Background: Worldwide distribution of surgical interventions is unequal. Developed countries account for the majority of surgeries and information about non-cardiac operations in developing countries is scarce. The purpose of our study was to describe the epidemiological data of non-cardiac surgeries performed in Brazil in the last years. Methods and Findings: This is a retrospective cohort study that investigated the time window from 1995 to 2007. We collected information from DATASUS, a national public health system database. The following variables were studied: number of surgeries, in-hospital expenses, blood transfusion related costs, length of stay and case fatality rates. The results were presented as sum, average and percentage. The trend analysis was performed by linear regression model. There were 32,659,513 non-cardiac surgeries performed in Brazil in thirteen years. An increment of 20.42% was observed in the number of surgeries in this period and nowadays nearly 3 million operations are performed annually. The cost of these procedures has increased tremendously in the last years. The increment of surgical cost was almost 200%. The total expenses related to surgical hospitalizations were more than $10 billion in all these years. The yearly cost of surgical procedures to public health system was more than $1.27 billion for all surgical hospitalizations, and in average, U$445.24 per surgical procedure. The total cost of blood transfusion was near $98 million in all years and annually approximately $10 million were spent in perioperative transfusion. The surgical mortality had an increment of 31.11% in the period. Actually, in 2007, the surgical mortality in Brazil was 1.77%. All the variables had a significant increment along the studied period: r square (r(2)) = 0.447 for the number of surgeries (P = 0.012), r(2) = 0.439 for in-hospital expenses (P = 0.014) and r(2) = 0.907 for surgical mortality (P = 0.0055). Conclusion: The volume of surgical procedures has increased substantially in Brazil through the past years. The expenditure related to these procedures and its mortality has also increased as the number of operations. Better planning of public health resource and strategies of investment are needed to supply the crescent demand of surgery in Brazil.	[Yu, Pai Ching; Calderaro, Daniela; Gualandro, Danielle Menosi; Marques, Andre Coelho; Pastana, Adriana Feio; Caramelli, Bruno] Univ Sao Paulo, Interdisciplinary Med Cardiol Unit, Heart Inst InCor, Hosp Clin,Med Sch, Sao Paulo, Brazil; [Prandini, Joao Carlos] Univ Sao Paulo, Dept Math, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Yu, PC (corresponding author), Univ Sao Paulo, Interdisciplinary Med Cardiol Unit, Heart Inst InCor, Hosp Clin,Med Sch, Sao Paulo, Brazil.	bcaramel@usp.br	Caramelli, Bruno/B-9916-2008; Gualandro, Danielle M/G-8386-2012; Yu, Pai/A-4235-2013	Caramelli, Bruno/0000-0001-6718-8456; Gualandro, Danielle M/0000-0001-9041-6250; 	Scholarship Program of Cardiology Society of Sao Paulo (SOCESP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Scholarship Program of Cardiology Society of Sao Paulo (SOCESP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was partially supported by grants from Scholarship Program of Cardiology Society of Sao Paulo (SOCESP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Feitosa Alina Coutinho Rodrigues, 2007, Arq Bras Cardiol, V88, pe139; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Juul AB, 2004, AM HEART J, V147, P677, DOI 10.1016/j.ahj.2003.10.030; Kalish R L, 1995, Am J Med Qual, V10, P48, DOI 10.1177/0885713X9501000108; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Martinez EA, 2005, J CARDIOTHOR VASC AN, V19, P577, DOI 10.1053/j.jvca.2005.07.002; McGirt MJ, 2005, J VASC SURG, V42, P829, DOI 10.1016/j.jvs.2005.08.039; Poldermans D, 2003, CIRCULATION, V107, P1848, DOI 10.1161/01.CIR.0000066286.15621.98; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Powell JT, 2005, J VASC SURG, V41, P602, DOI 10.1016/j.jvs.2005.01.048; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Vanhorebeek I, 2007, CHEST, V132, P268, DOI 10.1378/chest.06-3121; W.H. Organization, 2009, WORLD HLTH STAT 2009; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	21	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10607	10.1371/journal.pone.0010607	http://dx.doi.org/10.1371/journal.pone.0010607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485549	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563400014
J	Lanza, IR; Zhang, SC; Ward, LE; Karakelides, H; Raftery, D; Nair, KS				Lanza, Ian R.; Zhang, Shucha; Ward, Lawrence E.; Karakelides, Helen; Raftery, Daniel; Nair, K. Sreekumaran			Quantitative Metabolomics by H-1-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; AMINO-ACID-METABOLISM; WHOLE-BODY; BETA-HYDROXYBUTYRATE; INSULIN DEFICIENCY; SKELETAL-MUSCLE; METABONOMICS; LEUCINE; SPECTROSCOPY; PROTEOLYSIS	Insulin is as a major postprandial hormone with profound effects on carbohydrate, fat, and protein metabolism. In the absence of exogenous insulin, patients with type 1 diabetes exhibit a variety of metabolic abnormalities including hyperglycemia, glycosurea, accelerated ketogenesis, and muscle wasting due to increased proteolysis. We analyzed plasma from type 1 diabetic (T1D) humans during insulin treatment (I+) and acute insulin deprivation (I-) and non-diabetic participants (ND) by H-1 nuclear magnetic resonance spectroscopy and liquid chromatography-tandem mass spectrometry. The aim was to determine if this combination of analytical methods could provide information on metabolic pathways known to be altered by insulin deficiency. Multivariate statistics differentiated proton spectra from I- and I+ based on several derived plasma metabolites that were elevated during insulin deprivation (lactate, acetate, allantoin, ketones). Mass spectrometry revealed significant perturbations in levels of plasma amino acids and amino acid metabolites during insulin deprivation. Further analysis of metabolite levels measured by the two analytical techniques indicates several known metabolic pathways that are perturbed in T1D (I-) (protein synthesis and breakdown, gluconeogenesis, ketogenesis, amino acid oxidation, mitochondrial bioenergetics, and oxidative stress). This work demonstrates the promise of combining multiple analytical methods with advanced statistical methods in quantitative metabolomics research, which we have applied to the clinical situation of acute insulin deprivation in T1D to reflect the numerous metabolic pathways known to be affected by insulin deficiency.	[Lanza, Ian R.; Ward, Lawrence E.; Karakelides, Helen; Nair, K. Sreekumaran] Mayo Clin, Coll Med, Div Endocrinol, Endocrinol Res Unit, Rochester, MN 55905 USA; [Zhang, Shucha; Raftery, Daniel] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Mayo Clinic; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lanza, IR (corresponding author), Mayo Clin, Coll Med, Div Endocrinol, Endocrinol Res Unit, Rochester, MN 55905 USA.	nair.sree@mayo.edu		Lanza, Ian/0000-0002-9858-3384	National Institutes of Health (NIH) [UL1-RR-024150-01, R01-DK-41973]; National Center for Research Resources; David Murdock Dole Professorship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); David Murdock Dole Professorship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health (NIH) (grant UL1-RR-024150-01), from the National Center for Research Resources, a component of NIH, NIH Roadmap for Medical Research (grant R01-DK-41973), and the David Murdock Dole Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala L, 2006, MAGN RESON MED, V56, P738, DOI 10.1002/mrm.21041; BENNET WM, 1991, DIABETES, V40, P499, DOI 10.2337/diabetes.40.4.499; BENNET WM, 1990, DIABETOLOGIA, V33, P43, DOI 10.1007/BF00586460; BERGER M, 1978, METABOLISM, V27, P793, DOI 10.1016/0026-0495(78)90214-7; Boden G, 2003, DIABETES, V52, P133, DOI 10.2337/diabetes.52.1.133; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; ELIA M, 1981, BRIT MED J, V282, P351, DOI 10.1136/bmj.282.6261.351; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Feillet-Coudray C, 1999, CLIN CHIM ACTA, V284, P31, DOI 10.1016/S0009-8981(99)00046-7; FELIG P, 1971, J CLIN INVEST, V50, P1702, DOI 10.1172/JCI106659; FELIG P, 1970, DIABETES, V19, P727, DOI 10.2337/diab.19.10.727; GERICH JE, 1975, J CLIN ENDOCR METAB, V40, P526, DOI 10.1210/jcem-40-3-526; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Gruber J, 2009, ANTIOXID REDOX SIGN, V11, P1767, DOI [10.1089/ars.2008.2364, 10.1089/ARS.2008.2364]; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; JALEEL A, 2009, AM J PHYSL ENDOCRINO; Karakelides H, 2007, DIABETES, V56, P2683, DOI 10.2337/db07-0378; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; MILES JM, 1983, DIABETES, V32, P197, DOI 10.2337/diabetes.32.3.197; NAIR KS, 1984, DIABETOLOGIA, V27, P13, DOI 10.1007/BF00253494; NAIR KS, 1988, J CLIN INVEST, V82, P198, DOI 10.1172/JCI113570; NAIR KS, 1995, J CLIN INVEST, V95, P2926, DOI 10.1172/JCI118000; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; PACY PJ, 1989, DIABETES, V38, P618, DOI 10.2337/diabetes.38.5.618; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Robertson DG, 2005, TOXICOL SCI, V85, P809, DOI 10.1093/toxsci/kfi102; TESSARI P, 1990, AM J PHYSIOL, V259, pE96, DOI 10.1152/ajpendo.1990.259.1.E96; TESSARI P, 1986, J CLIN INVEST, V77, P575, DOI 10.1172/JCI112339; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041; Zuppi C, 2002, CLIN CHEM, V48, P660	37	198	214	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10538	10.1371/journal.pone.0010538	http://dx.doi.org/10.1371/journal.pone.0010538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479934	gold, Green Submitted, Green Published			2022-12-27	WOS:000277467900003
J	Tuite, AR; Fisman, DN; Kwong, JC; Greer, AL				Tuite, Ashleigh R.; Fisman, David N.; Kwong, Jeffrey C.; Greer, Amy L.			Optimal Pandemic Influenza Vaccine Allocation Strategies for the Canadian Population	PLOS ONE			English	Article							HEALTHY-CHILDREN; H1N1 VIRUS; MORTALITY; SPREAD; PRIORITIZATION; INFECTION; IMPACT; RATES; AGE	Background: The world is currently confronting the first influenza pandemic of the 21(st) century. Influenza vaccination is an effective preventive measure, but the unique epidemiological features of swine-origin influenza A (H1N1) (pH1N1) introduce uncertainty as to the best strategy for prioritization of vaccine allocation. We sought to determine optimal prioritization of vaccine distribution among different age and risk groups within the Canadian population, to minimize influenza-attributable morbidity and mortality. Methodology/Principal Findings: We developed a deterministic, age-structured compartmental model of influenza transmission, with key parameter values estimated from data collected during the initial phase of the epidemic in Ontario, Canada. We examined the effect of different vaccination strategies on attack rates, hospitalizations, intensive care unit admissions, and mortality. In all scenarios, prioritization of high-risk individuals (those with underlying chronic conditions and pregnant women), regardless of age, markedly decreased the frequency of severe outcomes. When individuals with underlying medical conditions were not prioritized and an age group-based approach was used, preferential vaccination of age groups at increased risk of severe outcomes following infection generally resulted in decreased mortality compared to targeting vaccine to age groups with higher transmission, at a cost of higher population-level attack rates. All simulations were sensitive to the timing of the epidemic peak in relation to vaccine availability, with vaccination having the greatest impact when it was implemented well in advance of the epidemic peak. Conclusions/Significance: Our model simulations suggest that vaccine should be allocated to high-risk groups, regardless of age, followed by age groups at increased risk of severe outcomes. Vaccination may significantly reduce influenza-attributable morbidity and mortality, but the benefits are dependent on epidemic dynamics, time for program roll-out, and vaccine uptake.	[Tuite, Ashleigh R.; Fisman, David N.; Kwong, Jeffrey C.] Univ Toronto, Dept Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Modelling & Project Sect, Surveillance & Risk Assessment Div, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Public Health Agency of Canada	Tuite, AR (corresponding author), Univ Toronto, Dept Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	david.fisman@utoronto.ca			Mathematics of Information Technology and Complex Systems (MITACS); Ontario Agency for Health Protection and Promotion; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research	Mathematics of Information Technology and Complex Systems (MITACS); Ontario Agency for Health Protection and Promotion; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Ms. Tuite receives support from the Mathematics of Information Technology and Complex Systems (MITACS) Accelerate program as a result of both MITACS funding and a matching contribution from the Ontario Agency for Health Protection and Promotion. Dr. Fisman is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation, the Canadian Institutes of Health Research-supported PanCanadian Pandemic Influenza Modeling Network, and MITACS. Dr. Greer was supported by a Post-doctoral Fellowship Award from the School of Graduate Studies at the University of Toronto during the initial phases of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Beland Yves, 2002, Health Rep, V13, P9; Bingle CL, 2005, CAN J PUBLIC HEALTH, V96, P145, DOI 10.1007/BF03403679; Centers for Disease Control and Prevention, 2008, PREV CONTR INFL REC; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; Kelly H, 2009, EUROSURVEILLANCE, V14, P6; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Manzoli L, 2007, PEDIATR INFECT DIS J, V26, P97, DOI 10.1097/01.inf.0000253053.01151.bd; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Negri E, 2005, VACCINE, V23, P2851, DOI 10.1016/j.vaccine.2004.11.053; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; *PUBL HLTH AG CAN, 2009, GUID H1N1 FLU VACC S; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Smith S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub2; *STAT CAN, 2005, PREGN OUTC AG GROUP; Statistics Canada, 2007, AG SEX HIGHL TABL 20; Statistics Canada, 2007, CAN COMM HLTH SURV C; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Uphoff H, 2009, EUROSURVEILLANCE, V14, P11; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wilson N, 2009, EUROSURVEILLANCE, V14	49	61	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10520	10.1371/journal.pone.0010520	http://dx.doi.org/10.1371/journal.pone.0010520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463898	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379800014
J	Hasegawa, S; Kohro, Y; Shiratori, M; Ishii, S; Shimizu, T; Tsuda, M; Inoue, K				Hasegawa, Shigeo; Kohro, Yuta; Shiratori, Miho; Ishii, Satoshi; Shimizu, Takao; Tsuda, Makoto; Inoue, Kazuhide			Role of PAF Receptor in Proinflammatory Cytokine Expression in the Dorsal Root Ganglion and Tactile Allodynia in a Rodent Model of Neuropathic Pain	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; SPINAL NERVE LIGATION; CYTOSOLIC PHOSPHOLIPASE A(2); PRIMARY SENSORY NEURONS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; PROTEIN-KINASE ACTIVATION; RAT SCIATIC-NERVE; PRIMARY AFFERENT; PERIPHERAL NEUROPATHY	Background: Neuropathic pain is a highly debilitating chronic pain following damage to peripheral sensory neurons and is often resistant to all treatments currently available, including opioids. We have previously shown that peripheral nerve injury induces activation of cytosolic phospholipase A(2) (cPLA(2)) in injured dorsal root ganglion (DRG) neurons that contribute to tactile allodynia, a hallmark of neuropathic pain. However, lipid mediators downstream of cPLA2 activation to produce tactile allodynia remain to be determined. Principal Findings: Here we provide evidence that platelet-activating factor (PAF) is a potential candidate. Pharmacological blockade of PAF receptors (PAFRs) reduced the development and expression of tactile allodynia following nerve injury. The expression of PAFR mRNA was increased in the DRG ipsilateral to nerve injury, which was seen mainly in macrophages. Furthermore, mice lacking PAFRs showed a reduction of nerve injury-induced tactile allodynia and, interestingly, a marked suppression of upregulation of tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL-1 beta) expression in the injured DRG, crucial proinflammatory cytokines involved in pain hypersensitivity. Conversely, a single injection of PAF near the DRG of naive rats caused a decrease in the paw withdrawal threshold to mechanical stimulation in a dose-dependent manner and an increase in the expression of mRNAs for TNF-alpha and IL-1 beta, both of which were inhibited by pretreatment with a PAFR antagonist. Conclusions: Our results indicate that the PAF/PAFR system has an important role in production of TNF alpha and IL-1 beta in the DRG and tactile allodynia following peripheral nerve injury and suggest that blocking PAFRs may be a viable therapeutic strategy for treating neuropathic pain.	[Hasegawa, Shigeo; Kohro, Yuta; Shiratori, Miho; Tsuda, Makoto; Inoue, Kazuhide] Kyushu Univ, Dept Mol & Syst Pharmacol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Ishii, Satoshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan	Kyushu University; University of Tokyo	Hasegawa, S (corresponding author), Kyushu Univ, Dept Mol & Syst Pharmacol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	inoue@phar.kyushu-u.ac.jp	Tsuda, Makoto/AAE-7256-2020; Shimizu, Takao/AAV-7052-2021	Kohro, Yuta/0000-0002-3128-7388	Ministry of Education, Culture, Sports, Science and Technology of Japan [20689030, 18GS0319]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20689030 to MT, #18GS0319 to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Chopra B, 2000, EUR J NEUROSCI, V12, P911, DOI 10.1046/j.1460-9568.2000.00979.x; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Dou WK, 2004, PROSTAG OTH LIPID M, V74, P29, DOI 10.1016/j.prostaglandins.2004.06.001; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Fernandes ES, 2005, BRIT J PHARMACOL, V146, P209, DOI 10.1038/sj.bjp.0706327; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hasegawa S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-22; Hefferan MP, 2003, ANESTHESIOLOGY, V99, P1180, DOI 10.1097/00000542-200311000-00027; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kihara Y, 2005, J EXP MED, V202, P853, DOI 10.1084/jem.20050660; Kihara Y, 2008, J IMMUNOL, V181, P5008, DOI 10.4049/jimmunol.181.7.5008; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; LEVINE JD, 1986, P NATL ACAD SCI USA, V83, P5331, DOI 10.1073/pnas.83.14.5331; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Li HQ, 2007, ANESTHESIOLOGY, V107, P469, DOI 10.1097/01.anes.0000278907.37774.8d; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; Liu LJ, 2006, J NEUROPHYSIOL, V95, P1478, DOI 10.1152/jn.00509.2005; Ma L, 2009, J NEUROCHEM, V109, P603, DOI 10.1111/j.1471-4159.2009.05987.x; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marotta DM, 2009, BIOCHEM PHARMACOL, V77, P1223, DOI 10.1016/j.bcp.2008.12.025; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; MINAMI T, 1994, PAIN, V57, P217, DOI 10.1016/0304-3959(94)90226-7; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Renback K, 1999, NEUROSCI LETT, V270, P59, DOI 10.1016/S0304-3940(99)00464-4; Ririe DG, 2006, ANESTHESIOLOGY, V104, P426, DOI 10.1097/00000542-200603000-00008; Sacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Schafers M, 2003, J NEUROSCI, V23, P2517; Schafers M, 2003, J NEUROSCI, V23, P3028; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; TERASHITA Z, 1983, LIFE SCI, V32, P1975, DOI 10.1016/0024-3205(83)90049-8; Trang T, 2004, EUR J PHARMACOL, V491, P21, DOI 10.1016/j.ejphar.2004.03.022; Trang T, 2003, BRIT J PHARMACOL, V140, P295, DOI 10.1038/sj.bjp.0705440; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2007, J NEUROCHEM, V103, P1408, DOI 10.1111/j.1471-4159.2007.04861.x; Tsuda M, 2007, J NEUROCHEM, V102, P1658, DOI 10.1111/j.1471-4159.2007.04796.x; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470; Zhao Z, 2000, NEUROSCIENCE, V97, P743, DOI 10.1016/S0306-4522(00)00052-X; Zhu XY, 2003, ANESTHESIOLOGY, V99, P1175, DOI 10.1097/00000542-200311000-00026; Zhu XY, 2003, PAIN, V104, P15, DOI 10.1016/S0304-3959(02)00465-7	66	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10467	10.1371/journal.pone.0010467	http://dx.doi.org/10.1371/journal.pone.0010467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454616	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240300028
J	Androutsellis-Theotokis, A; Walbridge, S; Park, DM; Lonser, RR; Mckay, RDG				Androutsellis-Theotokis, Andreas; Walbridge, Stuart; Park, Deric M.; Lonser, Russell R.; McKay, Ronald D. G.			Cholera Toxin Regulates a Signaling Pathway Critical for the Expansion of Neural Stem Cell Cultures from the Fetal and Adult Rodent Brains	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; IN-VIVO; DENTATE GYRUS; PROGENITOR PROLIFERATION; MOUSE BRAIN; NEUROGENESIS; NEURONS; DIFFERENTIATION; RAT	Background: New mechanisms that regulate neural stem cell (NSC) expansion will contribute to improved assay systems and the emerging regenerative approach that targets endogenous stem cells. Expanding knowledge on the control of stem cell self renewal will also lead to new approaches for targeting the stem cell population of cancers. Methodology/Principal Findings: Here we show that Cholera toxin regulates two recently characterized NSC markers, the Tie2 receptor and the transcription factor Hes3, and promotes the expansion of NSCs in culture. Cholera toxin increases immunoreactivity for the Tie2 receptor and rapidly induces the nuclear localization of Hes3. This is followed by powerful cultured NSC expansion and induction of proliferation both in the presence and absence of mitogen. Conclusions/Significance: Our data suggest a new cell biological mechanism that regulates the self renewal and differentiation properties of stem cells, providing a new logic to manipulate NSCs in the context of regenerative disease and cancer.	[Androutsellis-Theotokis, Andreas; Park, Deric M.; McKay, Ronald D. G.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Walbridge, Stuart; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Androutsellis-Theotokis, A (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	AndreasTheotokis@gmail.com	Park, Deric/C-5675-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	National Institute of Neurological Disorders and Stroke; Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, ZIANS002881, ZIANS003051] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, and by additional support from the Michael J. Fox Foundation, the National Parkinson's Foundation, and the Tuchman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; ANDROUTSELLISTH.A, PLOS ONE, V5, pE9414; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; FISHMAN PH, 1993, ADV LIPID RES, V25, P165; Gniadecki R, 2003, J INVEST DERMATOL, V121, P522, DOI 10.1046/j.1523-1747.2003.12419.x; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu JL, 1998, J NEUROSCI, V18, P7768; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maric Dragan, 2005, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0318s33; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007780; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Shindler KS, 1996, DEV BRAIN RES, V92, P199, DOI 10.1016/0165-3806(95)00215-4; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10841	10.1371/journal.pone.0010841	http://dx.doi.org/10.1371/journal.pone.0010841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520777	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500027
J	Lopez, MD; Guerra, JJM; Samuelsson, T				Davila Lopez, Marcela; Martinez Guerra, Juan Jose; Samuelsson, Tore			Analysis of Gene Order Conservation in Eukaryotes Identifies Transcriptionally and Functionally Linked Genes	PLOS ONE			English	Article							HEAD-TO-HEAD; BIDIRECTIONAL PROMOTER; EXPRESSION; EVOLUTION; PROTEIN; ORGANIZATION; METHYLATION; SENSITIVITY; PREDICTION; SEQUENCE	The order of genes in eukaryotes is not entirely random. Studies of gene order conservation are important to understand genome evolution and to reveal mechanisms why certain neighboring genes are more difficult to separate during evolution. Here, genome-wide gene order information was compiled for 64 species, representing a wide variety of eukaryotic phyla. This information is presented in a browser where gene order may be displayed and compared between species. Factors related to non-random gene order in eukaryotes were examined by considering pairs of neighboring genes. The evolutionary conservation of gene pairs was studied with respect to relative transcriptional direction, intergenic distance and functional relationship as inferred by gene ontology. The results show that among gene pairs that are conserved the divergently and co-directionally transcribed genes are much more common than those that are convergently transcribed. Furthermore, highly conserved pairs, in particular those of fungi, are characterized by a short intergenic distance. Finally, gene pairs of metazoa and fungi that are evolutionary conserved and that are divergently transcribed are much more likely to be related by function as compared to poorly conserved gene pairs. One example is the ribosomal protein gene pair L13/S16, which is unusual as it occurs both in fungi and alveolates. A specific functional relationship between these two proteins is also suggested by the fact that they are part of the same operon in both eubacteria and archaea. In conclusion, factors associated with non-random gene order in eukaryotes include relative gene orientation, intergenic distance and functional relationships. It seems likely that certain pairs of genes are conserved because the genes involved have a transcriptional and/or functional relationship. The results also indicate that studies of gene order conservation aid in identifying genes that are related in terms of transcriptional control.	[Davila Lopez, Marcela; Samuelsson, Tore] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Martinez Guerra, Juan Jose] Univ Autonoma Aguascalientes, Ctr Ciencias Basicas, Dept Quim, Aguascalientes, Mexico	University of Gothenburg; Universidad Autonoma de Aguascalientes	Lopez, MD (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	Tore.Samuelsson@medkem.gu.se	Samuelsson, Tore/B-3548-2008; Samuelsson, Tore/X-7335-2019; Lopez, Marcela Davila/I-5433-2019	Lopez, Marcela Davila/0000-0002-1619-6795	Erik Philip-Srensen Foundation	Erik Philip-Srensen Foundation	This work was supported by the Erik Philip-Srensen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Agirre X, 2006, INT J CANCER, V118, P1945, DOI 10.1002/ijc.21584; Albig W, 1999, BIOL CHEM, V380, P7, DOI 10.1515/BC.1999.002; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Ame JC, 2001, J BIOL CHEM, V276, P11092, DOI 10.1074/jbc.M007870200; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dresser DW, 2001, GENE, V277, P163, DOI 10.1016/S0378-1119(01)00690-4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAVALAS A, 1995, J BIOL CHEM, V270, P2403, DOI 10.1074/jbc.270.5.2403; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Huang CC, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-67; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JORGENEBERT LF, 2009, HUM MUTAT; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; KROMER WJ, 1991, J BIOL CHEM, V266, P24573; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee SG, 2000, MOL CELLS, V10, P47, DOI 10.1007/s10059-000-0047-z; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Moreno-Hagelsieb Gabriel, 2008, V453, P181, DOI 10.1007/978-1-60327-429-6_8; Myler PJ, 2001, MED MICROBIOL IMMUN, V190, P9, DOI 10.1007/s004300100070; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Poyatos JF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r233; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Requena JM, 1997, MEM I OSWALDO CRUZ, V92, P853, DOI 10.1590/S0074-02761997000600022; Ruths T, 2009, BIOINFORMATICS, V25, P1178, DOI 10.1093/bioinformatics/btp128; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; VandePeer Y, 1996, J MOL EVOL, V42, P201, DOI 10.1007/BF02198846; Vieira CP, 1997, MOL BIOL EVOL, V14, P985, DOI 10.1093/oxfordjournals.molbev.a025715; Voth H, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-28; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Yang MQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S9; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193	56	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10654	10.1371/journal.pone.0010654	http://dx.doi.org/10.1371/journal.pone.0010654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498846	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600017
J	Boucrot, E; Saffarian, S; Zhang, RY; Kirchhausen, T				Boucrot, Emmanuel; Saffarian, Saveez; Zhang, Rongying; Kirchhausen, Tomas			Roles of AP-2 in Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COATED PITS; PLASMA-MEMBRANE; CELLS; TRAFFICKING; INTERNALIZATION; INVAGINATIONS; ENDOSOMES; FM1-43; ARH	Background: The notion that AP-2 clathrin adaptor is an essential component of an endocytic clathrin coat appears to conflict with recent observations that substantial AP-2 depletion, using RNA interference with synthesis of AP-2 subunits, fails to block uptake of certain ligands known to internalize through a clathrin-based pathway. Methodology/Principal Findings: We report here the use of in vivo imaging data obtained by spinning-disk confocal microscopy to study the formation of clathrin-coated structures at the plasma membranes of BSC1 and HeLa cells depleted by RNAi of the clathrin adaptor, AP-2. Very few clathrin coats continue to assemble after AP-2 knockdown. Moreover, there is a total absence of clathrin-containing structures completely lacking AP-2 while all the remaining coats still contain a small amount of AP-2. These observations suggest that AP-2 is essential for endocytic coated-pit and coated-vesicle formation. We also find that AP-2 knockdown strongly inhibits light-density lipoprotein (LDL) receptor-mediated endocytosis, as long as cells are maintained in complete serum and at 37 degrees C. If cells are first incubated with LDL at 4 degrees C, followed by warming, there is little or no decrease in LDL uptake with respect to control cells. LDL uptake at 37 degrees C is also not affected in AP-2 depleted cells first deprived of LDL by incubation with either serum-starved or LDL-starved cells for 24 hr. The LDL-deprived cells display a significant increase in endocytic structures enriched on deeply invaginated tubes that contain LDL and we suggest that under this condition of stress, LDL might enter through this alternative pathway. Conclusions/Significance: These results suggest that AP-2 is essential for endocytic clathrin coated-pit and coated-vesicle formation. They also indicate that under normal conditions, functional endocytic clathrin coated pits are required for LDL internalization. We also show that under certain conditions of stress, cells can upregulate alternative endocytic structures with the potential to provide compensatory trafficking pathways.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Boucrot, E (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kirchhausen@crystal.harvard.edu		Boucrot, Emmanuel/0000-0001-7312-6462	National Institutes of Health (NIH) [GM 075252]; International Human Frontier Science Program Organization; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization(Human Frontier Science Program); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM 075252 (T.K.), the International Human Frontier Science Program Organization (E.B.) and the American Heart Association (S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; KIRCHHAUSEN T, 2009, TRENDS CELL BIOL; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Massol RH, 2005, EXP CELL RES, V306, P142, DOI 10.1016/j.yexcr.2005.01.021; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001	31	102	102	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10597	10.1371/journal.pone.0010597	http://dx.doi.org/10.1371/journal.pone.0010597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485680	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563400009
J	Wang, K; Sengupta, S; Magnani, L; Wilson, CA; Henry, RW; Knott, JG				Wang, Kai; Sengupta, Satyaki; Magnani, Luca; Wilson, Catherine A.; Henry, R. William; Knott, Jason G.			Brg1 Is Required for Cdx2-Mediated Repression of Oct4 Expression in Mouse Blastocysts	PLOS ONE			English	Article							EMBRYONIC STEM; TROPHECTODERM; CDX2; INNER; GENE; SPECIFICATION; COMPONENTS; CELLS; FATE	During blastocyst formation the segregation of the inner cell mass (ICM) and trophectoderm is governed by the mutually antagonistic effects of the transcription factors Oct4 and Cdx2. Evidence indicates that suppression of Oct4 expression in the trophectoderm is mediated by Cdx2. Nonetheless, the underlying epigenetic modifiers required for Cdx2-dependent repression of Oct4 are largely unknown. Here we show that the chromatin remodeling protein Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts. By employing a combination of RNA interference (RNAi) and gene expression analysis we found that both Brg1 Knockdown (KD) and Cdx2 KD blastocysts exhibit widespread expression of Oct4 in the trophectoderm. Interestingly, in Brg1 KD blastocysts and Cdx2 KD blastocysts, the expression of Cdx2 and Brg1 is unchanged, respectively. To address whether Brg1 cooperates with Cdx2 to repress Oct4 transcription in the developing trophectoderm, we utilized preimplantation embryos, trophoblast stem (TS) cells and Cdx2-inducible embryonic stem (ES) cells as model systems. We found that: (1) combined knockdown (KD) of Brg1 and Cdx2 levels in blastocysts resulted in increased levels of Oct4 transcripts compared to KD of Brg1 or Cdx2 alone, (2) endogenous Brg1 co-immunoprecipitated with Cdx2 in TS cell extracts, (3) in blastocysts Brg1 and Cdx2 co-localize in trophectoderm nuclei and (4) in Cdx2-induced ES cells Brg1 and Cdx2 are recruited to the Oct4 promoter. Lastly, to determine how Brg1 may induce epigenetic silencing of the Oct4 gene, we evaluated CpG methylation at the Oct4 promoter in the trophectoderm of Brg1 KD blastocysts. This analysis revealed that Brg1-dependent repression of Oct4 expression is independent of DNA methylation at the blastocyst stage. In toto, these results demonstrate that Brg1 cooperates with Cdx2 to repress Oct4 expression in the developing trophectoderm to ensure normal development.	[Wang, Kai; Magnani, Luca; Wilson, Catherine A.; Knott, Jason G.] Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA; [Sengupta, Satyaki; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Wang, K (corresponding author), Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA.	knottj@msu.edu	wang, kai/G-4932-2011; Magnani, Luca/N-1094-2015; Sengupta, Satyaki/AAD-6065-2022	Magnani, Luca/0000-0002-7534-0785; 	Intramural Research Grants Program (IRGP) grant at Michigan State University; National Institute of General Medical Sciences [R01GM095347]; Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095347] Funding Source: NIH RePORTER	Intramural Research Grants Program (IRGP) grant at Michigan State University; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Intramural Research Grants Program (IRGP) grant at Michigan State University and R01GM095347 from the National Institute of General Medical Sciences to J.G.K. Mr. Sengupta was supported in part by the Gene Expression in Development & Disease Focus Group (GEDD) at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; HO L, 2009, PNAS, V13, P5187; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Knott JG, 2006, DEV BIOL, V296, P388, DOI 10.1016/j.ydbio.2006.06.004; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200	23	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10622	10.1371/journal.pone.0010622	http://dx.doi.org/10.1371/journal.pone.0010622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485553	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563400024
J	Arnaud, N; Dabo, S; Maillard, P; Budkowska, A; Kalliampakou, KI; Mavromara, P; Garcin, D; Hugon, J; Gatignol, A; Akazawa, D; Wakita, T; Meurs, EF				Arnaud, Noella; Dabo, Stephanie; Maillard, Patrick; Budkowska, Agata; Kalliampakou, Katerina I.; Mavromara, Penelope; Garcin, Dominique; Hugon, Jacques; Gatignol, Anne; Akazawa, Daisuke; Wakita, Takaji; Meurs, Eliane F.			Hepatitis C Virus Controls Interferon Production through PKR Activation	PLOS ONE			English	Article							PROTEIN-KINASE PKR; RIG-I; RNA REPLICATION; INHIBITION; RECOGNITION; TRANSLATION; EXPRESSION; INFECTION; PATHWAY; MECHANISMS	Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of the mitochondria-adapter MAVS. Here, we have investigated the early events of IFN induction upon HCV infection, using the cell-cultured HCV JFH1 strain and the new HCV-permissive hepatoma-derived Huh7.25.CD81 cell subclone. These cells depend on ectopic expression of the RIG-I ubiquitinating enzyme TRIM25 to induce IFN through the RIG-I/MAVS pathway. We observed induction of IFN during the first 12 hrs of HCV infection, after which a decline occurred which was more abrupt at the protein than at the RNA level, revealing a novel HCV-mediated control of IFN induction at the level of translation. The cellular protein kinase PKR is an important regulator of translation, through the phosphorylation of its substrate the eIF2 alpha initiation factor. A comparison of the expression of luciferase placed under the control of an eIF2 alpha-dependent (IRESEMCV) or independent (IRESHCV) RNA showed a specific HCV-mediated inhibition of eIF2 alpha-dependent translation. We demonstrated that HCV infection triggers the phosphorylation of both PKR and eIF2 alpha at 12 and 15 hrs post-infection. PKR silencing, as well as treatment with PKR pharmacological inhibitors, restored IFN induction in JFH1-infected cells, at least until 18 hrs post-infection, at which time a decrease in IFN expression could be attributed to NS3/4A-mediated MAVS cleavage. Importantly, both PKR silencing and PKR inhibitors led to inhibition of HCV yields in cells that express functional RIG-I/MAVS. In conclusion, here we provide the first evidence that HCV uses PKR to restrain its ability to induce IFN through the RIG-I/MAVS pathway. This opens up new possibilities to assay PKR chemical inhibitors for their potential to boost innate immunity in HCV infection.	[Arnaud, Noella; Dabo, Stephanie; Maillard, Patrick; Budkowska, Agata; Meurs, Eliane F.] Inst Pasteur, Unite Hepacivirus & Immun Innee, Paris, France; [Kalliampakou, Katerina I.; Mavromara, Penelope] Hellenic Pasteur Inst, Mol Virol Lab, Athens, Greece; [Garcin, Dominique] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Hugon, Jacques] INSERM, UMRS 839, Inst Fer Moulin, Paris, France; [Gatignol, Anne] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Akazawa, Daisuke; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Lady Davis Institute; McGill University; National Institute of Infectious Diseases (NIID)	Arnaud, N (corresponding author), Inst Pasteur, Unite Hepacivirus & Immun Innee, Paris, France.	emeurs@pasteur.fr	Akazawa, Daisuke/S-5596-2019; Gatignol, Anne/AAA-6501-2020	Gatignol, Anne/0000-0002-4553-0836	Institut Pasteur (IP); CNRS [URA3015]; Ministere de l'Education et de la Recherche fellowship	Institut Pasteur (IP); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education et de la Recherche fellowship	Financial support was provided by grants from Institut Pasteur (IP) and CNRS (URA3015). Noella Arnaud is recipient of Ministere de l'Education et de la Recherche fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Brocard M, 2007, VIRUS GENES, V35, P5, DOI 10.1007/s11262-006-0038-z; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hugon J, 2009, EXPERT REV NEUROTHER, V9, P1455, DOI [10.1586/ern.09.92, 10.1586/ERN.09.92]; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kalliampakou KI, 2005, J GEN VIROL, V86, P1015, DOI 10.1099/vir.0.80728-0; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nekhai S, 2000, PEPTIDES, V21, P1449, DOI 10.1016/S0196-9781(00)00297-7; Pavio N, 2002, J VIROL, V76, P1265, DOI 10.1128/JVI.76.3.1265-1272.2002; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Yan XB, 2007, VIRUS RES, V125, P79, DOI 10.1016/j.virusres.2006.12.010; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	42	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10575	10.1371/journal.pone.0010575	http://dx.doi.org/10.1371/journal.pone.0010575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485506	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563200010
J	Proskocil, BJ; Bruun, DA; Thompson, CM; Fryer, AD; Lein, PJ				Proskocil, Becky J.; Bruun, Donald A.; Thompson, Charles M.; Fryer, Allison D.; Lein, Pamela J.			Organophosphorus Pesticides Decrease M2 Muscarinic Receptor Function in Guinea Pig Airway Nerves via Indirect Mechanisms	PLOS ONE			English	Article							PULMONARY PARASYMPATHETIC NERVES; MAST-CELL DEGRANULATION; MAJOR BASIC-PROTEIN; ACETYLCHOLINE-RECEPTOR; AGRICULTURAL HEALTH; CHLORPYRIFOS-OXON; MACROPHAGE FUNCTION; SARIN VAPOR; IN-VITRO; EXPOSURE	Background: Epidemiological studies link organophosphorus pesticide (OP) exposures to asthma, and we have shown that the OPs chlorpyrifos, diazinon and parathion cause airway hyperreactivity in guinea pigs 24 hr after a single subcutaneous injection. OP-induced airway hyperreactivity involves M2 muscarinic receptor dysfunction on airway nerves independent of acetylcholinesterase (AChE) inhibition, but how OPs inhibit neuronal M2 receptors in airways is not known. In the central nervous system, OPs interact directly with neurons to alter muscarinic receptor function or expression; therefore, in this study we tested whether the OP parathion or its oxon metabolite, paraoxon, might decrease M2 receptor function on peripheral neurons via similar direct mechanisms. Methodology/Principal Findings: Intravenous administration of paraoxon, but not parathion, caused acute frequency-dependent potentiation of vagally-induced bronchoconstriction and increased electrical field stimulation (EFS)-induced contractions in isolated trachea independent of AChE inhibition. However, paraoxon had no effect on vagally-induced bradycardia in intact guinea pigs or EFS-induced contractions in isolated ileum, suggesting mechanisms other than pharmacologic antagonism of M2 receptors. Paraoxon did not alter M2 receptor expression in cultured cells at the mRNA or protein level as determined by quantitative RT-PCR and radio-ligand binding assays, respectively. Additionally, a biotinlabeled fluorophosphonate, which was used as a probe to identify molecular targets phosphorylated by OPs, did not phosphorylate proteins in guinea pig cardiac membranes that were recognized by M2 receptor antibodies. Conclusions/Significance: These data indicate that neither direct pharmacologic antagonism nor downregulated expression of M2 receptors contributes to OP inhibition of M2 function in airway nerves, adding to the growing evidence of non-cholinergic mechanisms of OP neurotoxicity.	[Proskocil, Becky J.; Fryer, Allison D.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Bruun, Donald A.; Lein, Pamela J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Thompson, Charles M.] Univ Montana, Dept Biomed & Pharmaceut Sci, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	Oregon Health & Science University; University of California System; University of California Davis; University of Montana System; University of Montana	Proskocil, BJ (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	pjlein@ucdavis.edu	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Proskocil, Becky/0000-0002-7803-6447; Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [ES014521, RO1-ES014601, UO1-ES016102]; OHSU Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014601, F32ES014521, R01ES017592, U01ES016102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by the National Institutes of Health (ES014521 to BJP; RO1-ES014601 to ADF and PJL; and UO1-ES016102 to CMT) and the OHSU Foundation (Medical Research Foundation seed grant to PJL). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Berkowitz GS, 2003, ENVIRON HEALTH PERSP, V111, P79, DOI 10.1289/ehp.5619; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Billington CK, 2002, AM J RESP CELL MOL, V26, P269, DOI 10.1165/ajrcmb.26.3.f232; Bomser JA, 2001, TOXICOL LETT, V119, P21, DOI 10.1016/S0378-4274(00)00294-0; BRYANT DH, 1985, AUST NZ J MED, V15, P66, DOI 10.1111/j.1445-5994.1985.tb02740.x; Canning BJ, 2003, CURR OPIN PHARMACOL, V3, P244, DOI 10.1016/S1471-4892(03)00045-6; CASARETT LJ, 1975, TOXICOLOGY; *CDC, 2003, 030022 NCEH CDC; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; Coulson FR, 2003, PHARMACOL THERAPEUT, V98, P59, DOI 10.1016/S0163-7258(03)00004-4; Coulson FR, 2002, BRIT J PHARMACOL, V135, P1355, DOI 10.1038/sj.bjp.0704602; Dabisch PA, 2007, TOXICOL SCI, V99, P354, DOI 10.1093/toxsci/kfm167; DESCHAMPS D, 1994, LANCET, V344, P1712, DOI 10.1016/S0140-6736(94)90498-7; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; Duramad P, 2006, J APPL TOXICOL, V26, P458, DOI 10.1002/jat.1162; Ecobichon D.J., 2001, CASARETT DOULLS TOXI, V6th, P763; Eggleston PA, 2001, J ALLERGY CLIN IMMUN, V107, pS422, DOI 10.1067/mai.2001.113671; EHRICH M, 1994, J TOXICOL ENV HEALTH, V43, P51, DOI 10.1080/15287399409531903; ELBON CL, 1995, AM J RESP CELL MOL, V12, P320, DOI 10.1165/ajrcmb.12.3.7873198; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ernst P, 2002, AM J RESP CRIT CARE, V165, P563, DOI 10.1164/ajrccm.165.5.2201001c; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Fenske RA, 2002, ENVIRON HEALTH PERSP, V110, P549, DOI 10.1289/ehp.02110549; Finkelman FD, 2010, J ALLERGY CLIN IMMUN, V125, P312, DOI 10.1016/j.jaci.2009.12.936; FLIPO D, 1992, INT J IMMUNOPHARMACO, V14, P747, DOI 10.1016/0192-0561(92)90071-R; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; FRYER AD, 1991, J APPL PHYSIOL, V71, P2255, DOI 10.1152/jappl.1991.71.6.2255; Fryer AD, 2004, AM J PHYSIOL-LUNG C, V286, pL963, DOI 10.1152/ajplung.00343.2003; FRYER AD, 1989, MEMBRANE BIOCHEM, V8, P127, DOI 10.3109/09687688909025826; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120; GAMBONE LM, 1994, J APPL PHYSIOL, V77, P1492, DOI 10.1152/jappl.1994.77.3.1492; GUSTIN P, 1988, J APPL PHYSIOL, V64, P1786, DOI 10.1152/jappl.1988.64.5.1786; Hartert T V, 2000, Curr Opin Pulm Med, V6, P4, DOI 10.1097/00063198-200001000-00002; HERMANOWICZ A, 1984, CLIN IMMUNOL IMMUNOP, V33, P13, DOI 10.1016/0090-1229(84)90288-5; Higgins D., 1991, CULTURING NERVE CELL, P177; Hoppin JA, 2006, AM J EPIDEMIOL, V163, P1129, DOI 10.1093/aje/kwj138; Hoppin JA, 2002, AM J RESP CRIT CARE, V165, P683, DOI 10.1164/ajrccm.165.5.2106074; HOPPIN JA, 2007, AM J RESP CRIT CARE; Hoppin JA, 2007, AM J IND MED, V50, P969, DOI 10.1002/ajim.20523; Hoppin JA, 2006, ANN NY ACAD SCI, V1076, P343, DOI 10.1196/annals.1371.044; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Jacoby DB, 1998, J CLIN INVEST, V102, P242, DOI 10.1172/JCI1114; JACOBY DB, 1991, AM REV RESPIR DIS, V144, P1422, DOI 10.1164/ajrccm/144.6.1422a; Jacoby DB, 2001, AM J RESP CELL MOL, V24, P485, DOI 10.1165/ajrcmb.24.4.4379; JETT DA, 1994, TOXICOL LETT, V73, P33, DOI 10.1016/0378-4274(94)90186-4; KILBINGER H, 1980, NEUROSCIENCE, V5, P1331, DOI 10.1016/0306-4522(80)90205-5; KILBINGER H, 1993, J PHYSIOLOGY-PARIS, V87, P77, DOI 10.1016/0928-4257(93)90001-A; Koch D, 2002, ENVIRON HEALTH PERSP, V110, P829, DOI 10.1289/ehp.02110829; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Lee AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1255, DOI 10.1152/ajplung.00451.2003; Lein PJ, 2005, TOXICOL SCI, V83, P166, DOI 10.1093/toxsci/kfi001; LEIN PJ, 2009, ENCY NEUROSCIENCE, P625; Levy A, 2004, J APPL TOXICOL, V24, P501, DOI 10.1002/jat.1008; Lotti M., 2000, EXPT CLIN NEUROTOXIC, P898; Lu CS, 2001, ENVIRON HEALTH PERSP, V109, P299; MINETTE PA, 1988, J APPL PHYSIOL, V64, P2532, DOI 10.1152/jappl.1988.64.6.2532; MINETTE PAH, 1989, J APPL PHYSIOL, V67, P2461, DOI 10.1152/jappl.1989.67.6.2461; Moreno L, 2003, AM J PHYSIOL-LUNG C, V285, pL451, DOI 10.1152/ajplung.00046.2003; *NAT RES COUNC COA, 1993, ALT TECHN DESTR CHEM; Nelson CP, 2004, J PHARMACOL EXP THER, V310, P1255, DOI 10.1124/jpet.104.067140; Nie ZY, 2009, BRIT J PHARMACOL, V156, P201, DOI 10.1111/j.1476-5381.2008.00045.x; OMalley M, 1997, LANCET, V349, P1161, DOI 10.1016/S0140-6736(96)07222-4; Peeples ES, 2005, TOXICOL SCI, V83, P303, DOI 10.1093/toxsci/kfi023; Pena-Philippides JC, 2007, TOXICOL SCI, V97, P181, DOI 10.1093/toxsci/kfm017; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Proskocil BJ, 2008, ENVIRON HEALTH PERSP, V116, P381, DOI 10.1289/ehp.10694; Rodgers K, 1997, INT J IMMUNOPHARMACO, V19, P149, DOI 10.1016/S0192-0561(96)00073-2; RODGERS K, 1992, AGENTS ACTIONS, V35, P57, DOI 10.1007/BF01990952; Rodgers K, 1997, INT J IMMUNOPHARMACO, V19, P437, DOI 10.1016/S0192-0561(97)00098-2; Rodgers K, 1997, FUND APPL TOXICOL, V37, P95, DOI 10.1006/faat.1997.2302; RODGERS KE, 1990, AGENTS ACTIONS, V29, P277, DOI 10.1007/BF01966458; RODGERS KE, 1990, FUND APPL TOXICOL, V14, P309, DOI 10.1016/0272-0590(90)90210-B; ROFFEL A F, 1990, Pulmonary Pharmacology, V3, P47, DOI 10.1016/0952-0600(90)90009-8; ROFFEL AF, 1994, TRENDS PHARMACOL SCI, V15, P407, DOI 10.1016/0165-6147(94)90084-1; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; SAVOLAINEN KM, 1992, TOXICOL LETT, V64-5, P437, DOI 10.1016/0378-4274(92)90217-8; Schlador ML, 2000, J BIOL CHEM, V275, P23295, DOI 10.1074/jbc.M002380200; Schopfer LM, 2005, CHEM RES TOXICOL, V18, P747, DOI 10.1021/tx049672j; Segura P, 1999, N-S ARCH PHARMACOL, V360, P699, DOI 10.1007/s002109900101; SENTHILSELVAN A, 1992, AM REV RESPIR DIS, V146, P884, DOI 10.1164/ajrccm/146.4.884; SMOLEN A, 1985, PHARMACOL BIOCHEM BE, V22, P623, DOI 10.1016/0091-3057(85)90285-0; SMOLEN A, 1986, PHARMACOL BIOCHEM BE, V24, P1077, DOI 10.1016/0091-3057(86)90458-2; Sun Tingting, 2003, J Toxicol Sci, V28, P427, DOI 10.2131/jts.28.427; *USDA, 2003, AGR CHEM PROD TECHN; Verhein KC, 2008, AM J RESP CELL MOL, V39, P730, DOI 10.1165/rcmb.2008-0045OC; Ward TR, 1996, BRAIN RES BULL, V39, P49, DOI 10.1016/0361-9230(95)02044-6; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; WEITZMAN M, 1992, JAMA-J AM MED ASSOC, V268, P2673, DOI 10.1001/jama.268.19.2673; Whyatt RM, 2002, ENVIRON HEALTH PERSP, V110, P507, DOI 10.1289/ehp.02110507; WILHOIT L, 1999, PESTICIDE USE ANAL T; Xiong SQ, 1997, J TOXICOL ENV HEALTH, V51, P159, DOI 10.1080/009841097160140; Yagle K, 1996, NEUROTOXICOLOGY, V17, P523; Yang D, 2008, TOXICOL APPL PHARM, V228, P32, DOI 10.1016/j.taap.2007.11.005; Yoon HK, 2007, ENVIRON HEALTH PERSP, V115, P1557, DOI 10.1289/ehp.10289; Zamora EMU, 2008, J TOXICOL ENV HEAL A, V71, P1440, DOI 10.1080/15287390802328887	98	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10562	10.1371/journal.pone.0010562	http://dx.doi.org/10.1371/journal.pone.0010562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479945	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900017
J	Lienhardt, C; Fielding, K; Hane, AA; Niang, A; Ndao, CT; Karam, F; Fletcher, H; Mbow, F; Gomis, JF; Diadhiou, R; Toupane, M; Dieye, T; Mboup, S				Lienhardt, Christian; Fielding, Katherine; Hane, Abdoul A.; Niang, Aliou; Ndao, Cheikh T.; Karam, Farba; Fletcher, Helen; Mbow, Fatou; Gomis, Jules-Francois; Diadhiou, Roger; Toupane, Maxime; Dieye, Tandakha; Mboup, Souleymane			Evaluation of the Prognostic Value of IFN-gamma Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal	PLOS ONE			English	Article							LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PREDICTIVE-VALUE; DIAGNOSIS; DISEASE; RESPONSES; ELISPOT; RISK	Background: Chemoprophylaxis of contacts of infectious tuberculosis (TB) cases is recommended for TB control, particularly in endemic countries, but is hampered by the difficulty to diagnose latent TB infection (LTBI), classically assessed through response to the Tuberculin Skin Test (TST). Interferon-gamma release assays (IGRA) are proposed new tools to diagnose LTBI, but there are limited data on their ability to predict the development of active TB disease. To address this, we investigated the response to TST and IGRA in household contacts of infectious TB cases in a TB high-burden country and the potential correlation with development of TB. Methodology/Principal Findings: Prospective household contacts study conducted in two health centres in Dakar, Senegal. A total of 2679 household contacts of 206 newly detected smear and/or culture positive index TB cases aged 18 years or greater were identified A TST was performed in each contact and an ESAT6/CFP10 ELISPOT assay performed in a random sample of those. Contacts were followed-up for 24 months. TB was diagnosed in 52 contacts, an incidence rate of 9.27/1000 person-years. In univariable analysis, the presence of positive TST (>= 10 mm) and ELISPOT (> 32 SFC/million PBMC) responses at baseline were associated with active TB during follow-up: Rate Ratio [RR] = 2.32 (95%CI: 1.12-4.84) and RR = 2.09 (95%CI: 0.83-5.31), respectively. After adjustment for age, sex and proximity to index case, adjusted RRs were 1.51 (95%CI: 0.71-3.19) and 1.98 (95%CI: 0.77-5.09), respectively. Restricting analysis to the 40 microbiologically confirmed cases, the adjusted RR for positive ELISPOT was 3.61 (95%CI: 1.03-12.65). The median ELISPOT response in contacts who developed TB was 5-fold greater than in those who did not develop TB (p = 0.02). Conclusions/Significance: TST and IGRAs are markers of a contact of the immune system with tubercle bacilli. In a TB endemic area, a high ELISPOT response may reflect increased bacterial replication that may subsequently be associated with development of TB disease and may have a prognostic value. Further longitudinal data are needed to assess whether IGRAs are reliable markers to be used for targeting chemoprophylaxis.	[Lienhardt, Christian; Ndao, Cheikh T.; Mbow, Fatou; Gomis, Jules-Francois] Inst Rech Dev, Programme Tuberculose, Dakar, Senegal; [Fielding, Katherine] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Hane, Abdoul A.; Niang, Aliou] Hop Fann, Serv Pneumol, Dakar, Senegal; [Karam, Farba; Diadhiou, Roger; Toupane, Maxime; Dieye, Tandakha; Mboup, Souleymane] Hop Aristide Dantec, Lab Bacteriol Virol, Dakar, Senegal; [Fletcher, Helen] Univ Oxford, CCVTM, Churchill Hosp, Oxford, England	Institut de Recherche pour le Developpement (IRD); University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Lienhardt, C (corresponding author), Inst Rech Dev, Programme Tuberculose, Dakar, Senegal.	lienhardtc@who.int	Lienhardt, Christian/AAU-4969-2021; Fletcher, Helen/D-1470-2011	Lienhardt, Christian/0000-0003-0233-893X; Fletcher, Helen/0000-0002-0435-1006; GOMIS, Jules/0000-0002-5961-570X; Fielding, Katherine/0000-0002-6524-3754	European Commission [QOL 2001-01613]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study has been conducted under funding from the European Commission, Framework Programme 5, Project QOL 2001-01613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; *NICE, 2006, 33 NICE; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; Thiam S, 2005, Med Trop (Mars), V65, P43; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; Weis S, 2002, AM J RESP CRIT CARE, V166, P1016, DOI 10.1164/rccm.2207007; WHO, 2008, IMPL WHO STOP TB STR	31	44	49	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10508	10.1371/journal.pone.0010508	http://dx.doi.org/10.1371/journal.pone.0010508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463900	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000277379800004
J	Miller, JC; Danon, L; O'Hagan, JJ; Goldstein, E; Lajous, M; Lipsitch, M				Miller, Joel C.; Danon, Leon; O'Hagan, Justin J.; Goldstein, Edward; Lajous, Martin; Lipsitch, Marc			Student Behavior during a School Closure Caused by Pandemic Influenza A/H1N1	PLOS ONE			English	Article							TRANSMISSION	Background: Many schools were temporarily closed in response to outbreaks of the recently emerged pandemic influenza A/H1N1 virus. The effectiveness of closing schools to reduce transmission depends largely on student/family behavior during the closure. We sought to improve our understanding of these behaviors. Methodology/Principal Findings: To characterize this behavior, we surveyed students in grades 9-12 and parents of students in grades 5-8 about student activities during a weeklong closure of a school during the first months after the disease emerged. We found significant interaction with the community and other students-though less interaction with other students than during school-with the level of interaction increasing with grade. Conclusions: Our results are useful for the future design of social distancing policies and to improving the ability of modeling studies to accurately predict their impact.	[Miller, Joel C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Miller, Joel C.; Danon, Leon; O'Hagan, Justin J.; Goldstein, Edward; Lajous, Martin; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Danon, Leon] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Lajous, Martin] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; University of Warwick; Instituto Nacional de Salud Publica; Harvard University; Harvard T.H. Chan School of Public Health	Miller, JC (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	joel.c.miller.research@gmail.com	Danon, Leon/AFV-8758-2022; Miller, Joel C./C-4229-2015; Danon, Leon/J-6324-2012	Danon, Leon/0000-0002-7076-1871; Miller, Joel C./0000-0003-4426-0405; Danon, Leon/0000-0002-7076-1871; Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health [5U01GM076497]; Mexican National Council for Science and Technology (CONACyT); Ministry of Health of Mexico; Department of Epidemiology, Harvard School of Public Health; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Medical Research Council, United Kingdom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076497] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Health of Mexico; Department of Epidemiology, Harvard School of Public Health; Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health cooperative agreement 5U01GM076497 "Models of Infectious Disease Agent Study'' (M. Lipsitch, J.J.O'H. and E. G.), the Mexican National Council for Science and Technology (CONACyT), the Ministry of Health of Mexico (M.Lajous) and the Department of Epidemiology, Harvard School of Public Health (M.Lajous and J.J.O'H.), the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (J.C.M.), and the Medical Research Council, United Kingdom (L. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AP, 2009, NYC SCH OFF DEATH TI; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; CDC (Centers for Disease Control and Prevention), 2009, CDC GUID STAT LOC PU; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HALLORAN M, 2009, EPIDEMIOLOGY, V20; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; HEYMANN AD, 2009, EPIDEMIOL INFECT, P1; Mniszewski SM, 2008, P 2008 SPRING SIM MU, P556, DOI DOI 10.1145/1400549.1400636; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205	13	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10425	10.1371/journal.pone.0010425	http://dx.doi.org/10.1371/journal.pone.0010425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463960	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400007
J	Wang, Q; Symes, AJ; Kane, CA; Freeman, A; Nariculam, J; Munson, P; Thrasivoulou, C; Masters, JRW; Ahmed, A				Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Freeman, Alex; Nariculam, Joseph; Munson, Philippa; Thrasivoulou, Christopher; Masters, John R. W.; Ahmed, Aamir			A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer	PLOS ONE			English	Article							TYROSINE KINASE ROR2; WNT/BETA-CATENIN; BETA-CATENIN; TUMOR-SUPPRESSOR; TARGET GENES; WNT; EXPRESSION; IDENTIFICATION; PROLIFERATION; MECHANISMS	Wnt signaling is a critical regulatory pathway in development and disease. Very little is known about the mechanisms of Wnt signaling in prostate cancer, a leading cause of death in men. A quantitative analysis of the expression of Wnt5A protein in human tissue arrays, containing 600 prostate tissue cores, showed > 50% increase in malignant compared to benign cores (p < 0.0001). In a matched pair of prostate cancer and normal cell line, expression of Wnt5A protein was also increased. Calcium waves were induced in prostate cells in response to Wnt5A with a 3 fold increase in Flou-4 intensity. The activity of Ca2+/calmodulin dependent protein kinase (CaMKII), a transducer of the non-canonical Wnt/Ca2+ signaling, increased by 8 fold in cancer cells; no change was observed in beta-catenin expression, known to activate the canonical Wnt/beta-catenin pathway. Mining of publicly available human prostate cancer oligoarray datasets revealed that the expression of numerous genes (e.g., CCND1, CD44) under the control of beta-catenin transcription is down-regulated. Confocal and quantitative electron microscopy showed that specific inhibition of CaMKII in cancer cells causes remodeling of the actin cytoskeleton, irregular wound edges and loose intercellular architecture and a 6 and 8 fold increase in the frequency and length of filopodia, respectively. Conversely, untreated normal prostate cells showed an irregular wound edge and loose intercellular architecture; incubation of normal prostate cells with recombinant Wnt5A protein induced actin remodeling with a regular wound edge and increased wound healing capacity. Live cell imaging showed that a functional consequence of CaMKII inhibition was 80% decrease in wound healing capacity and reduced cell motility in cancer cells. We propose that non-canonical Wnt/Ca2+ signaling via CaMKII acts as a novel regulator of structural plasticity and cell motility in prostate cancer.	[Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Nariculam, Joseph; Masters, John R. W.; Ahmed, Aamir] UCL, Prostate Canc Res Ctr, London, England; [Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Nariculam, Joseph; Masters, John R. W.; Ahmed, Aamir] UCL, Div Surg, London, England; [Freeman, Alex] Univ Coll Hosp London Natl Hlth Serv Fdn Trust, Dept Histopathol, London, England; [Munson, Philippa] UCL, Univ Coll London Adv Diagnost, London, England; [Thrasivoulou, Christopher] UCL, Ctr Cell & Mol Dynam, London, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Wang, Q (corresponding author), UCL, Prostate Canc Res Ctr, London, England.	aamir.ahmed@ucl.ac.uk	Thrasivoulou, Christopher/F-7087-2010; Masters, John R/C-5694-2011; Freeman, Alex/J-8344-2019	Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	National Cancer Research Institute; Prostate Cancer Research Center, United Kingdom; MRC [G0100116] Funding Source: UKRI; Medical Research Council [G0100116] Funding Source: researchfish	National Cancer Research Institute; Prostate Cancer Research Center, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Cancer Research Institute and Prostate Cancer Research Center, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bright RK, 1997, CANCER RES, V57, P995; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; IOZZO RV, 1995, CANCER RES, V55, P3495; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2007, SCIENCE, V316, P988, DOI 10.1126/science.1143337; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rasband W, 1997, IMAGEJ SOFTWARE VERS; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YAMAMOTO H, 2010, ONCOGENE; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	47	86	94	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10456	10.1371/journal.pone.0010456	http://dx.doi.org/10.1371/journal.pone.0010456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454608	Green Submitted, gold, Green Published			2022-12-27	WOS:000277305300006
J	Perkol-Finkel, S; Airoldi, L				Perkol-Finkel, Shimrit; Airoldi, Laura			Loss and Recovery Potential of Marine Habitats: An Experimental Study of Factors Maintaining Resilience in Subtidal Algal Forests at the Adriatic Sea	PLOS ONE			English	Article							PHYSICAL DISTURBANCE; CLIMATE-CHANGE; KELP FORESTS; ECOLOGY; CONSEQUENCES; BIODIVERSITY; RESTORATION; DEGRADATION; VARIABILITY; LIMITATION	Background: Predicting and abating the loss of natural habitats present a huge challenge in science, conservation and management. Algal forests are globally threatened by loss and severe recruitment failure, but our understanding of resilience in these systems and its potential disruption by anthropogenic factors lags well behind other habitats. We tested hypotheses regarding triggers for decline and recovery potential in subtidal forests of canopy-forming algae of the genus Cystoseira. Methodology/Principal Findings: By using a combination of historical data, and quantitative in situ observations of natural recruitment patterns we suggest that recent declines of forests along the coasts of the north Adriatic Sea were triggered by increasing cumulative impacts of natural-and human-induced habitat instability along with several extreme storm events. Clearing and transplantation experiments subsequently demonstrated that at such advanced stages of ecosystem degradation, increased substratum stability would be essential but not sufficient to reverse the loss, and that for recovery to occur removal of the new dominant space occupiers (i.e., opportunistic species including turf algae and mussels) would be required. Lack of surrounding adult canopies did not seem to impair the potential for assisted recovery, suggesting that in these systems recovery could be actively enhanced even following severe depletions. Conclusions/Significance: We demonstrate that sudden habitat loss can be facilitated by long term changes in the biotic and abiotic conditions in the system, that erode the ability of natural ecosystems to absorb and recover from multiple stressors of natural and human origin. Moreover, we demonstrate that the mere restoration of environmental conditions preceding a loss, if possible, may be insufficient for ecosystem restoration, and is scarcely cost-effective. We conclude that the loss of complex marine habitats in human-dominated landscapes could be mitigated with appropriate consideration and management of incremental habitat changes and of attributes facilitating system recovery.	[Perkol-Finkel, Shimrit] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy; Univ Bologna, Ctr Interdipartimentale Ric Sci Ambientali, Ravenna, Italy	University of Bologna; University of Bologna	Perkol-Finkel, S (corresponding author), Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy.	sperkol@gmail.com	Airoldi, Laura/I-3553-2019	Airoldi, Laura/0000-0001-5046-0871	EU [FP7-PEOPLE-2007-2-1-IEF-219818]; Italian Ministry of Education, University, and Research, Italy; University of Bologna, Italy	EU(European Commission); Italian Ministry of Education, University, and Research, Italy(Ministry of Education, Universities and Research (MIUR)); University of Bologna, Italy	Funding: MarUrbe - Sustainable management of urban marine structures: EU - FP7-PEOPLE-2007-2-1-IEF-219818 (Marie Curie Fellowship - SPF). BIORES -The resistance and resilience of coastal biodiversity to synergic effects of global and local environmental changes (PRIN 2007, Italian Ministry of Education, University, and Research, Italy). AdriaBio - Past, present and future of marine biodiversity in the Adriatic sea (University of Bologna Strategic Project, University of Bologna, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; AIROLDI L, 2009, HARD BOTTOM COMMUNIT, V206, P269; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Ciavola P., 2007, J COAST RES SI, VS150, P1; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cormaci M, 1999, HYDROBIOLOGIA, V399, P75; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAVIS AN, 1987, MAR ECOL PROG SER, V37, P229, DOI 10.3354/meps037229; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; DEGRANDIS G, 2003, THESIS U BOLOGNA RAV; Edwards MS, 2006, MAR ECOL PROG SER, V320, P79, DOI 10.3354/meps320079; ESTES JA, 1989, CONSERV BIOL, V3, P252, DOI 10.1111/j.1523-1739.1989.tb00085.x; FABI G, 2003, AREA MARINA ANTISTAN; Falace A, 2006, HYDROBIOLOGIA, V555, P193, DOI 10.1007/s10750-005-1116-2; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; HANNAH L, 1994, AMBIO, V23, P246; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Irving AD, 2006, MAR ECOL PROG SER, V324, P127, DOI 10.3354/meps324127; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; LAM NWY, 2009, HONG KONG ZOOLOGICAL, V48, P184; LIEBERMAN M, 1979, ECOLOGY, V60, P1151, DOI 10.2307/1936963; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; MUNDA IM, 1993, HYDROBIOLOGIA, V261, P239; Ormerod SJ, 2003, J APPL ECOL, V40, P44, DOI 10.1046/j.1365-2664.2003.00799.x; OTT JA, 1990, 25 EUR MAR BIOL S, P45; Reed DC, 2004, J PHYCOL, V40, P275, DOI 10.1046/j.1529-8817.2004.03119.x; Sales M, 2009, ESTUAR COAST SHELF S, V84, P476, DOI 10.1016/j.ecss.2009.07.013; Scheibling RE, 2009, J EXP MAR BIOL ECOL, V368, P94, DOI 10.1016/j.jembe.2008.10.017; Schiel DR, 2006, J EXP MAR BIOL ECOL, V338, P233, DOI 10.1016/j.jembe.2006.06.023; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schmidt AL, 2007, J EXP MAR BIOL ECOL, V341, P110, DOI 10.1016/j.jembe.2006.10.003; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661	55	106	110	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10791	10.1371/journal.pone.0010791	http://dx.doi.org/10.1371/journal.pone.0010791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520726	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034600017
J	Moncaster, JA; Pineda, R; Moir, RD; Lu, SQ; Burton, MA; Ghosh, JG; Ericsson, M; Soscia, SJ; Mocofanescu, A; Folkerth, RD; Robb, RM; Kuszak, JR; Clark, JI; Tanzi, RE; Hunter, DG; Goldstein, LE				Moncaster, Juliet A.; Pineda, Roberto; Moir, Robert D.; Lu, Suqian; Burton, Mark A.; Ghosh, Joy G.; Ericsson, Maria; Soscia, Stephanie J.; Mocofanescu, Anca; Folkerth, Rebecca D.; Robb, Richard M.; Kuszak, Jer R.; Clark, John I.; Tanzi, Rudolph E.; Hunter, David G.; Goldstein, Lee E.			Alzheimer's Disease Amyloid-beta Links Lens and Brain Pathology in Down Syndrome	PLOS ONE			English	Article							PROTEIN-PRECURSOR; EXPRESSION; DEPOSITION; DEMENTIA; LOCUS; HYPOTHESIS; CRYSTALLIN; CATARACTS; PEOPLE; CDNA	Down syndrome (DS, trisomy 21) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans. In DS, triplication of chromosome 21 invariably includes the APP gene (21q21) encoding the Alzheimer's disease (AD) amyloid precursor protein (APP). Triplication of the APP gene accelerates APP expression leading to cerebral accumulation of APP-derived amyloid-beta peptides (A beta), early-onset AD neuropathology, and age-dependent cognitive sequelae. The DS phenotype complex also includes distinctive early-onset cerulean cataracts of unknown etiology. Previously, we reported increased A beta accumulation, co-localizing amyloid pathology, and disease-linked supranuclear cataracts in the ocular lenses of subjects with AD. Here, we investigate the hypothesis that related AD-linked A beta pathology underlies the distinctive lens phenotype associated with DS. Ophthalmological examinations of DS subjects were correlated with phenotypic, histochemical, and biochemical analyses of lenses obtained from DS, AD, and normal control subjects. Evaluation of DS lenses revealed a characteristic pattern of supranuclear opacification accompanied by accelerated supranuclear A beta accumulation, co-localizing amyloid pathology, and fiber cell cytoplasmic A beta aggregates (similar to 5 to 50 nm) identical to the lens pathology identified in AD. Peptide sequencing, immunoblot analysis, and ELISA confirmed the identity and increased accumulation of A beta in DS lenses. Incubation of synthetic A beta with human lens protein promoted protein aggregation, amyloid formation, and light scattering that recapitulated the molecular pathology and clinical features observed in DS lenses. These results establish the genetic etiology of the distinctive lens phenotype in DS and identify the molecular origin and pathogenic mechanism by which lens pathology is expressed in this common chromosomal disorder. Moreover, these findings confirm increased A beta accumulation as a key pathogenic determinant linking lens and brain pathology in both DS and AD.	[Moncaster, Juliet A.; Lu, Suqian; Burton, Mark A.; Ghosh, Joy G.; Mocofanescu, Anca; Goldstein, Lee E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Mol Aging & Dev Lab,Dept Surg, Boston, MA 02115 USA; [Pineda, Roberto] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Moir, Robert D.; Soscia, Stephanie J.; Tanzi, Rudolph E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA USA; [Ericsson, Maria] Harvard Univ, Dept Cell Biol, Sch Med, Elect Microscopy Facil, Boston, MA USA; [Folkerth, Rebecca D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Robb, Richard M.; Hunter, David G.] Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Kuszak, Jer R.] Rush Univ, Med Ctr, Dept Ophthalmol, Chicago, IL 60612 USA; [Kuszak, Jer R.] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Rush University; Rush University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moncaster, JA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Mol Aging & Dev Lab,Dept Surg, Boston, MA 02115 USA.	LGOLD@BU.EDU	Tanzi, Rudolph/AAE-9622-2019; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; Moir, Robert D./0000-0001-5431-3553; Hunter, David/0000-0002-4587-4794; Goldstein, Lee/0000-0001-8419-9800; Moncaster, Juliet/0000-0002-7849-4325	National Institutes of Health, Bethesda, MD [R01GM75986, K23AG024792]; American Federation for Aging Research, New York, NY; Alzheimer's Association, Chicago, IL; American Health Assistance Foundation, Clarksburg, MD; Cure Alzheimer's Fund, Wellesley Hills, MA; Boston University School of Medicine, Boston, MA; Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC) [P30AG13846]; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, K23AG024792] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research, New York, NY; Alzheimer's Association, Chicago, IL(Alzheimer's Association); American Health Assistance Foundation, Clarksburg, MD; Cure Alzheimer's Fund, Wellesley Hills, MA; Boston University School of Medicine, Boston, MA; Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: National Institutes of Health, Bethesda, MD (R01GM75986 and K23AG024792, LEG); American Federation for Aging Research, New York, NY (LEG); Alzheimer's Association, Chicago, IL (LEG); American Health Assistance Foundation, Clarksburg, MD (LEG); Anonymous Foundation (LEG); Cure Alzheimer's Fund, Wellesley Hills, MA (RDM); Boston University School of Medicine, Boston, MA (LEG); and Boston University Alzheimer's Disease Center, Boston, MA (NIH ADCC grant P30AG13846). The funding sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The senior corresponding author (LEG) has full access to all study data and takes final responsibility for the decision to submit the results of the study for publication.	[Anonymous], ONLINE MENDELIAN INH; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; COGAN DAVID G., 1962, DOCUMENTA OPHTHALMOL, V16, P73, DOI 10.1007/BF00146720; Costello MJ, 2007, INVEST OPHTH VIS SCI, V48, P303, DOI 10.1167/iovs.06-0480; Creavin AL, 2009, J PEDIAT OPHTH STRAB, V46, P76, DOI 10.3928/01913913-20090301-06; daCunha RP, 1996, AM J OPHTHALMOL, V122, P236, DOI 10.1016/S0002-9394(14)72015-X; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; EPSTEIN CJ, 2001, METABOLIC MOL BASES, P1223; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Frederikse PH, 1998, CURR EYE RES, V17, P947, DOI 10.1076/ceyr.17.9.947.5135; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Haargaard B, 2006, BRIT J OPHTHALMOL, V90, P1024, DOI 10.1136/bjo.2006.090639; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; IGERSHEIMER J, 1951, T AM OPHTHAL SOC, V49, P595; Kallen B, 1996, AM J MED GENET, V65, P160; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Leverenz JB, 1998, EXP NEUROL, V150, P296, DOI 10.1006/exnr.1997.6777; Li GH, 2003, MOL VIS, V9, P179; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; LOWE J, 1992, NEUROPATH APPL NEURO, V18, P341, DOI 10.1111/j.1365-2990.1992.tb00796.x; LOWE RF, 1949, BRIT J OPHTHALMOL, V33, P131, DOI 10.1136/bjo.33.3.131; LYLE R, 2008, EUR J HUM GENET, P1; MIKKELSEN M, 1977, HEREDITAS, V86, P45; Oliver C A, 1891, Trans Am Ophthalmol Soc, V6, P140; OYAMA F, 1994, J NEUROCHEM, V62, P1062; Pearce F H, 1910, Br Med J, V2, P186; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; PROPHET, 1992, LAB METHODS HISTOTEC; PUESCHEL SM, 1990, AM J MED GENET, P52; ROBAKIS NK, 1987, LANCET, V1, P384; ROBB RM, 1978, ARCH OPHTHALMOL-CHIC, V96, P1039; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schupf N, 2002, BRIT J PSYCHIAT, V180, P405, DOI 10.1192/bjp.180.5.405; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; The March of Dimes Birth Defects Foundation, 2006, MARCH DIM GLOB REP B; THULINE HC, 1982, ADV BIOMEDICINE BEHA; Wavrant-De Vrieze F, 1999, NEUROSCI LETT, V269, P67, DOI 10.1016/S0304-3940(99)00417-6; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	50	101	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10659	10.1371/journal.pone.0010659	http://dx.doi.org/10.1371/journal.pone.0010659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20502642	Green Published, gold			2022-12-27	WOS:000278017300002
J	Rogalewski, A; Dittgen, T; Klugmann, M; Kirsch, F; Kruger, C; Pitzer, C; Minnerup, J; Schabitz, WR; Schneider, A				Rogalewski, Andreas; Dittgen, Tanjew; Klugmann, Matthias; Kirsch, Friederike; Krueger, Carola; Pitzer, Claudia; Minnerup, Jens; Schaebitz, Wolf-Ruediger; Schneider, Armin			Semaphorin 6A Improves Functional Recovery in Conjunction with Motor Training after Cerebral Ischemia	PLOS ONE			English	Article							MOVEMENT REPRESENTATIONS; GENE-EXPRESSION; BRAIN-INJURY; CORTEX; RAT; REORGANIZATION; NEURONS; STROKE	Background: We have previously identified Semaphorin 6a (Sema6A) as an upregulated gene product in a gene expression screen in cortical ischemia [1]. Semaphorin 6a was regulated during the recovery phase following ischemia in the cortex. Semaphorin 6a is a member of the superfamily of semaphorins involved in axon guidance and other functions. We hypothesized that the upregulation indicates a crucial role of this molecule in post-stroke rewiring of the brain. Here we have tested this hypothesis by overexpressing semaphorin 6a in the cortex by microinjection of a modified AAV2-virus. A circumscribed cortical infarct was induced, and the recovery of rats monitored for up to 4 weeks using a well-established test battery (accelerated rotarod training paradigm, cylinder test, adhesive tape removal). We observed a significant improvement in post-ischemic recovery of animals injected with the semaphorin 6a virus versus animals treated with a control virus. We conclude that semaphorin 6a overexpressed in the cortex enhances recovery after cerebral ischemia. Semaphorin 6a may represent a novel therapeutic candidate for the treatment of chronic stroke.	[Rogalewski, Andreas; Minnerup, Jens; Schaebitz, Wolf-Ruediger] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Dittgen, Tanjew; Kirsch, Friederike; Krueger, Carola; Pitzer, Claudia] Sygnis Biosci, Heidelberg, Germany; [Klugmann, Matthias; Schneider, Armin] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-6500 Mainz, Germany	University of Munster; Johannes Gutenberg University of Mainz	Rogalewski, A (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	Wolf.Schaebitz@evkb.de; Schneider@Sygnis.de		Rogalewski, Andreas/0000-0002-6525-4832; Schneider, Armin/0000-0003-0296-0059	Sygnis Bioscience AG Heidelberg (Molecular Neurology); University of Muenster (Dept. of Neurology); University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry)	Sygnis Bioscience AG Heidelberg (Molecular Neurology); University of Muenster (Dept. of Neurology); University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry)	The authors' work is a collaboration of the Sygnis Bioscience AG Heidelberg (Molecular Neurology), University of Muenster (Dept. of Neurology), and University of Mainz (Inst. for Physiological Chemistry and Pathobiochemistry) without any further funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P184, DOI 10.1038/jcbfm.1986.31; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kruger C, 2006, EXP NEUROL, V200, P135, DOI 10.1016/j.expneurol.2006.01.025; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; Szumlinski KK, 2005, J NEUROSCI, V25, P7054, DOI 10.1523/JNEUROSCI.1529-05.2005; Xu XM, 2000, J NEUROSCI, V20, P2638; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10737	10.1371/journal.pone.0010737	http://dx.doi.org/10.1371/journal.pone.0010737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505770	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300011
J	Bjorkhem-Bergman, L; Bergman, P; Andersson, J; Lindh, JD				Bjorkhem-Bergman, Linda; Bergman, Peter; Andersson, Jan; Lindh, Jonatan D.			Statin Treatment and Mortality in Bacterial Infections - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; GASTRIC-ACID SUPPRESSANTS; POPULATION-BASED COHORT; ELDERLY-PATIENTS; ACE-INHIBITORS; ORGAN FAILURE; THERAPY; RISK; SEPSIS; OUTCOMES	Background: Several studies have reported improved survival in severe bacterial infections among statin treated patients. In addition, statins have been ascribed beneficial anti-inflammatory effects. The aim of this study was to evaluate the effect of statin-treatment on mortality in patients with bacterial infections, by means of a systematic review and a meta-analysis. Methodology and Principal Findings: Studies investigating the association between statin use and mortality in patients with bacterial disease were identified in a systematic literature review and a meta-analysis was performed to calculate the overall odds ratio of mortality in statin users. The literature search identified 947 citations from which 40 relevant studies were extracted. In all, 15 studies comprising 113 910 patients were included in the final analysis. Statin use was associated with a significantly (p<0.0001) reduced mortality in patients suffering from bacterial infections (OR 0.52, 95% CI 0.42-0.66). However, all studies included were of observational design and funnel plot analyses indicated influence by a possible publication bias (Egger's bias test p<0.05). When a precision estimate test was used to adjust for publication bias the effect of statin treatment was no longer significant, with an OR of 0.79 (95% CI 0.58-1.07). Conclusion/Significance: According to the meta-analysis of observational studies presented here, patients on statin therapy seem to have a better outcome in bacterial infections. However, the association did not reach statistical significance after adjustment for apparent publication bias. Thus, there is a great need for randomised controlled trials investigating the possible beneficial effect of statins in bacterial infections.	[Bjorkhem-Bergman, Linda; Lindh, Jonatan D.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Bergman, Peter] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bergman, Peter; Andersson, Jan] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Bjorkhem-Bergman, L (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.	linda.bjorkhem-bergman@karolinska.se	Lindh, Jonatan/A-2733-2012	Bergman, Peter/0000-0003-3306-3713	Karolinska Institutet; Stockholm County Council; Swedish Heart and Lung Foundation; Ake Wibergs stiftelse; David och Astrids Hagelens stiftelse; Magnus Bergvalls stiftelse	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Ake Wibergs stiftelse; David och Astrids Hagelens stiftelse; Magnus Bergvalls stiftelse	This work was financially supported by grants from Karolinska Institutet, Stockholm County Council, the Swedish Heart and Lung Foundation, Ake Wibergs stiftelse, David och Astrids Hagelens stiftelse and Magnus Bergvalls stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Andrews TC, 2001, AM J MED, V111, P185, DOI 10.1016/S0002-9343(01)00799-9; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Broady R, 2008, NAT MED, V14, P1155, DOI 10.1038/nm1108-1155; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570; Daneman N, 2009, ARCH SURG-CHICAGO, V144, P938, DOI 10.1001/archsurg.2009.167; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P621, DOI 10.1592/phco.29.6.621; Donnino MW, 2009, ACAD EMERG MED, V16, P230, DOI 10.1111/j.1553-2712.2009.00350.x; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; FLEMING DM, EPIDEMIOL INFECT, P1; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hauer-Jensen M, 2006, Hernia, V10, P48, DOI 10.1007/s10029-005-0030-x; HSU J, 2009, EUR J CLIN MICROBIOL; Ishida W, 2007, TOHOKU J EXP MED, V212, P265, DOI 10.1620/tjem.212.265; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kuoppala J, 2008, EUR J CANCER, V44, P2122, DOI 10.1016/j.ejca.2008.06.025; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Martin CP, 2007, PHARMACOTHERAPY, V27, P20, DOI 10.1592/phco.27.1.20; MARTIN LD, 2009, PRESSE MED; Mohamed R, 2009, CLIN INFECT DIS, V48, pE66, DOI 10.1086/597300; Montaner J, 2008, EUR J NEUROL, V15, P82, DOI 10.1111/j.1468-1331.2007.02015.x; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005019.pub3; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Qu HY, 2009, PHARM RES-DORDR, V26, P958, DOI 10.1007/s11095-008-9798-6; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schmidt H, 2006, INTENS CARE MED, V32, P1248, DOI 10.1007/s00134-006-0246-y; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Selvan PS, 2009, J PHARMACEUT BIOMED, V49, P780, DOI 10.1016/j.jpba.2008.12.031; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Stanley TD, 2008, OXFORD B ECON STAT, V70, P103, DOI 10.1111/j.1468-0084.2007.00487.x; Subramaniam K, 2008, J CLIN ANESTH, V20, P4, DOI 10.1016/j.jclinane.2007.09.003; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Yang KC, 2007, AM J EMERG MED, V25, P494, DOI 10.1016/j.ajem.2006.09.011; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988	58	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10702	10.1371/journal.pone.0010702	http://dx.doi.org/10.1371/journal.pone.0010702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502712	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400010
J	Chang, YS; Liu, WJ; Lee, CC; Chou, TL; Lee, YT; Wu, TS; Huang, JY; Huang, WT; Lee, TL; Kou, GH; Wang, AHJ; Lo, CF				Chang, Yun-Shiang; Liu, Wang-Jing; Lee, Cheng-Chung; Chou, Tsung-Lu; Lee, Yuan-Ting; Wu, Tz-Shian; Huang, Jiun-Yan; Huang, Wei-Tung; Lee, Tai-Lin; Kou, Guang-Hsiung; Wang, Andrew H. -J.; Lo, Chu-Fang			A 3D Model of the Membrane Protein Complex Formed by the White Spot Syndrome Virus Structural Proteins	PLOS ONE			English	Article							MAJOR ENVELOPE PROTEINS; HERPES-SIMPLEX-VIRUS; PENAEUS-MONODON; PROTEOMIC ANALYSIS; WSSV INFECTION; VIRAL-PROTEINS; SHRIMP CELLS; TIGER SHRIMP; IDENTIFICATION; VP26	Background: Outbreaks of white spot disease have had a large negative economic impact on cultured shrimp worldwide. However, the pathogenesis of the causative virus, WSSV (whit spot syndrome virus), is not yet well understood. WSSV is a large enveloped virus. The WSSV virion has three structural layers surrounding its core DNA: an outer envelope, a tegument and a nucleocapsid. In this study, we investigated the protein-protein interactions of the major WSSV structural proteins, including several envelope and tegument proteins that are known to be involved in the infection process. Principal Findings: In the present report, we used coimmunoprecipitation and yeast two-hybrid assays to elucidate and/or confirm all the interactions that occur among the WSSV structural (envelope and tegument) proteins VP51A, VP19, VP24, VP26 and VP28. We found that VP51A interacted directly not only with VP26 but also with VP19 and VP24. VP51A, VP19 and VP24 were also shown to have an affinity for self-interaction. Chemical cross-linking assays showed that these three self-interacting proteins could occur as dimers. Conclusions: From our present results in conjunction with other previously established interactions we construct a 3D model in which VP24 acts as a core protein that directly associates with VP26, VP28, VP38A, VP51A and WSV010 to form a membrane-associated protein complex. VP19 and VP37 are attached to this complex via association with VP51A and VP28, respectively. Through the VP26-VP51C interaction this envelope complex is anchored to the nucleocapsid, which is made of layers of rings formed by VP664. A 3D model of the nucleocapsid and the surrounding outer membrane is presented.	[Chang, Yun-Shiang; Chou, Tsung-Lu; Lee, Yuan-Ting; Wu, Tz-Shian; Huang, Wei-Tung; Lee, Tai-Lin] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Liu, Wang-Jing; Huang, Jiun-Yan; Kou, Guang-Hsiung; Lo, Chu-Fang] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lee, Cheng-Chung; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Da Yeh University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chang, YS (corresponding author), Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan.	yschang@mail.dyu.edu.tw; ahjwang@gate.sinica.edu.tw; gracelow@ntu.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	National Science Council [NSC95-2313-B-212-006-MY2, 97-2313-B-212-002-MY3, NSC 98-2311-B-002-013-MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported financially by National Science Council (http://web1.nsc.gov.tw/mp.aspx) grants NSC95-2313-B-212-006-MY2, 97-2313-B-212-002-MY3 and NSC 98-2311-B-002-013-MY2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Chang YS, 2008, J VIROL, V82, P12555, DOI 10.1128/JVI.01238-08; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen J, 2007, VIROLOGY, V364, P208, DOI 10.1016/j.virol.2007.02.030; Durand S, 1997, DIS AQUAT ORGAN, V29, P205, DOI 10.3354/dao029205; ERICKSON HP, 2009, BIOL PROCED ONLINE; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang CH, 2001, VIRUS RES, V76, P115, DOI 10.1016/S0168-1702(01)00247-7; Huang CH, 2002, J GEN VIROL, V83, P2385, DOI 10.1099/0022-1317-83-10-2385; Jie ZL, 2008, ARCH VIROL, V153, P2103, DOI 10.1007/s00705-008-0221-8; Kumar SR, 2008, FISH SHELLFISH IMMUN, V24, P467, DOI 10.1016/j.fsi.2008.01.004; Leu JH, 2005, J VIROL, V79, P140, DOI 10.1128/JVI.79.1.140-149.2005; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Liu QH, 2009, LETT APPL MICROBIOL, V48, P44, DOI 10.1111/j.1472-765X.2008.02482.x; Liu QH, 2009, DIS AQUAT ORGAN, V85, P23, DOI 10.3354/dao02050; Lo C.-F., 2005, DIS ASIAN AQUACULTUR, P421; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lo CF, 1999, DIS AQUAT ORGAN, V35, P175, DOI 10.3354/dao035175; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajcani J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P407, DOI 10.1556/AMicr.50.2003.4.8; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rout N, 2007, VACCINE, V25, P2778, DOI 10.1016/j.vaccine.2006.12.056; SEARS AE, 1991, P NATL ACAD SCI USA, V88, P5087, DOI 10.1073/pnas.88.12.5087; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tang XH, 2007, J VIROL, V81, P6709, DOI 10.1128/JVI.02505-06; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; van Hulten MCW, 2000, J GEN VIROL, V81, P2525, DOI 10.1099/0022-1317-81-10-2525; van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928; van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Vlak J.M., 2004, 8 INT COMM TAX VIR, P187; Wan Q, 2008, J VIROL, V82, P12598, DOI 10.1128/JVI.01732-08; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang H-C, 2004, MAR BIOTECHNOL, V6, pS95; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Xie XX, 2006, J VIROL, V80, P10615, DOI 10.1128/JVI.01452-06; Xie XX, 2006, J GEN VIROL, V87, P1903, DOI 10.1099/vir.0.81570-0; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; Zhang XB, 2004, PROTEINS, V55, P229, DOI 10.1002/prot.10640; Zhou Q, 2009, J VIROL, V83, P4709, DOI 10.1128/JVI.02360-08	55	64	67	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10718	10.1371/journal.pone.0010718	http://dx.doi.org/10.1371/journal.pone.0010718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502662	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400020
J	Edwards, LM; Murray, AJ; Tyler, DJ; Kemp, GJ; Holloway, CJ; Robbins, PA; Neubauer, S; Levett, D; Montgomery, HE; Grocott, MP; Clarke, K				Edwards, Lindsay M.; Murray, Andrew J.; Tyler, Damian J.; Kemp, Graham J.; Holloway, Cameron J.; Robbins, Peter A.; Neubauer, Stefan; Levett, Denny; Montgomery, Hugh E.; Grocott, Mike P.; Clarke, Kieran		Caudwell Xtreme Everest Res Grp	The Effect of High-Altitude on Human Skeletal Muscle Energetics: P-31-MRS Results from the Caudwell Xtreme Everest Expedition	PLOS ONE			English	Article							WEIGHT-LOSS; INTERLEUKIN-6 RESPONSE; IL-6-LIKE CYTOKINES; OPERATION EVEREST; BODY-COMPOSITION; CANCER CACHEXIA; OXYGEN-UPTAKE; EXERCISE; EXPOSURE; MRS	Many disease states are associated with regional or systemic hypoxia. The study of healthy individuals exposed to high-altitude hypoxia offers a way to explore hypoxic adaptation without the confounding effects of disease and therapeutic interventions. Using P-31 magnetic resonance spectroscopy and imaging, we investigated skeletal muscle energetics and morphology after exposure to hypobaric hypoxia in seven altitude-naive subjects (trekkers) and seven experienced climbers. The trekkers ascended to 5300 m while the climbers ascended above 7950 m. Before the study, climbers had better mitochondrial function (evidenced by shorter phosphocreatine recovery halftime) than trekkers: 16+/-1 vs. 22+/-2 s (mean +/- SE, p<0.01). Climbers had higher resting [Pi] than trekkers before the expedition and resting [Pi] was raised across both groups on their return (PRE: 2.6+/-0.2 vs. POST: 3.0+/-0.2 mM, p<0.05). There was significant muscle atrophy post-CXE (PRE: 4.7+/-0.2 vs. POST: 4.5+/-0.2 cm(2), p<0.05), yet exercising metabolites were unchanged. These results suggest that, in response to high altitude hypoxia, skeletal muscle function is maintained in humans, despite significant atrophy.	[Edwards, Lindsay M.; Murray, Andrew J.; Tyler, Damian J.; Robbins, Peter A.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Edwards, Lindsay M.; Tyler, Damian J.; Holloway, Cameron J.; Neubauer, Stefan] John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Oxford OX3 9DU, England; [Kemp, Graham J.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England; [Levett, Denny; Montgomery, Hugh E.; Grocott, Mike P.] UCL, Ctr Altitude Space & Extreme Environm Med, London, England; [Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, London, England	University of Oxford; University of Oxford; University of Liverpool; University of London; University College London; University of London; University College London	Edwards, LM (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	L.M.Edwards@utas.edu.au	o'dwyer, michael/D-6561-2012; Levett, Denny/F-4474-2011; Levett, Denny/D-2239-2017; Tyler, Damian/E-6296-2011; Murray, Andrew/B-3130-2010; Mythen, Michael G/G-8682-2011; Kemp, Graham J/A-7540-2008; Grocott, Michael/C-4394-2008; Neubauer, Stefan/B-8448-2011; Levett, Denny Zelda Hope/AAY-4627-2021; Montgomery, Hugh/L-1229-2019; Robbins, Peter/C-7846-2016; Montgomery, Hugh/C-2592-2008	Levett, Denny/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Tyler, Damian/0000-0002-0780-8905; Murray, Andrew/0000-0002-0929-9315; Kemp, Graham J/0000-0002-8324-9666; Grocott, Michael/0000-0002-9484-7581; Levett, Denny Zelda Hope/0000-0002-8418-1675; Robbins, Peter/0000-0002-4975-0609; Neubauer, Stefan/0000-0001-9017-5645; O'Dwyer, Michael J/0000-0003-4038-5745; Montgomery, Hugh/0000-0001-8797-5019	Defence Advanced Research Projects Agency (DARPA); Medical Research Council [G0601490]; Association of Anaesthetists of Great Britain and Ireland; Intensive Care Society; Sir Halley Stewart Trust; John Caudwell; BOC Medical (now Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; United Kingdom Department of Health's National Institute for Health Research; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	Defence Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association of Anaesthetists of Great Britain and Ireland; Intensive Care Society; Sir Halley Stewart Trust; John Caudwell; BOC Medical (now Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; United Kingdom Department of Health's National Institute for Health Research; British Heart Foundation(British Heart Foundation)	Drs. Edwards and Holloway were supported by a grant from Defence Advanced Research Projects Agency (DARPA, code: ASRJMT1). Dr Tyler was funded by the Medical Research Council, grant number G0601490. Caudwell Xtreme Everest (CXE) is a research project coordinated by the UCL Centre for Altitude, Space and Extreme Environment Medicine, University College London, United Kingdom, and funded by grants from the Association of Anaesthetists of Great Britain and Ireland, Intensive Care Society, Sir Halley Stewart Trust, John Caudwell, BOC Medical (now Linde Gas Therapeutics), Lilly Critical Care, The London Clinic, Smiths Medical, Deltex Medical and The Rolex Foundation. All monies were given as unrestricted grants: the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of this work was undertaken at University College London Hospital-University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme.	Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; Armellini F, 1997, HORM METAB RES, V29, P458, DOI 10.1055/s-2007-979077; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Barton BE, 2001, IMMUNOL RES, V23, P41, DOI 10.1385/IR:23:1:41; BOYER SJ, 1984, J APPL PHYSIOL, V57, P1580, DOI 10.1152/jappl.1984.57.5.1580; BRAUN M, 1941, DIFFERENTIAL EQUATIO; BUTTERFIELD GE, 1992, J APPL PHYSIOL, V72, P1741, DOI 10.1152/jappl.1992.72.5.1741; CONSOLAZIO CF, 1972, AM J CLIN NUTR, V25, P23; CONSOLAZIO CF, 1968, AM J CLIN NUTR, V21, P154, DOI 10.1093/ajcn/21.2.154; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; CYMERMAN A, 1989, J APPL PHYSIOL, V66, P2446, DOI 10.1152/jappl.1989.66.5.2446; GILL MB, 1964, J APPL PHYSIOL, V19, P949, DOI 10.1152/jappl.1964.19.5.949; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Green H, 2000, AM J PHYSIOL-REG I, V279, pR1872, DOI 10.1152/ajpregu.2000.279.5.R1872; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; GROVER RF, 1963, J APPL PHYSIOL, V18, P909, DOI 10.1152/jappl.1963.18.5.909; GUILLAND JC, 1985, EUR J APPL PHYSIOL O, V54, P517, DOI 10.1007/BF00422963; Hahn AG, 2001, SPORTS MED, V31, P533, DOI 10.2165/00007256-200131070-00008; HANNON JP, 1973, J APPL PHYSIOL, V34, P471, DOI 10.1152/jappl.1973.34.4.471; HANNON JP, 1976, AM J CLIN NUTR, V29, P604, DOI 10.1093/ajcn/29.6.604; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; HOCHACHKA PW, 2001, HIGH ALTITUDE EXPLOR, P131; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; KELLOGG RH, 1957, J APPL PHYSIOL, V11, P65, DOI 10.1152/jappl.1957.11.1.65; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Klausen B, 1997, AM J CLIN NUTR, V65, P895; Korzeniewski B, 2005, BIOPHYS CHEM, V116, P129, DOI 10.1016/j.bpc.2005.03.004; Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lundby C, 2004, EUR J APPL PHYSIOL, V91, P88, DOI 10.1007/s00421-003-0935-y; Lynn EG, 2007, ANTIOXID REDOX SIGN, V9, P1353, DOI 10.1089/ars.2007.1700; MATHEW L, 1976, Indian Journal of Physiology and Pharmacology, V20, P197; Mawson JT, 2000, J APPL PHYSIOL, V88, P272, DOI 10.1152/jappl.2000.88.1.272; Mazzeo RS, 2001, J APPL PHYSIOL, V91, P2143; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; POLGREEN KE, 1994, BBA-MOL CELL RES, V1223, P279, DOI 10.1016/0167-4889(94)90238-0; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; ROSSER BWC, 1993, EUR J APPL PHYSIOL O, V67, P513, DOI 10.1007/BF00241647; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Short K R, 2001, Exerc Sport Sci Rev, V29, P118, DOI 10.1097/00003677-200107000-00006; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; STOCK MJ, 1978, J APPL PHYSIOL, V45, P345, DOI 10.1152/jappl.1978.45.3.345; Tisdale MJ, 2001, FRONT BIOSCI, V6, pD164, DOI 10.2741/Tisdale; VANDENBORNE K, 1993, AM J PHYSIOL, V265, pC1332, DOI 10.1152/ajpcell.1993.265.5.C1332; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Westerterp KR, 2001, J EXP BIOL, V204, P3183	51	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10681	10.1371/journal.pone.0010681	http://dx.doi.org/10.1371/journal.pone.0010681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502713	Green Published, Green Accepted, gold			2022-12-27	WOS:000277845400006
J	Gou, DW; Rubalcava, M; Sauer, S; Mora-Bermudez, F; Erdjument-Bromage, H; Tempst, P; Kremmer, E; Sauer, F				Gou, Dawei; Rubalcava, Monica; Sauer, Silvia; Mora-Bermudez, Felipe; Erdjument-Bromage, Hediye; Tempst, Paul; Kremmer, Elisabeth; Sauer, Frank			RETRACTED: SETDB1 Is Involved in Postembryonic DNA Methylation and Gene Silencing in Drosophila (Retracted article. See vol. 13, art no E0194869, 2018)	PLOS ONE			English	Article; Retracted Publication							CPG-BINDING DOMAIN; EPIGENETIC REGULATION; GENOME; EXPRESSION; TRANSCRIPTION; WIDE; EYE; RBF	DNA methylation is fundamental for the stability and activity of genomes. Drosophila melanogaster and vertebrates establish a global DNA methylation pattern of their genome during early embryogenesis. Large-scale analyses of DNA methylation patterns have uncovered revealed that DNA methylation patterns are dynamic rather than static and change in a gene-specific fashion during development and in diseased cells. However, the factors and mechanisms involved in dynamic, postembryonic DNA methylation remain unclear. Methylation of lysine 9 in histone H3 (H3-K9) by members of the Su(var)3-9 family of histone methyltransferases (HMTs) triggers embryonic DNA methylation in Arthropods and Chordates. Here, we demonstrate that Drosophila SETDB1 (dSETDB1) can mediate DNA methylation and silencing of genes and retrotransposons. We found that dSETDB1 tri-methylates H3-K9 and binds methylated CpA motifs. Tri-methylation of H3-K9 by dSETDB1 mediates recruitment of DNA methyltransferase 2 (Dnmt2) and Su(var) 205, the Drosophila ortholog of mammalian "Heterochromatin Protein 1'', to target genes for dSETDB1. By enlisting Dnmt2 and Su(var) 205, dSETDB1 triggers DNA methylation and silencing of genes and retrotransposons in Drosophila cells. DSETDB1 is involved in postembryonic DNA methylation and silencing of Rt1b{} retrotransposons and the tumor suppressor gene retinoblastoma family protein 1 (Rb) in imaginal discs. Collectively, our findings implicate dSETDB1 in postembryonic DNA methylation, provide a model for silencing of the tumor suppressor Rb, and uncover a role for cell type-specific DNA methylation in Drosophila development.	[Gou, Dawei; Rubalcava, Monica; Sauer, Silvia; Sauer, Frank] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Mora-Bermudez, Felipe; Sauer, Frank] Heidelberg Univ, Zentrum Mol Biol, D-6900 Heidelberg, Germany; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany	University of California System; University of California Riverside; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gou, DW (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.	frank.sauer@ucr.edu		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	National Institute of General Medical Sciences [GM073776]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073776] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a grant (GM073776) from the National Institute of General Medical Sciences (www.nigms.nih.gov) to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB HDB; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brower-Toland B, 2009, GENETICS, V181, P1303, DOI 10.1534/genetics.108.100271; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Keller SA, 2005, GENE EXPR PATTERNS, V5, P411, DOI 10.1016/j.modgep.2004.09.005; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2006, CURR TOP MICROBIOL, V310, P23; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; MONK M, 1987, DEVELOPMENT, V99, P371; MORATA G, 1993, CURR OPIN GENET DEV, V3, P606, DOI 10.1016/0959-437X(93)90096-8; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Reddy MN, 2003, ONCOGENE, V22, P6301, DOI 10.1038/sj.onc.1206650; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Salzberg A, 2004, BIOCHEM BIOPH RES CO, V322, P465, DOI 10.1016/j.bbrc.2004.07.134; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Stabell M, 2006, HEREDITAS, V143, P177, DOI 10.1111/j.2006.0018-0661.01970.x; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xin SJ, 2002, DEVELOPMENT, V129, P1345; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	60	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10581	10.1371/journal.pone.0010581	http://dx.doi.org/10.1371/journal.pone.0010581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498723	Green Published, Green Submitted, gold			2022-12-27	WOS:000277773700002
J	Washburn, ML; Kovalev, GI; Koroleva, E; Fu, YX; Su, LS				Washburn, Michael L.; Kovalev, Grigoriy I.; Koroleva, Ekaterina; Fu, Yang-Xin; Su, Lishan			LIGHT Induces Distinct Signals to Clear an AAV-Expressed Persistent Antigen in the Mouse Liver and to Induce Liver Inflammation	PLOS ONE			English	Article							LYMPHOTOXIN BETA-RECEPTOR; VERSUS-HOST-DISEASE; CELL RESPONSE; GENE-TRANSFER; T-CELLS; TUMOR; ALPHA; ERADICATION; PATHWAY; MICE	Background: Infection with adeno-associated virus (AAV) vector with liver tropism leads to persistent expression of foreign antigens in the mouse liver, with no significant liver inflammation or pathology. This provides a model to investigate antigen persistence in the liver and strategies to modulate host immunity to reduce or clear the foreign antigen expressed from AAV vector in the liver. Methods/Principal Findings: We showed that expressing LIGHT with an adenovirus vector ( Ad) in mice with established AAV in the liver led to clearance of the AAV. Ad-LIGHT enhanced CD8 effector T cells in the liver, correlated with liver inflammation. LT beta R-Ig proteins blocked Ad-LIGHT in clearing AAV. Interestingly, in LT beta R-null mice, Ad-LIGHT still cleared AAV but caused no significant liver inflammation. Conclusions/Significance: Our data suggest that LIGHT interaction with the LT beta R plays a critical role in liver inflammation but is not required for LIGHT-mediated AAV clearance. These findings will shed light on developing novel immunotherapeutics in treating people chronically infected with hepato-tropic viruses.	[Washburn, Michael L.; Su, Lishan] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Washburn, Michael L.; Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Kovalev, Grigoriy I.; Su, Lishan] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Koroleva, Ekaterina; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Fu, Yang-Xin; Su, Lishan] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; Chinese Academy of Sciences; Institute of Biophysics, CAS	Washburn, ML (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	lsu@med.unc.edu	Kovalev, Grigoriy/V-8768-2018	fu, yang-xin/0000-0001-8441-6617; Kovalev, Grigoriy/0000-0003-4346-3585	National Institutes of Health (NIH) [AI076142, AA018009, CA115540, DK58891, T32 AI007273]; China MOST [0997141002]; NATIONAL CANCER INSTITUTE [R01CA115540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273, R21AI076142, R01AI077454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China MOST(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from National Institutes of Health (NIH), AI076142, AA018009 (L. S.), CA115540 and DK58891 (Y.X.F.), and T32 AI007273 (M. L. W), and China MOST 0997141002 (L. S. and Y.X.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Bartlett JS, 1996, P NATL ACAD SCI USA, V93, P8852, DOI 10.1073/pnas.93.17.8852; Browning JL, 1997, J IMMUNOL, V159, P3288; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Giannandrea M, 2009, HEPATOLOGY, V49, P2010, DOI 10.1002/hep.22869; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Lee CM, 2005, J GASTROEN HEPATOL, V20, P1762, DOI 10.1111/j.1440-1746.2005.04065.x; Li H, 2007, MOL THER, V15, P792, DOI 10.1038/sj.mt.6300090; Lin SW, 2007, J CLIN INVEST, V117, P3958, DOI 10.1172/JCI33138; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tamada K, 2000, NAT MED, V6, P283; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Xu YH, 2007, BLOOD, V109, P4097, DOI 10.1182/blood-2006-09-047332; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	20	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10585	10.1371/journal.pone.0010585	http://dx.doi.org/10.1371/journal.pone.0010585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498840	Green Published, Green Submitted, gold			2022-12-27	WOS:000277771600002
J	Bogunovic, B; Srinivasan, P; Ueda, Y; Tomita, Y; Maric, M				Bogunovic, Branka; Srinivasan, Priya; Ueda, Yumi; Tomita, York; Maric, Maja			Comparative Quantitative Mass Spectrometry Analysis of MHC Class II-Associated Peptides Reveals a Role of GILT in Formation of Self-Peptide Repertoire	PLOS ONE			English	Article							LYSOSOMAL THIOL REDUCTASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL EPITOPE; IN-VIVO; CYSTEINE RESIDUES; BINDING PEPTIDES; OXIDATIVE STRESS; CELIAC-DISEASE; ANTIGEN; MOLECULES	Gamma interferon Inducible Lysosomal Thiol reductase (GILT) is a unique lysosomal reductase that reduces disulfide bonds of endocytosed proteins. Lack of GILT clearly decreases CD4 T cell-antigen specific responses against some epitopes of antigens containing disulfide bonds, but not to proteins with few or no disulfide bridges. Hence, global impact of GILT on antigen presentation is currently not well understood. We used Nano-LC-ESI-MS/MS to investigate how GILT affects diversity of self-peptides presented by MHC class II molecules. Surprisingly, the repertoire of self-peptides in the absence of GILT does not appear to be significantly different, as only few peptide species (similar to 2%) were found to be the unique indicators of GILT's presence or absence. In the absence of GILT about thirty peptide species (similar to 5%) were found either uniquely or fourteen to hundred fold more abundantly expressed than in the presence of GILT. Our data indicate that GILT has limited yet unexpected effect on self-peptide species presented by MHC class II antigens.	[Bogunovic, Branka; Srinivasan, Priya; Maric, Maja] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC USA; [Ueda, Yumi; Tomita, York] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Bogunovic, B (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC USA.	mam254@georgetown.edu			American Cancer Society [RSG-05-204-01-LIB]	American Cancer Society(American Cancer Society)	This work has been supported by American Cancer Society (www.cancer.org) grant RSG-05-204-01-LIB awarded to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bogunovic B, 2008, J BIOL CHEM, V283, P8855, DOI 10.1074/jbc.M708998200; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chervonsky AV, 1998, P NATL ACAD SCI USA, V95, P10094, DOI 10.1073/pnas.95.17.10094; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kittlesen DJ, 1998, J IMMUNOL, V160, P2099; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Li P, 2002, J IMMUNOL, V169, P2444, DOI 10.4049/jimmunol.169.5.2444; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Maric M, 2009, J IMMUNOL, V182, P746, DOI 10.4049/jimmunol.182.2.746; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; Neugebauer KM, 2000, ARTHRITIS RHEUM, V43, P1768, DOI 10.1002/1529-0131(200008)43:8<1768::AID-ANR13>3.0.CO;2-9; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sealy R, 2008, CLIN VACCINE IMMUNOL, V15, P713, DOI 10.1128/CVI.00412-07; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sinnathamby G, 2004, J IMMUNOL, V172, P6607, DOI 10.4049/jimmunol.172.11.6607; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898; Thiede B, 2000, RAPID COMMUN MASS SP, V14, P496, DOI 10.1002/(SICI)1097-0231(20000331)14:6<496::AID-RCM899>3.0.CO;2-1; Utz PJ, 1997, J EXP MED, V185, P843, DOI 10.1084/jem.185.5.843; van Stipdonk MJB, 1998, INT IMMUNOL, V10, P943, DOI 10.1093/intimm/10.7.943; Vukmanovic S, 2005, CELL IMMUNOL, V233, P75, DOI 10.1016/j.cellimm.2005.04.011; Wucherpfennig KW, 2001, CURR OPIN IMMUNOL, V13, P650, DOI 10.1016/S0952-7915(01)00274-6; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755	40	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10599	10.1371/journal.pone.0010599	http://dx.doi.org/10.1371/journal.pone.0010599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485683	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563400010
J	Bollag, B; Hofstetter, CA; Reviriego-Mendoza, MM; Frisque, RJ				Bollag, Brigitte; Hofstetter, Catherine A.; Reviriego-Mendoza, Marta M.; Frisque, Richard J.			JC Virus Small t Antigen Binds Phosphatase PP2A and Rb Family Proteins and Is Required for Efficient Viral DNA Replication Activity	PLOS ONE			English	Article							SMALL TUMOR-ANTIGEN; SV40 SMALL-T; SIMIAN VIRUS-40; CELL-TRANSFORMATION; EPITHELIAL-CELLS; MONKEY CELLS; MIDDLE-T; IN-VITRO; SIMIAN-VIRUS-40; IDENTIFICATION	Background: The human polyomavirus, JC virus (JCV) produces five tumor proteins encoded by transcripts alternatively spliced from one precursor messenger RNA. Significant attention has been given to replication and transforming activities of JCV's large tumor antigen (TAg) and three T' proteins, but little is known about small tumor antigen (tAg) functions. Amino-terminal sequences of tAg overlap with those of the other tumor proteins, but the carboxy half of tAg is unique. These latter sequences are the least conserved among the early coding regions of primate polyomaviruses. Methodology and Findings: We investigated the ability of wild type and mutant forms of JCV tAg to interact with cellular proteins involved in regulating cell proliferation and survival. The JCV P99A tAg is mutated at a conserved proline, which in the SV40 tAg is required for efficient interaction with protein phosphatase 2A (PP2A), and the C157A mutant tAg is altered at one of two newly recognized LxCxE motifs. Relative to wild type and C157A tAgs, P99A tAg interacts inefficiently with PP2A in vivo. Unlike SV40 tAg, JCV tAg binds to the Rb family of tumor suppressor proteins. Viral DNAs expressing mutant t proteins replicated less efficiently than did the intact JCV genome. A JCV construct incapable of expressing tAg was replication-incompetent, a defect not complemented in trans using a tAg-expressing vector. Conclusions: JCV tAg possesses unique properties among the polyomavirus small t proteins. It contributes significantly to viral DNA replication in vivo; a tAg null mutant failed to display detectable DNA replication activity, and a tAg substitution mutant, reduced in PP2A binding, was replication-defective. Our observation that JCV tAg binds Rb proteins, indicates all five JCV tumor proteins have the potential to influence cell cycle progression in infected and transformed cells. It remains unclear how these proteins coordinate their unique and overlapping functions.	[Bollag, Brigitte; Hofstetter, Catherine A.; Reviriego-Mendoza, Marta M.; Frisque, Richard J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bollag, B (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	rjf6@psu.edu			National Cancer Institute [CA115771]; NATIONAL CANCER INSTITUTE [R01CA115771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Public Health Service grant CA115771 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; BOLLAG B, 1989, J VIROL, V63, P863, DOI 10.1128/JVI.63.2.863-872.1989; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CARBONE M, 1992, J VIROL, V66, P1804, DOI 10.1128/JVI.66.3.1804-1808.1992; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; CHANG LS, 1985, VIROLOGY, V146, P246, DOI 10.1016/0042-6822(85)90008-X; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; CHUKE WF, 1986, J VIROL, V60, P960, DOI 10.1128/JVI.60.3.960-971.1986; CICALA C, 1994, J VIROL, V68, P3138, DOI 10.1128/JVI.68.5.3138-3144.1994; Fahrbach KM, 2008, VIROLOGY, V370, P255, DOI 10.1016/j.virol.2007.09.008; Frisque RJ, 2006, ADV EXP MED BIOL, V577, P288; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; HAGGERTY S, 1989, J VIROL, V63, P2180, DOI 10.1128/JVI.63.5.2180-2190.1989; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; JOG P, 1990, J VIROL, V64, P2895, DOI 10.1128/JVI.64.6.2895-2900.1990; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LYNCH KJ, 1990, J VIROL, V64, P5812, DOI 10.1128/JVI.64.12.5812-5822.1990; LYNCH KJ, 1994, VIROLOGY, V204, P819, DOI 10.1006/viro.1994.1600; Mateer SC, 1998, J BIOL CHEM, V273, P35339, DOI 10.1074/jbc.273.52.35339; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; Nesper J, 1997, J VIROL, V71, P7421, DOI 10.1128/JVI.71.10.7421-7428.1997; Nunbhakdi-Craig V, 2003, J VIROL, V77, P2807, DOI 10.1128/JVI.77.5.2807-2818.2003; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; PAN W, 2002, CANCER RES, V61, P2885; PEDEN KWC, 1989, VIROLOGY, V168, P13, DOI 10.1016/0042-6822(89)90398-X; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Prins C, 2001, J NEUROVIROL, V7, P250; RAJ GV, 1995, VIROLOGY, V213, P283, DOI 10.1006/viro.1995.0001; Ravichandran V, 2006, PROTEOMICS, V6, P5628, DOI 10.1002/pmic.200600261; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; SWENSON JJ, 1995, VIROLOGY, V212, P295, DOI 10.1006/viro.1995.1487; TAVIS JE, 1994, VIROLOGY, V199, P384, DOI 10.1006/viro.1994.1136; TEVETHIA SS, 1992, VIROLOGY, V190, P459, DOI 10.1016/0042-6822(92)91234-L; TOPP WC, 1980, J VIROL, V33, P1208, DOI 10.1128/JVI.33.3.1208-1210.1980; Tyagarajan SK, 2006, J VIROL, V80, P2083, DOI 10.1128/JVI.80.5.2083-2091.2006; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	65	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10606	10.1371/journal.pone.0010606	http://dx.doi.org/10.1371/journal.pone.0010606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485545	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563400013
J	Kondratieva, E; Logunova, N; Majorov, K; Averbakh, M; Apt, A				Kondratieva, Elena; Logunova, Nadya; Majorov, Konstantin; Averbakh, Mikhail, Jr.; Apt, Alexander			Host Genetics in Granuloma Formation: Human-Like Lung Pathology in Mice with Reciprocal Genetic Susceptibility to M. tuberculosis and M. avium	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NEUTROPHIL MOBILIZATION; NITRIC-OXIDE; RESISTANT; INFECTION; IMMUNITY; CELLS; I/ST; PROTECTION; TRANSPORT	Development of lung granulomata is a hallmark of infections caused by virulent mycobacteria, reflecting both protective host response that restricts infection spreading and inflammatory pathology. The role of host genetics in granuloma formation is not well defined. Earlier we have shown that mice of the I/St strain are extremely susceptible to Mycobacterium tuberculosis but resistant to M. avium infection, whereas B6 mice show a reversed pattern of susceptibility. Here, by directly comparing: (i) characteristics of susceptibility to two infections in vivo; (ii) architecture of lung granulomata assessed by immune staining; and (iii) expression of genes encoding regulatory factors of neutrophil influx in the lung tissue, we demonstrate that genetic susceptibility of the host largely determines the pattern of lung pathology. Necrotizing granuloma surrounded by hypoxic zones, as well as a massive neutrophil influx, develop in the lungs of M. avium-infected B6 mice and in the lungs of M. tuberculosis-infected I/St mice, but not in the lungs of corresponding genetically resistant counterparts. The mirror-type lung tissue responses to two virulent mycobacteria indicate that the level of genetic susceptibility of the host to a given mycobacterial species largely determines characteristics of pathology, and directly demonstrate the importance of host genetics in pathogenesis.	[Kondratieva, Elena; Logunova, Nadya; Majorov, Konstantin; Averbakh, Mikhail, Jr.; Apt, Alexander] Cent Inst TB, Immunogenet Lab, Moscow, Russia		Kondratieva, E (corresponding author), Cent Inst TB, Immunogenet Lab, Moscow, Russia.	asapt@aha.ru	Majorov, Konstantin Borisovich/AIE-6667-2022	Apt, Alexander/0000-0002-3683-3085	NIH [AI078864]; Russian Foundation for Basic Research [07-04-00988, 09-04-00159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by the NIH grant AI078864 and the Russian Foundation for Basic Research grants 07-04-00988 and 09-04-00159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; APPELBERG R, 1990, CLIN EXP IMMUNOL, V80, P324, DOI 10.1111/j.1365-2249.1990.tb03288.x; APPELBERG R, 1995, INFECT IMMUN, V63, P3381, DOI 10.1128/IAI.63.9.3381-3387.1995; Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ehlers S, 1999, FEMS IMMUNOL MED MIC, V23, P149, DOI 10.1111/j.1574-695X.1999.tb01234.x; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Huang H, 2001, BIOCHEM BIOPH RES CO, V281, P378, DOI 10.1006/bbrc.2001.4363; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Kondratieva EV, 2007, INFECT IMMUN, V75, P4762, DOI 10.1128/IAI.00482-07; Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011; Kuhn DE, 2001, J LEUKOCYTE BIOL, V69, P43; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; PEDROSA J, 1994, CLIN EXP IMMUNOL, V98, P210; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Radaeva TV, 2008, TUBERCULOSIS, V88, P576, DOI 10.1016/j.tube.2008.05.003; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Samoszuk MK, 2004, J HISTOCHEM CYTOCHEM, V52, P837, DOI 10.1369/jhc.4B6248.2004; SCHURR E, 2008, HDB TUBERCULOSIS IMM, P295; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Wang CR, 2004, RHEUMATOLOGY, V43, P569, DOI 10.1093/rheumatology/keh147; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648	38	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10515	10.1371/journal.pone.0010515	http://dx.doi.org/10.1371/journal.pone.0010515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463893	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379800010
J	Sundstrom, G; Dreborg, S; Larhammar, D				Sundstrom, Gorel; Dreborg, Susanne; Larhammar, Dan			Concomitant Duplications of Opioid Peptide and Receptor Genes before the Origin of Jawed Vertebrates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROOPIOMELANOCORTIN GENE; CHROMOSOME DUPLICATIONS; EVOLUTION; GENOME; CLONING; IDENTIFICATION; PROENKEPHALIN; PRODYNORPHIN; ZEBRAFISH	Background: The opioid system is involved in reward and pain mechanisms and consists in mammals of four receptors and several peptides. The peptides are derived from four prepropeptide genes, PENK, PDYN, PNOC and POMC, encoding enkephalins, dynorphins, orphanin/nociceptin and beta-endorphin, respectively. Previously we have described how two rounds of genome doubling (2R) before the origin of jawed vertebrates formed the receptor family. Methodology/Principal Findings: Opioid peptide gene family members were investigated using a combination of sequence-based phylogeny and chromosomal locations of the peptide genes in various vertebrates. Several adjacent gene families were investigated similarly. The results show that the ancestral peptide gene gave rise to two additional copies in the genome doublings. The fourth member was generated by a local gene duplication, as the genes encoding POMC and PNOC are located on the same chromosome in the chicken genome and all three teleost genomes that we have studied. A translocation has disrupted this synteny in mammals. The PDYN gene seems to have been lost in chicken, but not in zebra finch. Duplicates of some peptide genes have arisen in the teleost fishes. Within the prepropeptide precursors, peptides have been lost or gained in different lineages. Conclusions/Significance: The ancestral peptide and receptor genes were located on the same chromosome and were thus duplicated concomitantly. However, subsequently genetic linkage has been lost. In conclusion, the system of opioid peptides and receptors was largely formed by the genome doublings that took place early in vertebrate evolution.	[Sundstrom, Gorel; Dreborg, Susanne; Larhammar, Dan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Sundstrom, G (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	dan.larhammar@neuro.uu.se			Swedish Research Council; Carl Trygger's Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger's Foundation	This work was supported by grants from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and Carl Trygger's Foundation (http://www.carltryggersstiftelse.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrubaian J, 2006, PEPTIDES, V27, P797, DOI 10.1016/j.peptides.2005.09.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bodnar RJ, 2009, PEPTIDES, V30, P2432, DOI 10.1016/j.peptides.2009.09.027; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; Civelli Olivier, 2008, V46, P1, DOI 10.1007/400_2007_057; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Conlon JM, 2005, GEN COMP ENDOCR, V142, P53, DOI 10.1016/j.ygcen.2004.11.016; Danielson P, 2002, NEUROENDOCRINOLOGY, V76, P55, DOI 10.1159/000063684; Danielson PB, 2001, J BIOL CHEM, V276, P22114, DOI 10.1074/jbc.M011741200; de Souza FSJ, 2005, MOL BIOL EVOL, V22, P2417, DOI 10.1093/molbev/msi236; DEEN PMT, 1992, MOL BIOL EVOL, V9, P483; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dores RM, 2002, MASS SPECTROM REV, V21, P220, DOI 10.1002/mas.10029; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Ewadinger NM, 1996, BRAIN RES, V737, P1, DOI 10.1016/0006-8993(96)00649-X; Gonzalez-Nunez V, 2003, BBA-GENE STRUCT EXPR, V1629, P114, DOI 10.1016/j.bbaexp.2003.08.001; Hurst LD, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-62; Hyndman KA, 2009, MOL PHYLOGENET EVOL, V52, P677, DOI 10.1016/j.ympev.2009.04.015; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Khalap A, 2005, ANN NY ACAD SCI, V1040, P22, DOI 10.1196/annals.1327.003; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Larhammar D, 2004, HANDB EXP PHARM, V162, P75; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; LENNARD A, 1992, CYTOKINE, V4, P83, DOI 10.1016/1043-4666(92)90041-O; LUSCHEN W, 1991, P NATL ACAD SCI USA, V88, P8671, DOI 10.1073/pnas.88.19.8671; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nunez VG, 2003, MOL BRAIN RES, V114, P31, DOI 10.1016/S0169-328X(03)00126-8; Okuda-Ashitaka E, 2000, PEPTIDES, V21, P1101, DOI 10.1016/S0196-9781(00)00247-3; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Pattee P, 2003, J BIOL CHEM, V278, P53098, DOI 10.1074/jbc.M306724200; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; STEFANO GB, 1993, P NATL ACAD SCI USA, V90, P11099, DOI 10.1073/pnas.90.23.11099; Sundstrom G, 2008, GEN COMP ENDOCR, V155, P705, DOI 10.1016/j.ygcen.2007.08.016; Takahashi A, 2006, GEN COMP ENDOCR, V148, P72, DOI 10.1016/j.ygcen.2005.09.003; Takahashi A, 2009, PEPTIDES, V30, P1374, DOI 10.1016/j.peptides.2009.04.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629	43	77	79	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10512	10.1371/journal.pone.0010512	http://dx.doi.org/10.1371/journal.pone.0010512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463905	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379800008
J	Bellemer, C; Chabosseau, P; Gallardo, F; Gleizes, PE; Stahl, G				Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume			Genetic Interactions Show the Importance of rRNA Modification Machinery for the Role of Rps15p during Ribosome Biogenesis in S. cerevisiae	PLOS ONE			English	Article							EFFICIENT NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; SMALL-SUBUNIT; YEAST; PROTEIN; PRERIBOSOMES; PRECURSORS; MATURATION; PROCESSOME; VECTORS	Rps15p, an essential ribosomal protein, was previously shown to be critical for nuclear export of small subunit pre-particles. We have designed a synthetic lethal screen in Saccharomyces cerevisi to identify its genetic partners and further elucidate its role during ribosomal biogenesis. Our screen revealed interactions with mutants affected at various stages during ribosome biogenesis, from early nucleolar steps to nuclear export. Mutations were identified in genes encoding proteins involved in early ribosome biogenesis steps, like the small subunit processome component Utp15p, the 90S pre-ribosome factor Slx9p and the H/ACA snoRNP core protein Nhp2p. In addition, we found a synthetic lethality with BUD23, a gene encoding a methyltransferase involved both in rRNA modification and small subunit nuclear export. Interestingly, deletion of snR36 or snR85, two H/ACA snoRNAs that direct modifications close to Rps15p's binding site on the rRNA, produces mild and opposite effects on growth in an rps15 hypomorphic background. These data uncover an unreported link between a ribosomal protein and rRNA modification machinery.	[Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume] Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume] CNRS, Lab Biol Mol Eucaryote, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bellemer, C (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France.	stahl@biotoul.fr	Stahl, Guillaume/O-1703-2014; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Gallardo, Franck/H-1817-2011; Gleizes, Pierre-Emmanuel/H-3821-2014	Stahl, Guillaume/0000-0002-6703-3929; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341	CNRS; Universite Paul Sabatier, ANR; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier, ANR(French National Research Agency (ANR)); Institut Universitaire de France	This work was supported by the CNRS, the Universite Paul Sabatier, ANR grants SNOSCA and RIBEUC and the Institut Universitaire de France ( to PEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Bernstein KA, 2004, MOL BIOL CELL, V15, P5038, DOI 10.1091/mbc.E04-06-0515; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; DiMario PJ, 2004, INT REV CYTOL, V239, P99, DOI 10.1016/S0074-7696(04)39003-0; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gleizes PE, 2001, J CELL BIOL, V155, P923, DOI 10.1083/jcb.200108142; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; POWERS T, 1988, J MOL BIOL, V200, P309, DOI 10.1016/0022-2836(88)90243-4; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; SIKORSKI RS, 1989, GENETICS, V122, P19; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Torchet C, 2005, RNA, V11, P928, DOI 10.1261/rna.2100905; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10472	10.1371/journal.pone.0010472	http://dx.doi.org/10.1371/journal.pone.0010472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454621	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300031
J	Kramski, M; Matz-Rensing, K; Stahl-Hennig, C; Kaup, FJ; Nitsche, A; Pauli, G; Ellerbrok, H				Kramski, Marit; Maetz-Rensing, Kerstin; Stahl-Hennig, Christiane; Kaup, Franz-Josef; Nitsche, Andreas; Pauli, Georg; Ellerbrok, Heinz			A Novel Highly Reproducible and Lethal Nonhuman Primate Model for Orthopox Virus Infection	PLOS ONE			English	Article							MODIFIED VACCINIA VIRUS; TO-HUMAN TRANSMISSION; HUMAN MONKEYPOX; COWPOX; SMALLPOX; EXPRESSION; PROTECTION; CHALLENGE; PATHOLOGY; RESERVOIR	The intentional re-introduction of Variola virus (VARV), the agent of smallpox, into the human population is of great concern due its bio-terroristic potential. Moreover, zoonotic infections with Cowpox (CPXV) and Monkeypox virus (MPXV) cause severe diseases in humans. Smallpox vaccines presently available can have severe adverse effects that are no longer acceptable. The efficacy and safety of new vaccines and antiviral drugs for use in humans can only be demonstrated in animal models. The existing nonhuman primate models, using VARV and MPXV, need very high viral doses that have to be applied intravenously or intratracheally to induce a lethal infection in macaques. To overcome these drawbacks, the infectivity and pathogenicity of a particular CPXV was evaluated in the common marmoset (Callithrix jacchus). A CPXV named calpox virus was isolated from a lethal orthopox virus (OPV) outbreak in New World monkeys. We demonstrated that marmosets infected with calpox virus, not only via the intravenous but also the intranasal route, reproducibly develop symptoms resembling smallpox in humans. Infected animals died within 1-3 days after onset of symptoms, even when very low infectious viral doses of 5 x 10(2) pfu were applied intranasally. Infectious virus was demonstrated in blood, saliva and all organs analyzed. We present the first characterization of a new OPV infection model inducing a disease in common marmosets comparable to smallpox in humans. Intranasal virus inoculation mimicking the natural route of smallpox infection led to reproducible infection. In vivo titration resulted in an MID50 (minimal monkey infectious dose 50%) of 8.3 x 10(2) pfu of calpox virus which is approximately 10,000-fold lower than MPXV and VARV doses applied in the macaque models. Therefore, the calpox virus/marmoset model is a suitable nonhuman primate model for the validation of vaccines and antiviral drugs. Furthermore, this model can help study mechanisms of OPV pathogenesis.	[Kramski, Marit; Nitsche, Andreas; Pauli, Georg; Ellerbrok, Heinz] Robert Koch Inst, D-1000 Berlin, Germany; [Maetz-Rensing, Kerstin; Stahl-Hennig, Christiane; Kaup, Franz-Josef] German Primate Ctr DPZ, Gottingen, Germany	Robert Koch Institute; Deutsches Primatenzentrum (DPZ)	Kramski, M (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	ellerbrokh@rki.de		Nitsche, Andreas/0000-0001-8185-3176	German Ministry of Health [1-121-42261]	German Ministry of Health	This work was supported by the German Ministry of Health (BMG-Erlass Foko 1-121-42261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault A, 2003, LANCET, V361, P1626, DOI 10.1016/S0140-6736(03)13318-1; BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x; BAXBY D, 1994, LANCET, V343, P543, DOI 10.1016/S0140-6736(94)91498-2; Becker C, 2009, DTSCH ARZTEBL INT, V106, P329, DOI 10.3238/arztebl.2009.0329; Breman JG, 2000, EMERGING INFECTIONS 4, P45; CAREY GJ, 1991, PHARM BIOCH BEHAV, V42, P143; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; CZERNY CP, 1991, J VET MED B, V38, P421, DOI 10.1111/j.1439-0450.1991.tb00891.x; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; DOWNIE AW, 1969, J HYG-CAMB, V67, P609, DOI 10.1017/S0022172400042066; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; FENNER F, 1988, HUMAN MONKEYPOX OTHE, P1287; FENNER F, 1988, CLIN FEATURES SMALLP, P1; FENNER F, 1988, PATHOGENESIS PATHOLO, P121; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Jordan Robert, 2006, Expert Rev Anti Infect Ther, V4, P277, DOI 10.1586/14787210.4.2.277; Kern ER, 2003, ANTIVIR RES, V57, P35, DOI 10.1016/S0166-3542(02)00198-5; KETTLE S, 1995, VIROLOGY, V206, P136, DOI 10.1016/S0042-6822(95)80028-X; KLINGEBIEL T, 1988, PEDIATR INFECT DIS J, V7, P883, DOI 10.1097/00006454-198807120-00013; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Lever MS, 2008, INT J EXP PATHOL, V89, P171, DOI 10.1111/j.1365-2613.2008.00581.x; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; MARENNIKOVA SS, 1976, ACTA VIROL, V20, P442; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; PILASKI J, 1986, ARCH VIROL, V88, P135, DOI 10.1007/BF01310898; Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003; Qutaishat Salah S, 2003, Clin Med Res, V1, P85; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; RYLANDS AB, 1997, HDB MARMOSETS TAMARI, P1; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smee DF, 2000, ANTIVIR RES, V47, P171, DOI 10.1016/S0166-3542(00)00105-4; Smee DF, 2003, ANTIVIR RES, V57, P41, DOI 10.1016/S0166-3542(02)00199-7; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; STAHLMANN R, 1995, HUM EXP TOXICOL, V14, P146, DOI 10.1177/096032719501400137; Staib C, 2006, J GEN VIROL, V87, P2917, DOI 10.1099/vir.0.82068-0; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; van Vliet SAM, 2008, EUR NEUROPSYCHOPHARM, V18, P383, DOI 10.1016/j.euroneuro.2007.11.003; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; *WHO, 1980, GLOB ER SMALLP; Wolfs TFW, 2002, EMERG INFECT DIS, V8, P1495, DOI 10.3201/eid0812.020089; Woollard DJ, 2008, J VIROL, V82, P3054, DOI 10.1128/JVI.01153-07; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	53	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10412	10.1371/journal.pone.0010412	http://dx.doi.org/10.1371/journal.pone.0010412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454688	Green Submitted, gold, Green Published			2022-12-27	WOS:000277240100020
J	Tchendjou, P; Same-Ekobo, C; Nga, A; Tejiokem, M; Kfutwah, A; Nlend, AN; Tsague, L; Bissek, AC; Ekoa, D; Orne-Gliemann, J; Rousset, D; Pouillot, R; Dabis, F				Tchendjou, Patrice; Same-Ekobo, Chantal; Nga, Annie; Tejiokem, Mathurin; Kfutwah, Anfumbom; Nlend, Anne Njom; Tsague, Landry; Bissek, Anne Cecile; Ekoa, Daniel; Orne-Gliemann, Joanna; Rousset, Dominique; Pouillot, Regis; Dabis, Francois			Effectiveness of Multidrug Antiretroviral Regimens to Prevent Mother-to-Child Transmission of HIV-1 in Routine Public Health Services in Cameroon	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED-TRIAL; COTE-DIVOIRE; FOLLOW-UP; ZIDOVUDINE; EFFICACY; INFANTS; INTRAPARTUM; PREGNANCY	Background: Multidrug antiretroviral (ARV) regimens including HAART and short-course dual antiretroviral (sc-dARV) regimens were introduced in 2004 to improve Prevention of Mother-to-Child Transmission (PMTCT) in Cameroon. We assessed the effectiveness of these regimens from 6-10 weeks and 12 months of age, respectively. Methodology/Findings: We conducted a retrospective cohort study covering the period from October 2004 to March 2008 in a reference hospital in Cameroon. HIV-positive pregnant women with CD4 <= 350 cells/mm(3) received first-line HAART [regimen 1] while the others received ARV prophylaxis including sc-dARV or single dose nevirapine (sd-NVP). Sc-dARV included at least two drugs according to different gestational ages: zidovudine (ZDV) from 28-32 weeks plus sd-NVP [regimen 2], ZDV and lamuvidine (3TC) from 33-36 weeks plus sd-NVP [regimen 3]. When gestational age was >= 37 weeks, women received sd-NVP during labour [regimen 4]. Infants received sd-NVP plus ZDV and 3TC for 7 days or 30 days. Early diagnosis (6-10 weeks) was done, using b-DNA and subsequently RT-PCR. We determined early MTCT rate and associated risk factors using logistic regression. The 12-month HIV-free survival was assessed using Cox regression. Among 418 mothers, 335 (80%) received multidrug ARV regimens (1, 2, and 3) and MTCT rate with multidrug regimens was 6.6% [95% CI: 4.3-9.6] at 6 weeks, without any significant difference between regimens. Duration of mother's ARV regimen <4 weeks [OR = 4.7, 95% CI: 1.3-17.6], mother's CD4 <350 cells/mm(3) [OR = 6.4, 95% CI: 1.8-22.5] and low birth weight [OR = 4.0, 95% CI: 1.4-11.3] were associated with early MTCT. By 12 months, mixed feeding [HR = 8.7, 95% CI: 3.6-20.6], prematurity [HR = 2.3, 95% CI: 1.2-4.3] and low birth weight were associated with children's risk of progressing to infection or death. Conclusions: Multidrug ARV regimens for PMTCT are feasible and effective in routine reference hospital. Early initiation of ARV during pregnancy and proper obstetrical care are essential to improve PMTCT.	[Tchendjou, Patrice; Tejiokem, Mathurin; Pouillot, Regis] Ctr Pasteur Cameroun, Lab Epidemiol, Yaounde, Cameroon; [Same-Ekobo, Chantal; Nga, Annie; Nlend, Anne Njom] Ctr Hosp Essos, Yaounde, Cameroon; [Kfutwah, Anfumbom; Rousset, Dominique] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Tsague, Landry; Bissek, Anne Cecile; Ekoa, Daniel] Minist Sante Publ Cameroun, Direct Lutte Malad, Yaounde, Cameroon; [Orne-Gliemann, Joanna; Dabis, Francois] Inst Sante Publ Epidemiol & Dev, INSERM, U897, Bordeaux, France	Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tchendjou, P (corresponding author), Ctr Pasteur Cameroun, Lab Epidemiol, Yaounde, Cameroon.	Tchendjou@pasteur-yaounde.org	DABIS, FRANCOIS/S-9298-2019; Pouillot, Regis/E-8103-2010; Rousset, Dominique/S-5400-2019; Orne-Gliemann, Joanna/T-2787-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Pouillot, Regis/0000-0002-6107-5212; Rousset, Dominique/0000-0002-1473-3147; 	Centre Pasteur du Cameroun	Centre Pasteur du Cameroun	This is a retrospective study. It was sponsored by the Centre Pasteur du Cameroun as part of its public health mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; ARMITAGE P, 2002, STAT METHODS MED RES, P488; Becquet R, 2005, JAIDS-J ACQ IMM DEF, V40, P600, DOI 10.1097/01.qai.0000171726.17436.82; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Institut National de la Statistique (INS) et ORC Macro, 2004, ENQ DEM SANT CAM 200 ENQ DEM SANT CAM 200; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001645; Mandelbrot L, 2002, SEX TRANSM INFECT, V78, P267, DOI 10.1136/sti.78.4.267; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2001, B WORLD HEALTH ORGAN, V79, P1138; Nlend AN, 2007, J TROP PEDIATRICS, V53, P438, DOI 10.1093/tropej/fmm045; Piechulek H., 1996, Medecine d'Afrique Noire, V43, P67; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202; Tejiokem MC, 2004, MED MALADIES INFECT, V34, pS57, DOI 10.1016/S0399-077X(04)90019-4; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; TINDYEBWA D, 2006, HDB PAEDIAT AIDS AFR; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UNAIDS, 2007, AIDS EP UPD DEC 207; *UNAIDS, 2005, AIDS EP UPD DEC 2005; WHO, 2022, ANT DRUGS TREAT PREG; *WHO, 2000, NEW DAT PREV MOTH TO	32	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10411	10.1371/journal.pone.0010411	http://dx.doi.org/10.1371/journal.pone.0010411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454459	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100019
J	Thacker, RW; Diaz, MC; de Voogd, NJ; van Soest, RWM; Freeman, CJ; Mobley, AS; LaPietra, J; Cope, K; McKenna, S				Thacker, Robert W.; Cristina Diaz, M.; de Voogd, Nicole J.; van Soest, Rob W. M.; Freeman, Christopher J.; Mobley, Andrew S.; LaPietra, Jessica; Cope, Kevin; McKenna, Sheila			Preliminary Assessment of Sponge Biodiversity on Saba Bank, Netherlands Antilles	PLOS ONE			English	Article							BOCAS DEL TORO; DISEASE; REEFS; SIZE	Background: Saba Bank Atoll, Netherlands Antilles, is one of the three largest atolls on Earth and provides habitat for an extensive coral reef community. To improve our knowledge of this vast marine resource, a survey of biodiversity at Saba Bank included a multi-disciplinary team that sampled fishes, mollusks, crustaceans, macroalgae, and sponges. Methodology/Principal Findings: A single member of the dive team conducted surveys of sponge biodiversity during eight dives at six locations, at depths ranging from 15 to 30 m. This preliminary assessment documented the presence of 45 species pooled across multiple locations. Rarefaction analysis estimated that only 48 to 84% of species diversity was sampled by this limited effort, clearly indicating a need for additional surveys. An analysis of historical collections from Saba and Saba Bank revealed an additional 36 species, yielding a total of 81 sponge species recorded from this area. Conclusions/Significance: This observed species composition is similar to that found on widespread Caribbean reefs, indicating that the sponge fauna of Saba Bank is broadly representative of the Caribbean as a whole. A robust population of the giant barrel sponge, Xestospongia muta, appeared healthy with none of the signs of disease or bleaching reported from other Caribbean reefs; however, more recent reports of anchor chain damage to these sponges suggests that human activities can have dramatic impacts on these communities. Opportunities to protect this extremely large habitat should be pursued, as Saba Bank may serve as a significant reservoir of sponge species diversity.	[Thacker, Robert W.; Freeman, Christopher J.; Mobley, Andrew S.; LaPietra, Jessica; Cope, Kevin] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Cristina Diaz, M.] Museo Marino Margarita, Nueva Esparta, Venezuela; [de Voogd, Nicole J.] Natl Museum Nat Hist, Leiden, Netherlands; [van Soest, Rob W. M.] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [McKenna, Sheila] Deep Search Fdn, Alameda, CA USA; [McKenna, Sheila] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [McKenna, Sheila] Univ Queensland, Commonwealth Facil Appl Environm Decis Anal, Brisbane, Qld, Australia	University of Alabama System; University of Alabama Birmingham; University of Amsterdam; University of Queensland; University of Queensland	Thacker, RW (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	thacker@uab.edu	de Voogd, Nicole/I-9280-2012	de Voogd, Nicole/0000-0002-7985-5604; Thacker, Robert/0000-0002-9654-0073	Conservation International; United States National Science Foundation [0829986]; Division Of Environmental Biology [0829986] Funding Source: National Science Foundation	Conservation International; United States National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by Conservation International (www.conservation.org) and the United States National Science Foundation (www.nsf.gov) under Grant No. 0829986 to RWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado Pedro M., 2002, Avicennia, V15, P53; ALCOLADO PM, 1994, SPONGES IN TIME AND SPACE, P251; [Anonymous], 2002, SYSTEMA PORIFERA GUI; Becerro MA, 2008, MAR ECOL-EVOL PERSP, V29, P167, DOI 10.1111/j.1439-0485.2008.00234.x; BRATTEGARD T, 1980, SARSIA, V65, P49, DOI 10.1080/00364827.1980.10431471; Bunkley-Williams L, 2004, CARIBB J SCI, V40, P88; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarke KR, 1994, CHANGE MARINE COMMUN; Colwell RK, 2013, ESTIMATES STAT ESTIM; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz MC, 2005, CARIBB J SCI, V41, P465; Dilrosun F, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P46; Dilrosun F, 2000, MONITORING SABA BANK; Freeman Christopher J., 2007, V28, P319; Gochfeld Deborah J., 2007, V28, P335; HOETJES P, 2010, PLOS ONE IN PRESS; Kadison E, 2009, B MAR SCI, V85, P101; KNUDSEN J, 1982, P K NED AKAD C BIOL, V85, P121; Lehnert Helmut, 1996, Beaufortia, V46, P53; Lehnert Helmut, 1999, Beaufortia, V49, P141; Lehnert Helmut, 1998, Beaufortia, V48, P71; McMurray SE, 2009, RESTOR ECOL, V17, P192, DOI 10.1111/j.1526-100X.2008.00463.x; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; MURICY G, 1991, Vie et Milieu, V41, P205; MURICY G, 1989, Revista Brasileira de Biologia, V49, P347; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rutzler K., 1986, MARINE FAUNA FLORA B, P111; Rutzler Klaus, 2000, Atoll Research Bulletin, V476, P229; Toller W, 2008, ASSESSMENT COMMERCIA; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; VANSOEST RWM, 1981, VERSLAGEN TECHNISCHE, V32, P1; Vilanova E., 2004, B MUS I BIOL U GEN, V68, P647; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WIEDENMAYER F, 1977, EXPERIENTIA S, V29; Wulff J, 2001, B MAR SCI, V69, P831; Wulff JL, 2006, CORAL REEFS, V25, P419, DOI 10.1007/s00338-006-0110-0	37	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e9622	10.1371/journal.pone.0009622	http://dx.doi.org/10.1371/journal.pone.0009622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502643	Green Submitted, Green Published, gold			2022-12-27	WOS:000278017400002
J	Guilbride, DL; Gawlinski, P; Guilbride, PDL				Guilbride, D. Lys; Gawlinski, Pawel; Guilbride, Patrick D. L.			Why Functional Pre-Erythrocytic and Bloodstage Malaria Vaccines Fail: A Meta-Analysis of Fully Protective Immunizations and Novel Immunological Model	PLOS ONE			English	Article							REGULATORY T-CELLS; PLASMODIUM-BERGHEI SPOROZOITES; PLASMACYTOID DENDRITIC CELLS; MEROZOITE SURFACE PROTEIN-1; GROWTH-FACTOR-BETA; FALCIPARUM CIRCUMSPOROZOITE PROTEIN; CARBOXYL-TERMINAL FRAGMENT; APICAL MEMBRANE ANTIGEN-1; LONG-LASTING PROTECTION; LIVER-STAGE ANTIGEN-1	Background: Clinically protective malaria vaccines consistently fail to protect adults and children in endemic settings, and at best only partially protect infants. Methodology/Principal Findings: We identify and evaluate 1916 immunization studies between 1965-February 2010, and exclude partially or nonprotective results to find 177 completely protective immunization experiments. Detailed reexamination reveals an unexpectedly mundane basis for selective vaccine failure: live malaria parasites in the skin inhibit vaccine function. We next show published molecular and cellular data support a testable, novel model where parasite-host interactions in the skin induce malaria-specific regulatory T cells, and subvert early antigen-specific immunity to parasite-specific immunotolerance. This ensures infection and tolerance to reinfection. Exposure to Plasmodium-infected mosquito bites therefore systematically triggers immunosuppression of endemic vaccine-elicited responses. The extensive vaccine trial data solidly substantiate this model experimentally. Conclusions/Significance: We conclude skinstage-initiated immunosuppression, unassociated with bloodstage parasites, systematically blocks vaccine function in the field. Our model exposes novel molecular and procedural strategies to significantly and quickly increase protective efficacy in both pipeline and currently ineffective malaria vaccines, and forces fundamental reassessment of central precepts determining vaccine development. This has major implications for accelerated local eliminations of malaria, and significantly increases potential for eradication.	[Guilbride, D. Lys; Gawlinski, Pawel] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Guilbride, DL (corresponding author), Tech Univ Darmstadt, Inst Microbiol & Genet, Dept Biol, Darmstadt, Germany.	lys@malariaresearchfoundation.com		Gawlinski, Pawel/0000-0002-3672-5834	Malaria Research Foundation (MRF)	Malaria Research Foundation (MRF)	The Malaria Research Foundation (MRF, P.O. Box 10420, CO 81612 USA) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Aidoo M, 2000, INFECT IMMUN, V68, P227, DOI 10.1128/IAI.68.1.227-232.2000; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; ALBANESI C, 2010, AUTOIMMUNITY; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; ALY AS, 2010, CELL MICROBIOL; Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744; Anderson CF, 2005, J IMMUNOL, V174, P2934, DOI 10.4049/jimmunol.174.5.2934; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; BARBOSA A, 2009, INFECT IMMUN; Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; BEAUDOIN RL, 1977, EXP PARASITOL, V42, P1, DOI 10.1016/0014-4894(77)90054-6; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Bellinghausen I, 2006, CLIN EXP ALLERGY, V36, P1546, DOI 10.1111/j.1365-2222.2006.02601.x; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; BenMohamed L, 2004, INFECT IMMUN, V72, P4376, DOI 10.1128/IAI.72.8.4376-4384.2004; BERGQVIST Y, 1983, J CHROMATOGR, V272, P137, DOI 10.1016/S0378-4347(00)86110-1; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Birch KE, 2005, BRIT J DERMATOL, V152, P409, DOI 10.1111/J.1365-2133.2005.06476.X; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bongfen SE, 2008, PARASITE IMMUNOL, V30, P375, DOI 10.1111/j.1365-3024.2008.01032.x; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Bowen DG, 2004, J CLIN INVEST, V114, P701, DOI 10.1172/JCI200421593; BOYD MARK F., 1939, AMER JOUR TROP MED, V19, P27; BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Bruna-Romera O, 2001, P NATL ACAD SCI USA, V98, P11491, DOI 10.1073/pnas.191380898; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burns JM, 2004, INFECT IMMUN, V72, P5605, DOI 10.1128/IAI.72.10.5605-5612.2004; BUTCHER GA, 1978, IMMUNOLOGY, V34, P77; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; CABRERA EJ, 1977, INFECT IMMUN, V15, P461, DOI 10.1128/IAI.15.2.461-465.1977; Calvo-Calle JM, 2005, J IMMUNOL, V175, P7575, DOI 10.4049/jimmunol.175.11.7575; Campanelli AP, 2006, J INFECT DIS, V193, P1313, DOI 10.1086/502980; Cao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006894; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Charoenvit Y, 1999, INFECT IMMUN, V67, P5604, DOI 10.1128/IAI.67.11.5604-5614.1999; Charoenvit Y, 2004, ANTIMICROB AGENTS CH, V48, P2455, DOI 10.1128/AAC.48.7.2455-2463.2004; CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; Chatterjee S, 1999, PARASITOLOGY, V118, P219, DOI 10.1017/S0031182098003825; Chatterjee S, 2001, Afr J Med Med Sci, V30 Suppl, P25; Chatterjee S, 1996, PARASITOL RES, V82, P297, DOI 10.1007/s004360050117; Chattopadhyay R, 2009, VACCINE, V27, P3675, DOI 10.1016/j.vaccine.2008.11.073; CHEN DH, 1977, J IMMUNOL, V118, P1322; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Chen ZM, 2003, BLOOD, V101, P5076, DOI 10.1182/blood-2002-09-2798; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; CLARK IA, 1977, PARASITOLOGY, V74, P9, DOI 10.1017/S003118200004748X; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; COLLINS WE, 1992, AM J TROP MED HYG, V46, P327, DOI 10.4269/ajtmh.1992.46.327; Cong YZ, 2005, J IMMUNOL, V174, P2787, DOI 10.4049/jimmunol.174.5.2787; COOK IF, 1985, J TROP MED HYG, V88, P261; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Cottrez F, 2001, J IMMUNOL, V167, P773, DOI 10.4049/jimmunol.167.2.773; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; COWAN G, 1992, LANCET, V339, P1412, DOI 10.1016/0140-6736(92)91229-2; DALY TM, 1995, J IMMUNOL, V155, P236; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Daubersies P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002659; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Degano P, 1999, VACCINE, V18, P623, DOI 10.1016/S0264-410X(99)00278-9; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Doolan Denise L, 2007, Expert Rev Vaccines, V6, P903, DOI 10.1586/14760584.6.6.903; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1999, J IMMUNOL, V163, P884; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; FANDEUR T, 1992, INFECT IMMUN, V60, P1390, DOI 10.1128/IAI.60.4.1390-1396.1992; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; FavilaCastillo L, 1996, PARASITE IMMUNOL, V18, P325, DOI 10.1046/j.1365-3024.1996.d01-117.x; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Flacher V, 2009, CANCER IMMUNOL IMMUN, V58, P1137, DOI 10.1007/s00262-008-0563-9; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Frischknecht F, 2007, CELL MICROBIOL, V9, P1630, DOI 10.1111/j.1462-5822.2007.00955.x; Futagami Y, 2007, J IMMUNOL, V178, P6994, DOI 10.4049/jimmunol.178.11.6994; Geissmann F, 1999, J IMMUNOL, V162, P4567; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Georger TC, 2003, EUR J IMMUNOL, V33, P502, DOI 10.1002/immu.200310026; Gilbert SC, 1999, BIOL CHEM, V380, P299, DOI 10.1515/BC.1999.041; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gondek DC, 2008, J IMMUNOL, V181, P4752, DOI 10.4049/jimmunol.181.7.4752; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Graves P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006198; Graves P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006199; Graves P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005966; GREENWOOD BM, 1972, LANCET, V1, P169; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; GRIFFITHS RB, 1952, ANN TROP MED PARASIT, V46, P311, DOI 10.1080/00034983.1952.11685536; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Hafalla JCR, 2003, J IMMUNOL, V171, P964, DOI 10.4049/jimmunol.171.2.964; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Hafalla JCR, 2007, J INFECT DIS, V196, P1827, DOI 10.1086/522965; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Heit A, 2008, EUR J IMMUNOL, V38, P1585, DOI 10.1002/eji.200737966; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; HERRINGTON DA, 1990, B WORLD HEALTH ORGAN, V68, P33; HERRINGTON DA, 1991, AM J TROP MED HYG, V45, P695, DOI 10.4269/ajtmh.1991.45.695; Hill A V, 2000, Dev Biol (Basel), V104, P171; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; Hirunpetcharat C, 2003, VACCINE, V21, P2923, DOI 10.1016/S0264-410X(03)00132-4; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; HOFFMAN SL, 1989, J IMMUNOL, V142, P3581; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Hogh B, 1996, Scand J Infect Dis Suppl, V102, P1; HOMMEL M, 1982, ANN INST PASTEUR IMM, VC133, P57, DOI 10.1016/0769-2625(82)90006-X; HOPE IA, 1984, NATURE, V308, P191, DOI 10.1038/308191a0; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; HUDSON A, 1960, SCIENCE, V131, P1730, DOI 10.1126/science.131.3415.1730; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; HUNTER RL, 1995, J IMMUNOL, V154, P1762; Iellem A, 2003, EUR J IMMUNOL, V33, P1488, DOI 10.1002/eji.200323658; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; IMAI T, 2010, EUR J IMMUNOL; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; KABILAN L, 1988, P NATL ACAD SCI USA, V85, P5659, DOI 10.1073/pnas.85.15.5659; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kapp JA, 2007, J IMMUNOL, V179, P2105, DOI 10.4049/jimmunol.179.4.2105; Kaur A, 2004, ACTA TROP, V91, P27, DOI 10.1016/j.actatropica.2004.02.009; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; KHAN ZM, 1992, INT IMMUNOL, V4, P711, DOI 10.1093/intimm/4.7.711; KHULLAR N, 1990, INDIAN J EXP BIOL, V28, P1112; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KRAMER LD, 1975, AM J TROP MED HYG, V24, P913, DOI 10.4269/ajtmh.1975.24.913; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; KRZYCH U, 1995, J IMMUNOL, V155, P4072; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumar KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004480; KUMAR S, 1989, J IMMUNOL, V143, P2017; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; Lanar DE, 1996, INFECT IMMUN, V64, P1666, DOI 10.1128/IAI.64.5.1666-1671.1996; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau AWT, 2008, J IMMUNOL, V180, P3889, DOI 10.4049/jimmunol.180.6.3889; Laveran A, 1880, B MEM SOC MED HOP P, V17, P158; Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lee EAM, 2001, AM J TROP MED HYG, V64, P194, DOI 10.4269/ajtmh.2001.64.194; Lee SJ, 2008, EUR J CLIN PHARMACOL, V64, P987, DOI 10.1007/s00228-008-0500-z; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Martinez PA, 2009, PEPTIDES, V30, P330, DOI 10.1016/j.peptides.2008.10.022; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; Matuschewski K, 2007, FEBS J, V274, P4680, DOI 10.1111/j.1742-4658.2007.05998.x; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; MCCARTHY VC, 1977, EXP PARASITOL, V41, P167, DOI 10.1016/0014-4894(77)90142-4; MCCOLM AA, 1982, PARASITE IMMUNOL, V4, P337, DOI 10.1111/j.1365-3024.1982.tb00445.x; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Migot-Nabias F, 2000, T ROY SOC TROP MED H, V94, P557, DOI 10.1016/S0035-9203(00)90086-5; Mikolajczak SA, 2008, MOL CELL BIOL, V28, P6196, DOI 10.1128/MCB.00553-08; MILLER A, 1993, J IMMUNOL, V151, P7307; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mobs C, 2008, INT ARCH ALLERGY IMM, V147, P171, DOI 10.1159/000142039; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515; Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905; MORENO A, 1993, J IMMUNOL, V151, P489; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; NARDIN EH, 1979, SCIENCE, V206, P597, DOI 10.1126/science.386511; NARDIN EH, 1989, SCIENCE, V246, P1603, DOI 10.1126/science.2480642; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; NUSSENZWEIG R, 1969, MIL MED, V134, P1176; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okitsu SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001278; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oliveira GA, 2008, INFECT IMMUN, V76, P1200, DOI 10.1128/IAI.00566-07; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; ORJIH AU, 1985, CLIN EXP IMMUNOL, V61, P67; ORJIH AU, 1980, AM J TROP MED HYG, V29, P343, DOI 10.4269/ajtmh.1980.29.343; ORJIH AU, 1982, T ROY SOC TROP MED H, V76, P57, DOI 10.1016/0035-9203(82)90019-0; ORJIH AU, 1979, CLIN EXP IMMUNOL, V38, P1; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pacheco N D, 1979, Bull World Health Organ, V57 Suppl 1, P159; Palmer DR, 2002, EUR J IMMUNOL, V32, P652, DOI 10.1002/1521-4141(200203)32:3<652::AID-IMMU652>3.0.CO;2-9; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patterson PS, 1999, VACCINE, V18, P173, DOI 10.1016/S0264-410X(99)00217-0; Peng ZK, 1996, ANN ALLERG ASTHMA IM, V77, P238, DOI 10.1016/S1081-1206(10)63262-0; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; Perlaza BL, 2003, EUR J IMMUNOL, V33, P1321, DOI 10.1002/eji.200323339; Perlaza BL, 2008, EUR J IMMUNOL, V38, P2610, DOI 10.1002/eji.200738055; Pichyangkul S, 2008, INFECT IMMUN, V76, P229, DOI 10.1128/IAI.00977-07; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Playfair J H, 1979, Parasite Immunol, V1, P197, DOI 10.1111/j.1365-3024.1979.tb00706.x; PLAYFAIR JHL, 1977, IMMUNOLOGY, V33, P507; Plebanski M, 1997, J IMMUNOL, V158, P2849; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Purcell LA, 2008, VACCINE, V26, P4880, DOI 10.1016/j.vaccine.2008.07.017; PURI SK, 1988, J INTERFERON RES, V8, P201, DOI 10.1089/jir.1988.8.201; Puri SK, 1996, J INTERF CYTOK RES, V16, P49, DOI 10.1089/jir.1996.16.49; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; PYE D, 1994, J PARASITOL, V80, P558, DOI 10.2307/3283191; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Reed RC, 1996, VACCINE, V14, P828, DOI 10.1016/0264-410X(95)00175-Z; Reed RC, 1997, VACCINE, V15, P482, DOI 10.1016/S0264-410X(96)00301-5; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; RENIA L, 1993, J IMMUNOL, V150, P1471; RENIA L, 1994, IMMUNOLOGY, V82, P164; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rieckmann K H, 1979, Bull World Health Organ, V57 Suppl 1, P261; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; RILEY EM, 1988, CLIN EXP IMMUNOL, V73, P17; ROBERTS DW, 1977, INFECT IMMUN, V16, P821, DOI 10.1128/IAI.16.3.821-826.1977; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Romero JF, 2007, PARASITE IMMUNOL, V29, P541, DOI 10.1111/j.1365-3024.2007.00972.x; Romero JF, 2009, VACCINE, V27, P1266, DOI 10.1016/j.vaccine.2008.12.010; Romero JF, 2001, PARASITE IMMUNOL, V23, P267, DOI 10.1046/j.1365-3024.2001.00381.x; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; SADOFF JC, 1988, SCIENCE, V240, P336, DOI 10.1126/science.3281260; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Sauerwein RW, 2009, IMMUNOL LETT, V122, P115, DOI 10.1016/j.imlet.2008.11.008; Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; SCHMIDT LH, 1985, ANTIMICROB AGENTS CH, V28, P612, DOI 10.1128/AAC.28.5.612; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2009, VACCINE, V27, P6103, DOI 10.1016/j.vaccine.2009.08.025; Schneider J, 2001, VACCINE, V19, P4595, DOI 10.1016/S0264-410X(01)00260-2; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Sedegah M, 2007, PARASITE IMMUNOL, V29, P559, DOI 10.1111/j.1365-3024.2007.00976.x; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; SHORTT HE, 1954, T ROY SOC TROP MED H, V48, P122, DOI 10.1016/0035-9203(54)90004-8; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; SIDDIQUI WA, 1986, INFECT IMMUN, V52, P314, DOI 10.1128/IAI.52.1.314-318.1986; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; SIGLER CI, 1984, AM J TROP MED HYG, V33, P544, DOI 10.4269/ajtmh.1984.33.544; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; SINA BJ, 1992, EXP PARASITOL, V74, P431, DOI 10.1016/0014-4894(92)90205-O; SINA BJ, 1993, EXP PARASITOL, V77, P129, DOI 10.1006/expr.1993.1069; SINA BJ, 1995, MOL BIOCHEM PARASIT, V69, P239, DOI 10.1016/0166-6851(94)00198-V; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; SPITALNY GL, 1973, EXP PARASITOL, V33, P168, DOI 10.1016/0014-4894(73)90022-2; SPITALNY GL, 1972, P HELM SOC WASH, V39, P506; SPITALNY GL, 1977, EXP PARASITOL, V42, P73, DOI 10.1016/0014-4894(77)90063-7; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; STEWART MJ, 1992, J PROTOZOOL, V39, P663, DOI 10.1111/j.1550-7408.1992.tb04446.x; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; SUHRBIER A, 1990, INFECT IMMUN, V58, P2834, DOI 10.1128/IAI.58.9.2834-2839.1990; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tartz S, 2008, VACCINE, V26, P5935, DOI 10.1016/j.vaccine.2008.08.057; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; TAYLORROBINSON AW, 1993, SCIENCE, V260, P1931, DOI 10.1126/science.8100366; TAYLORROBINSON AW, 1994, EUR J IMMUNOL, V24, P158, DOI 10.1002/eji.1830240124; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; Thompson FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001493; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Toure-Balde A, 2009, INFECT IMMUN, V77, P1189, DOI 10.1128/IAI.00780-07; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; TSUJI M, 1995, J IMMUNOL, V154, P5338; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; VANDERBERG JP, 1968, J PARASITOL, V54, P1175, DOI 10.2307/3276987; Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; Verhage DF, 2005, NETH J MED, V63, P52; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; VINETZ JM, 1990, J IMMUNOL, V144, P1069; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; WAKI S, 1989, PARASITOL RES, V75, P614, DOI 10.1007/BF00930958; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wang RB, 1996, J IMMUNOL, V157, P4061; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; WANG RB, 1995, J IMMUNOL, V154, P2784; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Whalen J., 2009, WALL STR J; WHITE KL, 1994, PARASITE IMMUNOL, V16, P479, DOI 10.1111/j.1365-3024.1994.tb00376.x; White KL, 1996, J IMMUNOL, V156, P3374; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; WILLIAMSON WA, 1978, LANCET, V1, P1328; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wipasa J, 2007, EXPERT OPIN BIOL TH, V7, P1841, DOI 10.1517/14712598.7.12.1841; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435; WIZEL B, 1995, J IMMUNOL, V155, P766; Wollenberg A, 2002, J INVEST DERMATOL, V119, P1096, DOI 10.1046/j.1523-1747.2002.19515.x; Wong KA, 2008, PARASITE IMMUNOL, V30, P482, DOI 10.1111/j.1365-3024.2008.01046.x; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; WYLER DJ, 1977, CLIN EXP IMMUNOL, V29, P401; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zhou Z, 2002, AM J TROP MED HYG, V66, P7, DOI 10.4269/ajtmh.2002.66.7; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	457	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10685	10.1371/journal.pone.0010685	http://dx.doi.org/10.1371/journal.pone.0010685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502667	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400007
J	Jackson, SA; Schiesser, J; Stanley, EG; Elefanty, AG				Jackson, Steven A.; Schiesser, Jacqueline; Stanley, Edouard G.; Elefanty, Andrew G.			Differentiating Embryonic Stem Cells Pass through 'Temporal Windows' That Mark Responsiveness to Exogenous and Paracrine Mesendoderm Inducing Signals	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; IN-VITRO DIFFERENTIATION; CANONICAL WNT/BETA-CATENIN; PRIMITIVE STREAK; GROWTH-FACTOR; MOUSE; MESODERM; EXPRESSION; TERATOCARCINOMAS; GASTRULATION	Background: Mesendoderm induction during embryonic stem cell (ESC) differentiation in vitro is stimulated by the Transforming Growth Factor and Wingless (Wnt) families of growth factors. Principal Findings: We identified the periods during which Bone Morphogenetic Protein (BMP) 4, Wnt3a or Activin A were able to induce expression of the mesendoderm marker, Mixl1, in differentiating mouse ESCs. BMP4 and Wnt3a were required between differentiation day (d) 1.5 and 3 to most effectively induce Mixl1, whilst Activin A induced Mixl1 expression in ESC when added between d2 and d4, indicating a subtle difference in the requirement for Activin receptor signalling in this process. Stimulation of ESCs with these factors at earlier or later times resulted in little Mixl1 induction, suggesting that the differentiating ESCs passed through 'temporal windows' in which they sequentially gained and lost competence to respond to each growth factor. Inhibition of either Activin or Wnt signalling blocked Mixl1 induction by any of the three mesendoderm-inducing factors. Mixing experiments in which chimeric EBs were formed between growth factor-treated and untreated ESCs revealed that BMP, Activin and Wnt signalling all contributed to the propagation of paracrine mesendoderm inducing signals between adjacent cells. Finally, we demonstrated that the differentiating cells passed through 'exit gates' after which point they were no longer dependent on signalling from inducing molecules for Mixl1 expression. Conclusions: These studies suggest that differentiating ESCs are directed by an interconnected network of growth factors similar to those present in early embryos and that the timing of growth factor activity is critical for mesendoderm induction.	[Jackson, Steven A.; Schiesser, Jacqueline; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	Monash University	Jackson, SA (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA.	andrew.elefanty@med.monash.edu.au	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Schiesser, Jacqueline/0000-0002-5655-4382; Elefanty, Andrew/0000-0001-6448-8314	National Health and Medical Research Council (NHMRC) of Australia; Juvenile Diabetes Research Foundation (JDRF); Australian Stem Cell Centre (ASCC)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Australian Stem Cell Centre (ASCC)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, the Juvenile Diabetes Research Foundation (JDRF) and the Australian Stem Cell Centre (ASCC). AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Askanazy M., 1907, VERHANDL DEUTSH PATH, V11, P39; Barnett LD, 2000, METH MOL B, V158, P65; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hamada S, 2007, BIOCHEM BIOPH RES CO, V355, P240, DOI 10.1016/j.bbrc.2007.01.143; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; KAHAN BW, 1970, J NATL CANCER I, V44, P1015; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MARTIN GR, 1975, CELL, V5, P229, DOI 10.1016/0092-8674(75)90098-7; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MARTIN GR, 1975, CELL, V6, P467, DOI 10.1016/0092-8674(75)90035-5; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; SMITH J, 2007, CURRENT PROTOCOLS ST, V1; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; STEVENS LC, 1960, DEV BIOL, V2, P285, DOI 10.1016/0012-1606(60)90010-5; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; TERESKY AK, 1974, J CELL PHYSIOL, V84, P319, DOI 10.1002/jcp.1040840218; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	63	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10706	10.1371/journal.pone.0010706	http://dx.doi.org/10.1371/journal.pone.0010706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502661	Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400012
J	Frank, DN; Feazel, LM; Bessesen, MT; Price, CS; Janoff, EN; Pace, NR				Frank, Daniel N.; Feazel, Leah M.; Bessesen, Mary T.; Price, Connie S.; Janoff, Edward N.; Pace, Norman R.			The Human Nasal Microbiota and Staphylococcus aureus Carriage	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; MOLECULAR ANALYSIS; HUMAN SKIN; STREPTOCOCCUS-PNEUMONIAE; SOFTWARE ENVIRONMENT; UNITED-STATES; COLONIZATION; DIVERSITY; BACTERIAL; PREVALENCE	Background: Colonization of humans with Staphylococcus aureus is a critical prerequisite of subsequent clinical infection of the skin, blood, lung, heart and other deep tissues. S. aureus persistently or intermittently colonizes the nares of similar to 50% of healthy adults, whereas similar to 50% of the general population is rarely or never colonized by this pathogen. Because microbial consortia within the nasal cavity may be an important determinant of S. aureus colonization we determined the composition and dynamics of the nasal microbiota and correlated specific microorganisms with S. aureus colonization. Methodology/Principal Findings: Nasal specimens were collected longitudinally from five healthy adults and a cross-section of hospitalized patients (26 S. aureus carriers and 16 non-carriers). Culture-independent analysis of 16S rRNA sequences revealed that the nasal microbiota of healthy subjects consists primarily of members of the phylum Actinobacteria (e. g., Propionibacterium spp. and Corynebacterium spp.), with proportionally less representation of other phyla, including Firmicutes (e. g., Staphylococcus spp.) and Proteobacteria (e. g. Enterobacter spp). In contrast, inpatient nasal microbiotas were enriched in S. aureus or Staphylococcus epidermidis and diminished in several actinobacterial groups, most notably Propionibacterium acnes. Moreover, within the inpatient population S. aureus colonization was negatively correlated with the abundances of several microbial groups, including S. epidermidis (p = 0.004). Conclusions/Significance: The nares environment is colonized by a temporally stable microbiota that is distinct from other regions of the integument. Negative association between S. aureus, S. epidermidis, and other groups suggests microbial competition during colonization of the nares, a finding that could be exploited to limit S. aureus colonization.	[Frank, Daniel N.; Feazel, Leah M.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Frank, Daniel N.; Bessesen, Mary T.; Janoff, Edward N.; Pace, Norman R.] Mucosal & Vaccine Res Program Colorado, Aurora, CO USA; [Bessesen, Mary T.; Janoff, Edward N.] Dept Vet Affairs Med Ctr, Denver, CO USA; [Frank, Daniel N.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA; [Price, Connie S.] Denver Hlth Med Ctr, Div Infect Dis, Denver, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Frank, DN (corresponding author), Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA.	norman.pace@colorado.edu		Bessesen, Mary/0000-0001-9305-1293	Butcher Foundation of Colorado; Mucosal and Vaccine Program Colorado (MAVRC); Veterans Affairs Research Service; University of Colorado Department of Medicine	Butcher Foundation of Colorado; Mucosal and Vaccine Program Colorado (MAVRC); Veterans Affairs Research Service(US Department of Veterans Affairs); University of Colorado Department of Medicine	This work was supported by the Butcher Foundation of Colorado, the Mucosal and Vaccine Program Colorado (MAVRC), the Veterans Affairs Research Service and the University of Colorado Department of Medicine Innovative grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; Beilman Greg J, 2005, Surg Infect (Larchmt), V6, P87, DOI 10.1089/sur.2005.6.87; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2009, WOUND REPAIR REGEN, V17, P163, DOI 10.1111/j.1524-475X.2009.00472.x; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2003, J CLIN MICROBIOL, V41, P295, DOI 10.1128/JCM.41.1.295-303.2003; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Huijsdens XW, 2006, EMERG INFECT DIS, V12, P1584, DOI 10.3201/eid1210.060387; Kaufman L., 2005, FINDING GROUPS DATA; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kreisel K, 2006, DIAGN MICR INFEC DIS, V55, P179, DOI 10.1016/j.diagmicrobio.2006.01.021; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LaMar JE, 2003, MIL MED, V168, P135, DOI 10.1093/milmed/168.2.135; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Main Cheryl L, 2005, Can J Infect Dis Med Microbiol, V16, P343; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quinn GA, 2007, IMMUNOLOGY, V122, P80, DOI 10.1111/j.1365-2567.2007.02615.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Stacey AR, 1998, BRIT J SPORT MED, V32, P153, DOI 10.1136/bjsm.32.2.153; Tanner MA, 1999, J CLIN MICROBIOL, V37, P1863, DOI 10.1128/JCM.37.6.1863-1870.1999; Velazquez-Guadarrama N, 2009, CLIN INVEST MED, V32, pE57; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes G., GPLOTS VARIOUS R PRO; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604	66	271	281	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10598	10.1371/journal.pone.0010598	http://dx.doi.org/10.1371/journal.pone.0010598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498722	Green Submitted, Green Published, gold			2022-12-27	WOS:000277773700004
J	Traven, A; Lo, TL; Lithgow, T; Heierhorst, J				Traven, Ana; Lo, Tricia L.; Lithgow, Trevor; Heierhorst, Joerg			The Yeast PUF Protein Puf5 Has Pop2-Independent Roles in Response to DNA Replication Stress	PLOS ONE			English	Article							RNA-BINDING PROTEIN; POLY(A) TAIL LENGTH; CELL-WALL INTEGRITY; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; CCR4-NOT COMPLEX; POSTTRANSCRIPTIONAL REGULATION; MITOCHONDRIAL BIOGENESIS; DEADENYLASE COMPLEXES	PUFs are RNA binding proteins that promote mRNA deadenylation and decay and inhibit translation. Yeast Puf5 is the prototype for studying PUF-dependent gene repression. Puf5 binds to the Pop2 subunit of the Ccr4-Pop2-NOT mRNA deadenylase, recruiting the deadenylase and associated translational repressors to mRNAs. Here we used yeast genetics to show that Puf5 has additional roles in vivo that do not require Pop2. Deletion of PUF5 caused increased sensitivity to DNA replication stress in cells lacking Pop2, as well as in cells mutated for two activities recruited to mRNAs by the Puf5-Pop2 interaction, the deadenylase Ccr4 and the translational repressor Dhh1. A functional Puf5 RNA binding domain was required, and Puf5 cytoplasmic localisation was sufficient for resistance to replication stress, indicating posttranscriptional gene expression control is involved. In contrast to DNA replication stress, in response to the cell wall integrity pathway activator caffeine, PUF5 and POP2 acted in the same genetic pathway, indicating that functions of Puf5 in the caffeine response are mediated by Pop2-dependent gene repression. Our results support a model in which Puf5 uses multiple, Pop2-dependent and Pop2-independent mechanisms to control mRNA expression. The Pop2-independent roles for Puf5 could involve spatial control of gene expression, a proposition supported by our data indicating that the active form of Puf5 is localised to cytoplasmic foci.	[Traven, Ana; Lo, Tricia L.; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Lo, Tricia L.; Heierhorst, Joerg] St Vincents Inst Med Res, Mol Genet Unit, Melbourne, Vic, Australia	Monash University; St. Vincent's Institute of Medical Research	Traven, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	ana.traven@med.monash.edu.au	Lithgow, Trevor J/H-5925-2017; Traven, Ana/H-8174-2017	Lithgow, Trevor J/0000-0002-0102-7884; Traven, Ana/0000-0001-6252-3104	Australian National Health and Medical Research Council (NHMRC) [ID 345438, 448302, ID 502600]; Ramaciotti establishment grant [RAO75/06]; Australian Research Council Federation [FF0883204]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti establishment grant; Australian Research Council Federation(Australian Research Council)	This work was supported by fellowships from the Australian National Health and Medical Research Council (NH&MRC) to AT and JH (ID 345438 and 448302), Ramaciotti establishment grant to AT (RAO75/06), NH&MRC project grant to JH (ID 502600) and Australian Research Council Federation Fellowship to TL (FF0883204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Denis CL, 2001, GENETICS, V158, P627; Falbo KB, 2009, MOL CELLS, V28, P149, DOI 10.1007/s10059-009-0127-7; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hammet A, 2002, J BIOL CHEM, V277, P22469, DOI 10.1074/jbc.M202473200; Hata H, 1998, GENETICS, V148, P571; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jiang YW, 2003, MOL BIOL CELL, V14, P5116, DOI 10.1091/mbc.E03-06-0375; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaeberlein M, 2002, GENETICS, V160, P83; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Ohkuni K, 2006, MOL GENET GENOMICS, V275, P81, DOI 10.1007/s00438-005-0064-x; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; Queralt E, 2005, GENETICS, V171, P1485, DOI 10.1534/genetics.105.045005; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Stewart MS, 2007, EUKARYOT CELL, V6, P262, DOI 10.1128/EC.00188-06; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Traven A, 2010, YEAST, V27, P41, DOI 10.1002/yea.1730; Traven A, 2009, GENETICS, V182, P955, DOI 10.1534/genetics.109.104414; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; WHARTON RP, 2006, SCI STKE, V354, pPE37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	45	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10651	10.1371/journal.pone.0010651	http://dx.doi.org/10.1371/journal.pone.0010651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498834	Green Published, gold			2022-12-27	WOS:000277771600015
J	Ahmed, K; Dehghani, H; Rugg-Gunn, P; Fussner, E; Rossant, J; Bazett-Jones, DP				Ahmed, Kashif; Dehghani, Hesam; Rugg-Gunn, Peter; Fussner, Eden; Rossant, Janet; Bazett-Jones, David P.			Global Chromatin Architecture Reflects Pluripotency and Lineage Commitment in the Early Mouse Embryo	PLOS ONE			English	Article							ZYGOTIC GENE ACTIVATION; STEM-CELLS; HISTONE H1; TRANSCRIPTION; METHYLATION; EXPRESSION; PROTEIN; GENOME; RNA; ORGANIZATION	An open chromatin architecture devoid of compact chromatin is thought to be associated with pluripotency in embryonic stem cells. Establishing this distinct epigenetic state may also be required for somatic cell reprogramming. However, there has been little direct examination of global structural domains of chromatin during the founding and loss of pluripotency that occurs in preimplantation mouse development. Here, we used electron spectroscopic imaging to examine large-scale chromatin structural changes during the transition from one-cell to early postimplantation stage embryos. In one-cell embryos chromatin was extensively dispersed with no noticeable accumulation at the nuclear envelope. Major changes were observed from one-cell to two-cell stage embryos, where chromatin became confined to discrete blocks of compaction and with an increased concentration at the nuclear envelope. In eight-cell embryos and pluripotent epiblast cells, chromatin was primarily distributed as an extended meshwork of uncompacted fibres and was indistinguishable from chromatin organization in embryonic stem cells. In contrast, lineage-committed trophectoderm and primitive endoderm cells, and the stem cell lines derived from these tissues, displayed higher levels of chromatin compaction, suggesting an association between developmental potential and chromatin organisation. We examined this association in vivo and found that deletion of Oct4, a factor required for pluripotency, caused the formation of large blocks of compact chromatin in putative epiblast cells. Together, these studies show that an open chromatin architecture is established in the embryonic lineages during development and is sufficient to distinguish pluripotent cells from tissue-restricted progenitor cells.	[Ahmed, Kashif; Fussner, Eden; Bazett-Jones, David P.] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Dehghani, Hesam] Ferdowsi Univ Mashhad, Dept Physiol, Sch Vet Med, Mashhad, Iran; [Dehghani, Hesam] Ferdowsi Univ Mashhad, Inst Biotechnol, Mashhad, Iran; [Rugg-Gunn, Peter; Rossant, Janet] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ferdowsi University Mashhad; Ferdowsi University Mashhad; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ahmed, K (corresponding author), Hosp Sick Children, Genet & Genome Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	david.bazett-jones@sickkids.ca	Dehghani, Hesam/D-1421-2010	Dehghani, Hesam/0000-0001-6750-0040; Rugg-Gunn, Peter/0000-0002-9601-5949	Canadian Institutes of Health Research [FRN14311, MOP77803]; Bisby Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bisby Fellowship	The research was funded by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through grants FRN14311 to DPB-J, MOP77803 to JR and a Bisby Fellowship to PR-G. DPB-J holds a Canada Research Chair in Molecular and Cellular Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Kashif, 2008, V464, P415; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; Bazett-Jones DP, 1999, METHODS, V17, P188, DOI 10.1006/meth.1998.0729; Bazett-Jones DP, 1999, MICRON, V30, P151, DOI 10.1016/S0968-4328(99)00019-0; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Beaujean N, 2004, CURR BIOL, V14, pR266, DOI 10.1016/j.cub.2004.03.019; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; CLARKE HJ, 1992, DEVELOPMENT, V115, P791; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dehghani H, 2005, MICRON, V36, P95, DOI 10.1016/j.micron.2004.10.003; Dellaire G, 2004, METHOD ENZYMOL, V375, P456; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gilbert N, 2005, INT REV CYTOL, V242, P283; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; MARTINEZSALAS E, 1989, GENE DEV, V3, P1493, DOI 10.1101/gad.3.10.1493; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; McGraw S, 2006, MOL REPROD DEV, V73, P692, DOI 10.1002/mrd.20448; Merico V, 2007, CHROMOSOME RES, V15, P341, DOI 10.1007/s10577-007-1130-5; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mohamed OA, 2001, DEV BIOL, V229, P237, DOI 10.1006/dbio.2000.9942; Nagy A., 2003, MANIPULATING MOUSE E; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHULTZ GA, 1986, EXPT APPROACHES MAMM, P239; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Spada F, 1998, MECH DEVELOP, V76, P57, DOI 10.1016/S0925-4773(98)00095-1; Stein P, 2000, MOL REPROD DEV, V55, P241, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;241::AID-MRD1&gt;3.0.CO;2-T; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; WIEKOWSKI M, 1991, DEV BIOL, V147, P403, DOI 10.1016/0012-1606(91)90298-H; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	67	183	186	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10531	10.1371/journal.pone.0010531	http://dx.doi.org/10.1371/journal.pone.0010531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479880	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800013
J	Halterman, DA; Chen, Y; Sopee, J; Berduo-Sandoval, J; Sanchez-Perez, A				Halterman, Dennis A.; Chen, Yu; Sopee, Jiraphan; Berduo-Sandoval, Julio; Sanchez-Perez, Amilcar			Competition between Phytophthora infestans Effectors Leads to Increased Aggressiveness on Plants Containing Broad-Spectrum Late Blight Resistance	PLOS ONE			English	Article							IPIO GENE; R-GENE; AVIRULENCE; POTATO; SOLANUM; PROTEIN; FLAX; RUST; CELL; RECOGNITION	Background: The destructive plant disease potato late blight is caused by the oomycete pathogen Phytophthora infestans (Mont.) de Bary. This disease has remained particularly problematic despite intensive breeding efforts to integrate resistance into cultivated potato, largely because of the pathogen's ability to quickly evolve to overcome major resistance genes. The RB gene, identified in the wild potato species S. bulbocastanum, encodes a protein that confers broad-spectrum resistance to most P. infestans isolates through its recognition of highly conserved members of the corresponding pathogen effector family IPI-O. IpiO is a multigene family of effectors and while the majority of IPI-O proteins are recognized by RB to elicit host resistance, some variants exist that are able to elude detection (e. g. IPI-O4). Methods and Findings: In the present study, analysis of ipiO variants among 40 different P. infestans isolates collected from Guatemala, Thailand, and the United States revealed a high degree of complexity within this gene family. Isolate aggressiveness was correlated with increased ipiO diversity and especially the presence of the ipiO4 variant. Furthermore, isolates expressing IPI-O4 overcame RB-mediated resistance in transgenic potato plants even when the resistance-eliciting IPI-O1 variant was present. In support of this finding, we observed that expression of IPI-O4 via Agrobacterium blocked recognition of IPI-O1, leading to inactivation of RB-mediated programmed cell death in Nicotiana benthamiana. Conclusions: In this study we definitively demonstrate and provide the first evidence that P. infestans can defeat an R protein through inhibition of recognition of the corresponding effector protein.	[Halterman, Dennis A.; Chen, Yu] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Halterman, Dennis A.] ARS, USDA, Vegetable Crops Res Unit, Madison, WI USA; [Sopee, Jiraphan] Kasetsart Univ, Dept Plant Pathol, Bangkok, Thailand; [Berduo-Sandoval, Julio; Sanchez-Perez, Amilcar] Univ San Carlos, Fac Agron, San Carlos, Guatemala	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Kasetsart University; Universidad de San Carlos de Guatemala	Halterman, DA (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	dennis.halterman@ars.usda.gov		Berduo Sandoval, Julio Ernesto/0000-0001-6043-9152	United States Department of Agriculture/Agricultural Research Service; Department of Plant Pathology at the University of Wisconsin-Madison; University of San Carlos; Kasetsart University	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Plant Pathology at the University of Wisconsin-Madison; University of San Carlos; Kasetsart University	Research funding was primarily provided by base funds from the United States Department of Agriculture/Agricultural Research Service. Salary support for Yu Chen was provided by the Department of Plant Pathology at the University of Wisconsin-Madison. Salary support for Julio Berduo and Amilcar Sanchez-Perez was provided by the University of San Carlos. Salary support for Jiraphan Sopee was provided by Kasetsart University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bradeen JM, 2009, MOL PLANT MICROBE IN, V22, P437, DOI 10.1094/MPMI-22-4-0437; Champouret N, 2009, MOL PLANT MICROBE IN, V22, P1535, DOI 10.1094/MPMI-22-12-1535; CHEN Y, 2010, PHYTOPATHOLOGY UNPUB; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JONES DA, 1988, PHYTOPATHOLOGY, V78, P342, DOI 10.1094/Phyto-78-342; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Liua Z, 2006, PHYSIOL MOL PLANT P, V69, P230, DOI 10.1016/j.pmpp.2007.05.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Marshall-Farrar KD, 1998, PLANT DIS, V82, P434, DOI 10.1094/PDIS.1998.82.4.434; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Spooner DM, 1998, AM J POTATO RES, V75, P3, DOI 10.1007/BF02883512; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang M, 2008, THEOR APPL GENET, V116, P933, DOI 10.1007/s00122-008-0725-3; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	47	45	51	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10536	10.1371/journal.pone.0010536	http://dx.doi.org/10.1371/journal.pone.0010536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479869	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800018
J	Shin, HY; Hong, YH; Jang, SS; Chae, HG; Paek, SL; Moon, HE; Kim, DG; Kim, J; Paek, SH; Kim, SJ				Shin, Hye Young; Hong, Yun Hwa; Jang, Sung Soo; Chae, Hong Gu; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Kim, Jun; Paek, Sun Ha; Kim, Sang Jeong			A Role of Canonical Transient Receptor Potential 5 Channel in Neuronal Differentiation from A2B5 Neural Progenitor Cells	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; STEM-CELLS; PLASMA-MEMBRANE; CALCIUM-ENTRY; TRP CHANNELS; WHITE-MATTER; STORE; BRAIN; SENSOR; STIM1	Store-operated Ca2+ entry (SOCE) channels are the main pathway of Ca2+ entry in non-excitable cells such as neural progenitor cells (NPCs). However, the role of SOCE channels has not been defined in the neuronal differentiation from NPCs. Here, we show that canonical transient receptor potential channel (TRPC) as SOCE channel influences the induction of the neuronal differentiation of A2B5(+) NPCs isolated from postnatal-12-day rat cerebrums. The amplitudes of SOCE were significantly higher in neural cells differentiated from proliferating A2B5+ NPCs and applications of SOCE blockers, 2-aminoethoxy-diphenylborane (2-APB), and ruthenium red (RR), inhibited their rise of SOCE. Among TRPC subtypes (TRPC1-7), marked expression of TRPC5 and TRPC6 with turned-off TRPC1 expression was observed in neuronal cells differentiated from proliferating A2B5(+) NPCs. TRPC5 small interfering RNA (siRNA) blocked the neuronal differentiation from A2B5(+) NPCs and reduced the rise of SOCE. In contrast, TRPC6 siRNA had no significant effect on the neuronal differentiation from A2B5(+) NPCs. These results indicate that calcium regulation by TRPC5 would play a key role as a switch between proliferation and neuronal differentiation from NPCs.	[Shin, Hye Young; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Canc Res Inst,Ischem Hypox Dis Inst, Seoul, South Korea; [Hong, Yun Hwa; Jang, Sung Soo; Chae, Hong Gu; Kim, Jun; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Brain & Cognit Sci, Dept Physiol,Neurosci Res Inst,Med Res Ctr, Seoul, South Korea; [Shin, Hye Young; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Shin, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurosurg, Canc Res Inst,Ischem Hypox Dis Inst, Seoul, South Korea.	paeksh@snu.ac.kr; sangjkim@snu.ac.kr	Paek, Sun Ha/J-2760-2012; Kim, Sang Jeong/J-2740-2012; Kim, Dong Gyu/J-5388-2012	Shin, Hye Young/0000-0002-6827-3406; Kim, Sang Jeong/0000-0001-8931-3713	Republic of Korea [A04-0018-AY1204-08A5-00050B]; Seoul National University Hospital; Korea Research Foundation; ministry of Education, Science and Technology [2009-0080939, R32-10142]	Republic of Korea; Seoul National University Hospital; Korea Research Foundation(National Research Foundation of Korea); ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported in part by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A04-0018-AY1204-08A5-00050B), a grant of Seoul National University Hospital, and grants of Korea Research Foundation funded by the ministry of Education, Science and Technology (No. 2009-0080939 and WCU program R32-10142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Maric D, 2000, CEREB CORTEX, V10, P561, DOI 10.1093/cercor/10.6.561; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meldolesi J, 1998, NATURE, V392, P863, DOI 10.1038/31804; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; RAFF MC, 1983, J NEUROSCI, V3, P1289; SCHNITZER J, 1982, CELL TISSUE RES, V224, P625; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	32	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10359	10.1371/journal.pone.0010359	http://dx.doi.org/10.1371/journal.pone.0010359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479868	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800002
J	Suominen-Taipale, AL; Partonen, T; Turunen, AW; Mannisto, S; Jula, A; Verkasalo, PK				Suominen-Taipale, Anna Liisa; Partonen, Timo; Turunen, Anu W.; Mannisto, Satu; Jula, Antti; Verkasalo, Pia K.			Fish Consumption and Omega-3 Polyunsaturated Fatty Acids in Relation to Depressive Episodes: A Cross-Sectional Analysis	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CHOLESTERYL ESTERS; ADIPOSE-TISSUE; SERUM PHOSPHOLIPIDS; GENERAL-POPULATION; COMMUNITY SAMPLE; DIETARY-INTAKE; FOLATE INTAKE; 7 COUNTRIES; MOOD	High fish consumption and omega-3 polyunsaturated fatty acid (PUFA) intake are suggested to benefit mental well-being but the current evidence is conflicting. Our aim was to evaluate whether a higher level of fish consumption, a higher intake of omega-3 PUFAs, and a higher serum concentration of omega-3 PUFAs link to a lower 12-month prevalence of depressive episodes. We used data from the nationwide Health 2000 Survey (n = 5492) and the Fishermen Study on Finnish professional fishermen and their family members (n = 1265). Data were based on questionnaires, interviews, health examinations, and blood samples. Depressive episodes were assessed with the M-CIDI (the Munich version of the Composite International Diagnostic Interview) and a self-report of two CIDI probe questions, respectively. Fish consumption was measured by a food frequency questionnaire (g/day) and independent frequency questions (times/month). Dietary intake (g/day) and serum concentrations (% from fatty acids) of PUFAs were determined. Fish consumption was associated with prevalence of depressive episodes in men but not in women. The prevalence of depressive episodes decreased from 9% to 5% across the quartiles of fish consumption (g/day) in men of the Health 2000 Survey (p for linear trend = 0.01), and from 17% to 3% across the quartiles of fish consumption (times/month) in men of the Fishermen Study (p for linear trend = 0.05). This association was modified by lifestyle; in the Health 2000 Survey a higher level of fish consumption was related to a lower prevalence of depressive episodes in men who consumed the most alcohol, were occasional or former smokers, or had intermediate physical activity. The associations between depressive episodes and the intake or serum concentrations of omega-3 PUFAs were not consistent. In men, fish consumption appears as a surrogate for underlying but unidentified lifestyle factors that protect against depression.	[Suominen-Taipale, Anna Liisa; Turunen, Anu W.; Verkasalo, Pia K.] Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland; [Suominen-Taipale, Anna Liisa] Univ Turku, Inst Dent, Dept Publ Hlth Dent, Turku, Finland; [Partonen, Timo] Natl Inst Hlth & Welf THL, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Mannisto, Satu] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Helsinki, Finland; [Jula, Antti] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Suominen-Taipale, AL (corresponding author), Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland.	liisa.suominen-taipale@thl.fi	Suominen, Anna L/AAE-6828-2021; Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Mannisto, Satu/0000-0002-8668-3046	Academy of Finland [52876, 206950, 107098, 100499, 205585]; Finnish Cancer Organisations; Yrjo Jahnsson Foundation; Juho Vainio Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Yrjo Jahnsson Foundation; Juho Vainio Foundation	This work was supported by the Academy of Finland (project numbers 52876, 206950, 107098, 100499; 205585); the Finnish Cancer Organisations; the Yrjo Jahnsson Foundation; and the Juho Vainio Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Appleton KM, 2007, SOC PSYCH PSYCH EPID, V42, P100, DOI 10.1007/s00127-006-0142-3; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Astorg P, 2008, PROSTAG LEUKOTR ESS, V78, P171, DOI 10.1016/j.plefa.2008.01.003; Chiuve SE, 2005, AM J CLIN NUTR, V82, P155, DOI 10.1093/ajcn/82.1.155; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Freeman M P, 2000, Ann Clin Psychiatry, V12, P159, DOI 10.1023/A:1009069002816; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hakkarainen R, 2004, AM J PSYCHIAT, V161, P567, DOI 10.1176/appi.ajp.161.3.567; Hakkarainen R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-14; HEISTARO S, 2008, HLTH 2000 SURVEY; Jacka FN, 2007, PSYCHOSOMATICS, V48, P54, DOI 10.1176/appi.psy.48.1.54; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jula A, 2005, ARTERIOSCL THROM VAS, V25, P1952, DOI 10.1161/01.ATV.0000177812.84927.fa; Kamphuis MH, 2006, AM J CLIN NUTR, V84, P1513, DOI 10.1093/ajcn/84.6.1513; Katan MB, 1997, J LIPID RES, V38, P2012; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Koehler KM, 2001, AM J CLIN NUTR, V73, P628; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Maes M, 1999, PSYCHIAT RES, V85, P275, DOI 10.1016/S0165-1781(99)00014-1; Maes M, 1996, J AFFECT DISORDERS, V38, P35, DOI 10.1016/0165-0327(95)00092-5; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P882, DOI 10.1038/sj.ejcn.1602394; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P1016, DOI 10.1038/sj.ejcn.1602413; Mamalakis G, 2004, PROSTAG LEUKOTR ESS, V70, P495, DOI 10.1016/j.plefa.2003.10.005; Mamalakis G, 2002, PROSTAG LEUKOTR ESS, V67, P311, DOI 10.1054/plef.2002.0435; Mamalakis G, 2008, PHARMACOL BIOCHEM BE, V89, P6, DOI 10.1016/j.pbb.2007.10.015; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Nanri A, 2010, EUR J CLIN NUTR, V64, P289, DOI 10.1038/ejcn.2009.143; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Paykel ES, 2005, EUR NEUROPSYCHOPHARM, V15, P411, DOI 10.1016/j.euroneuro.2005.04.008; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; REED V, 1998, INT J METH PSYCH RES, P142; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Sanchez-Villegas A, 2009, J HUM NUTR DIET, V22, P122, DOI 10.1111/j.1365-277X.2008.00931.x; Sanchez-Villegas A, 2007, EUR J NUTR, V46, P337, DOI 10.1007/s00394-007-0671-x; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Sontrop J, 2006, PREV MED, V42, P4, DOI 10.1016/j.ypmed.2005.11.005; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Suominen-Taipale AL, 2010, INT J EPIDEMIOL, V39, P494, DOI 10.1093/ije/dyp386; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Tolmunen T, 2004, PSYCHOTHER PSYCHOSOM, V73, P334, DOI 10.1159/000080385; Turunen AW, 2010, EUR J CLIN NUTR, V64, P313, DOI 10.1038/ejcn.2009.147; Turunen AW, 2008, INT J EPIDEMIOL, V37, P1008, DOI 10.1093/ije/dyn117; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Wittchen HU, 1998, ARCH GEN PSYCHIAT, V55, P1017, DOI 10.1001/archpsyc.55.11.1017	54	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10530	10.1371/journal.pone.0010530	http://dx.doi.org/10.1371/journal.pone.0010530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	593OI	20479881	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800012
J	Glas, J; Seiderer, J; Nagy, M; Fries, C; Beigel, F; Weidinger, M; Pfennig, S; Klein, W; Epplen, JT; Lohse, P; Folwaczny, M; Goke, B; Ochsenkuhn, T; Diegelmann, J; Muller-Myhsok, B; Roeske, D; Brand, S				Glas, Juergen; Seiderer, Julia; Nagy, Melinda; Fries, Christoph; Beigel, Florian; Weidinger, Maria; Pfennig, Simone; Klein, Wolfram; Epplen, Joerg T.; Lohse, Peter; Folwaczny, Matthias; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Mueller-Myhsok, Bertram; Roeske, Darina; Brand, Stephan			Evidence for STAT4 as a Common Autoimmune Gene: rs7574865 Is Associated with Colonic Crohn's Disease and Early Disease Onset	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; HIGH-RISK; VARIANTS; CARD15; EXPRESSION	Background: Recent studies demonstrated an association of STAT4 variants with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), indicating that multiple autoimmune diseases share common susceptibility genes. We therefore investigated the influence of STAT4 variants on the susceptibility and phenotype of inflammatory bowel diseases (IBD) in a large patient and control cohort. Methodology/Principal Findings: Genomic DNA from 2704 individuals of Caucasian origin including 857 patients with Crohn's disease (CD), 464 patients with ulcerative colitis (UC), and 1383 healthy, unrelated controls was analyzed for seven SNPs in the STAT4 gene (rs11889341, rs7574865, rs7568275, rs8179673, rs10181656, rs7582694, rs10174238). In addition, a detailed genotype-phenotype analysis was performed. Our analysis revealed an association of the STAT4 SNP rs7574865 with overall decreased susceptibility to CD (p = 0.047, OR 0.86 [95% CI 0.74-0.99]). However, compared to CD patients carrying the wild type genotype, the STAT4 SNP rs7574865 was significantly associated with early CD onset (p = 0.021) and colonic CD (p = 0.008; OR = 4.60, 95% CI 1.63-12.96). For two other STAT4 variants, there was a trend towards protection against CD susceptibility (rs7568275, p = 0.058, OR 0.86 [95% CI 0.74-1.00]; rs10174238, p = 0.057, OR 0.86 [95% CI 0.75-1.00]). In contrast, we did not observe any association with UC susceptibility. Evidence for weak gene-gene interaction of STAT4 with the IL23R SNP rs11209026 was lost after Bonferroni correction. Conclusions/Significance: Our results identified the STAT4 SNP rs7574865 as a disease-modifying gene variant in colonic CD. However, in contrast to SLE and RA, the effect of rs7574865 on CD susceptibility is only weak.	[Glas, Juergen; Seiderer, Julia; Nagy, Melinda; Fries, Christoph; Beigel, Florian; Weidinger, Maria; Pfennig, Simone; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Folwaczny, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Inst Human Genet, Aachen, Germany; [Klein, Wolfram; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Lohse, Peter] Univ Munich, Inst Clin Chem, Munich, Germany; [Mueller-Myhsok, Bertram; Roeske, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Ruhr University Bochum; University of Munich; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013	Epplen, Joerg T./0000-0002-6087-3327	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; DFG [BR 1912/5-1]; DCCV e.V. [2007]	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); DCCV e.V.	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J. S. and Promotionsstipendium to J. D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroner-Fresenius-Stiftung (Else Kroner-Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2009, AUTOIMMUNITY, V42, P126, DOI 10.1080/08916930802422265; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Begue B, 2006, J CELL PHYSIOL, V209, P241, DOI 10.1002/jcp.20739; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; DIAZGALLO LM, 2010, HUM IMMUNOL     0307; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fedetz M, 2009, TISSUE ANTIGENS, V74, P244, DOI 10.1111/j.1399-0039.2009.01298.x; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Mo CQ, 2008, J IMMUNOL, V181, P5681, DOI 10.4049/jimmunol.181.8.5681; MOON CM, 2010, LIFE SCI       0220; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; O'Malley JT, 2008, J IMMUNOL, V181, P5062, DOI 10.4049/jimmunol.181.7.5062; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Pang YH, 2007, CELL IMMUNOL, V248, P115, DOI 10.1016/j.cellimm.2007.10.003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2007, TISSUE ANTIGENS, V70, P238, DOI 10.1111/j.1399-0039.2007.00888.x; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zervou MI, 2009, HUM IMMUNOL, V70, P738, DOI 10.1016/j.humimm.2009.05.008	55	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10373	10.1371/journal.pone.0010373	http://dx.doi.org/10.1371/journal.pone.0010373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454450	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240100006
J	Montaudouin, C; Boucontet, L; Mailhe-Lembezat, MP; Mariotti-Ferrandiz, ME; Louise, A; Six, A; Freitas, AA; Garcia, S				Montaudouin, Caroline; Boucontet, Laurent; Mailhe-Lembezat, Marie-Pierre; Mariotti-Ferrandiz, Maria-Encarnita; Louise, Anne; Six, Adrien; Freitas, Antonio A.; Garcia, Sylvie			Endogenous TCR Recombination in TCR Tg Single RAG-Deficient Mice Uncovered by Robust In Vivo T Cell Activation and Selection	PLOS ONE			English	Article							ANTIGEN RECEPTOR; TRANSGENIC MICE; RAG-1-DEFICIENT MICE; V(D)J RECOMBINATION; POSITIVE SELECTION; LYMPHOCYTES-T; GENES; EXPRESSION; DELETION; REARRANGEMENT	Recombination activating gene (RAG)-deficient TCR (T Cell Receptor) Tg (transgenic) mice are routinely used as sources of monoclonal T cells. We found that after the transfer of T cells from a RAG-2-deficient 5CC7 TCR Tg mice into allogeneic hosts we recovered a population of T cells expressing diverse alpha beta-TCRs. In fact, in the thymus and spleen of the 5CC7 RAG-2deficient donor mice, we detected rare T cells expressing non-Tg TCR chains. Similar observations were obtained using T cells from two other TCR transgenic strains, namely RAG-2-deficient aHY and RAG-1-deficient OT-1 mice. The sequences of the endogenous TCR transcripts suggested that gene recombination could occur, albeit quite inefficiently, in the RAG-deficient mice we used. In agreement, we evidenced rare TCR V alpha and V beta-chain transcripts in non-Tg RAG-2-deficient mice. Since in these non-Tg RAG-deficient mice no mature T cells could ever be found, our findings suggested a role for the TCR Tg in rescuing rare recombined endogenous chains. Robust T-cell activation by the allogeneic environment favored the selection and expansion of the rare cells expressing endogenous TCRs. Potential mechanisms involved in the recombination of the endogenous TCR chains in the different strains of RAG-deficient mice used, and in particular the possibility of RAG-1 hypomorphism due to an incomplete knocking out procedure, are discussed. Our findings have important experimental implications for studies using TCR-Tg RAG-deficient cells as monoclonal T cell populations.	[Montaudouin, Caroline; Mailhe-Lembezat, Marie-Pierre; Freitas, Antonio A.; Garcia, Sylvie] Inst Pasteur, Dept Immunol, CNRS, Unite Biol Populat Lymphocytaires,URA 1961, F-75724 Paris, France; [Boucontet, Laurent] Inst Pasteur, INSERM, Dept Immunol, Unite Dev Lymphocytes,U668, F-75724 Paris, France; [Mariotti-Ferrandiz, Maria-Encarnita; Six, Adrien] Inst Pasteur, Dept Immunol, CNRS, Unite Physiopathol Infect,URA 1961, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Montaudouin, C (corresponding author), Inst Pasteur, Dept Immunol, CNRS, Unite Biol Populat Lymphocytaires,URA 1961, F-75724 Paris, France.	antonio.freitas@pasteur.fr; sylvie.garcia@pasteur.fr	Mariotti-Ferrandiz, Maria Encarnita/H-4788-2012; freitas, antonio/A-2482-2013; Mariotti-Ferrandiz, Encarnita/O-3262-2019	Mariotti-Ferrandiz, Encarnita/0000-0002-8770-0186; Garcia, Sylvie/0000-0002-7655-8911; freitas, antonio/0000-0001-6392-7178; Six, Adrien/0000-0001-5898-555X	French Ministry of Research; Pierre et Marie Curie University; Fond Inkermanns of Fondation de France; Institut Pasteur; Centre National de Recherche Scientifique; Agence Nationale de Recherche sur le SIDA; Agence Nationale de la Recherche; Association de Recherche sur le Cancer; Association Francaise contre les Myopathies	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Pierre et Marie Curie University; Fond Inkermanns of Fondation de France; Institut Pasteur(European Commission); Centre National de Recherche Scientifique; Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association de Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	CM is supported by the French Ministry of Research; MEMF is supported by Pierre et Marie Curie University, Fond Inkermanns of Fondation de France. This work was supported by the Institut Pasteur, the Centre National de Recherche Scientifique and grants from Agence Nationale de Recherche sur le SIDA, Agence Nationale de la Recherche, Association de Recherche sur le Cancer & Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Golub R, 2001, EUR J IMMUNOL, V31, P2919, DOI 10.1002/1521-4141(2001010)31:10<2919::AID-IMMU2919>3.0.CO;2-N; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Koh WP, 1999, J IMMUNOL, V162, P7208; Legrand N, 2001, J IMMUNOL, V167, P6158, DOI 10.4049/jimmunol.167.11.6158; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Sadofsky MJ, 2001, NUCLEIC ACIDS RES, V29, P1399, DOI 10.1093/nar/29.7.1399; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; XU B, 1994, SCIENCE, V265, P1590, DOI 10.1126/science.8079173; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	27	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10238	10.1371/journal.pone.0010238	http://dx.doi.org/10.1371/journal.pone.0010238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454452	gold, Green Published			2022-12-27	WOS:000277240100001
J	Emadi, A; Ross, AE; Cowan, KM; Fortenberry, YM; Vuica-Ross, M				Emadi, Ashkan; Ross, Ashley E.; Cowan, Kathleen M.; Fortenberry, Yolanda M.; Vuica-Ross, Milena			A Chemical Genetic Screen for Modulators of Asymmetrical 2,2'-Dimeric Naphthoquinones Cytotoxicity in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REGIOCONTROLLED SYNTHESIS; NATURAL-PRODUCTS; CELL-DEATH; CONOCURVONE; GENOME; STRESS; DEHYDROGENASE; MITOCHONDRIA; MECHANISMS	Background: Dimeric naphthoquinones (BiQ) were originally synthesized as a new class of HIV integrase inhibitors but have shown integrase-independent cytotoxicity in acute lymphoblastic leukemia cell lines suggesting their use as potential antineoplastic agents. The mechanism of this cytotoxicity is unknown. In order to gain insight into the mode of action of binaphthoquinones we performed a systematic high-throughput screen in a yeast isogenic deletion mutant array for enhanced or suppressed growth in the presence of binaphthoquinones. Methodology/Principal findings: Exposure of wild type yeast strains to various BiQs demonstrated inhibition of yeast growth with IC(50)s in the mu M range. Drug sensitivity and resistance screens were performed by exposing arrays of a haploid yeast deletion mutant library to BiQs at concentrations near their IC50. Sensitivity screens identified yeast with deletions affecting mitochondrial function and cellular respiration as having increased sensitivity to BiQs. Corresponding to this, wild type yeast grown in the absence of a fermentable carbon source were particularly sensitive to BiQs, and treatment with BiQs was shown to disrupt the mitochondrial membrane potential and lead to the generation of reactive oxygen species (ROS). Furthermore, baseline ROS production in BiQ sensitive mutant strains was increased compared to wild type and could be further augmented by the presence of BiQ. Screens for resistance to BiQ action identified the mitochondrial external NAD(P) H dehydrogenase, NDE1, as critical to BiQ toxicity and over-expression of this gene resulted in increased ROS production and increased sensitivity of wild type yeast to BiQ. Conclusions/Significance: In yeast, binaphthoquinone cytotoxicity is likely mediated through NAD(P)H:quonine oxidoreductases leading to ROS production and dysfunctional mitochondria. Further studies are required to validate this mechanism in mammalian cells.	[Emadi, Ashkan] Johns Hopkins Sch Med, Dept Internal Med & Oncol, Baltimore, MD 21218 USA; [Ross, Ashley E.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Cowan, Kathleen M.; Vuica-Ross, Milena] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Fortenberry, Yolanda M.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Emadi, A (corresponding author), Johns Hopkins Sch Med, Dept Internal Med & Oncol, Baltimore, MD 21218 USA.	mvuica@jhmi.edu			Richard Starr Ross Clinician Scientist Award; JHH Department of Pathology funds	Richard Starr Ross Clinician Scientist Award; JHH Department of Pathology funds	This work was supported by Richard Starr Ross Clinician Scientist Award (to MVR) and the JHH Department of Pathology funds (to MVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Bey EA, 2006, J CELL PHYSIOL, V209, P604, DOI 10.1002/jcp.20783; Bittner S, 2006, AMINO ACIDS, V30, P205, DOI 10.1007/s00726-005-0298-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; CLAYSON DB, 1994, MUTAT RES, V317, P25, DOI 10.1016/0165-1110(94)90010-8; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; DECOSTERD LA, 1993, J AM CHEM SOC, V115, P6673, DOI 10.1021/ja00068a026; Emadi A, 2002, ORG LETT, V4, P521, DOI 10.1021/ol010272m; FOX TD, 1991, METHODS ENZYMOL, V194, P149; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hallak M, 2009, BRIT J HAEMATOL, V147, P459, DOI 10.1111/j.1365-2141.2009.07867.x; Kanaan YM, 2009, ANTICANCER RES, V29, P191; Kuzyk MA, 2009, PROTEOMICS, V9, P3328, DOI 10.1002/pmic.200800412; LAATSCH H, 1994, ANGEW CHEM INT EDIT, V33, P422, DOI 10.1002/anie.199404221; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Lopez Andres, 2008, V66; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; MISKIMINS R, 1982, GENETICS, V101, P157; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; OHNISHI T, 1966, B SOC CHIM BIOL, V48, P1189; OLLINGER K, 1991, J BIOL CHEM, V266, P21496; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; ROCKWELL S, 1993, CANCER METAST REV, V12, P165, DOI 10.1007/BF00689808; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Small WC, 1998, J BACTERIOL, V180, P4051, DOI 10.1128/JB.180.16.4051-4055.1998; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Stagliano KW, 2006, BIOORGAN MED CHEM, V14, P5651, DOI 10.1016/j.bmc.2006.04.034; Stagliano KW, 2004, J ORG CHEM, V69, P5128, DOI 10.1021/jo049713g; STAGLIANO KW, 2004, Patent No. 6828347; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	42	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10846	10.1371/journal.pone.0010846	http://dx.doi.org/10.1371/journal.pone.0010846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520766	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221500031
J	Pei, YF; Zhang, L; Li, J; Deng, HW				Pei, Yu-Fang; Zhang, Lei; Li, Jian; Deng, Hong-Wen			Analyses and Comparison of Imputation-Based Association Methods	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; GENETIC ASSOCIATION; OPIATE WITHDRAWAL; IMMUNE-SYSTEM; POWER; EFFICIENCY; INFERENCE; VARIANTS; ACCURACY	Genotype imputation methods have become increasingly popular for recovering untyped genotype data. An important application with imputed genotypes is to test genetic association for diseases. Imputation-based association test can provide additional insight beyond what is provided by testing on typed tagging SNPs only. A variety of effective imputation-based association tests have been proposed. However, their performances are affected by a variety of genetic factors, which have not been well studied. In this study, using both simulated and real data sets, we investigated the effects of LD, MAF of untyped causal SNP and imputation accuracy rate on the performances of seven popular imputation-based association methods, including MACH2qtl/dat, SNPTEST, ProbABEL, Beagle, Plink, BIMBAM and SNPMStat. We also aimed to provide a comprehensive comparison among methods. Results show that: 1). imputation-based association tests can boost signals and improve power under medium and high LD levels, with the power improvement increasing with strengthening LD level; 2) the power increases with higher MAF of untyped causal SNPs under medium to high LD level; 3). under low LD level, a high imputation accuracy rate cannot guarantee an improvement of power; 4). among methods, MACH2qtl/dat, ProbABEL and SNPTEST perform similarly and they consistently outperform other methods. Our results are helpful in guiding the choice of imputation-based association test in practical application.	[Pei, Yu-Fang; Zhang, Lei; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Pei, Yu-Fang; Zhang, Lei; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Pei, Yu-Fang; Zhang, Lei; Li, Jian; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology	Pei, YF (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	dengh@umkc.edu	Li, Jian/G-4445-2015; Zhang, Lei/L-1016-2016	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Xi'an Jiaotong University; Ministry of Education of China; National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Xi'an Jiaotong University. The investigators of this work were also benefited from grants from the Ministry of Education of China, National Institutes of Health (grant numbers R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081) and National Science Foundation of China, Huo Ying Dong Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Clark AG, 2007, NAT GENET, V39, P815, DOI 10.1038/ng0707-815; DAFNY N, 1986, NEUROPHARMACOLOGY, V25, P815, DOI 10.1016/0028-3908(86)90003-1; DAFNY N, 1989, INT J IMMUNOPHARMACO, V11, P371, DOI 10.1016/0192-0561(89)90083-0; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DUPUIS J, NAT GENET, V42, P105; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; LI GAY, 2006, AM J HUM GENET; LI Y, 2006, AM J HUM GENET; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; LIU YZ, 2009, MOL PSYCHIAT; Marchini J, 2008, AM J HUM GENET, V83, P535, DOI 10.1016/j.ajhg.2008.09.007; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marquard V, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-3; Nannya Y, 2007, HUM MOL GENET, V16, P2494, DOI 10.1093/hmg/ddm205; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P703, DOI 10.1002/gepi.20181; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; SAXENA R, NAT GENET, V42, P142; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Taylor JR, 1999, INTRO ERROR ANAL STU, P128; TIH C, 2005, NATURE, V437, P1299; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10827	10.1371/journal.pone.0010827	http://dx.doi.org/10.1371/journal.pone.0010827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520814	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500014
J	Xie, WJ; Huang, YF; Xie, WL; Guo, AM; Wu, W				Xie, Wenjie; Huang, Yafang; Xie, Wenling; Guo, Aimin; Wu, Wei			Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN PROSTATE-CANCER; GROWTH-FACTOR-BETA; TUMOR-GROWTH; INNATE IMMUNITY; INVASION; INFLAMMATION; METASTASIS; AGONISTS; STAT3	Chronic bacterial infection increased the risk of many solid malignancies and the underlying mechanism is usually ascribed to bacterial-caused inflammation. However, the direct interaction of infectious bacteria with cancer cells has been largely overlooked. We identified that highly metastatic breast cancer MDA-MB-231 cells expressed high level of Toll-like receptor 2 (TLR2) in contrast to poorly metastatic breast cancer cells and homogenous untransformed breast cells. TLR2 in MDA-MB-231 cells were actively triggered by peptidoglycan (PGN) from infectious bacterium Staphylococcus aureus (PGN-SA), resulting in the promoted invasiveness and adhesiveness of the cancer cells in vitro. PGN-SA induced phosphorylation of TAK1 and I kappa B in the TLR2-NF-kappa B pathway of the cancer cells and stimulated IL-6 and TGF-beta secretion in MDA-MB-231 cells. All these effects were abrogated by TLR2 blockade. Further investigation showed that the NF-kappa B, STAT3 and Smad3 activities were augmented sequentially in MDA-MB-231 cells after PGN-SA stimulation. Phosphorylation of NF-kappa Bp65 was initially increased and then followed by phosphorylation of STAT3 and Smad3 in the delayed 4 or 6 hours. NF-kappa B inhibition attenuated STAT3 and Smad3 activities whereas PGN-SA-stimulated cell culture supernatants reversed these inhibitory effects. Our study indicated that TLR2 activation by infectious bacterial PGN played an important role in breast cancer cell invasiveness and illustrated a new link between infectious bacteria and the cancer cells, suggesting the importance of antibiotic therapy to treat cancer with bacterial infection.	[Xie, Wenjie] United Labs Int Holdings Ltd, Biol Res Inst, Zhuhai, Peoples R China; [Huang, Yafang; Guo, Aimin; Wu, Wei] Capital Univ Med Sci, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Xie, Wenling] Xinjiang Modern Women Hosp, Urumqi, Peoples R China	Capital Medical University	Xie, WJ (corresponding author), United Labs Int Holdings Ltd, Biol Res Inst, Zhuhai, Peoples R China.	xiewj75@126.com; elite010@163.com			Post-doctor Foundation of Zhu Hai; major Science and Technology Project of Zhu Hai	Post-doctor Foundation of Zhu Hai; major Science and Technology Project of Zhu Hai	This work was mainly supported by the Post-doctor Foundation of Zhu Hai (to W. Xie) and the major Science and Technology Project of Zhu Hai (to W. Xie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Becker C, 2005, CELL CYCLE, V4, P217; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Connolly Lynette, 2002, Br J Biomed Sci, V59, P11; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; FERRARA AR, 2008, RADIOL TECHNOL, V80, P49; Hooper AT, 2005, J CLIN ONCOL, V23, p871S; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Kokkinopoulos I, 2005, MOL IMMUNOL, V42, P957, DOI 10.1016/j.molimm.2004.09.037; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Labidi SI, 2008, ANN ONCOL, V19, P473, DOI 10.1093/annonc/mdm480; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lu S, 2007, CLIN CANCER RES, V13, P5692, DOI 10.1158/1078-0432.CCR-07-1078; Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Muss HB, 2006, NEW ENGL J MED, V355, P2783, DOI 10.1056/NEJMe068260; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; QUAN S, 2004, AM J RESP CELL MOL B; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; STEIN RA, 2008, JAMA-J AM MED ASSOC, V299, P837; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yoshioka T, 2001, J INT MED RES, V29, P409, DOI 10.1177/147323000102900505; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	49	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10850	10.1371/journal.pone.0010850	http://dx.doi.org/10.1371/journal.pone.0010850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520770	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500035
J	Hoetjes, PC; Carpenter, KE				Hoetjes, Paul C.; Carpenter, Kent E.			Saving Saba Bank: Policy Implications of Biodiversity Studies	PLOS ONE			English	Article								Saba Bank has always been an area of special importance to the neighboring island of Saba in the Netherlands Antilles. Sabans traditionally fished on the Bank as far back as 1907, but increasing foreign fishing pressures on the Bank in the 1970s and 1980s forced many Saban fishermen out. Concerns were compounded by the suspicion that shipping was also damaging the benthic habitat of the bank. Fishery legislation, enacted in 1996, brought an end to unlicensed fishing and established Coast Guard enforcement on the Bank, but also led to protests from neighboring countries that previously fished on the Bank. Research was necessary to support the need for protection. Review of available research of Saba Bank and rapid biological assessments and fisheries surveys since 1996 emphasized the richness of Saba Bank's biodiversity and the need for protection of fisheries stocks. The national nature policy plan recognized this and encouraged further research to base conservation measures on. Recent biological surveys of corals, fishes, and algae presented in this collection of articles emphasized habitat heterogeneity and the relative richness of the marine flora and fauna. These assessments formed the basis for a management plan to protect Saba Bank's biodiversity and a draft proposal to the International Maritime Organization (IMO) seeking Particularly Sensitive Sea Area (PSSA) status for the Bank. The intention of the PSSA proposal is to protect the benthic habitat on Saba Bank from anchor damage. This paper serves to provide the context for the results of the recent biodiversity surveys of Saba Bank. It is hoped that this collection will serve as a knowledge baseline and engender further research in the area.	[Hoetjes, Paul C.] Directorate Publ Hlth, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles; [Carpenter, Kent E.] Old Dominion Univ, Int Union Conservat Nat Species Programme Species, Norfolk, VA USA	Old Dominion University	Hoetjes, PC (corresponding author), Directorate Publ Hlth, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles.	paul@mina.vomil.an			Development Foundation of the Netherlands Antilles (SONA); Department of Environment and Nature of the Netherlands Antilles; Dutch Ministry of Transport and Water	Development Foundation of the Netherlands Antilles (SONA); Department of Environment and Nature of the Netherlands Antilles; Dutch Ministry of Transport and Water	This work was part of the implementation of the Nature and Environment Policy Plan (NEPP) of the Department of Environment and Nature of the Netherlands Antilles, funded by Dutch development support provided through the Development Foundation of the Netherlands Antilles (SONA) and carried out with the help of the Saba Conservation Foundation, Saba, Netherlands Antilles. Additional funding came from the Small Nature Projects Fund (KNAP fund) of the Department of Environment and Nature of the Netherlands Antilles, which made possible the first review of Saba Bank. The Dutch Ministry of Transport and Water provided funding for some of the preliminary work towards a Particularly Sensitive Sea Area (PSSA) status proposal to the International Maritime Organization (IMO) which also helped identify the needs for further research and data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeke J., 1907, RAPPORT BETREFFENDE; *CABS CONS INT, RAP ASS PROGR; DAVIS WM, 1926, AM GEOL SOC PUB, V2, P207; Dilrosun F, 2000, MONITORING SABA BANK; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; *IMO, 2001, GUID DES SPEC AR MAR; Littler MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010677; LUNDVAL S, 2008, SABA BANK SPECIAL MA; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; McKenna SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010749; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; SPENCER JW, 1904, T CAN I, V7, P351; Thacker RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009622; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; *TRAFFIC IUCN, 2003, 19 M AN COMM DOC 8 3; VANDERLAND J, 1977, 200 FAO, P469; VAUGHAN TW, 1919, SMITHSONIAN I US NAT, V103; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676	18	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10769	10.1371/journal.pone.0010769	http://dx.doi.org/10.1371/journal.pone.0010769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505823	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400021
J	Nickerson, ML; Kostiha, BN; Brandt, W; Fredericks, W; Xu, KP; Yu, FS; Gold, B; Chodosh, J; Goldberg, M; Lu, DW; Yamada, M; Tervo, TM; Grutzmacher, R; Croasdale, C; Hoeltzenbein, M; Sutphin, J; Malkowicz, SB; Wessjohann, L; Kruth, HS; Dean, M; Weiss, JS				Nickerson, Michael L.; Kostiha, Brittany N.; Brandt, Wolfgang; Fredericks, William; Xu, Ke-Ping; Yu, Fu-Shin; Gold, Bert; Chodosh, James; Goldberg, Marc; Lu, Da Wen; Yamada, Masakazu; Tervo, Timo M.; Grutzmacher, Richard; Croasdale, Chris; Hoeltzenbein, Maria; Sutphin, John; Malkowicz, S. Bruce; Wessjohann, Ludger; Kruth, Howard S.; Dean, Michael; Weiss, Jayne S.			UBIAD1 Mutation Alters a Mitochondrial Prenyltransferase to Cause Schnyder Corneal Dystrophy	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTALLINE DYSTROPHY; TOPOLOGY PREDICTION; PROTEIN STRUCTURES; CHOLESTEROL; GENE; MEMBRANE; TRANSFERASE; METABOLISM; BLADDER	Background: Mutations in a novel gene, UBIAD1, were recently found to cause the autosomal dominant eye disease Schnyder corneal dystrophy (SCD). SCD is characterized by an abnormal deposition of cholesterol and phospholipids in the cornea resulting in progressive corneal opacification and visual loss. We characterized lesions in the UBIAD1 gene in new SCD families and examined protein homology, localization, and structure. Methodology/Principal Findings: We characterized five novel mutations in the UBIAD1 gene in ten SCD families, including a first SCD family of Native American ethnicity. Examination of protein homology revealed that SCD altered amino acids which were highly conserved across species. Cell lines were established from patients including keratocytes obtained after corneal transplant surgery and lymphoblastoid cell lines from Epstein-Barr virus immortalized peripheral blood mononuclear cells. These were used to determine the subcellular localization of mutant and wild type protein, and to examine cholesterol metabolite ratios. Immunohistochemistry using antibodies specific for UBIAD1 protein in keratocytes revealed that both wild type and N102S protein were localized sub-cellularly to mitochondria. Analysis of cholesterol metabolites in patient cell line extracts showed no significant alteration in the presence of mutant protein indicating a potentially novel function of the UBIAD1 protein in cholesterol biochemistry. Molecular modeling was used to develop a model of human UBIAD1 protein in a membrane and revealed potentially critical roles for amino acids mutated in SCD. Potential primary and secondary substrate binding sites were identified and docking simulations indicated likely substrates including prenyl and phenolic molecules. Conclusions/Significance: Accumulating evidence from the SCD familial mutation spectrum, protein homology across species, and molecular modeling suggest that protein function is likely down-regulated by SCD mutations. Mitochondrial UBIAD1 protein appears to have a highly conserved function that, at least in humans, is involved in cholesterol metabolism in a novel manner.	[Nickerson, Michael L.; Kostiha, Brittany N.; Gold, Bert; Dean, Michael] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Nickerson, Michael L.] NIH, Grad Partnership Program, Bethesda, MD 20892 USA; [Nickerson, Michael L.] George Washington Univ, Inst Biomed Sci, Program Mol Med, Washington, DC USA; [Kostiha, Brittany N.] Hood Coll, Biomed Sci Grad Program, Frederick, MD 21701 USA; [Brandt, Wolfgang; Wessjohann, Ludger] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Fredericks, William; Malkowicz, S. Bruce] Univ Penn, Dept Surg, Div Urol, Philadelphia, PA 19104 USA; [Fredericks, William; Malkowicz, S. Bruce] Vet Affairs Med Ctr, Philadelphia, PA USA; [Xu, Ke-Ping; Yu, Fu-Shin; Weiss, Jayne S.] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; [Xu, Ke-Ping; Yu, Fu-Shin; Weiss, Jayne S.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA; [Chodosh, James] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Howe Lab, Cambridge, MA 02138 USA; [Goldberg, Marc] Inst Eye, Tulsa, OK USA; [Lu, Da Wen] Triserv Gen Hosp, Taipei, Taiwan; [Yamada, Masakazu] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Tervo, Timo M.] Univ Helsinki, Hosp Eye, Helsinki, Finland; [Grutzmacher, Richard] Grutzmacher Lewis & Sierra, Sacramento, CA USA; [Croasdale, Chris] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Hoeltzenbein, Maria] Max Planck Inst Mol Genet, Berlin, Germany; [Sutphin, John] Univ Kansas, Med Ctr, Dept Ophthalmol, Prairie Village, KS USA; [Kruth, Howard S.] NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; [Weiss, Jayne S.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; George Washington University; Leibniz Institut fur Pflanzenbiochemie; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Wayne State University; Wayne State University; Harvard University; Massachusetts Eye & Ear Infirmary; Tri-Service General Hospital; University of Helsinki; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wayne State University	Nickerson, ML (corresponding author), NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA.	nickersonml@mail.nih.gov; jweiss@med.wayne.edu	Dean, Michael/R-7501-2019; Wessjohann, Ludger/AAZ-3838-2021; Hoeltzenbein, Maria/AAP-4145-2020; Hoeltzenbein, Maria/B-1134-2016; Dean, Michael C/G-8172-2012; weiss, jayne/AAL-9912-2020	Hoeltzenbein, Maria/0000-0002-2451-4247; Hoeltzenbein, Maria/0000-0002-2451-4247; Dean, Michael C/0000-0003-2234-0631; Wessjohann, Ludger A./0000-0003-2060-8235	National Eye Institute [EY12972]; Eye Bank Association of America (JSW); Midwest Eye Banks; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010869, R01EY012972] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002832] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eye Bank Association of America (JSW); Midwest Eye Banks; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the National Eye Institute (grant EY12972 to J.S.W.) and by funding from the Eye Bank Association of America (JSW), and the Midwest Eye Banks (J.S.W. and K.-P.X.). This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Brauer L, 2004, J MOL MODEL, V10, P317, DOI 10.1007/s00894-004-0197-6; Breitling R, 2007, BIOESSAYS, V29, P1085, DOI 10.1002/bies.20663; BRON AJ, 1989, CORNEA, V8, P75; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kobayashi A, 2009, OPHTHALMOLOGY, V116, P1029, DOI 10.1016/j.ophtha.2008.12.042; KRUTH HS, 1995, J CELL BIOL, V129, P133, DOI 10.1083/jcb.129.1.133; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LISCH W, 1986, OPHTHALMIC PAED GEN, V7, P45, DOI 10.3109/13816818609058041; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; MOMOSE K, 1972, J BIOL CHEM, V247, P3930; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Riebeling P, 2003, OPHTHALMOLOGE, V100, P979, DOI 10.1007/s00347-003-0883-2; RODRIGUES MM, 1987, AM J OPHTHALMOL, V104, P157, DOI 10.1016/0002-9394(87)90008-0; Schnyder WF., 1929, SCHWEIZ MED WSCHR, V10, P559; Shirakawa H, 2006, BBA-GEN SUBJECTS, V1760, P1482, DOI 10.1016/j.bbagen.2006.05.008; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Van Went JM., 1924, NIEDERL TIJDSCHR GEN, V68, P2996; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss Jayne S, 2007, Trans Am Ophthalmol Soc, V105, P616; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; WEISS JS, 1992, CORNEA, V11, P93, DOI 10.1097/00003226-199203000-00001; Weiss JS, 1996, OPHTHALMOLOGY, V103, P465; Wessjohann L, 1996, ANGEW CHEM INT EDIT, V35, P1697, DOI 10.1002/anie.199616971; WESSJOHANN L, 2009, CHIMIA PHYT IN PRESS; Yellore VS, 2007, MOL VIS, V13, P1777	34	53	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10760	10.1371/journal.pone.0010760	http://dx.doi.org/10.1371/journal.pone.0010760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505825	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400016
J	Arias, A; Perales, C; Escarmis, C; Domingo, E				Arias, Armando; Perales, Celia; Escarmis, Cristina; Domingo, Esteban			Deletion Mutants of VPg Reveal New Cytopathology Determinants in a Picornavirus	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; DEPENDENT RNA-POLYMERASE; PROTEIN LINKAGE MAP; NONSTRUCTURAL PROTEINS; POLIOVIRUS 2C; VIRULENCE DETERMINANTS; ERROR CATASTROPHE; BINDING ACTIVITY; MULLERS RATCHET; DNA-POLYMERASE	Background: Success of a viral infection requires that each infected cell delivers a sufficient number of infectious particles to allow new rounds of infection. In picornaviruses, viral replication is initiated by the viral polymerase and a viral-coded protein, termed VPg, that primes RNA synthesis. Foot-and-mouth disease virus (FMDV) is exceptional among picornaviruses in that its genome encodes 3 copies of VPg. Why FMDV encodes three VPgs is unknown. Methodology and Principal Findings: We have constructed four mutant FMDVs that encode only one VPg: either VPg(1), VPg(3), or two chimeric versions containing part of VPg(1) and VPg(3). All mutants, except that encoding only VPg(1), were replication-competent. Unexpectedly, despite being replication-competent, the mutants did not form plaques on BHK-21 cell monolayers. The one-VPg mutant FMDVs released lower amounts of encapsidated viral RNA to the extracellular environment than wild type FMDV, suggesting that deficient plaque formation was associated with insufficient release of infectious progeny. Mutant FMDVs subjected to serial passages in BHK-21 cells regained plaque-forming capacity without modification of the number of copies of VPg. Substitutions in non-structural proteins 2C, 3A and VPg were associated with restoration of plaque formation. Specifically, replacement R55W in 2C was repeatedly found in several mutant viruses that had regained competence in plaque development. The effect of R55W in 2C was to mediate an increase in the extracellular viral RNA release without a detectable increase of total viral RNA that correlated with an enhanced capacity to alter and detach BHK-21 cells from the monolayer, the first stage of cell killing. Conclusions: The results link the VPg copies in the FMDV genome with the cytopathology capacity of the virus, and have unveiled yet another function of 2C: modulation of picornavirus cell-to-cell transmission. Implications for picornaviruses pathogenesis are discussed.	[Arias, Armando; Perales, Celia; Escarmis, Cristina; Domingo, Esteban] CSIC, Ctr Biol Mol Severo Ochoa UAM, Dept Virol & Microbiol, Madrid, Spain; [Perales, Celia; Domingo, Esteban] CIBERehd, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Arias, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England.	edomingo@cbm.uam.es	Arias, Armando/E-1393-2016; Domingo, Esteban/K-3937-2014	Arias, Armando/0000-0002-4138-4608; Perales Viejo, Celia Belen/0000-0003-1618-1937; Domingo, Esteban/0000-0002-0573-1676	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02816/BMC]; Fundacion R. Areces; Instituto de Salud Carlos III; Centro Superior de Investigaciones Cientificas (CSIC); CIBERehd	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion R. Areces(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro Superior de Investigaciones Cientificas (CSIC); CIBERehd	Work supported by grants BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion (MICINN), and Fundacion R. Areces. CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. AA was supported by an I3P contract from Centro Superior de Investigaciones Cientificas (CSIC) and CP is the recipient of a contract from CIBERehd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2005, J MOL BIOL, V353, P1021, DOI 10.1016/j.jmb.2005.09.022; Arias A, 2001, J GEN VIROL, V82, P1049, DOI 10.1099/0022-1317-82-5-1049; Arias A, 2004, J MOL BIOL, V339, P405, DOI 10.1016/j.jmb.2004.03.061; BALL LA, 2007, FIELDS VIROLOGY, P119; Banerjee R, 1997, J VIROL, V71, P9570, DOI 10.1128/JVI.71.12.9570-9578.1997; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; CAO XM, 1993, J VIROL, V67, P5572, DOI 10.1128/JVI.67.9.5572-5578.1993; Cao XM, 1996, EMBO J, V15, P23, DOI 10.1002/j.1460-2075.1996.tb00330.x; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P87, DOI 10.1016/B978-0-12-374153-0.00004-7; Escarmis C, 1996, J MOL BIOL, V264, P255, DOI 10.1006/jmbi.1996.0639; Escarmis C, 2009, J VIROL, V83, P6748, DOI 10.1128/JVI.00538-09; FALK MM, 1992, J VIROL, V66, P2251, DOI 10.1128/JVI.66.4.2251-2260.1992; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; FORSS S, 1982, NUCLEIC ACIDS RES, V10, P6441, DOI 10.1093/nar/10.20.6441; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042; Grubman MJ, 2008, FEMS IMMUNOL MED MIC, V53, P8, DOI 10.1111/j.1574-695X.2008.00409.x; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Harris JR, 2003, J VIROL, V77, P4773, DOI 10.1128/JVI.77.8.4773-4780.2003; Herrera M, 2007, PLOS PATHOG, V3, P498, DOI 10.1371/journal.ppat.0030053; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; KING AMQ, 1980, J VIROL, V34, P627, DOI 10.1128/JVI.34.3.627-634.1980; LEWIN B, 2007, GENES; LI JP, 1990, J VIROL, V64, P1102, DOI 10.1128/JVI.64.3.1102-1107.1990; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; Nunez JI, 2001, J VIROL, V75, P3977, DOI 10.1128/JVI.75.8.3977-3983.2001; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Paul AV, 2003, J VIROL, V77, P891, DOI 10.1128/JVI.77.2.891-904.2003; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Pauluhn A, 2002, ESA SP PUBL, V508, P227; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Ryan MD, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P53; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Tellez AB, 2006, J MOL BIOL, V357, P665, DOI 10.1016/j.jmb.2005.12.044; Teterina NL, 2003, J VIROL, V77, P12679, DOI 10.1128/JVI.77.23.12679-12691.2003; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; Toja M, 1999, VIRUS RES, V64, P161, DOI 10.1016/S0168-1702(99)00089-1; Vance LM, 1997, J VIROL, V71, P8759, DOI 10.1128/JVI.71.11.8759-8765.1997; Verdaguer N, 1997, J VIROL, V71, P9813, DOI 10.1128/JVI.71.12.9813-9816.1997; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; Yin J, 2007, J GEN VIROL, V88, P2259, DOI 10.1099/vir.0.82795-0	66	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10735	10.1371/journal.pone.0010735	http://dx.doi.org/10.1371/journal.pone.0010735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505767	gold, Green Submitted, Green Published			2022-12-27	WOS:000278017300019
J	Raboud, J; Shigayeva, A; McGeer, A; Bontovics, E; Chapman, M; Gravel, D; Henry, B; Lapinsky, S; Loeb, M; McDonald, LC; Ofner, M; Paton, S; Reynolds, D; Scales, D; Shen, S; Simor, A; Stewart, T; Vearncombe, M; Zoutman, D; Green, K				Raboud, Janet; Shigayeva, Altynay; McGeer, Allison; Bontovics, Erika; Chapman, Martin; Gravel, Denise; Henry, Bonnie; Lapinsky, Stephen; Loeb, Mark; McDonald, L. Clifford; Ofner, Marianna; Paton, Shirley; Reynolds, Donna; Scales, Damon; Shen, Sandy; Simor, Andrew; Stewart, Thomas; Vearncombe, Mary; Zoutman, Dick; Green, Karen			Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto, Canada	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HEALTH-CARE WORKERS; HOSPITAL WORKERS; OUTBREAK; INFECTION; TUBERCULOSIS; PRECAUTIONS; EXPOSURE; RUBELLA; SPREAD	Background: In the 2003 Toronto SARS outbreak, SARS-CoV was transmitted in hospitals despite adherence to infection control procedures. Considerable controversy resulted regarding which procedures and behaviours were associated with the greatest risk of SARS-CoV transmission. Methods: A retrospective cohort study was conducted to identify risk factors for transmission of SARS-CoV during intubation from laboratory confirmed SARS patients to HCWs involved in their care. All SARS patients requiring intubation during the Toronto outbreak were identified. All HCWs who provided care to intubated SARS patients during treatment or transportation and who entered a patient room or had direct patient contact from 24 hours before to 4 hours after intubation were eligible for this study. Data was collected on patients by chart review and on HCWs by interviewer-administered questionnaire. Generalized estimating equation (GEE) logistic regression models and classification and regression trees (CART) were used to identify risk factors for SARS transmission. Results: 45 laboratory-confirmed intubated SARS patients were identified. Of the 697 HCWs involved in their care, 624 (90%) participated in the study. SARS-CoV was transmitted to 26 HCWs from 7 patients; 21 HCWs were infected by 3 patients. In multivariate GEE logistic regression models, presence in the room during fiberoptic intubation (OR = 2.79, p = .004) or ECG (OR = 3.52, p = .002), unprotected eye contact with secretions (OR = 7.34, p = .001), patient APACHE II score >= 20 (OR = 17.05, p = .009) and patient Pa0(2)/Fi0(2) ratio <= 59 (OR = 8.65, p = .001) were associated with increased risk of transmission of SARS-CoV. In CART analyses, the four covariates which explained the greatest amount of variation in SARS-CoV transmission were covariates representing individual patients. Conclusion: Close contact with the airway of severely ill patients and failure of infection control practices to prevent exposure to respiratory secretions were associated with transmission of SARS-CoV. Rates of transmission of SARS-CoV varied widely among patients.	[Raboud, Janet; Shen, Sandy] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada; [Raboud, Janet; McGeer, Allison; Ofner, Marianna] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Shigayeva, Altynay; McGeer, Allison; Lapinsky, Stephen; Stewart, Thomas; Green, Karen] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [McGeer, Allison; Simor, Andrew; Vearncombe, Mary] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Bontovics, Erika] Ontario Minist Hlth & Long Term Care, Toronto, ON, Canada; [Chapman, Martin] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Chapman, Martin; Scales, Damon; Simor, Andrew; Vearncombe, Mary] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Gravel, Denise; Ofner, Marianna; Paton, Shirley] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Henry, Bonnie] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Lapinsky, Stephen; Scales, Damon; Stewart, Thomas] Univ Toronto, Dept Med, Toronto, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [McDonald, L. Clifford] Ctr Dis Control & Prevent, Atlanta, GA USA; [Reynolds, Donna] Durham Reg Hlth Dept, Whitby, ON, Canada; [Zoutman, Dick] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Public Health Agency of Canada; University of Toronto; McMaster University; Centers for Disease Control & Prevention - USA; Queens University - Canada	Raboud, J (corresponding author), Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.	amcgeer@mtsinai.on.ca	Lapinsky, Stephen/C-4624-2015; McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	Lapinsky, Stephen/0000-0002-6930-0306; McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; McDonald, L. Clifford/0000-0003-3044-5572	Ontario Ministry of Health and Long Term Care	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	This research was funded by a contract from the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino M, 2006, INFECT CONT HOSP EP, V27, P722, DOI 10.1086/504355; Breiman L., 1984, CLASSIFICATION REGRE; BROOKS SM, 1973, AM REV RESPIR DIS, V108, P799; Dimoulas P, 2005, EMERG INFECT DIS, V11, P625, DOI 10.3201/eid1104.040648; HATTIS RP, 1973, JAMA-J AM MED ASSOC, V223, P1019, DOI 10.1001/jama.223.9.1019; Ho AS, 2003, ANN INTERN MED, V139, P564, DOI 10.7326/0003-4819-139-7-200310070-00008; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kwok KO, 2007, P R SOC B, V274, P611, DOI 10.1098/rspb.2006.0026; Lau JTF, 2004, EMERG INFECT DIS, V10, P280, DOI 10.3201/eid1002.030534; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Ma Huai-jian, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P741; MARKS JS, 1981, AM J EPIDEMIOL, V114, P574, DOI 10.1093/oxfordjournals.aje.a113223; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; Ofner-Agostini M, 2006, INFECT CONT HOSP EP, V27, P473, DOI 10.1086/504363; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Pei Li-ying, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P271; *PUBL HLTH AG CAN, NAT CAS DEF SARS OUT; Reynolds MG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-207; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; Sherertz RJ, 1996, ANN INTERN MED, V124, P539, DOI 10.7326/0003-4819-124-6-199603150-00001; Shigayeva A, 2007, INFECT CONT HOSP EP, V28, P1275, DOI 10.1086/521661; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Tang P, 2004, CAN MED ASSOC J, V170, P47; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Varia M, 2003, CAN MED ASSOC J, V169, P285; Wang JP, 2003, CHEM J CHINESE U, V24, P565; Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yin Wen-wu, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P18; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	35	182	190	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10717	10.1371/journal.pone.0010717	http://dx.doi.org/10.1371/journal.pone.0010717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502660	gold, Green Submitted, Green Published			2022-12-27	WOS:000277845400019
J	Zhong, WM; Liu, F; Dong, LB; Lu, XH; Hancock, K; Reinherz, EL; Katz, JM; Sambhara, S				Zhong, Weimin; Liu, Feng; Dong, Libo; Lu, Xiuhua; Hancock, Kathy; Reinherz, Ellis L.; Katz, Jacqueline M.; Sambhara, Suryaprakash			Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; HETEROSUBTYPIC IMMUNITY; V-BETA; H5N1; EPITOPE; VACCINE; MICE; RECOGNITION; LYMPHOCYTES; REPERTOIRE	Background: Memory CD8 T cells to influenza A viruses are widely detectable in healthy human subjects and broadly cross-reactive for serologically distinct influenza A virus subtypes. However, it is not clear to what extent such pre-existing cellular immunity can provide cross-subtype protection against novel emerging influenza A viruses. Methodology/Principal Findings: We show in the mouse model that naturally occurring sequence variations of the conserved nucleoprotein of the virus significantly impact cross-protection against lethal disease in vivo. When priming and challenge viruses shared identical sequences of the immunodominant, protective NP366/D-b epitope, strong cross-subtype protection was observed. However, when they did not share complete sequence identity in this epitope, cross-protection was considerably reduced. Contributions of virus-specific antibodies appeared to be minimal under these circumstances. Detailed analysis revealed that the magnitude of the memory CD8 T cell response triggered by the NP366/D-b variants was significantly lower than those triggered by the homologous NP366/D-b ligand. It appears that strict specificity of a dominant public TCR to the original NP366/D-b ligand may limit the expansion of cross-reactive memory CD8 T cells to the NP366/D-b variants. Conclusions/Significance: Pre-existing CD8 T cell immunity may provide substantial cross-protection against hetero-subtypic influenza A viruses, provided that the priming and the subsequent challenge viruses share the identical sequences of the immunodominant, protective CTL epitopes.	[Zhong, Weimin; Liu, Feng; Dong, Libo; Lu, Xiuhua; Hancock, Kathy; Katz, Jacqueline M.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zhong, WM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	wzhong@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021		National Institutes of Health [U19 AI50900]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by a pilot project grant to WZ from National Institutes of Health (U19 AI50900. Project Director: ELR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Boon ACM, 2002, J VIROL, V76, P2567, DOI 10.1128/JVI.76.5.2567-2572.2002; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; Hiromoto Y, 2000, J GEN VIROL, V81, P1293, DOI 10.1099/0022-1317-81-5-1293; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Jameson J, 1999, J IMMUNOL, V162, P7578; Katz JM, 1997, J INFECT DIS, V175, P352, DOI 10.1093/infdis/175.2.352; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kendal AP, 1982, CONCEPTS PROCEDURES; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LIANG SH, 1994, J IMMUNOL, V152, P1653; LU LY, 1980, NATURE, V288, P164, DOI 10.1038/288164a0; McMichael A, 1994, Curr Top Microbiol Immunol, V189, P75; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0; Zhong WM, 2007, J MOL BIOL, V372, P535, DOI 10.1016/j.jmb.2007.06.057; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200; Zhong WM, 2004, INT IMMUNOL, V16, P1549, DOI 10.1093/intimm/dxh156	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10583	10.1371/journal.pone.0010583	http://dx.doi.org/10.1371/journal.pone.0010583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485501	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200016
J	Rosenberg, ES; Graham, BS; Chan, ES; Bosch, RJ; Stocker, V; Maenza, J; Markowitz, M; Little, S; Sax, PE; Collier, AC; Nabel, G; Saindon, S; Flynn, T; Kuritzkes, D; Barouch, DH				Rosenberg, Eric S.; Graham, Barney S.; Chan, Ellen S.; Bosch, Ronald J.; Stocker, Vicki; Maenza, Janine; Markowitz, Martin; Little, Susan; Sax, Paul E.; Collier, Ann C.; Nabel, Gary; Saindon, Suzanne; Flynn, Theresa; Kuritzkes, Daniel; Barouch, Dan H.		ACTG A5187 Team	Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection	PLOS ONE			English	Article							INTERRUPTION	Background: An effective therapeutic vaccine that could augment immune control of HIV-1 replication may abrogate or delay the need for antiretroviral therapy. AIDS Clinical Trials Group (ACTG) A5187 was a phase I/II, randomized, placebocontrolled, double-blinded trial to evaluate the safety and immunogenicity of an HIV-1 DNA vaccine (VRC-HVDNA 009-00-VP) in subjects treated with antiretroviral therapy during acute/early HIV-1 infection. (clinicaltrials.gov NCT00125099) Methods: Twenty healthy HIV-1 infected subjects who were treated with antiretroviral therapy during acute/early HIV-1 infection and had HIV-1 RNA, 50 copies/mL were randomized to receive either vaccine or placebo. The objectives of this study were to evaluate the safety and immunogenicity of the vaccine. Following vaccination, subjects interrupted antiretroviral treatment, and set-point HIV-1 viral loads and CD4 T cell counts were determined 17-23 weeks after treatment discontinuation. Results: Twenty subjects received all scheduled vaccinations and discontinued antiretroviral therapy at week 30. No subject met a primary safety endpoint. No evidence of differences in immunogenicity were detected in subjects receiving vaccine versus placebo. There were also no significant differences in set-point HIV-1 viral loads or CD4 T cell counts following treatment discontinuation. Median set-point HIV-1 viral loads after treatment discontinuation in vaccine and placebo recipients were 3.5 and 3.7 log10 HIV-1 RNA copies/mL, respectively. Conclusions: The HIV-1 DNA vaccine (VRC-HIVDNA 009-00-VP) was safe but poorly immunogenic in subjects treated with antiretroviral therapy during acute/early HIV-1 infection. Viral set-points were similar between vaccine and placebo recipients following treatment interruption. However, median viral load set-points in both groups were lower than in historical controls, suggesting a possible role for antiretroviral therapy in persons with acute or early HIV-1 infection and supporting the safety of discontinuing treatment in this group.	[Rosenberg, Eric S.; Saindon, Suzanne; Flynn, Theresa] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Graham, Barney S.; Nabel, Gary] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Chan, Ellen S.; Bosch, Ronald J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Stocker, Vicki] Social & Sci Syst, Silver Spring, MD USA; [Maenza, Janine; Collier, Ann C.] Univ Washington, Seattle, WA 98195 USA; [Markowitz, Martin] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Little, Susan] Univ Calif San Diego, San Diego, CA 92103 USA; [Sax, Paul E.; Kuritzkes, Daniel] Brigham & Womens Hosp, Boston, MA 02115 USA; [Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; Social & Scientific Systems; University of Washington; University of Washington Seattle; Rockefeller University; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rosenberg, ES (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	erosenberg1@mgh.harvard.edu	Little, Susan/AAA-6116-2019; Barouch, Dan/Y-3918-2019; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	NIH [ACTG, AI068636, AI068634, AI038858, AI038855, AI058727, AI066305, AI066924, AI078526, AI 40873]; Doris Duke Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI106039, U19AI078526, U01AI038855, U01AI038858, R01AI040873, U19AI066305, UM1AI068634, ZIAAI005048, U01AI068636, R21AI040873, R01AI058727, U01AI068634, R01AI066924, UM1AI068636] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH AIDS Clinical Trials Group (ACTG, AI068636, AI068634, AI038858, AI038855), Doris Duke Clinical Scientist Development Award (D. H. B.), and NIH grants AI058727, AI066305, AI066924, AI078526 (D. H. B.) and AI 40873 (E. S. R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Kassutto S, 2006, CLIN INFECT DIS, V42, P1024, DOI 10.1086/500410; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Kutzler MA, 2008, CURR OPIN HIV AIDS, V3, P131, DOI 10.1097/COH.0b013e3282f54cde; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Volberding P, 2009, AIDS, V23, P1987, DOI 10.1097/QAD.0b013e32832eb285	10	50	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10555	10.1371/journal.pone.0010555	http://dx.doi.org/10.1371/journal.pone.0010555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479938	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900011
J	Stapleton, JA; Swartz, JR				Stapleton, James A.; Swartz, James R.			A Cell-Free Microtiter Plate Screen for Improved [FeFe] Hydrogenases	PLOS ONE			English	Article							SINGLE-MOLECULE-PCR; IN-VITRO EXPRESSION; FREE PROTEIN-SYNTHESIS; HIGH-THROUGHPUT CONSTRUCTION; POLYMERASE-CHAIN-REACTION; CHLAMYDOMONAS-REINHARDTII; DIRECTED EVOLUTION; DIGITAL PCR; DNA; LIBRARIES	Background: [FeFe] hydrogenase enzymes catalyze the production and dissociation of H(2), a potential renewable fuel. Attempts to exploit these catalysts in engineered systems have been hindered by the biotechnologically inconvenient properties of the natural enzymes, including their extreme oxygen sensitivity. Directed evolution has been used to improve the characteristics of a range of natural catalysts, but has been largely unsuccessful for [FeFe] hydrogenases because of a lack of convenient screening platforms. Methodology/Principal Findings: Here we describe an in vitro screening technology for oxygen-tolerant and highly active [FeFe] hydrogenases. Despite the complexity of the protocol, we demonstrate a level of reproducibility that allows moderately improved mutants to be isolated. We have used the platform to identify a mutant of the Chlamydomonas reinhardtii [FeFe] hydrogenase HydA1 with a specific activity similar to 4 times that of the wild-type enzyme. Conclusions/Significance: Our results demonstrate the feasibility of using the screen presented here for large-scale efforts to identify improved biocatalysts for energy applications. The system is based on our ability to activate these complex enzymes in E. coli cell extracts, which allows unhindered access to the protein maturation and assay environment.	[Stapleton, James A.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Stapleton, JA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180	Global Climate and Energy Project (GCEP) at Stanford University; National Defense Science and Engineering (NDSEG)	Global Climate and Energy Project (GCEP) at Stanford University; National Defense Science and Engineering (NDSEG)	This work was funded by the Global Climate and Energy Project (GCEP) at Stanford University (http://gcep.stanford.edu/) as well as a National Defense Science and Engineering (NDSEG) Fellowship (http://ndseg.asee.org/) to JAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Arnold FH, 1998, ACCOUNTS CHEM RES, V31, P125, DOI 10.1021/ar960017f; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Cohen J, 2005, BIOCHEM SOC T, V33, P80, DOI 10.1042/BST0330080; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; ERBES DL, 1979, PLANT PHYSIOL, V63, P1138, DOI 10.1104/pp.63.6.1138; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Flynn T, 2002, INT J HYDROGEN ENERG, V27, P1421, DOI 10.1016/S0360-3199(02)00117-9; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutchison CA, 2006, NAT BIOTECHNOL, V24, P657, DOI 10.1038/nbt0606-657; Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Koga Yuichi, 2007, V375, P165; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Levin DB, 2004, INT J HYDROGEN ENERG, V29, P173, DOI 10.1016/S0360-3199(03)00094-6; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Maeda T, 2008, APPL MICROBIOL BIOT, V79, P77, DOI 10.1007/s00253-008-1416-3; MCCAUGHAN F, 2009, J PATHOL, DOI DOI 10.1002/PATH.2647; MCTAVISH H, 1995, J BACTERIOL, V177, P3960, DOI 10.1128/jb.177.14.3960-3964.1995; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Nagy LE, 2007, BIOTECHNOL LETT, V29, P421, DOI 10.1007/s10529-006-9254-9; Nakano H, 2000, J BIOSCI BIOENG, V90, P456, DOI 10.1016/S1389-1723(01)80019-0; Ohuchi S, 1998, NUCLEIC ACIDS RES, V26, P4339, DOI 10.1093/nar/26.19.4339; PECK HD, 1956, J BACTERIOL, V71, P70, DOI 10.1128/JB.71.1.70-80.1956; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Rungpragayphan S, 2004, J MOL CATAL B-ENZYM, V28, P223, DOI 10.1016/j.molcatb.2004.01.019; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Rungpragayphan Suang, 2007, V375, P79; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Tye JW, 2005, P NATL ACAD SCI USA, V102, P16911, DOI 10.1073/pnas.0508740102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Woodrow KA, 2006, J PROTEOME RES, V5, P3288, DOI 10.1021/pr050459y; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10554	10.1371/journal.pone.0010554	http://dx.doi.org/10.1371/journal.pone.0010554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479937	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900010
J	Hettiarachchi, G; Nguyen, D; Wu, J; Lucas, D; Ma, D; Isaacs, L; Briken, V				Hettiarachchi, Gaya; Nguyen, Duc; Wu, Jing; Lucas, Derick; Ma, Da; Isaacs, Lyle; Briken, Volker			Toxicology and Drug Delivery by Cucurbit[n]uril Type Molecular Containers	PLOS ONE			English	Article							NANOPARTICLES; CUCURBITURIL; TUBERCULOSIS; ENCAPSULATION; CYTOTOXICITY; RESISTANCE; DENDRIMERS; COMPLEXES; TOXICITY	Background: Many drug delivery systems are based on the ability of certain macrocyclic compounds - such as cyclodextrins (CDs) - to act as molecular containers for pharmaceutical agents in water. Indeed beta-CD and its derivatives have been widely used in the formulation of hydrophobic pharmaceuticals despite their poor abilities to act as a molecular container (e. g., weak binding (K-a < 10(4) M-1) and their challenges toward chemical functionalization. Cucurbit[n]urils (CB[n]) are a class of molecular containers that bind to a variety of cationic and neutral species with high affinity (K-a < 10(4) M-1) and therefore show great promise as a drug delivery system. Methodology: In this study we investigated the toxicology, uptake, and bioactivity of two cucurbit[n]urils (CB[5] and CB[7]) and three CB[n]-type containers (Pentamer 1, methyl hexamer 2, and phenyl hexamer 3). All five containers demonstrated high cell tolerance at concentrations of up to 1 mM in cell lines originating from kidney, liver or blood tissue using assays for metabolic activity and cytotoxicity. Furthermore, the CB[7] molecular container was efficiently internalized by macrophages indicating their potential for the intracellular delivery of drugs. Bioactivity assays showed that the first-line tuberculosis drug, ethambutol, was as efficient in treating mycobacteria infected macrophages when loaded into CB[7] as when given in the unbound form. This result suggests that CB[7]-bound drug molecules can be released from the container to find their intracellular target. Conclusion: Our study reveals very low toxicity of five members of the cucurbit[n]uril family of nanocontainers. It demonstrates the uptake of containers by cells and intracellular release of container-loaded drugs. These results provide initial proof-of-concept towards the use of CB[n] molecular containers as an advanced drug delivery system.	[Hettiarachchi, Gaya; Nguyen, Duc; Briken, Volker] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Wu, Jing; Lucas, Derick; Ma, Da; Isaacs, Lyle] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Hettiarachchi, G (corresponding author), Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.	LIsaacs@umd.edu; vbriken@umd.edu	Isaacs, Lyle D/B-4472-2009	Isaacs, Lyle D/0000-0002-4079-332X; Briken, Volker/0000-0001-5830-6107	Maryland Department of Business and Economic Development (Nano-Bio Initiative); Maryland Technology Development Corporation	Maryland Department of Business and Economic Development (Nano-Bio Initiative); Maryland Technology Development Corporation	The authors thank the Maryland Department of Business and Economic Development (Nano-Bio Initiative) and the Maryland Technology Development Corporation for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; BARANELLO L, 2009, NUCL ACIDS RES; Biagini CP, 2006, TOXICOL IN VITRO, V20, P1051, DOI 10.1016/j.tiv.2006.01.013; Cavagnaro JA, 2002, NAT REV DRUG DISCOV, V1, P469, DOI 10.1038/nrd822; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chaoui I, 2009, J INFECT DEV COUNTR, V3, P278; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065; Delogu G, 2009, J INFECT DEV COUNTR, V3, P5, DOI 10.3855/jidc.99; Dexheimer TS, 2009, J MED CHEM, V52, P7122, DOI 10.1021/jm901061s; Ge Z, 2008, ACTA PHARMACOL SIN, V29, P990, DOI 10.1111/j.1745-7254.2008.00825.x; Gelperina S, 2005, AM J RESP CRIT CARE, V172, P1487, DOI 10.1164/rccm.200504-613PP; He H, 2008, OPT LETT, V33, P2961, DOI 10.1364/OL.33.002961; HERRLING P, 2005, IMAGING DRUG DISCOVE; Huang WH, 2008, J AM CHEM SOC, V130, P8446, DOI 10.1021/ja8013693; Jeon YJ, 2005, ORG BIOMOL CHEM, V3, P2122, DOI 10.1039/b504487a; Jeon YM, 1996, J AM CHEM SOC, V118, P9790, DOI 10.1021/ja962071x; Jia J, 2005, BRIT J PHARMACOL, V144, P80, DOI 10.1038/sj.bjp.0705984; Kemp S, 2007, SUPRAMOL CHEM, V19, P475, DOI 10.1080/10610270601124019; Kim J, 2007, ANGEW CHEM INT EDIT, V46, P7393, DOI 10.1002/anie.200702540; Kim K, 2007, CHEM SOC REV, V36, P267, DOI 10.1039/b603088m; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Kuo JHS, 2005, J PHARM PHARMACOL, V57, P489, DOI 10.1211/0022357055803; Kuo JHS, 2005, COLLOID SURFACE B, V41, P189, DOI 10.1016/j.colsurfb.2004.12.008; Lagona J, 2005, ANGEW CHEM INT EDIT, V44, P4844, DOI 10.1002/anie.200460675; Liu SM, 2005, J AM CHEM SOC, V127, P15959, DOI 10.1021/ja055013x; MA D, 2010, J ORG CHEM UNPUB; MOCK WL, 1986, J ORG CHEM, V51, P4440, DOI 10.1021/jo00373a018; Montes-Navajas P, 2009, PHOTOCH PHOTOBIO SCI, V8, P1743, DOI 10.1039/b9pp00041k; Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477; Park KM, 2009, CHEM COMMUN, P71, DOI 10.1039/b815009e; Peck RW, 2007, DRUG DISCOV TODAY, V12, P289, DOI 10.1016/j.drudis.2007.02.004; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd1131; Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889; Sakagami H, 2009, ANTICANCER RES, V29, P343; Samad A, 2009, CURR PHARM DESIGN, V15, P2958, DOI 10.2174/138161209789058200; SCHOLFIELD C, 2009, LONZA RESOURCE NOTES, P6; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; SPATARO G, 2009, EUR J MED CHEM; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; VANDEWATERBEEMD HL, 2003, METHODS PRINCIPLES M; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Verma RK, 2002, J CONTROL RELEASE, V79, P7, DOI 10.1016/S0168-3659(01)00550-8; Wang RB, 2009, DALTON T, P3584, DOI 10.1039/b904028e; Wheate NJ, 2008, J INORG BIOCHEM, V102, P2060, DOI 10.1016/j.jinorgbio.2008.06.005; Wheate NJ, 2004, CHEM COMMUN, P1424, DOI 10.1039/b404358h; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhao LB, 2009, J PHYS CHEM B, V113, P14172, DOI 10.1021/jp907437e; Zhao YJ, 2009, DALTON T, P5190, DOI 10.1039/b905112k; Zhao YJ, 2008, ORG BIOMOL CHEM, V6, P4509, DOI 10.1039/b813759e	53	201	203	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10514	10.1371/journal.pone.0010514	http://dx.doi.org/10.1371/journal.pone.0010514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463906	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379800009
J	Malka, R; Shochat, E; Rom-Kedar, V				Malka, Roy; Shochat, Eliezer; Rom-Kedar, Vered			Bistability and Bacterial Infections	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; CHRONIC GRANULOMATOUS-DISEASE; REDUCED MATHEMATICAL-MODEL; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; NEUTROPHILS; DYNAMICS; QUANTITATION; NEUTROPENIA; HYSTERESIS	Bacterial infections occur when the natural host defenses are overwhelmed by invading bacteria. The main component of the host defense is impaired when neutrophil count or function is too low, putting the host at great risk of developing an acute infection. In people with intact immune systems, neutrophil count increases during bacterial infection. However, there are two important clinical cases in which they remain constant: a) in patients with neutropenic-associated conditions, such as those undergoing chemotherapy at the nadir (the minimum clinically observable neutrophil level); b) in ex vivo examination of the patient's neutrophil bactericidal activity. Here we study bacterial population dynamics under fixed neutrophil levels by mathematical modelling. We show that under reasonable biological assumptions, there are only two possible scenarios: 1) Bacterial behavior is monostable: it always converges to a stable equilibrium of bacterial concentration which only depends, in a gradual manner, on the neutrophil level (and not on the initial bacterial level). We call such a behavior type I dynamics. 2) The bacterial dynamics is bistable for some range of neutrophil levels. We call such a behavior type II dynamics. In the bistable case (type II), one equilibrium corresponds to a healthy state whereas the other corresponds to a fulminant bacterial infection. We demonstrate that published data of in vitro Staphylococcus epidermidis bactericidal experiments are inconsistent with both the type I dynamics and the commonly used linear model and are consistent with type II dynamics. We argue that type II dynamics is a plausible mechanism for the development of a fulminant infection.	[Malka, Roy; Rom-Kedar, Vered] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Estrin Family Chair Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shochat, Eliezer] Hoffmann La Roche AG, Pharma Res & Early Dev, Basel, Switzerland	Weizmann Institute of Science; Roche Holding	Malka, R (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Estrin Family Chair Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	vered.rom-kedar@weizmann.ac.il		Rom-Kedar, Vered/0000-0003-3855-6779; Malka, Roy/0000-0002-5091-8771	Israel Science Foundation [273/07]; Minerva Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation	This work was partially supported by the Israel Science Foundation (273/07), and the Minerva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Asachenkov A., 1993, DIS DYNAMICS; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BONGRAND P, 1976, J THEOR BIOL, V58, P197, DOI 10.1016/0022-5193(76)90147-8; CAPO C, 1974, J THEOR BIOL, V47, P177, DOI 10.1016/0022-5193(74)90108-8; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CLAWSON CC, 1976, J LAB CLIN MED, V88, P316; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Detilleux J, 2006, J DAIRY SCI, V89, P3455, DOI 10.3168/jds.S0022-0302(06)72383-9; Detilleux JC, 2004, J DAIRY SCI, V87, P3716, DOI 10.3168/jds.S0022-0302(04)73510-9; FEIGIN RD, 1987, TXB PEDIAT INFECT DI; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; GREEN JN, METHODS MOL BIOL, V412, P319; HAMERS MN, 1984, BLOOD, V64, P635, DOI 10.1182/blood.V64.3.635.635; HAMMER MC, 1981, J LAB CLIN MED, V98, P938; HERALD MC, 2009, B MATH BIOL; Huisman G, 1997, J THEOR BIOL, V185, P389, DOI 10.1006/jtbi.1996.0318; Imran M, 2007, DISCRETE CONT DYN-B, V8, P127; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; LEIJH PCJ, 1979, IMMUNOLOGY, V37, P453; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Marchuk G.I., 1983, MATH MODELS IMMUNOLO; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nasell I, 2001, J THEOR BIOL, V211, P11, DOI 10.1006/jtbi.2001.2328; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Popper K.R., 1959, LOGIC SCI DISCOVERY; Pugliese A, 2008, MATH BIOSCI, V214, P73, DOI 10.1016/j.mbs.2008.04.004; Rahman Z, 1997, CANCER, V79, P1150, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1150::AID-CNCR13>3.0.CO;2-Z; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Roos D, 2001, BLOOD CELL MOL DIS, V27, P1000, DOI 10.1006/bcmd.2001.0473; Shochat E, 2008, CLIN CANCER RES, V14, P6354, DOI 10.1158/1078-0432.CCR-08-0807; Skalski GT, 2001, ECOLOGY, V82, P3083; SPIERS ASD, 1980, J HYG-CAMBRIDGE, V84, P457, DOI 10.1017/S0022172400026991; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Wolach B, 2008, CLIN IMMUNOL, V129, P103, DOI 10.1016/j.clim.2008.06.012; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	43	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10010	10.1371/journal.pone.0010010	http://dx.doi.org/10.1371/journal.pone.0010010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463954	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400001
J	Petroczi, A; Aidman, EV; Hussain, I; Deshmukh, N; Nepusz, T; Uvacsek, M; Toth, M; Barker, J; Naughton, DP				Petroczi, Andrea; Aidman, Eugene V.; Hussain, Iltaf; Deshmukh, Nawed; Nepusz, Tamas; Uvacsek, Martina; Toth, Miklos; Barker, James; Naughton, Declan P.			Virtue or Pretense? Looking behind Self-Declared Innocence in Doping	PLOS ONE			English	Article							MEASURING INDIVIDUAL-DIFFERENCES; IMPLICIT SOCIAL COGNITION; DRUG-USE; ANABOLIC-STEROIDS; ASSOCIATION TEST; FALSE CONSENSUS; HAIR ANALYSIS; ATTITUDES; BIAS; ADOLESCENTS	Background: Social science studies of doping practices in sport rely predominantly on self-reports. Studies of psychoactive drug use indicate that self-reporting is characterised by under-reporting. Likewise doping practice is likely to be equally under-reported, if not more so. This calls for more sophisticated methods for such reporting and for independent, objective validation of its results. The aims of this study were: i) to contrast self-reported doping use with objective results from chemical hair analysis and ii) to investigate the influence of the discrepancy on doping attitudes, social projection, descriptive norms and perceived pressure to use doping. Methodology/Principal Findings: A doping attitudes questionnaire was developed and combined with a response latency-based implicit association test and hair sample analysis for key doping substances in 14 athletes selected from a larger sample (N = 82) to form contrast comparison groups. Results indicate that patterns of group differences in social projection, explicit attitude about and perceived pressure to use doping, vary depending on whether the user and non-user groups are defined by self-report or objectively verified through hair analysis. Thus, self-confessed users scored higher on social projection, explicit attitude to doping and perceived pressure. However, when a doping substance was detected in the hair of an athlete who denied doping use, their self-report evidenced extreme social desirability (negative attitude, low projection and low perceived pressure) and contrasted sharply with a more positive estimate of their implicit doping attitude. Conclusions/Significance: Hair analysis for performance enhancing substances has shown considerable potential in validating athletes' doping attitude estimations and admissions of use. Results not only confirm the need for improved self-report methodology for future research in socially-sensitive domains but also indicate where the improvements are likely to come from: as chemical validation remains expensive, a more realistic promise for large scale studies and online data collection efforts is held by measures of implicit social cognition.	[Petroczi, Andrea; Aidman, Eugene V.; Nepusz, Tamas; Naughton, Declan P.] Kingston Univ London, Sch Life Sci, Kingston upon Thames, Surrey, England; [Petroczi, Andrea] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Aidman, Eugene V.] Def Sci & Technol Org, Land Operat Div, Edinburgh, Midlothian, Scotland; [Hussain, Iltaf; Deshmukh, Nawed; Barker, James] Kingston Univ London, Sch Pharm & Chem, Kingston upon Thames, Surrey, England; [Uvacsek, Martina; Toth, Miklos] Semmelweis Univ, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary	Kingston University; University of Sheffield; Defence Science & Technology; Kingston University; Semmelweis University; University of Physical Education	Petroczi, A (corresponding author), Kingston Univ London, Sch Life Sci, Kingston upon Thames, Surrey, England.	A.Petroczi@kingston.ac.uk	Barker, James/A-5103-2018; Petroczi, Andrea/ABG-9863-2021	Barker, James/0000-0002-5863-9400; Petroczi, Andrea/0000-0002-8365-6173; AIDMAN, Eugene/0000-0002-7711-794X; SHAH, ILTAF/0000-0002-3739-6083	World Anti-Doping Agency	World Anti-Doping Agency	World Anti-Doping Agency Social Science Research Grant 2007/Petroczi entitled 'Measurement Tool for estimating the prevalence of doping: development and validation of a self-report measure of performance enhancing drug use' (http://www.wada-ama.org/en/Education-Awareness/Social-Science/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDMAN E, 2006, PERSPECT PSYCHOL SCI, P91; Aidman EV, 2002, BEHAV RES METH INS C, V34, P83, DOI 10.3758/BF03195426; Aidman EV, 1999, PERS INDIV DIFFER, V27, P211, DOI 10.1016/S0191-8869(98)00234-7; BACKHOUSE S, 2007, ATTITUDES BEHAV KNOW; Breivik G, 2009, SPORT SOC, V12, P737, DOI 10.1080/17430430902944183; Crano W. D., 1995, ATTITUDE STRENGTH AN, V4, P131; Cunningham WA, 2007, TRENDS COGN SCI, V11, P97, DOI 10.1016/j.tics.2006.12.005; Donovan RJ, 2002, SPORTS MED, V32, P269, DOI 10.2165/00007256-200232040-00005; Dumestre-Toulet V, 2002, J FORENSIC SCI, V47, P211; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Gawronski B, 2005, J PERS SOC PSYCHOL, V89, P672, DOI 10.1037/0022-3514.89.5.672; Glintborg B, 2008, CLIN TOXICOL, V46, P239, DOI 10.1080/15563650701586397; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hanstad DV, 2009, EUR J SPORT SCI, V9, P3, DOI 10.1080/17461390802594219; Harris KM, 2008, J SUBST ABUSE TREAT, V34, P347, DOI 10.1016/j.jsat.2007.05.004; Johnson T, 2005, ANN EPIDEMIOL, V15, P381, DOI 10.1016/j.annepidem.2004.09.004; Kicman AT, 2008, BRIT J PHARMACOL, V154, P502, DOI 10.1038/bjp.2008.165; Kintz P, 1999, FORENSIC SCI INT, V101, P209, DOI 10.1016/S0379-0738(99)00024-9; Ledgerwood DM, 2008, ADDICT BEHAV, V33, P1131, DOI 10.1016/j.addbeh.2008.04.009; Lippi G, 2008, BRIT MED BULL, V86, P95, DOI 10.1093/bmb/ldn014; Lucidi F, 2004, INT J SPORT PSYCHOL, V35, P133; Lucidi F, 2008, J SPORT SCI, V26, P447, DOI 10.1080/02640410701579370; Monin B, 2003, PERS SOC PSYCHOL B, V29, P559, DOI 10.1177/0146167203029005001; Musshoff F, 2006, FORENSIC SCI INT, V156, P118, DOI 10.1016/j.forsciint.2004.07.024; Paulhus DL, 2002, ROLE OF CONSTRUCTS IN PYSCHOLOGICAL AND EDUCATIONAL MEASUREMENT, P49; Petroczi Andrea, 2008, J Occup Med Toxicol, V3, P19, DOI 10.1186/1745-6673-3-19; Petroczi A, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-9; Petroczi A, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-34; Petroczi A, 2009, PSYCHOL SPORT EXERC, V10, P390, DOI 10.1016/j.psychsport.2008.11.001; Pitsch W, 2007, EUR J SPORT SOC, V4, P89, DOI 10.1080/16138171.2007.11687797; Rasinski KA, 2005, J EXP SOC PSYCHOL, V41, P321, DOI 10.1016/j.jesp.2004.07.001; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Sas-Nowosielski K, 2008, INT J SPORTS MED, V29, P607, DOI 10.1055/s-2007-965817; Schirlin O, 2009, PSYCHOL SPORT EXERC, V10, P615, DOI 10.1016/j.psychsport.2009.03.010; Sechrest L, 1996, AM PSYCHOL, V51, P1065, DOI 10.1037/0003-066X.51.10.1065; Shakeri J, 2009, IRAN J PSYCHIATRY BE, V3, P38; Shen M, 2009, STEROIDS, V74, P773, DOI 10.1016/j.steroids.2009.04.008; SRIRAM N, 2009, EXPER PSYCH IN PRESS; Strelan P, 2003, J APPL SPORT PSYCHOL, V15, P176, DOI [10.1080/10413200305396, 10.1080/10413200390213795]; Strelan P, 2006, J APPL SOC PSYCHOL, V36, P2909, DOI 10.1111/j.0021-9029.2006.00135.x; Striegel H, 2010, DRUG ALCOHOL DEPEN, V106, P230, DOI 10.1016/j.drugalcdep.2009.07.026; Tang J, 1999, GENES IMMUN, V1, P20, DOI 10.1038/sj.gene.6363640; TANGEN JO, 1997, CORPUS PSYCHE SOC, V4, P41; Trout GJ, 2004, CHEM SOC REV, V33, P1, DOI 10.1039/b201476a; Uvacsek M, 2011, SCAND J MED SCI SPOR, V21, P224, DOI 10.1111/j.1600-0838.2009.01041.x; *WADA, WADA 2009 PROH LIST; *WADA LAB, WADA LAB RES; Wiefferink CH, 2008, HEALTH EDUC RES, V23, P70, DOI 10.1093/her/cym004; Williams RJ, 2005, SUBST USE MISUSE, V40, P299, DOI 10.1081/JA-200049327; Wittenbrink Bernd., 2007, IMPLICIT MEASURES AT	54	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10457	10.1371/journal.pone.0010457	http://dx.doi.org/10.1371/journal.pone.0010457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592LC	20463978	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000277379400011
J	Herrera, M; Roberts, DC; Gulbahce, N				Herrera, Mark; Roberts, David C.; Gulbahce, Natali			Mapping the Evolution of Scientific Fields	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PREDICTION; NETWORKS; MAPS	Despite the apparent cross-disciplinary interactions among scientific fields, a formal description of their evolution is lacking. Here we describe a novel approach to study the dynamics and evolution of scientific fields using a network-based analysis. We build an idea network consisting of American Physical Society Physics and Astronomy Classification Scheme (PACS) numbers as nodes representing scientific concepts. Two PACS numbers are linked if there exist publications that reference them simultaneously. We locate scientific fields using a community finding algorithm, and describe the time evolution of these fields over the course of 1985-2006. The communities we identify map to known scientific fields, and their age depends on their size and activity. We expect our approach to quantifying the evolution of ideas to be relevant for making predictions about the future of science and thus help to guide its development.	[Herrera, Mark] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Herrera, Mark] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA; [Roberts, David C.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Roberts, David C.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Gulbahce, Natali] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Gulbahce, Natali] Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA; [Gulbahce, Natali] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute	Herrera, M (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	dcr@lanl.gov; natali.gulbahce@gmail.com	Herrera, Mark/I-2446-2012		Center for Nonlinear Studies at Los Alamos National Laboratory; Los Alamos Physics Summer School; Feynman Fellowship; National Institutes of Health [P50HG004233]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER	Center for Nonlinear Studies at Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Los Alamos Physics Summer School(United States Department of Energy (DOE)Los Alamos National Laboratory); Feynman Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All authors were partially funded by the Center for Nonlinear Studies at Los Alamos National Laboratory. MH was also funded by the Los Alamos Physics Summer School, DCR was funded by the Feynman Fellowship, and NG was funded in part by National Institutes of Health grant P50HG004233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bettencourt LMA, 2008, SCIENTOMETRICS, V75, P495, DOI 10.1007/s11192-007-1888-4; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Frauenfelder H, 1999, REV MOD PHYS, V71, pS419, DOI 10.1103/RevModPhys.71.S419; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOFFMAN W, 1971, NATURE, V229, P103, DOI 10.1038/229103a0; Gulbahce N, 2008, BIOESSAYS, V30, P934, DOI 10.1002/bies.20820; Herr BW, 2008, IEEE INT CONF INF VI, P421, DOI 10.1109/IV.2008.97; HERRERA M, GULBAHCE N; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Lehmann S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026113; Leydesdorff L, 2007, J AM SOC INF SCI TEC, V58, P1303, DOI 10.1002/asi.20614; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PRICE DJD, 1965, SCIENCE, V149, P510; Tabah AN, 1999, ANNU REV INFORM SCI, V34, P249; WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	26	58	58	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10355	10.1371/journal.pone.0010355	http://dx.doi.org/10.1371/journal.pone.0010355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20463949	Green Published, gold, Green Submitted			2022-12-27	WOS:000277305300002
J	Cardoso, SC; Alves, VGL; da Rosa, LAR; Campos, LT; Batista, DVS; Facure, A				Cardoso, Simone C.; Alves, Victor Gabriel L.; da Rosa, Luiz Antonio R.; Campos, Luciana T.; Batista, Delano V. S.; Facure, Alessandro			Monte Carlo Simulation of Bony Heterogeneity Effects on Dose Profile for Small Irradiation Field in Radiotherapy	PLOS ONE			English	Article							CALCULATION ALGORITHMS; EQUIVALENT HETEROGENEITIES; STEREOTACTIC RADIOSURGERY; SMALL BEAMS; PHOTON; DISTRIBUTIONS; DOSIMETRY; PHANTOMS; ENERGY	In the radiotherapy treatment planning of a lesion located in the head region with small field radiation beams, the heterogeneity corrections play an important role. In this work, we investigated the influence of a bony heterogeneity on dose profile inside a soft tissue phantom containing a bony material. PDD curves were obtained by simulation using the Monte Carlo code EGSnrc and employing Eclipse (R) treatment planning system algorithms (Batho, Modified Batho, Equivalent TAR and Anisotropic Analytic Algorithm) for a 15 MV photon beam and field sizes of 2x2 and 10x10 cm(2). The Equivalent TAR method exhibited better agreement with Monte Carlo simulations for the 2x2 cm(2) field size. The magnitude of the effect on PDD due to the bony heterogeneity for 1x1, 2x2 and 10x10 cm(2) field sizes increases to 10, 5 and 3%, respectively.	[Cardoso, Simone C.; Alves, Victor Gabriel L.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [da Rosa, Luiz Antonio R.; Campos, Luciana T.] CNEN, IRD, Rio De Janeiro, Brazil; [Batista, Delano V. S.] Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Facure, Alessandro] Comissao Nacl Energia Nucl, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; National Cancer Institute (Inca); Comissao Nacional de Energia Nuclear (CNEN)	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.	simone@if.ufrj.br	Metrologia das radiacoes, Inct/H-9981-2013; Cardoso, Simone/V-2514-2019; Cardoso, Simone/AAH-4274-2021; Alves, Victor Gabriel Leandro/AAO-5748-2021; Tourinho Campos, Luciana/O-1173-2017	Alves, Victor Gabriel Leandro/0000-0001-7982-2039; Tourinho Campos, Luciana/0000-0003-4751-129X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding was received from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAPM, 2004, 85 AAPM RAD THER COM; [Anonymous], 1976, 24 ICRU; Attix F.H., 2008, INTRO RADIOLOGICAL P; BATHO H F, 1964, J Can Assoc Radiol, V15, P79; BJARNGARD BE, 1990, MED PHYS, V17, P794, DOI 10.1118/1.596475; Carrasco P, 2004, MED PHYS, V31, P2899, DOI 10.1118/1.1788932; Carrasco P, 2007, MED PHYS, V34, P3323, DOI 10.1118/1.2750972; Cheung JYC, 2001, APPL RADIAT ISOTOPES, V54, P461, DOI 10.1016/S0969-8043(00)00283-9; Fogliata A, 2007, PHYS MED BIOL, V52, P1363, DOI 10.1088/0031-9155/52/5/011; ICRU, 1984, 37 ICRU; Kawrakow I., 2000, PIRS701; Martens C, 2000, PHYS MED BIOL, V45, P2519, DOI 10.1088/0031-9155/45/9/306; MIJNHEER BJ, 1987, RADIOTHER ONCOL, V8, P237, DOI 10.1016/S0167-8140(87)80247-5; MOHAN R, 1985, MED PHYS, V12, P592, DOI 10.1118/1.595680; RICE RK, 1987, PHYS MED BIOL, V32, P1087, DOI 10.1088/0031-9155/32/9/002; Rogers D.W.O., 2021, NRC USER CODES EGSNR; Rustgi SN, 1995, MED PHYS, V22, P2117, DOI 10.1118/1.597655; Rustgi SN, 1998, PHYS MED BIOL, V43, P3509, DOI 10.1088/0031-9155/43/12/009; SONTAG M R, 1977, Medical Physics (Woodbury), V4, P431, DOI 10.1118/1.594329; SONTAG MR, 1978, RADIOLOGY, V129, P787, DOI 10.1148/129.3.787; Spirydovich S, 2006, RADIOTHER ONCOL, V81, P309, DOI 10.1016/j.radonc.2006.10.010; Ulmer W, 2005, PHYS MED BIOL, V50, P1767, DOI 10.1088/0031-9155/50/8/010; Ulmer W, 1995, Z MED PHYS, V5, P25; Verhaegen F, 1998, PHYS MED BIOL, V43, P2755, DOI 10.1088/0031-9155/43/10/006; Westermark M, 2000, PHYS MED BIOL, V45, P685, DOI 10.1088/0031-9155/45/3/308; WONG JW, 1990, MED PHYS, V17, P807, DOI 10.1118/1.596555	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10466	10.1371/journal.pone.0010466	http://dx.doi.org/10.1371/journal.pone.0010466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454675	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300027
J	Morelli, L; Contu, D; Santoni, F; Whalen, MB; Francalacci, P; Cucca, F				Morelli, Laura; Contu, Daniela; Santoni, Federico; Whalen, Michael B.; Francalacci, Paolo; Cucca, Francesco			A Comparison of Y-Chromosome Variation in Sardinia and Anatolia Is More Consistent with Cultural Rather than Demic Diffusion of Agriculture	PLOS ONE			English	Article							GENETIC-EVIDENCE; DIVERGENCE TIME; MUTATION-RATE; POPULATION; EUROPE; INFERENCES; DIVERSITY; EXPANSION; ANCESTRY; CORSICA	Two alternative models have been proposed to explain the spread of agriculture in Europe during the Neolithic period. The demic diffusion model postulates the spreading of farmers from the Middle East along a Southeast to Northeast axis. Conversely, the cultural diffusion model assumes transmission of agricultural techniques without substantial movements of people. Support for the demic model derives largely from the observation of frequency gradients among some genetic variants, in particular haplogroups defined by single nucleotide polymorphisms (SNPs) in the Y-chromosome. A recent network analysis of the R-M269 Y chromosome lineage has purportedly corroborated Neolithic expansion from Anatolia, the site of diffusion of agriculture. However, the data are still controversial and the analyses so far performed are prone to a number of biases. In the present study we show that the addition of a single marker, DYSA7.2, dramatically changes the shape of the R-M269 network into a topology showing a clear Western-Eastern dichotomy not consistent with a radial diffusion of people from the Middle East. We have also assessed other Y-chromosome haplogroups proposed to be markers of the Neolithic diffusion of farmers and compared their intra-lineage variation-defined by short tandem repeats (STRs)-in Anatolia and in Sardinia, the only Western population where these lineages are present at appreciable frequencies and where there is substantial archaeological and genetic evidence of pre-Neolithic human occupation. The data indicate that Sardinia does not contain a subset of the variability present in Anatolia and that the shared variability between these populations is best explained by an earlier, pre-Neolithic dispersal of haplogroups from a common ancestral gene pool. Overall, these results are consistent with the cultural diffusion and do not support the demic model of agriculture diffusion.	[Morelli, Laura; Francalacci, Paolo] Univ Sassari, Dipartimento Zool & Genet Evoluzionist, I-07100 Sassari, Italy; [Morelli, Laura; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Contu, Daniela] Osped Microcitem, Immunogenet Lab, Cagliari, Italy; [Santoni, Federico; Whalen, Michael B.] Ctr Adv Studies Res & Dev Sardinia CRS4, Biomed Applicat Area, Pula, Italy; [Santoni, Federico] Univ Geneva, Swiss Inst Bioinformat, Geneva, Switzerland; [Cucca, Francesco] Ist Neurogenet & Neurofarmacol NN CNR, Monserrato, Italy	University of Sassari; University of Sassari; Swiss Institute of Bioinformatics; University of Geneva	Morelli, L (corresponding author), Univ Sassari, Dipartimento Zool & Genet Evoluzionist, I-07100 Sassari, Italy.	francesco.cucca@inn.cnr.it		Santoni, Federico/0000-0002-3258-4747; CUCCA, Francesco/0000-0002-7414-1995; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; FRANCALACCI, Paolo/0000-0001-7912-162X	Italian Ministry for Universities (MURST)	Italian Ministry for Universities (MURST)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the Italian Ministry for Universities (MURST, 40%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bickel DR, 2002, COMPUT STAT DATA AN, V39, P153, DOI 10.1016/S0167-9473(01)00057-3; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Hedges SB, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-31; *INT SOC GEN GEN, 2010, Y DNA HAPL TREE; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JOBLING MA, 2003, GARLAND SCI     0412; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; McEvoy B, 2008, AM J PHYS ANTHROPOL, V136, P415, DOI 10.1002/ajpa.20823; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Moore LT, 2006, AM J HUM GENET, V78, P334, DOI 10.1086/500055; Morelli L, 2000, HUM BIOL, V72, P585; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Quintana-Murci L, 2003, AM J PHYS ANTHROPOL, V121, P157, DOI 10.1002/ajpa.10187; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; SONDAAR PY, 1993, RIV SCI PREISTORICHE, V45, P243; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10419	10.1371/journal.pone.0010419	http://dx.doi.org/10.1371/journal.pone.0010419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454687	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100025
J	van den Wijngaard, CC; van Asten, L; van Pelt, W; Doornbos, G; Nagelkerke, NJD; Donker, GA; van der Hoek, W; Koopmans, MPG				van den Wijngaard, Cees C.; van Asten, Liselotte; van Pelt, Wilfrid; Doornbos, Gerda; Nagelkerke, Nico J. D.; Donker, Ge A.; van der Hoek, Wim; Koopmans, Marion P. G.			Syndromic Surveillance for Local Outbreaks of Lower-Respiratory Infections: Would It Work?	PLOS ONE			English	Article							DISEASE; NETHERLANDS; INFLUENZA	Background: Although syndromic surveillance is increasingly used to detect unusual illness, there is a debate whether it is useful for detecting local outbreaks. We evaluated whether syndromic surveillance detects local outbreaks of lower-respiratory infections (LRIs) without swamping true signals by false alarms. Methods and Findings: Using retrospective hospitalization data, we simulated prospective surveillance for LRI-elevations. Between 1999-2006, a total of 290762 LRIs were included by date of hospitalization and patients place of residence (>80% coverage, 16 million population). Two large outbreaks of Legionnaires disease in the Netherlands were used as positive controls to test whether these outbreaks could have been detected as local LRI elevations. We used a space-time permutation scan statistic to detect LRI clusters. We evaluated how many LRI-clusters were detected in 1999-2006 and assessed likely causes for the cluster-signals by looking for significantly higher proportions of specific hospital discharge diagnoses (e. g. Legionnaires disease) and overlap with regional influenza elevations. We also evaluated whether the number of space-time signals can be reduced by restricting the scan statistic in space or time. In 1999-2006 the scan-statistic detected 35 local LRI clusters, representing on average 5 clusters per year. The known Legionnaires' disease outbreaks in 1999 and 2006 were detected as LRI-clusters, since cluster-signals were generated with an increased proportion of Legionnaires disease patients (p:<0.0001). 21 other clusters coincided with local influenza and/or respiratory syncytial virus activity, and 1 cluster appeared to be a data artifact. For 11 clusters no likely cause was defined, some possibly representing as yet undetected LRI-outbreaks. With restrictions on time and spatial windows the scan statistic still detected the Legionnaires' disease outbreaks, without loss of timeliness and with less signals generated in time (up to 42% decline). Conclusions: To our knowledge this is the first study that systematically evaluates the performance of space-time syndromic surveillance with nationwide high coverage data over a longer period. The results show that syndromic surveillance can detect local LRI-outbreaks in a timely manner, independent of laboratory-based outbreak detection. Furthermore, since comparatively few new clusters per year were observed that would prompt investigation, syndromic hospital-surveillance could be a valuable tool for detection of local LRI-outbreaks.	[van den Wijngaard, Cees C.; van Asten, Liselotte; van Pelt, Wilfrid; Doornbos, Gerda; van der Hoek, Wim; Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Nagelkerke, Nico J. D.] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Donker, Ge A.] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Koopmans, Marion P. G.] Erasmus MC, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; United Arab Emirates University; Netherlands Institute for Health Services Research; Erasmus University Rotterdam; Erasmus MC	van den Wijngaard, CC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	kees.van.den.wijngaard@rivm.nl	Donker, Gé/AAX-8564-2021	Koopmans, Marion/0000-0002-5204-2312; Donker, Ge/0000-0001-6314-9249	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-6; Balter Sharon, 2005, MMWR Suppl, V54, P175; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Cooper DL, 2008, EPIDEMIOL INFECT, V136, P222, DOI 10.1017/S0950268807008412; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; DONKER GA, 2007, CONTINUOUS MORBIDITY; Fleming D M, 2004, Commun Dis Public Health, V7, P68; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Hope K, 2006, J EPIDEMIOL COMMUN H, V60, P374, DOI 10.1136/jech.2005.035337; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; KULLDORFF M, 2006, SATSCANTM V7 0 SOFTW; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Lai PC, 2004, ENVIRON HEALTH PERSP, V112, P1550, DOI 10.1289/ehp.7117; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; Miller Megge, 2004, Commun Dis Intell Q Rep, V28, P311; MORROY G, 2008, INFECTIEZIEKTEN B, V19, P66; Nordin JD, 2005, EMERG INFECT DIS, V11, P1394, DOI 10.3201/eid1109.050223; Ohkusa Yasushi, 2005, MMWR Suppl, V54, P47; Olson KL, 2006, AM J PUBLIC HEALTH, V96, P2002, DOI 10.2105/AJPH.2005.069526; SLOBBE LCJ, CLASSIFICATION DIAGN; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; van den Hoek J A R, 2006, Ned Tijdschr Geneeskd, V150, P1808; van der Eerden MM, 2005, EUR J CLIN MICROBIOL, V24, P241, DOI 10.1007/s10096-005-1316-8; Van Hest NAH, 2008, EPIDEMIOL INFECT, V136, P540, DOI 10.1017/S0950268807008977; Van Steenbergen J E, 2007, Ned Tijdschr Geneeskd, V151, P1998	30	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10406	10.1371/journal.pone.0010406	http://dx.doi.org/10.1371/journal.pone.0010406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454449	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100016
J	Combadiere, B; Vogt, A; Mahe, B; Costagliola, D; Hadam, S; Bonduelle, O; Sterry, W; Staszewski, S; Schaefer, H; van der Werf, S; Katlama, C; Autran, B; Blume-Peytavi, U				Combadiere, Behazine; Vogt, Annika; Mahe, Brice; Costagliola, Dominique; Hadam, Sabrina; Bonduelle, Olivia; Sterry, Wolfram; Staszewski, Shlomo; Schaefer, Hans; van der Werf, Sylvie; Katlama, Christine; Autran, Brigitte; Blume-Peytavi, Ulrike			Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial	PLOS ONE			English	Article							HUMAN LANGERHANS CELLS; HAIR FOLLICLE SIZE; DENDRITIC CELLS; VIRUS-INFECTIONS; PROTECTIVE IMMUNITY; TOPICAL APPLICATION; LYMPHOCYTE ACTIVITY; MEDIATED-IMMUNITY; MELANOMA PATIENTS; CHOLERA-TOXIN	Background: Current conventional vaccination approaches do not induce potent CD8 T-cell responses for fighting mostly variable viral diseases such as influenza, avian influenza viruses or HIV. Following our recent study on vaccine penetration by targeting of vaccine to human hair follicular ducts surrounded by Langerhans cells, we tested in the first randomized Phase-Ia trial based on hair follicle penetration (namely transcutaneous route) the induction of virus-specific CD8 T cell responses. Methods and Findings: We chose the inactivated influenza vaccine - a conventional licensed tetanus/influenza (TETAGRIP (R)) vaccine - to compare the safety and immunogenicity of transcutaneous (TC) versus IM immunization in two randomized controlled, multi-center Phase I trials including 24 healthy-volunteers and 12 HIV-infected patients. Vaccination was performed by application of inactivated influenza vaccine according to a standard protocol allowing the opening of the hair duct for the TC route or needle-injection for the IM route. We demonstrated that the safety of the two routes was similar. We showed the superiority of TC application, but not the IM route, to induce a significant increase in influenza-specific CD8 cytokine-producing cells in healthy-volunteers and in HIV-infected patients. However, these routes did not differ significantly for the induction of influenza-specific CD4 responses, and neutralizing antibodies were induced only by the IM route. The CD8 cell response is thus the major immune response observed after TC vaccination. Conclusions: This Phase Ia clinical trial (Manon05) testing an anti-influenza vaccine demonstrated that vaccines designed for antibody induction by the IM route, generate vaccine-specific CD8 T cells when administered transcutaneously. These results underline the necessity of adapting vaccination strategies to control complex infectious diseases when CD8 cellular responses are crucial. Our work opens up a key area for the development of preventive and therapeutic vaccines for diseases in which CD8 cells play a crucial role.	[Combadiere, Behazine; Mahe, Brice; Bonduelle, Olivia; Autran, Brigitte] INSERM, Inst Natl Sante & Rech Med, U945, Paris, France; [Combadiere, Behazine; Mahe, Brice; Costagliola, Dominique; Bonduelle, Olivia; Katlama, Christine; Autran, Brigitte] Univ Paris 06, Paris, France; [Combadiere, Behazine; Mahe, Brice; Bonduelle, Olivia; Katlama, Christine; Autran, Brigitte] AP HP, Lab Immun & Infect, Paris, France; [Vogt, Annika; Hadam, Sabrina; Schaefer, Hans; Blume-Peytavi, Ulrike] Charite, Dept Dermatol & Allergy, Clin Res Ctr Hair & Skin Sci, D-13353 Berlin, Germany; [Costagliola, Dominique] INSERM, U720, Paris, France; [Staszewski, Shlomo] Hop La Pitie Salpetriere, Serv Malad Infect, Paris, France; [van der Werf, Sylvie] Univ Paris 07, Pasteur Inst Paris, CNRS, Lab Genet Mol Virus Resp,URA1966, Paris, France; [Katlama, Christine] Goethe Univ Frankfurt, Dept Internal Med 2, HIV Treatment & Res Unit, Frankfurt, Germany; [Autran, Brigitte] INSERM, Ctr Invest Clin, U945, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Goethe University Frankfurt; Institut National de la Sante et de la Recherche Medicale (Inserm)	Combadiere, B (corresponding author), INSERM, Inst Natl Sante & Rech Med, U945, Paris, France.	behazine.combadiere@upmc.fr	Costagliola, Dominique/H-5849-2011; Combadiere, Behazine/G-3881-2013; Combadiere, Behazine/S-8054-2019	Costagliola, Dominique/0000-0003-0765-0869; Combadiere, Behazine/0000-0002-2353-4406; Blume-Peytavi, Ulrike/0000-0003-3528-3752; van der WERF, Sylvie/0000-0002-1148-4456; Vogt, Annika/0000-0001-9134-8413	ORVACS (Objectifs Recherches VACcins SIDA); Ministere de la Recherche et des Technologies; Agence Nationale de Recherche, Fondation pour la Recherche Medicale and Interface-INSERM	ORVACS (Objectifs Recherches VACcins SIDA); Ministere de la Recherche et des Technologies; Agence Nationale de Recherche, Fondation pour la Recherche Medicale and Interface-INSERM(French National Research Agency (ANR))	This work was funded by ORVACS (Objectifs Recherches VACcins SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. B. Mahe was supported by a grant from the Ministere de la Recherche et des Technologies. B. Combadiere is a recipient of a Young Investigator Award from the Agence Nationale de Recherche, Fondation pour la Recherche Medicale and Interface-INSERM-AP/HP programs.	Appay V, 2002, J IMMUNOL METHODS, V268, P9, DOI 10.1016/S0022-1759(02)00195-3; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; BEAVIS AJ, 2001, CURR PROTOC CYTOM, pCH1; Belyakov Igor M, 2004, Expert Rev Vaccines, V3, pS65, DOI 10.1586/14760584.3.4.S65; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Belz GT, 2001, J VIROL, V75, P4435, DOI 10.1128/JVI.75.9.4435-4438.2001; Bernstein E, 1999, VACCINE, V17, P82, DOI 10.1016/S0264-410X(98)00117-0; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Boon ACM, 2005, CLIN EXP IMMUNOL, V142, P45, DOI 10.1111/j.1365-2249.2005.02880.X; BOS JD, 1993, IMMUNOL TODAY, V14, P75, DOI 10.1016/0167-5699(93)90062-P; BROWN LE, 2009, IMMUNOL CELL BIOL; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Combadiere B, 2008, COMP IMMUNOL MICROB, V31, P293, DOI 10.1016/j.cimid.2007.07.015; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; DOHERTY PC, 1994, CURR OPIN IMMUNOL, V6, P545, DOI 10.1016/0952-7915(94)90139-2; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Epstein SL, 1998, J IMMUNOL, V160, P322; Etchart N, 2007, VACCINE, V25, P6891, DOI 10.1016/j.vaccine.2007.07.014; Fan HR, 1999, NAT BIOTECHNOL, V17, P870, DOI 10.1038/12856; Frerichs DM, 2008, VACCINE, V26, P2782, DOI 10.1016/j.vaccine.2008.02.070; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Glenn GM, 2006, CURR TOP MICROBIOL, V304, P247; Glenn GM, 1998, J IMMUNOL, V161, P3211; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Glenn GM, 1998, NATURE, V391, P851, DOI 10.1038/36014; Glenn GM, 2007, EXPERT REV VACCINES, V6, P809, DOI 10.1586/14760584.6.5.809; Godelaine D, 2003, J IMMUNOL, V171, P4893, DOI 10.4049/jimmunol.171.9.4893; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Halperin SA, 2005, HUM VACCINES, V1, P37, DOI 10.4161/hv.1.1.1553; HAMMARLUND E, 2003, NAT MED; Hammond SA, 2001, VACCINE, V19, P2701, DOI 10.1016/S0264-410X(00)00506-5; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kissenpfennig A, 2006, TRENDS IMMUNOL, V27, P132, DOI 10.1016/j.it.2006.01.003; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kohlmeier JE, 2003, IMMUNOLOGY, V108, P152, DOI 10.1046/j.1365-2567.2003.01578.x; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; KUWANO K, 1988, J IMMUNOL, V140, P1264; KUWANO K, 1990, VIROLOGY, V178, P174, DOI 10.1016/0042-6822(90)90391-4; KUWANO K, 1989, Viral Immunology, V2, P163, DOI 10.1089/vim.1989.2.163; KUWANO K, 1989, J EXP MED, V169, P1361, DOI 10.1084/jem.169.4.1361; Lademann J, 2006, SKIN PHARMACOL PHYS, V19, P232, DOI 10.1159/000093119; Lademann J, 2005, J INVEST DERM SYMP P, V10, P301, DOI 10.1111/j.1087-0024.2005.10121.x; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; MAHE B, 2008, J INVEST DERMATOL; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Mangelsdorf S, 2006, SKIN PHARMACOL PHYS, V19, P159, DOI 10.1159/000093050; Matsuo M, 2004, P NATL ACAD SCI USA, V101, P14467, DOI 10.1073/pnas.0405947101; Matyas GR, 2004, INFECT IMMUN, V72, P1181, DOI 10.1128/IAI.72.2.1181-1183.2004; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Naito S, 2007, VACCINE, V25, P8762, DOI 10.1016/j.vaccine.2007.10.031; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; PALA P, 1986, EUR J IMMUNOL, V16, P193, DOI 10.1002/eji.1830160215; Patterson Steven, 2009, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-540-71029-5_13; Post JJ, 2009, CELL MOL LIFE SCI, V66, P733, DOI 10.1007/s00018-008-8270-4; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Ratzinger G, 2004, J IMMUNOL, V173, P2780, DOI 10.4049/jimmunol.173.4.2780; Robinson HL, 2003, NAT IMMUNOL, V4, P12, DOI 10.1038/ni0103-12; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stoitzner P, 2005, J INVEST DERMATOL, V125, P116, DOI 10.1111/j.0022-202X.2005.23757.x; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Tamura M, 1998, J VIROL, V72, P9404, DOI 10.1128/JVI.72.11.9404-9406.1998; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Vogt A, 2005, J INVEST DERM SYMP P, V10, P252, DOI 10.1111/j.1087-0024.2005.10124.x; Vogt A, 2008, J IMMUNOL, V180, P1482, DOI 10.4049/jimmunol.180.3.1482; Vogt A, 2006, J INVEST DERMATOL, V126, P1316, DOI 10.1038/sj.jid.5700226; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watabe S, 2001, VACCINE, V19, P4434, DOI 10.1016/S0264-410X(01)00194-3; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; White A, 2008, MED HYPOTHESES, V71, P909, DOI 10.1016/j.mehy.2008.07.027; Yagi H, 2006, CANCER RES, V66, P10136, DOI 10.1158/0008-5472.CAN-06-1029	91	79	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10818	10.1371/journal.pone.0010818	http://dx.doi.org/10.1371/journal.pone.0010818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520820	Green Published, gold			2022-12-27	WOS:000278221500012
J	Shrager, J				Shrager, Jeff			The Promise and Perils of Pre-Publication Review: A Multi-Agent Simulation of Biomedical Discovery Under Varying Levels of Review Stringency	PLOS ONE			English	Article								The Internet has enabled profound changes in the way science is performed, especially in scientific communications. Among the most important of these changes is the possibility of new models for pre-publication review, ranging from the current, relatively strict peer-review model, to entirely unreviewed, instant self-publication. Different models may affect scientific progress by altering both the quality and quantity of papers available to the research community. To test how models affect the community, I used a multi-agent simulation of treatment selection and outcome in a patient population to examine how various levels of pre-publication review might affect the rate of scientific progress. I identified a "sweet spot'' between the points of very limited and very strict requirements for pre-publication review. The model also produced a u-shaped curve where very limited review requirement was slightly superior to a moderate level of requirement, but not as large as the aforementioned sweet spot. This unexpected phenomenon appears to result from the community taking longer to discover the correct treatment with more strict pre-publication review. In the parameter regimens I explored, both completely unreviewed and very strictly reviewed scientific communication seems likely to hinder scientific progress. Much more investigation is warranted. Multi-agent simulations can help to shed light on complex questions of scientific communication and exhibit interesting, unexpected behaviors.	[Shrager, Jeff] Stanford Univ, Symbol Syst Program, Stanford, CA 94305 USA; [Shrager, Jeff] CollabRx Inc, Palo Alto, CA USA	Stanford University	Shrager, J (corresponding author), Stanford Univ, Symbol Syst Program, Stanford, CA 94305 USA.	jshrager@stanford.edu						Meyer M, 2009, J ARTIFICIAL SOC SOC, V12; PAYETTE N, 2009, C MOD SCI UND FOR CO; Poschl U, 2004, LEARN PUBL, V17, P105, DOI 10.1087/095315104322958481; Shrager J, 2010, TOP COGN SCI, V2, P53, DOI 10.1111/j.1756-8765.2009.01049.x; Smith R., 2009, J PARTICIPAT MED, V1, pe13	5	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10782	10.1371/journal.pone.0010782	http://dx.doi.org/10.1371/journal.pone.0010782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520812	Green Submitted, gold, Green Published			2022-12-27	WOS:000278221500006
J	Yang, CC; Liang, W; Cai, Y; Shi, SH; Takasu, F; Moller, AP; Antonov, A; Fossoy, F; Moksnes, A; Roskaft, E; Stokke, BG				Yang, Canchao; Liang, Wei; Cai, Yan; Shi, Suhua; Takasu, Fugo; Moller, Anders P.; Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.			Coevolution in Action: Disruptive Selection on Egg Colour in an Avian Brood Parasite and Its Host	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; NEST PREDATION; COMMON CUCKOO; REED WARBLERS; RAPID DECLINE; OIL DROPLETS; EVOLUTION; BIRDS; APPEARANCE; REJECTION	Background: Trait polymorphism can evolve as a consequence of frequency-dependent selection. Coevolutionary interactions between hosts and parasites may lead to selection on both to evolve extreme phenotypes deviating from the norm, through disruptive selection. Methodology/Principal finding: Here, we show through detailed field studies and experimental procedures that the ashy-throated parrotbill (Paradoxornis alphonsianus) and its avian brood parasite, the common cuckoo (Cuculus canorus), have both evolved egg polymorphism manifested in discrete immaculate white, pale blue, and blue egg phenotypes within a single population. In this host-parasite system the most common egg colours were white and blue, with no significant difference in parasitism rates between hosts laying eggs of either colour. Furthermore, selection on parasites for countering the evolution of host egg types appears to be strong, since ashy-throated parrotbills have evolved rejection abilities for even partially mimetic eggs. Conclusions/Significance: The parrotbill-cuckoo system constitutes a clear outcome of disruptive selection on both host and parasite egg phenotypes driven by coevolution, due to the cost of parasitism in the host and by host defences in the parasite. The present study is to our knowledge the first to report the influence of disruptive selection on evolution of discrete phenotypes in both parasite and host traits in an avian brood parasitism system.	[Yang, Canchao; Shi, Suhua] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Canchao; Liang, Wei; Cai, Yan] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Takasu, Fugo] Nara Womens Univ, Dept Informat & Comp Sci, Nara 630, Japan; [Moller, Anders P.] Univ Paris Sud, Lab Ecol Systemat & Evolut, Orsay, France; [Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Yang, Canchao; Liang, Wei; Takasu, Fugo; Moller, Anders P.; Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.] CAS, Oslo, Norway	Sun Yat Sen University; Hainan Normal University; Nara Womens University; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Norwegian University of Science & Technology (NTNU)	Yang, CC (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Bard.Stokke@bio.ntnu.no	Moller, Anders/O-6665-2016; Røskaft, Eivin/N-7476-2019; Fossoy, Frode/O-3073-2017	Moller, Anders/0000-0003-3739-4675; Røskaft, Eivin/0000-0003-0262-8443; Fossoy, Frode/0000-0002-7535-9574	Program for New Century Excellent Talents in University [NCET-10-0111]; Norwegian Research Council [i77709/V40]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Program for New Century Excellent Talents in University (NCET-10-0111) to LW, and from the Norwegian Research Council (No. i77709/V40) to ER, AM, FF and BGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2009, ARDEA, V97, P17, DOI 10.5253/078.097.0103; Alvarez F, 2000, IBIS, V142, P683, DOI 10.1111/j.1474-919X.2000.tb04470.x; ALVAREZ F, 1994, J AVIAN BIOL, V25, P239, DOI 10.2307/3677081; Antonov A, 2007, NATURWISSENSCHAFTEN, V94, P307, DOI 10.1007/s00114-006-0189-8; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2006, EVOL ECOL RES, V8, P493; BROOKE MD, 1987, J ANIM ECOL, V56, P873, DOI 10.2307/4954; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; BROOKE MD, 1988, NATURE, V335, P630; Cherry MI, 2007, J EVOLUTION BIOL, V20, P1218, DOI 10.1111/j.1420-9101.2007.01308.x; Cook LM, 1999, P ROY SOC B-BIOL SCI, V266, P293, DOI 10.1098/rspb.1999.0636; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DECHAVIGNY J, 1938, ALAUDA, V10, P91; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Galeotti P, 2004, BIOL J LINN SOC, V82, P237, DOI 10.1111/j.1095-8312.2004.00355.x; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; GOTMARK F, 1992, BEHAV ECOL SOCIOBIOL, V30, P245, DOI 10.1007/BF00166709; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAYS H, 1971, WILSON BULL, V83, P425; HOLM S, 1979, SCAND J STAT, V6, P65; HOYT DF, 1979, AUK, V96, P73; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kettlewell H.B.D., 1973, EVOLUTION MELANISM; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kim CH, 1995, AUK, V112, P831; LACK DAVID, 1958, IBIS, V100, P145; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Lee Jin-Won, 2004, Korean Journal of Biological Sciences, V8, P77; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Majerus M, 1998, MELANISM EVOLUTION A; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin-Vivaldi M, 2002, J AVIAN BIOL, V33, P295, DOI 10.1034/j.1600-048X.2002.330311.x; Miller MR, 2005, J THEOR BIOL, V236, P198, DOI 10.1016/j.jtbi.2005.03.005; MOKSNES A, 1992, ORNIS SCAND, V23, P17, DOI 10.2307/3676422; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; MOKSNES A, 1987, ORNIS SCAND, V18, P168, DOI 10.2307/3676762; MOLLER AP, 1990, OIKOS, V57, P237, DOI 10.2307/3565945; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Payne RB, 2005, THE CUCKOOS; PETRIE M, 1991, TRENDS ECOL EVOL, V6, P315, DOI 10.1016/0169-5347(91)90038-Y; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Robson C, 2007, HDB BIRDS WORLD, V12, P292; Rothstein SI, 1998, PARASITIC BIRDS THEI; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Soler JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-88; SPOTTISWOODE CN, 2010, P NATL ACAD SCI US; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stokke BG, 2008, BEHAV ECOL, V19, P612, DOI 10.1093/beheco/arn007; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke BG, 2007, OIKOS, V116, P913, DOI 10.1111/j.0030-1299.2007.15832.x; Stokke BG, 2002, EVOLUTION, V56, P199; Takasu F, 2003, EVOL ECOL RES, V5, P345; Takasu F, 1998, AM NAT, V151, P193, DOI 10.1086/286111; Takasu Fugo, 2005, Ornithological Science, V4, P1, DOI 10.2326/osj.4.1; Thompson J. N., 2005, INTERSPEC INTERACT; Underwood TJ, 2002, OX ORN SER, V13, P280; Vikan JR, 2009, ETHOLOGY, V115, P840, DOI 10.1111/j.1439-0310.2009.01679.x; VIKAN JR, 2010, EVOL ECOL IN PRESS; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Weidinger K, 2001, BEHAV ECOL SOCIOBIOL, V49, P456, DOI 10.1007/s002650100324; Westmoreland D, 2008, J FIELD ORNITHOL, V79, P263, DOI 10.1111/j.1557-9263.2008.00172.x; Westmoreland D, 2007, J AVIAN BIOL, V38, P682, DOI 10.1111/j.2007.0908-8857.04066.x; Wolinska J, 2009, EVOLUTION, V63, P1893, DOI 10.1111/j.1558-5646.2009.00663.x; Wyllie I., 1981, CUCKOO	76	83	104	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10816	10.1371/journal.pone.0010816	http://dx.doi.org/10.1371/journal.pone.0010816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520815	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221500011
J	Moonen, RMJ; Reyes, I; Cavallaro, G; Gonzalez-Luis, G; Bakker, JA; Villamor, E				Moonen, Rob M. J.; Reyes, Iballa; Cavallaro, Giacomo; Gonzalez-Luis, Gema; Bakker, Jaap A.; Villamor, Eduardo			The T1405N Carbamoyl Phosphate Synthetase Polymorphism Does Not Affect Plasma Arginine Concentrations in Preterm Infants	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BIRTH-WEIGHT INFANTS; ASYMMETRIC DIMETHYLARGININE; NECROTIZING ENTEROCOLITIS; ENDOGENOUS INHIBITOR; ENHANCED METABOLISM; PREMATURE-INFANTS; AMINO-ACIDS; RISK-FACTOR; GLUTAMINE	Background: A C-to-A nucleotide transversion (T1405N) in the gene that encodes carbamoyl-phosphate synthetase 1 (CPS1) has been associated with changes in plasma concentrations of L-arginine in term and near term infants but not in adults. In preterm infants homozygosity for the CPS1 Thr1405 variant (CC genotype) was associated with an increased risk of having necrotizing enterocolitis (NEC). Plasma L-arginine concentrations are decreased in preterm infants with NEC. Aim: To examine the putative association between the CPS1 T1405N polymorphism and plasma arginine concentrations in preterm infants. Methods: Prospective multicenter cohort study. Plasma and DNA samples were collected from 128 preterm infants (, 30 weeks) between 6 and 12 hours after birth. Plasma amino acid and CPS1 T1405N polymorphism analysis were performed. Results: Distribution of genotypes did not differ between the preterm (CC:CA:AA = 55.5%: 33.6%: 10.9%, n = 128) and term infants (CC:CA:AA = 54.2%: 35.4%: 10.4%, n = 96). There was no association between the CPS1 genotype and plasma L-arginine or L-citrulline concentration, or the ornithine to citrulline ratio, which varies inversely with CPS1 activity. Also the levels of asymmetric dimethylarginine, and symmetric dimethylarginine were not significantly different among the three genotypes. Conclusions: The present study in preterm infants did not confirm the earlier reported association between CPS1 genotype and L-arginine levels in term infants.	[Moonen, Rob M. J.; Villamor, Eduardo] Maastricht Univ Med Ctr, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Moonen, Rob M. J.] Atrium Med Ctr Parkstad, Dept Pediat, Heerlen, Netherlands; [Reyes, Iballa; Gonzalez-Luis, Gema] Hosp Univ Materno Infantil Canarias, Dept Pediat, Las Palmas Gran Canaria, Spain; [Cavallaro, Giacomo] Univ Milan, Inst Pediat & Neonatol, Fdn IRCCS, Osped Maggiore Policlin Mangiagalli & Regina Elen, Milan, Italy; [Bakker, Jaap A.] Maastricht Univ Med Ctr, Dept Clin Genet, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Atrium Medical Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Maastricht University; Maastricht University Medical Centre (MUMC)	Moonen, RMJ (corresponding author), Maastricht Univ Med Ctr, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.	e.villamor@mumc.nl	Bakker, J. A./H-7910-2019; Cavallaro, Giacomo/F-5660-2011	Cavallaro, Giacomo/0000-0002-4921-1437; Bakker, Jaap A./0000-0002-2918-7361	Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Neonatologia	Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Neonatologia	This work was supported by grants from: 1) Fundacion de Investigacion Medica Mutua Madrilena, URL: http://www.mutua-mad.es/FundMM/jsp/Fhome.jsp, 2) Sociedad Espanola de Neonatologia, URL: http://www.se-neonatal.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HJ, 2002, J PEDIATR-US, V140, P425, DOI 10.1067/mpd.2002.123289; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, pF162, DOI 10.1136/adc.2007.115824; Chokshi NK, 2008, SEMIN PERINATOL, V32, P92, DOI 10.1053/j.semperi.2008.01.002; Colonna VDG, 2009, MED SCI MONITOR, V15, pRA91; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Figueras-Aloy J, 2003, ACTA PAEDIATR, V92, P582; Flynn NE, 1999, J NUTR, V129, P799, DOI 10.1093/jn/129.4.799; Flynn NE, 1997, AM J PHYSIOL-GASTR L, V272, pG474, DOI 10.1152/ajpgi.1997.272.3.G474; Flynn NE, 1997, J NUTR, V127, P732, DOI 10.1093/jn/127.5.732; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Henderson G, 2009, ARCH DIS CHILD-FETAL, V94, pF124, DOI 10.1136/adc.2007.119933; Kallianpur AR, 2005, BONE MARROW TRANSPL, V35, P1155, DOI 10.1038/sj.bmt.1704943; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Maeda T, 2003, J SOC GYNECOL INVEST, V10, P2, DOI 10.1016/S1071-5576(02)00192-2; Martens-Lobenhoffer J, 2007, J CHROMATOGR B, V851, P30, DOI 10.1016/j.jchromb.2006.07.038; Mittermayer F, 2006, EARLY HUM DEV, V82, P421, DOI 10.1016/j.earlhumdev.2005.08.005; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; Nowicki PT, 2006, PEDIATR RES, V59, P500, DOI 10.1203/01.pdr.0000203094.27615.5f; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Pierce Christine M, 2004, Pediatr Crit Care Med, V5, P517, DOI 10.1097/01.PCC.0000144715.03515.55; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Reber KM, 2002, CLIN PERINATOL, V29, P23, DOI 10.1016/S0095-5108(03)00063-0; Rees CM, 2008, ARCH DIS CHILD-FETAL, V93, pF395, DOI 10.1136/adc.2007.136994; Richir MC, 2007, BRIT J NUTR, V97, P906, DOI 10.1017/S0007114507669268; Richir MC, 2008, PEDIATR PULM, V43, P1161, DOI 10.1002/ppul.20886; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Siroen MPC, 2006, ANNU REV NUTR, V26, P203, DOI 10.1146/annurev.nutr.26.061505.111320; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; van den Berg A, 2005, J PEDIATR GASTR NUTR, V41, P66, DOI 10.1097/01.mpg.0000167497.55321.65; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Vida G, 2007, NEONATOLOGY, V92, P8, DOI 10.1159/000098411; Vida G, 2009, ACTA PAEDIATR, V98, P437, DOI 10.1111/j.1651-2227.2008.01115.x; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10792	10.1371/journal.pone.0010792	http://dx.doi.org/10.1371/journal.pone.0010792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520828	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034800002
J	Brandl, C; Ortler, S; Herrmann, T; Cardell, S; Lutz, MB; Wiendl, H				Brandl, Carolin; Ortler, Sonja; Herrmann, Thomas; Cardell, Susanna; Lutz, Manfred B.; Wiendl, Heinz			B7-H1-Deficiency Enhances the Potential of Tolerogenic Dendritic Cells by Activating CD1d-Restricted Type II NKT Cells	PLOS ONE			English	Article							KILLER T-CELLS; B7 FAMILY; IMMUNE-RESPONSES; ANERGY INDUCTION; CROSS-REGULATION; CUTTING EDGE; EXPRESSION; LIGANDS; PD-1; AUTOIMMUNITY	Background: Dendritic cells (DC) can act tolerogenic at a semi-mature stage by induction of protective CD4(+) T cell and NKT cell responses. Methodology/Principal Findings: Here we studied the role of the co-inhibitory molecule B7-H1 (PD-L1, CD274) on semimature DC that were generated from bone marrow (BM) cells of B7-H1(-/-) mice and applied to the model of Experimental Autoimmune Encephalomyelitis (EAE). Injections of B7-H1-deficient DC showed increased EAE protection as compared to wild type (WT)-DC. Injections of B7-H1(-/-) TNF-DC induced higher release of peptide-specific IL-10 and IL-13 after restimulation in vitro together with elevated serum cytokines IL-4 and IL-13 produced by NKT cells, and reduced IL-17 and IFN-gamma production in the CNS. Experiments in CD1d(-/-) and J alpha 281(-/-) mice as well as with type I and II NKT cell lines indicated that only type II NKT cells but not type I NKT cells (invariant NKT cells) could be stimulated by an endogenous CD1d-ligand on DC and were responsible for the increased serum cytokine production in the absence of B7-H1. Conclusions/Significance: Together, our data indicate that BM-DC express an endogenous CD1d ligand and B7-H1 to ihibit type II but not type I NKT cells. In the absence of B7-H1 on these DC their tolerogenic potential to stimulate tolerogenic CD4(+) and NKT cell responses is enhanced.	[Brandl, Carolin; Herrmann, Thomas; Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Ortler, Sonja; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Cardell, Susanna] Gothenburg Univ, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Wurzburg; University of Wurzburg; University of Gothenburg	Brandl, C (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.	m.lutz@vim.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021; Herrmann, Thomas/J-4943-2012; Cardell, Susanna/ABC-4944-2021	Herrmann, Thomas/0000-0002-1093-0194; Wiendl, Heinz/0000-0003-4310-3432; Lutz, Manfred B./0000-0001-9193-1772	German Research Council (DFG); Collaborative Research Centre [SFB581]	German Research Council (DFG)(German Research Foundation (DFG)); Collaborative Research Centre	This study was supported by the German Research Council (DFG, www.dfg.de) by the projects A8 (S.O., H.W.) and A9 (C.G., M.B.L.) of the Collaborative Research Centre (SFB581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Arrenberg P, 2009, J CELL PHYSIOL, V218, P246, DOI 10.1002/jcp.21597; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Behar SM, 1999, J IMMUNOL, V162, P161; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Carreno BM, 2005, CURR OPIN PHARMACOL, V5, P424, DOI 10.1016/j.coph.2005.02.003; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hayakawa Y, 2004, NAT IMMUNOL, V5, P590, DOI 10.1038/ni1069; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Makowska A, 2000, SCAND J IMMUNOL, V52, P71; Martin-Orozco N, 2006, J IMMUNOL, V177, P8291, DOI 10.4049/jimmunol.177.12.8291; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Parekh VV, 2009, J IMMUNOL, V182, P2816, DOI 10.4049/jimmunol.0803648; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Skold M, 2000, J IMMUNOL, V165, P168, DOI 10.4049/jimmunol.165.1.168; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wiethe C, 2007, J IMMUNOL, V178, P4908, DOI 10.4049/jimmunol.178.8.4908; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhu B, 2006, J IMMUNOL, V176, P3480, DOI 10.4049/jimmunol.176.6.3480; Zozulya AL, 2009, J NEUROSCI, V29, P140, DOI 10.1523/JNEUROSCI.2199-08.2009	45	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10800	10.1371/journal.pone.0010800	http://dx.doi.org/10.1371/journal.pone.0010800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520738	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034600027
J	Norum, M; Tang, E; Chavoshi, T; Schwarz, H; Linke, D; Uv, A; Moussian, B				Norum, Michaela; Tang, Erika; Chavoshi, Tina; Schwarz, Heinz; Linke, Dirk; Uv, Anne; Moussian, Bernard			Trafficking through COPII Stabilises Cell Polarity and Drives Secretion during Drosophila Epidermal Differentiation	PLOS ONE			English	Article							APICAL EXTRACELLULAR-MATRIX; ENDOPLASMIC-RETICULUM; MICROTUBULE ORGANIZATION; CUTICLE DIFFERENTIATION; PLASMA-MEMBRANE; LARVAL CUTICLE; ZYGOTIC LOCI; MELANOGASTER; PROTEINS; CHITIN	Background: The differentiation of an extracellular matrix (ECM) at the apical side of epithelial cells implies massive polarised secretion and membrane trafficking. An epithelial cell is hence engaged in coordinating secretion and cell polarity for a correct and efficient ECM formation. Principal Findings: We are studying the molecular mechanisms that Drosophila tracheal and epidermal cells deploy to form their specific apical ECM during differentiation. In this work we demonstrate that the two genetically identified factors haunted and ghost are essential for polarity maintenance, membrane topology as well as for secretion of the tracheal luminal matrix and the cuticle. We show that they code for the Drosophila COPII vesicle-coating components Sec23 and Sec24, respectively, that organise vesicle transport from the ER to the Golgi apparatus. Conclusion: Taken together, epithelial differentiation during Drosophila embryogenesis is a concerted action of ECM formation, plasma membrane remodelling and maintenance of cell polarity that all three rely mainly, if not absolutely, on the canonical secretory pathway from the ER over the Golgi apparatus to the plasma membrane. Our results indicate that COPII vesicles constitute a central hub for these processes.	[Norum, Michaela; Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, Tubingen, Germany; [Tang, Erika; Chavoshi, Tina; Uv, Anne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Schwarz, Heinz; Linke, Dirk] Max Planck Inst Dev Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Gothenburg; Max Planck Society	Norum, M (corresponding author), Univ Tubingen, Interfac Inst Cell Biol, Tubingen, Germany.	bernard.moussian@medgen.gu.se	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752; Moussian, Bernard/0000-0002-2854-9500	Deutsche Forschungsgemeinschaft (DFG) [MO 1714/2-1]; Gothenburg University; Vetenskapsradet (VR); Wenner Gren Foundation; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gothenburg University; Vetenskapsradet (VR)(Swedish Research Council); Wenner Gren Foundation; Max Planck Society(Max Planck Society)	Funding: MN and BM were supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de, MO 1714/2-1) and the Gothenburg University. ET, TC and AU were supported by the Vetenskapsradet (VR; www.vr.se) and by the Gothenborg University. BM and AU were additionally supported by the Wenner Gren Foundation (www.swgc.org). HS and DL were supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; Ashburner M., 2004, DROSOPHILA LAB HDB; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Denef N, 2008, DEV CELL, V14, P354, DOI 10.1016/j.devcel.2007.12.012; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Giesen K, 2003, MECH DEVELOP, V120, P401, DOI 10.1016/S0925-4773(03)00009-1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hartenstein V., 1985, EMBRYONIC DEV DROSOP; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KONIKOFF C, 2009, FLYEXPRESS PLATFORM; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; LAYNE E, 1957, SPECTROPHOTOMETRIC T, P447; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Locke M, 2001, J INSECT PHYSIOL, V47, P495, DOI 10.1016/S0022-1910(00)00123-2; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001; Moussian B, 2006, ARTHROPOD STRUCT DEV, V35, P137, DOI 10.1016/j.asd.2006.05.003; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schimmelpfeng K, 2006, MECH DEVELOP, V123, P487, DOI 10.1016/j.mod.2006.03.004; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Schotman H, 2009, J CELL SCI, V122, P2662, DOI 10.1242/jcs.039347; SORROSAL G, 2010, EMBO REP; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Strating JRPM, 2009, BIOL CELL, V101, P207, DOI 10.1042/BC20080075; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhu MY, 2005, GENETICS, V170, P767, DOI 10.1534/genetics.104.039750	66	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10802	10.1371/journal.pone.0010802	http://dx.doi.org/10.1371/journal.pone.0010802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520821	Green Submitted, gold, Green Published			2022-12-27	WOS:000278034600021
J	Toller, W; Debrot, AO; Vermeij, MJA; Hoetjes, PC				Toller, Wes; Debrot, Adolphe O.; Vermeij, Mark J. A.; Hoetjes, Paul C.			Reef Fishes of Saba Bank, Netherlands Antilles: Assemblage Structure across a Gradient of Habitat Types	PLOS ONE			English	Article							CORAL-REEF; SEAGRASS BEDS; COMMUNITY STRUCTURE; SPECIES RICHNESS; MANGROVES; NURSERY; BIODIVERSITY; HYPOTHESIS; COMPLEXITY; RANGE	Saba Bank is a 2,200 km(2) submerged carbonate platform in the northeastern Caribbean Sea off Saba Island, Netherlands Antilles. The presence of reef-like geomorphic features and significant shelf edge coral development on Saba Bank have led to the conclusion that it is an actively growing, though wholly submerged, coral reef atoll. However, little information exists on the composition of benthic communities or associated reef fish assemblages of Saba Bank. We selected a 40 km(2) area of the bank for an exploratory study. Habitat and reef fish assemblages were investigated in five shallow-water benthic habitat types that form a gradient from Saba Bank shelf edge to lagoon. Significant coral cover was restricted to fore reef habitat (average cover 11.5%) and outer reef flat habitat (2.4%) and declined to near zero in habitats of the central lagoon zone. Macroalgae dominated benthic cover in all habitats (average cover: 32.5-48.1%) but dominant algal genera differed among habitats. A total of 97 fish species were recorded. The composition of Saba Bank fish assemblages differed among habitat types. Highest fish density and diversity occurred in the outer reef flat, fore reef and inner reef flat habitats. Biomass estimates for commercially valued species in the reef zone (fore reef and reef flat habitats) ranged between 52 and 83 g/m(2). The composition of Saba Bank fish assemblages reflects the absence of important nursery habitats, as well as the effects of past fishing. The relatively high abundance of large predatory fish (i.e. groupers and sharks), which is generally considered an indicator of good ecosystem health for tropical reef systems, shows that an intact trophic network is still present on Saba Bank.	[Toller, Wes] Saba Conservat Fdn, Saba, Neth Antilles; [Debrot, Adolphe O.; Vermeij, Mark J. A.] Caribbean Res & Management Biodivers Fdn, Willemstad, Curacao, Neth Antilles; [Hoetjes, Paul C.] Minist Publ Hlth & Social Dev, Dept Environm & Nat, Willemstad, Curacao, Neth Antilles		Toller, W (corresponding author), Accreditat Serv Int GmbH, Bonn, Germany.	westoller@yahoo.com	Vermeij, Mark/B-2752-2013; Vermeij, Mark/AAR-6757-2020	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527	Development Foundation of the Netherlands Antilles (SONA)	Development Foundation of the Netherlands Antilles (SONA)	This work was part of the implementation of the Nature and Environment Policy Plan (NEPP) of the Department of Environment and Nature of the Netherlands Antilles, funded by Dutch development support provided through the Development Foundation of the Netherlands Antilles (SONA) and carried out with the help of the Saba Conservation Foundation, Saba, Netherlands Antilles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK R P M, 1975, Bijdragen tot de Dierkunde, V45, P181; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bohnsack J.A., 1986, STATIONARY VISUAL CE; BORTONE S A, 1989, Northeast Gulf Science, V10, P85; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Diaz Juan M., 1996, Atoll Research Bulletin, V435, P1; Dilrosun F, 2000, MONITORING SABA BANK; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hilborn Ray, 1997, V28; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Kendall MS, 2001, METHODS USED MAP BEN; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; MCKENNA S, 2006, PRELIMINARY REPORT M; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Monaco ME, 2007, FISHERIES MANAG ECOL, V14, P33, DOI 10.1111/j.1365-2400.2006.00521.x; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I., 2003, Gulf and Caribbean Research, V14, P43; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Rothenberger Paige, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P29; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Toller W, 2008, ASSESSMENT COMMERCIA; Toller W., 2008, SOME OBSERVATIONS MA; VANDERLAND J, 1977, 200 FAO, P469; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; WANDERS J B W, 1976, Aquatic Botany, V2, P327, DOI 10.1016/0304-3770(76)90030-9	42	17	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e9207	10.1371/journal.pone.0009207	http://dx.doi.org/10.1371/journal.pone.0009207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502637	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400001
J	Ragnarsdottir, B; Jonsson, K; Urbano, A; Gronberg-Hernandez, J; Lutay, N; Tammi, M; Gustafsson, M; Lundstedt, AC; Leijonhufvud, I; Karpman, D; Wullt, B; Truedsson, L; Jodal, U; Andersson, B; Svanborg, C				Ragnarsdottir, Bryndis; Jonsson, Klas; Urbano, Alexander; Gronberg-Hernandez, Jenny; Lutay, Nataliya; Tammi, Martti; Gustafsson, Mattias; Lundstedt, Ann-Charlotte; Leijonhufvud, Irene; Karpman, Diana; Wullt, Bjorn; Truedsson, Lennart; Jodal, Ulf; Andersson, Bjorn; Svanborg, Catharina			Toll-Like Receptor 4 Promoter Polymorphisms: Common TLR4 Variants May Protect against Severe Urinary Tract Infection	PLOS ONE			English	Article							DEFICIENCY CONFERS SUSCEPTIBILITY; UROPATHOGENIC ESCHERICHIA-COLI; HOST RESPONSE INDUCTION; ASYMPTOMATIC BACTERIURIA; ACUTE PYELONEPHRITIS; P-FIMBRIAE; CYTOKINE RESPONSES; SIGNALING PATHWAY; EPITHELIAL-CELLS; INNATE IMMUNITY	Background: Polymorphisms affecting Toll-like receptor (TLR) structure appear to be rare, as would be expected due to their essential coordinator role in innate immunity. Here, we assess variation in TLR4 expression, rather than structure, as a mechanism to diversify innate immune responses. Methodology/Principal Findings: We sequenced the TLR4 promoter (4,3 kb) in Swedish blood donors. Since TLR4 plays a vital role in susceptibility to urinary tract infection (UTI), promoter sequences were obtained from children with mild or severe disease. We performed a case-control study of pediatric patients with asymptomatic bacteriuria (ABU) or those prone to recurrent acute pyelonephritis (APN). Promoter activity of the single SNPs or multiple allelic changes corresponding to the genotype patterns (GPs) was tested. We then conducted a replication study in an independent cohort of adult patients with a history of childhood APN. Last, in vivo effects of the different GPs were examined after therapeutic intravesical inoculation of 19 patients with Escherichia coli 83972. We identified in total eight TLR4 promoter sequence variants in the Swedish control population, forming 19 haplotypes and 29 genotype patterns, some with effects on promoter activity. Compared to symptomatic patients and healthy controls, ABU patients had fewer genotype patterns, and their promoter sequence variants reduced TLR4 expression in response to infection. The ABU associated GPs also reduced innate immune responses in patients who were subjected to therapeutic urinary E. coli tract inoculation. Conclusions: The results suggest that genetic variation in the TLR4 promoter may be an essential, largely overlooked mechanism to influence TLR4 expression and UTI susceptibility.	[Ragnarsdottir, Bryndis; Lutay, Nataliya; Gustafsson, Mattias; Lundstedt, Ann-Charlotte; Leijonhufvud, Irene; Truedsson, Lennart; Svanborg, Catharina] Lund Univ, Inst Lab Med Lund, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Jonsson, Klas; Urbano, Alexander; Svanborg, Catharina] ASTAR, Inst Biomed Sci, Singapore Immunol Network, Singapore, Singapore; [Gronberg-Hernandez, Jenny; Wullt, Bjorn] Lund Univ, Univ Lund Hosp, Inst Clin Sci Lund, Dept Urol, Lund, Sweden; [Tammi, Martti] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Karpman, Diana] Lund Univ, Dept Pediat, Inst Clin Sci Lund, Lund, Sweden; [Jodal, Ulf] Gothenburg Univ, Dept Pediat, Queen Silvia Childrens Hosp, S-41124 Gothenburg, Sweden; [Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Lund University; Skane University Hospital; National University of Singapore; Lund University; Queen Silvia Children's Hospital; University of Gothenburg; Karolinska Institutet	Ragnarsdottir, B (corresponding author), Lund Univ, Inst Lab Med Lund, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Lutay, Nataliya/K-1733-2014; Andersson, Bjorn/G-9832-2013; Gustafsson, Mattias C. U./A-7451-2010	Lutay, Nataliya/0000-0003-1852-1288; Andersson, Bjorn/0000-0002-4624-0259; Gustafsson, Mattias C. U./0000-0003-3260-0724; Aradottir, Sigridur Sunna/0000-0002-6898-3256; Karpman, Diana/0000-0001-7220-7658	Swedish Medical Research Council; Network of Excellence: EuroPathoGenomics; Crafoord, Wallenberg, Lundberg and Osterlund Foundations; Blood and Defense Network (Faculty of Medicine, Lund University); Royal Physiografic Society	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Network of Excellence: EuroPathoGenomics; Crafoord, Wallenberg, Lundberg and Osterlund Foundations; Blood and Defense Network (Faculty of Medicine, Lund University); Royal Physiografic Society(Royal Society of London)	This study was supported by grants from the Swedish Medical Research Council, the Network of Excellence: EuroPathoGenomics, the Crafoord, Wallenberg, Lundberg and Osterlund Foundations, the Blood and Defense Network (Faculty of Medicine, Lund University) and the Royal Physiografic Society. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bergsten G, 2005, INT J MED MICROBIOL, V295, P487, DOI 10.1016/j.ijmm.2005.07.008; Bergsten G, 2004, J INFECT DIS, V189, P1734, DOI 10.1086/383278; Bergsten G, 2007, CELL MICROBIOL, V9, P1766, DOI 10.1111/j.1462-5822.2007.00912.x; De Staercke C, 2007, THROMB RES, V119, P105, DOI 10.1016/j.thromres.2005.12.010; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; FISCHER H, 2007, CELL MICROBIOL; Fischer JE, 2006, SURG-J R COLL SURG E, V4, P267, DOI 10.1016/S1479-666X(06)80003-X; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FOXMAN B, 1985, AM J PUBLIC HEALTH, V75, P1314, DOI 10.2105/AJPH.75.11.1314; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Frendeus B, 2001, MOL MICROBIOL, V40, P37, DOI 10.1046/j.1365-2958.2001.02361.x; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Gollapudi R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-414; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Ingberg CM, 1998, DIABETES METAB, V24, P351; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; KININGHAM RB, 1993, AM FAM PHYSICIAN, V47, P1232; Kunin CM, 1997, URINARY TRACT INFECT; LEFFLER H, 1980, FEMS MICROBIOL LETT, V8, P127, DOI 10.1111/j.1574-6968.1980.tb05064.x; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Lichtinger M, 2007, J BIOL CHEM, V282, P26874, DOI 10.1074/jbc.M703856200; LINDBERG U, 1978, J PEDIATR-US, V92, P194, DOI 10.1016/S0022-3476(78)80003-1; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Mably JD, 1996, CIRC RES, V79, P4, DOI 10.1161/01.RES.79.1.4; MARTINELL J, 1995, PEDIATR NEPHROL, V9, P131, DOI 10.1007/BF00860724; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NICOLLE LE, 1994, J ANTIMICROB CHEMOTH, V33, P99, DOI 10.1093/jac/33.suppl_A.99; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; Smirnova I, 2001, GENETICS, V158, P1657; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Svensson M, 2008, KIDNEY INT, V74, P81, DOI 10.1038/ki.2008.105; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; WEGNER M, 1993, P NATL ACAD SCI USA, V90, P4743, DOI 10.1073/pnas.90.10.4743; Wullt B, 2000, MOL MICROBIOL, V38, P456, DOI 10.1046/j.1365-2958.2000.02165.x; Wullt B, 1998, J UROLOGY, V159, P2057, DOI 10.1016/S0022-5347(01)63246-4; Wullt B, 2001, J INFECT DIS, V183, pS43, DOI 10.1086/318849; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	57	76	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10734	10.1371/journal.pone.0010734	http://dx.doi.org/10.1371/journal.pone.0010734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505764	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017300010
J	Li, MC; Liang, JF; Li, YC; Feng, B; Yang, ZL; James, TY; Xu, JP				Li, Mochan; Liang, Junfeng; Li, Yanchun; Feng, Bang; Yang, Zhu-Liang; James, Timothy Y.; Xu, Jianping			Genetic Diversity of Dahongjun, the Commercially Important "Big Red Mushroom'' from Southern China	PLOS ONE			English	Article							TRICHOLOMA-MATSUTAKE; ECTOMYCORRHIZAL FUNGI; SPECIES RECOGNITION; RUSSULA; GENEALOGIES; RECOMBINATION; BASIDIOMYCETE; POPULATIONS; ECOLOGY; COMMON	Background: In southern China, a wild ectomycorrhizal mushroom commonly called "Dahongjun'' or "Big Red Mushroom'' by the local residents, has been harvested, consumed, and/or exported as an exotic food for many years. Although ecologically and economically important, very little is known about this mushroom, including its diversity and population structure. Methodology and Principal Findings: In this study, we analyzed 122 samples from five local populations representing the known distribution ranges of this mushroom in southern China. We investigated the genetic diversity and geographic structure of this mushroom using sequences from four DNA fragments. Our analyses identified that this mushroom contained at least three divergent lineages: one corresponds to a recently described species Russula griseocarnosa from southern China and the remaining two likely represent two novel species. While these lineages were prominently structured geographically based on ITS sequences, evidence for ancient and/or recent gene flow was also identified within individual lineages. In addition, a local population from Ailaoshan in central Yunnan Province where 85 of our 122 specimens came from showed clear evidence of recombination. Conclusion and Significance: The ectomycorrhizal mushroom "Dahongjun'' from southern China is a species complex with at least three divergent lineages. These lineages are largely geographically structured and there is evidence for recombination in nature. Our results indicate mature Dahongjun mushrooms with abundant basidiospores are important for the reproduction of this mushroom in nature and that individual populations of this species should be managed separately.	[Li, Mochan; James, Timothy Y.; Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Liang, Junfeng] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Li, Yanchun; Feng, Bang; Yang, Zhu-Liang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China	McMaster University; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, MC (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca		Li, Yanchun/0000-0002-7109-9269	Natural Science and Engineering Research Council of Canada; National Natural Science Foundation of China; Yunnan Provincial Government [U0836604]; National Basic Research Program of China [2009CB522300]; Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences [0806371111]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; National Basic Research Program of China(National Basic Research Program of China); Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences	This study was supported by Natural Science and Engineering Research Council of Canada, Premiers Research Excellence Award, the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U0836604), the National Basic Research Program of China (No. 2009CB522300), and the Key Laboratory of Biodiversity and Biogeography of the Chinese Academy of Sciences (No. 0806371111). The authors confirm that the funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Allen MF, 1984, MYCOLOGICAL SOC AM N, V35, P17; Bergemann SE, 2006, NEW PHYTOL, V170, P177, DOI 10.1111/j.1469-8137.2006.01654.x; Bergemann SE, 2005, MOL ECOL NOTES, V5, P472, DOI 10.1111/j.1471-8286.2005.00949.x; Bergemann SE, 2002, NEW PHYTOL, V156, P313, DOI 10.1046/j.1469-8137.2002.00507.x; Bertolino S, 2004, FOREST ECOL MANAG, V202, P227, DOI 10.1016/j.foreco.2004.07.024; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Buyck B, 2006, MYCOLOGIA, V98, P612, DOI 10.3852/mycologia.98.4.612; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Hedh J, 2008, MYCOL RES, V112, P965, DOI 10.1016/j.mycres.2008.01.026; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Kasuga T, 2003, MOL ECOL, V12, P3383, DOI 10.1046/j.1365-294X.2003.01995.x; Kauserud H, 2006, MOL ECOL, V15, P421, DOI 10.1111/j.1365-294X.2005.02768.x; Kirk PM., 2008, DICT FUNGI, V10th ed; LAMB RJ, 1979, AUST FOREST RES, V9, P25; LEGON NW, 2005, CHECKLIST BRIT IRISH, P517; Li Mo-Chan, 2009, Acta Botanica Yunnanica, V31, P193, DOI 10.3724/SP.J.1143.2009.09086; LIAN B, 2008, J BIOTECHNOL, V11, P1; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Liang Y, 2004, MYCORRHIZA, V14, P235, DOI 10.1007/s00572-003-0260-7; Miller SL, 2002, MYCOL RES, V106, P259, DOI 10.1017/S0953756202005610; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pujol C, 2005, EVOL GENET, P149; Redecker D, 2001, MOL ECOL, V10, P1025, DOI 10.1046/j.1365-294X.2001.01230.x; RICHARDSON MJ, 1970, T BRIT MYCOL SOC, V55, P217, DOI 10.1016/S0007-1536(70)80006-7; Romagnesi H, 1967, RUSSULES EUROPE AFRI; Sha T, 2008, MICROBIOL-SGM, V154, P3460, DOI 10.1099/mic.0.2008/020495-0; Sha T, 2007, CHINESE SCI BULL, V52, P1212, DOI 10.1007/s11434-007-0194-0; Singer R, 1986, AGARICALES MODERN TA, P1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang XH, 2009, NOVA HEDWIGIA, V88, P269, DOI 10.1127/0029-5035/2009/0088-0269; Xu J., 2005, EVOL GENET, P87; Xu J, 2005, EVOL GENET, P189; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Xu JP, 2007, MICROBIOL-SGM, V153, P2002, DOI 10.1099/mic.0.2006/005686-0; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; Xu JP, 1996, MYCOL RES, V100, P188, DOI 10.1016/S0953-7562(96)80119-5; Yang Z. L., 2004, Frontiers in Basidiomycote mycology, P419; [杨祝良 Yang Zhuliang], 2002, [自然资源学报, Journal of Natural Resources], V17, P463	46	15	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10684	10.1371/journal.pone.0010684	http://dx.doi.org/10.1371/journal.pone.0010684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502696	Green Published, gold, Green Submitted			2022-12-27	WOS:000277776500003
J	Ratai, EM; Bombardier, JP; Joo, CG; Annamalai, L; Burdo, TH; Campbell, J; Fell, R; Hakimelahi, R; He, J; Autissier, P; Lentz, MR; Halpern, EF; Masliah, E; Williams, KC; Westmoreland, SV; Gonzalez, RG				Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Annamalai, Lakshmanan; Burdo, Tricia H.; Campbell, Jennifer; Fell, Robert; Hakimelahi, Reza; He, Julian; Autissier, Patrick; Lentz, Margaret R.; Halpern, Elkan F.; Masliah, Eliezer; Williams, Kenneth C.; Westmoreland, Susan V.; Gonzalez, R. Gilberto			Proton Magnetic Resonance Spectroscopy Reveals Neuroprotection by Oral Minocycline in a Nonhuman Primate Model of Accelerated NeuroAIDS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS DEMENTIA COMPLEX; NAIVE HIV PATIENTS; MICROGLIAL ACTIVATION; N-ACETYLASPARTATE; NEURONAL INJURY; SIV INFECTION; BRAIN-INJURY; HUNTINGTONS-DISEASE	Background: Despite the advent of highly active anti-retroviral therapy (HAART), HIV-associated neurocognitive disorders continue to be a significant problem. In efforts to understand and alleviate neurocognitive deficits associated with HIV, we used an accelerated simian immunodeficiency virus (SIV) macaque model of NeuroAIDS to test whether minocycline is neuroprotective against lentiviral-induced neuronal injury. Methodology/Principal Findings: Eleven rhesus macaques were infected with SIV, depleted of CD8+ lymphocytes, and studied until eight weeks post inoculation (wpi). Seven animals received daily minocycline orally beginning at 4 wpi. Neuronal integrity was monitored in vivo by proton magnetic resonance spectroscopy and post-mortem by immunohistochemistry for synaptophysin (SYN), microtubule-associated protein 2 (MAP2), and neuronal counts. Astrogliosis and microglial activation were quantified by measuring glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (IBA-1), respectively. SIV infection followed by CD8+ cell depletion induced a progressive decline in neuronal integrity evidenced by declining N-acetylaspartate/creatine (NAA/Cr), which was arrested with minocycline treatment. The recovery of this ratio was due to increases in NAA, indicating neuronal recovery, and decreases in Cr, likely reflecting downregulation of glial cell activation. SYN, MAP2, and neuronal counts were found to be higher in minocycline-treated animals compared to untreated animals while GFAP and IBA-1 expression were decreased compared to controls. CSF and plasma viral loads were lower in MN-treated animals. Conclusions/Significance: In conclusion, oral minocycline alleviates neuronal damage induced by the AIDS virus.	[Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Fell, Robert; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Gonzalez, R. Gilberto] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Fell, Robert; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Neuroradiol Div, Charlestown, MA USA; [Ratai, Eva-Maria; Joo, Chan-Gyu; Annamalai, Lakshmanan; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Westmoreland, Susan V.; Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Boston, MA USA; [Annamalai, Lakshmanan; Westmoreland, Susan V.] New England Reg Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA; [Burdo, Tricia H.; Campbell, Jennifer; Autissier, Patrick; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Halpern, Elkan F.] Massachusetts Gen Hosp, Dept Radiol, Inst Technol Assessment, Boston, MA 02114 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston College; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Ratai, EM (corresponding author), Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA.	ratai@nmr.mgh.harvard.edu	Gendelman, Howard E/G-8242-2012	Ratai, Eva-Maria/0000-0001-9476-6207	NIH [R21NS059331, R01NS050041, R01NS040237, R01NS37654, R01MH62962, MH59754, MH62512, RR00168]; NIH Nonhuman Primate Reagent Resource [R24 RR016001, N01 AI040101]; National Center for Research Resources [P41RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168, P41RR014075, R24RR016001, K26RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062962, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059331, R01NS040237, R01NS050041, R01NS037654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nonhuman Primate Reagent Resource; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R21NS059331 (EMR), R01NS050041 (RGG), R01NS040237 (KW), R01NS37654 (KW), R01MH62962 (EM), MH59754 (EM), MH62512 (EM), and RR00168 (NEPRC Base Grant). Depleting anti-CD8 (human recombinant, cM-807) used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (R24 RR016001, N01 AI040101). The Massachusetts General Hospital A. A. Martinos Center for Biomedical Imaging is also supported by the National Center for Research Resources grant number P41RR14075 and the Mental Illness and Neuroscience Discovery (MIND) Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; BARKER PB, 1995, RADIOLOGY, V195, P58, DOI 10.1148/radiology.195.1.7892496; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burudi EME, 2001, ADV VIRUS RES, V56, P435, DOI 10.1016/S0065-3527(01)56035-2; Chang L, 2003, ANTIVIR THER, V8, P17; Chang L, 2002, NEUROIMAGE, V17, P1638, DOI 10.1006/nimg.2002.1254; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; CHONG WK, 1993, RADIOLOGY, V188, P119, DOI 10.1148/radiology.188.1.8099750; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; DICKSON DW, 1991, LAB INVEST, V64, P135; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Everall IP, 1997, J NEUROPATH EXP NEUR, V56, P1202, DOI 10.1097/00005072-199711000-00004; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gonzalez RG, 2000, AIDS, V14, P2841, DOI 10.1097/00002030-200012220-00005; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Greco JB, 2004, MAGN RESON MED, V51, P1108, DOI 10.1002/mrm.20073; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jenwitheesuk E, 2007, BIOINFORMATICS, V23, P2797, DOI 10.1093/bioinformatics/btm424; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim JP, 2005, AM J NEURORADIOL, V26, P752; Lentz MR, 2008, NMR BIOMED, V21, P878, DOI 10.1002/nbm.1276; Lentz MR, 2005, RADIOLOGY, V235, P461, DOI 10.1148/radiol.2352040003; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Marcus CD, 1998, METAB BRAIN DIS, V13, P123, DOI 10.1023/A:1020609213664; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Meyerhoff DJ, 1999, NEUROLOGY, V52, P995, DOI 10.1212/WNL.52.5.995; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; Moller HE, 1999, J MAGN RESON IMAGING, V9, P10, DOI 10.1002/(SICI)1522-2586(199901)9:1<10::AID-JMRI2>3.0.CO;2-W; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; RATAI EM, 2009, 9 INT S NEUR MIAM BE; RATAI EM, 2009, 17 SCI M EXH HON HI; Ratai EM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-63; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Salvan AM, 1997, AIDS RES HUM RETROV, V13, P1055, DOI 10.1089/aid.1997.13.1055; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SHARER LR, 1992, J NEUROPATH EXP NEUR, V51, P3, DOI 10.1097/00005072-199201000-00002; SHARER LR, 1988, ANN NEUROL, V23, pS108, DOI 10.1002/ana.410230727; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tracey I, 1996, NEUROLOGY, V46, P783, DOI 10.1212/WNL.46.3.783; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zink M, 2000, NEUROAIDS, V3; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	82	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10523	10.1371/journal.pone.0010523	http://dx.doi.org/10.1371/journal.pone.0010523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479889	gold, Green Submitted, Green Published			2022-12-27	WOS:000277467800008
J	Zelko, H; Zammar, GR; Ferreira, APB; Phadtare, A; Shah, J; Pietrobon, R				Zelko, Hilary; Zammar, Guilherme Roberto; Bonilauri Ferreira, Ana Paula; Phadtare, Amruta; Shah, Jatin; Pietrobon, Ricardo			Selection Mechanisms Underlying High Impact Biomedical Research - A Qualitative Analysis and Causal Model	PLOS ONE			English	Article							PEER FEEDBACK; DISCOVERY; PROOFS	Background: Although scientific innovation has been a long-standing topic of interest for historians, philosophers and cognitive scientists, few studies in biomedical research have examined from researchers' perspectives how high impact publications are developed and why they are consistently produced by a small group of researchers. Our objective was therefore to interview a group of researchers with a track record of high impact publications to explore what mechanism they believe contribute to the generation of high impact publications. Methodology/Principal Findings: Researchers were located in universities all over the globe and interviews were conducted by phone. All interviews were transcribed using standard qualitative methods. A Grounded Theory approach was used to code each transcript, later aggregating concept and categories into overarching explanation model. The model was then translated into a System Dynamics mathematical model to represent its structure and behavior. Five emerging themes were found in our study. First, researchers used heuristics or rules of thumb that came naturally to them. Second, these heuristics were reinforced by positive feedback from their peers and mentors. Third, good communication skills allowed researchers to provide feedback to their peers, thus closing a positive feedback loop. Fourth, researchers exhibited a number of psychological attributes such as curiosity or open-mindedness that constantly motivated them, even when faced with discouraging situations. Fifth, the system is dominated by randomness and serendipity and is far from a linear and predictable environment. Some researchers, however, took advantage of this randomness by incorporating mechanisms that would allow them to benefit from random findings. The aggregation of these themes into a policy model represented the overall expected behavior of publications and their impact achieved by high impact researchers. Conclusions: The proposed selection mechanism provides insights that can be translated into research coaching programs as well as research policy models to optimize the introduction of high impact research at a broad scale among institutional and governmental agencies.	[Zelko, Hilary] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Zelko, Hilary; Zammar, Guilherme Roberto; Bonilauri Ferreira, Ana Paula; Phadtare, Amruta; Shah, Jatin; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA; [Zammar, Guilherme Roberto] Pontificia Univ Catolica Parana PUCPR, Curitiba, Parana, Brazil; [Bonilauri Ferreira, Ana Paula] Univ Joinville UNIVILLE, Joinville, Brazil; [Phadtare, Amruta] Kalpavriksha Healthcare & Res, Thana, Maharashtra, India; [Shah, Jatin; Pietrobon, Ricardo] Duke NUS Grad Med Sch, Singapore, Singapore	Duke University; Duke University; Pontificia Universidade Catolica do Parana; Universidade da Regiao de Joinville; National University of Singapore	Zelko, H (corresponding author), Duke Univ, Dept Surg, Durham, NC 27710 USA.	rpietro@duke.edu	Shah, Jatin/B-6039-2011	Shah, Jatin/0000-0002-2457-491X; Zelko, Hilary/0000-0003-4413-6949; Pietrobon, Ricardo/0000-0003-2996-2193				Barnes B., 1996, SCI KNOWLEDGE SOCIOL; Bland CJ, 2005, ACAD MED, V80, P225, DOI 10.1097/00001888-200503000-00006; BOSSEL H, 2007, BOD, P372; CAMPBELL DT, 1999, VARIATIONS ORG SCI H; CHARLES D, 1889, ORIGIN SPECIES; Dominick PG, 1997, GROUP ORGAN MANAGE, V22, P508, DOI 10.1177/1059601197224006; DUNBAR K, 1993, COGNITIVE SCI, V17, P397, DOI 10.1207/s15516709cog1703_3; FALCHIKOV N, 1995, INNOV EDUC TRAIN INT, V32, P175, DOI 10.1080/1355800950320212; Feyeraband P, 1993, METHOD; Garcia J.M., 2006, THEORY PRACTICAL EXE; Garfield E., 1992, SCI PUBL POLICY, V19, P321, DOI [DOI 10.1093/SPP/19.5.321, 10.1093/spp/19.5.321]; Glaser B., 1999, DISCOVERY GROUNDED T; Gonzalez-Brambilia C., 2007, DETERMINANTS RES PRO; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hull D. L., 1990, SCI PROCESS EVOLUTIO; JACOBS G, 1987, SYSTEM, V15, P325, DOI 10.1016/0346-251X(87)90006-6; Kiss Olga, 2006, Perspectives on Science, V14, P302, DOI 10.1162/posc.2006.14.3.302; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; LAKATOS I, 1963, BRIT J PHILOS SCI, V14, P1; LAKATOS I, 1963, BRIT J PHILOS SCI, V14, P120; LAKATOS I, 1963, BRIT J PHILOS SCI, V14, P221; Lakatos I., 1976, PROOF REFUTATIONS LO; Latour B., 1986, LAB LIFE CONSTRUCTIO; Merton RK, 2004, TRAVELS AND ADVENTURES OF SERENDIPITY: A STUDY IN SOCIOLOGICAL SEMANTICS AND THE SOCIOLOGY OF SCIENCE, P1; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MUNHALL PL, 2001, NURSING RES; Nersessian N. J., 2008, CREATING SCI CONCEPT; Oliver DG, 2005, SOC FORCES, V84, P1273, DOI 10.1353/sof.2006.0023; Paulus T. M., 1999, J SECOND LANG WRIT, V8, P265, DOI DOI 10.1016/S1060-3743(99)80117-9; Pendlebury D.A., 2008, WHITE PAPER USING BI; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Poland BD, 1995, QUAL INQ, DOI DOI 10.1177/107780049500100302; RADZICKI M, 1997, INTRO SYSTEMS DYNAMI; Roberts C., 2007, QUALITATIVE RES METH; Roberts R. M., 1989, SERENDIPITY ACCIDENT; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Simonton D.K., 2004, CREATIVITY SCI CHANC; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stoskopf MK, 2005, ILAR J, V46, P332, DOI 10.1093/ilar.46.4.332; Strauss A, 1997, GROUNDED THEORY PRAC; WEISBERG R, 2006, CREATIVITY SCI UNDER; Wolstenholme EF, 2003, SYST DYNAM REV, V19, P7, DOI 10.1002/sdr.259; Zhang S., 1995, J 2 LANG WRITING, V4, P209, DOI [DOI 10.1016/1060-3743(95)90010-1, 10.1016/1060-3743(95)90010-1]; SOFWARE VENSIM DSS 5	44	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10535	10.1371/journal.pone.0010535	http://dx.doi.org/10.1371/journal.pone.0010535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	593OI	20479867	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800017
J	Laborte, AG; Maunahan, AA; Hijmans, RJ				Laborte, Alice G.; Maunahan, Aileen A.; Hijmans, Robert J.			Spectral Signature Generalization and Expansion Can Improve the Accuracy of Satellite Image Classification	PLOS ONE			English	Article							LANDSAT; SPACE	Conventional supervised classification of satellite images uses a single multi-band image and coincident ground observations to construct spectral signatures of land cover classes. We compared this approach with three alternatives that derive signatures from multiple images and time periods: (1) signature generalization: spectral signatures are derived from multiple images within one season, but perhaps from different years; (2) signature expansion: spectral signatures are created with data from images acquired during different seasons of the same year; and (3) combinations of expansion and generalization. Using data for northern Laos, we assessed the quality of these different signatures to (a) classify the images used to derive the signature, and (b) for use in temporal signature extension, i.e., applying a signature obtained from data of one or several years to images from other years. When applying signatures to the images they were derived from, signature expansion improved accuracy relative to the conventional method, and variability in accuracy declined markedly. In contrast, signature generalization did not improve classification. When applying signatures to images of other years (temporal extension), the conventional method, using a signature derived from a single image, resulted in very low classification accuracy. Signature expansion also performed poorly but multi-year signature generalization performed much better and this appears to be a promising approach in the temporal extension of spectral signatures for satellite image classification.	[Laborte, Alice G.; Maunahan, Aileen A.; Hijmans, Robert J.] Int Rice Res Inst, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI)	Laborte, AG (corresponding author), Int Rice Res Inst, Los Banos, Laguna, Philippines.	aglaborte@gmail.com	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872	International Rice Research Institute	International Rice Research Institute(CGIAR)	Funding was received from the International Rice Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER ME, 1979, REMOTE SENS ENVIRON, V8, P77, DOI 10.1016/0034-4257(79)90025-7; Bow Sing T, 2002, PATTERN RECOGNITION; Canty MJ, 2004, REMOTE SENS ENVIRON, V91, P441, DOI 10.1016/j.rse.2003.10.024; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; Hadjimitsis DG, 2009, INT J APPL EARTH OBS, V11, P192, DOI 10.1016/j.jag.2009.01.005; HALL FG, 1991, REMOTE SENS ENVIRON, V35, P11, DOI 10.1016/0034-4257(91)90062-B; Langley SK, 2001, J ARID ENVIRON, V49, P401, DOI 10.1006/jare.2000.0771; Olthof I, 2005, REMOTE SENS ENVIRON, V95, P290, DOI 10.1016/j.rse.2004.12.015; Pax-Lenney M, 2001, REMOTE SENS ENVIRON, V77, P241, DOI 10.1016/S0034-4257(01)00208-5; PaxLenney M, 1997, REMOTE SENS ENVIRON, V59, P522, DOI 10.1016/S0034-4257(96)00124-1; QUIREIN JA, 1975, S MACH CLASS REM SEN, P26; Van Niel TG, 2004, COMPUT ELECTRON AGR, V45, P91, DOI 10.1016/j.compag.2004.06.003; Woodcock CE, 2001, REMOTE SENS ENVIRON, V78, P194, DOI 10.1016/S0034-4257(01)00259-0	13	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10516	10.1371/journal.pone.0010516	http://dx.doi.org/10.1371/journal.pone.0010516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463895	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379800011
J	Srivastava, K; Field, DJ; Aggrey, A; Yamakuchi, M; Morrell, CN				Srivastava, Kalyan; Field, David J.; Aggrey, Angela; Yamakuchi, Munekazu; Morrell, Craig N.			Platelet Factor 4 Regulation of Monocyte KLF4 in Experimental Cerebral Malaria	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ACTIVATED PLATELETS; IN-VIVO; PLASMODIUM-FALCIPARUM; SMOOTH-MUSCLE; T-CELLS; ATHEROSCLEROSIS; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; PATHOLOGY	Cerebral malaria continues to be a difficult to treat complication of Plasmodium falciparum infection in children. We have shown that platelets can have major deleterious immune functions in experimental cerebral malaria (ECM). One of the platelet derived mediators we have identified as particularly important is platelet factor 4/CXCL4. Our prior work demonstrated that PF4(-/-) mice are protected from ECM, have reduced plasma cytokines, and have reduced T-cell trafficking to the brain. We now show that PF4 drives monocyte cytokine production in a Kruppel like factor 4 (KLF4) dependent manner. Monocyte depleted Plasmodium berghei infected mice have improved survival, and KLF4 is greatly increased in control, but not monocyte depleted mice. PF4(-/-) mice have less cerebral monocyte trafficking and no change in KLF4 expression. These data indicate that PF4 induction of monocyte KLF4 expression may be an important step in the pathogenesis of ECM.	[Srivastava, Kalyan; Field, David J.; Aggrey, Angela; Yamakuchi, Munekazu; Morrell, Craig N.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA	University of Rochester	Srivastava, K (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	Craig_Morrell@URMC.Rochester.edu			National Institutes of Health (NIH) [R01HL093179, R01HL094547]; Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094547, R01HL093179] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R01HL093179 and R01HL094547 and a Johns Hopkins Malaria Research Institute Pilot Project grant to C.N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; AZIZ KA, 1995, BRIT J HAEMATOL, V91, P846, DOI 10.1111/j.1365-2141.1995.tb05399.x; Bikfalvi A, 2004, SEMIN THROMB HEMOST, V30, P379, DOI 10.1055/s-2004-831051; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; ENGSTAD CS, 1995, J LEUKOCYTE BIOL, V58, P575, DOI 10.1002/jlb.58.5.575; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; ESSIEN EM, 1983, ACTA HAEMATOL-BASEL, V70, P183, DOI 10.1159/000206720; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; GRAU GE, 1993, RES IMMUNOL, V144, P355, DOI 10.1016/S0923-2494(93)80080-I; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; HARPAZ R, 1992, J CLIN INVEST, V90, P515, DOI 10.1172/JCI115889; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Huo YQ, 2004, TRENDS CARDIOVAS MED, V14, P18, DOI 10.1016/j.tcm.2003.09.007; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lou JN, 1997, AM J PATHOL, V151, P1397; McKenzie SE, 2004, SEMIN THROMB HEMOST, V30, P559, DOI 10.1055/s-2004-835676; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Poncz M, 2005, SEMIN THORAC CARDIOV, V17, P73, DOI 10.1053/j.semtcvs.2004.12.007; Poncz M, 2006, PATHOPHYSIOL HAEMO T, V35, P46, DOI 10.1159/000093543; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Sachais BS, 2004, SEMIN THROMB HEMOST, V30, P351, DOI 10.1055/s-2004-831048; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Smyth SS, 2009, J THROMB HAEMOST; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van der Heyde HC, 2005, BLOOD, V105, P1956, DOI 10.1182/blood-2004-06-2206; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wassmer SC, 2003, ANN NY ACAD SCI, V992, P30, DOI 10.1111/j.1749-6632.2003.tb03135.x; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yan FF, 2008, MED HYPOTHESES, V70, P845, DOI 10.1016/j.mehy.2007.07.031; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; ZHENG B, IUBMB LIFE, V62, P132	55	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10413	10.1371/journal.pone.0010413	http://dx.doi.org/10.1371/journal.pone.0010413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454664	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240300004
J	Castellino, RC; Barwick, BG; Schniederjan, M; Buss, MC; Becher, O; Hambardzumyan, D; MacDonald, TJ; Brat, DJ; Durden, DL				Castellino, Robert C.; Barwick, Benjamin G.; Schniederjan, Matthew; Buss, Meghan C.; Becher, Oren; Hambardzumyan, Dolores; MacDonald, Tobey J.; Brat, Daniel J.; Durden, Donald L.			Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma	PLOS ONE			English	Article							BRAIN-TUMORS; SONIC HEDGEHOG; GROWTH-FACTOR; MICROVESSEL DENSITY; EXPRESSION; MICE; ANGIOGENESIS; CHILDHOOD; PATHWAY; CELLS	Background: Recent publications have described an important role for cross talk between PI-3 kinase and sonic hedgehog signaling pathways in the pathogenesis of medulloblastoma. Methodology/Principal Findings: We crossed mice with constitutive activation of Smoothened, SmoA1, with Pten deficient mice. Both constitutive and conditional Pten deficiency doubled the incidence of mice with symptoms of medulloblastoma and resulted in decreased survival. Analysis revealed a clear separation of gene signatures, with up-regulation of genes in the PI-3 kinase signaling pathway, including downstream activation of angiogenesis in SmoA1+/-; Pten +/- medulloblastomas. Western blotting and immunohistochemistry confirmed reduced or absent Pten, Akt activation, and increased angiogenesis in Pten deficient tumors. Down-regulated genes included genes in the sonic hedgehog pathway and tumor suppressor genes. SmoA1+/-; Pten +/+ medulloblastomas appeared classic in histology with increased proliferation and diffuse staining for apoptosis. In contrast, Pten deficient tumors exhibited extensive nodularity with neuronal differentiation separated by focal areas of intense staining for proliferation and virtually absent apoptosis. Examination of human medulloblastomas revealed low to absent PTEN expression in over half of the tumors. Kaplan-Meier analysis confirmed worse overall survival in patients whose tumor exhibited low to absent PTEN expression. Conclusions/Significance: This suggests that PTEN expression is a marker of favorable prognosis and mouse models with activation of PI-3 kinase pathways may be important tools for preclinical evaluation of promising agents for the treatment of medulloblastoma.	[Castellino, Robert C.; Buss, Meghan C.; MacDonald, Tobey J.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Castellino, Robert C.; Buss, Meghan C.; MacDonald, Tobey J.] Emory Univ, Sch Med, Blood Disorders Serv, Childrens Healthcare Atlanta, Atlanta, GA USA; [Barwick, Benjamin G.; Brat, Daniel J.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Schniederjan, Matthew; Brat, Daniel J.] Emory Univ, Sch Med, Lab Med, Atlanta, GA USA; [Becher, Oren] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Durden, Donald L.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego	Castellino, RC (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA.	rccaste@emory.edu	Castellino, Robert/GRF-7847-2022; MacDonald, Tobey/D-4554-2013; Becher, Oren/AAI-7495-2020; Barwick, Benjamin/O-5185-2019	Barwick, Benjamin/0000-0001-9810-3566; Becher, Oren/0000-0003-4016-8492	St. Baldrick's Foundation Scholar Award; Bear Necessities Pediatric Cancer Foundation; AACR-Aflac, Inc. Career Development Award; CURE Childhood Cancer Foundation; Winship Cancer Institute MPB Program Seed Grant; Emory Egleston Children's Research Center Seed Grant; NIH [R01CA94233]; Goldhirsh Foundation; Alex's Lemonade Stand; NATIONAL CANCER INSTITUTE [R01CA094233] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	St. Baldrick's Foundation Scholar Award; Bear Necessities Pediatric Cancer Foundation; AACR-Aflac, Inc. Career Development Award; CURE Childhood Cancer Foundation; Winship Cancer Institute MPB Program Seed Grant; Emory Egleston Children's Research Center Seed Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldhirsh Foundation; Alex's Lemonade Stand; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	RCC: St. Baldrick's Foundation Scholar Award, Bear Necessities Pediatric Cancer Foundation, AACR-Aflac, Inc. Career Development Award in Pediatric Cancer Research, CURE Childhood Cancer Foundation, Winship Cancer Institute MPB Program Seed Grant, Emory Egleston Children's Research Center Seed Grant; DLD: NIH R01CA94233, Goldhirsh Foundation, Alex's Lemonade Stand, CURE Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Ellison D, 2002, NEUROPATH APPL NEURO, V28, P257, DOI 10.1046/j.1365-2990.2002.00419.x; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Garre ML, 2009, CLIN CANCER RES, V15, P2463, DOI 10.1158/1078-0432.CCR-08-2023; GRIFFIN CA, 1988, CANCER RES, V48, P175; Grotzer MA, 2001, NEUROPEDIATRICS, V32, P75, DOI 10.1055/s-2001-13872; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hartmann W, 2006, CLIN CANCER RES, V12, P3019, DOI 10.1158/1078-0432.CCR-05-2187; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Huber H, 2001, EUR J CANCER, V37, P2064, DOI 10.1016/S0959-8049(01)00225-8; Iijima M, 1997, PATHOL INT, V47, P25, DOI 10.1111/j.1440-1827.1997.tb04431.x; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; LI VW, 1994, LANCET, V344, P82, DOI 10.1016/S0140-6736(94)91280-7; Lin CH, 2004, DEV BIOL, V265, P234, DOI 10.1016/j.ydbio.2003.08.027; Longo R, 2008, EXPERT REV MOL DIAGN, V8, P301, DOI 10.1586/14737159.8.3.301; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; McCall TD, 2007, CANCER RES, V67, P5179, DOI 10.1158/0008-5472.CAN-06-4177; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Packer RJ, 2003, PEDIATR NEUROSURG, V39, P60, DOI 10.1159/000071316; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; [No title captured]	41	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10849	10.1371/journal.pone.0010849	http://dx.doi.org/10.1371/journal.pone.0010849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520772	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500034
J	Puterman, E; Lin, J; Blackburn, E; O'Donovan, A; Adler, N; Epel, E				Puterman, Eli; Lin, Jue; Blackburn, Elizabeth; O'Donovan, Aoife; Adler, Nancy; Epel, Elissa			The Power of Exercise: Buffering the Effect of Chronic Stress on Telomere Length	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; CORTISOL RESPONSES; HUMAN T; ASSOCIATION; MORTALITY; HEALTH; MEN	Background: Chronic psychological stress is associated with detrimental effects on physical health, and may operate in part through accelerated cell aging, as indexed by shorter telomeres at the ends of chromosomes. However, not all people under stress have distinctly short telomeres, and we examined whether exercise can serve a stress-buffering function. We predicted that chronic stress would be related to short telomere length (TL) in sedentary individuals, whereas in those who exercise, stress would not have measurable effects on telomere shortening. Methodology and Principal Findings: 63 healthy post-menopausal women underwent a fasting morning blood draw for whole blood TL analysis by a quantitative polymerase chain reaction method. Participants completed the Perceived Stress Scale (Cohen et al., 1983), and for three successive days reported daily minutes of vigorous activity. Participants were categorized into two groups-sedentary and active (those getting Centers for Disease Control-recommended daily amount of activity). The likelihood of having short versus long telomeres was calculated as a function of stress and exercise group, covarying age, BMI and education. Logistic regression analyses revealed a significant moderating effect of exercise. As predicted, among non-exercisers a one unit increase in the Perceived Stress Scale was related to a 15-fold increase in the odds of having short telomeres (p<.05), whereas in exercisers, perceived stress appears to be unrelated to TL ( B = -.59, SE = .78, p = .45). Discussion: Vigorous physical activity appears to protect those experiencing high stress by buffering its relationship with TL. We propose pathways through which physical activity acts to buffer stress effects.	[Puterman, Eli; O'Donovan, Aoife; Adler, Nancy; Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Lin, Jue; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [O'Donovan, Aoife] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puterman, E (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	eli.puterman@ucsf.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348	Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health [R56]; Bernard and Barbro Foundation; UCSF-GIVI Center for AIDS Research [P30AI027763]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bernard and Barbro Foundation; UCSF-GIVI Center for AIDS Research; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research study was supported by the Division of Behavioral and Social Research at the National Institute of Aging/National Institutes of Health R56 grant (Epel) and Bernard and Barbro Foundation (Blackburn). The Gladstone flow core and the Core Immunology Lab were supported by the UCSF-GIVI Center for AIDS Research P30AI027763. The CTSI CCRC and the Core Immunology Lab were supported by NIH/NCRR UCSF-CTSI grant number UL1 RR024131. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2003, CURR DIR PSYCHOL SCI, V12, P119, DOI 10.1111/1467-8721.01245; ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010; Bayne S, 2008, CELL RES, V18, P1141, DOI 10.1038/cr.2008.291; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Castillo-Garzon MJ, 2006, CLIN INTERV AGING, V1, P213, DOI 10.2147/ciia.2006.1.3.213; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Craft LL, 2005, PSYCHOL SPORT EXERC, V6, P151, DOI 10.1016/j.psychsport.2003.11.003; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; *DNPAO CDC, PHYS ACT EV GUID AD; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Earnest CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002288; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; FORD ES, 1991, AM J EPIDEMIOL, V133, P1246, DOI 10.1093/oxfordjournals.aje.a115836; Fransson E, 2008, J CLIN EPIDEMIOL, V61, P840, DOI 10.1016/j.jclinepi.2007.09.004; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; Gillmore MR, 2001, J SEX RES, V38, P35, DOI 10.1080/00224490109552068; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Janicki-Deverts D, 2008, ANN BEHAV MED, V36, P176, DOI 10.1007/s12160-008-9056-5; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; Kiecolt-Glaser JK, 1999, JAMA-J AM MED ASSOC, V282, P2259, DOI 10.1001/jama.282.23.2259; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P523, DOI 10.1097/00006842-198709000-00008; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Li GL, 2009, MED HYPOTHESES, V72, P527, DOI 10.1016/j.mehy.2008.12.037; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Mueller PJ, 2007, CLIN EXP PHARMACOL P, V34, P377, DOI 10.1111/j.1440-1681.2007.04590.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; SHEPHARD RJ, 1994, BRIT J SPORT MED, V28, P247, DOI 10.1136/bjsm.28.4.247; Steptoe A, 2005, PSYCHOSOM MED, V67, P281, DOI 10.1097/01.psy.0000156932.96261.d2; Traustadottir T, 2005, PSYCHONEUROENDOCRINO, V30, P392, DOI 10.1016/j.psyneuen.2004.11.002; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; VERBRUGGE LM, 1980, MED CARE, V18, P73, DOI 10.1097/00005650-198001000-00006; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Zoccola PM, 2008, PSYCHOSOM MED, V70, P661, DOI 10.1097/PSY.0b013e31817bbc77	61	220	224	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10837	10.1371/journal.pone.0010837	http://dx.doi.org/10.1371/journal.pone.0010837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603PW	20520771	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221500023
J	Petruney, T; Harlan, SV; Lanham, M; Robinson, ET				Petruney, Tricia; Harlan, Sarah V.; Lanham, Michele; Robinson, Elizabeth T.			Increasing Support for Contraception as HIV Prevention: Stakeholder Mapping to Identify Influential Individuals and Their Perceptions	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; WOMEN; PROGRAMS; DESIRES	Background: Voluntary contraceptive use by HIV-positive women currently prevents more HIV-positive births, at a lower cost, than anti-retroviral drug (ARV) regimens. Despite this evidence, most prevention of mother-to-child transmission (PMTCT) programs focus solely on providing ARV prophylaxis to pregnant women and rarely include the prevention of unintended pregnancies among HIV-positive women. Methodology/Principal Findings: To strengthen support for family planning as HIV prevention, we systematically identified key individuals in the field of international HIV/AIDS-those who could potentially influence the issue-and sought to determine their perceptions of barriers to and facilitators for implementing this PMTCT strategy. We used a criteria-based approach to determine which HIV/AIDS stakeholders have the most significant impact on HIV/AIDS research, programs, funding and policy and stratified purposive sampling to conduct interviews with a subset of these individuals. The interview findings pointed to obstacles to strengthening linkages between family planning and HIV/AIDS, including the need for: resources to integrate family planning and HIV services, infrastructure or capacity to provide integrated services at the facility level, national leadership and coordination, and targeted advocacy to key decision-makers. Conclusions/Significance: The individuals we identified as having regional or international influence in the field of HIV/AIDS have the ability to leverage an increasingly conducive funding environment and a growing evidence base to address the policy, programmatic and operational challenges to integrating family planning with HIV/AIDS. Fostering greater support for implementing contraception for HIV prevention will require the dedication, collaboration and coordination of many such actors. Our findings can inform a targeted advocacy campaign.	[Petruney, Tricia] Family Hlth Int, Res Utilizat, Res Triangle Pk, NC 27709 USA; [Harlan, Sarah V.; Robinson, Elizabeth T.] Family Hlth Int, Informat Programs, Res Triangle Pk, NC 27709 USA; [Lanham, Michele] Family Hlth Int, Behav & Biomed Res, Res Triangle Pk, NC 27709 USA		Petruney, T (corresponding author), Family Hlth Int, Res Utilizat, POB 13950, Res Triangle Pk, NC 27709 USA.	tpetruney@fhi.org		Lanham, Michele/0000-0003-3012-5683	Family Health International (FHI), United States Agency for International Development (USAID) [GPO-A-00-05-00022-00]	Family Health International (FHI), United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding: Support for this study was provided by Family Health International (FHI) with funds from the United States Agency for International Development (USAID), Cooperative Agreement Number GPO-A-00-05-00022-00, although the views expressed in this publication do not necessarily reflect those of FHI or USAID (www.usaid.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Dearing JW, 2004, J HEALTH COMMUN, V9, P21, DOI 10.1080/10810730490271502; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Elul B, 2009, AIDS, V23, pS19, DOI 10.1097/01.aids.0000363774.91376.dc; Gladwell M., 2006, TIPPING POINT LITTLE; Guest G., 2008, HDB TEAM BASED QUALI; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Johnson KB, 2009, AIDS, V23, pS7, DOI 10.1097/01.aids.0000363773.83753.27; Kates J., 2009, FINANCING RESPONSE A; Nutt P.C., 1992, STRATEG MANAG; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; *PEPFAR, 2009, PEPFAR OV US COMM GL; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rutenberg N, 2005, STUD FAMILY PLANN, V36, P235, DOI 10.1111/j.1728-4465.2005.00064.x; Schmeer K., 1999, GUIDELINES CONDUCTIN; Singh S, 2009, ADDING IT COSTS BENE; Spaulding AB, 2009, AIDS, V23, pS79, DOI 10.1097/01.aids.0000363780.42956.ff; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Ulin PR, 2005, QUALITATIVE METHODS; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, 2002, WHO M PRES MORG SWIT; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; World Health Organization, 2002, STRAT APPR PREV HIV; World Health Organization (WHO), 2009, STRAT CONS STRENGTH	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10781	10.1371/journal.pone.0010781	http://dx.doi.org/10.1371/journal.pone.0010781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520728	Green Submitted, gold, Green Published			2022-12-27	WOS:000278034600004
J	Chouker, A; Kaufmann, I; Kreth, S; Hauer, D; Feuerecker, M; Thieme, D; Vogeser, M; Thiel, M; Schelling, G				Chouker, Alexander; Kaufmann, Ines; Kreth, Simone; Hauer, Daniela; Feuerecker, Matthias; Thieme, Detlef; Vogeser, Michael; Thiel, Manfred; Schelling, Gustav			Motion Sickness, Stress and the Endocannabinoid System	PLOS ONE			English	Article							CB1 RECEPTORS; INHIBIT EMESIS; CANNABINOIDS; ACTIVATION; RELEASE; EXPRESSION; NEURONS; NAUSEA	Background: A substantial number of individuals are at risk for the development of motion sickness induced nausea and vomiting (N&V) during road, air or sea travel. Motion sickness can be extremely stressful but the neurobiologic mechanisms leading to motion sickness are not clear. The endocannabinoid system (ECS) represents an important neuromodulator of stress and N&V. Inhibitory effects of the ECS on N&V are mediated by endocannabinoid-receptor activation. Methodology/Principal Findings: We studied the activity of the ECS in human volunteers (n = 21) during parabolic flight maneuvers (PFs). During PFs, microgravity conditions (<10(-2) g) are generated for approximately 22 s which results in a profound kinetic stimulus. Blood endocannabinoids (anandamide and 2-arachidonoylglycerol, 2-AG) were measured from blood samples taken in-flight before start of the parabolic maneuvers, after 10, 20, and 30 parabolas, in-flight after termination of PFs and 24 h later. Volunteers who developed acute motion sickness (n = 7) showed significantly higher stress scores but lower endocannabinoid levels during PFs. After 20 parabolas, blood anandamide levels had dropped significantly in volunteers with motion sickness (from 0.39+/-0.40 to 0.22+/-0.25 ng/ml) but increased in participants without the condition (from 0.43+/-0.23 to 0.60+/-0.38 ng/ml) resulting in significantly higher anandamide levels in participants without motion sickness (p = 0.02). 2-AG levels in individuals with motion sickness were low and almost unchanged throughout the experiment but showed a robust increase in participants without motion sickness. Cannabinoid-receptor 1 (CB1) but not cannabinoid-receptor 2 (CB2) mRNA expression in leucocytes 4 h after the experiment was significantly lower in volunteers with motion sickness than in participants without N&V. Conclusions/Significance: These findings demonstrate that stress and motion sickness in humans are associated with impaired endocannabinoid activity. Enhancing ECS signaling may represent an alternative therapeutic strategy for motion sickness in individuals who do not respond to currently available treatments.	[Chouker, Alexander; Kaufmann, Ines; Kreth, Simone; Hauer, Daniela; Feuerecker, Matthias; Schelling, Gustav] Univ Munich, Dept Anesthesiol, Munich, Germany; [Thieme, Detlef] Inst Doping Anal & Sports Biochem, Dresden, Germany; [Vogeser, Michael] Univ Munich, Dept Clin Chem, Munich, Germany; [Thiel, Manfred] Heidelberg Univ, Dept Anaesthesiol & Intens Care, Med Fac Mannheim, Univ Med Ctr Mannheim, D-6800 Mannheim, Germany	University of Munich; University of Munich; Ruprecht Karls University Heidelberg	Chouker, A (corresponding author), Univ Munich, Dept Anesthesiol, Munich, Germany.	gustav.schelling@med.uni-muenchen.de	Chouker, Alexander/H-2490-2017; Schelling, Gustav/U-2603-2018	Schelling, Gustav/0000-0002-6538-0652; Kreth, Simone/0000-0002-0073-2098	German Space Agency (DLR); Federal Ministry of Economics and Technology [BMWi 50WB0523, BMWi 50WB0719]; European Space Agency (ESA); Centre National d'Etudes Spatiales (CNES)	German Space Agency (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); European Space Agency (ESA)(European Space Agency); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	The study was financed by the German National Space Program by the German Space Agency (DLR), the Federal Ministry of Economics and Technology (BMWi 50WB0523 and 50WB0719) and supported by the European Space Agency (ESA) and Centre National d'Etudes Spatiales (CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Caraceni P, 2010, LIVER INT, V30, P816, DOI 10.1111/j.1478-3231.2009.02137.x; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Darmani NA, 2004, EUR J PHARMACOL, V488, P201, DOI 10.1016/j.ejphar.2004.02.018; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Finley JC, 2004, J APPL PHYSIOL, V96, P2231, DOI 10.1152/japplphysiol.00527.2003; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Hu DL, 2007, CELL MICROBIOL, V9, P2267, DOI 10.1111/j.1462-5822.2007.00957.x; Juhasz G, 2009, NEUROSCI LETT, V461, P116, DOI 10.1016/j.neulet.2009.06.021; Kim J, 2002, J NEUROSCI, V22, P10182; Lawson BD, 1998, ACTA ASTRONAUT, V43, P181, DOI 10.1016/S0094-5765(98)00153-2; LAWTHER A, 1988, AVIAT SPACE ENVIR MD, V59, P399; Mathison R, 2004, BRIT J PHARMACOL, V142, P1247, DOI 10.1038/sj.bjp.0705889; Mueller B., 1993, KURZFRAGEBOGEN AKTUE; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Otto B, 2006, AUTON NEUROSCI-BASIC, V129, P17, DOI 10.1016/j.autneu.2006.07.010; Parker LA, 2009, PHYSIOL BEHAV, V97, P121, DOI 10.1016/j.physbeh.2009.02.014; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reavley CM, 2006, AVIAT SPACE ENVIR MD, V77, P1148; Rocha FCM, 2008, EUR J CANCER CARE, V17, P431, DOI 10.1111/j.1365-2354.2008.00917.x; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Turner M, 1999, ERGONOMICS, V42, P444, DOI 10.1080/001401399185586; Turner M, 2000, AVIAT SPACE ENVIR MD, V71, P1181; Van Sickle MD, 2003, AM J PHYSIOL-GASTR L, V285, pG566, DOI 10.1152/ajpgi.00113.2003; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Vogeser M, 2006, CLIN CHEM LAB MED, V44, P488, DOI 10.1515/CCLM.2006.065; Vogeser M, 2007, CLIN CHEM LAB MED, V45, P1023, DOI 10.1515/CCLM.2007.197; Weis F, 2010, J MOL CELL CARDIOL, V48, P1187, DOI 10.1016/j.yjmcc.2009.10.025; ZIEGLER CG, 2009, HORM METAB RES, V42	41	91	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10752	10.1371/journal.pone.0010752	http://dx.doi.org/10.1371/journal.pone.0010752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505775	gold, Green Published			2022-12-27	WOS:000278017400020
J	Pinzan, CF; Ruas, LP; Casabona-Fortunato, AS; Carvalho, FC; Roque-Barreira, MC				Pinzan, Camila Figueiredo; Ruas, Luciana Pereira; Casabona-Fortunato, Analia Sulamita; Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina			Immunological Basis for the Gender Differences in Murine Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STEROID SEX-HORMONES; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; TNF-ALPHA; MACROPHAGE FUNCTION; INTERFERON-GAMMA; BINDING LECTIN; YEAST-CELLS; IMMUNITY	This study aimed to investigate the immunological mechanisms involved in the gender distinct incidence of paracoccidioidomycosis (pcm), an endemic systemic mycosis in Latin America, which is at least 10 times more frequent in men than in women. Then, we compared the immune response of male and female mice to Paracoccidioides brasiliensis infection, as well as the influence in the gender differences exerted by paracoccin, a P. brasiliensis component with carbohydrate recognition property. High production of Th1 cytokines and T-bet expression have been detected in the paracoccin stimulated cultures of spleen cells from infected female mice. In contrast, in similar experimental conditions, cells from infected males produced higher levels of the Th2 cytokines and expressed GATA-3. Macrophages from male and female mice when stimulated with paracoccin displayed similar phagocytic capability, while fungicidal activity was two times more efficiently performed by macrophages from female mice, a fact that was associated with 50% higher levels of nitric oxide production. In order to evaluate the role of sexual hormones in the observed gender distinction, we have utilized mice that have been submitted to gonadectomy followed by inverse hormonal reconstitution. Spleen cells derived from castrated males reconstituted with estradiol have produced higher levels of IFN-gamma (1291+/-15 pg/mL) and lower levels of IL-10 (494+/-38 pg/mL), than normal male in response to paracoccin stimulus. In contrast, spleen cells from castrated female mice that had been treated with testosterone produced more IL-10 (1284+/-36 pg/mL) and less IFN-gamma (587614 pg/mL) than cells from normal female. In conclusion, our results reveal that the sexual hormones had a profound effect on the biology of immune cells, and estradiol favours protective responses to P. brasiliensis infection. In addition, fungal components, such as paracoccin, may provide additional support to the gender dimorphic immunity that marks P. brasiliensis infection.	[Pinzan, Camila Figueiredo; Ruas, Luciana Pereira; Casabona-Fortunato, Analia Sulamita; Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Pinzan, CF (corresponding author), Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Pinzan, Camila Figueiredo/C-2470-2015; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008	Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq). C.F.P. is a PhD student with a scholarship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANGO M, 1982, MYCOPATHOLOGIA, V79, P115, DOI 10.1007/BF00468089; Aristizabal BH, 2002, MED MYCOL, V40, P169, DOI 10.1080/mmy.40.2.169.178; Aristizabal BH, 1998, INFECT IMMUN, V66, P5587, DOI 10.1128/IAI.66.11.5587-5591.1998; Azenabor AA, 2004, BIOCHEM CELL BIOL, V82, P381, DOI 10.1139/O04-032; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benten WPM, 1997, J ENDOCRINOL, V153, P275, DOI 10.1677/joe.0.1530275; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Calich VLG, 1998, RES IMMUNOL, V149, P407, DOI 10.1016/S0923-2494(98)80764-5; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Chao T C, 1996, Changgeng Yi Xue Za Zhi, V19, P95; Chao TC, 1996, AM J REPROD IMMUNOL, V35, P106; CHAO TC, 1995, CELL IMMUNOL, V160, P43, DOI 10.1016/0008-8749(95)80007-6; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; DUTT A, 1986, ENDOCRINOLOGY, V118, P661, DOI 10.1210/endo-118-2-661; FOX HS, 1991, J IMMUNOL, V146, P4362; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; GIRALDO R, 1976, MYCOPATHOLOGIA, V58, P63, DOI 10.1007/BF00707174; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Grosso DD, 2003, INFECT IMMUN, V71, P6534, DOI 10.1128/IAI.71.11.6534-6542.2003; Hannah MF, 2008, BRAIN BEHAV IMMUN, V22, P503, DOI 10.1016/j.bbi.2007.10.005; HAYES GR, 1983, J BIOL CHEM, V258, P5095; Hong M, 2004, EXP TOXICOL PATHOL, V55, P385, DOI 10.1078/0940-2993-00335; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Karpuzoglu E, 2007, MOL IMMUNOL, V44, P1808, DOI 10.1016/j.molimm.2006.08.005; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Karpuzoglu E, 2009, ENDOCRINOLOGY, V150, P1310, DOI 10.1210/en.2008-0832; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Karpuzoglu-Sahin E, 2001, CYTOKINE, V14, P208, DOI 10.1006/cyto.2001.0876; KASHINO SS, 1995, MYCOPATHOLOGIA, V130, P131, DOI 10.1007/BF01103095; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; LOOSE DS, 1983, P NATL ACAD SCI-BIOL, V80, P7659, DOI 10.1073/pnas.80.24.7659; Marques Silvio Alencar, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P261, DOI 10.1590/S0036-46651995000300014; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Moreira AP, 2008, MYCOPATHOLOGIA, V166, P17, DOI 10.1007/s11046-007-9046-3; MOTA NGS, 1985, T ROY SOC TROP MED H, V79, P765, DOI 10.1016/0035-9203(85)90112-9; Muchmore H G, 1974, Bol Oficina Sanit Panam, V77, P55; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pereira A.J.C.S., 1988, REV PAT TROP, V17, P157; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; RAMOS ESM, 2008, DERMATOL CLIN, V26, pR7; Ramos-E-Silva M, 2008, DERMATOL CLIN, V26, P257, DOI 10.1016/j.det.2007.11.005; RESTREPO A, 1984, INFECT IMMUN, V46, P346, DOI 10.1128/IAI.46.2.346-353.1984; Restrepo A, 2008, SEMIN RESP CRIT CARE, V29, P182, DOI 10.1055/s-2008-1063857; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Roberts CW, 1996, PARASITOL TODAY, V12, P382, DOI 10.1016/0169-4758(96)10060-0; Rodrigues DR, 2007, MED MYCOL, V45, P27, DOI 10.1080/13693780600981676; Romano CC, 2002, CYTOKINE, V18, P149, DOI 10.1006/cyto.2002.0884; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; San-Blas G, 2005, J CLIN MICROBIOL, V43, P4255, DOI 10.1128/JCM.43.8.4255-4257.2005; Sano T, 1999, PLANT CELL PHYSIOL, V40, P1, DOI 10.1093/oxfordjournals.pcp.a029464; SINGERVERMES LM, 1993, CLIN EXP IMMUNOL, V94, P75, DOI 10.1111/j.1365-2249.1993.tb05980.x; Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265; Sommer P, 2001, CELL BIOL INT, V25, P103, DOI 10.1006/cbir.2000.0682; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; STARR CM, 1985, ARCH BIOCHEM BIOPHYS, V237, P261, DOI 10.1016/0003-9861(85)90277-2; STEVENS DA, 1989, J MED VET MYCOL, V27, P133; Tobon AM, 2003, CLIN INFECT DIS, V37, P898, DOI 10.1086/377538; Vijay IK, 1998, J MAMMARY GLAND BIOL, V3, P325, DOI 10.1023/A:1018771628925; Wilcoxen SC, 2000, J IMMUNOL, V164, P6237, DOI 10.4049/jimmunol.164.12.6237; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; You HJ, 2003, BIOCHEM BIOPH RES CO, V303, P1129, DOI 10.1016/S0006-291X(03)00477-7	73	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10757	10.1371/journal.pone.0010757	http://dx.doi.org/10.1371/journal.pone.0010757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505765	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400013
J	Al-Swailem, AM; Shehata, MM; Abu-Duhier, FM; Al-Yamani, EJ; Al-Busadah, KA; Al-Arawi, MS; Al-Khider, AY; Al-Muhaimeed, AN; Al-Qahtani, FH; Manee, MM; Al-Shomrani, BM; Al-Qhtani, SM; Al-Harthi, AS; Akdemir, KC; Inan, MS; Otu, HH				Al-Swailem, Abdulaziz M.; Shehata, Maher M.; Abu-Duhier, Faisel M.; Al-Yamani, Essam J.; Al-Busadah, Khalid A.; Al-Arawi, Mohammed S.; Al-Khider, Ali Y.; Al-Muhaimeed, Abdullah N.; Al-Qahtani, Fahad H.; Manee, Manee M.; Al-Shomrani, Badr M.; Al-Qhtani, Saad M.; Al-Harthi, Amer S.; Akdemir, Kadir C.; Inan, Mehmet S.; Otu, Hasan H.			Sequencing, Analysis, and Annotation of Expressed Sequence Tags for Camelus dromedarius	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; FATTY-ACID COMPOSITION; CONSTANT-REGION GENES; ALPHA-GENES; STRESS; ORGANIZATION; P27(KIP1); ALIGNMENT; GLUCOSE; BLOOD	Despite its economical, cultural, and biological importance, there has not been a large scale sequencing project to date for Camelus dromedarius. With the goal of sequencing complete DNA of the organism, we first established and sequenced camel EST libraries, generating 70,272 reads. Following trimming, chimera check, repeat masking, cluster and assembly, we obtained 23,602 putative gene sequences, out of which over 4,500 potentially novel or fast evolving gene sequences do not carry any homology to other available genomes. Functional annotation of sequences with similarities in nucleotide and protein databases has been obtained using Gene Ontology classification. Comparison to available full length cDNA sequences and Open Reading Frame (ORF) analysis of camel sequences that exhibit homology to known genes show more than 80% of the contigs with an ORF>300 bp and similar to 40% hits extending to the start codons of full length cDNAs suggesting successful characterization of camel genes. Similarity analyses are done separately for different organisms including human, mouse, bovine, and rat. Accompanying web portal, CAGBASE (http://camel.kacst.edu.sa/), hosts a relational database containing annotated EST sequences and analysis tools with possibility to add sequences from public domain. We anticipate our results to provide a home base for genomic studies of camel and other comparative studies enabling a starting point for whole genome sequencing of the organism.	[Al-Swailem, Abdulaziz M.; Shehata, Maher M.; Abu-Duhier, Faisel M.; Al-Yamani, Essam J.; Al-Arawi, Mohammed S.; Al-Khider, Ali Y.; Al-Muhaimeed, Abdullah N.; Al-Qahtani, Fahad H.; Manee, Manee M.; Al-Shomrani, Badr M.; Al-Qhtani, Saad M.; Al-Harthi, Amer S.; Inan, Mehmet S.; Otu, Hasan H.] King Abdulaziz City Sci & Technol, Biotechnol Res Ctr, Nat Resources & Environm Res Inst, Riyadh, Saudi Arabia; [Al-Busadah, Khalid A.] King Faisal Univ, Fac Vet Med & Anim Resources, Al Hasa, Saudi Arabia; [Akdemir, Kadir C.; Otu, Hasan H.] Harvard Univ, Sch Med, Dept Med, BIDMC Genom Ctr, Boston, MA USA	King Abdulaziz City for Science & Technology; King Faisal University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Al-Swailem, AM (corresponding author), King Abdulaziz City Sci & Technol, Biotechnol Res Ctr, Nat Resources & Environm Res Inst, Riyadh, Saudi Arabia.	hotu@bidmc.harvard.edu	Manee, Manee/CAA-8005-2022; Almuhaimeed, Abdullah/GPG-4180-2022	Manee, Manee/0000-0001-9493-619X; Almuhaimeed, Abdullah/0000-0002-1155-9382; Alqahtani, Fahad/0000-0002-2498-4871; Otu, Hasan/0000-0002-9253-8152; Al-Shomrani, Badr M/0000-0002-7015-6110; Al-Swailem, Abdulaziz/0000-0002-9484-5973	King Abdulaziz City for Science and Technology (KACST); Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia; Dubai-Harvard Foundation for Medical Research	King Abdulaziz City for Science and Technology (KACST); Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia; Dubai-Harvard Foundation for Medical Research	This project was supported by a grant from King Abdulaziz City for Science and Technology (KACST), Natural Resources and Environment Research Institute (NRERI), Riyadh, Saudi Arabia (http://www.kacst.edu.sa). HHO is partially supported by Dubai-Harvard Foundation for Medical Research (http://www.dhfmr.hms.harvard.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah M, 1999, J VET MED A, V46, P473, DOI 10.1046/j.1439-0442.1999.00237.x; Al Ani F.K., 2004, CAMEL MANAGEMENT DIS; Al-Hashem F. H., 2009, American Journal of Applied Sciences, V6, P1868, DOI 10.3844/ajassp.2009.1868.1875; Al-Swailem AM, 2007, J FOOD AGRIC ENVIRON, V5, P143; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anonymous, 2003, Archives of Physiology and Biochemistry, V111, P407, DOI 10.3109/13813450312331342265; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; BUTLER JE, 1994, VET IMMUNOL IMMUNOP, V43, P5, DOI 10.1016/0165-2427(94)90114-7; DUNCAN WRH, 1967, J SCI FOOD AGR, V18, P99, DOI 10.1002/jsfa.2740180304; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Elmahdi B, 1997, COMP BIOCHEM PHYS A, V118, P147, DOI 10.1016/S0300-9629(96)00449-5; EMMANUEL B, 1980, COMP BIOCHEM PHYS B, V67, P701, DOI 10.1016/0305-0491(80)90435-6; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; HOLLER H, 1989, COMP BIOCHEM PHYS B, V93, P413, DOI 10.1016/0305-0491(89)90101-6; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Kaske M, 2001, J COMP PHYSIOL B, V171, P549, DOI 10.1007/s003600100205; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KNIGHT KL, 1985, J IMMUNOL, V134, P1245; KNIGHT KL, 1988, J IMMUNOL, V140, P3654; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Malde K, 2006, BIOINFORMATICS, V22, P2232, DOI 10.1093/bioinformatics/btl368; Mao CH, 2003, BIOINFORMATICS, V19, P1720, DOI 10.1093/bioinformatics/btg205; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Muyldermans S, 2001, J Biotechnol, V74, P277; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; ROSATI M, 1991, NUCLEIC ACIDS RES, V19, P5661, DOI 10.1093/nar/19.20.5661; Saleh MA, 2009, VET PARASITOL, V162, P192, DOI 10.1016/j.vetpar.2009.03.035; Schmidt-Nielsen K, 1979, DESERT ANIMALS PHYSL; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; SHIRAZIBEECHY SP, 1994, RUM PHYS DIG MET GRO; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Terada Y, 1999, KIDNEY INT, V56, P494, DOI 10.1046/j.1523-1755.1999.00568.x; Tibary A, 2007, Soc Reprod Fertil Suppl, V64, P297; Wagner B, 2002, IMMUNOGENETICS, V54, P353, DOI 10.1007/s00251-002-0458-4; Wagner B, 1998, IMMUNOBIOLOGY, V199, P105, DOI 10.1016/S0171-2985(98)80067-3; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; YAGIL R, 1985, DESERT CAMEL COMP PH; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496	50	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10720	10.1371/journal.pone.0010720	http://dx.doi.org/10.1371/journal.pone.0010720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502665	Green Published, gold			2022-12-27	WOS:000277845400022
J	Senar, JC; Moller, AP; Ruiz, I; Negro, JJ; Broggi, J; Hohtola, E				Carlos Senar, Juan; Moller, Anders Pape; Ruiz, Iker; Jose Negro, Juan; Broggi, Juli; Hohtola, Esa			Specific Appetite for Carotenoids in a Colorful Bird	PLOS ONE			English	Article							PARUS; DIET; QUANTIFICATION; PIGMENTS; BLUE	Background: Since carotenoids have physiological functions necessary for maintaining health, individuals should be selected to actively seek and develop a specific appetite for these compounds. Methodology/Principal Findings: Great tits Parus major in a diet choice experiment, both in captivity and the field, preferred carotenoid-enriched diets to control diets. The food items did not differ in any other aspects measured besides carotenoid content. Conclusions/Significance: Specific appetite for carotenoids is here demonstrated for the first time, placing these compounds on a par with essential nutrients as sodium or calcium.	[Carlos Senar, Juan; Ruiz, Iker; Broggi, Juli] Museu Ciencies Nat Barcelona, CSIC, Evolutionary & Behav Ecol Associate Res Unit, Barcelona, Spain; [Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Moller, Anders Pape] Ctr Adv Study, Oslo, Norway; [Jose Negro, Juan; Broggi, Juli] CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Hohtola, Esa] Univ Oulu, Dept Biol, Oulu, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oulu	Senar, JC (corresponding author), Museu Ciencies Nat Barcelona, CSIC, Evolutionary & Behav Ecol Associate Res Unit, Barcelona, Spain.	jcsenar@bcn.cat	Senar, Joan Carles/V-2371-2018; Moller, Anders/O-6665-2016; Negro, Juan Jose/I-2653-2015; Broggi, Juli/AAB-1796-2020	Senar, Joan Carles/0000-0001-9955-3892; Moller, Anders/0000-0003-3739-4675; Negro, Juan Jose/0000-0002-8697-5647; Broggi, Juli/0000-0002-1706-4014	Spanish Research Council; Ministerio de Educacion y Ciencia; CIRIT [FPI2000-0014]; Generalitat de Catalunya;  [CGL2006-07481]	Spanish Research Council; Ministerio de Educacion y Ciencia(Spanish Government); CIRIT; Generalitat de Catalunya(Generalitat de Catalunya); 	This work was funded by CGL2006-07481 research project to JCS and JJN, from the Spanish Research Council, Ministerio de Educacion y Ciencia and FPI2000-0014 to IR from CIRIT, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2007, J AGR FOOD CHEM, V55, P787, DOI 10.1021/jf062764p; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; BLEM CR, 1976, AM ZOOL, V16, P671; Clarke T, 2001, NATURE, V412, P263; CZECZUGA B, 1990, FOLIA BIOL-KRAKOW, V38, P5; de Oliveira GPR, 2007, J FOOD SCI, V72, pS79, DOI 10.1111/j.1750-3841.2006.00235.x; Goodwin TW., 1976, CHEM BIOCH PLANT PIG, V1; Gosler A, 1993, GREAT TIT; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Hurst W.J., 2002, METHODS ANAL FUNCTIO; Isaksson C, 2007, J AVIAN BIOL, V38, P564, DOI 10.1111/j.2007.0908-8857.04030.x; ISLER O, 1971, CAROTENOIDS; MCPHERSON JM, 1988, ANIM BEHAV, V36, P961, DOI 10.1016/S0003-3472(88)80054-X; *MIN CORP LTD, 1994, PREC COL COMM COL CO; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; MURPHY ME, 1987, PHYSIOL ZOOL, V60, P279, DOI 10.1086/physzool.60.2.30158652; NEAVE HR, 1992, DISTRIBUTION FREE TE; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; PARTALI V, 1987, COMP BIOCHEM PHYS B, V87, P885, DOI 10.1016/0305-0491(87)90408-1; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Senar JC, 2008, BEHAVIOUR, V145, P1195, DOI 10.1163/156853908785387638; Senar J.C., 1997, Butlleti del Grup Catala d'Anellament, V14, P17; SHULKIN J, 1992, SODIUM HUNGER, P204; Tordoff MG, 2001, PHYSIOL REV, V81, P1567, DOI 10.1152/physrev.2001.81.4.1567	28	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10716	10.1371/journal.pone.0010716	http://dx.doi.org/10.1371/journal.pone.0010716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502717	Green Published, gold			2022-12-27	WOS:000277845400018
J	Liang, CW; Zhang, XW; Zou, J; Xu, D; Su, F; Ye, NH				Liang, Chengwei; Zhang, Xiaowen; Zou, Jian; Xu, Dong; Su, Feng; Ye, Naihao			Identification of miRNA from Porphyra yezoensis by High-Throughput Sequencing and Bioinformatics Analysis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SMALL RNAS; REGULATORY ROLES; PLANT MICRORNAS; PREDICTION; TARGETS; BIOGENESIS; DIVERSE; CLONING; SYSTEM	Background: miRNAs are a class of non-coding, small RNAs that are approximately 22 nucleotides long and play important roles in the translational level regulation of gene expression by either directly binding or cleaving target mRNAs. The red alga, Porphyra yezoensis is one of the most important marine economic crops worldwide. To date, only a few miRNAs have been identified in green unicellar alga and there is no report about Porphyra miRNAs. Methodology/Principal Findings: To identify miRNAs in Porphyra yezoensis, a small RNA library was constructed. Solexa technology was used to perform high throughput sequencing of the library and subsequent bioinformatics analysis to identify novel miRNAs. Specifically, 180,557,942 reads produced 13,324 unique miRNAs representing 224 conserved miRNA families that have been identified in other plants species. In addition, seven novel putative miRNAs were predicted from a limited number of ESTs. The potential targets of these putative miRNAs were also predicted based on sequence homology search. Conclusions/Significance: This study provides a first large scale cloning and characterization of Porphyra miRNAs and their potential targets. These miRNAs belong to 224 conserved miRNA families and 7 miRNAs are novel in Porphyra. These miRNAs add to the growing database of new miRNA and lay the foundation for further understanding of miRNA function in the regulation of Porphyra yezoensis development.	[Liang, Chengwei; Su, Feng] Qingdao Univ Technol & Sci, Qingdao, Peoples R China; [Zhang, Xiaowen; Zou, Jian; Xu, Dong; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Qingdao University of Science & Technology; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Liang, CW (corresponding author), Qingdao Univ Technol & Sci, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			National Natural Science Foundation of China [40706050, 40706048, 30700619]; National Science Technology [2006BAD01A13, 2008BAC49B04]; National Special Fund [2009ZX08009-019B]; Natural Science Foundation of Shandong Province [2009ZRA02075, 2008D03]; Qingdao Municipal Science and Technology [09-2-5-8-hy]; Open Foundation of Chemical Engineering Subject; Qingdao University of Science & Technology, China; Hi-TechResearch and Development Program (863) of China [2009AA10Z106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Technology; National Special Fund; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology; Open Foundation of Chemical Engineering Subject; Qingdao University of Science & Technology, China; Hi-TechResearch and Development Program (863) of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (40706050, 40706048 and 30700619), the National Science & Technology Pillar Program (2006BAD01A13 and 2008BAC49B04), National Special Fund for Transgenic Project (2009ZX08009-019B), Natural Science Foundation of Shandong Province (2009ZRA02075 and 2008D03), Qingdao Municipal Science and Technology Plan Project (09-2-5-8-hy), Open Foundation of Chemical Engineering Subject, Qingdao University of Science & Technology, China and the Hi-TechResearch and Development Program (863) of China (2009AA10Z106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saga N, 2002, FISH SCI S, V68, P1075, DOI DOI 10.2331/fishsci.68.sup2_1075; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	74	79	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10698	10.1371/journal.pone.0010698	http://dx.doi.org/10.1371/journal.pone.0010698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502668	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400008
J	Buchanan, TW; Bibas, D; Adolphs, R				Buchanan, Tony W.; Bibas, David; Adolphs, Ralph			Associations between Feeling and Judging the Emotions of Happiness and Fear: Findings from a Large-Scale Field Experiment	PLOS ONE			English	Article							HUMAN AMYGDALA; RECOGNITION; EXPERIENCE; DISGUST; EXPRESSION; MODEL; MOOD	Background: How do we recognize emotions from other people? One possibility is that our own emotional experiences guide us in the online recognition of emotion in others. A distinct but related possibility is that emotion experience helps us to learn how to recognize emotions in childhood. Methodology/Principal Findings: We explored these ideas in a large sample of people (N = 4,608) ranging from 5 to over 50 years old. Participants were asked to rate the intensity of emotional experience in their own lives, as well as to perform a task of facial emotion recognition. Those who reported more intense experience of fear and happiness were significantly more accurate (closer to prototypical) in recognizing facial expressions of fear and happiness, respectively, and intense experience of fear was associated also with more accurate recognition of surprised and happy facial expressions. The associations held across all age groups. Conclusions: These results suggest that the intensity of one's own emotional experience of fear and happiness correlates with the ability to recognize these emotions in others, and demonstrate such an association as early as age 5.	[Buchanan, Tony W.] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Bibas, David] Calif Sci Ctr, Los Angeles, CA USA; [Adolphs, Ralph] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Dept Humanities & Social Sci, Pasadena, CA 91125 USA	Saint Louis University; California Institute of Technology; California Institute of Technology	Buchanan, TW (corresponding author), St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA.	tbuchan7@slu.edu		Lauwereyns, Jan/0000-0003-0551-2550; Buchanan, Tony/0000-0002-9166-8457	National Science Foundation [ESI-0515470]; National Institute of Mental Health [1 R01 MH067681]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721, R01MH067681] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Goose Bumps!: The Science of Fear was developed by the California Science Center with support from National Science Foundation Grant # ESI-0515470. R. A. was also supported by National Institute of Mental Health Grant 1 R01 MH067681. T. W. B. was supported by a National Alliance for Research on Schizophrenia and Depression Young Investigator Award. The authors thank the staff of the California Science Center for their extensive help in setting up this study and collecting the data for it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Barrett LF, 1997, PERS SOC PSYCHOL B, V23, P1100, DOI 10.1177/01461672972310010; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Ekman P., 1976, PICTURES FACIAL AFFE; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Izard CE, 2004, EMOTION, V4, P251, DOI 10.1037/1528-3542.4.3.251; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Nabi RL, 2002, COGNITION EMOTION, V16, P695, DOI 10.1080/02699930143000437; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Zaki J, 2008, PSYCHOL SCI, V19, P399, DOI 10.1111/j.1467-9280.2008.02099.x	22	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10640	10.1371/journal.pone.0010640	http://dx.doi.org/10.1371/journal.pone.0010640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597PU	20498838	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000277771600007
J	Lee, AY; Perreault, R; Harel, S; Boulier, EL; Suderman, M; Hallett, M; Jenna, S				Lee, Anna Y.; Perreault, Richard; Harel, Sharon; Boulier, Elodie L.; Suderman, Matthew; Hallett, Michael; Jenna, Sarah			Searching for Signaling Balance through the Identification of Genetic Interactors of the Rab Guanine-Nucleotide Dissociation Inhibitor gdi-1	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; CAENORHABDITIS-ELEGANS; SYNAPTIC PLASTICITY; KINASE ACTIVATION; GONAD DEVELOPMENT; SOMATIC GONAD; RHO GTPASES; PROTEIN; RECEPTOR; MUSCLE	Background: The symptoms of numerous diseases result from genetic mutations that disrupt the homeostasis maintained by the appropriate integration of signaling gene activities. The relationships between signaling genes suggest avenues through which homeostasis can be restored and disease symptoms subsequently reduced. Specifically, disease symptoms caused by loss-of-function mutations in a particular gene may be reduced by concomitant perturbations in genes with antagonistic activities. Methodology/Principal Findings: Here we use network-neighborhood analyses to predict genetic interactions in Caenorhabditis elegans towards mapping antagonisms and synergisms between genes in an animal model. Most of the predicted interactions are novel, and the experimental validation establishes that our approach provides a gain in accuracy compared to previous efforts. In particular, we identified genetic interactors of gdi-1, the orthologue of GDI1, a gene associated with mental retardation in human. Interestingly, some gdi-1 interactors have human orthologues with known neurological functions, and upon validation of the interactions in mammalian systems, these orthologues would be potential therapeutic targets for GDI1-associated neurological disorders. We also observed the conservation of a gdi-1 interaction between different cellular systems in C. elegans, suggesting the involvement of GDI1 in human muscle degeneration. Conclusions/Significance: We developed a novel predictor of genetic interactions that may have the ability to significantly streamline the identification of therapeutic targets for monogenic disorders involving genes conserved between human and C. elegans.	[Lee, Anna Y.; Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Lee, Anna Y.; Hallett, Michael] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Perreault, Richard; Harel, Sharon; Boulier, Elodie L.; Jenna, Sarah] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada	McGill University; McGill University; McGill University; University of Quebec; University of Quebec Montreal	Lee, AY (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	jenna.sarah@uqam.ca		Hallett, Michael/0000-0001-6738-6786; Suderman, Matthew/0000-0002-2715-9930	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation; Canada Research Chair program; Fonds de la recherche en santedu Quebec	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); Fonds de la recherche en santedu Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) of Canada and the Canada Foundation for Innovation (http://www.innovation.ca). S.J. is funded by the Canada Research Chair program (http://www.chairs-chaires.gc.ca). A.Y.L. and S. H. are funded by the NSERC, and R.P. by the Fonds de la recherche en santedu Quebec (http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barbara JG, 2002, BBA-PROTEINS PROTEOM, V1600, P12, DOI 10.1016/S1570-9639(02)00439-9; Bender AM, 2007, DEV BIOL, V302, P448, DOI 10.1016/j.ydbio.2006.09.051; Bender AM, 2004, DEV BIOL, V273, P335, DOI 10.1016/j.ydbio.2004.06.009; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Blake DJ, 2002, NEUROMUSCULAR DISORD, V12, pS110, DOI 10.1016/S0960-8966(02)00091-3; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; BOTTCHER SG, 2003, J STAT SOFTW, V8, P1; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Adamo P, 2004, EUR J NEUROSCI, V19, P1895, DOI 10.1111/j.1460-9568.2004.03270.x; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; de Voer G, 2008, BBA-MOL BASIS DIS, V1782, P433, DOI 10.1016/j.bbadis.2008.04.003; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2002, NEUROMUSCULAR DISORD, V12, P371, DOI 10.1016/S0960-8966(01)00330-3; Gilbert SF, 2001, J EXP ZOOL, V291, P1, DOI 10.1002/jez.1; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grote P, 2006, DEV CELL, V11, P561, DOI 10.1016/j.devcel.2006.07.015; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; Johnson RP, 2006, DEVELOPMENT, V133, P1911, DOI 10.1242/dev.02363; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kim H, 2004, NATURE, V430, P891, DOI 10.1038/nature02798; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lamprecht R, 2006, NEUROSCIENCE, V139, P821, DOI 10.1016/j.neuroscience.2005.12.055; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Mercer KB, 2006, MOL BIOL CELL, V17, P3832, DOI 10.1091/mbc.E06-02-0144; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Miskowski J, 2001, DEV BIOL, V230, P61, DOI 10.1006/dbio.2000.9998; MOORE D, 2009, INTRO PRACTISE STAT, P16; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; R Development Core Team, 2007, R LANG ENV STAT COMP; Riddle DL, 1997, C ELEGANS; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tokuoka SM, 2008, MOL BIOL CELL, V19, P2241, DOI 10.1091/mbc.E07-09-0982; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wissmann A, 1999, DEV BIOL, V209, P111, DOI 10.1006/dbio.1999.9242; Xu XJ, 2005, FEBS LETT, V579, P549, DOI 10.1016/j.febslet.2004.12.026; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	72	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10624	10.1371/journal.pone.0010624	http://dx.doi.org/10.1371/journal.pone.0010624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498707	Green Submitted, Green Published, gold			2022-12-27	WOS:000277633500013
J	Qin, JY; Zhang, L; Clift, KL; Hulur, I; Xiang, AP; Ren, BZ; Lahn, BT				Qin, Jane Yuxia; Zhang, Li; Clift, Kayla L.; Hulur, Imge; Xiang, Andy Peng; Ren, Bing-Zhong; Lahn, Bruce T.			Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter	PLOS ONE			English	Article							IMMEDIATE-EARLY PROMOTER; HORMONE GENE-EXPRESSION; LONG TERMINAL REPEAT; TUMOR-CELL-LINES; CMV PROMOTER; PLASMID VECTORS; VIRUS; OPTIMIZATION; MICE; DNA	Constitutive promoters are used routinely to drive ectopic gene expression. Here, we carried out a systematic comparison of eight commonly used constitutive promoters (SV40, CMV, UBC, EF1A, PGK and CAGG for mammalian systems, and COPIA and ACT5C for Drosophila systems). We also included in the comparison the TRE promoter, which can be activated by the rtTA transcriptional activator in a doxycycline-inducible manner. To make our findings representative, we conducted the comparison in a variety of cell types derived from several species. We found that these promoters vary considerably from one another in their strength. Most promoters have fairly consistent strengths across different cell types, but the CMV promoter can vary considerably from cell type to cell type. At maximal induction, the TRE promoter is comparable to a strong constitutive promoter. These results should facilitate more rational choices of promoters in ectopic gene expression studies.	[Qin, Jane Yuxia; Ren, Bing-Zhong] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Qin, Jane Yuxia; Zhang, Li; Clift, Kayla L.; Hulur, Imge; Lahn, Bruce T.] Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; [Xiang, Andy Peng] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Key Lab Stem Cells & Tissue Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Northeast Normal University - China; Howard Hughes Medical Institute; University of Chicago; Sun Yat Sen University	Qin, JY (corresponding author), NE Normal Univ, Sch Life Sci, Changchun, Peoples R China.	renbz279@nenu.edu.cn; blahn@bsd.uchicago.edu		Hulur, Imge/0000-0001-6252-0771	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study is funded by the Howard Hughes Medical Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum Buzz, 2008, V420, P391, DOI 10.1007/978-1-59745-583-1_25; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419; MARTINGALLARDO A, 1988, GENE, V70, P51, DOI 10.1016/0378-1119(88)90103-5; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Nguyen AT, 2008, J SURG RES, V148, P60, DOI 10.1016/j.jss.2008.02.016; OELLIG C, 1990, J NEUROSCI RES, V26, P390, DOI 10.1002/jnr.490260317; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PASLEAU F, 1985, GENE, V38, P227, DOI 10.1016/0378-1119(85)90221-5; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Xu ZL, 2001, GENE, V272, P149, DOI 10.1016/S0378-1119(01)00550-9; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yew NS, 1997, HUM GENE THER, V8, P575, DOI 10.1089/hum.1997.8.5-575	18	300	352	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10611	10.1371/journal.pone.0010611	http://dx.doi.org/10.1371/journal.pone.0010611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485554	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563400016
J	Strotmann, R; Semtner, M; Kepura, F; Plant, TD; Schoneberg, T				Strotmann, Rainer; Semtner, Marcus; Kepura, Frauke; Plant, Tim D.; Schoeneberg, Torsten			Interdomain Interactions Control Ca2+-Dependent Potentiation in the Cation Channel TRPV4	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CALMODULIN-BINDING DOMAIN; NUCLEOTIDE-GATED CHANNELS; HEAT-EVOKED ACTIVATION; PROTEIN-KINASE-C; EPITHELIAL-CELLS; CA2+ DEPENDENCE; ION-CHANNEL; VR-OAC; CALCIUM	Several Ca2+-permeable channels, including the non-selective cation channel TRPV4, are subject to Ca2+-dependent facilitation. Although it has been clearly demonstrated in functional experiments that calmodulin (CaM) binding to intracellular domains of TRP channels is involved in this process, the molecular mechanism remains elusive. In this study, we provide experimental evidence for a comprehensive molecular model that explains Ca2+-dependent facilitation of TRPV4. In the resting state, an intracellular domain from the channel N terminus forms an autoinhibitory complex with a C-terminal domain that includes a high-affinity CaM binding site. CaM binding, secondary to rises in intracellular Ca2+, displaces the N-terminal domain which may then form a homologous interaction with an identical domain from a second subunit. This represents a novel potentiation mechanism that may also be relevant in other Ca2+-permeable channels.	[Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Fak Med, Inst Biochem, Leipzig, Germany; [Semtner, Marcus; Kepura, Frauke; Plant, Tim D.] Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, D-3550 Marburg, Germany	Leipzig University; Philipps University Marburg	Strotmann, R (corresponding author), Univ Leipzig, Fak Med, Inst Biochem, Leipzig, Germany.	rainer.strotmann@medizin.uni-leipzig.de			IZKF Leipzig; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung	IZKF Leipzig; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the IZKF Leipzig, the Deutsche Forschungsgemeinschaft and Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; ARNIGES M, 2005, J BIOL CHEM; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hirnet D, 2003, CELL CALCIUM, V33, P509, DOI 10.1016/S0143-4160(03)00066-6; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Paszty K, 2002, J BIOL CHEM, V277, P36146, DOI 10.1074/jbc.M205457200; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zheng J, 2003, J NEUROSCI, V23, P8167; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10580	10.1371/journal.pone.0010580	http://dx.doi.org/10.1371/journal.pone.0010580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485495	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200014
J	Duarte, J; Agua-Doce, A; Oliveira, VG; Fonseca, JE; Graca, L				Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Fonseca, Joao Eurico; Graca, Luis			Modulation of IL-17 and Foxp3 Expression in the Prevention of Autoimmune Arthritis in Mice	PLOS ONE			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; TRANSPLANTATION TOLERANCE; CYTOKINE MILIEU; INDUCTION; INTERLEUKIN-17; CD4(+)CD25(+); RECRUITMENT	Background: Rheumatoid Arthritis (RA) is a chronic immune mediated disease associated with deregulation of many cell types. It has been reported that different T cell subsets have opposite effects in disease pathogenesis, in particular Th17 and Treg cells. Methodology and Findings: We investigated whether non-depleting anti-CD4 monoclonal antibodies, which have been reported as pro-tolerogenic, can lead to protection from chronic autoimmune arthritis in SKG mice - a recently described animal model of RA - by influencing the Th17/Treg balance. We found that non-depleting anti-CD4 prevented the onset of chronic autoimmune arthritis in SKG mice. Moreover, treated mice were protected from the induction of arthritis up to 60 days following anti-CD4 treatment, while remaining able to mount CD4-dependent immune responses to unrelated antigens. The antibody treatment also prevented disease progression in arthritic mice, although without leading to remission. Protection from arthritis was associated with an increased ratio of Foxp3, and decreased IL-17 producing T cells in the synovia. In vitro assays under Th17-polarizing conditions showed CD4-blockade prevents Th17 polarization, while favoring Foxp3 induction. Conclusions: Non-depleting anti-CD4 can therefore induce long-term protection from chronic autoimmune arthritis in SKG mice through reciprocal changes in the frequency of Treg and Th17 cells in peripheral tissues, thus shifting the balance towards immune tolerance.	[Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Fonseca, Joao Eurico; Graca, Luis] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Duarte, Joana; Agua-Doce, Ana; Oliveira, Vanessa G.; Graca, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Fonseca, Joao Eurico] Hosp Santa Maria, Dept Rheumatol, Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria	Duarte, J (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	lgraca@fm.ul.pt	iMed.ULisboa, EEPHIV/B-4222-2014; Duarte, Joana/A-6184-2014; Graca, Luis/B-8887-2008; Agua-Doce, Ana/L-2997-2014	Duarte, Joana/0000-0002-5736-9138; Graca, Luis/0000-0001-6935-8500; Goncalves de Oliveira, Vanessa Alexandra/0000-0001-6884-2675; Fonseca, Joao/0000-0003-1432-3671; Agua-Doce, Ana/0000-0002-0466-7297	SUDOE [IMMUNONET-SOE1/1P1/E014]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [FCT/POCI/SAU-MMO/55974/2004]; FCT [SFRH/BD/23631/2005, SFRH/BD/49093/2008, SFRH/BPD/22575/2005]	SUDOE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by SUDOE, grant number IMMUNONET-SOE1/1P1/E014, and supported by a research grant from Fundacao para a Ciencia e Tecnologia (FCT), Portugal (FCT/POCI/SAU-MMO/55974/2004). JD, AA-D, and VGO are funded with scholarships from FCT (SFRH/BD/23631/2005, SFRH/BD/49093/2008, and SFRH/BPD/22575/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 1992, CELL IMMUNOL, V144, P347, DOI 10.1016/0008-8749(92)90250-S; BREEDVELD FC, 1989, CELL IMMUNOL, V121, P1, DOI 10.1016/0008-8749(89)90001-4; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chehata JC, 2001, RHEUMATOLOGY, V40, P447, DOI 10.1093/rheumatology/40.4.447; Choy EHS, 2000, RHEUMATOLOGY, V39, P1139, DOI 10.1093/rheumatology/39.10.1139; Chu CQ, 1996, J IMMUNOL, V157, P2685; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Coppieters K, 2007, RHEUMATOLOGY, V46, P565, DOI 10.1093/rheumatology/kel437; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Graca L, 2004, P NATL ACAD SCI USA, V101, P10122, DOI 10.1073/pnas.0400084101; Graca L, 2003, IMMUNOL RES, V28, P181, DOI 10.1385/IR:28:3:181; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Graca L, 2006, METH MOL B, V333, P247; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; HERZOG C, 1987, LANCET, V2, P1461; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HORNEFF G, 1991, ARTHRITIS RHEUM, V34, P129, DOI 10.1002/art.1780340202; HORNEFF G, 1991, CLIN IMMUNOL IMMUNOP, V59, P89, DOI 10.1016/0090-1229(91)90084-N; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Isaacs JD, 2007, CURR OPIN PHARMACOL, V7, P418, DOI 10.1016/j.coph.2007.05.001; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Karim M, 2002, CURR OPIN IMMUNOL, V14, P584, DOI 10.1016/S0952-7915(02)00379-5; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Mason U, 2002, J RHEUMATOL, V29, P220; Mauri C, 1997, J IMMUNOL, V159, P5032; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; Ranges G E, 1988, Int Rev Immunol, V4, P83, DOI 10.3109/08830188809044772; RANGES GE, 1985, J EXP MED, V162, P1105, DOI 10.1084/jem.162.3.1105; REITER C, 1991, ARTHRITIS RHEUM-US, V34, P525, DOI 10.1002/art.1780340504; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schulze-Koops H, 1999, DRUG TODAY, V35, P327, DOI 10.1358/dot.1999.35.4-5.552208; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	46	37	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10558	10.1371/journal.pone.0010558	http://dx.doi.org/10.1371/journal.pone.0010558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479941	Green Published, gold			2022-12-27	WOS:000277467900014
J	Kim, H; Lee, BS; Tomita, M; Kanai, A				Kim, Hyunchul; Lee, Baek-Seok; Tomita, Masaru; Kanai, Akio			Transcription-Associated Mutagenesis Increases Protein Sequence Diversity More Effectively than Does Random Mutagenesis in Escherichia coli	PLOS ONE			English	Article							BASE-SUBSTITUTION MUTATIONS; NONTRANSCRIBED STRAND; THYMINE MUTATIONS; DNA-SEQUENCES; EVOLUTION; RATES; GENE; FRAMESHIFT; MODEL; PAIRS	Background: During transcription, the nontranscribed DNA strand becomes single-stranded DNA (ssDNA), which can form secondary structures. Unpaired bases in the ssDNA are less protected from mutagens and hence experience more mutations than do paired bases. These mutations are called transcription-associated mutations. Transcription-associated mutagenesis is increased under stress and depends on the DNA sequence. Therefore, selection might significantly influence protein-coding sequences in terms of the transcription-associated mutability per transcription event under stress to improve the survival of Escherichia coli. Methodology/Principal Findings: The mutability index (MI) was developed by Wright et al. to estimate the relative transcription-associated mutability of bases per transcription event. Using the most stable fold of each ssDNA that have an average length n, MI was defined as (the number of folds in which the base is unpaired)/nx(highest-Delta G of all n folds in which the base is unpaired), where Delta G is the free energy. The MI values show a significant correlation with mutation data under stress but not with spontaneous mutations in E. coli. Protein sequence diversity is preferred under stress but not under favorable conditions. Therefore, we evaluated the selection pressure on MI in terms of the protein sequence diversity for all the protein-coding sequences in E. coli. The distributions of the MI values were lower at bases that could be substituted with each of the other three bases without affecting the amino acid sequence than at bases that could not be so substituted. Start codons had lower distributions of MI values than did nonstart codons. Conclusions/Significance: Our results suggest that the majority of protein-coding sequences have evolved to promote protein sequence diversity and to reduce gene knockout under stress. Consequently, transcription-associated mutagenesis increases protein sequence diversity more effectively than does random mutagenesis under stress. Nonrandom transcription-associated mutagenesis under stress should improve the survival of E. coli.	[Kim, Hyunchul; Lee, Baek-Seok; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Kim, Hyunchul; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan	Keio University; Keio University	Kim, H (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014	Kanai, Akio/0000-0002-6362-2419	Keio University Global Center; Yamagata prefectural government; Tsuruoka City, Japan	Keio University Global Center; Yamagata prefectural government; Tsuruoka City, Japan	This research was supported in part by a Grant-in-Aid from Keio University Global Center of Excellence Program and Mori memorial grant and by research funds from the Yamagata prefectural government and Tsuruoka City, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Beletskii A, 2001, J BACTERIOL, V183, P6491, DOI 10.1128/JB.183.21.6491-6493.2001; Beletskii A, 2000, J MOL BIOL, V300, P1057, DOI 10.1006/jmbi.2000.3944; Burkala E, 2007, MICROBIOL-SGM, V153, P2180, DOI 10.1099/mic.0.2007/005470-0; Da Sylva TR, 2009, MUTAT RES-FUND MOL M, V670, P68, DOI 10.1016/j.mrfmmm.2009.07.008; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; Day MJ, 2004, MICROBIAL EVOLUTION: GENE ESTABLISHMENT, SURVIVAL, AND EXCHANGE, P290; DEBOER JG, 1984, P NATL ACAD SCI-BIOL, V81, P5528; Drake JW, 1998, GENETICS, V148, P1667; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fix D, 2008, DNA REPAIR, V7, P1289, DOI 10.1016/j.dnarep.2008.04.008; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hoede C, 2006, PLOS GENET, V2, P1697, DOI 10.1371/journal.pgen.0020176; Hudson RE, 2003, NUCLEIC ACIDS RES, V31, P4517, DOI 10.1093/nar/gkg651; Klapacz J, 2005, DNA REPAIR, V4, P806, DOI 10.1016/j.dnarep.2005.04.017; Klapacz J, 2002, J BACTERIOL, V184, P6866, DOI 10.1128/JB.184.24.6866-6872.2002; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; R Core Team, 2018, R LANG ENV STAT COMP; Reimers JM, 2004, MICROBIOL-SGM, V150, P1457, DOI 10.1099/mic.0.26954-0; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; SKANDALIS A, 1994, MUTAT RES, V314, P21, DOI 10.1016/0921-8777(94)90057-4; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; WILLIAMS LD, 1987, P NATL ACAD SCI USA, V84, P1779, DOI 10.1073/pnas.84.7.1779; Wright BE, 2008, MOL IMMUNOL, V45, P3600, DOI 10.1016/j.molimm.2008.05.012; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10567	10.1371/journal.pone.0010567	http://dx.doi.org/10.1371/journal.pone.0010567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479947	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467900019
J	Rowland, JG; Pang, X; Suzuki, I; Murata, N; Simon, WJ; Slabas, AR				Rowland, John G.; Pang, Xin; Suzuki, Iwane; Murata, Norio; Simon, William J.; Slabas, Antoni R.			Identification of Components Associated with Thermal Acclimation of Photosystem II in Synechocystis sp PCC6803	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; BLUE-GREEN-ALGAE; SP PCC 6803; HIGH-TEMPERATURE; GENE-EXPRESSION; MEMBRANE-LIPIDS; CHILLING SENSITIVITY; SP PCC-6803; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES	Background: Photosystem II (PSII) is the most thermally sensitive component of photosynthesis. Thermal acclimation of this complex activity is likely to be critically important to the ability of photosynthetic organisms to tolerate temperature changes in the environment. Methodology/Findings: We have analysed gene expression using whole-genome microarrays and monitored alterations in physiology during acclimation of PSII to elevated growth temperature in Synechocystis sp. PCC 6803. PSII acclimation is complete within 480 minutes of exposure to elevated temperature and is associated with a highly dynamic transcriptional response. 176 genes were identified and classified into seven distinct response profile groups. Response profiles suggest the existence of an early transient phase and a sustained phase to the acclimation response. The early phase was characterised by induction of general stress response genes, including heat shock proteins, which are likely to influence PSII thermal stability. The sustained phase consisted of acclimation-specific alterations that are involved in other cellular processes. Sustained responses included genes involved in phycobillisome structure and modification, photosynthesis, respiration, lipid metabolism and motility. Approximately 60% of genes with sustained altered expression levels have no known function. The potential role of differentially expressed genes in thermotolerance and acclimation is discussed. We have characterised the acclimation physiology of selected gene 'knockouts' to elucidate possible gene function in the response. Conclusions/Significance: All mutants show lower PSII rates under normal growth conditions. Basal PSII thermotolerance was affected by mutations in clpB1, cpcC2, hspA, htpG and slr1674. Final PSII thermotolerance was affected by mutations in cpcC2, hik34, hspA and hypA1, suggesting that these gene products play roles in long-term thermal acclimation of PSII.	[Rowland, John G.; Pang, Xin; Simon, William J.; Slabas, Antoni R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Suzuki, Iwane] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Murata, Norio] Natl Inst Basic Biol, Dept Regulat Biol, Okazaki, Japan	Durham University; University of Tsukuba; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Rowland, JG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.slabas@durham.ac.uk	Murata, Norio/E-6569-2010; Rowland, John/B-5783-2008; Murata, Norio/O-7945-2019	Rowland, John/0000-0002-9819-1540; Murata, Norio/0000-0002-6605-5800	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C503946/1]; BBSRC [BB/H014241/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503946/1, BB/H014241/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk) grant number BB/C503946/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal TK, 2005, J APPL MICROBIOL, V98, P114, DOI 10.1111/j.1365-2672.2004.02431.x; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Do JH, 2008, MOL CELLS, V25, P279; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson MJ, 1996, J BACTERIOL, V178, P4839, DOI 10.1128/jb.178.16.4839-4846.1996; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P3584, DOI 10.1128/jb.170.8.3584-3592.1988; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GOMBOS Z, 1994, PLANT PHYSIOL, V104, P563, DOI 10.1104/pp.104.2.563; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; IshizakiNishizawa O, 1996, NAT BIOTECHNOL, V14, P1003, DOI 10.1038/nbt0896-1003; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; KATOH S, 1967, ARCH BIOCHEM BIOPHYS, V122, P144, DOI 10.1016/0003-9861(67)90133-6; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; KOVACS E, 1994, PLANT PHYSIOL BIOCH, V32, P285; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Marin K, 2004, PLANT PHYSIOL, V136, P3290, DOI 10.1104/pp.104.045047; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; MOON BY, 1995, P NATL ACAD SCI USA, V92, P6219, DOI 10.1073/pnas.92.14.6219; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; MURATA N, 1995, BIOCHEM J, V308, P1; Nefedova L. N., 2003, Genetika, V39, P478; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; NISHIYAMA Y, 1994, PLANT PHYSIOL, V105, P1313, DOI 10.1104/pp.105.4.1313; NISHIYAMA Y, 1993, PLANT CELL PHYSIOL, V34, P337; Nishiyama Y, 2006, PHOTOSYNTH RES, V90, P223, DOI 10.1007/s11120-007-9138-4; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Sakamoto T, 1997, MOL MICROBIOL, V23, P1281, DOI 10.1046/j.1365-2958.1997.3071676.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; SANTARIUS KA, 1976, J THERM BIOL, V1, P101, DOI 10.1016/0306-4565(76)90028-0; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Tanaka Y, 2000, PLANT PHYSIOL, V124, P441, DOI 10.1104/pp.124.1.441; Tolle J, 2002, MICROBIOL-SGM, V148, P3293, DOI 10.1099/00221287-148-10-3293; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; WADA H, 1994, P NATL ACAD SCI USA, V91, P4273, DOI 10.1073/pnas.91.10.4273; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; Webb R., 1994, MOL BIOL CYANOBACTER, P751; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; WOLTER FP, 1992, EMBO J, V11, P4685, DOI 10.1002/j.1460-2075.1992.tb05573.x; Yamaguchi K, 2002, PLANT CELL, V14, P2901, DOI 10.1105/tpc.006262; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; YAMASHITA T, 1968, PLANT PHYSIOL, V43, P2037, DOI 10.1104/pp.43.12.2037; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	71	27	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10511	10.1371/journal.pone.0010511	http://dx.doi.org/10.1371/journal.pone.0010511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463904	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000277379800007
J	Alexeyenko, A; Wassenberg, DM; Lobenhofer, EK; Yen, J; Linney, E; Sonnhammer, ELL; Meyer, JN				Alexeyenko, Andrey; Wassenberg, Deena M.; Lobenhofer, Edward K.; Yen, Jerry; Linney, Elwood; Sonnhammer, Erik L. L.; Meyer, Joel N.			Dynamic Zebrafish Interactome Reveals Transcriptional Mechanisms of Dioxin Toxicity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; TROUT ONCORHYNCHUS-MYKISS; APOPTOTIC CELL-DEATH; CHICKEN-EMBRYO HEPATOCYTES; OXIDATIVE STRESS-RESPONSE; UP RAINBOW-TROUT; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; DEVELOPMENTAL TOXICITY; CYTOCHROME-P450 1A	Background: In order to generate hypotheses regarding the mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) causes toxicity, we analyzed global gene expression changes in developing zebrafish embryos exposed to this potent toxicant in the context of a dynamic gene network. For this purpose, we also computationally inferred a zebrafish (Danio rerio) interactome based on orthologs and interaction data from other eukaryotes. Methodology/Principal Findings: Using novel computational tools to analyze this interactome, we distinguished between dioxin-dependent and dioxin-independent interactions between proteins, and tracked the temporal propagation of dioxin-dependent transcriptional changes from a few genes that were altered initially, to large groups of biologically coherent genes at later times. The most notable processes altered at later developmental stages were calcium and iron metabolism, embryonic morphogenesis including neuronal and retinal development, a variety of mitochondria-related functions, and generalized stress response (not including induction of antioxidant genes). Within the interactome, many of these responses were connected to cytochrome P4501A (cyp1a) as well as other genes that were dioxin-regulated one day after exposure. This suggests that cyp1a may play a key role initiating the toxic dysregulation of those processes, rather than serving simply as a passive marker of dioxin exposure, as suggested by earlier research. Conclusions/Significance: Thus, a powerful microarray experiment coupled with a flexible interactome and multi-pronged interactome tools (which are now made publicly available for microarray analysis and related work) suggest the hypothesis that dioxin, best known in fish as a potent cardioteratogen, has many other targets. Many of these types of toxicity have been observed in mammalian species and are potentially caused by alterations to cyp1a.	[Alexeyenko, Andrey; Sonnhammer, Erik L. L.] Stockholm Univ, Stockholm Bioinformat Ctr, S-10691 Stockholm, Sweden; [Wassenberg, Deena M.; Yen, Jerry; Linney, Elwood] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Lobenhofer, Edward K.] Cogenics, Morrisville, NC USA; [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Stockholm University; Duke University; Duke University	Alexeyenko, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	joel.meyer@duke.edu	Alexeyenko, Andrey/F-1924-2016; Meyer, Joel/G-9836-2017	Alexeyenko, Andrey/0000-0001-8812-6481; Meyer, Joel/0000-0003-1219-0983; Sonnhammer, Erik/0000-0002-9015-5588	National Institutes of Health [ES011375, ES10356]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES011375, P42ES010356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health ES011375 and ES10356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Aragon AC, 2008, TOXICOL SCI, V101, P321, DOI 10.1093/toxsci/kfm272; Augspurger TP, 2008, ARCH ENVIRON CON TOX, V55, P659, DOI 10.1007/s00244-008-9198-2; Baccarelli A, 2002, ENVIRON HEALTH PERSP, V110, P1169, DOI 10.1289/ehp.021101169; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belair CD, 2001, DEV DYNAM, V222, P581, DOI 10.1002/dvdy.1213; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Billiard SM, 2008, TOXICOL SCI, V105, P5, DOI 10.1093/toxsci/kfm303; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; Blankenship AL, 2003, COMP BIOCHEM PHYS C, V136, P47, DOI 10.1016/S1532-0456(03)00166-2; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Cantrell SM, 1998, TOXICOL APPL PHARM, V148, P24, DOI 10.1006/taap.1997.8309; Cantrell SM, 1996, TOXICOL APPL PHARM, V141, P23; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carney SA, 2004, MOL PHARMACOL, V66, P512; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Carvalho PSM, 2004, ENVIRON SCI TECHNOL, V38, P6300, DOI 10.1021/es034857i; Carvalho PSM, 2004, COMP BIOCHEM PHYS C, V137, P133, DOI 10.1016/j.cca.2003.12.005; Chen J, 2008, PHYSIOL GENOMICS, V33, P148, DOI 10.1152/physiolgenomics.00214.2007; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; Davies R, 2008, CHEM RES TOXICOL, V21, P330, DOI 10.1021/tx700176r; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Dragin N, 2008, MOL PHARMACOL, V73, P1844, DOI 10.1124/mol.108.045658; Dragin N, 2006, J BIOL CHEM, V281, P18591, DOI 10.1074/jbc.M601159200; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Frueh FW, 2001, TOXICOL LETT, V122, P189, DOI 10.1016/S0378-4274(01)00364-2; Genter MB, 2006, BIOCHEM BIOPH RES CO, V342, P1375, DOI 10.1016/j.bbrc.2006.02.121; Goldstone HMH, 2006, DRUG METAB REV, V38, P261, DOI 10.1080/03602530600570099; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn ME, 1996, ARCH BIOCHEM BIOPHYS, V329, P163, DOI 10.1006/abbi.1996.0205; Hahn ME, 2001, MAR BIOTECHNOL, V3, pS224, DOI 10.1007/s10126-001-0045-Y; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241; Hodson PV, 2007, AQUAT TOXICOL, V81, P275, DOI 10.1016/j.aquatox.2006.12.012; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; HUITSON A, 1966, ANAL VARIANCE; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ivnitski I, 2001, TERATOLOGY, V64, P201, DOI 10.1002/tera.1065; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lorenzen A, 1997, BIOCHEM PHARMACOL, V53, P373, DOI 10.1016/S0006-2952(96)00739-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Miettinen HM, 2004, TOXICOL LETT, V150, P285, DOI 10.1016/j.toxlet.2004.02.009; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Park JYK, 1996, P NATL ACAD SCI USA, V93, P2322, DOI 10.1073/pnas.93.6.2322; Pelclova Daniela, 2006, Reviews on Environmental Health, V21, P119; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; Puga A, 2000, BIOCHEM PHARMACOL, V60, P1129, DOI 10.1016/S0006-2952(00)00403-2; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Schlezinger JJ, 2006, AQUAT TOXICOL, V77, P422, DOI 10.1016/j.aquatox.2006.01.012; Schlezinger JJ, 2001, AQUAT TOXICOL, V52, P101, DOI 10.1016/S0166-445X(00)00141-7; Senft AP, 2002, TOXICOL APPL PHARM, V178, P15, DOI 10.1006/taap.2001.9314; Shertzer HG, 1998, BIOCHEM BIOPH RES CO, V253, P44, DOI 10.1006/bbrc.1998.9753; Shertzer HG, 2004, FREE RADICAL BIO MED, V36, P618, DOI 10.1016/j.freeradbiomed.2003.11.014; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Sul D, 2009, TOXICOLOGY, V255, P65, DOI 10.1016/j.tox.2008.10.006; Teraoka H, 2003, BIOCHEM BIOPH RES CO, V304, P223, DOI 10.1016/S0006-291X(03)00576-X; Thackaberry EA, 2005, TOXICOL SCI, V88, P231, DOI 10.1093/toxsci/kfi301; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tittlemier SA, 2003, ENVIRON TOXICOL CHEM, V22, P1622, DOI 10.1002/etc.5620220726; Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; Urban P, 2007, EUR J NEUROL, V14, P213, DOI 10.1111/j.1468-1331.2006.01618.x; Vezina CM, 2009, BIOCHEM PHARMACOL, V77, P566, DOI 10.1016/j.bcp.2008.09.039; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yeager RL, 2006, REPROD TOXICOL, V22, P811, DOI 10.1016/j.reprotox.2006.07.004; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; [No title captured]	92	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10465	10.1371/journal.pone.0010465	http://dx.doi.org/10.1371/journal.pone.0010465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463971	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400014
J	Beck, J; Sieber, A				Beck, Jan; Sieber, Andrea			Is the Spatial Distribution of Mankind's Most Basic Economic Traits Determined by Climate and Soil Alone?	PLOS ONE			English	Article							SPECIES DISTRIBUTION; GEOGRAPHIC DISTRIBUTIONS; NEOLITHIC REVOLUTION; BIOGEOGRAPHY; CONSEQUENCES; BIODIVERSITY; EVOLUTION; FRAMEWORK; SELECTION; MODELS	Background: Several authors, most prominently Jared Diamond (1997, Guns, Germs and Steel), have investigated biogeographic determinants of human history and civilization. The timing of the transition to an agricultural lifestyle, associated with steep population growth and consequent societal change, has been suggested to be affected by the availability of suitable organisms for domestication. These factors were shown to quantitatively explain some of the current global inequalities of economy and political power. Here, we advance this approach one step further by looking at climate and soil as sole determining factors. Methodology/Principal Findings: As a simplistic 'null model', we assume that only climate and soil conditions affect the suitability of four basic landuse types - agriculture, sedentary animal husbandry, nomadic pastoralism and hunting-and-gathering. Using ecological niche modelling (ENM), we derive spatial predictions of the suitability for these four landuse traits and apply these to the Old World and Australia. We explore two aspects of the properties of these predictions, conflict potential and population density. In a calculation of overlap of landuse suitability, we map regions of potential conflict between landuse types. Results are congruent with a number of real, present or historical, regions of conflict between ethnic groups associated with different landuse traditions. Furthermore, we found that our model of agricultural suitability explains a considerable portion of population density variability. We mapped residuals from this correlation, finding geographically highly structured deviations that invite further investigation. We also found that ENM of agricultural suitability correlates with a metric of local wealth generation (Gross Domestic Product, Purchasing Power Parity). Conclusions/Significance: From simplified assumptions on the links between climate, soil and landuse we are able to provide good predictions on complex features of human geography. The spatial distribution of deviations from ENM predictions identifies those regions requiring further investigation of potential explanations. Our findings and methodological approaches may be of applied interest, e.g., in the context of climate change.	[Beck, Jan; Sieber, Andrea] Univ Basel, Dept Environm Sci, Basel, Switzerland	University of Basel	Beck, J (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	jan.beck@unibas.ch	Beck, Jan/L-5659-2015	Beck, Jan/0000-0003-1170-4751	Swiss National Science Foundation (SNF) [31003A_119879]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	JB is supported by the Swiss National Science Foundation (SNF Grant 31003A_119879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Brown C, 2006, NAT RESOUR FORUM, V30, P306, DOI 10.1111/j.1477-8947.2006.00118.x; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Collier P., 2007, BOTTOM BILLION WHY P; Dawkins Richard, 1976, SELFISH GENE; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Diamond J., 1997, GUNS GERMS STEEL SHO; Diamond J., 2011, COLLAPSE SOC CHOOSE; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Easterly W, 2003, J MONETARY ECON, V50, P3, DOI 10.1016/S0304-3932(02)00200-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Erb KH, 2009, ECOL ECON, V69, P328, DOI 10.1016/j.ecolecon.2009.06.025; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; GOTELLI NJ, 2008, IBS NEWSLETTER, V6, P3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hibbs DA, 2004, P NATL ACAD SCI USA, V101, P3715, DOI 10.1073/pnas.0305531101; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Koch NE, 1999, NEW FOREST, V17, P11, DOI 10.1023/A:1006520809425; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Munguia M, 2008, J BIOGEOGR, V35, P1879, DOI 10.1111/j.1365-2699.2008.01921.x; Newbold T, 2009, BIODIVERS CONSERV, V18, P3629, DOI 10.1007/s10531-009-9668-5; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Olsson O, 2005, EUR ECON REV, V49, P909, DOI 10.1016/j.euroecorev.2003.08.010; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Peterson AT, 2009, FRONTIERS BIOGEOGRAP, V1, P19, DOI DOI 10.21425/F5FBG12232; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Putterman L, 2008, ECONOMICA, V75, P729, DOI 10.1111/j.1468-0335.2007.00652.x; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reader J., 1998, AFRICA BIOGRAPHY CON; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Sachs J., 2001, GEOGRAPHY POVERTY WE, P71; Schwanghart W, 2008, GLOBAL ECOL BIOGEOGR, V17, P566, DOI 10.1111/j.1466-8238.2008.00390.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; STOCKWELL D, 2007, MATH COMPUTATIONAL B; TAYLOR M, 2003, REV INT ECON, V11, P436, DOI DOI 10.1016/J.JOEP.2006.04.003; WEISCHET W, 1977, OKOLOGISCHE BENACHTE; Weisdorf JL, 2005, J ECON SURV, V19, P561, DOI 10.1111/j.0950-0804.2005.00259.x; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	47	21	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10416	10.1371/journal.pone.0010416	http://dx.doi.org/10.1371/journal.pone.0010416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592LC	20463959	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400005
J	Poplawski, NJ; Shirinifard, A; Agero, U; Gens, JS; Swat, M; Glazier, JA				Poplawski, Nikodem J.; Shirinifard, Abbas; Agero, Ubirajara; Gens, J. Scott; Swat, Maciej; Glazier, James A.			Front Instabilities and Invasiveness of Simulated 3D Avascular Tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LUNG BRANCHING MORPHOGENESIS; CELLULAR-AUTOMATON MODEL; HEPATOCYTE GROWTH-FACTOR; B-16 MELANOMA-CELLS; MATHEMATICAL-MODEL; NONLINEAR SIMULATION; EMBRYONIC-TISSUES; SCATTER-FACTOR; EXTRACELLULAR-MATRIX	We use the Glazier-Graner-Hogeweg model to simulate three-dimensional (3D), single-phenotype, avascular tumors growing in an homogeneous tissue matrix (TM) supplying a single limiting nutrient. We study the effects of two parameters on tumor morphology: a diffusion-limitation parameter defined as the ratio of the tumor-substrate consumption rate to the substrate-transport rate, and the tumor-TM surface tension. This initial model omits necrosis and oxidative/hypoxic metabolism effects, which can further influence tumor morphology, but our simplified model still shows significant parameter dependencies. The diffusion-limitation parameter determines whether the growing solid tumor develops a smooth (noninvasive) or fingered (invasive) interface, as in our earlier two-dimensional (2D) simulations. The sensitivity of 3D tumor morphology to tumor-TM surface tension increases with the size of the diffusion-limitation parameter, as in 2D. The 3D results are unexpectedly close to those in 2D. Our results therefore may justify using simpler 2D simulations of tumor growth, instead of more realistic but more computationally expensive 3D simulations. While geometrical artifacts mean that 2D sections of connected 3D tumors may be disconnected, the morphologies of 3D simulated tumors nevertheless correlate with the morphologies of their 2D sections, especially for low-surface-tension tumors, allowing the use of 2D sections to partially reconstruct medically-important 3D-tumor structures.	[Poplawski, Nikodem J.; Shirinifard, Abbas; Gens, J. Scott; Swat, Maciej; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA; [Poplawski, Nikodem J.; Shirinifard, Abbas; Gens, J. Scott; Swat, Maciej; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Agero, Ubirajara] Univ Fed Minas Gerais, Dept Fis, BR-30161 Belo Horizonte, MG, Brazil	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidade Federal de Minas Gerais	Poplawski, NJ (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA.	nipoplaw@indiana.edu	Agero, Ubirajara/B-2254-2010; Complexos, INCT Fluidos/H-9172-2013	Agero, Ubirajara/0000-0002-4987-9031; Glazier, James Alexander/0000-0003-3634-190X	National Institutes of Health, National Institute of General Medical Sciences [R01 GM76692, R01 GM077138]; Biocomplexity Institute at Indiana University; Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biocomplexity Institute at Indiana University; Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health, National Institute of General Medical Sciences grants R01 GM76692 and R01 GM077138, the Biocomplexity Institute at Indiana University and the Indiana University Faculty Research Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; BALTER A, 2007, SINGLE CELL BASED MO; Bello L, 2001, CANCER RES, V61, P8730; Beysens DA, 2000, CAN J PHYS, V78, P243, DOI 10.1139/cjp-78-3-243; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; BYRNE HM, 1999, J THEOR MED, V1, P275; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; CHAPLAIN MAJ, 1993, J MATH BIOL, V31, P431, DOI 10.1007/BF00173886; Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033; Chaturvedi R, 2004, LECT NOTES COMPUT SC, V3305, P543; Chaturvedi R, 2003, LECT NOTES COMPUT SC, V2659, P39; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; CICKOVSKI TM, 2005, ACM T COMP BIOL BIOI, V2, P1; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Deisboeck TS, 2008, MED HYPOTHESES, V71, P186, DOI 10.1016/j.mehy.2008.02.010; DORMANN S, 2002, SILICO BIOL, V2, P35; Duchting W, 1996, EUR J CANCER, V32A, P1283, DOI 10.1016/0959-8049(96)00075-5; DUCHTING W, 1990, COMPUT GRAPH, V14, P505, DOI 10.1016/0097-8493(90)90073-7; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Foty RA, 1996, DEVELOPMENT, V122, P1611; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Glazier J. A., 2007, SINGLE CELL BASED MO; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guiot C, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-4; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartmann D, 2006, J THEOR BIOL, V242, P862, DOI 10.1016/j.jtbi.2006.05.009; HOLM EA, 1991, PHYS REV A, V43, P2662, DOI 10.1103/PhysRevA.43.2662; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; KIMMEL M, 1991, J THEOR BIOL, V153, P157, DOI 10.1016/S0022-5193(05)80420-5; KLOMINEK J, 1993, CANCER RES, V53, P4376; LACOVARA J, 1984, CANCER RES, V44, P1657; Lawrence JA, 1996, WORLD J UROL, V14, P124; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li XR, 2007, DISCRETE CONT DYN-B, V7, P581; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIOTTA LA, 1983, LAB INVEST, V49, P636; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; MCCARTHY JB, 1984, J CELL BIOL, V98, P1474, DOI 10.1083/jcb.98.4.1474; MELICOW MM, 1982, J THEOR BIOL, V94, P471, DOI 10.1016/0022-5193(82)90322-8; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Moore MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030601; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; Orme ME, 1996, MATH COMPUT MODEL, V23, P43, DOI 10.1016/0895-7177(96)00053-2; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perumpanani AJ, 1996, INVAS METAST, V16, P209; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; QUIGLEY JP, 1983, J CELL BIOL, V97, pA450; Rejniak KA, 2005, MATH BIOSCI ENG, V2, P643, DOI 10.3934/mbe.2005.2.643; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; SHERRATT JA, 1992, P ROY SOC B-BIOL SCI, V248, P261, DOI 10.1098/rspb.1992.0071; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SMOLLE J, 1993, J THEOR BIOL, V160, P63, DOI 10.1006/jtbi.1993.1004; STETLERSTEVENSO.WG, 1996, CANC BIOL, V7, P147; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; Tracqui P, 1995, ACTA BIOTHEOR, V43, P443, DOI 10.1007/BF00713564; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Turner S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021910; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wang ZH, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-50; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; Weinberg RA, 2006, BIOL CANC; WHELDON TE, 1986, MATH METHODS MED; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	101	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10641	10.1371/journal.pone.0010641	http://dx.doi.org/10.1371/journal.pone.0010641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520818	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221500003
J	Richardson, CR; Luo, QJ; Gontcharova, V; Jiang, YW; Samanta, M; Youn, E; Rock, CD				Richardson, Casey R.; Luo, Qing-Jun; Gontcharova, Viktoria; Jiang, Ying-Wen; Samanta, Manoj; Youn, Eunseog; Rock, Christopher D.			Analysis of Antisense Expression by Whole Genome Tiling Microarrays and siRNAs Suggests Mis-Annotation of Arabidopsis Orphan Protein-Coding Genes	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CAP-BINDING COMPLEX; MESSENGER-RNA; NONCODING RNAS; WIDE ANALYSIS; COMPUTATIONAL PREDICTION; THALIANA MICRORNAS; REGULATORY ROLES; DNA METHYLATION; PLANT MICRORNAS	Background: MicroRNAs (miRNAs) and trans-acting small-interfering RNAs (tasi-RNAs) are small (20-22 nt long) RNAs (smRNAs) generated from hairpin secondary structures or antisense transcripts, respectively, that regulate gene expression by Watson-Crick pairing to a target mRNA and altering expression by mechanisms related to RNA interference. The high sequence homology of plant miRNAs to their targets has been the mainstay of miRNA prediction algorithms, which are limited in their predictive power for other kingdoms because miRNA complementarity is less conserved yet transitive processes (production of antisense smRNAs) are active in eukaryotes. We hypothesize that antisense transcription and associated smRNAs are biomarkers which can be computationally modeled for gene discovery. Principal Findings: We explored rice (Oryza sativa) sense and antisense gene expression in publicly available whole genome tiling array transcriptome data and sequenced smRNA libraries (as well as C. elegans) and found evidence of transitivity of MIRNA genes similar to that found in Arabidopsis. Statistical analysis of antisense transcript abundances, presence of antisense ESTs, and association with smRNAs suggests several hundred Arabidopsis 'orphan' hypothetical genes are non-coding RNAs. Consistent with this hypothesis, we found novel Arabidopsis homologues of some MIRNA genes on the antisense strand of previously annotated protein-coding genes. A Support Vector Machine (SVM) was applied using thermodynamic energy of binding plus novel expression features of sense/antisense transcription topology and siRNA abundances to build a prediction model of miRNA targets. The SVM when trained on targets could predict the "ancient'' (deeply conserved) class of validated Arabidopsis MIRNA genes with an accuracy of 84%, and 76% for "new'' rapidly-evolving MIRNA genes. Conclusions: Antisense and smRNA expression features and computational methods may identify novel MIRNA genes and other non-coding RNAs in plants and potentially other kingdoms, which can provide insight into antisense transcription, miRNA evolution, and post-transcriptional gene regulation.	[Richardson, Casey R.; Luo, Qing-Jun; Jiang, Ying-Wen; Rock, Christopher D.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Gontcharova, Viktoria; Youn, Eunseog] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA; [Samanta, Manoj] Systemix Inst, Redmond, WA USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Richardson, CR (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	chris.rock@ttu.edu		, Christopher/0000-0002-2090-0650	National Institutes of Health (NIH) [R21GM077245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM077245] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R21GM077245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Ansari AZ, 2009, CRIT REV BIOCHEM MOL, V44, P50, DOI [10.1080/10409230902734044, 10.1080/10409230902734044 ]; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Bulow L, 2009, NUCLEIC ACIDS RES, V37, pD983, DOI 10.1093/nar/gkn709; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; CAWLEY GC, MATLAB SUPPORT VECTO; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chen J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-414; Chen XM, 2010, PLANT J, V61, P941, DOI 10.1111/j.1365-313X.2009.04089.x; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P1488, DOI 10.1093/nar/gkm027; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; He HS, 2007, GENOME RES, V17, P1471, DOI 10.1101/gr.6611807; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Hilbricht T, 2008, NEW PHYTOL, V179, P877, DOI 10.1111/j.1469-8137.2008.02480.x; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jiang SY, 2009, PLANT PHYSIOL, V150, P1997, DOI 10.1104/pp.109.139402; Jiao YL, 2008, PLANT CELL, V20, P2571, DOI 10.1105/tpc.108.062786; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joung JG, 2009, BIOINFORMATICS, V25, P387, DOI 10.1093/bioinformatics/btn626; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Kato A, 1999, GENE, V239, P309, DOI 10.1016/S0378-1119(99)00403-5; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kurihara Y, 2008, BIOCHEM BIOPH RES CO, V376, P553, DOI 10.1016/j.bbrc.2008.09.046; Kurihara Y, 2009, PLANT CELL PHYSIOL, V50, P1715, DOI 10.1093/pcp/pcp109; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindow M, 2007, PLOS COMPUT BIOL, V3, P2379, DOI 10.1371/journal.pcbi.0030238; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; MacIntosh GC, 2001, PLANT PHYSIOL, V127, P765, DOI 10.1104/pp.010501; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marker C, 2002, CURR BIOL, V12, P2002, DOI 10.1016/S0960-9822(02)01304-0; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mhuantong W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-366; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Nelson DC, 2007, FEBS LETT, V581, P3363, DOI 10.1016/j.febslet.2007.06.033; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Riano-Pachon DM, 2005, PLANT J, V43, P205, DOI 10.1111/j.1365-313X.2005.02438.x; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Song DD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S36; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, P13; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Taft RJ, 2009, CELL CYCLE, V8, P2332, DOI 10.4161/cc.8.15.9154; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Teramoto H, 1996, PLANT MOL BIOL, V32, P797, DOI 10.1007/BF00020478; Terryn N, 1998, GENE, V215, P11, DOI 10.1016/S0378-1119(98)00286-8; TISDALL JD, 2003, MASTERING PERL BIOIN, P377; Trask HW, 2009, RNA, V15, P1917, DOI 10.1261/rna.1677409; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; WU L, 2010, MOL CELL, DOI DOI 10.1016/J.MOLCEL.2010.1003.1008; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	159	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10710	10.1371/journal.pone.0010710	http://dx.doi.org/10.1371/journal.pone.0010710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520764	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221500004
J	Alekseyenko, OV; Lee, C; Kravitz, EA				Alekseyenko, Olga V.; Lee, Carol; Kravitz, Edward A.			Targeted Manipulation of Serotonergic Neurotransmission Affects the Escalation of Aggression in Adult Male Drosophila melanogaster	PLOS ONE			English	Article							NERVOUS-SYSTEM; TYROSINE-HYDROXYLASE; L-DOPA; CEREBRAL MONOAMINES; GENETIC DISSECTION; ECTOPIC EXPRESSION; AGONISTIC BEHAVIOR; COURTSHIP BEHAVIOR; NEURONS; MUTANTS	Dopamine (DA) and serotonin (5HT) are reported to serve important roles in aggression in a wide variety of animals. Previous investigations of 5HT function in adult Drosophila behavior have relied on pharmacological manipulations, or on combinations of genetic tools that simultaneously target both DA and 5HT neurons. Here, we generated a transgenic line that allows selective, direct manipulation of serotonergic neurons and asked whether DA and 5HT have separable effects on aggression. Quantitative morphological examination demonstrated that our newly generated tryptophan hydroxylase (TRH)-Gal4 driver line was highly selective for 5HT-containing neurons. This line was used in conjunction with already available Gal4 driver lines that target DA or both DA and 5HT neurons to acutely alter the function of aminergic systems. First, we showed that acute impairment of DA and 5HT neurotransmission using expression of a temperature sensitive form of dynamin completely abolished mid-and high-level aggression. These flies did not escalate fights beyond brief low-intensity interactions and therefore did not yield dominance relationships. We showed next that manipulation of either 5HT or DA neurotransmission failed to duplicate this phenotype. Selective disruption of 5HT neurotransmission yielded flies that fought, but with reduced ability to escalate fights, leading to fewer dominance relationships. Acute activation of 5HT neurons using temperature sensitive dTrpA1 channel expression, in contrast, resulted in flies that escalated fights faster and that fought at higher intensities. Finally, acute disruption of DA neurotransmission produced hyperactive flies that moved faster than controls, and rarely engaged in any social interactions. By separately manipulating 5HT- and DA- neuron systems, we collected evidence demonstrating a direct role for 5HT in the escalation of aggression in Drosophila.	[Alekseyenko, Olga V.; Kravitz, Edward A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lee, Carol] Albert Einstein Coll Med, New York, NY USA	Harvard University; Harvard Medical School; Yeshiva University	Alekseyenko, OV (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	olga_alekseenko@hms.harvard.edu			National Institute of General Medical Sciences [GM-067645, GM-074675]; Brooks Fellowship; Neurobiology Department, Harvard Medical School [T32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067645, R01GM074675] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brooks Fellowship; Neurobiology Department, Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by grants from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/; GM-067645; GM-074675 to E. A. K.), Brooks Fellowship and T32 training grant from the Neurobiology Department, Harvard Medical School (to O.V.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2000, J NEUROGENET, V14, P227, DOI 10.3109/01677060009084500; ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; BELTZ BS, 1990, J NEUROBIOL, V21, P521, DOI 10.1002/neu.480210402; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1987, J NEUROGENET, V4, P309, DOI 10.3109/01677068709102351; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; CLARK AG, 1984, GENETICS, V108, P181; COCCARO EF, 1989, BRIT J PSYCHIAT, V155, P52, DOI 10.1192/S0007125000291769; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Doernberg SB, 2001, J COMP PHYSIOL A, V187, P91, DOI 10.1007/s003590000178; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gibert P, 2001, EVOLUTION, V55, P205, DOI 10.1111/j.0014-3820.2001.tb01286.x; GLOVER JC, 1987, J NEUROSCI, V7, P581; GOLDBERG JI, 1989, DEV BIOL, V131, P483, DOI 10.1016/S0012-1606(89)80019-3; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HADLER NM, 1964, GENETICS, V50, P1269; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hing ALY, 1996, J NEUROBIOL, V30, P454; HIRSH J, 1981, MOL CELL BIOL, V1, P475, DOI 10.1128/MCB.1.6.475; HOLLISTER AS, 1979, J PHARMACOL EXP THER, V208, P37; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KONIG N, 1988, J NEUROSCI RES, V20, P212, DOI 10.1002/jnr.490200210; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KULKARNI SJ, 1987, GENETICS, V115, P461; Lauder J M, 1983, Monogr Neural Sci, V9, P3; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Mundiyanapurath S, 2009, FLY, V3, P179, DOI 10.4161/fly.3.3.8989; NASSEL DR, 1985, NEUROSCIENCE, V15, P293, DOI 10.1016/0306-4522(85)90136-8; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; NG KY, 1971, NATURE, V230, P331, DOI 10.1038/230331a0; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Nilsson EE, 2000, J NEUROGENET, V13, P213, DOI 10.3109/01677060009084495; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Panksepp JB, 2002, J NEUROBIOL, V50, P276, DOI 10.1002/neu.10035; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park SK, 2006, J NEUROBIOL, V66, P452, DOI 10.1002/neu.20222; PETER D, 1995, J NEUROSCI, V15, P6179; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Simon AF, 2009, GENETICS, V181, P525, DOI 10.1534/genetics.108.094110; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; VALLES AM, 1986, J NEUROSCI, V6, P1482; WALLACE JA, 1985, J COMP NEUROL, V236, P443, DOI 10.1002/cne.902360403; WRIGHT TRF, 1976, GENETICS, V84, P287; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	71	152	153	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10806	10.1371/journal.pone.0010806	http://dx.doi.org/10.1371/journal.pone.0010806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520823	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600023
J	Arora, G; Sajid, A; Gupta, M; Bhaduri, A; Kumar, P; Basu-Modak, S; Singh, Y				Arora, Gunjan; Sajid, Andaleeb; Gupta, Meetu; Bhaduri, Asani; Kumar, Pawan; Basu-Modak, Sharmila; Singh, Yogendra			Understanding the Role of PknJ in Mycobacterium tuberculosis: Biochemical Characterization and Identification of Novel Substrate Pyruvate Kinase A	PLOS ONE			English	Article							SERINE/THREONINE PROTEIN-KINASE; CELL-DIVISION; SER/THR KINASE; ESCHERICHIA-COLI; STRESS-RESPONSE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; INFECTION; SEQUENCE	Reversible protein phosphorylation is a prevalent signaling mechanism which modulates cellular metabolism in response to changing environmental conditions. In this study, we focus on previously uncharacterized Mycobacterium tuberculosis Ser/Thr protein kinase (STPK) PknJ, a putative transmembrane protein. PknJ is shown to possess autophosphorylation activity and is also found to be capable of carrying out phosphorylation on the artificial substrate myelin basic protein (MyBP). Previous studies have shown that the autophosphorylation activity of M. tuberculosis STPKs is dependent on the conserved residues in the activation loop. However, our results show that apart from the conventional conserved residues, additional residues in the activation loop may also play a crucial role in kinase activation. Further characterization of PknJ reveals that the kinase utilizes unusual ions (Ni2+, Co2+) as cofactors, thus hinting at a novel mechanism for PknJ activation. Additionally, as shown for other STPKs, we observe that PknJ possesses the capability to dimerize. In order to elucidate the signal transduction cascade emanating from PknJ, the M. tuberculosis membrane-associated protein fraction is treated with the active kinase and glycolytic enzyme Pyruvate kinase A (mtPykA) is identified as one of the potential substrates of PknJ. The phospholabel is found to be localized on serine and threonine residue(s), with Ser(37) identified as one of the sites of phosphorylation. Since Pyk is known to catalyze the last step of glycolysis, our study shows that the fundamental pathways such as glycolysis can also be governed by STPK-mediated signaling.	[Arora, Gunjan; Sajid, Andaleeb; Gupta, Meetu; Bhaduri, Asani; Kumar, Pawan; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Arora, Gunjan; Basu-Modak, Sharmila] Univ Delhi, Dept Zool, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Arora, G (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Kumar, Pawan/GXF-7072-2022; Arora, Gunjan/AAL-3448-2020	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205	Council of Industrial Research, Government of India [NWP 0038]	Council of Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Funding: This work was supported by a grant (NWP 0038) from the Council of Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lu TJ, 2005, J INORG BIOCHEM, V99, P1306, DOI 10.1016/j.jinorgbio.2005.03.003; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; SAEKI T, 1974, J BIOCHEM-TOKYO, V76, P631, DOI 10.1093/oxfordjournals.jbchem.a130607; SCHWORER CM, 1985, J BIOL CHEM, V260, P3018; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Singh A, 2006, TUBERCULOSIS, V86, P28, DOI 10.1016/j.tube.2005.04.002; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Voet D, 2006, FUNDAMENTALS BIOCH; Vohra Reena, 2006, Recent Pat Antiinfect Drug Discov, V1, P95, DOI 10.2174/157489106775244127; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Xiong Y, 2005, J PROTEOME RES, V4, P855, DOI 10.1021/pr0500049	57	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10772	10.1371/journal.pone.0010772	http://dx.doi.org/10.1371/journal.pone.0010772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520732	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600006
J	Bandera, A; Ferrario, G; Saresella, M; Marventano, I; Soria, A; Zanini, F; Sabbatini, F; Airoldi, M; Marchetti, G; Franzetti, F; Trabattoni, D; Clerici, M; Gori, A				Bandera, Alessandra; Ferrario, Giulio; Saresella, Marina; Marventano, Ivana; Soria, Alessandro; Zanini, Fabio; Sabbatini, Francesca; Airoldi, Monica; Marchetti, Giulia; Franzetti, Fabio; Trabattoni, Daria; Clerici, Mario; Gori, Andrea			CD4+T Cell Depletion, Immune Activation and Increased Production of Regulatory T Cells in the Thymus of HIV-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; LYMPHOID-TISSUES; GASTROINTESTINAL-TRACT; PERIPHERAL-BLOOD; SIV INFECTION; IN-VITRO; CD4(+); RECONSTITUTION; THYMOPOIESIS	Mechanisms by which HIV affects the thymus are multiple and only partially known, and the role of thymic dysfunction in HIV/AIDS immunopathogenesis remains poorly understood. To evaluate the effects of HIV infection on intra-thymic precursors of T cells in HIV-infected adults, we conducted a detailed immunophenotypic study of thymic tissue isolated from 7 HIV-infected and 10 HIV-negative adults who were to undergo heart surgery. We found that thymuses of HIV-infected individuals were characterized by a relative depletion of CD4+ single positive T cells and a corresponding enrichment of CD8+ single positive T cells. In addition, thymocytes derived from HIV-infected subjects showed increased levels of activated and proliferating cells. Our analysis also revealed a decreased expression of interleukin-7 receptor in early thymocytes from HIV-infected individuals, along with an increase in this same expression in mature double-and single-positive cells. Frequency of regulatory T cells (CD25+FoxP3+) was significantly increased in HIV-infected thymuses, particularly in priorly-committed CD4 single positive cells. Our data suggest that HIV infection is associated with a complex set of changes in the immunophenotype of thymocytes, including a reduction of intrathymic CD4+ T cell precursors, increased expression of activation markers, changes in the expression pattern of IL-7R and enrichment of T regulatory cells generation.	[Bandera, Alessandra; Soria, Alessandro; Sabbatini, Francesca; Airoldi, Monica; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Ferrario, Giulio; Zanini, Fabio; Franzetti, Fabio] Univ Milan, Luigi Sacco Hosp, Dept Clin Sci, Infect Dis Sect, Milan, Italy; [Saresella, Marina; Marventano, Ivana; Clerici, Mario] Don C Gnocchi Fdn IRCCS, Milan, Italy; [Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, Milan, Italy; [Trabattoni, Daria] Univ Milan, Dept Preclin Sci, LITA VIALBA, Chair Immunol, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, Chair Immunol, I-20133 Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; Luigi Sacco Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; University of Milan	Bandera, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.bandera@hsgerardo.org	Bandera, Alessandra/AAC-6081-2022; Bandera, Alessandra/D-6255-2015; franzetti, fabio/AAK-9158-2020; Saresella, Marina/G-7810-2012; Trabattoni, Daria/G-7424-2012; Marchetti, Giulia/GPX-7655-2022; Gori, Andrea/AAC-6078-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	franzetti, fabio/0000-0001-9253-4453; Saresella, Marina/0000-0002-2295-3043; Trabattoni, Daria/0000-0001-9535-3359; BANDERA, ALESSANDRA/0000-0001-9440-4601; Bandera, Alessandra/0000-0003-1626-0328; SORIA, Alessandro/0000-0002-4447-2574; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Clerici, Mario/0000-0001-5920-6191; Marventano, Ivana/0000-0001-8111-3522	Cariplo Foundation [2006.0687/10.4877]; "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Cariplo Foundation(Fondazione Cariplo); "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Funding: The present study was funded by a grant from Cariplo Foundation (2006.0687/10.4877), "Ermenegildo Zegna" Foundation, Italy, and Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; BASKIN GB, 1991, LAB INVEST, V65, P400; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, J VIROL, V80, P6801, DOI 10.1128/JVI.00070-06; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fernandez S, 2006, AIDS RES HUM RETROV, V22, P163, DOI 10.1089/aid.2006.22.163; Franco JM, 2002, BLOOD, V99, P3702, DOI 10.1182/blood.V99.10.3702; GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hardy G, 2004, HIV MED, V5, P67, DOI 10.1111/j.1468-1293.2004.00187.x; Haynes BF, 1999, J CLIN INVEST, V103, P453, DOI 10.1172/JCI5201; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; HELLER DE, 1999, REV AFRICAN AM ED, V1, P5; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; JOSHI VV, 1986, ARCH PATHOL LAB MED, V110, P837; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Lee JC, 2006, AIDS, V20, P667, DOI 10.1097/01.aids.0000216366.46195.81; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Markert ML, 2001, AIDS RES HUM RETROV, V17, P1635, DOI 10.1089/088922201753342040; Napolitano LA, 2003, J IMMUNOL, V171, P645, DOI 10.4049/jimmunol.171.2.645; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; PAPIERNIK M, 1992, PEDIATRICS, V89, P297; Plum J, 1996, BLOOD, V88, P4239; Ruiz-Mateos E, 2004, CLIN EXP IMMUNOL, V136, P501, DOI 10.1111/j.1365-2249.2004.02474.x; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Siliciano JD, 2000, J CLIN INVEST, V106, P823, DOI 10.1172/JCI11246; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2000, EUR J IMMUNOL, V30, P1145, DOI 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Zaitseva MB, 1998, J IMMUNOL, V161, P3103	43	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10788	10.1371/journal.pone.0010788	http://dx.doi.org/10.1371/journal.pone.0010788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520721	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034600014
J	Yang, JC; Gao, C; Chai, L; Ma, YP				Yang, Jianchang; Gao, Chong; Chai, Li; Ma, Yupo			A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells	PLOS ONE			English	Article							TOWNES-BROCKS-SYNDROME; RENAL-OCULAR SYNDROME; RADIAL RAY SYNDROME; OKIHIRO-SYNDROME; KIDNEY DEVELOPMENT; MURINE HOMOLOG; GENE; SALL1; MUTATIONS; NANOG	Background: SALL4 is a member of the SALL gene family that encodes a group of putative developmental transcription factors. Murine Sall4 plays a critical role in maintaining embryonic stem cell (ES cell) pluripotency and self-renewal. We have shown that Sall4 activates Oct4 and is a master regulator in murine ES cells. Other SALL gene members, especially Sall1 and Sall3 are expressed in both murine and human ES cells, and deletions of these two genes in mice lead to perinatal death due to developmental defects. To date, little is known about the molecular mechanisms controlling the regulation of expressions of SALL4 or other SALL gene family members. Methodology/Principal Findings: This report describes a novel SALL4/OCT4 regulator feedback loop in ES cells in balancing the proper expression dosage of SALL4 and OCT4 for the maintenance of ESC stem cell properties. While we have observed that a positive feedback relationship is present between SALL4 and OCT4, the strong self-repression of SALL4 seems to be the "break'' for this loop. In addition, we have shown that SALL4 can repress the promoters of other SALL family members, such as SALL1 and SALL3, which competes with the activation of these two genes by OCT4. Conclusions/Significance: Our findings, when taken together, indicate that SALL4 is a master regulator that controls its own expression and the expression of OCT4. SALL4 and OCT4 work antagonistically to balance the expressions of other SALL gene family members. This novel SALL4/OCT4 transcription regulation feedback loop should provide more insight into the mechanism of governing the "stemness'' of ES cells.	[Yang, Jianchang; Ma, Yupo] Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA; [Gao, Chong; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yang, JC (corresponding author), Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA.	lchai@partners.org; yma@nvcancer.org		Chai, Li/0000-0003-1937-4750	Leukemia & Lymphoma Society [3366-09]; NIH [R01HL087948, R21CA131522, RO1HL092437]; NATIONAL CANCER INSTITUTE [R21CA131522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948, R01HL092437] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Leukemia & Lymphoma Society special fellow award (3366-09) (to J.Y.), the NIH under grants R01HL087948, NIH R21CA131522 (to Y.M.) and RO1HL092437 (to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Chai L, 2006, J BIOL CHEM, V281, P18918, DOI 10.1074/jbc.M600180200; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Haus AH, 2008, OPHTHALMOLOGE, V105, P588, DOI 10.1007/s00347-007-1633-7; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Li SSL, 2006, STEM CELLS DEV, V15, P532, DOI 10.1089/scd.2006.15.532; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Paradisi I, 2007, AM J MED GENET A, V143A, P326, DOI 10.1002/ajmg.a.31603; Parrish M, 2004, MOL CELL BIOL, V24, P7102, DOI 10.1128/MCB.24.16.7102-7112.2004; Powell CM, 1999, J MED GENET, V36, P89; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	28	99	117	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10766	10.1371/journal.pone.0010766	http://dx.doi.org/10.1371/journal.pone.0010766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505821	Green Submitted, Green Published, gold			2022-12-27	WOS:000278017400024
J	Gao, L; Zhou, F; Li, XW; Jin, Q				Gao, Lei; Zhou, Feng; Li, XiangWei; Jin, Qi			HIV/TB Co-Infection in Mainland China: A Meta-Analysis	PLOS ONE			English	Article							TUBERCULOSIS; TB; INFECTION; PREVALENCE; ROUTINE; SEX	Background: TB and HIV co-epidemic is a major public health problem in many parts of the world, particularly in developing counties. We aimed to summarize the prevalence of TB and HIV co-infection in mainland China, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and Chinese BioMedical Literature Databases, on the prevalence of HIV infection among TB patients and on the prevalence of TB among HIV/AIDS population until 15 April 2010, and quantitatively summarized the estimates using meta-analysis. Results: In total, 29 studies were included in this review, with consistently homogeneous results. TB patients, for whom the summary prevalence of HIV infection was 0.9% (0.6%-1.4%) in mainland China, were found to be a potential target population for HIV screening. The prevalence of TB among HIV/AIDS population was 7.2% (4.2%-12.3%), but this was much higher when the analyses were restricted to AIDS patients (22.8%). Significantly higher prevalence was observed for males and hospital-based studies. Conclusions: Our analyses indicated that the prevalence of HIV/TB co-infection in China deserves special attention, screening of TB among HIV/AIDS populations should be attached more importance, which would be much more helpful for treatment of both diseases.	[Gao, Lei; Zhou, Feng; Li, XiangWei; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Gao, L (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China.	gaolei@ipbcams.ac.cn; jinqi@ipbcams.ac.cn	Jin, Qi/B-5379-2009		National Key Technologies RD Program [2002BA711A14]	National Key Technologies RD Program(National Key Technology R&D Program)	The work was supported by National Key Technologies R&D Program (Accession number: 2002BA711A14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Beckwith CG, 2002, ARCH INTERN MED, V162, P2252, DOI 10.1001/archinte.162.19.2252; Breen RAM, 2006, DRUGS, V66, P2299, DOI 10.2165/00003495-200666180-00003; CAO G, 2006, DIS SURVEILLANCE, V21, P400; CAO J, 2008, J APPL PREVENTIIVE M, V14, P71; Chen XY, 2004, LANCET, V364, P417; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; de Carvalho BM, 2008, BRAZ J INFECT DIS, V12, P281, DOI 10.1590/S1413-86702008000400005; FENG D, 2001, J CHINESE ANTITUBERC, V23, P158; Ferrer L, 2007, J ASSOC NURSE AIDS C, V18, P51, DOI 10.1016/j.jana.2007.07.001; Friedlaender MH, 2007, CLIN OPHTHALMOL, V1, P3; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Girardi E, 2001, J BIOL REG HOMEOS AG, V15, P218; Girardi E, 2000, AIDS, V14, pS47; Harrington M, 2010, CLIN INFECT DIS, V50, pS260, DOI 10.1086/651500; HE L, 2006, GUANGXI MED J, V28, P1762; Hilton C, 2002, JAIDS, V31, P416, DOI 10.1097/00126334-200212010-00008; Jiang XY, 2008, SOUTH MED J, V101, P914, DOI 10.1097/SMJ.0b013e31817c13ab; JIN K, 2005, J CHINESE ANTITUBERC, V27, P51; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; KONG W, 1999, CHINESE J TUBERCULOS, V22, P150; Kurth AE, 2005, SEX TRANSM DIS, V32, P370, DOI 10.1097/01.olq.0000154499.17511.0a; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; LI A, 2001, B MED RES, V30, P58; LI H, 2009, CHINA PRACTICE MED, V4, P258; Li S, 2008, CHINESE HLTH SERVICE, V11, P783; LIN G, 2006, CHINESE PREVENTION M, V7, P446; Lin X, 2008, INT J TUBERC LUNG D, V12, P288; LIU F, 2006, J GUANGXI PREVENTION, V12, P5; LIU X, 2006, SOFT SCI HLTH, V20, P143; LU L, 2008, CHINESE J PEST CONTR, V24, P31; Lu L, 2008, OCCUPATION HLTH, V24, P964; McShane H, 2005, INT J STD AIDS, V16, P95, DOI 10.1258/0956462053057576; Mendelson M, 2007, BRIT MED BULL, V81-82, P149, DOI 10.1093/bmb/ldm009; Meya DB, 2007, J INTERN MED, V261, P309, DOI 10.1111/j.1365-2796.2007.01795.x; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; PENG Y, 2008, NINGXIA MED J, V30, P744; Qian HZ, 2009, SE ASIAN J TROP MED, V40, P108; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; SHI X, 2008, CHINESE J AIDS STD, V14, P292; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Tang Z, 2009, GUANGXI MED J, V31, P240; WANG A, 2008, ANHUI J PREVENT MED, V14, P42; Wang Dong, 2004, Acta Genetica Sinica, V31, P257; Wang LY, 2010, JAIDS-J ACQ IMM DEF, V53, pS61, DOI 10.1097/QAI.0b013e3181c7db2e; Wang Margaret Q, 2003, J Biol, V3, P4, DOI 10.1186/1475-4924-3-4; WANG X, 2007, MODERN PREVENTIVE ME, V34, P4457; Watts J, 2008, LANCET, V371, P103, DOI 10.1016/S0140-6736(08)60087-2; WEI F, 2009, J GUANGXI MED U, V26, P573; Weis SE, 1999, AM J PUBLIC HEALTH, V89, P73, DOI 10.2105/AJPH.89.1.73; YIN J, 2007, J CHINESE ANTITUBERC, V29, P458; [于兰 YU Lan], 2009, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V32, P377; ZHEN X, 2004, CHINESE J AIDS STD, V10, P354; ZHOU R, 2006, CHINESE J AIDS STD, V12, P262; 周梅, 2002, [中华流行病学杂志, Chinese Journal of Epidemiology], V23, P482	57	44	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10736	10.1371/journal.pone.0010736	http://dx.doi.org/10.1371/journal.pone.0010736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505769	Green Submitted, gold, Green Published			2022-12-27	WOS:000278017300020
J	Sabatelli, L				Sabatelli, Lorenzo			Effect of Heterogeneous Mixing and Vaccination on the Dynamics of Anthelmintic Resistance: A Nested Model	PLOS ONE			English	Article							HOOKWORM INFECTION; DRUG-RESISTANCE; PARASITE TRANSMISSION; DENSITY-DEPENDENCE; EFFICACY; POPULATION; VACCINES; MALARIA; PREDISPOSITION; EPIDEMIOLOGY	Anthelmintic resistance is a major threat to current measures for helminth control in humans and animals. The introduction of anthelmintic vaccines, as a complement to or replacement for drug treatments, has been advocated as a preventive measure. Here, a computer-based simulation, tracking the dynamics of hosts, parasites and parasite-genes, shows that, depending on the degree of host-population mixing, the frequency of totally recessive autosomes associated with anthelmintic resistance can follow either a fast dynamical regime with a low equilibrium point or a slow dynamical regime with a high equilibrium point. For fully dominant autosomes, only one regime is predicted. The effectiveness of anthelminthic vaccines against resistance is shown to be strongly influenced by the underlying dynamics of resistant autosomes. Vaccines targeting adult parasites, by decreasing helminth fecundity or lifespan, are predicted to be more effective than vaccines targeting parasite larvae, by decreasing host susceptibility to infection, in reducing the spread of resistance. These results may inform new strategies to prevent, monitor and control the spread of anthelmintic resistance, including the development of viable anthelmintic vaccines.	[Sabatelli, Lorenzo] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Sabatelli, L (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA.	lsabatel@fhcrc.org						Albonico M, 2005, INT J PARASITOL, V35, P803, DOI 10.1016/j.ijpara.2005.02.016; Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9; ANDERSON R M, 1991; Anderson R.M., 1982, P67; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; ANDERSON RM, 1985, ADV PARASITOLOGY, V24; [Anonymous], 2006, PREV CHEM HUM HELM C; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; BRADLEY M, 1992, T ROY SOC TROP MED H, V86, P73, DOI 10.1016/0035-9203(92)90448-L; BUNDY DAP, 1995, PARASITOLOGY, V110, pS51, DOI 10.1017/S0031182000001499; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Churcher TS, 2008, EVOLUTION, V62, P528, DOI 10.1111/j.1558-5646.2007.00290.x; Cornell SJ, 2003, P NATL ACAD SCI USA, V100, P7401, DOI 10.1073/pnas.0832206100; DIETZ K, 1988, PARASITOL TODAY, V4, P91, DOI 10.1016/0169-4758(88)90034-8; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; HADELER KP, 1983, COMPUT MATH APPL, V9, P415, DOI 10.1016/0898-1221(83)90056-1; Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990; Hartwell L., 2018, GENETICS GENES GENOM; Hotez PJ, 2006, TRENDS PARASITOL, V22, P327, DOI 10.1016/j.pt.2006.05.004; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; MEDLEY GF, 1993, PARASITOLOGY, V106, P211, DOI 10.1017/S0031182000075016; Montresor A., 1998, WORLD HLTH ORG; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Quinnell RJ, 2004, J INFECT DIS, V190, P430, DOI 10.1086/422256; Quinnell RJ, 2001, T ROY SOC TROP MED H, V95, P139, DOI 10.1016/S0035-9203(01)90138-5; QUINNELL RJ, 1993, PARASITOLOGY, V106, P379, DOI 10.1017/S0031182000067123; Sabatelli L, 2008, J R SOC INTERFACE, V5, P1329, DOI 10.1098/rsif.2007.1255; Schad G. A., 1984, Tropical and geographical medicine., P359; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Schwab AE, 2007, PARASITOLOGY, V134, P1025, DOI 10.1017/S0031182007002363; SHIELD JM, 1981, PAPUA NEW GUINEA MED, V24, P19; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith WD, 2006, VET PARASITOL, V139, P347, DOI 10.1016/j.vetpar.2006.04.024; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WIJFFELS GL, 1994, EXP PARASITOL, V78, P132, DOI 10.1006/expr.1994.1014; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10686	10.1371/journal.pone.0010686	http://dx.doi.org/10.1371/journal.pone.0010686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502690	Green Published, gold, Green Submitted			2022-12-27	WOS:000277776500004
J	Baldridge, D; Lennington, J; Weis, M; Homan, EP; Jiang, MM; Munivez, E; Keene, DR; Hogue, WR; Pyott, S; Byers, PH; Krakow, D; Cohn, DH; Eyre, DR; Lee, B; Morello, R				Baldridge, Dustin; Lennington, Jennifer; Weis, MaryAnn; Homan, Erica P.; Jiang, Ming-Ming; Munivez, Elda; Keene, Douglas R.; Hogue, William R.; Pyott, Shawna; Byers, Peter H.; Krakow, Deborah; Cohn, Daniel H.; Eyre, David R.; Lee, Brendan; Morello, Roy			Generalized Connective Tissue Disease in Crtap-/- Mouse	PLOS ONE			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; CARTILAGE-ASSOCIATED PROTEIN; PULMONARY HYPOPLASIA; COLLAGEN; MUTATION; SKIN; DEFICIENCY; DISORDERS; FIBRILS; COL5A1	Mutations in CRTAP (coding for cartilage-associated protein), LEPRE1 (coding for prolyl 3-hydroxylase 1 [P3H1]) or PPIB (coding for Cyclophilin B [CYPB]) cause recessive forms of osteogenesis imperfecta and loss or decrease of type I collagen prolyl 3-hydroxylation. A comprehensive analysis of the phenotype of the Crtap-/- mice revealed multiple abnormalities of connective tissue, including in the lungs, kidneys, and skin, consistent with systemic dysregulation of collagen homeostasis within the extracellular matrix. Both Crtap-/- lung and kidney glomeruli showed increased cellular proliferation. Histologically, the lungs showed increased alveolar spacing, while the kidneys showed evidence of segmental glomerulosclerosis, with abnormal collagen deposition. The Crtap-/- skin had decreased mechanical integrity. In addition to the expected loss of proline 986 3-hydroxylation in alpha 1(I) and alpha 1(II) chains, there was also loss of 3Hyp at proline 986 in alpha 2(V) chains. In contrast, at two of the known 3Hyp sites in alpha 1(IV) chains from Crtap-/- kidneys there were normal levels of 3-hydroxylation. On a cellular level, loss of CRTAP in human OI fibroblasts led to a secondary loss of P3H1, and vice versa. These data suggest that both CRTAP and P3H1 are required to maintain a stable complex that 3-hydroxylates canonical proline sites within clade A (types I, II, and V) collagen chains. Loss of this activity leads to a multi-systemic connective tissue disease that affects bone, cartilage, lung, kidney, and skin.	[Baldridge, Dustin; Lennington, Jennifer; Homan, Erica P.; Jiang, Ming-Ming; Munivez, Elda; Lee, Brendan; Morello, Roy] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA; [Hogue, William R.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Little Rock, AR 72205 USA; [Pyott, Shawna; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Byers, Peter H.] Univ Washington, Dept Med, Seattle, WA USA; [Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90095 USA; [Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute	Baldridge, D (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.edu	Krakow, Deborah/B-5778-2009	Krakow, Deborah/0000-0001-9906-4968; Byers, Peter H./0000-0001-7786-7030	NIH [AR051459, HD022657, DE1771, AR36794]; Baylor College of Medicine IDDRC [HD024064]; Osteogenesis Imperfecta Foundation; Rolanette and Berdon Lawrence Bone Disease Program of Texas; Freudmann Fund at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036794, R37AR037318, R01AR036794, R03AR051459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine IDDRC; Osteogenesis Imperfecta Foundation; Rolanette and Berdon Lawrence Bone Disease Program of Texas; Freudmann Fund at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants AR051459 (RM), HD022657 (BL, DHC, DK, DRE), DE1771 (BL), AR36794 (DRE), the Baylor College of Medicine IDDRC HD024064 (BL), the Osteogenesis Imperfecta Foundation (RM, SP, PHB), the Rolanette and Berdon Lawrence Bone Disease Program of Texas (BL, RM), and the Freudmann Fund at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BIRK DE, 1990, J CELL SCI, V95, P649; Bodian DL, 2009, HUM MOL GENET, V18, P463, DOI 10.1093/hmg/ddn374; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Burnei G, 2008, J AM ACAD ORTHOP SUR, V16, P356, DOI 10.5435/00124635-200806000-00008; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHANG W, 2009, HUM MOL GENET; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; CHINES A, 1995, BONE, V16, P333, DOI 10.1016/8756-3282(94)00046-8; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; FALVO KA, 1973, J BONE JOINT SURG AM, VA 55, P275, DOI 10.2106/00004623-197355020-00003; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hakim AJ, 2006, CLIN DERMATOL, V24, P521, DOI 10.1016/j.clindermatol.2006.07.013; Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909; HOLBROOK KA, 1982, J INVEST DERMATOL, V79, pS7, DOI 10.1111/1523-1747.ep12544609; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kypreos KE, 2000, J CELL BIOCHEM, V80, P146; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; McComb JG, 2008, AM J PATHOL, V173, P949, DOI 10.2353/ajpath.2008.071034; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; PENTTINEN RP, 1975, P NATL ACAD SCI USA, V72, P586, DOI 10.1073/pnas.72.2.586; Phillips CL, 2002, KIDNEY INT, V62, P383, DOI 10.1046/j.1523-1755.2002.00451.x; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SHAPIRO JR, 1989, BONE, V10, P165, DOI 10.1016/8756-3282(89)90049-5; Thibeault DW, 1995, PEDIATR PULM, V20, P301, DOI 10.1002/ppul.1950200508; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; VANDIJK FS, 2009, EUR J HUM GENET; VETTER U, 1989, EUR J PEDIATR, V149, P184, DOI 10.1007/BF01958277; VRANKA JA, 2004, J BIOL CHEM; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	39	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10560	10.1371/journal.pone.0010560	http://dx.doi.org/10.1371/journal.pone.0010560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485499	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200003
J	Kunderfranco, P; Mello-Grand, M; Cangemi, R; Pellini, S; Mensah, A; Albertini, V; Malek, A; Chiorino, G; Catapano, CV; Carbone, GM				Kunderfranco, Paolo; Mello-Grand, Maurizia; Cangemi, Romina; Pellini, Stefania; Mensah, Afua; Albertini, Veronica; Malek, Anastasia; Chiorino, Giovanna; Catapano, Carlo V.; Carbone, Giuseppina M.			ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer	PLOS ONE			English	Article							GROUP PROTEIN EZH2; MAMMARY EPITHELIAL-CELLS; TARGET GENES; STEM-CELLS; EXPRESSION; ACTIVATION; DIFFERENTIATION; METHYLATION; PROGRESSION; FUSIONS	Background: ETS transcription factors regulate important signaling pathways involved in cell differentiation and development in many tissues and have emerged as important players in prostate cancer. However, the biological impact of ETS factors in prostate tumorigenesis is still debated. Methodology/Principal Findings: We performed an analysis of the ETS gene family using microarray data and real-time PCR in normal and tumor tissues along with functional studies in normal and cancer cell lines to understand the impact in prostate tumorigenesis and identify key targets of these transcription factors. We found frequent dysregulation of ETS genes with oncogenic (i.e., ERG and ESE1) and tumor suppressor (i.e., ESE3) properties in prostate tumors compared to normal prostate. Tumor subgroups (i.e., ERG(high), ESE1(high), ESE3(low) and NoETS tumors) were identified on the basis of their ETS expression status and showed distinct transcriptional and biological features. ERG(high) and ESE3(low) tumors had the most robust gene signatures with both distinct and overlapping features. Integrating genomic data with functional studies in multiple cell lines, we demonstrated that ERG and ESE3 controlled in opposite direction transcription of the Polycomb Group protein EZH2, a key gene in development, differentiation, stem cell biology and tumorigenesis. We further demonstrated that the prostate-specific tumor suppressor gene Nkx3.1 was controlled by ERG and ESE3 both directly and through induction of EZH2. Conclusions/Significance: These findings provide new insights into the role of the ETS transcriptional network in prostate tumorigenesis and uncover previously unrecognized links between aberrant expression of ETS factors, deregulation of epigenetic effectors and silencing of tumor suppressor genes. The link between aberrant ETS activity and epigenetic gene silencing may be relevant for the clinical management of prostate cancer and design of new therapeutic strategies.	[Kunderfranco, Paolo; Cangemi, Romina; Pellini, Stefania; Mensah, Afua; Albertini, Veronica; Malek, Anastasia; Catapano, Carlo V.; Carbone, Giuseppina M.] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland; [Mello-Grand, Maurizia; Chiorino, Giovanna] Fondo Edo Tempia, Lab Canc Genom, Biella, Italy	Institute of Oncology Research (IOR)	Kunderfranco, P (corresponding author), Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland.	pina.carbone@irb.unisi.ch	Malek, Anastasia V/R-8804-2016; Kunderfranco, Paolo/J-7636-2016; Chiorino, Giovanna/K-5037-2016; Kunderfranco, Paolo/GUQ-8968-2022; Kunderfranco, Paolo/ABH-9294-2020	Malek, Anastasia V/0000-0001-5334-7292; Kunderfranco, Paolo/0000-0003-3636-3391; Chiorino, Giovanna/0000-0002-9502-6400; Kunderfranco, Paolo/0000-0001-7477-8710; Kunderfranco, Paolo/0000-0001-7477-8710; Mensah, Afua Adjeiwaa/0000-0001-8113-3689; Catapano, Carlo V./0000-0002-7079-557X	Oncosuisse [OCS-01913-08]; Swiss National Science Foundation [FNS-31003A-118113]; Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy	Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo)	This work was supported by grants from Oncosuisse (OCS-01913-08), Swiss National Science Foundation (FNS-31003A-118113) and Ticino Foundation for Cancer Research to GMC. MGM and CG were supported by Compagnia di San Paolo, Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bryant RJ, 2008, PROSTATE, V68, P255, DOI 10.1002/pros.20705; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; CAO Q, 2008, ONCOGENE; Carbone GM, 2003, NUCLEIC ACIDS RES, V31, P833, DOI 10.1093/nar/gkg198; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Ekins S, 2007, METH MOL B, V356, P319; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang J, 2009, ANIMAL, V3, P1, DOI [10.1017/S1751731108003054, 10.1109/ISDRS.2009.5378133]; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	47	103	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10547	10.1371/journal.pone.0010547	http://dx.doi.org/10.1371/journal.pone.0010547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479932	Green Submitted, gold, Green Published			2022-12-27	WOS:000277467900005
J	Lu, R; Wu, SP; Liu, XY; Xia, YL; Zhang, YG; Sun, J				Lu, Rong; Wu, Shaoping; Liu, Xingyin; Xia, Yinglin; Zhang, Yong-Guo; Sun, Jun			Chronic Effects of a Salmonella Type III Secretion Effector Protein AvrA In Vivo	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM COLITIS; NF-KAPPA-B; HOST-CELLS; MICE; INFECTION; BACTERIA; CANCER; INFLAMMATION; ACTIVATION; RESPONSES	Background: Salmonella infection is a common public health problem that can become chronic and increase the risk of inflammatory bowel diseases and cancer. AvrA is a Salmonella bacterial type III secretion effector protein. Increasing evidence demonstrates that AvrA is a multi-functional enzyme with critical roles in inhibiting inflammation, regulating apoptosis, and enhancing proliferation. However, the chronic effects of Salmonella and effector AvrA in vivo are still unknown. Moreover, alive, mutated, non-invasive Salmonella is used as a vector to specifically target cancer cells. However, studies are lacking on chronic infection with non-pathogenic or mutated Salmonella in the host. Methods/Principal Findings: We infected mice with Salmonella Typhimurium for 27 weeks and investigated the physiological effects as well as the role of AvrA in intestinal inflammation. We found altered body weight, intestinal pathology, and bacterial translocation in spleen, liver, and gallbladder in chronically Salmonella-infected mice. Moreover, AvrA suppressed intestinal inflammation and inhibited the secretion of cytokines IL-12, IFN-gamma, and TNF-alpha. AvrA expression in Salmonella enhanced its invasion ability. Liver abscess and Salmonella translocation in the gallbladder were observed and may be associated with AvrA expression in Salmonella. Conclusion/Significance: We created a mouse model with persistent Salmonella infection in vivo. Our study further emphasizes the importance of the Salmonella effector protein AvrA in intestinal inflammation, bacterial translocation, and chronic infection in vivo.	[Lu, Rong; Wu, Shaoping; Liu, Xingyin; Zhang, Yong-Guo; Sun, Jun] Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Lu, R (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	jun_sun@urmc.rochester.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133; Liu, Xingyin/0000-0001-8770-3494	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [KO1 DK075386]; American Cancer Society [RSG-09-075-01-MBC]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) KO1 DK075386 and American Cancer Society Research Scholar Award RSG-09-075-01-MBC to Jun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrach N, 2008, CANCER RES, V68, P4827, DOI 10.1158/0008-5472.CAN-08-0552; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Darveau R, 1999, NAT BIOTECHNOL, V17, P19, DOI 10.1038/5188; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; GAST RK, 2004, AVIAN DIS, V18, P863; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; JEAMS AR, 2007, TRAVEL MED INFECT DI, V5, P144; Jimenez-Saenz M, 2001, EUR J GASTROEN HEPAT, V13, P587; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kumar S, 2006, J SURG ONCOL, V93, P633, DOI 10.1002/jso.20530; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; LIU X, FEBS LETT, V584, P911; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Okamura M, 2001, AVIAN DIS, V45, P61, DOI 10.2307/1593012; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Siccardi D, 2008, AM J PHYSIOL-GASTR L, V294, pG1392, DOI 10.1152/ajpgi.00599.2007; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Vidal José E., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P115; Woo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001603; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104	42	51	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10505	10.1371/journal.pone.0010505	http://dx.doi.org/10.1371/journal.pone.0010505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463922	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400036
J	Fadaee-Shohada, MJ; Hirst, RA; Rutman, A; Roberts, IS; O'Callaghan, C; Andrew, PW				Fadaee-Shohada, Mina J.; Hirst, Robert A.; Rutman, Andrew; Roberts, Ian S.; O'Callaghan, Chris; Andrew, Peter W.			The Behaviour of Both Listeria monocytogenes and Rat Ciliated Ependymal Cells Is Altered during Their Co-Culture	PLOS ONE			English	Article							VIRULENCE GENES; BEAT FREQUENCY; PRFA; BRAIN; MENINGOENCEPHALITIS; ULTRASTRUCTURE; IDENTIFICATION; HYDROCEPHALUS; PNEUMOLYSIN; INFECTIONS	Background: Ciliated ependymal cells line the cerebral ventricles and aqueducts separating the infected CSF from the brain parenchyma in meningitis. Principal Findings: Investigation of the interaction of Listeria monocytogenes with cultured rat brain ependymal cells showed that certain strains reduced the beat frequency of the cilia but all the strains studied significantly reduced the ciliary beat amplitude (the linear distance travelled by the tip of each cilium per beat cycle). Conclusion: The presence of the ependyma caused aggregation of some listeria strains and in some cases extracellular material also was seen in association with bacterial aggregates. These observations were dependent on the expression of genes required for invasion, intracellular survival and listerial cell to cell spread that are regulated by the transcriptional activator, positive regulatory factor A (PrfA).	[Fadaee-Shohada, Mina J.; Hirst, Robert A.; Rutman, Andrew; O'Callaghan, Chris; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Leicester; University of Manchester	Fadaee-Shohada, MJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	sam20@le.ac.uk	Hirst, Robert/AAD-1649-2022; Andrew, Peter W/G-7526-2012	Hirst, Robert Anthony/0000-0003-1989-1790	Children's Research Fund; MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: researchfish	Children's Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was kindly supported by the Children's Research Fund (http://www.childrensresearchfund.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriao A, 2008, INT J FOOD MICROBIOL, V123, P142, DOI 10.1016/j.ijfoodmicro.2007.12.016; Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, THORAX, V58, P333, DOI 10.1136/thorax.58.4.333; Deckert M, 2001, INFECT IMMUN, V69, P4561, DOI 10.1128/IAI.69.7.4561-4571.2001; DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102; Drevets DA, 2004, CLIN MICROBIOL REV, V17, P323, DOI 10.1128/CMR.17.2.323-347.2004; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; FREITAG NE, 1992, J BACTERIOL, V174, P1293, DOI 10.1128/jb.174.4.1293-1298.1992; Glaser P, 2001, SCIENCE, V294, P849; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hirst RA, 2000, PEDIATR RES, V47, P381, DOI 10.1203/00006450-200003000-00016; HULTGREN SJ, 1985, INFECT IMMUN, V50, P370, DOI 10.1128/IAI.50.2.370-377.1985; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; JOHNSON NT, 1991, AM REV RESPIR DIS, V144, P1091, DOI 10.1164/ajrccm/144.5.1091; JURADO RL, 1993, CLIN INFECT DIS, V17, P224, DOI 10.1093/clinids/17.2.224; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; McLauchlin J, 1997, REV MED MICROBIOL, V8, P1; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Michelet C, 1999, ANTIMICROB AGENTS CH, V43, P1651, DOI 10.1128/AAC.43.7.1651; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Mohammed BJ, 1999, MICROB PATHOGENESIS, V27, P303, DOI 10.1006/mpat.1999.0306; Monkkonen KS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-26; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; O'Callaghan CL, 2008, NEUROSCI LETT, V439, P56, DOI 10.1016/j.neulet.2008.04.095; PICCO P, 1993, EUR J PEDIATR SURG, V3, P20; Remer KA, 2001, INFECT IMMUN, V69, P4086, DOI 10.1128/IAI.69.6.4086-4093.2001; RUBINO S, 1993, INFECT IMMUN, V61, P1786, DOI 10.1128/IAI.61.5.1786-1792.1993; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; SEELIGER DJH, 1986, GENUS LISTERIA, P1235; SHIMIZU A, 1992, CHILD NERV SYST, V8, P25, DOI 10.1007/BF00316558; Stewart PS, 2001, TRENDS MICROBIOL, V9, P204, DOI 10.1016/S0966-842X(01)01983-7; WEIBEL M, 1986, DEV BRAIN RES, V25, P199, DOI 10.1016/0165-3806(86)90209-9	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10450	10.1371/journal.pone.0010450	http://dx.doi.org/10.1371/journal.pone.0010450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454610	Green Published, gold, Green Submitted			2022-12-27	WOS:000277305300003
J	Harma, V; Virtanen, J; Makela, R; Happonen, A; Mpindi, JP; Knuuttila, M; Kohonen, P; Lotjonen, J; Kallioniemi, O; Nees, M				Harma, Ville; Virtanen, Johannes; Makela, Rami; Happonen, Antti; Mpindi, John-Patrick; Knuuttila, Matias; Kohonen, Pekka; Lotjonen, Jyrki; Kallioniemi, Olli; Nees, Matthias			A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; TUMOR-CELL INVASION; STEM-CELLS; BREAST-CANCER; MAMMARY EPITHELIA; CULTURE MODEL; METASTASIS; LINES; DIFFERENTIATION	Prostate epithelial cells from both normal and cancer tissues, grown in three-dimensional (3D) culture as spheroids, represent promising in vitro models for the study of normal and cancer-relevant patterns of epithelial differentiation. We have developed the most comprehensive panel of miniaturized prostate cell culture models in 3D to date (n = 29), including many non-transformed and most currently available classic prostate cancer (PrCa) cell lines. The purpose of this study was to analyze morphogenetic properties of PrCa models in 3D, to compare phenotypes, gene expression and metabolism between 2D and 3D cultures, and to evaluate their relevance for pre-clinical drug discovery, disease modeling and basic research. Primary and non-transformed prostate epithelial cells, but also several PrCa lines, formed well-differentiated round spheroids. These showed strong cell-cell contacts, epithelial polarization, a hollow lumen and were covered by a complete basal lamina (BL). Most PrCa lines, however, formed large, poorly differentiated spheroids, or aggressively invading structures. In PC-3 and PC-3M cells, well-differentiated spheroids formed, which were then spontaneously transformed into highly invasive cells. These cell lines may have previously undergone an epithelial-to-mesenchymal transition (EMT), which is temporarily suppressed in favor of epithelial maturation by signals from the extracellular matrix (ECM). The induction of lipid and steroid metabolism, epigenetic reprogramming, and ECM remodeling represents a general adaptation to 3D culture, regardless of transformation and phenotype. In contrast, PI3-Kinase, AKT, STAT/interferon and integrin signaling pathways were particularly activated in invasive cells. Specific small molecule inhibitors targeted against PI3-Kinase blocked invasive cell growth more effectively in 3D than in 2D monolayer culture, or the growth of normal cells. Our panel of cell models, spanning a wide spectrum of phenotypic plasticity, supports the investigation of different modes of cell migration and tumor morphologies, and will be useful for predictive testing of anti-cancer and anti-metastatic compounds.	[Harma, Ville; Makela, Rami; Nees, Matthias] VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland; [Happonen, Antti; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Turku, Finland; [Virtanen, Johannes; Mpindi, John-Patrick; Knuuttila, Matias; Kohonen, Pekka] Univ Turku, Ctr Biotechnol, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	VTT Technical Research Center Finland; VTT Technical Research Center Finland; University of Turku; University of Helsinki	Harma, V (corresponding author), VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland.	matthias.nees@vtt.fi	Kohonen, Pekka/F-9596-2011; Nees, Matthias/AAT-5577-2020; Happonen, Antti/M-7644-2014; Nees, Matthias/W-6596-2018; Kallioniemi, Olli P/H-5111-2011	Kohonen, Pekka/0000-0002-7845-3611; Nees, Matthias/0000-0002-9034-301X; Kallioniemi, Olli P/0000-0002-3231-0332; Knuuttila, Matias/0000-0002-9953-5755; Harma, Ville/0000-0001-5767-5226	Finnish Academy [111597]; European commission	Finnish Academy(Academy of Finland); European commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant of the Finnish Academy to MN (No. 111597). Additional funding to OK and JV was provided by FP6 and FP7 Integrated Projects PRIMA and EPITRON of the European commission. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bissell Mina, 2009, J Cell Biol, V185, P374, DOI 10.1083/jcb.1853pi; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Carmona-Fontaine C, 2008, CELL ADHES MIGR, V2, P240, DOI 10.4161/cam.2.4.6747; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Simian M, 2001, DEVELOPMENT, V128, P3117; Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang SY, 2009, METHODS MOL BIOL, V568, P151, DOI 10.1007/978-1-59745-280-9_9; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850	65	248	256	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10431	10.1371/journal.pone.0010431	http://dx.doi.org/10.1371/journal.pone.0010431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454659	Green Published, gold			2022-12-27	WOS:000277240300008
J	Karner, CM; Dietrich, MF; Johnson, EB; Kappesser, N; Tennert, C; Percin, F; Wollnik, B; Carroll, TJ; Herz, J				Karner, Courtney M.; Dietrich, Martin F.; Johnson, Eric B.; Kappesser, Natalie; Tennert, Christian; Percin, Ferda; Wollnik, Bernd; Carroll, Thomas J.; Herz, Joachim			Lrp4 Regulates Initiation of Ureteric Budding and Is Crucial for Kidney Formation - A Mouse Model for Cenani-Lenz Syndrome	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; UROGENITAL SYSTEM; IN-VIVO; MICE; MUTATION; ORGANOGENESIS; EXPRESSION; RECEPTOR; PAX-2; GENE	Background: Development of the kidney is initiated when the ureteric bud (UB) branches from the Wolffian duct and invades the overlying metanephric mesenchyme (MM) triggering the mesenchymal/epithelial interactions that are the basis of organ formation. Multiple signaling pathways must be integrated to ensure proper timing and location of the ureteric bud formation. Methods and Principal Findings: We have used gene targeting to create an Lrp4 null mouse line. The mutation results in early embryonic lethality with a subpenetrant phenotype of kidney agenesis. Ureteric budding is delayed with a failure to stimulate the metanephric mesenchyme in a timely manner, resulting in failure of cellular differentiation and resulting absence of kidney formation in the mouse as well as comparable malformations in humans with Cenani-Lenz syndrome. Conclusion: Lrp4 is a multi-functional receptor implicated in the regulation of several molecular pathways, including Wnt and Bmp signaling. Lrp4(-/-) mice show a delay in ureteric bud formation that results in unilateral or bilateral kidney agenesis. These data indicate that Lrp4 is a critical regulator of UB branching and lack of Lrp4 results in congenital kidney malformations in humans and mice.	[Karner, Courtney M.; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Dietrich, Martin F.; Johnson, Eric B.; Kappesser, Natalie; Tennert, Christian; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Percin, Ferda] Gazi Univ, Fac Med, Dept Med Genet, Ankara, Turkey; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, CMMC, Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Inst Human Genet, Cologne, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Gazi University; University of Cologne; University of Cologne	Karner, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	Percin, Ferda E/H-6850-2016; Wollnik, Bernd/GRY-6062-2022	Percin, Ferda E/0000-0001-9317-8155; Wollnik, Bernd/0000-0003-2589-0364; Karner, Courtney/0000-0003-0387-4486	Boehringer Ingelheim Foundation; German Federal Ministry of Education and Research (BMBF) [01GM0880, 01GM0801]; National Institutes of Health; American Health Assistance Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M.F.D. is supported by a fellowship from the Boehringer Ingelheim Foundation. B. W. was supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM0880 (SKELNET) and 01GM0801 (E-RARE network CRANIRARE). J.H. is supported by grants from the National Institutes of Health, the American Health Assistance Foundation, and the Perot Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates CM, 2000, MOL GENET METAB, V71, P391, DOI 10.1006/mgme.2000.3072; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Gluecksohn-Schoenheimer S, 1943, GENETICS, V28, P341; GLUECKSOHNSCHOENHEIMER S, 1945, GENETICS, V30, P29; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; LI Y, 2010, AM J HUM GEN UNPUB; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; MAAS R, 1994, DEV DYNAM, V199, P214, DOI 10.1002/aja.1001990306; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; PHELPS DE, 1993, DEV BIOL, V157, P251, DOI 10.1006/dbio.1993.1129; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sampogna RV, 2004, PHYSIOLOGY, V19, P339, DOI 10.1152/physiol.00025.2004; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; Tomita Y, 1998, J BIOCHEM-TOKYO, V124, P784, DOI 10.1093/oxfordjournals.jbchem.a022180; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696	31	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10418	10.1371/journal.pone.0010418	http://dx.doi.org/10.1371/journal.pone.0010418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454682	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100024
J	Aslam, A; Logie, C				Aslam, Aamir; Logie, Colin			Histone H3 Serine 57 and Lysine 56 Interplay in Transcription Elongation and Recovery from S-Phase Stress	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; H3K56 ACETYLATION; DNA-DAMAGE; CELL-CYCLE; ANGSTROM RESOLUTION; GENOMIC STABILITY; STRUCTURAL BASIS; REPLICATION	Background: Acetylation of lysine 56 of histone H3 plays an important role in the DNA damage response and it has been postulated to play an as yet undefined role in transcription, both in yeast and in higher eukaryotes. Because phosphorylated human histone H3 serine 57 peptides have been detected by mass spectrometry we examined whether H3-S57 phosphorylation interplays with H3-K56 acetylation in vivo. Methodology/Principal Findings: To explore the physiological role of H3-S57, H3-K56 was mutated to mimic constitutively (un)acetylated forms of H3-K56 and these were combined with constitutively (un) phosphorylated mimics of H3-S57, in yeast. A phosphorylated serine mimic at position 57 lessened sensitivities to a DNA replication fork inhibitor and to a transcription elongation inhibitor that were caused by an acetylated lysine mimic at position 56, while the same substitution exacerbated sensitivities due to mimicking a constitutive non-acetylated lysine at position 56. Strikingly, opposite results were obtained in the context of a serine to alanine substitution at position 57 of histone H3. Conclusions/Significance: The phenotypes elicited and the context-dependent interplay of the H3-K56 and -S57 point mutations that mimic their respective modification states suggest that serine 57 phosphorylation promotes a nucleosomal transaction when lysine 56 is acetylated. We speculate that histone H3-S57 couples H3-K56 acetylation to histone quaternary structures involving arginine 40 on histone H4 helix 1.	[Aslam, Aamir; Logie, Colin] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen	Aslam, A (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands.	c.logie@ncmls.ru.nl	Logie, Colin/A-1528-2010; Logie, Colin/L-9833-2019	Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582	Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Higher Education Commission of Pakistan	Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by grants from the Dutch Cancer Foundation Koningin Wilhelmina Fonds (KWF) and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) to C. Logie, and from the Higher Education Commission of Pakistan to A. Aslam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davidson MB, 2009, DNA REPAIR, V8, P1110, DOI 10.1016/j.dnarep.2009.03.010; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Erkmann JA, 2009, DNA REPAIR, V8, P1371, DOI 10.1016/j.dnarep.2009.09.004; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Knapp AR, 2007, METHODS, V41, P312, DOI 10.1016/j.ymeth.2006.08.017; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schleker T, 2009, DNA REPAIR, V8, P1089, DOI 10.1016/j.dnarep.2009.04.010; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998d; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yang JH, 2010, DNA REPAIR, V9, P414, DOI 10.1016/j.dnarep.2009.12.022; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k	54	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10851	10.1371/journal.pone.0010851	http://dx.doi.org/10.1371/journal.pone.0010851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520775	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500036
J	Filippi, M; Riccitelli, G; Falini, A; Di Salle, F; Vuilleumier, P; Comi, G; Rocca, MA				Filippi, Massimo; Riccitelli, Gianna; Falini, Andrea; Di Salle, Francesco; Vuilleumier, Patrik; Comi, Giancarlo; Rocca, Maria A.			The Brain Functional Networks Associated to Human and Animal Suffering Differ among Omnivores, Vegetarians and Vegans	PLOS ONE			English	Article							AMYGDALA RESPONSE; EMPATHY QUOTIENT; EMOTION; FMRI; STIMULI; CORTEX; METAANALYSIS; NEUROSCIENCE; MODULATION; SYSTEMS	Empathy and affective appraisals for conspecifics are among the hallmarks of social interaction. Using functional MRI, we hypothesized that vegetarians and vegans, who made their feeding choice for ethical reasons, might show brain responses to conditions of suffering involving humans or animals different from omnivores. We recruited 20 omnivore subjects, 19 vegetarians, and 21 vegans. The groups were matched for sex and age. Brain activation was investigated using fMRI and an event-related design during observation of negative affective pictures of human beings and animals (showing mutilations, murdered people, human/animal threat, tortures, wounds, etc.). Participants saw negative-valence scenes related to humans and animals, alternating with natural landscapes. During human negative valence scenes, compared with omnivores, vegetarians and vegans had an increased recruitment of the anterior cingulate cortex (ACC) and inferior frontal gyrus (IFG). More critically, during animal negative valence scenes, they had decreased amygdala activation and increased activation of the lingual gyri, the left cuneus, the posterior cingulate cortex and several areas mainly located in the frontal lobes, including the ACC, the IFG and the middle frontal gyrus. Nonetheless, also substantial differences between vegetarians and vegans have been found responding to negative scenes. Vegetarians showed a selective recruitment of the right inferior parietal lobule during human negative scenes, and a prevailing activation of the ACC during animal negative scenes. Conversely, during animal negative scenes an increased activation of the inferior prefrontal cortex was observed in vegans. These results suggest that empathy toward non conspecifics has different neural representation among individuals with different feeding habits, perhaps reflecting different motivational factors and beliefs.	[Filippi, Massimo; Riccitelli, Gianna; Rocca, Maria A.] Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, Milan, Italy; [Filippi, Massimo; Riccitelli, Gianna; Falini, Andrea; Rocca, Maria A.] Univ Hosp San Raffaele, Milan, Italy; [Filippi, Massimo; Rocca, Maria A.] Inst Sci, Dept Neurol, Milan, Italy; [Falini, Andrea] Inst Sci, Dept Neuroradiol, Milan, Italy; [Di Salle, Francesco] Univ Maastricht, Dept Cognit Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Vuilleumier, Patrik] Univ Geneva, Ctr Med Univ Geneva, Geneva, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Maastricht University; University of Geneva	Filippi, M (corresponding author), Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, Milan, Italy.	filippi.massimo@hsr.it	Riccitelli, Gianna Carla/AAD-9415-2020; Filippi, Massimo/K-1755-2018; Vuilleumier, Patrik/AAJ-1839-2021; Rocca, Maria Assunta/K-1619-2018	Riccitelli, Gianna Carla/0000-0002-1202-5534; Filippi, Massimo/0000-0002-5485-0479; Vuilleumier, Patrik/0000-0002-8198-9214; Rocca, Maria Assunta/0000-0003-2358-4320; falini, andrea/0000-0002-1461-8755				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; DARGEMBEAU A, 2009, J COGN NEUROSCI; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Lang P.J., 2008, A8 U FLOR; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Regan T., 1985, CASE ANIMAL RIGHTS; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Schienle A, 2006, NEUROSCI LETT, V393, P174, DOI 10.1016/j.neulet.2005.09.072; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Westbury HR, 2008, BIOL PSYCHOL, V78, P66, DOI 10.1016/j.biopsycho.2007.12.009	39	50	52	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10847	10.1371/journal.pone.0010847	http://dx.doi.org/10.1371/journal.pone.0010847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520767	Green Submitted, gold, Green Published			2022-12-27	WOS:000278221500032
J	Li, ZY; Qi, CF; Shin, DM; Zingone, A; Newbery, HJ; Kovalchuk, AL; Abbott, CM; Morse, HC				Li, Zhaoyang; Qi, Chen-Feng; Shin, Dong-Mi; Zingone, Adriana; Newbery, Helen J.; Kovalchuk, Alexander L.; Abbott, Catherine M.; Morse, Herbert C., III			Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; MULTIPLE-MYELOMA; THERAPEUTIC TARGET; OVARIAN CARCINOMAS; MAMMALIAN-CELLS; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR 1A; JAK-STAT; B-CELLS	Background: The canonical function of EEF1A2, normally expressed only in muscle, brain, and heart, is in translational elongation, but recent studies suggest a non-canonical function as a proto-oncogene that is overexpressed in a variety of solid tumors including breast and ovary. Transcriptional profiling of a spectrum of primary mouse B cell lineage neoplasms showed that transcripts encoding EEF1A2 were uniquely overexpressed in plasmacytomas (PCT), tumors of mature plasma cells. Cases of human multiple myeloma expressed significantly higher levels of EEF1A2 transcripts than normal bone marrow plasma cells. High-level expression was also a feature of a subset of cell lines developed from mouse PCT and from the human MM. Methodology/Principal Findings: Heightened expression of EEF1A2 was not associated with increased copy number or coding sequence mutations. shRNA-mediated knockdown of Eef1a2 transcripts and protein was associated with growth inhibition due to delayed G1-S progression, and effects on apoptosis that were seen only under serum-starved conditions. Transcriptional profiles and western blot analyses of knockdown cells revealed impaired JAK/STAT and PI3K/AKT signaling suggesting their contributions to EEF1A2-mediated effects on PCT induction or progression. Conclusions/Significance: EEF1A2 may play contribute to the induction or progression of some PCT and a small percentage of MM. Eef1a2 could also prove to be a useful new marker for a subset of MM and, ultimately, a possible target for therapy.	[Li, Zhaoyang; Qi, Chen-Feng; Shin, Dong-Mi; Kovalchuk, Alexander L.; Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD USA; [Zingone, Adriana] USN Hosp, NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20814 USA; [Newbery, Helen J.; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Mol Med Ctr, Edinburgh, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; University of Edinburgh	Li, ZY (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	hmorse@niaid.nih.gov	Abbott, Catherine M/C-7306-2013	Abbott, Catherine/0000-0001-8794-7173; Morse, Herbert/0000-0002-9331-3705; Kovalchuk, Alexander/0000-0003-2761-0442	National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001024, ZIAAI000858] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute. Work in the lab of CMA is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Fredrickson TN, 1999, AM J PATHOL, V154, P805, DOI 10.1016/S0002-9440(10)65327-8; Grassi G, 2007, BIOCHIMIE, V89, P1544, DOI 10.1016/j.biochi.2007.07.007; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; Jeganathan S, 2007, J BIOL CHEM, V282, P372, DOI 10.1074/jbc.M602955200; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; Kim MJ, 1999, MOL CELLS, V9, P631; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; LEE S, 1995, EXP CELL RES, V219, P589, DOI 10.1006/excr.1995.1268; LEE S, 1992, J BIOL CHEM, V267, P24064; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Morse HC, 2001, LEUKEMIA RES, V25, P719, DOI 10.1016/S0145-2126(01)00022-4; Morse HC, 2003, ADV IMMUNOL, V81, P97, DOI 10.1016/S0065-2776(03)81003-9; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Park ES, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-302; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Qi CF, 2006, LEUKEMIA RES, V30, P153, DOI 10.1016/j.leukres.2005.06.025; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Qi CF, 2010, J PATHOL, V221, P106, DOI 10.1002/path.2692; Quintanilla-Martinez L, 2003, AM J PATHOL, V162, P1449, DOI 10.1016/S0002-9440(10)64278-2; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shin DM, 2008, CANCER RES, V68, P9202, DOI 10.1158/0008-5472.CAN-07-6555; Sun Y, 2008, INT J CANCER, V123, P1761, DOI 10.1002/ijc.23708; Tomlinson VAL, 2007, BRIT J CANCER, V96, P1613, DOI 10.1038/sj.bjc.6603748; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Zhang JQ, 2004, J EXP MED, V200, P1467, DOI 10.1084/jem.20041575	49	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10755	10.1371/journal.pone.0010755	http://dx.doi.org/10.1371/journal.pone.0010755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505761	Green Submitted, Green Published, gold			2022-12-27	WOS:000278017400012
J	McKenna, SA; Etnoyer, P				McKenna, Sheila A.; Etnoyer, Peter			Rapid Assessment of Stony Coral Richness and Condition on Saba Bank, Netherlands Antilles	PLOS ONE			English	Article							CLIMATE-CHANGE; REEFS; COMMUNITY; IMPACTS; FLORIDA	The benthic habitats of Saba Bank (17 degrees 25'N, 63 degrees 30'W) are at risk from maritime traffic, especially oil tankers (e.g., anchoring). To mitigate this risk, information is needed on the biodiversity and location of habitats to develop a zone use plan. A rapid survey to document the biodiversity of macro-algae, sponges, corals and fishes was conducted. Here we report on the richness and condition of stony coral species at 18 select sites, and we test for the effects of bottom type, depth, and distance from platform edge. Species richness was visually assessed by roving scuba diver with voucher specimens of each species collected. Coral tissue was examined for bleaching and diseases. Thirty-three coral species were documented. There were no significant differences in coral composition among bottom types or depth classes (ANOSIM, P>0.05). There was a significant difference between sites (ANOSIM, P<0.05) near and far from the platform edge. The number of coral species observed ranged from zero and one in algal dominated habitats to 23 at a reef habitat on the southern edge of the Bank. Five reef sites had stands of Acropora cervicornis, a critically endangered species on the IUCN redlist. Bleaching was evident at 82% of the sites assessed with 43 colonies bleached. Only three coral colonies were observed to have disease. Combining our findings with that of other studies, a total of 43 species have been documented from Saba Bank. The coral assemblage on the bank is representative and typical of those found elsewhere in the Caribbean. Although our findings will help develop effective protection, more information is needed on Saba Bank to create a comprehensive zone use plan. Nevertheless, immediate action is warranted to protect the diverse coral reef habitats documented here, especially those containing A. cervicornis.	[McKenna, Sheila A.] Ctr Appl Biodivers Sci Conservat Int, Arlington, VA USA; [McKenna, Sheila A.] Mission Blue, Alameda, CA USA; [McKenna, Sheila A.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [McKenna, Sheila A.] Univ Queensland, Commonwealth Facil Appl Environm Decis Anal AEDA, Brisbane, Qld, Australia; [Etnoyer, Peter] NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA	University of Queensland; University of Queensland; National Oceanic Atmospheric Admin (NOAA) - USA	McKenna, SA (corresponding author), Ctr Appl Biodivers Sci Conservat Int, Arlington, VA USA.	sheilamckenna@yahoo.com		Etnoyer, Peter/0000-0002-9932-3066	Center for Applied Biodiversity Science at Conservation International; Netherlands Antilles Department of Environment and Nature (MINA); Saba Bank Conservation Foundation; Saba National Marine Park; Nature Foundation St. Maarten; Conservation International	Center for Applied Biodiversity Science at Conservation International; Netherlands Antilles Department of Environment and Nature (MINA); Saba Bank Conservation Foundation; Saba National Marine Park; Nature Foundation St. Maarten; Conservation International	The Saba Bank rapid assessment was funded by the Center for Applied Biodiversity Science at Conservation International, Netherlands Antilles Department of Environment and Nature (MINA) and Saba Bank Conservation Foundation. In kind support was provided by Saba National Marine Park and Nature Foundation St. Maarten. The publication fees for this contribution on the stony corals of Saba Bank are funded by Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON R, 2008, IUCN 2009 IUCN RED L; Bouchon C., 2008, STATUS CORAL REEFS L, P85; CAIRNS SD, 2000, STUDIES NATURAL HIST, V75, P1; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P13; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chiappone M., 1996, Caribbean Journal of Science, V32, P1; Clarke K.R., 2006, PRIMER V6 1 USER MAN; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collier C, 2007, RAPID RESPONSE RESTO; Colwell RK, 2013, ESTIMATES STAT ESTIM; DAVIS G E, 1977, Biological Conservation, V11, P29, DOI 10.1016/0006-3207(77)90024-6; Diaz JM, 2000, SCI MAR, V64, P327, DOI 10.3989/scimar.2000.64n3327; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Fenner D, 2001, B MAR SCI, V69, P1175; Fenner Douglas, 1998, Caribbean Marine Studies, V6, P19; Global Invasive Species Database, 2005, GLOBAL INVASIVE SPEC; HOETJES P, 2002, STATUS CORAL REEFS W, P325; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; Kramer P., 2005, ATLANTIC GULF RAPID; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; *NOAA COR REEF HLT, NOAAS COR REEF HLTH; *SOC MAN EL BIOD D, 2009, WORLD REG MAR SPEC; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Weil E, 2004, CORAL HEALTH AND DISEASE, P35	33	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10749	10.1371/journal.pone.0010749	http://dx.doi.org/10.1371/journal.pone.0010749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505771	Green Published, Green Accepted, gold			2022-12-27	WOS:000278017400010
J	Lauren, HB; Lopez-Picon, FR; Brandt, AM; Rios-Rojas, CJ; Holopainen, IE				Lauren, Hanna B.; Lopez-Picon, Francisco R.; Brandt, Annika M.; Rios-Rojas, Clarissa J.; Holopainen, Irma E.			Transcriptome Analysis of the Hippocampal CA1 Pyramidal Cell Region after Kainic Acid-Induced Status Epilepticus in Juvenile Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CALCIUM-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; SUBUNIT MESSENGER-RNA; GENE-EXPRESSION; GABA(A) RECEPTOR; INDUCED SEIZURES; DENTATE GYRUS; ADULT-RAT	Molecular mechanisms involved in epileptogenesis in the developing brain remain poorly understood. The gene array approach could reveal some of the factors involved by allowing the identification of a broad scale of genes altered by seizures. In this study we used microarray analysis to reveal the gene expression profile of the laser microdissected hippocampal CA1 subregion one week after kainic acid (KA)-induced status epilepticus (SE) in 21-day-old rats, which are developmentally roughly comparable to juvenile children. The gene expression analysis with the Chipster software generated a total of 1592 differently expressed genes in the CA1 subregion of KA-treated rats compared to control rats. The KEGG database revealed that the identified genes were involved in pathways such as oxidative phosporylation (26 genes changed), and long-term potentiation (LTP; 18 genes changed). Also genes involved in Ca2+ homeostasis, gliosis, inflammation, and GABAergic transmission were altered. To validate the microarray results we further examined the protein expression for a subset of selected genes, glial fibrillary protein (GFAP), apolipoprotein E (apo E), cannabinoid type 1 receptor (CB1), Purkinje cell protein 4 (PEP-19), and interleukin 8 receptor (CXCR1), with immunohistochemistry, which confirmed the transcriptome results. Our results showed that SE resulted in no obvious CA1 neuronal loss, and alterations in the expression pattern of several genes during the early epileptogenic phase were comparable to previous gene expression studies of the adult hippocampus of both experimental epileptic animals and patients with temporal lobe epilepsy (TLE). However, some changes seem to occur after SE specifically in the juvenile rat hippocampus. Insight of the SE-induced alterations in gene expression and their related pathways could give us hints for the development of new target-specific antiepileptic drugs that interfere with the progression of the disease in the juvenile age group.	[Lauren, Hanna B.; Lopez-Picon, Francisco R.; Holopainen, Irma E.] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Lauren, Hanna B.; Holopainen, Irma E.] MediCity Res Lab, Turku, Finland; [Brandt, Annika M.; Rios-Rojas, Clarissa J.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Brandt, Annika M.; Rios-Rojas, Clarissa J.] Abo Akad Univ, Turku, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University	Lauren, HB (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	irma.holopainen@utu.fi		Rios Rojas, Clarissa Jazmin/0000-0001-6544-4663; Lopez Picon, Francisco R./0000-0002-3871-1735	Academy of Finland [8117438, 8127008]; Arvo and Lea Ylppo Foundation; Finnish Cultural Foundation; Drug Discovery Graduate School; Finnish Graduate School of Neuroscience	Academy of Finland(Academy of Finland); Arvo and Lea Ylppo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Drug Discovery Graduate School; Finnish Graduate School of Neuroscience	The financial support of the Academy of Finland, projects # 8117438 (IEH) and # 8127008 (HBL), the Arvo and Lea Ylppo Foundation (IEH), the Finnish Cultural Foundation (HBL), the Drug Discovery Graduate School (HBL), and the Finnish Graduate School of Neuroscience (FRL) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Akahoshi N, 2007, NEUROSCI LETT, V429, P136, DOI 10.1016/j.neulet.2007.10.007; Aronica E, 2001, EUR J NEUROSCI, V14, P1485, DOI 10.1046/j.0953-816x.2001.01779.x; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bendotti C, 2000, EXP NEUROL, V161, P317, DOI 10.1006/exnr.1999.7262; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Bo T, 2004, DEV BRAIN RES, V152, P137, DOI 10.1016/j.devbrainres.2004.06.011; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; BRZIN J, 1984, BIOCHEM BIOPH RES CO, V118, P103, DOI 10.1016/0006-291X(84)91073-8; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Carter DS, 2008, EPILEPSY RES, V79, P213, DOI 10.1016/j.eplepsyres.2008.02.006; Champagne D, 2005, EXP NEUROL, V194, P31, DOI 10.1016/j.expneurol.2005.01.016; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Danik M, 2003, J NEUROSCI RES, V74, P286, DOI 10.1002/jnr.10744; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Ding M, 2000, NEUROCHEM INT, V36, P313, DOI 10.1016/S0197-0186(99)00139-4; Elliott RC, 2003, J NEUROSCI, V23, P2218; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; Gorter JA, 2003, EPILEPSIA, V44, P647, DOI 10.1046/j.1528-1157.2003.53902.x; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Haas KZ, 2001, HIPPOCAMPUS, V11, P615, DOI 10.1002/hipo.1076; Hashiguchi A, 2003, NEUROSCIENCE, V121, P379, DOI 10.1016/S0306-4522(03)00490-1; Haut SR, 2004, LANCET NEUROL, V3, P608, DOI 10.1016/S1474-4422(04)00881-6; Hellsten J, 2005, BIOL PSYCHIAT, V58, P871, DOI 10.1016/j.biopsych.2005.05.023; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Houser CR, 2003, HIPPOCAMPUS, V13, P633, DOI 10.1002/hipo.10108; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jarvela JT, 2008, EPILEPSIA, V49, P832, DOI 10.1111/j.1528-1167.2007.01454.x; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Lauren HB, 2005, J NEUROCHEM, V94, P1384, DOI 10.1111/j.1471-4159.2005.03274.x; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; LERANTH C, 1991, EXP BRAIN RES, V85, P129; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lopez-Picon F, 2004, NEUROBIOL DIS, V17, P415, DOI 10.1016/j.nbd.2004.08.004; Lopez-Picon FR, 2003, HIPPOCAMPUS, V13, P767, DOI 10.1002/hipo.10122; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; MARKS N, 1988, ARCH BIOCHEM BIOPHYS, V267, P448, DOI 10.1016/0003-9861(88)90050-1; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matsumoto T, 1997, LAB INVEST, V77, P119; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mennicken F, 2002, GLIA, V37, P124, DOI 10.1002/glia.10021; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Montpied P, 1999, EPILEPSY RES, V35, P135, DOI 10.1016/S0920-1211(99)00003-0; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Puma C, 2001, J NEUROCHEM, V78, P960, DOI 10.1046/j.1471-4159.2001.00469.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Rice A, 1996, P NATL ACAD SCI USA, V93, P9665, DOI 10.1073/pnas.93.18.9665; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sanden E, 2003, AM J DENT, V16, P170; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Takano H, 2004, BIOL PHARM BULL, V27, P1788, DOI 10.1248/bpb.27.1788; Tang FR, 2006, NEUROSCIENCE, V140, P1467, DOI 10.1016/j.neuroscience.2006.03.022; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TORRE ER, 1993, BRAIN RES, V631, P256, DOI 10.1016/0006-8993(93)91543-2; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wasterlain CG, 2002, PROG BRAIN RES, V135, P335; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007; Zhao XY, 2001, J COMP NEUROL, V441, P187, DOI 10.1002/cne.1406	101	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10733	10.1371/journal.pone.0010733	http://dx.doi.org/10.1371/journal.pone.0010733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505763	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300009
J	Gupta, N; Fisker, N; Asselin, MC; Lindholm, M; Rosenbohm, C; Orum, H; Elmen, J; Seidah, NG; Straarup, EM				Gupta, Nidhi; Fisker, Niels; Asselin, Marie-Claude; Lindholm, Marie; Rosenbohm, Christoph; Orum, Henrik; Elmen, Joacim; Seidah, Nabil G.; Straarup, Ellen Marie			A Locked Nucleic Acid Antisense Oligonucleotide (LNA) Silences PCSK9 and Enhances LDLR Expression In Vitro and In Vivo	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; NONHUMAN-PRIMATES; LIVER-REGENERATION; PLASMA-CHOLESTEROL; MOUSE-LIVER; MICE; DEGRADATION; MUTATIONS	Background: The proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important factor in the etiology of familial hypercholesterolemia (FH) and is also an attractive therapeutic target to reduce low density lipoprotein (LDL) cholesterol. PCSK9 accelerates the degradation of hepatic low density lipoprotein receptor (LDLR) and low levels of hepatic PCSK9 activity are associated with reduced levels of circulating LDL-cholesterol. Methodology/Principal Findings: The present study presents the first evidence for the efficacy of a locked nucleic acid (LNA) antisense oligonucleotide (LNA ASO) that targets both human and mouse PCSK9. We employed human hepatocytes derived cell lines HepG2 and HuH7 and a pancreatic mouse beta-TC3 cell line known to express high endogenous levels of PCSK9. LNA ASO efficiently reduced the mRNA and protein levels of PCSK9 with a concomitant increase in LDLR protein levels after transfection in these cells. In vivo efficacy of LNA ASO was further investigated in mice by tail vein intravenous administration of LNA ASO in saline solution. The level of PCSK9 mRNA was reduced by similar to 60%, an effect lasting more than 16 days. Hepatic LDLR protein levels were significantly up-regulated by 2.5-3 folds for at least 8 days and similar to 2 fold for 16 days. Finally, measurement of liver alanine aminotransferase (ALT) levels revealed that long term LNA ASO treatment (7 weeks) does not cause hepatotoxicity. Conclusion/Significance: LNA-mediated PCSK9 mRNA inhibition displayed potent reduction of PCSK9 in cell lines and mouse liver. Our data clearly revealed the efficacy and safety of LNA ASO in reducing PCSK9 levels, an approach that is now ready for testing in primates. The major significance and take home message of this work is the development of a novel and promising approach for human therapeutic intervention of the PCSK9 pathway and hence for reducing some of the cardiovascular risk factors associated with the metabolic syndrome.	[Gupta, Nidhi; Asselin, Marie-Claude; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Fisker, Niels; Lindholm, Marie; Rosenbohm, Christoph; Orum, Henrik; Elmen, Joacim; Straarup, Ellen Marie] Santaris Pharma AS, Horsholm, Denmark	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Gupta, N (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Lindholm, Marie W/B-8736-2015; Seidah, Nabil/I-3596-2013; Gupta, Nidhi/ADR-1996-2022	Lindholm, Marie W/0000-0003-4309-3203; Seidah, Nabil/0000-0001-6503-9342; Gupta, Nidhi/0000-0002-1086-1336; Wikstrom Lindholm, Marie/0000-0002-0975-2394	Canadian Institutes of Health [MOP 36496, CTP 82946]; Santaris Pharma A/S	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Santaris Pharma A/S	This work was supported by a Canadian Institutes of Health Research grant MOP 36496 and a team grant CTP 82946. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, this project was partially funded by Santaris Pharma A/S, allowing a collaborative effort in which Santaris Pharma was co-author in this study. The design of the LNA and its synthesis and mouse work was done at Santaris, and the extensive cell biology work was done at the IRCM. The decision to publish and prepration of the manuscript was by common agreement and effort between the IRCM and Santaris.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cariou B, 2009, ARTERIOSCL THROM VAS, V29, P2191, DOI 10.1161/ATVBAHA.109.194191; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	37	148	157	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10682	10.1371/journal.pone.0010682	http://dx.doi.org/10.1371/journal.pone.0010682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498851	gold, Green Published, Green Submitted			2022-12-27	WOS:000277773700018
J	Qi, QB; Li, HX; Loos, RJF; Liu, C; Hu, FB; Wu, HY; Yu, ZJ; Lin, X				Qi, Qibin; Li, Huaixing; Loos, Ruth J. F.; Liu, Chen; Hu, Frank B.; Wu, Hongyu; Yu, Zhijie; Lin, Xu			Association of PCSK1 rs6234 with Obesity and Related Traits in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; GENE; ADULTS; RISK	Methodology/Principal Findings: Two PCSK1 variants rs6234 and rs6235 (in strong LD with each other, r(2) = 0.98) were genotyped in a population-based cohort of 3,210 Chinese Hans. The rs6234 was used for further association analyses with obesity and related traits. We found no significant association of rs6234 with obesity, overweight, BMI, waist circumference, or body fat percentage (P > 0.05) in all participants. However, the rs6234 G-allele showed a significant association with increased risk of combined phenotype of obesity and overweight (OR 1.21[1.03-1.43], P = 0.0193) and a trend toward association with obesity (OR 1.25[0.98-1.61], P = 0.08) in men, but not in women (P >= 0.29). Consistently, the rs6234 G-allele showed significant association with increased BMI (P = 0.0043), waist circumference (P = 0.008) and body fat percentage (P = 0.0131) only in men, not in women (P >= 0.24). Interestingly, the rs6234 G-allele was significantly associated with increased HOMA-B (P = 0.0059) and decreased HOMA-S (P = 0.0349) in all participants. Conclusion/Significance: In this study, we found modest evidence for association of the PCSK1 rs6234 with BMI and overweight in men only but not in women, which suggested that PCSK1 rs6234 might not be an important contributor to obesity in Chinese Hans. However, further studies with larger sample sizes are needed to draw a firm conclusion.	[Qi, Qibin; Li, Huaixing; Liu, Chen; Wu, Hongyu; Yu, Zhijie; Lin, Xu] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Qi, Qibin; Li, Huaixing; Liu, Chen; Wu, Hongyu; Yu, Zhijie; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health	Qi, QB (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Qi, Qibin/H-9055-2012	Loos, Ruth J F/0000-0002-8532-5087; 	Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [SIBS2008006, KSCX1-YW-02]; National Natural Science Foundation of China [30930081]; Ministry of Science and Technology of China [2006CB503900, 2007AA02Z332, 2008DFA31960]; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006), the National Natural Science Foundation of China (30930081), the Ministry of Science and Technology of China (973 Program, Grant No. 2006CB503900; 863 Program, Grant No. 2007AA02Z332; and International Collaboration Program, Grant No. 2008DFA31960), and the Chinese Academy of Sciences (The Knowledge Innovation Program, Grant No. KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; CHANG YC, 2009, OBESITY         1029, DOI DOI 10.1038/OBY.2009.390; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	12	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10590	10.1371/journal.pone.0010590	http://dx.doi.org/10.1371/journal.pone.0010590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498726	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700003
J	Bernhard, S; Noe, F				Bernhard, Stefan; Noe, Frank			Optimal Identification of Semi-Rigid Domains in Macromolecules from Molecular Dynamics Simulation	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; STRUCTURAL DOMAINS; TRANSTHYRETIN; FLEXIBILITY; MICROHETEROGENEITY; CONFORMATION; PREALBUMIN; STABILITY; PROTEINS	Biological function relies on the fact that biomolecules can switch between different conformations and aggregation states. Such transitions involve a rearrangement of parts of the biomolecules involved that act as dynamic domains. The reliable identification of such domains is thus a key problem in biophysics. In this work we present a method to identify semi-rigid domains based on dynamical data that can be obtained from molecular dynamics simulations or experiments. To this end the average inter-atomic distance-deviations are computed. The resulting matrix is then clustered by a constrained quadratic optimization problem. The reliability and performance of the method are demonstrated for two artificial peptides. Furthermore we correlate the mechanical properties with biological malfunction in three variants of amyloidogenic transthyretin protein, where the method reveals that a pathological mutation destabilizes the natural dimer structure of the protein. Finally the method is used to identify functional domains of the GroEL-GroES chaperone, thus illustrating the efficiency of the method for large biomolecular machines.	[Bernhard, Stefan; Noe, Frank] Free Univ Berlin, DFG Res Ctr MATHEON, D-1000 Berlin, Germany	Free University of Berlin; German Research Foundation (DFG)	Bernhard, S (corresponding author), Free Univ Berlin, DFG Res Ctr MATHEON, D-1000 Berlin, Germany.	bernhard@math.fu-berlin.de	Noe, Frank/Y-2766-2019		DFG Research Center	DFG Research Center(German Research Foundation (DFG))	This work was funded by the DFG Research Center MATHEON (http://www.matheon.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2006, PROTEINS, V63, P1038, DOI 10.1002/prot.20907; Altland K, 1999, ELECTROPHORESIS, V20, P1349, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1349::AID-ELPS1349>3.0.CO;2-5; Altland K, 2007, ELECTROPHORESIS, V28, P2053, DOI 10.1002/elps.200600840; Anselmi C, 2001, BIOPOLYMERS, V58, P218, DOI 10.1002/1097-0282(200102)58:2<218::AID-BIP100>3.0.CO;2-M; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Ayton GS, 2007, CURR OPIN STRUC BIOL, V17, P192, DOI 10.1016/j.sbi.2007.03.004; Bagci Z, 2002, J CHEM PHYS, V116, P2269, DOI 10.1063/1.1432502; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Bao G, 2002, J MECH PHYS SOLIDS, V50, P2237, DOI 10.1016/S0022-5096(02)00035-2; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carlson HA, 2000, MOL PHARMACOL, V57, P213; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; CHENNUBHOTLA C, 2006, MOL SYST BIOL, V36, P1; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gill P., 1995, USERS GUIDE QPOPT 1; Hayward S, 2004, J MOL BIOL, V339, P1001, DOI 10.1016/j.jmb.2004.04.004; Hery S, 1998, J MOL BIOL, V279, P303, DOI 10.1006/jmbi.1998.1754; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; Jenne DE, 1996, P NATL ACAD SCI USA, V93, P6302, DOI 10.1073/pnas.93.13.6302; JUNGER M, 2004, OPTIMIZATION OPERATI, P321; Keskin O, 2002, BIOCHEMISTRY-US, V41, P491, DOI 10.1021/bi011393x; Kim MK, 2005, BIOPHYS J, V89, P43, DOI 10.1529/biophysj.104.044347; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lavery R, 2002, J PHYS-CONDENS MAT, V14, pR383, DOI 10.1088/0953-8984/14/14/202; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; Liljas A., 1974, ANNU REV BIOCHEM, V43, P475; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Menor SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036017; Micheletti C, 2002, J MOL BIOL, V321, P909, DOI 10.1016/S0022-2836(02)00710-6; Motozaki Y, 2007, J NEUROL SCI, V260, P236, DOI 10.1016/j.jns.2007.03.021; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Navizet I, 2004, PROTEINS, V54, P384, DOI 10.1002/prot.10476; NICOLAS WL, 1995, PROTEIN-STRUCT FUNCT, V23, P38; Noe F, 2008, J PHYS CHEM B, V112, P11155, DOI 10.1021/jp801391t; Potestio R, 2009, BIOPHYS J, V96, P4993, DOI 10.1016/j.bpj.2009.03.051; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; SHIBUYA T, 2008, IEEE ACM T COMPUT BI, P1; Sorensen J, 2007, BIOPOLYMERS, V86, P73, DOI 10.1002/bip.20705; SPLETTSTOESSER T, 2008, PROTEINS STRUCTURE F; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TAKEUCHI M, 2006, PROTEIN-STRUCT FUNCT, V66, P716; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Taylor WR, 1999, PROTEIN ENG, V12, P203, DOI 10.1093/protein/12.3.203; Walter S, 2002, CELL MOL LIFE SCI, V59, P1589, DOI 10.1007/PL00012485; WODAK SJ, 1981, BIOCHEMISTRY-US, V20, P6544, DOI 10.1021/bi00526a005; Wriggers W, 1997, PROTEINS, V29, P1; Xuan ZY, 2000, EUR BIOPHYS J BIOPHY, V29, P7, DOI 10.1007/s002490050246; Yesylevskyy SO, 2009, PROTEINS, V74, P980, DOI 10.1002/prot.22208; Yesylevskyy SO, 2006, BIOPHYS CHEM, V119, P84, DOI 10.1016/j.bpc.2005.07.004; ZEHFUS MH, 1987, PROTEIN-STRUCT FUNCT, V16, P90; Zhang ZY, 2008, BIOPHYS J, V95, P5073, DOI 10.1529/biophysj.108.139626	66	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10491	10.1371/journal.pone.0010491	http://dx.doi.org/10.1371/journal.pone.0010491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498702	Green Submitted, Green Published, gold			2022-12-27	WOS:000277633500004
J	Naylor, MG; Lin, XH; Weiss, ST; Raby, BA; Lange, C				Naylor, Melissa G.; Lin, Xihong; Weiss, Scott T.; Raby, Benjamin A.; Lange, Christoph			Using Canonical Correlation Analysis to Discover Genetic Regulatory Variants	PLOS ONE			English	Article								Background: Discovering genetic associations between genetic markers and gene expression levels can provide insight into gene regulation and, potentially, mechanisms of disease. Such analyses typically involve a linkage or association analysis in which expression data are used as phenotypes. This approach leads to a large number of multiple comparisons and may therefore lack power. We assess the potential of applying canonical correlation analysis to partitioned genomewide data as a method for discovering regulatory variants. Methodology/Principal Findings: Simulations suggest that canonical correlation analysis has higher power than standard pairwise univariate regression to detect single nucleotide polymorphisms when the expression trait has low heritability. The increase in power is even greater under the recessive model. We demonstrate this approach using the Childhood Asthma Management Program data. Conclusions/Significance: Our approach reduces multiple comparisons and may provide insight into the complex relationships between genotype and gene expression.	[Naylor, Melissa G.; Lin, Xihong; Lange, Christoph] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Weiss, Scott T.; Raby, Benjamin A.; Lange, Christoph] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Naylor, MG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	mnaylor@hsph.harvard.edu	Raby, Benjamin/AAK-3866-2021		National Institutes of Health (NIH) [T32 MH17119, T32 HL07427-26, R01 HL086601, 1 UL1 RR025780]; NIH/National Heart, Lung and Blood Institute [U01 HL075419, U01 HL65899, P01 HL083069, T32 HL07427]; National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075419, T32HL007427, R01HL086601, P01HL083069, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017119] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by the National Institutes of Health (NIH) through grants T32 MH17119, T32 HL07427-26, and R01 HL086601. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069 and T32 HL07427 from the NIH/National Heart, Lung and Blood Institute, and through the Colorado Clinical and Translational Science Award (CTSA) grant 1 UL1 RR025780 from the NIH and National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartlett MS, 1941, BIOMETRIKA, V32, P29; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; JOHNSON RA, 2001, APPL MULTIVARIATE ST; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; R Core Team, 2020, R LANG ENV STAT COMP; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Waaijenborg S, 2008, STAT APPL GENET MOL, V7	11	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10395	10.1371/journal.pone.0010395	http://dx.doi.org/10.1371/journal.pone.0010395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485529	Green Submitted, Green Published, gold			2022-12-27	WOS:000277633500002
J	Tommasi, S; Kim, SI; Zhong, XY; Wu, XW; Pfeifer, GP; Besaratinia, A				Tommasi, Stella; Kim, Sang-in; Zhong, Xueyan; Wu, Xiwei; Pfeifer, Gerd P.; Besaratinia, Ahmad			Investigating the Epigenetic Effects of a Prototype Smoke-Derived Carcinogen in Human Cells	PLOS ONE			English	Article							GENE PROMOTER HYPERMETHYLATION; ISLAND RECOVERY ASSAY; LUNG-CANCER; DNA METHYLATION; 5-METHYLCYTOSINE CONTENT; CPG-ISLANDS; HYPOMETHYLATION; METHYLTRANSFERASE; EPIGENOMICS; RESOLUTION	Global loss of DNA methylation and locus/gene-specific gain of DNA methylation are two distinct hallmarks of carcinogenesis. Aberrant DNA methylation is implicated in smoking-related lung cancer. In this study, we have comprehensively investigated the modulation of DNA methylation consequent to chronic exposure to a prototype smoke-derived carcinogen, benzo[a] pyrene diol epoxide (B[a]PDE), in genomic regions of significance in lung cancer, in normal human cells. We have used a pulldown assay for enrichment of the CpG methylated fraction of cellular DNA combined with microarray platforms, followed by extensive validation through conventional bisulfite-based analysis. Here, we demonstrate strikingly similar patterns of DNA methylation in non-transformed B[a]PDE-treated cells vs control using high-throughput microarray-based DNA methylation profiling confirmed by conventional bisulfite-based DNA methylation analysis. The absence of aberrant DNA methylation in our model system within a timeframe that precedes cellular transformation suggests that following carcinogen exposure, other as yet unknown factors (secondary to carcinogen treatment) may help initiate global loss of DNA methylation and region-specific gain of DNA methylation, which can, in turn, contribute to lung cancer development. Unveiling the initiating events that cause aberrant DNA methylation in lung cancer has tremendous public health relevance, as it can help define future strategies for early detection and prevention of this highly lethal disease.	[Tommasi, Stella; Kim, Sang-in; Zhong, Xueyan; Pfeifer, Gerd P.; Besaratinia, Ahmad] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Div Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Tommasi, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ania@coh.org		Tommasi, Stella/0000-0001-6897-4985; Besaratinia, Ahmad/0000-0001-7231-228X	University of California [18KT-0040]; National Cancer Institute [2R01CA084469]; NATIONAL CANCER INSTITUTE [R01CA084469] Funding Source: NIH RePORTER	University of California(University of California System); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of California Tobacco Related Disease Research Program (18KT-0040 to A. B.), and National Cancer Institute (2R01CA084469 to G.P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskunov VB, 2005, BIOCHEMISTRY-US, V44, P1054, DOI 10.1021/bi048130y; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Besaratinia A, 2008, LANCET ONCOL, V9, P657, DOI 10.1016/S1470-2045(08)70172-4; Besaratinia A, 2006, CARCINOGENESIS, V27, P1526, DOI 10.1093/carcin/bgi311; Besaratinia A, 2005, CARCINOGENIC EFFECTS OF POLYCYCLIC AROMATIC HYDROCARBONS, P171; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1988, CANCER RES, V48, P1159; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Girard L, 2000, CANCER RES, V60, P4894; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Hsu GW, 2005, J BIOL CHEM, V280, P3764, DOI 10.1074/jbc.M411276200; Hutt JA, 2005, CARCINOGENESIS, V26, P1999, DOI 10.1093/carcin/bgi150; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim DH, 2001, ONCOGENE, V20, P1765, DOI 10.1038/sj.onc.1204302; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kuerbitz SJ, 1996, CELL GROWTH DIFFER, V7, P847; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nia AB, 2000, CARCINOGENESIS, V21, P1335, DOI 10.1093/carcin/21.7.1335; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PFEIFER GP, 1984, CARCINOGENESIS, V5, P931, DOI 10.1093/carcin/5.7.931; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Sadikovic B, 2007, TOXICOL APPL PHARM, V225, P300, DOI 10.1016/j.taap.2007.08.013; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Subach OM, 2006, BIOCHEMISTRY-US, V45, P6142, DOI 10.1021/bi0511639; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tommasi S, 2000, NUCLEIC ACIDS RES, V28, P3991, DOI 10.1093/nar/28.20.3991; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; VENKATACHALAM S, 1994, CARCINOGENESIS, V15, P565, DOI 10.1093/carcin/15.4.565; Vuillemenot BR, 2006, MOL CANCER RES, V4, P267, DOI 10.1158/1541-7786.MCR-05-0218; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; WILSON VL, 1984, CARCINOGENESIS, V5, P1027, DOI 10.1093/carcin/5.8.1027; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	52	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10594	10.1371/journal.pone.0010594	http://dx.doi.org/10.1371/journal.pone.0010594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485678	Green Submitted, Green Published, gold			2022-12-27	WOS:000277563400007
J	Bhandari, DR; Seo, KW; Roh, KH; Jung, JW; Kang, SK; Kang, KS				Bhandari, Dilli Ram; Seo, Kwang-Won; Roh, Kyoung-Hwan; Jung, Ji-Won; Kang, Soo-Kyung; Kang, Kyung-Sun			REX-1 Expression and p38 MAPK Activation Status Can Determine Proliferation/Differentiation Fates in Human Mesenchymal Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; UMBILICAL-CORD BLOOD; PROGENITOR CELLS; PHOSPHATIDYLSERINE EXPRESSION; PROTEIN-KINASES; BONE-MARROW; PPAR-GAMMA; ANNEXIN-V; IN-VITRO; ES CELLS	Background: REX1/ZFP42 is a well-known embryonic stem cell (ESC) marker. However, the role of REX1, itself, is relatively unknown because the function of REX1 has only been reported in the differentiation of ESCs via STAT signaling pathways. Human mesenchymal stem cells (hMSCs) isolated from young tissues and cancer cells express REX1. Methodology/Principal Finding: Human umbilical cord blood-derived MSCs (hUCB-MSCs) and adipose tissue-derived MSCs (hAD-MSCs) strongly express REX1 and have a lower activation status of p38 MAPK, but bone marrow-derived MSCs (hBM-MSCs) have weak REX1 expression and higher activation of p38 MAPK. These results indicated that REX1 expression in hMSCs was positively correlated with proliferation rates but inversely correlated with the phosphorylation of p38 MAPK. In hUCB-MSCs, the roles of REX1 and p38 MAPK were investigated, and a knockdown study was performed using a lentiviral vector-based small hairpin RNA (shRNA). After REX1 knockdown, decreased cell proliferation was observed. In REX1 knocked-down hUCB-MSCs, the osteogenic differentiation ability deteriorated, but the adipogenic potential increased or was similar to that observed in the controls. The phosphorylation of p38 MAPK in hUCB-MSCs significantly increased after REX1 knockdown. After p38 MAPK inhibitor treatment, the cell growth in REX1 knocked-down hUCB-MSCs almost recovered, and the suppressed expression levels of CDK2 and CCND1 were also restored. The expression of MKK3, an upstream regulator of p38 MAPK, significantly increased in REX1 knocked-down hUCB-MSCs. The direct binding of REX1 to the MKK3 gene was confirmed by a chromatin immunoprecipitation (ChIP) assay. Conclusions/Significance: These findings showed that REX1 regulates the proliferation/differentiation of hMSCs through the suppression of p38 MAPK signaling via the direct suppression of MKK3. Therefore, p38 MAPK and REX-1 status can determine the cell fate of adult stem cells (ASCs). These results were the first to show the role of REX1 in the proliferation/differentiation of ASCs.	[Bhandari, Dilli Ram; Seo, Kwang-Won; Roh, Kyoung-Hwan; Jung, Ji-Won; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Lab Stem Cell & Tumor Biol, Dept Vet Publ Hlth, Seoul, South Korea; [Kang, Soo-Kyung] Seoul Natl Univ, Lab Vet Biotechnol, Coll Vet Med, Seoul, South Korea; [Kang, Soo-Kyung] Seoul Natl Univ, Program Vet Sci BK21, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Bhandari, DR (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Stem Cell & Tumor Biol, Dept Vet Publ Hlth, Seoul, South Korea.	kangpub@snu.ac.kr	Seo, Kwang Won/AAB-4821-2020; Kang, Kyung-Sun/G-6205-2013	Seo, Kwang Won/0000-0003-1025-6133; 	Korea Research Foundation; Korean government (MEST) [M1084000119-08N4100-11910]; Brain Korea 21 program	Korea Research Foundation(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Korea Research Foundation funded by the Korean government (MEST, No. M1084000119-08N4100-11910) and Brain Korea 21 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Chakraborty S, 2009, DIFFERENTIATION, V78, P143, DOI 10.1016/j.diff.2009.05.006; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Guarnaccia C, 2004, FEBS LETT, V574, P156, DOI 10.1016/j.febslet.2004.08.022; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Inoue T, 2005, J IMMUNOL, V174, P4301, DOI 10.4049/jimmunol.174.7.4301; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mittelstadt PR, 2005, CELL CYCLE, V4, P1189, DOI 10.4161/cc.4.9.2043; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng J, 2009, IN VITRO CELL DEV-AN, V45, P558, DOI 10.1007/s11626-009-9223-4; Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roche S, 2007, J CELL BIOCHEM, V101, P271, DOI 10.1002/jcb.21185; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu J, 2008, J MOL BIOL, V377, P28, DOI 10.1016/j.jmb.2007.12.038; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	65	50	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10493	10.1371/journal.pone.0010493	http://dx.doi.org/10.1371/journal.pone.0010493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463961	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400027
J	Ford, N; Darder, M; Spelman, T; Maclean, E; Mills, E; Boulle, A				Ford, Nathan; Darder, Marta; Spelman, Tim; Maclean, Emi; Mills, Edward; Boulle, Andrew			Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Auppression: Five-Year Follow Up of an Observational Cohort	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CLINICAL-TRIALS; SOUTH-AFRICA; VIRAL LOAD; THERAPY; METAANALYSIS; KHAYELITSHA; SURVIVAL; OUTCOMES; FAILURE	Background: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen containing stavudine, lamivudine, and nevirapine. One of the primary concerns with the use of this regimen is nevirapine-associated hepatotoxicity. Methodology: Study participants were 1809 HIV-infected, antiretroviral naive adults initiating nevirapine-based antiretroviral therapy between November 2002 and December 2006. The primary outcome was early hepatotoxicity. Secondary outcomes were associations with hepatotoxicity and mortality at six months. The cumulative proportion of early hepatotoxicity ranged from 1.0-2.0% giving an incidence-rate at 102 days of 3.6-7.6 per 100 person-years. Median time to hepatotoxicity was 32 (IQR 28-58) days. At 12 weeks, only 8% of patients had alanine aminotransferase monitoring at all the time-points recommended by national guidelines. No association was found between age, gender, baseline CD4 count, concurrent tuberculosis infection, prior participation in a prevention of mother-to-child-transmission program, or baseline weight and early hepatotoxicity. There was no association between early hepatotoxicity and mortality. Conclusions: The cumulative proportion of early hepatotoxicity in nevirapine based antiretroviral therapy was low in this resource-constrained setting. Hepatotoxicity was not associated with mortality. Frequent routine monitoring of alanine aminotransferase proved difficult to implement in this public sector primary care programme. Focused monitoring in the first month may be a more cost-effective and pragmatic option in settings with limited resources. Correlation with clinical signs and symptoms may allow future alanine aminotransferase testing to be dictated by clinical criteria.	[Ford, Nathan; Darder, Marta; Maclean, Emi] Med Sans Frontieres, Cape Town, South Africa; [Spelman, Tim] Burnet Inst, Melbourne, Vic, Australia; [Mills, Edward] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Boulle, Andrew] Univ Cape Town, Ctr Infect Dis & Epidemiol Res, ZA-7925 Cape Town, South Africa	Burnet Institute; University of Ottawa; University of Cape Town	Ford, N (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	nathan.ford@joburg.msf.org	Boulle, Andrew/C-1413-2008	Boulle, Andrew/0000-0002-7713-8062	M�decins Sans Fronti�res [09_NAT_ERB_014] Funding Source: researchfish	M�decins Sans Fronti�res		Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Boulle A, 2009, 5 IAS C HIV PATH TRE; Boulle A, 2007, ANTIVIR THER, V12, P753; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Colosimo EA, 2002, J STAT COMPUT SIM, V72, P299, DOI 10.1080/00949650212847; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Friedland GH, 2006, JAIDS-J ACQ IMM DEF, V43, pS3, DOI 10.1097/01.qai.0000248333.44449.ea; Garcia R, 2006, AIDS RES HUM RETROV, V22, P1248, DOI 10.1089/aid.2006.22.1248; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Orrell C, 2009, ANTIVIR THER, V14, P523; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	23	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10460	10.1371/journal.pone.0010460	http://dx.doi.org/10.1371/journal.pone.0010460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20485480	Green Published, gold			2022-12-27	WOS:000277379400012
J	Smith, DP; Kitner, JB; Norbeck, AD; Clauss, TR; Lipton, MS; Schwalbach, MS; Steindler, L; Nicora, CD; Smith, RD; Giovannoni, SJ				Smith, Daniel P.; Kitner, Joshua B.; Norbeck, Angela D.; Clauss, Therese R.; Lipton, Mary S.; Schwalbach, Michael S.; Steindler, Laura; Nicora, Carrie D.; Smith, Richard D.; Giovannoni, Stephen J.			Transcriptional and Translational Regulatory Responses to Iron Limitation in the Globally Distributed Marine Bacterium Candidatus Pelagibacter Ubique	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; EQUATORIAL PACIFIC-OCEAN; COLD-SHOCK PROTEINS; DNA-BINDING SITE; ESCHERICHIA-COLI; GENE-EXPRESSION; IRR PROTEIN; CSPA-FAMILY; BRADYRHIZOBIUM-JAPONICUM; MASS-SPECTROMETRY	Iron is recognized as an important micronutrient that limits microbial plankton productivity over vast regions of the oceans. We investigated the gene expression responses of Candidatus Pelagibacter ubique cultures to iron limitation in natural seawater media supplemented with a siderophore to chelate iron. Microarray data indicated transcription of the periplasmic iron binding protein sfuC increased by 16-fold, and iron transporter subunits, iron-sulfur center assembly genes, and the putative ferroxidase rubrerythrin transcripts increased to a lesser extent. Quantitative peptide mass spectrometry revealed that sfuC protein abundance increased 27-fold, despite an average decrease of 59% across the global proteome. Thus, we propose sfuC as a marker gene for indicating iron limitation in marine metatranscriptomic and metaproteomic ecological surveys. The marked proteome reduction was not directly correlated to changes in the transcriptome, implicating post-transcriptional regulatory mechanisms as modulators of protein expression. Two RNA-binding proteins, CspE and CspL, correlated well with iron availability, suggesting that they may contribute to the observed differences between the transcriptome and proteome. We propose a model in which the RNA-binding activity of CspE and CspL selectively enables protein synthesis of the iron acquisition protein SfuC during transient growth-limiting episodes of iron scarcity.	[Smith, Daniel P.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Kitner, Joshua B.; Schwalbach, Michael S.; Steindler, Laura; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Norbeck, Angela D.; Clauss, Therese R.; Lipton, Mary S.; Nicora, Carrie D.; Smith, Richard D.] Pacific NW Natl Lab, Biol & Computat Sci Div, Richland, WA 99352 USA	Oregon State University; Oregon State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Smith, DP (corresponding author), Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019; Smith, Richard D/J-3664-2012; Lipton, Mary S/H-3913-2012	Smith, Daniel/0000-0002-2479-2044; Smith, Richard D/0000-0002-2381-2349; 	Gordon and Betty Moore Foundation [607_01]; U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory; DOE [DE-AC05-76RL01830]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory; DOE(United States Department of Energy (DOE))	This work was supported by Marine Microbiology Initiative award number 607_01 from the Gordon and Betty Moore Foundation (http://www.moore.org/). Portions of this research were performed at the W. R. Wiley Environmental Molecular Science Laboratory, a national scientific user facility sponsored by the U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory (http://www.pnl.gov/). PNNL is operated by Battelle Memorial Institute under DOE contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Friedman YE, 2003, J BIOL CHEM, V278, P38395, DOI 10.1074/jbc.M306710200; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GOLDMAN JC, 1984, B MAR SCI, V35, P462; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hofweber R, 2005, FEBS J, V272, P4691, DOI 10.1111/j.1742-4658.2005.04885.x; Hu KH, 1996, GENETICS, V143, P1521; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Marzi S, 2008, BIOL CHEM, V389, P585, DOI 10.1515/BC.2008.055; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Phadtare S, 2003, METHOD ENZYMOL, V371, P460; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; SCHWALBACH MS, 2009, ENV MICROBIOL; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Tiss A, 2005, FEBS LETT, V579, P5454, DOI 10.1016/j.febslet.2005.08.067; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; VENTURI V, 1995, MOL MICROBIOL, V15, P1081, DOI 10.1111/j.1365-2958.1995.tb02283.x; Vergara SV, 2008, BIOCHEM SOC T, V36, P1088, DOI 10.1042/BST0361088; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wilhelm SW, 1996, LIMNOL OCEANOGR, V41, P89, DOI 10.4319/lo.1996.41.1.0089; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200	72	34	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10487	10.1371/journal.pone.0010487	http://dx.doi.org/10.1371/journal.pone.0010487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463970	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379400023
J	Heg, D; Taborsky, M				Heg, Dik; Taborsky, Michael			Helper Response to Experimentally Manipulated Predation Risk in the Cooperatively Breeding Cichlid Neolamprologus pulcher	PLOS ONE			English	Article							GROUP-SIZE; BROODCARE HELPERS; DOMINANT MALES; NEST DEFENSE; COHO SALMON; REFUGE USE; BEHAVIOR; FISH; EVOLUTION; PAY	Background: We manipulated predation risk in a field experiment with the cooperatively breeding cichlid Neolamprologus pulcher by releasing no predator, a medium- or a large-sized fish predator inside underwater cages enclosing two to three natural groups. We assessed whether helpers changed their helping behaviour, and whether within-group conflict changed, depending on these treatments, testing three hypotheses: 'pay-to-stay' PS, 'risk avoidance' RA, or (future) reproductive benefits RB. We also assessed whether helper food intake was reduced under risk, because this might reduce investments in other behaviours to save energy. Methodology/Principal Findings: Medium and large helpers fed less under predation risk. Despite this effect helpers invested more in territory defence, but not territory maintenance, under the risk of predation (supporting PS). Experimentally covering only the breeding shelter with sand induced more helper digging under predation risk compared to the control treatment (supporting PS). Aggression towards the introduced predator did not differ between the two predator treatments and increased with group member size and group size (supporting PS and RA). Large helpers increased their help ratio (helping effort/breeder aggression received, 'punishment' by the dominant pair in the group) in the predation treatments compared to the control treatment, suggesting they were more willing to PS. Medium helpers did not show such effects. Large helpers also showed a higher submission ratio (submission/breeder aggression received) in all treatments, compared to the medium helpers (supporting PS). Conclusions/Significance: We conclude that predation risk reduces helper food intake, but despite this effect, helpers were more willing to support the breeders, supporting PS. Effects of breeder punishment suggests that PS might be more important for large compared to the medium helpers. Evidence for RA was also detected. Finally, the results were inconsistent with RB.	[Heg, Dik; Taborsky, Michael] Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland	University of Bern	Heg, D (corresponding author), Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland.	dik.heg@iee.unibe.ch	Taborsky, Michael/F-8420-2013	Taborsky, Michael/0000-0002-1357-4316; Heg, Dik/0000-0002-8766-7945	Swiss National Science Foundation (SNSF) [3100-064396, 3100A0-108473]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by the Swiss National Science Foundation (SNSF grant 3100-064396 to M. T.). D. H. was supported by SNSF grant 3100A0-108473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 2000, ETHOLOGY, V106, P385, DOI 10.1046/j.1439-0310.2000.00545.x; AUSTAD SN, 1985, BEHAV ECOL SOCIOBIOL, V17, P19, DOI 10.1007/BF00299423; Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Balshine S, 2001, BEHAV ECOL SOCIOBIOL, V50, P134, DOI 10.1007/s002650100343; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Bednekoff PA, 1998, P ROY SOC B-BIOL SCI, V265, P2021, DOI 10.1098/rspb.1998.0535; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Bruintjes R, 2008, ANIM BEHAV, V75, P1843, DOI 10.1016/j.anbehav.2007.12.004; Candolin U, 1998, ANIM BEHAV, V56, P1205, DOI 10.1006/anbe.1998.0892; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Desiardins JK, 2008, ANIM BEHAV, V75, P595, DOI 10.1016/j.anbehav.2007.05.025; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dierkes P, 1999, BEHAV ECOL, V10, P510, DOI 10.1093/beheco/10.5.510; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; GAROFALO CA, 1992, INSECT SOC, V39, P301, DOI 10.1007/BF01323950; Gashagaza M.M., 1988, African Study Monographs, V9, P1; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; Grantner A, 1998, J COMP PHYSIOL B, V168, P427, DOI 10.1007/s003600050162; HAILMAN JP, 1994, ETHOLOGY, V97, P119; Hamilton IM, 2005, BEHAVIOUR, V142, P1591, DOI 10.1163/156853905774831846; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, pS505, DOI 10.1098/rsbl.2004.0232; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, BIOL LETTERS, V4, P606, DOI 10.1098/rsbl.2008.0365; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005458; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; Hill RA, 1998, BEHAVIOUR, V135, P411; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Janson CH, 1998, BEHAVIOUR, V135, P389, DOI 10.1163/156853998793066177; Johnsson JI, 2004, BEHAV ECOL SOCIOBIOL, V56, P388, DOI 10.1007/s00265-004-0791-8; Johnsson JI, 2003, J FISH BIOL, V63, P863, DOI 10.1046/j.1095-8649.2003.00187.x; KALAS K, 1975, THESIS U GIESSEN GER; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Krause J, 1998, P ROY SOC B-BIOL SCI, V265, P2373, DOI 10.1098/rspb.1998.0586; Krause J., 2002, LIVING GROUPS, P210; Kukuk PF, 1998, NATURWISSENSCHAFTEN, V85, P445, DOI 10.1007/s001140050528; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIMBERGER D, 1983, Z TIERPSYCHOL, V62, P115; MAGNHAGEN C, 1995, ANIM BEHAV, V50, P1123, DOI 10.1016/0003-3472(95)80111-1; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; Maklakov AA, 2002, BEHAV ECOL SOCIOBIOL, V52, P372, DOI 10.1007/s00265-002-0528-5; MAPPES J, 1995, BEHAV ECOL SOCIOBIOL, V36, P343, DOI 10.1007/BF00167795; MARTEL G, 1995, ETHOLOGY, V99, P139; Mitchell JS, 2009, BEHAVIOUR, V146, P1665, DOI 10.1163/000579509X12459328580026; Mitchell JS, 2009, ETHOLOGY, V115, P1162, DOI 10.1111/j.1439-0310.2009.01705.x; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; Norusis M.J, 2007, SPSS 15 0 ADV STAT P; RASA OAE, 1987, ADV STUD BEHAV, V17, P121, DOI 10.1016/S0065-3454(08)60178-3; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; SIH A, 1988, AM NAT, V132, P463, DOI 10.1086/284865; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Skubic E, 2004, J THEOR BIOL, V227, P487, DOI 10.1016/j.jtbi.2003.11.021; Steele MA, 1998, OECOLOGIA, V115, P222, DOI 10.1007/s004420050511; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2006, ANIM BEHAV, V71, P449, DOI 10.1016/j.anbehav.2005.06.011; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; STRASSMANN JE, 1988, ECOLOGY, V69, P1497, DOI 10.2307/1941647; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; Taborsky M, 1998, ANIM BEHAV, V56, P1375, DOI 10.1006/anbe.1998.0918; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; TABORSKY M, 1986, Koninklijk Museum voor Midden-Afrika Tervuren Belgie Annalen Zoologische Wetenschappen, V251, P7; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; van der Veen IT, 1999, BEHAV ECOL, V10, P545, DOI 10.1093/beheco/10.5.545; Werner NY, 2003, BEHAV ECOL, V14, P749, DOI 10.1093/beheco/arg067	83	48	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10784	10.1371/journal.pone.0010784	http://dx.doi.org/10.1371/journal.pone.0010784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520816	Green Published, gold			2022-12-27	WOS:000278221500007
J	Stevens, KN; Hakonarson, H; Kim, CE; Doevendans, PA; Koeleman, BPC; Mital, S; Raue, J; Glessner, JT; Coles, JG; Moreno, V; Granger, A; Gruber, SB; Gruber, PJ				Stevens, Kristen N.; Hakonarson, Hakon; Kim, Cecilia E.; Doevendans, Pieter A.; Koeleman, Bobby P. C.; Mital, Seema; Raue, Jennifer; Glessner, Joseph T.; Coles, John G.; Moreno, Victor; Granger, Anne; Gruber, Stephen B.; Gruber, Peter J.			Common Variation in ISL1 Confers Genetic Susceptibility for Human Congenital Heart Disease	PLOS ONE			English	Article							CELLS; MUTATIONS; LINEAGES; DEFECTS; POPULATION; GATA4	Congenital heart disease (CHD) is the most common birth abnormality and the etiology is unknown in the overwhelming majority of cases. ISLET1 (ISL1) is a transcription factor that marks cardiac progenitor cells and generates diverse multipotent cardiovascular cell lineages. The fundamental role of ISL1 in cardiac morphogenesis makes this an exceptional candidate gene to consider as a cause of complex congenital heart disease. We evaluated whether genetic variation in ISL1 fits the common variant-common disease hypothesis. A 2-stage case-control study examined 27 polymorphisms mapping to the ISL1 locus in 300 patients with complex congenital heart disease and 2,201 healthy pediatric controls. Eight genic and flanking ISL1 SNPs were significantly associated with complex congenital heart disease. A replication study analyzed these candidate SNPs in 1,044 new cases and 3,934 independent controls and confirmed that genetic variation in ISL1 is associated with risk of non-syndromic congenital heart disease. Our results demonstrate that two different ISL1 haplotypes contribute to risk of CHD in white and black/African American populations.	[Stevens, Kristen N.; Gruber, Stephen B.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Hakonarson, Hakon; Kim, Cecilia E.; Raue, Jennifer; Glessner, Joseph T.; Granger, Anne; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Doevendans, Pieter A.] UMC Utrecht, Dept Cardiol, Utrecht, Netherlands; [Koeleman, Bobby P. C.] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Mital, Seema; Coles, John G.] Hosp Sick Children, Ctr Heart, Toronto, ON M5G 1X8, Canada; [Moreno, Victor] IDIBELL Catalan Inst Oncol, Biostat & Bioinformat Unit, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Hosp Llobregat, Barcelona, Spain; [Gruber, Stephen B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gruber, Stephen B.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Gruber, Peter J.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Gruber, Peter J.] Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania	Stevens, KN (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	pgruber@mail.med.upenn.edu; sgruber@umich.edu	Purrington, Kristen/AAN-6494-2021; Mital, Seema/G-7456-2011; Moreno, Victor/A-1697-2010	Purrington, Kristen/0000-0002-5710-1692; Moreno, Victor/0000-0002-2818-5487; Glessner, Joseph/0000-0001-5131-2811	Fondacion Leducq (PJG)	Fondacion Leducq (PJG)	Fondacion Leducq (PJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048	19	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10855	10.1371/journal.pone.0010855	http://dx.doi.org/10.1371/journal.pone.0010855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520780	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500039
J	Zuluaga, AF; Agudelo, M; Cardeno, JJ; Rodriguez, CA; Vesga, O				Zuluaga, Andres F.; Agudelo, Maria; Cardeno, John J.; Rodriguez, Carlos A.; Vesga, Omar			Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; DRUG SUBSTITUTION; BIOEQUIVALENCE; ISSUES; MICE; CEFUROXIME; EXCIPIENTS; MEDICINES; CALCIUM; HEPARIN	Background: Drug regulatory agencies (DRA) support prescription of generic products of intravenous antibiotics assuming therapeutic equivalence from pharmaceutical equivalence. Recent reports of deaths associated with generic heparin and metoprolol have raised concerns about the efficacy and safety of DRA-approved drugs. Methodology/Principal Findings: To challenge the assumption that pharmaceutical equivalence predicts therapeutic equivalence, we determined in vitro and in vivo the efficacy of the innovator product and 20 pharmaceutically equivalent generics of gentamicin. The data showed that, while only 1 generic product failed in vitro (MIC = 45.3 vs. 0.7 mg/L, P < 0.05), 10 products (including gentamicin reference powder) failed in vivo against E. coli due to significantly inferior efficacy (E-max = 4.81 to 5.32 vs. 5.99 log(10) CFU/g, P <= 0.043). Although the design lacked power to detect differences in survival after thigh infection with P. aeruginosa, dissemination to vital organs was significantly higher in animals treated with generic gentamicin despite 4 days of maximally effective treatment. Conclusion: Pharmaceutical equivalence does not predict therapeutic equivalence of generic gentamicin. Stricter criteria based on solid experimental evidence should be required before approval for human use.	[Zuluaga, Andres F.; Rodriguez, Carlos A.; Vesga, Omar] Univ Antioquia, Sch Med, Dept Pharmacol & Toxicol, Medellin, Colombia; [Zuluaga, Andres F.; Agudelo, Maria; Cardeno, John J.; Rodriguez, Carlos A.; Vesga, Omar] Univ Antioquia, Sch Med, Grp Investigador Problemas Enfermedades Infeccios, Medellin, Colombia; [Vesga, Omar] Hosp Univ San Vicente de Paul, Dept Med, Infect Dis Sect, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Zuluaga, AF (corresponding author), Univ Antioquia, Sch Med, Dept Pharmacol & Toxicol, Medellin, Colombia.	omar.vesga@siu.udea.edu.co	Rodriguez, Carlos A./P-8324-2019; Zuluaga, Andres F./K-7366-2016	Rodriguez, Carlos A./0000-0002-4042-4313; Zuluaga, Andres F./0000-0001-5656-4153; Cardeno, John/0000-0003-3145-3945	University of Antioquia, and Colciencias [1115-04-731-98]	University of Antioquia, and Colciencias	This work was financed by the University of Antioquia, and Colciencias (grant number 1115-04-731-98). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers MJ, 2002, J PHARM SCI-US, V91, P2283, DOI 10.1002/jps.10154; Allen LV, 2008, CLIN THER, V30, P2102, DOI 10.1016/j.clinthera.2008.11.015; Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; APTE SP, 2003, PHARM TECHNOL EUROPE, V15, P45; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Brashier MK, 1998, AM J VET RES, V59, P1055; *CLIN LAB STAND I, 2003, M7A6 CLSI; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Crowley PJ, 1999, PHARM SCI TECHNOL TO, V2, P237, DOI 10.1016/S1461-5347(99)00158-3; DETTELBACH HR, 1986, J CLIN PHARMACOL, V26, P307, DOI 10.1002/j.1552-4604.1986.tb03530.x; Dodd S, 2009, CURR DRUG SAF, V4, P1, DOI 10.2174/157488609787354431; Duenas-Laita A, 2009, NEW ENGL J MED, V361, P1317, DOI 10.1056/NEJMc0904562; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Feldschreiber P, 2009, CLIN MED, V9, P63, DOI 10.7861/clinmedicine.9-1-63; *FOOD DRUG ADM, 2001, GUID IND BIOAN METH, V22; *GEN DRUGS, 2002, MED LETT DRUGS THER, V44, P89; GERBER AU, 1983, J INFECT DIS, V147, P910, DOI 10.1093/infdis/147.5.910; Glantz SA, 2006, PRIMER BIOSTATISTICS; Gonzalez LS, 1998, AM FAM PHYSICIAN, V58, P1811; Henderson JD, 2001, SOUTHERN MED J, V94, P16; Henry D, 2002, LANCET, V360, P1590, DOI 10.1016/S0140-6736(02)11527-3; Jia H, 2008, NAT BIOTECHNOL, V26, P477, DOI 10.1038/nbt0508-477; Jones RN, 2008, DIAGN MICR INFEC DIS, V61, P76, DOI 10.1016/j.diagmicrobio.2007.12.010; Katzung BG, 2007, BASIC CLIN PHARM; Kirking D M, 2001, J Am Pharm Assoc (Wash), V41, P578; Lees P, 2004, J VET PHARMACOL THER, V27, P397, DOI 10.1111/j.1365-2885.2004.00620.x; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; Mattew A, 2006, M2A9 CLSI; Meredith P, 2003, CLIN THER, V25, P2875, DOI 10.1016/S0149-2918(03)80340-5; Moellering RC, 2009, CLIN INFECT DIS, V49, P1006, DOI 10.1086/605556; NAPKE E, 1984, CAN MED ASSOC J, V131, P1449; NATION RL, 1994, PHARMACOL THERAPEUT, V62, P41, DOI 10.1016/0163-7258(94)90004-3; POLLACK M, 1984, REV INFECT DIS, V6, pS617; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; RHEINSTEIN PH, 1990, DRUG SAFETY, V5, P114, DOI 10.2165/00002018-199000051-00018; Rodriguez CA, 2009, J INFECTION, V59, P277, DOI 10.1016/j.jinf.2009.08.005; Roy Jiben, 2002, AAPS PharmSciTech, V3, pE6; SINGH YN, 1978, ANESTHESIOLOGY, V48, P418, DOI 10.1097/00000542-197806000-00008; STROM BL, 1987, NEW ENGL J MED, V316, P1456, DOI 10.1056/NEJM198706043162306; Toutain PL, 2004, J VET PHARMACOL THER, V27, P467, DOI 10.1111/j.1365-2885.2004.00613.x; Tracy M, 2001, ANTIMICROB AGENTS CH, V45, P1511, DOI 10.1128/AAC.45.5.1511-1514.2001; *US FDA, 2001, GUID IND STAT APPR; *US PHARM CONV, 2002, PHARM US AM; WANG D, 1994, J PHARM SCI, V83, P577, DOI 10.1002/jps.2600830427; WEINSTEIN MJ, 1963, J MED CHEM, V6, P463, DOI 10.1021/jm00340a034; Welage L S, 2001, J Am Pharm Assoc (Wash), V41, P856; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga Andres F, 2009, BMC Clin Pharmacol, V9, P1, DOI 10.1186/1472-6904-9-1	48	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10744	10.1371/journal.pone.0010744	http://dx.doi.org/10.1371/journal.pone.0010744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505762	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300016
J	Telleria, EL; de Araujo, APO; Secundino, NF; d'Avila-Levy, CM; Traub-Cseko, YM				Telleria, Erich Loza; Oliveira de Araujo, Adriana Pereira; Secundino, Nagila Francinete; d'Avila-Levy, Claudia Masini; Traub-Csekoe, Yara Maria			Trypsin-Like Serine Proteases in Lutzomyia longipalpis - Expression, Activity and Possible Modulation by Leishmania infantum chagasi	PLOS ONE			English	Article							CHYMOTRYPSIN-LIKE ENZYMES; AEGYPTI L DIPTERA; PHLEBOTOMUS-PAPATASI; AEDES-AEGYPTI; SAND FLIES; BLOOD-MEAL; VISCERAL LEISHMANIASIS; MIDGUT TRANSCRIPTOME; ANTHOPHORA DIPTERA; DIGESTIVE ENZYMES	Background: Midgut enzymatic activity is one of the obstacles that Leishmania must surpass to succeed in establishing infection. Trypsins are abundant digestive enzymes in most insects. We have previously described two trypsin cDNAs of L. longipalpis: one (Lltryp1) with a bloodmeal induced transcription pattern, the other (Lltryp2) with a constitutive transcription pattern. We have now characterized the expression and activity of trypsin-like proteases of Lutzomyia longipalpis, the main vector of visceral leishmaniasis in Brazil. Methodology and Principal Findings: In order to study trypsin expression profiles we produced antibodies against peptides specific for Lltryp1 and Lltryp2. The anti-Lltryp1-peptide antibody revealed a band of 28 kDa between 6 and 48 hours. The anti-Lltryp2 peptide antibody did not evidence any band. When proteinaceous substrates (gelatin, hemoglobin, casein or albumin) were co-polymerized in polyacrylamide gels, insect midguts obtained at 12 hours after feeding showed a unique proteolytic pattern for each substrate. All activity bands were strongly inhibited by TLCK, benzamidine and 4-amino-benzamidine, indicating that they are trypsin-like proteases. The trypsin-like activity was also measured in vitro at different time points after ingestion of blood or blood containing Leishmania infantum chagasi, using the chromogenic substrate BA rho NA. L. longipalpis females fed on blood infected with L. i. chagasi had lower levels of trypsin activity after 12 and 48 hours than non-infected insects, suggesting that the parasite may have a role in this modulation. Conclusions and Significance: Trypsins are important and abundant digestive enzymes in L. longipalpis. Protein production and enzymatic activity followed previously identified gene expression of a blood modulated trypsin gene. A decrease of enzymatic activity upon the parasite infection, previously detected mostly in Old World vectors, was detected for the first time in the natural vector-parasite pair L. longipalpis-L. i. chagasi.	[Telleria, Erich Loza; Oliveira de Araujo, Adriana Pereira; Traub-Csekoe, Yara Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Secundino, Nagila Francinete] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil; [d'Avila-Levy, Claudia Masini] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Telleria, EL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br	Telleria, Erich L/F-1580-2015; Traub-Cseko, Yara M/F-2723-2015; Secundino, Nagila/AAM-4553-2020; d'Avila-Levy, Claudia M/O-7192-2014	Telleria, Erich L/0000-0003-0006-0057; d'Avila-Levy, Claudia M/0000-0001-8042-4695	CNPq; FAPERJ; FIOCRUZ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This study was supported by the Brazilian funding agencies: CNPq, FAPERJ and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; BOROVSKY D, 1987, MED VET ENTOMOL, V1, P235, DOI 10.1111/j.1365-2915.1987.tb00349.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Brazil RP, 2003, FLEBOTOMINEOS BRASIL, P257; DILLON RJ, 1993, PARASITOL RES, V79, P492, DOI 10.1007/BF00931590; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; GOODING R H, 1975, Acta Tropica, V32, P96; GRAF R, 1982, REV SUISSE ZOOL, V89, P845, DOI 10.5962/bhl.part.82479; GRAF R, 1991, EXPERIENTIA, V47, P603, DOI 10.1007/BF01949885; GRAF R, 1989, INSECT BIOCHEM, V19, P129, DOI 10.1016/0020-1790(89)90083-8; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; HOPP TP, 1981, P NATL ACAD SCI USA, V86, P152; HORLER E, 1995, ARCH INSECT BIOCHEM, V28, P189, DOI 10.1002/arch.940280208; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LEHANE MJ, 1994, INT J PARASITOL, V24, P27, DOI 10.1016/0020-7519(94)90056-6; MAHMOOD F, 1992, J MED ENTOMOL, V29, P489, DOI 10.1093/jmedent/29.3.489; MAHMOOD F, 1993, J MED ENTOMOL, V30, P683, DOI 10.1093/jmedent/30.4.683; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; MULLER HM, 1993, EMBO J, V12, P2891, DOI 10.1002/j.1460-2075.1993.tb05951.x; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P163, DOI 10.1016/S0965-1748(02)00187-X; Ramalho-Ortigao JM, 2001, MEM I OSWALDO CRUZ, V96, P105, DOI 10.1590/S0074-02762001000100012; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Rosenfeld A, 1998, J PARASITOL, V84, P361, DOI 10.2307/3284496; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Schlein Y, 1998, PARASITOLOGY, V117, P467, DOI 10.1017/S0031182098003321; Shahabuddin M, 1996, INFECT IMMUN, V64, P739, DOI 10.1128/IAI.64.3.739-743.1996; Telleria EL, 2007, ARCH INSECT BIOCHEM, V66, P53, DOI 10.1002/arch.20198; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; WARD CW, 1973, ANAL BIOCHEM, V56, P596, DOI 10.1016/0003-2697(73)90228-5	43	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10697	10.1371/journal.pone.0010697	http://dx.doi.org/10.1371/journal.pone.0010697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502532	Green Published, Green Submitted, gold			2022-12-27	WOS:000277776500014
J	Manoj, KM; Baburaj, A; Ephraim, B; Pappachan, F; Maviliparambathu, PP; Vijayan, UK; Narayanan, SV; Periasamy, K; George, EA; Mathew, LT				Manoj, Kelath Murali; Baburaj, Arun; Ephraim, Binoy; Pappachan, Febin; Maviliparambathu, Pravitha Parapurathu; Vijayan, Umesh K.; Narayanan, Sivaprasad Valiyaveettil; Periasamy, Kalaiselvi; George, Ebi Ashley; Mathew, Lazar T.			Explaining the Atypical Reaction Profiles of Heme Enzymes with a Novel Mechanistic Hypothesis and Kinetic Treatment	PLOS ONE			English	Article							SUBSTRATE-INHIBITION; COMPOUND-I; CYTOCHROME-P450; CHLOROPEROXIDASE; PEROXIDASE; OXIDATION; ROLES	Many heme enzymes show remarkable versatility and atypical kinetics. The fungal extracellular enzyme chloroperoxidase (CPO) characterizes a variety of one and two electron redox reactions in the presence of hydroperoxides. A structural counterpart, found in mammalian microsomal cytochrome P450 (CYP), uses molecular oxygen plus NADPH for the oxidative metabolism (predominantly hydroxylation) of substrate in conjunction with a redox partner enzyme, cytochrome P450 reductase. In this study, we employ the two above-mentioned heme-thiolate proteins to probe the reaction kinetics and mechanism of heme enzymes. Hitherto, a substrate inhibition model based upon non-productive binding of substrate (two-site model) was used to account for the inhibition of reaction at higher substrate concentrations for the CYP reaction systems. Herein, the observation of substrate inhibition is shown for both peroxide and final substrate in CPO catalyzed peroxidations. Further, analogy is drawn in the "steady state kinetics" of CPO and CYP reaction systems. New experimental observations and analyses indicate that a scheme of competing reactions (involving primary product with enzyme or other reaction components/intermediates) is relevant in such complex reaction mixtures. The presence of non-selective reactive intermediate(s) affords alternate reaction routes at various substrate/product concentrations, thereby leading to a lowered detectable concentration of "the product of interest" in the reaction milieu. Occam's razor favors the new hypothesis. With the new hypothesis as foundation, a new biphasic treatment to analyze the kinetics is put forth. We also introduce a key concept of "substrate concentration at maximum observed rate". The new treatment affords a more acceptable fit for observable experimental kinetic data of heme redox enzymes.	[Manoj, Kelath Murali; Periasamy, Kalaiselvi; George, Ebi Ashley; Mathew, Lazar T.] Vellore Inst Technol Univ, Ctr Biomed Res, Vellore, Tamil Nadu, India; [Baburaj, Arun; Ephraim, Binoy; Pappachan, Febin; Maviliparambathu, Pravitha Parapurathu; Vijayan, Umesh K.; Narayanan, Sivaprasad Valiyaveettil] Mala Educ Trust METs Sch Engn, Mala, Thrissur, India	Vellore Institute of Technology	Manoj, KM (corresponding author), Vellore Inst Technol Univ, Ctr Biomed Res, Vellore, Tamil Nadu, India.	muralimanoj@vit.ac.in			Science Foundation and departmental research funds of Vellore Institute of Technology (VIT); University and Mala Education Trust (MET's) School of Engineering, India	Science Foundation and departmental research funds of Vellore Institute of Technology (VIT); University and Mala Education Trust (MET's) School of Engineering, India	This research was powered by Satyamjayatu: The Science Foundation and departmental research funds of Vellore Institute of Technology (VIT) University and Mala Education Trust (MET's) School of Engineering, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Bhakta MN, 2005, EUR J ORG CHEM, V2005, P4801, DOI 10.1002/ejoc.200500333; CASELLA L, 1994, BIOCHEMISTRY-US, V33, P6377, DOI 10.1021/bi00187a001; Collom SL, 2008, J BIOL CHEM, V283, P3487, DOI 10.1074/jbc.M707630200; COPELAND RA, 2000, ENZYMES PRACTICAL IN, P136; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; DEMONTELLANO PRO, 1987, J BIOL CHEM, V262, P11641; Guengerich FP, 1996, J BIOL CHEM, V271, P27321, DOI 10.1074/jbc.271.44.27321; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HOLLENBERG PF, 1992, FASEB J, V6, P686, DOI 10.1096/fasebj.6.2.1537457; Koley AP, 1996, BIOCHIMIE, V78, P706, DOI 10.1016/S0300-9084(97)82528-X; Kumar S, 2005, DRUG METAB DISPOS, V33, P1131, DOI 10.1124/dmd.105.004606; LIBBY RD, 1982, J BIOL CHEM, V257, P5030; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Manoj KM, 2007, PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON CYTOCHROMES P450 - BIOCHEMISTRY, BIOPHYSICS AND FUNCTIONAL GENOMICS, P97; Manoj KM, 2008, BIOCHEMISTRY-US, V47, P2997, DOI 10.1021/bi7022656; Manoj KM, 2006, BBA-PROTEINS PROTEOM, V1764, P1325, DOI 10.1016/j.bbapap.2006.05.012; MANOJ KM, 2002, RECENT RES DEV ORG C, V6, P393; MCCARTHY MB, 1983, J BIOL CHEM, V258, P9153; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shou M, 2001, CURR DRUG METAB, V2, P17, DOI 10.2174/1389200013338784; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yun CH, 2006, CURR DRUG METAB, V7, P411, DOI 10.2174/138920006776873472; Zhang R, 2006, ORG LETT, V8, P2731, DOI 10.1021/ol060762k	28	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10601	10.1371/journal.pone.0010601	http://dx.doi.org/10.1371/journal.pone.0010601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498847	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700005
J	Read, TD; Turingan, RS; Cook, C; Giese, H; Thomann, UH; Hogan, CC; Tan, E; Selden, RF				Read, Timothy D.; Turingan, Rosemary S.; Cook, Christopher; Giese, Heidi; Thomann, Ulrich Hans; Hogan, Catherine C.; Tan, Eugene; Selden, Richard F.			Rapid Multi-Locus Sequence Typing Using Microfluidic Biochips	PLOS ONE			English	Article							BACILLUS-CEREUS; POPULATION-STRUCTURE; DIVERSITY; ANTHRACIS; THURINGIENSIS; EVOLUTION	Background: Multiple locus sequence typing (MLST) has become a central genotyping strategy for analysis of bacterial populations. The scheme involves de novo sequencing of 6-8 housekeeping loci to assign unique sequence types. In this work we adapted MLST to a rapid microfluidics platform in order to enhance speed and reduce laboratory labor time. Methodology/Principal Findings: Using two integrated microfluidic devices, DNA was purified from 100 Bacillus cereus soil isolates, used as a template for multiplex amplification of 7 loci and sequenced on forward and reverse strands. The time on instrument from loading genomic DNA to generation of electropherograms was only 1.5 hours. We obtained full-length sequence of all seven MLST alleles from 84 representing 46 different Sequence Types. At least one allele could be sequenced from a further 15 strains. The nucleotide diversity of B. cereus isolated in this study from one location in Rockville, Maryland (0.04 substitutions per site) was found to be as great as the global collection of isolates. Conclusions/Significance: Biogeographical investigation of pathogens is only one of a panoply of possible applications of microfluidics based MLST; others include microbiologic forensics, biothreat identification, and rapid characterization of human clinical samples.	[Read, Timothy D.; Cook, Christopher] USN, Med Res Ctr, Biol Def Res Directorate, Rockville, MD USA; [Read, Timothy D.] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Turingan, Rosemary S.; Giese, Heidi; Thomann, Ulrich Hans; Hogan, Catherine C.; Tan, Eugene; Selden, Richard F.] Network Biosyst Inc, Woburn, MA USA	United States Department of Defense; United States Navy; Emory University; Emory University	Read, TD (corresponding author), USN, Med Res Ctr, Biol Def Res Directorate, Rockville, MD USA.	tread@emory.edu	Read, Timothy/E-6240-2011	Read, Timothy/0000-0001-8966-9680	Emory University School of Medicine; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) [TMTI0068_07_NM_T]; Defense Threat Reduction Agency Initiative; Network Biosystems Inc. Development; Wellcome Trust	Emory University School of Medicine; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency Initiative(United States Department of DefenseDefense Threat Reduction Agency); Network Biosystems Inc. Development; Wellcome Trust(Wellcome Trust)	This work was supported by a developmental grant from Emory University School of Medicine to TDR, grant TMTI0068_07_NM_T from the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), Defense Threat Reduction Agency Initiative to TDR and internal funding from Network Biosystems Inc. Development and maintenance of the PubMLST site used in this study has been funded by the Wellcome Trust. Network Biosystems employees were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; Barker M, 2005, FEMS MICROBIOL LETT, V245, P179, DOI 10.1016/j.femsle.2005.03.003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Collier FA, 2005, FEMS MICROBIOL ECOL, V54, P417, DOI 10.1016/j.femsec.2005.05.005; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; GIESE H, 2009, J FORENSIC IN PRESS; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourasse NJ, 2008, NUCLEIC ACIDS RES, V36, pD461, DOI 10.1093/nar/gkm877; Vilas-Boas G, 2002, APPL ENVIRON MICROB, V68, P1414, DOI 10.1128/AEM.68.3.1414-1424.2002; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x	29	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10595	10.1371/journal.pone.0010595	http://dx.doi.org/10.1371/journal.pone.0010595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485679	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563400008
J	Cordey, S; Junier, T; Gerlach, D; Gobbini, F; Farinelli, L; Zdobnov, EM; Winther, B; Tapparel, C; Kaiser, L				Cordey, Samuel; Junier, Thomas; Gerlach, Daniel; Gobbini, Francesca; Farinelli, Laurent; Zdobnov, Evgeny M.; Winther, Birgit; Tapparel, Caroline; Kaiser, Laurent			Rhinovirus Genome Evolution during Experimental Human Infection	PLOS ONE			English	Article							VIRUS; SUSCEPTIBILITY; IDENTIFICATION; PLECONARIL; RESISTANCE; INHIBITOR; INSIGHTS; MUTATION; COLDS	Human rhinoviruses (HRVs) evolve rapidly due in part to their error-prone RNA polymerase. Knowledge of the diversity of HRV populations emerging during the course of a natural infection is essential and represents a basis for the design of future potential vaccines and antiviral drugs. To evaluate HRV evolution in humans, nasal wash samples were collected daily for five days from 15 immunocompetent volunteers experimentally infected with a reference stock of HRV-39. In parallel, HeLa-OH cells were inoculated to compare HRV evolution in vitro. Nasal wash in vivo assessed by real-time PCR showed a viral load that peaked at 48-72 h. Ultra-deep sequencing was used to compare the low-frequency mutation populations present in the HRV-39 inoculum in two human subjects and one HeLa-OH supernatant collected 5 days post-infection. The analysis revealed hypervariable mutation locations in VP2, VP3, VP1, 2C and 3C genes and conserved regions in VP4, 2A, 2B, 3A, 3B and 3D genes. These results were confirmed by classical sequencing of additional samples, both from inoculated volunteers and independent cell infections, and suggest that HRV inter-host transmission is not associated with a strong bottleneck effect. A specific analysis of the VP1 capsid gene of 15 human cases confirmed the high mutation incidence in this capsid region, but not in the antiviral drug-binding pocket. We could also estimate a mutation frequency in vivo of 3.4x10(-4) mutations/nucleotides and 3.1x10(-4) over the entire ORF and VP1 gene, respectively. In vivo, HRV generate new variants rapidly during the course of an acute infection due to mutations that accumulate in hot spot regions located at the capsid level, as well as in 2C and 3C genes.	[Cordey, Samuel; Gobbini, Francesca; Tapparel, Caroline; Kaiser, Laurent] Univ Hosp Geneva, Div Infect Dis, Virol Lab, Geneva, Switzerland; [Cordey, Samuel; Gobbini, Francesca; Tapparel, Caroline; Kaiser, Laurent] Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Junier, Thomas; Gerlach, Daniel; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Junier, Thomas; Gerlach, Daniel; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, Geneva, Switzerland; [Farinelli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland; [Winther, Birgit] Univ Virginia, Dept Pediat, Div Gen Pediat, Charlottesville, VA USA	University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Virginia	Cordey, S (corresponding author), Univ Hosp Geneva, Div Infect Dis, Virol Lab, Geneva, Switzerland.	samuel.cordey@hcuge.ch	Zdobnov, Evgeny/AAB-2745-2022; Cordey, Samuel/C-9240-2018; Junier, Thomas/A-6748-2011; Zdobnov, Evgeny M/K-1133-2012	Zdobnov, Evgeny/0000-0002-5178-1498; Cordey, Samuel/0000-0002-2684-5680; Gerlach, Daniel/0000-0001-9338-3765; Tapparel Vu, Caroline/0000-0002-0411-6567; Kaiser, Laurent/0000-0002-0857-2252	Swiss National Science Foundation [3200B0-101670, 3100A0112588/I]; Department of Medicine of the University Hospitals of Geneva (fonds de perequation) [PRD 06-II-06]; University of Geneva Dean's Program for the Promotion of Women in Science; Infectigen Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Department of Medicine of the University Hospitals of Geneva (fonds de perequation); University of Geneva Dean's Program for the Promotion of Women in Science; Infectigen Foundation	This study was supported by the Swiss National Science Foundation (grants 3200B0-101670 to L. K. and 3100A0112588/I to E.Z.), the Department of Medicine of the University Hospitals of Geneva (fonds de perequation, PRD 06-II-06), the University of Geneva Dean's Program for the Promotion of Women in Science (C.T.), and the Infectigen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binford SL, 2005, ANTIMICROB AGENTS CH, V49, P619, DOI 10.1128/AAC.49.2.619-626.2005; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; DENNY FW, 1995, AM J RESP CRIT CARE, V152, pS4, DOI 10.1164/ajrccm/152.4_Pt_2.S4; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Gerber K, 2001, J VIROL, V75, P10979, DOI 10.1128/JVI.75.22.10979-10990.2001; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GWALTNEY JM, 1992, PROG MED VIROL, V39, P256; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Ledford RM, 2005, ANTIVIR RES, V68, P135, DOI 10.1016/j.antiviral.2005.08.003; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Love RA, 2004, STRUCTURE, V12, P1533, DOI 10.1016/j.str.2004.05.024; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; R Core Team, 2020, R LANG ENV STAT COMP; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Sanders SP, 2004, J ALLERGY CLIN IMMUN, V113, P697, DOI 10.1016/j.jaci.2004.01.755; Schmidtke M, 2005, J ANTIMICROB CHEMOTH, V56, P648, DOI 10.1093/jac/dki263; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; TYRRELL DAJ, 1993, EPIDEMIOL INFECT, V111, P143, DOI 10.1017/S0950268800056764; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zeileis A, 2005, J STAT SOFTW, V14	32	40	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10588	10.1371/journal.pone.0010588	http://dx.doi.org/10.1371/journal.pone.0010588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485673	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200019
J	Li, N; Zhao, CT; Wang, Y; Yuan, XB				Li, Ning; Zhao, Chun-Tao; Wang, Ying; Yuan, Xiao-Bing			The Transcription Factor Cux1 Regulates Dendritic Morphology of Cortical Pyramidal Neurons	PLOS ONE			English	Article							CCAAT DISPLACEMENT PROTEIN; CELL-CYCLE EXIT; HOMEODOMAIN PROTEIN; HOMEOBOX GENE; CEREBRAL-CORTEX; RHO-GTPASES; P27(KIP1) EXPRESSION; SUBVENTRICULAR ZONE; TRANSGENIC MICE; DROSOPHILA CUT	In the murine cerebral cortex, mammalian homologues of the Cux family transcription factors, Cux1 and Cux2, have been identified as restricted molecular markers for the upper layer (II-IV) pyramidal neurons. However, their functions in cortical development are largely unknown. Here we report that increasing the intracellular level of Cux1, but not Cux2, reduced the dendritic complexity of cultured cortical pyramidal neurons. Consistently, reducing the expression of Cux1 promoted the dendritic arborization in these pyramidal neurons. This effect required the existence of the DNA-binding domains, hence the transcriptional passive repression activity of Cux1. Analysis of downstream signals suggested that Cux1 regulates dendrite development primarily through suppressing the expression of the cyclin-dependent kinase inhibitor p27(Kip1), and RhoA may mediate the regulation of dendritic complexity by Cux1 and p27. Thus, Cux1 functions as a negative regulator of dendritic complexity for cortical pyramidal neurons.	[Li, Ning; Zhao, Chun-Tao; Yuan, Xiao-Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Li, Ning; Zhao, Chun-Tao; Yuan, Xiao-Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurobiol, Shanghai, Peoples R China; [Li, Ning; Zhao, Chun-Tao] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Wang, Ying] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Wenzhou Medical University	Li, N (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	yuanxb@ion.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460	National Basic Research Program of China [2006CB943903]; National Natural Science Foundation of China [30625023]; Chinese Academy of Sciences [KSCX2-YW-R-103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (2006CB943903, 2006CB943903) and grants from the National Natural Science Foundation of China (30625023) and the Chinese Academy of Sciences (KSCX2-YW-R-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Akashiba H, 2006, CELL MOL LIFE SCI, V63, P2397, DOI 10.1007/s00018-006-6194-4; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Cadieux C, 2008, J BIOL CHEM, V283, P13817, DOI 10.1074/jbc.M709332200; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Dergham P, 2002, J NEUROSCI, V22, P6570; Ferrere A, 2006, ANAT REC PART A, V288A, P158, DOI 10.1002/ar.a.20284; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Iulianella A, 2008, DEVELOPMENT, V135, P729, DOI 10.1242/dev.013276; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Quaggin SE, 1997, J CLIN INVEST, V99, P718, DOI 10.1172/JCI119216; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Redmond L, 2008, NEUROSIGNALS, V16, P194, DOI 10.1159/000111563; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sharma M, 2009, GENE, V439, P87, DOI 10.1016/j.gene.2009.03.014; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VandenHeuvel GB, 1996, BIOL REPROD, V55, P731, DOI 10.1095/biolreprod55.4.731; VANWIJNEN AJ, 1991, P NATL ACAD SCI USA, V88, P2573, DOI 10.1073/pnas.88.6.2573; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	48	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10596	10.1371/journal.pone.0010596	http://dx.doi.org/10.1371/journal.pone.0010596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485671	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200023
J	Rios, JJ; Fleming, JGW; Bryant, UK; Carter, CN; Huber, JC; Long, MT; Spencer, TE; Adelson, DL				Rios, Jonathan J.; Fleming, JoAnn G. W.; Bryant, Uneeda K.; Carter, Craig N.; Huber, John C., Jr.; Long, Maureen T.; Spencer, Thomas E.; Adelson, David L.			OAS1 Polymorphisms Are Associated with Susceptibility to West Nile Encephalitis in Horses	PLOS ONE			English	Article							2'-5'-OLIGOADENYLATE SYNTHETASE GENE; MOLECULAR-WEIGHT INHIBITOR; INTERFERON-TREATED CELLS; FREE PROTEIN-SYNTHESIS; VIRUS-INFECTION; 2',5'-OLIGOADENYLATE SYNTHETASE; REGULATORY ELEMENTS; EXPRESSION; PATHOGENICITY; ACTIVATION	West Nile virus, first identified within the United States in 1999, has since spread across the continental states and infected birds, humans and domestic animals, resulting in numerous deaths. Previous studies in mice identified the Oas1b gene, a member of the OAS/RNASEL innate immune system, as a determining factor for resistance to West Nile virus (WNV) infection. A recent case-control association study described mutations of human OAS1 associated with clinical susceptibility to WNV infection. Similar studies in horses, a particularly susceptible species, have been lacking, in part, because of the difficulty in collecting populations sufficiently homogenous in their infection and disease states. The equine OAS gene cluster most closely resembles the human cluster, with single copies of OAS1, OAS3 and OAS2 in the same orientation. With naturally occurring susceptible and resistant sub-populations to lethal West Nile encephalitis, we undertook a case-control association study to investigate whether, similar to humans (OAS1) and mice (Oas1b), equine OAS1 plays a role in resistance to severe WNV infection. We identified naturally occurring single nucleotide mutations in equine (Equus caballus) OAS1 and RNASEL genes and, using Fisher's Exact test, we provide evidence that mutations in equine OAS1 contribute to host susceptibility. Virtually all of the associated OAS1 polymorphisms were located within the interferon-inducible promoter, suggesting that differences in OAS1 gene expression may determine the host's ability to resist clinical manifestations associated with WNV infection.	[Rios, Jonathan J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Fleming, JoAnn G. W.; Spencer, Thomas E.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Bryant, Uneeda K.; Carter, Craig N.] Univ Kentucky, Livestock Dis Diagnost Ctr, Lexington, KY USA; [Huber, John C., Jr.] Texas A&M Univ, Sch Rural Publ Hlth, College Stn, TX USA; [Long, Maureen T.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; University of Kentucky; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; State University System of Florida; University of Florida; University of Adelaide	Rios, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	david.adelson@adelaide.edu.au	Spencer, Thomas/AAD-6434-2020; Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Spencer, Thomas/0000-0003-2815-766X	Texas A&M University Patsy Link Endowment for Equine Research	Texas A&M University Patsy Link Endowment for Equine Research	This work was supported by the Texas A&M University Patsy Link Endowment for Equine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGLIONI C, 1978, NATURE, V273, P684, DOI 10.1038/273684a0; BARNARD BJH, 1986, ONDERSTEPOORT J VET, V53, P235; BENECH P, 1987, MOL CELL BIOL, V7, P4498, DOI 10.1128/MCB.7.12.4498; BLACKBURN NK, 1989, J COMP PATHOL, V100, P59, DOI 10.1016/0021-9975(89)90090-X; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; DOHOO WMI, 2003, VET EPIDEMIOLOGIC RE; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; Floyd-Smith G, 1999, EXP CELL RES, V246, P138, DOI 10.1006/excr.1998.4296; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; Hovnanian A, 1998, GENOMICS, V52, P267, DOI 10.1006/geno.1998.5443; ILKAL MA, 1994, ACTA VIROL, V38, P157; JOHN J, 1991, MOL CELL BIOL, V11, P4189, DOI 10.1128/MCB.11.8.4189; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KERR IM, 1977, NATURE, V268, P540, DOI 10.1038/268540a0; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; MCINTOSH B, 1982, ZOONOSES B; McLean RG, 2002, CURR TOP MICROBIOL, V267, P271; Naganuma A, 2000, J VIROL, V74, P8744, DOI 10.1128/JVI.74.18.8744-8750.2000; Ostlund EN, 2001, EMERG INFECT DIS, V7, P665; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Perelygin AA, 2005, CYTOGENET GENOME RES, V111, P51, DOI 10.1159/000085670; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Perelygin AA, 2006, J MOL EVOL, V63, P562, DOI 10.1007/s00239-006-0073-3; R Core Team, 2018, R LANG ENV STAT COMP; Rios JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-313; ROBERTS WK, 1976, NATURE, V264, P477, DOI 10.1038/264477a0; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; StataCorp, 2005, STAT STAT SOFTW REL; Tnani M, 1998, BBA-MOL CELL RES, V1402, P139, DOI 10.1016/S0167-4889(97)00158-4; VanHeeke G, 1996, J INTERF CYTOK RES, V16, P119, DOI 10.1089/jir.1996.16.119; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340	36	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10537	10.1371/journal.pone.0010537	http://dx.doi.org/10.1371/journal.pone.0010537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479874	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800019
J	Castilho, RM; Squarize, CH; Leelahavanichkul, K; Zheng, Y; Bugge, T; Gutkind, JS				Castilho, Rogerio M.; Squarize, Cristiane H.; Leelahavanichkul, Kantima; Zheng, Yi; Bugge, Thomas; Gutkind, J. Silvio			Rac1 Is Required for Epithelial Stem Cell Function during Dermal and Oral Mucosal Wound Healing but Not for Tissue Homeostasis in Mice	PLOS ONE			English	Article							HAIR FOLLICLE; HUMAN KERATINOCYTES; RHO-GTPASES; SKIN; EXPRESSION; EPIDERMIS; ACTIVATION; DIFFERENTIATION; TRANSFORMATION; MECHANISMS	Background: The regenerative capacity of the skin, including the continuous replacement of exfoliated cells and healing of injuries relies on the epidermal stem cells and their immediate cell descendants. The relative contribution of the hair follicle stem cells and the interfollicular stem cells to dermal wound healing is an area of active investigation. Recent studies have revealed that the small GTPase Rac1, which regulates cell migration and nuclear gene expression, is required for hair follicle stem function but not for the normal homeostasis of the interfollicular skin. Methodology/Principal Findings: Here we explored whether Rac1 contributes to wound healing in the skin and in the oral mucosa, the latter an anatomical site that presents similar architecture to that of the skin but is devoid of any hair follicle structures, and hence lacks hair follicle stem cells. Epidermal Rac1 gene excision led to the clearly delayed closure of cutaneous wounds. Remarkably, genetic ablation of Rac1 from the oral mucosa resulted in the complete inability of oral wounds to heal. We present evidence that the lack of oral mucosal re-epithelization may result from the reduced migratory capacity of cells lacking Rac1 together with altered expression of injury-induced proliferative and cellular stress-related expression programs. Conclusions/Significance: Together, these observations support that while the normal development and homeostasis of the interfollicular skin and oral mucosa do not require Rac1 function, the interfollicular and oral epithelial stem cells may require a Rac1-dependent program to orchestrate the tissue response to injury and ultimate for wound closure. Ultimately, these findings may enable the molecular characterization of the acute tissue regenerative response of these stem cell populations, thus facilitating the identification of novel molecular-targeted strategies aimed at accelerating wound closure.	[Castilho, Rogerio M.; Squarize, Cristiane H.; Leelahavanichkul, Kantima; Bugge, Thomas; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Zheng, Yi] Univ Cincinnati, Med Ctr, Div Expt Hematol, Childrens Hosp, Cincinnati, OH 45267 USA; [Castilho, Rogerio M.; Squarize, Cristiane H.] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA.	sg39v@nih.gov	Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016; Zheng, Yi/J-7235-2015; Gutkind, J. Silvio/A-1053-2009	Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Zheng, Yi/0000-0001-7089-6074; Squarize, Cristiane/0000-0002-6782-3429	Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research [Z01DE00558-18]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000558] Funding Source: NIH RePORTER	Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research, project Z01DE00558-18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Bartkova J, 2003, ARCH ORAL BIOL, V48, P125, DOI 10.1016/S0003-9969(02)00202-9; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Elias PM, 2005, EXP DERMATOL, V14, P719, DOI 10.1111/j.1600-0625.2005.00363.x; ELIAS PM, 1983, J INVEST DERMATOL, V80, P44, DOI DOI 10.1038/JID.1983.12); Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 2008, COLD SH Q B, V73, P333, DOI 10.1101/sqb.2008.73.032; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; GRAFSTROM RC, 2002, CULTURE EPITHELIAL C; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Haas AF, 1998, FREE RADICAL BIO MED, V25, P998, DOI 10.1016/S0891-5849(98)00135-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kwei KA, 2006, CANCER LETT, V231, P326, DOI 10.1016/j.canlet.2005.02.031; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Neub A, 2007, J INVEST DERMATOL, V127, P2453, DOI 10.1038/sj.jid.5700864; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shirai K, 2001, EXP EYE RES, V73, P461, DOI 10.1006/exer.2001.1052; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; TYNER AL, 1986, J CELL BIOL, V103, P1945, DOI 10.1083/jcb.103.5.1945; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6	39	77	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10503	10.1371/journal.pone.0010503	http://dx.doi.org/10.1371/journal.pone.0010503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463891	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379800002
J	Birkenmeier, G; Stegemann, C; Hoffmann, R; Gunther, R; Huse, K; Birkemeyer, C				Birkenmeier, Gerd; Stegemann, Christin; Hoffmann, Ralf; Guenther, Robert; Huse, Klaus; Birkemeyer, Claudia			Posttranslational Modification of Human Glyoxalase 1 Indicates Redox-Dependent Regulation	PLOS ONE			English	Article							PROTEIN MIXED-DISULFIDES; S-GLUTATHIONYLATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; METHYLGLYOXAL; OXIDE; IDENTIFICATION; MECHANISM; ENZYME; EXPRESSION	Background: Glyoxalase 1 (Glo1) and glyoxalase 2 (Glo2) are ubiquitously expressed cytosolic enzymes that catalyze the conversion of toxic alpha-oxo-aldehydes into the corresponding alpha-hydroxy acids using L-glutathione (GSH) as a cofactor. Human Glo1 exists in various isoforms; however, the nature of its modifications and their distinct functional assignment is mostly unknown. Methodology/Principal Findings: We characterized native Glo1 purified from human erythrocytes by mass spectrometry. The enzyme was found to undergo four so far unidentified posttranslational modifications: (i) removal of the N-terminal methionine 1, (ii) N-terminal acetylation at alanine 2, (iii) a vicinal disulfide bridge between cysteine residues 19 and 20, and (iv) a mixed disulfide with glutathione on cysteine 139. Glutathionylation of Glo1 was confirmed by immunological methods. Both, N-acetylation and the oxidation state of Cys(19/20), did not impact enzyme activity. In contrast, glutathionylation strongly inhibited Glo1 activity in vitro. The discussed mechanism for enzyme inhibition by glutathionylation was validated by molecular dynamics simulation. Conclusion/Significance: It is shown for the first time that Glo1 activity directly can be regulated by an oxidative posttranslational modification that was found in the native enzyme, i. e., glutathionylation. Inhibition of Glo1 by chemical reaction with its co-factor and the role of its intramolecular disulfides are expected to be important factors within the context of redox-dependent regulation of glucose metabolism in cells.	[Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany; [Stegemann, Christin; Hoffmann, Ralf] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Fac Chem & Mineral, Leipzig, Germany; [Guenther, Robert] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany; [Huse, Klaus] Fritz Lipmann Inst eV, Leibniz Inst Age Res, Jena, Germany; [Birkemeyer, Claudia] Univ Leipzig, Inst Analyt Chem, Fac Chem & Mineral, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leipzig University	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany.	birkemeyer@chemie.uni-leipzig.de	Birkemeyer, Claudia S/L-8687-2015; Hoffmann, Ralf/ABD-8779-2020; Günther, Robert/B-5498-2008	Birkemeyer, Claudia S/0000-0002-8538-8838; Günther, Robert/0000-0002-3533-9747; Huse, Klaus/0000-0003-3854-1884; Birkenmeier, Gerd/0000-0001-7805-9924	BMBF, Germany [01GS0809]; University of Leipzig	BMBF, Germany(Federal Ministry of Education & Research (BMBF)); University of Leipzig	The study was partially supported by grant 01GS0809 from BMBF, Germany, and by the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS TW, 1989, DIABETES RES CLIN EX, V11, P125; AYOUB F, 1993, ANTICANCER RES, V13, P151; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Chauhan SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006805; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Cooper AJL, 1997, BIOL CHEM, V378, P793; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; De Hemptinne V, 2007, BIOCHEM J, V407, P121, DOI 10.1042/BJ20070379; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; GRIMM LM, 1985, BIOCHIM BIOPHYS ACTA, V844, P50, DOI 10.1016/0167-4889(85)90232-0; GUY GR, 1993, J BIOL CHEM, V268, P2141; Hemptinne F, 2009, MOL CELL BIOCHEM, V325, P169; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Klatt P, 2002, METHOD ENZYMOL, V348, P157, DOI 10.1016/S0076-6879(02)48635-1; Kuhla B, 2007, NEUROBIOL AGING, V28, P29, DOI 10.1016/j.neurobiolaging.2005.11.007; Laden BP, 2001, J LIPID RES, V42, P235; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; LAN Y, 1995, J BIOL CHEM, V270, P12957, DOI 10.1074/jbc.270.22.12957; Lee HJ, 2005, ANN NY ACAD SCI, V1043, P135, DOI 10.1196/annals.1333.017; MANNERVIK B, 1982, METHOD ENZYMOL, V90, P535; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Mitsumoto A, 2000, J BIOCHEM, V128, P647, DOI 10.1093/oxfordjournals.jbchem.a022797; Mitsumoto A, 1999, BIOCHEM J, V344, P837, DOI 10.1042/0264-6021:3440837; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; PRINS HK, 1966, BLOOD-J HEMATOL, V27, P145, DOI 10.1182/blood.V27.2.145.145; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Ralph Stephen John, 2008, Metal-Based Drugs, P260146, DOI 10.1155/2008/260146; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; Ratliff DM, 1996, J CLIN ENDOCR METAB, V81, P488, DOI 10.1210/jc.81.2.488; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; SELLIN S, 1982, BIOCHEMISTRY-US, V21, P4850, DOI 10.1021/bi00263a004; Shelton MD, 2008, MOL CELLS, V25, P332; Staniszewska MM, 2006, MOL CELL BIOCHEM, V288, P29, DOI 10.1007/s11010-005-9115-1; Stokvis E, 2000, J PROTEIN CHEM, V19, P389, DOI 10.1023/A:1026439531005; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Van Herreweghe F, 2002, P NATL ACAD SCI USA, V99, P949, DOI 10.1073/pnas.012432399; VANDERJAGT DL, 2001, CHEM-BIOL INTERACT, P130; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Verspohl EJ, 2006, ENDOCR J, V53, P21, DOI 10.1507/endocrj.53.21; WHITTAKER VP, 1947, BIOCHEM J, V41, P56, DOI 10.1042/bj0410056; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K; Yen TY, 2002, J MASS SPECTROM, V37, P15, DOI 10.1002/jms.241	58	70	71	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10399	10.1371/journal.pone.0010399	http://dx.doi.org/10.1371/journal.pone.0010399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454679	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100011
J	Austin, P; Heller, M; Williams, DE; McIntosh, LP; Vogl, AW; Foster, LJ; Andersen, RJ; Roberge, M; Roskelley, CD				Austin, Pamela; Heller, Markus; Williams, David E.; McIntosh, Lawrence P.; Vogl, A. Wayne; Foster, Leonard J.; Andersen, Raymond J.; Roberge, Michel; Roskelley, Calvin D.			Release of Membrane-Bound Vesicles and Inhibition of Tumor Cell Adhesion by the Peptide Neopetrosiamide A	PLOS ONE			English	Article							FOCAL ADHESIONS; CANCER-THERAPY; STRESS FIBERS; INVASION; INTEGRINS; PROTEIN; ACTIN; STRONGYLOPHORINE-26; ANGIOGENESIS; ASSOCIATION	Background: Neopetrosiamide A (NeoA) is a 28-amino acid tricyclic peptide originally isolated from a marine sponge as a tumor cell invasion inhibitor whose mechanism of action is unknown. Methodology/Principal Findings: We show that NeoA reversibly inhibits tumor cell adhesion, disassembles focal adhesions in pre-attached cells, and decreases the level of beta 1 integrin subunits on the cell surface. NeoA also induces the formation of dynamic, membrane-bound protrusions on the surface of treated cells and the release of membrane-bound vesicles into the culture medium. Proteomic analysis indicates that the vesicles contain EGF and transferrin receptors as well as a number of proteins involved in adhesion and migration including: beta 1 integrin and numerous alpha integrin subunits; actin and actin-binding proteins such as cofilin, moesin and myosin 1C; and membrane modulating eps15 homology domain (EHD) proteins. Surface labeling, trafficking inhibition, and real-time imaging experiments all suggest that beta 1 integrin-containing vesicles are released directly from NeoA-induced cell surface protrusions rather than from vesicles generated intracellularly. The biological activity of NeoA is dependent on its disulfide bond pattern and NMR spectroscopy indicates that the peptide is globular with a continuous ridge of hydrophobic groups flanked by charged amino acid residues that could facilitate a simultaneous interaction with lipids and proteins in the membrane. Conclusions/Significance: NeoA is an anti-adhesive peptide that decreases cell surface integrin levels through a novel, yet to be elucidated, mechanism that involves the release of adhesion molecule-containing vesicles from the cell surface.	[Austin, Pamela; Vogl, A. Wayne; Roskelley, Calvin D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Austin, Pamela; Heller, Markus; McIntosh, Lawrence P.; Foster, Leonard J.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; McIntosh, Lawrence P.; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Roskelley, Calvin D.] Univ British Columbia, Program Breast Canc Metastasis, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Austin, P (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	roskelly@interchange.ubc.ca	Roskelley, Calvin D/F-4630-2011		Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Breast Cancer Research Alliance; Michael Smith Foundation for Health Research; Canadian Institutes for Health Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; UBC Blusson Fund; Alexander-von-Humboldt Foundation	Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Breast Cancer Research Alliance; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; UBC Blusson Fund; Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by grants from the Canadian Cancer Society through the National Cancer Institute of Canada (to MR and CDR, RJA, LPM), the Canadian Breast Cancer Research Alliance Metastasis Program (CDR), and by funding from the Michael Smith Foundation for Health Research to the Solid Tumor Progression Research Unit (CDR, MR, RJA). LJF is Canada Research Chair in Organelle Proteomics and a Michael Smith Foundation Scholar. Instrument support was provided by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the UBC Blusson Fund, and the Michael Smith Foundation for Health Research. MH gratefully acknowledges the Alexander-von-Humboldt Foundation for a Feodor-Lynen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerner JL, 2005, MOL ENDOCRINOL, V19, P2660, DOI 10.1210/me.2004-0439; Bonilha VL, 2004, MOL CELL PROTEOMICS, V3, P1119, DOI 10.1074/mcp.M400106-MCP200; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Marrero AR, 2006, ORG LETT, V8, P3749, DOI 10.1021/ol061333p; DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173; Dunehoo AL, 2006, J PHARM SCI-US, V95, P1856, DOI 10.1002/jps.20676; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Elvin P, 2005, CURR OPIN PHARMACOL, V5, P374, DOI 10.1016/j.coph.2005.02.008; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Han KH, 1997, BIOCHEMISTRY-US, V36, P1669, DOI 10.1021/bi962301k; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Keezer SM, 2003, CANCER RES, V63, P6405; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kuo HJ, 2001, J BIOL CHEM, V276, P43103, DOI 10.1074/jbc.M106128200; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; LIU H, J AM CHEM SOC, V132, P1486; Maciver SK, 2002, GENOME BIOL, V3; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; McHardy LM, 2004, CANCER RES, V64, P1468, DOI 10.1158/0008-5472.CAN-03-2733; Paradela A, 2005, J PROTEOME RES, V4, P2435, DOI 10.1021/pr050308v; Park SK, 1996, J BIOCHEM, V119, P235; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Roskelley CD, 2001, CANCER RES, V61, P6788; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; SIMPSON KJ, 2008, NAT CELL BIOL; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; Warabi K, 2004, J NAT PROD, V67, P1387, DOI 10.1021/np0340246; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; Williams DE, 2005, ORG LETT, V7, P4173, DOI 10.1021/ol051524c; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059	52	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10836	10.1371/journal.pone.0010836	http://dx.doi.org/10.1371/journal.pone.0010836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520768	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500022
J	Lundgren, JG; Lehman, M				Lundgren, Jonathan G.; Lehman, Michael			Bacterial Gut Symbionts Contribute to Seed Digestion in an Omnivorous Beetle	PLOS ONE			English	Article							CHRYSOPERLA-RUFILABRIS NEUROPTERA; GENOME SEQUENCE; BLOCHMANNIA-FLORIDANUS; VERTICAL TRANSMISSION; ABUTILON-THEOPHRASTI; CHRYSOPIDAE ADULTS; POECILUS-CHALCITES; OBLIGATE SYMBIONT; GROUND BEETLE; LIFE-CYCLE	Background: Obligate bacterial symbionts alter the diets of host animals in numerous ways, but the ecological roles of facultative bacterial residents that colonize insect guts remain unclear. Carabid beetles are a common group of beneficial insects appreciated for their ability to consume insect prey and seeds, but the contributions of microbes to diet diversification in this and similar groups of facultative granivores are largely unknown. Methodology and Principal Findings: Using 16S rRNA gene clone libraries and terminal restriction fragment (tRF) length polymorphism analyses of these genes, we examined the bacterial communities within the guts of facultatively granivorous, adult Harpalus pensylvanicus (Carabidae), fed one of five dietary treatments: 1) an untreated Field population, 2) Seeds with antibiotics (seeds were from Chenopodium album), 3) Seeds without antibiotics, 4) Prey with antibiotics (prey were Acheta domesticus eggs), and 5) Prey without antibiotics. The number of seeds and prey consumed by each beetle were recorded following treatment. Harpalus pensylvanicus possessed a fairly simple gut community of approximately 3-4 bacterial operational taxonomic units (OTU) per beetle that were affiliated with the Gammaproteobacteria, Bacilli, Alphaproteo-bacteria, and Mollicutes. Bacterial communities of the host varied among the diet and antibiotic treatments. The field population and beetles fed seeds without antibiotics had the closest matching bacterial communities, and the communities in the beetles fed antibiotics were more closely related to each other than to those of the beetles that did not receive antibiotics. Antibiotics reduced and altered the bacterial communities found in the beetle guts. Moreover, beetles fed antibiotics ate fewer seeds, and those beetles that harbored the bacterium Enterococcus faecalis consumed more seeds on average than those lacking this symbiont. Conclusions/Significance: We conclude that the relationships between the bacterium E. faecalis and this factultative granivore's ability to consume seeds merit further investigation, and that facultative associations with symbiotic bacteria have important implications for the nutritional ecology of their hosts.	[Lundgren, Jonathan G.; Lehman, Michael] ARS, N Cent Agr Res Lab, USDA, Brookings, SD USA	United States Department of Agriculture (USDA)	Lundgren, JG (corresponding author), ARS, N Cent Agr Res Lab, USDA, Brookings, SD USA.	Jonathan.Lundgren@ars.usda.gov		Lehman, Michael/0000-0002-3391-3178	United States Department of Agriculture Agricultural Research Service	United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1990, ROLE GROUND BEETLES; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; AZAMBUJA P, 2005, TRENDS PARISITOLOGY, V21, DOI DOI 10.1016/J.PT.2005.1009.1011; Ba AS, 1996, MYCOL RES, V100, P740, DOI 10.1016/S0953-7562(96)80208-5; Ball GE, 2000, AM BEETLES, V1, P32; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Blackburn MB, 2008, BIOL CONTROL, V46, P434, DOI 10.1016/j.biocontrol.2008.05.005; Brauman A, 2001, FEMS MICROBIOL ECOL, V35, P27, DOI 10.1111/j.1574-6941.2001.tb00785.x; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brust G. E., 1988, American Journal of Alternative Agriculture, V3, P19, DOI 10.1017/S0889189300002083; BRUST GE, 1986, ENVIRON ENTOMOL, V15, P1017, DOI 10.1093/ee/15.5.1017; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Campbell B.C., 1989, P1; Chandler SM, 2008, P ROY SOC B-BIOL SCI, V275, P565, DOI 10.1098/rspb.2007.1478; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Doring TF, 2003, AGR ECOSYST ENVIRON, V98, P133, DOI 10.1016/S0167-8809(03)00075-6; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ennahar S, 2003, APPL ENVIRON MICROB, V69, P444, DOI 10.1128/AEM.69.1.444-451.2003; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; FORSYTHE TG, 1983, ZOOL J LINN SOC-LOND, V79, P319, DOI 10.1111/j.1096-3642.1983.tb01170.x; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Heggenstaller AH, 2006, J APPL ECOL, V43, P999, DOI 10.1111/j.1365-2664.2006.01198.x; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Honek A, 2005, J ECOL, V93, P345, DOI 10.1111/j.1365-2745.2005.00987.x; Honek A, 2003, EUR J ENTOMOL, V100, P531, DOI 10.14411/eje.2003.081; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hunter MD, 2009, AGR FOREST ENTOMOL, V11, P125, DOI 10.1111/j.1461-9563.2008.00427.x; Inglis GD, 2000, J ECON ENTOMOL, V93, P1619, DOI 10.1603/0022-0493-93.6.1619; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Jones C.G., 1984, P53; Jorgensen HB, 1997, ECOL ENTOMOL, V22, P7, DOI 10.1046/j.1365-2311.1997.00045.x; KAUFMAN MG, 1989, J INSECT PHYSIOL, V35, P957, DOI 10.1016/0022-1910(89)90019-X; KAUFMAN MG, 1991, COMP BIOCHEM PHYS A, V98, P117, DOI 10.1016/0300-9629(91)90588-4; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; KIRK VM, 1972, ANN ENTOMOL SOC AM, V65, P1426, DOI 10.1093/aesa/65.6.1426; KIRK VM, 1973, ANN ENTOMOL SOC AM, V66, P513, DOI 10.1093/aesa/66.3.513; KLIMES P, 2010, J APPL ENTO IN PRESS; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Li HW, 2005, J INVERTEBR PATHOL, V89, P203, DOI 10.1016/j.jip.2005.05.008; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lundgren JG, 2005, J ENTOMOL SCI, V40, P126, DOI 10.18474/0749-8004-40.2.126; LUNDGREN JG, 2009, RELATIONSHI IN PRESS; Lundgren JG, 2007, ARTHROPOD-PLANT INTE, V1, P93, DOI 10.1007/s11829-007-9008-1; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Lundgren JG, 2006, RENEW AGR FOOD SYST, V21, P227, DOI 10.1079/RAF2006152; Macovei L, 2006, APPL ENVIRON MICROB, V72, P4028, DOI 10.1128/AEM.00034-06; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; MARTIN MM, 1992, AM ZOOL, V32, P593; MARTIN MM, 1980, OECOLOGIA, V46, P360, DOI 10.1007/BF00346265; Mauchline AL, 2005, WEED RES, V45, P157, DOI 10.1111/j.1365-3180.2004.00443.x; Menalled FD, 1999, BIOCONTROL, V43, P441, DOI 10.1023/A:1009946004251; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Morales-Ramos JA, 2000, ANN ENTOMOL SOC AM, V93, P541, DOI 10.1603/0013-8746(2000)093[0541:SRBHHC]2.0.CO;2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nguyen NH, 2006, MYCOL RES, V110, P346, DOI 10.1016/j.mycres.2005.11.010; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2009, CURR MICROBIOL, V58, P64, DOI 10.1007/s00284-008-9267-9; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; *SYST SOFTW INC, 2004, SYSTAT SOFTW 1 SYSTA; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1016/S0168-6496(97)00053-6; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; van der Hoeven R, 2008, FEMS MICROBIOL LETT, V286, P249, DOI 10.1111/j.1574-6968.2008.01277.x; Vasanthakumar A, 2006, ENVIRON ENTOMOL, V35, P1710, DOI 10.1603/0046-225X(2006)35[1710:COGBIL]2.0.CO;2; Westerman P, 2005, WEED SCI, V53, P382, DOI 10.1614/WS-04-130R; Westerman PR, 2003, AGR ECOSYST ENVIRON, V95, P417, DOI 10.1016/S0167-8809(02)00224-4; Woolfolk SW, 2004, ANN ENTOMOL SOC AM, V97, P796, DOI 10.1603/0013-8746(2004)097[0796:MOTACO]2.0.CO;2; Woolfolk SW, 2004, BIOL CONTROL, V29, P155, DOI 10.1016/S1049-9644(03)00139-7; YAMANOUCHI T, 1992, INT J REMOTE SENS, V13, P111, DOI 10.1080/01431169208904029; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; ZHaVOROnKOVa T.n., 1969, ENTOMOL REV, V48, P462; Zientz E, 2006, APPL ENVIRON MICROB, V72, P6027, DOI 10.1128/AEM.00933-06	91	55	62	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10831	10.1371/journal.pone.0010831	http://dx.doi.org/10.1371/journal.pone.0010831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520762	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221500017
J	Berry, RP; Ibbotson, MR				Berry, Richard P.; Ibbotson, Michael R.			A Three-Dimensional Atlas of the Honeybee Neck	PLOS ONE			English	Article							APIS-MELLIFERA; MOTOR-NEURONS; BRAIN; RECONSTRUCTION; ANATOMY; FLOW	Three-dimensional digital atlases are rapidly becoming indispensible in modern biology. We used serial sectioning combined with manual registration and segmentation of images to develop a comprehensive and detailed three-dimensional atlas of the honeybee head-neck system. This interactive atlas includes skeletal structures of the head and prothorax, the neck musculature, and the nervous system. The scope and resolution of the model exceeds atlases previously developed on similar sized animals, and the interactive nature of the model provides a far more accessible means of interpreting and comprehending insect anatomy and neuroanatomy.	[Berry, Richard P.; Ibbotson, Michael R.] Australian Natl Univ, Sch Biol, Div Biomed Sci & Biochem, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia	Australian National University	Berry, RP (corresponding author), Australian Natl Univ, Sch Biol, Div Biomed Sci & Biochem, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	Michael.Ibbotson@anu.edu.au	Ibbotson, Michael R/C-9305-2009	Ibbotson, Michael R/0000-0002-3803-6653; Berry, Richard/0000-0002-7594-1433	ARC Centre of Excellence in Vision Science, Air Force Office of Scientific Research [CE0561903, FA 4869]	ARC Centre of Excellence in Vision Science, Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)Australian Research Council)	Funding: This work was funded by the ARC Centre of Excellence in Vision Science (CE0561903) together with the Air Force Office of Scientific Research (FA 4869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; HOYLE G, 1966, PFLUG ARCH GES PHYS, V291, P12, DOI 10.1007/BF00362649; IBBOTSON MR, 1991, J EXP BIOL, V157, P573; Kelber C, 2006, J COMP NEUROL, V496, P395, DOI 10.1002/cne.20930; Kikinis R, 1996, IEEE T VIS COMPUT GR, V2, P232, DOI 10.1109/2945.537306; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Markl H., 1966, Zoologische Jahrbuecher (Anatomie), V83, P107; ODGAARD A, 1990, J MICROSC-OXFORD, V159, P335, DOI 10.1111/j.1365-2818.1990.tb03038.x; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Schroter U, 2007, J COMP PHYSIOL A, V193, P289, DOI 10.1007/s00359-006-0182-x; SHEPHEARD P, 1973, J MORPHOL, V139, P439, DOI 10.1002/jmor.1051390406; Snodgrass R. E., 1942, SMITHSONIAN MISC COLL, V103, P1; STRAUSFELD NJ, 1987, J COMP PHYSIOL A, V160, P205, DOI 10.1007/BF00609727; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TOGA AW, 1995, BRAIN RES BULL, V38, P77, DOI 10.1016/0361-9230(95)00074-O; Weninger WJ, 1998, ANAT EMBRYOL, V197, P341, DOI 10.1007/s004290050144	19	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10771	10.1371/journal.pone.0010771	http://dx.doi.org/10.1371/journal.pone.0010771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520729	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600005
J	Tondo, ML; Petrocelli, S; Ottado, J; Orellano, EG				Laura Tondo, Maria; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.			The Monofunctional Catalase KatE of Xanthomonas axonopodis pv. citri Is Required for Full Virulence in Citrus Plants	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; SUPEROXIDE-DISMUTASE; GROWTH-PHASE; HRP CLUSTER; OXYGEN; PHYTOPATHOGEN; VESICATORIA; EXPRESSION; RESISTANCE; RESPONSES	Background: Xanthomonas axonopodis pv. citri (Xac) is an obligate aerobic phytopathogen constantly exposed to hydrogen peroxide produced by normal aerobic respiration and by the plant defense response during plant-pathogen interactions. Four putative catalase genes have been identified in silico in the Xac genome, designated as katE, catB, srpA (monofunctional catalases) and katG (bifunctional catalase). Methodology/Principal Findings: Xac catalase activity was analyzed using native gel electrophoresis and semi-quantitative RT-PCR. We demonstrated that the catalase activity pattern was regulated in different growth stages displaying the highest levels during the stationary phase. KatE was the most active catalase in this phase of growth. At this stage cells were more resistant to hydrogen peroxide as was determined by the analysis of CFU after the exposition to different H2O2 concentrations. In addition, Xac exhibited an adaptive response to hydrogen peroxide, displaying higher levels of catalase activity and H2O2 resistance after treatment with sub-lethal concentrations of the oxidant. In the plant-like medium XVM2 the expression of KatE was strongly induced and in this medium Xac was more resistant to H2O2. A XackatE mutant strain was constructed by insertional mutagenesis. We observed that catalase induction in stationary phase was lost meanwhile the adaptive response to peroxide was maintained in this mutant. Finally, the XackatE strain was assayed in planta during host plant interaction rendering a less aggressive phenotype with a minor canker formation. Conclusions: Our results confirmed that in contrast to other Xanthomonas species, Xac catalase-specific activity is induced during the stationary phase of growth in parallel with the bacterial resistance to peroxide challenge. Moreover, Xac catalases expression pattern is modified in response to any stimuli associated with the plant or the microenvironment it provides. The catalase KatE has been shown to have an important function for the colonization and survival of the bacterium in the citrus plant during the pathogenic process. Our work provides the first genetic evidence to support a monofunctional catalase as a virulence factor in Xac.	[Laura Tondo, Maria; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.] Univ Nacl Rosario, Div Mol Biol, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn,Inst Biol Mol &, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Tondo, ML (corresponding author), Univ Nacl Rosario, Div Mol Biol, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn,Inst Biol Mol &, RA-2000 Rosario, Santa Fe, Argentina.	orellano@ibr.gov.ar		Tondo, Maria Laura/0000-0002-0160-1882	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	Funding: This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783 to Elena G. Orellano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGO and JO are staff members and MLT and SP are Fellows of the Consejo Nacional de Investigaciones Cienti-ficas y Tecnologicas Tecnicas (CONICET, Argentina).	BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; BEERS RF, 1952, J BIOL CHEM, V195, P133; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; CHAMNONGPOL S, 1995, APPL ENVIRON MICROB, V61, P393, DOI 10.1128/AEM.61.1.393-396.1995; Chauvatcharin N, 2003, CURR MICROBIOL, V46, P83, DOI 10.1007/s00284-002-3812-8; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hanyu M, 2009, J BACTERIOL, V191, P1463, DOI 10.1128/JB.01583-08; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; KLOTZ MG, 1992, APPL ENVIRON MICROB, V58, P2468, DOI 10.1128/AEM.58.8.2468-2473.1992; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LOEWEN PC, 1997, OXIDATIVE STRESS MOL, P273; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mongkolsuk S, 1997, FEMS MICROBIOL LETT, V146, P217, DOI 10.1111/j.1574-6968.1997.tb10196.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCANDALIOS JG, 1968, ANN NY ACAD SCI, V151, P274, DOI 10.1111/j.1749-6632.1968.tb11896.x; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SWITALA J, 1990, CAN J MICROBIOL, V36, P728, DOI 10.1139/m90-123; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vattanaviboon P, 2000, GENE, V241, P259, DOI 10.1016/S0378-1119(99)00483-7; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996	34	50	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10803	10.1371/journal.pone.0010803	http://dx.doi.org/10.1371/journal.pone.0010803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520822	Green Submitted, gold, Green Published			2022-12-27	WOS:000278034600022
J	Kvell, K; Varecza, Z; Bartis, D; Hesse, S; Parnell, S; Anderson, G; Jenkinson, EJ; Pongracz, JE				Kvell, Krisztian; Varecza, Zoltan; Bartis, Domokos; Hesse, Sebastian; Parnell, Sonia; Anderson, Graham; Jenkinson, Eric J.; Pongracz, Judit E.			Wnt4 and LAP2alpha as Pacemakers of Thymic Epithelial Senescence	PLOS ONE			English	Article							CELLS; GENE; ADIPOGENESIS; REGENERATION; THYMOCYTES; INVOLUTION; RECEPTORS; DISEASE; CANCER; MICE	Age-associated thymic involution has considerable physiological impact by inhibiting de novo T-cell selection. This impaired T-cell production leads to weakened immune responses. Yet the molecular mechanisms of thymic stromal adipose involution are not clear. Age-related alterations also occur in the murine thymus providing an excellent model system. In the present work structural and molecular changes of the murine thymic stroma were investigated during aging. We show that thymic epithelial senescence correlates with significant destruction of epithelial network followed by adipose involution. We also show in purified thymic epithelial cells the age-related down-regulation of Wnt4 (and subsequently FoxN1), and the prominent increase in LAP2 alpha expression. These senescence-related changes of gene expression are strikingly similar to those observed during mesenchymal to pre-adipocyte differentiation of fibroblast cells suggesting similar molecular background in epithelial cells. For molecular level proof-of-principle stable LAP2 alpha and Wnt4-over-expressing thymic epithelial cell lines were established. LAP2 alpha over-expression provoked a surge of PPAR gamma expression, a transcription factor expressed in pre-adipocytes. In contrast, additional Wnt4 decreased the mRNA level of ADRP, a target gene of PPAR gamma. Murine embryonic thymic lobes have also been transfected with LAP2 alpha- or Wnt4-encoding lentiviral vectors. As expected LAP2 alpha over-expression increased, while additional Wnt4 secretion suppressed PPAR gamma expression. Based on these pioneer experiments we propose that decreased Wnt activity and increased LAP2 alpha expression provide the molecular basis during thymic senescence. We suggest that these molecular changes trigger thymic epithelial senescence accompanied by adipose involution. This process may either occur directly where epithelium can trans-differentiate into pre-adipocytes; or indirectly where first epithelial to mesenchymal transition (EMT) occurs followed by subsequent pre-adipocyte differentiation. The latter version fits better with literature data and is supported by the observed histological and molecular level changes.	[Kvell, Krisztian; Varecza, Zoltan; Bartis, Domokos; Hesse, Sebastian; Pongracz, Judit E.] Univ Pecs, Dept Med Biotechnol, Inst Immunol & Biotechnol, Pecs, Hungary; [Parnell, Sonia; Anderson, Graham; Jenkinson, Eric J.; Pongracz, Judit E.] Univ Birmingham, Dept Anat, Inst Biomed Res, Div Immun & Infect, Birmingham, W Midlands, England	University of Pecs; University of Birmingham	Kvell, K (corresponding author), Univ Pecs, Dept Med Biotechnol, Inst Immunol & Biotechnol, Pecs, Hungary.	judit.e.pongracz@aok.pte.hu	Bartis, Domokos/C-7763-2016; Pongracz, Judit E/N-7927-2018; Pongracz, Judit E/J-7517-2019	Bartis, Domokos/0000-0003-2301-3704; Pongracz, Judit E/0000-0002-0278-5556; Pongracz, Judit E/0000-0002-0278-5556; anderson, graham/0000-0002-2917-4085; Kvell MD PhD dr. habil., Krisztian/0000-0001-8609-6274	Wellcome Trust [079415]; 'Science Please' Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; OTKA [78310]; MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); 'Science Please' Research Team on Innovation; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research was supported by the following grants: The Wellcome Trust grant No.: 079415 (grant-holders: J.E.P., G. A. and E.J.J.), 'Science Please' Research Team on Innovation grant No.: SROP-4.2.2/08/1/2008-0011 (grant holder: J.E.P.) and OTKA (Hungarian Scientific Research Fund) type: PD (post-doctoral) grant No.: 78310 (grant-holder: K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; BEARDSLEY TR, 1983, P NATL ACAD SCI-BIOL, V80, P6005, DOI 10.1073/pnas.80.19.6005; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Chidgey A, 2007, SEMIN IMMUNOL, V19, P331, DOI 10.1016/j.smim.2007.10.006; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Dreger M, 1999, BIOCHEMISTRY-US, V38, P9426, DOI 10.1021/bi990645f; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grubeck-Loebenstein B, 2009, J COMP PATHOL; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; HIRIPI L, TRANSGENIC RES; Hsu HC, 2003, IMMUNOL ALLERGY CLIN, V23, P65, DOI 10.1016/S0889-8561(02)00074-7; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kvell K, 2005, MOL THER, V12, P892, DOI 10.1016/j.ymthe.2005.05.010; KVELL K, TRANSGENIC RES, V19, P105; Marinova TT, 2005, GERONTOLOGY, V51, P14, DOI 10.1159/000081429; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; OKSANEN A, 1971, J PATHOL, V105, P223, DOI 10.1002/path.1711050310; Osada M, 2006, CLIN DEV IMMUNOL, V13, P299, DOI 10.1080/17402520600935097; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Pongracz JE, 2006, EUR J IMMUNOL, V36, P2376, DOI 10.1002/eji.200535721; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Seike Masahiro, 2009, J Nippon Med Sch, V76, P181; Torday JS, 2006, PEDIATR RES, V60, P382, DOI 10.1203/01.pdr.0000238326.42590.03	30	49	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10701	10.1371/journal.pone.0010701	http://dx.doi.org/10.1371/journal.pone.0010701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502698	gold, Green Published, Green Submitted			2022-12-27	WOS:000277776500016
J	Biagi, E; Nylund, L; Candela, M; Ostan, R; Bucci, L; Pini, E; Nikkila, J; Monti, D; Satokari, R; Franceschi, C; Brigidi, P; De Vos, W				Biagi, Elena; Nylund, Lotta; Candela, Marco; Ostan, Rita; Bucci, Laura; Pini, Elisa; Nikkila, Janne; Monti, Daniela; Satokari, Reetta; Franceschi, Claudio; Brigidi, Patrizia; De Vos, Willem			Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; REAL-TIME PCR; BUTYRATE-PRODUCING BACTERIA; FECAL MICROBIOTA; EUBACTERIUM-LIMOSUM; HUMAN FECES; HUMAN LONGEVITY; HUMAN COLON; T-CELLS; AGE	Background: Age-related physiological changes in the gastrointestinal tract, as well as modifications in lifestyle, nutritional behaviour, and functionality of the host immune system, inevitably affect the gut microbiota, resulting in a greater susceptibility to infections. Methodology/Principal Findings: By using the Human Intestinal Tract Chip (HITChip) and quantitative PCR of 16S rRNA genes of Bacteria and Archaea, we explored the age-related differences in the gut microbiota composition among young adults, elderly, and centenarians, i.e subjects who reached the extreme limits of the human lifespan, living for over 100 years. We observed that the microbial composition and diversity of the gut ecosystem of young adults and seventy-years old people is highly similar but differs significantly from that of the centenarians. After 100 years of symbiotic association with the human host, the microbiota is characterized by a rearrangement in the Firmicutes population and an enrichment in facultative anaerobes, notably pathobionts. The presence of such a compromised microbiota in the centenarians is associated with an increased inflammatory status, also known as inflammageing, as determined by a range of peripheral blood inflammatory markers. This may be explained by a remodelling of the centenarians' microbiota, with a marked decrease in Faecalibacterium prauznitzii and relatives, symbiotic species with reported anti-inflammatory properties. As signature bacteria of the long life we identified specifically Eubacterium limosum and relatives that were more than ten-fold increased in the centenarians. Conclusions/Significance: We provide evidence for the fact that the ageing process deeply affects the structure of the human gut microbiota, as well as its homeostasis with the host's immune system. Because of its crucial role in the host physiology and health status, age-related differences in the gut microbiota composition may be related to the progression of diseases and frailty in the elderly population.	[Biagi, Elena; Candela, Marco; Brigidi, Patrizia] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Nylund, Lotta; Satokari, Reetta] Univ Turku, Turku, Finland; [Nylund, Lotta; Nikkila, Janne] Univ Helsinki, Div Microbiol & Epidemiol, Dept Basic Vet Med, Helsinki, Finland; [Ostan, Rita; Bucci, Laura; Pini, Elisa; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Ostan, Rita; Bucci, Laura; Pini, Elisa; Franceschi, Claudio] Univ Bologna, CIG Interdepartmental Ctr L Galvani, Bologna, Italy; [Monti, Daniela] Univ Florence, Dept Expt Pathol, Florence, Italy; [De Vos, Willem] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	University of Bologna; University of Turku; University of Helsinki; University of Bologna; University of Bologna; University of Florence; Wageningen University & Research	Biagi, E (corresponding author), Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy.	elena.biagi@unibo.it; elena.biagi@unibo.it	Monti, Daniela/G-9556-2012; Candela, Marco/G-5411-2012; Satokari, Reetta/C-4782-2011; Ostan, Rita/K-3074-2018; Franceschi, Claudio/L-4484-2017	Monti, Daniela/0000-0001-8651-8123; Ostan, Rita/0000-0002-0299-2811; Franceschi, Claudio/0000-0001-9841-6386; Brigidi, Patrizia/0000-0001-8375-6150; Satokari, Reetta/0000-0002-4258-3414; Nylund, Lotta/0000-0002-4765-9537				Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baggio G, 1998, FASEB J, V12, P433, DOI 10.1096/fasebj.12.6.433; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; BROKLEHU.JC, 1972, P ROY SOC MED, V65, P66, DOI 10.1177/003591577206500126; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hur HG, 2000, FEMS MICROBIOL LETT, V192, P21, DOI 10.1111/j.1574-6968.2000.tb09353.x; IMAHORI K, 1992, NUTR REV, V50, P351; Kanauchi O, 2006, WORLD J GASTROENTERO, V12, P1071, DOI 10.3748/wjg.v12.i7.1071; Kaufmann P, 1997, APPL ENVIRON MICROB, V63, P1268, DOI 10.1128/AEM.63.4.1268-1273.1997; Kleessen B, 1997, AM J CLIN NUTR, V65, P1397, DOI 10.1093/ajcn/65.5.1397; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kullen MJ, 2000, J APPL MICROBIOL, V89, P511, DOI 10.1046/j.1365-2672.2000.01146.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Leps J, 2003, MULTIVARIATE ANAL EC; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; LEY R, 2006, NATURE, V444, P1023; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MACFARLANE GT, 1989, J APPL BACTERIOL, V67, P521, DOI 10.1111/j.1365-2672.1989.tb02524.x; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nasi M, 2006, AGING CELL, V5, P167, DOI 10.1111/j.1474-9726.2006.00204.x; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Passeri G, 2003, J CLIN ENDOCR METAB, V88, P5109, DOI 10.1210/jc.2003-030515; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Possemiers S, 2008, J NUTR, V138, P1310, DOI 10.1093/jn/138.7.1310; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; RAJILICSTOJANOV.M, 2009, ENV MICROBIOL; Recasens N, 2005, J CLIN ENDOCR METAB, V90, P112, DOI 10.1210/jc.2004-0708; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SALONEN A, 2010, J MICROBIOL METHODS; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Sansonetti PJ, 2009, CELL, V138, P416, DOI 10.1016/j.cell.2009.07.024; Satokari R., 2010, HDB PREBIOTICS PROBI, P341; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SWIDSINSKI A, 2009, GUT; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002	67	896	939	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10667	10.1371/journal.pone.0010667	http://dx.doi.org/10.1371/journal.pone.0010667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498852	Green Published, gold			2022-12-27	WOS:000277773700011
J	Cavalheiro, RA; Marin, RM; Rocco, SA; Cerqueira, FM; da Silva, CCC; Rittner, R; Kowaltowski, AJ; Vercesi, AE; Franchini, KG; Castilho, RF				Cavalheiro, Renata A.; Marin, Rodrigo M.; Rocco, Silvana A.; Cerqueira, Fernanda M.; Caldeira da Silva, Camille C.; Rittner, Roberto; Kowaltowski, Alicia J.; Vercesi, Anibal E.; Franchini, Kleber G.; Castilho, Roger F.			Potent Cardioprotective Effect of the 4-Anilinoquinazoline Derivative PD153035: Involvement of Mitochondrial K-ATP Channel Activation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PERMEABILITY TRANSITION; REPERFUSION INJURY; PROTEIN-KINASE; POTASSIUM-TRANSPORT; CANCER-CHEMOTHERAPY; CARDIAC-HYPERTROPHY; POSSIBLE MECHANISM; OXIDATIVE STRESS; EGF RECEPTOR	Background: The aim of the present study was to evaluate the protective effects of the 4-anilinoquinazoline derivative PD153035 on cardiac ischemia/reperfusion and mitochondrial function. Methodology/Principal Findings: Perfused rat hearts and cardiac HL-1 cells were used to determine cardioprotective effects of PD153035. Isolated rat heart mitochondria were studied to uncover mechanisms of cardioprotection. Nanomolar doses of PD153035 strongly protect against heart and cardiomyocyte damage induced by ischemia/reperfusion and cyanide/aglycemia. PD153035 did not alter oxidative phosphorylation, nor directly prevent Ca2+ induced mitochondrial membrane permeability transition. The protective effect of PD153035 on HL-1 cells was also independent of AKT phosphorylation state. Interestingly, PD153035 activated K+ transport in isolated mitochondria, in a manner prevented by ATP and 5-hydroxydecanoate, inhibitors of mitochondrial ATP-sensitive K+ channels (mitoK(ATP)). 5-Hydroxydecanoate also inhibited the cardioprotective effect of PD153035 in cardiac HL-1 cells, demonstrating that this protection is dependent on mitoK(ATP) activation. Conclusions/Significance: We conclude that PD153035 is a potent cardioprotective compound and acts in a mechanism involving mitoK(ATP) activation.	[Cavalheiro, Renata A.; Vercesi, Anibal E.; Castilho, Roger F.] Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil; [Marin, Rodrigo M.; Rocco, Silvana A.; Franchini, Kleber G.] Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Campinas, SP, Brazil; [Cerqueira, Fernanda M.; Caldeira da Silva, Camille C.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Rittner, Roberto] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Cavalheiro, RA (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil.	franchin@unicamp.br; roger@fcm.unicamp.br	Vercesi, Aníbal E/C-8767-2012; Rocco, Silvana Aparecida/Q-3828-2019; Marin, Rodrigo Miguel/M-5687-2013; Castilho, Roger F/G-3906-2012; Kowaltowski, Alicia J/H-8698-2012; cerqueira, fernanda/C-8326-2014; Rocco, Silvana Aparecida/H-6300-2014	Rocco, Silvana Aparecida/0000-0003-4551-3443; Rocco, Silvana Aparecida/0000-0003-4551-3443; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Rittner, Roberto/0000-0002-4715-6139; Franchini, Kleber/0000-0002-0190-6635; Castilho, Roger/0000-0003-2338-8717	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Supported by Brazilian funding agencies Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq). RAC was supported by a CNPq fellowship and RMM and FMC were supported by FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2003, CLIN CANCER RES, V9, P1579; AUCHAMPACH JA, 1992, CARDIOVASC RES, V26, P1054, DOI 10.1093/cvr/26.11.1054; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Belisle E, 2002, J BIOENERG BIOMEMBR, V34, P285, DOI 10.1023/A:1020256502583; Ciardiello F, 2000, DRUGS, V60, P25, DOI 10.2165/00003495-200060001-00003; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Domingos PP, 2002, AM J PHYSIOL-HEART C, V282, pH556, DOI 10.1152/ajpheart.00534.2001; Dos Santos P, 2002, AM J PHYSIOL-HEART C, V283, pH284, DOI 10.1152/ajpheart.00034.2002; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Facundo HTF, 2007, FREE RADICAL BIO MED, V42, P1039, DOI 10.1016/j.freeradbiomed.2007.01.001; Facundo HTF, 2006, FREE RADICAL BIO MED, V40, P469, DOI 10.1016/j.freeradbiomed.2005.08.041; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Facundo HTF, 2005, J BIOENERG BIOMEMBR, V37, P75, DOI 10.1007/s10863-005-4130-1; Fry DW, 1999, PHARMACOL THERAPEUT, V82, P207, DOI 10.1016/S0163-7258(98)00050-3; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Garlid KD, 1997, CIRC RES, V81, P1072; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Ishida H, 2001, CIRC RES, V89, P856, DOI 10.1161/hh2201.100341; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Kagiyama S, 2002, CIRCULATION, V106, P909, DOI 10.1161/01.CIR.0000030181.63741.56; KARSTEN U, 1980, EXPERIENTIA, V36, P263, DOI 10.1007/BF01953772; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Liu N, 2009, J NUCL MED, V50, P303, DOI 10.2967/jnumed.108.056556; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Minarini A, 1998, BIOORG MED CHEM LETT, V8, P1353, DOI 10.1016/S0960-894X(98)00217-0; Mironova GD, 2004, J BIOL CHEM, V279, P32562, DOI 10.1074/jbc.M401115200; Mubagwa K, 2001, CARDIOVASC RES, V52, P25, DOI 10.1016/S0008-6363(01)00358-3; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Rewcastle GW, 2000, CURR ORG CHEM, V4, P679, DOI 10.2174/1385272003376094; Rocco SA, 2004, SYNTHESIS-STUTTGART, P429, DOI 10.1055/s-2004-815949; Scarpa A, 1979, Methods Enzymol, V56, P301; Seymour EM, 2003, J SURG RES, V114, P187, DOI 10.1016/S0022-4804(03)00248-8; Spector NL, 2007, P NATL ACAD SCI USA, V104, P10607, DOI 10.1073/pnas.0701286104; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; Szewczyk A, 2006, BBA-BIOENERGETICS, V1757, P715, DOI 10.1016/j.bbabio.2006.05.002; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Yamazaki T, 1998, CELL SIGNAL, V10, P693, DOI 10.1016/S0898-6568(98)00036-9	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10666	10.1371/journal.pone.0010666	http://dx.doi.org/10.1371/journal.pone.0010666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498724	Green Published, Green Submitted, gold			2022-12-27	WOS:000277773700010
J	Jeyabalan, J; Nesbit, MA; Galvanovskis, J; Callaghan, R; Rorsman, P; Thakker, RV				Jeyabalan, Jeshmi; Nesbit, M. Andrew; Galvanovskis, Juris; Callaghan, Richard; Rorsman, Patrik; Thakker, Rajesh V.			SEDLIN Forms Homodimers: Characterisation of SEDLIN Mutations and Their Interactions with Transcription Factors MBP1, PITX1 and SF1	PLOS ONE			English	Article							LINKED SPONDYLOEPIPHYSEAL DYSPLASIA; PROTEIN; GENE; LOCALIZATION; PHOSPHORYLATION; EXPRESSION; COMPLEX; TARDA; TRAPP	Background: SEDLIN, a 140 amino acid subunit of the Transport Protein Particle (TRAPP) complex, is ubiquitously expressed and interacts with the transcription factors c-myc promoter-binding protein 1 (MBP1), pituitary homeobox 1 (PITX1) and steroidogenic factor 1 (SF1). SEDLIN mutations cause X-linked spondyloepiphyseal dysplasia tarda (SEDT). Methodology/Principal Findings: We investigated the effects of 4 missense (Asp47Tyr, Ser73Leu, Phe83Ser and Val130Asp) and the most C-terminal nonsense (Gln131Stop) SEDT-associated mutations on interactions with MBP1, PITX1 and SF1 by expression in COS7 cells. Wild-type SEDLIN was present in the cytoplasm and nucleus and interacted with MBP1, PITX1 and SF1; the SEDLIN mutations did not alter these subcellular localizations or the interactions. However, SEDLIN was found to homodimerize, and the formation of dimers between wild-type and mutant SEDLIN would mask a loss in these interactions. A mammalian SEDLIN null cell-line is not available, and the interactions between SEDLIN and the transcription factors were therefore investigated in yeast, which does not endogenously express SEDLIN. This revealed that all the SEDT mutations, except Asp47Tyr, lead to a loss of interaction with MBP1, PITX1 and SF1. Three-dimensional modelling studies of SEDLIN revealed that Asp47 resides on the surface whereas all the other mutant residues lie within the hydrophobic core of the protein, and hence are likely to affect the correct folding of SEDLIN and thereby disrupt protein-protein interactions. Conclusions/Significance: Our studies demonstrate that SEDLIN is present in the nucleus, forms homodimers and that SEDT-associated mutations cause a loss of interaction with the transcription factors MBP1, PITX1 and SF1.	[Jeyabalan, Jeshmi; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp,Acad Endocrine Unit, Oxford, England; [Galvanovskis, Juris; Rorsman, Patrik] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs,Churchill Hosp, Oxford, England; [Callaghan, Richard] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Jeyabalan, J (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp,Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Callaghan, Richard/B-7032-2012; Callaghan, Richard/ABG-1638-2020; Rorsman, Patrik/A-4331-2016	Callaghan, Richard/0000-0001-6136-3532; Callaghan, Richard/0000-0001-6136-3532; Rorsman, Patrik/0000-0001-7578-0767; Thakker, Rajesh/0000-0002-1438-3220	Oliver Bird Fund [RHE/00029/G]; Nuffield Foundation; Arthritis Research Campaign [16438]; European Community [HEALTH-F2-2008-00]; Medical Research Council; Medical Research Council [G9825289] Funding Source: researchfish; MRC [G9825289] Funding Source: UKRI	Oliver Bird Fund; Nuffield Foundation; Arthritis Research Campaign(Versus Arthritis); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Oliver Bird Fund (Studentship No. RHE/00029/G), The Nuffield Foundation (J.J.), Arthritis Research Campaign (Grant ID 16438) (M.A.N. and R. V. T.), European Community Framework 7 programme grant TREAT-OA (HEALTH-F2-2008-00) (M.A.N. and R. V. T.) and the Medical Research Council (J.J., M.A.N. and R. V. T.). J.J. was an Oliver Bird funded PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 1999, J BONE JOINT SURG BR, V81B, P921, DOI 10.1302/0301-620X.81B5.9492; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Borsello T, 2007, J NEUROSCI RES, V85, P3632, DOI 10.1002/jnr.21435; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CRAVCHIK A, 1993, GENE, V137, P139, DOI 10.1016/0378-1119(93)90262-2; Fan LB, 2003, FEBS LETT, V540, P77, DOI 10.1016/S0014-5793(03)00228-X; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; Ghosh AK, 2003, J BIOL CHEM, V278, P24033, DOI 10.1074/jbc.M211982200; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Grunebaum E, 2001, J MED GENET, V38, P409, DOI 10.1136/jmg.38.6.409; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Mumm S, 2001, GENE, V273, P285, DOI 10.1016/S0378-1119(01)00571-6; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Shaw MA, 2003, CLIN GENET, V64, P235, DOI 10.1034/j.1399-0004.2003.00132.x; Takahashi T, 2002, CLIN GENET, V61, P319; Whyte MP, 1999, MEDICINE, V78, P9, DOI 10.1097/00005792-199901000-00002; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235	27	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10646	10.1371/journal.pone.0010646	http://dx.doi.org/10.1371/journal.pone.0010646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498720	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600010
J	Stein, DJ; Chiu, WT; Hwang, I; Kessler, RC; Sampson, N; Alonso, J; Borges, G; Bromet, E; Bruffaerts, R; de Girolamo, G; Florescu, S; Gureje, O; He, YL; Kovess-Masfety, V; Levinson, D; Matschinger, H; Mneimneh, Z; Nakamura, Y; Ormel, J; Posada-Villa, J; Sagar, R; Scott, KM; Tomov, T; Viana, MC; Williams, DR; Nock, MK				Stein, Dan J.; Chiu, Wai Tat; Hwang, Irving; Kessler, Ronald C.; Sampson, Nancy; Alonso, Jordi; Borges, Guilherme; Bromet, Evelyn; Bruffaerts, Ronny; de Girolamo, Giovanni; Florescu, Silvia; Gureje, Oye; He, Yanling; Kovess-Masfety, Viviane; Levinson, Daphna; Matschinger, Herbert; Mneimneh, Zeina; Nakamura, Yosikazu; Ormel, Johan; Posada-Villa, Jose; Sagar, Rajesh; Scott, Kate M.; Tomov, Toma; Viana, Maria Carmen; Williams, David R.; Nock, Matthew K.			Cross-National Analysis of the Associations between Traumatic Events and Suicidal Behavior: Findings from the WHO World Mental Health Surveys	PLOS ONE			English	Article							CHILDHOOD SEXUAL-ABUSE; SURVIVAL ANALYSIS; RISK-FACTORS; DISORDERS; DEPRESSION; PSYCHOPATHOLOGY; ORGANIZATION; PREVALENCE; ADOLESCENT; REGRESSION	Background: Community and clinical data have suggested there is an association between trauma exposure and suicidal behavior (i.e., suicide ideation, plans and attempts). However, few studies have assessed which traumas are uniquely predictive of: the first onset of suicidal behavior, the progression from suicide ideation to plans and attempts, or the persistence of each form of suicidal behavior over time. Moreover, few data are available on such associations in developing countries. The current study addresses each of these issues. Methodology/Principal Findings: Data on trauma exposure and subsequent first onset of suicidal behavior were collected via structured interviews conducted in the households of 102,245 (age 18+) respondents from 21 countries participating in the WHO World Mental Health Surveys. Bivariate and multivariate survival models tested the relationship between the type and number of traumatic events and subsequent suicidal behavior. A range of traumatic events are associated with suicidal behavior, with sexual and interpersonal violence consistently showing the strongest effects. There is a dose-response relationship between the number of traumatic events and suicide ideation/attempt; however, there is decay in the strength of the association with more events. Although a range of traumatic events are associated with the onset of suicide ideation, fewer events predict which people with suicide ideation progress to suicide plan and attempt, or the persistence of suicidal behavior over time. Associations generally are consistent across high-, middle-, and low-income countries. Conclusions/Significance: This study provides more detailed information than previously available on the relationship between traumatic events and suicidal behavior and indicates that this association is fairly consistent across developed and developing countries. These data reinforce the importance of psychological trauma as a major public health problem, and highlight the significance of screening for the presence and accumulation of traumatic exposures as a risk factor for suicide ideation and attempt.	[Stein, Dan J.] Groote Schuur Hosp, Dept Psychiat, ZA-7925 Cape Town, South Africa; [Chiu, Wai Tat; Hwang, Irving; Kessler, Ronald C.; Sampson, Nancy] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Alonso, Jordi] CIBERESP, Hlth Serv Res Unit, Inst Municipal Invest Med, Hosp del Mar, Barcelona, Spain; [Borges, Guilherme] Natl Inst Psychiat Mexico, Dept Epidemiol Res, Div Epidemiol & Psychosocial Res, Mexico City, DF, Mexico; [Borges, Guilherme] Metropolitan Autonomous Univ, Mexico City, DF, Mexico; [Bromet, Evelyn] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Bruffaerts, Ronny] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [de Girolamo, Giovanni] IRCCS, Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy; [Florescu, Silvia] Natl Sch Publ Hlth & Hlth Serv Management, Bucharest, Romania; [Gureje, Oye] Univ Coll Ibadan Hosp, Ibadan, Nigeria; [He, Yanling] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Kovess-Masfety, Viviane] Univ Paris 05, EA 4069, Paris, France; [Levinson, Daphna] Minist Hlth, Mental Hlth Serv, Jerusalem, Israel; [Matschinger, Herbert] Univ Leipzig, Psychiat Clin, Leipzig, Germany; [Mneimneh, Zeina] IDRAAC, Beirut, Lebanon; [Mneimneh, Zeina] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Dept Psychiat & Psychiat Epidemiol, NL-9713 AV Groningen, Netherlands; [Posada-Villa, Jose] Univ Javerina, Ctr Med Sabana, Bogota, Colombia; [Sagar, Rajesh] All India Inst Med Sci, Dept Psychiat, Delhi, India; [Scott, Kate M.] Wellington Sch Med & Hlth Sci, Dept Psychol Med, Otago, New Zealand; [Tomov, Toma] New Bulgarian Univ, Inst Human Relat, Sofia, Bulgaria; [Viana, Maria Carmen] Univ Sao Paulo, Dept Psychiat Epidemiol, Inst Psychiat, Sao Paulo, Brazil; [Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Nock, Matthew K.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Cape Town; Harvard University; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Autonoma Metropolitana - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; KU Leuven; University Hospital Leuven; IRCCS Fatebenefratelli; UDICE-French Research Universities; Universite Paris Cite; Leipzig University; University of Michigan System; University of Michigan; University of Groningen; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Otago; New Bulgarian University; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Stein, DJ (corresponding author), Groote Schuur Hosp, Dept Psychiat, ZA-7925 Cape Town, South Africa.	Kessler@hcp.med.harvard.edu	Nock, Matthew/AAE-8330-2019; Alonso, Jordi/A-5514-2010; Sagar, Rajesh/L-7775-2016; ormel, johan/AAC-5584-2019; Stein, Dan/A-1752-2008; kerolos, Rebecca/Z-6182-2019; BRUFFAERTS, RONNY/AAA-2364-2021; Adewuya, Abiodun/N-4997-2017; Florescu, Silvia/AAX-7951-2020; Gureje, Oye/J-1183-2014; Mneimneh, Zeina/ABG-3516-2020; de Girolamo, Giovanni/K-3062-2016; Ormel, Johan/C-6094-2013; Posada-Villa, Jose/AAA-2355-2019; Viana, Maria Carmen/B-6047-2013	Alonso, Jordi/0000-0001-8627-9636; ormel, johan/0000-0002-5463-037X; Stein, Dan/0000-0001-7218-7810; BRUFFAERTS, RONNY/0000-0002-0330-3694; Adewuya, Abiodun/0000-0002-7611-6953; Gureje, Oye/0000-0003-0094-5947; de Girolamo, Giovanni/0000-0002-1611-8324; Posada-Villa, Jose/0000-0001-5840-3118; kovess-masfety, viviane/0000-0001-7045-6175; Viana, Maria Carmen/0000-0002-0464-4845; SAGAR, RAJESH/0000-0003-4563-7841; Matschinger, Herbert/0000-0001-7146-6770; Borges, Guilherme/0000-0002-3269-0507	United States National Institute of Mental Health [R01MH070884, R01MH077883]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; State of Sao Paulo Research Foundation (FAPESP) [03/00204-3]; Ministry of Health; National Center for Public Health Protection; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; Ministry of Social Protection; European Commission [QLG5-1999-01042, SANCO 2004123]; Piedmont Region (Italy); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]; Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]; Departament de Salut, Generalitat de Catalunya, Spain; Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]; WHO (India); Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Lebanese Ministry of Public Health; WHO (Lebanon); Fogarty International; Janssen Cilag; Eli Lilly; Roche; Novartis; National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]; National Council on Science and Technology [CONACyT-G30544-H]; New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council; WHO (Geneva); WHO (Nigeria); Federal Ministry of Health, Abuja, Nigeria; Ministry of Public Health (former Ministry of Health); Astrazeneca; Jazz Pharmaceuticals; Johnson Johnson; Lundbeck; Orion; Pfizer; Pharmacia; Servier; Solvay; Sumitomo; Takeda; Tikvah; Wyeth; Ortho-McNeil Pharmaceuticals; Sanofi-Aventis; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070884, R13MH066849, R01MH077883, R01MH069864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly and Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Health; National Center for Public Health Protection; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; Ministry of Social Protection; European Commission(European CommissionEuropean Commission Joint Research Centre); Piedmont Region (Italy)(Regione PiemonteInstituto de Salud Carlos III); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departament de Salut, Generalitat de Catalunya, Spain(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); WHO (India)(World Health Organization); Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Lebanese Ministry of Public Health; WHO (Lebanon)(World Health Organization); Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Roche(Roche Holding); Novartis(Novartis); National Institute of Psychiatry Ramon de la Fuente; National Council on Science and Technology; New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council; WHO (Geneva)(World Health Organization); WHO (Nigeria)(World Health Organization); Federal Ministry of Health, Abuja, Nigeria; Ministry of Public Health (former Ministry of Health); Astrazeneca(AstraZeneca); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Lundbeck(Lundbeck Corporation); Orion; Pfizer(Pfizer); Pharmacia; Servier(Servier); Solvay(Solvay SA); Sumitomo; Takeda(Takeda Pharmaceutical Company Ltd); Tikvah; Wyeth(Wyeth); Ortho-McNeil Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This report was carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. These activities were supported by the United States National Institute of Mental Health (R01MH070884, R01MH077883), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly and Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. The Sao Paulo Megacity Mental Health Survey is supported by the State of Sao Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The Bulgarian Epidemiological Study of common mental disorders (EPIBUL) is supported by the Ministry of Health and the National Center for Public Health Protection. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The WMHI was funded by WHO (India) and helped by Dr. R. Chandrasekaran, JIPMER. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), Fogarty International, anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche, and Novartis. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria.; The Romania WMH study projects "Policies in Mental Health Area" and "National Study regarding Mental Health and Services Use" were carried out by National School of Public Health and Health Services Managemet (former National Institute for Research and Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics-National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Roman.; Dr. Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Takeda, Tikvah, and Wyeth. Dr. Kessler has been a consultant for GlaxoSmithKline, Kaiser Permanente, Pfizer, Sanofi-Aventis, Shire Pharmaceuticals, and Wyeth-Ayerst; has served on advisory boards for Eli Lilly and Company and Wyeth-Ayerst; and has had research support for his epidemiological studies from Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Pharmaceuticals, Pfizer, and Sanofi-Aventis. These competing interest statements do not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.	ALLISON PD, 1985, J AM STAT ASSOC, V80, P315, DOI 10.2307/2287888; Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; [Anonymous], 2005, SUDAAN 9 0 2 PROF SO; [Anonymous], PREV SUIC GUID FORM; [Anonymous], 2008, WHO WORLD MENTAL HLT; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Brodsky BS, 2008, PSYCHIAT CLIN N AM, V31, P223, DOI 10.1016/j.psc.2008.02.002; Brodsky BS, 2001, AM J PSYCHIAT, V158, P1871, DOI 10.1176/appi.ajp.158.11.1871; Brown J, 1999, J AM ACAD CHILD PSY, V38, P1490, DOI 10.1097/00004583-199912000-00009; BRUFFAERTS R, BRIT J PSYC IN PRESS; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Fergusson DM, 1996, J AM ACAD CHILD PSY, V35, P1355, DOI 10.1097/00004583-199610000-00023; GUREJE O, 2010, PARENTAL PSYCH UNPUB; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2006, EPIDEMIOL PSICHIAT S, V15, P161, DOI 10.1017/S1121189X00004395; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez SR, 2000, ANNU REV PSYCHOL, V51, P571, DOI 10.1146/annurev.psych.51.1.571; Makhija N, 2007, QJM-INT J MED, V100, P305, DOI 10.1093/qjmed/hcm024; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Minzenberg MJ, 2008, DEV PSYCHOPATHOL, V20, P341, DOI 10.1017/S0954579408000163; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Neeleman J, 2004, J AFFECT DISORDERS, V82, P43, DOI 10.1016/j.jad.2003.09.005; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Roy A, 2007, NEUROPSYCHOPHARMACOL, V32, P2046, DOI 10.1038/sj.npp.1301331; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Santa Mina EE, 1998, CAN J PSYCHIAT, V43, P793, DOI 10.1177/070674379804300803; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Schraedley PK, 2002, J HEALTH SOC BEHAV, V43, P307, DOI 10.2307/3090206; Stein DJ, 2009, SAMJ S AFR MED J, V99, P390; Tiet QQ, 2006, PSYCHIAT SERV, V57, P107, DOI 10.1176/appi.ps.57.1.107; *USDOHAH S, 2000, HLTH PEOPL 2010; *USPH S, 1999, SURG GEN CALL ACT PR; van Es B, 2000, J STAT PLAN INFER, V91, P295, DOI 10.1016/S0378-3758(00)00183-X; Wiederman M W, 1998, Violence Vict, V13, P3; Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557; Williams SL, 2007, J TRAUMA STRESS, V20, P845, DOI 10.1002/jts.20252; Wolter K. M., 1985, INTRO VARIANCE ESTIM; World Bank, 2008, DAT STAT; World Health Organization, 2002, WORLD REPORT VIOLENC; Yamaguchi K, 2003, SOCIOL METHODOL, V33, P81, DOI 10.1111/j.0081-1750.2003.t01-1-00128.x	48	216	217	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10574	10.1371/journal.pone.0010574	http://dx.doi.org/10.1371/journal.pone.0010574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	595SN	20485530	Green Published, gold			2022-12-27	WOS:000277633500006
J	Boominathan, L				Boominathan, Lakshmanane			The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex	PLOS ONE			English	Article							NEGATIVE REGULATOR; DICER EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; DIFFERENTIAL REGULATION; REDUCED EXPRESSION; GENE-EXPRESSION; UP-REGULATION; SELF-RENEWAL; STEM-CELLS; C-MYC	The tumor suppressors p53, p73, and p63 are known to function as transcription factors. They promote either growth arrest or apoptosis, depending upon the DNA damage. A number of microRNAs (miRNAs) have been shown to function as transcriptional targets of p53 and they appear to aid p53 in promoting growth arrest and apoptosis. However, the question of p53/p63/p73 regulating the miRNA processing complex has not been addressed in depth so far. Comparative/computational genomic analysis was performed using Target scan, Mami, and Diana software to identify miRNAs that regulate the miRNA processing complex. Here, I present evidence for the first time that the tumor suppressors p53, p63, and p73 function as both positive and negative regulators of the miRNA processing components. Curated p53-dependent miRNA expression data was used to identify p53-miRs that target the components of the miRNA-processing complex. This analysis suggests that most of the components (mRNAs' 3'UTR) of the miRNA processing complex are targeted by p53-miRs. Remarkably, this data revealed the conserved nature of p53-miRs in targeting a number of components of the miRNA processing complex. p53/p73/p63 appears to regulate the major components of the miRNA processing, such as Drosha-DGCR8, Dicer-TRBP2, and Argonaute proteins. In particular, p53/p73/p63 appears to regulate the processing of miRNAs, such as let-7, miR-200c, miR-143, miR-107, miR-16, miR-145, miR-134, miR-449a, miR-503, and miR-21. Interestingly, there seems to be a phenotypic similarity between p63(-/-) and dicer(-/-) mice, suggesting that p63 and dicer could regulate each other. In addition, p63, p73, and the DGCR8 proteins contain a conserved interaction domain. Further, promoters of a number of components of the miRNA processing machinery, including dicer and P2P-R, contain p53-REs, suggesting that they could be direct transcriptional targets of p63/p73/p53. Together, this study provides mechanistic insights into how p53, p63, and p73 regulate the components of the miRNA processing; and how p53, TA-p63, and TA-p73 regulated miRNAs inhibit tumorigenesis, EMT, metastasis, and cancer stem cell proliferation.	Genome Discovery, Murungapakkam, India		Boominathan, L (corresponding author), Genome Discovery, Murungapakkam, India.	lakshmanan.boominathan@gmail.com	Lakshamanane, Boominathan/AAW-5331-2020; Xie, Huangming/B-2260-2012					Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BOOMINATHAN L, 2010, NATURE PRECEDINGS; BOOMINATHAN L, 2009, NATURE PRECEDINGS; Boominathan L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-27; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cui XS, 2007, BIOCHEM BIOPH RES CO, V352, P231, DOI 10.1016/j.bbrc.2006.11.009; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fontemaggi G, 2005, ONCOGENE, V24, P7273, DOI 10.1038/sj.onc.1208891; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; Scheel AHJ, 2009, CELL CYCLE, V8, P1426, DOI 10.4161/cc.8.9.8324; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Ting AH, 2008, CANCER RES, V68, P2570, DOI 10.1158/0008-5472.CAN-07-6405; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Waltermann A, 2003, ONCOGENE, V22, P5686, DOI 10.1038/sj.onc.1206859; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901; YAMAGATA K, 2009, CELL, V36, P340; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105	82	149	164	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10615	10.1371/journal.pone.0010615	http://dx.doi.org/10.1371/journal.pone.0010615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485546	Green Published, gold			2022-12-27	WOS:000277563400018
J	Tennie, C; Call, J; Tomasello, M				Tennie, Claudio; Call, Josep; Tomasello, Michael			Evidence for Emulation in Chimpanzees in Social Settings Using the Floating Peanut Task	PLOS ONE			English	Article							NUT-CRACKING BEHAVIOR; PAN-TROGLODYTES; TOOL USE; IMITATION; EVOLUTION; APES	Background: It is still unclear which observational learning mechanisms underlie the transmission of difficult problem-solving skills in chimpanzees. In particular, two different mechanisms have been proposed: imitation and emulation. Previous studies have largely failed to control for social factors when these mechanisms were targeted. Methods: In an attempt to resolve the existing discrepancies, we adopted the 'floating peanut task', in which subjects need to spit water into a tube until it is sufficiently full for floating peanuts to be grasped. In a previous study only a few chimpanzees were able to invent the necessary solution (and they either did so in their first trials or never). Here we compared success levels in baseline tests with two experimental conditions that followed: 1) A full model condition to test whether social demonstrations would be effective, and 2) A social emulation control condition, in which a human experimenter poured water from a bottle into the tube, to test whether results information alone (present in both experimental conditions) would also induce successes. Crucially, we controlled for social factors in both experimental conditions. Both types of demonstrations significantly increased successful spitting, with no differences between demonstration types. We also found that younger subjects were more likely to succeed than older ones. Our analysis showed that mere order effects could not explain our results. Conclusion: The full demonstration condition (which potentially offers additional information to observers, in the form of actions), induced no more successes than the emulation condition. Hence, emulation learning could explain the success in both conditions. This finding has broad implications for the interpretation of chimpanzee traditions, for which emulation learning may perhaps suffice.	[Tennie, Claudio; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Max Planck Society	Tennie, C (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	tennie@eva.mpg.de		Tennie, Claudio/0000-0002-5302-4925; Call Balaguer, Josep/0000-0002-8597-8336				Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Caldwell CA, 2008, PHILOS T R SOC B, V363, P3529, DOI 10.1098/rstb.2008.0133; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Call J, 2002, FROM ANIM ANIMAT, P211; CALL J, 2005, INTERACTION STUDIES, V6, P413; Carpenter M, 2002, DEVELOPMENTAL SCI, V5, P22, DOI 10.1111/1467-7687.00199; Custance D, 1999, J COMP PSYCHOL, V113, P13, DOI 10.1037/0735-7036.113.1.13; Dai B., 2008, IME4 LINEAR MIXED EF; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DEWAAL FBM, APE SUSHI MASTER CUL, P448; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; FARAWAY JJ, EXTENDING LINEAR MOD; Galef BG, 2009, QUESTION ANIMAL CULT, P222; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; HANUS D, COMPARING PERF UNPUB; Hopper LM, 2008, P ROY SOC B-BIOL SCI, V275, P835, DOI 10.1098/rspb.2007.1542; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Horne PJ, 2009, BRIT J DEV PSYCHOL, V27, P269, DOI 10.1348/026151008X297126; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huang CT, 2005, J EXP CHILD PSYCHOL, V92, P276, DOI 10.1016/j.jecp.2005.06.003; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; Lonsdorf EV, 2009, ANIM BEHAV, V77, P1119, DOI 10.1016/j.anbehav.2009.01.020; Marshall-Pescini S, 2008, J COMP PSYCHOL, V122, P186, DOI 10.1037/0735-7036.122.2.186; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; R Core Team, 2018, R LANG ENV STAT COMP; Richerson PJ., 2005, NOT GENES ALONE CULT; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Stoinski TS, 2001, J COMP PSYCHOL, V115, P272, DOI 10.1037//0735-7036.115.3.272; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Tennie C, 2009, ANIM SCI ISSUES PROF, P95; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Thorpe, 1963, LEARNING INSTINCT AN; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; TOMASELLO M, 1990, ANGUAGE INTELLIGENCE, P274; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; VISALBERGHI E, 1987, FOLIA PRIMATOL, V49, P168, DOI 10.1159/000156320; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 1998, J COMP PSYCHOL, V112, P270, DOI 10.1037/0735-7036.112.3.270; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	53	64	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10544	10.1371/journal.pone.0010544	http://dx.doi.org/10.1371/journal.pone.0010544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485684	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563400002
J	Xia, A; Sharakhova, MV; Leman, SC; Tu, ZJ; Bailey, JA; Smith, CD; Sharakhov, IV				Xia, Ai; Sharakhova, Maria V.; Leman, Scotland C.; Tu, Zhijian; Bailey, Jeffrey A.; Smith, Christopher D.; Sharakhov, Igor V.			Genome Landscape and Evolutionary Plasticity of Chromosomes in Malaria Mosquitoes	PLOS ONE			English	Article							VECTOR ANOPHELES-FUNESTUS; TRANSPOSABLE ELEMENT; DROSOPHILA-MELANOGASTER; SEGMENTAL DUPLICATIONS; GAMBIAE COMPLEX; SPECIES COMPLEX; NUCLEAR LAMINS; GENE ONTOLOGY; INVERSION 2LA; SPECIATION	Background: Nonrandom distribution of rearrangements is a common feature of eukaryotic chromosomes that is not well understood in terms of genome organization and evolution. In the major African malaria vector Anopheles gambiae, polymorphic inversions are highly nonuniformly distributed among five chromosomal arms and are associated with epidemiologically important adaptations. However, it is not clear whether the genomic content of the chromosomal arms is associated with inversion polymorphism and fixation rates. Methodology/Principal Findings: To better understand the evolutionary dynamics of chromosomal inversions, we created a physical map for an Asian malaria mosquito, Anopheles stephensi, and compared it with the genome of An. gambiae. We also developed and deployed novel Bayesian statistical models to analyze genome landscapes in individual chromosomal arms An. gambiae. Here, we demonstrate that, despite the paucity of inversion polymorphisms on the X chromosome, this chromosome has the fastest rate of inversion fixation and the highest density of transposable elements, simple DNA repeats, and GC content. The highly polymorphic and rapidly evolving autosomal 2R arm had overrepresentation of genes involved in cellular response to stress supporting the role of natural selection in maintaining adaptive polymorphic inversions. In addition, the 2R arm had the highest density of regions involved in segmental duplications that clustered in the breakpoint-rich zone of the arm. In contrast, the slower evolving 2L, 3R, and 3L, arms were enriched with matrix-attachment regions that potentially contribute to chromosome stability in the cell nucleus. Conclusions/Significance: These results highlight fundamental differences in evolutionary dynamics of the sex chromosome and autosomes and revealed the strong association between characteristics of the genome landscape and rates of chromosomal evolution. We conclude that a unique combination of various classes of genes and repetitive DNA in each arm, rather than a single type of repetitive element, is likely responsible for arm-specific rates of rearrangements.	[Xia, Ai; Sharakhova, Maria V.; Sharakhov, Igor V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Leman, Scotland C.] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Div Transfus Med, Dept Med, Worcester, MA 01605 USA; [Smith, Christopher D.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Smith, Christopher D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Xia, A (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu	Sharakhov, Igor/B-1972-2008	Sharakhov, Igor/0000-0003-0752-3747	National Institutes of Health [1R21AI081023-01, 5R01HG000747-14]; Virginia Tech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 1R21AI081023-01 and startup funds from Virginia Tech ( to I.V.S) and NIH 5R01HG000747-14 (to C.D.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulard S, 2004, HEREDITY, V92, P151, DOI 10.1038/sj.hdy.6800375; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baricheva EA, 1996, GENE, V171, P171, DOI 10.1016/0378-1119(96)00002-9; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 1997, EVOLUTION, V51, P1149, DOI 10.1111/j.1558-5646.1997.tb03962.x; Cassone BJ, 2008, MOL ECOL, V17, P2491, DOI 10.1111/j.1365-294X.2008.03774.x; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1973, Parassitologia (Rome), V15, P129; Cornel AJ, 2000, J HERED, V91, P364, DOI 10.1093/jhered/91.5.364; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Costantini C., 1999, Parassitologia (Rome), V41, P595; Coulibaly MB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000849; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DELGADO CLR, 2009, CHROMOSOME RES; DEVI KG, 1992, J CYTOL GENET, V27, P153; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Fisher AM, 2005, GENE CHROMOSOME CANC, V43, P383, DOI 10.1002/gcc.20196; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602.ArticlepublishedonlinebeforeprintinJanuary2002; Goidts V, 2004, HUM GENET, V115, P116, DOI 10.1007/s00439-004-1120-z; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Gonzalez J, 2002, GENETICS, V161, P1137; Gordon L, 2007, GENOME RES, V17, P1603, DOI 10.1101/gr.6775107; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; GREEN CA, 1980, GENETICA, V51, P187, DOI 10.1007/BF00121610; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; KITZMILLER J B, 1977, Mosquito Systematics, V9, P112; Krimbas Costas B., 1992, P1; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; LYTTLE TW, 1992, GENETICA, V86, P113, DOI 10.1007/BF00133715; Machado CA, 2007, GENETICS, V175, P1289, DOI 10.1534/genetics.106.064758; MAHMOOD F, 1984, CAN J GENET CYTOL, V26, P538, DOI 10.1139/g84-086; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Mathiopoulos KD, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P119; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sharakhov I, 2004, J HERED, V95, P29, DOI 10.1093/jhered/esh011; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2006, J MED ENTOMOL, V43, P861, DOI 10.1603/0022-2585(2006)43[861:ASCPFT]2.0.CO;2; Slotman M, 2005, EVOLUTION, V59, P1016, DOI 10.1111/j.0014-3820.2005.tb01040.x; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Subbarao Sarala K., 1996, Proceedings of the National Academy of Sciences India Section B (Biological Sciences), V66, P51; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	69	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10592	10.1371/journal.pone.0010592	http://dx.doi.org/10.1371/journal.pone.0010592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485676	gold, Green Submitted, Green Published			2022-12-27	WOS:000277563400006
J	Ji, JB; Braam, J				Ji, Jiabing; Braam, Janet			Restriction Site Extension PCR: A Novel Method for High-Throughput Characterization of Tagged DNA Fragments and Genome Walking	PLOS ONE			English	Article							LIGATION-MEDIATED PCR; POLYMERASE CHAIN-REACTION; FLANKING DNA; T-DNA; ARABIDOPSIS; AMPLIFICATION; SEQUENCES; INSERTION; CLONING	Background: Insertion mutant isolation and characterization are extremely valuable for linking genes to physiological function. Once an insertion mutant phenotype is identified, the challenge is to isolate the responsible gene. Multiple strategies have been employed to isolate unknown genomic DNA that flanks mutagenic insertions, however, all these methods suffer from limitations due to inefficient ligation steps, inclusion of restriction sites within the target DNA, and nonspecific product generation. These limitations become close to insurmountable when the goal is to identify insertion sites in a high throughput manner. Methodology/Principal Findings: We designed a novel strategy called Restriction Site Extension PCR (RSE-PCR) to efficiently conduct large-scale isolation of unknown genomic DNA fragments linked to DNA insertions. The strategy is a modified adaptor-mediated PCR without ligation. An adapter, with complementarity to the 3' overhang of the endonuclease (KpnI, NsiI, PstI, or SacI) restricted DNA fragments, extends the 3' end of the DNA fragments in the first cycle of the primary RSE-PCR. During subsequent PCR cycles and a second semi-nested PCR (secondary RSE-PCR), touchdown and two-step PCR are combined to increase the amplification specificity of target fragments. The efficiency and specificity was demonstrated in our characterization of 37 tex mutants of Arabidopsis. All the steps of RSE-PCR can be executed in a 96 well PCR plate. Finally, RSE-PCR serves as a successful alternative to Genome Walker as demonstrated by gene isolation from maize, a plant with a more complex genome than Arabidopsis. Conclusions/Significance: RSE-PCR has high potential application in identifying tagged (T-DNA or transposon) sequence or walking from known DNA toward unknown regions in large-genome plants, with likely application in other organisms as well.	[Ji, Jiabing; Braam, Janet] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Ji, JB (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	ji6@purdue.edu; braam@rice.edu	Braam, Janet/B-3549-2009		National Science Foundation [0313432, MCB 0817976]; Div Of Molecular and Cellular Bioscience [0817976] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation grants # 0313432 and MCB 0817976 to Janet Braam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 1991, PCR Methods Appl, V1, P39; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; Dai SM, 2000, NAT BIOTECHNOL, V18, P1108, DOI 10.1038/80323; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; JONES DH, 1992, NUCLEIC ACIDS RES, V20, P595, DOI 10.1093/nar/20.3.595; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Krysan Patrick J., 2002, OMICS A Journal of Integrative Biology, V6, P163, DOI 10.1089/153623102760092760; Levano-Garcia J, 2005, BIOTECHNIQUES, V38, P225, DOI 10.2144/05382ST03; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Nardmann J, 2004, DEVELOPMENT, V131, P2827, DOI 10.1242/dev.01164; OCHMAN H, 1988, GENETICS, V120, P621; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; RICH JJ, 1990, NUCLEIC ACIDS RES, V18, P6673, DOI 10.1093/nar/18.22.6673; RILEY J, 1990, NUCLEIC ACIDS RES, V19, P5395; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Spertini D, 1999, BIOTECHNIQUES, V27, P308, DOI 10.2144/99272st01; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UPCROFT P, 1993, NUCLEIC ACIDS RES, V21, P4854, DOI 10.1093/nar/21.20.4854; WARSHAWSKY D, 1994, BIOTECHNIQUES, V16, P792; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; ZAMBRYSKI P, 1988, ANNU REV GENET, V22, P1, DOI 10.1146/annurev.ge.22.120188.000245	26	32	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10577	10.1371/journal.pone.0010577	http://dx.doi.org/10.1371/journal.pone.0010577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485508	Green Published, gold			2022-12-27	WOS:000277563200012
J	Lou, JJW; Chua, YL; Chew, EH; Gao, J; Bushell, M; Hagen, T				Lou, Jessica Jie Wei; Chua, Yee Liu; Chew, Eng Hui; Gao, Jie; Bushell, Martin; Hagen, Thilo			Inhibition of Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) Protein Synthesis by DNA Damage Inducing Agents	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; FACTOR 1-ALPHA; E-CADHERIN; FACTOR EXPRESSION; DOWN-REGULATION; PATHWAY; TRANSCRIPTION; TRANSLATION; ACTIVATION	Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that is composed of a hypoxia-inducible alpha subunit (HIF-1 alpha and HIF-2 alpha) and a constitutively expressed beta subunit (HIF-1 beta). HIF mediates the adaptation of cells and tissues to low oxygen concentrations. It also plays an important role in tumorigenesis and constitutes an important therapeutic target in anti-tumor therapy. We have screened a number of reported HIF inhibitors for their effects on HIF-transcriptional activity and found that the DNA damage inducing agents camptothecin and mitomycin C produced the most robust effects. Camptothecin is a reported inhibitor of HIF-1 alpha translation, while mitomycin C has been reported to induce p53-dependent HIF-1 alpha degradation. In this study we demonstrate that the inhibitory effect of mitomycin C on HIF-1 alpha protein expression is not dependent on p53 and protein degradation, but also involves HIF-1 alpha translational regulation. Initiation of a DNA damage response with the small molecule p53 activator NSC-652287 (RITA) has been reported to inhibit HIF-1 alpha protein synthesis by increasing the phosphorylation of eIF2 alpha. However, we show here that even when eIF2 alpha phosphorylation is prevented, the DNA damage inducing drugs mitomycin C, camptothecin and NSC-652287 still inhibit HIF-1 alpha protein synthesis to the same extent. The inhibitory effects of camptothecin on HIF-1 alpha expression but not that of mitomycin C and NSC-652287 were dependent on cyclin-dependent kinase activity. In conclusion, specific types of DNA damage can bring about selective inhibition of HIF-1 alpha protein synthesis. Further characterization of the involved mechanisms may reveal important novel therapeutic targets.	[Lou, Jessica Jie Wei; Chua, Yee Liu; Chew, Eng Hui; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Gao, Jie; Bushell, Martin] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	National University of Singapore; University of Nottingham	Lou, JJW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Office of the Deputy President (Research & Technology) of the National University of Singapore; University of Nottingham Biomedical Research Committee	Office of the Deputy President (Research & Technology) of the National University of Singapore; University of Nottingham Biomedical Research Committee	The work was supported through Cross-Faculty Research Grant funding from the Office of the Deputy President (Research & Technology) of the National University of Singapore and funding from the University of Nottingham Biomedical Research Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranello L, 2010, NUCLEIC ACIDS RES, V38, P159, DOI 10.1093/nar/gkp817; Blum R, 2005, CANCER RES, V65, P999; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jin X, 2008, EUR J PHARMACOL, V592, P41, DOI 10.1016/j.ejphar.2008.06.104; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Moynahan ME, 2001, CANCER RES, V61, P4842; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Rapisarda A, 2004, CANCER RES, V64, P1475, DOI 10.1158/0008-5472.CAN-03-3139; Rapisarda A, 2002, CANCER RES, V62, P4316; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; STEEGENGA WT, 1995, VIROLOGY, V212, P543, DOI 10.1006/viro.1995.1512; Steegenga WT, 1996, MOL CELL BIOL, V16, P2101; Tan C, 2005, CANCER RES, V65, P605; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Xue ZH, 2005, BIOCHEM BIOPH RES CO, V332, P1140, DOI 10.1016/j.bbrc.2005.05.066; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	45	44	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10522	10.1371/journal.pone.0010522	http://dx.doi.org/10.1371/journal.pone.0010522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479887	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000277467800007
J	Danilov, SM; Kalinin, S; Chen, ZL; Vinokour, EI; Nesterovitch, AB; Schwartz, DE; Gribouval, O; Gubler, MC; Minshall, RD				Danilov, Sergei M.; Kalinin, Sergey; Chen, Zhenlong; Vinokour, Elena I.; Nesterovitch, Andrew B.; Schwartz, David E.; Gribouval, Olivier; Gubler, Marie-Claire; Minshall, Richard D.			Angiotensin I-Converting Enzyme Gln1069Arg Mutation Impairs Trafficking to the Cell Surface Resulting in Selective Denaturation of the C-Domain	PLOS ONE			English	Article							RENAL TUBULAR DYSGENESIS; ACE-DEFICIENT MICE; 2 ACTIVE-SITES; MONOCLONAL-ANTIBODIES; N-DOMAIN; CRYSTAL-STRUCTURE; KININASE-II; HUMAN BLOOD; INHIBITORS; DISEASE	Background: Angiotensin-converting enzyme (ACE; Kininase II; CD143) hydrolyzes small peptides such as angiotensin I, bradykinin, substance P, LH-RH and several others and thus plays a key role in blood pressure regulation and vascular remodeling. Complete absence of ACE in humans leads to renal tubular dysgenesis (RTD), a severe disorder of renal tubule development characterized by persistent fetal anuria and perinatal death. Methodology/Principal Findings: Patient with RTD in Lisbon, Portugal, maintained by peritoneal dialysis since birth, was found to have a homozygous substitution of Arg for Glu at position 1069 in the C-terminal domain of ACE (Q1069R) resulting in absence of plasma ACE activity; both parents and a brother who are heterozygous carriers of this mutation had exactly half-normal plasma ACE activity compared to healthy individuals. We hypothesized that the Q1069R substitution impaired ACE trafficking to the cell surface and led to accumulation of catalytically inactive ACE in the cell cytoplasm. CHO cells expressing wild-type (WT) vs. Q1069R-ACE demonstrated the mutant accumulates intracellularly and also that it is significantly degraded by intracellular proteases. Q1069R-ACE retained catalytic and immunological characteristics of WT-ACE N domain whereas it had 10-20% of the nativity of the WT-ACE C domain. A combination of chemical (sodium butyrate) or pharmacological (ACE inhibitor) chaperones with proteasome inhibitors (MG 132 or bortezomib) significantly restored trafficking of Q1069R-ACE to the cell surface and increased ACE activity in the cell culture media 4-fold. Conclusions/Significance: Homozygous Q1069R substitution results in an ACE trafficking and processing defect which can be rescued, at least in cell culture, by a combination of chaperones and proteasome inhibitors. Further studies are required to determine whether similar treatment of individuals with this ACE mutation would provide therapeutic benefits such as concentration of primary urine.	[Danilov, Sergei M.; Kalinin, Sergey; Vinokour, Elena I.; Nesterovitch, Andrew B.; Schwartz, David E.; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA; [Chen, Zhenlong; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Gribouval, Olivier; Gubler, Marie-Claire] Univ Paris 05, INSERM, Hop Necker Enfants Malad, U574, Paris, France; [Danilov, Sergei M.] Natl Cardiol Res Ctr, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Medical Research Center of Cardiology	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA.	danilov@uic.edu	Gribouval, Olivier/A-7689-2015; Chen, Zhenlong/AAQ-9578-2021	Gribouval, Olivier/0000-0003-0238-8224; Gubler, Marie-Claire/0000-0002-3526-5661	Department of Anesthesiology, University of Illinois at Chicago	Department of Anesthesiology, University of Illinois at Chicago	This work was supported by the Department of Anesthesiology, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2005, TISSUE ANTIGENS, V65, P240, DOI 10.1111/j.1399-0039.2005.00364.x; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Balyasnikova IV, 1998, IN VITRO CELL DEV-AN, V34, P545; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; Bernstein KE, 1998, NEPHROL DIAL TRANSPL, V13, P2991, DOI 10.1093/ndt/13.12.2991; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Deddish PA, 1996, J PHARMACOL EXP THER, V279, P1582; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; Ehlers M R, 1991, Protein Expr Purif, V2, P1, DOI 10.1016/1046-5928(91)90001-Y; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Georgiadis D, 2003, CIRC RES, V93, P148, DOI 10.1161/01.RES.0000081593.33848.FC; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; IWATA K, 1983, ARCH BIOCHEM BIOPHYS, V227, P188, DOI 10.1016/0003-9861(83)90362-4; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kishimoto, 1997, LEUCOCYTE TYPING, P746; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lacoste M, 2006, J AM SOC NEPHROL, V17, P2253, DOI 10.1681/ASN.2005121303; Marcic B, 2000, HYPERTENSION, V36, P116, DOI 10.1161/01.HYP.36.1.116-a; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Montgomery H, 2002, EUR HEART J, V23, P1083, DOI 10.1053/euhj.2001.2980; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; NONOTTE I, 1995, REGUL PEPTIDES, V59, P379, DOI 10.1016/0167-0115(95)00090-X; O'Neill HG, 2008, BIOL CHEM, V389, P1153, DOI 10.1515/BC.2008.131; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SKIDGEL RA, 1993, RENIN ANGIOTENSIN SY; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; Skirgello OE, 2005, BIOCHEM J, V391, P641, DOI 10.1042/BJ20050702; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; SOLOMON B, 1995, J MOL RECOGNIT, V8, P72, DOI 10.1002/jmr.300080113; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; Sturrock ED, 1996, BIOCHEMISTRY-US, V35, P9560, DOI 10.1021/bi960243x; Traynor T, 1999, AM J PHYSIOL-RENAL, V276, pF751, DOI 10.1152/ajprenal.1999.276.5.F751; Uematsu M, 2009, EUR J PEDIATR, V168, P207, DOI 10.1007/s00431-008-0743-9; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Voronov S, 2002, FEBS LETT, V522, P77, DOI 10.1016/S0014-5793(02)02888-0; Watermeyer JM, 2008, BIOCHEMISTRY-US, V47, P5942, DOI 10.1021/bi8002605; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1991, J BIOL CHEM, V266, P9002; Williams TA, 1996, BIOCHEM PHARMACOL, V51, P11, DOI 10.1016/0006-2952(95)02125-6; Woodman ZL, 2006, BIOL CHEM, V387, P1043, DOI 10.1515/BC.2006.129	75	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10438	10.1371/journal.pone.0010438	http://dx.doi.org/10.1371/journal.pone.0010438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454656	Green Published, gold			2022-12-27	WOS:000277240300014
J	Lind, EM; Parker, JD				Lind, Eric M.; Parker, John D.			Novel Weapons Testing: Are Invasive Plants More Chemically Defended than Native Plants?	PLOS ONE			English	Article							INCREASED COMPETITIVE ABILITY; ENEMY RELEASE HYPOTHESIS; BIOTIC RESISTANCE; NATURAL ENEMIES; GROWTH-RATE; LEAF-AREA; HERBIVORES; EVOLUTION; TRAITS; SUCCESS	Background: Exotic species have been hypothesized to successfully invade new habitats by virtue of possessing novel biochemistry that repels native enemies. Despite the pivotal long-term consequences of invasion for native food-webs, to date there are no experimental studies examining directly whether exotic plants are any more or less biochemically deterrent than native plants to native herbivores. Methodology/Principal Findings: In a direct test of this hypothesis using herbivore feeding assays with chemical extracts from 19 invasive plants and 21 co-occurring native plants, we show that invasive plant biochemistry is no more deterrent (on average) to a native generalist herbivore than extracts from native plants. There was no relationship between extract deterrence and length of time since introduction, suggesting that time has not mitigated putative biochemical novelty. Moreover, the least deterrent plant extracts were from the most abundant species in the field, a pattern that held for both native and exotic plants. Analysis of chemical deterrence in context with morphological defenses and growth-related traits showed that native and exotic plants had similar trade-offs among traits. Conclusions/Significance: Overall, our results suggest that particular invasive species may possess deterrent secondary chemistry, but it does not appear to be a general pattern resulting from evolutionary mismatches between exotic plants and native herbivores. Thus, fundamentally similar processes may promote the ecological success of both native and exotic species.	[Lind, Eric M.; Parker, John D.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Lind, EM (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	linde@si.edu	Parker, John D/F-9761-2010	Parker, John D/0000-0002-3632-7625; Lind, Eric/0000-0003-3051-7724	Earthwatch Institute/HSBC Climate Partnership; George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds	Earthwatch Institute/HSBC Climate Partnership; George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds	Discussions with colleagues in the Global Invasions Network (NSF RCN DEB-0541673) inspired portions of this work. J.P.'s research on forest invasions is funded by the Earthwatch Institute/HSBC Climate Partnership, and the George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds to the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Craine JM, 2003, OECOLOGIA, V134, P471, DOI 10.1007/s00442-002-1155-6; Daehler CC, 1997, OECOLOGIA, V110, P99, DOI 10.1007/s004420050138; Davis M. A., 2009, INVASION BIOL; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Frankfater C, 2005, J CHEM ECOL, V31, P2541, DOI 10.1007/s10886-005-7612-z; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; HAY M. E., 1998, METHODS CHEM ECOLOGY, V2, P39; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Higman D, 1968, ECOLOGICALLY ANNOTAT; HOKKANEN HMT, 1989, CAN ENTOMOL, V121, P829, DOI 10.4039/Ent121829-10; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; Lee KP, 2002, J INSECT PHYSIOL, V48, P655, DOI 10.1016/S0022-1910(02)00088-4; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; Li Jianhua, 2006, Harvard Papers in Botany, V11, P101, DOI 10.3100/1043-4534(2006)11[101:POAASB]2.0.CO;2; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Martin JM, 1999, J NAT PROD, V62, P2, DOI 10.1021/np980308s; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; PARKER JD, BIOL INVASI IN PRESS; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; R Core Team, 2020, R LANG ENV STAT COMP; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Rosenthal GA., 1992, HERBIVORES THEIR INT; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Wagner D.L, 2005, CATERPILLARS E N AM, DOI [DOI 10.1515/9781400834143, DOI 10.1515/9781400838295], Patent No. [2203.04766, 220304766]; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452	60	48	48	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10429	10.1371/journal.pone.0010429	http://dx.doi.org/10.1371/journal.pone.0010429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454658	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300007
J	Lindshield, BL; Ford, NA; Canene-Adams, K; Diamond, AM; Wallig, MA; Erdman, JW				Lindshield, Brian L.; Ford, Nikki A.; Canene-Adams, Kirstie; Diamond, Alan M.; Wallig, Matthew A.; Erdman, John W., Jr.			Selenium, but Not Lycopene or Vitamin E, Decreases Growth of Transplantable Dunning R3327-H Rat Prostate Tumors	PLOS ONE			English	Article							GAMMA-TOCOPHEROL; ANDROGEN-RECEPTOR; CANCER PREVENTION; METHYLSELENINIC ACID; ALPHA-TOCOPHEROL; GENE-EXPRESSION; DOWN-REGULATION; MAMMARY-CANCER; ANTIOXIDANT SUPPLEMENTATION; ANTIGEN-EXPRESSION	Background: Lycopene, selenium, and vitamin E are three micronutrients commonly consumed and supplemented by men diagnosed with prostate cancer. However, it is not clear whether consumption of these compounds, alone or in combination, results in improved outcomes. Methodology/Principal Findings: We evaluated the effects of dietary lycopene (250 mg/kg diet), selenium (methylselenocysteine, 1 mg/kg diet), and vitamin E (gamma-tocopherol, 200 mg/kg diet) alone and in combination on the growth of androgen-dependent Dunning R3327-H rat prostate adenocarcinomas in male, Copenhagen rats. AIN-93G diets containing these micronutrients were prefed for 4 to 6 weeks prior to tumor implantation by subcutaneous injection. Tumors were allowed to grow for similar to 18 weeks. Across diet groups, methylselenocysteine consumption decreased final tumor area (P = 0.003), tumor weight (P = 0.003), and the tumor weight/body weight ratio (P = 0.003), but lycopene and gamma-tocopherol consumption intake did not alter any of these measures. There were no significant interactions among nutrient combinations on tumor growth. Methylselenocysteine consumption also led to small, but significant decreases in body weight (P = 0.007), food intake (P = 0.012), and body weight gain/food intake ratio (P = 0.022). However, neither body weight nor gain/food intake ratio was correlated with tumor weight. Methylselenocysteine, lycopene, and gamma-tocopherol consumed alone and in combination did not alter serum testosterone or dihydrotestosterone concentrations; tumor proliferation or apoptosis rates. In addition, the diets also did not alter tumor or prostate androgen receptor, probasin, selenoprotein 15, selenoprotein P, or selenium binding protein 2 mRNA expression. However, using castration and finasteride-treated tissues from a previous study, we found that androgen ablation altered expression of these selenium-associated proteins. Conclusions: Of the three micronutrients tested, only methylselenocysteine consumption reduced growth of transplantable Dunning R3327-H prostate tumors, albeit through an unresolved mechanism.	[Lindshield, Brian L.; Ford, Nikki A.; Canene-Adams, Kirstie; Diamond, Alan M.; Wallig, Matthew A.; Erdman, John W., Jr.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Erdman, John W., Jr.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Wallig, Matthew A.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Diamond, Alan M.] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lindshield, BL (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	jwerdman@illinois.edu	Ford, Nikki/G-7157-2011	Canene-Adams, Kirstie/0000-0003-4617-448X	American Institute for Cancer Research [05A021]; College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign	American Institute for Cancer Research; College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign	Supported in part by American Institute for Cancer Research (http://www.aicr.org/site/PageServer) Grant 05A021 and Jonathan Baldwin Turner Fellowships (to B.L.L and K.C-A) from the College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2022, CANC FACTS FIGURES 2; BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071; Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Block KI, 2009, INTEGR CANCER THER, V8, P5, DOI 10.1177/1534735409332380; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Boileau TWM, 2001, J NUTR, V131, P1746, DOI 10.1093/jn/131.6.1746; Boileau TWM, 2000, J NUTR, V130, P1613, DOI 10.1093/jn/130.6.1613; Boon H, 2003, UROLOGY, V62, P849, DOI 10.1016/S0090-4295(03)00668-X; Bosland MC, 2009, JAMA-J AM MED ASSOC, V301, P1877, DOI 10.1001/jama.2009.628; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Calvo A, 2002, CANCER RES, V62, P5325; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; Cheetham PJ, 2001, PROSTATE CANCER P D, V4, P235, DOI 10.1038/sj.pcan.4500536; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cho SD, 2004, MOL CANCER THER, V3, P605; Chun JY, 2006, MOL CANCER THER, V5, P913, DOI 10.1158/1535-7163.MCT-05-0389; Clement M, 1997, BBA-GEN SUBJECTS, V1334, P173, DOI 10.1016/S0304-4165(96)00090-6; CLINTON SK, 1988, J NUTR, V118, P908, DOI 10.1093/jn/118.7.908; Cohen J., 1983, APPL MULTIPLE REGRES; Corcoran NM, 2004, J UROLOGY, V171, P907, DOI 10.1097/01.ju.0000092859.16817.8e; COUNCIL NR, 1995, ANONYMOUS NUTR REQUI, P11; Craft NE, 2004, FASEB J, V18, pA534; Davis CD, 2002, J NUTR, V132, P307, DOI 10.1093/jn/132.2.307; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; El-Bayoumy K, 2009, NUTR CANCER, V61, P285, DOI 10.1080/01635580902892829; Finley JW, 2001, BIOFACTORS, V14, P191, DOI 10.1002/biof.5520140124; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; Fleshner N, 1999, J UROLOGY, V161, P1651, DOI 10.1016/S0022-5347(05)68998-7; Galli F, 2004, ARCH BIOCHEM BIOPHYS, V423, P97, DOI 10.1016/j.abb.2003.11.014; Gann PH, 2009, JAMA-J AM MED ASSOC, V301, P102, DOI 10.1001/jama.2008.863; Gann PH, 2003, JNCI-J NATL CANCER I, V95, P1563, DOI 10.1093/jnci/djg112; Gysin R, 2002, FASEB J, V16, P1952, DOI 10.1096/fj.02-0362fje; Helzlsouer KJ, 2000, J NATL CANCER I, V92, P2018, DOI 10.1093/jnci/92.24.2018; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Husbeck B, 2006, MOL CANCER THER, V5, P2078, DOI 10.1158/1535-7163.MCT-06-0056; IP C, 1995, CARCINOGENESIS, V16, P2649, DOI 10.1093/carcin/16.11.2649; IP C, 1992, NUTR CANCER, V17, P279, DOI 10.1080/01635589209514197; IP C, 1994, CARCINOGENESIS, V15, P1881, DOI 10.1093/carcin/15.9.1881; Ip C, 1996, CARCINOGENESIS, V17, P1979, DOI 10.1093/carcin/17.9.1979; Ip C, 2000, J AGR FOOD CHEM, V48, P2062, DOI 10.1021/jf000051f; Ip C, 1999, ANTICANCER RES, V19, P2875; IP C, 1992, CARCINOGENESIS, V13, P1167, DOI 10.1093/carcin/13.7.1167; Ip C, 2000, CANCER RES, V60, P2882; IP C, 1991, CANCER RES, V51, P595; IP C, 1994, CARCINOGENESIS, V15, P573, DOI 10.1093/carcin/15.4.573; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Ishida T, 2002, J HEALTH SCI, V48, P62, DOI 10.1248/jhs.48.62; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kasper S, 2000, BBA-PROTEIN STRUCT M, V1482, P249, DOI 10.1016/S0167-4838(00)00170-9; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335; Lee SO, 2006, PROSTATE, V66, P1070, DOI 10.1002/pros.20329; Legg RL, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-57; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li L, 2005, J BIOCHEM MOL TOXIC, V19, P396, DOI 10.1002/jbt.20105; Limpens J, 2006, J NUTR, V136, P1287, DOI 10.1093/jn/136.5.1287; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahn AV, 2009, J NUTR BIOCHEM, V20, P791, DOI 10.1016/j.jnutbio.2008.07.008; Mahn AV, 2009, BIOL RES, V42, P163, DOI [10.4067/S0716-97602009000200004, /S0716-97602009000200004]; Marshall JR, 2006, CANCER EPIDEM BIOMAR, V15, P1479, DOI 10.1158/1055-9965.EPI-05-0585; MCCORMICK D, 2010, CANC PREVENTION RES; McCormick DL, 1999, EUR UROL, V35, P464, DOI 10.1159/000019880; MCKOWN DM, 1978, J RADIOANAL CHEM, V43, P411, DOI 10.1007/BF02519502; Medina D, 2001, NUTR CANCER, V40, P12, DOI 10.1207/S15327914NC401_5; Morris JDH, 2006, CANCER LETT, V239, P111, DOI 10.1016/j.canlet.2005.07.037; Narayanan A, 1996, EXACT METHODS NPAR1W; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Pinto JT, 2007, INT J CANCER, V120, P1410, DOI 10.1002/ijc.22500; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Sambrook J., 2001, MOL CLONING LAB MANU; SAMUELS BL, 1991, CANCER RES, V51, P521; Siler U, 2004, FASEB J, V18, P1019, DOI 10.1096/fj.03-1116fje; Takahashi S, 2009, PROSTATE, V69, P644, DOI 10.1002/pros.20915; Takahashi Y, 2006, MOL CARCINOGEN, V45, P18, DOI 10.1002/mc.20153; Tang LL, 2005, J NUTR, V135, P287, DOI 10.1093/jn/135.2.287; Tennant TR, 2000, PROSTATE, V43, P295, DOI 10.1002/1097-0045(20000601)43:4<295::AID-PROS9>3.0.CO;2-W; Unni E, 2004, BREAST CANCER RES, V6, pR586, DOI 10.1186/bcr914; VATASSERY GT, 1993, ANAL BIOCHEM, V214, P426, DOI 10.1006/abio.1993.1518; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Venkateswaran V, 2004, CANCER RES, V64, P5891, DOI 10.1158/0008-5472.CAN-04-0690; Venkateswaran V, 2004, PROSTATE CANCER P D, V7, P54, DOI 10.1038/sj.pcan.4500707; Venkateswaran V, 2009, CANCER PREV RES, V2, P473, DOI 10.1158/1940-6207.CAPR-08-0124; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; WEIGEL RM, 1991, CONTROL CLIN TRIALS, V12, P378, DOI 10.1016/0197-2456(91)90018-H; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; Yang MH, 1998, CANCER RES, V58, P3150; Zhang X, 2008, CANCER PREV RES, V1, P119, DOI 10.1158/1940-6207.CAPR-08-0036; Zhao HJ, 2004, MOL BIOL CELL, V15, P506, DOI 10.1091/mbc.E03-07-0501; Zu K, 2003, CANCER RES, V63, P6988	100	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10423	10.1371/journal.pone.0010423	http://dx.doi.org/10.1371/journal.pone.0010423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454690	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100027
J	Beenken, KE; Mrak, LN; Griffin, LM; Zielinska, AK; Shaw, LN; Rice, KC; Horswill, AR; Bayles, KW; Smeltzer, MS				Beenken, Karen E.; Mrak, Lara N.; Griffin, Linda M.; Zielinska, Agnieszka K.; Shaw, Lindsey N.; Rice, Kelly C.; Horswill, Alexander R.; Bayles, Kenneth W.; Smeltzer, Mark S.			Epistatic Relationships between sarA and agr in Staphylococcus aureus Biofilm Formation	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; IN-VITRO; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; REGULATOR; SIGMA(B); USA300	Background: The accessory gene regulator (agr) and staphylococcal accessory regulator (sarA) play opposing roles in Staphylococcus aureus biofilm formation. There is mounting evidence to suggest that these opposing roles are therapeutically relevant in that mutation of agr results in increased biofilm formation and decreased antibiotic susceptibility while mutation of sarA has the opposite effect. To the extent that induction of agr or inhibition of sarA could potentially be used to limit biofilm formation, this makes it important to understand the epistatic relationships between these two loci. Methodology/Principal Findings: We generated isogenic sarA and agr mutants in clinical isolates of S. aureus and assessed the relative impact on biofilm formation. Mutation of agr resulted in an increased capacity to forma biofilmin the 8325-4 laboratory strain RN6390 but had little impact in clinical isolates S. aureus. In contrast, mutation of sarA resulted in a reduced capacity to form a biofilm in all clinical isolates irrespective of the functional status of agr. This suggests that the regulatory role of sarA in biofilm formation is independent of the interaction between sarA and agr and that sarA is epistatic to agr in this context. This was confirmed by demonstrating that restoration of sarA function restored the ability to form a biofilm even in the corresponding agr mutants. Mutation of sarA in clinical isolates also resulted in increased production of extracellular proteases and extracellular nucleases, both of which contributed to the biofilm-deficient phenotype of sarA mutants. However, studies comparing different strains with and without proteases inhibitors and/or mutation of the nuclease genes demonstrated that the agr-independent, sarA-mediated repression of extracellular proteases plays a primary role in this regard. Conclusions and Significance: The results we report suggest that inhibitors of sarA-mediated regulation could be used to limit biofilm formation in S. aureus and that the efficacy of such inhibitors would not be limited by spontaneous mutation of agr in the human host.	[Beenken, Karen E.; Mrak, Lara N.; Griffin, Linda M.; Zielinska, Agnieszka K.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Shaw, Lindsey N.] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Rice, Kelly C.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bayles, Kenneth W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Arkansas System; University of Arkansas Medical Sciences; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; University of Iowa; University of Nebraska System; University of Nebraska Medical Center	Beenken, KE (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shaw, Lindsey/AAI-1741-2020; Smeltzer, Mark/M-2009-2018	Shaw, Lindsey/0000-0002-0629-8990; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Disease [AI43356, AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, R01AI074935, R01AI043356] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by grants AI43356 (MSS) and AI083211 (KWB, ARH) from the National Institute of Allergy and Infectious Disease. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Calhoun JH, 2005, INFECT DIS CLIN N AM, V19, P765, DOI 10.1016/j.idc.2005.07.009; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chien YT, 1998, MOL MICROBIOL, V30, P991, DOI 10.1046/j.1365-2958.1998.01126.x; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Eggimann P, 2004, MICROBES INFECT, V6, P1033, DOI 10.1016/j.micinf.2004.05.018; Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Sakoulas G, 2006, CLIN INFECT DIS, V42, pS40, DOI 10.1086/491713; Sau S, 1997, J BACTERIOL, V179, P1614, DOI 10.1128/jb.179.5.1614-1621.1997; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Sifri CD, 2007, CLIN INFECT DIS, V45, pE113, DOI 10.1086/522171; Tang JN, 2008, FEMS MICROBIOL LETT, V284, P176, DOI 10.1111/j.1574-6968.2008.01194.x; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Viale P, 2006, J CHEMOTHERAPY, V18, P235, DOI 10.1179/joc.2006.18.3.235; Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07	57	112	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10790	10.1371/journal.pone.0010790	http://dx.doi.org/10.1371/journal.pone.0010790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520723	gold, Green Submitted, Green Published			2022-12-27	WOS:000278034600016
J	Bonowski, F; Kitanovic, A; Ruoff, P; Holzwarth, J; Kitanovic, I; Bui, VN; Lederer, E; Wolfl, S				Bonowski, Felix; Kitanovic, Ana; Ruoff, Peter; Holzwarth, Jinda; Kitanovic, Igor; Bui, Van Ngoc; Lederer, Elke; Woelfl, Stefan			Computer Controlled Automated Assay for Comprehensive Studies of Enzyme Kinetic Parameters	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; PYRUVATE-KINASE; EFFICIENT; SCALE	Stability and biological activity of proteins is highly dependent on their physicochemical environment. The development of realistic models of biological systems necessitates quantitative information on the response to changes of external conditions like pH, salinity and concentrations of substrates and allosteric modulators. Changes in just a few variable parameters rapidly lead to large numbers of experimental conditions, which go beyond the experimental capacity of most research groups. We implemented a computer-aided experimenting framework ("robot lab assistant'') that allows us to parameterize abstract, human-readable descriptions of micro-plate based experiments with variable parameters and execute them on a conventional 8 channel liquid handling robot fitted with a sensitive plate reader. A set of newly developed R-packages translates the instructions into machine commands, executes them, collects the data and processes it without user-interaction. By combining script-driven experimental planning, execution and data-analysis, our system can react to experimental outcomes autonomously, allowing outcome-based iterative experimental strategies. The framework was applied in a response-surface model based iterative optimization of buffer conditions and investigation of substrate, allosteric effector, pH and salt dependent activity profiles of pyruvate kinase (PYK). A diprotic model of enzyme kinetics was used to model the combined effects of changing pH and substrate concentrations. The 8 parameters of the model could be estimated from a single two-hour experiment using nonlinear least-squares regression. The model with the estimated parameters successfully predicted pH and PEP dependence of initial reaction rates, while the PEP concentration dependent shift of optimal pH could only be reproduced with a set of manually tweaked parameters. Differences between model-predictions and experimental observations at low pH suggest additional protonation-sites at the enzyme or substrates critical for enzymatic activity. The developed framework is a powerful tool to investigate enzyme reaction specifics and explore biological system behaviour in a wide range of experimental conditions.	[Bonowski, Felix; Kitanovic, Ana; Holzwarth, Jinda; Kitanovic, Igor; Bui, Van Ngoc; Lederer, Elke; Woelfl, Stefan] Ruperto Carola Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany; [Ruoff, Peter] Univ Stavanger, Fac Sci & Technol, Ctr Organelle Res, Stavanger, Norway	Ruprecht Karls University Heidelberg; Universitetet i Stavanger	Bonowski, F (corresponding author), Ruperto Carola Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany.	wolfl@uni-hd.de		Ruoff, Peter/0000-0003-4430-0382; Bui, Van Ngoc/0000-0002-4659-7338	EU-BMBF; Federal Ministry of Education and Research (BMBF) [FKZ.01EA0509]	EU-BMBF; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the SysMO Project Network (EU-BMBF) on Systems Biology of Microorganisms (MOSES, WP 4.3, S.W. and A.K) and Federal Ministry of Education and Research (BMBF, FKZ.01EA0509, Nutrition Net, S. W. and I. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung NJ, 2008, J BIOMOL SCREEN, V13, P142, DOI 10.1177/1087057107312032; Cressie N., 2011, STAT SPATIO TEMPORAL; FLETCHER RR, 2007, PRACTICAL METHODS OP; HESS B, 1967, NATURE, V214, P848, DOI 10.1038/214848a0; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; IRVING MG, 1973, BIOCHEM J, V131, P287, DOI 10.1042/bj1310287; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jones DR, 2001, J GLOBAL OPTIM, V21, P345, DOI 10.1023/A:1012771025575; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Michaelis L, 1913, BIOCHEM Z, V49, P333; Nocedal J., 2000, NUMERICAL OPTIMIZATI; R Development Core Team, 2005, R LANG ENV STAT COMP; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Seeberger PH, 2005, NAT REV DRUG DISCOV, V4, P751, DOI 10.1038/nrd1823; Segel IH, 1975, ENZYME KINETICS BEHA; Tipton K F, 1979, Methods Enzymol, V63, P183; WALEY SG, 1953, BIOCHIM BIOPHYS ACTA, V10, P27, DOI 10.1016/0006-3002(53)90206-6; Wharton C. W., 1981, MOL ENZYMOLOGY, V1	21	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10727	10.1371/journal.pone.0010727	http://dx.doi.org/10.1371/journal.pone.0010727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502716	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400027
J	Irie, T; Nagata, N; Igarashi, T; Okamoto, I; Sakaguchi, T				Irie, Takashi; Nagata, Natsuko; Igarashi, Tomoki; Okamoto, Isao; Sakaguchi, Takemasa			Conserved Charged Amino Acids within Sendai Virus C Protein Play Multiple Roles in the Evasion of Innate Immune Responses	PLOS ONE			English	Article							VIRAL-RNA SYNTHESIS; RIG-I; ANTIVIRAL RESPONSE; STRANDED-RNA; V-PROTEINS; WILD-TYPE; EXPRESSION; ACTIVATION; INDUCTION; PROMOTER	One of the accessory proteins of Sendai virus (SeV), C, translated from an alternate reading frame of P/V mRNA has been shown to function at multiple stages of infection in cell cultures as well as in mice. C protein has been reported to counteract signal transduction by interferon (IFN), inhibit apoptosis induced by the infection, enhance the efficiency of budding of viral particles, and regulate the polarity of viral genome-length RNA synthesis to maximize production of infectious particles. In this study, we have generated a series of SeV recombinants containing substitutions of highly conserved, charged residues within the C protein, and characterized them together with previously-reported C'/C(-), 4C(-), and F170S recombinant viruses in infected cell cultures in terms of viral replication, cytopathogenicity, and antagonizing effects on host innate immunity. Unexpectedly, the amino acid substitutions had no or minimal effect on viral growth and viral RNA synthesis. However, all the substitutions of charged amino acids resulted in the loss of a counteracting effect against the establishment of an IFN-alpha-mediated anti-viral state. Infection by the virus (Cm2') containing mutations at K77 and D80 induced significant IFN-beta production, severe cytopathic effects, and detectable amounts of viral dsRNA production. In addition to the Cm2' virus, the virus containing mutations at E114 and E115 did not inhibit the poly(I:C)triggered translocation of cellular IRF-3 to the nucleus. These results suggest that the C protein play important roles in viral escape from induction of IFN-beta and cell death triggered by infection by means of counteracting the pathway leading to activation of IRF-3 as well as of minimizing viral dsRNA production.	[Irie, Takashi; Nagata, Natsuko; Igarashi, Tomoki; Okamoto, Isao; Sakaguchi, Takemasa] Hiroshima Univ, Grad Sch Biomed Sci, Dept Virol, Hiroshima, Japan	Hiroshima University	Irie, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Virol, Hiroshima, Japan.	tirie@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Grandvaux N, 2005, FEBS J, V272, P3120, DOI 10.1111/j.1742-4658.2005.04726.x; Grogan CC, 2001, VIROLOGY, V288, P96, DOI 10.1006/viro.2001.1068; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Itoh M, 1998, J VIROL, V72, P2927, DOI 10.1128/JVI.72.4.2927-2934.1998; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; Kato A, 2001, J VIROL, V75, P3802, DOI 10.1128/JVI.75.8.3802-3810.2001; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Koyama AH, 2003, MICROBES INFECT, V5, P373, DOI 10.1016/S1286-4579(03)00043-1; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997	39	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10719	10.1371/journal.pone.0010719	http://dx.doi.org/10.1371/journal.pone.0010719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502666	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400021
J	Geisbert, TW; Daddario-DiCaprio, KM; Hickey, AC; Smith, MA; Chan, YP; Wang, LF; Mattapallil, JJ; Geisbert, JB; Bossart, KN; Broder, CC				Geisbert, Thomas W.; Daddario-DiCaprio, Kathleen M.; Hickey, Andrew C.; Smith, Mark A.; Chan, Yee-Peng; Wang, Lin-Fa; Mattapallil, Joseph J.; Geisbert, Joan B.; Bossart, Katharine N.; Broder, Christopher C.			Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection	PLOS ONE			English	Article							EMERGENT DEADLY PARAMYXOVIRUS; HENDRA-VIRUS; EQUINE MORBILLIVIRUS; RECEPTOR-BINDING; SUBUNIT VACCINE; G-GLYCOPROTEIN; HAMSTER MODEL; FLYING-FOXES; PIG-FARMERS; ENCEPHALITIS	Nipah virus (NiV) is an enigmatic emerging pathogen that causes severe and often fatal neurologic and/or respiratory disease in both animals and humans. Amongst people, case fatality rates range between 40 and 75 percent and there are no vaccines or treatments approved for human use. Guinea pigs, hamsters, cats, ferrets, pigs and most recently squirrel monkeys (New World monkey) have been evaluated as animal models of human NiV infection, and with the exception of the ferret, no model recapitulates all aspects of NiV-mediated disease seen in humans. To identify a more viable nonhuman primate (NHP) model, we examined the pathogenesis of NiV in African green monkeys (AGM). Exposure of eight monkeys to NiV produced a severe systemic infection in all eight animals with seven of the animals succumbing to infection. Viral RNA was detected in the plasma of challenged animals and occurred in two of three subjects as a peak between days 7 and 21, providing the first clear demonstration of plasma-associated viremia in NiV experimentally infected animals and suggested a progressive infection that seeded multiple organs simultaneously from the initial site of virus replication. Unlike the cat, hamster and squirrel monkey models of NiV infection, severe respiratory pathology, neurological disease and generalized vasculitis all manifested in NiV-infected AGMs, providing an accurate reflection of what is observed in NiV-infected humans. Our findings demonstrate the first consistent and highly pathogenic NHP model of NiV infection, providing a new and critical platform in the evaluation and licensure of either passive and active immunization or therapeutic strategies for human use.	[Geisbert, Thomas W.; Daddario-DiCaprio, Kathleen M.; Geisbert, Joan B.; Bossart, Katharine N.] Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA; [Geisbert, Thomas W.; Bossart, Katharine N.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Hickey, Andrew C.; Smith, Mark A.; Chan, Yee-Peng; Mattapallil, Joseph J.; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA; [Smith, Mark A.] USA, Div Pathol, Med Res Inst Infect Dis, Frederick, MD USA; [Wang, Lin-Fa] Australian Commonwealth Sci & Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia	Boston University; Boston University; Boston University; Uniformed Services University of the Health Sciences - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Geisbert, TW (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA.	cbroder@usuhs.mil	wang, lin/GSE-3040-2022; Broder, Christopher/E-1169-2013	Bossart, Katharine/0000-0001-6886-6896; Mattapallil, Joseph/0000-0002-7412-9507	Department of Health and Human Services, National Institutes of Health [AI082121, AI057159, DE018339, DE019397, AI071812, AI054715, AI077995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077995, U54AI057159, R01AI054715, K22AI071812, U01AI082121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018339, R01DE019397] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by the Department of Health and Human Services, National Institutes of Health, grants AI082121 and AI057159 to TWG; DE018339, DE019397 and AI071812 to JJM, and AI054715 and AI077995 to CCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bishop Kimberly A., 2008, V8, P155; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart Katharine N, 2007, Open Virol J, V1, P14, DOI 10.2174/1874357900701010014; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Bossart KN, 2009, VIRAL ENTRY HOST CEL; BRODER CC, 2008, NEW GENERATION VACCI; Carbone KM, 2007, FIELDS VIROLOGY, P1527; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Guillaume V, 2006, J VIROL, V80, P1972, DOI 10.1128/JVI.80.4.1972-1978.2006; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harit AK, 2006, INDIAN J MED RES, V123, P553; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hooper PT, 1997, VET PATHOL, V34, P323, DOI 10.1177/030098589703400408; JAHRLING PB, 1999, MANUAL CLIN MICROBIO, P1125; Karron RA., 2007, FIELDS VIROLOGY, V5, P1497; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Marianneau P, 2010, EMERG INFECT DIS, V16, P507, DOI 10.3201/eid1603.091346; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2007, J INFECT DIS, V196, P812, DOI 10.1086/520818; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Tan Chong-Tin, 2008, Curr Infect Dis Rep, V10, P315, DOI 10.1007/s11908-008-0051-6; Westbury HA, 1996, AUST VET J, V74, P132, DOI 10.1111/j.1751-0813.1996.tb14813.x; Williamson MM, 2001, J COMP PATHOL, V124, P273, DOI 10.1053/jcpa.2001.0464; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Zhu Z, 2008, J INFECT DIS, V197, P846, DOI 10.1086/528801	48	104	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10690	10.1371/journal.pone.0010690	http://dx.doi.org/10.1371/journal.pone.0010690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502528	Green Published, Green Submitted, gold			2022-12-27	WOS:000277776500007
J	Petersen, L; Andersen, PK; Sorensen, TIA				Petersen, Liselotte; Andersen, Per Kragh; Sorensen, Thorkild I. A.			Genetic Influences on Incidence and Case-Fatality of Infectious Disease	PLOS ONE			English	Article							ADULT ADOPTEES; PREMATURE DEATH; ENVIRONMENTAL-INFLUENCES; MENINGOCOCCAL DISEASE; OTITIS-MEDIA; SUSCEPTIBILITY; HERITABILITY; ASSOCIATION; GENOMICS; TWIN	Background: Family, twin and adoption studies suggest that genetic susceptibility contributes to familial aggregation of infectious diseases or to death from infections. We estimated genetic and shared environmental influences separately on the risk of acquiring an infection (incidence) and on dying from it (case fatality). Methods: Genetic influences were estimated by the association between rates of hospitalization for infections and between case-fatality rates of adoptees and their biological full- and half-siblings. Familial environmental influences were investigated in adoptees and their adoptive siblings. Among 14,425 non-familial adoptions, granted in Denmark during the period 1924-47, we selected 1,603 adoptees, who had been hospitalized for infections and/or died with infection between 1977 and 1993. Their siblings were considered predisposed to infection, and compared with non-predisposed siblings of randomly selected 1,348 adoptees alive in 1993 and not hospitalized for infections in the observation period. The risk ratios presented were based on a Cox regression model. Results: Among 9971 identified siblings, 2829 had been hospitalised for infections. The risk of infectious disease was increased among predisposed compared with non-predisposed in both biological (1.18; 95% confidence limits 1.03-1.36) and adoptive siblings (1.23; 0.98-1.53). The risk of a fatal outcome of the infections was strongly increased (9.36; 2.94-29.8) in biological full siblings, but such associations were not observed for the biological half siblings or for the adoptive siblings. Conclusion: Risk of getting infections appears to be weakly influenced by both genetically determined susceptibility to infection and by family environment, whereas there appears to be a strong non-additive genetic influence on risk of fatal outcome.	[Petersen, Liselotte] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Petersen, Liselotte; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen	Petersen, L (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark.	llp@ncrr.dk		Petersen, Liselotte Vogdrup/0000-0002-0479-5379	Danish National Research Foundation; Lundbeck Foundation; Velux Fonden	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Velux Fonden(Velux Fonden)	The Danish National Research Foundation supported the adoption study. This work was also supported by grants from The Lundbeck Foundation and from Velux Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2007, J INTERN MED, V261, P112, DOI 10.1111/j.1365-2796.2006.01742.x; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; BORCHJOHNSEN K, 1993, ACTA PSYCHIAT SCAND, V87, P73, DOI 10.1111/j.1600-0447.1993.tb05364.x; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; ELDRED CA, 1976, AM J ORTHOPSYCHIAT, V46, P279, DOI 10.1111/j.1939-0025.1976.tb00928.x; Folstein Marshal F., J PSYCHIATR RES, V12, P189, DOI [10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(68)90026-5]; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hjuler T, 2008, AM J EPIDEMIOL, V167, P814, DOI 10.1093/aje/kwm376; LIN TM, 1989, ANTICANCER RES, V9, P737; LYKKEN DT, 1990, BEHAV GENET, V20, P547, DOI 10.1007/BF01065871; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Motsinger AA, 2007, J INFECT DIS, V195, P1737, DOI 10.1086/518247; Obel N, 2010, AM J EPIDEMIOL, V171, P1007, DOI 10.1093/aje/kwq037; Petersen L, 2005, GENET EPIDEMIOL, V28, P376, DOI 10.1002/gepi.20071; Petersen L, 2002, GENET EPIDEMIOL, V23, P123, DOI 10.1002/gepi.1122; Petersen L, 2008, EPIDEMIOLOGY, V19, P472, DOI 10.1097/EDE.0b013e3181692769; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Tuite A, 2006, MICROBES INFECT, V8, P1647, DOI 10.1016/j.micinf.2005.11.016; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361	28	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10603	10.1371/journal.pone.0010603	http://dx.doi.org/10.1371/journal.pone.0010603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498716	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600003
J	Vermeij, MJA; Marhaver, KL; Huijbers, CM; Nagelkerken, I; Simpson, SD				Vermeij, Mark J. A.; Marhaver, Kristen L.; Huijbers, Chantal M.; Nagelkerken, Ivan; Simpson, Stephen D.			Coral Larvae Move toward Reef Sounds	PLOS ONE			English	Article							FISHES; RECRUITMENT; ATTRACTION	Free-swimming larvae of tropical corals go through a critical life-phase when they return from the open ocean to select a suitable settlement substrate. During the planktonic phase of their life cycle, the behaviours of small coral larvae (, 1 mm) that influence settlement success are difficult to observe in situ and are therefore largely unknown. Here, we show that coral larvae respond to acoustic cues that may facilitate detection of habitat from large distances and from upcurrent of preferred settlement locations. Using in situ choice chambers, we found that settling coral larvae were attracted to reef sounds, produced mainly by fish and crustaceans, which we broadcast underwater using loudspeakers. Our discovery that coral larvae can detect and respond to sound is the first description of an auditory response in the invertebrate phylum Cnidaria, which includes jellyfish, anemones, and hydroids as well as corals. If, like settlement-stage reef fish and crustaceans, coral larvae use reef noise as a cue for orientation, the alleviation of noise pollution in the marine environment may gain further urgency.	[Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Curacao, Neth Antilles; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Marhaver, Kristen L.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Huijbers, Chantal M.; Nagelkerken, Ivan] Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [Simpson, Stephen D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Amsterdam; University of California System; University of California San Diego; Scripps Institution of Oceanography; Radboud University Nijmegen; University of Bristol	Vermeij, MJA (corresponding author), Carmabi Fdn, Willemstad, Curacao, Neth Antilles.	m.vermeij@carmabi.org	Nagelkerken, Ivan/E-1093-2011; Vermeij, Mark/AAR-6757-2020; Huijbers, Chantal/J-5176-2014; Langhamer, Olivia/J-3425-2012; Marhaver, Kristen L/B-4948-2011; Vermeij, Mark/B-2752-2013	Nagelkerken, Ivan/0000-0003-4499-3940; Vermeij, Mark/0000-0001-9612-9527; Huijbers, Chantal/0000-0001-5206-3415; Marhaver, Kristen L/0000-0002-8953-1902; Vermeij, Mark/0000-0001-9612-9527; Simpson, Stephen/0000-0002-4856-6164	Scripps Graduate Department; National Science Foundation; Natural Environment Research Council; Netherlands Organization for Scientific Research (NWO)	Scripps Graduate Department; National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	KLM was supported by the Scripps Graduate Department and a National Science Foundation Graduate Research Fellowship. SDS was supported by the Natural Environment Research Council. CMH and IN were supported by a Vidi grant from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Cato D, 1992, ACOUST AUST, V20, P76; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Mann DA, 2007, J FISH BIOL, V70, P109, DOI 10.1111/j.1095-8649.2006.01279.x; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; MCCAULEY RD, 1997, ASPECTS MARINE BIOL, V4; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Robert D, 2009, CURR BIOL, V19, pR446, DOI 10.1016/j.cub.2009.04.021; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Swearer SE, 2002, B MAR SCI, V70, P251; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119	17	124	125	7	203	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10660	10.1371/journal.pone.0010660	http://dx.doi.org/10.1371/journal.pone.0010660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498831	Green Submitted, Green Published, gold			2022-12-27	WOS:000277771600020
J	Chaturvedi, P; Parnaik, VK				Chaturvedi, Pankaj; Parnaik, Veena K.			Lamin A Rod Domain Mutants Target Heterochromatin Protein 1 alpha and beta for Proteasomal Degradation by Activation of F-Box Protein, FBXW10	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; A-TYPE LAMINS; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; INHIBITING FARNESYLATION; RETINOBLASTOMA PROTEIN; DILATED CARDIOMYOPATHY; PARTIAL LIPODYSTROPHY; HP1 PROTEINS; ORGANIZATION	Background: Lamins are major structural proteins of the nucleus and contribute to the organization of various nuclear functions. Mutations in the human lamin A gene cause a number of highly degenerative diseases, collectively termed as laminopathies. Cells expressing lamin mutations exhibit abnormal nuclear morphology and altered heterochromatin organization; however, the mechanisms responsible for these defects are not well understood. Methodology and Principal Findings: The lamin A rod domain mutants G232E, Q294P and R386K are either diffusely distributed or form large aggregates in the nucleoplasm, resulting in aberrant nuclear morphology in various cell types. We examined the effects of these lamin mutants on the distribution of heterochromatin protein 1 (HP1) isoforms. HeLa cells expressing these mutants showed a heterogeneous pattern of HP1 alpha and beta depletion but without altering HP1 gamma levels. Changes in HP1 alpha and beta were not observed in cells expressing wild-type lamin A or mutant R482L, which assembled normally at the nuclear rim. Treatment with proteasomal inhibitors led to restoration of levels of HP1 isoforms and also resulted in stable association of lamin mutants with the nuclear periphery, rim localization of the inner nuclear membrane lamin-binding protein emerin and partial improvement of nuclear morphology. A comparison of the stability of HP1 isoforms indicated that HP1 alpha and beta displayed increased turnover and higher basal levels of ubiquitination than HP1 gamma. Transcript analysis of components of the ubiquitination pathway showed that a specific F-box protein, FBXW10 was induced several-fold in cells expressing lamin mutants. Importantly, ectopic expression of FBXW10 in HeLa cells led to depletion of HP1 alpha and beta without alteration of HP1 gamma levels. Conclusions: Mislocalized lamins can induce ubiquitin-mediated proteasomal degradation of certain HP1 isoforms by activation of FBXW10, a member of the F-box family of proteins that is involved in E3 ubiquitin ligase activity.	[Chaturvedi, Pankaj; Parnaik, Veena K.] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chaturvedi, P (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	veenap@ccmb.res.in	Chaturvedi, Pankaj/ABC-4658-2020	Chaturvedi, Pankaj/0000-0001-7596-2165	Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Department of Biotechnology, India. PC was supported by a pre-doctoral fellowship from the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; De Conto F, 2000, J CELL SCI, V113, P2399; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Gilchrist S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-46; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; Matitioli E, 2008, EXP CELL RES, V314, P453, DOI 10.1016/j.yexcr.2O07.11.012; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Muchir A, 2006, BIOCHEM BIOPH RES CO, V351, P1011, DOI 10.1016/j.bbrc.2006.10.147; NICKERSON JA, 1992, J CELL BIOL, V116, P977, DOI 10.1083/jcb.116.4.977; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Ostlund C, 2001, J CELL SCI, V114, P4435; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2006, J BIOSCIENCES, V31, P405, DOI 10.1007/BF02704113; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ritou E, 2007, J CELL SCI, V120, P3425, DOI 10.1242/jcs.012955; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Tripathi K, 2009, INT J INTEGRATIVE BI, V5, P1; Vaughan OA, 2001, J CELL SCI, V114, P2577; Vigouroux C, 2001, J CELL SCI, V114, P4459; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	62	33	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10620	10.1371/journal.pone.0010620	http://dx.doi.org/10.1371/journal.pone.0010620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498703	gold, Green Published			2022-12-27	WOS:000277633500011
J	Halfon, P; Giorgetti, C; Khiri, H; Penaranda, G; Terriou, P; Porcu-Buisson, G; Chabert-Orsini, V				Halfon, Philippe; Giorgetti, Claude; Khiri, Hacene; Penaranda, Guillaume; Terriou, Philippe; Porcu-Buisson, Geraldine; Chabert-Orsini, Veronique			Semen May Harbor HIV Despite Effective HAART: Another Piece in the Puzzle	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS; HIV-1-DISCORDANT COUPLES; SEXUAL TRANSMISSION; RNA; SPERM; BLOOD; COMPARTMENTALIZATION; INFECTION; EFFICIENT	Background: The risk of male-to-female intravaginal HIV-1 transmission is estimated at about 1 event per 200-2000 coital acts. The aim of this study was to assess the residual risk of HIV presence in semen in patients under HAART therapy. Methods and Findings: The study took place in France from October 2001 to March 2009. 394 paired blood and semen samples were provided from 332 HIV-1 infected men. The Roche Cobas AMPLICOR Monitor HIV assay was used to quantify HIV-1 RNA in blood and in seminal plasma. Three percent of 394 HIV-1 infected men enrolled in an assisted reproductive technology program harbored detectable HIV-1 RNA in semen, although they had no other sexually transmitted disease and their blood viral load was undetectable for at least 6 months under antiretroviral treatment. Conclusion: These data suggest that undetectable plasma HIV RNA means a lower risk of viral transmission through seminal fluid on a population level, but not necessarily at the level of the individual.	[Halfon, Philippe] Lab Alphabio, Dept Virol, Marseille, France; [Giorgetti, Claude; Terriou, Philippe; Porcu-Buisson, Geraldine; Chabert-Orsini, Veronique] Inst Reprod Med, Marseille, France; [Khiri, Hacene] Lab Alphabio, Dept Mol Biol, Marseille, France; [Penaranda, Guillaume] Lab Alphabio, Dept Biostat, Marseille, France		Halfon, P (corresponding author), Lab Alphabio, Dept Virol, Marseille, France.	philippe.halfon@alphabio.fr; g.penaranda@alphabio.fr		PENARANDA, Guillaume/0000-0002-7461-4254				BEATEN J, 2009, GENITAL HIV 1 RNA CO; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Halfon P, 2006, AIDS, V20, P241, DOI 10.1097/01.aids.0000200532.56490.fe; Kashima K, 2009, JPN J INFECT DIS, V62, P173; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Munch J, 2005, J VIROL, V79, P10547, DOI 10.1128/JVI.79.16.10547-10560.2005; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, J ANTIMICROB CHEMOTH, V48, P351, DOI 10.1093/jac/48.3.351; TAYLOR S, 2010, DARUNAVIR DRV CONCEN; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006	20	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10569	10.1371/journal.pone.0010569	http://dx.doi.org/10.1371/journal.pone.0010569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485526	gold, Green Published			2022-12-27	WOS:000277633500005
J	Meijerink, M; van Hemert, S; Taverne, N; Wels, M; de Vos, P; Bron, PA; Savelkoul, HF; van Bilsen, J; Kleerebezem, M; Wells, JM				Meijerink, Marjolein; van Hemert, Saskia; Taverne, Nico; Wels, Michiel; de Vos, Paul; Bron, Peter A.; Savelkoul, Huub F.; van Bilsen, Jolanda; Kleerebezem, Michiel; Wells, Jerry M.			Identification of Genetic Loci in Lactobacillus plantarum That Modulate the Immune Response of Dendritic Cells Using Comparative Genome Hybridization	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LACTIC-ACID BACTERIA; REGULATORY T-CELLS; FUNCTIONAL-ANALYSIS; LIPOTEICHOIC ACID; IMMUNOMODULATORY PROPERTIES; INTESTINAL INFLAMMATION; MANGANESE TRANSPORT; PROBIOTIC BACTERIA; ALLERGIC DISEASES	Background: Probiotics can be used to stimulate or regulate epithelial and immune cells of the intestinal mucosa and generate beneficial mucosal immunomodulatory effects. Beneficial effects of specific strains of probiotics have been established in the treatment and prevention of various intestinal disorders, including allergic diseases and diarrhea. However, the precise molecular mechanisms and the strain-dependent factors involved are poorly understood. Methodology/Principal Findings: In this study, we aimed to identify gene loci in the model probiotic organism Lactobacillus plantarum WCFS1 that modulate the immune response of host dendritic cells. The amounts of IL-10 and IL-12 secreted by dendritic cells (DCs) after stimulation with 42 individual L. plantarum strains were measured and correlated with the strain-specific genomic composition using comparative genome hybridisation and the Random Forest algorithm. This in silico "gene-trait matching" approach led to the identification of eight candidate genes in the L. plantarum genome that might modulate the DC cytokine response to L. plantarum. Six of these genes were involved in bacteriocin production or secretion, one encoded a bile salt hydrolase and one encoded a transcription regulator of which the exact function is unknown. Subsequently, gene deletions mutants were constructed in L. plantarum WCFS1 and compared to the wild-type strain in DC stimulation assays. All three bacteriocin mutants as well as the transcription regulator (lp_2991) had the predicted effect on cytokine production confirming their immunomodulatory effect on the DC response to L. plantarum. Transcriptome analysis and qPCR data showed that transcript level of gtcA3, which is predicted to be involved in glycosylation of cell wall teichoic acids, was substantially increased in the lp_2991 deletion mutant (44 and 29 fold respectively). Conclusion: Comparative genome hybridization led to the identification of gene loci in L. plantarum WCFS1 that modulate the immune response of DCs.	[Meijerink, Marjolein; van Hemert, Saskia; Taverne, Nico; Wels, Michiel; de Vos, Paul; Bron, Peter A.; Savelkoul, Huub F.; van Bilsen, Jolanda; Kleerebezem, Michiel; Wells, Jerry M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Savelkoul, Huub F.] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [van Hemert, Saskia; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [van Bilsen, Jolanda] TNO Qual Life, Zeist, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; NIZO Food Research; University of Groningen; Netherlands Organization Applied Science Research; Wageningen University & Research	Meijerink, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	jerry.wells@wur.nl	Meijerink, Marjolein/B-9258-2014; de Vos, Paul/A-3170-2013; Kleerebezem, Michiel/AAT-2078-2021; Savelkoul, Huub FJ/F-6026-2012; van Hemert, Saskia/H-9308-2013; van Hemert, Saskia/P-8135-2019	Meijerink, Marjolein/0000-0003-3994-9785; van Hemert, Saskia/0000-0002-1098-1477; van Hemert, Saskia/0000-0002-1098-1477; Kleerebezem, Michiel/0000-0001-8552-2235; de vos, paul/0000-0001-9618-2408; van Bilsen, Jolanda/0000-0003-3439-5445	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Diep DB, 1996, J BACTERIOL, V178, P4472, DOI 10.1128/jb.178.15.4472-4483.1996; Diep DB, 2009, PEPTIDES, V30, P1562, DOI 10.1016/j.peptides.2009.05.014; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; FABIA R, 1993, SCAND J GASTROENTERO, V28, P155, DOI 10.3109/00365529309096063; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Groot MNN, 2005, MICROBIOL-SGM, V151, P1229, DOI 10.1099/mic.0.27375-0; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jim K, 2004, GENOME RES, V14, P109; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kim HG, 2007, FEMS IMMUNOL MED MIC, V49, P205, DOI 10.1111/j.1574-695X.2006.00175.x; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Maldonado A, 2002, INT J FOOD MICROBIOL, V77, P117, DOI 10.1016/S0168-1605(02)00049-1; Mao YL, 1996, GASTROENTEROLOGY, V111, P334, DOI 10.1053/gast.1996.v111.pm8690198; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Remiger A, 1999, J APPL MICROBIOL, V86, P1053, DOI 10.1046/j.1365-2672.1999.00792.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Resta-Lenert SC, 2009, ANN NY ACAD SCI, V1165, P175, DOI 10.1111/j.1749-6632.2009.04042.x; Rijkers GT, 2010, J NUTR, V140, p671S, DOI 10.3945/jn.109.113779; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rojo-Bezares B, 2008, ARCH MICROBIOL, V189, P491, DOI 10.1007/s00203-007-0342-6; Ross RP, 1999, ANTON LEEUW INT J G, V76, P337, DOI 10.1023/A:1002069416067; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; SIEZEN RJ, 2009, ENV MICROBI IN PRESS; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Troost FJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-374; Twomey D, 2002, ANTON LEEUW INT J G, V82, P165, DOI 10.1023/A:1020660321724; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Montfrans C, 2002, GASTROENTEROLOGY, V123, P1877, DOI 10.1053/gast.2002.37066; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wells JM, 2010, INT J MED MICROBIOL, V300, P41, DOI 10.1016/j.ijmm.2009.08.008; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yasuda E, 2008, APPL ENVIRON MICROB, V74, P4746, DOI 10.1128/AEM.00412-08; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	81	141	148	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10632	10.1371/journal.pone.0010632	http://dx.doi.org/10.1371/journal.pone.0010632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498715	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500018
J	Boomsma, DI; Saviouk, V; Hottenga, JJ; Distel, MA; de Moor, MHM; Vink, JM; Geels, LM; van Beek, JHDA; Bartels, M; de Geus, EJC; Willemsen, G				Boomsma, Dorret I.; Saviouk, Viatcheslav; Hottenga, Jouke-Jan; Distel, Marijn A.; de Moor, Marleen H. M.; Vink, Jacqueline M.; Geels, Lot M.; van Beek, Jenny H. D. A.; Bartels, Meike; de Geus, Eco J. C.; Willemsen, Gonneke			Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; ENVIRONMENT INTERACTION; DUTCH TWINS; LIFE-STYLE; PREVALENCE; METAANALYSIS; HERITABILITY; SYMPTOMS; GENOTYPE; FAMILIES	Context: In contrast to the large number of studies in children, there is little information on the contribution of genetic factors to Attention Deficit Hyperactivity Disorder (ADHD) in adults. Objective: To estimate the heritability of ADHD in adults as assessed by the ADHD index scored from the CAARS (Conners' Adult ADHD Rating Scales). Design: Phenotype data from over 12,000 adults (twins, siblings and parents) registered with the Netherlands Twin Register were analyzed using genetic structural equation modeling. Main outcome measures: Heritability estimates for ADHD from the twin-family study. Results: Heritability of ADHD in adults is estimated around 30% in men and women. There is some evidence for assortative mating. All familial transmission is explained by genetic inheritance, there is no support for the hypothesis that cultural transmission from parents to offspring is important. Conclusion: Heritability for ADHD features in adults is present, but is substantially lower than it is in children.	[Boomsma, Dorret I.; Saviouk, Viatcheslav; Hottenga, Jouke-Jan; Distel, Marijn A.; de Moor, Marleen H. M.; Vink, Jacqueline M.; Geels, Lot M.; van Beek, Jenny H. D. A.; Bartels, Meike; de Geus, Eco J. C.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Boomsma, DI (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	dorret@psy.vu.nl	Boomsma, Dorret I/AAX-4470-2020; de Geus, Eco J.C./M-9318-2015; de Moor, Marleen/J-7434-2019; Vink, Jacqueline/A-7648-2012; Bartels, Meike/D-4492-2014	de Geus, Eco J.C./0000-0001-6022-2666; de Moor, Marleen/0000-0001-7177-5637; Bartels, Meike/0000-0002-9667-7555; Willemsen, Gonneke/0000-0003-3755-0236	Spinozapremie [NWO/SPI 56-464-14192]; Twin-Family Database for Behavior Genetics and Genomics [NWO 480-04004]; Borderline Personality Disorder Research Foundation; ZonMW Addiction [31160008]; EMGO+; EU	Spinozapremie; Twin-Family Database for Behavior Genetics and Genomics; Borderline Personality Disorder Research Foundation; ZonMW Addiction(Netherlands Organization for Health Research and Development); EMGO+; EU(European Commission)	This study was supported by Spinozapremie (NWO/SPI 56-464-14192) and Twin-Family Database for Behavior Genetics and Genomics (NWO 480-04004). Data collection was funded by the Borderline Personality Disorder Research Foundation and by ZonMW Addiction (Project nr 31160008). M. B. is financially supported by a senior fellowship of the EMGO+ institution. V. S. is supported by the EU Marie Curie Research Training Networks grant (EUTwinS, PI Igor Nenadic, RTN, FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1997, MANUAL YOUNG ADULT S, P207; Antshel KM, 2009, PSYCHOL MED, V39, P1325, DOI 10.1017/S0033291708004959; Asherson P, 2008, MOL PSYCHIATR, V13, P514, DOI 10.1038/sj.mp.4002140; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Brookes KJ, 2006, ARCH GEN PSYCHIAT, V63, P74, DOI 10.1001/archpsyc.63.1.74; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P508; CLONINGER CR, 1980, GENET RES, V36, P117; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Derks EM, 2006, BEHAV GENET, V36, P833, DOI 10.1007/s10519-006-9084-5; Derks EM, 2004, BEHAV GENET, V34, P571, DOI 10.1007/s10519-004-5585-2; Derks EM, 2010, HANDBOOK OF BEHAVIOR GENETICS, P361, DOI 10.1007/978-0-387-76727-7_25; Distel MA, 2007, TWIN RES HUM GENET, V10, P348, DOI 10.1375/twin.10.2.348; Faraone Stephen V, 2005, J Atten Disord, V9, P384, DOI 10.1177/1087054705281478; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2004, PSYCHIAT CLIN N AM, V27, P303, DOI 10.1016/S0193-953X(03)00090-X; Faraone SV, 2001, CHILD ADOL PSYCH CL, V10, P299; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Ficks CA, 2009, CURR PSYCHIAT REP, V11, P387, DOI 10.1007/s11920-009-0058-1; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; HAWORTH CMA, 2009, MOL PSYCHIA IN PRESS; Hudziak JJ, 2005, BIOL PSYCHIAT, V58, P562, DOI 10.1016/j.biopsych.2005.03.024; Kahn RS, 2003, J PEDIATR-US, V143, P104, DOI 10.1016/S0022-3476(03)00208-7; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Maes HHM, 1998, PSYCHOL MED, V28, P1389, DOI 10.1017/S0033291798007326; McIntosh D, 2009, NEUROPSYCH DIS TREAT, V5, P137; MOLENAAR PCM, 1987, BEHAV GENET, V17, P71, DOI 10.1007/BF01066011; Moss SB, 2007, PRIMARY CARE, V34, P445, DOI 10.1016/j.pop.2007.05.005; Neale M. C., 2006, MX STAT MODELING, V7th; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polderman TJC, 2009, NEUROPSYCHOLOGY, V23, P381, DOI 10.1037/a0014915; Posthuma D, 2000, BEHAV GENET, V30, P147, DOI 10.1023/A:1001959306025; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rietveld MJH, 2004, J CHILD PSYCHOL PSYC, V45, P577, DOI 10.1111/j.1469-7610.2004.00247.x; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; van den Berg SM, 2006, AM J MED GENET B, V141B, P55, DOI 10.1002/ajmg.b.30251; van Grootheest DS, 2008, PSYCHOL MED, V38, P1731, DOI 10.1017/S0033291708003024; Vink JM, 2004, EUR J EPIDEMIOL, V19, P623, DOI 10.1023/B:EJEP.0000036814.56108.66; Waldman ID, 2006, CLIN PSYCHOL REV, V26, P396, DOI 10.1016/j.cpr.2006.01.007; WILLEMSEN G, 2010, TWIN RES HU IN PRESS; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	46	93	93	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10621	10.1371/journal.pone.0010621	http://dx.doi.org/10.1371/journal.pone.0010621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594UC	20485550	Green Published, gold			2022-12-27	WOS:000277563400023
J	Vasiev, B; Balter, A; Chaplain, M; Glazier, JA; Weijer, CJ				Vasiev, Bakhtier; Balter, Ariel; Chaplain, Mark; Glazier, James A.; Weijer, Cornelis J.			Modeling Gastrulation in the Chick Embryo: Formation of the Primitive Streak	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; EXPRESSION PATTERNS; AXIAL STRUCTURES; CELL-MOVEMENT; CHEMOTAXIS; DIFFERENTIATION; INDUCTION; AMNIOTE; GENE	The body plan of all higher organisms develops during gastrulation. Gastrulation results from the integration of cell proliferation, differentiation and migration of thousands of cells. In the chick embryo gastrulation starts with the formation of the primitive streak, the site of invagination of mesoderm and endoderm cells, from cells overlaying Koller's Sickle. Streak formation is associated with large-scale cell flows that carry the mesoderm cells overlying Koller's sickle into the central midline region of the embryo. We use multi-cell computer simulations to investigate possible mechanisms underlying the formation of the primitive streak in the chick embryo. Our simulations suggest that the formation of the primitive streak employs chemotactic movement of a subpopulation of streak cells, as well as differential adhesion between the mesoderm cells and the other cells in the epiblast. Both chemo-attraction and chemo-repulsion between various combinations of cell types can create a streak. However, only one combination successfully reproduces experimental observations of the manner in which two streaks in the same embryo interact. This finding supports a mechanism in which streak tip cells produce a diffusible morphogen which repels cells in the surrounding epiblast. On the other hand, chemotactic interaction alone does not reproduce the experimental observation that the large-scale vortical cell flows develop simultaneously with streak initiation. In our model the formation of large scale cell flows requires an additional mechanism that coordinates and aligns the motion of neighboring cells.	[Vasiev, Bakhtier; Chaplain, Mark] Univ Dundee, Div Math, Dundee, Scotland; [Balter, Ariel; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Balter, Ariel; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Weijer, Cornelis J.] Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee, Scotland	University of Dundee; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Dundee	Vasiev, B (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England.	bnvasiev@liverpool.ac.uk	Vasiev, Bakhtier/D-8006-2011; Chaplain, Mark AJ/A-5355-2010; weijer, cornelis j/I-4538-2012	Vasiev, Bakhtier/0000-0002-3452-7885; Chaplain, Mark AJ/0000-0001-5727-2160; Glazier, James Alexander/0000-0003-3634-190X; Weijer, Cornelis/0000-0003-2192-8150	Biotechnology and Biological Sciences Research Council (BBSRC) [94/E18787]; Biocomplexity Institute; Indiana University Faculty Research Support Program [NIGMS R01 GM76692, NIGMS R01 GM077138]; Biotechnology and Biological Sciences Research Council [G18071, E18787] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biocomplexity Institute; Indiana University Faculty Research Support Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Biotechnology and Biological Sciences Research Council (BBSRC) Grant 94/E18787, "An individual based mathematical model of chick embryo gastrulation: developing a virtual embryo computational tool''; the Biocomplexity Institute and the Indiana University Faculty Research Support Program, NIGMS R01 GM76692 and NIGMS R01 GM077138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Bertocchini F, 2004, DEVELOPMENT, V131, P3381, DOI 10.1242/dev.01178; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bodenstein L, 2005, J THEOR BIOL, V233, P253, DOI 10.1016/j.jtbi.2004.10.008; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chuai M, 2008, CURR TOP DEV BIOL, V81, P135, DOI 10.1016/S0070-2153(07)81004-0; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Cui C, 2005, DEV BIOL, V284, P37, DOI 10.1016/j.ydbio.2005.04.021; DeLuca SM, 1999, EXP CELL RES, V251, P3, DOI 10.1006/excr.1999.4577; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Eichmann A, 1998, DEVELOPMENT, V125, P743; Graeper L, 1929, WILHELM ROUX ARCH EN, V116, P382; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hogeweg P, 2002, BIOSYSTEMS, V64, P97, DOI 10.1016/S0303-2647(01)00178-2; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Lawson A, 2001, GENESIS, V29, P188, DOI 10.1002/gene.1023; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; MITRANI E, 1990, SCIENCE, V247, P1092, DOI 10.1126/science.11032544; Painter KJ, 2000, B MATH BIOL, V62, P501, DOI 10.1006/bulm.1999.0166; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Seleiro EAP, 1996, CURR BIOL, V6, P1476, DOI 10.1016/S0960-9822(96)00752-X; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Skromne I, 2001, DEVELOPMENT, V128, P2915; STERN CD, 1990, DEVELOPMENT, V110, P1271; STERN CD, 2004, GASTRULATION CELLS E, P219; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; WEINBERGER C, 1982, ROUX ARCH DEV BIOL, V191, P127, DOI 10.1007/BF00848450; Wolpert L., 2002, PRINCIPLES DEV; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; ZIV T, 1992, DEVELOPMENT, V115, P689	39	49	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10571	10.1371/journal.pone.0010571	http://dx.doi.org/10.1371/journal.pone.0010571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485500	Green Submitted, Green Published, gold			2022-12-27	WOS:000277563200007
J	Zhu, FX; Sathish, N; Yuan, Y				Zhu, Fan Xiu; Sathish, Narayanan; Yuan, Yan			Antagonism of Host Antiviral Responses by Kaposi's Sarcoma-Associated Herpesvirus Tegument Protein ORF45	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR; IMMUNODEFICIENCY-VIRUS REPLICATION; BACTERIAL ARTIFICIAL CHROMOSOME; PRIMARY EFFUSION LYMPHOMA; I INTERFERON; GENE INDUCTION; DNA-SEQUENCES; SIMPLEX-VIRUS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Virus infection of a cell generally evokes an immune response by the host to defeat the intruder in its effort. Many viruses have developed an array of strategies to evade or antagonize host antiviral responses. Kaposi's sarcoma-associated herpesvirus (KSHV) is demonstrated in this report to be able to prevent activation of host antiviral defense mechanisms upon infection. Cells infected with wild-type KSHV were permissive for superinfection with vesicular stomatitis virus (VSV), suggesting that KSHV virions fail to induce host antiviral responses. We previously showed that ORF45, a KSHV immediate-early protein as well as a tegument protein of virions, interacts with IRF-7 and inhibits virus-mediated type I interferon induction by blocking IRF-7 phosphorylation and nuclear translocation (Zhu et al., Proc. Natl. Acad. Sci. USA. 99:5573-5578, 2002). Here, using an ORF45-null recombinant virus, we demonstrate a profound role of ORF45 in inhibiting host antiviral responses. Infection of cells with an ORF45-null mutant recombinant KSHV (BAC-stop45) triggered an immune response that resisted VSV super-infection, concomitantly associated with appreciable increases in transcription of type I IFN and downstream anti-viral effector genes. Gain-of-function analysis showed that ectopic expression of ORF45 in human fibroblast cells by a lentivirus vector decreased the antiviral responses of the cells. shRNA-mediated silencing of IRF-7, that predominantly regulates both the early and late phase induction of type I IFNs, clearly indicated its critical contribution to the innate antiviral responses generated against incoming KSHV particles. Thus ORF45 through its targeting of the crucial IRF-7 regulated type I IFN antiviral responses significantly contributes to the KSHV survival immediately following a primary infection allowing for progression onto subsequent stages in its life-cycle.	[Zhu, Fan Xiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Sathish, Narayanan; Yuan, Yan] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	State University System of Florida; Florida State University; University of Pennsylvania	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	yuan2@pobox.upenn.edu			National Institutes of Health [R01CA86839, R01DE016680]; NATIONAL CANCER INSTITUTE [R01CA086839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants R01CA86839 to Y.Y. and R01DE016680 to F.Z. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Al-Khatib K, 2003, VIROLOGY, V313, P126, DOI 10.1016/S0042-6822(03)00298-8; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; ASANO M, 1990, VIROLOGY, V176, P30, DOI 10.1016/0042-6822(90)90227-I; BACA LM, 1994, J LEUKOCYTE BIOL, V55, P299, DOI 10.1002/jlb.55.3.299; Berking C, 2001, CANCER RES, V61, P8306; Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Browne EP, 2003, P NATL ACAD SCI USA, V100, P11439, DOI 10.1073/pnas.1534570100; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; DeFilippis V, 2005, J VIROL, V79, P6419, DOI 10.1128/JVI.79.10.6419-6431.2005; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Duguay D, 2002, CANCER RES, V62, P5148; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; Gaidano G, 2001, ADV CANCER RES, V80, P115, DOI 10.1016/S0065-230X(01)80014-2; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kenworthy R, 2009, NUCLEIC ACIDS RES, V37, P6587, DOI 10.1093/nar/gkp714; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Larcher C, 2005, EXP DERMATOL, V14, P41, DOI 10.1111/j.0906-6705.2005.00234.x; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li MT, 1998, J VIROL, V72, P5433, DOI 10.1128/JVI.72.7.5433-5440.1998; Liang CY, 2008, SEMIN CANCER BIOL, V18, P423, DOI 10.1016/j.semcancer.2008.09.003; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; RAMEZANI A, 2002, CURRENT PROTOCOL MOL; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sangfelt O, 2001, MED ONCOL, V18, P3, DOI 10.1385/MO:18:1:3; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	67	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10573	10.1371/journal.pone.0010573	http://dx.doi.org/10.1371/journal.pone.0010573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485504	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200009
J	Couvreur, TLP; Gort, G; Richardson, JE; Sosef, MSM; Chatrou, LW				Couvreur, Thomas L. P.; Gort, Gerrit; Richardson, James E.; Sosef, Marc S. M.; Chatrou, Lars W.			Insights into the Influence of Priors in Posterior Mapping of Discrete Morphological Characters: A Case Study in Annonaceae	PLOS ONE			English	Article							PHYLOGENY RECONSTRUCTION; PRIOR DISTRIBUTIONS; BAYESIAN-INFERENCE; EVOLUTION; STATES; LIKELIHOOD; MODEL; RATES; SYNCARPY; HISTORY	Background: Posterior mapping is an increasingly popular hierarchical Bayesian based method used to infer character histories and reconstruct ancestral states at nodes of molecular phylogenies, notably of morphological characters. As for all Bayesian analyses specification of prior values is an integrative and important part of the analysis. He we provide an example of how alternative prior choices can seriously influence results and mislead interpretations. Methods/Principal Findings: For two contrasting discrete morphological characters, namely a slow and a fast evolving character found in the plant family Annonaceae, we specified a total of eight different prior distributions per character. We investigated how these prior settings affected important summary statistics. Our analyses showed that the different prior distributions had marked effects on the results in terms of average number of character state changes. These differences arise because priors play a crucial role in determining which areas of parameter space the values of the simulation will be drawn from, independent of the data at hand. However, priors seemed to fit the data better if they would result in a more even sampling of parameter space (normal posterior distribution), in which case alternative standard deviation values had little effect on the results. The most probable character history for each character was affected differently by the prior. For the slower evolving character, the same character history always had the highest posterior probability independent of the priors used. In contrast, the faster evolving character showed different most probable character histories depending on the prior. These differences could be related to the level of homoplasy exhibited by each character. Conclusions: Although our analyses were restricted to two morphological characters within a single family, our results underline the importance of carefully choosing prior values for posterior mapping. Prior specification will be of crucial importance when interpreting the results in a meaningful way. It is hard to suggest a statistically sound method for prior specification without more detailed studies. Meanwhile, we propose that the data could be used to estimate the prior value of the gamma distribution placed on the transformation rate in posterior mapping.	[Couvreur, Thomas L. P.] New York Bot Garden, New York, NY USA; [Couvreur, Thomas L. P.; Sosef, Marc S. M.] Wageningen Univ, Biosystemat Grp, Netherlands Ctr Biodivers Nat, Sect Natl Herbarium Nerderland, Wageningen, Netherlands; [Richardson, James E.] Royal Bot Gardens, Edinburgh, Midlothian, Scotland	New York Botanical Garden; Wageningen University & Research; Royal Botanic Gardens, Kew	Couvreur, TLP (corresponding author), New York Bot Garden, New York, NY USA.	tcouvreur@nybg.org	Sosef, Marc SM/N-3655-2017; Couvreur, Thomas LP/D-8172-2011; Richardson, James-Edward/L-2768-2016	Sosef, Marc SM/0000-0002-6997-5813; Couvreur, Thomas LP/0000-0002-8509-6587; Richardson, James-Edward/0000-0001-9014-4865; Chatrou, Lars/0000-0003-0131-0302				Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Archie James W., 1996, P153, DOI 10.1016/B978-012618030-5/50008-3; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bollback JP, 2005, STAT BIOL HEALTH, P439, DOI 10.1007/0-387-27733-1_16; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Buschbom J, 2006, SYST BIOL, V55, P471, DOI 10.1080/10635150600697465; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Carr SGM, 1961, PHYTOMORPHOLOGY, V11, P249, DOI DOI 10.1046/J.1460-9592.2001.0666H.X; Chaverri P, 2005, MYCOLOGIA, V97, P1225, DOI 10.3852/mycologia.97.6.1225; Couvreur TLP, 2008, MOL PHYLOGENET EVOL, V47, P302, DOI 10.1016/j.ympev.2008.01.018; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; Doyle J. A., 1996, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V18, P279; Eilers PHC, 2007, STAT MODEL, V7, P239, DOI 10.1177/1471082X0700700302; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; ENDRESS P K, 1990, Memoirs of the New York Botanical Garden, V55, P5; ENDRESS PK, 1982, TAXON, V31, P48, DOI 10.2307/1220588; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kass RE, 1996, J AM STAT ASSOC, V91, P1343, DOI 10.2307/2291752; Leschen RAB, 2007, SYST BIOL, V56, P97, DOI 10.1080/10635150701211844; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; MADDISON WP, 2006, MESQUITE MODULAR SYS; McLeish MJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-3; Mols JB, 2004, AM J BOT, V91, P590, DOI 10.3732/ajb.91.4.590; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA., 2004, BIOINFORMATICS; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; PIRIE MD, 2005, CREMASTOSPERMA OTHER, P1; RAMBAUT A, 2003, TRACER VERSION 1 4; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sanderson Michael J., 1996, P67, DOI 10.1016/B978-012618030-5/50005-8; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schultz TR, 1999, SYST BIOL, V48, P651, DOI 10.1080/106351599260229; Smedmark JEE, 2006, MOL PHYLOGENET EVOL, V39, P706, DOI 10.1016/j.ympev.2006.01.018; Stern DL, 1998, EVOLUTION, V52, P155, DOI 10.2307/2410930; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Van Dongen S, 2006, J THEOR BIOL, V242, P90, DOI 10.1016/j.jtbi.2006.02.002; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zwickl DJ, 2004, SYST BIOL, V53, P877, DOI 10.1080/10635150490522584	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10473	10.1371/journal.pone.0010473	http://dx.doi.org/10.1371/journal.pone.0010473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479935	gold, Green Published			2022-12-27	WOS:000277467900002
J	Hermans, SM; Kiragga, AN; Schaefer, P; Kambugu, A; Hoepelman, AIM; Manabe, YC				Hermans, Sabine M.; Kiragga, Agnes N.; Schaefer, Petra; Kambugu, Andrew; Hoepelman, Andy I. M.; Manabe, Yukari C.			Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; CD4 CELL COUNT; TERM IMMUNOLOGICAL RESPONSE; RESOURCE-LIMITED SETTINGS; INFECTED PATIENTS; SOUTH-AFRICA; TREATMENT FAILURE; PULMONARY TUBERCULOSIS; VIROLOGICAL RESPONSES; DISCORDANT RESPONSES	Background: Antiretroviral therapy (ART) effectively decreases tuberculosis (TB) incidence long-term, but is associated with high TB incidence rates in the first 6 months. We sought to determine the incidence and the long-term effects of TB during ART on HIV treatment outcome, and the risk factors for incident TB during ART in a large urban HIV clinic in Uganda. Methodology/Principal Findings: Routinely collected longitudinal clinical data from all patients initiated on first-line ART was retrospectively analysed. 5,982 patients were included with a median baseline CD4+ T cell count (CD4 count) of 117 cells/mm(3) (interquartile range [IQR]; 42, 182). In the first 2 years, there were 336 (5.6%) incident TB events in 10,710 person-years (py) of follow-up (3.14 cases/100pyar [95% CI 2.82-3.49]); incidence rates at 0-3, 3-6, 6-12 and 12-24 months were 11.25 (9.58-13.21), 6.27 (4.99-7.87), 2.47 (1.87-3.36) and 1.02 (0.80-1.31), respectively. Incident TB during ART was independently associated with baseline CD4 count of < 50 cells/mm(3) (hazard ratio [HR] 1.84 [1.25-2.70], P=0.002) and male gender (HR 1.68 [1.34-2.11], P < 0.001). After two years on ART, the patients who had developed TB in the first 12 months had a significantly lower median CD4 count increase (184 cells/mm(3) [IQR; 107, 258, n=118] vs 209 cells/mm(3) [124, 309, n=2166], P=0.01), a larger proportion of suboptimal immune reconstitution according to two definitions (increase in CD4 count < 200 cells/mm(3): 57.4% vs 46.9%, P=0.03, and absolute CD4 count < 200 cells/mm(3): 30.4 vs 19.9%, P=0.006), and a higher percentage of immunological failure according to the WHO criteria (13.6% vs 6.5%, P=0.003). Incident TB during ART was independently associated with poor CD4 count recovery and fulfilling WHO immunogical failure definitions. Conclusions/Significance: Incident TB during ART occurs most often within 3 months and in patients with CD4 counts less than 50 cells/mm(3). Incident TB during ART is associated with long-term impairment in immune recovery.	[Hermans, Sabine M.; Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Hermans, Sabine M.; Kiragga, Agnes N.; Schaefer, Petra; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Utrecht University; Utrecht University Medical Center; Makerere University; Johns Hopkins University	Hermans, SM (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	shermans@idi.co.ug		Hermans, Sabine/0000-0001-5146-2932	Infectious Diseases Institute research department; Gilead IDSA Exchange Fellowship; University Medical Center Utrecht; Accordia Global Health Foundation; Wellcome Trust	Infectious Diseases Institute research department; Gilead IDSA Exchange Fellowship(Gilead Sciences); University Medical Center Utrecht; Accordia Global Health Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Infectious Diseases Institute research department core funding. S. H. was supported by a Gilead IDSA Exchange Fellowship as well as by the University Medical Center Utrecht. Y.M. receives salary support from Accordia Global Health Foundation. A. K. is supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JF, 2004, INT J TUBERC LUNG D, V8, P435; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breen RAM, 2006, J INFECT DIS, V193, P1437, DOI 10.1086/503437; Cassol E, 2005, J INFECT DIS, V191, P324, DOI 10.1086/427337; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Castelnuovo B, 2009, AIDS, V23, P1295, DOI 10.1097/QAD.0b013e32832cbd43; Chi BH, 2009, JAIDS-J ACQ IMM DEF, V52, P125, DOI 10.1097/QAI.0b013e3181ab6d8b; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Huttner AC, 2007, AIDS, V21, P939, DOI 10.1097/QAD.0b013e3280f00fd6; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kigozi Brian K, 2009, AIDS Res Ther, V6, P17, DOI 10.1186/1742-6405-6-17; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawn SD, 2005, CLIN INFECT DIS, V41, P1783, DOI 10.1086/498308; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2004, J INFECTION, V48, P1, DOI 10.1016/j.jinf.2003.09.001; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Ministry of Health Uganda, 2008, NAT ANT TREATM CAR G; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1; MUWANGA A, 2008, C RETR OPP INF; Nakamura H, 2008, PHYS STATUS SOLIDI C, V5, P23, DOI 10.1002/pssc.200776546; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; *WHO, 2009, REP GLOB TUB CONTR; World Health Organization, 2006, ANT THER HIV INF AD	61	60	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10527	10.1371/journal.pone.0010527	http://dx.doi.org/10.1371/journal.pone.0010527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479873	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800011
J	Wolff, FH; Fuchs, SC; Barcellos, NNT; de Alencastro, PR; Ikeda, MLR; Brandao, ABM; Falavigna, M; Fuchs, FD				Wolff, Fernando H.; Fuchs, Sandra C.; Barcellos, Nemora N. T.; de Alencastro, Paulo Ricardo; Ikeda, Maria Leticia R.; Brandao, Ajacio B. M.; Falavigna, Maicon; Fuchs, Flavio D.			Co-Infection by Hepatitis C Virus in HIV-Infected Patients in Southern Brazil: Genotype Distribution and Clinical Correlates	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ALPHA-2A PLUS RIBAVIRIN; RISK-FACTORS; PREVALENCE; RESOLUTION; TIME	Background: Prevalence rates of Hepatitis C Virus (HCV) co-infection, the distribution of HCV genotypes, and the frequency of spontaneous resolution of hepatitis C in patients infected with the Human Immunodeficiency Virus (HIV) have a worldwide disparity. The purpose of this study is to investigate the prevalence of HCV antibodies (anti-HCV) in patients with HIV, the proportion and correlates of infection by different HCV genotypes, and rates of spontaneous resolution of HCV infection. Methods: A cross-sectional study was conducted among 1143 HIV patients under follow-up in a HIV/AIDS outpatient reference center of the Brazilian public health system. From 357 anti-HCV positive patients, a consecutive sample of 227 individuals HCV treatment-naive was interviewed and 207 was tested for HCV-RNA and genotypes. Results: Anti-HCV was detected in 357 patients (31.2%). HCV-RNA was undetectable in 16.4% of 207 anti-HCV positive individuals. Genotype 1 was diagnosed in 81.5% of the sample, genotype 2 in 1.7% and genotype 3 in 16.2%. Male gender was the unique characteristic associated with higher prevalence of genotype 1 HCV. Conclusions: Co-infection by HCV is frequent among patients with HIV in our State, and it is particularly high the infection by HCV genotype 1. Further investigation is necessary to explain the important regional variation in the proportion of infection by the different HCV genotypes and to better understand rates of spontaneous HCV clearance.	[Wolff, Fernando H.; Fuchs, Sandra C.; Barcellos, Nemora N. T.; Brandao, Ajacio B. M.; Fuchs, Flavio D.] Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil; [Wolff, Fernando H.; de Alencastro, Paulo Ricardo] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Barcellos, Nemora N. T.; Ikeda, Maria Leticia R.] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Sch Med, Porto Alegre, RS, Brazil; [Barcellos, Nemora N. T.; de Alencastro, Paulo Ricardo; Ikeda, Maria Leticia R.] Sanatorio Partenon Hosp, Therapeut Attent Serv, Porto Alegre, RS, Brazil; [Brandao, Ajacio B. M.] Fed Univ Hlth Sci Porto Alegre, Sch Med, Porto Alegre, RS, Brazil; [Falavigna, Maicon] CEARGS, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Wolff, FH (corresponding author), Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil.	fhwolff@terra.com.br	Fuchs, Flávio D/L-5078-2016; Fuchs, Sandra C/T-2670-2019; Iats, Inct/K-2300-2013	Brandao, Ajacio/0000-0001-8411-5654; fuchs, flavio/0000-0002-1191-0523	Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES); National Council for Scientific and Technological Development (CNPq); Universidade Federal do Rio Grande do Sul; National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil	Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio Grande do Sul; National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by a grant from the Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES); the National Council for Scientific and Technological Development (CNPq); and Graduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul. This study was supported, in part, by the National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amin J, 2004, HIV MED, V5, P174, DOI 10.1111/j.1468-1293.2004.00207.x; Barcellos NT, 2003, SEX TRANSM DIS, V30, P166, DOI 10.1097/00007435-200302000-00014; Bollepalli S, 2007, SEX TRANSM DIS, V34, P367, DOI 10.1097/01.olq.0000240295.35457.b1; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Busch MP, 2006, TRANSFUSION, V46, P469, DOI 10.1111/j.1537-2995.2006.00745.x; Caballero MR, 2005, MED CLIN-BARCELONA, V125, P56, DOI 10.1157/13076466; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Folgori A, 2006, GUT, V55, P1012, DOI 10.1136/gut.2005.080077; Fonseca ASK, 1999, XX WORLD CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, P69; Galperim Bruno, 2006, Arq. Gastroenterol., V43, P81, DOI 10.1590/S0004-28032006000200004; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gonzalez SA, 2006, JAIDS-J ACQ IMM DEF, V41, P582, DOI 10.1097/01.qai.0000214806.90841.c8; Hyder Qurratulain, 2009, JPMA Journal of the Pakistan Medical Association, V59, P430; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Krug LP, 1996, BRAZ J MED BIOL RES, V29, P1629; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Lock G, 2006, J VIRAL HEPATITIS, V13, P571, DOI 10.1111/j.1365-2893.2006.00735.x; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mendoza RJ, 2001, NEUROREHAB NEURAL RE, V15, P9, DOI 10.1177/154596830101500102; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Monteiro Maria Rita de Cassia Costa, 2004, Rev. Soc. Bras. Med. Trop., V37, P40; Pavan Maria Helena P., 2003, Braz J Infect Dis, V7, P253, DOI 10.1590/S1413-86702003000400005; Pereira GAS, 2006, J MED VIROL, V78, P719, DOI 10.1002/jmv.20613; Quinn PG, 1999, AM J GASTROENTEROL, V94, P668, DOI 10.1111/j.1572-0241.1999.00934.x; Ramos B, 2007, J INFECTION, V54, P173, DOI 10.1016/j.jinf.2006.02.006; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Tovo CV, 2007, LIVER INT, V27, P40, DOI 10.1111/j.1478-3231.2006.01344.x; *UNAIDS, GLOB REP 2006; Wolff FH, 2008, DIGEST LIVER DIS, V40, P460, DOI 10.1016/j.dld.2007.11.010; Zocratto Keli Bahia Felicíssimo, 2006, Cad. Saúde Pública, V22, P839, DOI 10.1590/S0102-311X2006000400022; Zylberberg H, 1999, GUT, V45, P112, DOI 10.1136/gut.45.1.112	42	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10494	10.1371/journal.pone.0010494	http://dx.doi.org/10.1371/journal.pone.0010494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463962	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400028
J	Bertrand-Vallery, V; Belot, N; Dieu, M; Delaive, E; Ninane, N; Demazy, C; Raes, M; Salmon, M; Poumay, Y; Debacq-Chainiaux, F; Toussaint, O				Bertrand-Vallery, Veronique; Belot, Nathalie; Dieu, Marc; Delaive, Edouard; Ninane, Noelle; Demazy, Catherine; Raes, Martine; Salmon, Michel; Poumay, Yves; Debacq-Chainiaux, Florence; Toussaint, Olivier			Proteomic Profiling of Human Keratinocytes Undergoing UVB-Induced Alternative Differentiation Reveals TRIpartite Motif Protein 29 as a Survival Factor	PLOS ONE			English	Article							D-COMPLEMENTING GENE; KINASE-C; ATAXIA-TELANGIECTASIA; INDUCED APOPTOSIS; EPIDERMAL DIFFERENTIATION; INDUCED SENESCENCE; DNA-DAMAGE; HUMAN SKIN; EXPRESSION; CANCER	Background: Repeated exposures to UVB of human keratinocytes lacking functional p16(INK-4a) and able to differentiate induce an alternative state of differentiation rather than stress-induced premature senescence. Methodology/Principal Findings: A 2D-DIGE proteomic profiling of this alternative state of differentiation was performed herein at various times after the exposures to UVB. Sixty-nine differentially abundant protein species were identified by mass spectrometry, many of which are involved in keratinocyte differentiation and survival. Among these protein species was TRIpartite Motif Protein 29 (TRIM29). Increased abundance of TRIM29 following UVB exposures was validated by Western blot using specific antibody and was also further analysed by immunochemistry and by RT-PCR. TRIM29 was found very abundant in keratinocytes and reconstructed epidermis. Knocking down the expression of TRIM29 by short-hairpin RNA interference decreased the viability of keratinocytes after UVB exposure. The abundance of involucrin mRNA, a marker of late differentiation, increased concomitantly. In TRIM29-knocked down reconstructed epidermis, the presence of picnotic cells revealed cell injury. Increased abundance of TRIM29 was also observed upon exposure to DNA damaging agents and PKC activation. The UVB-induced increase of TRIM29 abundance was dependent on a PKC signaling pathway, likely PKC delta. Conclusions/Significance: These findings suggest that TRIM29 allows keratinocytes to enter a protective alternative differentiation process rather than die massively after stress.	[Bertrand-Vallery, Veronique; Dieu, Marc; Delaive, Edouard; Ninane, Noelle; Demazy, Catherine; Raes, Martine; Debacq-Chainiaux, Florence; Toussaint, Olivier] Univ Namur FUNDP, Res Unit Cellular Biol, Namur, Belgium; [Belot, Nathalie; Salmon, Michel] StratiCELL SA, Isnes, Belgium; [Poumay, Yves] Univ Namur FUNDP, URPHYM, Cell & Tissue Lab, Namur, Belgium	University of Namur; University of Namur	Bertrand-Vallery, V (corresponding author), Univ Namur FUNDP, Res Unit Cellular Biol, Namur, Belgium.	olivier.toussaint@fundp.ac.be	Poumay, Yves/G-4525-2016	Poumay, Yves/0000-0001-5200-3367; Dieu, Marc/0000-0002-3902-542X; Debacq-Chainiaux, Florence/0000-0003-3949-395X	FRIA; FRFC (Belgium) [2.4506.01]; FNRS (Belgium) [1.5.033.06F]; European Commission [LSMH-CT-2005-518230, HEALTH-F4-2008-200880, HEALTH-F2-2009-223576, LSHM-CT-2005-513866, MTKI-CT-2006-042768]	FRIA(Fonds de la Recherche Scientifique - FNRS); FRFC (Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre)	VB-V had a FRIA fellowship. FDC and OT are respectively Research Associate and Senior Research Associate of the Belgian FNRS. This work received financial support through FRFC Grant 2.4506.01 (Belgium) to YP and OT and FNRS Grant 1.5.033.06F (Belgium) to YP. The authors acknowledge the Region Wallonne/FSE for the 'Nanotoxico' projects. The authors also thank the European Commission for the Integrated Projects 'Proteomage' (LSMH-CT-2005-518230), 'Markage' (HEALTH-F4-2008-200880) and 'Myoage' (HEALTH-F2-2009-223576); Coordination Action Link-Age (LSHM-CT-2005-513866) and 'Matiss' Marie Curie Project (MTKI-CT-2006-042768). The funders and the StratiCELL SA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Armeni T, 2001, BIOL CHEM, V382, P1697, DOI 10.1515/BC.2001.205; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; BERTRANDVALLERY V, 2009, BIOGERONTOLOGY; Boxman ILA, 2002, BRIT J DERMATOL, V146, P777, DOI 10.1046/j.1365-2133.2002.04714.x; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; D'Errico M, 2003, CELL DEATH DIFFER, V10, P754, DOI 10.1038/sj.cdd.4401224; Decraene D, 2005, J INVEST DERMATOL, V125, P1026, DOI 10.1111/j.0022-202X.2005.23909.x; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Ernst T, 2002, VERH DEUT G, V86, P165; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Han JL, 2004, CANCER RES, V64, P3009, DOI 10.1158/0008-5472.CAN-04-0246; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Huang CM, 2005, EXPERT REV PROTEOMIC, V2, P809, DOI 10.1586/14789450.2.5.809; Huang CM, 2003, J INVEST DERMATOL, V121, P51, DOI 10.1046/j.1523-1747.2003.12327.x; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; KAPP LN, 1989, INT J RADIAT BIOL, V56, P667, DOI 10.1080/09553008914551891; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Laderoute KR, 1996, INT J CANCER, V66, P772, DOI 10.1002/(SICI)1097-0215(19960611)66:6<772::AID-IJC11>3.0.CO;2-5; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURNANE JP, 1993, SEMIN CANCER BIOL, V4, P93; Nacht M, 1999, CANCER RES, V59, P5464; Onoue S, 2003, J DERMATOL SCI, V33, P105, DOI 10.1016/j.jdermsci.2003.08.002; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Sano T, 2009, ARCH DERMATOL RES, V301, P227, DOI 10.1007/s00403-008-0914-6; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Weisfelner Michelle Emily, 2003, J Drugs Dermatol, V2, P385; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Wong JW, 2000, J INVEST DERMATOL, V115, P427, DOI 10.1046/j.1523-1747.2000.00077.x	57	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10462	10.1371/journal.pone.0010462	http://dx.doi.org/10.1371/journal.pone.0010462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454669	Green Published, gold			2022-12-27	WOS:000277240300026
J	Kim, MS; Kim, T; Kong, SY; Kwon, S; Bae, CY; Choi, J; Kim, CH; Lee, ES; Park, JK				Kim, Minseok S.; Kim, Taemin; Kong, Sun-Young; Kwon, Soim; Bae, Chae Yun; Choi, Jaekyu; Kim, Chul Hwan; Lee, Eun Sook; Park, Je-Kyun			Breast Cancer Diagnosis Using a Microfluidic Multiplexed Immunohistochemistry Platform	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; GENE-EXPRESSION PATTERNS; TISSUE MICROARRAYS; PREOPERATIVE CHEMOTHERAPY; MOLECULAR PATHOLOGY; BIOMARKER ANALYSIS; CELLULAR TARGETS; PROSTATE-CANCER; QUANTIFICATION; CARCINOMAS	Background: Biomarkers play a key role in risk assessment, assessing treatment response, and detecting recurrence and the investigation of multiple biomarkers may also prove useful in accurate prediction and prognosis of cancers. Immunohistochemistry (IHC) has been a major diagnostic tool to identify therapeutic biomarkers and to subclassify breast cancer patients. However, there is no suitable IHC platform for multiplex assay toward personalized cancer therapy. Here, we report a microfluidics-based multiplexed IHC (MMIHC) platform that significantly improves IHC performance in reduction of time and tissue consumption, quantification, consistency, sensitivity, specificity and cost-effectiveness. Methodology/Principal Findings: By creating a simple and robust interface between the device and human breast tissue samples, we not only applied conventional thin-section tissues into on-chip without any additional modification process, but also attained perfect fluid control for various solutions, without any leakage, bubble formation, or cross-contamination. Four biomarkers, estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR) and Ki-67, were examined simultaneously on breast cancer cells and human breast cancer tissues. The MMIHC method improved immunoreaction, reducing time and reagent consumption. Moreover, it showed the availability of semi-quantitative analysis by comparing Western blot. Concordance study proved strong consensus between conventional whole-section analysis and MMIHC (n = 105, lowest Kendall's coefficient of concordance, 0.90). To demonstrate the suitability of MMIHC for scarce samples, it was also applied successfully to tissues from needle biopsies. Conclusions/Significance: The microfluidic system, for the first time, was successfully applied to human clinical tissue samples and histopathological diagnosis was realized for breast cancers. Our results showing substantial agreement indicate that several cancer-related proteins can be simultaneously investigated on a single tumor section, giving clear advantages and technical advances over standard immunohistochemical method. This novel concept will enable histopathological diagnosis using numerous specific biomarkers at a time even for small-sized specimens, thus facilitating the individualization of cancer therapy.	[Kim, Minseok S.; Bae, Chae Yun; Choi, Jaekyu; Park, Je-Kyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Taemin] Korea Adv Inst Sci & Technol, Dept Elect Engn & Comp Sci, Taejon 305701, South Korea; [Kong, Sun-Young] Natl Canc Ctr, Res Inst & Hosp, Dept Lab Med, Goyang, South Korea; [Kwon, Soim; Lee, Eun Sook] Korea Univ, Coll Med, Dept Breast & Endocrine Surg, Seoul 136705, South Korea; [Kim, Chul Hwan] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea; [Park, Je-Kyun] Korea Adv Inst Sci & Technol, Inst NanoCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea Advanced Institute of Science & Technology (KAIST)	Kim, MS (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	eslee@korea.ac.kr; jekyun@kaist.ac.kr	Park, Je-Kyun/A-4911-2011; Kong, Sun-Young/ABB-7914-2021; Kim, Minseok S./AAJ-4797-2020	Park, Je-Kyun/0000-0003-4522-2574; 	Ministry of Education, Science and Technology (MEST) [R0A-2008-000-20109-0, 2008-00771]; Korea University [K0823791]	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University	This work was supported by the National Research Laboratory (NRL) Program grant (R0A-2008-000-20109-0) and by the Nano/Bio Science and Technology Program grant (2008-00771) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST), and by the Korea University grant (K0823791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Dietel M, 2006, VIRCHOWS ARCH, V448, P744, DOI 10.1007/s00428-006-0189-2; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Fountaine TJ, 2006, MODERN PATHOL, V19, P1181, DOI 10.1038/modpathol.3800628; Garcia S, 2007, BRIT J CANCER, V96, P329, DOI 10.1038/sj.bjc.6603569; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Hahn YK, 2007, ANAL CHEM, V79, P2214, DOI 10.1021/ac061522l; Halushka MK, 2010, CARDIOVASC PATHOL, V19, P136, DOI 10.1016/j.carpath.2008.12.007; Hassan S, 2008, CURR OPIN BIOTECH, V19, P19, DOI 10.1016/j.copbio.2007.10.009; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JE, 2007, J CLIN NEUROL, V3, P9, DOI 10.3988/jcn.2007.3.1.9; Kim MS, 2008, BIOTECHNOL BIOENG, V101, P1005, DOI 10.1002/bit.21962; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lakhani SR, 2001, NAT REV CANCER, V1, P151, DOI 10.1038/35101087; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Netto GJ, 2006, ARCH PATHOL LAB MED, V130, P1157; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Regitnig P, 2002, VIRCHOWS ARCH, V441, P328, DOI 10.1007/s00428-002-0646-5; Rosen DG, 2004, MODERN PATHOL, V17, P790, DOI 10.1038/modpathol.3800120; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stearns V, 2006, NAT REV CANCER, V6, P886, DOI 10.1038/nrc1992; Sweeney E, 2008, BIOCHEM BIOPH RES CO, V374, P181, DOI 10.1016/j.bbrc.2008.06.127; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Wang HN, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065101; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107; Yeon JH, 2007, BIOCHIP J, V1, P17; Yeon JH, 2009, ANAL CHEM, V81, P1944, DOI 10.1021/ac802351w; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8	44	52	57	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10441	10.1371/journal.pone.0010441	http://dx.doi.org/10.1371/journal.pone.0010441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454672	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300017
J	Sanchez-Vives, MV; Spanlang, B; Frisoli, A; Bergamasco, M; Slater, M				Sanchez-Vives, Maria V.; Spanlang, Bernhard; Frisoli, Antonio; Bergamasco, Massimo; Slater, Mel			Virtual Hand Illusion Induced by Visuomotor Correlations	PLOS ONE			English	Article							RUBBER HAND; BODY; OWNERSHIP	Background: Our body schema gives the subjective impression of being highly stable. However, a number of easily-evoked illusions illustrate its remarkable malleability. In the rubber-hand illusion, illusory ownership of a rubber-hand is evoked by synchronous visual and tactile stimulation on a visible rubber arm and on the hidden real arm. Ownership is concurrent with a proprioceptive illusion of displacement of the arm position towards the fake arm. We have previously shown that this illusion of ownership plus the proprioceptive displacement also occurs towards a virtual 3D projection of an arm when the appropriate synchronous visuotactile stimulation is provided. Our objective here was to explore whether these illusions (ownership and proprioceptive displacement) can be induced by only synchronous visuomotor stimulation, in the absence of tactile stimulation. Methodology/Principal Findings: To achieve this we used a data-glove that uses sensors transmitting the positions of fingers to a virtually projected hand in the synchronous but not in the asynchronous condition. The illusion of ownership was measured by means of questionnaires. Questions related to ownership gave significantly larger values for the synchronous than for the asynchronous condition. Proprioceptive displacement provided an objective measure of the illusion and had a median value of 3.5 cm difference between the synchronous and asynchronous conditions. In addition, the correlation between the feeling of ownership of the virtual arm and the size of the drift was significant. Conclusions/Significance: We conclude that synchrony between visual and proprioceptive information along with motor activity is able to induce an illusion of ownership over a virtual arm. This has implications regarding the brain mechanisms underlying body ownership as well as the use of virtual bodies in therapies and rehabilitation.	[Sanchez-Vives, Maria V.; Slater, Mel] Inst Catalana Recerca Estudis Avancats, Barcelona, Spain; [Sanchez-Vives, Maria V.] IDIBAPS, Barcelona, Spain; [Spanlang, Bernhard] Univ Politecn Cataluna, Barcelona, Spain; [Frisoli, Antonio; Bergamasco, Massimo] Scuola Super Sant Anna, CEIICP, PERCRO, Pisa, Italy; [Slater, Mel] Univ Barcelona, Barcelona, Spain; [Slater, Mel] UCL, London, England	ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; Scuola Superiore Sant'Anna; University of Barcelona; University of London; University College London	Sanchez-Vives, MV (corresponding author), Inst Catalana Recerca Estudis Avancats, Barcelona, Spain.	msanche3@clinic.ub.es	Slater, Mel/M-5210-2014; Sanchez-Vives, Maria/J-8526-2014	Slater, Mel/0000-0002-6223-0050; Sanchez-Vives, Maria/0000-0002-8437-9083; BERGAMASCO, Massimo/0000-0002-7418-2332; Spanlang, Bernhard/0000-0002-9659-635X	EU Future and Emerging Technologies [27731]; ICREA Funding Source: Custom	EU Future and Emerging Technologies; ICREA(ICREA)	This project was funded under the EU Future and Emerging Technologies 6th Framework Integrated Project PRESENCCIA Contract Number 27731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; BERGAMASCO M, 2008, GONIOMETRIC SENSOR; BOTVINICK M, 1998, RUBBER HANDS FEEL TO; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kammers MPM, 2009, PERCEPTION, V38, P1804, DOI 10.1068/p6389; KAVAN L, 2007, SKINNING DUAL QUATER; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; Raz L, 2008, LECT NOTES COMPUT SC, V5024, P367, DOI 10.1007/978-3-540-69057-3_47; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Spanlang B., 2009, HALCA HARDWARE ACCEL; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2	19	234	237	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10381	10.1371/journal.pone.0010381	http://dx.doi.org/10.1371/journal.pone.0010381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PU	20454463	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100008
J	Verine, J; Lehmann-Che, J; Soliman, H; Feugeas, JP; Vidal, JS; Mongiat-Artus, P; Belhadj, S; Philippe, J; Lesage, M; Wittmer, E; Chanel, S; Couvelard, A; Ferlicot, S; Rioux-Leclercq, N; Vignaud, JM; Janin, A; Germain, S				Verine, Jerome; Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Vidal, Jean-Sebastien; Mongiat-Artus, Pierre; Belhadj, Stephanie; Philippe, Josette; Lesage, Matthieu; Wittmer, Evelyne; Chanel, Stephane; Couvelard, Anne; Ferlicot, Sophie; Rioux-Leclercq, Nathalie; Vignaud, Jean-Michel; Janin, Anne; Germain, Stephane			Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; COILED-COIL DOMAIN; TUMOR-SUPPRESSOR; EPITHELIAL TUMORS; GENE; CLASSIFICATION; EXPRESSION; MUTATIONS; PROTEIN; UTILITY	Background: We have previously shown that angiopoietin-like 4 (angptl4) mRNA, a hypoxia-inducible gene, is highly expressed in clear cell renal-cell carcinoma (ccRCC), the most common subtype of RCC for which no specific marker is available. We here investigated whether angptl4 mRNA 1) could be a useful diagnostic and/or prognostic marker of ccRCC in a large and comprehensive retrospective series, 2) induction is dependent on the VHL status of tumors. Methodology/Principal Findings: Using in situ hybridization, we report that angptl4 mRNA is expressed in 100% of both sporadic (n = 102) and inherited (n = 6) primary ccRCCs, without any statistical association with nuclear grade (p = 0.39), tumor size (p = 0.09), stage grouping (p = 0.17), progression-free survival (p = 0.94), and overall survival (p = 0.80). Angptl4 mRNA was also expressed in 26 (87%) of 30 secondary ccRCCs but neither in any other secondary RCCs (n = 7). In contrast, angptl4 mRNA was neither expressed in 94% non-ccRCC renal tumors (papillary RCCs (n = 46), chromophobe RCCs (n = 28), and oncocytomas (n = 9)), nor in non-renal clear cell carcinomas (n = 39). Angptl4 expression was also examined in tumors associated (n = 23) or not associated (n = 66) with VHL disease. 40 (98%) hemangioblastomas expressed angptl4 whereas all pheochromocytomas (n = 23) and pancreatic tumors (n = 25) were angptl4-negative, whatever their VHL status. Conclusions/Significance: Angptl4 mRNA expression was highly associated with ccRCC (p = 1.5 10(-49), Chi square test) allowing to define its expression as a diagnosis marker for primary ccRCC. Moreover, angptl4 mRNA allows to discriminate the renal origin of metastases of clear-cell carcinomas arising from various organs. Finally, inactivation of VHL gene is neither necessary nor sufficient for angptl4 mRNA induction.	[Verine, Jerome; Philippe, Josette; Lesage, Matthieu; Germain, Stephane] INSERM, U833, Paris, France; [Verine, Jerome; Philippe, Josette; Lesage, Matthieu; Germain, Stephane] Coll France, Chaire Med Expt, F-75231 Paris, France; [Verine, Jerome; Belhadj, Stephanie; Janin, Anne] INSERM, U728, Paris, France; [Verine, Jerome; Lehmann-Che, Jacqueline; Feugeas, Jean-Paul; Mongiat-Artus, Pierre; Janin, Anne] Univ Paris Diderot Paris 7, Paris, France; [Verine, Jerome; Janin, Anne] Hop St Louis, AP HP, Pathol Lab, Paris, France; [Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Wittmer, Evelyne] Hop St Louis, AP HP, Biochim Lab, Paris, France; [Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Mongiat-Artus, Pierre] INSERM, U944, Paris, France; [Vidal, Jean-Sebastien] INSERM, U708, Paris, France; [Mongiat-Artus, Pierre] Hop St Louis, AP HP, Serv Urol, Paris, France; [Chanel, Stephane] Lab Pasteur Cerba, Cergy Pontoise, France; [Couvelard, Anne] Hop Beaujon, AP HP, Pathol Lab, Clichy, France; [Ferlicot, Sophie] Hop Bicetre, AP HP, Pathol Lab, Le Kremlin Bicetre, France; [Rioux-Leclercq, Nathalie] CHU Rennes, Pathol Lab, Rennes, France; [Vignaud, Jean-Michel] CHU Nancy, Pathol Lab, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Rennes; CHU de Nancy	Verine, J (corresponding author), INSERM, U833, Paris, France.	stephane.germain@college-de-france.fr	Vidal, Jean-Sebastien/D-1941-2016; Germain, Stephane/E-2301-2016; rioux-leclercq, nathalie/I-2820-2015	Vidal, Jean-Sebastien/0000-0001-6770-0720; Germain, Stephane/0000-0001-5992-1275; Anne, Couvelard/0000-0002-6316-1210; FERLICOT, SOPHIE/0000-0003-4124-9227; Lehmann-Che, jacqueline/0000-0001-6685-3354	Programme Hospitalier de Recherche Clinique National 2006 [AOM 06 144]	Programme Hospitalier de Recherche Clinique National 2006	This work was supported by a grant from Programme Hospitalier de Recherche Clinique National 2006 (AOM 06 144). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allory Y, 2008, HISTOPATHOLOGY, V52, P158, DOI 10.1111/j.1365-2559.2007.02900.x; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ficarra V, 2007, LANCET ONCOL, V8, P554, DOI 10.1016/S1470-2045(07)70173-0; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gokden N, 2008, AM J SURG PATHOL, V32, P1462, DOI 10.1097/PAS.0b013e318176dba7; Gupta R, 2009, AM J SURG PATHOL, V33, P241, DOI 10.1097/PAS.0b013e318181b828; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Lane BR, 2009, J UROLOGY, V181, P849, DOI 10.1016/j.juro.2008.10.069; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Ortiz-Rey J A, 2006, Actas Urol Esp, V30, P281; OSUNKOYA AO, 2009, HUM PATHOL; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pascual D, 2008, ADV UROL, V2008, DOI 10.1155/2008/782381; Perigny M, 2009, AM J SURG PATHOL, V33, P739, DOI 10.1097/PAS.0b013e3181967992; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Skinnider BF, 2005, SEMIN DIAGN PATHOL, V22, P51, DOI 10.1053/j.semdp.2005.11.004; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Weinbreck N, 2008, AM J SURG PATHOL, V32, P1051, DOI 10.1097/PAS.0b013e3181609d7d; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	33	26	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10421	10.1371/journal.pone.0010421	http://dx.doi.org/10.1371/journal.pone.0010421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454689	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100026
J	Slobbe, L; Doorduijn, JK; Lugtenburg, PJ; el Barzouhi, A; Boersma, E; van Leeuwen, WB; Rijnders, BJA				Slobbe, Lennert; Doorduijn, Jeanette K.; Lugtenburg, Pieternella J.; el Barzouhi, Abdelilah; Boersma, Eric; van Leeuwen, Willem B.; Rijnders, Bart J. A.			Prevention of Catheter-Related Bacteremia with a Daily Ethanol Lock in Patients with Tunnelled Catheters: A Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; NEGATIVE STAPHYLOCOCCAL BACTEREMIA; CRITICALLY-ILL PATIENTS; DOUBLE-BLIND TRIAL; ATTRIBUTABLE MORTALITY; INTRAVASCULAR DEVICES; NEUTROPENIC PATIENTS; DIAGNOSIS; MICROORGANISMS; POLYURETHANE	Background: Catheter-related bloodstream infection (CRBSI) results in significant attributable morbidity and mortality. In this randomized, double-blind, placebo-controlled trial, we studied the efficacy and safety of a daily ethanol lock for the prevention of CRBSI in patients with a tunnelled central venous catheter (CVC). Methodology: From 2005 through 2008, each lumen of the CVC of adult hematology patients was locked for 15 minutes per day with either 70%-ethanol or placebo, where after the lock solution was flushed through. As a primary endpoint, the incidence rates of endoluminal CRBSI were compared. Principal Findings: The intent-to-treat analysis was based on 376 patients, accounting for 448 CVCs and 27,745 catheter days. For ethanol locks, the incidence of endoluminal CRBSI per 1000 CVC-days was 0.70 (95%-CI, 0.4-1.3), compared to 1.19 (95% confidence interval, 0.7-1.9) for placebo (incidence rate-ratio, 0.59; 95% confidence interval, 0.27-1.30; P = .19). For endoluminal CRBSI according to the strictest definition (positive hub culture and identical bacterial strain in blood), a 3.6 fold, non-significant, reduction was observed for patients receiving ethanol (2 of 226 versus 7 of 222; P = .103). No life-threatening adverse events were observed. More patients receiving ethanol discontinued lock-therapy (11 of 226 versus 1 of 222; P = .006) or continued with decreased lock-frequency (10 of 226 versus 0 of 222; P = .002), due to non-severe adverse events. Conclusions: In this study, the reduction in the incidence of endoluminal CRBSI using preventive ethanol locks was nonsignificant, although the low incidence of endoluminal CRBSI precludes definite conclusions. Therefore, the lack of statistical significance may partially reflect a lack of power. Significantly more patients treated with ethanol locks discontinued their prophylactic treatment due to adverse effects, which were non-severe but reasonably ethanol related. Additional studies should be performed in populations with higher incidence of (endoluminal) CRBSI. Alternative sources of bacteremia, like exoluminal CRBSI or microbial translocation during chemotherapy-induced mucositis may have been more important in our patients.	[Slobbe, Lennert; el Barzouhi, Abdelilah; van Leeuwen, Willem B.; Rijnders, Bart J. A.] Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands; [Slobbe, Lennert; el Barzouhi, Abdelilah; van Leeuwen, Willem B.; Rijnders, Bart J. A.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Doorduijn, Jeanette K.; Lugtenburg, Pieternella J.] Erasmus MC, Dept Haematol, Rotterdam, Netherlands; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Slobbe, L (corresponding author), Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands.	b.rijnders@erasmusmc.nl	rijnders, bart/AAB-2868-2019; rijnders, bart ja/V-7527-2018	rijnders, bart/0000-0003-3343-9610; 	Fonds NutsOhra; Netherlands	Fonds NutsOhra; Netherlands(Netherlands Government)	This study was supported by Fonds NutsOhra, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrino D, 2009, NEPHROL DIAL TRANSPL, V24, P3204, DOI 10.1093/ndt/gfp187; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; Broom J, 2008, SCAND J INFECT DIS, V40, P399, DOI 10.1080/00365540701756953; BYERS K, 1995, P 5 ANN M SOC HOSP E; Carratala J, 1999, ANTIMICROB AGENTS CH, V43, P2200, DOI 10.1128/AAC.43.9.2200; Costa SF, 2006, AM J INFECT CONTROL, V34, P36, DOI 10.1016/j.ajic.2005.10.007; Costa SF, 2004, LANCET INFECT DIS, V4, P278, DOI 10.1016/S1473-3099(04)01003-5; Crnich CJ, 2005, INFECT CONT HOSP EP, V26, P708, DOI 10.1086/502607; Crnich CJ, 2009, 49 INT C ANT AG CHEM; Dannenberg C, 2003, J PEDIAT HEMATOL ONC, V25, P616, DOI 10.1097/00043426-200308000-00006; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Henrickson KJ, 2000, J CLIN ONCOL, V18, P1269, DOI 10.1200/JCO.2000.18.6.1269; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Laird J, 2005, J INFECTION, V51, P338, DOI 10.1016/j.jinf.2005.02.009; Maiefski M, 2009, INFECT CONT HOSP EP, V30, P1096, DOI 10.1086/606162; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; MAKI DG, 1998, HOSP INFECT, P689; McHugh GJ, 1997, ANAESTH INTENS CARE, V25, P350, DOI 10.1177/0310057X9702500404; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; Mouw E, 2008, J PEDIATR SURG, V43, P1025, DOI 10.1016/j.jpedsurg.2008.02.026; Nouwen JL, 1999, J CLIN ONCOL, V17, P1304, DOI 10.1200/JCO.1999.17.4.1304; O'Grady NP, 2002, AM J INFECT CONTROL, V30, P476, DOI 10.1067/mic.2002.129427; Onland W, 2006, ARCH PEDIAT ADOL MED, V160, P1049, DOI 10.1001/archpedi.160.10.1049; Opilla MT, 2007, JPEN-PARENTER ENTER, V31, P302, DOI 10.1177/0148607107031004302; Percival SL, 2007, J VASC ACCESS, V8, P69, DOI 10.1177/112972980700800202; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Qu Y, 2009, J MED MICROBIOL, V58, P442, DOI 10.1099/jmm.0.006387-0; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Rello J, 2000, AM J RESP CRIT CARE, V162, P1027, DOI 10.1164/ajrccm.162.3.9911093; Safdar N, 2005, ANN INTERN MED, V142, P451, DOI 10.7326/0003-4819-142-6-200503150-00011; Safdar N, 2006, CLIN INFECT DIS, V43, P474, DOI 10.1086/505976; Sampath LA, 2001, INFECT CONT HOSP EP, V22, P640, DOI 10.1086/501836; Sanders J, 2008, J ANTIMICROB CHEMOTH, V62, P809, DOI 10.1093/jac/dkn284; VANBELKUM A, 1995, J CLIN MICROBIOL, V33, P1537, DOI 10.1128/JCM.33.6.1537-1547.1995; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203	39	87	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10840	10.1371/journal.pone.0010840	http://dx.doi.org/10.1371/journal.pone.0010840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520776	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500026
J	Boyko, RH; Marshall, AJ				Boyko, Ryan H.; Marshall, Andrew J.			Using Simulation Models to Evaluate Ape Nest Survey Techniques	PLOS ONE			English	Article							ORANGUTAN PONGO-PYGMAEUS; WEST KALIMANTAN; POPULATION; FOREST	Background: Conservationists frequently use nest count surveys to estimate great ape population densities, yet the accuracy and precision of the resulting estimates are difficult to assess. Methodology/Principal Findings: We used mathematical simulations to model nest building behavior in an orangutan population to compare the quality of the population size estimates produced by two of the commonly used nest count methods, the 'marked recount method' and the 'matrix method.' We found that when observers missed even small proportions of nests in the first survey, the marked recount method produced large overestimates of the population size. Regardless of observer reliability, the matrix method produced substantial overestimates of the population size when surveying effort was low. With high observer reliability, both methods required surveying approximately 0.26% of the study area (0.26 km(2) out of 100 km(2) in this simulation) to achieve an accurate estimate of population size; at or above this sampling effort both methods produced estimates within 33% of the true population size 50% of the time. Both methods showed diminishing returns at survey efforts above 0.26% of the study area. The use of published nest decay estimates derived from other sites resulted in widely varying population size estimates that spanned nearly an entire order of magnitude. The marked recount method proved much better at detecting population declines, detecting 5% declines nearly 80% of the time even in the first year of decline. Conclusions/Significance: These results highlight the fact that neither nest surveying method produces highly reliable population size estimates with any reasonable surveying effort, though either method could be used to obtain a gross population size estimate in an area. Conservation managers should determine if the quality of these estimates are worth the money and effort required to produce them, and should generally limit surveying effort to 0.26% of the study area, unless specific management goals require more intensive sampling. Using site-and time-specific nest decay rates (or the marked recount method) are essential for accurate population size estimation. Marked recount survey methods with sufficient sampling effort hold promise for detecting population declines.	[Boyko, Ryan H.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Boyko, RH (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	rboyko@ucdavis.edu						Buij R, 2002, BIOL CONSERV, V107, P83, DOI 10.1016/S0006-3207(02)00048-4; Buij R, 2003, BIOL CONSERV, V114, P103, DOI 10.1016/S0006-3207(03)00015-6; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Husson Simon J., 2009, P77; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; K?hl H., 2008, BEST PRACTICE GUIDEL; KEMENY JG, 1956, INTRO FINITE MATH; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; MOLYNEAUX A, 2007, THESIS OXFORD BROOKS; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Prasetyo Didik, 2009, P269; Russon AE, 2001, BIOL CONSERV, V97, P21, DOI 10.1016/S0006-3207(00)00087-2; Singleton I, 2000, THESIS U KENT CANTER THESIS U KENT CANTER; van Schaik Carel P., 2009, P351; vanSchaik CP, 1995, NEGLECTED APE, P109; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	18	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10754	10.1371/journal.pone.0010754	http://dx.doi.org/10.1371/journal.pone.0010754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505781	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400011
J	Jung, M; Peterson, H; Chavez, L; Kahlem, P; Lehrach, H; Vilo, J; Adjaye, J				Jung, Marc; Peterson, Hedi; Chavez, Lukas; Kahlem, Pascal; Lehrach, Hans; Vilo, Jaak; Adjaye, James			A Data Integration Approach to Mapping OCT4 Gene Regulatory Networks Operative in Embryonic Stem Cells and Embryonal Carcinoma Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; TARGET GENES; CHIP-CHIP; EC CELLS; EXPRESSION; NANOG; DIFFERENTIATION; IDENTIFICATION; BINDING	It is essential to understand the network of transcription factors controlling self-renewal of human embryonic stem cells (ESCs) and human embryonal carcinoma cells (ECs) if we are to exploit these cells in regenerative medicine regimes. Correlating gene expression levels after RNAi-based ablation of OCT4 function with its downstream targets enables a better prediction of motif-specific driven expression modules pertinent for self-renewal and differentiation of embryonic stem cells and induced pluripotent stem cells. We initially identified putative direct downstream targets of OCT4 by employing CHIP-on-chip analysis. A comparison of three peak analysis programs revealed a refined list of OCT4 targets in the human EC cell line NCCIT, this list was then compared to previously published OCT4 CHIP-on-chip datasets derived from both ES and EC cells. We have verified an enriched POU-motif, discovered by a de novo approach, thus enabling us to define six distinct modules of OCT4 binding and regulation of its target genes. A selection of these targets has been validated, like NANOG, which harbours the evolutionarily conserved OCT4-SOX2 binding motif within its proximal promoter. Other validated targets, which do not harbour the classical HMG motif are USP44 and GADD45G, a key regulator of the cell cycle. Overexpression of GADD45G in NCCIT cells resulted in an enrichment and up-regulation of genes associated with the cell cycle (CDKN1B, CDKN1C, CDK6 and MAPK4) and developmental processes (BMP4, HAND1, EOMES, ID2, GATA4, GATA5, ISL1 and MSX1). A comparison of positively regulated OCT4 targets common to EC and ES cells identified genes such as NANOG, PHC1, USP44, SOX2, PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types. Finally we have created a user-friendly database (http://biit.cs.ut.ee/escd/), integrating all OCT4 and stem cell related datasets in both human and mouse ES and EC cells. In the current era of systems biology driven research, we envisage that our integrated embryonic stem cell database will prove beneficial to the booming field of ES, iPS and cancer research.	[Jung, Marc; Chavez, Lukas; Lehrach, Hans; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Peterson, Hedi] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Peterson, Hedi; Vilo, Jaak] Quretec Ltd, Tartu, Estonia; [Kahlem, Pascal] EMBL European Bioinformat Inst, Cambridge, England; [Vilo, Jaak] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia	Max Planck Society; University of Tartu; European Molecular Biology Laboratory (EMBL); University of Tartu	Jung, M (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany.	jung@molgen.mpg.de; adjaye@molgen.mpg.de	Peterson, Hedi/F-4920-2017; Vilo, Jaak/AAK-2228-2020; Peterson, Hedi/ABA-3355-2020; Vilo, Jaak/A-7183-2008; Peterson, Hedi/C-7514-2012	Peterson, Hedi/0000-0001-9951-5116; Vilo, Jaak/0000-0001-5604-4107; Peterson, Hedi/0000-0001-9951-5116; Vilo, Jaak/0000-0001-5604-4107; Kahlem, Pascal/0000-0002-8810-444X; Chavez, Lukas/0000-0002-8718-8848	ENFIN; European Commission [LSHG-CT-2005-518254]; Max Planck Society	ENFIN(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health'', contract number LSHG-CT-2005-518254, and also the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Adjaye J, 1999, GENE, V237, P373, DOI 10.1016/S0378-1119(99)00329-7; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; DAMJANOV I, 1993, LAB INVEST, V68, P220; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GORDAN R, 2009, GENOME RES; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; Goto T, 1999, MOL HUM REPROD, V5, P851, DOI 10.1093/molehr/5.9.851; GREBER B, 2008, STEM CELLS DEV; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Li HY, 2008, OBESITY, V16, P356, DOI 10.1038/oby.2007.76; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; LISTER R, 2009, NATURE; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; Regenbrecht CRA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-49; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; TANTIN D, 2008, GENOME RES; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Xiong C, 2005, STEM CELLS DEV, V14, P367, DOI 10.1089/scd.2005.14.367	76	72	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10709	10.1371/journal.pone.0010709	http://dx.doi.org/10.1371/journal.pone.0010709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505756	Green Submitted, gold, Green Published			2022-12-27	WOS:000278017400009
J	Imanian, B; Pombert, JF; Keeling, PJ				Imanian, Behzad; Pombert, Jean-Francois; Keeling, Patrick J.			The Complete Plastid Genomes of the Two 'Dinotoms' Durinskia baltica and Kryptoperidinium foliaceum	PLOS ONE			English	Article							DINOFLAGELLATE PERIDINIUM-BALTICUM; SP-NOV DINOPHYCEAE; GLENODINIUM-FOLIACEUM; MARINE DINOFLAGELLATE; DIATOM ENDOSYMBIONT; SERIAL REPLACEMENT; QUINQUECORNE ABE; GENE-TRANSFER; CHLOROPLAST; RECOMBINATION	Background: In one small group of dinoflagellates, photosynthesis is carried out by a tertiary endosymbiont derived from a diatom, giving rise to a complex cell that we collectively refer to as a 'dinotom'. The endosymbiont is separated from its host by a single membrane and retains plastids, mitochondria, a large nucleus, and many other eukaryotic organelles and structures, a level of complexity suggesting an early stage of integration. Although the evolution of these endosymbionts has attracted considerable interest, the plastid genome has not been examined in detail, and indeed no tertiary plastid genome has yet been sequenced. Methodology/Principal Findings: Here we describe the complete plastid genomes of two closely related dinotoms, Durinskia baltica and Kryptoperidinium foliaceum. The D. baltica (116470 bp) and K. foliaceum (140426 bp) plastid genomes map as circular molecules featuring two large inverted repeats that separate distinct single copy regions. The organization and gene content of the D. baltica plastid closely resemble those of the pennate diatom Phaeodactylum tricornutum. The K. foliaceum plastid genome is much larger, has undergone more reorganization, and encodes a putative tyrosine recombinase (tyrC) also found in the plastid genome of the heterokont Heterosigma akashiwo, and two putative serine recombinases (serC1 and serC2) homologous to recombinases encoded by plasmids pCf1 and pCf2 in another pennate diatom, Cylindrotheca fusiformis. The K. foliaceum plastid genome also contains an additional copy of serC1, two degenerate copies of another plasmid-encoded ORF, and two non-coding regions whose sequences closely resemble portions of the pCf1 and pCf2 plasmids. Conclusions/Significance: These results suggest that while the plastid genomes of two dinotoms share very similar gene content and genome organization with that of the free-living pennate diatom P. tricornutum, the K. folicaeum plastid genome has absorbed two exogenous plasmids. Whether this took place before or after the tertiary endosymbiosis is not clear.	[Imanian, Behzad; Pombert, Jean-Francois; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Imanian, B (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375; Imanian, Behzad/0000-0002-8768-0453	Natural Sciences and Engineering Research Council of Canada [227301]; Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet(FQRNT)	This work was supported by a Natural Sciences and Engineering Research Council operating grant (227301) to PJK. BI is the recipient of a Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada. JFP is the recipient of the Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Scholar of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; BLAKELY GW, 1994, NUCLEIC ACIDS RES, V22, P5613; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; CARTY S, 1986, PHYCOLOGIA, V25, P197, DOI 10.2216/i0031-8884-25-2-197.1; Cattolico RA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-211; Chesnick JM, 1997, J EUKARYOT MICROBIOL, V44, P314, DOI 10.1111/j.1550-7408.1997.tb05672.x; CHESNICK JM, 1987, BIOSYSTEMS, V21, P69, DOI 10.1016/0303-2647(87)90007-4; CHESNICK JM, 1989, AM J BOT, V76, P1060, DOI 10.2307/2444528; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deane JA, 2000, PROTIST, V151, P239, DOI 10.1078/1434-4610-00022; DEMADARIAGA I, 1989, BOT MAR, V32, P159, DOI 10.1515/botm.1989.32.2.159; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; ESCHBACH S, 1990, J PHYCOL, V26, P324, DOI 10.1111/j.0022-3646.1990.00324.x; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Figueroa RI, 2009, PROTIST, V160, P285, DOI 10.1016/j.protis.2008.12.003; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Garate-Lizarraga I, 2008, ACTA BOT MEX, V83, P33, DOI 10.21829/abm83.2008.1059; GORDON D, 2004, CURRENT PROTOCOLS BI; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; HAN YPW, 1993, EMBO J, V12, P4577, DOI 10.1002/j.1460-2075.1993.tb06146.x; Hewes CD, 1998, J PHYCOL, V34, P945, DOI 10.1046/j.1529-8817.1998.340945.x; HILDEBRAND M, 1991, J BACTERIOL, V173, P5924, DOI 10.1128/jb.173.18.5924-5927.1991; HILDEBRAND M, 1992, PLANT MOL BIOL, V19, P759, DOI 10.1007/BF00027072; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Imanian B, 2007, J EUKARYOT MICROBIOL, V54, P146, DOI 10.1111/j.1550-7408.2007.00245.x; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Jarvis P, 2002, BBA-MOL CELL RES, V1590, P177, DOI 10.1016/S0167-4889(02)00176-3; JEFFREY SW, 1976, J PHYCOL, V12, P450, DOI 10.1111/j.1529-8817.1976.tb02872.x; JEFFREY SW, 1975, J PHYCOL, V11, P374, DOI 10.1111/j.1529-8817.1975.tb02799.x; Kempton Jason W., 2002, Harmful Algae, V1, P383, DOI 10.1016/S1568-9883(02)00051-3; KITE GC, 1988, BIOSYSTEMS, V21, P151, DOI 10.1016/0303-2647(88)90008-1; KITE GC, 1985, J PHYCOL, V21, P50; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; MANDELLI EF, 1968, J PHYCOL, V4, P347, DOI 10.1111/j.1529-8817.1968.tb04706.x; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McEwan ML, 2004, J EUKARYOT MICROBIOL, V51, P651, DOI 10.1111/j.1550-7408.2004.tb00604.x; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Pienaar RN, 2007, J PLANT RES, V120, P247, DOI 10.1007/s10265-006-0047-y; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Takano Y, 2008, PHYCOLOGIA, V47, P41, DOI 10.2216/07-36.1; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; TIPPIT DH, 1976, J CELL SCI, V21, P273; TOMAS RN, 1973, J PHYCOL, V9, P304; WITHERS NW, 1977, J PHYCOL, V13, P354, DOI 10.1111/j.0022-3646.1977.00354.x; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	64	69	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10711	10.1371/journal.pone.0010711	http://dx.doi.org/10.1371/journal.pone.0010711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502706	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400014
J	Zeller, T; Wild, P; Szymczak, S; Rotival, M; Schillert, A; Castagne, R; Maouche, S; Germain, M; Lackner, K; Rossmann, H; Eleftheriadis, M; Sinning, CR; Schnabel, RB; Lubos, E; Mennerich, D; Rust, W; Perret, C; Proust, C; Nicaud, V; Loscalzo, J; Hubner, N; Tregouet, D; Munzel, T; Ziegler, A; Tiret, L; Blankenberg, S; Cambien, F				Zeller, Tanja; Wild, Philipp; Szymczak, Silke; Rotival, Maxime; Schillert, Arne; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Lackner, Karl; Rossmann, Heidi; Eleftheriadis, Medea; Sinning, Christoph R.; Schnabel, Renate B.; Lubos, Edith; Mennerich, Detlev; Rust, Werner; Perret, Claire; Proust, Carole; Nicaud, Viviane; Loscalzo, Joseph; Huebner, Norbert; Tregouet, David; Muenzel, Thomas; Ziegler, Andreas; Tiret, Laurence; Blankenberg, Stefan; Cambien, Francois			Genetics and Beyond - The Transcriptome of Human Monocytes and Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; EXPRESSION PROFILES; GENES; LOCI; VARIANTS; RISK; MACROPHAGES; HAPLOTYPE; SMOKING	Background: Variability of gene expression in human may link gene sequence variability and phenotypes; however, non-genetic variations, alone or in combination with genetics, may also influence expression traits and have a critical role in physiological and disease processes. Methodology/Principal Findings: To get better insight into the overall variability of gene expression, we assessed the transcriptome of circulating monocytes, a key cell involved in immunity-related diseases and atherosclerosis, in 1,490 unrelated individuals and investigated its association with >675,000 SNPs and 10 common cardiovascular risk factors. Out of 12,808 expressed genes, 2,745 expression quantitative trait loci were detected (P<5.78x10(-12)), most of them (90%) being cis-modulated. Extensive analyses showed that associations identified by genome-wide association studies of lipids, body mass index or blood pressure were rarely compatible with a mediation by monocyte expression level at the locus. At a study-wide level (P<3.9x10(-7)), 1,662 expression traits (13.0%) were significantly associated with at least one risk factor. Genome-wide interaction analyses suggested that genetic variability and risk factors mostly acted additively on gene expression. Because of the structure of correlation among expression traits, the variability of risk factors could be characterized by a limited set of independent gene expressions which may have biological and clinical relevance. For example expression traits associated with cigarette smoking were more strongly associated with carotid atherosclerosis than smoking itself. Conclusions/Significance: This study demonstrates that the monocyte transcriptome is a potent integrator of genetic and non-genetic influences of relevance for disease pathophysiology and risk assessment.	[Zeller, Tanja; Wild, Philipp; Eleftheriadis, Medea; Sinning, Christoph R.; Schnabel, Renate B.; Lubos, Edith; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Mainz, Germany; [Szymczak, Silke; Schillert, Arne; Ziegler, Andreas] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Rotival, Maxime; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Perret, Claire; Proust, Carole; Nicaud, Viviane; Tregouet, David; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Rotival, Maxime; Castagne, Raphaele; Maouche, Seraya; Germain, Marine; Perret, Claire; Proust, Carole; Nicaud, Viviane; Tregouet, David; Tiret, Laurence; Cambien, Francois] Sch Med, Paris, France; [Lackner, Karl; Rossmann, Heidi] Johannes Gutenberg Univ Mainz, Inst Klin Chem & Labs Med, Mainz, Germany; [Mennerich, Detlev; Rust, Werner] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany	Johannes Gutenberg University of Mainz; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Johannes Gutenberg University of Mainz; Boehringer Ingelheim; Harvard University; Brigham & Women's Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Zeller, T (corresponding author), Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Mainz, Germany.	blankenberg@2-med.klinik.uni-mainz.de; francois.cambien@upmc.fr	Szymczak, Silke/C-6625-2013; Wild, Philipp S./M-2106-2019; Loscalzo, Joseph/ABD-8980-2021; Trégouët, David-Alexandre/P-9210-2019; Schnabel, Renate B/ABE-6668-2021; Schnabel, Renate B/F-6527-2014; Munzel, Thomas/A-2912-2014; Rossmann, Heidi/ABE-5694-2020; Tregouet, David-Alexandre/E-3961-2016; Szymczak, Silke/HGT-8202-2022; Cambien, Francois/AAP-9751-2020; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Rossmann, Heidi/0000-0002-7532-8540; Rotival, Maxime/0000-0003-2519-8044; Castagne, Raphaele/0000-0003-0067-6775; Maouche, Seraya/0000-0001-8186-1635; Wild, Philipp/0000-0003-4413-9752; Ziegler, Andreas/0000-0002-8386-5397; Germain, Marine/0000-0002-8489-8916; Zeller, Tanja/0000-0003-3379-2641; Szymczak, Silke/0000-0002-8897-9035	government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation) [AZ 961-386261/733]; Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research, Germany [A3 01GS0833]	government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation); Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	The Gutenberg Heart Study is funded through the government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fur Innovation, contract number AZ 961-386261/733), the research programs Wissen schafft Zukunft and Schwerpunkt Vaskulare Pravention of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Heart Study. Specifically, the research reported in this article was supported by the National Genome Network NGFNplus (contract number project A3 01GS0833) by the Federal Ministry of Education and Research, Germany. For this particular research paper, Boehringer Ingelheim provided payment of two employees for expression microarray analyses and array purchase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 1932, STAT METHODS RES WOR; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Buttner P, 2007, IMMUNOGENETICS, V59, P37, DOI 10.1007/s00251-006-0177-3; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Charles PC, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-38; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Huber W, 2002, BIOINFORMATICS, V18, pS96; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lindholm D, 2009, CELL MOL LIFE SCI, V66, P3399, DOI 10.1007/s00018-009-0127-y; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; R Core Team, 2018, R LANG ENV STAT COMP; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmitz G, 2001, J LIPID RES, V42, P1513; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tan QH, 2008, GENOMICS, V92, P94, DOI 10.1016/j.ygeno.2008.04.001; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Watanabe M, 2002, CIRC RES, V91, P382, DOI 10.1161/01.RES.0000033593.05545.7B; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279; Zudaire E, 2006, J LEUKOCYTE BIOL, V80, P237, DOI 10.1189/jlb.0206123	57	479	489	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10693	10.1371/journal.pone.0010693	http://dx.doi.org/10.1371/journal.pone.0010693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502693	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000277776500010
J	Prakash, H; Luth, A; Grinkina, N; Holzer, D; Wadgaonkar, R; Gonzalez, AP; Anes, E; Kleuser, B				Prakash, Hridayesh; Lueth, Anja; Grinkina, Natalia; Holzer, Daniela; Wadgaonkar, Raj; Gonzalez, Alexis Perez; Anes, Elsa; Kleuser, Burkhard			Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; BACILLUS-CALMETTE-GUERIN; NITRIC-OXIDE PRODUCTION; PHAGOSOME MATURATION; IN-VITRO; DIFFERENTIAL REGULATION; GRANULOMA-FORMATION; GROWTH-FACTOR	Sphingosine kinase-1 is known to mediate Mycobacterium smegmatis induced inflammatory responses in macrophages, but its role in controlling infection has not been reported to date. We aimed to unravel the significance of SphK-1 in controlling M. smegmatis infection in RAW 264.7 macrophages. Our results demonstrated for the first time that selective inhibition of SphK-1 by either D, L threo dihydrosphingosine (DHS; a competitive inhibitor of Sphk-1) or Sphk-1 siRNA rendered RAW macrophages sensitive to M. smegmatis infection. This was due to the reduction in the expression of iNOs, p38, pp-38, late phagosomal marker, LAMP-2 and stabilization of the RelA (pp-65) subunit of NF-kappa B. This led to a reduction in the generation of NO and secretion of TNF-alpha in infected macrophages. Congruently, overexpression of SphK-1 conferred resistance in macrophages to infection which was due to enhancement in the generation of NO and expression of iNOs, pp38 and LAMP-2. In addition, our results also unraveled a novel regulation of p38MAPK by SphK-1 during M. smegmatis infection and generation of NO in macrophages. Enhanced NO generation and expression of iNOs in SphK-1++ infected macrophages demonstrated their M-1(bright) phenotype of these macrophages. These findings thus suggested a novel antimycobacterial role of SphK-1 in macrophages.	[Prakash, Hridayesh; Holzer, Daniela] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Gonzalez, Alexis Perez] European Mol Biol Lab, Flow Cytometry Core Facil, Heidelberg, Germany; [Lueth, Anja; Kleuser, Burkhard] Univ Potsdam, Fac Math & Nat Sci, Berlin, Germany; [Anes, Elsa] Univ Lisbon, Fac Farm, Ctr Patogenese Mol URIA, Inst Mol Med, Lisbon, Portugal; [Grinkina, Natalia; Wadgaonkar, Raj] SUNY, Dept Med, Brooklyn, NY USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Potsdam; Universidade de Lisboa; State University of New York (SUNY) System; SUNY Maritime College	Prakash, H (corresponding author), German Canc Res Ctr, Div Tumor Immunol, D-6900 Heidelberg, Germany.	h.prakash@dkfz-heidelberg.de	Hridayesh, Prakash/W-9478-2019; iMed.ULisboa, HPI/B-4239-2014; Anes, Elsa/K-3124-2013	Hridayesh, Prakash/0000-0001-5269-2481; iMed.ULisboa, HPI/0000-0001-5934-0198; Anes, Elsa/0000-0001-5934-0198; Kleuser, Burkhard/0000-0002-1888-9595	Deutsche Forschungsgemeinschaft (German Research Foundation); Portuguese National Foundation for Science [PIC/IC/82859/2007, PTDC/SAU-MII/098024/2008]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Portuguese National Foundation for Science	This work was supported by the SFB grant from Deutsche Forschungsgemeinschaft (German Research Foundation) and Portuguese National Foundation for Science (PIC/IC/82859/2007; PTDC/SAU-MII/098024/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bermudez LE, 1999, CLIN EXP IMMUNOL, V116, P94; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; Castillo SS, 2001, J NUTR, V131, P2826, DOI 10.1093/jn/131.11.2826; CHAMPSI JH, 1994, BIOTHERAPY, V7, P187, DOI 10.1007/BF01878485; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chernenko SM, 2006, J HEART LUNG TRANSPL, V25, P1447, DOI 10.1016/j.healun.2006.09.003; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Doherty TM, 1997, J IMMUNOL, V158, P4822; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehlers S, 1999, IMMUNOLOGY, V98, P313; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Galkina E, 2007, ADV EXP MED BIOL, V601, P75; Garg SK, 2004, J INFECT DIS, V189, P2129, DOI 10.1086/386286; Gauthier DT, 2008, ECOL APPL, V18, P1718, DOI 10.1890/07-2083.1; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hollingsworth JW, 2007, J IMMUNOL, V179, P4367, DOI 10.4049/jimmunol.179.7.4367; Iyer Shankar S., 2009, V531, P347, DOI 10.1007/978-1-59745-396-7_21; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; KAWAMORI T, 2008, FASEB J; Kusner DJ, 2007, J BIOL CHEM, V282, P23147, DOI 10.1074/jbc.M700193200; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lahiri A, 2008, MICROBES INFECT, V10, P1166, DOI 10.1016/j.micinf.2008.06.008; Lahti Aleksi, 2006, BMC Pharmacology, V6, P5, DOI 10.1186/1471-2210-6-5; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Li QF, 2008, BIOCHEM BIOPH RES CO, V371, P159, DOI 10.1016/j.bbrc.2008.04.037; Limaye V, 2008, ENDOTHELIUM-J ENDOTH, V15, P101, DOI 10.1080/10623320802125342; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maher P, 2001, J NEUROSCI, V21, P2929, DOI 10.1523/JNEUROSCI.21-09-02929.2001; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Marshall BG, 1997, INFECT IMMUN, V65, P1931, DOI 10.1128/IAI.65.5.1931-1935.1997; Melendez AJ, 2008, BBA-PROTEINS PROTEOM, V1784, P66, DOI 10.1016/j.bbapap.2007.07.013; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Orman KL, 2000, J INFECT DIS, V182, P1561, DOI 10.1086/315861; Tumitan ARP, 2007, MICROBIOL IMMUNOL, V51, P1021, DOI 10.1111/j.1348-0421.2007.tb03986.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Plum J, 1999, PERITON DIALYSIS INT, V19, pS378; Pyne NJ, 2008, BBA-MOL CELL BIOL L, V1781, P467, DOI 10.1016/j.bbalip.2008.05.004; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang F, 1996, GLYCOCONJUGATE J, V13, P937, DOI 10.1007/BF01053189; Wang SL, 2002, J EUKARYOT MICROBIOL, V49, P305, DOI 10.1111/j.1550-7408.2002.tb00374.x; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919; Yan GJ, 2008, CARDIOVASC RES, V78, P308, DOI 10.1093/cvr/cvn006; Yang JF, 2005, J IMMUNOL, V175, P6580, DOI 10.4049/jimmunol.175.10.6580; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	79	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10657	10.1371/journal.pone.0010657	http://dx.doi.org/10.1371/journal.pone.0010657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498849	Green Published, gold			2022-12-27	WOS:000277773700008
J	Penolazzi, B; Di Domenico, A; Marzoli, D; Mammarella, N; Fairfield, B; Franciotti, R; Brancucci, A; Tommasi, L				Penolazzi, Barbara; Di Domenico, Alberto; Marzoli, Daniele; Mammarella, Nicola; Fairfield, Beth; Franciotti, Raffaella; Brancucci, Alfredo; Tommasi, Luca			Effects of Transcranial Direct Current Stimulation on Episodic Memory Related to Emotional Visual Stimuli	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; PREFRONTAL CORTEX; RIGHT-HEMISPHERE; WORKING-MEMORY; TEMPORAL-LOBE; PERCEPTION; LATERALIZATION; FACILITATION; ENHANCEMENT; ASYMMETRY	The present study investigated emotional memory following bilateral transcranial electrical stimulation (direct current of 1 mA, for 20 minutes) over fronto-temporal cortical areas of healthy participants during the encoding of images that differed in affective arousal and valence. The main result was a significant interaction between the side of anodal stimulation and image emotional valence. Specifically, right anodal/left cathodal stimulation selectively facilitated the recall of pleasant images with respect to both unpleasant and neutral images whereas left anodal/right cathodal stimulation selectively facilitated the recall of unpleasant images with respect to both pleasant and neutral images. From a theoretical perspective, this double dissociation between the side of anodal stimulation and the advantage in the memory performance for a specific type of stimulus depending on its pleasantness supported the specific-valence hypothesis of emotional processes, which assumes a specialization of the right hemisphere in processing unpleasant stimuli and a specialization of the left hemisphere in processing pleasant stimuli. From a methodological point of view, first we found tDCS effects strictly dependent on the stimulus category, and second a pattern of results in line with an interfering and inhibitory account of anodal stimulation on memory performance. These findings need to be carefully considered in applied contexts, such as the rehabilitation of altered emotional processing or eye-witness memory, and deserve to be further investigated in order to understand their underlying mechanisms of action.	[Penolazzi, Barbara] Univ Alma Mater Studiorum Bologna, Dept Psychol, Bologna, Italy; [Penolazzi, Barbara; Marzoli, Daniele; Brancucci, Alfredo] Univ G dAnnunzio Chieti, Dept Biomed Sci, Chieti, Italy; [Di Domenico, Alberto; Mammarella, Nicola; Fairfield, Beth; Franciotti, Raffaella; Tommasi, Luca] Univ G dAnnunzio Chieti, Dept Neurosci & Imaging, Chieti, Italy	University of Bologna; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Penolazzi, B (corresponding author), Univ Alma Mater Studiorum Bologna, Dept Psychol, Bologna, Italy.	luca.tommasi@unich.it	Franciotti, Raffaella/AAC-2664-2022; Di Domenico, Alberto/O-2111-2015; Tommasi, Luca/F-3638-2012; Fairfield, Beth/HHM-4985-2022; Di Domenico, Alberto/AIB-7965-2022; Westwood, Sam/P-7000-2015	Di Domenico, Alberto/0000-0002-9962-2891; Di Domenico, Alberto/0000-0002-9962-2891; Mammarella, Nicola/0000-0003-1240-702X; PENOLAZZI, Barbara/0000-0001-8717-6233; Tommasi, Luca/0000-0003-0664-714X	Commission of the European Communities	Commission of the European Communities(European Commission)	This research is part of the project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization, 2006-2009), supported by the Commission of the European Communities within the framework of the specific research and technological development programme 'Integrating and strengthening the European Research Area' (initiative 'What it means to be human'), through a financial grant to Luca Tommasi. Grant number: 28806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; AHERN GL, 1979, NEUROPSYCHOLOGIA, V17, P693, DOI 10.1016/0028-3932(79)90045-9; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; DAVIDSON RJ, 1989, HDB NEUROPSYCHOLOGY, V3, P419; Elmer S., 2009, BEHAV BRAIN FUNCT, V15, P5; Epstein CM, 2002, NEUROSCI LETT, V320, P5, DOI 10.1016/S0304-3940(01)02573-3; Ferrucci R, 2008, J COGNITIVE NEUROSCI, V20, P1687, DOI 10.1162/jocn.2008.20112; FERTONANI A, 2009, BEHAV BRAIN IN PRESS; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; WEDDING D, 1985, INT J NEUROSCI, V27, P277, DOI 10.3109/00207458509149773	36	45	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10623	10.1371/journal.pone.0010623	http://dx.doi.org/10.1371/journal.pone.0010623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498700	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500012
J	Derkarabetian, S; Steinmann, DB; Hedin, M				Derkarabetian, Shahan; Steinmann, David B.; Hedin, Marshal			Repeated and Time-Correlated Morphological Convergence in Cave-Dwelling Harvestmen (Opiliones, Laniatores) from Montane Western North America	PLOS ONE			English	Article							EVOLUTION; DIVERGENCE; AUSTRALIA; PLANTHOPPERS; SPIDERS; ARANEAE; FAUNA; LONG	Background: Many cave-dwelling animal species display similar morphologies (troglomorphism) that have evolved convergent within and among lineages under the similar selective pressures imposed by cave habitats. Here we study such ecomorphological evolution in cave-dwelling Sclerobuninae harvestmen (Opiliones) from the western United States, providing general insights into morphological homoplasy, rates of morphological change, and the temporal context of cave evolution. Methodology/Principal Findings: We gathered DNA sequence data from three independent gene regions, and combined these data with Bayesian hypothesis testing, morphometrics analysis, study of penis morphology, and relaxed molecular clock analyses. Using multivariate morphometric analysis, we find that phylogenetically unrelated taxa have convergently evolved troglomorphism; alternative phylogenetic hypotheses involving less morphological convergence are not supported by Bayesian hypothesis testing. In one instance, this morphology is found in specimens from a high-elevation stony debris habitat, suggesting that troglomorphism can evolve in non-cave habitats. We discovered a strong positive relationship between troglomorphy index and relative divergence time, making it possible to predict taxon age from morphology. Most of our time estimates for the origin of highly-troglomorphic cave forms predate the Pleistocene. Conclusions/Significance: While several regions in the eastern and central United States are well-known hotspots for cave evolution, few modern phylogenetic studies have addressed the evolution of cave-obligate species in the western United States. Our integrative studies reveal the recurrent evolution of troglomorphism in a perhaps unexpected geographic region, at surprisingly deep time depths, and in sometimes surprising habitats. Because some newly discovered troglomorphic populations represent undescribed species, our findings stress the need for further biological exploration, integrative systematic research, and conservation efforts in western US cave habitats.	[Derkarabetian, Shahan; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Steinmann, David B.] Denver Museum Nat & Sci, Dept Zool, Denver, CO USA	California State University System; San Diego State University	Derkarabetian, S (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	mhedin@sciences.sdsu.edu			Cave Conservancy Foundation; Society for Integrative and Comparative Biology; American Arachnological Society; US National Science Foundation [0640173, 0640179]; Lloyd David and Carlye Cannon Wattis Foundation; Zocchi Foundation	Cave Conservancy Foundation; Society for Integrative and Comparative Biology; American Arachnological Society; US National Science Foundation(National Science Foundation (NSF)); Lloyd David and Carlye Cannon Wattis Foundation; Zocchi Foundation	This research was supported by the Cave Conservancy Foundation (Fellowship in Karst Studies), the Society for Integrative and Comparative Biology (Grants in Aid of Research), the American Arachnological Society (Vincent Roth Fund for Systematic Research), a collaborative US National Science Foundation grant awarded to M. Hedin (Award No. 0640173) and Dr. Jeff Shultz (Award No. 0640179), a grant from the Lloyd David and Carlye Cannon Wattis Foundation, and the Zocchi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Padilla F, 2009, CLADISTICS, V25, P109, DOI 10.1111/j.1096-0031.2008.00242.x; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Arnedo MA, 2007, INVERTEBR SYST, V21, P623, DOI 10.1071/IS07015; Bahlcke J., 2005, ENZYKLOP DIE NEUZEIT, V1; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; BARR THOMAS C., 1968, P35; Briggs T. S., 1971, Occasional Papers Calif Acad Sci, VNo. 90, P1; BRIGGS TS, 1971, PAN-PAC ENTOMOL, V47, P165; Briggs TS, 1974, J ARACHNOL, V1, P205; Brunsfeld S. J., 2001, INTEGRATING ECOLOGY; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; CHAMBERS SM, 1993, FED REGISTER, V56, P43818; CHRISTIANSEN KA, 1962, SPELUNCA, V2, P76; COKENDOLPHER JC, 2004, SPELEOLOGICAL MONOGR, V6, P143; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Culver DC, 2003, BIODIVERS CONSERV, V12, P441, DOI 10.1023/A:1022425908017; DERKARABETIAN S, 2010, THESIS SAN DIEGO STA; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Faille A, 2010, MOL PHYLOGENET EVOL, V54, P97, DOI 10.1016/j.ympev.2009.10.008; Forster R. R., 1965, Rec Otago Mus, VNo. 2, P1; Giribet Gonzalo, 2007, P62; GONZALEZ AP, 2002, REV IBERICA ARACHNOL, V5, P43; GREELEY R, 1972, GEOL SOC AM BULL, V83, P2397, DOI 10.1130/0016-7606(1972)83[2397:LTOTCB]2.0.CO;2; Hedin M, 2010, J ARACHNOL, V38, P9, DOI 10.1636/HA09-49.1; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; HOCH H, 1989, SYST ENTOMOL, V14, P377, DOI 10.1111/j.1365-3113.1989.tb00291.x; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Juberthei C., 1981, Proceedings of the International Congress of Speleology, V8, P203; Karaman IM, 2005, REV SUISSE ZOOL, V112, P439, DOI 10.5962/bhl.part.80308; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; LONGACRE C, 2000, FED REGISTER, V65, P81419; Losos Jonathan B., 1994, P60; Luiszer FG, 2007, ACTA CARSOLOGICA, V36, P157; MADDISON DR, 2003, MACCLADE 4 RELEASE V; MARTENS J, 1986, 10 ACT C INT AR JAC, V1, P289; MAURY E A, 1988, Memoires de Biospeologie, V15, P117; Moore G., 1997, SPELEOLOGY CAVES CAV; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; NYLANDER JA, 2003, MRMODELTEST 1 1 B; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OROMI P, 1986, C INT ESP, V2, P147; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PECK S B, 1981, Great Basin Naturalist, V41, P207; PECK S B, 1980, NSS Bulletin, V42, P53; PECK S B, 1978, Southwestern Naturalist, V23, P227, DOI 10.2307/3669771; Pinto-da-Rocha Ricardo, 2007, P88; Porter ML, 2007, ACTA CARSOLOGICA, V36, P173; Porter ML, 2007, J CAVE KARST STUD, V69, P179; RUZICKA J, 1998, CAVE ROCK DEBRIS DWE, P261; Ruzicka V, 1999, J NAT HIST, V33, P255, DOI 10.1080/002229399300407; Shear WA, 2009, ZOOTAXA, P47; SHULTZ JW, 2007, HARVESTMEN BIOL OPIL, P14; Thomas SM, 2008, MOL PHYLOGENET EVOL, V46, P645, DOI 10.1016/j.ympev.2007.10.013; Thomas SM, 2006, ZOOTAXA, P21; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ubick D, 2002, J ARACHNOL, V30, P435, DOI 10.1636/0161-8202(2002)030[0435:THFPAR]2.0.CO;2; UBICK D, 2004, SPELEOLOGICAL MONOGR, V6, P101; UBICK D, 1992, SPELEOLOGICAL MONOGR, V3, P155; Ubick Darrell, 2008, Proceedings of the California Academy of Sciences, V59, P1; Ubick Darrell, 2005, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V8, P75; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Welbourn W. Calvin, 1999, Journal of Caves and Karst Studies, V61, P93; Wessel A, 2007, ACTA CARSOLOGICA, V36, P199; White W.B., 1988, GEOMORPHOLOGY HYDROL; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wilcox TP, 2004, MOL PHYLOGENET EVOL, V31, P1101, DOI 10.1016/j.ympev.2003.11.006	71	62	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10388	10.1371/journal.pone.0010388	http://dx.doi.org/10.1371/journal.pone.0010388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479884	Green Published, gold			2022-12-27	WOS:000277467800003
J	Thorogood, NP; Brown, CJ				Thorogood, Nancy P.; Brown, Carolyn J.			Active Chromatin Marks Are Retained on X Chromosomes Lacking Gene or Repeat Silencing Despite XIST/Xist Expression in Somatic Cell Hybrids	PLOS ONE			English	Article							XIST RNA; DNA METHYLATION; INACTIVATION; LOCALIZATION; STABILIZATION; INITIATION	Background: X-chromosome inactivation occurs early in mammalian development and results in the inactive X chromosome acquiring numerous hallmarks of heterochromatin. While XIST is a key player in the inactivation process, the method of action of this ncRNA is yet to be determined. Methodology/Principal Findings: To assess which features of heterochromatin may be directly recruited by the expression and localization of the XIST RNA we have analyzed a mouse/human somatic cell hybrid in which expression of human and mouse XIST/Xist has been induced from the active X by demethylation. Such hybrids had previously been demonstrated to disconnect XIST/Xist expression from gene silencing and we confirm maintenance of X-linked gene expression, even close to the Xist locus, despite the localized expression of mouse Xist. Conclusions/Significance: Loss of the active chromatin marks H3 acetylation and H3 lysine 4 methylation was not observed upon XIST/Xist expression, nor was there a gain of DNA methylation; thus these marks of facultative heterochromatin are not solely dependent upon Xist expression. Cot-1 holes, regions of depleted RNA hybridization with a Cot-1 probe, were observed upon Xist expression; however, these were at reduced frequency and intensity in these somatic cells. Domains of human Cot-1 transcription were observed corresponding to the human chromosomes in the somatic cell hybrids. The Cot-1 domain of the X was not reduced with the expression of XIST, which fails to localize to the human X chromosome in a mouse somatic cell background. The human inactive X in a mouse/human hybrid cell also shows delocalized XIST expression and an ongoing Cot-1 domain, despite X-linked gene silencing. These results are consistent with recent reports separating Cot-1 silencing from genic silencing, but also demonstrate repetitive element expression from an otherwise silent X chromosome in these hybrid cells.	[Thorogood, Nancy P.; Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia	Thorogood, NP (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	cbrown@interchange.ubc.ca	Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101; Thorogood, Nancy/0000-0002-1135-8476	Canadian Institute for Health Research [MOP-13690]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding: The work was supported by the Canadian Institute for Health Research (MOP-13690) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2002, HUM GENET, V110, P271, DOI 10.1007/s00439-002-0676-8; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; CHEN TR, 1987, CANCER GENET CYTOGEN, V24, P95, DOI 10.1016/0165-4608(87)90086-0; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hansen RS, 1998, P NATL ACAD SCI USA, V95, P5133, DOI 10.1073/pnas.95.9.5133; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Komura J, 1997, J BIOL CHEM, V272, P10975; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; OHNO S, 1967, MONOGRAPHS ENDROCRIN, P192; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2004, J CELL BIOL, V167, P1025, DOI 10.1083/jcb.200409026; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; Sado T, 2004, DEVELOPMENT, V131, P975, DOI 10.1242/dev.00995; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Tinker AV, 1998, NUCLEIC ACIDS RES, V26, P2935, DOI 10.1093/nar/26.12.2935; Veerla S, 2008, GENE CHROMOSOME CANC, V47, P368, DOI 10.1002/gcc.20542; WILLARD HF, 1993, COLD SPRING HARB SYM, V58, P315, DOI 10.1101/SQB.1993.058.01.037; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10787	10.1371/journal.pone.0010787	http://dx.doi.org/10.1371/journal.pone.0010787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520737	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034600013
J	Nikolaev, Y; Deillon, C; Hoffmann, SRK; Bigler, L; Friess, S; Zenobi, R; Pervushin, K; Hunziker, P; Gutte, B				Nikolaev, Yaroslav; Deillon, Christine; Hoffmann, Stefan R. K.; Bigler, Laurent; Friess, Sebastian; Zenobi, Renato; Pervushin, Konstantin; Hunziker, Peter; Gutte, Bernd			The Leucine Zipper Domains of the Transcription Factors GCN4 and c-Jun Have Ribonuclease Activity	PLOS ONE			English	Article							COILED-COIL; ARTIFICIAL RIBONUCLEASES; QUALITY-CONTROL; MESSENGER-RNA; PEPTIDE; HYDROLYSIS; REPRESSOR; PROTEINS; CLEAVAGE; OLIGONUCLEOTIDES	Basic-region leucine zipper (bZIP) proteins are one of the largest transcription factor families that regulate a wide range of cellular functions. Owing to the stability of their coiled coil structure leucine zipper (LZ) domains of bZIP factors are widely employed as dimerization motifs in protein engineering studies. In the course of one such study, the X-ray structure of the retro-version of the LZ moiety of yeast transcriptional activator GCN4 suggested that this retro-LZ may have ribonuclease activity. Here we show that not only the retro-LZ but also the authentic LZ of GCN4 has weak but distinct ribonuclease activity. The observed cleavage of RNA is unspecific, it is not suppressed by the ribonuclease A inhibitor RNasin and involves the breakage of 39,59-phosphodiester bonds with formation of 29,39-cyclic phosphates as the final products as demonstrated by HPLC/electrospray ionization mass spectrometry. Several mutants of the GCN4 leucine zipper are catalytically inactive, providing important negative controls and unequivocally associating the enzymatic activity with the peptide under study. The leucine zipper moiety of the human factor c-Jun as well as the entire c-Jun protein are also shown to catalyze degradation of RNA. The presented data, which was obtained in the test-tube experiments, adds GCN4 and c-Jun to the pool of proteins with multiple functions (also known as moonlighting proteins). If expressed in vivo, the endoribonuclease activity of these bZIP-containing factors may represent a direct coupling between transcription activation and controlled RNA turnover. As an additional result of this work, the retro-leucine zipper of GCN4 can be added to the list of functional retro-peptides.	[Nikolaev, Yaroslav; Deillon, Christine; Hoffmann, Stefan R. K.; Gutte, Bernd] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Nikolaev, Yaroslav; Pervushin, Konstantin] Univ Basel, Biozentrum, Basel, Switzerland; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Friess, Sebastian; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Hunziker, Peter] Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University of Basel; University of Zurich; ETH Zurich	Nikolaev, Y (corresponding author), Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.	gutte@bioc.unizh.ch	Zenobi, Renato/F-1113-2010; Bigler, Laurent/AAP-3799-2020; Pervushin, Konstantin/AAJ-6580-2020; Nikolaev, Yaroslav/I-1976-2013	Bigler, Laurent/0000-0003-3548-3594; Pervushin, Konstantin/0000-0002-6393-4340; Nikolaev, Yaroslav/0000-0002-1479-7474	Kanton of Zurich; Mesta Foundation; Swiss National Science Foundation [3100A0-118381]; Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	Kanton of Zurich; Mesta Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	This work was supported by the Kanton of Zurich, the Mesta Foundation, Swiss National Science Foundation (grant 3100A0-118381 to K. Pervushin) and the Stiftung fur wissenschaftliche Forschung an der Universitat Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053; BASHKIN JK, 1994, J AM CHEM SOC, V116, P5981, DOI 10.1021/ja00092a064; Bibillo A, 1999, NUCLEIC ACIDS RES, V27, P3931, DOI 10.1093/nar/27.19.3931; BRESLOW R, 1978, J AM CHEM SOC, V100, P3227, DOI 10.1021/ja00478a052; Brittain IJ, 1998, BIOCHEMISTRY-US, V37, P12113, DOI 10.1021/bi9806605; Caderas G, 1999, EUR J BIOCHEM, V266, P599, DOI 10.1046/j.1432-1327.1999.00899.x; CARPINO LA, 1970, J AM CHEM SOC, V92, P5748, DOI 10.1021/ja00722a043; d'Avignon DA, 2006, BIOPOLYMERS, V83, P255, DOI 10.1002/bip.20555; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fouace S, 2004, NUCLEIC ACIDS RES, V32, P151, DOI 10.1093/nar/gkh157; Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f; HEHLGANS T, 1993, FEBS LETT, V315, P51, DOI 10.1016/0014-5793(93)81131-I; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Koroleva LS, 2007, PROTEIN PEPTIDE LETT, V14, P151, DOI 10.2174/092986607779816177; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Landt O, 1997, BIOL CHEM, V378, P553, DOI 10.1515/bchm.1997.378.6.553; Lei G, 1998, ARCH BIOCHEM BIOPHYS, V355, P160, DOI 10.1006/abbi.1998.0735; Lima WF, 1999, P NATL ACAD SCI USA, V96, P10010, DOI 10.1073/pnas.96.18.10010; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu N, 2001, CURR PROTEIN PEPT SC, V2, P107, DOI 10.2174/1389203013381161; Liu NK, 1997, EUR BIOPHYS J BIOPHY, V25, P399, DOI 10.1007/s002490050052; Liu NK, 1998, PROTEIN SCI, V7, P1214, DOI 10.1002/pro.5560070517; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1995, PEPTIDES SYNTHESIS S, P93; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Niittymaki T, 2006, ORG BIOMOL CHEM, V4, P15, DOI 10.1039/b509022a; Nikolaev Y, 2007, J AM CHEM SOC, V129, P6461, DOI 10.1021/ja0685295; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perreault DM, 1997, BIOORGAN MED CHEM, V5, P1209, DOI 10.1016/S0968-0896(97)00051-5; Pitsch S, 2003, HELV CHIM ACTA, V86, P3740, DOI 10.1002/hlca.200390316; RICHARDS FM, 1971, ENZYMES, V4, P647; Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6; Scheffer U, 2005, J AM CHEM SOC, V127, P2211, DOI 10.1021/ja0443934; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; STADLER K, 1995, INT J PEPT PROT RES, V46, P333; STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10765	10.1371/journal.pone.0010765	http://dx.doi.org/10.1371/journal.pone.0010765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505831	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400019
J	Aluru, N; Leatherland, JF; Vijayan, MM				Aluru, Neelakanteswar; Leatherland, John F.; Vijayan, Mathilakath M.			Bisphenol A in Oocytes Leads to Growth Suppression and Altered Stress Performance in Juvenile Rainbow Trout	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; ONCORHYNCHUS-MYKISS; MESSENGER-RNA; EMBRYONIC-DEVELOPMENT; HORMONE RECEPTORS; MATERNAL EXPOSURE; GENE-EXPRESSION; THYROID-HORMONE; AXIS; ESTROGEN	Background: Bisphenol A (BPA), used in the manufacture of plastics, is ubiquitously distributed in the aquatic environment. However, the effect of maternal transfer of these xenobiotics on embryonic development and growth is poorly understood in fish. We tested the hypothesis that BPA in eggs, mimicking maternal transfer, impact development, growth and stress performance in juveniles of rainbow trout (Oncorhynchus mykiss). Methodology/Principal Findings: Trout oocytes were exposed to 0, 30 and 100 mu g.mL(-1) BPA for 3 h in ovarian fluid, followed by fertilization. The embryos were maintained in clean water and sampled temporally over 156-days post-fertilization (dpf), and juveniles were sampled at 400-dpf. The egg BPA levels declined steadily after exposure and were undetectable after 21-dpf. Oocyte exposure to BPA led to a delay in hatching and yolk absorption and a consistently lower body mass over 152-dpf. The growth impairment, especially in the high BPA group, correlated with higher growth hormone (GH) content and lower GH receptors gene expression. Also, mRNA abundances of insulin-like growth factors (IGF-1 and IGF-2) and their receptors were suppressed in the BPA treated groups. The juvenile fish grown from the BPA-enriched eggs had lower body mass and showed perturbations in plasma cortisol and glucose response to an acute stressor. Conclusion: BPA accumulation in eggs, prior to fertilization, leads to hatching delays, growth suppression and altered stress response in juvenile trout. The somatotropic axis appears to be a key target for BPA impact during early embryogenesis, leading to long term growth and stress performance defects in fish.	[Aluru, Neelakanteswar; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Leatherland, John F.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Waterloo; University of Guelph	Aluru, N (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mvijayan@uwaterloo.ca	Vijayan, Mathilakath/AAC-2190-2020; Vijayan, Mathilakath/F-6756-2012		Natural Science and Engineering Research Council (NSERC) of Canada; Ontario Ministry of Agriculture and Food	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture and Food	This work was supported by funds from the Natural Science and Engineering Research Council (NSERC) of Canada Discovery grant and the Ontario Ministry of Agriculture and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2006, ENDOCRINOLOGY, V147, P1895, DOI 10.1210/en.2005-1143; Aluru N, 2004, AM J PHYSIOL-REG I, V287, pR787, DOI 10.1152/ajpregu.00091.2004; Ashfield LA, 1998, ENVIRON TOXICOL CHEM, V17, P679; Bjerregaard P, 2007, ENVIRON TOXICOL CHEM, V26, P1910, DOI 10.1897/06-645R.1; Carlson DB, 2000, ENVIRON HEALTH PERSP, V108, P249, DOI 10.2307/3454442; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Davis LK, 2007, BIOL REPROD, V77, P614, DOI 10.1095/biolreprod.107.060947; FARBRIDGE KJ, 1992, FISH PHYSIOL BIOCHEM, V10, P245, DOI 10.1007/BF00004518; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Finn RN, 2007, AQUAT TOXICOL, V81, P337, DOI 10.1016/j.aquatox.2006.12.021; Gabillard JC, 2003, J EXP ZOOL PART A, V298A, P134, DOI 10.1002/jez.a.10280; Gabillard JC, 2003, MOL REPROD DEV, V64, P32, DOI 10.1002/mrd.10222; Gomez JM, 1999, J REPROD FERTIL, V115, P275, DOI 10.1530/jrf.0.1150275; Holt RIG, 2002, TRENDS ENDOCRIN MET, V13, P392, DOI 10.1016/S1043-2760(02)00697-5; Honkanen JO, 2004, CHEMOSPHERE, V55, P187, DOI 10.1016/j.chemosphere.2003.10.028; HONTELA A, 2008, ADRENAL TOX IN PRESS; Iwama George K., 2006, P319; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahnsteiner F, 2005, AQUAT TOXICOL, V75, P213, DOI 10.1016/j.aquatox.2005.08.004; LeGac F, 1996, MOL REPROD DEV, V44, P23, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;23::AID-MRD3&gt;3.0.CO;2-V; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Li M, 2006, COMP BIOCHEM PHYS A, V143, P514, DOI 10.1016/j.cbpa.2006.01.024; Li M, 2007, GEN COMP ENDOCR, V153, P302, DOI 10.1016/j.ygcen.2007.02.012; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Norbeck LA, 2007, GEN COMP ENDOCR, V151, P332, DOI 10.1016/j.ygcen.2007.01.039; Nye JA, 2007, AQUAT TOXICOL, V82, P242, DOI 10.1016/j.aquatox.2007.02.011; Ostrach DJ, 2008, P NATL ACAD SCI USA, V105, P19354, DOI 10.1073/pnas.0802616105; Pedersen SN, 1999, J CHROMATOGR A, V864, P17, DOI 10.1016/S0021-9673(99)01011-0; Pierce AL, 2005, GEN COMP ENDOCR, V140, P192, DOI 10.1016/j.ygcen.2004.10.017; Raine JC, 2004, J FISH BIOL, V65, P206, DOI 10.1111/j.0022-1112.2004.00445.x; Raine JC, 2003, COMP BIOCHEM PHYS B, V136, P267, DOI 10.1016/S1096-4959(03)00203-3; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schlueter PJ, 2007, DEV BIOL, V305, P377, DOI 10.1016/j.ydbio.2007.02.015; SHAMBLOTT MJ, 1995, P NATL ACAD SCI USA, V92, P6943, DOI 10.1073/pnas.92.15.6943; Shioda T, 2000, CHEMOSPHERE, V40, P239, DOI 10.1016/S0045-6535(99)00235-0; Vijayan MM, 2005, BIOCH MOLEC, V6, P365; Westerlund L, 2000, ENVIRON TOXICOL CHEM, V19, P1582, DOI 10.1002/etc.5620190615; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Yamamoto T, 2001, CHEMOSPHERE, V42, P415, DOI 10.1016/S0045-6535(00)00079-5; Yang BY, 1999, MOL REPROD DEV, V53, P127, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;127::AID-MRD1&gt;3.0.CO;2-H; Yeoh CG, 1996, GEN COMP ENDOCR, V102, P197, DOI 10.1006/gcen.1996.0061; Zha JM, 2006, SCI TOTAL ENVIRON, V357, P112, DOI 10.1016/j.scitotenv.2005.04.038; Zhu Y, 2007, GEN COMP ENDOCR, V150, P395, DOI 10.1016/j.ygcen.2006.10.009	46	75	79	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10741	10.1371/journal.pone.0010741	http://dx.doi.org/10.1371/journal.pone.0010741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505776	Green Published, gold			2022-12-27	WOS:000278017300014
J	Koehler, RN; Walsh, AM; Sanders-Buell, EE; Eller, LA; Eller, M; Currier, JR; Bautista, CT; Wabwire-Mangen, F; Hoelscher, M; Maboko, L; Kim, J; Michael, NL; Robb, ML; McCutchan, FE; Kijak, GH				Koehler, Rebecca N.; Walsh, Anne M.; Sanders-Buell, Eric E.; Eller, Leigh Anne; Eller, Michael; Currier, Jeffrey R.; Bautista, Christian T.; Wabwire-Mangen, Fred; Hoelscher, Michael; Maboko, Leonard; Kim, Jerome; Michael, Nelson L.; Robb, Merlin L.; McCutchan, Francine E.; Kijak, Gustavo H.			High-Throughput High- Resolution Class I HLA Genotyping in East Africa	PLOS ONE			English	Article							RAKAI DISTRICT; MBEYA REGION; GENOMIC DNA; B ALLELES; HIV-1; POPULATIONS; DIVERSITY; SELECTION; POLYMORPHISM; DISEASE	HLA, the most genetically diverse loci in the human genome, play a crucial role in host-pathogen interaction by mediating innate and adaptive cellular immune responses. A vast number of infectious diseases affect East Africa, including HIV/AIDS, malaria, and tuberculosis, but the HLA genetic diversity in this region remains incompletely described. This is a major obstacle for the design and evaluation of preventive vaccines. Available HLA typing techniques, that provide the 4-digit level resolution needed to interpret immune responses, lack sufficient throughput for large immunoepidemiological studies. Here we present a novel HLA typing assay bridging the gap between high resolution and high throughput. The assay is based on real-time PCR using sequence-specific primers (SSP) and can genotype carriers of the 49 most common East African class I HLA-A, -B, and -C alleles, at the 4-digit level. Using a validation panel of 175 samples from Kampala, Uganda, previously defined by sequence-based typing, the new assay performed with 100% sensitivity and specificity. The assay was also implemented to define the HLA genetic complexity of a previously uncharacterized Tanzanian population, demonstrating its inclusion in the major East African genetic cluster. The availability of genotyping tools with this capacity will be extremely useful in the identification of correlates of immune protection and the evaluation of candidate vaccine efficacy.	[Koehler, Rebecca N.; Walsh, Anne M.; Sanders-Buell, Eric E.; Currier, Jeffrey R.; Bautista, Christian T.; Robb, Merlin L.; McCutchan, Francine E.; Kijak, Gustavo H.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA; [Eller, Leigh Anne; Eller, Michael] Makerere Univ, Walter Reed Res Project, Henry M Jackson Fdn, Kampala, Uganda; [Hoelscher, Michael] Univ Munich, Dept Trop Med & Infect Dis, Munich, Germany; [Hoelscher, Michael; Maboko, Leonard] Mbeya Med Res Program, Mbeya, Tanzania; [Kim, Jerome; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Makerere University; University of Munich; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Koehler, RN (corresponding author), Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA.	gkijak@hivresearch.org	Bautista, Christian/B-2812-2011; Hoelscher, Michael/D-3436-2012; Walsh, Anne/GXI-0454-2022; Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Bautista, Christian/0000-0002-1228-0754; Lenzi, Rebecca/0000-0002-7975-9268	Henry M. Jackson Foundation; United States Department of Defense; National Institute for Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-2642-11]	Henry M. Jackson Foundation; United States Department of Defense(United States Department of Defense); National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Defense, by the National Institute for Allergy and Infectious Diseases, National Institutes of Health ("HIV Vaccine Research and Development - Project 2'' Y1-AI-2642-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*A NOL RES I, 2009, FULL LIST HLA CLASS; ABDELSALAM E, 1986, TISSUE ANTIGENS, V27, P142, DOI 10.1111/j.1399-0039.1986.tb01513.x; Adams Sharon D, 2004, J Transl Med, V2, P30, DOI 10.1186/1479-5876-2-30; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2007, RIFT VALL FEV KEN SO; Arroyo MA, 2005, AIDS, V19, P1517, DOI 10.1097/01.aids.0000183515.14642.76; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Brander C, 2006, CURR OPIN IMMUNOL, V18, P430, DOI 10.1016/j.coi.2006.05.012; BROWNING MJ, 1993, P NATL ACAD SCI USA, V90, P2842, DOI 10.1073/pnas.90.7.2842; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Ellis JM, 2000, TISSUE ANTIGENS, V56, P291, DOI 10.1034/j.1399-0039.2000.560401.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; HILL AVS, 1994, PHILOS T R SOC B, V346, P379, DOI 10.1098/rstb.1994.0155; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP 200; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kettaneh A, 2006, INT J TUBERC LUNG D, V10, P717; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kijak GH, 2009, TISSUE ANTIGENS, V73, P262, DOI 10.1111/j.1399-0039.2008.01192.x; KITTS A, 2003, NCBI HDB; Koehler RN, 2009, TISSUE ANTIGENS, V74, P73, DOI 10.1111/j.1399-0039.2009.01265.x; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Lienert K, 1996, IMMUNOL CELL BIOL, V74, P349, DOI 10.1038/icb.1996.62; Louie LG, 2004, J INFECT DIS, V189, P1084, DOI 10.1086/382030; Luedeck H, 1997, TISSUE ANTIGENS, V50, P627, DOI 10.1111/j.1399-0039.1997.tb02921.x; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27; Olsson KS, 2008, EUR J HAEMATOL, V81, P36, DOI 10.1111/j.1600-0609.2008.01078.x; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Probst CM, 2000, HUM BIOL, V72, P597; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Raja A, 2004, INDIAN J MED RES, V120, P213; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Robinson James, 2007, V409, P61, DOI 10.1007/978-1-60327-118-9_4; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez A, 2007, J INFECT DIS, V196, pS329, DOI 10.1086/520588; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Slateva K, 1998, TISSUE ANTIGENS, V52, P462, DOI 10.1111/j.1399-0039.1998.tb03073.x; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JM, 2000, EXP CLIN IMMUNOGENET, V17, P185, DOI 10.1159/000019138; *TEL AV MED CTR, GLOB INF DIS EP NETW; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Walczak R, 2008, MIXDES 2008: PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON MIXED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS, P633; *WHO, 2007, EB HAEM FEV UG; *WHO, 2006, WEEKLY EPIDEMIOLOGIC, V82, P381; *WHO, 2009, WHO REP 2009 GLOB TU; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P145; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; World Health Organisation, 2008, WORLD MAL REP 2008; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8	79	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10751	10.1371/journal.pone.0010751	http://dx.doi.org/10.1371/journal.pone.0010751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505773	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017300022
J	Rangarajan, ES; Lee, JH; Yogesha, SD; Izard, T				Rangarajan, Erumbi S.; Lee, Jun Hyuck; Yogesha, S. D.; Izard, Tina			A Helix Replacement Mechanism Directs Metavinculin Functions	PLOS ONE			English	Article							F-ACTIN-BINDING; DILATED CARDIOMYOPATHY; VINCULIN BINDING; CRYSTAL-STRUCTURE; PROTEIN; ADHESION; TALIN; MODEL; ASSOCIATION; RAVER1	Cells require distinct adhesion complexes to form contacts with their neighbors or the extracellular matrix, and vinculin links these complexes to the actin cytoskeleton. Metavinculin, an isoform of vinculin that harbors a unique 68-residue insert in its tail domain, has distinct actin bundling and oligomerization properties and plays essential roles in muscle development and homeostasis. Moreover, patients with sporadic or familial mutations in the metavinculin-specific insert invariably develop fatal cardiomyopathies. Here we report the high resolution crystal structure of the metavinculin tail domain, as well as the crystal structures of full-length human native metavinculin (1,134 residues) and of the full-length cardiomyopathy-associated Delta Leu954 metavinculin deletion mutant. These structures reveal that an alpha-helix (H1') and extended coil of the metavinculin insert replace alpha-helix H1 and its preceding extended coil found in the N-terminal region of the vinculin tail domain to form a new five-helix bundle tail domain. Further, biochemical analyses demonstrate that this helix replacement directs the distinct actin bundling and oligomerization properties of metavinculin. Finally, the cardiomyopathy associated Delta Leu954 and Arg975Trp metavinculin mutants reside on the replaced extended coil and the H1' alpha-helix, respectively. Thus, a helix replacement mechanism directs metavinculin's unique functions.	[Rangarajan, Erumbi S.; Lee, Jun Hyuck; Yogesha, S. D.; Izard, Tina] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Rangarajan, ES (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL USA.	mkernick@scripps.edu			National Institutes of Health (NIH); American Heart Association (AHA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071596] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health (NIH) and American Heart Association (AHA) funded part of the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2003, TRENDS CELL BIOL, V13, P163, DOI 10.1016/S0962-8924(03)00030-8; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; HUANG FL, 1991, J BIOL CHEM, V266, P8727; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Korneeva NL, 1996, EUR J CELL BIOL, V71, P351; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Madl T, 2009, STRUCTURE, V17, P781, DOI 10.1016/j.str.2009.05.004; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller GJ, 2001, J BIOL CHEM, V276, P11729, DOI 10.1074/jbc.M008646200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; Rudiger M, 1998, FEBS LETT, V431, P49, DOI 10.1016/S0014-5793(98)00723-6; SMART OS, 2008, ANN M AM CRYST ASS K; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Nhieu GT, 2007, EMBO J, V26, P4588; Vasile VC, 2006, MOL GENET METAB, V87, P169, DOI 10.1016/j.ymgme.2005.08.006; Weis WI, 2004, NATURE, V430, P513, DOI 10.1038/430513a; Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200; Xu WM, 1998, DEVELOPMENT, V125, P327; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zieseniss A, 2007, CELL TISSUE RES, V327, P583, DOI 10.1007/s00441-006-0322-1	42	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10679	10.1371/journal.pone.0010679	http://dx.doi.org/10.1371/journal.pone.0010679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502710	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400004
J	Ma, J; Naumann, RT; Kanwal, JS				Ma, Jie; Naumann, Robert T.; Kanwal, Jagmeet S.			Fear Conditioned Discrimination of Frequency Modulated Sweeps within Species-Specific Calls of Mustached Bats	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; LATERAL AMYGDALA; BASOLATERAL AMYGDALA; COMPLEX SOUNDS; HEART-RATE; MEMORY CONSOLIDATION; COMMUNICATION CALLS; NUCLEUS BASALIS; TARGET RANGE; NEURONS	Social and echolocation vocalizations of bats contain different patterns of frequency modulations. An adult bat's ability to discriminate between various FM parameters, however, is not well established. Using changes in heart rate (HR) as a quantitative measure of associative learning, we demonstrate that mustached bats (Pteronotus parnellii) can be fear conditioned to linear frequency modulated (FM) sweeps typically centered at their acoustic fovea (similar to 60 kHz). We also show that HR is sensitive to a change in the direction of the conditional frequency modulation keeping all other parameters constant. In addition, a change in either depth or duration co-varied with FM rate is reflected in the change in HR. Finally, HR increases linearly with FM rate incremented by 0.1 kHz/ms from a pure tone to a target rate of 1.0 kHz/ms of the conditional stimulus. Learning is relatively rapid, occurring after a single training session. We also observed that fear conditioning enhances local field potential activity within the basolateral amygdala. Neural response enhancement coinciding with rapid learning and a fine scale cortical representation of FM sweeps shown earlier make FMs prime candidates for discriminating between different call types and possibly communicating socially relevant information within species-specific sounds.	[Ma, Jie; Naumann, Robert T.; Kanwal, Jagmeet S.] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA	Georgetown University	Ma, J (corresponding author), Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA.	kanwalj@georgetown.edu	Kanwal, Jagmeet/D-2145-2009	Kanwal, Jagmeet/0000-0002-4529-3631	National Institute for Deafness and other Communication Disorders (NIDCD), NIH [DC008822, DC01009]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008822] Funding Source: NIH RePORTER	National Institute for Deafness and other Communication Disorders (NIDCD), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported in part by a NIH research grants DC008822 to J.S.K. and DC01009 to R.T.N. from the National Institute for Deafness and other Communication Disorders (NIDCD). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; APPLEGATE CD, 1982, BRAIN RES, V238, P457, DOI 10.1016/0006-8993(82)90123-8; AUBIN T, 1987, BEHAVIOUR, V100, P123, DOI 10.1163/156853987X00107; Becker P.H., 1982, P213; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; Blair HT, 2005, NEUROSCIENCE, V133, P561, DOI 10.1016/j.neuroscience.2005.02.043; BURNS LH, 1994, BEHAV NEURAL BIOL, V61, P242, DOI 10.1016/S0163-1047(05)80007-X; Charrier I, 2005, BEHAV PROCESS, V70, P271, DOI 10.1016/j.beproc.2005.07.007; Clement Matthew J., 2006, P57; Cuddy LL, 2005, MED HYPOTHESES, V64, P229, DOI 10.1016/j.mehy.2004.09.005; DELIEGE I, 1996, MUSICAL BEGINNINGS O; Erulkar S D, 1968, Contrib Sens Physiol, V3, P149; Esser KH, 1997, J COMP PHYSIOL A, V180, P513, DOI 10.1007/s003590050068; Esser KH, 1996, J COMP PHYSIOL A, V178, P787; Fenton MB, 2004, J ZOOL, V262, P11, DOI 10.1017/S095283690300431X; Fenzl T, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-17; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; FLOODY OR, 1977, J COMP PHYSIOL PSYCH, V91, P443, DOI 10.1037/h0077341; Gaese BH, 2006, JARO-J ASSOC RES OTO, V7, P48, DOI 10.1007/s10162-005-0022-7; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Gordon M, 1998, HEARING RES, V122, P97, DOI 10.1016/S0378-5955(98)00087-2; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; HAUSER MD, 1991, ETHOLOGY, V89, P29; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HEIL P, 1992, J COMP PHYSIOL A, V171, P583; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HORNBY PJ, 1988, BRAIN BEHAV EVOLUT, V31, P181, DOI 10.1159/000116585; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; KANWAL JS, 2006, BEHAV NEURODYNAMICS, P163; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kraus M, 2002, LEARN MEMORY, V9, P293, DOI 10.1101/lm.47502; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1986, NEUROSCIENCE, V17, P615, DOI 10.1016/0306-4522(86)90034-5; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Medvedev AV, 2004, J NEUROPHYSIOL, V92, P52, DOI 10.1152/jn.01253.2003; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MENDELSON JR, 1993, EXP BRAIN RES, V94, P65; Mercado E, 2005, J COMP PSYCHOL, V119, P90, DOI 10.1037/0735-7036.119.1.90; METZNER W, 1987, J COMP PHYSIOL A, V160, P395, DOI 10.1007/BF00613029; Miasnikov AA, 2006, NEUROBIOL LEARN MEM, V86, P47, DOI 10.1016/j.nlm.2005.12.010; Miller CT, 2004, ANIM BEHAV, V68, P713, DOI 10.1016/j.anbehav.2003.10.028; Morton E.S., 1982, P183; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; ONEILL WE, 1982, J NEUROSCI, V2, P17; ONEILL WE, 1979, SCIENCE, V203, P69, DOI 10.1126/science.758681; Orduna I, 2005, BEHAV NEUROSCI, V119, P256, DOI 10.1037/0735-7044.119.1.256; Pare D, 2000, J NEUROSCI, V20, P2701; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; PHILLIPS DP, 1985, EXP BRAIN RES, V58, P443; POLA YV, 1975, ANIM BEHAV, V23, P826, DOI 10.1016/0003-3472(75)90108-6; POON PWF, 1991, EXP BRAIN RES, V83, P598; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROVERUD RC, 1993, J NEUROSCI, V13, P2306, DOI 10.1523/JNEUROSCI.13-06-02306.1993; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SCHULLER G, 1986, J NEUROSCI METH, V18, P339, DOI 10.1016/0165-0270(86)90022-1; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; SUGA N, 1972, AUDIOLOGY, V11, P58; SUGA N, 1968, J PHYSIOL-LONDON, V198, P51, DOI 10.1113/jphysiol.1968.sp008593; Suga N, 1983, ADV VERTEBRATE NEURO, P829; Suga N, 2008, LEARN MEMORY, V15, P198, DOI 10.1101/lm.791408; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Sugiura H, 1998, ANIM BEHAV, V55, P673, DOI 10.1006/anbe.1997.0602; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Washington SD, 2008, J NEUROPHYSIOL, V100, P3285, DOI 10.1152/jn.90442.2008; Weinberger NM, 2008, LEARN MEMORY, V15, P202, DOI 10.1101/lm.914208; Wellman LL, 2005, J NEUROSCI, V25, P4577, DOI 10.1523/JNEUROSCI.2257-04.2005; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	87	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10579	10.1371/journal.pone.0010579	http://dx.doi.org/10.1371/journal.pone.0010579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485675	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563400004
J	Wang, MJ; Larsen, MV; Nielsen, M; Harndahl, M; Justesen, S; Dziegiel, MH; Buus, S; Tang, ST; Lund, O; Claesson, MH				Wang, Mingjun; Larsen, Mette V.; Nielsen, Morten; Harndahl, Mikkel; Justesen, Sune; Dziegiel, Morten H.; Buus, Soren; Tang, Sheila T.; Lund, Ole; Claesson, Mogens H.			HLA Class I Binding 9mer Peptides from Influenza A Virus Induce CD4(+) T Cell Responses	PLOS ONE			English	Article							TAP TRANSPORT EFFICIENCY; CTL EPITOPES; MOLECULES; LIGATION; VARIOLA; H5N1	Background: Identification of human leukocyte antigen class I (HLA-I) restricted cytotoxic T cell (CTL) epitopes from influenza virus is of importance for the development of new effective peptide-based vaccines. Methodology/Principal Findings: In the present work, bioinformatics was used to predict 9mer peptides derived from available influenza A viral proteins with binding affinity for at least one of the 12 HLA-I supertypes. The predicted peptides were then selected in a way that ensured maximal coverage of the available influenza A strains. One hundred and thirty one peptides were synthesized and their binding affinities for the HLA-I supertypes were measured in a biochemical assay. Influenza-specific T cell responses towards the peptides were quantified using IFN gamma ELISPOT assays with peripheral blood mononuclear cells (PBMC) from adult healthy HLA-I typed donors as responder cells. Of the 131 peptides, 21 were found to induce T cell responses in 19 donors. In the ELISPOT assay, five peptides induced responses that could be totally blocked by the pan-specific anti-HLA-I antibody W6/32, whereas 15 peptides induced responses that could be completely blocked in the presence of the pan-specific anti-HLA class II (HLA-II) antibody IVA12. Blocking of HLA-II subtype reactivity revealed that 8 and 6 peptide responses were blocked by anti-HLA-DR and -DP antibodies, respectively. Peptide reactivity of PBMC depleted of CD4(+) or CD8(+) T cells prior to the ELISPOT culture revealed that effectors are either CD4(+) (the majority of reactivities) or CD8(+) T cells, never a mixture of these subsets. Three of the peptides, recognized by CD4(+) T cells showed binding to recombinant DRA1*0101/DRB1*0401 or DRA1*0101/DRB5*0101 molecules in a recently developed biochemical assay. Conclusions/Significance: HLA-I binding 9mer influenza virus-derived peptides induce in many cases CD4(+) T cell responses restricted by HLA-II molecules.	[Wang, Mingjun; Harndahl, Mikkel; Justesen, Sune; Buus, Soren; Claesson, Mogens H.] Univ Copenhagen, Fac Heath Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Larsen, Mette V.; Nielsen, Morten; Tang, Sheila T.; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Dziegiel, Morten H.] Copenhagen Univ Hosp, H S Blood Bank KI 2034, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Wang, MJ (corresponding author), Univ Copenhagen, Fac Heath Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	mwang429@gmail.com; claesson@sund.ku.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Dziegiel, Morten Hanefeld/0000-0001-8034-1523; Buus, Soren/0000-0001-8363-1999; WANG, MINGJUN/0000-0002-5848-0444	National Institutes of Health [HHSN266200400083C, HHSN266200400025C]; EU [6FP 503231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission)	This work was supported by National Institutes of Health contracts HHSN266200400083C, HHSN266200400025C and EU 6FP 503231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Berkhoff EGM, 2007, J GEN VIROL, V88, P530, DOI 10.1099/vir.0.82120-0; Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2; KUWANO K, 1988, J IMMUNOL, V140, P1264; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Skov S, 1997, J CELL BIOL, V139, P1523, DOI 10.1083/jcb.139.6.1523; Skov S, 1997, J IMMUNOL, V158, P3189; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	27	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10533	10.1371/journal.pone.0010533	http://dx.doi.org/10.1371/journal.pone.0010533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479886	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800015
J	Yang, LC; Zhang, QG; Zhou, CF; Yang, F; Zhang, YD; Wang, RM; Brann, DW				Yang, Li-cai; Zhang, Quan-Guang; Zhou, Cai-feng; Yang, Fang; Zhang, Yi-dong; Wang, Rui-min; Brann, Darrell W.			Extranuclear Estrogen Receptors Mediate the Neuroprotective Effects of Estrogen in the Rat Hippocampus	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; FOCAL BRAIN ISCHEMIA; PLASMA-MEMBRANE; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; CEREBRAL-ISCHEMIA; MOUSE HIPPOCAMPUS; NEURONAL SURVIVAL; GLOBAL-ISCHEMIA	Background: 17 beta-estradiol (E2) has been implicated to exert neuroprotective effects in the brain following cerebral ischemia. Classically, E2 is thought to exert its effects via genomic signaling mediated by interaction with nuclear estrogen receptors. However, the role and contribution of extranuclear estrogen receptors (ER) is unclear and was the subject of the current study. Methodology/Principal Findings: To accomplish this goal, we employed two E2 conjugates (E2 dendrimer, EDC, and E2-BSA) that can interact with extranuclear ER and exert rapid nongenomic signaling, but lack the ability to interact with nuclear ER due to their inability to enter the nucleus. EDC or E2-BSA (10 mu M) was injected icv 60 min prior to global cerebral ischemia (GCI). FITC-tagged EDC or E2-BSA revealed high uptake in the hippocampal CA1 region after icv injection, with a membrane (extranuclear) localization pattern in cells. Both EDC and E2-BSA exerted robust neuroprotection in the CA1 against GCI, and the effect was blocked by the ER antagonist, ICI182,780. EDC and E2-BSA both rapidly enhanced activation of the prosurvival kinases, ERK and Akt, while attenuating activation of the proapoptotic kinase, JNK following GCI, effects that were blocked by ICI182,780. Administration of an MEK or PI3K inhibitor blocked the neuroprotective effects of EDC and E2-BSA. Further studies showed that EDC increased p-CREB and BDNF in the CA1 region in an ERK- and Akt-dependent manner, and that cognitive outcome after GCI was preserved by EDC in an ER-dependent manner. Conclusions/Significance: In conclusion, the current study demonstrates that activation of extranuclear ER results in induction of ERK-Akt-CREB-BDNF signaling in the hippocampal CA1 region, which significantly reduces ischemic neuronal injury and preserves cognitive function following GCI. The study adds to a growing literature that suggests that extranuclear ER can have important actions in the brain.	[Yang, Li-cai; Zhou, Cai-feng; Yang, Fang; Zhang, Yi-dong; Wang, Rui-min] N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China; [Zhang, Quan-Guang; Brann, Darrell W.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	North China University of Science & Technology; University System of Georgia; Augusta University	Yang, LC (corresponding author), N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China.	rmwang1213@yahoo.com.cn; dbrann@mcg.edu			National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA [NS050730]; National Natural Science Foundation of China [30970664]; Natural Science Foundation of Hebei Provinces of China [C2008000997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050730] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Provinces of China(Natural Science Foundation of Hebei Province); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a research grant (NS050730) (to DWB) from the National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA, and a research grant (to RMW) from the National Natural Science Foundation (30970664) (to RMW) of China and the Natural Science Foundation (C2008000997) (to RMW) of Hebei Provinces of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, REPRODUCTION, V131, P763, DOI 10.1530/rep.1.00807; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Azcoitia I, 1999, GLIA, V26, P260; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Elzer J.G., 2009, J CEREB BLOOD FLOW M; Evinger AJ, 2005, STEROIDS, V70, P361, DOI 10.1016/j.steroids.2005.02.015; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kalita K, 2005, HIPPOCAMPUS, V15, P404, DOI 10.1002/hipo.20066; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marin R, 2009, J STEROID BIOCHEM, V114, P2, DOI 10.1016/j.jsbmb.2008.12.014; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Milner TA, 2001, J COMP NEUROL, V429, P355; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy SJ, 2004, ILAR J, V45, P147, DOI 10.1093/ilar.45.2.147; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Nishio M, 2004, NEUROSCI LETT, V355, P109, DOI 10.1016/j.neulet.2003.10.064; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Porte Y, 2008, LEARN MEMORY, V15, P885, DOI 10.1101/lm.1094208; Raval AP, 2009, NEUROSCIENCE, V160, P307, DOI 10.1016/j.neuroscience.2009.02.065; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Soderstrom I, 2009, EUR J NEUROSCI, V29, P1215, DOI 10.1111/j.1460-9568.2009.06662.x; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	70	143	157	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e9851	10.1371/journal.pone.0009851	http://dx.doi.org/10.1371/journal.pone.0009851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479872	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800001
J	Gandhi, KS; Mckay, FC; Diefenbach, E; Crossett, B; Schibeci, SD; Heard, RN; Stewart, GJ; Booth, DR; Arthur, JW				Gandhi, Kaushal S.; Mckay, Fiona C.; Diefenbach, Eve; Crossett, Ben; Schibeci, Stephen D.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.; Arthur, Jonathan W.			Novel Approaches to Detect Serum Biomarkers for Clinical Response to Interferon-beta Treatment in Multiple Sclerosis	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS; T-LYMPHOCYTES; NEUTRALIZING ANTIBODIES; EXPERIMENTAL-DESIGN; EARLY INTERVENTION; CHEMOKINE	Interferon beta (IFN beta) is the most common immunomodulatory treatment for relapsing-remitting multiple sclerosis (RRMS). However, some patients fail to respond to treatment. In this study, we identified putative clinical response markers in the serum and plasma of people with multiple sclerosis (MS) treated with IFN beta. In a discovery-driven approach, we use 2D-difference gel electrophoresis (DIGE) to identify putative clinical response markers and apply power calculations to identify the sample size required to further validate those markers. In the process we have optimized a DIGE protocol for plasma to obtain cost effective and high resolution gels for effective spot comparison. APOA1, A2M, and FIBB were identified as putative clinical response markers. Power calculations showed that the current DIGE experiment requires a minimum of 10 samples from each group to be confident of 1.5 fold difference at the p<0.05 significance level. In a complementary targeted approach, Cytometric Beadarray (CBA) analysis showed no significant difference in the serum concentration of IL-6, IL-8, MIG, Eotaxin, IP-10, MCP-1, and MIP-1 alpha, between clinical responders and non-responders, despite the association of these proteins with IFN beta treatment in MS.	[Gandhi, Kaushal S.; Mckay, Fiona C.; Diefenbach, Eve; Schibeci, Stephen D.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Gandhi, Kaushal S.; Arthur, Jonathan W.] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Crossett, Ben] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Gandhi, KS (corresponding author), Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jonathan.arthur@sydney.edu.au	Arthur, Jonathan/A-5367-2009; Crossett, Ben/G-2316-2011	Arthur, Jonathan/0000-0003-3615-7352; McKay, Fiona Catherine/0000-0002-9610-0668	Australian Research Council [LP0668335]	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council (www.arc.gov.au) Linkage Grant (LP0668335), partnered by Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alexander JS, 2007, J MOL NEUROSCI, V32, P169, DOI 10.1007/s12031-007-0018-3; Baker PW, 1999, J LIPID RES, V40, P345; Boz C, 2006, CLIN NEUROL NEUROSUR, V108, P124, DOI 10.1016/j.clineuro.2005.01.005; Buttmann M, 2004, J NEUROIMMUNOL, V156, P195, DOI 10.1016/j.jneuroim.2004.07.016; Calabresi PA, 2001, J NEUROIMMUNOL, V115, P161, DOI 10.1016/S0165-5728(01)00253-3; Comabella M, 2002, J NEUROIMMUNOL, V126, P205, DOI 10.1016/S0165-5728(02)00064-4; Comabella M, 2009, CLIN IMMUNOL, V130, P145, DOI 10.1016/j.clim.2008.09.010; Conroy DM, 2001, RESP RES, V2, P150, DOI 10.1186/rr52; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Durelli L, 2001, NEUROL SCI, V22, P201, DOI 10.1007/s100720170024; Flachenecker P, 2003, DRUGS, V63, P1525, DOI 10.2165/00003495-200363150-00001; Franciotta D, 2006, J NEUROL SCI, V247, P202, DOI 10.1016/j.jns.2006.05.049; Galvani M, 2001, ELECTROPHORESIS, V22, P2066, DOI 10.1002/1522-2683(200106)22:10<2066::AID-ELPS2066>3.0.CO;2-8; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Gneiss C, 2004, MULT SCLER J, V10, P507, DOI 10.1191/1352458504ms1074oa; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Gunnarsson M, 2003, ACTA NEUROL SCAND, V108, P16, DOI 10.1034/j.1600-0404.2003.00079.x; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Hartung HP, 2005, EUR J NEUROL, V12, P588, DOI 10.1111/j.1468-1331.2005.01104.x; Horgan GW, 2007, J PROTEOME RES, V6, P2884, DOI 10.1021/pr070114a; Hunt SMN, 2005, J PROTEOME RES, V4, P809, DOI 10.1021/pr049758y; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jeffery DR, 2002, J NEUROL SCI, V197, P1, DOI 10.1016/S0022-510X(02)00039-4; Jensen PEH, 2004, BBA-MOL BASIS DIS, V1690, P203, DOI 10.1016/j.bbadis.2004.06.010; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Kappos L, 2004, NEUROLOGY, V63, P1779, DOI 10.1212/01.WNL.0000145561.08973.4F; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Khan A, 2005, CLIN CHIM ACTA, V358, P119, DOI 10.1016/j.cccn.2005.03.013; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Lund BT, 2004, J NEUROIMMUNOL, V155, P161, DOI 10.1016/j.jneuroim.2004.06.008; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Muller D, 2000, VIRCHOWS ARCH, V437, P521, DOI 10.1007/s004280000271; Muller Diane M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P279, DOI 10.2174/1568010043343732; Nakatsuji Y, 2006, CYTOKINE, V36, P69, DOI 10.1016/j.cyto.2006.10.013; Nicoletti F, 2000, CYTOKINE, V12, P682, DOI 10.1006/cyto.1999.0616; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Sena A, 2000, CLIN CHEM LAB MED, V38, P209, DOI 10.1515/CCLM.2000.030; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Szczucinski A, 2004, FOLIA NEUROPATHOL, V42, P15; TARLORI C, 2002, J NEUROIMMUNOL, V123, P170; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Tumani H, 2010, EXPERT REV PROTEOMIC, V7, P29, DOI 10.1586/EPR.09.99; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Waubant E, 2003, NEUROLOGY, V61, P184, DOI 10.1212/01.WNL.0000078888.07196.0B; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zang YCQ, 2001, J NEUROIMMUNOL, V112, P174, DOI 10.1016/S0165-5728(00)00397-0	54	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10484	10.1371/journal.pone.0010484	http://dx.doi.org/10.1371/journal.pone.0010484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463963	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400020
J	Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M				Mader, Simone; Lutterotti, Andreas; Di Pauli, Franziska; Kuenz, Bettina; Schanda, Kathrin; Aboul-Enein, Fahmy; Khalil, Michael; Storch, Maria K.; Jarius, Sven; Kristoferitsch, Wolfgang; Berger, Thomas; Reindl, Markus			Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; PATHOGENESIS; IGG; DISTINCTION; PREDICTORS; RITUXIMAB; MARKER; NMO	Background: Neuromyelitis optica (NMO), a severe demyelinating disease, represents itself with optic neuritis and longitudinally extensive transverse myelitis. Serum NMO-IgG autoantibodies (Abs), a specific finding in NMO patients, target the water channel protein aquaporin-4 (AQP4), which is expressed as a long (M-1) or a short (M-23) isoform. Methodology/Principal Findings: The aim of this study was to analyze serum samples from patients with NMO and controls for the presence and epitope specificity of IgG and IgM anti-AQP4 Abs using an immunofluorescence assay with HEK293 cells expressing M-1 or M-23 human AQP4. We included 56 patients with definite NMO (n = 30) and high risk NMO (n = 26), 101 patients with multiple sclerosis, 27 patients with clinically isolated syndromes (CIS), 30 patients with systemic lupus erythematosus (SLE) or Sjogren's syndrome, 29 patients with other neurological diseases and 47 healthy controls. Serum anti-AQP4 M-23 IgG Abs were specifically detected in 29 NMO patients, 17 patients with high risk NMO and two patients with myelitis due to demyelination (CIS) and SLE. In contrast, IgM anti-AQP4 Abs were not only found in some NMO and high risk patients, but also in controls. The sensitivity of the M-23 AQP4 IgG assay was 97% for NMO and 65% for high risk NMO, with a specificity of 100% compared to the controls. Sensitivity with M-1 AQP4 transfected cells was lower for NMO (70%) and high risk NMO (39%). The conformational epitopes of M-23 AQP4 are the primary targets of NMO-IgG Abs, whereas M-1 AQP4 Abs are developed with increasing disease duration and number of relapses. Conclusions: Our results confirm M-23 AQP4-IgG Abs as reliable biomarkers in patients with NMO and high risk syndromes. M-1 and M-23 AQP4-IgG Abs are significantly associated with a higher number of relapses and longer disease duration.	[Mader, Simone; Lutterotti, Andreas; Di Pauli, Franziska; Kuenz, Bettina; Schanda, Kathrin; Berger, Thomas; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Khalil, Michael; Storch, Maria K.] Med Univ Graz, Dept Neurol, Graz, Austria; [Jarius, Sven] Univ Heidelberg, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany	Medical University of Innsbruck; Donauspital; Medical University of Graz; Ruprecht Karls University Heidelberg	Mader, S (corresponding author), Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria.	markus.reindl@i-med.ac.at	Reindl, Markus/ABE-5880-2020	Reindl, Markus/0000-0003-2817-1402; Mader, Simone/0000-0002-2844-9091; Berger, Thomas/0000-0001-5626-1144; Khalil, Michael/0000-0002-5350-3328	European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) [2007104]	European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)	Research grant (no. 2007104) of the interdisciplinary center for research and treatment (IFTZ), Innsbruck Medical University, Research Fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; CRANE JM, 2009, NEUROSCIENCE; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Takahashi T, 2006, TOHOKU J EXP MED, V210, P307, DOI 10.1620/tjem.210.307; Waters P, 2008, Int MS J, V15, P99; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Weinshenker BG, 2007, ARCH NEUROL-CHICAGO, V64, P899, DOI 10.1001/archneur.64.6.899; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, NEUROLOGIST, V13, P2, DOI 10.1097/01.nrl.0000250927.21903.f8; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	31	122	128	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10455	10.1371/journal.pone.0010455	http://dx.doi.org/10.1371/journal.pone.0010455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463974	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400010
J	Pohjoismaki, JLO; Goffart, S; Taylor, RW; Turnbull, DM; Suomalainen, A; Jacobs, HT; Karhunen, PJ				Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Taylor, Robert W.; Turnbull, Douglas M.; Suomalainen, Anu; Jacobs, Howard T.; Karhunen, Pekka J.			Developmental and Pathological Changes in the Human Cardiac Muscle Mitochondrial DNA Organization, Replication and Copy Number	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS; TRANSCRIPTION FACTOR-A; AUTOSOMAL-DOMINANT; HELICASE TWINKLE; MUTATIONS; HEART; EXPRESSION; SKELETAL; FAILURE	Adult human heart mitochondrial DNA (mtDNA) has recently been shown to have a complex organization with abundant dimeric molecules, branched structures and four-way junctions. In order to understand the physiological significance of the heart-specific mtDNA maintenance mode and to find conditions that modify human heart mtDNA structure and replication, we analyzed healthy human heart of various ages as well as several different heart diseases, including ischemic heart disease, dilated as well as hypertrophic cardiomyopathies, and several mitochondrial disorders. By using one-and two-dimensional agarose gel electrophoresis, various enzymatic treatments and quantitative PCR we found that in human newborns heart mtDNA has a simple organization, lacking junctional forms and dimers. The adult-type branched forms are acquired in the early childhood, correlating with an increase in mtDNA copy number. Mitochondrial disorders involving either mutations in the mtDNA polymerase gamma (PolG alpha) or mtDNA helicase Twinkle, while having no obvious cardiac manifestation, show distinct mtDNA maintenance phenotypes, which are not seen in various types of diseased heart or in mitochondrial disorders caused by point mutations or large-scale deletions of mtDNA. The findings suggest a link between cardiac muscle development, mtDNA copy number, replication mode and topological organization. Additionally, we show that Twinkle might have a direct role in the maintenance of four-way junctions in human heart mtDNA.	[Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland; [Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Taylor, Robert W.; Turnbull, Douglas M.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Helsinki, Finland	Tampere University; Tampere University; Newcastle University - UK; University of Helsinki	Pohjoismaki, JLO (corresponding author), Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.	Jaakko.Pohjoismaki@uta.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019; Goffart, Steffi/N-3597-2015; Jacobs, Howard T/G-2434-2011	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Goffart, Steffi/0000-0001-8491-1458; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Jacobs, Howard/0000-0003-1895-6003; Turnbull, Doug/0000-0002-8878-9901	EU; Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National Comissioning Group; Medical Research Council [G0700718B] Funding Source: researchfish	EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle upon Tyne Hospitals NHS Trust; UK National Comissioning Group; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JLP was funded by the EU's 7th Framework Program Collaborative Project, AtheroRemo. RWT and DMT acknowledge the continuing financial support of a Wellcome Trust Programme Grant and the Newcastle upon Tyne Hospitals NHS Trust. Mitochondrial diagnostic testing in Newcastle is funded by the UK National Comissioning Group to provide the "Rare Mitochondrial Disorders of Adults and Children'' Diagnostics Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x; BOGENHAGEN D, 1981, J MOL BIOL, V148, P77, DOI 10.1016/0022-2836(81)90236-9; Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334; Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Leipe DD, 2000, GENOME RES, V10, P5; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SWALWELL H, 2008, EUR J HUM GENET, V18, P63; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392	36	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10426	10.1371/journal.pone.0010426	http://dx.doi.org/10.1371/journal.pone.0010426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454654	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300006
J	Sayre, EC; Li, LC; Kopec, JA; Esdaile, JM; Bar, S; Cibere, J				Sayre, Eric C.; Li, Linda C.; Kopec, Jacek A.; Esdaile, John M.; Bar, Sherry; Cibere, Jolanda			The Effect of Disease Site (Knee, Hip, Hand, Foot, Lower Back or Neck) on Employment Reduction Due to Osteoarthritis	PLOS ONE			English	Article							PREVALENCE; DISABILITY; PAIN; POPULATION; ARTHRITIS; WORK; DETERMINANTS; INDIVIDUALS; ASSOCIATION; PERSPECTIVE	Background: Osteoarthritis (OA) has a significant impact on individuals' ability to work. Our goal was to investigate the effects of the site of OA (knee, hip, hand, foot, lower back or neck) on employment reduction due to OA (EROA). Methods and Findings: This study involved a random sample of 6,000 patients with OA selected from the Medical Service Plan database in British Columbia, Canada. A total of 5,491 were alive and had valid addresses, and of these, 2,259 responded (response rate = 41%), from which 2,134 provided usable data. Eligible participants were 19 or older with physician diagnosed OA based on administrative data between 1992 and 2006. Data of 688 residents were used (mean age 62.1 years (27 to 86); 60% women). EROA had three levels: no reduction; reduced hours; and total cessation due to OA. The (log) odds of EROA was regressed on OA sites, adjusting for age, sex, education and comorbidity. Odds ratios (ORs) represented the effect predicting total cessation and reduced hours/total cessation. The strongest effect was found in lower back OA, with OR = 2.08 (95% CI: 1.47, 2.94), followed by neck (OR = 1.59; 95% CI: 1.11, 2.27) and knee (OR = 1.43; 95% CI: 1.02, 2.01). We found an interaction between sex and foot OA (men: OR = 1.94; 95% CI: 1.05, 3.59; women: OR = 0.89; 95% CI = 0.57, 1.39). No significant effect was found for hip OA (OR = 1.33) or hand OA (OR = 1.11). Limitations of this study included a modest response rate, the lack of an OA negative group, the use of administrative databases to identify eligible participants, and the use of patient self-reported data. Conclusions: After adjusting for socio-demographic variables, comorbidity, and other OA disease sites, we find that OA of the lower back, neck and knee are significant predictors for EROA. Foot OA is only significantly associated with EROA in males. For multi-site combinations, ORs are multiplicative. These findings may be used to guide resource allocation for future development/improvement of vocational rehabilitation programs for site-specific OA.	[Sayre, Eric C.; Li, Linda C.; Kopec, Jacek A.; Esdaile, John M.; Cibere, Jolanda] Arthrit Res Ctr Canada, Vancouver, BC, Canada; [Sayre, Eric C.; Kopec, Jacek A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Esdaile, John M.; Cibere, Jolanda] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC V5Z 1M9, Canada; [Li, Linda C.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Bar, Sherry] British Columbia Minist Hlth Serv, Victoria, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Sayre, EC (corresponding author), Arthrit Res Ctr Canada, Vancouver, BC, Canada.	esayre@arthritisresearch.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR); American College of Rheumatology Research and Education Foundation; Arthritis Society British Columbia; Yukon Division	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American College of Rheumatology Research and Education Foundation; Arthritis Society British Columbia; Yukon Division	Dr. Sayre is supported by a Canadian Arthritis Network (CAN) Postdoctoral Fellowship Award. Dr. Li is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award, and an American College of Rheumatology Research and Education Foundation Health Professional New Investigator Award. This study was supported by funding from the Arthritis Society British Columbia and Yukon Division (TAS;http://www.arthritis.ca/) and the Healthy Heart Society (http://www.healthyheart.bc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo L, 2008, ARTHRIT RHEUM-ARTHR, V59, P489, DOI 10.1002/art.23537; BADLEY EM, 1995, J RHEUMATOL, V43, pS19; Besse JL, 2006, REV CHIR ORTHOP, V92, P175, DOI 10.1016/S0035-1040(06)75703-8; Botha-Scheepers SA, 2004, ANN RHEUM DIS, V63, P72; BROSSEAU L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004259; Brosseau L, 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD004522; Carreira AG, 2007, ANN RHEUM DIS, V66, P659; Chen JC, 2007, OCCUP ENVIRON MED, V64, P798, DOI 10.1136/oem.2006.030148; Dahaghin S, 2005, ANN RHEUM DIS, V64, P99, DOI 10.1136/ard.2003.017087; Gignac MAM, 2008, ARTHRIT RHEUM-ARTHR, V59, P1805, DOI 10.1002/art.24085; Gobelet C, 2007, DISABIL REHABIL, V29, P1331, DOI 10.1080/09638280701315094; Gravlee JR, 2007, AM FAM PHYSICIAN, V75, P342; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Hammond A, 2008, BEST PRACT RES CL RH, V22, P435, DOI 10.1016/j.berh.2008.02.003; Heijbel B, 2005, J OCCUP REHABIL, V15, P167, DOI 10.1007/s10926-005-1216-x; Hirata S, 2006, J RHEUMATOL, V33, P939; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hostler D, 2009, PREHOSP EMERG CARE, V13, P256, DOI 10.1080/10903120802706195; JENNINGS MB, 1994, J AM PODIAT MED ASSN, V84, P348, DOI 10.7547/87507315-84-7-348; Kaptein SA, 2009, ARTHRIT RHEUM-ARTHR, V61, P605, DOI 10.1002/art.24427; Klobas L, 2006, ACTA ODONTOL SCAND, V64, P341, DOI 10.1080/00016350600825310; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; Levine B, 2009, CLIN ORTHOP RELAT R, V467, P1468, DOI 10.1007/s11999-009-0779-9; Li L, 2008, BRIT COLUMBIA OSTEOA; Menz HB, 2005, J AM PODIAT MED ASSN, V95, P573, DOI 10.7547/0950573; Min JL, 2005, ARTHRITIS RHEUM-US, V52, P1077, DOI 10.1002/art.20993; Muraki S, 2007, CALCIFIED TISSUE INT, V80, pS67; Palmer KT, 2005, OCCUP ENVIRON MED, V62, P54, DOI 10.1136/oem.2004.014977; Roos E, 2006, FOOT ANKLE INT, V27, P606, DOI 10.1177/107110070602700807; Rytter S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-93; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Viieland TPMV, 2009, CURR OPIN RHEUMATOL, V21, P183, DOI 10.1097/BOR.0b013e328324e6eb; Wilder FV, 2006, OSTEOARTHR CARTILAGE, V14, P953, DOI 10.1016/j.joca.2006.04.013	33	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10470	10.1371/journal.pone.0010470	http://dx.doi.org/10.1371/journal.pone.0010470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454665	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300030
J	Wolters, JC; Berntsson, RPA; Gul, N; Karasawa, A; Thunnissen, AMWH; Slotboom, DJ; Poolman, B				Wolters, Justina C.; Berntsson, Ronnie P-A.; Gul, Nadia; Karasawa, Akira; Thunnissen, Andy-Mark W. H.; Slotboom, Dirk-Jan; Poolman, Bert			Ligand Binding and Crystal Structures of the Substrate-Binding Domain of the ABC Transporter OpuA	PLOS ONE			English	Article							SOLUTES GLYCINE BETAINE; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; CORYNEBACTERIUM-GLUTAMICUM; COMPATIBLE SOLUTES; IONIC-STRENGTH; PROLINE BETAINE; PROTEIN OPUAC; SPECIFICITY	The ABC transporter OpuA from Lactococcus lactis transports glycine betaine upon activation by threshold values of ionic strength. In this study, the ligand binding characteristics of purified OpuA in a detergent-solubilized state and of its substrate-binding domain produced as soluble protein (OpuAC) was characterized. Principal Findings: The binding of glycine betaine to purified OpuA and OpuAC (K(D) = 4-6 mu M) did not show any salt dependence or cooperative effects, in contrast to the transport activity. OpuAC is highly specific for glycine betaine and the related proline betaine. Other compatible solutes like proline and carnitine bound with affinities that were 3 to 4 orders of magnitude lower. The low affinity substrates were not noticeably transported by membrane-reconstituted OpuA. OpuAC was crystallized in an open (1.9 angstrom) and closed-liganded (2.3 angstrom) conformation. The binding pocket is formed by three tryptophans (Trp-prism) coordinating the quaternary ammonium group of glycine betaine in the closed-liganded structure. Even though the binding site of OpuAC is identical to that of its B. subtilis homolog, the affinity for glycine betaine is 4-fold higher. Conclusions: Ionic strength did not affect substrate binding to OpuA, indicating that regulation of transport is not at the level of substrate binding, but rather at the level of translocation. The overlap between the crystal structures of OpuAC from L. lactis and B. subtilis, comprising the classical Trp-prism, show that the differences observed in the binding affinities originate from outside of the ligand binding site.	[Wolters, Justina C.; Berntsson, Ronnie P-A.; Gul, Nadia; Karasawa, Akira; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Dept Biochem, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst,Netherland, Groningen, Netherlands; [Thunnissen, Andy-Mark W. H.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Wolters, JC (corresponding author), Univ Groningen, Dept Biochem, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst,Netherland, Groningen, Netherlands.	b.poolman@rug.nl	Berntsson, Ronnie/J-3535-2019; Institute, Zernike/W-7033-2019; Karasawa, Akira/ABF-4128-2021; Thunnissen, Andy-Mark/A-1777-2010; Berntsson, Ronnie/K-1326-2012; Poolman, Bert/D-1882-2012; Karasawa, Akira/ABC-9782-2021	Berntsson, Ronnie/0000-0001-6848-322X; Thunnissen, Andy-Mark/0000-0002-1915-9850; 	Marie Curie Early Stage Training (EST); Netherlands Organisation for Scientific research (NWO) [700-56-302]; Vidi grant; EU; Netherlands Proteomics Centre (NPC)	Marie Curie Early Stage Training (EST)(European Commission); Netherlands Organisation for Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Vidi grant; EU(European Commission); Netherlands Proteomics Centre (NPC)	This work was supported by grants from Marie Curie Early Stage Training (EST, to RB), The Netherlands Organisation for Scientific research (NWO, Chemical Sciences Top Subsidy to BP; grant number 700-56-302; Vidi grant to DJS), EU (EMEP and EDICT programs) and the Netherlands Proteomics Centre (NPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; BOCH J, 1994, J BACTERIOL, V176, P5364; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kappes RM, 1998, MICROBIOL-UK, V144, P83, DOI 10.1099/00221287-144-1-83; Lanfermeijer FC, 1999, BIOCHEMISTRY-US, V38, P14440, DOI 10.1021/bi9914715; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Mahmood NABN, 2009, J BIOL CHEM, V284, P14368, DOI 10.1074/jbc.M901238200; MAO B, 1982, J BIOL CHEM, V257, P1131; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monnet V, 2003, CELL MOL LIFE SCI, V60, P2100, DOI 10.1007/s00018-003-3054-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oswald C, 2008, J BIOL CHEM, V283, P32848, DOI 10.1074/jbc.M806021200; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Romeo Y, 2007, FEBS LETT, V581, P3387, DOI 10.1016/j.febslet.2007.06.037; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Smits SHJ, 2008, J BACTERIOL, V190, P5663, DOI 10.1128/JB.00346-08; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Van der Heide T, 2000, J BACTERIOL, V182, P203, DOI 10.1128/JB.182.1.203-206.2000; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	47	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10361	10.1371/journal.pone.0010361	http://dx.doi.org/10.1371/journal.pone.0010361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454456	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100004
J	Bhadra, R; Guan, HB; Khan, IA				Bhadra, Rajarshi; Guan, Hongbing; Khan, Imtiaz A.			Absence of Both IL-7 and IL-15 Severely Impairs the Development of CD8(+) T Cell Response against Toxoplasma gondii	PLOS ONE			English	Article							IFN-GAMMA; RECEPTOR-ALPHA; CUTTING EDGE; HOMEOSTATIC PROLIFERATION; MURINE TOXOPLASMOSIS; MEDIATED-IMMUNITY; MEMORY; EXPRESSION; INFECTION; MICE	CD8(+) T cells play an essential role in the protection against both acute as well as chronic Toxoplasma gondii infection. Although the role of IL-15 has been reported to be important for the development of long-term CD8(+) T cell immunity against the pathogen, the simultaneous roles played by both IL-15 and related gamma-chain family cytokine IL-7 in the generation of this response during acute phase of infection has not been described. We demonstrate that while lack of IL-7 or IL-15 alone has minimal impact on splenic CD8(+) T cell maturation or effector function development during acute Toxoplasmosis, absence of both IL-7 and IL-15 only in the context of infection severely down-regulates the development of a potent CD8(+) T cell response. This impairment is characterized by reduction in CD44 expression, IFN-gamma production, proliferation and cytotoxicity. However, attenuated maturation and decreased effector functions in these mice are essentially downstream consequences of reduced number of antigen-specific CD8(+) T cells. Interestingly, the absence of both cytokines did not impair initial CD8(+) T cell generation but affected their survival and differentiation into memory phenotype IL-7R alpha(hi) cells. Significantly lack of both cytokines severely affected expression of Bcl-2, an anti-apoptotic protein, but minimally affected proliferation. The overarching role played by these cytokines in eliciting a potent CD8(+) T cell immunity against T. gondii infection is further evidenced by poor survival and high parasite burden in anti IL-7 treated IL-15(-/-) mice. These studies demonstrate that the two cytokines, IL-7 and IL-15, are exclusively important for the development of protective CD8(+) T cell immune response against T. gondii. To the best of our knowledge this synergism between IL-7 and IL-15 in generating an optimal CD8(+) T cell immunity against intracellular parasite or any other infectious disease model has not been previously reported.	[Bhadra, Rajarshi; Khan, Imtiaz A.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Guan, Hongbing] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	George Washington University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bhadra, R (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	mtmixk@gwumc.edu			National Institutes of Health [AI33325]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033325, R21AI033325, R01AI033325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI33325 awarded to IAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Blass SL, 2001, J IMMUNOL, V166, P5726, DOI 10.4049/jimmunol.166.9.5726; Borger P, 1996, J IMMUNOL, V156, P1333; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; CANDOLFI E, 1994, INFECT IMMUN, V62, P1995, DOI 10.1128/IAI.62.5.1995-2001.1994; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Casciotti L, 2002, INFECT IMMUN, V70, P434, DOI 10.1128/IAI.70.2.434-443.2002; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cheung KP, 2009, J IMMUNOL, V182; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Combe CL, 2006, P NATL ACAD SCI USA, V103, P6635, DOI 10.1073/pnas.0506180103; Denkers EY, 1997, J IMMUNOL, V159, P1903; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Guan HB, 2007, J IMMUNOL, V179, P590, DOI 10.4049/jimmunol.179.1.590; HAKIM FT, 1991, J IMMUNOL, V147, P2310; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; HAQUE S, 1994, INFECT IMMUN, V62, P2908, DOI 10.1128/IAI.62.7.2908-2916.1994; HUGHES HPA, 1988, CLIN EXP IMMUNOL, V72, P394; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karawajew L, 2000, BLOOD, V96, P297, DOI 10.1182/blood.V96.1.297.013k24_297_306; KASPER LH, 1995, J IMMUNOL, V155, P4798; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Khan IA, 1999, J IMMUNOL, V163, P4503; Khan IA, 2002, J EXP MED, V195, P1463, DOI 10.1084/jem.20011915; Khan IA, 1996, J IMMUNOL, V157, P2103; Khan IA, 1999, INFECT IMMUN, V67, P5869, DOI 10.1128/IAI.67.11.5869-5876.1999; KHAN IA, 1994, J IMMUNOL, V152, P1856; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakazato K, 2007, J IMMUNOL, V178, P757, DOI 10.4049/jimmunol.178.2.757; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Purner MB, 1996, INFECT IMMUN, V64, P4330, DOI 10.1128/IAI.64.10.4330-4338.1996; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Starborg M, 1996, J CELL SCI, V109, P143; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	61	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10842	10.1371/journal.pone.0010842	http://dx.doi.org/10.1371/journal.pone.0010842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520779	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221500028
J	Mao, CH; Wang, MA; Luo, BQ; Wey, SA; Dong, DZ; Wesselschmidt, R; Rawlings, S; Lee, AS				Mao, Changhui; Wang, Miao; Luo, Biquan; Wey, Shiuan; Dong, Dezheng; Wesselschmidt, Robin; Rawlings, Stephen; Lee, Amy S.			Targeted Mutation of the Mouse Grp94 Gene Disrupts Development and Perturbs Endoplasmic Reticulum Stress Signaling	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; GLUCOSE-REGULATED PROTEINS; PEPTIDE-BINDING-SITE; ER CHAPERONE; IN-VIVO; GRP78/BIP; INDUCTION; CELLS; APOPTOSIS; PROMOTER	Glucose-regulated protein 94 (GRP94) is one of the most abundant endoplasmic reticulum (ER) resident proteins and is the ER counterpart of the cytoplasmic heat shock protein 90 (HSP90). GRP94, a component of the GRP78 chaperone system in protein processing, has pro-survival properties with implicated function in cancer progression and autoimmune disease. Previous studies on the loss of GRP94 function showed that it is required for embryonic development, regulation of toll-like receptors and innate immunity of macrophages. Here we report the creation of mouse models targeting exon 2 of the Grp94 allele that allows both traditional and conditional knockout (KO) of Grp94. In this study, we utilized the viable Grp94+/+ and +/- mice, as well as primary mouse embryonic fibroblasts generated from them as experimental tools to study its role in ER chaperone balance and ER stress signaling. Our studies reveal that while Grp94 heterozygosity reduces GRP94 level it does not alter ER chaperone levels or the ER stress response. To study the effect of complete loss of GRP94 function, since homozygous GRP94 KO leads to embryonic lethality, we generated Grp94-/- embryonic stem cells. In contrast to Grp94 heterozygosity, complete knockout of GRP94 leads to compensatory upregulation of the ER chaperones GRP78, calnexin and calreticulin but not protein disulphide isomerase. Unexpectedly, loss of GRP94 leads to significant decrease in the level of ER-stress induced spliced form of XBP-1 protein, a downstream target of the IRE1 signaling pathway. Furthermore, from analysis of microarray database and immunohistochemical staining, we present predictions where GRP94 may play an important role in specific adult organ homeostasis and function.	[Mao, Changhui; Wang, Miao; Luo, Biquan; Wey, Shiuan; Dong, Dezheng; Rawlings, Stephen; Lee, Amy S.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Wesselschmidt, Robin] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Mao, CH (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	NIH/NCI [CA027607]; NATIONAL CANCER INSTITUTE [R37CA027607, R01CA027607] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI, CA027607, http://www.nih.gov/; Freeman Cosmetic Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Baker-LePain JC, 2004, J IMMUNOL, V172, P4195, DOI 10.4049/jimmunol.172.7.4195; Barnes JA, 1997, ANAT EMBRYOL, V196, P335, DOI 10.1007/s004290050102; Barnes JA, 2000, ANAT EMBRYOL, V202, P67, DOI 10.1007/s004290000090; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Facciponte JG, 2006, CANCER IMMUNOL IMMUN, V55, P339, DOI 10.1007/s00262-005-0020-y; Fu H, 2007, GENESIS, V45, P477, DOI 10.1002/dvg.20316; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; Hilf N, 2002, INT J HYPERTHER, V18, P521, DOI 10.1080/02656730210166177; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; Le YZ, 2000, METH MOL B, V136, P477; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Linderoth NA, 2001, J BIOL CHEM, V276, P11049, DOI 10.1074/jbc.M010059200; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; MARTINON F, 2010, NAT IMMUNOL; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Menoret A, 2001, J BIOL CHEM, V276, P33313, DOI 10.1074/jbc.M103383200; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Nardai G, 2006, TRENDS IMMUNOL, V27, P74, DOI 10.1016/j.it.2005.11.009; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; RAMAKRISHNAN M, 1995, DNA CELL BIOL, V14, P373, DOI 10.1089/dna.1995.14.373; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Wagner E, 2002, J CELL SCI, V115, P3033; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755	52	57	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10852	10.1371/journal.pone.0010852	http://dx.doi.org/10.1371/journal.pone.0010852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520781	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500037
J	Gajewski, KM; Schulz, RA				Gajewski, Kathleen M.; Schulz, Robert A.			CF2 Represses Actin 88F Gene Expression and Maintains Filament Balance during Indirect Flight Muscle Development in Drosophila	PLOS ONE			English	Article							TRANSCRIPTION FACTOR CF2; HEAVY-CHAIN GENE; ENHANCER FACTOR-2; MELANOGASTER; MUTANT; OVEREXPRESSION; OOGENESIS; ISOFORMS; DEFECTS; PROTEIN	The zinc finger protein CF2 is a characterized activator of muscle structural genes in the body wall muscles of the Drosophila larva. To investigate the function of CF2 in the indirect flight muscle (IFM), we examined the phenotypes of flies bearing five homozygous viable mutations. The gross structure of the IFM was not affected, but the stronger hypomorphic alleles caused an increase of up to 1.5X in the diameter of the myofibrils. This size increase did not cause any disruption of the hexameric arrangement of thick and thin filaments. RT-PCR analysis revealed an increase in the transcription of several structural genes. Ectopic overexpression of CF2 in the developing IFM disrupts muscle formation. While our results indicate a role for CF2 as a direct negative regulator of the thin filament protein gene Actin 88F (Act88F), effects on levels of transcripts of myosin heavy chain (mhc) appear to be indirect. This role is in direct contrast to that described in the larval muscles, where CF2 activates structural gene expression. The variation in myofibril phenotypes of CF2 mutants suggest the CF2 may have separate functions in fine-tuning expression of structural genes to insure proper filament stoichiometry, and monitoring and/or controlling the final myofibril size.	[Gajewski, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Texas System; UTMD Anderson Cancer Center; University of Notre Dame	Gajewski, KM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	kmgajews@mdanderson.org			NIH [CA16672, HL059151]; AHA SDG; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA SDG(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The MD Anderson EM Core and MD Anderson DNA Sequencing Core are supported by NIH grant CA16672. KMG was supported by an AHA SDG. RAS was supported by NIH grant HL059151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; Bagni C, 2002, MECH DEVELOP, V117, P265, DOI 10.1016/S0925-4773(02)00176-4; BARBAS JA, 1993, MOL CELL BIOL, V13, P1433, DOI 10.1128/MCB.13.3.1433; BARTHMAIER P, 1995, DEV BIOL, V169, P770, DOI 10.1006/dbio.1995.1186; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; CRIPPS RM, 1994, J CELL BIOL, V126, P689, DOI 10.1083/jcb.126.3.689; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Gajewski KM, 2006, DEV BIOL, V289, P17, DOI 10.1016/j.ydbio.2005.09.039; Garcia-Zaragoza E, 2008, MECH DEVELOP, V125, P617, DOI 10.1016/j.mod.2008.03.003; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; Hess NK, 2007, GENE EXPR PATTERNS, V7, P413, DOI 10.1016/j.modgep.2006.11.007; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; Kelly KK, 2002, MECH DEVELOP, V110, P39, DOI 10.1016/S0925-4773(01)00586-X; KOANA T, 1978, J EMBRYOL EXP MORPH, V45, P123; Lin MH, 1996, P NATL ACAD SCI USA, V93, P4623, DOI 10.1073/pnas.93.10.4623; Mantrova EY, 1998, GENE DEV, V12, P1166; Marco-Ferreres R, 2005, BIOCHEM J, V386, P145, DOI 10.1042/BJ20041240; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Nongthomba U, 2001, J MUSCLE RES CELL M, V22, P111, DOI 10.1023/A:1010308326890; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314	26	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10713	10.1371/journal.pone.0010713	http://dx.doi.org/10.1371/journal.pone.0010713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520827	gold, Green Submitted, Green Published			2022-12-27	WOS:000278034800001
J	Kovalenko, OA; Kaplunov, J; Herbig, U; Detoledo, S; Azzam, EI; Santos, JH				Kovalenko, Olga A.; Kaplunov, Jessica; Herbig, Utz; deToledo, Sonia; Azzam, Edouard I.; Santos, Janine H.			Expression of (NES-)hTERT in Cancer Cells Delays Cell Cycle Progression and Increases Sensitivity to Genotoxic Stress	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; MITOCHONDRIAL-DNA DAMAGE; HUMAN BREAST-CANCER; HUMAN TUMOR-CELLS; IONIZING-RADIATION; INDUCED APOPTOSIS; HUMAN FIBROBLASTS; MTDNA DAMAGE; NECK-CANCER; S-PHASE	Telomerase is a reverse transcriptase associated with cellular immortality through telomere maintenance. This enzyme is activated in 90% of human cancers, and inhibitors of telomerase are currently in clinical trials to counteract tumor growth. Many aspects of telomerase biology have been investigated for therapy, particularly inhibition of the enzyme, but little was done regarding its subcellular shuttling. We have recently shown that mutations in the nuclear export signal of hTERT, the catalytic component of telomerase, led to a mutant ((NES-)hTERT) that failed to immortalize cells despite nuclear localization and catalytic activity. Expression of (NES-)hTERT in primary fibroblast resulted in telomere-based premature senescence and mitochondrial dysfunction. Here we show that expression of (NES-)hTERT in LNCaP, SQ20B and HeLa cells rapidly and significantly decreases their proliferation rate and ability to form colonies in soft agar while not interfering with endogenous telomerase activity. The cancer cells showed increased DNA damage at telomeric and extra-telomeric sites, and became sensitive to ionizing radiation and hydrogen peroxide exposures. Our data show that expression of (NES-)hTERT efficiently counteracts cancer cell growth in vitro in at least two different ways, and suggest manipulation with the NES of hTERT or its subcellular shuttling as a new strategy for cancer treatment.	[Kovalenko, Olga A.; Santos, Janine H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Kovalenko, Olga A.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA; [Kaplunov, Jessica; Herbig, Utz] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [deToledo, Sonia; Azzam, Edouard I.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kovalenko, OA (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	santosja@umdnj.edu			New Jersey Commission on Cancer Research (NJCCR) [808033, 09-1124-CCR-EO, 10-2412-CCR-E0]; Army Research Office [56027LS]; Ellison Medical Foundation [AG-NS-0387-07]	New Jersey Commission on Cancer Research (NJCCR); Army Research Office; Ellison Medical Foundation(Lawrence Ellison Foundation)	This study was supported by The New Jersey Commission on Cancer Research (NJCCR), grant number 808033 (J.H.S.), 09-1124-CCR-EO (U. H.) and 10-2412-CCR-E0 (J.F.), the Army Research Office, grant number 56027LS (J.H.S.), the Ellison Medical Foundation grant AG-NS-0387-07 (U. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Azzam EI, 2000, CANCER RES, V60, P2623; Boix-Chornet M, 2006, J BIOL CHEM, V281, P13540, DOI 10.1074/jbc.M601136200; BRACHMAN DG, 1993, CANCER RES, V53, P3667; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Corey DR, 2002, ONCOGENE, V21, P631, DOI 10.1038/sj.onc.1205063; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dahlberg WK, 1999, CANCER RES, V59, P5365; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Fennell M, 2006, J BIOMOL SCREEN, V11, P296, DOI 10.1177/1087057105284618; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gellert GC, 2006, BREAST CANCER RES TR, V96, P73, DOI 10.1007/s10549-005-9043-5; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gorbunova V, 2003, J BIOL CHEM, V278, P7692, DOI 10.1074/jbc.M212944200; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HERMAN JG, 1995, CANCER RES, V55, P4525; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2-9; Hurley LH, 2000, PHARMACOL THERAPEUT, V85, P141, DOI 10.1016/S0163-7258(99)00068-6; Jerome KR, 2001, J IMMUNOL, V167, P3928, DOI 10.4049/jimmunol.167.7.3928; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Kelland LR, 2001, LANCET ONCOL, V2, P95, DOI 10.1016/S1470-2045(00)00226-6; Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Kraemer K, 2003, CLIN CANCER RES, V9, P3794; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Lu CB, 2001, DEV BRAIN RES, V131, P167, DOI 10.1016/S0165-3806(01)00237-1; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Ren JG, 2001, FEBS LETT, V488, P133, DOI 10.1016/S0014-5793(00)02397-8; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; Rubio MA, 2002, J BIOL CHEM, V277, P28609, DOI 10.1074/jbc.M203747200; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sedelnikova OA, 2004, INT J RADIAT BIOL, V80, P927, DOI 10.1080/09553000400017648; SHAW JP, 1986, J CELL PHYSIOL, V129, P193, DOI 10.1002/jcp.1041290210; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tamulevicius P, 2007, RADIAT RES, V167, P1, DOI 10.1667/RR0751.1; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; van Houten VMM, 2000, RECENT RESULTS CANC, V157, P90; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	68	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10812	10.1371/journal.pone.0010812	http://dx.doi.org/10.1371/journal.pone.0010812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520826	gold, Green Submitted, Green Published			2022-12-27	WOS:000278034800010
J	Musch, T; Oz, Y; Lyko, F; Breiling, A				Musch, Tanja; Oez, Yuva; Lyko, Frank; Breiling, Achim			Nucleoside Drugs Induce Cellular Differentiation by Caspase-Dependent Degradation of Stem Cell Factors	PLOS ONE			English	Article							HUMAN EMBRYONAL CARCINOMA; POLYCOMB; METHYLATION; CANCER; EXPRESSION; COMPLEX; EZH2; PLURIPOTENCY; DISRUPTION; ACTIVATION	Background: Stem cell characteristics are an important feature of human cancer cells and play a major role in the therapy resistance of tumours. Strategies to target cancer stem cells are thus of major importance for cancer therapy. Differentiation therapy by nucleoside drugs represents an attractive approach for the elimination of cancer stem cells. However, even if it is generally assumed that the activity of these drugs is mediated by their ability to modulate epigenetic pathways, their precise mode of action remains to be established. We therefore analysed the potential of three nucleoside analogues to induce differentiation of the embryonic cancer stem cell line NTERA 2 D1 and compared their effect to the natural ligand retinoic acid. Methodology/Principal Findings: All nucleoside analogues analyzed, but not retinoic acid, triggered proteolytic degradation of the Polycomb group protein EZH2. Two of them, 3-Deazaneplanocin A (DZNep) and 29-deoxy-5-azacytidine (decitabine), also induced a decrease in global DNA methylation. Nevertheless, only decitabine and 1b-arabinofuranosylcytosine (cytarabine) effectively triggered neuronal differentiation of NT2 cells. We show that drug-induced differentiation, in contrast to retinoic acid induction, is caused by caspase activation, which mediates depletion of the stem cell factors NANOG and OCT4. Consistent with this observation, protein degradation and differentiation could be counteracted by co-treatment with caspase inhibitors or by depletion of CASPASE-3 and CASPASE-7 through dsRNA interference. In agreement with this, OCT4 was found to be a direct in-vitro-target of CASPASE-7. Conclusions/Significance: We show that drug-induced differentiation is not a consequence of pharmacologic epigenetic modulation, but is induced by the degradation of stem-cell-specific proteins by caspases. Our results thus uncover a novel pathway that induces differentiation of embryonic cancer stem cells and is triggered by the established anticancer drugs cytarabine and decitabine. These findings suggest new approaches for directly targeting the stem cell fraction of human tumours.	[Musch, Tanja; Oez, Yuva; Lyko, Frank; Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Musch, T (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-6900 Heidelberg, Germany.	a.breiling@dkfz.de		Breiling, Achim/0000-0002-7928-299X	DKFZ; Deutsche Forschungsgemeinschaft [1356]	DKFZ(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the DKFZ Intramural Research Programme and the Deutsche Forschungsgemeinschaft (Priority Programme 1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Capp JP, 2005, BIOESSAYS, V27, P1277, DOI 10.1002/bies.20326; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; D'Sa-Eipper C, 2000, DEV NEUROSCI-BASEL, V22, P116, DOI 10.1159/000017433; DEGOS L, 1990, LEUKEMIA RES, V14, P717, DOI 10.1016/0145-2126(90)90101-E; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; LEE VMY, 1986, J NEUROSCI, V6, P514; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Rao R, 2008, BLOOD, V112, P327; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sheridan KM, 1998, J MOL NEUROSCI, V10, P121, DOI 10.1007/BF02737123; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Tamm I, 2005, ANN HEMATOL, V84, P47, DOI 10.1007/s00277-005-0013-0; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; von Wangenheim KH, 2008, J CANCER RES CLIN, V134, P725, DOI 10.1007/s00432-008-0381-7; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; WU C, 1989, METHOD ENZYMOL, V170, P269; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200	55	37	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10726	10.1371/journal.pone.0010726	http://dx.doi.org/10.1371/journal.pone.0010726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502711	gold, Green Published, Green Submitted			2022-12-27	WOS:000277845400026
J	Chaput-Bardy, A; Gregoire, A; Baguette, M; Pagano, A; Secondi, J				Chaput-Bardy, Audrey; Gregoire, Arnaud; Baguette, Michel; Pagano, Alain; Secondi, Jean			Condition and Phenotype-Dependent Dispersal in a Damselfly, Calopteryx splendens	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BODY-SIZE; TRADE-OFF; SURVIVAL ESTIMATION; NATURAL-POPULATION; GOLDENROD BEETLE; MATING TACTICS; FLIGHT; DENSITY; BEHAVIOR	Individual dispersal decisions may be affected by the internal state of the individual and the external information of its current environment. Here we estimated the influence of dispersal on survival and investigated if individual phenotype (sex and wing length) and environmental condition (conspecific density and sex-ratio) affected dispersal decisions in the banded damselfly, Calopteryx splendens. As suspected from the literature, we showed that the proportion of dispersing individuals was higher in females than in males. We also found negative-density dependent dispersal in both sexes and influence of sex-ratio on dispersal. Individuals moved less when sex-ratio was male biased. These results are consistent with a lek mating system where males aggregate in a place and hold mating territories. Contrary to our expectations, neither dispersal nor survival was affected by wing length. Nevertheless, mean adult survival was about 8% lower in dispersing individuals than in residents. This might reflect a mortality cost due to dispersal.	[Chaput-Bardy, Audrey; Pagano, Alain; Secondi, Jean] Univ Angers, Lab Etud Environm Syst Anthropises, Angers, France; [Gregoire, Arnaud] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Chaput-Bardy, Audrey; Baguette, Michel] MNHN, CNRS, UMR 7179, Equipe EvolTrait, Brunoy, France; [Baguette, Michel] CNRS, Stn Expt, USR 2936, Moulis, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Chaput-Bardy, A (corresponding author), Univ Angers, Lab Etud Environm Syst Anthropises, Angers, France.	chaput_bardy_audrey@hotmail.com	Gregoire, Arnaud/B-6321-2008; Pagano, Alain/A-2478-2009; Baguette, Michel/HHZ-3609-2022; Baguette, Michel/E-4754-2011	Gregoire, Arnaud/0000-0001-6103-355X; Pagano, Alain/0000-0001-8487-8352; Secondi, Jean/0000-0001-8130-1195	Region Pays-de-la-Loire	Region Pays-de-la-Loire(Region Pays de la Loire)	This study was funded by Region Pays-de-la-Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew R. R., 2004, DRAGONFLIES EUROPE; Baguette M, 1998, ACTA OECOL, V19, P17, DOI 10.1016/S1146-609X(98)80004-0; Baguette M, 1996, ACTA OECOL, V17, P225; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Beck ML, 2002, ETHOLOGY, V108, P779, DOI 10.1046/j.1439-0310.2002.00814.x; Beirinckx K, 2006, OIKOS, V113, P539, DOI 10.1111/j.2006.0030-1299.14391.x; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Beukema JJ, 2002, ODONATOLOGICA, V31, P9; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaput-Bardy A, 2007, FRESHWATER BIOL, V52, P1677, DOI 10.1111/j.1365-2427.2007.01794.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2009, BEHAVIOUR, V146, P189, DOI 10.1163/156853909X410739; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; DENNO RF, 1991, AM NAT, V138, P1513, DOI 10.1086/285298; Denno Robert F., 1995, P113, DOI 10.1016/B978-012159270-7/50007-5; Dobzhansky T., 1977, EVOLUTION; Fernando CH, 1958, CEYLON J SCI BIOL SC, V1, P117; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Gu HN, 2006, ECOL ENTOMOL, V31, P68, DOI 10.1111/j.0307-6946.2006.00761.x; Gundersen G, 2002, ECOL LETT, V5, P294, DOI 10.1046/j.1461-0248.2002.00320.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; HASSON E, 1993, GENETICA, V92, P61, DOI 10.1007/BF00057508; Hedenstrom A, 2001, FUNCT ECOL, V15, P417, DOI 10.1046/j.0269-8463.2001.00531.x; HERZIG AL, 1995, ECOLOGY, V76, P2044, DOI 10.2307/1941679; Herzig AL, 1996, ECOL ENTOMOL, V21, P344, DOI 10.1046/j.1365-2311.1996.00023.x; Horton GE, 2008, OIKOS, V117, P1131, DOI 10.1111/j.0030-1299.2008.16686.x; ICHIKAWA T, 1982, APPL ENTOMOL ZOOL, V17, P439, DOI 10.1303/aez.17.439; IMS RAI, 2001, DISPERSAL, P110; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Ishikawa A, 2009, EVOL DEV, V11, P680, DOI 10.1111/j.1525-142X.2009.00375.x; Johansen NS, 1997, ENTOMOL EXP APPL, V83, P347, DOI 10.1046/j.1570-7458.1997.00190.x; Kingsolver JG, 1999, EVOLUTION, V53, P1479, DOI [10.2307/2640894, 10.1111/j.1558-5646.1999.tb05412.x]; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Koskimaki J, 2009, ODONATOLOGICA, V38, P159; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Lambin Xavier, 2001, P110; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Letcher BH, 2005, EVOL ECOL RES, V7, P643; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Malmqvist B, 2000, BIOL CONSERV, V93, P271, DOI 10.1016/S0006-3207(99)00139-1; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; Menendez R, 2002, ECOL ENTOMOL, V27, P317, DOI 10.1046/j.1365-2311.2002.00404.x; Morrissey MB, 2009, AM NAT, V174, P875, DOI 10.1086/648311; Nespolo RF, 2008, FUNCT ECOL, V22, P624, DOI 10.1111/j.1365-2435.2008.01394.x; Nichols J., 2001, DISPERSAL; Raihani G, 2008, ANIM BEHAV, V75, P1851, DOI 10.1016/j.anbehav.2007.11.002; RAY C, 1991, BIOL J LINN SOC, V42, P123, DOI 10.1111/j.1095-8312.1991.tb00555.x; REHFELDT G, 1992, OECOLOGIA, V89, P550, DOI 10.1007/BF00317162; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI [10.1111/j.1558-5646.1999.tb03796.x, 10.2307/2640797]; ROFF DA, 1994, RES POPUL ECOL, V36, P145, DOI 10.1007/BF02514929; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rouquette JR, 2007, J APPL ECOL, V44, P692, DOI 10.1111/j.1365-2664.2007.01284.x; Rouquette JR, 2005, BIOL CONSERV, V123, P225, DOI 10.1016/j.biocon.2004.11.011; SHAPIRO AM, 1970, AM NAT, V104, P367, DOI 10.1086/282670; Sokolovska N, 2000, ECOL ENTOMOL, V25, P239, DOI 10.1046/j.1365-2311.2000.00251.x; SPEDDING GR, 1992, MECH ANIMAL LOCOMOTI, P51; Srygley RB, 1999, P ROY SOC B-BIOL SCI, V266, P2239, DOI 10.1098/rspb.1999.0914; Stenseth N.C., 1992, ANIMAL DISPERSAL SMA; Stettmer C, 1996, EUR J ENTOMOL, V93, P579; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; THOMPSON DJ, 1991, OECOLOGIA, V87, P600, DOI 10.1007/BF00320427; Toivanen T, 2009, CAN J ZOOL, V87, P684, DOI 10.1139/Z09-055; Ward L, 2005, EUR J ENTOMOL, V102, P47, DOI 10.14411/eje.2005.007; Ward L, 2007, EUR J ENTOMOL, V104, P195, DOI 10.14411/eje.2007.030; Weisser Wolfgang W., 2001, Symposia of the Royal Entomological Society of London, V20, P261, DOI 10.1079/9780851994567.0261; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	76	44	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10694	10.1371/journal.pone.0010694	http://dx.doi.org/10.1371/journal.pone.0010694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502694	Green Published, gold			2022-12-27	WOS:000277776500011
J	Wang, S; Zhang, LL; Meyer, E; Matz, MV				Wang, Shi; Zhang, Lingling; Meyer, Eli; Matz, Mikhail V.			Characterization of a Group of MITEs with Unusual Features from Two Coral Genomes	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; INVERTED-REPEAT; WIDE ANALYSIS; ARABIDOPSIS-THALIANA; RECENT AMPLIFICATION; REPETITIVE ELEMENTS; TRANSPOSITION; EVOLUTION; PIGGYBAC; FAMILY	Background: Miniature inverted-repeat transposable elements (MITEs), which are common in eukaryotic genomes, are small non-coding elements that transpose by utilizing transposases encoded by autonomous transposons. Recent genome-wide analyses and cross-mobilization assays have greatly improved our knowledge on MITE proliferation, however, specific mechanisms for the origin and evolution of MITEs are still unclear. Principal Findings: A group of coral MITEs called CMITE were identified from two corals, Acropora millepora and Acropora palmata. CMITEs conform to many common characteristics of MITEs, but also present several unusual features. The most unusual feature of CMITEs is conservation of the internal region, which is more conserved between MITE families than the TIRs. The origin of this internal region remains unknown, although we found one CMITE family that seems to be derived from a piggyBac-like transposon in A. millepora. CMITEs can form tandem arrays, suggesting an unconventional way for MITEs to increase copy numbers. We also describe a case in which a novel transposable element was created by a CMITE insertion event. Conclusions: To our knowledge, this is the first report of identification of MITEs from coral genomes. Proliferation of CMITEs seems to be related to the transposition machinery of piggyBac-like autonomous transposons. The highly conserved internal region of CMITEs suggests a potential role for this region in their successful transposition. However, the origin of these unusual features in CMITEs remains unclear, and thus represents an intriguing topic for future investigations.	[Wang, Shi; Meyer, Eli; Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Wang, Shi; Zhang, Lingling] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wang, S (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	swang@mail.utexas.edu	zhang, lingling/HDM-2189-2022; Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819				Adelman ZN, 2004, TRANSGENIC RES, V13, P411, DOI 10.1007/s11248-004-6067-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benjak A, 2009, GENOME BIOL EVOL, V1, P75, DOI 10.1093/gbe/evp009; Bergemann M, 2008, J MOL EVOL, V67, P631, DOI 10.1007/s00239-008-9164-7; Dufresne M, 2007, GENETICS, V175, P441, DOI 10.1534/genetics.106.064360; Elick TA, 1997, MOL GEN GENET, V255, P605, DOI 10.1007/s004380050534; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2000, GENE, V250, P109, DOI 10.1016/S0378-1119(00)00187-6; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Hikosaka A, 2004, J MOL EVOL, V59, P738, DOI 10.1007/s00239-004-2664-1; Hikosaka A, 2000, J MOL EVOL, V51, P554, DOI 10.1007/s002390010119; Hikosaka A, 2007, MOL BIOL EVOL, V24, P2648, DOI 10.1093/molbev/msm191; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izsvak Z, 1999, J MOL EVOL, V48, P13, DOI 10.1007/PL00006440; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Matz Mikhail V, 2003, Methods Mol Biol, V221, P103; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Song WY, 1998, MOL GEN GENET, V258, P449, DOI 10.1007/s004380050755; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tu ZJ, 2001, MOL BIOL EVOL, V18, P893, DOI 10.1093/oxfordjournals.molbev.a003871; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; UNSAL K, 1995, J MOL BIOL, V248, P812, DOI 10.1006/jmbi.1995.0262; Wessler SR, 2006, IMPLICIT GENOME, P138; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	38	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10700	10.1371/journal.pone.0010700	http://dx.doi.org/10.1371/journal.pone.0010700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502527	Green Submitted, Green Published, gold			2022-12-27	WOS:000277776500015
J	Dickerson, BR; Ream, RR; Vignieri, SN; Bentzen, P				Dickerson, Bobette R.; Ream, Rolf R.; Vignieri, Sacha N.; Bentzen, Paul			Population Structure as Revealed by mtDNA and Microsatellites in Northern Fur Seals, Callorhinus ursinus, throughout Their Range	PLOS ONE			English	Article							ARCTOCEPHALUS-GAZELLA; CONTROL-REGION; SITE FIDELITY; DIFFERENTIATION; MITOCHONDRIAL; ISLAND; SEQUENCES; GENETICS; GROWTH; DIET	Background: The northern fur seal (Callorhinus ursinus; NFS) is a widely distributed pinniped that has been shown to exhibit a high degree of philopatry to islands, breeding areas on an island, and even to specific segments of breeding areas. This level of philopatry could conceivably lead to highly genetically divergent populations. However, northern fur seals have the potential for dispersal across large distances and have experienced repeated rapid population expansions following glacial retreat and the more recent cessation of intensive harvest pressure. Methodology/Principal Findings: Using microsatellite and mitochondrial loci, we examined population structure in NFS throughout their range. We found only weak population genetic structure among breeding islands including significant F-ST and Phi(ST) values between eastern and western Pacific islands. Conclusions: We conclude that insufficient time since rapid population expansion events (both post glacial and following the cessation of intense harvest pressure) mixed with low levels of contemporary migration have resulted in an absence of genetic structure across the entire northern fur seal range.	[Dickerson, Bobette R.; Ream, Rolf R.] NOAA, Natl Marine Fisheries Serv, Mol Ecol Res Lab, Natl Marine Mammal Lab,Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Vignieri, Sacha N.] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA; [Bentzen, Paul] Dalhousie Univ, Halifax, NS, Canada	National Oceanic Atmospheric Admin (NOAA) - USA; Harvard University; Dalhousie University	Dickerson, BR (corresponding author), NOAA, Natl Marine Fisheries Serv, Mol Ecol Res Lab, Natl Marine Mammal Lab,Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	Bobette.Dickerson@noaa.gov		Bentzen, Paul/0000-0003-4288-7730	Alaska Fisheries Science Center	Alaska Fisheries Science Center	Funding came from the Alaska Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Antonelis GA, 1997, J ZOOL, V242, P435, DOI 10.1111/j.1469-7998.1997.tb03847.x; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04.022; CHELNOKOV FG, 1982, STUDY PRESERVATION R, P401; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FitzSimmons NN, 1997, GENETICS, V147, P1843; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Goldsworthy S, 2000, J HERED, V91, P371, DOI 10.1093/jhered/91.5.371; Goodman SJ, 1997, ANIM GENET, V28, P310; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; GRIBEN MR, 1979, THESIS U WASHINGTON; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haberl M, 1999, MOL ECOL, V8, P1347, DOI 10.1046/j.1365-294X.1999.00692.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Hoelzel AR, 1999, BEHAV ECOL SOCIOBIOL, V46, P298; Hoffman JI, 2006, MOL ECOL, V15, P2821, DOI 10.1111/j.1365-294X.2006.02991.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Kenyon K. W., 1960, Mammalia Paris, V24, P431; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; LANDER RH, 1982, FAO FISH SER 5, V4, P319; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; LOUGHLIN TR, 1989, ARCTIC, V42, P368; MANTEL N, 1967, CANCER RES, V27, P209; Matthee CA, 2006, MAR BIOL, V148, P899, DOI 10.1007/s00227-005-0121-3; *NAT MAR FISH SERV, 1993, FIN CONS PLAN NO FUR; PETERSON RS, 1968, NATURE, V219, P899, DOI 10.1038/219899a0; Pielou EC, 1991, ICE AGE RETURN LIFE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Ream RR, 1999, FUR SEAL INVESTIGATI, P81; ROBERTSON BC, 2005, DOC SCI INTERNAL SER, V196; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Slade RW, 1998, GENETICS, V149, P1945; SLATKIN M, 1991, GENETICS, V129, P555; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Towell RG, 2006, MAR MAMMAL SCI, V22, P486, DOI 10.1111/j.1748-7692.2006.00026.x; Trujillo RG, 2004, J MAMMAL, V85, P338, DOI 10.1644/1545-1542(2004)085<0338:VIMAMA>2.0.CO;2; Waples RS, 1995, AM FISH S S, V17, P8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wynen LP, 2000, MOL ECOL, V9, P299, DOI 10.1046/j.1365-294x.2000.00856.x; YORK AE, 1981, CAN J FISH AQUAT SCI, V38, P84, DOI 10.1139/f81-011; Zeppelin TK, 2006, J ZOOL, V270, P565, DOI 10.1111/j.1469-7998.2006.00122.x	58	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10671	10.1371/journal.pone.0010671	http://dx.doi.org/10.1371/journal.pone.0010671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498854	gold, Green Published, Green Submitted			2022-12-27	WOS:000277773700014
J	Vallely, A; Hambleton, IR; Kasindi, S; Knight, L; Francis, SC; Chirwa, T; Everett, D; Shagi, C; Cook, C; Barberousse, C; Watson-Jones, D; Changalucha, J; Ross, D; Hayes, RJ				Vallely, Andrew; Hambleton, Ian R.; Kasindi, Stella; Knight, Louise; Francis, Suzanna C.; Chirwa, Tobias; Everett, Dean; Shagi, Charles; Cook, Claire; Barberousse, Celia; Watson-Jones, Deborah; Changalucha, John; Ross, David; Hayes, Richard J.		Microbicides Dev Programme	Are Women Who Work in Bars, Guesthouses and Similar Facilities a Suitable Study Population for Vaginal Microbicide Trials in Africa?	PLOS ONE			English	Article							VACCINE EFFICACY TRIALS; FEMALE SEX WORKERS; SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USERS; HIV PREVENTION; INFORMED-CONSENT; NORTHERN TANZANIA; HOTEL WORKERS; MBEYA REGION; GAY MEN	Background: A feasibility study was conducted to investigate whether an occupational at-risk cohort of women in Mwanza, Tanzania are a suitable study population for future phase III vaginal microbicide trials. Methodology/Principal Findings: 1573 women aged 16-54 y working in traditional and modern bars, restaurants, hotels, guesthouses or as local food-handlers were enrolled at community-based reproductive health clinics, provided specimens for HIV/STI and pregnancy testing, and asked to attend three-monthly clinical follow-up visits for 12-months. HIV positive and negative women were eligible to enter the feasibility study and to receive free reproductive health services at any time. HIV prevalence at baseline was 26.5% (417/1573). HIV incidence among 1156 sero-negative women attending at baseline was 2.9/100PYs. Among 1020 HIV sero-negative, non-pregnant women, HIV incidence was 2.0/100PYs, HSV-2 incidence 12.7/100PYs and pregnancy rate 17.8/100PYs. Retention at three-months was 76.3% (778/1020). Among 771 HIV seronegative, non-pregnant women attending at three-months, subsequent follow-up at 6, 9 and 12-months was 83.7%, 79.6%, and 72.1% respectively. Older women, those who had not moved home or changed their place of work in the last year, and women working in traditional bars or as local food handlers had the highest re-attendance. Conclusions/Significance: Women working in food outlets and recreational facilities in Tanzania and other parts of Africa may be a suitable study population for microbicide and other HIV prevention trials. Effective locally-appropriate strategies to address high pregnancy rates and early losses to follow-up are essential to minimise risk to clinical trials in these settings.	[Vallely, Andrew; Hambleton, Ian R.; Knight, Louise; Francis, Suzanna C.; Chirwa, Tobias; Everett, Dean; Cook, Claire; Barberousse, Celia; Watson-Jones, Deborah; Ross, David; Hayes, Richard J.] London Sch Hyg & Trop Med, London WC1, England; [Vallely, Andrew; Kasindi, Stella; Shagi, Charles; Watson-Jones, Deborah] African Med & Res Fdn, Mwanza, Tanzania; [Hambleton, Ian R.; Knight, Louise; Chirwa, Tobias; Everett, Dean; Cook, Claire; Barberousse, Celia; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Hambleton, Ian R.] Univ W Indies, Res Inst Trop Med, Bridgetown, Barbados	University of London; London School of Hygiene & Tropical Medicine; African Medical & Research Foundation (AMREF); National Institute of Medical Research; University West Indies Mona Jamaica; University of the West Indies Open Campus	Vallely, A (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	a.vallely@uq.edu.au	Chirwa, Tobias/AAI-9087-2021; Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794; Everett, Dean/0000-0002-8458-6779; Francis, Suzanna Carter/0000-0002-3724-4813; Vallely, Andrew/0000-0003-1558-4822; Hayes, Richard/0000-0002-1729-9892	Department for International Development; Medical Research Council, United Kingdom; MRC [G0701039, G0901756, G0700837, G0100137] Funding Source: UKRI; Medical Research Council [G0100137, G0701039, G0901756, G0700837] Funding Source: researchfish	Department for International Development; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Department for International Development and the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2000, J ACQ IMMUN DEF SYND, V24, P458, DOI 10.1097/00126334-200008150-00011; Bakobaki JM, 2005, AIDS, V19, P2149, DOI 10.1097/01.aids.0000194129.05264.55; Behets F, 2005, SEX TRANSM INFECT, V81, P472, DOI 10.1136/sti.2005.015107; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Esparza J, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200100005-00008; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Guenter D, 2000, J MED ETHICS, V26, P37, DOI 10.1136/jme.26.1.37; Halpern SD, 2001, J ACQ IMMUN DEF SYND, V27, P281, DOI 10.1097/00126334-200107010-00011; JACKSON DJ, 1995, AIDS, V9, P1279, DOI 10.1097/00002030-199511000-00010; Joseph P, 2006, JAIDS-J ACQ IMM DEF, V42, P588, DOI 10.1097/01.qai.0000229998.59869.05; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kelly JA, 2006, BMJ-BRIT MED J, V333, P1098, DOI 10.1136/bmj.38992.478299.55; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lazzarini Z, 2000, AIDS PUBLIC POLICY J, V15, P105; Mantell JE, 2006, AM J PUBLIC HEALTH, V96, P1073, DOI 10.2105/AJPH.2004.047514; Markowitz LE, 1999, J ACQ IMMUN DEF SYND, V20, P488, DOI 10.1097/00042560-199904150-00012; McCormack S, 2001, BRIT MED J, V322, P410, DOI 10.1136/bmj.322.7283.410; MEYERS K, 1995, J ACQ IMMUN DEF SYND, V10, P577, DOI 10.1097/00042560-199510050-00012; Mgalla Z, 1997, AIDS CARE, V9, P407, DOI 10.1080/713613167; Mills E, 2006, PLOS MED, V3, P308, DOI 10.1371/journal.pmed.0030094; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Moser DJ, 2004, COMPR PSYCHIAT, V45, P1, DOI 10.1016/j.comppsych.2003.09.009; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; NKYA WMMM, 1991, INT J STD AIDS, V2, P432, DOI 10.1177/095646249100200608; Nuttall J, 2007, INFECT DIS CLIN N AM, V21, P219, DOI 10.1016/j.idc.2007.01.009; Nyamathi Adeline, 2004, J Interprof Care, V18, P369, DOI 10.1080/13561820400011735; NYAMATHI AM, 2006, AIDS BEHAV, V3, P3; Olin J, 2006, CULT HEALTH SEX, V8, P529, DOI 10.1080/13691050600888434; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Ramjee Gita, 2006, AIDS Res Ther, V3, P25, DOI 10.1186/1742-6405-3-25; Reproductive & Child Health Section MoH Tanzania, 2003, SEX TRANSM INF MAN S; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Salvi V, 2006, J POSTGRAD MED, V52, P161; Scheer S, 1999, J ACQ IMMUN DEF SYND, V20, P172, DOI 10.1097/00042560-199902010-00010; Shapiro K, 2005, J MED ETHICS, V31, P39, DOI 10.1136/jme.2004.008102; Sherr L, 2004, AIDS CARE, V16, P565, DOI 10.1080/0954010001716351; Suligoi B, 2005, VACCINE, V23, P1437, DOI 10.1016/j.vaccine.2004.10.002; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Tolley EE, 2006, CULT HEALTH SEX, V8, P351, DOI 10.1080/13691050600793071; VALLELY A, 2007, MICROBICIDES DEV PRO; Vallely A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-133; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Veldhuijzen N, 2006, CULT HEALTH SEX, V8, P395, DOI 10.1080/13691050600859302; Verastegui EL, 2006, BMC MED ETHICS, V7, P13, DOI [10.1186/1472-6939-7-13, DOI 10.1186/1472-6939-7-13]; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9	52	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10661	10.1371/journal.pone.0010661	http://dx.doi.org/10.1371/journal.pone.0010661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597PU	20498833	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000277771600021
J	Sellier, P; Mannioui, A; Bourry, O; Dereuddre-Bosquet, N; Delache, B; Brochard, P; Calvo, J; Prevot, S; Roques, P				Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Prevot, Sophie; Roques, Pierre			Antiretroviral Treatment Start-Time during Primary SIVmac Infection in Macaques Exerts a Different Impact on Early Viral Replication and Dissemination	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL DEPLETION; POSTEXPOSURE PROPHYLAXIS; HIV-INFECTION; GASTROINTESTINAL-TRACT; ANTIVIRAL THERAPY; TYPE-1 INFECTION; RHESUS MACAQUES; LYMPHOID-TISSUE; RESTORATION	Background: The time therapy (ART) on the peripheral viral load and the establishment of viral reservoirs are poorly understood. Methodology/Principal Findings: Six groups of macaques, infected intravenously with SIVmac251, were given placebo or antiretroviral therapy to explore reservoir establishment; macaques were treated for 2 weeks, with treatment starting 4 hours, 7 or 14 days after infection. Viral replication and dissemination were measured in the gut (rectum), in the lung and in blood and lymphoid tissues (peripheral lymph nodes), by quantifying viral RNA, DNA and 2LTR circles. We used immunohistochemistry (CD4 and CD68) to assess the impact of these treatments on the relative amount of virus target cells in tissue. Treatment that was started 4 hours post-infection (pi) decreased viral replication and dissemination in blood and tissue samples, which were assessed on day 14 (RNA/DNA/2LTR circles). The virus remained detectable and lymphoid tissues were activated in LN and the gut in both placebo- and ART-treated animals. Viral RNA in plasma continued to be lower in macaques treated seven days after infection; however, this was not the case for viral DNA in peripheral blood mononuclear cells. There was a small but significant difference in RNA and DNA levels in tissues between placebo- and ART-treated animals on day 21. When started 14 days after infection, treatment resulted in a limited decrease in the plasma viral load. Conclusions: Treatment that was started 4 hours after infection significantly reduced viral replication and dissemination. When started 7 days after infection, it was of slight virological benefit in peripheral blood and in tissues, and treatment was even less effective if started 14 days pi. These data favor starting ART no longer than one week after intravenous SIVmac251 exposure.	[Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Roques, Pierre] CEA, Inst Emerging Dis & Innovat Therapies IMETI, Div ImmunoVirol SIV, Fontenay Aux Roses, France; [Sellier, Pierre; Mannioui, Abdelkrim; Bourry, Olivier; Dereuddre-Bosquet, Nathalie; Delache, Benoit; Brochard, Patricia; Calvo, Julien; Roques, Pierre] Univ Paris 11, UMR E1, Orsay, France; [Sellier, Pierre] Hop Lariboisiere, AP HP, F-75475 Paris, France; [Prevot, Sophie] Hop Antoine Beclere, AP HP, Serv Anat & Cytol Pathol, Clamart, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Sellier, P (corresponding author), CEA, Inst Emerging Dis & Innovat Therapies IMETI, Div ImmunoVirol SIV, Fontenay Aux Roses, France.	pierre.roques@cea.fr	Roques, Pierre/M-2212-2013; Calvo, Julien/HCI-0693-2022	Roques, Pierre/0000-0003-1825-1054; 	APHP-CEA PhD; EMPRO [LSH-2002-2.3.0-2]; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France); Commissariat a l'Energie Atomique (CEA, France)	APHP-CEA PhD; EMPRO; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France)(ANRSFrench National Research Agency (ANR)); Commissariat a l'Energie Atomique (CEA, France)(French Atomic Energy Commission)	PS was awarded an APHP-CEA PhD fellowship. AM is financed by the "European Microbicide project'' EMPRO (LSH-2002-2.3.0-2). This work was supported by Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS, Paris France), and the Commissariat a l'Energie Atomique (CEA, France). AZT and 3TC were provided by GSK GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Bourry O, 2009, AIDS, V23, P447, DOI 10.1097/QAD.0b013e328321302d; Cara A, 2004, VIROLOGY, V324, P531, DOI 10.1016/j.virol.2004.04.006; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hodge S, 1999, J VIROL, V73, P8630, DOI 10.1128/JVI.73.10.8630-8639.1999; Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514; Hu YL, 2004, PRENATAL DIAG, V24, P704, DOI 10.1002/pd.968; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Le Grand R, 2000, AIDS, V14, P1864; LEGRAND R, 1994, AIDS RES HUM RETROV, V10, P1279, DOI 10.1089/aid.1994.10.1279; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Mallik RC, 2008, MET MATER INT, V14, P223, DOI 10.3365/met.mat.2008.04.223; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; Mattapallil JJ, 1999, J VIROL, V73, P6661, DOI 10.1128/JVI.73.8.6661-6669.1999; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Merchant RC, 2004, EMERG MED J, V21, P449, DOI 10.1136/emj.2002.002824; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Smith MS, 2000, VIROLOGY, V277, P306, DOI 10.1006/viro.2000.0609; Tincati C, 2009, ANTIVIR THER, V14, P321; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Verhoeven D, 2007, J MED PRIMATOL, V36, P219, DOI 10.1111/j.1600-0684.2007.00239.x; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; YENI P, 2008, PRISE CHARGE MED PER, P412	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10570	10.1371/journal.pone.0010570	http://dx.doi.org/10.1371/journal.pone.0010570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485497	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200006
J	Funakoshi, Y; Negishi, Y; Gergen, JP; Seino, J; Ishii, K; Lennarz, WJ; Matsuo, I; Ito, Y; Taniguchi, N; Suzuki, T				Funakoshi, Yoko; Negishi, Yuki; Gergen, J. Peter; Seino, Junichi; Ishii, Kumiko; Lennarz, William J.; Matsuo, Ichiro; Ito, Yukishige; Taniguchi, Naoyuki; Suzuki, Tadashi			Evidence for an Essential Deglycosylation-Independent Activity of PNGase in Drosophila melanogaster	PLOS ONE			English	Article							PEPTIDE-N-GLYCANASE; RETICULUM-ASSOCIATED DEGRADATION; CYTOPLASMIC PEPTIDE; FREE OLIGOSACCHARIDES; ENZYMATIC-PROPERTIES; YEAST PEPTIDE; PUB DOMAIN; PROTEIN; IDENTIFICATION; COMPLEX	Background: Peptide: N-glycanase (PNGase) is an enzyme which releases N-linked glycans from glycopeptides/glycoproteins. This enzyme plays a role in the ER-associated degradation (ERAD) pathway in yeast and mice, but the biological importance of this activity remains unknown. Principal Findings: In this study, we characterized the ortholog of cytoplasmic PNGases, PNGase-like (Pngl), in Drosophila melanogaster. Pngl was found to have a molecular weight of similar to 74K and was mainly localized in the cytosol. Pngl lacks a CXXC motif that is critical for enzymatic activity in other species and accordingly did not appear to possess PNGase activity, though it still retains carbohydrate-binding activity. We generated microdeletions in the Pngl locus in order to investigate the functional importance of this protein in vivo. Elimination of Pngl led to a serious developmental delay or arrest during the larval and pupal stages, and surviving mutant adult males and females were frequently sterile. Most importantly, these phenotypes were rescued by ubiquitous expression of Pngl, clearly indicating that those phenotypic consequences were indeed due to the lack of functional Pngl. Interestingly, a putative "catalytic-inactive" mutant could not rescue the growth-delay phenotype, indicating that a biochemical activity of this protein is important for its biological function. Conclusion: Pngl was shown to be inevitable for the proper developmental transition and the biochemical properties other than deglycosylation activity is important for its biological function.	[Funakoshi, Yoko; Negishi, Yuki; Seino, Junichi; Ishii, Kumiko; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama, Japan; [Gergen, J. Peter] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Gergen, J. Peter; Lennarz, William J.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Lennarz, William J.] SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; [Matsuo, Ichiro] Gunma Univ, Dept Chem & Chem Biol, Gunma, Japan; [Ito, Yukishige] RIKEN, Adv Sci Inst, Synthet Cellular Chem Lab, Wako, Saitama, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy, Glycotril Project, Kawaguchi, Saitama, Japan; [Taniguchi, Naoyuki] Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama, Japan	RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gunma University; RIKEN; Japan Science & Technology Agency (JST); Osaka University; RIKEN	Funakoshi, Y (corresponding author), RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama, Japan.	yokofuna@riken.jp; tsuzuki_gm@riken.jp	Ito, Yukishige/ACL-6203-2022; Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016; Ito, Yukishige/M-5119-2014	Ito, Yukishige/0000-0001-6251-7249; Suzuki, Tadashi/0000-0003-1030-7631; Taniguchi, Naoyuki/0000-0001-5889-5968; Ito, Yukishige/0000-0001-6251-7249	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Global COE (Center of Excellence) Program and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Della Mea M, 2004, PLANT PHYSIOL, V135, P2046, DOI 10.1104/pp.104.042549; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Habibi-Babadi N, 2010, J NEUROSCI, V30, P1766, DOI 10.1523/JNEUROSCI.4962-08.2010; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; Kim HS, 2006, DYNAM CONT DIS SER B, V13, P1; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li GT, 2005, P NATL ACAD SCI USA, V102, P15809, DOI 10.1073/pnas.0507155102; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Miyazaki A, 2009, GLYCOCONJUGATE J, V26, P133, DOI 10.1007/s10719-008-9171-3; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; ROSEMAN RR, 1995, GENETICS, V141, P1061; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; SEKO A, 1991, BIOCHEM BIOPH RES CO, V180, P1165, DOI 10.1016/S0006-291X(05)81318-X; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; STAPLETON M, 2002, GENOME BIOL, V0003; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	55	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10545	10.1371/journal.pone.0010545	http://dx.doi.org/10.1371/journal.pone.0010545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479940	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900004
J	Jiao, J; Herl, LD; Farese, RV; Gao, FB				Jiao, Jian; Herl, Lauren D.; Farese, Robert V., Jr.; Gao, Fen-Biao			MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia	PLOS ONE			English	Article							LOBAR DEGENERATION; EPITHELIN PRECURSOR; MUTATIONS; TDP-43; TAU; DISEASE; BONE; FUS	Progranulin deficiency is thought to cause some forms of frontotemporal dementia (FTD), a major early-onset age-dependent neurodegenerative disease. How progranulin (PGRN) expression is regulated is largely unknown. We identified an evolutionarily conserved binding site for microRNA-29b (miR-29b) in the 3' untranslated region (3'UTR) of the human PGRN (hPGRN) mRNA. miR-29b downregulates the expression of luciferase through hPGRN or mouse PGRN (mPGRN) 3'UTRs, and the regulation was abolished by mutations in the miR-29b binding site. To examine the direct effect of manipulating endogenous miR-29b on hPGRN expression, we established a stable NIH3T3 cell line that expresses hPGRN under the control of the cytomegalovirus promoter. Ectopic expression of miR-29b decreased hPGRN expression at the both mRNA and protein levels. Conversely, knockdown of endogenous miR-29b with locked nucleic acid increased the production and secretion of hPGRN in NIH3T3 cells. Endogenous hPGRN in HEK 293 cells was also regulated by miR-29b. These findings identify miR-29b as a novel posttranscriptional regulator of PGRN expression, raising the possibility that miR-29b or other miRNAs might be targeted therapeutically to increase hPGRN levels in some FTD patients.	[Jiao, Jian; Gao, Fen-Biao] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Jiao, Jian; Gao, Fen-Biao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Herl, Lauren D.; Farese, Robert V., Jr.; Gao, Fen-Biao] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiao, J (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	fen-biao.gao@umassmed.edu			Consortium for FTD Research; National Institutes of Health [NS066586, NS057553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS057553, R01NS057553, R01NS066586] Funding Source: NIH RePORTER	Consortium for FTD Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Consortium for FTD Research and the National Institutes of Health (NS066586 and NS057553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Boxer AL, 2005, ALZ DIS ASSOC DIS, V19, pS3, DOI 10.1097/01.wad.0000183086.99691.91; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee JA, 2008, BMB REP, V41, P827, DOI 10.5483/BMBRep.2008.41.12.827; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; ROLLINSON S, 2009, NEUROBIOL AGING 0513; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THURN T, 2008, NATURE, V456, P980; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Vossel KA, 2008, CURR OPIN NEUROL, V21, P708, DOI 10.1097/WCO.0b013e328318444d; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517	40	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10551	10.1371/journal.pone.0010551	http://dx.doi.org/10.1371/journal.pone.0010551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479936	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900007
J	Pfister, CA; Meyer, F; Antonopoulos, DA				Pfister, Catherine A.; Meyer, Folker; Antonopoulos, Dionysios A.			Metagenomic Profiling of a Microbial Assemblage Associated with the California Mussel: A Node in Networks of Carbon and Nitrogen Cycling	PLOS ONE			English	Article							DIVERSITY; COASTAL; ECOLOGY; REGENERATION; COMPETITION; INCREASES; ENDOLITHS; ECOSYSTEM; PATTERNS; PLANKTON	Mussels are conspicuous and often abundant members of rocky shores and may constitute an important site for the nitrogen cycle due to their feeding and excretion activities. We used shotgun metagenomics of the microbial community associated with the surface of mussels (Mytilus californianus) on Tatoosh Island in Washington state to test whether there is a nitrogen-based microbial assemblage associated with mussels. Analyses of both tidepool mussels and those on emergent benches revealed a diverse community of Bacteria and Archaea with approximately 31 million bp from 6 mussels in each habitat. Using MG-RAST, between 22.5-25.6% were identifiable using the SEED non-redundant database for proteins. Of those fragments that were identifiable through MG-RAST, the composition was dominated by Cyanobacteria and Alpha and Gamma-proteobacteria. Microbial composition was highly similar between the tidepool and emergent bench mussels, suggesting similar functions across these different microhabitats. One percent of the proteins identified in each sample were related to nitrogen cycling. When normalized to protein discovery rate, the high diversity and abundance of enzymes related to the nitrogen cycle in mussel-associated microbes is as great or greater than that described for other marine metagenomes. In some instances, the nitrogen-utilizing profile of this assemblage was more concordant with soil metagenomes in the Midwestern U. S. than for open ocean system. Carbon fixation and Calvin cycle enzymes further represented 0.65 and 1.26% of all proteins and their abundance was comparable to a number of open ocean marine metagenomes. In sum, the diversity and abundance of nitrogen and carbon cycle related enzymes in the microbes occupying the shells of Mytilus californianus suggest these mussels provide a node for microbial populations and thus biogeochemical processes.	[Pfister, Catherine A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Meyer, Folker] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Meyer, Folker; Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Antonopoulos, Dionysios A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Pfister, CA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	cpfister@uchicago.edu	Antonopoulos, Dionysios/ABE-6212-2020	Antonopoulos, Dionysios/0000-0002-2238-5031; Meyer, Folker/0000-0003-1112-2284	National Science Foundation [OCE-0928232]; Argonne National Labs; Division Of Ocean Sciences [0928232] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Argonne National Labs(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by National Science Foundation OCE-0928232 to CAP and Argonne National Labs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2007, LIMNOL OCEANOGR, V52, P2233, DOI 10.4319/lo.2007.52.5.2233; Aquilino KM, 2009, LIMNOL OCEANOGR, V54, P309, DOI 10.4319/lo.2009.54.1.0309; BARBER RT, 2001, EXCELLENCE ECOLOGY, V13; BAYNE BL, 1976, OECOLOGIA, V22, P211, DOI 10.1007/BF00344793; Bode A, 2004, J PLANKTON RES, V26, P11, DOI 10.1093/plankt/fbh003; Bracken MES, 2004, J PHYCOL, V40, P1032, DOI 10.1111/j.1529-8817.2004.03106.x; Bracken MES, 2004, ECOLOGY, V85, P2828, DOI 10.1890/03-0651; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; EPPLEY RW, 1973, LIMNOL OCEANOGR, V18, P534, DOI 10.4319/lo.1973.18.4.0534; FIELD D, 2009, NAT BIOTECHNOL, V26, P541; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hansen J. E., 1981, NATURAL HIST ANO NUE, P183; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; Howarth R. W., 2000, ISSUES ECOLOGY, V7, P1; Jensen Susan L., 1994, Pacific Science, V48, P32; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paerl HW, 2000, MICROBIAL ECOLOGY OC, P387; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Pfister CA, 2007, ECOLOGY, V88, P1647, DOI 10.1890/06-1913.1; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suchanek T. H., 1979, THESIS U WASHINGTON; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward B.B., 2000, MICROBIAL ECOLOGY OC, P427; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C	51	36	38	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10518	10.1371/journal.pone.0010518	http://dx.doi.org/10.1371/journal.pone.0010518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463896	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379800012
J	Bachstetter, AD; Jernberg, J; Schlunk, A; Vila, JL; Hudson, C; Cole, MJ; Shytle, RD; Tan, J; Sanberg, PR; Sanberg, CD; Boriongan, C; Kaneko, Y; Tajiri, N; Gemma, C; Bickford, PC				Bachstetter, Adam D.; Jernberg, Jennifer; Schlunk, Andrea; Vila, Jennifer L.; Hudson, Charles; Cole, Michael J.; Shytle, R. Douglas; Tan, Jun; Sanberg, Paul R.; Sanberg, Cyndy D.; Boriongan, Cesario; Kaneko, Yuji; Tajiri, Naoki; Gemma, Carmelina; Bickford, Paula C.			Spirulina Promotes Stem Cell Genesis and Protects against LPS Induced Declines in Neural Stem Cell Proliferation	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; DIETARY SUPPLEMENTATION; PLATENSIS; POLYSACCHARIDE; BRAIN; RAT; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; IL-1-BETA	Adult stem cells are present in many tissues including, skin, muscle, adipose, bone marrow, and in the brain. Neuroinflammation has been shown to be a potent negative regulator of stem cell and progenitor cell proliferation in the neurogenic regions of the brain. Recently we demonstrated that decreasing a key neuroinflammatory cytokine IL-1 beta in the hippocampus of aged rats reversed the age-related cognitive decline and increased neurogenesis in the age rats. We also have found that nutraceuticals have the potential to reduce neuroinflammation, and decrease oxidative stress. The objectives of this study were to determine if spirulina could protect the proliferative potential of hippocampal neural progenitor cells from an acute systemic inflammatory insult of lipopolysaccharide (LPS). To this end, young rats were fed for 30 days a control diet or a diet supplemented with 0.1% spirulina. On day 28 the rats were given a single i.p. injection of LPS (1 mg/kg). The following day the rats were injected with BrdU (50 mg/kg b.i.d. i.p.) and were sacrificed 24 hours after the first injection of BrdU. Quantification of the BrdU positive cells in the subgranular zone of the dentate gyrus demonstrated a decrease in proliferation of the stem/progenitor cells in the hippocampus as a result of the LPS insult. Furthermore, the diet supplemented with spirulina was able to negate the LPS induced decrease in stem/progenitor cell proliferation. In a second set of studies we examined the effects of spirulina either alone or in combination with a proprietary formulation (NT-020) of blueberry, green tea, vitamin D3 and carnosine on the function of bone marrow and CD34(+) cells in vitro. Spirulina had small effects on its own and more than additive effects in combination with NT-020 to promote mitochondrial respiration and/or proliferation of these cells in culture. When examined on neural stem cells in culture spirulina increased proliferation at baseline and protected against the negative influence of TNF alpha to reduce neural stem cell proliferation. These results support the hypothesis that a diet enriched with spirulina and other nutraceuticals may help protect the stem/progenitor cells from insults.	[Bachstetter, Adam D.; Gemma, Carmelina; Bickford, Paula C.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Bachstetter, Adam D.; Jernberg, Jennifer; Schlunk, Andrea; Vila, Jennifer L.; Cole, Michael J.; Shytle, R. Douglas; Sanberg, Paul R.; Boriongan, Cesario; Kaneko, Yuji; Tajiri, Naoki; Gemma, Carmelina; Bickford, Paula C.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Hudson, Charles; Boriongan, Cesario; Gemma, Carmelina; Bickford, Paula C.] James A Haley Vet Adm Hosp, Res Serv, Tampa, FL USA; [Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy D.] NaturaTherapeutics Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Bachstetter, AD (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	pbickfor@health.usf.edu	Tan, Jun/I-5339-2012; Tajiri, Naoki/K-1230-2012; Shytle, Roland D/J-4249-2012; Bickford, Paula C/J-5970-2012	Tajiri, Naoki/0000-0003-2189-662X; Bickford, Paula C/0000-0001-9657-7725; Bachstetter, Adam/0000-0003-4646-6757; Gemma, Carmelina/0000-0002-4480-0056; Sanberg, Paul/0000-0001-9130-4592; Borlongan, Cesar/0000-0002-2966-9782	National Institutes of Health (NIH) [R21AG024165, PO1AG04418]; United States Veterans Administration Medical Research Service; NATIONAL INSTITUTE ON AGING [P01AG004418, R21AG024165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Veterans Administration Medical Research Service; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R21AG024165 (CG) and PO1AG04418 (PCB), and the United States Veterans Administration Medical Research Service (PCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balachandran P, 2006, INT IMMUNOPHARMACOL, V6, P1808, DOI 10.1016/j.intimp.2006.08.001; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gemma C, 2002, J NEUROSCI, V22, P6114; Gordon MN, 1997, J COMP NEUROL, V388, P106; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; LEE SC, 1993, J IMMUNOL, V150, P2659; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lobner M, 2008, J MED FOOD, V11, P313, DOI 10.1089/jmf.2007.564; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; NARAYANAN N, 1975, AUST J EXP BIOL MED, V53, P59, DOI 10.1038/icb.1975.6; Pugh N, 2001, PLANTA MED, V67, P737, DOI 10.1055/s-2001-18358; Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P465, DOI 10.3109/08923979609052748; Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P457, DOI 10.3109/08923979609052747; Reddy CM, 2000, BIOCHEM BIOPH RES CO, V277, P599, DOI 10.1006/bbrc.2000.3725; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sheng WS, 2005, J LEUKOCYTE BIOL, V78, P1233, DOI 10.1189/jlb.0405221; Shytle RD, 2007, REJUV RES, V10, P173, DOI 10.1089/rej.2006.0515; Stromberg I, 2005, EXP NEUROL, V196, P298, DOI 10.1016/j.expneurol.2005.08.013; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Trushina E. N., 2007, Voprosy Pitaniya, V76, P21; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608	32	43	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10496	10.1371/journal.pone.0010496	http://dx.doi.org/10.1371/journal.pone.0010496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463965	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400029
J	Tian, W; Qin, LL; Song, QL; He, L; Ai, MD; Jin, Y; Zhou, ZY; You, S; Long, YQ; Yu, Q				Tian, Wei; Qin, Lili; Song, Qiaoling; He, Li; Ai, Midan; Jin, Yi; Zhou, Zuyu; You, Song; Long, Yaqiu; Yu, Qiang			A Novel Synthetic Analog of 5, 8-Disubstituted Quinazolines Blocks Mitosis and Induces Apoptosis of Tumor Cells by Inhibiting Microtubule Polymerization	PLOS ONE			English	Article							BREAST-CANCER CELLS; IN-VITRO; ANTIMITOTIC ACTIVITY; DESTABILIZING DRUGS; CENTROMERE DYNAMICS; SPINDLE CHECKPOINT; AGENTS; TAXOL; TUBULIN; BINDING	Many mitosis inhibitors are powerful anticancer drugs. Tremendous efforts have been made to identify new anti-mitosis compounds for developing more effective and less toxic anti-cancer drugs. We have identified LJK-11, a synthetic analog of 5, 8-disubstituted quinazolines, as a novel mitotic blocker. LJK-11 inhibited growth and induced apoptosis of many different types of tumor cells. It prevented mitotic spindle formation and arrested cells at early phase of mitosis. Detailed in vitro analysis demonstrated that LJK-11 inhibited microtubule polymerization. In addition, LJK-11 had synergistic effect with another microtubule inhibitor colchicine on blocking mitosis, but not with vinblastine or nocodazole. Therefore, LJK-11 represents a novel anti-microtubule structure. Understanding the function and mechanism of LJK-11 will help us to better understand the action of anti-microtubule agents and to design better anti-cancer drugs.	[Tian, Wei; Qin, Lili; You, Song] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Song, Qiaoling; He, Li; Ai, Midan; Jin, Yi; Zhou, Zuyu; Long, Yaqiu; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Tian, W (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China.	qyu@sibs.ac.cn			China National Natural Science Foundation [30672481, 30771097]; Shanghai Science and Technology [03XD14002]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology(Shanghai Science & Technology Committee)	This work was supported by China National Natural Science Foundation grants 30672481 and 30771097 and the Shanghai Science and Technology grant 03XD14002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; Chen JG, 2002, CANCER RES, V62, P1935; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gupta S, 2003, MOL CELL BIOCHEM, V253, P41, DOI 10.1023/A:1026045100219; Hong FD, 1999, CARCINOGENESIS, V20, P1161, DOI 10.1093/carcin/20.7.1161; Jin Y, 2005, BIOORGAN MED CHEM, V13, P5613, DOI 10.1016/j.bmc.2005.05.045; Jin Y, 2006, BIOORG MED CHEM LETT, V16, P5864, DOI 10.1016/j.bmcl.2006.08.058; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Karbowski M, 2001, J CELL SCI, V114, P281; Kelling J, 2003, CANCER RES, V63, P2794; Kovacs P, 2006, CELL BIOCHEM FUNCT, V24, P419, DOI 10.1002/cbf.1238; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lee EA, 2004, MOL CANCER THER, V3, P661; Leoni LM, 2000, JNCI-J NATL CANCER I, V92, P217, DOI 10.1093/jnci/92.3.217; Mani S, 2004, ANTI-CANCER DRUG, V15, P553, DOI 10.1097/01.cad.0000131681.21637.b2; Margolis RL, 1998, BIOESSAYS, V20, P830, DOI 10.1002/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N; Martello LA, 2000, CLIN CANCER RES, V6, P1978; Martin JHJ, 2002, ONCOL REP, V9, P379; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Okouneva T, 2003, MOL CANCER THER, V2, P427; Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560; Photiou A, 1997, EUR J CANCER, V33, P463, DOI 10.1016/S0959-8049(96)00451-0; Rowinsky EK, 2001, CANC PRINCIPLES PRAC, P431; Sasaki J, 2002, MOL CANCER THER, V1, P1201; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shin DY, 2004, J REPROD DEVELOP, V50, P647, DOI 10.1262/jrd.50.647; Tahir SK, 2001, CANCER RES, V61, P5480; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Wall ME, 1996, J ETHNOPHARMACOL, V51, P239, DOI 10.1016/0378-8741(95)01367-9; Weiderhold KN, 2006, INT J CANCER, V118, P1032, DOI 10.1002/ijc.21424; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Yoshida D, 2000, J NEURO-ONCOL, V47, P133, DOI 10.1023/A:1006393705560; Zanelli GD, 1997, EUR J CANCER, V33, P486, DOI 10.1016/S0959-8049(96)00478-9	38	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10499	10.1371/journal.pone.0010499	http://dx.doi.org/10.1371/journal.pone.0010499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463925	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400032
J	Angelakis, E; Raoult, D				Angelakis, Emmanouil; Raoult, Didier			The Increase of Lactobacillus Species in the Gut Flora of Newborn Broiler Chicks and Ducks Is Associated with Weight Gain	PLOS ONE			English	Article							FED DIETS; GROWTH-PERFORMANCE; MICROBIOTA; OBESITY; STRAINS; PROBIOTICS; CULTURES; MICE	Background: A bacterial role in the obesity pandemic has been suspected based on the ingestion of probiotics that can modify the gut flora. The objective of our study was to determine if increased Lactobacillus sp. in the gut flora of newborn broiler chicks and ducks could result in weight gain increase. Methodology: Female broiler chicks (Gallus gallus domesticus) and ducks (Anas platyrhynchos domestica) were separated into one control and two experimental groups, and inoculated once or twice with 4610 10 Lactobacillus spp. per animal in PBS, or with PBS alone. Fecal samples were collected before and at 24 hours, 2, 4, 8, 16 and 30 days after the inoculation. DNA was extracted from the stools, and qPCR assays were performed on a MX3000 (TM) system for the detection and quantification of Lactobacillus sp., Bacteroidetes and Firmicutes, using a quantification plasmid. Animals were measured and sacrificed 60 days after the beginning of the experiment, and livers were collected and measured. Principal Findings: Chicks inoculated once and twice with Lactobacillus weighed 10.2% (p = 0.0162) and 13.5% (p = 0.0064) more than the control group animals, respectively. Similarly, ducks inoculated once and twice weighed 7.7% (p = 0.05) and 14% (p = 0.035) more than those in the control group, respectively. Liver mass was also significantly higher in inoculated animals compared to the control group. Inoculation with Lactobacillus sp. increased the DNA copies of Lactobacillus spp. and Firmicutes in the stools. Bacteroidetes remained stable, and only the second Lactobacillus sp. inoculation significantly decreased its population in chicks. The ratio of DNA copies of Firmicutes to those of Bacteroidetes increased to as much as 6,4 in chicks and 8,3 in ducks. Conclusions: Differences in the intestinal microbiota may precede weight increase, as we found that an increase of Lactobacillus sp. in newborn ducks and chicks preceded the development of weight gain.	[Angelakis, Emmanouil; Raoult, Didier] Univ Mediterranee, Unite Rickettsies, CNRS UMR 6020, Fac Med,IFR 48, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Angelakis, E (corresponding author), Univ Mediterranee, Unite Rickettsies, CNRS UMR 6020, Fac Med,IFR 48, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Angelakis, Emmanouil/A-9873-2015; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Angelakis, Emmanouil/0000-0001-7327-5441				Anadon A, 2006, REGUL TOXICOL PHARM, V45, P91, DOI 10.1016/j.yrtph.2006.02.004; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Bailey JS, 2000, J FOOD PROTECT, V63, P867, DOI 10.4315/0362-028X-63.7.867; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Chang YH, 2001, ANTON LEEUW INT J G, V80, P193, DOI 10.1023/A:1012213728917; Craven SE, 1999, AVIAN DIS, V43, P484, DOI 10.2307/1592646; Bernardez PF, 2008, J FOOD PROTECT, V71, P1797, DOI 10.4315/0362-028X-71.9.1797; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Jin LZ, 2000, POULTRY SCI, V79, P886, DOI 10.1093/ps/79.6.886; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Khan M, 2007, BRIT POULTRY SCI, V48, P732, DOI 10.1080/00071660701716222; Lan PTN, 2004, MICROBIOL IMMUNOL, V48, P917, DOI 10.1111/j.1348-0421.2004.tb03620.x; Lan PTN, 2003, J GEN APPL MICROBIOL, V49, P29; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu JR, 2007, BRIT POULTRY SCI, V48, P507, DOI 10.1080/00071660701485034; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Raoult D, 2008, NATURE, V454, P690, DOI 10.1038/454690c; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c3; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Vanderhoof JA, 2008, CLIN INFECT DIS, V46, pS67, DOI 10.1086/523339; Yeo J, 1997, POULTRY SCI, V76, P381, DOI 10.1093/ps/76.2.381; Zulkifli I, 2000, BRIT POULTRY SCI, V41, P593, DOI 10.1080/713654979	30	101	114	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10463	10.1371/journal.pone.0010463	http://dx.doi.org/10.1371/journal.pone.0010463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454557	Green Published, Green Submitted, gold			2022-12-27	WOS:000277305300008
J	Aggarwal, S; Bradel-Tretheway, B; Takimoto, T; Dewhurst, S; Kim, B				Aggarwal, Shilpa; Bradel-Tretheway, Birgit; Takimoto, Toru; Dewhurst, Stephen; Kim, Baek			Biochemical Characterization of Enzyme Fidelity of Influenza A Virus RNA Polymerase Complex	PLOS ONE			English	Article							TYPE-1 REVERSE-TRANSCRIPTASE; DNA-POLYMERASE; IN-VITRO; INCORPORATION OPPOSITE; MANGANESE MUTAGENESIS; TRIPHOSPHATE POOLS; LEUKEMIA-VIRUS; PB2 SUBUNIT; PA SUBUNIT; VIRAL-RNA	Background: It is widely accepted that the highly error prone replication process of influenza A virus (IAV), together with viral genome assortment, facilitates the efficient evolutionary capacity of IAV. Therefore, it has been logically assumed that the enzyme responsible for viral RNA replication process, influenza virus type A RNA polymerase (IAV Pol), is a highly error-prone polymerase which provides the genomic mutations necessary for viral evolution and host adaptation. Importantly, however, the actual enzyme fidelity of IAV RNA polymerase has never been characterized. Principal Findings: Here we established new biochemical assay conditions that enabled us to assess both polymerase activity with physiological NTP pools and enzyme fidelity of IAV Pol. We report that IAV Pol displays highly active RNA-dependent RNA polymerase activity at unbiased physiological NTP substrate concentrations. With this robust enzyme activity, for the first time, we were able to compare the enzyme fidelity of IAV Pol complex with that of bacterial phage T7 RNA polymerase and the reverse transcriptases (RT) of human immunodeficiency virus (HIV-1) and murine leukemia virus (MuLV), which are known to be low and high fidelity enzymes, respectively. We observed that IAV Pol displayed significantly higher fidelity than HIV-1 RT and T7 RNA polymerase and equivalent or higher fidelity than MuLV RT. In addition, the IAV Pol complex showed increased fidelity at lower temperatures. Moreover, upon replacement of Mg++ with Mn++, IAV Pol displayed increased polymerase activity, but with significantly reduced processivity, and misincorporation was slightly elevated in the presence of Mn++. Finally, when the IAV nucleoprotein (NP) was included in the reactions, the IAV Pol complex exhibited enhanced polymerase activity with increased fidelity. Significance: Our study indicates that IAV Pol is a high fidelity enzyme. We envision that the high fidelity nature of IAV Pol may be important to counter-balance the multiple rounds of IAV genome amplification per infection cycle, which provides IAV Pol with ample opportunities to generate and amplify genomic founder mutations, and thus achieve optimal viral mutagenesis for its evolution.	[Aggarwal, Shilpa; Bradel-Tretheway, Birgit; Takimoto, Toru; Dewhurst, Stephen; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health (NIH) [NIH/NIAID HHSN266200700008C]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a National Institutes of Health (NIH) contract granted to the New York Influenza Center of Excellence (NIH/NIAID HHSN266200700008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Berkhout B, 2001, Science, V292, P7; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40; Burnouf DY, 2009, J MOL BIOL, V386, P951, DOI 10.1016/j.jmb.2008.12.067; DONALD HB, 1954, J GEN MICROBIOL, V10, P457, DOI 10.1099/00221287-10-3-457; Drosopoulos WC, 1998, J VIROL, V72, P4224, DOI 10.1128/JVI.72.5.4224-4230.1998; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; HONDA A, 1988, J BIOCHEM-TOKYO, V104, P1021, DOI 10.1093/oxfordjournals.jbchem.a122569; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Hu DJ, 1996, JAMA-J AM MED ASSOC, V275, P210, DOI 10.1001/jama.275.3.210; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; Kochetkov SN, 1998, FEBS LETT, V440, P264, DOI 10.1016/S0014-5793(98)01484-7; Lee MTM, 2003, NUCLEIC ACIDS RES, V31, P1624, DOI 10.1093/nar/gkg253; Malboeuf CM, 2001, BIOTECHNIQUES, V30, P1074, DOI 10.2144/01305rr06; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MURAKAMI Y, 1988, ARCH VIROL, V100, P231, DOI 10.1007/BF01487686; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Pauli EK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-38; Perlow-Poehnelt RA, 2007, J BIOL CHEM, V282, P1397, DOI 10.1074/jbc.M606769200; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P8343, DOI 10.1073/pnas.86.21.8343; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; SARGENT RG, 1987, J BIOL CHEM, V262, P5546; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; STRIDH S, 1983, ARCH VIROL, V77, P223, DOI 10.1007/BF01309269; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003; ZHANG S, BIOCH BIOPHYS RES CO, V391, P570	45	23	24	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10372	10.1371/journal.pone.0010372	http://dx.doi.org/10.1371/journal.pone.0010372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454455	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100005
J	Fisher, Y; Nemirovsky, A; Baron, R; Monsonego, A				Fisher, Yair; Nemirovsky, Anna; Baron, Rona; Monsonego, Alon			T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERFERON-GAMMA; A-BETA; IFN-GAMMA; CEREBRAL-HEMORRHAGE; NASAL VACCINATION; IMMUNE INVASION; TRANSGENIC MICE; ANIMAL-MODEL; IMMUNIZATION	Patients with Alzheimer's disease (AD) exhibit substantial accumulation of amyloid-beta (A beta) plaques in the brain. Here, we examine whether A beta vaccination can facilitate the migration of T lymphocytes to specifically target A beta plaques and consequently enhance their removal. Using a new mouse model of AD, we show that immunization with A beta, but not with the encephalitogenic proteolipid protein (PLP), results in the accumulation of T cells at A beta plaques in the brain. Although both A beta-reactive and PLP-reactive T cells have a similar phenotype of Th1 cells secreting primarily IFN-gamma, the encephalitogenic T cells penetrated the spinal cord and caused experimental autoimmune encephalomyelitis (EAE), whereas A beta T cells accumulated primarily at A beta plaques in the brain but not the spinal cord and induced almost complete clearance of A beta. Furthermore, while a single vaccination with A beta resulted in upregulation of the phagocytic markers triggering receptors expressed on myeloid cells-2 (TREM2) and signal regulatory protein-beta 1 (SIRP beta 1) in the brain, it caused downregulation of the proinflammatory cytokines TNF-alpha and IL-6. We thus suggest that A beta deposits in the hippocampus area prioritize the targeting of A beta-reactive but not PLP-reactive T cells upon vaccination. The stimulation of A beta-reactive T cells at sites of A beta plaques resulted in IFN-gamma-induced chemotaxis of leukocytes and therapeutic clearance of A beta.	[Fisher, Yair] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Fisher, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	alonmon@bgu.ac.il			Israel Science Foundation (ISF) [846/05]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by the Israel Science Foundation (ISF 846/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; BOCHE D, 2008, BRAIN; Buckwalter MS, 2006, J NEUROSCI, V26, P11437, DOI 10.1523/JNEUROSCI.2436-06.2006; Burbach GJ, 2006, NEUROBIOL AGING; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; BUTOVSKY O, 2005, MOL CELL NEUROSCI; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; Doak C, 2008, FASEB J, V22; Ercolini AM, 2006, J IMMUNOL, V176, P3293, DOI 10.4049/jimmunol.176.6.3293; FRANK MG, 2005, NEUROBIOL AGING; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Gaikwad S, 2009, AM J PATHOL, V175, P2528, DOI 10.2353/ajpath.2009.090147; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hohlfeld R, 2006, NEUROL SCI, V27, pS1, DOI 10.1007/s10072-006-0537-7; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holmoy T, 2008, EUR J NEUROL, V15, P360, DOI 10.1111/j.1468-1331.2008.02065.x; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Lee J, 2006, J NEUROSCI RES, V83, P1552, DOI 10.1002/jnr.20831; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monsonego A, 2006, P NATL ACAD SCI USA, V103, P5048, DOI 10.1073/pnas.0506209103; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Renno T, 1998, MOL CELL NEUROSCI, V12, P376, DOI 10.1006/mcne.1998.0725; Rosenmann H, 2008, EXP NEUROL, V212, P71, DOI 10.1016/j.expneurol.2008.03.007; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shankar GM, 2008, NAT MED; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Wheeler RD, 2006, IMMUNOLOGY, V118, P527, DOI 10.1111/j.1365-2567.2006.02395.x; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	63	60	64	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10830	10.1371/journal.pone.0010830	http://dx.doi.org/10.1371/journal.pone.0010830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520819	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221500016
J	Jin, ZC; Yu, DH; Zhang, LM; Meng, H; Lu, J; Gao, QB; Cao, Y; Ma, XQ; Wu, C; He, Q; Wang, R; He, J				Jin, Zhichao; Yu, Danghui; Zhang, Luoman; Meng, Hong; Lu, Jian; Gao, Qingbin; Cao, Yang; Ma, Xiuqiang; Wu, Cheng; He, Qian; Wang, Rui; He, Jia			A Retrospective Survey of Research Design and Statistical Analyses in Selected Chinese Medical Journals in 1998 and 2008	PLOS ONE			English	Article							QUALITY	Background: High quality clinical research not only requires advanced professional knowledge, but also needs sound study design and correct statistical analyses. The number of clinical research articles published in Chinese medical journals has increased immensely in the past decade, but study design quality and statistical analyses have remained suboptimal. The aim of this investigation was to gather evidence on the quality of study design and statistical analyses in clinical researches conducted in China for the first decade of the new millennium. Methodology/Principal Findings: Ten (10) leading Chinese medical journals were selected and all original articles published in 1998 (N = 1,335) and 2008 (N = 1,578) were thoroughly categorized and reviewed. A well-defined and validated checklist on study design, statistical analyses, results presentation, and interpretation was used for review and evaluation. Main outcomes were the frequencies of different types of study design, error/defect proportion in design and statistical analyses, and implementation of CONSORT in randomized clinical trials. From 1998 to 2008: The error/defect proportion in statistical analyses decreased significantly (chi(2) = 12.03, p<0.001), 59.8% (545/1,335) in 1998 compared to 52.2% (664/1,578) in 2008. The overall error/defect proportion of study design also decreased (chi(2) = 21.22, p<0.001), 50.9% (680/1,335) compared to 42.40% (669/1,578). In 2008, design with randomized clinical trials remained low in single digit (3.8%, 60/1,578) with two-third showed poor results reporting (defects in 44 papers, 73.3%). Nearly half of the published studies were retrospective in nature, 49.3% (658/1,335) in 1998 compared to 48.2% (761/1,578) in 2008. Decreases in defect proportions were observed in both results presentation (chi(2) = 93.26, p<0.001), 92.7% (945/1,019) compared to 78.2% (1023/1,309) and interpretation (chi(2) = 27.26, p<0.001), 9.7% (99/1,019) compared to 4.3% (56/1,309), some serious ones persisted. Conclusions/Significance: Chinese medical research seems to have made significant progress regarding statistical analyses, but there remains ample room for improvement regarding study designs. Retrospective clinical studies are the most often used design, whereas randomized clinical trials are rare and often show methodological weaknesses. Urgent implementation of the CONSORT statement is imperative.	[Jin, Zhichao; Zhang, Luoman; Meng, Hong; Lu, Jian; Gao, Qingbin; Cao, Yang; Ma, Xiuqiang; Wu, Cheng; He, Qian; Wang, Rui; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Yu, Danghui] Second Mil Med Univ, Acad Journal, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Jin, ZC (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com	Gao, Qing-Bin/G-9825-2011; Cao, Yang/C-6185-2008; Jin, Zhichao/AAF-7234-2019; Cao, Yang/HGD-6463-2022	Cao, Yang/0000-0002-3552-9153; He, Jia/0000-0002-2338-9501; Jin, Zhichao/0000-0002-3180-6475	Ministry of Science and Technology of China [2009ZX09312-025, 2008ZX09312-007]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the funding of the Ministry of Science and Technology of China (2009ZX09312-025, 2008ZX09312-007). The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; ALTMAN DG, 1981, BRIT MED J, V282, P44, DOI 10.1136/bmj.282.6257.44; ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206; Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; *CTR EV BAS MED OX, STUD DES; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206; Garcia-Berthou E, 2004, BMC MED RES METHODOL, V28, P4; He J, 2009, LANCET, V373, P2091, DOI 10.1016/S0140-6736(09)60867-9; Horton NJ, 2005, NEW ENGL J MED, V353, P1977, DOI 10.1056/NEJM200511033531823; Li You-Ping, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P331; MCDERMOTT MM, 1995, J GEN INTERN MED, V10, P13, DOI 10.1007/BF02599570; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Pocock SJ, 2009, LANCET, V373, P1926, DOI 10.1016/S0140-6736(09)60499-2; Rennie D, 2003, JAMA-J AM MED ASSOC, V289, P89, DOI 10.1001/jama.289.1.89; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang QA, 1998, JAMA-J AM MED ASSOC, V280, P283, DOI 10.1001/jama.280.3.283; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; YATES F, 1964, J R STAT SOC SER A-G, V127, P199, DOI 10.2307/2344003; 2005, NATURE MED, V11, P1	22	15	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10822	10.1371/journal.pone.0010822	http://dx.doi.org/10.1371/journal.pone.0010822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520824	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034800017
J	Hypponen, E; Berry, D; Cortina-Borja, M; Power, C				Hyppoenen, Elina; Berry, Diane; Cortina-Borja, Mario; Power, Chris			25-Hydroxyvitamin D and Pre-Clinical Alterations in Inflammatory and Hemostatic Markers: A Cross Sectional Analysis in the 1958 British Birth Cohort	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; AGE 45 YEARS; SERUM 25-HYDROXYVITAMIN-D; CARDIOVASCULAR-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; MYOCARDIAL-INFARCTION; PARATHYROID-HORMONE; D ANALOGS; RISK; HEMODIALYSIS	Background: Vitamin D deficiency has been suggested as a cardiovascular risk factor, but little is known about underlying mechanisms or associations with inflammatory or hemostatic markers. Our aim was to investigate the association between 25-hydroxyvitamin D [25(OH) D, a measure for vitamin D status] concentrations with pre-clinical variations in markers of inflammation and hemostasis. Methodology/Principal Findings: Serum concentrations of 25(OH) D, C-reactive protein (CRP), fibrinogen, D-dimer, tissue plasminogen activator (tPA) antigen, and von Willebrand factor (vWF) were measured in a large population based study of British whites (aged 45y). Participants for the current investigation were restricted to individuals free of drug treated cardiovascular disease (n=6538). Adjusted for sex and month, 25(OH) D was inversely associated with all outcomes (p<0.015 for all), but associations with CRP, fibrinogen, and vWF were explained by adiposity. Association with tPA persisted after full adjustment (body mass index, waist circumference, physical activity, TV watching, smoking, alcohol consumption, social class, sex, and month), and average concentrations were 18.44% (95% CI 8.13, 28.75) lower for 25(OH) D >= 75 nmol/l compared to,25 nmol/l. D-dimer concentrations were lower for participants with 25(OH) D 50-90nmol/l compared to others (quadratic term p=0.01). We also examined seasonal variation in hemostatic and inflammatory markers, and evaluated 25(OH) D contribution to the observed patterns using mediation models. TPA concentrations varied by season (p=0.02), and much of this pattern was related to fluctuations in 25(OH) D concentrations (p<0.001). Some evidence of a seasonal variation was observed also for fibrinogen, D-dimer and vWF (p<0.05 for all), with 25(OH)D mediating some of the pattern for fibrinogen and D-dimer, but not vWF. Conclusions: Current vitamin D status was associated with tPA concentrations, and to a lesser degree with fibrinogen and D-dimer, suggesting that vitamin D status/intake may be important for maintaining antithrombotic homeostasis.	[Hyppoenen, Elina] UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England; UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of London; University College London; University of London; University College London	Hypponen, E (corresponding author), UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England.	e.hypponen@ich.ucl.ac.uk	Hypponen, Elina/B-2596-2014; Borja, Mario Cortina/A-3847-2009	Hypponen, Elina/0000-0003-3670-9399; Borja, Mario Cortina/0000-0003-0627-2624	British Heart Foundation [PG/09/023]; UK Medical Research Council (MRC) [G0601653, G0000934]; BUPA Foundation; NHS; MRC [G0601653, G0400546, G0000934] Funding Source: UKRI; Medical Research Council [G0601653, G0000934, G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; NHS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This study was supported by the British Heart Foundation (PG/09/023). Data collection at age 44-46 years and statistical analyses were funded by the UK Medical Research Council (MRC grants G0601653, G0000934), and 25(OH) D assays by the BUPA Foundation. E. H. is a Department of Health (UK) Public Health Career Scientist. This work was undertaken at the Centre for Paediatric Epidemiology and Biostatistics which benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executive. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Atherton K, 2007, EUR J PUBLIC HEALTH, V17, P486, DOI 10.1093/eurpub/ckl269; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Heaney RP, 2005, J ENDOCRINOL INVEST, V28, P180, DOI 10.1007/BF03345364; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jefferis BJMH, 2004, J PUBLIC HEALTH-UK, V26, P13, DOI 10.1093/pubmed/fdh110; Jorde R, 2007, ACTA HAEMATOL-BASEL, V117, P91, DOI 10.1159/000097383; Kelly GS, 2005, ALTERN MED REV, V10, P307; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Manfredini R, 2004, AM J CARDIOL, V94, P276, DOI 10.1016/j.amjcard.2004.02.076; Manfredini R, 2009, AM J EMERG MED, V27, P1097, DOI 10.1016/j.ajem.2008.08.009; Norman PE, 2005, ARTERIOSCL THROM VAS, V25, P39, DOI 10.1161/01.ATV.0000148450.56697.4a; Parsons TJ, 2006, MED SCI SPORT EXER, V38, P547, DOI 10.1249/01.mss.0000188446.65651.67; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pradhan AD, 2004, CIRCULATION, V110, P292, DOI 10.1161/01.CIR.0000134965.73212.A6; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; Towler DA, 2007, J AM SOC NEPHROL, V18, P369, DOI 10.1681/ASN.2006121367; Towler DA, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P899; Vieth R, 2005, J ENDOCRINOL INVEST, V28, P183, DOI 10.1007/BF03345365; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133; Wu-Wong JR, 2006, THROMB RES, V118, P709, DOI 10.1016/j.thromres.2005.10.017; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 2007, CURR OPIN LIPIDOL, V18, P41, DOI 10.1097/MOL.0b013e328011c6fc; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	50	81	82	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10801	10.1371/journal.pone.0010801	http://dx.doi.org/10.1371/journal.pone.0010801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520739	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000278034600028
J	Satoh, R; Oizumi, M; Kazama, H; Okada, M				Satoh, Ryota; Oizumi, Masafumi; Kazama, Hokto; Okada, Masato			Mechanisms of Maximum Information Preservation in the Drosophila Antennal Lobe	PLOS ONE			English	Article							OLFACTORY LOCAL INTERNEURONS; GAIN-CONTROL; MAP; NEURONS; REPRESENTATION; POPULATIONS; INHIBITION	We examined the presence of maximum information preservation, which may be a fundamental principle of information transmission in all sensory modalities, in the Drosophila antennal lobe using an experimentally grounded network model and physiological data. Recent studies have shown a nonlinear firing rate transformation between olfactory receptor neurons (ORNs) and second-order projection neurons (PNs). As a result, PNs can use their dynamic range more uniformly than ORNs in response to a diverse set of odors. Although this firing rate transformation is thought to assist the decoder in discriminating between odors, there are no comprehensive, quantitatively supported studies examining this notion. Therefore, we quantitatively investigated the efficiency of this firing rate transformation from the viewpoint of information preservation by computing the mutual information between odor stimuli and PN responses in our network model. In the Drosophila olfactory system, all ORNs and PNs are divided into unique functional processing units called glomeruli. The nonlinear transformation between ORNs and PNs is formed by intraglomerular transformation and interglomerular interaction through local neurons (LNs). By exploring possible nonlinear transformations produced by these two factors in our network model, we found that mutual information is maximized when a weak ORN input is preferentially amplified within a glomerulus and the net LN input to each glomerulus is inhibitory. It is noteworthy that this is the very combination observed experimentally. Furthermore, the shape of the resultant nonlinear transformation is similar to that observed experimentally. These results imply that information related to odor stimuli is almost maximally preserved in the Drosophila olfactory circuit. We also discuss how intraglomerular transformation and interglomerular inhibition combine to maximize mutual information.	[Satoh, Ryota; Oizumi, Masafumi; Okada, Masato] Univ Tokyo, Kashiwa, Chiba, Japan; [Kazama, Hokto] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Okada, Masato] RIKEN Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; Harvard University; Harvard Medical School; RIKEN	Satoh, R (corresponding author), Univ Tokyo, Kashiwa, Chiba, Japan.	okada@k.u-tokyo.ac.jp	Kazama, Hokto/N-7505-2015	Kazama, Hokto/0000-0002-3239-1873; Oizumi, Masafumi/0000-0001-8802-2607; Sato, Ryota/0000-0002-3418-2987	Ministry of Education, Culture, Sports, Science and Technology, Japan [18079003, 20240020, 20650019]; JSPS [08J08950]; National Institutes of Health (NIH) [F32DC009538]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC009538] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Grants-in-Aid for Scientific Research (18079003, 20240020, 20650019) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M. Okada). M. Oizumi was supported by a Grant-in-Aid for JSPS Fellows (08J08950). H. K. was supported by a postdoctoral fellowship from the National Institutes of Health (NIH) (F32DC009538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Dan Y, 1996, J NEUROSCI, V16, P3351; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10644	10.1371/journal.pone.0010644	http://dx.doi.org/10.1371/journal.pone.0010644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502639	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017400005
J	Varanasi, SS; Olstad, OK; Swan, DC; Sanderson, P; Gautvik, VT; Reppe, S; Francis, RM; Gautvik, KM; Datta, HK				Varanasi, Satya S.; Olstad, Ole K.; Swan, Daniel C.; Sanderson, Paul; Gautvik, Vigdis T.; Reppe, Sjur; Francis, Roger M.; Gautvik, Kaare M.; Datta, Harish K.			Skeletal Site-Related Variation in Human Trabecular Bone Transcriptome and Signaling	PLOS ONE			English	Article							MINERAL DENSITY; GENOME SCREEN; LOCI; OSTEOCYTES; STRAIN; GENE; OSTEOPOROSIS; POLYMORPHISM; FORCES; BMD	Background: The skeletal site-specific influence of multiple genes on bone morphology is recognised, but the question as to how these influences may be exerted at the molecular and cellular level has not been explored. Methodology: To address this question, we have compared global gene expression profiles of human trabecular bone from two different skeletal sites that experience vastly different degrees of mechanical loading, namely biopsies from iliac crest and lumbar spinal lamina. Principal Findings: In the lumbar spine, compared to the iliac crest, the majority of the differentially expressed genes showed significantly increased levels of expression; 3406 transcripts were up-whilst 838 were down-regulated. Interestingly, all gene transcripts that have been recently demonstrated to be markers of osteocyte, as well as osteoblast and osteoclast-related genes, were markedly up-regulated in the spine. The transcriptome data is consistent with osteocyte numbers being almost identical at the two anatomical sites, but suggesting a relatively low osteocyte functional activity in the iliac crest. Similarly, osteoblast and osteoclast expression data suggested similar numbers of the cells, but presented with higher activity in the spine than iliac crest. This analysis has also led to the identification of expression of a number of transcripts, previously known and novel, which to our knowledge have never earlier been associated with bone growth and remodelling. Conclusions and Significance: This study provides molecular evidence explaining anatomical and micro-architectural site-related changes in bone cell function, which is predominantly attributable to alteration in cell transcriptional activity. A number of novel signaling molecules in critical pathways, which have been hitherto not known to be expressed in bone cells of mature vertebrates, were identified.	[Varanasi, Satya S.; Datta, Harish K.] Univ Newcastle, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Olstad, Ole K.; Gautvik, Vigdis T.; Reppe, Sjur; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Clin Biochem, Ulleval, Norway; [Swan, Daniel C.] Univ Newcastle, Sch Med, Bioinformat Support Unit, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Sanderson, Paul] Newcastle Gen Hosp, Dept Orthopaed Surg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Francis, Roger M.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Gautvik, Vigdis T.; Reppe, Sjur; Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Gautvik, Kaare M.] Lovisenberg Deacon Hosp, Dept Clin Chem, Oslo, Norway	Newcastle University - UK; University of Oslo; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; University of Oslo	Varanasi, SS (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	h.k.datta@ncl.ac.uk	Datta, Harish/AAN-5621-2020	Swan, Daniel/0000-0001-8978-8129	EU [FP6-502491]; Newcastle University; Newcastle University Hospital Trust	EU(European Commission); Newcastle University; Newcastle University Hospital Trust	The support of the EU project OSTEOGENE (No. FP6-502491) was under FP6 programme and partially funded by Newcastle University and Newcastle University Hospital Trust is thankfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 1997, J ENDOCRINOL, V155, P411, DOI 10.1677/joe.0.1550411; Al-oanzi ZH, 2006, CLIN CHEM, V52, P248, DOI 10.1373/clinchem.2005.059568; Bonewald L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P331; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; DATTA HK, 2009, ASBMR 31 ANN M; DATTA HK, 2008, EUROPEAN MUSCULOSKEL, V3, P48; Enjuanes A, 2006, BONE, V38, P738, DOI 10.1016/j.bone.2005.10.010; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KALOGEROPOULOS M, 2010, FASEB J IN PRESS; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorentzon M, 2004, J BONE MINER RES, V19, P2005, DOI 10.1359/JBMR.040909; Mannion AF, 2000, SPINE, V25, P842, DOI 10.1097/00007632-200004010-00013; NAGANATHAN V, 2003, J BONE MINER RES, V18, P1531; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Peacock M, 2004, OSTEOPOROSIS INT, V15, P489, DOI 10.1007/s00198-003-1560-7; Peacock M, 2005, BONE, V37, P467, DOI 10.1016/j.bone.2005.05.005; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Reppe S, 2006, BONE, V39, P189, DOI 10.1016/j.bone.2005.12.020; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; SEMB H, 1969, ACTA ORTHOP SCAND, V40, P552, DOI 10.3109/17453676908989520; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Zerath E, 1998, ADV SPACE RES, V21, P1049, DOI 10.1016/S0273-1177(98)00026-X; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10692	10.1371/journal.pone.0010692	http://dx.doi.org/10.1371/journal.pone.0010692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502692	gold, Green Published, Green Submitted			2022-12-27	WOS:000277776500009
J	Aho, T; Almusa, H; Matilainen, J; Larjo, A; Ruusuvuori, P; Aho, KL; Wilhelm, T; Lahdesmaki, H; Beyer, A; Harju, M; Chowdhury, S; Leinonen, K; Roos, C; Yli-Harja, O				Aho, Tommi; Almusa, Henrikki; Matilainen, Jukka; Larjo, Antti; Ruusuvuori, Pekka; Aho, Kaisa-Leena; Wilhelm, Thomas; Lahdesmaki, Harri; Beyer, Andreas; Harju, Manu; Chowdhury, Sharif; Leinonen, Kalle; Roos, Christophe; Yli-Harja, Olli			Reconstruction and Validation of RefRec: A Global Model for the Yeast Molecular Interaction Network	PLOS ONE			English	Article							BIOLOGY MARKUP LANGUAGE; SACCHAROMYCES-CEREVISIAE; GENOME ANNOTATION; DATABASE; ONTOLOGY; DELETION; ENZYMES; SYSTEM; GENES	Molecular interaction networks establish all cell biological processes. The networks are under intensive research that is facilitated by new high-throughput measurement techniques for the detection, quantification, and characterization of molecules and their physical interactions. For the common model organism yeast Saccharomyces cerevisiae, public databases store a significant part of the accumulated information and, on the way to better understanding of the cellular processes, there is a need to integrate this information into a consistent reconstruction of the molecular interaction network. This work presents and validates RefRec, the most comprehensive molecular interaction network reconstruction currently available for yeast. The reconstruction integrates protein synthesis pathways, a metabolic network, and a protein-protein interaction network from major biological databases. The core of the reconstruction is based on a reference object approach in which genes, transcripts, and proteins are identified using their primary sequences. This enables their unambiguous identification and non-redundant integration. The obtained total number of different molecular species and their connecting interactions is similar to 67,000. In order to demonstrate the capacity of RefRec for functional predictions, it was used for simulating the gene knockout damage propagation in the molecular interaction network in similar to 590,000 experimentally validated mutant strains. Based on the simulation results, a statistical classifier was subsequently able to correctly predict the viability of most of the strains. The results also showed that the usage of different types of molecular species in the reconstruction is important for accurate phenotype prediction. In general, the findings demonstrate the benefits of global reconstructions of molecular interaction networks. With all the molecular species and their physical interactions explicitly modeled, our reconstruction is able to serve as a valuable resource in additional analyses involving objects from multiple molecular -omes. For that purpose, RefRec is freely available in the Systems Biology Markup Language format.	[Aho, Tommi; Larjo, Antti; Ruusuvuori, Pekka; Aho, Kaisa-Leena; Lahdesmaki, Harri; Harju, Manu; Chowdhury, Sharif; Leinonen, Kalle; Yli-Harja, Olli] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Almusa, Henrikki; Matilainen, Jukka; Roos, Christophe] Medicel Ltd, Espoo, Finland; [Wilhelm, Thomas] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, FIN-02150 Espoo, Finland; [Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	Tampere University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Aalto University; Technische Universitat Dresden	Aho, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tommi.aho@tut.fi	Ruusuvuori, Pekka/AAC-2617-2022; Ruusuvuori, Pekka/C-9229-2016; Beyer, Andreas/AAQ-5519-2020; Beyer, Andreas/A-3352-2009	Ruusuvuori, Pekka/0000-0001-9086-9591; Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123; Roos, Christophe/0000-0003-0982-7664; Yli-Harja, Olli/0000-0001-8581-4414	Academy of Finland; EU [APO-SYS/200767]; BBSRC [BBS/E/F/00044461] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044461] Funding Source: researchfish	Academy of Finland(Academy of Finland); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	At Tampere University of Technology, this work was supported by the Academy of Finland, (http://www.aka.fi, application number 213462, Finnish Programme for Centres of Excellence in Research 2006-2011). Some of the work done at Medicel on data integration is supported by EU/FP7/HEALTH grant (http://cordis.europa.eu/fp7/health/, APO-SYS/200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO T, 2006, P 4 TICSP WORKSH COM, P23; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Coles SJ, 2005, ORG BIOMOL CHEM, V3, P1832, DOI 10.1039/b502828k; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goto S, 1998, BIOINFORMATICS, V14, P591, DOI 10.1093/bioinformatics/14.7.591; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2004, BIOINFORMATICS, V20, P178, DOI 10.1093/bioinformatics/bth930; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lemke N, 2004, BIOINFORMATICS, V20, P115, DOI 10.1093/bioinformatics/btg386; Maltsev N, 2006, NUCLEIC ACIDS RES, V34, pD369, DOI 10.1093/nar/gkj095; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Philippi S, 2006, NAT REV GENET, V7, P482, DOI 10.1038/nrg1872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Stein SE, 2003, PROCEEDINGS OF THE 2003 INTERNATIONAL CHEMICAL INFORMATION CONFERENCE, P131; Sulakhe Dinanath, 2005, J Clin Monit Comput, V19, P361, DOI 10.1007/s10877-005-3463-y; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TONG AH, 2004, SCIENCE, V303, P774; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10662	10.1371/journal.pone.0010662	http://dx.doi.org/10.1371/journal.pone.0010662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498836	Green Published, Green Submitted, gold			2022-12-27	WOS:000277771600022
J	Miller, J; Parker, M; Bourret, RB; Giddings, MC				Miller, Jameson; Parker, Miles; Bourret, Robert B.; Giddings, Morgan C.			An Agent-Based Model of Signal Transduction in Bacterial Chemotaxis	PLOS ONE			English	Article							PHOSPHORYLATED CHEY; SIMULATED DIFFUSION; ASPARTATE RECEPTOR; LIGAND-BINDING; DOMAIN; ORGANIZATION; SENSITIVITY; CYTOPLASM; PROTEINS; COMPLEX	We report the application of agent-based modeling to examine the signal transduction network and receptor arrays for chemotaxis in Escherichia coli, which are responsible for regulating swimming behavior in response to environmental stimuli. Agent-based modeling is a stochastic and bottom-up approach, where individual components of the modeled system are explicitly represented, and bulk properties emerge from their movement and interactions. We present the Chemoscape model: a collection of agents representing both fixed membrane-embedded and mobile cytoplasmic proteins, each governed by a set of rules representing knowledge or hypotheses about their function. When the agents were placed in a simulated cellular space and then allowed to move and interact stochastically, the model exhibited many properties similar to the biological system including adaptation, high signal gain, and wide dynamic range. We found the agent based modeling approach to be both powerful and intuitive for testing hypotheses about biological properties such as self-assembly, the non-linear dynamics that occur through cooperative protein interactions, and non-uniform distributions of proteins in the cell. We applied the model to explore the role of receptor type, geometry and cooperativity in the signal gain and dynamic range of the chemotactic response to environmental stimuli. The model provided substantial qualitative evidence that the dynamic range of chemotactic response can be traced to both the heterogeneity of receptor types present, and the modulation of their cooperativity by their methylation state.	[Miller, Jameson; Giddings, Morgan C.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Miller, Jameson; Giddings, Morgan C.] Univ N Carolina, Bioinformat & Computat Biol Training Program, Chapel Hill, NC USA; [Parker, Miles] Metascape LLC, Nelson, BC, Canada; [Bourret, Robert B.; Giddings, Morgan C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Giddings, Morgan C.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Miller, J (corresponding author), Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA.	giddings@unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	NIH [RR020823, HG003700, GM050860]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020823] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards RR020823 and HG003700 to MCG, and GM050860 to RBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, BIOPHYS J, V86, P2650, DOI 10.1016/S0006-3495(04)74321-0; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Bornhorst JA, 2001, J GEN PHYSIOL, V118, P693, DOI 10.1085/jgp.118.6.693; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; BRAY D, 1995, MOL BIOL CELL, V6, P1367, DOI 10.1091/mbc.6.10.1367; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Corning P. A., 2002, Complexity, V7, P18, DOI 10.1002/cplx.10043; DANIELSON MA, 1994, BIOCHEMISTRY-US, V33, P6100, DOI 10.1021/bi00186a009; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elliott Euel, 2004, Nonlinear Dynamics Psychol Life Sci, V8, P121; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; FOWLER DJ, 2010, BIOCHEMISTRY; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Goldman JP, 2009, MOL BIOSYST, V5, P1853, DOI [10.1039/B903397a, 10.1039/b903397a]; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2005, J BACTERIOL, V187, P23, DOI 10.1128/JB.187.1.23-25.2005; Inchiosa ME, 2002, P NATL ACAD SCI USA, V99, P7304, DOI 10.1073/pnas.082081199; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; LEVIN MD, 2008, RATE TABLES; Levit MN, 2002, J BIOL CHEM, V277, P36748, DOI 10.1074/jbc.M204317200; LI M, 2005, MOL MICROBIOL, V61, P407; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; LOVDOK L, 2007, J BIOTECHNOL; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; Mello BA, 2004, BIOPHYS J, V87, P1578, DOI 10.1529/biophysj.104.042739; Mello BA, 2003, P NATL ACAD SCI USA, V100, P8223, DOI 10.1073/pnas.1330839100; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; PARKER MT, 2001, JASSS-J ARTIF SOC S, V4, pU101; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; Rao CV, 2004, J MOL BIOL, V343, P291, DOI 10.1016/j.jmb.2004.08.046; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Shimizu TS, 2003, J MOL BIOL, V329, P291, DOI 10.1016/S0022-2836(03)00437-6; Silversmith RE, 2008, J BIOL CHEM, V283, P756, DOI 10.1074/jbc.M704400200; Skoge ML, 2006, BIOPHYS J, V90, P4317, DOI 10.1529/biophysj.105.079905; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Weis RM, 2003, J BACTERIOL, V185, P3636, DOI 10.1128/JB.185.12.3636-3643.2003; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	62	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e9454	10.1371/journal.pone.0009454	http://dx.doi.org/10.1371/journal.pone.0009454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485527	Green Published, Green Submitted, gold			2022-12-27	WOS:000277633500001
J	Coulombe, Y; Lemieux, M; Moreau, J; Aubin, J; Joksimovic, M; Berube-Simard, FA; Tabaries, S; Boucherat, O; Guillou, F; Larochelle, C; Tuggle, CK; Jeannotte, L				Coulombe, Yan; Lemieux, Margot; Moreau, Julie; Aubin, Josee; Joksimovic, Milan; Berube-Simard, Felix-Antoine; Tabaries, Sebastien; Boucherat, Olivier; Guillou, Francois; Larochelle, Christian; Tuggle, Christopher K.; Jeannotte, Lucie			Multiple Promoters and Alternative Splicing: Hoxa5 Transcriptional Complexity in the Mouse Embryo	PLOS ONE			English	Article							MESSENGER-RNA; CHROMATIN DECONDENSATION; ANTISENSE TRANSCRIPTION; NUCLEAR REORGANIZATION; GENE-EXPRESSION; NERVOUS-SYSTEM; PROTEIN; SPECIFICATION; LOCUS; MECHANISMS	Background: The genomic organization of Hox clusters is fundamental for the precise spatio-temporal regulation and the function of each Hox gene, and hence for correct embryo patterning. Multiple overlapping transcriptional units exist at the Hoxa5 locus reflecting the complexity of Hox clustering: a major form of 1.8 kb corresponding to the two characterized exons of the gene and polyadenylated RNA species of 5.0, 9.5 and 11.0 kb. This transcriptional intricacy raises the question of the involvement of the larger transcripts in Hox function and regulation. Methodology/Principal Findings: We have undertaken the molecular characterization of the Hoxa5 larger transcripts. They initiate from two highly conserved distal promoters, one corresponding to the putative Hoxa6 promoter, and a second located nearby Hoxa7. Alternative splicing is also involved in the generation of the different transcripts. No functional polyadenylation sequence was found at the Hoxa6 locus and all larger transcripts use the polyadenylation site of the Hoxa5 gene. Some larger transcripts are potential Hoxa6/Hoxa5 bicistronic units. However, even though all transcripts could produce the genuine 270 a. a. HOXA5 protein, only the 1.8 kb form is translated into the protein, indicative of its essential role in Hoxa5 gene function. The Hoxa6 mutation disrupts the larger transcripts without major phenotypic impact on axial specification in their expression domain. However, Hoxa5-like skeletal anomalies are observed in Hoxa6 mutants and these defects can be explained by the loss of expression of the 1.8 kb transcript. Our data raise the possibility that the larger transcripts may be involved in Hoxa5 gene regulation. Significance: Our observation that the Hoxa5 larger transcripts possess a developmentally-regulated expression combined to the increasing sum of data on the role of long noncoding RNAs in transcriptional regulation suggest that the Hoxa5 larger transcripts may participate in the control of Hox gene expression.	[Coulombe, Yan; Lemieux, Margot; Moreau, Julie; Aubin, Josee; Berube-Simard, Felix-Antoine; Tabaries, Sebastien; Boucherat, Olivier; Guillou, Francois; Larochelle, Christian; Jeannotte, Lucie] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech & Cancerol, Quebec City, PQ, Canada; [Joksimovic, Milan; Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Laval University; Iowa State University	Coulombe, Y (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech & Cancerol, Quebec City, PQ, Canada.	lucie.jeannotte@crhdq.ulaval.ca		Joksimovic, Milan/0000-0002-3936-4632; Jeannotte, Lucie/0000-0001-5578-420X	Canadian Institutes of Health Research (CIHR) [MOP-68999]; Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MOP-68999 to L.J.) and a postdoctoral fellowship from the Fonds de la Recherche en Sante du Quebec-Institut National de la Sante et de la Recherche Medicale (FRSQ-INSERM; to O.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Aubin J, 1998, DEV DYNAM, V212, P141, DOI 10.1002/(SICI)1097-0177(199805)212:1<141::AID-AJA13>3.0.CO;2-A; Aubin J, 2002, DEVELOPMENT, V129, P4075; Aubin J, 1999, AM J PHYSIOL-CELL PH, V277, pC965, DOI 10.1152/ajpcell.1999.277.5.C965; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Bradshaw MS, 1996, P NATL ACAD SCI USA, V93, P2426, DOI 10.1073/pnas.93.6.2426; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brock HW, 2009, BIOCHEM CELL BIOL, V87, P27, DOI 10.1139/O08-108; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Dintilhac A, 2004, GENE EXPR PATTERNS, V4, P215, DOI 10.1016/j.modgep.2003.08.006; DONY C, 1987, EMBO J, V6, P2965, DOI 10.1002/j.1460-2075.1987.tb02602.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Folberg A, 1997, J BIOL CHEM, V272, P29151, DOI 10.1074/jbc.272.46.29151; Garin E, 2006, DEV DYNAM, V235, P1858, DOI 10.1002/dvdy.20822; GAUNT SJ, 1990, DEVELOPMENT, V109, P329; Gendronneau G, 2010, AM J PATHOL, V176, P995, DOI 10.2353/ajpath.2010.090499; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hogan B, 1994, MANIPULATING MOUSE E; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; JAFFE L, 1990, J IMMUNOL, V145, P3474; JEANNOTTE L, 1991, MOL CELL BIOL, V11, P5578, DOI 10.1128/MCB.11.11.5578; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Joksimovic M, 2005, GENE EXPR PATTERNS, V5, P792, DOI 10.1016/j.modgep.2005.03.008; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Meunier D, 2003, DEV DYNAM, V227, P367, DOI 10.1002/dvdy.10325; Moreau J, 2002, DNA SEQUENCE, V13, P203, DOI 10.1080/10425170290034507; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nowling T, 1999, DEV BIOL, V208, P134, DOI 10.1006/dbio.1998.9189; ODENWALD WF, 1987, GENE DEV, V1, P482, DOI 10.1101/gad.1.5.482; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Packer AI, 1998, DEVELOPMENT, V125, P1991; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Popovic R, 2008, BLOOD CELL MOL DIS, V40, P156, DOI 10.1016/j.bcmd.2007.07.016; PUSCHEL AW, 1990, DEVELOPMENT, V108, P435; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P724, DOI 10.1016/j.bbrc.2007.03.200; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Tabaries S, 2007, GENESIS, V45, P218, DOI 10.1002/dvg.20292; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	64	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10600	10.1371/journal.pone.0010600	http://dx.doi.org/10.1371/journal.pone.0010600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485555	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563400011
J	Pimiento, C; Ehret, DJ; MacFadden, BJ; Hubbell, G				Pimiento, Catalina; Ehret, Dana J.; MacFadden, Bruce J.; Hubbell, Gordon			Ancient Nursery Area for the Extinct Giant Shark Megalodon from the Miocene of Panama	PLOS ONE			English	Article							SPHYRNA-LEWINI GRIFFITH; OFFSHORE FORAGING AREA; CARCHARODON-CARCHARIAS; WHITE SHARK; ONTOGENIC CHANGES; SOUTH-CAROLINA; KANEOHE BAY; CALIFORNIA; MIGRATION; BEHAVIOR	Background: As we know from modern species, nursery areas are essential shark habitats for vulnerable young. Nurseries are typically highly productive, shallow-water habitats that are characterized by the presence of juveniles and neonates. It has been suggested that in these areas, sharks can find ample food resources and protection from predators. Based on the fossil record, we know that the extinct Carcharocles megalodon was the biggest shark that ever lived. Previous proposed paleo-nursery areas for this species were based on the anecdotal presence of juvenile fossil teeth accompanied by fossil marine mammals. We now present the first definitive evidence of ancient nurseries for C. megalodon from the late Miocene of Panama, about 10 million years ago. Methodology/Principal Findings: We collected and measured fossil shark teeth of C. megalodon, within the highly productive, shallow marine Gatun Formation from the Miocene of Panama. Surprisingly, and in contrast to other fossil accumulations, the majority of the teeth from Gatun are very small. Here we compare the tooth sizes from the Gatun with specimens from different, but analogous localities. In addition we calculate the total length of the individuals found in Gatun. These comparisons and estimates suggest that the small size of Gatun's C. megalodon is neither related to a small population of this species nor the tooth position within the jaw. Thus, the individuals from Gatun were mostly juveniles and neonates, with estimated body lengths between 2 and 10.5 meters. Conclusions/Significance: We propose that the Miocene Gatun Formation represents the first documented paleo-nursery area for C. megalodon from the Neotropics, and one of the few recorded in the fossil record for an extinct selachian. We therefore show that sharks have used nursery areas at least for 10 millions of years as an adaptive strategy during their life histories.	[Pimiento, Catalina] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Pimiento, Catalina; Ehret, Dana J.; MacFadden, Bruce J.] Univ Florida, Florida Museum Nat Hist, Div Vertebrate Paleontol, Gainesville, FL 32611 USA; [Pimiento, Catalina] Smithsonian Trop Res Inst, Ctr Paleoecol & Archaeol, Panama City, Panama; [Ehret, Dana J.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [MacFadden, Bruce J.] Natl Sci Fdn, Div Res Learning Educ & Human Resources, Arlington, VA 22230 USA; [Hubbell, Gordon] Jaws Int, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; State University System of Florida; University of Florida; National Science Foundation (NSF)	Pimiento, C (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	pimientoc@ufl.edu	Pimiento, Catalina/ABF-1204-2020	Pimiento, Catalina/0000-0002-5320-7246; Ehret, Dana/0000-0002-5041-5699	NSF [EAR 0418042]; Sigma [Xi G2009100426]; Florida Museum of Natural History; Smithsonian Tropical Research Institute; Mitchell Hope Scholarship; Ken Ericson Scholarship	NSF(National Science Foundation (NSF)); Sigma; Florida Museum of Natural History; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Mitchell Hope Scholarship; Ken Ericson Scholarship	This project was funded by NSF EAR 0418042 (http://www.nsf.gov/funding), Sigma Xi G2009100426 (http://www.sigmaxi.org/programs/giar/index.shtml), The Florida Museum of Natural History (www.flmnh.ufl.edu), The Smithsonian Tropical Research Institute (www.stri.org), The Mitchell Hope Scholarship(http://www.southwestfloridafossilclub.com/) and the Ken Ericson Scholarship(http://www.flmnh.ufl.edu/vertpaleo/kenericsonscholarship.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA O, 1996, PALCOBIOTIC SURVEY C, P251; AINLEY DG, 1985, S CALIF ADAC SCI MEM, V8, P109; Alejo-Plata C, 2007, REV BIOL MAR OCEANOG, V42, P403; Applegate SP, 1996, GREAT WHITE SHARKS, P19, DOI 10.1016/B978-012415031-7/50005-7; Blake S.F., 1862, GEOLOGIST, V5, P316; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Casier E., 1960, Ann Mus Congo belge A III, V1, P1; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; CLIFF G, 1989, SHARKS CAUGHT PROTEC, V2, P131; COATES AG, 1996, B PALEONTOLOGICAL RE, V357, P17; Coates Anthony G., 1996, P21; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Ebert DA, 2002, MAR FRESHWATER RES, V53, P517, DOI 10.1071/MF01143; Ehret DJ, 2009, J VERTEBR PALEONTOL, V29, P1; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Gillette D.D., 1984, Journal of Vertebrate Paleontology, V4, P172; GLUCKMAN LS, 1964, SHARKS PALEOGENE STR; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gussone N, 2004, EARTH PLANET SC LETT, V227, P201, DOI 10.1016/j.epsl.2004.09.004; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Heihaus Michael R., 2007, V50, P3; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Hubbell G, 1996, GREAT WHITE SHARKS, P9, DOI 10.1016/B978-012415031-7/50004-5; Jordan D. S., 1923, Bulletin of the Southern California Academy of Sciences, V22, P27; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MCCANDLESS CT, 2007, AM FISHERIES SOC S, V50, P1; McElroy WD, 2006, ENVIRON BIOL FISH, V76, P81, DOI 10.1007/s10641-006-9010-y; MORGAN GS, 1994, CONTRIBUTIONS MARINE, P239; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; Nyberg KG, 2006, J VERTEBR PALEONTOL, V26, P806, DOI 10.1671/0272-4634(2006)26[806:TTAOTG]2.0.CO;2; PIMIENTO C, 2010, SYSTEMATICS PALEOBIO; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Purdy RW, 2001, SM C PALEOB, V90, P71; Purdy RW, 1998, T AM PHILOS SOC, V88, P122, DOI 10.2307/1006671; Shimada K., 2003, J FOSSIL RES, V35, P28; Teranes Jane L., 1996, P105; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Voorhies M.R., 2004, LATE CRETACEOUS CENO; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward Lauck W., 2008, Virginia Museum of Natural History Special Publication, V14, P325; Yamaguchi A, 2000, FISHERIES SCI, V66, P1039, DOI 10.1046/j.1444-2906.2000.00166.x; ZHELEZKO V, 1999, ELASMOBRANCHII PALEO, V3	52	64	69	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10552	10.1371/journal.pone.0010552	http://dx.doi.org/10.1371/journal.pone.0010552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479893	gold, Green Published, Green Submitted			2022-12-27	WOS:000277467900008
J	Sebinger, DDR; Unbekandt, M; Ganeva, VV; Ofenbauer, A; Werner, C; Davies, JA				Sebinger, David D. R.; Unbekandt, Mathieu; Ganeva, Veronika V.; Ofenbauer, Andreas; Werner, Carsten; Davies, Jamie A.			A Novel, Low-Volume Method for Organ Culture of Embryonic Kidneys That Allows Development of Cortico-Medullary Anatomical Organization	PLOS ONE			English	Article							DEVELOPING MOUSE KIDNEY; BRANCHING MORPHOGENESIS; IN-VITRO; GROWTH-FACTOR; TUBULE DIFFERENTIATION; NEUROTROPHIC FACTOR; INTERFERON-GAMMA; SKELETAL-MUSCLE; CELL-ADHESION; EXPRESSION	Here, we present a novel method for culturing kidneys in low volumes of medium that offers more organotypic development compared to conventional methods. Organ culture is a powerful technique for studying renal development. It recapitulates many aspects of early development very well, but the established techniques have some disadvantages: in particular, they require relatively large volumes (1-3 mls) of culture medium, which can make high-throughput screens expensive, they require porous (filter) substrates which are difficult to modify chemically, and the organs produced do not achieve good cortico-medullary zonation. Here, we present a technique of growing kidney rudiments in very low volumes of medium-around 85 microliters-using silicone chambers. In this system, kidneys grow directly on glass, grow larger than in conventional culture and develop a clear anatomical cortico-medullary zonation with extended loops of Henle.	[Sebinger, David D. R.; Ofenbauer, Andreas; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany; [Unbekandt, Mathieu; Ganeva, Veronika V.; Davies, Jamie A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; University of Edinburgh	Sebinger, DDR (corresponding author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany.	jamie.davies@ed.ac.uk	Werner, Carsten/F-8127-2010; Davies, Jamie/AAE-7111-2019; Werner, Carsten/AAF-1510-2019	Werner, Carsten/0000-0003-0189-3448; Davies, Jamie/0000-0001-6660-4032; Ofenbauer, Andreas/0000-0003-0379-9105	European Union [LSHG-CT-2004-005085, MRTN-CT-2006-036097, HEALTH-F5-2008-223007]; National Centre for 3Rs [G0700480]; National Centre for the Replacement [G0700480/1] Funding Source: researchfish	European Union(European Commission); National Centre for 3Rs; National Centre for the Replacement	This work was supported by the European Union - EU Framework 6 (EuReGene: LSHG-CT-2004-005085), EU and Framework 7 (MRTN-CT-2006-036097 KidStem and HEALTH-F5-2008-223007 STAR-T REK) and National Centre for 3Rs (G0700480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Tetsu, 2005, Organogenesis, V2, P17; AUERBACH R, 1958, EXP CELL RES, V15, P384, DOI 10.1016/0014-4827(58)90039-9; AVNER ED, 1982, IN VITRO CELL DEV B, V18, P675; BARD JBL, 1991, DEVELOPMENT, V113, P193; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; DAVIES J, 1994, DEV DYNAM, V199, P45, DOI 10.1002/aja.1001990105; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; DAVIES JA, 1995, DEV BIOL, V167, P50, DOI 10.1006/dbio.1995.1006; ENGELMYER E, 1995, J AM SOC NEPHROL, V5, P1675; Fisher CE, 2001, DEVELOPMENT, V128, P4329; GLEUCKSOHNWAELS.S, 1963, DEV BIOL, V7, P432; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; GROBSTEIN C, 1953, J EXP ZOOL, V124, P383, DOI 10.1002/jez.1401240211; HANSEN FK, 1991, J COLLOID INTERF SCI, V141, P1, DOI 10.1016/0021-9797(91)90296-K; HIGHTOWER LE, 1981, J CELL PHYSIOL, V108, P261, DOI 10.1002/jcp.1041080216; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lee Wen-Chin, 2008, Organogenesis, V4, P176; LIU LT, 1993, KIDNEY INT, V44, P322, DOI 10.1038/ki.1993.247; Loughna S, 1998, BIOCHEM BIOPH RES CO, V247, P361, DOI 10.1006/bbrc.1998.8768; MATSUSHIMA K, 1989, CYTOKINE, V1, P1; McEarchern JA, 1999, CANCER IMMUNOL IMMUN, V48, P63, DOI 10.1007/s002620050549; Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x; Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x; MICHOS O, 2007, DEVELOPMENT; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Pillai RG, 2008, BRIT J OPHTHALMOL, V92, P259, DOI 10.1136/bjo.2007.115923; RIENHOFF WF, 1922, J HOPKINS HOSP B, V33, P392; Rogers Sharon A, 2004, Organogenesis, V1, P52; Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034; Sainio K, 1997, DEVELOPMENT, V124, P4077; SAINIO K, 1994, CELL MOL NEUROBIOL, V14, P439, DOI 10.1007/BF02088830; Sakurai H, 1997, AM J PHYSIOL-RENAL, V272, pF139, DOI 10.1152/ajprenal.1997.272.1.F139; Saxen L., 1968, P251; SAXEN L, 1962, J NATL CANCER I, V29, P597; SAXEN L, 1966, INT J CANCER, V1, P271, DOI 10.1002/ijc.2910010307; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shibata F, 1996, CYTOKINE, V8, P222, DOI 10.1006/cyto.1996.0031; TAJIMA K, 1985, BIOPHYS J, V47, P203, DOI 10.1016/S0006-3495(85)83892-3; Tan HK, 2008, BIOTECHNOL APPL BIOC, V49, P247, DOI 10.1042/BA20070032; THESLEFF I, 1984, J EMBRYOL EXP MORPH, V82, P147; Towers PR, 1998, EXP NEPHROL, V6, P337; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Voronov DA, 2002, DEV DYNAM, V224, P413, DOI 10.1002/dvdy.10121; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Yamagata M, 2001, ENDOCRINOLOGY, V142, P3223, DOI 10.1210/en.142.7.3223	52	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10550	10.1371/journal.pone.0010550	http://dx.doi.org/10.1371/journal.pone.0010550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479933	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467900006
J	Sun, JJ; Collier, RJ				Sun, Jianjun; Collier, R. John			Disulfide Bonds in the Ectodomain of Anthrax Toxin Receptor 2 Are Required for the Receptor-Bound Protective-Antigen Pore to Function	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; INFANTILE SYSTEMIC HYALINOSIS; CRYSTAL-STRUCTURE; MUTATIONS; CELLS; FORMS; TRANSLOCATION; FIBROMATOSIS; GENE; EXPRESSION	Background: Cell-surface receptors play essential roles in anthrax toxin action by providing the toxin with a high-affinity anchor and self-assembly site on the plasma membrane, mediating the toxin entry into cells through endocytosis, and shifting the pH threshold for prepore-to-pore conversion of anthrax toxin protective antigen (PA) to a more acidic pH, thereby inhibiting premature pore formation. Each of the two known anthrax toxin receptors, ANTXR1 and ANTXR2, has an ectodomain comprised of an N-terminal von Willebrand factor A domain (VWA), which binds PA, and an uncharacterized immunoglobulin-like domain (Ig) that connects VWA to the membrane-spanning domain. Potential roles of the receptor Ig domain in anthrax toxin action have not been investigated heretofore. Methodology/Principal Findings: We expressed and purified the ANTXR2 ectodomain (R2-VWA-Ig) in E. coli and showed that it contains three disulfide bonds: one in R2-VWA and two in R2-Ig. Reduction of the ectodomain inhibited functioning of the pore, as measured by K(+) release from liposomes or Chinese hamster ovary cells or by PA-mediated translocation of a model substrate across the plasma membrane. However, reduction did not affect binding of the ectodomain to PA or the transition of ectodomain-bound PA prepore to the pore conformation. The inhibitory effect depended specifically on reduction of the disulfides within R2-Ig. Conclusions/Significance: We conclude that disulfide integrity within R2-Ig is essential for proper functioning of receptor-bound PA pore. This finding provides a novel venue to investigate the mechanism of anthrax toxin action and suggests new strategies for inhibiting toxin action.	[Sun, Jianjun; Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sun, JJ (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	jsun@utep.edu		Collier, R John/0000-0002-2427-4239	NIAID [RO1-AI022021]; UTEP-New faculty Start-UP fund; NIH [5G12RR008124]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UTEP-New faculty Start-UP fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID grant RO1-AI022021 (to R.J.C.), UTEP-New faculty Start-UP fund (to J.S.) and NIH Grant #5G12RR008124 (To UTEP-BBRC DNA Analysis core facility and Biomolecule Analysis core facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antaya RJ, 2007, AM J DERMATOPATH, V29, P99, DOI 10.1097/01.dad.0000245636.39098.e5; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bell SE, 2001, J CELL SCI, V114, P2755; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; HA SD, 2009, J BIOL CHEM; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lee JYY, 2005, CLIN EXP DERMATOL, V30, P176, DOI 10.1111/j.1365-2230.2004.01698.x; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200; Yan M, 2003, MOL MED, V9, P46, DOI 10.1007/BF03402106; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103	36	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10553	10.1371/journal.pone.0010553	http://dx.doi.org/10.1371/journal.pone.0010553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479891	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467900009
J	Formann, AK				Formann, Anton K.			The Newcomb-Benford Law in Its Relation to Some Common Distributions	PLOS ONE			English	Article							SIGNIFICANT-DIGIT; 1ST DIGIT; RANDOM-VARIABLES; NUMBERS; RATIO; ZIPF	An often reported, but nevertheless persistently striking observation, formalized as the Newcomb-Benford law (NBL), is that the frequencies with which the leading digits of numbers occur in a large variety of data are far away from being uniform. Most spectacular seems to be the fact that in many data the leading digit 1 occurs in nearly one third of all cases. Explanations for this uneven distribution of the leading digits were, among others, scale-and base-invariance. Little attention, however, found the interrelation between the distribution of the significant digits and the distribution of the observed variable. It is shown here by simulation that long right-tailed distributions of a random variable are compatible with the NBL, and that for distributions of the ratio of two random variables the fit generally improves. Distributions not putting most mass on small values of the random variable (e. g. symmetric distributions) fail to fit. Hence, the validity of the NBL needs the predominance of small values and, when thinking of real-world data, a majority of small entities. Analyses of data on stock prices, the areas and numbers of inhabitants of countries, and the starting page numbers of papers from a bibliography sustain this conclusion. In all, these findings may help to understand the mechanisms behind the NBL and the conditions needed for its validity. That this law is not only of scientific interest per se, but that, in addition, it has also substantial implications can be seen from those fields where it was suggested to be put into practice. These fields reach from the detection of irregularities in data (e. g. economic fraud) to optimizing the architecture of computers regarding number representation, storage, and round-off errors.	Univ Vienna, Dept Psychol Basic Res, Vienna, Austria	University of Vienna	Formann, AK (corresponding author), Univ Vienna, Dept Psychol Basic Res, Vienna, Austria.	anton.formann@univie.ac.at						Adhikari A. K., 1968, SANKHYA B, V30, P47; ADHIKARI AK, 1969, SANKHYA SER B, V31, P413; [Anonymous], 1994, CONTINUOUS UNIVARIAT; Beer TW, 2009, J CLIN PATHOL, V62, P192, DOI 10.1136/jcp.2008.061721; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; BERGER A, 2010, BENFORD ONLINE BIBLI; Brown A, 1998, IMECHE SEM, V1998, P1; Diekmann A, 2007, J APPL STAT, V34, P321, DOI 10.1080/02664760601004940; Duembgen L, 2008, ELECTRON COMMUN PROB, V13, P99; el Sehity T, 2005, INT J RES MARK, V22, P471, DOI 10.1016/j.ijresmar.2005.09.002; Engel HA, 2003, STAT PROBABIL LETT, V63, P361, DOI 10.1016/S0167-7152(03)00101-9; FURRY WH, 1945, NATURE, V155, P52, DOI 10.1038/155052a0; Giles DE, 2007, APPL ECON LETT, V14, P157, DOI 10.1080/13504850500425667; Gottwald GA, 2002, PHYSICA A, V303, P387, DOI 10.1016/S0378-4371(01)00497-6; Hales DN, 2008, EUR J OPER RES, V189, P583, DOI 10.1016/j.ejor.2006.09.092; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; HILL TP, 1995, P AM MATH SOC, V123, P887, DOI 10.2307/2160815; Hill TP, 1998, AM SCI, V86, P358, DOI 10.1511/1998.4.358; HILL TP, 1995, AM MATH MON, V102, P322, DOI 10.2307/2974952; HINKLEY DV, 1969, BIOMETRIKA, V56, P635, DOI 10.1093/biomet/56.3.635; Hurlimann W., 2006, BENFORDS LAW 1881 20; Irmay S, 1997, J APPL STAT, V24, P383, DOI 10.1080/02664769723594; Janvresse T, 2004, J APPL PROBAB, V41, P1203, DOI 10.1239/jap/1101840566; Judge G, 2009, J HUM RESOUR, V44, P1; Kim HJ, 2006, COMMUN STAT-THEOR M, V35, P965, DOI 10.1080/03610920600672229; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Leemis LM, 2000, AM STAT, V54, P236, DOI 10.2307/2685773; Ley E, 1996, AM STAT, V50, P311, DOI 10.2307/2684926; Lolbert T, 2008, MATH SOC SCI, V55, P103, DOI 10.1016/j.mathsocsci.2007.09.001; Luque B, 2009, P ROY SOC A-MATH PHY, V465, P2197, DOI 10.1098/rspa.2009.0126; MILLER SJ, 2008, ARXIVMATH0601344V5; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; Nigrini Mark John, 2000, DIGITAL ANAL USING B; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; PINKHAM RS, 1961, ANN MATH STAT, V32, P1223, DOI 10.1214/aoms/1177704862; RAIMI RA, 1976, AM MATH MON, V83, P521, DOI 10.2307/2319349; Rodriguez RJ, 2004, AM STAT, V58, P64, DOI 10.1198/0003130042782; Schatte P, 1998, STAT PROBABIL LETT, V37, P391, DOI 10.1016/S0167-7152(97)00142-9; Torres J, 2007, EUR J PHYS, V28, pL17, DOI 10.1088/0143-0807/28/3/N04	39	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10541	10.1371/journal.pone.0010541	http://dx.doi.org/10.1371/journal.pone.0010541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	593OI	20479878	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800022
J	Leissring, MA; Malito, E; Hedouin, S; Reinstatler, L; Sahara, T; Abdul-Hay, SO; Choudhry, S; Maharvi, GM; Fauq, AH; Huzarska, M; May, PS; Choi, S; Logan, TP; Turk, BE; Cantley, LC; Manolopoulou, M; Tang, WJ; Stein, RL; Cuny, GD; Selkoe, DJ				Leissring, Malcolm A.; Malito, Enrico; Hedouin, Sabrine; Reinstatler, Lael; Sahara, Tomoko; Abdul-Hay, Samer O.; Choudhry, Shakeel; Maharvi, Ghulam M.; Fauq, Abdul H.; Huzarska, Malwina; May, Philip S.; Choi, Sungwoon; Logan, Todd P.; Turk, Benjamin E.; Cantley, Lewis C.; Manolopoulou, Marika; Tang, Wei-Jen; Stein, Ross L.; Cuny, Gregory D.; Selkoe, Dennis J.			Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; MOLECULAR-BASIS; DEGRADATION; SOFTWARE; RECOGNITION; PEPTIDASE; INSULYSIN; CLEAVAGE; TARGET; IDE	Background: Insulin is a vital peptide hormone that is a central regulator of glucose homeostasis, and impairments in insulin signaling cause diabetes mellitus. In principle, it should be possible to enhance the activity of insulin by inhibiting its catabolism, which is mediated primarily by insulin-degrading enzyme (IDE), a structurally and evolutionarily distinctive zinc-metalloprotease. Despite interest in pharmacological inhibition of IDE as an attractive anti-diabetic approach dating to the 1950s, potent and selective inhibitors of IDE have not yet emerged. Methodology/Principal Findings: We used a rational design approach based on analysis of combinatorial peptide mixtures and focused compound libraries to develop novel peptide hydroxamic acid inhibitors of IDE. The resulting compounds are similar to 10(6) times more potent than existing inhibitors, non-toxic, and surprisingly selective for IDE vis-a-vis conventional zincmetalloproteases. Crystallographic analysis of an IDE-inhibitor complex reveals a novel mode of inhibition based on stabilization of IDE's "closed,'' inactive conformation. We show further that pharmacological inhibition of IDE potentiates insulin signaling by a mechanism involving reduced catabolism of internalized insulin. Conclusions/Significance: The inhibitors we describe are the first to potently and selectively inhibit IDE or indeed any member of this atypical zinc-metalloprotease superfamily. The distinctive structure of IDE's active site, and the mode of action of our inhibitors, suggests that it may be possible to develop inhibitors that cross-react minimally with conventional zinc-metalloproteases. Significantly, our results reveal that insulin signaling is normally regulated by IDE activity not only extracellularly but also within cells, supporting the longstanding view that IDE inhibitors could hold therapeutic value for the treatment of diabetes.	[Leissring, Malcolm A.; Hedouin, Sabrine; Reinstatler, Lael; Sahara, Tomoko; Abdul-Hay, Samer O.; Choudhry, Shakeel; Maharvi, Ghulam M.; Fauq, Abdul H.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Leissring, Malcolm A.; Huzarska, Malwina; May, Philip S.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Leissring, Malcolm A.; Logan, Todd P.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Leissring, Malcolm A.; Logan, Todd P.; Cantley, Lewis C.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA USA; [Malito, Enrico; Manolopoulou, Marika; Tang, Wei-Jen] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Choi, Sungwoon; Stein, Ross L.; Cuny, Gregory D.] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Choi, Sungwoon; Stein, Ross L.; Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Mayo Clinic; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Yale University; Harvard University; Beth Israel Deaconess Medical Center	Leissring, MA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	Leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021; Cantley, Lewis C/D-1800-2014	LEISSRING, MALCOLM/0000-0001-7185-4255; Cantley, Lewis C/0000-0002-1298-7653; Hedouin, Sabrine/0000-0002-3977-1852; Cuny, Gregory/0000-0002-3188-4748; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [AG025070, DA024888, AG12749, GM81539]; Ellison Medical Foundation; American Health Assistance Foundation; Unforgettable Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM081539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012749, R21AG025070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation(BrightFocus Foundation); Unforgettable Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (AG025070 and DA024888 to MAL; AG12749 to MAL and DJS; GM81539 to W-JT), the Ellison Medical Foundation (to MAL), the American Health Assistance Foundation (to EM), and by a generous donation from The Unforgettable Fund (to SH and MAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; BECKER AB, 1995, METHOD ENZYMOL, V248, P693; Brange J, 1993, Pharm Biotechnol, V5, P315; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1981, ENDOCR REV, V2, P210, DOI 10.1210/edrv-2-2-210; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; GARCIA JV, 1988, BIOCHEMISTRY-US, V27, P4237, DOI 10.1021/bi00412a006; Giugliano D, 2009, ACTA DIABETOL, V46, P173, DOI 10.1007/s00592-009-0134-3; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hentz NG, 1997, ANAL CHEM, V69, P4994, DOI 10.1021/ac970726m; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; MIRSKY IA, 1956, METABOLISM, V5, P138; MIRSKY IA, 1957, RECENT PROG HORM RES, V13, P429; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; NISHINO N, 1978, BIOCHEMISTRY-US, V17, P2846, DOI 10.1021/bi00607a023; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powers J C, 1993, Agents Actions Suppl, V42, P3; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; TERRIS S, 1975, J BIOL CHEM, V250, P8389; Tong M, 2006, BIOCHEM PHARMACOL, V72, P701, DOI 10.1016/j.bcp.2006.06.004; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; WATANABE T, 2009, CANC SCI; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	50	86	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10504	10.1371/journal.pone.0010504	http://dx.doi.org/10.1371/journal.pone.0010504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20498699	gold, Green Published, Green Submitted			2022-12-27	WOS:000277467800004
J	Martinez, O; Reyes-Valdes, MH; Herrera-Estrella, L				Martinez, Octavio; Humberto Reyes-Valdes, M.; Herrera-Estrella, Luis			Cancer Reduces Transcriptome Specialization	PLOS ONE			English	Article							GENE-EXPRESSION; CELL; DIVERSITY; SIGNATURE; ORIGIN	A central goal of cancer biology is to understand how cells from this family of genetic diseases undergo specific morphological and physiological changes and regress to a de-regulated state of the cell cycle. The fact that tumors are unable to perform most of the specific functions of the original tissue led us to hypothesize that the degree of specialization of the transcriptome of cancerous tissues must be less than their normal counterparts. With the aid of information theory tools, we analyzed four datasets derived from transcriptomes of normal and tumor tissues to quantitatively test the hypothesis that cancer reduces transcriptome specialization. Here, we show that the transcriptional specialization of a tumor is significantly less than the corresponding normal tissue and comparable with the specialization of dedifferentiated embryonic stem cells. Furthermore, we demonstrate that the drop in specialization in cancerous tissues is largely due to a decrease in expression of genes that are highly specific to the normal organ. This approach gives us a better understanding of carcinogenesis and offers new tools for the identification of genes that are highly influential in cancer progression.	[Martinez, Octavio; Herrera-Estrella, Luis] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Martinez, O (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	omartine@ira.cinvestav.mx	Herrera-Estrella, Luis/ABC-7431-2020; Herrera-Estrella, Luis/AAL-2472-2020; Martinez, Octavio/F-3951-2014; Estrella, Luis R Herrera/G-7351-2011	Herrera-Estrella, Luis/0000-0001-7936-3856; Martinez, Octavio/0000-0002-7590-0041; Estrella, Luis R Herrera/0000-0001-7936-3856	Consejo Nacional de Ciencia y Tecnologia (Conacyt); Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav); Universidad Autonoma Agraria Antonio Narro (UAAAN)	Consejo Nacional de Ciencia y Tecnologia (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav); Universidad Autonoma Agraria Antonio Narro (UAAAN)	This work was supported by Consejo Nacional de Ciencia y Tecnologia (Conacyt), Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg), Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav) and Universidad Autonoma Agraria Antonio Narro (UAAAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; CROSBIE RE, 1993, EUROSIM 92 - SIMULATION CONGRESS, P1; Di CH, 2005, CANCER RES, V65, P919; EVERITT BS, 1992, ANAL CONTINGENCY TAB, P1; Ewens W.J., 2001, STAT METHODS BIOINFO; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Inamura K, 2007, HUM PATHOL, V38, P702, DOI 10.1016/j.humpath.2006.11.019; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Klausner RD, 2002, CANCER CELL, V1, P3, DOI 10.1016/S1535-6108(02)00020-X; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; MAJETI R, 2009, P NATL ACAD SCI; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Mihich E, 2002, CANCER RES, V62, P3883; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Park JC, 2008, BIOCHEM BIOPH RES CO, V365, P221, DOI 10.1016/j.bbrc.2007.10.144; Porter D, 2003, EXPERT OPIN THER TAR, V7, P759; R Development Core Team, 2005, R LANG ENV STAT COMP; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reyes I, 2007, BIOMEDICA, V27, P190; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wodarz D, 2005, COMPUTATIONAL BIOLOGY OF CANCER: LECTURE NOTES AND MATHEMATICAL MODELING, P1, DOI 10.1142/9789812701367; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10398	10.1371/journal.pone.0010398	http://dx.doi.org/10.1371/journal.pone.0010398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454660	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240300003
J	Kvennefors, ECE; Sampayo, EM; Ridgway, T; Barnes, AC; Hoegh-Guldberg, O				Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Ridgway, Tyrone; Barnes, Andrew C.; Hoegh-Guldberg, Ove			Bacterial Communities of Two Ubiquitous Great Barrier Reef Corals Reveals Both Site- and Species-Specificity of Common Bacterial Associates	PLOS ONE			English	Article							BLACK BAND DISEASE; GRADIENT GEL-ELECTROPHORESIS; ACROPORID WHITE SYNDROME; RIBOSOMAL-RNA GENES; PLAGUE-LIKE DISEASE; MICROBIAL COMMUNITIES; CAUSATIVE AGENT; INDO-PACIFIC; SP-NOV.; SCLERACTINIAN CORALS	Background: Coral-associated bacteria are increasingly considered to be important in coral health, and altered bacterial community structures have been linked to both coral disease and bleaching. Despite this, assessments of bacterial communities on corals rarely apply sufficient replication to adequately describe the natural variability. Replicated data such as these are crucial in determining potential roles of bacteria on coral. Methodology/Principal Findings: Denaturing Gradient Gel Electrophoresis (DGGE) of the V3 region of the 16S ribosomal DNA was used in a highly replicated approach to analyse bacterial communities on both healthy and diseased corals. Although site-specific variations in the bacterial communities of healthy corals were present, host species-specific bacterial associates within a distinct cluster of gamma-proteobacteria could be identified, which are potentially linked to coral health. Corals affected by "White Syndrome" (WS) underwent pronounced changes in their bacterial communities in comparison to healthy colonies. However, the community structure and bacterial ribotypes identified in diseased corals did not support the previously suggested theory of a bacterial pathogen as the causative agent of the syndrome. Conclusions/Significance: This is the first study to employ large numbers of replicated samples to assess the bacterial communities of healthy and diseased corals, and the first culture-independent assessment of bacterial communities on WS affected Acroporid corals on the GBR. Results indicate that a minimum of 6 replicate samples are required in order to draw inferences on species, spatial or health-related changes in community composition, as a set of clearly distinct bacterial community profiles exist in healthy corals. Coral bacterial communities may be both site and species specific. Furthermore, a cluster of gamma-proteobacterial ribotypes may represent a group of specific common coral and marine invertebrate associates. Finally, the results did not support the contention that a single bacterial pathogen may be the causative agent of WS Acroporids on the GBR.	[Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Ridgway, Tyrone; Barnes, Andrew C.; Hoegh-Guldberg, Ove] Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia; [Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Barnes, Andrew C.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Kvennefors, E. Charlotte E.; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Kvennefors, ECE (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia.	c.kvennefors@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Barnes, Andrew/J-9012-2014; Hoegh-Guldberg, Ove/H-6169-2011; Barnes, Andrew C/G-7334-2012; Kvennefors, Eva Charlotte E/B-9585-2013	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Barnes, Andrew/0000-0002-3990-8070; Hoegh-Guldberg, Ove/0000-0001-7510-6713; 	Australian Research Council Centre of Excellence for Coral Reef Studies; Coral Reef Targeted Research Project; Centre for Marine Studies and Global Change Institute (The University of Queensland); Australian Coral Reef Society	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Coral Reef Targeted Research Project; Centre for Marine Studies and Global Change Institute (The University of Queensland)(University of Queensland); Australian Coral Reef Society	This project was funded by the Australian Research Council Centre of Excellence for Coral Reef Studies (to OHG), Coral Reef Targeted Research Project to (OHG), Centre for Marine Studies and Global Change Institute (The University of Queensland) and the Australian Coral Reef Society. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Ainsworth T, 2008, ISME J, V2, P67, DOI 10.1038/ismej.2007.88; Ainsworth TD, 2006, APPL ENVIRON MICROB, V72, P3016, DOI 10.1128/AEM.72.4.3016-3020.2006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arboleda M, 2009, MICROB ECOL, V57, P117, DOI 10.1007/s00248-008-9400-0; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Chimetto LA, 2008, SYST APPL MICROBIOL, V31, P312, DOI 10.1016/j.syapm.2008.06.001; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Gloess S, 2008, APPL ENVIRON MICROB, V74, P4231, DOI 10.1128/AEM.02545-07; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hirst CN, 2007, DIVERS DISTRIB, V13, P361, DOI 10.1111/j.1472-4642.2007.00307.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Johnston IS, 2007, CORAL REEFS, V26, P375, DOI 10.1007/s00338-007-0208-z; Kellogg CA, 2004, MAR ECOL PROG SER, V273, P81, DOI 10.3354/meps273081; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Kushmaro A, 2004, CORAL HEALTH AND DISEASE, P231; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Quinn G. P., 2002, EXPT DESIGN DATA ANA, P1; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Rincon-Rosales R, 2009, FEMS MICROBIOL ECOL, V67, P103, DOI 10.1111/j.1574-6941.2008.00590.x; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 1994, PROCEEDINGS OF THE FIFTH SYMPOSIUM ON THE NATURAL HISTORY OF THE BAHAMAS, P75; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Ritchie Kim B., 1995, Journal of Marine Biotechnology, V3, P105; Roff G, 2008, CORAL REEFS, V27, P373, DOI 10.1007/s00338-007-0339-2; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rohwer F, 2004, CORAL HEALTH AND DISEASE, P265; SANTAVY DL, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P211; Schuett C, 2007, HELGOLAND MAR RES, V61, P211, DOI 10.1007/s10152-007-0069-4; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Stamper DM, 2003, APPL ENVIRON MICROB, V69, P852, DOI 10.1128/AEM.69.2.852-860.2003; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; SWOFFORD L, 2000, PAUP PHYLOGENETIC AN; Theron J, 2000, CRIT REV MICROBIOL, V26, P37, DOI 10.1080/10408410091154174; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	89	97	100	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10401	10.1371/journal.pone.0010401	http://dx.doi.org/10.1371/journal.pone.0010401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454460	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100013
J	Polo, ML; Arnoni, MV; Riggio, M; Wargon, V; Lanari, C; Novaro, V				Laura Polo, Maria; Victoria Arnoni, Maria; Riggio, Marina; Wargon, Victoria; Lanari, Claudia; Novaro, Virginia			Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MOUSE MAMMARY-TUMOR; IN-VITRO; MEDROXYPROGESTERONE ACETATE; ENDOCRINE THERAPY; EPITHELIAL INTERACTIONS; PROGESTERONE-RECEPTORS; 3-DIMENSIONAL CULTURE; MODEL; RESISTANCE	Background: A significant proportion of breast cancer patients face failure of endocrine therapy due to the acquisition of endocrine resistance. We have explored mechanisms involved in such disease progression by using a mouse breast cancer model that is induced by medroxyprogesterone acetate (MPA). These tumors transit through different stages of hormone sensitivity. However, when cells from tumor variants were seeded on plastic, all were stimulated by progestins and inhibited by antiprogestins such as RU486. Furthermore, cells from a RU486-resistant tumor variant recovered antiprogestin sensitivity. Hypothesis: A three-dimensional (3D) culture system, by maintaining differential cellular organization that is typical of each tumor variant, may allow for the maintenance of particular hormone responses and thus be appropriate for the study of the effects of specific inhibitors of signaling pathways associated with disease progression. Method: We compared the behavior of tumors growing in vivo and cancer cells ex vivo ( in 3D Matrigel). In this system, we evaluated the effects of kinase inhibitors and hormone antagonists on tumor growth. Principal Findings: LY294002, a PI3K/AKT pathway inhibitor, decreased both tumor growth in vivo and cell survival in Matrigel in MPA-independent tumors with higher AKT activity. Induction of cell death by anti-hormones such as ICI182780 and ZK230211 was more effective in MPA-dependent tumors with lower AKT activity. Inhibition of MEK with PD98059 did not affect tumor growth in any tested variant. Finally, while Matrigel reproduced differential responsiveness of MPA-dependent and -independent breast cancer cells, it was not sufficient to preserve antiprogestin resistance of RU486-resistant tumors. Conclusion: We demonstrated that the PI3K/AKT pathway is relevant for MPA-independent tumor growth. Three-dimensional cultures were useful to test the effects of kinase inhibitors on breast cancer growth and highlight the need for in vivo models to validate experimental tools used for selective therapeutic targeting.	[Laura Polo, Maria; Victoria Arnoni, Maria; Riggio, Marina; Wargon, Victoria; Lanari, Claudia; Novaro, Virginia] Natl Council Sci & Tech Res CONICET, Inst Expt Biol & Med IBYME, Lab Hormonal Carcinogenesis, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Polo, ML (corresponding author), Natl Council Sci & Tech Res CONICET, Inst Expt Biol & Med IBYME, Lab Hormonal Carcinogenesis, Buenos Aires, DF, Argentina.	vnovaro@gmail.com		Novaro, Virginia/0000-0002-9917-4953; Lanari, Claudia/0000-0003-0555-2309	Sales Foundation, by Sciences and Technology Secretary (SECyT) [PICT 03 01-15038, PICT 07 00939]; National Council for Scientific and Technical Research (CONICET), Argentina	Sales Foundation, by Sciences and Technology Secretary (SECyT)(Secretaria de Ciencia y Tecnologia (SECYT)); National Council for Scientific and Technical Research (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Sales Foundation, by Sciences and Technology Secretary (SECyT, Grant numbers: PICT 03 01-15038 and PICT 07 00939), and by National Council for Scientific and Technical Research (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, J MAMMARY GLAND BIOL, V13, P279, DOI 10.1007/s10911-008-9093-5; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Beeram M, 2007, ANN ONCOL, V18, P1323, DOI 10.1093/annonc/mdm170; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Fuhrmann U, 2000, J MED CHEM, V43, P5010, DOI 10.1021/jm001000c; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Helguero LA, 2003, BREAST CANCER RES TR, V79, P379, DOI 10.1023/A:1024029826248; Hu LM, 2002, CANCER RES, V62, P1087; *I LAB AN RES COMM, 1996, GUID CAR US LAB AN; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; KLIJN JGM, 1989, CANCER RES, V49, P2851; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Lamb C, 1999, J STEROID BIOCHEM, V70, P133, DOI 10.1016/S0960-0760(99)00108-9; LANARI C, 1986, CANCER LETT, V33, P215, DOI 10.1016/0304-3835(86)90027-3; Lanari C, 2001, CANCER RES, V61, P293; Lanari C, 2009, ENDOCR-RELAT CANCER, V16, P333, DOI 10.1677/ERC-08-0244; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Liang Y, 2007, CANCER RES, V67, P9929, DOI 10.1158/0008-5472.CAN-07-1103; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Macedo LF, 2008, CANCER RES, V68, P3516, DOI 10.1158/0008-5472.CAN-07-6807; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; MOLINOLO AA, 1987, J NATL CANCER I, V79, P1341; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Novaro V, 2004, CLIN CANCER RES, V10, p402S, DOI 10.1158/1078-0432.CCR-031209; Novaro V, 2003, J CELL SCI, V116, P2975, DOI 10.1242/jcs.00523; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pontiggia O, 2009, BREAST CANCER RES TR, V116, P247, DOI 10.1007/s10549-008-0113-3; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Robertson JFR, 2007, ONCOLOGIST, V12, P774, DOI 10.1634/theoncologist.12-7-774; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Simian M, 2006, AM J PATHOL, V168, P270, DOI 10.2353/ajpath.2006.050012; Simian M, 2009, BREAST CANCER RES TR, V113, P1, DOI 10.1007/s10549-007-9888-x; SOLDATI R, 2009, BREAST CANC RES 1211; Vanzulli S, 2002, CARCINOGENESIS, V23, P749, DOI 10.1093/carcin/23.5.749; Vanzulli SI, 2005, CARCINOGENESIS, V26, P1055, DOI 10.1093/carcin/bgi060; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; WEIGELT B, 2009, BREAST CANC RES 0822; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wells V, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2217; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008; Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415	63	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10786	10.1371/journal.pone.0010786	http://dx.doi.org/10.1371/journal.pone.0010786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520761	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500008
J	Wikelski, M; Moxley, J; Eaton-Mordas, A; Lopez-Uribe, MM; Holland, R; Moskowitz, D; Roubik, DW; Kays, R				Wikelski, Martin; Moxley, Jerry; Eaton-Mordas, Alexander; Lopez-Uribe, Margarita M.; Holland, Richard; Moskowitz, David; Roubik, David W.; Kays, Roland			Large-Range Movements of Neotropical Orchid Bees Observed via Radio Telemetry	PLOS ONE			English	Article							EULAEMA-MERIANA HYMENOPTERA; EUGLOSSINE BEES; HARMONIC RADAR; POLLEN DISPERSAL; FORAGING RANGE; INSECT PESTS; FLIGHT; APIDAE; POLLINATORS; LANDSCAPE	Neotropical orchid bees (Euglossini) are often cited as classic examples of trapline-foragers with potentially extensive foraging ranges. If long-distance movements are habitual, rare plants in widely scattered locations may benefit from euglossine pollination services. Here we report the first successful use of micro radio telemetry to track the movement of an insect pollinator in a complex and forested environment. Our results indicate that individual male orchid bees (Exaerete frontalis) habitually use large rainforest areas (at least 42-115 ha) on a daily basis. Aerial telemetry located individuals up to 5 km away from their core areas, and bees were often stationary, for variable periods, between flights to successive localities. These data suggest a higher degree of site fidelity than what may be expected in a free living male bee, and has implications for our understanding of biological activity patterns and the evolution of forest pollinators.	[Wikelski, Martin; Holland, Richard] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Wikelski, Martin; Moxley, Jerry] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Eaton-Mordas, Alexander] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Lopez-Uribe, Margarita M.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Moskowitz, David] EcolSciences Inc, Rockaway, NJ USA; [Wikelski, Martin; Roubik, David W.; Kays, Roland] Smithsonian Trop Res Inst, Balboa, Panama; [Kays, Roland] New York State Museum & Sci Serv, Albany, NY USA	Max Planck Society; Princeton University; University of Arizona; Cornell University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wikelski, M (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	rkays@mail.nysed.gov	Holland, Richard A/A-6107-2010	Holland, Richard A/0000-0003-4495-8061; Kays, Roland/0000-0002-2947-6665	US Environmental Protection Agency; New York State Museum; EcolSciences, Inc.; Smithsonian Tropical Research Institute; National Geographic Society	US Environmental Protection Agency(United States Environmental Protection Agency); New York State Museum; EcolSciences, Inc.; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); National Geographic Society(National Geographic Society)	The study was supported by the US Environmental Protection Agency, New York State Museum, EcolSciences, Inc., Smithsonian Tropical Research Institute and the National Geographic Society. EcolSciences, as the only commercial company among the funding organizations, had a role in the analysis, decision to publish, and preparation of the manuscript through the involvment of David Moskowitz.	ACKERMAN JD, 1982, BIOTROPICA, V14, P241, DOI 10.2307/2388080; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P299; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boiteau G, 2009, ENVIRON ENTOMOL, V38, P168, DOI 10.1603/022.038.0121; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Brosi BJ, 2007, ECOL APPL, V17, P418, DOI 10.1890/06-0029; Cameron SA, 2004, ANNU REV ENTOMOL, V49, P377, DOI 10.1146/annurev.ento.49.072103.115855; Cameron SA, 2001, J KANSAS ENTOMOL SOC, V74, P142; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Combes SA, 2005, INTEGR COMP BIOL, V45, P980; Darveau CA, 2005, J EXP BIOL, V208, P3593, DOI 10.1242/jeb.01777; Darwin C, 1862, FERTILIZATION ORCHID; Degen B, 2004, BIOTROPICA, V36, P165; Dillon ME, 2004, J EXP BIOL, V207, P417, DOI 10.1242/jeb.00777; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; DODSON CH, 1970, BIOCH COEVOLUTION RO; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; DUDLEY R, 1995, J EXP BIOL, V198, P1065; Eltz T, 1999, J CHEM ECOL, V25, P157, DOI 10.1023/A:1020897302355; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hedin J, 2002, COMPUT ELECTRON AGR, V35, P171, DOI 10.1016/S0168-1699(02)00017-0; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; JANZEN DH, 1982, ECOLOGY, V63, P66, DOI 10.2307/1937032; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; KROODSMA D E, 1975, Biotropica, V7, P71, DOI 10.2307/2989803; MacLeod A, 2002, CROP PROT, V21, P635, DOI 10.1016/S0261-2194(02)00016-9; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PEDGLEY DE, 1993, INT J PEST MANAGE, V39, P3, DOI 10.1080/09670879309371751; Pemberton RW, 2006, ECOLOGY, V87, P1995, DOI 10.1890/0012-9658(2006)87[1995:OBDNOE]2.0.CO;2; RAW A, 1989, Revista Brasileira de Entomologia, V33, P103; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Roubik D. W., 2004, ORCHID BEES TROPICAL; Roubik DW, 1999, J KANSAS ENTOMOL SOC, V72, P394; ROUBIK DW, 1995, APIDOLOGIE, V26, P197, DOI 10.1051/apido:19950303; ROUBIK DW, 1983, J KANSAS ENTOMOL SOC, V56, P217; ROUBIK DW, 1993, J INSECT BEHAV, V6, P659, DOI 10.1007/BF01201668; Simpkin JL, 2000, WEST N AM NATURALIST, V60, P320; STERN DL, 1991, J KANSAS ENTOMOL SOC, V64, P421; Sword GA, 2005, NATURE, V433, P703, DOI 10.1038/433703a; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; von Frisch K, 1942, NATURWISSENSCHAFTEN, V30, P269; White G.C., 1990, ANAL WILDLIFE RADIO; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X	53	109	114	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10738	10.1371/journal.pone.0010738	http://dx.doi.org/10.1371/journal.pone.0010738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520813	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500005
J	Andreu, N; Zelmer, A; Fletcher, T; Elkington, PT; Ward, TH; Ripoll, J; Parish, T; Bancroft, GJ; Schaible, U; Robertson, BD; Wiles, S				Andreu, Nuria; Zelmer, Andrea; Fletcher, Taryn; Elkington, Paul T.; Ward, Theresa H.; Ripoll, Jorge; Parish, Tanya; Bancroft, Gregory J.; Schaible, Ulrich; Robertson, Brian D.; Wiles, Siouxsie			Optimisation of Bioluminescent Reporters for Use with Mycobacteria	PLOS ONE			English	Article							EXPRESSING FIREFLY LUCIFERASE; IN-VIVO; BOVIS BCG; ESCHERICHIA-COLI; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; BACTERIAL LUCIFERASE; RAPID DETECTION; ANTIMYCOBACTERIAL ACTIVITY; ANTIMICROBIAL AGENTS	Background: Mycobacterium tuberculosis, the causative agent of tuberculosis, still represents a major public health threat in many countries. Bioluminescence, the production of light by luciferase-catalyzed reactions, is a versatile reporter technology with multiple applications both in vitro and in vivo. In vivo bioluminescence imaging (BLI) represents one of its most outstanding uses by allowing the non-invasive localization of luciferase-expressing cells within a live animal. Despite the extensive use of luminescent reporters in mycobacteria, the resultant luminescent strains have not been fully applied to BLI. Methodology/Principal Findings: One of the main obstacles to the use of bioluminescence for in vivo imaging is the achievement of reporter protein expression levels high enough to obtain a signal that can be detected externally. Therefore, as a first step in the application of this technology to the study of mycobacterial infection in vivo, we have optimised the use of firefly, Gaussia and bacterial luciferases in mycobacteria using a combination of vectors, promoters, and codon-optimised genes. We report for the first time the functional expression of the whole bacterial lux operon in Mycobacterium tuberculosis and M. smegmatis thus allowing the development of auto-luminescent mycobacteria. We demonstrate that the Gaussia luciferase is secreted from bacterial cells and that this secretion does not require a signal sequence. Finally we prove that the signal produced by recombinant mycobacteria expressing either the firefly or bacterial luciferases can be non-invasively detected in the lungs of infected mice by bioluminescence imaging. Conclusions/Significance: While much work remains to be done, the finding that both firefly and bacterial luciferases can be detected non-invasively in live mice is an important first step to using these reporters to study the pathogenesis of M. tuberculosis and other mycobacterial species in vivo. Furthermore, the development of auto-luminescent mycobacteria has enormous ramifications for high throughput mycobacterial drug screening assays which are currently carried out either in a destructive manner using LuxAB or the firefly luciferase.	[Andreu, Nuria; Fletcher, Taryn; Elkington, Paul T.; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Zelmer, Andrea; Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich; Wiles, Siouxsie] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Ripoll, Jorge] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Crete, Greece; [Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Schaible, Ulrich] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Foundation for Research & Technology - Hellas (FORTH); University of London; Queen Mary University London; Forschungszentrum Borstel; University of Auckland	Andreu, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	s.wiles@auckland.ac.nz	Ripoll, Jorge/AAW-2245-2020; Wiles, Siouxsie/E-1690-2011; Schaible, Ulrich/C-7837-2011; Ripoll, Jorge/J-8134-2012; Ward, Theresa H./E-9650-2013	Ripoll, Jorge/0000-0001-8856-7738; Wiles, Siouxsie/0000-0002-0467-0015; Schaible, Ulrich/0000-0002-6638-7282; Ripoll, Jorge/0000-0001-8856-7738; Ward, Theresa H./0000-0002-9881-8649; Robertson, Brian D./0000-0001-5785-5307; Andreu, Nuria/0000-0001-5768-6566; Elkington, Paul/0000-0003-0390-0613	Bill and Melinda Gates Foundation [42786]; BBSRC [BB/E52708X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; National Institute for Health Research [DHCS/06/05/012] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This work is funded by an award (42786) to the Imaging TB Consortium from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) TB Drug Accelerator program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2006, CLIN EXP IMMUNOL, V145, P520, DOI 10.1111/j.1365-2249.2006.03133.x; ANDREW PW, 1993, J CLIN MICROBIOL, V31, P2251, DOI 10.1128/JCM.31.9.2251-2254.1993; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1536, DOI 10.1128/AAC.40.6.1536; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1542, DOI 10.1128/AAC.40.6.1542; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; Banaiee N, 2008, TUBERCULOSIS, V88, P64, DOI 10.1016/j.tube.2007.08.006; Bardarov S, 2003, DIAGN MICR INFEC DIS, V45, P53, DOI 10.1016/S0732-8893(02)00478-9; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Barker LP, 1999, FEMS MICROBIOL LETT, V175, P79, DOI 10.1111/j.1574-6968.1999.tb13604.x; Bastos RG, 2002, VACCINE, V21, P21, DOI 10.1016/S0264-410X(02)00443-7; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bonay M, 1999, AM J RESP CRIT CARE, V159, P1629, DOI 10.1164/ajrccm.159.5.9807021; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Buckley SMK, 2008, HUM GENE THER, V19, P1050, DOI 10.1089/hum.2008.023; Carriere C, 1997, J CLIN MICROBIOL, V35, P3232; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; COOKSEY RC, 1995, ANTIMICROB AGENTS CH, V39, P754, DOI 10.1128/AAC.39.3.754; COOKSEY RC, 1993, ANTIMICROB AGENTS CH, V37, P1348, DOI 10.1128/AAC.37.6.1348; Craney A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm086; da Cruz FW, 2001, VACCINE, V20, P731, DOI 10.1016/S0264-410X(01)00414-5; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Deb DK, 2000, BIOCHEM BIOPH RES CO, V279, P457, DOI 10.1006/bbrc.2000.3957; DELLAGOSTIN OA, 1995, MICROBIOL-UK, V141, P1785, DOI 10.1099/13500872-141-8-1785; Dennehy M, 2005, VACCINE, V23, P1209, DOI 10.1016/j.vaccine.2004.08.039; Dennehy M, 2007, VACCINE, V25, P3646, DOI 10.1016/j.vaccine.2007.01.087; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Gheysens O, 2009, METHODS, V48, P139, DOI 10.1016/j.ymeth.2009.03.013; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Heuts F, 2009, MICROBES INFECT, V11, P1114, DOI 10.1016/j.micinf.2009.08.005; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JANASZEK W, 1987, J BIOL STAND, V15, P11, DOI 10.1016/0092-1157(87)90012-6; Kadurugamuwa Jagath L, 2005, Mol Imaging, V4, P137; Kadurugamuwa JL, 2005, INFECT IMMUN, V73, P7836, DOI 10.1128/IAI.73.12.7836-7843.2005; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Koga K, 2005, MOL GENET GENOMICS, V274, P180, DOI 10.1007/s00438-005-0008-5; KONG DQ, 1995, INFECT IMMUN, V63, P799, DOI 10.1128/IAI.63.3.799-803.1995; Kumar D, 1998, VACCINE, V16, P1212, DOI 10.1016/S0264-410X(98)80121-7; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; Loimaranta V, 1998, ANTIMICROB AGENTS CH, V42, P1906, DOI 10.1128/AAC.42.8.1906; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Morin CE, 2009, FEMS IMMUNOL MED MIC, V57, P69, DOI 10.1111/j.1574-695X.2009.00580.x; Pai M, 2005, J INFECTION, V51, P175, DOI 10.1016/j.jinf.2005.05.017; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; PRIOLI RP, 1985, TUBERCLE, V66, P99, DOI 10.1016/0041-3879(85)90074-1; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; RANES MG, 1990, J BACTERIOL, V172, P2793, DOI 10.1128/jb.172.5.2793-2797.1990; Riska PF, 1997, J CLIN MICROBIOL, V35, P3225, DOI 10.1128/JCM.35.12.3225-3231.1997; Riska PF, 1998, METH MOL B, V101, P431, DOI 10.1385/0-89603-471-2:431; Shawar RM, 1997, ANTIMICROB AGENTS CH, V41, P570, DOI 10.1128/AAC.41.3.570; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Steinhuber A, 2008, INT J MED MICROBIOL, V298, P599, DOI 10.1016/j.ijmm.2007.09.008; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Szittner R, 2003, BIOCHEM BIOPH RES CO, V309, P66, DOI 10.1016/S0006-291X(03)01530-4; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Turner DJ, 2002, MICROBIOL-SGM, V148, P2929, DOI 10.1099/00221287-148-10-2929; Wang HF, 2007, PARASITOL INT, V56, P263, DOI 10.1016/j.parint.2007.04.003; WHO, 2009, GLOB TUB CONTR 2009; Wiles S, 2005, APPL ENVIRON MICROB, V71, P3427, DOI 10.1128/AEM.71.7.3427-3432.2005; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	75	183	184	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10777	10.1371/journal.pone.0010777	http://dx.doi.org/10.1371/journal.pone.0010777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520722	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600008
J	Sei, Y; Li, Z; Song, J; Ren-Patterson, R; Tunbridge, EM; Iizuka, Y; Inoue, M; Alfonso, BT; Beltaifa, S; Nakai, Y; Kolachana, BS; Chen, JS; Weinberger, DR				Sei, Yoshitatsu; Li, Zhen; Song, Jian; Ren-Patterson, Renee; Tunbridge, Elizabeth M.; Iizuka, Yukihiko; Inoue, Masahiro; Alfonso, Berenice T.; Beltaifa, Senda; Nakai, Yoko; Kolachana, Bhaskar S.; Chen, Jingshan; Weinberger, Daniel R.			Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE B/AKT; WORKING-MEMORY; BREAST-CANCER; GENETIC-VARIATION; MESSENGER-RNA; HUMAN BRAIN; SCHIZOPHRENIA; ASSOCIATION; RISK	Background: Neuregulin1 (NRG1)-ErbB signaling has been implicated in the pathogenesis of cancer and schizophrenia. We have previously reported that NRG1-stimulated migration of B lymphoblasts is PI3K-AKT1dependent and impaired in patients with schizophrenia and significantly linked to the catechol-o-methyltransferase (COMT) Val108/158Met functional polymorphism. Methodology/Principal Findings: We have now examined AKT1 activation in NRG1-stimulated B lymphoblasts and other cell models and explored a functional relationship between COMT and AKT1. NRG1-induced AKT1 phosphorylation was significantly diminished in Val carriers compared to Met carriers in both normal subjects and in patients. Further, there was a significant epistatic interaction between a putatively functional coding SNP in AKT1 (rs1130233) and COMT Val108/158Met genotype on AKT1 phosphorylation. NRG1 induced translocation of AKT1 to the plasma membrane also was impaired in Val carriers, while PIP3 levels were not decreased. Interestingly, the level of COMT enzyme activity was inversely correlated with the cells' ability to synthesize phosphatidylserine (PS), a factor that attracts the pleckstrin homology domain (PHD) of AKT1 to the cell membrane. Transfection of SH-SY5Y cells with a COMT Val construct increased COMT activity and significantly decreased PS levels as well as NRG1-induced AKT1 phosphorylation and migration. Administration of S-adenosylmethionine (SAM) rescued all of these deficits. These data suggest that AKT1 function is influenced by COMT enzyme activity through competition with PS synthesis for SAM, which in turn dictates AKT1-dependent cellular responses to NRG1-mediated signaling. Conclusion/Significance: Our findings implicate genetic and functional interactions between COMT and AKT1 and may provide novel insights into pathogenesis of schizophrenia and other ErbB-associated human diseases such as cancer.	[Sei, Yoshitatsu; Li, Zhen; Song, Jian; Ren-Patterson, Renee; Iizuka, Yukihiko; Alfonso, Berenice T.; Beltaifa, Senda; Nakai, Yoko; Kolachana, Bhaskar S.; Chen, Jingshan; Weinberger, Daniel R.] NIMH, Clin Brain Disorder Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Tunbridge, Elizabeth M.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Inoue, Masahiro] Kurume Univ Med, Dept Infect Dis, Fukuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Oxford; Kurume University	Sei, Y (corresponding author), NIMH, Clin Brain Disorder Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA.	seiy@mail.nih.gov; daniel.weinberger@mail.nih.gov		Tunbridge, Elizabeth/0000-0002-2966-2281	National Institute of Mental Health, NIH; UK Medical Research Council; University College, Oxford; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002907] Funding Source: NIH RePORTER	National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College, Oxford; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported by the Intramural Research Program of the National Institute of Mental Health, NIH. EMT is supported by a project grant from the UK Medical Research Council and the Weir Junior Research Fellowship, University College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Al-Fulaij MA, 2008, J MOL NEUROSCI, V34, P211, DOI 10.1007/s12031-007-9030-x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bajestan SN, 2006, AM J MED GENET B, V141B, P383, DOI 10.1002/ajmg.b.30291; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Catts VS, 2008, ACTA PSYCHIAT SCAND, V117, P323, DOI 10.1111/j.1600-0447.2008.01163.x; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HUANG BX, 2007, FASEB J, V21, P781; Huang CS, 1999, CANCER RES, V59, P4870; Inoue H, 2005, ONCOL REP, V14, P707; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Lavigne JA, 1997, CANCER RES, V57, P5493; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Matsui A, 2000, CANCER LETT, V150, P23, DOI 10.1016/S0304-3835(99)00368-7; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Norton N, 2007, SCHIZOPHR RES, V93, P58, DOI 10.1016/j.schres.2007.02.006; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Sazci A, 2004, TOXICOLOGY, V204, P197, DOI 10.1016/j.tox.2004.06.026; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Sei Y, 2007, MOL PSYCHIATR, V12, P946, DOI 10.1038/sj.mp.4001994; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Suzuki M, 2005, EUR UROL, V48, P752, DOI 10.1016/j.eururo.2005.07.007; Tan Changqiang, 2003, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V17, P25; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; TUNBRIDGE EM, 2008, AM J MED GENET B; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Weickert TW, 2004, BIOL PSYCHIAT, V56, P677, DOI 10.1016/j.biopsych.2004.08.012; Xu MQ, 2007, J CLIN PSYCHIAT, V68, P1358, DOI 10.4088/JCP.v68n0906; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10789	10.1371/journal.pone.0010789	http://dx.doi.org/10.1371/journal.pone.0010789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520724	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600015
J	Hu, QY; Fink, E; Hong, Y; Wang, C; Grant, CK; Elder, JH				Hu, Qiong-Ying; Fink, Elizabeth; Hong, Yang; Wang, Cathy; Grant, Chris K.; Elder, John H.			Fine Definition of the CXCR4-Binding Region on the V3 Loop of Feline Immunodeficiency Virus Surface Glycoprotein	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; 2ND EXTRACELLULAR LOOP; MONOCLONAL-ANTIBODY; FIV INFECTION; UP-REGULATION; CELL TROPISM; BINDING-SITE; TYPE-1 GP120; SHARED USAGE; ENVELOPE	The chemokine receptor CXCR4 is shared by primary and laboratory-adapted strains of feline immunodeficiency virus (FIV) for viral entry. Our previous studies implicated a contiguous nine-amino-acid region of the V3 loop of the FIV envelope surface as important in CXCR4 binding and virus entry. The binding is specific for CXCR4 since it can be inhibited by AMD3100, a selective CXCR4 inhibitor. Additional site-directed mutagenesis was used to further reveal the key residues. Binding studies indicated that basic residues R395, K397, R399 as well as N398 are critical for CXCR4 binding. The effect of other amino acid residues on receptor binding depends on the type of amino acid residue substituted. The binding study results were confirmed on human CXCR4-expressing SupT1 cells and correlated with entry efficiency using a virus entry assay. Amino acid residues critical for CXCR4 are not critical for interactions with the primary binding receptor CD134, which has an equivalent role as CD4 for HIV-1 binding. The ELISA results show that W394 and W400 are crucial for the recognition by neutralizing anti-V3 antibodies. Since certain strains of HIV-1 also use CXCR4 as the entry receptor, the findings make the feline model attractive for development of broad-based entry antagonists and for study of the molecular mechanism of receptor/virus interactions.	[Hu, Qiong-Ying; Fink, Elizabeth; Hong, Yang; Wang, Cathy; Elder, John H.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Grant, Chris K.] Custom Monoclonals Int, W Sacramento, CA USA	Scripps Research Institute	Hu, QY (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jelder@scripps.edu			National Institute of Allergy and Infection Diseases [R01 AI25825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025825] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by grant (R01 AI25825) from the National Institute of Allergy and Infection Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chabot DJ, 1999, J VIROL, V73, P6598, DOI 10.1128/JVI.73.8.6598-6609.1999; de Parseval A, 2006, J VIROL, V80, P3088, DOI 10.1128/JVI.80.6.3088-3091.2006; de Parseval A, 2005, NAT STRUCT MOL BIOL, V12, P60, DOI 10.1038/nsmb872; de Parseval A, 2004, J VIROL, V78, P9132, DOI 10.1128/JVI.78.17.9132-9143.2004; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; deParseval A, 1997, J VIROL, V71, P5742, DOI 10.1128/JVI.71.8.5742-5749.1997; Dittmar MT, 1997, NATURE, V385, P495, DOI 10.1038/385495a0; Elder JH, 2008, VET IMMUNOL IMMUNOP, V123, P3, DOI 10.1016/j.vetimm.2008.01.007; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hatse S, 2003, FEBS LETT, V546, P300, DOI 10.1016/S0014-5793(03)00609-4; Huang QG, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/03/001; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Lerner DL, 1998, VET IMMUNOL IMMUNOP, V65, P277, DOI 10.1016/S0165-2427(98)00162-7; Ling H, 2004, AIDS RES HUM RETROV, V20, P213, DOI 10.1089/088922204773004932; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; MORIKAWA S, 1991, VIRUS RES, V21, P53, DOI 10.1016/0168-1702(91)90071-3; Pancino G, 1994, Curr Top Microbiol Immunol, V188, P77; PANCINO G, 1993, VIROLOGY, V192, P659, DOI 10.1006/viro.1993.1083; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; PODELL M, 2002, CURR PROTOC NEUROSCI, V9; Richardson J, 1999, J VIROL, V73, P3661, DOI 10.1128/JVI.73.5.3661-3671.1999; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Sanders T, 2007, BRIT J SOCIOL, V58, P1, DOI 10.1111/j.1468-4446.2007.00136.x; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; SIEBELINK KHJ, 1992, J VIROL, V66, P1091, DOI 10.1128/JVI.66.2.1091-1097.1992; Sundaravaradan V, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-126; Sundstrom M, 2008, J VIROL, V82, P9134, DOI 10.1128/JVI.00394-08; Sundstrom M, 2008, VIROLOGY, V371, P394, DOI 10.1016/j.virol.2007.09.039; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Uhl EW, 2008, VET IMMUNOL IMMUNOP, V123, P65, DOI 10.1016/j.vetimm.2008.01.030; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; Willett BJ, 1998, J VIROL, V72, P6475, DOI 10.1128/JVI.72.8.6475-6481.1998; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Willett BJ, 2002, J VIROL, V76, P9242, DOI 10.1128/JVI.76.18.9242-9252.2002; Willett BJ, 2008, VET IMMUNOL IMMUNOP, V123, P56, DOI 10.1016/j.vetimm.2008.01.012; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	49	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10689	10.1371/journal.pone.0010689	http://dx.doi.org/10.1371/journal.pone.0010689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502526	gold, Green Submitted, Green Published			2022-12-27	WOS:000277776500006
J	Baron, RM; Lopez-Guzman, S; Riascos, DF; Macias, AA; Layne, MD; Cheng, GY; Harris, C; Chung, SW; Reeves, R; von Andrian, UH; Perrella, MA				Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Layne, Matthew D.; Cheng, Guiying; Harris, Cailin; Chung, Su Wol; Reeves, Raymond; von Andrian, Ulrich H.; Perrella, Mark A.			Distamycin A Inhibits HMGA1-Binding to the P-Selectin Promoter and Attenuates Lung and Liver Inflammation during Murine Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; MOBILITY GROUP-I(Y) PROTEIN; MINOR-GROOVE BINDERS; TRANSCRIPTIONAL REGULATION; INDUCED EXPRESSION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; IMPROVES SURVIVAL; VIRUS INDUCTION; DOWN-REGULATION	Background: The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes'') that upregulate expression of select genes within the inflammatory cascade during critical illness syndromes such as acute lung injury (ALI). AT-rich regions of DNA surround transcription factor binding sites in genes critical for the inflammatory response. Minor groove binding drugs (MGBs), such as Distamycin A (Dist A), interfere with AT-rich region DNA binding in a sequence and conformation-specific manner, and HMGA1 is one of the few transcription factors whose binding is inhibited by MGBs. Objectives: To determine whether MGBs exert beneficial effects during endotoxemia through attenuating tissue inflammation via interfering with HMGA1-DNA binding and modulating expression of adhesion molecules. Methodology/Principal Findings: Administration of Dist A significantly decreased lung and liver inflammation during murine endotoxemia. In intravital microscopy studies, Dist A attenuated neutrophil-endothelial interactions in vivo following an inflammatory stimulus. Endotoxin induction of P-selectin expression in lung and liver tissue and promoter activity in endothelial cells was significantly reduced by Dist A, while E-selectin induction was not significantly affected. Moreover, Dist A disrupted formation of an inducible complex containing NF-kappa B that binds an AT-rich region of the P-selectin promoter. Transfection studies demonstrated a critical role for HMGA1 in facilitating cytokine and NF-kappa B induction of P-selectin promoter activity, and Dist A inhibited binding of HMGA1 to this AT-rich region of the P-selectin promoter in vivo. Conclusions/Significance: We describe a novel targeted approach in modulating lung and liver inflammation in vivo during murine endotoxemia through decreasing binding of HMGA1 to a distinct AT-rich region of the P-selectin promoter. These studies highlight the ability of MGBs to function as molecular tools for dissecting transcriptional mechanisms in vivo and suggest alternative treatment approaches for critical illness.	[Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Harris, Cailin; Chung, Su Wol; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Baron, Rebecca M.; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA; [Riascos, Dario F.] Pontificia Univ Javeriana, Dept Physiol Sci, Bogota, Colombia; [Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chung, Su Wol] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Reeves, Raymond] Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pontificia Universidad Javeriana; Boston University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Ulsan; Washington State University	Baron, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	rbaron@partners.org	von Andrian, Ulrich H/A-5775-2008; Lopez-Guzman, Silvia/G-7595-2012	Layne, Matthew/0000-0003-0007-4870; Riascos Bernal, Dario/0000-0002-8790-4699; Lopez-Guzman, Silvia/0000-0003-0271-3576	National Institutes of Health [AI054465, HL091957, AI061246, GM53249, HL60788]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091957, R01HL060788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061246, K08AI054465, R01AI072252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants AI054465 (to R. M. B.), HL091957 (to R. M. B.), AI061246 (to M. A. P.), GM53249 (to M. A. P.), and HL60788 (to M. A. P.), all from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; ASADUZZAMAN M, 2009, BRIT J PHARMACOL, DOI DOI 10.1111/J.1476-5381.2008.00021; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Baraldi PG, 2007, BIOORGAN MED CHEM, V15, P17, DOI 10.1016/j.bmc.2006.07.004; Baron RM, 2004, FASEB J, V18, P1276, DOI 10.1096/fj.04-1518fje; Baron RM, 2004, J IMMUNOL, V173, P4147, DOI 10.4049/jimmunol.173.6.4147; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Bell A, 1997, J MOL RECOGNIT, V10, P245, DOI 10.1002/(SICI)1099-1352(199711/12)10:6<245::AID-JMR367>3.0.CO;2-3; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Carvajal IM, 2002, CRIT CARE MED, V30, pS36, DOI 10.1097/00003246-200201001-00005; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COUGHLAN AF, 1994, J EXP MED, V179, P329, DOI 10.1084/jem.179.1.329; Cozzi P, 2000, FARMACO, V55, P168, DOI 10.1016/S0014-827X(00)00013-6; Dolenc J, 2005, NUCLEIC ACIDS RES, V33, P725, DOI 10.1093/nar/gki195; Dolenc J, 2006, BIOPHYS J, V91, P1460, DOI 10.1529/biophysj.105.074617; Doss RM, 2006, J AM CHEM SOC, V128, P9074, DOI 10.1021/ja0621795; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Ghersa P, 1997, NUCLEIC ACIDS RES, V25, P339, DOI 10.1093/nar/25.2.339; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grant MA, 2009, BIOCHEM J, V418, P103, DOI 10.1042/BJ20081427; Henikoff S, 2000, CELL, V103, P695, DOI 10.1016/S0092-8674(00)00172-0; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Lewis JF, 2003, CRIT CARE MED, V31, pS324, DOI 10.1097/01.CCM.0000057911.19145.9F; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Marshall JC, 1999, SEPSIS, V3, P5; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Pellacani A, 2001, J BIOL CHEM, V276, P1653, DOI 10.1074/jbc.M008170200; Pellacani A, 1999, J BIOL CHEM, V274, P1525, DOI 10.1074/jbc.274.3.1525; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reeves R, 1999, METHOD ENZYMOL, V304, P155; REEVES R, 1990, J BIOL CHEM, V265, P8573; SANDERS WE, 1992, BLOOD, V80, P795; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Steeber DA, 1998, P NATL ACAD SCI USA, V95, P7562, DOI 10.1073/pnas.95.13.7562; Steeber DA, 1999, J IMMUNOL, V163, P2176; Susbielle Guillaume, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P409, DOI 10.2174/1568011054222355; Takamiya R, 2008, FEBS LETT, V582, P810, DOI 10.1016/j.febslet.2008.02.008; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMAS R, 2004, NUCLEIC ACIDS RES, V32, P1; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang X, 2004, J BIOL CHEM, V279, P5237, DOI 10.1074/jbc.M309271200; Wang Y, 2006, J IMMUNOL, V176, P275, DOI 10.4049/jimmunol.176.1.275; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; WELLER A, 1992, J BIOL CHEM, V267, P15176; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	75	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10656	10.1371/journal.pone.0010656	http://dx.doi.org/10.1371/journal.pone.0010656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498830	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600018
J	Cornelissen, LAHM; de Vries, RP; de Boer-Luijtze, EA; Rigter, A; Rottier, PJM; de Haan, CAM				Cornelissen, Lisette A. H. M.; de Vries, Robert P.; de Boer-Luijtze, Els A.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.			A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1	PLOS ONE			English	Article							PANDEMIC INFLUENZA; VACCINE; MICE; INFECTIONS; CHALLENGE; ADJUVANTS; PROTEINS; EFFICACY; IMMUNITY; BINDING	Background: The highly pathogenic avian influenza (HPAI) virus H5N1 causes multi-organ disease and death in poultry, resulting in significant economic losses in the poultry industry. In addition, it poses a major public health threat as it can be transmitted directly from infected poultry to humans with very high (60%) mortality rate. Effective vaccination against HPAI H5N1 would protect commercial poultry and would thus provide an important control measure by reducing the likelihood of bird-to-bird and bird-to-human transmission. Methodology/Principal Findings: In the present study we evaluated the vaccine potential of recombinant soluble trimeric subtype 5 hemagglutinin (sH5(3)) produced in mammalian cells. The secreted, purified sH5(3) was biologically active as demonstrated by its binding to ligands in a sialic acid-dependent manner. It was shown to protect chickens, in a dose-dependent manner, against a lethal challenge with H5N1 after a single vaccination. Protected animals did not shed challenge virus as determined by a quantitative RT-PCR on RNA isolated from trachea and cloaca swabs. Also in mice, vaccination with sH5(3) provided complete protection against challenge with HPAI H5N1. Conclusions/Significance: Our results demonstrate that sH5(3) constitutes an attractive vaccine antigen for protection of chickens and mammals against HPAI H5N1. As these recombinant soluble hemagglutinin preparations can be produced with high yields and with relatively short lead time, they enable a rapid response to circulating and potentially pandemic influenza viruses.	[Cornelissen, Lisette A. H. M.; de Boer-Luijtze, Els A.] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [de Vries, Robert P.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Cornelissen, LAHM (corresponding author), Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands.	c.a.m.dehaan@uu.nl	de Vries, Robert/K-7212-2013	de Haan, Cornelis/0000-0002-4459-9874; Tripp, Ralph/0000-0002-2924-9956; de Vries, Robert/0000-0002-1586-4464	Economic Structure Enhancing Fund	Economic Structure Enhancing Fund	This work has been financially supported by the Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck I, 2003, VACCINE, V21, P1006, DOI 10.1016/S0264-410X(02)00552-2; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Herfst S, 2007, J GEN VIROL, V88, P2702, DOI 10.1099/vir.0.83084-0; Keitel WA, 2009, CURR TOP MICROBIOL, V333, P431, DOI 10.1007/978-3-540-92165-3_21; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; LEENAARS PPAM, 1994, VET IMMUNOL IMMUNOP, V40, P225, DOI 10.1016/0165-2427(94)90022-1; Mueller SN, 2010, J VIROL, V84, P1847, DOI 10.1128/JVI.01317-09; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Reeves PJ, 1999, P NATL ACAD SCI USA, V96, P1927, DOI 10.1073/pnas.96.5.1927; Safdar A, 2007, EXPERT OPIN INV DRUG, V16, P927, DOI 10.1517/13543784.16.7.927; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x; van Oirschot JT, 2001, VET QUART, V23, P100, DOI 10.1080/01652176.2001.9695094; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zwicker N, 1999, BIOTECHNIQUES, V27, P368, DOI 10.2144/99272rr05	30	64	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10645	10.1371/journal.pone.0010645	http://dx.doi.org/10.1371/journal.pone.0010645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498717	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600009
J	Yu, YD; Choi, Y; Teo, YY; Dalby, AR				Yu, Yoon-Dong; Choi, Yoonjoo; Teo, Yik-Ying; Dalby, Andrew R.			Developing Stochastic Models for Spatial Inference: Bacterial Chemotaxis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOCHEMICAL PATHWAYS; PARAMETER-ESTIMATION; GENE-EXPRESSION; SINGLE-CELL; LOCALIZATION; COMPLEX; CYTOPLASM; CHEA; OPTIMIZATION	Background: Biological systems are inherently inhomogeneous and spatial effects play a significant role in processes such as pattern formation. At the cellular level proteins are often localised either through static attachment or via a dynamic equilibrium. As well as spatial heterogeneity many cellular processes exhibit stochastic fluctuations and so to make inferences about the location of molecules there is a need for spatial stochastic models. A test case for spatial models has been bacterial chemotaxis which has been studied extensively as a model of signal transduction. Results: By creating specific models of a cellular system that incorporate the spatial distributions of molecules we have shown how the fit between simulated and experimental data can be used to make inferences about localisation, in the case of bacterial chemotaxis. This method allows the robust comparison of different spatial models through alternative model parameterisations. Conclusions: By using detailed statistical analysis we can reliably infer the parameters for the spatial models, and also to evaluate alternative models. The statistical methods employed in this case are particularly powerful as they reduce the need for a large number of simulation replicates. The technique is also particularly useful when only limited molecular level data is available or where molecular data is not quantitative.	[Yu, Yoon-Dong; Choi, Yoonjoo; Dalby, Andrew R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Teo, Yik-Ying] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 3TG, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Yu, YD (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	dalby@stats.ox.ac.uk	Choi, Yoonjoo/AAH-6163-2020	Choi, Yoonjoo/0000-0001-9687-8093; Dalby, Andrew/0000-0002-3598-8595	Sulsong Foundation of South Korea	Sulsong Foundation of South Korea	During his DPhil studies, Y-DY is supported by the Sulsong Foundation of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Cantwell BJ, 2003, J BACTERIOL, V185, P2354, DOI 10.1128/JB.185.7.2354-2361.2003; Cleveland W.S., 1992, LOCAL REGRESSION MOD, P309; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; DELOURA M, 2001, GAMES PROGRAMMING GE, V2; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Francis NR, 2002, J BIOL CHEM, V277, P36755, DOI 10.1074/jbc.M204324200; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; KOSHLAND DE, 1981, ANNU REV BIOCHEM, V50, P765, DOI 10.1146/annurev.bi.50.070181.004001; Lewontin R, 2000, TRIPLE HELIX; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; LUBYPHELPS K, 2000, CYTOARCHITECTURE PHY, V192; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Paton R, 2004, IEEE T NANOBIOSCI, V3, P208, DOI 10.1109/TNB.2004.833701; R Core Team, 2020, R LANG ENV STAT COMP; Rao CV, 2005, PHYS BIOL, V2, P148, DOI 10.1088/1478-3975/2/3/002; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stewart RC, 2000, BIOCHEMISTRY-US, V39, P13157, DOI 10.1021/bi001100k; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yaffee R.A., 2000, INTRO TIME SERIES AN; Yi TM, 2007, METHOD ENZYMOL, V422, P123, DOI 10.1016/S0076-6879(06)22006-8	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10464	10.1371/journal.pone.0010464	http://dx.doi.org/10.1371/journal.pone.0010464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498704	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000277633500003
J	Becchio, C; Mari, M; Castiello, U				Becchio, Cristina; Mari, Morena; Castiello, Umberto			Perception of Shadows in Children with Autism Spectrum Disorders	PLOS ONE			English	Article							INDIVIDUALS	Background: Cast shadows in visual scenes can have profound effects on visual perception. Much as they are informative, they also constitute noise as they are salient features of the visual scene potentially interfering with the processing of other features. Here we asked i) whether individuals with autism can exploit the information conveyed by cast shadows; ii) whether they are especially sensitive to noise aspects of shadows. Methodology/Principal Findings: Twenty high-functioning children with autism and twenty typically developing children were asked to recognize familiar objects while the presence, position, and shape of the cast shadow were systematically manipulated. Analysis of vocal reaction time revealed that whereas typically developing children used information from cast shadows to improve object recognition, in autistic children the presence of cast shadows-either congruent or incongruent-interfered with object recognition. Critically, vocal reaction times were faster when the object was presented without a cast shadow. Conclusions/Significance: We conclude that shadow-processing mechanisms are abnormal in autism. As a result, processing shadows becomes costly and cast shadows interfere rather than help object recognition.	[Becchio, Cristina] Univ Turin, Dipartimento Psicol, Ctr Cognit Sci, Turin, Italy; [Mari, Morena; Castiello, Umberto] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Turin; University of Padua	Becchio, C (corresponding author), Univ Turin, Dipartimento Psicol, Ctr Cognit Sci, Turin, Italy.	umberto.castiello@unipd.it		Becchio, Cristina/0000-0002-6845-0521; Castiello, Umberto/0000-0003-0629-1286	Regione Piemonte; bando Scienze Umane e Sociali [4/2006]	Regione Piemonte(Regione Piemonte); bando Scienze Umane e Sociali	CB was supported by the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Behrmann M, 2006, NEUROPSYCHOLOGIA, V44, P110, DOI 10.1016/j.neuropsychologia.2005.04.002; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Casati R, 2006, TRENDS COGN SCI, V10, P54, DOI 10.1016/j.tics.2005.12.008; Casati R, 2008, PERCEPTION, V37, P495, DOI 10.1068/p5588; Castiello U, 2001, VISION RES, V41, P2305, DOI 10.1016/S0042-6989(01)00141-9; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; FRITH U, 1993, SCI AM, V268, P108, DOI 10.1038/scientificamerican0693-108; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lovell PG, 2009, J VISION, V9, DOI 10.1167/9.1.37; Mamassian P, 2004, PERCEPTION, V33, P1279, DOI 10.1068/p5280; Mamassian P, 1998, TRENDS COGN SCI, V2, P288, DOI 10.1016/S1364-6613(98)01204-2; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Rensink RA, 2004, PERCEPTION, V33, P1339, DOI 10.1068/p5322; Schopler E., 1993, CHILDHOOD AUTISM RAT; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; Teunisse JP, 2003, BRAIN COGNITION, V52, P285, DOI 10.1016/S0278-2626(03)00042-3; Wright MJ, 2005, SPATIAL VISION, V18, P413, DOI 10.1163/1568568054389633	32	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10582	10.1371/journal.pone.0010582	http://dx.doi.org/10.1371/journal.pone.0010582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594UB	20485498	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200015
J	Engkilde, K; Buschard, K; Hansen, AK; Menne, T; Johansen, JD				Engkilde, Kaare; Buschard, Karsten; Hansen, Axel Kornerup; Menne, Torkil; Johansen, Jeanne Duus			Prevention of Diabetes in NOD Mice by Repeated Exposures to a Contact Allergen Inducing a Sub-Clinical Dermatitis	PLOS ONE			English	Article							CD8+ T-CELLS; CYTOKINE PRODUCTION; NKT CELLS; HYPERSENSITIVITY; SENSITIVITY; SKIN; PARAPHENYLENEDIAMINE; MOUSE; ASSAY; SENSITIZATION	Background: Type 1 diabetes is an autoimmune disease, while allergic contact dermatitis although immune mediated, is considered an exposure driven disease that develops due to epicutanous contact with reactive low-molecular chemicals. The objective of the present study was to experimentally study the effect of contact allergens on the development of diabetes in NOD mice. As the link between contact allergy and diabetes is yet unexplained we also examined the effect of provocation with allergens on Natural Killer T (NKT) cells, since involvement of NKT cells could suggest an innate connection between the two diseases. Method: NOD mice 4 weeks of age were exposed, on the ears, to two allergens, p-phenylenediamine and 2,4-dinitrochlorobenzene respectively, to investigate the diabetes development. The mice were followed for a maximum of 32 weeks, and they were either repeatedly exposed to the allergens or only sensitized a week after arrival. The stimulation of NKT cells by the two allergens were additionally studied in C57BL/6 mice. The mice were sensitized and two weeks later provocated with the allergens. The mice were subsequently euthanized at different time points after the provocation. Results: It was found that repeated application of p-phenylenediamine reduced the incidence of diabetes compared to application with water (47% vs. 93%, P = 0.004). Moreover it was shown that in C57BL/6 mice both allergens resulted in a slight increment in the quantity of NKT cells in the liver. Application of the allergens at the same time resulted in an increased number of NKT cells in the draining auricular lymph node, and the increase appeared to be somewhat allergen specific as the accumulation was stronger for p-phenylenediamine. Conclusion: The study showed that repeated topical application on the ears with a contact allergen could prevent the development of diabetes in NOD mice. The contact allergens gave a non-visible, sub-clinical dermatitis on the application site. The preventive effect on diabetes may be due to stimulation of peripheral NKT cells, as shown for provocation with p-phenylenediamine in the C57BL/6 mouse. This epicutanous procedure may lead to new strategies in prevention of type 1 diabetes in humans.	[Engkilde, Kaare; Menne, Torkil; Johansen, Jeanne Duus] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Gentofte, Denmark; [Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Axel Kornerup] Univ Copenhagen, Fac Life Sci, Dept Dis Biol, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Engkilde, K (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Gentofte, Denmark.	kaaeng02@geh.regionh.dk	Johansen, Jeanne/AAM-6382-2021	Johansen, Jeanne/0000-0002-3537-8463; Buschard, Karsten/0000-0002-0126-7423	National Board of Health; Research Foundation of the Region of Copenhagen	National Board of Health; Research Foundation of the Region of Copenhagen	This work was supported by the National Board of Health and the Research Foundation of the Region of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Basketter DA, 2008, BRIT J DERMATOL, V159, P267, DOI 10.1111/j.1365-2133.2008.08625.x; Basketter DA, 2007, CONTACT DERMATITIS, V57, P70, DOI 10.1111/j.1600-0536.2007.01141.x; BONEFELD CM, 2009, BR J DERMATOL; Campos RA, 2006, J IMMUNOL, V177, P3686, DOI 10.4049/jimmunol.177.6.3686; Cardell SL, 2006, CLIN EXP IMMUNOL, V143, P194, DOI 10.1111/j.1365-2249.2005.02942.x; Cardwell CR, 2003, DIABETES CARE, V26, P2568, DOI 10.2337/diacare.26.9.2568; Cavani A, 2007, CURR OPIN ALLERGY CL, V7, P404, DOI 10.1097/ACI.0b013e3282ef6923; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497; EDWARDS EK, 1984, CUTIS, V34, P87; Engkilde K, 2006, DIABETOLOGIA, V49, P644, DOI 10.1007/s00125-006-0162-2; FURUE M, 1985, J INVEST DERMATOL, V85, P139, DOI 10.1111/1523-1747.ep12276557; Gazda LS, 1996, IMMUNOL CELL BIOL, V74, P401, DOI 10.1038/icb.1996.69; Gober MD, 2008, J INVEST DERMATOL, V128, P1460, DOI 10.1038/sj.jid.5701199; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Green A, 2000, LANCET, V355, P873; Harada D, 2005, J DERMATOL SCI, V37, P159, DOI 10.1016/j.jdermsci.2004.11.007; KAUFMAN A, 2009, DIABETES METAB RES R; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Mitjans M, 2007, TOXICOL LETT, V172, pS86, DOI 10.1016/j.toxlet.2007.05.242; NAKANO Y, 1981, IMMUNOLOGY, V42, P111; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Olesen AB, 2001, LANCET, V357, P1749, DOI 10.1016/S0140-6736(00)04896-0; Poulton LD, 2001, DIABETES-METAB RES, V17, P429, DOI 10.1002/dmrr.238; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Seidel-Guyenot W, 2006, J ALLERGY CLIN IMMUN, V117, P1170, DOI 10.1016/j.jaci.2006.01.014; Tirosh A, 2006, ANN INTERN MED, V144, P877, DOI 10.7326/0003-4819-144-12-200606200-00004; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Warbrick EV, 1999, J APPL TOXICOL, V19, P255, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<255::AID-JAT573>3.0.CO;2-S; White JML, 2007, CONTACT DERMATITIS, V56, P262, DOI 10.1111/j.1600-0536.2007.01072.x; Wu L, 2007, AM J PHYSIOL-GASTR L, V293, pG919, DOI 10.1152/ajpgi.00242.2007; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10591	10.1371/journal.pone.0010591	http://dx.doi.org/10.1371/journal.pone.0010591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485668	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563200021
J	Wilson, JJ				Wilson, John James			Assessing the Value of DNA Barcodes and Other Priority Gene Regions for Molecular Phylogenetics of Lepidoptera	PLOS ONE			English	Article							NOCTUOIDEA INSECTA; UTILITY; BUTTERFLIES; MITOCHONDRIAL; DIVERGENCE; CHARACTERS; MORPHOLOGY; EVOLUTION; SEQUENCES; PATTERNS	Background: Despite apparently abundant amounts of observable variation and species diversity, the order Lepidoptera exhibits a morphological homogeneity that has provided only a limited number of taxonomic characters and led to widespread use of nucleotides for inferring relationships. This study aims to characterize and develop methods to quantify the value of priority gene regions designated for Lepidoptera molecular systematics. In particular, I assess how the DNA barcode segment of the mitochondrial COI gene performs across a broad temporal range given its number one position of priority, most sequenced status, and the conflicting opinions on its phylogenetic performance. Methodology/Principal Findings: Gene regions commonly sequenced for Lepidoptera phylogenetics were scored using multiple measures across three categories: practicality, which includes universality of primers and sequence quality; phylogenetic utility; and phylogenetic signal. I found that alternative measures within a category often appeared correlated, but high scores in one category did not necessarily translate into high scores in another. The DNA barcode was easier to sequence than other genes, and had high scores for utility but low signal above the genus level. Conclusions/Significance: Given limited financial resources and time constraints, careful selection of gene regions for molecular phylogenetics is crucial to avoid wasted effort producing partially informative data. This study introduces an approach to assessing the value of gene regions prior to the initiation of new studies and presents empirical results to help guide future selections.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wilson, JJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jwilso04@uoguelph.ca	Wilson, John-James/C-4656-2012	Wilson, John-James/0000-0002-3583-3550	NSERC; Genome Canada through the Ontario Genomics Institute	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This study was funded by grants from NSERC and Genome Canada through the Ontario Genomics Institute to Paul D. N. Hebert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker RH, 2001, SYST BIOL, V50, P87, DOI 10.1080/106351501750107512; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Brower AVZ, 1996, ANNU REV ECOL SYST, V27, P423, DOI 10.1146/annurev.ecolsys.27.1.423; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; Kitching I. J., 1998, CLADISTICS THEORY PR; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Mitchell A, 1997, MOL BIOL EVOL, V14, P381, DOI 10.1093/oxfordjournals.molbev.a025774; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Phillips AJ, 2006, J BIOMED INFORM, V39, P18, DOI 10.1016/j.jbi.2005.11.005; POGUE MG, 2009, INSECT BIODIVERSITY, P263; Purvis A, 1997, TRENDS ECOL EVOL, V12, P49, DOI 10.1016/S0169-5347(96)30066-9; Reed RD, 1999, MOL BIOL EVOL, V16, P286, DOI 10.1093/oxfordjournals.molbev.a026110; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; SCOBLE MJ, 1992, LEPIDOPTERA FUNCTION; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Solis M. Alma, 1999, American Entomologist, V45, P206; Sperling Felix, 2003, P431; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Vane-Wright Richard I., 2003, P477; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; WAHLBERG N, 2006, ESF LESC EXPL WORKSH; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084; Whinnett A, 2005, P ROY SOC B-BIOL SCI, V272, P2525, DOI 10.1098/rspb.2005.3247; Wiegmann BM, 2000, MOL PHYLOGENET EVOL, V15, P242, DOI 10.1006/mpev.1999.0746; Wortley AH, 2006, TAXON, V55, P431, DOI 10.2307/25065589; Zhang Min, 2008, Agricultural Sciences in China, V7, P731, DOI 10.1016/S1671-2927(08)60108-X	55	35	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10525	10.1371/journal.pone.0010525	http://dx.doi.org/10.1371/journal.pone.0010525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479871	Green Published, gold			2022-12-27	WOS:000277467800010
J	Chen, PL; O'Neal, JF; Ebelt, ND; Cantrell, MA; Mitra, S; Nasrazadani, A; Vandenbroek, TL; Heasley, LE; Van Den Berg, CL				Chen, Peila; O'Neal, Jamye F.; Ebelt, Nancy D.; Cantrell, Michael A.; Mitra, Shreya; Nasrazadani, Azadeh; Vandenbroek, Tracy L.; Heasley, Lynn E.; Van Den Berg, Carla L.			Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model	PLOS ONE			English	Article							DNA-LIGASE-I; DEPENDENT PHOSPHORYLATION; CHECKPOINT; DAMAGE; ACTIVATION; REQUIREMENT; PATHWAY; CELLS; IDENTIFICATION; TRANSFORMATION	Oncogenes induce cell proliferation leading to replicative stress, DNA damage and genomic instability. A wide variety of cellular stresses activate c-Jun N-terminal kinase (JNK) proteins, but few studies have directly addressed the roles of JNK isoforms in tumor development. Herein, we show that jnk2 knockout mice expressing the Polyoma Middle T Antigen transgene developed mammary tumors earlier and experienced higher tumor multiplicity compared to jnk2 wildtype mice. Lack of jnk2 expression was associated with higher tumor aneuploidy and reduced DNA damage response, as marked by fewer pH2AX and 53BP1 nuclear foci. Comparative genomic hybridization further confirmed increased genomic instability in PyV MT/jnk22/2 tumors. In vitro, PyV MT/jnk22/2 cells underwent replicative stress and cell death as evidenced by lower BrdU incorporation, and sustained chromatin licensing and DNA replication factor 1 (CDT1) and p21(Waf1) protein expression, and phosphorylation of Chk1 after serum stimulation, but this response was not associated with phosphorylation of p53 Ser15. Adenoviral overexpression of CDT1 led to similar differences between jnk2 wildtype and knockout cells. In normal mammary cells undergoing UV induced single stranded DNA breaks, JNK2 localized to RPA (Replication Protein A) coated strands indicating that JNK2 responds early to single stranded DNA damage and is critical for subsequent recruitment of DNA repair proteins. Together, these data support that JNK2 prevents replicative stress by coordinating cell cycle progression and DNA damage repair mechanisms.	[Chen, Peila; O'Neal, Jamye F.; Mitra, Shreya; Nasrazadani, Azadeh; Vandenbroek, Tracy L.; Van Den Berg, Carla L.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Heasley, Lynn E.] Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA; [Ebelt, Nancy D.; Cantrell, Michael A.] Univ Texas Austin, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Austin	Chen, PL (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu		Ebelt, Nancy/0000-0002-1998-3719	National Institutes of Health [CA100238]; NATIONAL CANCER INSTITUTE [R01CA116527, R01CA100238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA100238 (to C. L. V. D. B.). The content of this information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bentley AM, 2002, J CELL SCI, V115, P949; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Chen NY, 2001, CANCER RES, V61, P3908; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Downey M, 2006, CELL CYCLE, V5, P1376, DOI 10.4161/cc.5.13.2899; Farrants AKO, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Li YH, 2002, J INFRARED MILLIM W, V21, P1; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; She QB, 2002, CANCER RES, V62, P1343; Shen Q, 2006, DEV BIOL, V295, P589, DOI 10.1016/j.ydbio.2006.03.042; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Squires S, 2004, CELL CYCLE, V3, P1543, DOI 10.4161/cc.3.12.1272; SRINIVAS S, 1994, P NATL ACAD SCI USA, V91, P10064, DOI 10.1073/pnas.91.21.10064; Stuart SA, 2009, J BIOL CHEM, V284, P15061, DOI 10.1074/jbc.M808810200; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Sun DY, 2002, CLIN CANCER RES, V8, P1189; Tapia-Alveal C, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-8; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	52	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10443	10.1371/journal.pone.0010443	http://dx.doi.org/10.1371/journal.pone.0010443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454618	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300019
J	Hajdin, K; D'Alessandro, V; Niggli, FK; Schafer, BW; Bernasconi, M				Hajdin, Katarina; D'Alessandro, Valentina; Niggli, Felix K.; Schaefer, Beat W.; Bernasconi, Michele			Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; PRO-PROTEIN CONVERTASES; CANCER-THERAPY; PHAGE DISPLAY; MONOCLONAL-ANTIBODIES; HOMING PEPTIDE; TUMOR-CELLS; HUMAN HEAD; GROWTH; INHIBITION	Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Improvement of treatment efficacy and decreased side effects through tumor-targeted drug delivery would be desirable. By panning with a phage-displayed cyclic random peptide library we selected a peptide with strong affinity for RMS in vitro and in vivo. The peptide minimal binding motif Arg-X-(Arg/Lys)(Arg/Lys) identified by alanine-scan, suggested the target receptor to be a proprotein convertase (PC). Expression profiling of all PCs in RMS biopsies and cell lines revealed consistent high expression levels for the membrane-bound furin and PC7. Direct binding of RMS-P3 peptide to furin was demonstrated by affinity chromatography and supported by activity and colocalization studies. Treatment of RMS in mice with doxorubicin coupled to the targeting peptide resulted in a two-fold increase in therapeutic efficacy compared to doxorubicin treatment alone. Our findings indicate surface-furin binding as novel mechanism for therapeutic cell penetration which needs to be further investigated. Furthermore, this work demonstrates that specific targeting of membrane-bound furin in tumors is possible for and suggests that RMS and other tumors might benefit from proprotein convertases targeted drug delivery.	[Hajdin, Katarina; D'Alessandro, Valentina; Niggli, Felix K.; Schaefer, Beat W.; Bernasconi, Michele] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University Children's Hospital Zurich	Hajdin, K (corresponding author), Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland.	michele.bernasconi@kispi.uzh.ch	Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022; Bernasconi, Michele/C-6734-2008; Niggli, Felix/L-6547-2017	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Niggli, Felix/0000-0002-7553-3712; Schafer, Beat/0000-0001-5988-2915	Swiss Bridge Foundation; Schweizer Forschungstiftung Kind und Krebs	Swiss Bridge Foundation; Schweizer Forschungstiftung Kind und Krebs	This work was supported by the Swiss Bridge Foundation, the Schweizer Forschungstiftung Kind und Krebs (http://www.kindundkrebs.ch/) and the Zurcher Krebsliga (http://www.krebsliga-zh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; AINA O, 2007, MOL PHARM; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Basak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007700; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Enback J, 2007, BIOCHEM SOC T, V35, P780, DOI 10.1042/BST0350780; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; HOFFMAN JA, 2004, PHAGE DISPLAY PRACTI, P169; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; KIDO H, 1993, J BIOL CHEM, V268, P13406; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Laprise MH, 2002, BLOOD, V100, P3578, DOI 10.1182/blood.V100.10.3578; Levene AP, 2005, J ROY SOC MED, V98, P146, DOI 10.1258/jrsm.98.4.146; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; NELSEN SM, 2009, J BIOL CHEM; NISHIMURA S, 2008, J BIOL CHEM; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; REMACLE AG, 2010, INT J BIOCH CELL BIO; Ruoslahti E, 2004, BIOCHEM SOC T, V32, P397, DOI 10.1042/BST0320397; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Stawowy P, 2004, BIOCHEM BIOPH RES CO, V321, P531, DOI 10.1016/j.bbrc.2004.07.001; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sun XW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-73; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wick W, 2004, J NEUROCHEM, V91, P1275, DOI 10.1111/j.1471-4159.2004.02806.x; Witt H, 2009, INT J CANCER, V124, P2026, DOI 10.1002/ijc.24170; Zurita AJ, 2003, J CONTROL RELEASE, V91, P183, DOI 10.1016/S0168-3659(03)00236-0	58	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10445	10.1371/journal.pone.0010445	http://dx.doi.org/10.1371/journal.pone.0010445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454619	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240300020
J	Sun, YL; Wang, HB				Sun, Yanlong; Wang, Hongbin			Perception of Space by Multiple Intrinsic Frames of Reference	PLOS ONE			English	Article							DISTORTIONS; MEMORY	It has been documented that when memorizing a physical space, the person's mental representation of that space is biased with distortion and segmentation. Two experiments reported here suggest that distortion and segmentation arise due to a hierarchical organization of the spatial representation. The spatial relations associated with salient landmarks are more strongly encoded and easier to recall than those associated with non-salient landmarks. In the presence of multiple salient landmarks, multiple intrinsic frames of reference are formed and spatial relations are anchored to each individual frame of reference. Multiple such representations may co-exist and interactively determine a person's spatial performance.	[Sun, Yanlong; Wang, Hongbin] Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Sun, YL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX 77225 USA.	yanlong.sun@uth.tmc.edu		Sun, Yanlong/0000-0003-4332-5983	Office of Naval Research [N00014-01-1-0074, N00014-04-1-0132, N00014-08-1-0042]	Office of Naval Research(Office of Naval Research)	Funding: Office of Naval Research Cognitive Science Program (Grant Nos. N00014-01-1-0074, N00014-04-1-0132, N00014-08-1-0042). http://www.onr.navy.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer B., 1993, SPATIAL REPRESENTATI, P25; BURGESS N, 1999, HIPPOCAMAL PARIETAL; Friedman A, 2000, J EXP PSYCHOL LEARN, V26, P900, DOI 10.1037/0278-7393.26.4.900; Friedman A, 2000, J EXP PSYCHOL GEN, V129, P193, DOI 10.1037/0096-3445.129.2.193; Friedman A, 2002, PSYCHON B REV, V9, P151, DOI 10.3758/BF03196272; GARNHAM A, 1989, COGNITION, V31, P45, DOI 10.1016/0010-0277(89)90017-6; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; Hunt E., 1999, ORIENTATION WAYFINDI; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Klatzky R.L., 1997, C RAUMKOGNITION C P; LEVINSON SC, 1996, LANGUAGE SPACE; Logan G. D., 1996, LANGUAGE SPACE; MCDONALD TP, 1993, BEHAV ENV PSYCHOL GE; McNamara TP, 2003, LECT NOTES ARTIF INT, V2685, P174; Mou WM, 2008, COGNITION, V106, P750, DOI 10.1016/j.cognition.2007.04.009; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Newcombe N, 1999, J EXP PSYCHOL LEARN, V25, P986, DOI 10.1037/0278-7393.25.4.986; Newcombe N.S., 2000, MAKING SPACE DEV SPA; Newcombe NS, 2007, MEM COGNITION, V35, P895, DOI 10.3758/BF03193464; Palmer B., 2002, P 2002 C AUSTR LING; SCHIANO DJ, 1992, MEM COGNITION, V20, P12, DOI 10.3758/BF03208249; STEVENS A, 1978, COGNITIVE PSYCHOL, V10, P422, DOI 10.1016/0010-0285(78)90006-3; Talmy L., 1983, SPATIAL ORIENTATION, P177, DOI [10.1007/978-1-4615-9325-6_11, DOI 10.1007/978-1-4615-9325-6_11]; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Tversky Barbara, 2000, OXFORD HDB MEMORY; WANG H, 2005, P 27 ANN M COGN SCI, P2337; WANG H, 2001, P 4 INT C COGN SCI B; Wang HB, 2005, MEM COGNITION, V33, P1147, DOI 10.3758/BF03193219; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Wang XD, 2005, WIREL COMMUN MOB COM, V5, P113, DOI 10.1002/wcm.285	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10442	10.1371/journal.pone.0010442	http://dx.doi.org/10.1371/journal.pone.0010442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PW	20454617	gold, Green Submitted, Green Published			2022-12-27	WOS:000277240300018
J	Miles, LK; Karpinska, K; Lumsden, J; Macrae, CN				Miles, Lynden K.; Karpinska, Katarzyna; Lumsden, Joanne; Macrae, C. Neil			The Meandering Mind: Vection and Mental Time Travel	PLOS ONE			English	Article							DEFAULT NETWORK; FUTURE; MEMORY; EXPERIENCE; IMAGINE; SPACE	Background: The ability to travel mentally through time sets humans apart from many other species, yet little is known about this core cognitive capacity. In particular, what shapes the passage of the mind's journey through time? Guided by the viewpoint that higher cognitive activity can have a sensory-motor grounding, we explored the possibility that mental time travel is influenced by apparent movement through space. Methodology/Principal Findings: Participants performed a mundane vigilance task, during which they were expected to daydream, while viewing a display that elicited an illusion of self-motion (i.e., vection). Afterwards, the contents of their mind wandering experiences were probed. The results revealed that the direction of apparent motion influenced the temporal focus of mental time travel. While backward vection prompted thinking about the past, forward vection triggered a preponderance of future-oriented thoughts. Conclusions/Significance: Consistent with recent evidence that traveling mentally through time entails associated movements in space, the current results demonstrate the converse relationship-apparent movement through space influenced the temporal locus of mental activity. Together, these findings corroborate the viewpoint that mental time travel may be grounded in the embodiment of spatiotemporal information in a bidirectional manner.	[Miles, Lynden K.; Karpinska, Katarzyna; Lumsden, Joanne; Macrae, C. Neil] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	University of Aberdeen	Miles, LK (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen, Scotland.	lynden.miles@abdn.ac.uk	Miles, Lynden/X-1557-2019; Miles, Lynden/C-5168-2008; Macrae, Neil/C-4761-2008	Miles, Lynden/0000-0002-4164-3470; Miles, Lynden/0000-0002-4164-3470; 	United Kingdom Academic Fellowship; Royal Society-Wolfson Fellowship	United Kingdom Academic Fellowship; Royal Society-Wolfson Fellowship	LKM was supported by a Research Councils of the United Kingdom Academic Fellowship and CNM was supported by a Royal Society-Wolfson Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P9; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, COGNITION, V115, P179, DOI 10.1016/j.cognition.2009.11.002; Casasanto D, 2010, COGNITIVE SCI, V34, P387, DOI 10.1111/j.1551-6709.2010.01094.x; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Fodor J. A., 1975, LANGUAGE THOUGHT; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert DT, 2009, PHILOS T R SOC B, V364, P1335, DOI 10.1098/rstb.2008.0305; JASON LA, 1989, PSYCHOL REP, V64, P1199, DOI 10.2466/pr0.1989.64.3c.1199; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Lakoff G., 1999, PHILOS FLESH; Lakoff G., 1980, METAPHORS WE LIVE, P256; Maass A, 2009, EUR J SOC PSYCHOL, V39, P1290, DOI 10.1002/ejsp.696; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McCormack T, 1999, DEV REV, V19, P154, DOI 10.1006/drev.1998.0476; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Mussweiler T, 2006, PSYCHOL SCI, V17, P17, DOI 10.1111/j.1467-9280.2005.01659.x; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Nunez RE, 2006, COGNITIVE SCI, V30, P401, DOI 10.1207/s15516709cog0000_62; Perner J, 2001, SELF IN TIME: DEVELOPMENTAL PERSPECTIVES, P181; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schooler JW, 2004, THINKING AND SEEING, P203; Singer J.L., 1966, DAYDREAMING INTRO EX; Smallwood J, 2004, CONSCIOUS COGN, V13, P789, DOI 10.1016/j.concog.2004.07.004; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Trutoiu LC, 2009, COMPUT GRAPH-UK, V33, P47, DOI 10.1016/j.cag.2008.11.008; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E., 2002, PRINCIPLES FRONTAL L, P311, DOI [10.1093/acprof:oso/9780195134971.003.0020, DOI 10.1093/ACPROF:OSO/9780195134971.003.0020]; Warren R., 1990, PERCEPTION CONTROL S; Wertheim A.H., 1990, PERCEPTION CONTROL S, P33	50	55	55	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10825	10.1371/journal.pone.0010825	http://dx.doi.org/10.1371/journal.pone.0010825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CE	20520831	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034800018
J	Pisciotta, JM; Zou, Y; Baskakov, IV				Pisciotta, John M.; Zou, Yongjin; Baskakov, Ilia V.			Light-Dependent Electrogenic Activity of Cyanobacteria	PLOS ONE			English	Article							MARINE; ENERGY; CELLS; PHOTOTAXIS; DIVERSITY; SYSTEMS; SITE; CO2	Background: Cyanobacteria account for 20-30% of Earth's primary photosynthetic productivity and convert solar energy into biomass-stored chemical energy at the rate of similar to 450 TW [1]. These single-cell microorganisms are resilient predecessors of all higher oxygenic phototrophs and can be found in self-sustaining, nitrogen-fixing communities the world over, from Antarctic glaciers to the Sahara desert [2]. Methodology/Principal Findings: Here we show that diverse genera of cyanobacteria including biofilm-forming and pelagic strains have a conserved light-dependent electrogenic activity, i.e. the ability to transfer electrons to their surroundings in response to illumination. Naturally-growing biofilm-forming photosynthetic consortia also displayed light-dependent electrogenic activity, demonstrating that this phenomenon is not limited to individual cultures. Treatment with site-specific inhibitors revealed the electrons originate at the photosynthetic electron transfer chain (P-ETC). Moreover, electrogenic activity was observed upon illumination only with blue or red but not green light confirming that P-ETC is the source of electrons. The yield of electrons harvested by extracellular electron acceptor to photons available for photosynthesis ranged from 0.05% to 0.3%, although the efficiency of electron harvesting likely varies depending on terminal electron acceptor. Conclusions/Significance: The current study illustrates that cyanobacterial electrogenic activity is an important microbiological conduit of solar energy into the biosphere. The mechanism responsible for electrogenic activity in cyanobacteria appears to be fundamentally different from the one exploited in previously discovered electrogenic bacteria, such as Geobacter, where electrons are derived from oxidation of organic compounds and transported via a respiratory electron transfer chain (R-ETC) [3,4]. The electrogenic pathway of cyanobacteria might be exploited to develop light-sensitive devices or future technologies that convert solar energy into limited amounts of electricity in a self-sustainable, CO2-free manner.	[Pisciotta, John M.; Zou, Yongjin; Baskakov, Ilia V.] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Pisciotta, JM (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Zou, Yongjin/B-2830-2015	Zou, Yongjin/0000-0002-9012-2639	Elkins Professorship Award	Elkins Professorship Award	This research was supported by Elkins Professorship Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WW, 2006, ADV PHOTO RESPIRAT, V21, P49; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BENNETTO HP, 1983, BIOTECHNOL BIOENG, V25, P559, DOI 10.1002/bit.260250219; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; BUDKOV NG, 2003, BIOCHIM BIOPHYS ACTA, V1604, P115; CHAIN RK, 2006, ARCH BIOCHEM BIOPHYS, V197, P52; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Gomez-Alvarez V, 2007, FEMS MICROBIOL ECOL, V60, P60, DOI 10.1111/j.1574-6941.2006.00253.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; HIYAMA T, 1970, PLANT PHYSIOL, V46, P163, DOI 10.1104/pp.46.1.163; HONEYCUTT RC, 1972, PLANT PHYSIOL, V49, P376, DOI 10.1104/pp.49.3.376; Huner N. P. A., 2008, PHOTOPROTECTION PHOT, P155; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; LAVERGNE J, 1982, BIOCHIM BIOPHYS ACTA, V682, P345, DOI 10.1016/0005-2728(82)90048-2; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Lovley DR, 2008, GEOBIOLOGY, V6, P225, DOI 10.1111/j.1472-4669.2008.00148.x; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Ng WO, 2003, J BACTERIOL, V185, P1599, DOI 10.1128/JB.185.5.1599-1607.2003; NULTSCH W, 1983, ARCH MICROBIOL, V134, P33, DOI 10.1007/BF00429403; Paumann M, 2005, BBA-BIOENERGETICS, V1707, P231, DOI 10.1016/j.bbabio.2004.12.007; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PROTEAU PJ, 1993, EXPERIENTIA, V49, P825, DOI 10.1007/BF01923559; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Roberts AG, 2004, BIOCHEMISTRY-US, V43, P7707, DOI 10.1021/bi049521f; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; TANAKA K, 1988, J CHEM TECHNOL BIOT, V42, P235; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; YAGISHITA T, 1993, J CHEM TECHNOL BIOT, V56, P393; YAMAGISHI A, 1987, ARCH BIOCHEM BIOPHYS, V259, P124, DOI 10.1016/0003-9861(87)90477-2; ZOU Y, 2009, BIOELECTROC IN PRESS; Zou YJ, 2009, BIOTECHNOL BIOENG, V104, P939, DOI 10.1002/bit.22466	37	139	142	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10821	10.1371/journal.pone.0010821	http://dx.doi.org/10.1371/journal.pone.0010821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520829	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034800016
J	Kabbarah, O; Nogueira, C; Feng, B; Nazarian, RM; Bosenberg, M; Wu, M; Scott, KL; Kwong, LN; Xiao, YH; Cordon-Cardo, C; Granter, SR; Ramaswamy, S; Golub, T; Duncan, LM; Wagner, SN; Brennan, C; Chin, L				Kabbarah, Omar; Nogueira, Cristina; Feng, Bin; Nazarian, Rosalynn M.; Bosenberg, Marcus; Wu, Min; Scott, Kenneth L.; Kwong, Lawrence N.; Xiao, Yonghong; Cordon-Cardo, Carlos; Granter, Scott R.; Ramaswamy, Sridhar; Golub, Todd; Duncan, Lyn M.; Wagner, Stephan N.; Brennan, Cameron; Chin, Lynda			Integrative Genome Comparison of Primary and Metastatic Melanomas	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; HUMAN HEPATOCELLULAR-CARCINOMA; PROTEIN-KINASE PATHWAY; COPY NUMBER ANALYSIS; MALIGNANT-MELANOMA; CELL CARCINOMAS; CUTANEOUS MELANOMA; UVEAL MELANOMA; BREAST-CANCER; LUNG-CANCER	A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study, we conducted global genomic characterization of primary and metastatic melanomas to examine the genomic landscape associated with metastatic progression. In addition to uncovering three genomic subclasses of metastastic melanomas, we delineated 39 focal and recurrent regions of amplification and deletions, many of which encompassed resident genes that have not been implicated in cancer or metastasis. To identify progressionassociated metastasis gene candidates, we applied a statistical approach, Integrative Genome Comparison (IGC), to define 32 genomic regions of interest that were significantly altered in metastatic relative to primary melanomas, encompassing 30 resident genes with statistically significant expression deregulation. Functional assays on a subset of these candidates, including MET, ASPM, AKAP9, IMP3, PRKCA, RPA3, and SCAP2, validated their pro-invasion activities in human melanoma cells. Validity of the IGC approach was further reinforced by tissue microarray analysis of Survivin showing significant increased protein expression in thick versus thin primary cutaneous melanomas, and a progression correlation with lymph node metastases. Together, these functional validation results and correlative analysis of human tissues support the thesis that integrated genomic and pathological analyses of staged melanomas provide a productive entry point for discovery of melanoma metastases genes.	[Kabbarah, Omar; Nogueira, Cristina; Wu, Min; Scott, Kenneth L.; Kwong, Lawrence N.; Golub, Todd; Chin, Lynda] Dana Faber Canc Inst, Dept Med Oncol, Boston, MA USA; [Kabbarah, Omar; Nogueira, Cristina; Wu, Min; Scott, Kenneth L.; Kwong, Lawrence N.; Golub, Todd; Chin, Lynda] Harvard Med Sch, Boston, MA USA; [Nogueira, Cristina; Xiao, Yonghong] Univ Porto, Inst Mol Pathol & Immunol, Oporto, Portugal; [Feng, Bin; Xiao, Yonghong; Chin, Lynda] Dana Faber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA; [Nazarian, Rosalynn M.; Duncan, Lyn M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol,Dermatopathol Unit, Boston, MA USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol, New York, NY USA; [Granter, Scott R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Ramaswamy, Sridhar] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA; [Golub, Todd] MIT, Braod Inst, Boston, MA USA; [Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, DIAID, Vienna, Austria; [Wagner, Stephan N.] Austrian Acad Sci, Ctr Mol Med, Vienna, Austria; [Brennan, Cameron] Memorial Sloan Kettering Canc Ctr, Dept Neurosurg, HOPP, New York, NY USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Universidade do Porto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Vienna; Austrian Academy of Sciences; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital	Kabbarah, O (corresponding author), Dana Faber Canc Inst, Dept Med Oncol, Boston, MA USA.	cbrennan@mskcc.org; lynda_chin@dfci.harvard.edu	Nogueira, Cristina/N-4574-2015; Brennan, Cameron/R-7082-2019; Nazarian, Rosalynn/AFL-3176-2022	Nogueira, Cristina/0000-0002-0853-5304; Brennan, Cameron/0000-0003-4064-8891; Nazarian, Rosalynn/0000-0003-4003-7193; Wagner, Stephan/0000-0003-4941-7029	National Institutes of Health [T32 AR07098, UO1 CA84313, RO1 CA93947, P50 CA93683]; Foundation for Science and Technology [PRAXIS/BD/21794/99]; NATIONAL CANCER INSTITUTE [R01CA093947, P50CA089393, U01CA084313, P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health training grant (T32 AR07098) to O. K. Fellowship from the Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia , PRAXIS/BD/21794/99) to C. N. National Institutes of Health grants UO1 CA84313, RO1 CA93947, and P50 CA93683 to L. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Bastian BC, 2003, ONCOGENE, V22, P3081, DOI 10.1038/sj.onc.1206463; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Cheng CY, 2009, J CELL PHYSIOL, V219, P183, DOI 10.1002/jcp.21669; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Frank B, 2008, J NATL CANCER I, V100, P437, DOI 10.1093/jnci/djn037; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gronwald J, 1997, CANCER RES, V57, P481; Han W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-92; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kjellman P, 2001, GENE CHROMOSOME CANC, V32, P43, DOI 10.1002/gcc.1165; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu TH, 2006, CANCER RES, V66, P653, DOI 10.1158/0008-5472.CAN-05-3712; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nobeyama Y, 2007, INT J CANCER, V121, P301, DOI 10.1002/ijc.22637; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Petersen S, 2000, BRIT J CANCER, V82, P65; Pichon B, 2004, EUR J HUM GENET, V12, P419, DOI 10.1038/sj.ejhg.5201169; Preis M, 2006, BIOCHEM BIOPH RES CO, V348, P1024, DOI 10.1016/j.bbrc.2006.07.156; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Qin LX, 1999, CANCER RES, V59, P5662; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmidt H, 1999, GENE CHROMOSOME CANC, V25, P205, DOI 10.1002/(SICI)1098-2264(199907)25:3<205::AID-GCC2>3.0.CO;2-B; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Thomas J, 2007, CANCER RES, V67, P5172, DOI 10.1158/0008-5472.CAN-06-3669; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tschentscher F, 2003, CANCER RES, V63, P2578; Ubagai T, 2001, ONCOL REP, V8, P83; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Weiss MM, 2004, CELL ONCOL, V26, P307; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0	55	132	135	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10770	10.1371/journal.pone.0010770	http://dx.doi.org/10.1371/journal.pone.0010770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520718	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600003
J	Banyai, L; Sonderegger, P; Patthy, L				Banyai, Laszlo; Sonderegger, Peter; Patthy, Laszlo			Agrin Binds BMP2, BMP4 and TGF beta 1	PLOS ONE			English	Article							FOLLISTATIN-RELATED PROTEIN; NEUROMUSCULAR-JUNCTION; DENDRITIC FILOPODIA; GROWTH; MYOSTATIN; CELLS; SYNAPTOGENESIS; IDENTIFICATION; NEUROTRYPSIN; INHIBITION	The C-terminal 95 kDa fragment of some isoforms of vertebrate agrins is sufficient to induce clustering of acetylcholine receptors but despite two decades of intense agrin research very little is known about the function of the other isoforms and the function of the larger, N-terminal part of agrins that is common to all isoforms. Since the N-terminal part of agrins contains several follistatin-domains, a domain type that is frequently implicated in binding TGF beta s, we have explored the interaction of the N-terminal part of rat agrin (Agrin-Nterm) with members of the TGF beta family using surface plasmon resonance spectroscopy and reporter assays. Here we show that agrin binds BMP2, BMP4 and TGF beta 1 with relatively high affinity, the K-D values of the interactions calculated from SPR experiments fall in the 10(-8) M-10(-7) M range. In reporter assays Agrin-Nterm inhibited the activities of BMP2 and BMP4, half maximal inhibition being achieved at similar to 5x10(-7) M. Paradoxically, in the case of TGF beta 1 Agrin N-term caused a slight increase in activity in reporter assays. Our finding that agrin binds members of the TGF beta family may have important implications for the role of these growth factors in the regulation of synaptogenesis as well as for the role of agrin isoforms that are unable to induce clustering of acetylcholine receptors. We suggest that binding of these TGF beta family members to agrin may have a dual function: agrin may serve as a reservoir for these growth factors and may also inhibit their growth promoting activity. Based on analysis of the evolutionary history of agrin we suggest that agrin's growth factor binding function is more ancient than its involvement in acetylcholine receptor clustering.	[Banyai, Laszlo; Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Budapest, Hungary; [Sonderegger, Peter] Univ Zurich, Dept Biochem, Zurich, Switzerland	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Zurich	Banyai, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Budapest, Hungary.	patthy@enzim.hu	Patthy, Laszlo/Q-6058-2019; Patthy, Laszlo/A-2353-2013		National Scientific Research Fund of Hungary [72125, 75836]	National Scientific Research Fund of Hungary	This work was supported by grants 72125 and 75836 from the National Scientific Research Fund of Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Baerwald-De La Torre K, 2004, J NEUROCHEM, V90, P50, DOI 10.1111/j.1471-4159.2004.02454.x; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bixby JL, 2002, J NEUROBIOL, V50, P164, DOI 10.1002/neu.10025; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hrus A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000731; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; PATTHY L, 1987, J MOL BIOL, V198, P567, DOI 10.1016/0022-2836(87)90200-2; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Porten E, 2010, J BIOL CHEM, V285, P3114, DOI 10.1074/jbc.M109.039420; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; Sidis Y, 2002, ENDOCRINOLOGY, V143, P1613, DOI 10.1210/en.143.5.1613; Sonderegger P, 2007, SCIENCE, V316, DOI 10.1126/science.1138410; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	37	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10758	10.1371/journal.pone.0010758	http://dx.doi.org/10.1371/journal.pone.0010758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505824	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400014
J	Egles, C; Huet, HA; Dogan, F; Cho, S; Dong, SM; Smith, A; Knight, EB; McLachlan, KR; Garlick, JA				Egles, Christophe; Huet, Heather A.; Dogan, Furkan; Cho, Sam; Dong, Shumin; Smith, Avi; Knight, Elana B.; McLachlan, Karen R.; Garlick, Jonathan A.			Integrin-Blocking Antibodies Delay Keratinocyte Re-Epithelialization in a Human Three-Dimensional Wound Healing Model	PLOS ONE			English	Article							ALPHA(6)BETA(4) INTEGRIN; TUMOR PROGRESSION; CARCINOMA; ACTIVATION; GROWTH; DIFFERENTIATION; ALPHA-6-BETA-4; EXPRESSION; SURVIVAL; ADHESION	The alpha 6 beta 4 integrin plays a significant role in tumor growth, angiogenesis and metastasis through modulation of growth factor signaling, and is a potentially important therapeutic target. However, alpha 6 beta 4-mediated cell-matrix adhesion is critical in normal keratinocyte attachment, signaling and anchorage to the basement membrane through its interaction with laminin-5, raising potential risks for targeted therapy. Bioengineered Human Skin Equivalent (HSE), which have been shown to mimic their normal and wounded counterparts, have been used here to investigate the consequences of targeting beta 4 to establish toxic effects on normal tissue homeostasis and epithelial wound repair. We tested two antibodies directed to different beta 4 epitopes, one adhesion-blocking (ASC-8) and one non-adhesion blocking (ASC-3), and determined that these antibodies were appropriately localized to the basal surface of keratinocytes at the basement membrane interface where beta 4 is expressed. While normal tissue architecture was not altered, ASC-8 induced a sub-basal split at the basement membrane in non-wounded tissue. In addition, wound closure was significantly inhibited by ASC-8, but not by ASC-3, as the epithelial tongue only covered 40 percent of the wound area at 120 hours post-wounding. These results demonstrate beta 4 adhesion-blocking antibodies may have adverse effects on normal tissue, whereas antibodies directed to other epitopes may provide safer alternatives for therapy. Taken together, we conclude that these three-dimensional tissue models provide a biologically relevant platform to identify toxic effects induced by candidate therapeutics, which will allow generation of findings that are more predictive of in vivo responses early in the drug development process.	[Egles, Christophe; Dogan, Furkan; Dong, Shumin; Smith, Avi; Knight, Elana B.; Garlick, Jonathan A.] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA; [Huet, Heather A.] Biogen Idec Inc, Discovery Oncobiol, Cambridge, MA USA; [Cho, Sam; McLachlan, Karen R.] Biogen Idec Inc, Translat Oncobiol, San Diego, CA USA	Tufts University; Biogen; Biogen	Egles, C (corresponding author), Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA.	Christophe.egles@tufts.edu		Smith, Avi/0000-0002-8904-7539; EGLES, Christophe/0000-0003-0982-7752	Biogen-Idec; Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine	Biogen-Idec(Biogen); Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine	This work was funded by Biogen-Idec and by the Center for Integrated Tissue Engineering at Tufts University, School of Dental Medicine. Other than the input of three authors in the wording of the manuscript, and in providing materials and approving permission to publish freely, Biogen-Idec as a funder had no direct role in the conception of the method, the study design, data collection, or analysis. The Center for Integrated Tissue Engineering, as a funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra M, 2003, J INVEST DERMATOL, V121, P1336, DOI 10.1111/j.1523-1747.2003.12625.x; Andriani F, 2003, J INVEST DERMATOL, V120, P923, DOI 10.1046/j.1523-1747.2003.12235.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; CARLSON MW, 2008, CURR PROTOC CELL BIO, V19; Chen LL, 2008, CELL COMMUN ADHES, V15, P317, DOI 10.1080/15419060802428356; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Garlick JA, 1996, J DENT RES, V75, P912, DOI 10.1177/00220345960750030801; GARLICK JA, 1994, LAB INVEST, V70, P916; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-23; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Pylayeva Y, 2007, METHOD ENZYMOL, V426, P439, DOI 10.1016/S0076-6879(07)26019-7; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; Vaccariello M, 1999, J INVEST DERMATOL, V113, P384, DOI 10.1046/j.1523-1747.1999.00701.x; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Westmoreland C, 2009, ORGANOGENESIS, V5, P67, DOI 10.4161/org.5.2.9128; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941	29	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10528	10.1371/journal.pone.0010528	http://dx.doi.org/10.1371/journal.pone.0010528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502640	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400004
J	Mouchet, N; Adamski, H; Bouvet, R; Corre, S; Courbebaisse, Y; Watier, E; Mosser, J; Chesne, C; Galibert, MD				Mouchet, Nicolas; Adamski, Henri; Bouvet, Regis; Corre, Sebastien; Courbebaisse, Yann; Watier, Eric; Mosser, Jean; Chesne, Christophe; Galibert, Marie-Dominique			In Vivo Identification of Solar Radiation-Responsive Gene Network: Role of the p38 Stress-Dependent Kinase	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; ULTRAVIOLET-B IRRADIATION; NORMAL HUMAN MELANOCYTES; UV-RADIATION; SKIN CARCINOGENESIS; CDNA MICROARRAY; DOWN-REGULATION; DNA-DAMAGE; TNF-ALPHA; EXPRESSION	Solar radiation is one of the most common threats to the skin, with exposure eliciting a specific protective cellular response. To decrypt the underlying mechanism, we used whole genome microarrays (Agilent 44K) to study epidermis gene expression in vivo in skin exposed to simulated solar radiation (SSR). We procured epidermis samples from healthy Caucasian patients, with phototypes II or III, and used two different SSR doses (2 and 4 J/cm(2)), the lower of which corresponded to the minimal erythemal dose. Analyses were carried out five hours after irradiation to identify early gene expression events in the photoprotective response. About 1.5% of genes from the human genome showed significant changes in gene expression. The annotations of these affected genes were assessed. They indicated a strengthening of the inflammation process and up-regulation of the JAK-STAT pathway and other pathways. Parallel to the p53 pathway, the p38 stress-responsive pathway was affected, supporting and mediating p53 function. We used an ex vivo assay with a specific inhibitor of p38 (SB203580) to investigate genes the expression of which was associated with active p38 kinase. We identified new direct p38 target genes and further characterized the role of p38. Our findings provide further insight into the physiological response to UV, including cell-cell interactions and cross-talk effects.	[Mouchet, Nicolas; Corre, Sebastien; Galibert, Marie-Dominique] Equipe RTO, Inst Genet & Dev Rennes, CNRS, UMR 6061, Rennes, France; [Mouchet, Nicolas; Corre, Sebastien; Galibert, Marie-Dominique] Univ Rennes 1, Fac Med, GFAS IFR140, Rennes, France; [Mouchet, Nicolas; Courbebaisse, Yann; Chesne, Christophe] PROCLAIM, St Gregoire, France; [Adamski, Henri] CHU Rennes, Serv Dermatol, Rennes, France; [Bouvet, Regis; Mosser, Jean; Galibert, Marie-Dominique] CHU Rennes, Lab Genom Med, Rennes, France; [Watier, Eric] CHU Rennes, Serv Chirurg Plast, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU Rennes; CHU Rennes; CHU Rennes	Mouchet, N (corresponding author), Equipe RTO, Inst Genet & Dev Rennes, CNRS, UMR 6061, Rennes, France.	mgaliber@univ-rennes1.fr	CORRE, Sebastien/B-7069-2018; Mouchet, Nicolas/AAP-6126-2020	CORRE, Sebastien/0000-0003-1532-5660; Mouchet, Nicolas/0000-0002-2849-9953	CRITT-Rennes; La Ligue Nationale contre le cancer, Comites Departmentaux du Grand Ouest; CNRS; Rennes1 University; Cifre grant	CRITT-Rennes; La Ligue Nationale contre le cancer, Comites Departmentaux du Grand Ouest; CNRS(Centre National de la Recherche Scientifique (CNRS)); Rennes1 University; Cifre grant	This work was supported by the "CRITT-Rennes'' and "La Ligue Nationale contre le cancer, Comites Departmentaux du Grand Ouest'', the CNRS and Rennes1 University. NM was supported by a Cifre grant. With the exception of the PROCLAIM collaborators, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April CS, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030009; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; deLaat A, 1996, PHOTOCHEM PHOTOBIOL, V63, P492; Duval C, 2002, PIGM CELL RES, V15, P440, DOI 10.1034/j.1600-0749.2002.02055.x; Duval C, 2001, PIGM CELL RES, V14, P348, DOI 10.1034/j.1600-0749.2001.140506.x; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enk CD, 2006, ONCOGENE, V25, P2601, DOI 10.1038/sj.onc.1209292; Enk CD, 2004, PHOTODERMATOL PHOTO, V20, P129, DOI 10.1111/j.1600-0781.2004.00097.x; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Halliday GM, 2008, PHOTOCHEM PHOTOBIOL, V84, P272, DOI 10.1111/j.1751-1097.2007.00247.x; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Howell BG, 2004, J DERMATOL SCI, V34, P185, DOI 10.1016/j.jdermsci.2004.01.004; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lee KM, 2005, BRIT J DERMATOL, V152, P52, DOI 10.1111/J.1365-2133.2005.06412.X; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; MUTHUSAMY V, 2009, ARCH DERMATOL RES; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Nordlund JJ, 2007, DERMATOL CLIN, V25, P271, DOI 10.1016/j.det.2007.04.001; Oh J, 2009, ONCOGENE, V28, P3145, DOI 10.1038/onc.2009.169; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Papoutsaki M, 2005, ONCOGENE, V24, P6970, DOI 10.1038/sj.onc.1208835; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; PEARSE AD, 1987, J INVEST DERMATOL, V88, P83, DOI 10.1111/1523-1747.ep12465094; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pillai S., 2005, International Journal of Cosmetic Science, V27, P17, DOI 10.1111/j.1467-2494.2004.00241.x; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Regnier M, 1999, CELL MOL BIOL, V45, P969; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Scott MC, 2002, PIGM CELL RES, V15, P433, DOI 10.1034/j.1600-0749.2002.02051.x; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Skiba B, 2005, PHOTODERMATOL PHOTO, V21, P173, DOI 10.1111/j.1600-0781.2005.00162.x; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; SMYTH G, 2004, LIMMA PACKAGE VIGNET; Steinbrenner H, 2003, BIOCHEM BIOPH RES CO, V308, P486, DOI 10.1016/S0006-291X(03)01430-X; Takao J, 2002, PHOTODERMATOL PHOTO, V18, P5, DOI 10.1034/j.1600-0781.2002.180102.x; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Valery C, 2001, J INVEST DERMATOL, V117, P1471, DOI 10.1046/j.0022-202x.2001.01607.x; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; ZEISE L, 1995, MELANIN ITS ROLE HUM, P1	57	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10776	10.1371/journal.pone.0010776	http://dx.doi.org/10.1371/journal.pone.0010776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505830	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400023
J	Nahid, P; Bliven, EE; Kim, EY; Mac Kenzie, WR; Stout, JE; Diem, L; Johnson, JL; Gagneux, S; Hopewell, PC; Kato-Maeda, M				Nahid, Payam; Bliven, Erin E.; Kim, Elizabeth Y.; Mac Kenzie, William R.; Stout, Jason E.; Diem, Lois; Johnson, John L.; Gagneux, Sebastien; Hopewell, Philip C.; Kato-Maeda, Midori		TB Trials Consortium	Influence of M. tuberculosis Lineage Variability within a Clinical Trial for Pulmonary Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENOTYPE; DIVERSITY; STRAINS	Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Canada, South Africa, Spain, Uganda and the United States, and secondarily explored the relationship between lineage, clinical presentation and response to treatment. Large sequence polymorphisms and single nucleotide polymorphisms were analyzed to determine lineage and sublineage of isolates. Of 306 isolates genotyped, 246 (80.4%) belonged to the Euro-American lineage, with sublineage 724 predominating at African sites (99/192, 51.5%), and the Euro-American strains other than 724 predominating at non-African sites (89/114, 78.1%). Uneven distribution of lineages across regions limited our ability to discern significant associations, nonetheless, in univariate analyses, Euro-American sublineage 724 was associated with more severe disease at baseline, and along with the East Asian lineage was associated with lower bacteriologic conversion after 8 weeks of treatment. Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status.	[Nahid, Payam; Kim, Elizabeth Y.; Hopewell, Philip C.; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Natl TB Ctr, San Francisco, CA 94143 USA; [Bliven, Erin E.; Mac Kenzie, William R.; Diem, Lois] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Stout, Jason E.] Duke Univ, Med Ctr, Durham, NC USA; [Johnson, John L.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Gagneux, Sebastien] Natl Inst Med Res, MRC, London NW7 1AA, England; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Duke University; Case Western Reserve University; MRC National Institute for Medical Research; University of Basel; Swiss Tropical & Public Health Institute	Nahid, P (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Natl TB Ctr, San Francisco, CA 94143 USA.	pnahid@ucsf.edu	Kenzie, William R Mac/F-1528-2013; Gagneux, Sebastien/ABE-7909-2020; Mayanja-Kizza, Harriet/AAM-5372-2020	Kenzie, William R Mac/0000-0001-7723-0339; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Narita, Masahiro/0000-0001-5825-5450; Nahid, Payam/0000-0003-2811-1311; Gagneux, Sebastien/0000-0001-7783-9048; Joloba, Moses/0000-0002-0334-9983; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Stout, Jason/0000-0002-6698-8176	Centers for Disease Control and Prevention; National Institutes of Health through the National Heart, Lung, and Blood Institute [K23HL092629]; National Institute of Allergy and Infectious Diseases [AI034238]; CDC; MRC [MC_U117588500] Funding Source: UKRI; Medical Research Council [MC_U117588500] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health through the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention-funded Tuberculosis Trials Consortium and the National Institutes of Health through the National Heart, Lung, and Blood Institute (K23HL092629) and National Institute of Allergy and Infectious Diseases (AI034238). Several of the authors listed (EEB, LD and WRM) are employed by the the CDC-funded TBTC and are listed as they participated in the analysis of data and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Manca C, 1999, J IMMUNOL, V162, P6740; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	22	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10753	10.1371/journal.pone.0010753	http://dx.doi.org/10.1371/journal.pone.0010753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505778	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300023
J	Heimburger, DC; Koethe, JR; Nyirenda, C; Bosire, C; Chiasera, JM; Blevins, M; Munoz, AJ; Shepherd, BE; Potter, D; Zulu, I; Chisembele-Taylor, A; Chi, BH; Stringer, JSA; Kabagambe, EK				Heimburger, Douglas C.; Koethe, John R.; Nyirenda, Christopher; Bosire, Claire; Chiasera, Janelle M.; Blevins, Meridith; Munoz, Andres Julian; Shepherd, Bryan E.; Potter, Dara; Zulu, Isaac; Chisembele-Taylor, Angela; Chi, Benjamin H.; Stringer, Jeffrey S. A.; Kabagambe, Edmond K.			Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study	PLOS ONE			English	Article							REFEEDING SYNDROME; CLINICAL-OUTCOMES; 1ST YEAR; AFRICA; ADHERENCE; DISTRICT; PROGRAM; DEATH	Background: Patients starting antiretroviral therapy (ART) for acquired immunodeficiency syndrome (AIDS) in sub-Saharan Africa have high rates of mortality in the initial weeks of treatment. We assessed the association of serum phosphate with early mortality among HIV-infected adults with severe malnutrition and/or advanced immunosuppression. Methodology/Principal Findings: An observational cohort of 142 HIV-infected adults initiating ART in Lusaka, Zambia with body mass index (BMI),16 kg/m(2) or CD4(+) lymphocyte count <50 cells/mu L, or both, was followed prospectively during the first 12 weeks of ART. Detailed health and dietary intake history, review of systems, physical examination, serum metabolic panel including phosphate, and serum ferritin and high-sensitivity C-reactive protein (hsCRP) were monitored. The primary outcome was mortality. Baseline serum phosphate was a significant predictor of mortality; participants alive at 12 weeks had a median value of 1.30 mmol/L (interquartile range [IQR]: 1.04, 1.43), compared to 1.06 mmol/L (IQR: 0.89, 1.27) among those who died (p<0.01). Each 0.1 mmol/L increase in baseline phosphate was associated with an incremental decrease in mortality (AHR 0.83; 95% CI 0.72 to 0.95). The association was independent of other metabolic parameters and known risk factors for early ART-associated mortality in sub-Saharan Africa. While participant attrition represented a limitation, it was consistent with local program experience. Conclusions/Significance: Low serum phosphate at ART initiation was an independent predictor of early mortality among HIV patients starting ART with severe malnutrition or advanced immunosuppression. This may represent a physiologic phenomenon similar to refeeding syndrome, and may lead to therapeutic interventions that could reduce mortality.	[Heimburger, Douglas C.; Koethe, John R.; Nyirenda, Christopher; Potter, Dara; Zulu, Isaac; Chisembele-Taylor, Angela; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Heimburger, Douglas C.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA; [Heimburger, Douglas C.; Koethe, John R.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Nyirenda, Christopher; Zulu, Isaac] Univ Teaching Hosp, Dept Internal Med, Lusaka, Zambia; [Heimburger, Douglas C.; Bosire, Claire; Munoz, Andres Julian] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA; [Bosire, Claire; Kabagambe, Edmond K.] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Chi, Benjamin H.; Stringer, Jeffrey S. A.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Chiasera, Janelle M.] Univ Alabama, Dept Clin Lab Sci, Birmingham, AL 35294 USA; [Munoz, Andres Julian] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Zambia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan	Heimburger, DC (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	douglas.heimburger@vanderbilt.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216; Chiasera, Janelle/0000-0003-2994-485X; Blevins, Meridith/0000-0002-3861-9859; Kabagambe, Edmond/0000-0002-8993-3186	National Institute of Allergy and Infectious Diseases, US National Institutes of Health [R21 AI076430]; University of Alabama at Birmingham Center for AIDS Research; Fogarty International Clinical Research Scholars Program; United States Department of State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076430] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Alabama at Birmingham Center for AIDS Research; Fogarty International Clinical Research Scholars Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); United States Department of State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by Award Number R21 AI076430 from the National Institute of Allergy and Infectious Diseases, US National Institutes of Health. The study was also supported by the University of Alabama at Birmingham Center for AIDS Research; the Fogarty International Clinical Research Scholars Program; and the Fulbright Scholars Program, United States Department of State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Boateng AA, 2010, NUTRITION, V26, P156, DOI 10.1016/j.nut.2009.11.017; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; BROZEK J, 1948, JAMA-J AM MED ASSOC, V137, P1569, DOI 10.1001/jama.1948.02890520001001; *CENTR STAT OFF, 2002, PREL REP CENS 2000; CHI BH, 2009, J ACQ IMMUN DEF SYND, P2009; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Heimburger D.C., 2006, HDB CLIN NUTR; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; KNOCHEL JP, 1977, ARCH INTERN MED, V137, P203, DOI 10.1001/archinte.137.2.203; Koethe JR, 2010, JAIDS-J ACQ IMM DEF, V53, P507, DOI 10.1097/QAI.0b013e3181b32baf; Kohn MR, 1998, J ADOLESCENT HEALTH, V22, P239, DOI 10.1016/S1054-139X(97)00163-8; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Little R. J. A., 1987, STAT ANAL MISSING DA; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Muranga F. I., 2007, African Journal of Biochemistry Research, V1, P72; Nyirenda C., 2009, BMJ CASE REPORTS; Nyirenda D. B., 2005, REVISED FOOD COMPOSI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; SCHNITKER MA, 1951, ANN INTERN MED, V35, P69, DOI 10.7326/0003-4819-35-1-69; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2008, REP GLOB AIDS EP; *US AG INT DEV, US AG INT DEV FOOD C; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	31	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10687	10.1371/journal.pone.0010687	http://dx.doi.org/10.1371/journal.pone.0010687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502700	Green Published, gold, Green Submitted			2022-12-27	WOS:000277776500005
J	Dudas, S; Yang, JM; Graham, C; Czub, M; McAllister, TA; Coulthart, MB; Czub, S				Dudas, Sandor; Yang, Jianmin; Graham, Catherine; Czub, Markus; McAllister, Tim A.; Coulthart, Michael B.; Czub, Stefanie			Molecular, Biochemical and Genetic Characteristics of BSE in Canada	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; STRAIN VARIATION; ATYPICAL BSE; SCRAPIE; IDENTIFICATION; VARIANT; SHEEP; DISCRIMINATION; TRANSMISSION	The epidemiology and possibly the etiology of bovine spongiform encephalopathy (BSE) have recently been recognized to be heterogeneous. In particular, three types [classical (C) and two atypical (H, L)] have been identified, largely on the basis of characteristics of the proteinase K (PK)-resistant core of the misfolded prion protein associated with the disease (PrPres). The present study was conducted to characterize the 17 Canadian BSE cases which occurred prior to November 2009 based on the molecular and biochemical properties of their PrPres, including immunoreactivity, molecular weight, glycoform profile and relative PK sensitivity. Two cases exhibited molecular weight and glycoform profiles similar to those of previously reported atypical cases, one corresponding to H-type BSE (case 6) and the other to L-type BSE (case 11). All other cases were classified as C-type. PK digestion under mild and stringent conditions revealed a reduced protease resistance in both of these cases compared to the C-type cases. With Western immunoblotting, N-terminal-specific antibodies bound to PrPres from case 6 but not to that from case 11 or C-type cases. C-terminal-specific antibodies revealed a shift in the glycoform profile and detected a fourth protein fragment in case 6, indicative of two PrPres subpopulations in H-type BSE. No mutations suggesting a genetic etiology were found in any of the 17 animals by sequencing the full PrP-coding sequence in exon 3 of the PRNP gene. Thus, each of the three known BSE types have been confirmed in Canadian cattle and show molecular characteristics highly similar to those of classical and atypical BSE cases described from Europe, Japan and the USA. The occurrence of atypical cases of BSE in countries such as Canada with low BSE prevalence and transmission risk argues for the occurrence of sporadic forms of BSE worldwide.	[Dudas, Sandor; Yang, Jianmin; Graham, Catherine; Czub, Stefanie] Canadian Food Inspect Agcy Lethbridge Lab, Canadian & OIE Reference Labs BSE, Lethbridge, AB, Canada; [Yang, Jianmin; McAllister, Tim A.] Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada; [Yang, Jianmin] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Czub, Markus] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Coulthart, Michael B.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	Canadian Food Inspection Agency; Agriculture & Agri Food Canada; China Agricultural University; University of Calgary; Public Health Agency of Canada	Dudas, S (corresponding author), Canadian Food Inspect Agcy Lethbridge Lab, Canadian & OIE Reference Labs BSE, Lethbridge, AB, Canada.	stefanie.czub@inspection.gc.ca	yang, jian/HIK-0188-2022; McAllister, Tim A./R-9201-2017	McAllister, Tim A./0000-0002-8266-6513	Canadian Food Inspection Agency	Canadian Food Inspection Agency	Funding for this project was provided by the Canadian Food Inspection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1996, LANCET, V347, P916, DOI 10.1016/S0140-6736(96)91407-5; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; DEBOSSCHERE RS, 2004, J APPL RES VET MED, V2, P52; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Hagiwara K, 2007, JPN J INFECT DIS, V60, P305; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; Nicholson EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002912; Orge L, 2000, VET REC, V147, P486, DOI 10.1136/vr.147.17.486; Polak MP, 2008, ARCH VIROL, V153, P69, DOI 10.1007/s00705-007-1062-6; Prusiner Stanley B., 2004, VVolume 41, P1; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Terry LA, 2007, VET REC, V160, P873, DOI 10.1136/vr.160.25.873; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	37	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10638	10.1371/journal.pone.0010638	http://dx.doi.org/10.1371/journal.pone.0010638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498835	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600006
J	Bueno, R; De Rienzo, A; Dong, LS; Gordon, GJ; Hercus, CF; Richards, WG; Jensen, RV; Anwar, A; Maulik, G; Chirieac, LR; Ho, KF; Taillon, BE; Turcotte, CL; Hercus, RG; Gullans, SR; Sugarbaker, DJ				Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Hercus, Colin F.; Richards, William G.; Jensen, Roderick V.; Anwar, Arif; Maulik, Gautam; Chirieac, Lucian R.; Ho, Kim-Fong; Taillon, Bruce E.; Turcotte, Cynthia L.; Hercus, Robert G.; Gullans, Steven R.; Sugarbaker, David J.			Second Generation Sequencing of the Mesothelioma Tumor Genome	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; COPY-NUMBER; LYMPHOBLASTIC-LEUKEMIA; STRUCTURAL VARIATION; GENE-EXPRESSION; CANCER GENOMES; ARRAY-CGH; FUSION; MUTATION; CLONING	The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome on a global scale. We examined the genome of a human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using a combination of sequencing-by-synthesis and pyrosequencing methodologies to a 9.6X depth of coverage. Read density analysis uncovered significant aneuploidy and numerous rearrangements. Method-dependent informatics rules, which combined the results of different sequencing platforms, were developed to identify and validate candidate mutations of multiple types. Many more tumor-specific rearrangements than point mutations were uncovered at this depth of sequencing, resulting in novel, large-scale, inter-and intra-chromosomal deletions, inversions, and translocations. Nearly all candidate point mutations appeared to be previously unknown SNPs. Thirty tumor-specific fusions/translocations were independently validated with PCR and Sanger sequencing. Of these, 15 represented disrupted gene-encoding regions, including kinases, transcription factors, and growth factors. One large deletion in DPP10 resulted in altered transcription and expression of DPP10 transcripts in a set of 53 additional MPM tumors correlated with survival. Additionally, three point mutations were observed in the coding regions of NKX6-2, a transcription regulator, and NFRKB, a DNA-binding protein involved in modulating NFKB1. Several regions containing genes such as PCBD2 and DHFR, which are involved in growth factor signaling and nucleotide synthesis, respectively, were selectively amplified in the tumor. Second-generation sequencing uncovered all types of mutations in this MPM tumor, with DNA rearrangements representing the dominant type.	[Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Richards, William G.; Maulik, Gautam; Chirieac, Lucian R.; Sugarbaker, David J.] Brigham & Womens Hosp, Int Mesothelioma Program, Boston, MA 02115 USA; [Bueno, Raphael; De Rienzo, Assunta; Dong, Lingsheng; Gordon, Gavin J.; Richards, William G.; Maulik, Gautam; Sugarbaker, David J.] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Taillon, Bruce E.; Turcotte, Cynthia L.] 454 Life Sci Inc, Branford, CT USA; [Hercus, Colin F.; Anwar, Arif; Ho, Kim-Fong; Hercus, Robert G.] Synamatix, Kuala Lumpur, Malaysia; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Gullans, Steven R.] Excel Med Ventures, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Virginia Polytechnic Institute & State University	Bueno, R (corresponding author), Brigham & Womens Hosp, Int Mesothelioma Program, 75 Francis St, Boston, MA 02115 USA.	dsugarbaker@partners.org	Chirieac, Lucian R./AAD-2030-2019		International Mesothelioma Program (IMP) at Brigham and Women's Hospital; NCI [P20CA9057801-A1, U01 CA65170-07, U24CA114725-01, RO1 CA 120528, R21/R33 CA 100315]; NATIONAL CANCER INSTITUTE [U01CA065170, R33CA100315, U24CA114725, R21CA100315, R01CA120528, P20CA090578] Funding Source: NIH RePORTER	International Mesothelioma Program (IMP) at Brigham and Women's Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the International Mesothelioma Program (IMP) at Brigham and Women's Hospital (www.impmeso.org). DJS is also supported by P20CA9057801-A1, U01 CA65170-07 and U24CA114725-01 from the NCI, WGR is also supported by P20CA9057801-A1 and U24CA114725-01 from the NCI, RB is also supported by RO1 CA 120528 and R21/R33 CA 100315 from the NCI.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Blaschke S, 2002, INT J CANCER, V101, P327, DOI 10.1002/ijc.10623; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; De Rienzo A, 2000, GENE CHROMOSOME CANC, V28, P337, DOI 10.1002/1098-2264(200007)28:3<337::AID-GCC12>3.0.CO;2-B; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HUNCHAREK M, 1995, EUR J CANCER, V31A, P1741, DOI 10.1016/0959-8049(95)00365-P; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joshi N, 2006, CANCER RES, V66, P6851, DOI 10.1158/0008-5472.CAN-06-0662; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim N, 2006, NUCLEIC ACIDS RES, V34, pD21, DOI 10.1093/nar/gkj019; Kindler H L, 2000, Curr Treat Options Oncol, V1, P313, DOI 10.1007/s11864-000-0047-4; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Krug LM, 2005, HEMATOL ONCOL CLIN N, V19, P1117, DOI 10.1016/j.hoc.2005.09.010; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lee SH, 2001, MAMM GENOME, V12, P157, DOI 10.1007/s003350010247; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li HL, 2006, AM J PHYSIOL-CELL PH, V291, pC966, DOI 10.1152/ajpcell.00571.2005; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morales C, 2005, ONCOGENE, V24, P6842, DOI 10.1038/sj.onc.1208834; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.cancergencyto.2006.04.011; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Ong ST, 1996, J CLIN ONCOL, V14, P1007, DOI 10.1200/JCO.1996.14.3.1007; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pylkkanen L, 2002, ONCOL REP, V9, P955; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Qiao Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-167; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rebouissou S, 2004, ONCOGENE, V23, P7588, DOI 10.1038/sj.onc.1207989; RICHARDS WG, 2007, BIOTECH HISTOCHEM, P1; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Schmid M, 2000, ONCOGENE, V19, P5747, DOI 10.1038/sj.onc.1203942; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Sugarbaker DJ, 2006, J THORAC ONCOL, V1, P175, DOI 10.1097/01243894-200602000-00014; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tyybakinoja A, 2006, GENE CHROMOSOME CANC, V45, P257, DOI 10.1002/gcc.20288; Vauhkonen H, 2007, CYTOGENET GENOME RES, V118, P277, DOI 10.1159/000108311; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitson BA, 2006, CANCER LETT, V239, P183, DOI 10.1016/j.canlet.2005.08.010; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; XIAO S, 1995, ONCOGENE, V11, P511; Yamamoto F, 2007, ELECTROPHORESIS, V28, P1882, DOI 10.1002/elps.200700093; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	62	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10612	10.1371/journal.pone.0010612	http://dx.doi.org/10.1371/journal.pone.0010612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485525	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500010
J	van den Boorn, JG; Konijnenberg, D; Tjin, EPM; Picavet, DI; Meeuwenoord, NJ; Filippov, DV; van der Veen, JPW; Bos, JD; Melief, CJM; Luiten, RM				van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; Meeuwenoord, Nico J.; Filippov, Dmitri V.; van der Veen, J. P. Wietze; Bos, Jan D.; Melief, Cornelis J. M.; Luiten, Rosalie M.			Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG	PLOS ONE			English	Article							MURINE MALIGNANT-MELANOMA; DENDRITIC CELLS; IN-VIVO; RECOMBINANT INTERLEUKIN-2; CANCER-IMMUNOTHERAPY; TUMOR-GROWTH; VITILIGO; REGRESSION; INHIBITION; INTERFERON	Background: Presently melanoma still lacks adequate treatment options for metastatic disease. While melanoma is exceptionally challenging to standard regimens, it is suited for treatment with immunotherapy based on its immunogenicity. Since treatment-related skin depigmentation is considered a favourable prognostic sign during melanoma intervention, we here aimed at the reverse approach of directly inducing vitiligo as a shortcut to effective anti-melanoma immunity. Methodology and Principal Findings: We developed an effective and simple to use form of immunotherapy by combining the topical skin-bleaching agent monobenzone with immune-stimulatory imiquimod cream and cytosine-guanine oligodeoxynucleotides (CpG) injections (MIC therapy). This powerful new approach promptly induced a melanoma antigen-specific immune response, which abolished subcutaneous B16. F10 melanoma growth in up to 85% of C57BL/6 mice. Importantly, this regimen induced over 100 days of tumor-free survival in up to 60% of the mice, and forcefully suppressed tumor growth upon re-challenge either 65- or 165 days after MIC treatment cessation. Conclusions: MIC therapy is effective in eradicating melanoma, by vigilantly incorporating NK-, B-and T cells in its therapeutic effect. Based on these results, the MIC regimen presents a high-yield, low-cost and simple therapy, readily applicable in the clinic.	[van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; van der Veen, J. P. Wietze; Bos, Jan D.; Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van den Boorn, Jasper G.; Konijnenberg, Debby; Tjin, Esther P. M.; Picavet, Daisy I.; van der Veen, J. P. Wietze; Bos, Jan D.; Luiten, Rosalie M.] Univ Amsterdam, Acad Med Ctr, Netherlands Inst Pigment Disorders, NL-1105 AZ Amsterdam, Netherlands; [Meeuwenoord, Nico J.; Filippov, Dmitri V.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RA Leiden, Netherlands; [van der Veen, J. P. Wietze] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Dermatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	van den Boorn, JG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands.	r.m.luiten@amc.uva.nl	Luiten, Rosalie M/I-7633-2019; Filippov, Dmitri/J-7612-2017	Luiten, Rosalie M/0000-0002-0800-0721; Filippov, Dmitri/0000-0002-6978-7425; Tjin, Esther/0000-0001-8642-168X	Dutch Organization for Scientific Research [NWO VIDI 016.056.337]; Dutch Cancer Societ [UvA 2006-3606]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Societ	J.G.v.d.B. was supported by a grant from the Dutch Organization for Scientific Research (grant NWO VIDI 016.056.337; www.nwo.nl). E. P. M. T. was supported by a grant from the Dutch Cancer Society (grant UvA 2006-3606; www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Anbar TS, 2009, J EUR ACAD DERMATOL, V23, P934, DOI 10.1111/j.1468-3083.2009.03233.x; BART RS, 1980, CANCER RES, V40, P614; BECKER SW, 1962, JAMA-J AM MED ASSOC, V180, P279, DOI 10.1001/jama.1962.03050170011003; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Cormier JN, 1998, J IMMUNOTHER, V21, P27, DOI 10.1097/00002371-199801000-00003; Fang L, 2008, J INVEST DERMATOL, V128, P2596, DOI 10.1038/jid.2008.101; FORMAN L, 1953, BRIT J DERMATOL, V65, P406, DOI 10.1111/j.1365-2133.1953.tb13174.x; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; GROJEAN MF, 1982, ANN DERMATOL VENER, V109, P641; Hariharan V, 2010, J INVEST DERMATOL, V130, P211, DOI 10.1038/jid.2009.214; KAHN G, 1970, ARCH DERMATOL, V102, P177; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941, DOI 10.4049/jimmunol.171.8.3941; Luiten RM, 2005, J CLIN ONCOL, V23, P8978, DOI 10.1200/JCO.2005.01.6816; Lyon CC, 1998, CONTACT DERMATITIS, V39, P132, DOI 10.1111/j.1600-0536.1998.tb05863.x; MANINI P, 2009, CHEM RES TOXICOL; MCGUIRE J, 1971, J INVEST DERMATOL, V57, P256, DOI 10.1111/1523-1747.ep12261579; MENTER JM, 1993, MELANOMA RES, V3, P443, DOI 10.1097/00008390-199311000-00007; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; MOSHER DB, 1977, BRIT J DERMATOL, V97, P669, DOI 10.1111/j.1365-2133.1977.tb14275.x; Najar HM, 2008, J INVEST DERMATOL, V128, P2204, DOI 10.1038/jid.2008.59; NAZIH A, 1993, CHEM RES TOXICOL, V6, P215, DOI 10.1021/tx00032a011; OLIVER E. A., 1939, Journal of the American Medical Association, V113, P927; Overwijk WW, 2005, CURR OPIN IMMUNOL, V17, P187, DOI 10.1016/j.coi.2005.01.011; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; Ray CM, 2005, INT J DERMATOL, V44, P428, DOI 10.1111/j.1365-4632.2005.02582.x; Redondo P, 2007, J INVEST DERMATOL, V127, P1673, DOI 10.1038/sj.jid.5700777; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ruckert R, 1998, J INVEST DERMATOL, V111, P25, DOI 10.1046/j.1523-1747.1998.00228.x; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Sharma S, 2003, BIOTECHNOL LETT, V25, P149, DOI 10.1023/A:1021927621813; SIDKY YA, 1992, CANCER RES, V52, P3528; SMITH JL, 1965, CANCER-AM CANCER SOC, V18, P1399, DOI 10.1002/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Switaj T, 2004, CLIN CANCER RES, V10, P4165, DOI 10.1158/1078-0432.CCR-04-0022; Tayama K, 2002, PIGM CELL RES, V15, P447, DOI 10.1034/j.1600-0749.2002.02057.x; van den Boorn JG, 2006, INT REV IMMUNOL, V25, P235, DOI 10.1080/08830180600743081; van den Boorn JG, 2009, J INVEST DERMATOL; Wooldridge JE, 1997, BLOOD, V89, P2994, DOI 10.1182/blood.V89.8.2994	48	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10626	10.1371/journal.pone.0010626	http://dx.doi.org/10.1371/journal.pone.0010626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498710	gold, Green Submitted, Green Published			2022-12-27	WOS:000277633500014
J	Engel, A; Aguilar, PS; Walter, P				Engel, Alex; Aguilar, Pablo S.; Walter, Peter			The Yeast Cell Fusion Protein Prm1p Requires Covalent Dimerization to Promote Membrane Fusion	PLOS ONE			English	Article							INFLUENZA HEMAGGLUTININ; LYSIS; MECHANISMS; SNARES	Prm1p is a multipass membrane protein that promotes plasma membrane fusion during yeast mating. The mechanism by which Prm1p and other putative regulators of developmentally controlled cell-cell fusion events facilitate membrane fusion has remained largely elusive. Here, we report that Prm1p forms covalently linked homodimers. Covalent Prm1p dimer formation occurs via intermolecular disulfide bonds of two cysteines, Cys-120 and Cys-545. PRM1 mutants in which these cysteines have been substituted are fusion defective. These PRM1 mutants are normally expressed, retain homotypic interaction and can traffic to the fusion zone. Because prm1-C120S and prm1-C545S mutants can form covalent dimers when coexpressed with wild-type PRM1, an intermolecular C120-C545 disulfide linkage is inferred. Cys-120 is adjacent to a highly conserved hydrophobic domain. Mutation of a charged residue within this hydrophobic domain abrogates formation of covalent dimers, trafficking to the fusion zone, and fusion-promoting activity. The importance of intermolecular disulfide bonding informs models regarding the mechanism of Prm1-mediated cell-cell fusion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Engel, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	alex.engel@berkeley.edu	Aguilar, Pablo/E-4576-2010; Aguilar, Pablo/AAV-7336-2020	Aguilar, Pablo/0000-0002-9312-2474	National Institutes of Health [5R01GM032384-27]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, grant 5R01GM032384-27 (http://grants.nih.gov/grants/guide/index.html), and Peter Walter is an investigator of the Howard Hughes Medical Institute (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2007, MOL BIOL CELL, V18, P547, DOI 10.1091/mbc.E06-09-0776; Clemente-Ramos JA, 2009, MOL MICROBIOL, V73, P695, DOI 10.1111/j.1365-2958.2009.06800.x; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Blumenthal R, 1999, MOL MEMBR BIOL, V16, P43, DOI 10.1080/096876899294742; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Cho SJ, 2002, ANN NY ACAD SCI, V971, P254, DOI 10.1111/j.1749-6632.2002.tb04471.x; Engel A, 2008, J CELL BIOL, V183, P181, DOI 10.1083/jcb.200805182; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jin H, 2004, EUKARYOT CELL, V3, P1664, DOI 10.1128/EC.3.6.1664-1673.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Muller M, 2003, BIOPHYS J, V85, P1611, DOI 10.1016/S0006-3495(03)74592-5; Olmo VN, 2010, J BIOL CHEM, V285, P2284, DOI 10.1074/jbc.M109.068874; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	26	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10593	10.1371/journal.pone.0010593	http://dx.doi.org/10.1371/journal.pone.0010593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485669	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200022
J	Xu, JZ; Seo, AY; Vorobyeva, DA; Carter, CS; Anton, SD; Lezza, AMS; Leeuwenburgh, C				Xu, Jinze; Seo, Arnold Y.; Vorobyeva, Darya A.; Carter, Christy S.; Anton, Stephen D.; Lezza, Angela M. S.; Leeuwenburgh, Christiaan			Beneficial Effects of a Q-ter (R) Based Nutritional Mixture on Functional Performance, Mitochondrial Function, and Oxidative Stress in Rats	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; SKELETAL-MUSCLE APOPTOSIS; COENZYME Q(10); CREATINE SUPPLEMENTATION; MECHANICAL VENTILATION; ANTIOXIDANT CAPACITY; PANAX-GINSENG; INTERFIBRILLAR MITOCHONDRIA; NEURODEGENERATIVE DISEASES; PROTEIN CARBONYLATION	Background: Mitochondrial dysfunction and oxidative stress are central mechanisms underlying the aging process and the pathogenesis of many age-related diseases. Selected antioxidants and specific combinations of nutritional compounds could target many biochemical pathways that affect both oxidative stress and mitochondrial function and, thereby, preserve or enhance physical performance. Methodology/Principal Findings: In this study, we evaluated the potential anti-aging benefits of a Q-ter (R) based nutritional mixture (commercially known as Eufortyn (R)) mainly containing the following compounds: terclatrated coenzyme Q(10) (Q-ter (R)), creatine and a standardized ginseng extract. We found that Eufortyn (R) supplementation significantly ameliorated the age-associated decreases in grip strength and gastrocnemius subsarcolemmal mitochondria Ca(2+) retention capacity when initiated in male Fischer344 x Brown Norway rats at 21 months, but not 29 months, of age. Moreover, the increases in muscle RNA oxidation and subsarcolemmal mitochondrial protein carbonyl levels, as well as the decline of total urine antioxidant power, which develop late in life, were mitigated by Eufortyn (R) supplementation in rats at 29 months of age. Conclusions/Significance: These data imply that Eufortyn (R) is efficacious in reducing oxidative damage, improving the age-related mitochondrial functional decline, and preserving physical performance when initiated in animals at early midlife (21 months). The efficacy varied, however, according to the age at which the supplementation was provided, as initiation in late middle age (29 months) was incapable of restoring grip strength and mitochondrial function. Therefore, the Eufortyn (R) supplementation may be particularly beneficial when initiated prior to major biological and functional declines that appear to occur with advancing age.	[Xu, Jinze; Seo, Arnold Y.; Vorobyeva, Darya A.; Carter, Christy S.; Anton, Stephen D.; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32610 USA; [Lezza, Angela M. S.] Univ Bari, Dept Biochem & Mol Biol E Quagliariello, Bari, Italy	State University System of Florida; University of Florida; Universita degli Studi di Bari Aldo Moro	Xu, JZ (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32610 USA.	jxu@aging.ufl.edu; cleeuwen@aging.ufl.edu	Xu, Jinze/G-7868-2011; Carter, Christy/E-6630-2011	Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994]; University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center National Institutes of Health [1 P30 AG028740]; American Heart Association [09POST2060112, 09CRP2390173, 1K23AT004251]; University of Florida Honors Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K23AT004251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017994, P30AG028740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center National Institutes of Health; American Heart Association(American Heart Association); University of Florida Honors Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Pharmaland SA, grants to CL from the National Institute on Aging (AG17994), the University of Florida Institute on Aging and the Claude D. Pepper Older Americans Independence Center National Institutes of Health Grant (1 P30 AG028740), fellowship awards from the American Heart Association to JX (09POST2060112) and SDA (09CRP2390173 and 1K23AT004251), and a University Scholars Program award from the University of Florida Honors Program to DAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Beal F, 2004, METHOD ENZYMOL, V382, P473; Beal MF, 2003, ANN NEUROL, V53, pS39, DOI 10.1002/ana.10479; Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; Bentler SE, 2005, J CLIN PSYCHIAT, V66, P625, DOI 10.4088/JCP.v66n0513; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Boctor SY, 2010, NEUROTOXICOLOGY, V31, P42, DOI 10.1016/j.neuro.2009.10.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buford TW, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-6; Campos C, 2010, CLIN BIOCHEM, V43, P228, DOI 10.1016/j.clinbiochem.2009.09.017; Carli F., 2003, Patent Number, Patent No. [03097012, 03/097012 A1]; Carter CS, 2009, J GERONTOL A-BIOL, V64, P850, DOI 10.1093/gerona/glp060; Carter CS, 2004, J GERONTOL A-BIOL, V59, P416; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Cordero MD, 2009, TOXICOL APPL PHARM, V235, P329, DOI 10.1016/j.taap.2008.12.026; Czarkowska-Paczek Bozena, 2006, Przegl Lek, V63, P658; de Oliveira ACC, 2005, J ETHNOPHARMACOL, V97, P211, DOI 10.1016/j.jep.2004.10.029; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Engelhardt M, 1998, MED SCI SPORT EXER, V30, P1123, DOI 10.1097/00005768-199807000-00016; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; Feng J, 2008, ELECTROPHORESIS, V29, P475, DOI 10.1002/elps.200700262; Fetoni AR, 2009, BRAIN RES, V1257, P108, DOI 10.1016/j.brainres.2008.12.027; Fu Y, 2003, J NUTR, V133, P3603, DOI 10.1093/jn/133.11.3603; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Goffaux J, 2005, SOUTH MED J, V98, P985, DOI 10.1097/01.smj.0000182178.22607.47; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004; Hyun DH, 2006, AGEING RES REV, V5, P209, DOI 10.1016/j.arr.2006.03.005; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kehl LJ, 2000, PAIN, V85, P333, DOI 10.1016/S0304-3959(99)00282-1; Kennedy DO, 2003, PHARMACOL BIOCHEM BE, V75, P687, DOI 10.1016/S0091-3057(03)00126-6; Kim YH, 1996, J BIOL CHEM, V271, P24539, DOI 10.1074/jbc.271.40.24539; Kirkland JL, 2009, J GERONTOL A-BIOL, V64, P209, DOI 10.1093/gerona/gln063; Kirschbaum B, 2001, CLIN CHIM ACTA, V305, P167, DOI 10.1016/S0009-8981(01)00381-3; Kooncumchoo P, 2006, J MOL NEUROSCI, V28, P125, DOI 10.1385/JMN:28:2:125; Koren E, 2009, J INHERIT METAB DIS, V32, P651, DOI 10.1007/s10545-009-1242-5; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Leeuwenburgh C, 1999, AM J PHYSIOL-REG I, V276, pR128, DOI 10.1152/ajpregu.1999.276.1.R128; Leeuwenburgh C, 2006, ANTIOXID REDOX SIGN, V8, P503, DOI 10.1089/ars.2006.8.503; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Li G, 2005, BIOFACTORS, V25, P97, DOI 10.1002/biof.5520250111; Li XT, 2009, AM J CHINESE MED, V37, P1139, DOI 10.1142/S0192415X09007454; Littarru GP, 2007, MOL BIOTECHNOL, V37, P31, DOI 10.1007/s12033-007-0052-y; Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004; Mannello F, 2009, CELL ONCOL, V31, P383, DOI 10.3233/CLO-2009-0483; Margetis PI, 2009, EXP MOL PATHOL, V87, P76, DOI 10.1016/j.yexmp.2009.04.001; Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; McClung JM, 2008, AM J PHYSIOL-REG I, V294, pR1608, DOI 10.1152/ajpregu.00044.2008; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Qian ZM, 2009, J CHROMATOGR A, V1216, P3825, DOI 10.1016/j.chroma.2009.02.065; Raj IS, 2010, EXP GERONTOL, V45, P81, DOI 10.1016/j.exger.2009.10.013; Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688; Sahach V F, 2007, Fiziol Zh, V53, P35; Schmelzer C, 2009, J CLIN BIOCHEM NUTR, V44, P62, DOI 10.3164/jcbn.08-182; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4; TAKAHASHI T, 1993, LIPIDS, V28, P803, DOI 10.1007/BF02536234; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067; Voces J, 2004, BRAZ J MED BIOL RES, V37, P1863, DOI 10.1590/S0100-879X2004001200012; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Werbach M R, 2000, Altern Med Rev, V5, P93; Williams MH, 1998, J AM COLL NUTR, V17, P216, DOI 10.1080/07315724.1998.10718751; Willoughby DS, 2003, MED SCI SPORT EXER, V35, P923, DOI 10.1249/01.MSS.0000069746.05241.F0; Willoughby DS, 2001, MED SCI SPORT EXER, V33, P1674, DOI 10.1097/00005768-200110000-00010; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002; ZHANG YY, 1995, J NUTR, V125, P446; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Zmitek J, 2008, ANN NUTR METAB, V52, P281, DOI 10.1159/000129661	91	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10572	10.1371/journal.pone.0010572	http://dx.doi.org/10.1371/journal.pone.0010572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485503	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200008
J	Slagter, HA; Johnstone, T; Beets, IAM; Davidson, RJ				Slagter, Heleen A.; Johnstone, Tom; Beets, Iseult A. M.; Davidson, Richard J.			Neural Competition for Conscious Representation across Time: An fMRI Study	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; ATTENTIONAL BLINK; TEMPORAL ATTENTION; TASK; CORTEX; PERCEPTION; MASKING; SUPPRESSION; PERFORMANCE; SELECTION	Background: The information processing capacity of the human mind is limited, as is evidenced by the attentional blink (AB) - a deficit in identifying the second of two temporally-close targets (T1 and T2) embedded in a rapid stream of distracters. Theories of the AB generally agree that it results from competition between stimuli for conscious representation. However, they disagree in the specific mechanisms, in particular about how attentional processing of T1 determines the AB to T2. Methodology/Principal Findings: The present study used the high spatial resolution of functional magnetic resonance imaging ( fMRI) to examine the neural mechanisms underlying the AB. Our research approach was to design T1 and T2 stimuli that activate distinguishable brain areas involved in visual categorization and representation. ROI and functional connectivity analyses were then used to examine how attentional processing of T1, as indexed by activity in the T1 representation area, affected T2 processing. Our main finding was that attentional processing of T1 at the level of the visual cortex predicted T2 detection rates Those individuals who activated the T1 encoding area more strongly in blink versus no-blink trials generally detected T2 on a lower percentage of trials. The coupling of activity between T1 and T2 representation areas did not vary as a function of conscious T2 perception. Conclusions/Significance: These data are consistent with the notion that the AB is related to attentional demands of T1 for selection, and indicate that these demands are reflected at the level of visual cortex. They also highlight the importance of individual differences in attentional settings in explaining AB task performance.	[Slagter, Heleen A.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [Slagter, Heleen A.; Johnstone, Tom; Beets, Iseult A. M.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Johnstone, Tom] Univ Reading, Sch Psychol, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Johnstone, Tom] Univ Reading, CLS, Reading, Berks, England; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Amsterdam; University of Wisconsin System; University of Wisconsin Madison; University of Reading; University of Reading; University of Wisconsin System; University of Wisconsin Madison	Slagter, HA (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	h.a.slagter@uva.nl	Slagter, Heleen/ABF-1338-2020; Johnstone, Tom/C-5909-2011	Slagter, Heleen/0000-0002-4180-1483; Johnstone, Tom/0000-0001-8635-8158; Davidson, Richard/0000-0002-8506-4964	National Institute of Mental Health [R01-MH43454]; University of Leiden, The Netherlands; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Leiden, The Netherlands(Netherlands Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institute of Mental Health (R01-MH43454 to RJD) and an outbound study grant from the University of Leiden, The Netherlands (to IAMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRASTON P, J COGNITIVE IN PRESS; DESIMONE R, 2005, ANN REV NEUROSCIL, V8, P193; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ., 2004, HUMAN BRAIN FUNCTION, P971, DOI DOI 10.1016/B978-012264841-0/50050-0; Giesbrecht B, 1998, J EXP PSYCHOL HUMAN, V24, P1454, DOI 10.1037/0096-1523.24.5.1454; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hein G, 2009, J COGNITIVE NEUROSCI, V21, P197, DOI 10.1162/jocn.2008.21026; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Johnston SJ, 2007, NEUROREPORT, V18, P1475, DOI 10.1097/WNR.0b013e3282cdeefd; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Marcantoni WS, 2003, BRAIN COGNITION, V53, P318, DOI 10.1016/S0278-2626(03)00134-9; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Shapiro KL, 2007, NEUROREPORT, V18, P341, DOI 10.1097/WNR.0b013e32801299e2; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2009, J COGNITIVE NEUROSCI, V21, P1536, DOI 10.1162/jocn.2009.21125; Stein T, 2008, NEUROREPORT, V19, P1277, DOI 10.1097/WNR.0b013e32830bab02; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Williams MA, 2008, J NEUROSCI, V28, P9890, DOI 10.1523/JNEUROSCI.3057-08.2008; WYBLE B, J EXP PSYCH IN PRESS	58	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10556	10.1371/journal.pone.0010556	http://dx.doi.org/10.1371/journal.pone.0010556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479939	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467900012
J	Lee, SC; Corradi, N; Doan, S; Dietrich, FS; Keeling, PJ; Heitman, J				Lee, Soo Chan; Corradi, Nicolas; Doan, Sylvia; Dietrich, Fred S.; Keeling, Patrick J.; Heitman, Joseph			Evolution of the sex-Related Locus and Genomic Features Shared in Microsporidia and Fungi	PLOS ONE			English	Article							MATING-TYPE LOCUS; ENCEPHALITOZOON-CUNICULI; CRYPTOCOCCUS-NEOFORMANS; PHYLOGENETIC ANALYSIS; CANDIDA-ALBICANS; INTRACELLULAR PARASITES; BALANCING SELECTION; ALPHA-TUBULIN; POLAR TUBE; GENES	Background: Microsporidia are obligate intracellular, eukaryotic pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists. The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it. Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes. Methodology/Principal Findings: Here we expanded this analysis and also examined a putative sex-locus for variability between microsporidian populations. Whole genome inspection reveals a unique syntenic gene pair (RPS9-RPL21) present in the vast majority of fungi and the microsporidians but not in other eukaryotic lineages. Two other unique gene fusions (glutamyl-prolyl tRNA synthetase and ubiquitin-ribosomal subunit S30) that are present in metazoans, choanoflagellates, and filasterean opisthokonts are unfused in the fungi and microsporidians. One locus previously found to be conserved in many microsporidian genomes is similar to the sex locus of zygomycetes in gene order and architecture. Both sex-related and sex loci harbor TPT, HMG, and RNA helicase genes forming a syntenic gene cluster. We sequenced and analyzed the sex-related locus in 11 different Encephalitozoon cuniculi isolates and the sibling species E. intestinalis (3 isolates) and E. hellem (1 isolate). There was no evidence for an idiomorphic sex-related locus in this Encephalitozoon species sample. According to sequence-based phylogenetic analyses, the TPT and RNA helicase genes flanking the HMG genes are paralogous rather than orthologous between zygomycetes and microsporidians. Conclusion/Significance: The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi. And the sex/sex-related loci appear to have been subject to frequent gene conversion and translocations in microsporidia and zygomycetes.	[Lee, Soo Chan; Dietrich, Fred S.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Corradi, Nicolas; Doan, Sylvia; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Dietrich, Fred S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Duke University	Lee, SC (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021	Corradi, Nicolas/0000-0002-7932-7932; Keeling, Patrick/0000-0002-7644-0745	National Institutes of Health (NIH) [AI50113, AI052080]; Canadian Institute for Health Research; Swiss National Science Foundation [PA00P3_124166]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085331, R01AI050113, T32AI052080] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI50113 to J.H., a grant from the Canadian Institute for Health Research to P.J.K., the Molecular Mycology Pathogenesis Training Program fellowship (AI052080) from the NIH to S. C. L., and a senior postdoctoral fellowship from the Swiss National Science Foundation (PA00P3_124166) to N.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Badrane H, 1999, MOL BIOL EVOL, V16, P975, DOI 10.1093/oxfordjournals.molbev.a026187; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Burglin TR, 2003, DEV GENES EVOL, V213, P50, DOI 10.1007/s00427-002-0287-3; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; CAVALIERSMITH T, 1986, NATURE, V324, P416, DOI 10.1038/324416a0; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Corradi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r106; Daniels KJ, 2006, EMBO J, V25, P2240, DOI 10.1038/sj.emboj.7601099; Didier Elizabeth S, 2005, Expert Rev Anti Infect Ther, V3, P419, DOI 10.1586/14787210.3.3.419; Didier ES, 1996, J EUKARYOT MICROBIOL, V43, P34, DOI 10.1111/j.1550-7408.1996.tb02470.x; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; DIDIER PJ, 1991, J PROTOZOOL, V38, P502, DOI 10.1111/j.1550-7408.1991.tb04824.x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dyer PS, 2008, CURR BIOL, V18, pR1012, DOI 10.1016/j.cub.2008.09.034; Dyer PS, 2008, CURR BIOL, V18, pR207, DOI 10.1016/j.cub.2008.01.014; Edlind TD, 1996, MOL PHYLOGENET EVOL, V5, P359; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fraser James A., 2007, P19, DOI 10.1037/11499-002; Fraser JA, 2007, EUKARYOT CELL, V6, P622, DOI 10.1128/EC.00018-07; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Green LC, 1999, J EUKARYOT MICROBIOL, V46, P434, DOI 10.1111/j.1550-7408.1999.tb04624.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAZARD EI, 1984, J INVERTEBR PATHOL, V44, P3, DOI 10.1016/0022-2011(84)90039-9; Heitman J, 2009, NATURE, V460, P807, DOI 10.1038/460807a; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Ironside JE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-48; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kahmann Regine, 2007, P377; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; LEE SC, 2010, MICROBIOL M IN PRESS; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee Soo Chan, 2009, Commun Integr Biol, V2, P414; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lin X., 2007, SEX FUNGI; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; May G, 1999, P NATL ACAD SCI USA, V96, P9172, DOI 10.1073/pnas.96.16.9172; Morrow CA, 2009, FEMS YEAST RES, V9, P161, DOI 10.1111/j.1567-1364.2008.00475.x; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Polonais V, 2005, FUNGAL GENET BIOL, V42, P791, DOI 10.1016/j.fgb.2005.05.005; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; SWEENEY AW, 1988, J INVERTEBR PATHOL, V51, P46, DOI 10.1016/0022-2011(88)90087-0; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Weiss LM, 1999, J EUKARYOT MICROBIOL, V46, p17S, DOI 10.1111/j.1550-7408.1999.tb06055.x; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Wittner M., 1999, MICROSPORIDIA MICROS; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Xiao LH, 2001, J CLIN MICROBIOL, V39, P2248, DOI 10.1128/JCM.39.6.2248-2253.2001; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006	79	49	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10539	10.1371/journal.pone.0010539	http://dx.doi.org/10.1371/journal.pone.0010539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479876	Green Submitted, gold, Green Published			2022-12-27	WOS:000277467800020
J	Mishra, AC; Chadha, MS; Choudhary, ML; Potdar, VA				Mishra, Akhilesh C.; Chadha, Mandeep S.; Choudhary, Manohar L.; Potdar, Varsha A.			Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India	PLOS ONE			English	Article							SWINE; VIRUS; EPIDEMIOLOGY; TRANSMISSION; PATHOGENESIS; FERRETS	Background: Pandemic influenza A (H1N1) 2009 has posed a serious public health challenge world-wide. In absence of reliable information on severity of the disease, the nations are unable to decide on the appropriate response against this disease. Methods: Based on the results of laboratory investigations, attendance in outpatient department, hospital admissions and mortality from the cases of influenza like illness from 1 August to 31 October 2009 in Pune urban agglomeration, risk of hospitalization and case fatality ratio were assessed to determine the severity of pandemic H1N1 and seasonal influenza-A infections. Results: Prevalence of pandemic H1N1 as well as seasonal-A cases were high in Pune urban agglomeration during the study period. The cases positive for pandemic H1N1 virus had significantly higher risk of hospitalization than those positive for seasonal influenza-A viruses (OR: 1.7). Of 93 influenza related deaths, 57 and 8 deaths from Pune (urban) and 27 and 1 death from Pune (rural) were from pandemic H1N1 positive and seasonal-A positive cases respectively. The case fatality ratio 0.86% for pandemic H1N1 was significantly higher than that of seasonal-A (0.13%) and it was in category 3 of the pandemic severity index of CDC, USA. The data on the cumulative fatality of rural and urban Pune revealed that with time the epidemic is spreading to rural areas. Conclusions: The severity of the H1N1 influenza pandemic is less than that reported for 'Spanish flu 1918' but higher than other pandemics of the 20(th) century. Thus, pandemic influenza should be considered as serious health threat and unprecedented global response seems justified.	[Mishra, Akhilesh C.; Chadha, Mandeep S.; Choudhary, Manohar L.; Potdar, Varsha A.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mishra, AC (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	acm1750@rediffmail.com	Jadhav, Santoshkumar/AAB-7634-2021; Potdar, Varsha/ABA-3799-2021; Choudhary, Manohar Lal/ABA-6120-2021; Choudhary, Manohar Lal/K-2055-2019	Potdar, Varsha/0000-0002-7535-7878; Choudhary, Manohar Lal/0000-0001-9968-8957; 	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 2009, EUROSURVEILLANCE, V14, P42; Baker MG, 2009, EUROSURVEILLANCE, V14, P2; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; *CDC, 2007, COMM STRAT PAND INFL; CDC, 2009, CDC PROT REALT RTPCR; Chan M., WORLD NOW START 2009; Collignon P, 2009, AUSTRALAS EMERG NURS, V12, P71, DOI 10.1016/j.aenj.2009.06.001; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Enserink M, 2009, SCIENCE, V325, P17, DOI 10.1126/science.325_17; FOX M, 2009, SWINE FLU DEATH RATE; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; Hasegawa G, 2006, J CLIN VIROL, V37, P233, DOI 10.1016/j.jcv.2006.08.003; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Leo YS, 2009, LANCET INFECT DIS, V9, P457, DOI 10.1016/S1473-3099(09)70182-3; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McConnell J, 2009, LANCET INFECT DIS, V9, P590, DOI 10.1016/S1473-3099(09)70242-7; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P175, DOI 10.1007/s00430-009-0118-5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; *NY CIT DEP HLTH H, 2009, COMM TRANSM H1N1 FLU; Rao BL, 2003, NATL MED J INDIA, V16, P143; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; World Health Organisation, WHO PAND H1N1 2009 U; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU	31	66	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10540	10.1371/journal.pone.0010540	http://dx.doi.org/10.1371/journal.pone.0010540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479875	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800021
J	Patrick, SM; White, E; Shiels, HA				Patrick, Simon M.; White, Ed; Shiels, Holly A.			Mechano-Electric Feedback in the Fish Heart	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; MONOPHASIC ACTION-POTENTIALS; RAINBOW-TROUT; VENTRICULAR MYOCYTES; OXYGEN-CONSUMPTION; MECHANICAL PERFORMANCE; ATRIAL-FIBRILLATION; CLINICAL-RELEVANCE; DEPENDENT CHANGES; CARDIAC MYOCYTES	Background: Mechanoelectric feedback (MEF) describes the modulation of electrical activity by mechanical activity. This may occur via the activation of mechanosensitive ion channels (MSCs). MEF has not previously been investigated in fish ventricular tissue even though fish can greatly increase ventricular end diastolic volume during exercise which should therefore provide a powerful mechanical stimulus for MEF. Methodology/Principal Finding: When the ventricles of extrinsically paced, isolated working trout hearts were dilated by increasing afterload, monophasic action potential (MAP) duration was significantly shortened at 25% repolarisation, unaltered at 50% repolarisation and significantly lengthened at 90% repolarisation. This observation is consistent with the activation of cationic non-selective MSCs (MSC(NS)s). We then cloned the trout ortholog of TRPC1, a candidate MSC(NS) and confirmed its presence in the trout heart. Conclusions/Significance: Our results have validated the use of MAP technology for the fish heart and suggest that, in common with amphibians and mammals, MEF operates in fish ventricular myocardium, possibly via the activation of mechanosensitive TRPC1 ion channels.	[Patrick, Simon M.; Shiels, Holly A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [White, Ed] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England; [White, Ed] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England	University of Manchester; University of Leeds; University of Leeds	Patrick, SM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	simon.patrick@postgrad.manchester.ac.uk			Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberra A, 2001, EXP PHYSIOL, V86, P27, DOI 10.1113/eph8602051; Agnisola C, 2003, J EXP BIOL, V206, P4003, DOI 10.1242/jeb.00623; Bainbridge FA, 1915, J PHYSIOL-LONDON, V50, P65; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Belus A, 2003, J PHYSIOL-LONDON, V546, P501, DOI 10.1113/jphysiol.2002.027573; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Burggren W., 1997, HDB PHYSL, P215; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cousins KL, 1996, CAN J ZOOL, V74, P380, DOI 10.1139/z96-044; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Farrell Anthony P., 1992, P1; Farrell AP, 2000, PHYSIOL BIOCHEM ZOOL, V73, P1, DOI 10.1086/316727; Farrell AP, 1996, J EXP BIOL, V199, P663; Frank O., 1895, Z BIOL, V32, P370; Franz MR, 1999, CARDIOVASC RES, V41, P25, DOI 10.1016/S0008-6363(98)00268-5; Franz MR, 1996, CARDIOVASC RES, V32, P15, DOI 10.1016/0008-6363(96)00074-0; GRAHAM MS, 1990, PHYSIOL ZOOL, V63, P536, DOI 10.1086/physzool.63.3.30156227; GRAHAM MS, 1989, PHYSIOL ZOOL, V62, P38, DOI 10.1086/physzool.62.1.30159997; Greve G, 2001, EXP PHYSIOL, V86, P651, DOI 10.1113/eph8602225; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hansen J, 2002, J COMP PHYSIOL B, V172, P477, DOI 10.1007/s00360-002-0270-3; Harwood CL, 2000, J EXP BIOL, V203, P493; Hondeghem LM, 2001, CIRCULATION, V103, P2004; JENSEN D, 1969, COMP BIOCHEM PHYSIOL, V30, P685, DOI 10.1016/0010-406X(69)92147-1; JENSEN D, 1970, Comparative and General Pharmacology, V1, P254, DOI 10.1016/0010-4035(70)90061-3; Kamkin A, 2000, CARDIOVASC RES, V48, P409, DOI 10.1016/S0008-6363(00)00208-X; KAUFMANN RL, 1971, PFLUG ARCH EUR J PHY, V324, P100, DOI 10.1007/BF00592656; KICENIUK JW, 1977, J EXP BIOL, V69, P247; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; Kohl P, 1998, CAN J CARDIOL, V14, P111; LAB MJ, 1978, CARDIOVASC RES, V12, P555, DOI 10.1093/cvr/12.9.555; LAB MJ, 1982, CIRC RES, V50, P757, DOI 10.1161/01.RES.50.6.757; LAB MJ, 1978, CIRC RES, V42, P519, DOI 10.1161/01.RES.42.4.519; Lab MJ, 1996, CARDIOVASC RES, V32, P3, DOI 10.1016/S0008-6363(96)00088-0; LAB MJ, 1984, CIRC RES, V55, P825, DOI 10.1161/01.RES.55.6.825; Martinac B, 2003, PROG BIOPHYS MOL BIO, V82, P11, DOI 10.1016/S0079-6107(03)00002-6; Moeller CC, 2008, GENE EXPR PATTERNS, V8, P291, DOI 10.1016/j.gep.2008.02.002; Nazir SA, 1996, CARDIOVASC RES, V32, P112, DOI 10.1016/0008-6363(96)00077-6; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Patterson SW, 1914, J PHYSIOL-LONDON, V48, P357; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Ravens U, 2003, PROG BIOPHYS MOL BIO, V82, P255, DOI 10.1016/S0079-6107(03)00026-9; RUNNALLS ME, 1987, AM J PHYSIOL, V253, pH1315, DOI 10.1152/ajpheart.1987.253.5.H1315; Rytter D, 2007, COMP BIOCHEM PHYS A, V147, P1083, DOI 10.1016/j.cbpa.2007.03.031; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Shiels HA, 2000, J EXP BIOL, V203, P2771; Shiels HA, 2006, J GEN PHYSIOL, V128, P37, DOI 10.1085/jgp.200609543; Shiels HA, 2008, J EXP BIOL, V211, P2005, DOI 10.1242/jeb.003145; Taggart P, 1996, CARDIOVASC RES, V32, P38; Taggart P, 1999, PROG BIOPHYS MOL BIO, V71, P139, DOI 10.1016/S0079-6107(98)00039-X; Vassort G, 2009, CAN J PHYSIOL PHARM, V87, P100, DOI 10.1139/Y08-112; Ward ML, 2008, PROG BIOPHYS MOL BIO, V97, P232, DOI 10.1016/j.pbiomolbio.2008.02.009; WHITE E, 2005, CARDIAC MECHANO ELEC, P83; White E, 2006, CURR PHARM DESIGN, V12, P3645, DOI 10.2174/138161206778522083; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548	58	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10548	10.1371/journal.pone.0010548	http://dx.doi.org/10.1371/journal.pone.0010548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479879	gold, Green Published, Green Submitted			2022-12-27	WOS:000277467800026
J	Soler, JJ; Aviles, JM				Soler, Juan J.; Aviles, Jesus M.			Sibling Competition and Conspicuousness of Nestling Gapes in Altricial Birds: A Comparative Study	PLOS ONE			English	Article							CONE PHOTORECEPTOR DISTRIBUTION; COLOR-VISION; VISUAL PIGMENTS; OIL DROPLETS; MOUTH COLOR; EVOLUTION; PATTERNS; NEED; PLUMAGE; CHICKS	Background: Nestlings of altricial birds capture parents' attention through conspicuous visual displays, including exposure of their gape coloration which informs parents about their level of need, competitive ability or health; information that parents use for deciding food allocation among their offspring. Thus, because nestlings compete with nest mates for parental care, nestling conspicuousness is expected to increase with level of sibling competition along bird phylogeny. Methodology/Principal Findings: We test this prediction by jointly using information of brood reduction, clutch size and duration of nestling period as proxies for intensity of sibling competition, and visual models that assess detectability of nestlings by adult birds. As predicted, we found a positive association between nestling conspicuousness and intensity of brood reduction, while clutch size and duration of nestling period did not enter in the best models. Level of brood reduction was positively related with the achromatic component of nestling conspicuousness and body mass was negatively related with the chromatic component. Conclusions: These associations are in agreement with the hypothesis that sibling competition for parental attention has driven the evolution of visual nestling conspicuousness in a context of parent-offspring communication in altricial birds.	[Soler, Juan J.; Aviles, Jesus M.] Estac Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Soler, JJ (corresponding author), Estac Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain.	jsoler@eeza.csic.es	Avilés, Jesús/K-3332-2014; Soler, J. J./H-2363-2011	Avilés, Jesús/0000-0002-1463-8393; Soler, J. J./0000-0003-2990-1489	Ministerio de Educacion y Ciencia/FEDER [CGL2004-01777/BOS, CGL2007-61251/BOS, CGL2008-00718/BOS]	Ministerio de Educacion y Ciencia/FEDER(Spanish Government)	This work was supported by the Ministerio de Educacion y Ciencia/FEDER, CGL2004-01777/BOS, CGL2007-61251/BOS, CGL2008-00718/BOS Junta de Andalucia grants to research groups RNM 340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Aviles JM, 2009, J EVOLUTION BIOL, V22, P376, DOI 10.1111/j.1420-9101.2008.01655.x; Aviles JM, 2008, AM NAT, V171, P327, DOI 10.1086/527493; Bize P, 2006, P R SOC B, V273, P2063, DOI 10.1098/rspb.2006.3546; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; BRISKIE JV, 1994, P ROY SOC B-BIOL SCI, V258, P73, DOI 10.1098/rspb.1994.0144; Burnham KP, 2007, MODEL SELECTION MULT; Cramp S., 1998, CRAMPS COMPLETE BIRD; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; de Ayala RM, 2007, BEHAV ECOL, V18, P526, DOI 10.1093/beheco/arm006; Doucet SM, 2007, AM NAT, V169, pS62, DOI 10.1086/510162; Drummond H, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P337, DOI 10.1007/0-306-47660-6_18; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Ewen JG, 2008, OECOLOGIA, V157, P361, DOI 10.1007/s00442-008-1073-3; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; Gomez D, 2007, AM NAT, V169, pS42, DOI 10.1086/510138; Gonzalez-Voyer A, 2007, EVOLUTION, V61, P1946, DOI 10.1111/j.1558-5646.2007.00152.x; Gotmark F, 1997, P ROY SOC B-BIOL SCI, V264, P959, DOI 10.1098/rspb.1997.0132; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2002, J EXP BIOL, V205, P3925; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 1998, J EXP BIOL, V201, P1433; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hastad O, 2005, P NATL ACAD SCI USA, V102, P6391, DOI 10.1073/pnas.0409228102; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Hunt S, 2003, P ROY SOC B-BIOL SCI, V270, pS25, DOI 10.1098/rsbl.2003.0009; Jonsson KA, 2006, ZOOL SCR, V35, P149, DOI 10.1111/j.1463-6409.2006.00221.x; Jourdie V, 2004, NATURE, V431, P262, DOI 10.1038/431262a; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Kilner RM, 1999, BEHAVIOUR, V136, P779, DOI 10.1163/156853999501568; KILNER RM, 2006, BIRD COLORATION, V2, P201; Krebs EA, 2004, BEHAV ECOL, V15, P946, DOI 10.1093/beheco/arh078; Lack D., 1954, P343; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mock D. W., 1997, EVOLUTION SIBLING RI; MOCK DW, 1994, J AVIAN BIOL, V25, P3, DOI 10.2307/3677288; Noble DG, 1999, BEHAVIOUR, V136, P759, DOI 10.1163/156853999501559; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Osorio D, 1999, J EXP BIOL, V202, P2951; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PERRINS CM, 1987, NUEVA GENERACION GUI; Ricklefs RE, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P283, DOI 10.1007/0-306-47660-6_15; Saino N, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P245, DOI 10.1007/0-306-47660-6_13; Saino N, 2003, BEHAV ECOL, V14, P16, DOI 10.1093/beheco/14.1.16; Saino N, 2000, P ROY SOC B-BIOL SCI, V267, P57, DOI 10.1098/rspb.2000.0966; Soler JJ, 1998, EVOL ECOL, V12, P427, DOI 10.1023/A:1006520821219; Soler JJ, 2007, ANIM BEHAV, V74, P1139, DOI 10.1016/j.anbehav.2006.09.026; Thorogood R, 2008, FUNCT ECOL, V22, P1044, DOI 10.1111/j.1365-2435.2008.01455.x; Tschirren B, 2005, OECOLOGIA, V143, P477, DOI 10.1007/s00442-004-1812-z; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	63	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10509	10.1371/journal.pone.0010509	http://dx.doi.org/10.1371/journal.pone.0010509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463902	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379800005
J	Mitchell, P; Mould, R; Dillon, J; Glautier, S; Andrianakis, I; James, C; Pugh, A; Holden-Dye, L; O'Connor, V				Mitchell, Philippa; Mould, Richard; Dillon, James; Glautier, Steven; Andrianakis, Ioannis; James, Christopher; Pugh, Amanda; Holden-Dye, Lindy; O'Connor, Vincent			A Differential Role for Neuropeptides in Acute and Chronic Adaptive Responses to Alcohol: Behavioural and Genetic Analysis in Caenorhabditis elegans	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ETHANOL TOLERANCE; PHARMACOLOGICAL EVIDENCE; POTASSIUM CHANNEL; NEURAL MECHANISMS; NATURAL VARIATION; OPIOID SYSTEMS; ANIMAL-MODELS; DARK SIDE; NEMATODE	Prolonged alcohol consumption in humans followed by abstinence precipitates a withdrawal syndrome consisting of anxiety, agitation and in severe cases, seizures. Withdrawal is relieved by a low dose of alcohol, a negative reinforcement that contributes to alcohol dependency. This phenomenon of 'withdrawal relief' provides evidence of an ethanol-induced adaptation which resets the balance of signalling in neural circuits. We have used this as a criterion to distinguish between direct and indirect ethanol-induced adaptive behavioural responses in C. elegans with the goal of investigating the genetic basis of ethanol-induced neural plasticity. The paradigm employs a 'food race assay' which tests sensorimotor performance of animals acutely and chronically treated with ethanol. We describe a multifaceted C. elegans 'withdrawal syndrome'. One feature, decrease reversal frequency is not relieved by a low dose of ethanol and most likely results from an indirect adaptation to ethanol caused by inhibition of feeding and a food-deprived behavioural state. However another aspect, an aberrant behaviour consisting of spontaneous deep body bends, did show withdrawal relief and therefore we suggest this is the expression of ethanol-induced plasticity. The potassium channel, slo-1, which is a candidate ethanol effector in C. elegans, is not required for the responses described here. However a mutant deficient in neuropeptides, egl-3, is resistant to withdrawal (although it still exhibits acute responses to ethanol). This dependence on neuropeptides does not involve the NPY-like receptor npr-1, previously implicated in C. elegans ethanol withdrawal. Therefore other neuropeptide pathways mediate this effect. These data resonate with mammalian studies which report involvement of a number of neuropeptides in chronic responses to alcohol including corticotrophin-releasing-factor (CRF), opioids, tachykinins as well as NPY. This suggests an evolutionarily conserved role for neuropeptides in ethanol-induced plasticity and opens the way for a genetic analysis of the effects of alcohol on a simple model system.	[Mitchell, Philippa; Mould, Richard; Dillon, James; Pugh, Amanda; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Glautier, Steven] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Andrianakis, Ioannis; James, Christopher] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Mitchell, P (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	lmhd@soton.ac.uk	James, Christopher/AAV-4770-2020; Glautier, Steven/H-5444-2011	Glautier, Steven/0000-0001-8852-3268; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483; Holden-Dye, Lindy/0000-0002-9704-1217	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; Medical Research Council (MRC); British Pharmacological Society; National Institutes of Health (NIH) National Center for Research Resources (NCRR); BBSRC [BB/E022251/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022251/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Pharmacological Society; National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Richard Mould, James Dillon and Yiannis Andrianakis were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom, through a joint Medical Research Council (MRC) and BBSRC, UK, Initiative in the Neurobiological Basis of Mental Health and Behaviour; Philippa Mitchell was funded by a BBSRC Priority Studentship in Interdisciplinary Brain Science. Amanda Pugh was funded by a vacation scholarship from the British Pharmacological Society. Some nematode strains used in this work were provided by the Caenorhabditis elegans Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, DIAGNOSTIC STAT MANU; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; BRENNER S, 1974, GENETICS, V77, P71; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis JR, 2008, ALCOHOL CLIN EXP RES, V32, P853, DOI 10.1111/j.1530-0277.2008.00639.x; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; EDWARDS G, 1976, BRIT MED J, V1, P1058, DOI 10.1136/bmj.1.6017.1058; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Faingold CL, 2004, ALCOHOL CLIN EXP RES, V28, P268, DOI 10.1097/01.ALC.0000113421.41962.8D; Gehlert DR, 2007, J NEUROSCI, V27, P2718, DOI 10.1523/JNEUROSCI.4985-06.2007; George DT, 2008, SCIENCE, V319, P1536, DOI 10.1126/science.1153813; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guest M, 2007, INT J PARASITOL, V37, P1577, DOI 10.1016/j.ijpara.2007.05.006; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS255; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Koob GF, 2008, P NATL ACAD SCI USA, V105, P8809, DOI 10.1073/pnas.0804354105; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 2006, NEUR ADD; Kwon JY, 2004, GENOMICS, V83, P600, DOI 10.1016/j.ygeno.2003.10.008; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Morgan PG, 1995, ALCOHOL CLIN EXP RES, V19, P1423, DOI 10.1111/j.1530-0277.1995.tb01002.x; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Pastor R, 2008, P NATL ACAD SCI USA, V105, P9070, DOI 10.1073/pnas.0710181105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Scholz H, 2009, J NEUROGENET, V23, P111, DOI 10.1080/01677060802471676; Schuckit MA, 2000, AM J ADDICTION, V9, P103, DOI 10.1080/10550490050173172; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Stewart J, 2008, PHILOS T R SOC B, V363, P3147, DOI 10.1098/rstb.2008.0084; Thorsell A, 2007, PEPTIDES, V28, P480, DOI 10.1016/j.peptides.2006.11.017; Thorsell A, 2010, PSYCHOPHARMACOLOGY, V209, P103, DOI 10.1007/s00213-010-1775-1; Thorsell A, 2008, ANN NY ACAD SCI, V1148, P136, DOI 10.1196/annals.1410.083; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Walker BM, 2008, NEUROPSYCHOPHARMACOL, V33, P643, DOI 10.1038/sj.npp.1301438; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	60	39	41	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10422	10.1371/journal.pone.0010422	http://dx.doi.org/10.1371/journal.pone.0010422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454655	Green Published, gold			2022-12-27	WOS:000277240300005
J	Schartau, JM; Kroger, RHH; Sjogreen, B				Schartau, J. Marcus; Kroger, Ronald H. H.; Sjogreen, Bodil			Dopamine Induces Optical Changes in the Cichlid Fish Lens	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; MULTIFOCAL LENSES; EPITHELIAL-CELLS; RETINA; PERMEABILITY; VERTEBRATES; VISUALIZATION; MOVEMENTS; RECEPTOR; RELEASE	The crystalline lens in the cichlid fish Aequidens pulcher undergoes a transformation of its optical properties every dawn and dusk as the eye adapts to changes in light conditions. During dusk the transformation result in an increase of the refractive power in the lens cortex, the outermost 40 percent. The change is thought to match the optical properties of the lens to the requirements of the retina. Using a short term in vitro lens culturing system together with optical measurements we here present data that confirm that the optical properties of the lens can change within hours and that dopamine influences the optical properties of the lens. Dopamine yields dose-dependent decrease of the refractive power in the lens cortex. The D1-agonist SKF-38393 induces a similar decrease of the refractive power in the cortex, while the D2-agonist quinpirole has no effect. The effect of dopamine can be blocked by using the D1-antagonist SCH 23390. Our results suggest that dopamine alone could be responsible for the light/dark adaptive optical changes in the lens, but the involvement of other signaling substances cannot be ruled out.	[Schartau, J. Marcus; Kroger, Ronald H. H.; Sjogreen, Bodil] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Schartau, JM (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	marcus.schartau@cob.lu.se	Kroger, Ronald/L-2090-2016	Kroger, Ronald/0000-0002-6006-6728	Swedish Research Council [2005-2852]; Royal Physiographic Society in Lund; Lars Hierta Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Lars Hierta Memorial Foundation	The study was supported by grant 2005-2852 from the Swedish Research Council to R. H. H. K. and grants from the Royal Physiographic Society in Lund and the Lars Hierta Memorial Foundation to J.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; Burnside B, 2001, Prog Brain Res, V131, P477; Burnside B., 1983, PROG RETIN RES, V2, P67, DOI [10.1016/0278-4327(83)90004-4, DOI 10.1016/0278-4327(83)90004-4]; Cardinaud B, 1997, J BIOL CHEM, V272, P2778, DOI 10.1074/jbc.272.5.2778; Churchill GC, 1999, AM J PHYSIOL-CELL PH, V276, pC426, DOI 10.1152/ajpcell.1999.276.2.C426; DEARRY A, 1989, J NEUROCHEM, V53, P870, DOI 10.1111/j.1471-4159.1989.tb11785.x; Delgado MJ, 2001, NEUROSCI LETT, V300, P129, DOI 10.1016/S0304-3940(01)01560-9; DOUGLAS RH, 1982, J EXP BIOL, V96, P389; FRAIL DE, 1993, MOL PHARMACOL, V44, P1113; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Karpestam B, 2007, J EXP BIOL, V210, P2923, DOI 10.1242/jeb.002956; KOLBINGER W, 1990, VISUAL NEUROSCI, V5, P143, DOI 10.1017/S0952523800000183; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2; Lind OE, 2008, J EXP BIOL, V211, P2752, DOI 10.1242/jeb.018630; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Malkki PE, 2005, J OPT A-PURE APPL OP, V7, P691, DOI 10.1088/1464-4258/7/11/012; Malmstrom T, 2006, J EXP BIOL, V209, P18, DOI 10.1242/jeb.01959; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; MCCORMACK CA, 1994, J GEN PHYSIOL, V103, P487, DOI 10.1085/jgp.103.3.487; Nguyen TA, 2003, EXP EYE RES, V76, P565, DOI 10.1016/S0014-4835(03)00049-6; Ohngemach S, 1997, VISUAL NEUROSCI, V14, P493, DOI 10.1017/S0952523800012153; Schartau JM, 2009, CURR BIOL, V19, P122, DOI 10.1016/j.cub.2008.11.062; SROCZYNSKI S, 1977, J COMP PHYSIOL, V121, P135, DOI 10.1007/BF00614185; Vaghefi E, 2009, PHYSIOL MEAS, V30, P1061, DOI 10.1088/0967-3334/30/10/007; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; VOORTER CEM, 1989, BIOCHIM BIOPHYS ACTA, V986, P8, DOI 10.1016/0005-2736(89)90265-4; WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P5667, DOI 10.1073/pnas.90.12.5667	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10402	10.1371/journal.pone.0010402	http://dx.doi.org/10.1371/journal.pone.0010402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454461	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100014
J	Dong, J; Jiang, GQ; Asmann, YW; Tomaszek, S; Jen, J; Kislinger, T; Wigle, DA				Dong, Jie; Jiang, Guoqian; Asmann, Yan W.; Tomaszek, Sandra; Jen, Jin; Kislinger, Thomas; Wigle, Dennis A.			MicroRNA Networks in Mouse Lung Organogenesis	PLOS ONE			English	Article							EXPRESSION PROFILES; EMBRYONIC LUNG; MESSENGER-RNAS; BINDING-SITES; IDENTIFICATION; CANCER; PATHWAY; TARGETS; ADENOCARCINOMAS; PROLIFERATION	Background: MicroRNAs (miRNAs) are known to be important regulators of both organ development and tumorigenesis. MiRNA networks and their regulation of messenger RNA (mRNA) translation and protein expression in specific biological processes are poorly understood. Methods: We explored the dynamic regulation of miRNAs in mouse lung organogenesis. Comprehensive miRNA and mRNA profiling was performed encompassing all recognized stages of lung development beginning at embryonic day 12 and continuing to adulthood. We analyzed the expression patterns of dynamically regulated miRNAs and mRNAs using a number of statistical and computational approaches, and in an integrated manner with protein levels from an existing mass-spectrometry derived protein database for lung development. Results: In total, 117 statistically significant miRNAs were dynamically regulated during mouse lung organogenesis and clustered into distinct temporal expression patterns. 11,220 mRNA probes were also shown to be dynamically regulated and clustered into distinct temporal expression patterns, with 3 major patterns accounting for 75% of all probes. 3,067 direct miRNA-mRNA correlation pairs were identified involving 37 miRNAs. Two defined correlation patterns were observed upon integration with protein data: 1) increased levels of specific miRNAs directly correlating with downregulation of predicted mRNA targets; and 2) increased levels of specific miRNAs directly correlating with downregulation of translated target proteins without detectable changes in mRNA levels. Of 1345 proteins analyzed, 55% appeared to be regulated in this manner with a direct correlation between miRNA and protein level, but without detectable change in mRNA levels. Conclusion: Systematic analysis of microRNA, mRNA, and protein levels over the time course of lung organogenesis demonstrates dynamic regulation and reveals 2 distinct patterns of miRNA-mRNA interaction. The translation of target proteins affected by miRNAs independent of changes in mRNA level appears to be a prominent mechanism of developmental regulation in lung organogenesis.	[Dong, Jie; Tomaszek, Sandra; Wigle, Dennis A.] Mayo Clin, Div Gen Thorac Surg, Ctr Canc, Rochester, MN 55905 USA; [Jiang, Guoqian; Asmann, Yan W.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kislinger, Thomas] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	Mayo Clinic; Mayo Clinic; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dong, J (corresponding author), Mayo Clin, Div Gen Thorac Surg, Ctr Canc, Rochester, MN 55905 USA.	wigle.dennis@mayo.edu	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong J, 2009, CANCER BIOL THER, V8, P312, DOI 10.4161/cbt.8.4.7522; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	54	62	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10854	10.1371/journal.pone.0010854	http://dx.doi.org/10.1371/journal.pone.0010854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520778	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500038
J	Pitala, N; Siitari, H; Gustafsson, L; Brommer, JE				Pitala, Natalia; Siitari, Heli; Gustafsson, Lars; Brommer, Jon E.			Costs and Benefits of Experimentally Induced Changes in the Allocation of Growth versus Immune Function under Differential Exposure to Ectoparasites	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; NESTLING GREAT TITS; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; GLUTATHIONE DEPLETION; LOCAL RECRUITMENT; RESPONSES; PARASITE; BIRD; IMMUNOCOMPETENCE	Background: Ecological immunology has focused on the costs of investment in immunocompetence. However, understanding optimal resource allocation to immune defence requires also identification of its benefits, which are likely to occur only when parasites are abundant. Methodology: We manipulated the abundance of parasitic hen fleas in blue tit (Cyanistes caeruleus) nests, and supplemented their hosts, the nestlings, with methionine (a sulphur amino acid enhancing cell-mediated immunity) during day 3-6. We found a significant interaction between these two experimental factors on the development of immune defences and growth rates. Only in parasitized nests did methionine supplementation boost immune (PHA) response, and did nestling with experimentally increased immunocompetence show a relatively faster growth rate than control nestlings between days 6-9. Hence, the allocation of resources into immune defence and its growth-benefits are apparent only in presence of parasites. The main cost of methionine-induced increased allocation to the immune system was an increase in mortality, independently of ectoparasites. Nestlings in all treatments compensated initial growth reduction and all reached equal body size at day 16 (just prior to fledging), indicating a lack of long-term benefits. In addition, methionine treatment tended (P = 0.09) to lower circulating plasma immunoglobulin levels, possibly indicating a trade-off between the cell-mediated and humoral components of the immune system. Conclusions: We found no strong benefits of an increased investment in immunocompetence in a parasite-rich environment. Any deviation from the growth trajectory (due to changes in allocation induced by methionine) is largely detrimental for survival. Hence, while costs are apparent identifying the benefits of investment in immunocompetence during ontogeny is challenging.	[Pitala, Natalia; Brommer, Jon E.] Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, Helsinki, Finland; [Siitari, Heli] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Pitala, Natalia; Gustafsson, Lars] Uppsala Univ, Dept Anim Ecol Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden	University of Helsinki; University of Jyvaskyla; Uppsala University	Pitala, N (corresponding author), Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, Helsinki, Finland.	jon.brommer@helsinki.fi	Gustafsson, Lars/A-7634-2012; Gustafsson, Lars/O-8056-2019; Brommer, Jon E/C-3613-2008	Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Brommer, Jon E/0000-0002-2435-2612	Academy of Finland [1106104, 1118484, 1131390]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (www.aka.fi) grant numbers 1106104, 1118484 and 1131390 (to J.E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APANIUS V, 1998, AVIAN GROWTH DEV EVO; Baker DH, 2006, J NUTR, V136, p1670S, DOI 10.1093/jn/136.6.1670S; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Bjorklund M, 1997, J EVOLUTION BIOL, V10, P139, DOI 10.1046/j.1420-9101.1997.10020139.x; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Christe P, 2000, HEREDITY, V85, P75, DOI 10.1046/j.1365-2540.2000.00732.x; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Deng K, 2007, ANIM FEED SCI TECH, V134, P66, DOI 10.1016/j.anifeedsci.2006.05.008; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; GMUNDER H, 1991, CELL IMMUNOL, V138, P229, DOI 10.1016/0008-8749(91)90147-4; Grimble RF, 1998, NUTRITION, V14, P605, DOI 10.1016/S0899-9007(98)80041-5; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; GROSS RL, 1980, PHYSIOL REV, V60, P188, DOI 10.1152/physrev.1980.60.1.188; HARPER GH, 1992, J ANIM ECOL, V61, P317, DOI 10.2307/5324; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; Kilpimaa J, 2005, EVOLUTION, V59, P2483, DOI 10.1554/04-678.1; KINSCHERF R, 1994, FASEB J, V8, P448, DOI 10.1096/fasebj.8.6.7909525; LIANG CM, 1989, J BIOL CHEM, V264, P13519; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Merino S, 2001, INT J PARASITOL, V31, P1187, DOI 10.1016/S0020-7519(01)00243-0; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; NUR N, 1984, J ANIM ECOL, V53, P497, DOI 10.2307/4530; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Pitala N, 2009, EVOL ECOL RES, V11, P79; Potti J, 1999, OECOLOGIA, V120, P1, DOI 10.1007/s004420050826; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; Rubin LL, 2007, BRAZ J POULT SCI, V9, P241, DOI 10.1590/S1516-635X2007000400006; Saino N, 1998, OIKOS, V81, P217, DOI 10.2307/3547043; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tripet F, 1999, ECOLOGY, V80, P1267, DOI 10.1890/0012-9658(1999)080[1267:DDPITP]2.0.CO;2; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2007, FUNCT ECOL, V21, P372, DOI 10.1111/j.1365-2435.2007.01235.x; Tschirren B, 2006, P ROY SOC B-BIOL SCI, V273, P1773, DOI 10.1098/rspb.2006.3524; TSIAGBE VK, 1987, POULTRY SCI, V66, P1147, DOI 10.3382/ps.0661147	53	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10814	10.1371/journal.pone.0010814	http://dx.doi.org/10.1371/journal.pone.0010814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520832	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034800011
J	Kapoula, Z; Yang, Q; Bonnet, A; Bourtoire, P; Sandretto, J				Kapoula, Zoi; Yang, Qing; Bonnet, Audrey; Bourtoire, Pauline; Sandretto, Jean			EMDR Effects on Pursuit Eye Movements	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POSTERIOR PARIETAL CORTEX; SMOOTH-PURSUIT; AUTOBIOGRAPHICAL MEMORIES; DESENSITIZATION; SCHIZOPHRENIA; SACCADES; TRACKING; DEFICITS; FMRI	This study aimed to objectivize the quality of smooth pursuit eye movements in a standard laboratory task before and after an Eye Movement Desensitization and Reprocessing (EMDR) session run on seven healthy volunteers. EMDR was applied on autobiographic worries causing moderate distress. The EMDR session was complete in 5 out of the 7 cases; distress measured by SUDS (Subjective Units of Discomfort Scale) decreased to a near zero value. Smooth pursuit eye movements were recorded by an Eyelink II video system before and after EMDR. For the five complete sessions, pursuit eye movement improved after their EMDR session. Notably, the number of saccade intrusions-catch-up saccades (CUS)-decreased and, reciprocally, there was an increase in the smooth components of the pursuit. Such an increase in the smoothness of the pursuit presumably reflects an improvement in the use of visual attention needed to follow the target accurately. Perhaps EMDR reduces distress thereby activating a cholinergic effect known to improve ocular pursuit.	[Kapoula, Zoi; Yang, Qing; Bonnet, Audrey; Bourtoire, Pauline] Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, FRE 3154, Lab IRIS,CNRS, Paris, France; [Bonnet, Audrey; Bourtoire, Pauline] Univ Catholique, Ecole Psychol Praticiens, Paris, France; [Sandretto, Jean] EMDR Assoc France, Res Comm, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kapoula, Z (corresponding author), Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, FRE 3154, Lab IRIS,CNRS, Paris, France.	zoi.kapoula@egp.aphp.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This study is funded by CNRS (www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; Armstrong MS, 1996, J BEHAV THER EXP PSY, V27, P21, DOI 10.1016/0005-7916(95)00056-9; Aubert-Khalfa S, 2008, J EMDR PRACT RES, V2, P51, DOI 10.1891/1933-3196.2.1.51; Barrowcliff AL, 2004, J FORENSIC PSYCHI PS, V15, P325, DOI 10.1080/14789940410001673042; Barrowcliff AL, 2003, BRIT J CLIN PSYCHOL, V42, P289, DOI 10.1348/01446650360703393; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BLACK JL, 1984, PERCEPT MOTOR SKILL, V59, P91, DOI 10.2466/pms.1984.59.1.91; Breese CR, 2000, NEUROPSYCHOPHARMACOL, V23, P351, DOI 10.1016/S0893-133X(00)00121-4; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Elofsson UOE, 2008, J ANXIETY DISORD, V22, P622, DOI 10.1016/j.janxdis.2007.05.012; Frazier SH, 1998, AM J PSYCHIAT, V155, P20; FRIEDMAN L, 1992, BIOL PSYCHIAT, V31, P1110, DOI 10.1016/0006-3223(92)90155-S; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Hogberg G, 2007, NORD J PSYCHIAT, V61, P54, DOI 10.1080/08039480601129408; Hong LE, 2003, SCHIZOPHR RES, V63, P39, DOI 10.1016/S0920-9964(02)00388-2; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; Karoumi B, 2001, PSYCHIAT RES, V101, P209, DOI 10.1016/S0165-1781(01)00227-X; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lansing K, 2005, J NEUROPSYCH CLIN N, V17, P526, DOI 10.1176/appi.neuropsych.17.4.526; Lee CW, 2008, J ANXIETY DISORD, V22, P801, DOI 10.1016/j.janxdis.2007.08.007; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Levin P, 1999, J ANXIETY DISORD, V13, P159, DOI 10.1016/S0887-6185(98)00045-0; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Macculloch MJ, 1996, BRIT J PSYCHIAT, V169, P571, DOI 10.1192/bjp.169.5.571; Moschner C, 1999, BRAIN, V122, P2147, DOI 10.1093/brain/122.11.2147; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Ross RG, 2002, PSYCHOPHYSIOLOGY, V39, P809, DOI 10.1111/1469-8986.3960809; Sack M, 2008, J ANXIETY DISORD, V22, P1264, DOI 10.1016/j.janxdis.2008.01.007; Shapiro F., 2001, EYE MOVEMENT DESENSI; SHAPIRO F, 1995, EYE MOVEMENT DENSITI; Sherr JD, 2002, BIOL PSYCHIAT, V52, P721, DOI 10.1016/S0006-3223(02)01342-2; Sweeney JA, 1998, BIOL PSYCHIAT, V44, P698, DOI 10.1016/S0006-3223(98)00035-3; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; THYER BA, 1984, J BEHAV THER EXP PSY, V15, P3, DOI 10.1016/0005-7916(84)90115-0; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Tregellas JR, 2005, AM J PSYCHIAT, V162, P391, DOI 10.1176/appi.ajp.162.2.391; Trillenberg P, 2004, CURR OPIN NEUROL, V17, P43, DOI 10.1097/00019052-200402000-00008; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121; VANGELDER P, 1995, VISION RES, V35, P667, DOI 10.1016/0042-6989(94)00161-E; Wilson DL, 1996, J BEHAV THER EXP PSY, V27, P219, DOI 10.1016/S0005-7916(96)00026-2; WOLPE J, 1991, J BEHAV THER EXP PSY, V22, P39, DOI 10.1016/0005-7916(91)90032-Z; Yang Q, 2004, INVEST OPHTH VIS SCI, V45, P2231, DOI 10.1167/iovs.03-1291	49	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10762	10.1371/journal.pone.0010762	http://dx.doi.org/10.1371/journal.pone.0010762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	600VQ	20505828	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017400017
J	Williams, JT; Carpenter, KE; Van Tassell, JL; Hoetjes, P; Toller, W; Etnoyer, P; Smith, M				Williams, Jeffrey T.; Carpenter, Kent E.; Van Tassell, James L.; Hoetjes, Paul; Toller, Wes; Etnoyer, Peter; Smith, Michael			Biodiversity Assessment of the Fishes of Saba Bank Atoll, Netherlands Antilles	PLOS ONE			English	Article								Biodiversity surveys were conducted on Saba Bank, Netherlands Antilles, to assess ichthyofaunal richness and to compare with published surveys of other Caribbean localities. The primary objective was to estimate the total species richness of the Saba Bank ichthyofauna. A variety of sampling techniques was utilized to survey the fish species of both the visually accessible megafauna and the camouflaged and small-sized species comprising the cryptic ichthyofauna. Based on results presented herein, the number of species known on Saba Bank is increased from 42 previously known species to 270 species. Expected species-accumulation curves demonstrate that the current estimate of species richness of fishes for Saba Bank under represents the actual richness, and our knowledge of the ichthyofauna has not plateaued. The total expected fish-species richness may be somewhere between 320 and 411 species. The Saba Bank ichthyofaunal assemblage is compared to fish assemblages found elsewhere in the Caribbean. Despite the absence of shallow or emergent shore habitats like mangroves, Saba Bank ranks as having the eighth highest ichthyofaunal richness of surveyed localities in the Greater Caribbean. Some degree of habitat heterogeneity was evident. Fore-reef, patch-reef, and lagoonal habitats were sampled. Fish assemblages were significantly different between habitats. Species richness was highest on the fore reef, but 11 species were found only at lagoonal sites. A comprehensive, annotated list of the fishes currently known to occur on Saba Bank, Netherland Antilles, is provided and color photographs of freshly collected specimens are presented for 165 of the listed species of Saba Bank fishes to facilitate identification and taxonomic comparison with similar taxa at other localities. Coloration of some species is shown for the first time. Preliminary analysis indicates that at least six undescribed new species were collected during the survey and these are indicated in the annotated list.	[Williams, Jeffrey T.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Fish Div, Suitland, MD USA; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Van Tassell, James L.] Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA; [Hoetjes, Paul] Minist Publ Hlth & Social Dev, Dept Environm & Nat, Curacao, Neth Antilles; [Toller, Wes] Saba Conservat Fdn, Ft Bay, Saba, Neth Antilles; [Etnoyer, Peter] Texas A&M Univ Corpus Christi, Harte Res Inst, Corpus Christi, TX USA; [Smith, Michael] Conservat Int Arlington, Ctr Appl Biodivers Sci, Arlington, VA USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Old Dominion University; American Museum of Natural History (AMNH); Texas A&M University System; Texas A&M University Corpus Christi; Conservation International	Williams, JT (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Fish Div, Suitland, MD USA.	williamsjt@si.edu			Department of Environment and Nature of the Netherlands Antilles; Conservation International	Department of Environment and Nature of the Netherlands Antilles; Conservation International	The Department of Environment and Nature of the Netherlands Antilles and Conservation International provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlke J. E., 1968, FISHES BAHAMAS ADJAC; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CLAVIJO IE, 1980, SPECIAL PUBLICATION; Collette Bruce B., 2003, Aqua (Miradolo Terme), V6, P89; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Dennis GD, 2005, CARIBB J SCI, V41, P716; Lavett C., 2003, ATOLL RES B, V497, P1, DOI [10.5479/si.00775630.497.1, DOI 10.5479/SI.00775630.497.1]; LONGLEY WH, 1941, CARNEGIE I WASHINGTO, V535; MEESTERS EH, 1996, SUSTAINABLE MA UNPUB; Mejia Luz Stella, 1998, Boletin Ecotropica, V32, P25; Smith-Vaniz W.F., 1999, SPECIAL PUBLICATION, V4; Smith-Vaniz WF, 2006, B MAR SCI, V79, P17; Starck WA, 1968, UNDERSEA BIOL, V1, P5; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; WILLIAMS JT, 2003, SPECIAL PUBLICATION, V5, P1761	15	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10676	10.1371/journal.pone.0010676	http://dx.doi.org/10.1371/journal.pone.0010676			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505760	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017400007
J	Noren Hooten, N; Abdelmohsen, K; Gorospe, M; Ejiogu, N; Zonderman, AB; Evans, MK				Noren Hooten, Nicole; Abdelmohsen, Kotb; Gorospe, Myriam; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.			microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age	PLOS ONE			English	Article							CELLULAR SENESCENCE; LIFE-SPAN; REPLICATIVE SENESCENCE; RECEPTOR; RECOGNITION; SUPPRESSION; P16(INK4A); REDUCTION; PATHWAYS; SUBSETS	Recent evidence supports a role for microRNAs (miRNAs) in regulating the life span of model organisms. However, little is known about how these small RNAs contribute to human aging. Here, we profiled the expression of over 800 miRNAs in peripheral blood mononuclear cells from young and old individuals by real-time RT-PCR analysis. This genome-wide assessment of miRNA expression revealed that the majority of miRNAs studied decreased in abundance with age. We identified nine miRNAs (miR-103, miR-107, miR-128, miR-130a, miR-155, miR-24, miR-221, miR-496, miR-1538) that were significantly lower in older individuals. Among them, five have been implicated in cancer pathogenesis. Predicted targets of several of these miRNAs, including PI3 kinase (PI3K), c-Kit and H2AX, were found to be elevated with advancing age, supporting a possible role for them in the aging process. Furthermore, we found that decreasing the levels of miR-221 was sufficient to cause a corresponding increase in the expression of the predicted target, PI3K. Taken together, these findings demonstrate that changes in miRNA expression occur with human aging and suggest that miRNAs and their predicted targets have the potential to be diagnostic indicators of age or age-related diseases.	[Noren Hooten, Nicole; Abdelmohsen, Kotb; Gorospe, Myriam; Evans, Michele K.] NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; [Ejiogu, Ngozi; Evans, Michele K.] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Zonderman, Alan B.] NIA, Lab Personal & Cognit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Noren Hooten, N (corresponding author), NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA.	evansmi@grc.nia.nih.gov	Evans, Michele Kim/AAE-4776-2019; Huang, H/E-9490-2010; Noren Hooten, Nicole/J-5498-2019; Zonderman, Alan B/A-5807-2013; Ezike, Ngozi/AAL-3075-2021; Abdelmohsen, Kotb/AAX-4191-2020	Noren Hooten, Nicole/0000-0002-1683-3838; Zonderman, Alan B/0000-0003-3530-2319; Abdelmohsen, Kotb/0000-0001-6240-5810; Zonderman, Alan B/0000-0002-6523-4778; Evans, Michele/0000-0002-8546-2831	National Institute of Aging Intramural Research Program at the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000519, ZIAAG000394, ZIAAG000513] Funding Source: NIH RePORTER	National Institute of Aging Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study has been supported in full by National Institute of Aging Intramural Research Program at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BATES DJ, 2009, AGING CELL; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; DEPAOLI P, 1988, CLIN IMMUNOL IMMUNOP, V48, P290, DOI 10.1016/0090-1229(88)90022-0; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI N, 2009, NEUROBIOL AGING; Liang RQ, 2009, CURR GENOMICS, V10, P184, DOI 10.2174/138920209788185225; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x	50	250	261	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10724	10.1371/journal.pone.0010724	http://dx.doi.org/10.1371/journal.pone.0010724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505758	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017300004
J	Prasmickaite, L; Engesaeter, BO; Skrbo, N; Hellenes, T; Kristian, A; Oliver, NK; Suo, ZH; Maelandsmo, GM				Prasmickaite, Lina; Engesaeter, Birgit O.; Skrbo, Nirma; Hellenes, Tina; Kristian, Alexandr; Oliver, Nina K.; Suo, Zhenhe; Maelandsmo, Gunhild M.			Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST CANCERS; EXPRESSION; MARKER; CHEMOTHERAPY; THERAPY; TUMORS	Background: Malignant melanoma is an exceptionally aggressive, drug-resistant and heterogeneous cancer. Recently it has been shown that melanoma cells with high clonogenic and tumourigenic abilities are common, but markers distinguishing such cells from cells lacking these abilities have not been identified. There is therefore no definite evidence that an exclusive cell subpopulation, i.e. cancer stem cells (CSC), exists in malignant melanoma. Rather, it is suggested that multiple cell populations are implicated in initiation and progression of the disease, making it of importance to identify subpopulations with elevated aggressive properties. Methods and Findings: In several other cancer forms, Aldehyde Dehydrogenase (ALDH), which plays a role in stem cell biology and resistance, is a valuable functional marker for identification of cells that show enhanced aggressiveness and drug-resistance. Furthermore, the presence of ALDH(+) cells is linked to poor clinical prognosis in these cancers. By analyzing cell cultures, xenografts and patient biopsies, we showed that aggressive melanoma harboured a large, distinguishable ALDH(+) subpopulation. In vivo, ALDH(+) cells gave rise to ALDH(-) cells, while the opposite conversion was rare, indicating a higher abilities of ALDH(+) cells to reestablish tumour heterogeneity with respect to the ALDH phenotype. However, both ALDH(+) and ALDH(-) cells demonstrated similarly high abilities for clone formation in vitro and tumour initiation in vivo. Furthermore, both subpopulations showed similar sensitivity to the anti-melanoma drugs, dacarbazine and lexatumumab. Conclusions: These findings suggest that ALDH does not distinguish tumour-initiating and/or therapy-resistant cells, implying that the ALDH phenotype is not associated with more-aggressive subpopulations in malignant melanoma, and arguing against ALDH as a "universal'' marker. Besides, it was shown that the ability to reestablish tumour heterogeneity is not necessarily linked to the more aggressive phenotype.	[Prasmickaite, Lina; Engesaeter, Birgit O.; Skrbo, Nirma; Hellenes, Tina; Kristian, Alexandr; Maelandsmo, Gunhild M.] Oslo Univ Hosp, Radiumhosp, Dept Tumour Biol, Oslo, Norway; [Oliver, Nina K.] Oslo Univ Hosp, Radiumhosp, Dept Surg, Oslo, Norway; [Suo, Zhenhe] Oslo Univ Hosp, Radiumhosp, Dept Pathol, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Prasmickaite, L (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Tumour Biol, Oslo, Norway.	linap@rr-research.no	Mælandsmo, Gunhild Mari/AFV-4446-2022		South-Eastern Norway Regional Health Authority; Cancer Stem Cell Innovation Center [174938]; Jeanette and Soerenren Bothners Legacy	South-Eastern Norway Regional Health Authority; Cancer Stem Cell Innovation Center; Jeanette and Soerenren Bothners Legacy	This work was supported by South-Eastern Norway Regional Health Authority, Cancer Stem Cell Innovation Center (Grant. No 174938) and Jeanette and Soerenren Bothners Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; MORGAN AC, 1981, HYBRIDOMA, V1, P27, DOI 10.1089/hyb.1.1981.1.27; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; PRASMICKAITE L, 2010, CELL MELANO IN PRESS; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	24	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10731	10.1371/journal.pone.0010731	http://dx.doi.org/10.1371/journal.pone.0010731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505780	gold, Green Submitted, Green Published			2022-12-27	WOS:000278017300007
J	Papatheodorou, P; Zamboglou, C; Genisyuerek, S; Guttenberg, G; Aktories, K				Papatheodorou, Panagiotis; Zamboglou, Constantinos; Genisyuerek, Selda; Guttenberg, Gregor; Aktories, Klaus			Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							DIFFICILE TOXIN; INDEPENDENT ENDOCYTOSIS; CHOLERA-TOXIN; LIPID RAFTS; RECEPTOR; INTERNALIZATION; INHIBITION; DYNAMIN; RHO; CYTOTOXICITY	Clostridium difficile toxin A (TcdA) and toxin B (TcdB), C. sordellii lethal toxin (TcsL) and C. novyi alpha-toxin (TcnA) are important pathogenicity factors, which represent the family of the clostridial glucosylating toxins (CGTs). Toxin A and B are associated with antibiotic-associated diarrhea and pseudomembraneous colitis. Lethal toxin is involved in toxic shock syndrome after abortion and alpha-toxin in gas gangrene development. CGTs enter cells via receptor-mediated endocytosis and require an acidified endosome for translocation of the catalytic domain into the cytosol. Here we studied the endocytic processes that mediate cell internalization of the CGTs. Intoxication of cells was monitored by analyzing cell morphology, status of Rac glucosylation in cell lysates and transepithelial resistance of cell monolayers. We found that the intoxication of cultured cells by CGTs was strongly delayed when cells were preincubated with dynasore, a cell-permeable inhibitor of dynamin, or chlorpromazine, an inhibitor of the clathrin-dependent endocytic pathway. Additional evidence about the role of clathrin in the uptake of the prototypical CGT family member toxin B was achieved by expression of a dominant-negative inhibitor of the clathrin-mediated endocytosis (Eps15 DN) or by siRNA against the clathrin heavy chain. Accordingly, cells that expressed dominant-negative caveolin-1 were not protected from toxin B-induced cell rounding. In addition, lipid rafts impairment by exogenous depletion of sphingomyelin did not decelerate intoxication of HeLa cells by CGTs. Taken together, our data indicate that the endocytic uptake of the CGTs involves a dynamin-dependent process that is mainly governed by clathrin.	[Papatheodorou, Panagiotis; Zamboglou, Constantinos; Genisyuerek, Selda; Guttenberg, Gregor; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Freiburg, Germany	University of Freiburg	Papatheodorou, P (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Papatheodorou, Panagiotis/N-7509-2015; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AK6/16-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Benmerah A, 1999, J CELL SCI, V112, P1303; BETTE P, 1989, INFECT IMMUN, V57, P2507, DOI 10.1128/IAI.57.8.2507-2513.1989; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; BORIELLO SP, 2005, TOPLEY WILSONS MICRO, P1089; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Fujimoto T, 2000, J CELL SCI, V113, P3509; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Ho CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.023; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Just I., 1997, BACTERIAL TOXINS TOO, P159; Kelly CP, 1998, ANNU REV MED, V49, P375; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; KRIVAN HC, 1987, INFECT IMMUN, V55, P1873, DOI 10.1128/IAI.55.8.1873-1877.1987; KUSHNARYOV VM, 1989, INFECT IMMUN, V57, P3914, DOI 10.1128/IAI.57.12.3914-3921.1989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Matsuda S, 2010, INFECT IMMUN, V78, P603, DOI 10.1128/IAI.00946-09; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mirre C, 1996, AM J PHYSIOL-CELL PH, V271, pC887, DOI 10.1152/ajpcell.1996.271.3.C887; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Tsokos M, 2008, INT J LEGAL MED, V122, P35, DOI 10.1007/s00414-007-0163-9; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	51	115	118	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10673	10.1371/journal.pone.0010673	http://dx.doi.org/10.1371/journal.pone.0010673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498856	Green Published, Green Submitted, gold			2022-12-27	WOS:000277773700016
J	Roblek, M; Schuchner, S; Huber, V; Ollram, K; Vlcek-Vesely, S; Foisner, R; Wehnert, M; Ogris, E				Roblek, Marko; Schuechner, Stefan; Huber, Veronika; Ollram, Katrin; Vlcek-Vesely, Sylvia; Foisner, Roland; Wehnert, Manfed; Ogris, Egon			Monoclonal Antibodies Specific for Disease-Associated Point-Mutants: Lamin A/C R453W and R482W	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; PARTIAL LIPODYSTROPHY; INTERPHASE NUCLEI; CRYSTAL-STRUCTURE; MUTATIONS; LAMINOPATHIES; CARDIOMYOPATHY; PROTEIN	Background: Disease-linked missense mutations can alter a protein's function with fatal consequences for the affected individual. How a single amino acid substitution in a protein affects its properties, is difficult to study in the context of the cellular proteome, because mutant proteins can often not be traced in cells due to the lack of mutation-specific detection tools. Antibodies, however, with their exquisite epitope specificity permit the detection of single amino acid substitutions but are not available for the vast majority of disease-causing mutant proteins. One of the most frequently missense-mutated human genes is the LMNA gene coding for A-type lamins. Mutations in LMNA cause phenotypically heterogenous, mostly autosomal-dominant inherited diseases, termed laminopathies. The molecular mechanisms underlying the phenotypic heterogeneity of laminopathies, however, are not well understood. Hence, the goal of this study was the development of monoclonal antibodies specific for disease-linked point-mutant A-type lamins. Methodology/Principal Findings: Using two different approaches of antigen presentation, namely KLH-coupled peptides and the display of a complete protein domain fused to the Hepatitis B virus capsid protein, we developed monoclonal antibodies against two disease-associated lamin A/C mutants. Both antibodies display exquisite specificity for the respective mutant proteins. We show that with the help of these novel antibodies it is now possible for the first time to study specifically the properties of the mutant proteins in primary patient cells in the background of wild-type protein. Conclusions: We report here the development of two point-mutant specific antibodies against A-type lamins. While synthetic peptides may be the prime choice of antigen, our results show that a given target sequence may have to be presented in alternative ways to ensure the induction of a mutant-specific immune response. Point-mutant specific antibodies will represent valuable tools for basic and clinical research on a number of hereditary as well as acquired diseases caused by dominant missense mutations.	[Roblek, Marko; Schuechner, Stefan; Huber, Veronika; Ollram, Katrin; Vlcek-Vesely, Sylvia; Foisner, Roland; Ogris, Egon] Med Univ Vienna, Dept Med Biochem, Max Perutz Labs, Vienna, Austria; [Wehnert, Manfed] Ernst Moritz Arndt Univ Greifswald, Inst Human Genet, Greifswald, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Ernst Moritz Arndt Universitat Greifswald	Roblek, M (corresponding author), Med Univ Vienna, Dept Med Biochem, Max Perutz Labs, Vienna, Austria.	egon.ogris@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019	Ogris, Egon/0000-0001-5950-9264; Foisner, Roland/0000-0003-4734-4647	Austrian Science Foundation [FWF L340-B05, FWF L697-B20]; Austrian Science Fund (FWF) [L 697] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported primarily by grants FWF L340-B05 and FWF L697-B20 from the Austrian Science Foundation (http://www.fwf.ac.at/) and to a minor extent by royalty payments from licensing agreements (for the sales of antibodies not used in this study) with the biotechnology companies Millipore Corporation and Santa Cruz Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Benjamin DC, 1995, ADV EXP MED BIOL, V386, P95; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8; GOTZMANN J, 2004, MOL MECH MUSCULAR DY, P1; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Harlow E., 1988, ANTIBODIES LAB MANUA; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Khan S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-56; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Magracheva E, 2009, ACTA CRYSTALLOGR F, V65, P665, DOI 10.1107/S1744309109020302; Manilal S, 2004, BBA-GEN SUBJECTS, V1671, P87, DOI 10.1016/j.bbagen.2004.01.008; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; Ostlund C, 2001, J CELL SCI, V114, P4435; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Vigouroux C, 2001, J CELL SCI, V114, P4459; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10604	10.1371/journal.pone.0010604	http://dx.doi.org/10.1371/journal.pone.0010604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498701	gold, Green Published, Green Submitted			2022-12-27	WOS:000277633500008
J	Garbuzova-Davis, S; Woods, RL; Louis, MK; Zesiewicz, TA; Kuzmin-Nichols, N; Sullivan, KL; Miller, AM; Hernandez-Ontiveros, DG; Sanberg, PR				Garbuzova-Davis, Svitlana; Woods, Robert L., III; Louis, Michael K.; Zesiewicz, Theresa A.; Kuzmin-Nichols, Nicole; Sullivan, Kelly L.; Miller, Amber M.; Hernandez-Ontiveros, Diana G.; Sanberg, Paul R.			Reduction of Circulating Endothelial Cells in Peripheral Blood of ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; VON-WILLEBRAND-FACTOR; SPINAL-CORD; PROGENITOR CELLS; BRAIN-BARRIER; MOTOR-NEURONS; MOUSE MODEL; UP-REGULATION; DISEASE; EXPRESSION	Background: Amyotrophic Lateral Sclerosis (ALS) treatment is complicated by the various mechanisms underlying motor neuron degeneration. Recent studies showed that the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) are compromised in an animal model of ALS due to endothelial cell degeneration. A later study demonstrated a loss of endothelium integrity in the spinal cords of ALS patients. Since circulating endothelial cells (CECs) in the peripheral blood are associated with endothelium damage, being detached dysfunctional endothelial cells, we hypothesized that CEC levels may reflect endothelium condition in ALS patients. Methodology/Principal Findings: CEC levels were estimated in whole blood smears from ALS patients with moderate stage ((M)ALS), severe stage ((S)ALS), and healthy controls by CD146 expression using immunocytochemistry. A significant reduction of CECs was detected in (M)ALS and (S)ALS patients. Conclusions/Significance: CECs did not predict endothelium state in ALS patients; however, endothelial damage and/or impaired endothelium repair may occur in ALS leading to BBB/BSCB dysfunction. Reduced CECs in peripheral blood of ALS patients may indicate different mechanisms of endothelial damage and repair, rather than only detachment of dysfunctional endothelial cells. Although a potential mechanism of CEC reduction is discussed, establishing a reliable indicator of endothelial dysfunction/damage is important for evaluation of BBB/BSCB status in ALS patients during disease progression.	[Garbuzova-Davis, Svitlana; Woods, Robert L., III; Louis, Michael K.; Hernandez-Ontiveros, Diana G.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Zesiewicz, Theresa A.; Sullivan, Kelly L.; Miller, Amber M.] Univ S Florida, Dept Neurol, Coll Med, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Coll Med, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Dept Psychiat, Coll Med, Tampa, FL 33620 USA; [Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019	Sanberg, Paul/0000-0001-9130-4592	Departments of Neurosurgery and Neurology, University of South Florida; Muscular Dystrophy Association [92452]	Departments of Neurosurgery and Neurology, University of South Florida; Muscular Dystrophy Association(Muscular Dystrophy Association)	This research was supported in part by the Departments of Neurosurgery and Neurology, University of South Florida, and by the Muscular Dystrophy Association (Grant # 92452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; Appel S H, 2001, Curr Neurol Neurosci Rep, V1, P303, DOI 10.1007/s11910-001-0081-z; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AVATA C, 2002, J CLIN NEUROSCI, V9, P113; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Chong AY, 2006, EUR J HEART FAIL, V8, P167, DOI 10.1016/j.ejheart.2005.06.010; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Consilvio C, 2004, EXP NEUROL, V187, P1, DOI 10.1016/j.expneurol.2003.12.009; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Erdbruegger U, 2006, CLIN CHIM ACTA, V373, P17, DOI 10.1016/j.cca.2006.05.016; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Garbuzova-Davis S, 2008, AMYOTROPH LATERAL SC, V9, P375, DOI 10.1080/17482960802160990; Goon P, 2009, NEOPLASIA, V11, P771, DOI 10.1593/neo.09490; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Henkel JS, 2009, NEUROLOGY, V72, P1614, DOI 10.1212/WNL.0b013e3181a41228; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hensley K, 2002, J NEUROCHEM, V82, P365, DOI 10.1046/j.1471-4159.2002.00968.x; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hunting CB, 2005, VOX SANG, V88, P1, DOI 10.1111/j.1423-0410.2005.00589.x; JUNG JE, 2010, MOL NEUROBIOL   0217; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Lee KW, 2005, BLOOD, V105, P526, DOI 10.1182/blood-2004-03-1106; Levine JB, 1999, GLIA, V28, P215; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Nadar SK, 2005, THROMB HAEMOSTASIS, V94, P707; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Nicaise C, 2009, ANAT REC, V292, P207, DOI 10.1002/ar.20838; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Woywodt A, 2002, NEPHROL DIAL TRANSPL, V17, P1728, DOI 10.1093/ndt/17.10.1728; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476	54	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10614	10.1371/journal.pone.0010614	http://dx.doi.org/10.1371/journal.pone.0010614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485543	gold, Green Published			2022-12-27	WOS:000277563400017
J	Liu, L; Chen, L; Luo, Y; Chen, WX; Zhou, HY; Xu, BS; Han, XZ; Shen, T; Huang, SL				Liu, Lei; Chen, Long; Luo, Yan; Chen, Wenxing; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Huang, Shile			Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; RICTOR-MTOR COMPLEX; MAMMALIAN TARGET; SIGNAL-TRANSDUCTION; CATALYTIC SUBUNIT; BINDING PARTNER; KINASE-ACTIVITY; ALPHA4 PROTEIN; TOR PROTEINS; PHOSPHORYLATION	Serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) has been implicated as a novel component of the mammalian target of rapamycin (mTOR) signaling pathway. Recently we have demonstrated that mTOR regulates cell motility in part through p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) pathways. Little is known about the role of PP2A in the mTOR-mediated cell motility. Here we show that rapamycin inhibited the basal or insulin-like growth factor 1 (IGF-1)-induced motility of human Ewing sarcoma (Rh1) and rhabdomyosarcoma (Rh30) cells. Treatment of the cells with rapamycin activated PP2A activity, and concurrently inhibited IGF-1 stimulated phosphorylation of Erk1/2. Inhibition of Erk1/2 with PD98059 did not significantly affect the basal mobility of the cells, but dramatically inhibited IGF-1-induced cell motility. Furthermore, inhibition of PP2A with okadaic acid significantly attenuated the inhibitory effect of rapamycin on IGF-1-stimulated phosphorylation of Erk1/2 as well as cell motility. Consistently, expression of dominant negative PP2A conferred resistance to IGF-1-stimulated phosphorylation of Erk1/2 and cell motility. Expression of constitutively active MKK1 also attenuated rapamycin inhibition of IGF-1-stimulated phosphorylation of Erk1/2 and cell motility. The results suggest that rapamycin inhibits cell motility, in part by targeting PP2A-Erk1/2 pathway.	[Liu, Lei; Chen, Long; Luo, Yan; Chen, Wenxing; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Liu, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	shuan1@lsuhsc.edu	Xu, Baoshan/H-6435-2011; Chen, Wenxing/GSI-9910-2022; Huang, Shile/I-1632-2019; luo, yan/I-5305-2015	Huang, Shile/0000-0002-3239-1072; Xu, Baoshan/0000-0001-8902-1243; Chen, Wenxing/0000-0003-4571-7622	National Institutes of Health (NIH) [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health (NIH) grant CA115414 (S.H.), and American Cancer Society Award RSG-08-135-01-CNE (S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Fasolo A, 2008, EXPERT OPIN INV DRUG, V17, P1717, DOI [10.1517/13543784.17.11.1717, 10.1517/13543784.17.11.1717 ]; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hosoi H, 1999, CANCER RES, V59, P886; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jackson JL, 2003, CLIN EXP METASTAS, V20, P357, DOI 10.1023/A:1024012000009; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; O'Connor R, 2003, HORM METAB RES, V35, P771; Parameswaran N, 2000, EUR J PHARMACOL, V388, P133, DOI 10.1016/S0014-2999(99)00848-1; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Sakakibara K, 2005, AM J PHYSIOL-HEART C, V288, pH2861, DOI 10.1152/ajpheart.00561.2004; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yumoto N, 2006, MOL CELL BIOCHEM, V285, P165, DOI 10.1007/s11010-005-9075-5	54	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10578	10.1371/journal.pone.0010578	http://dx.doi.org/10.1371/journal.pone.0010578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485667	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200013
J	Dai, E; Liu, LY; Wang, H; McIvor, D; Sun, YM; Macaulay, C; King, E; Munuswamy-Ramanujam, G; Bartee, MY; Williams, J; Davids, J; Charo, I; McFadden, G; Esko, JD; Lucas, AR				Dai, Erbin; Liu, Li-Ying; Wang, Hao; McIvor, Dana; Sun, Yun Ming; Macaulay, Colin; King, Elaine; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Davids, Jennifer; Charo, Israel; McFadden, Grant; Esko, Jeffrey D.; Lucas, Alexandra R.			Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERFERON-GAMMA RECEPTOR; HEPARAN-SULFATE; RENAL-TRANSPLANTATION; BINDING PROTEIN; CARDIAC GRAFTS; M-T7; HOMOLOG; ATHEROSCLEROSIS; OLIGOMERIZATION	Background: Binding of chemokines to glycosaminoglycans (GAGs) is classically described as initiating inflammatory cell migration and creating tissue chemokine gradients that direct local leukocyte chemotaxis into damaged or transplanted tissues. While chemokine-receptor binding has been extensively studied during allograft transplantation, effects of glycosaminoglycan (GAG) interactions with chemokines on transplant longevity are less well known. Here we examine the impact of interrupting chemokine-GAG interactions and chemokine-receptor interactions, both locally and systemically, on vascular disease in allografts. Methodology/Principal Findings: Analysis of GAG or CC chemokine receptor 2 (CCR2) deficiency were coupled with the infusion of viral chemokine modulating proteins (CMPs) in mouse aortic allograft transplants (n = 239 mice). Inflammatory cell invasion and neointimal hyperplasia were significantly reduced in N-deacetylase-N-sulfotransferase-1 (Ndst1(f/f)TekCre(+)) heparan sulfate (GAG)-deficient (Ndst1(-/-), p < 0.044) and CCR2-deficient (Ccr2(-/-), p < 0.04) donor transplants. Donor tissue GAG or CCR2 deficiency markedly reduced inflammation and vasculopathy, whereas recipient deficiencies did not. Treatment with three CMPs was also investigated; Poxviral M-T1 blocks CC chemokine receptor binding, M-T7 blocks C, CC, and CXC GAG binding, and herpesviral M3 binds receptor and GAG binding for all classes. M-T7 reduced intimal hyperplasia in wild type (WT) (Ccr2(+/+), p <= 0.003 and Ccr2(-/-), p <= 0.027) aortic allografts, but not in Ndst1(-/-) aortic allografts (p = 0.933). M-T1 and M3 inhibited WT (Ccr2(+/+) and Ndst1(+/+), p <= 0.006) allograft vasculopathy, but did not block vasculopathy in Ccr2(-/-) (p = 0.61). M-T7 treatment alone, even without immunosuppressive drugs, also significantly prolonged survival of renal allograft transplants (p <= 0.001). Conclusions/Significance: Interruption of chemokine-GAG interactions, even in the absence of chemokine-receptor blockade, is a highly effective approach to reduction of allograft rejection, reducing vascular inflammation and prolonging allograft survival. Although chemokines direct both local and systemic cell migration, interruption of inherent chemokine responses in the donor tissue unexpectedly had a greater therapeutic impact on allograft vasculopathy.	[Dai, Erbin; Liu, Li-Ying; Sun, Yun Ming; Munuswamy-Ramanujam, Ganesh; Lucas, Alexandra R.] Univ Western Ontario, Vasc Biol Res Grp, Robarts Res Inst, London, ON, Canada; [Wang, Hao; McIvor, Dana; McFadden, Grant; Lucas, Alexandra R.] Univ Western Ontario, Dept Med & Surg, London, ON, Canada; [Wang, Hao; McIvor, Dana; McFadden, Grant; Lucas, Alexandra R.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Dai, Erbin; Liu, Li-Ying; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Lucas, Alexandra R.] Univ Florida, Div Cardiovasc Med, Gainesville, FL USA; [Dai, Erbin; Liu, Li-Ying; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Davids, Jennifer; McFadden, Grant; Lucas, Alexandra R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sun, Yun Ming; Macaulay, Colin; King, Elaine] Viron Therapeut Inc, London, ON, Canada; [Charo, Israel] Gladstone Inst, San Francisco, CA USA; [Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Dai, E (corresponding author), Univ Western Ontario, Vasc Biol Res Grp, Robarts Res Inst, London, ON, Canada.	alexandra.lucas@medicine.ufl.edu	Munuswamy-Ramanujam, Ganesh/ABE-7225-2021	Munuswamy-Ramanujam, Ganesh/0000-0001-8021-601X; McFadden, Grant/0000-0002-2556-3526; Macaulay, Colin/0000-0003-0118-7674	National Institutes of Health American Recovery Act (ARRA, RC1) [1RC1HL100202-01]; Canadian Institutes of Health Research (CIHR) [MOP 577578]; American Heart Association Grant In Aid (GIA) [0855421 E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER	National Institutes of Health American Recovery Act (ARRA, RC1)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American Heart Association Grant In Aid (GIA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was received from the National Institutes of Health American Recovery Act (ARRA, RC1) Grant # 1RC1HL100202-01, Canadian Institutes of Health Research (CIHR) - Grant # MOP 577578, and the American Heart Association Grant In Aid (GIA) Grant # 0855421 E. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Alexis JD, 2008, J VASC RES, V45, P538, DOI 10.1159/000129688; Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Bedard ELR, 2003, TRANSPLANTATION, V76, P249, DOI 10.1097/01.TP.0000061604.57432.E3; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cheng O, 2006, AM J TRANSPLANT, V6, P2292, DOI 10.1111/j.1600-6143.2006.01493.x; Christopher K, 2002, J IMMUNOL, V169, P522, DOI 10.4049/jimmunol.169.1.522; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Cripps JG, 2005, INT IMMUNOPHARMACOL, V5, P1622, DOI 10.1016/j.intimp.2005.04.010; Da Silva CC, 2009, IMMUNOLOGY, V126, P394, DOI 10.1111/j.1365-2567.2008.02906.x; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; David G, 1995, ATHEROSCLEROSIS, V118, pS57, DOI 10.1016/0021-9150(95)90074-8; Deng SP, 1996, TRANSPLANTATION, V61, P1300, DOI 10.1097/00007890-199605150-00003; Eefting D, 2009, J VASC SURG, V50, P152, DOI 10.1016/j.jvs.2009.03.027; Fairchild RL, 1997, TRANSPLANTATION, V63, P1807, DOI 10.1097/00007890-199706270-00018; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Hancock WW, 2002, TRANSPLANTATION, V73, P1392, DOI 10.1097/00007890-200205150-00006; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Horiguchi K, 2002, J HEART LUNG TRANSPL, V21, P1090, DOI 10.1016/S1053-2498(02)00443-6; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Lindow M, 2003, TRENDS PHARMACOL SCI, V24, P126, DOI 10.1016/S0165-6147(03)00033-6; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; MOSSMAN K, 1995, J BIOL CHEM, V270, P3031, DOI 10.1074/jbc.270.7.3031; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nickerson MM, 2009, ARTERIOSCL THROM VAS, V29, P1794, DOI 10.1161/ATVBAHA.109.194019; Papaioannou EG, 2004, SURG TODAY, V34, P668, DOI 10.1007/s00595-004-2795-4; Peters W, 2001, CURR OPIN LIPIDOL, V12, P175, DOI 10.1097/00041433-200104000-00011; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAMANUJAM GM, 2010, THROMB HAEMOSTASIS, V103, P545; Rivas-Caicedo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007066; RUSSELL ME, 1993, P NATL ACAD SCI USA, V90, P6086, DOI 10.1073/pnas.90.13.6086; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; STEVENS RR, 1993, TRANSPLANT P, V25, P382; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zhao DXM, 2002, J IMMUNOL, V169, P1556, DOI 10.4049/jimmunol.169.3.1556	48	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10510	10.1371/journal.pone.0010510	http://dx.doi.org/10.1371/journal.pone.0010510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463901	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379800006
J	Kover, H; Bao, SW				Koever, Hania; Bao, Shaowen			Cortical Plasticity as a Mechanism for Storing Bayesian Priors in Sensory Perception	PLOS ONE			English	Article							EXPERIENCE; REPRESENTATION; VARIABILITY; INTEGRATION; MODULATION; CATEGORIES; DYNAMICS; INFANTS	Human perception of ambiguous sensory signals is biased by prior experiences. It is not known how such prior information is encoded, retrieved and combined with sensory information by neurons. Previous authors have suggested dynamic encoding mechanisms for prior information, whereby top-down modulation of firing patterns on a trial-by-trial basis creates short-term representations of priors. Although such a mechanism may well account for perceptual bias arising in the short-term, it does not account for the often irreversible and robust changes in perception that result from long-term, developmental experience. Based on the finding that more frequently experienced stimuli gain greater representations in sensory cortices during development, we reasoned that prior information could be stored in the size of cortical sensory representations. For the case of auditory perception, we use a computational model to show that prior information about sound frequency distributions may be stored in the size of primary auditory cortex frequency representations, read-out by elevated baseline activity in all neurons and combined with sensory-evoked activity to generate a percept that conforms to Bayesian integration theory. Our results suggest an alternative neural mechanism for experience-induced long-term perceptual bias in the context of auditory perception. They make the testable prediction that the extent of such perceptual prior bias is modulated by both the degree of cortical reorganization and the magnitude of spontaneous activity in primary auditory cortex. Given that cortical over-representation of frequently experienced stimuli, as well as perceptual bias towards such stimuli is a common phenomenon across sensory modalities, our model may generalize to sensory perception, rather than being specific to auditory perception.	[Koever, Hania; Bao, Shaowen] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kover, H (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sbao@berkeley.edu			NIH [DC007883, DC009259]; Boehringer Ingelheim Fonds, Germany; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC007883, R01DC009259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds, Germany(Boehringer Ingelheim); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH grants DC007883 and DC009259. H. K. was supported by a predoctoral fellowship from Boehringer Ingelheim Fonds, Germany (http://www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW H, 2001, NETWORK, V12; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Feldman N. H., 2007, P 29 ANN C COGN SCI; FELDMAN NH, 2009, PSYCHOL REV IN PRESS; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; GRISHICK AR, 2010, COSYNE ABSTR 2010; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Iverson P, 2003, COGNITION, V87, pB47, DOI 10.1016/S0010-0277(02)00198-1; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kim H, 2008, J COMPUT NEUROSCI, V24, P277, DOI 10.1007/s10827-007-0055-5; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kossut M, 1998, EXP BRAIN RES, V123, P110, DOI 10.1007/s002210050551; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POWELL M J D, 1977, FAST ALGORITHM NONLI; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SIMONCELLI E, 2009, OPTIMAL ESTIMA UNPUB; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	31	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10497	10.1371/journal.pone.0010497	http://dx.doi.org/10.1371/journal.pone.0010497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463967	Green Submitted, gold, Green Published			2022-12-27	WOS:000277379400030
J	Gomez-Diaz, E; Gonzalez-Solis, J				Gomez-Diaz, Elena; Gonzalez-Solis, Jacob			Trophic Structure in a Seabird Host-Parasite Food Web: Insights from Stable Isotope Analyses	PLOS ONE			English	Article							FEATHER MITES; DIET; SHEARWATERS; DISCRIMINATION; NITROGEN; BEHAVIOR; ECOLOGY; MODELS; CARBON; BIRDS	Ecological studies on food webs rarely include parasites, partly due to the complexity and dimensionality of host-parasite interaction networks. Multiple co-occurring parasites can show different feeding strategies and thus lead to complex and cryptic trophic relationships, which are often difficult to disentangle by traditional methods. We analyzed stable isotope ratios of C (C-13/C-12, delta C-13) and N (N-15/N-14, delta N-15) of host and ectoparasite tissues to investigate trophic structure in 4 co-occurring ectoparasites: three lice and one flea species, on two closely related and spatially segregated seabird hosts (Calonectris shearwaters). delta C-13 isotopic signatures confirmed feathers as the main food resource for the three lice species and blood for the flea species. All ectoparasite species showed a significant enrichment in delta N-15 relatively to the host tissue consumed (discrimination factors ranged from 2 to 5% depending on the species). Isotopic differences were consistent across multiple host-ectoparasite locations, despite of some geographic variability in baseline isotopic levels. Our findings illustrate the influence of both ectoparasite and host trophic ecology in the isotopic structuring of the Calonectris ectoparasite community. This study highlights the potential of stable isotope analyses in disentangling the nature and complexity of trophic relationships in symbiotic systems.	[Gomez-Diaz, Elena] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain	University of Barcelona; University of Barcelona	Gomez-Diaz, E (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	elegomez@ub.edu	Gonzalez-Solis, Jacob/C-3942-2008; Gonzalez-Solis, Jacob/AAZ-5338-2021; Gómez-Díaz, Elena/AAA-9141-2019; González-Solís, Jacob/AAB-1161-2019; Gómez-Díaz, Elena/G-2503-2011	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gómez-Díaz, Elena/0000-0002-4146-9003; Gómez-Díaz, Elena/0000-0002-4146-9003	Generalitat de Catalunya; Ministerio de Educacion y Ciencia (MEyC); Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER) [CGL2006-01315/BOS]	Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia (MEyC)(Spanish Government); Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	E. G.-D. was supported by a postgraduate grant from the Generalitat de Catalunya and J.G.-S. was supported by the Program Ramon y Cajal funded by the Ministerio de Educacion y Ciencia (MEyC). Financial support was provided by the project CGL2006-01315/BOS from the Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Blanco G, 1997, J AVIAN BIOL, V28, P197, DOI 10.2307/3676970; Boag B, 1997, ISOT ENVIRON HEALT S, V33, P81, DOI 10.1080/10256019708036335; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CLAYTON DH, 1995, PARASITOLOGY, V110, P195, DOI 10.1017/S0031182000063964; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deudero S, 2002, DIS AQUAT ORGAN, V52, P77, DOI 10.3354/dao052077; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2008, ECOGRAPHY, V31, P477, DOI 10.1111/j.0906-7590.2008.05330.x; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; JANOVY J, 1997, PROTOZOA HELMINTHS A; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; MEY E, 2006, B CHILENO ORNITOLOGI, V12, P30; MOLLER A, 2010, OECOLOGIA IN PRESS; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; Neilson R, 2005, PARASITOLOGY, V131, P279, DOI 10.1017/S0031182005007717; O'Grady SP, 2006, OECOLOGIA, V150, P355, DOI 10.1007/s00442-006-0487-z; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinnegar JK, 2001, J FISH BIOL, V59, P494, DOI 10.1006/jfbi.2001.1660; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Price R.D., 2003, ILL NAT HIS SURV SPE; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013	41	21	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10454	10.1371/journal.pone.0010454	http://dx.doi.org/10.1371/journal.pone.0010454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454612	gold, Green Published, Green Submitted			2022-12-27	WOS:000277305300005
J	Berny, MA; Munnix, ICA; Auger, JM; Schols, SEM; Cosemans, JMEM; Panizzi, P; Bock, PE; Watson, SP; McCarty, OJT; Heemskerk, JWM				Berny, Michelle A.; Munnix, Imke C. A.; Auger, Jocelyn M.; Schols, Saskia E. M.; Cosemans, Judith M. E. M.; Panizzi, Peter; Bock, Paul E.; Watson, Steve P.; McCarty, Owen J. T.; Heemskerk, Johan W. M.			Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FLOWING HUMAN BLOOD; IN-VIVO; PLATELET ACTIVATION; GAMMA-CHAIN; ANNEXIN-V; FIBRINOGEN; COMPLEX; COLLAGEN; BINDING	Background: The generation of thrombin is a critical process in the formation of venous thrombi. In isolated plasma under static conditions, phosphatidylserine (PS)-exposing platelets support coagulation factor activation and thrombin generation; however, their role in supporting coagulation factor binding under shear conditions remains unclear. We sought to determine where activated factor X (FXa), (pro) thrombin, and fibrin(ogen) are localized in thrombi formed under venous shear. Methodology/Principal Findings: Fluorescence microscopy was used to study the accumulation of platelets, FXa, (pro) thrombin, and fibrin(ogen) in thrombi formed in vitro and in vivo. Co-perfusion of human blood with tissue factor resulted in formation of visible fibrin at low, but not at high shear rate. At low shear, platelets demonstrated increased Ca(2+) signaling and PS exposure, and supported binding of FXa and prothrombin. However, once cleaved, (pro) thrombin was observed on fibrin fibers, covering the whole thrombus. In vivo, wild-type mice were injected with fluorescently labeled coagulation factors and venous thrombus formation was monitored in mesenteric veins treated with FeCl(3). Thrombi formed in vivo consisted of platelet aggregates, focal spots of platelets binding FXa, and large areas binding (pro) thrombin and fibrin(ogen). Conclusions/Significance: FXa bound in a punctate manner to thrombi under shear, while thrombin and fibrin(ogen) distributed ubiquitously over platelet-fibrin thrombi. During thrombus formation under venous shear, thrombin may relocate from focal sites of formation (on FXa-binding platelets) to dispersed sites of action (on fibrin fibers).	[Berny, Michelle A.; Munnix, Imke C. A.; Schols, Saskia E. M.; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.] Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands; [Berny, Michelle A.; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Auger, Jocelyn M.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Panizzi, Peter] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Panizzi, Peter; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Oregon Health & Science University; University of Birmingham; Harvard University; Massachusetts General Hospital; Vanderbilt University	Berny, MA (corresponding author), Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands.	mccartyo@ohsu.edu; jwm.heemskerk@biochem.unimaas.nl	Watson, Stephen P/Q-6292-2016; Panizzi, Peter/A-6072-2019; Heemskerk, Johan/AAM-8323-2021; Cosemans, Judith MEM/C-8161-2016	Watson, Stephen P/0000-0002-7846-7423; Panizzi, Peter/0000-0003-0141-8807; Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Berny-Lang, Michelle/0000-0001-5889-4295	American Heart Association [09PRE2230117, 09GRNT2150003]; Netherlands Organization for Scientific Research [11-400-0076]; Wellcome Trust [073107]; National Institutes of Health [R37HL071544, RO1HL038779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038779, R37HL071544, R00HL094533] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (http://www.americanheart.org; M. A. B. - 09PRE2230117 and O.J.T.M. - 09GRNT2150003), the Netherlands Organization for Scientific Research (http://www.nwo.nl; J.W.M.H. and J.M.E.M.C. - 11-400-0076), the Wellcome Trust (http://www.wellcome.ac.uk; J.M.A. and S. P. W. - 073107), and the National Institutes of Health (http://www.nih.gov; P. E. B. - R37HL071544 and RO1HL038779 from the National Heart, Lung, and Blood Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Ahmad SS, 2003, J THROMB HAEMOST, V1, P2348, DOI 10.1046/j.1538-7836.2003.00428.x; Ahmad SS, 2003, J THROMB HAEMOST, V1, P48, DOI 10.1046/j.1538-7836.2003.00020.x; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; COLLER BS, 1980, BLOOD, V55, P169; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; Dubois C, 2007, J CLIN INVEST, V117, P953, DOI 10.1172/JCI30537; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589; INAUEN W, 1990, ARTERIOSCLEROSIS, V10, P607, DOI 10.1161/01.ATV.10.4.607; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kalia N, 2008, MICROCIRCULATION, V15, P325, DOI 10.1080/10739680701728822; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kaneko N, 1996, CLIN CHIM ACTA, V251, P65, DOI 10.1016/0009-8981(96)06294-8; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Masuda J, 2004, THROMB HAEMOSTASIS, V91, P1129, DOI 10.1160/TH03-12-0778; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; MOSESSON MW, 1972, J BIOL CHEM, V247, P5223; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, BLOOD, V102, P3609, DOI 10.1182/blood-2003-03-0850; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; TRACY PB, 1985, J BIOL CHEM, V260, P2119; van Lier M, 2008, THROMB HAEMOSTASIS, V99, P1068, DOI 10.1160/TH07-08-0528; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; WEISS HJ, 1986, J CLIN INVEST, V78, P1072, DOI 10.1172/JCI112663; Weitz JI, 1998, CIRCULATION, V97, P544; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	43	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10415	10.1371/journal.pone.0010415	http://dx.doi.org/10.1371/journal.pone.0010415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454680	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100022
J	Rodriguez-Calvo, T; Ojosnegros, S; Sanz-Ramos, M; Garcia-Arriaza, J; Escarmis, C; Domingo, E; Sevilla, N				Rodriguez-Calvo, Teresa; Ojosnegros, Samuel; Sanz-Ramos, Marta; Garcia-Arriaza, Juan; Escarmis, Cristina; Domingo, Esteban; Sevilla, Noemi			New Vaccine Design Based on Defective Genomes That Combines Features of Attenuated and Inactivated Vaccines	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; RECOMBINANT MEASLES VIRUSES; BINARY ETHYLENIMINE; IMMUNE-RESPONSES; CELL-CULTURES; IN-VIVO; FOOT; CATTLE; INFECTION; SWINE	Background: New vaccine designs are needed to control diseases associated with antigenically variable RNA viruses. Foot-and-mouth disease (FMD) is a highly contagious disease of livestock that inflicts severe economic losses. Although the current whole-virus chemically inactivated vaccine has proven effective, it has led to new outbreaks of FMD because of incomplete inactivation of the virus or the escape of infectious virus from vaccine production premises. We have previously shown that serial passages of FMD virus (FMDV) C-S8c1 at high multiplicity of infection in cell culture resulted in virus populations consisting of defective genomes that are infectious by complementation (termed C-S8p260). Principal Finding: Here we evaluate the immunogenicity of C-S8p260, first in a mouse model system to establish a proof of principle, and second, in swine, the natural host of FMDV C-S8c1. Mice were completely protected against a lethal challenge with FMDV C-S8c1, after vaccination with a single dose of C-S8p260. Pigs immunized with different C-S8p260 doses and challenged with FMDV C-S8c1 either did not develop any clinical signs or showed delayed and mild disease symptoms. C-S8p260 induced high titers of both FMDV-specific, neutralizing antibodies and activated FMDV-specific T cells in swine, that correlated with solid protection against FMDV. Conclusions: The defective virus-based vaccine did not produce detectable levels of transmissible FMDV. Therefore, a segmented, replication-competent form of a virus, such as FMDV C-S8p260, can provide the basis of a new generation of attenuated antiviral vaccines with two safety barriers. The design can be extended to any viral pathogen that encodes transacting gene products, allowing complementation between replication-competent, defective forms.	[Rodriguez-Calvo, Teresa; Sanz-Ramos, Marta; Sevilla, Noemi] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Ojosnegros, Samuel; Sanz-Ramos, Marta; Garcia-Arriaza, Juan; Escarmis, Cristina; Domingo, Esteban] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Domingo, Esteban] CIBERehd, Barcelona, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Rodriguez-Calvo, T (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain.	sevilla@inia.es	GARCIA-ARRIAZA, JUAN/Q-6243-2017; Sevilla, Noemi/K-8648-2014; Rodriguez-Calvo, Teresa/A-6831-2010; Rodriguez-Calvo, Teresa/AAH-2365-2019; Domingo, Esteban/K-3937-2014	GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Sevilla, Noemi/0000-0003-0118-0376; Domingo, Esteban/0000-0002-0573-1676; Ojosnegros, Samuel/0000-0002-9562-3264	Ministerio de Ciencia e Innovacion, Spain [AGL2004-0049, AGL2007-61374, CSD2006-07, BFU2008-02816/BMC]; European Union [FOOD-CT-2006-016236]; Instituto de Salud Carlos III; Fundacion Ramon Areces; Comunidad Autonoma de Madrid; Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government)	This research was supported by grants AGL2004-0049, AGL2007-61374, CSD2006-07 and BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion, Spain, and European Union, Network of Excellence, EPIZONE (Contract # FOOD-CT-2006-016236). CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. Work at Centro de Biologia Molecular "Severo Ochoa" (CISC-UAM) was supported by an institutional grant from Fundacion Ramon Areces. T.R-C. was supported by a contract from Comunidad Autonoma de Madrid; S.O. and M.S-R were supported by a predoctoral fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHNEMANN HG, 1975, ARCH VIROL, V47, P47, DOI 10.1007/BF01315592; BAHNEMANN HG, 1990, VACCINE, V8, P299, DOI 10.1016/0264-410X(90)90083-X; Barteling SJ, 2004, DEV BIOLOGICALS, V119, P449; BECK E, 1987, J VIROL, V61, P1621, DOI 10.1128/JVI.61.5.1621-1629.1987; Billeter MA, 2009, CURR TOP MICROBIOL, V329, P129; BUDOWSKY EI, 1991, VACCINE, V9, P319, DOI 10.1016/0264-410X(91)90057-D; Chinsangaram J, 1998, VACCINE, V16, P1516, DOI 10.1016/S0264-410X(98)00029-2; Chinsangaram J, 2003, J VIROL, V77, P1621, DOI 10.1128/JVI.77.2.1621-1625.2003; Collen T, 1998, VIRUS RES, V56, P125, DOI 10.1016/S0168-1702(98)00035-5; COLLEN T, 1991, J IMMUNOL, V146, P749; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; DIEZ J, 1990, VIRUS RES, V18, P3, DOI 10.1016/0168-1702(90)90084-O; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Domingo E, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P261; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; DOMINGO E, 1990, APPL VIROLOGY RES; DOUGHERTY E, 1968, AM J VET RES, V29, P693; Eble PL, 2007, VACCINE, V25, P1043, DOI 10.1016/j.vaccine.2006.09.066; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; FRANCIS MJ, 1983, J HYG-CAMBRIDGE, V91, P329, DOI 10.1017/S0022172400060344; Galloway I. A., 1962, Bulletin de l'Office International des Epizooties, V57, P748; Garcia-Arriaza J, 2005, VIROLOGY, V335, P155, DOI 10.1016/j.virol.2005.02.012; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Arriaza J, 2006, J MOL BIOL, V360, P558, DOI 10.1016/j.jmb.2006.05.027; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Kitching RP, 2005, VET J, V169, P197, DOI 10.1016/j.tvjl.2004.06.001; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KUPPER H, 1981, NATURE, V289, P555, DOI 10.1038/289555a0; Liniger M, 2009, VACCINE, V27, P3299, DOI 10.1016/j.vaccine.2009.01.057; Manrubia SC, 2006, EUROPHYS LETT, V74, P547, DOI 10.1209/epl/i2005-10560-9; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Mason PW, 1997, VIROLOGY, V227, P96, DOI 10.1006/viro.1996.8309; MATEU MG, 1988, VIROLOGY, V167, P113, DOI 10.1016/0042-6822(88)90060-8; MATEU MG, 1989, P NATL ACAD SCI USA, V86, P5883, DOI 10.1073/pnas.86.15.5883; MATEU MG, 1987, VIRUS RES, V8, P261, DOI 10.1016/0168-1702(87)90020-7; MCCULLOUGH KC, 1992, J VIROL, V66, P1835, DOI 10.1128/JVI.66.4.1835-1840.1992; McInerney GM, 2000, J GEN VIROL, V81, P1699, DOI 10.1099/0022-1317-81-7-1699; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; MURPHY BR, 1996, VIROLOGY, P467; NICHOLSON, 1994, SYNTHETIC VACCINES; Pereira H. G., 1981, Virus diseases of food animals. Volume II, P333; Pluimers FH, 2002, REV SCI TECH OIE, V21, P711, DOI 10.20506/rst.21.3.1371; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Rowlands DJ, 2003, VIRUS RES, V91, P1, DOI 10.1016/S0168-1702(02)00264-2; Rweyemamu MM, 1999, ADV VIRUS RES, V53, P111, DOI 10.1016/S0065-3527(08)60345-0; Salguero FJ, 2005, VIROLOGY, V332, P384, DOI 10.1016/j.virol.2004.11.005; Salt JS, 1996, EPIDEMIOL INFECT, V117, P349, DOI 10.1017/S0950268800001539; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; SOBRINO F, 2004, FOOT AND MOUTH DIS C; Taboga O, 1997, J VIROL, V71, P2606, DOI 10.1128/JVI.71.4.2606-2614.1997; Tami C, 2003, J VIROL, V77, P1219, DOI 10.1128/JVI.77.2.1219-1226.2003; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Zuniga A, 2007, VACCINE, V25, P2974, DOI 10.1016/j.vaccine.2007.01.064	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10414	10.1371/journal.pone.0010414	http://dx.doi.org/10.1371/journal.pone.0010414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454676	Green Published, gold			2022-12-27	WOS:000277240100021
J	Fred, RG; Bang-Berthelsen, CH; Mandrup-Poulsen, T; Grunnet, LG; Welsh, N				Fred, Rikard G.; Bang-Berthelsen, Claus H.; Mandrup-Poulsen, Thomas; Grunnet, Lars G.; Welsh, Nils			High Glucose Suppresses Human Islet Insulin Biosynthesis by Inducing miR-133a Leading to Decreased Polypyrimidine Tract Binding Protein-Expression	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; MESSENGER-RNA STABILITY; BETA-CELL DEATH; 3'-UNTRANSLATED REGION; CHRONIC EXPOSURE; GENE-EXPRESSION; RIN-5F CELLS; FATTY-ACIDS; IDENTIFICATION; CYTOKINES	Background: Prolonged periods of high glucose exposure results in human islet dysfunction in vitro. The underlying mechanisms behind this effect of high glucose are, however, unknown. The polypyrimidine tract binding protein (PTB) is required for stabilization of insulin mRNA and the PTB mRNA 3'-UTR contains binding sites for the microRNA molecules miR-133a, miR-124a and miR-146. The aim of this study was therefore to investigate whether high glucose increased the levels of these three miRNAs in association with lower PTB levels and lower insulin biosynthesis rates. Methodology/Principal Findings: Human islets were cultured for 24 hours in the presence of low (5.6 mM) or high glucose (20 mM). Islets were also exposed to sodium palmitate or the proinflammatory cytokines IL-1 beta and IFN-gamma, since saturated free fatty acids and cytokines also cause islet dysfunction. RNA was then isolated for real-time RT-PCR analysis of miR-133a, miR-124a, miR-146, insulin mRNA and PTB mRNA contents. Insulin biosynthesis rates were determined by radioactive labeling and immunoprecipitation. Synthetic miR-133a precursor and inhibitor were delivered to dispersed islet cells by lipofection, and PTB was analyzed by immunoblotting following culture at low or high glucose. Culture in high glucose resulted in increased islet contents of miR-133a and reduced contents of miR-146. Cytokines increased the contents of miR-146. The insulin and PTB mRNA contents were unaffected by high glucose. However, both PTB protein levels and insulin biosynthesis rates were decreased in response to high glucose. The miR-133a inhibitor prevented the high glucose-induced decrease in PTB and insulin biosynthesis, and the miR-133a precursor decreased PTB levels and insulin biosynthesis similarly to high glucose. Conclusion: Prolonged high-glucose exposure down-regulates PTB levels and insulin biosynthesis rates in human islets by increasing miR-133a levels. We propose that this mechanism contributes to hyperglycemia-induced beta-cell dysfunction.	[Fred, Rikard G.; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Bang-Berthelsen, Claus H.; Mandrup-Poulsen, Thomas] Hagedorn Res Inst, Gentofte, Denmark; [Mandrup-Poulsen, Thomas; Grunnet, Lars G.] Univ Copenhagen, Core Unit Med Res Methodol, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Uppsala University; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Karolinska Institutet	Fred, RG (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Nils.Welsh@mcb.uu.se		/0000-0003-4541-2538; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Fred, Rikard/0000-0002-2273-6719	Swedish Research Council [2006-11590]; Swedish Diabetes Association; Wallenberg Foundation; Family Ernfors Fund; Novo-Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Wallenberg Foundation(European Commission); Family Ernfors Fund; Novo-Nordisk Foundation(Novo Nordisk Foundation)	This work was supported in part by the Swedish Research Council (2006-11590), the Swedish Diabetes Association, the Wallenberg Foundation, the Family Ernfors Fund and the Novo-Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Goto T, 2005, TRANSPL P, V37, P3430, DOI 10.1016/j.transproceed.2005.09.041; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hagerkvist R, 2005, ANN NY ACAD SCI, V1040, P114, DOI 10.1196/annals.1327.014; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaneto Hideaki, 2005, Am J Ther, V12, P529, DOI 10.1097/01.mjt.0000178773.31525.c2; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Rabinovitch A, 1999, DIABETES, V48, P1223, DOI 10.2337/diabetes.48.6.1223; ROBERTSON RP, 1992, J CLIN INVEST, V90, P320, DOI 10.1172/JCI115865; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tillmar L, 2004, MOL CELL BIOCHEM, V260, P85, DOI 10.1023/B:MCBI.0000026059.56089.e4; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Xiao JN, 2007, J BIOL CHEM, V282, P12363, DOI 10.1074/jbc.C700015200; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	50	65	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10843	10.1371/journal.pone.0010843	http://dx.doi.org/10.1371/journal.pone.0010843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520763	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500029
J	Adams, SJ; DeTure, MA; McBride, M; Dickson, DW; Petrucelli, L				Adams, Stephanie J.; DeTure, Michael A.; McBride, Melinda; Dickson, Dennis W.; Petrucelli, Leonard			Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments	PLOS ONE			English	Article							PROTEIN-TAU; EXPRESSION; AGGREGATION; CONSISTS; MUTATION; GENE	Tauopathies are defined by assembly of the microtubule associated protein tau into filamentous tangles and classified by the predominant tau isoform within these aggregates. The major isoforms are determined by alternative mRNA splicing of exon 10 generating tau with three (3R) or four (4R) similar to 32 amino acid imperfect repeats in the microtubule binding domain. In normal adult brains there is an approximately equimolar ratio of 3R and 4R tau which is altered by several disease-causing mutations in the tau gene. We hypothesized that when 4R and 3R tau isoforms are not at equimolar ratios aggregation is favored. Here we provide evidence for the first time that the combination of 3R and 4R tau isoforms results in less in vitro heparin induced polymerization than with 4R preparations alone. This effect was independent of reducing conditions and the presence of alternatively spliced exons 2 and 3 N-terminal inserts. The addition of even small amounts of 3R to 4R tau assembly reactions significantly decreased 4R assembly. Together these findings suggest that co-expression of 3R and 4R tau isoforms reduce tau filament assembly and that 3R tau isoforms inhibit 4R tau assembly. Expression of equimolar amounts of 3R and 4R tau in adult humans may be necessary to maintain proper neuronal microtubule dynamics and to prevent abnormal tau filament assembly. Importantly, these findings indicate that disruption of the normal equimolar 3R to 4R ratio may be sufficient to drive tau aggregation and that restoration of the tau isoform balance may have important therapeutic implications in tauopathies.	[Adams, Stephanie J.; DeTure, Michael A.; McBride, Melinda; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA	Mayo Clinic	Adams, SJ (corresponding author), Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA.	deture.michael@mayo.edu; petrucelli.leonard@mayo.edu		Dickson, Dennis W/0000-0001-7189-7917	NIA/NIH [AG027638, P01AG017216]; Robert and Clarice Smith Fellowship; NIH/NINDS [R21NS059363]; Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, F32AG027638] Funding Source: NIH RePORTER	NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert and Clarice Smith Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Research Service Award postdoctoral fellowship AG027638 from NIA/NIH (S.J.A.), Robert and Clarice Smith Fellowship (S.J.A.). Alzheimer's Association (L. P.), NIH/NIA P01AG017216 (L. P. and D. W. D.), NIH/NINDS R21NS059363 (L. P.) and Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; DeTure M, 2006, BIOCHEM BIOPH RES CO, V339, P858, DOI 10.1016/j.bbrc.2005.11.087; DeTure MA, 2002, J BIOL CHEM, V277, P34755, DOI 10.1074/jbc.M201201200; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	33	71	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10810	10.1371/journal.pone.0010810	http://dx.doi.org/10.1371/journal.pone.0010810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520830	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034800008
J	Littler, MM; Littler, DS; Brooks, BL				Littler, Mark M.; Littler, Diane S.; Brooks, Barrett L.			Marine Macroalgal Diversity Assessment of Saba Bank, Netherlands Antilles	PLOS ONE			English	Article								Background: Located in the Dutch Windward Islands, Saba Bank is a flat-topped seamount (20-45 m deep in the shallower regions). The primary goals of the survey were to improve knowledge of biodiversity for one of the world's most significant, but little-known, seamounts and to increase basic data and analyses to promote the development of an improved management plan. Methodology/Principal Findings: Our team of three divers used scuba to collect algal samples to depths of 50 m at 17 dive sites. Over 360 macrophyte specimens (12 putative new species) were collected, more than 1,000 photographs were taken in truly exceptional habitats, and three astonishing new seaweed community types were discovered. These included: (1) "Field of Greens'' (N 17 degrees 30.620', W 63 degrees 27.707') dominated by green seaweeds as well as some filamentous reds, (2) "Brown Town'' (N 17 degrees 28.027', W 63 degrees 14.944') dominated by large brown algae, and (3) "Seaweed City'' (N 17 degrees 26.485', W 63 degrees 16.850') with a diversity of spectacular fleshy red algae. Conclusions/Significance: Dives to 30 m in the more two-dimensional interior habitats revealed particularly robust specimens of algae typical of shallower seagrass beds, but here in the total absence of any seagrasses (seagrasses generally do not grow below 20 m). Our preliminary estimate of the number of total seaweed species on Saba Bank ranges from a minimum of 150 to 200. Few filamentous and thin sheet forms indicative of stressed or physically disturbed environments were observed. A more precise number still awaits further microscopic and molecular examinations in the laboratory. The expedition, while intensive, has only scratched the surface of this unique submerged seamount/atoll.	[Littler, Mark M.; Littler, Diane S.; Brooks, Barrett L.] Smithsonian Inst, Dept Bot, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Littler, MM (corresponding author), Smithsonian Inst, Dept Bot, Washington, DC 20560 USA.	littlerm@si.edu	Brooks, Barrett L/C-5306-2008	Brooks, Barrett L/0000-0003-0476-9530; Littler, Dene/0000-0001-5904-1905	Department of Environment and Nature of the Netherlands Antilles; Conservation International; Smithsonian Marine Station at Ft. Pierce (SMSFP)	Department of Environment and Nature of the Netherlands Antilles; Conservation International; Smithsonian Marine Station at Ft. Pierce (SMSFP)	Financial support for this study came from the Department of Environment and Nature of the Netherlands Antilles, Conservation International and the Smithsonian Marine Station at Ft. Pierce (SMSFP Contribution No. 810). The funding sources provided critical assistance in determining dive site locations but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S, 2005, PLANT CONSERVATION: A NATURAL HISTORY APPROACH, P257; Colwell R.K., 2006, ESTIMATES STAT ESTIM; DAVIS WM, 1926, PUBLICATION AM GEOGR, V2, P212; Klomp Kristi D., 2003, Atoll Research Bulletin, V496, P404; LITTLER DS, 2007, PLANTS LICHENS SABA; Littler M.N., 1993, P 7 INT COR REEF S, V1, P335; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; LITTLER MM, 1997, B BIOL SOC WASH, V9, P149; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; MEESTERS EH, 1996, SUSTAINABLE MANAGEME; SPENCER JW, 1904, T CAN I, V7, P351; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; VAUGHAN TW, 1919, BULLETIN US NATL MUS, V103	13	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10677	10.1371/journal.pone.0010677	http://dx.doi.org/10.1371/journal.pone.0010677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505757	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400008
J	Wehling-Henricks, M; Jordan, MC; Gotoh, T; Grody, WW; Roos, KP; Tidball, JG				Wehling-Henricks, Michelle; Jordan, Maria C.; Gotoh, Tomomi; Grody, Wayne W.; Roos, Kenneth P.; Tidball, James G.			Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; SKELETAL-MUSCLE; TRANSCRIPTIONAL REGULATION; PULMONARY-FUNCTION; MESSENGER-RNAS; EXPRESSION; MOUSE; ARGINASE; SARCOLEMMA	Background: Duchenne muscular dystrophy (DMD) is the most common, lethal disease of childhood. One of 3500 new-born males suffers from this universally-lethal disease. Other than the use of corticosteroids, little is available to affect the relentless progress of the disease, leading many families to use dietary supplements in hopes of reducing the progression or severity of muscle wasting. Arginine is commonly used as a dietary supplement and its use has been reported to have beneficial effects following short-term administration to mdx mice, a genetic model of DMD. However, the long-term effects of arginine supplementation are unknown. This lack of knowledge about the long-term effects of increased arginine metabolism is important because elevated arginine metabolism can increase tissue fibrosis, and increased fibrosis of skeletal muscles and the heart is an important and potentially life-threatening feature of DMD. Methodology: We use both genetic and nutritional manipulations to test whether changes in arginase metabolism promote fibrosis and increase pathology in mdx mice. Our findings show that fibrotic lesions in mdx muscle are enriched with arginase-2-expressing macrophages and that muscle macrophages stimulated with cytokines that activate the M2 phenotype show elevated arginase activity and expression. We generated a line of arginase-2-null mutant mdx mice and found that the mutation reduced fibrosis in muscles of 18-month-old mdx mice, and reduced kyphosis that is attributable to muscle fibrosis. We also observed that dietary supplementation with arginine for 17-months increased mdx muscle fibrosis. In contrast, arginine-2 mutation did not reduce cardiac fibrosis or affect cardiac function assessed by echocardiography, although 17-months of dietary supplementation with arginine increased cardiac fibrosis. Long-term arginine treatments did not decrease matrix metalloproteinase-2 or -9 or increase the expression of utrophin, which have been reported as beneficial effects of short-term treatments. Conclusions/Significance: Our findings demonstrate that arginine metabolism by arginase promotes fibrosis of muscle in muscular dystrophy and contributes to kyphosis. Our findings also show that long-term, dietary supplementation with arginine exacerbates fibrosis of dystrophic heart and muscles. Thus, commonly-practiced dietary supplementation with arginine by DMD patients has potential risk for increasing pathology when performed for long periods, despite reports of benefits acquired with short-term supplementation.	[Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Gotoh, Tomomi] Kumamoto Univ, Sch Med, Dept Mol Genet, Kumamoto 860, Japan; [Grody, Wayne W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Grody, Wayne W.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Grody, Wayne W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kumamoto University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wehling-Henricks, M (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu	Jordan, Maria/HHN-5358-2022; Tidball, James/H-7970-2012	Tidball, James/0000-0003-1202-8038	Muscular Dystrophy Association [4031, 157881, 4006]; National Institutes of Health [R01 AR40343, R01 AR47721]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047721, R01AR054451, R01AR040343] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (4031 and 157881 to JGT; 4006 to MW-H) and the National Institutes of Health (R01 AR40343, R01 AR47721 to JGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; Bani C, 2008, MUSCLE NERVE, V37, P583, DOI 10.1002/mus.20970; BARBUL A, 1990, SURGERY, V108, P331; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Deignan JL, 2006, MOL GENET METAB, V89, P87, DOI 10.1016/j.ymgme.2006.04.007; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Forst J, 1999, NEUROMUSCULAR DISORD, V9, P176, DOI 10.1016/S0960-8966(98)00113-8; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; HECKER M, 1995, P NATL ACAD SCI USA, V92, P4671, DOI 10.1073/pnas.92.10.4671; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hrabak A, 1996, FEBS LETT, V390, P203, DOI 10.1016/0014-5793(96)00659-X; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Jung AS, 2006, AM J PHYSIOL-HEART C, V290, pH1756, DOI 10.1152/ajpheart.01104.2005; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; KUBO M, 1993, PEDIATR CARDIOL, V14, P214, DOI 10.1007/BF00795373; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MIYOSHI K, 1991, BRIT HEART J, V66, P452; MONTGOMERY AMP, 1993, BIOCHIM BIOPHYS ACTA, V1176, P265, DOI 10.1016/0167-4889(93)90054-S; Moriuchi T, 1993, Tokushima J Exp Med, V40, P83; Morrison J, 2005, AM J PATHOL, V166, P1701, DOI 10.1016/S0002-9440(10)62480-7; NODA M, 1989, ENDOCRINOLOGY, V124, P612, DOI 10.1210/endo-124-2-612; NODA M, 1988, J BIOL CHEM, V263, P13916; NODA M, 1987, J CELL PHYSIOL, V133, P426, DOI 10.1002/jcp.1041330303; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; RIDEAU Y, 1981, MUSCLE NERVE, V4, P155, DOI 10.1002/mus.880040213; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Salimena M, 2004, HISTOCHEM CELL BIOL, V122, P435, DOI 10.1007/s00418-004-0707-8; Satriano J, 2004, AMINO ACIDS, V26, P321, DOI 10.1007/s00726-004-0078-4; Segalat L, 2005, EXP CELL RES, V302, P170, DOI 10.1016/j.yexcr.2004.09.007; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; STAHLEBACKDAHL M, 1994, J CLIN INVEST, V93, P2022, DOI 10.1172/JCI117196; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Steppan J, 2006, P NATL ACAD SCI USA, V103, P4759, DOI 10.1073/pnas.0506589103; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wehling-Henricks M, 2008, HUM MOL GENET, V17, P2280, DOI 10.1093/hmg/ddn129; Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x; Witte MB, 2003, J GASTROINTEST SURG, V7, P378, DOI 10.1016/S1091-255X(02)00431-6; Yamashita T, 2001, J PEDIATR ORTHOPED, V21, P113, DOI 10.1097/01241398-200101000-00022; YANAGISAWA A, 1992, AM HEART J, V124, P1244, DOI 10.1016/0002-8703(92)90407-M	82	85	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10763	10.1371/journal.pone.0010763	http://dx.doi.org/10.1371/journal.pone.0010763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505827	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400018
J	Liu, HS; Zhang, JH; Liu, CY; Wang, IJ; Sieber, M; Chang, J; Jester, JV; Kao, WWY				Liu, Hongshan; Zhang, Jianhua; Liu, Chia-Yang; Wang, I-Jong; Sieber, Martin; Chang, John; Jester, James V.; Kao, Winston W. Y.			Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; CONFOCAL MICROSCOPY; SKELETAL-MUSCLE; SPINAL-CORD; TRANSPLANTATION; TISSUE; EXPRESSION; KERATOCAN; REPAIR	Background: Keratoplasty is the most effective treatment for corneal blindness, but suboptimal medical conditions and lack of qualified medical personnel and donated cornea often prevent the performance of corneal transplantation in developing countries. Our study aims to develop alternative treatment regimens for congenital corneal diseases of genetic mutation. Methodology/Principal Findings: Human mesenchymal stem cells isolated from neonatal umbilical cords were transplanted to treat thin and cloudy corneas of lumican null mice. Transplantation of umbilical mesenchymal stem cells significantly improved corneal transparency and increased stromal thickness of lumican null mice, but human umbilical hematopoietic stem cells failed to do the same. Further studies revealed that collagen lamellae were re-organized in corneal stroma of lumican null mice after mesenchymal stem cell transplantation. Transplanted umbilical mesenchymal stem cells survived in the mouse corneal stroma for more than 3 months with little or no graft rejection. In addition, these cells assumed a keratocyte phenotype, e. g., dendritic morphology, quiescence, expression of keratocyte unique keratan sulfated keratocan and lumican, and CD34. Moreover, umbilical mesenchymal stem cell transplantation improved host keratocyte functions, which was verified by enhanced expression of keratocan and aldehyde dehydrogenase class 3A1 in lumican null mice. Conclusions/Significance: Umbilical mesenchymal stem cell transplantation is a promising treatment for congenital corneal diseases involving keratocyte dysfunction. Unlike donated corneas, umbilical mesenchymal stem cells are easily isolated, expanded, stored, and can be quickly recovered from liquid nitrogen when a patient is in urgent need.	[Liu, Hongshan; Zhang, Jianhua; Liu, Chia-Yang; Kao, Winston W. Y.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45221 USA; [Wang, I-Jong] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei 10764, Taiwan; [Sieber, Martin; Chang, John] Bionet Corp, Taipei, Taiwan; [Jester, James V.] Univ Calif Irvine, Med Ctr, Gavin Herbert Eye Inst, Orange, CA USA	University System of Ohio; University of Cincinnati; National Taiwan University; University of California System; University of California Irvine	Liu, HS (corresponding author), Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45221 USA.	Winston.Kao@UC.Edu		Jester, James/0000-0002-9246-0981; Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614	NIH/NEI [EY 011845, EY016663]; Research to Prevent Blindness Inc.; Ohio Lions Eye Res. Foundation; NATIONAL EYE INSTITUTE [R24EY016663, R01EY011845] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); Ohio Lions Eye Res. Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was in part supported by grants NIH/NEI EY 011845, EY016663, Research to Prevent Blindness Inc. and Ohio Lions Eye Res. Foundation. Dr. Martin Sieber and Mr. John Chang are employees of Bionet Corp., Taipei, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except the initial characterizations of the stem cells.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0; Chhabra P, 2009, CURR OPIN ORGAN TRAN, V14, P72, DOI 10.1097/MOT.0b013e328320d2f5; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Dai LJ, 2009, STEM CELL RES, V2, P16, DOI 10.1016/j.scr.2008.07.005; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Garg P, 2005, EYE, V19, P1106, DOI 10.1038/sj.eye.6701968; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Ikehara S, 2010, CLIN REV ALLERG IMMU, V38, P292, DOI 10.1007/s12016-009-8159-5; Isaikina Ya., 2008, Experimental Oncology, V30, P121; Jester JV, 1999, METHOD ENZYMOL, V307, P230; Jester JV, 2001, VISION RES, V41, P1283, DOI 10.1016/S0042-6989(00)00222-4; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph A, 2003, INVEST OPHTH VIS SCI, V44, P4689, DOI 10.1167/iovs.02-0999; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Khan Bilal F., 2007, International Ophthalmology Clinics, V47, P61, DOI 10.1097/IIO.0b013e318036bd8b; Kitada M, 2009, HISTOL HISTOPATHOL, V24, P631, DOI 10.14670/HH-24.631; Lasala GP, 2009, HEART LUNG CIRC, V18, P171, DOI 10.1016/j.hlc.2008.09.007; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mobasheri A, 2009, HISTOL HISTOPATHOL, V24, P347, DOI 10.14670/HH-24.347; Moffatt SL, 2005, CLIN EXP OPHTHALMOL, V33, P642, DOI 10.1111/j.1442-9071.2005.01134.x; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Morishige N, 2006, J CATARACT REFR SURG, V32, P1784, DOI 10.1016/j.jcrs.2006.08.027; Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n; Nadri S, 2008, DIFFERENTIATION, V76, P223, DOI 10.1111/j.1432-0436.2007.00216.x; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PITTENGER MF, SCIENCE, V284, P143; Popp FC, 2009, TRANSPLANTATION, V87, pS57, DOI 10.1097/TP.0b013e3181a288aa; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raimondo S, 2006, J ANAT, V208, P3, DOI 10.1111/j.1469-7580.2006.00511.x; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463	54	81	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10707	10.1371/journal.pone.0010707	http://dx.doi.org/10.1371/journal.pone.0010707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502663	Green Published, gold			2022-12-27	WOS:000277845400013
J	Bishay, P; Schmidt, H; Marian, C; Haussler, A; Wijnvoord, N; Ziebell, S; Metzner, J; Koch, M; Myrczek, T; Bechmann, I; Kuner, R; Costigan, M; Dehghani, F; Geisslinger, G; Tegeder, I				Bishay, Philipp; Schmidt, Helmut; Marian, Claudiu; Hauessler, Annett; Wijnvoord, Nina; Ziebell, Simone; Metzner, Julia; Koch, Marco; Myrczek, Thekla; Bechmann, Ingo; Kuner, Rohini; Costigan, Michael; Dehghani, Faramarz; Geisslinger, Gerd; Tegeder, Irmgard			R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; ACTIVATED PROTEIN-KINASE; ACID AMIDE HYDROLASE; DORSAL-ROOT GANGLION; SPINAL-CORD; MICROGLIA CONTRIBUTES; INDUCED HYPERALGESIA; MULTIPLE-SCLEROSIS; PROSTAGLANDIN E-2; GAMMA-SECRETASE	Background: R-flurbiprofen, one of the enantiomers of flurbiprofen racemate, is inactive with respect to cyclooxygenase inhibition, but shows analgesic properties without relevant toxicity. Its mode of action is still unclear. Methodology/Principal Findings: We show that R-flurbiprofen reduces glutamate release in the dorsal horn of the spinal cord evoked by sciatic nerve injury and thereby alleviates pain in sciatic nerve injury models of neuropathic pain in rats and mice. This is mediated by restoring the balance of endocannabinoids (eCB), which is disturbed following peripheral nerve injury in the DRGs, spinal cord and forebrain. The imbalance results from transcriptional adaptations of fatty acid amide hydrolase (FAAH) and NAPE-phospholipase D, i.e. the major enzymes involved in anandamide metabolism and synthesis, respectively. R-flurbiprofen inhibits FAAH activity and normalizes NAPE-PLD expression. As a consequence, R-Flurbiprofen improves endogenous cannabinoid mediated effects, indicated by the reduction of glutamate release, increased activity of the anti-inflammatory transcription factor PPAR gamma and attenuation of microglia activation. Antinociceptive effects are lost by combined inhibition of CB1 and CB2 receptors and partially abolished in CB1 receptor deficient mice. R-flurbiprofen does however not cause changes of core body temperature which is a typical indicator of central effects of cannabinoid-1 receptor agonists. Conclusion: Our results suggest that R-flurbiprofen improves the endogenous mechanisms to regain stability after axonal injury and to fend off chronic neuropathic pain by modulating the endocannabinoid system and thus constitutes an attractive, novel therapeutic agent in the treatment of chronic, intractable pain.	[Bishay, Philipp; Schmidt, Helmut; Marian, Claudiu; Hauessler, Annett; Wijnvoord, Nina; Ziebell, Simone; Metzner, Julia; Myrczek, Thekla; Geisslinger, Gerd; Tegeder, Irmgard] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Bechmann, Ingo] Goethe Univ Frankfurt, Dept Clin Neuroanat, Frankfurt, Germany; [Koch, Marco; Dehghani, Faramarz] Goethe Univ Frankfurt, Dept Expt Neurobiol, Inst Anat, Frankfurt, Germany; [Kuner, Rohini] Univ Heidelberg, Dept Pharmacol, D-6900 Heidelberg, Germany; [Costigan, Michael] Harvard Univ, Sch Med, Boston, MA USA; [Costigan, Michael] Massachusetts Gen Hosp, Neuroplast Res Grp, Dept Anaesthesia, Boston, MA 02114 USA	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Bishay, P (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	tegeder@em.uni-frankfurt.de	Tegeder, Irmgard/AAM-2266-2020; Kuner, Rohini/AGU-0204-2022; Tegeder, Irmgard/AAM-2246-2020	Tegeder, Irmgard/0000-0001-7524-8025; Tegeder, Irmgard/0000-0001-7524-8025	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Else Kroner Fresenius Foundation; PAZ GmbH, Frankfurt; Interdisciplinary Center of Neuroscience Frankfurt, ICNF	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Else Kroner Fresenius Foundation; PAZ GmbH, Frankfurt; Interdisciplinary Center of Neuroscience Frankfurt, ICNF	This work was supported by LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF, http://www.liff-ffm.de/liff/mission.php; to IT), Else Kroner Fresenius Foundation (http://www.ekfs.de/de/start.html, to IT), PAZ GmbH, Frankfurt (http://www.paz.de/to GG) and the Interdisciplinary Center of Neuroscience Frankfurt, ICNF (http://www.izn-frankfurt.de/web-content_en/index.html, to IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fowler CJ, 2003, J ENZYM INHIB MED CH, V18, P55, DOI 10.1080/1475636021000049726; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Geisslinger G, 2000, J NEUROCHEM, V74, P2094, DOI 10.1046/j.1471-4159.2000.0742094.x; GEISSLINGER G, 1993, AGENT ACTION SUPPL, V44, P31; Griffin RS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-105; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Holzer P, 2001, INFLAMM RES, V50, P602, DOI 10.1007/PL00000241; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Jin SX, 2003, J NEUROSCI, V23, P4017; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; LOTSCH J, 1995, BRIT J CLIN PHARMACO, V40, P339, DOI 10.1111/j.1365-2125.1995.tb04556.x; Ma WY, 2007, EXPERT OPIN THER TAR, V11, P307, DOI 10.1517/14728222.11.3.307; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Piao ZG, 2006, PAIN, V121, P219, DOI 10.1016/j.pain.2005.12.023; Pollmann W, 2008, CNS DRUGS, V22, P291; Pollock G, 2005, EXP BRAIN RES, V165, P470, DOI 10.1007/s00221-005-2318-6; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Schmidtko A, 2005, PAIN, V115, P171, DOI 10.1016/j.pain.2005.02.027; SCHMIDTKO A, 2008, PAIN; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Scholz J, 2008, PAIN, V138, P130, DOI 10.1016/j.pain.2007.11.019; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tegeder I, 2001, FASEB J, V15, P595, DOI 10.1096/fasebj.15.3.595; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Vetter G, 2001, PAIN, V92, P213, DOI 10.1016/S0304-3959(01)00258-5; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Wilcock GK, 2008, LANCET NEUROL, V7, P483, DOI 10.1016/S1474-4422(08)70090-5; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016	49	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10628	10.1371/journal.pone.0010628	http://dx.doi.org/10.1371/journal.pone.0010628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498712	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500016
J	Brooks, R; Maklakov, A				Brooks, Robert; Maklakov, Alexei			Sex Differences in Obesity Associated with Total Fertility Rate	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; ANTHROPOMETRIC MEASURES; REPRODUCTIVE FACTORS; WEIGHT; PARITY; GENDER	The identification of biological and ecological factors that contribute to obesity may help in combating the spreading obesity crisis. Sex differences in obesity rates are particularly poorly understood. Here we show that the strong female bias in obesity in many countries is associated with high total fertility rate, which is well known to be correlated with factors such as low average income, infant mortality and female education. We also document effects of reduced access to contraception and increased inequality of income among households on obesity rates. These results are consistent with studies that implicate reproduction as a risk factor for obesity in women and that suggest the effects of reproduction interact with socioeconomic and educational factors. We discuss our results in the light of recent research in dietary ecology and the suggestion that insulin resistance during pregnancy is due to historic adaptation to protect the developing foetus during famine. Increased access to contraception and education in countries with high total fertility rate might have the additional benefit of reducing the rates of obesity in women.	[Brooks, Robert] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Maklakov, Alexei] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	University of New South Wales Sydney; Uppsala University	Brooks, R (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	rob.brooks@unsw.edu.au	Brooks, Robert/A-1251-2008; Maklakov, Alexei/AAS-5968-2021; Maklakov, Alexei A/F-8167-2014	Brooks, Robert/0000-0001-6926-0781; Maklakov, Alexei/0000-0002-5809-1203; 				ARROYO P, 1995, INT J GYNECOL OBSTET, V48, P269, DOI 10.1016/0020-7292(94)02284-6; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Bjorkelund C, 1996, INT J OBESITY, V20, P213; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; BROOKS RC, 2010, OBESITY REV IN PRESS; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Corbett SJ, 2009, AM J HUM BIOL, V21, P587, DOI 10.1002/ajhb.20937; Daly M, 2001, CAN J CRIMINOL, V43, P219; Davis EM, 2009, AM J PUBLIC HEALTH, V99, P294, DOI 10.2105/AJPH.2007.132373; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; FAO, 2008, STAT FOOD INS WORLD; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; HALL MD, 2009, FUNCTIONAL IN PRESS; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Kim SA, 2007, INT J EPIDEMIOL, V36, P93, DOI 10.1093/ije/dyl252; Koch E, 2008, J EPIDEMIOL COMMUN H, V62, P461, DOI 10.1136/jech.2007.062240; Lutz W, 2009, PHILOS T R SOC B, V364, P3031, DOI 10.1098/rstb.2009.0156; Maklakov AA, 2008, EVOL HUM BEHAV, V29, P444, DOI 10.1016/j.evolhumbehav.2008.08.002; Mansour AA, 2009, EAT WEIGHT DISORD-ST, V14, pE50, DOI 10.1007/BF03327800; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Nesse RM, 2006, SCIENCE, V311, P1071, DOI 10.1126/science.1125956; Newby PK, 2005, INT J OBESITY, V29, P1084, DOI 10.1038/sj.ijo.0802996; Olson CM, 2008, J RURAL HEALTH, V24, P60, DOI 10.1111/j.1748-0361.2008.00138.x; Short RV, 2009, PHILOS T R SOC B, V364, P2971, DOI 10.1098/rstb.2009.0144; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; STUBBS RJ, 1995, INT J OBESITY, V19, pS11; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wardle J, 2002, AM J PUBLIC HEALTH, V92, P1299, DOI 10.2105/AJPH.92.8.1299; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Wen W, 2003, INT J OBESITY, V27, P933, DOI 10.1038/sj.ijo.0802318; WHO, 2010, WHO GLOB DAT BOD MAS; Wilkinson R, 2009, SPIRIT LEVEL WHY GRE, V1	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10587	10.1371/journal.pone.0010587	http://dx.doi.org/10.1371/journal.pone.0010587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594UC	20485682	Green Published, gold			2022-12-27	WOS:000277563400005
J	Menoni, V; Lucas, N; Leforestier, JF; Dimet, J; Doz, F; Chatellier, G; Treluyer, JM; Chappuy, H				Menoni, Veronique; Lucas, Noel; Leforestier, Jean Francois; Dimet, Jerome; Doz, Francois; Chatellier, Gilles; Treluyer, Jean-Marc; Chappuy, Helene			The Readability of Information and Consent Forms in Clinical Research in France	PLOS ONE			English	Article							INFORMED-CONSENT; BIOMEDICAL-RESEARCH; PATIENTS UNDERSTAND; PROCESSABILITY	Background: Quantitative tools have been developed to evaluate the readability of written documents and have been used in several studies to evaluate information and consent forms. These studies all showed that such documents had a low level of readability. Our objective is to evaluate the readability of Information and Consent Forms (ICFs) used in clinical research. Methods and Findings: Clinical research protocols were collected from four public clinical research centers in France. Readability was evaluated based on three criteria: the presence of an illustration, the length of the text and its Flesch score. Potential effects of protocol characteristics on the length and readability of the ICFs were determined. Medical and statutory parts of the ICF form were analyzed separately. The readability of these documents was compared with that of everyday contracts, press articles, literary extracts and political speeches. We included 209 protocols and the corresponding 275 ICFs. The median length was 1304 words. Their Flesch readability scores were low (median: 24), and only about half that of selected press articles. ICF s for industrially sponsored and randomized protocols were the longest and had the highest readability scores. More than half (52%) of the text in ICFs concerned medical information, and this information was statistically (p < 0.05) more readable (Flesch: 28) than statutory information (Flesch: 21). Conclusion: Regardless of the field of research, the ICFs for protocols included had poor readability scores. However, a prospective analysis of this test in French should be carried out before it is put into general use.	[Menoni, Veronique; Treluyer, Jean-Marc; Chappuy, Helene] Univ Paris 05, AP HP, Hop Necker Enfants Malad, Unite Rech,Clin Paris Ctr, Paris, France; [Menoni, Veronique; Chappuy, Helene] Univ Paris 05, Lab Eth Med, Paris, France; [Lucas, Noel; Leforestier, Jean Francois; Chatellier, Gilles] Univ Paris 05, AP HP, Hop Europeen Georges Pompidou, CIC Inserm E4, Paris, France; [Dimet, Jerome] CHD Vendee, Unite Rech Clin, La Roche Sur Yon, France; [Doz, Francois] Inst Curie, Paris, France; [Treluyer, Jean-Marc] Univ Paris 05, AP HP, Hop Cochin St Vincent de Paul, Paris, France; [Treluyer, Jean-Marc; Chappuy, Helene] Univ Paris 05, EA3620, Paris, France; [Treluyer, Jean-Marc] Univ Paris 05, AP HP, Hop Necker Enfants Malad, Ctr Invest,Clin Paris Ctr, Paris, France; [Chappuy, Helene] Univ Paris 05, AP HP, Hop Necker Enfants Malad, Serv Urgences Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHD Vendee; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Menoni, V (corresponding author), Univ Paris 05, AP HP, Hop Necker Enfants Malad, Unite Rech,Clin Paris Ctr, Paris, France.	helene.chappuy@nck.aphp.fr	treluyer, Jean-Marc/F-8036-2010	Doz, Francois/0000-0001-9286-4831	Assistance Publique des Hopitaux de Paris	Assistance Publique des Hopitaux de Paris	This study was funded by the Assistance Publique des Hopitaux de Paris as a Programme Hospitalier de Recherche Clinique. The funder played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5; Bailin A, 2001, LANG COMMUN, V21, P285, DOI 10.1016/S0271-5309(01)00005-2; Christopher PP, 2007, PSYCHIAT SERV, V58, P227, DOI 10.1176/appi.ps.58.2.227; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; GRUNDNER TM, 1980, NEW ENGL J MED, V302, P900, DOI 10.1056/NEJM198004173021606; HOPPER KD, 1995, AM J ROENTGENOL, V164, P493, DOI 10.2214/ajr.164.2.7839996; Mader TJ, 1997, ANN EMERG MED, V29, P534, DOI 10.1016/S0196-0644(97)70229-4; MORROW GR, 1980, JAMA-J AM MED ASSOC, V244, P56, DOI 10.1001/jama.244.1.56; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Paris A, 2005, PRESSE MED, V34, P13, DOI 10.1016/S0755-4982(05)83877-1; Paris A, 2007, FUND CLIN PHARMACOL, V21, P207, DOI 10.1111/j.1472-8206.2007.00472.x; PHILIPSON SJ, 1995, J INVEST MED, V43, P459; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Tait AR, 2005, ARCH PEDIAT ADOL MED, V159, P347, DOI 10.1001/archpedi.159.4.347; TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58; White LJ, 1996, ACAD EMERG MED, V3, P745, DOI 10.1111/j.1553-2712.1996.tb03509.x; *WHO CIOMS, 1981, WHO CIOMS GUID PROP; World Medical Association, 2008, DECL HELS ETH PRINC; 1996, GUIDELINE GOOD CLIN; 2005, ADDITIONAL PROTOCOL	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10576	10.1371/journal.pone.0010576	http://dx.doi.org/10.1371/journal.pone.0010576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485505	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563200011
J	Wernimont, SA; Simonson, WTN; Greer, PA; Seroogy, CM; Huttenlocher, A				Wernimont, Sarah A.; Simonson, William T. N.; Greer, Peter A.; Seroogy, Christine M.; Huttenlocher, Anna			Calpain 4 Is Not Necessary for LFA-1-Mediated Function in CD4+T Cells	PLOS ONE			English	Article							PERIPHERAL T-CELLS; UBIQUITOUS CALPAINS; CYTOPLASMIC DOMAIN; ACTIVATION; LFA-1; APOPTOSIS; MIGRATION; DEATH; DISRUPTION; INHIBITORS	Background: T cell activation and immune synapse formation require the appropriate activation and clustering of the integrin, LFA-1. Previous work has reported that the calpain family of calcium-dependent proteases are important regulators of integrin activation and modulate T cell adhesion and migration. However, these studies have been limited by the use of calpain inhibitors, which have known off-target effects. Methodology/Principal Findings: Here, we used a LoxP/CRE system to specifically deplete calpain 4, a small regulatory calpain subunit required for expression and activity of ubiquitously expressed calpains 1 and 2, in CD4+ T cells. CD4+ and CD8+ T cells developed normally in Capn4(F/F): CD4-CRE mice and had severely diminished expression of Calpain 1 and 2, diminished talin proteolysis and impaired casein degradation. Calpain 4-deficient T cells showed no difference in adhesion or migration on the LFA-1 ligand ICAM-1 compared to control T cells. Moreover, there was no impairment in conjugation between Capn4(F/F):CD4-CRE T cells and antigen presenting cells, and the conjugates were still capable of polarizing LFA-1, PKC-theta and actin to the immune synapse. Furthermore, T cells from Capn4(F/F):CD4-CRE mice showed normal proliferation in response to either anti-CD3/CD28 coated beads or cognate antigen-loaded splenocytes. Finally, there were no differences in the rates of apoptosis following extrinsic and intrinsic apoptotic stimuli. Conclusion/Significance: Our findings demonstrate that calpain 4 is not necessary for LFA-1-mediated adhesion, conjugation or migration. These results challenge previous reports that implicate a central role for calpains in the regulation of T cell LFA-1 function.	[Wernimont, Sarah A.; Simonson, William T. N.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Seroogy, Christine M.; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Seroogy, Christine M.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; McMaster University; Queens University - Canada; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wernimont, SA (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Wernimont, Sarah/0000-0002-6894-7837	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI068062]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) R01 to A. H. [AI068062]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bleijs DA, 2001, J BIOL CHEM, V276, P10338, DOI 10.1074/jbc.M008967200; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; CRAWFORD C, 1988, BIOCHEM J, V253, P751, DOI 10.1042/bj2530751; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dreolini L, 2007, BIOCHEM BIOPH RES CO, V356, P207, DOI 10.1016/j.bbrc.2007.02.100; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; SARIN A, 1993, J EXP MED, V178, P1693, DOI 10.1084/jem.178.5.1693; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Squier MKT, 1997, J IMMUNOL, V158, P3690; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Varghese J, 2001, EUR J IMMUNOL, V31, P2035, DOI 10.1002/1521-4141(200107)31:7<2035::AID-IMMU2035>3.0.CO;2-Y; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Yang YL, 1997, BLOOD, V89, P550, DOI 10.1182/blood.V89.2.550	34	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10513	10.1371/journal.pone.0010513	http://dx.doi.org/10.1371/journal.pone.0010513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479866	Green Submitted, gold, Green Published			2022-12-27	WOS:000277467800005
J	Bagaitkar, J; Demuth, DR; Daep, CA; Renaud, DE; Pierce, DL; Scott, DA				Bagaitkar, Juhi; Demuth, Donald R.; Daep, Carlo Amorin; Renaud, Diane E.; Pierce, Deanne L.; Scott, David A.			Tobacco Upregulates P. gingivalis Fimbrial Proteins Which Induce TLR2 Hyposensitivity	PLOS ONE			English	Article							CIGARETTE-SMOKE EXTRACT; CREVICULAR FLUID LEVELS; INNATE IMMUNE-RESPONSE; PORPHYROMONAS-GINGIVALIS; EPITHELIAL-CELLS; CYTOKINE PRODUCTION; TNF-ALPHA; IN-VIVO; ACTIVATION; VIRULENCE	Background: Tobacco smokers are more susceptible to periodontitis than non-smokers but exhibit reduced signs of clinical inflammation. The underlying mechanisms are unknown. We have previously shown that cigarette smoke extract (CSE) represents an environmental stress to which P. gingivalis adapts by altering the expression of several virulence factors including major and minor fimbrial antigens (FimA and Mfa1, respectively) and capsule - concomitant with a reduced pro-inflammatory potential of intact P. gingivalis. Methodology/Principal Findings: We hypothesized that CSE-regulation of capsule and fimbrial genes is reflected at the ultrastructural and functional levels, alters the nature of host-pathogen interactions, and contributes to the reduced pro-inflammatory potential of smoke exposed P. gingivalis. CSE induced ultrastructural alterations were determined by electron microscopy, confirmed by Western blot and physiological consequences studied in open-flow biofilms. Inflammatory profiling of specific CSE-dysregulated proteins, rFimA and rMfa1, was determined by quantifying cytokine induction in primary human innate and OBA-9 cells. CSE up-regulates P. gingivalis FimA at the protein level, suppresses the production of capsular polysaccharides at the ultrastructural level, and creates conditions that promote biofilm formation. We further show that while FimA is recognized by TLR2/6, it has only minimal inflammatory activity in several cell types. Furthermore, FimA stimulation chronically abrogates the pro-inflammatory response to subsequent TLR2 stimulation by other TLR-2-specific agonists (Pam3CSK4, FSL, Mfa1) in an IkB alpha- and IRAK-1-dependent manner. Conclusions/Significance: These studies provide some of the first information to explain, mechanistically, how tobacco smoke changes the P. gingivalis phenotype in a manner likely to promote P. gingivalis colonization and infection while simultaneously reducing the host response to this major mucosal pathogen.	[Bagaitkar, Juhi; Demuth, Donald R.; Daep, Carlo Amorin; Scott, David A.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Demuth, Donald R.; Renaud, Diane E.; Pierce, Deanne L.; Scott, David A.] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Res Grp, Dept Oral Hlth & Rehabil, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bagaitkar, J (corresponding author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	dascot07@louisville.edu	Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	National Institute of Environmental Health Sciences (NIEHS); Integrative Biology at the University of Louisville [1P30ES014443-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Integrative Biology at the University of Louisville; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by a National Institute of Environmental Health Sciences (NIEHS) pilot grant awarded to the Center for Environmental Genomics and Integrative Biology at the University of Louisville (1P30ES014443-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the investigators had any direct or indirect tobacco funding for their salaries.	Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Andreou V, 2004, J PERIODONTOL, V75, P939, DOI 10.1902/jop.2004.75.7.939; BAGAITKAR J, 2009, ENV MICROBIOL; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Bergstrom J, 2000, J CLIN PERIODONTOL, V27, P61, DOI 10.1034/j.1600-051x.2000.027001061.x; Bergstrom Jan, 2006, J Evid Based Dent Pract, V6, P33, DOI 10.1016/j.jebdp.2005.12.018; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bostrom L, 1999, J CLIN PERIODONTOL, V26, P352, DOI 10.1034/j.1600-051X.1999.260604.x; Calsina G, 2002, J CLIN PERIODONTOL, V29, P771; Chamekh M, 2008, J IMMUNOL, V180, P4292, DOI 10.4049/jimmunol.180.6.4292; d'Empaire G, 2006, INFECT IMMUN, V74, P6236, DOI 10.1128/IAI.00519-06; Daep CA, 2006, INFECT IMMUN, V74, P5756, DOI 10.1128/IAI.00813-06; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; de Heens GLT, 2009, J PERIODONTAL RES, V44, P28, DOI 10.1111/j.1600-0765.2007.01047.x; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Eggert FM, 2001, J PERIODONTOL, V72, P1210, DOI 10.1902/jop.2000.72.9.1210; Erdemir EO, 2004, J CLIN PERIODONTOL, V31, P99, DOI 10.1111/j.0303-6979.2004.00454.x; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Fraser HS, 2001, J DENT RES, V80, P1643, DOI 10.1177/00220345010800070901; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Graves DT, 2005, J ENDOTOXIN RES, V11, P13, DOI 10.1179/096805105225006722; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P377, DOI 10.1034/j.1600-051x.2001.028005377.x; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hamada N, 2002, ORAL MICROBIOL IMMUN, V17, P197, DOI 10.1034/j.1399-302X.2002.170311.x; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuboniwa M, 2009, ORAL MICROBIOL IMMUN, V24, P260, DOI 10.1111/j.1399-302X.2009.00511.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Murakami Y, 2006, ARCH BIOCHEM BIOPHYS, V449, P171, DOI 10.1016/j.abb.2006.02.005; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nair P, 2003, J CLIN PERIODONTOL, V30, P435, DOI 10.1034/j.1600-051X.2003.20039.x; Nakagawa I, 2006, INFECT IMMUN, V74, P3773, DOI 10.1128/IAI.01902-05; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Petropoulos G, 2004, J CLIN PERIODONTOL, V31, P390, DOI 10.1111/j.1600-051X.2004.00489.x; Pierce DL, 2009, INFECT IMMUN, V77, P3294, DOI 10.1128/IAI.00262-09; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Robbins CS, 2008, J IMMUNOL, V180, P6623, DOI 10.4049/jimmunol.180.10.6623; Sayers NM, 1999, J PERIODONTOL, V70, P1269, DOI 10.1902/jop.1999.70.11.1269; Sayers NM, 1997, J CLIN PATHOL, V50, P245, DOI 10.1136/jcp.50.3.245; Scott D A, 2004, Int J Dent Hyg, V2, P104, DOI 10.1111/j.1601-5037.2004.00079.x; Scott DA, 2006, WORLD J GASTROENTERO, V12, P7451, DOI 10.3748/wjg.v12.i46.7451; Shirodaria S, 2000, J DENT RES, V79, P1864, DOI 10.1177/00220345000790110801; Siedlar M, 2004, J IMMUNOL, V173, P2736, DOI 10.4049/jimmunol.173.4.2736; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Xu MQ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-19; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050; Zappacosta B, 2001, LUMINESCENCE, V16, P315, DOI 10.1002/bio.661; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	67	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e9323	10.1371/journal.pone.0009323	http://dx.doi.org/10.1371/journal.pone.0009323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454607	Green Submitted, Green Published, gold			2022-12-27	WOS:000277305300001
J	Dutta, S; Rittinger, K				Dutta, Sujit; Rittinger, Katrin			Regulation of NOXO1 Activity through Reversible Interactions with p22(phox) and NOXA1	PLOS ONE			English	Article							PHAGOCYTE NADPH OXIDASE; PHOSPHORYLATION-INDUCED ACTIVATION; PROTEIN-KINASE-C; SH3 DOMAINS; NAD(P)H OXIDASE-1; SUPEROXIDE; P47(PHOX); BINDING; P67(PHOX); FAMILY	Reactive oxygen species (ROS) have been known for a long time to play important roles in host defense against microbial infections. In addition, it has become apparent that they also perform regulatory roles in signal transduction and cell proliferation. The source of these chemicals are members of the NOX family of NADPH oxidases that are found in a variety of tissues. NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity. Unlike NOX2, the phagocytic NADPH oxidase whose activity is tightly repressed in the resting state, NOX1 produces superoxide constitutively at low levels. These levels can be further increased in a stimulus-dependent manner, yet the molecular details regulating this activity are not fully understood. Here we present the first quantitative characterization of the interactions made between the cytosolic regulators NOXO1 and NOXA1 and membrane-bound p22(phox). Using isothermal titration calorimetry we show that the isolated tandem SH3 domains of NOXO1 bind to p22(phox) with high affinity, most likely adopting a superSH3 domain conformation. In contrast, complex formation is severely inhibited in the presence of the C-terminal tail of NOXO1, suggesting that this region competes for binding to p22(phox) and thereby contributes to the regulation of superoxide production. Furthermore, we provide data indicating that the molecular details of the interaction between NOXO1 and NOXA1 is significantly different from that between the homologous proteins of the phagocytic oxidase, suggesting that there are important functional differences between the two systems. Taken together, this study provides clear evidence that the assembly of the NOX1 oxidase complex can be regulated through reversible protein-protein interactions.	[Dutta, Sujit; Rittinger, Katrin] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Dutta, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435	Medical Research Council, UK; Medical Research Council [MC_U117565398] Funding Source: researchfish; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; CHENG G, 2006, J BIOL CHEM; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Huang J, 1999, J BIOL CHEM, V274, P19731, DOI 10.1074/jbc.274.28.19731; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-178; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; Pires JR, 2003, J MOL BIOL, V326, P1427, DOI 10.1016/S0022-2836(03)00039-1; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Yamamoto A, 2007, BIOCHEM BIOPH RES CO, V352, P560, DOI 10.1016/j.bbrc.2006.11.060; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	44	40	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10478	10.1371/journal.pone.0010478	http://dx.doi.org/10.1371/journal.pone.0010478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454568	Green Published, Green Submitted, gold			2022-12-27	WOS:000277305300012
J	Faghiri, Z; Camargo, SMR; Huggel, K; Forster, IC; Ndegwa, D; Verrey, F; Skelly, PJ				Faghiri, Zahra; Camargo, Simone M. R.; Huggel, Katja; Forster, Ian C.; Ndegwa, David; Verrey, Francois; Skelly, Patrick J.			The Tegument of the Human Parasitic Worm Schistosoma mansoni as an Excretory Organ: The Surface Aquaporin SmAQP Is a Lactate Transporter	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; WATER CHANNELS; FUNCTIONAL EXPRESSION; METABOLISM; CLONING; SELECTIVITY; APPEARANCE; PROTEINS; GLYCEROL; GLYCOGEN	Adult schistosomes are intravascular parasites that metabolize imported glucose largely via glycolysis. How the parasites get rid of the large amounts of lactic acid this generates is unknown at the molecular level. Here, we report that worms whose aquaporin gene (SmAQP) has been suppressed using RNAi fail to rapidly acidify their culture medium and excrete less lactate compared to controls. Functional expression of SmAQP in Xenopus oocytes demonstrates that this protein can transport lactate following Michaelis-Menten kinetics with low apparent affinity (Km = 41+/-5.8 mM) and with a low energy of activation (E-a = 7.18+/-0.7 kcal/mol). Phloretin, a known inhibitor of lactate release from schistosomes, also inhibits lactate movement in SmAQP-expressing oocytes. In keeping with the substrate promiscuity of other aquaporins, SmAQP is shown here to be also capable of transporting water, mannitol, fructose and alanine but not glucose. Using immunofluorescent and immuno-EM, we confirm that SmAQP is localized in the tegument of adult worms. These findings extend the proposed functions of the schistosome tegument beyond its known capacity as an organ of nutrient uptake to include a role in metabolic waste excretion.	[Faghiri, Zahra; Ndegwa, David; Skelly, Patrick J.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Mol Helminthol Lab,Div Infect Dis, Grafton, MA USA; [Camargo, Simone M. R.; Huggel, Katja; Forster, Ian C.; Verrey, Francois] Univ Zurich, Inst Physiol, Zurich, Switzerland	Tufts University; University of Zurich	Faghiri, Z (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Mol Helminthol Lab,Div Infect Dis, Grafton, MA USA.	Patrick.Skelly@Tufts.edu		Forster, Ian/0000-0003-3087-9952; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	NIH-NIAID [AI-056273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056273] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH-NIAID grant AI-056273. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bacconi A, 2007, J MEMBRANE BIOL, V215, P81, DOI 10.1007/s00232-007-9008-1; Braschi S, 2006, PROTEOMICS, V6, P1471, DOI 10.1002/pmic.200500368; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; BUEDING E, 1950, J GEN PHYSL, V33; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; DA'Dara AA, 2003, PARASITE IMMUNOL, V25, P429, DOI 10.1111/j.1365-3024.2003.00651.x; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079; Faghiri Z, 2009, FASEB J, V23, P2780, DOI 10.1096/fj.09-130757; Githui E. K., 2006, Journal of Tropical Microbiology and Biotechnology, V2, P31; Githui EK, 2006, EXP PARASITOL, V114, P180, DOI 10.1016/j.exppara.2006.03.007; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HOREMANS AMC, 1991, PARASITOLOGY, V102, P259, DOI 10.1017/S0031182000062570; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212; Krautz-Peterson G, 2007, J BIOL CHEM, V282, P21767, DOI 10.1074/jbc.M703512200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Meredith D, 2008, XENOBIOTICA, V38, P1072, DOI [10.1080/00498250802010868, 10.1080/00498250802010868 ]; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Ohgusu Y, 2008, DRUG METAB PHARMACOK, V23, P279, DOI 10.2133/dmpk.23.279; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; SHAPIRO TA, 1982, EXP PARASITOL, V54, P379, DOI 10.1016/0014-4894(82)90047-9; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Skelly PJ, 2000, INT J PARASITOL, V30, P625, DOI 10.1016/S0020-7519(00)00031-X; Skelly PJ, 2001, PARASITOLOGY, V123, P277, DOI 10.1017/S0031182001008484; Skelly PJ, 2001, PARASITOLOGY, V122, P67, DOI 10.1017/S0031182000007071; Skelly PJ, 1998, PARASITOL TODAY, V14, P402, DOI 10.1016/S0169-4758(98)01319-2; THOMPSON DP, 1984, MOL BIOCHEM PARASIT, V13, P39, DOI 10.1016/0166-6851(84)90100-2; TIELENS AGM, 1990, MOL BIOCHEM PARASIT, V39, P195, DOI 10.1016/0166-6851(90)90058-T; TIELENS AGM, 1989, EXP PARASITOL, V68, P235, DOI 10.1016/0014-4894(89)90103-3; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Yukutake Y, 2008, BIOL CELL, V100, P355, DOI 10.1042/BC20070132; ZHANG R, 1990, J BIOL CHEM, V265, P15375	38	62	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10451	10.1371/journal.pone.0010451	http://dx.doi.org/10.1371/journal.pone.0010451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454673	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240300023
J	Gulliford, MC; Dodhia, H; Sivaprasad, S; Ashworth, M				Gulliford, Martin C.; Dodhia, Hiten; Sivaprasad, Sobha; Ashworth, Mark			Family Practices' Achievement of Diabetes Quality of Care Targets and Risk of Screen-Detected Diabetic Retinopathy	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; SOCIOECONOMIC-STATUS; SOCIAL DEPRIVATION; OUTCOMES; PAY; PERFORMANCE; ENGLAND; INEQUALITIES; INCENTIVES; ILLNESS	Background: We aimed to determine whether family practices' achievement of diabetes quality of care targets is associated with diabetic retinal disease in registered patients. Methods: Data for achievement of diabetes quality of care targets, including the proportion of patients with HbA1c <= 7.5%, for 144 family practices in London UK, for the years 2004/5 to 2007/8, were linked to data from a population-based diabetes eye screening programme collected from September 2007 to February 2009. Analyses were adjusted for age, sex, duration and type of diabetes, unadjusted diabetes prevalence, ethnicity and deprivation category. Results: Data were analysed for 24,458 participants with one or more eye screening results in the period. There were 9,332 (38%) with any diabetic retinopathy and 2,819 (11.5%) with sight threatening diabetic retinopathy (STDR), including 2,654 (10.9%) with maculopathy. Among participants registered at 13 family practices that were in the highest quartile for achievement of the HbA1c quality of care target for all four years of study, the relative odds of any diabetic retinopathy were 0.78 (0.69 to 0.88) P<0.001. For participants at 12 practices consistently in the lowest quartile of HbA1c achievement, the relative odds of any diabetic retinopathy were 1.16 (1.03 to 1.30), P = 0.015. In the highest achieving practices, the relative odds of maculopathy were 0.74 (0.62 to 0.89), P = 0.001 and STDR 0.77 (0.65 to 0.92), P = 0.004. Conclusions: The risk of diabetic retinopathy might be lower at family practices that consistently achieve highly on diabetes quality of care targets for HbA1c.	[Gulliford, Martin C.; Ashworth, Mark] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Dodhia, Hiten] Lambeth NHS Primary Care Trust, Dept Publ Hlth, London, England; [Sivaprasad, Sobha] Kings Coll Hosp London, Dept Ophthalmol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Gulliford, MC (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England.	martin.gulliford@kcl.ac.uk	Sivaprasad, S./D-6876-2015; Gulliford, Martin C/I-8606-2018	Sivaprasad, S./0000-0001-8952-0659; Gulliford, Martin C/0000-0003-1898-9075; Ashworth, Mark/0000-0001-6514-9904	Lambeth NHS Primary Care Trusts, London UK; Southwark NHS Primary Care Trusts, London UK; Lewisham NHS Primary Care Trusts, London UK	Lambeth NHS Primary Care Trusts, London UK; Southwark NHS Primary Care Trusts, London UK; Lewisham NHS Primary Care Trusts, London UK	The study was supported by Lambeth, Southwark and Lewisham NHS Primary Care Trusts, London UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth M, 2008, MED J AUSTRALIA, V189, P60, DOI 10.5694/j.1326-5377.2008.tb01916.x; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Edwards R, 2003, DIABETOLOGIA, V46, P750, DOI 10.1007/s00125-003-1102-z; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Gulliford MC, 2007, DIABETIC MED, V24, P505, DOI 10.1111/j.1464-5491.2007.02090.x; Gulliford MC, 2010, DIABETIC MED, V27, P282, DOI 10.1111/j.1464-5491.2010.02946.x; HAFFNER SM, 1989, DIABETES CARE, V12, P128, DOI 10.2337/diacare.12.2.128; Hart JT, 2000, BRIT MED J, V320, P18; *I MED, 2005, COMM QUAL HLTH CAR A; KELLY WF, 1993, BRIT MED J, V307, P1115, DOI 10.1136/bmj.307.6912.1115; Khunti K, 2001, FAM PRACT, V18, P27, DOI 10.1093/fampra/18.1.27; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Millett C, 2006, J MED SCREEN, V13, P152, DOI 10.1258/096914106778440608; *NAT SCREEN PROGR, 2009, NAT PROGR; *OFF NAT STAT, 2009, NEIGHB STAT; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Stata Corporation, 2009, STAT STAT SOFTW REL; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10424	10.1371/journal.pone.0010424	http://dx.doi.org/10.1371/journal.pone.0010424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454691	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100028
J	Patel, CJ; Bhattacharya, J; Butte, AJ				Patel, Chirag J.; Bhattacharya, Jayanta; Butte, Atul J.			An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; NATIONAL-HEALTH; ALPHA-TOCOPHEROL; RISK-FACTORS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; SUSCEPTIBILITY LOCI; BETA-CAROTENE; PREVALENCE; EXPOSURE	Background: Type 2 Diabetes (T2D) and other chronic diseases are caused by a complex combination of many genetic and environmental factors. Few methods are available to comprehensively associate specific physical environmental factors with disease. We conducted a pilot Environmental-Wide Association Study (EWAS), in which epidemiological data are comprehensively and systematically interpreted in a manner analogous to a Genome Wide Association Study (GWAS). Methods and Findings: We performed multiple cross-sectional analyses associating 266 unique environmental factors with clinical status for T2D defined by fasting blood sugar (FBG) concentration >= 126 mg/dL. We utilized available Centers for Disease Control (CDC) National Health and Nutrition Examination Survey (NHANES) cohorts from years 1999 to 2006. Within cohort sample numbers ranged from 503 to 3,318. Logistic regression models were adjusted for age, sex, body mass index (BMI), ethnicity, and an estimate of socioeconomic status (SES). As in GWAS, multiple comparisons were controlled and significant findings were validated with other cohorts. We discovered significant associations for the pesticide-derivative heptachlor epoxide (adjusted OR in three combined cohorts of 1.7 for a 1 SD change in exposure amount; p<0.001), and the vitamin c-tocopherol (adjusted OR 1.5; p<0.001). Higher concentrations of polychlorinated biphenyls (PCBs) such as PCB170 (adjusted OR 2.2; p<0.001) were also found. Protective factors associated with T2D included b-carotenes (adjusted OR 0.6; p<0.001). Conclusions and Significance: Despite difficulty in ascertaining causality, the potential for novel factors of large effect associated with T2D justify the use of EWAS to create hypotheses regarding the broad contribution of the environment to disease. Even in this study based on prior collected epidemiological measures, environmental factors can be found with effect sizes comparable to the best loci yet found by GWAS.	[Patel, Chirag J.; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat & Med, Stanford, CA 94305 USA; [Patel, Chirag J.; Butte, Atul J.] Stanford Univ, Sch Med, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Patel, Chirag J.; Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Bhattacharya, Jayanta] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Patel, CJ (corresponding author), Stanford Univ, Sch Med, Dept Pediat & Med, Stanford, CA 94305 USA.	abutte@stanford.edu			National Library of Medicine [T15 LM 007033, R01 LM009719]; National Institute on Aging [K02 AG024237]; Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences [(R01 GM079719]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024237] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	C.J.P. was funded by the National Library of Medicine (T15 LM 007033). J. B. was funded in part by the National Institute on Aging (K02 AG024237). A.J.B. was funded in part by the Lucile Packard Foundation for Children's Health, the National Library of Medicine (R01 LM009719), the National Institute of General Medical Sciences (R01 GM079719), and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; *ADA, 2009, DIAB INF ALL AB DIAB; *AG TOX SUBST DIS, 2007, HEPT HEPT EP; Arnlov J, 2009, DIABETOLOGIA, V52, P97, DOI 10.1007/s00125-008-1189-3; Burton GW, 1998, AM J CLIN NUTR, V67, P669, DOI 10.1093/ajcn/67.4.669; Campbell S, 2003, CRIT REV ONCOL HEMAT, V47, P249, DOI 10.1016/S1040-8428(03)00042-8; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2020, NAT HLTH NUTR EX SUR; Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315; *COMM EWG, HUM TOX PROJ; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DAVID ED, 2009, EXPT MAN WHAT ONE MA; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gong KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r149; Hindorff LA, 2009, CATALOG PUBLISHED GE; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Ioannidis JPA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000247; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; JUDSON RS, 2009, ENV HLTH PERSPECT; Kataja-Tuomola M, 2008, DIABETOLOGIA, V51, P47, DOI 10.1007/s00125-007-0864-0; Kitao Y, 2000, PSYCHIAT GENET, V10, P139, DOI 10.1097/00041444-200010030-00006; Klein BEK, 1996, DIABETES CARE, V19, P827, DOI 10.2337/diacare.19.8.827; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lumley T., 2009, SURVEY ANAL COMPLEX; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Montgomery MP, 2008, AM J EPIDEMIOL, V167, P1235, DOI 10.1093/aje/kwn028; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; *OFF WAT REG STAND, 1980, AMB WAT QUAL CRIT HE; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Polidori MC, 2000, DIABETES-METAB RES, V16, P15, DOI 10.1002/(SICI)1520-7560(200001/02)16:1<15::AID-DMRR71>3.3.CO;2-2; *R DEV COR TEAM, 2009, R LANG STAT COMP; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Schwartz D, 2007, SCIENCE, V316, P695, DOI 10.1126/science.1141331; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; StataCorp, 2007, STAT STAT SOFTW REL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Toscano William A, 2005, Int J Environ Res Public Health, V2, P4, DOI 10.3390/ijerph2005010004; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Wang L, 2006, AM J EPIDEMIOL, V164, P576, DOI 10.1093/aje/kwj240; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	377	388	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10746	10.1371/journal.pone.0010746	http://dx.doi.org/10.1371/journal.pone.0010746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505766	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017300017
J	Super, H; Romeo, A; Keil, M				Super, Hans; Romeo, August; Keil, Matthias			Feed-Forward Segmentation of Figure-Ground and Assignment of Border-Ownership	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CONTEXTUAL MODULATION; SPATIAL-DISTRIBUTION; RECEPTIVE-FIELD; NEURAL MODEL; SURROUND SUPPRESSION; DISTINCT MODES; NEURONS; V1	Figure-ground is the segmentation of visual information into objects and their surrounding backgrounds. Two main processes herein are boundary assignment and surface segregation, which rely on the integration of global scene information. Recurrent processing either by intrinsic horizontal connections that connect surrounding neurons or by feedback projections from higher visual areas provide such information, and are considered to be the neural substrate for figure-ground segmentation. On the contrary, a role of feedforward projections in figure-ground segmentation is unknown. To have a better understanding of a role of feedforward connections in figure-ground organization, we constructed a feedforward spiking model using a biologically plausible neuron model. By means of surround inhibition our simple 3-layered model performs figure-ground segmentation and one-sided border-ownership coding. We propose that the visual system uses feed forward suppression for figure-ground segmentation and border-ownership assignment.	[Super, Hans; Romeo, August; Keil, Matthias] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Super, Hans; Keil, Matthias] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Dept Basic Psychol, Barcelona, Spain.	hans.super@icrea.es		Super, Hans/0000-0001-9328-0096	Ministry of Education and Science (MICINN) [SEJ2006-15095, SAF2009-10367]; Catalan government (AGAUR) [(2009-SGR-308]; ICREA Funding Source: Custom	Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants (SEJ2006-15095 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Baek K, 2005, IEEE T NEUR SYS REH, V13, P125, DOI 10.1109/TNSRE.2005.847388; Bair W, 2003, J NEUROSCI, V23, P7690; Barenholtz E, 2006, COGNITION, V101, P530, DOI 10.1016/j.cognition.2005.12.002; Bhatt R, 2007, VISION RES, V47, P3173, DOI 10.1016/j.visres.2007.07.013; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Carandini M, 2002, J NEUROSCI, V22, P10053; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Domijan D, 2008, J VISION, V8, DOI 10.1167/8.7.10; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grossberg S, 2001, CEREB CORTEX, V11, P37, DOI 10.1093/cercor/11.1.37; Huang X, 2008, J NEUROPHYSIOL, V100, P539, DOI 10.1152/jn.00997.2007; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; Jehee JFM, 2007, VISION RES, V47, P1153, DOI 10.1016/j.visres.2006.12.018; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Knierim J J, 1992, Curr Opin Neurobiol, V2, P150, DOI 10.1016/0959-4388(92)90003-4; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Landman R, 2004, NEUROREPORT, V15, P2211, DOI 10.1097/00001756-200410050-00013; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Nishimoto S, 2006, J NEUROSCI, V26, P3269, DOI 10.1523/JNEUROSCI.4558-05.2006; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Sakai K, 2006, J COGNITIVE NEUROSCI, V18, P562, DOI 10.1162/jocn.2006.18.4.562; SHEN ZM, 2007, J PHYSL, P581; Sincich LC, 2007, J NEUROSCI, V27, P2683, DOI 10.1523/JNEUROSCI.5077-06.2007; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; SUN H, 1999, IEEE T NEURAL NETWOR, V10, P4; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 1999, INVEST OPHTH VIS SCI, V40, pS357; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Thielscher A, 2003, NEUROSCIENCE, V122, P921, DOI 10.1016/j.neuroscience.2003.08.050; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; van der Velde F, 2001, J COGNITIVE NEUROSCI, V13, P479, DOI 10.1162/08989290152001907; von der Heydt R, 2004, PERCEPTION, V33, P46; Wagatsuma N, 2008, J VISION, V8, DOI 10.1167/8.7.22; Webb BS, 2005, J NEUROPHYSIOL, V94, P1789, DOI 10.1152/jn.00826.2004; Wersing H, 2001, NEURAL COMPUT, V13, P357, DOI 10.1162/089976601300014574; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376; Zwickel T, 2007, BIOSYSTEMS, V89, P216, DOI 10.1016/j.biosystems.2006.04.019	59	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10705	10.1371/journal.pone.0010705	http://dx.doi.org/10.1371/journal.pone.0010705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502718	Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400011
J	Seixas, C; Cruto, T; Tavares, A; Gaertig, J; Soares, H				Seixas, Cecilia; Cruto, Teresa; Tavares, Alexandra; Gaertig, Jacek; Soares, Helena			CCT alpha and CCT delta Chaperonin Subunits Are Essential and Required for Cilia Assembly and Maintenance in Tetrahymena	PLOS ONE			English	Article							MICROTUBULE CAPPING STRUCTURES; COMPLEX POLYPEPTIDE-1 INTERACTS; BARDET-BIEDL-SYNDROME; EUKARYOTIC CHAPERONIN; MOLECULAR CHAPERONE; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; GENE REPLACEMENT; KINESIN-II; PROTEIN	Background: The eukaryotic cytosolic chaperonin CCT is a hetero-oligomeric complex formed by two rings connected back-to-back, each composed of eight distinct subunits (CCT alpha to CCT zeta). CCT complex mediates the folding, of a wide range of newly synthesised proteins including tubulin (alpha, beta and gamma) and actin, as quantitatively major substrates. Methodology/Principal Findings: We disrupted the genes encoding CCT alpha and CCT delta subunits in the ciliate Tetrahymena. Cells lacking the zygotic expression of either CCT alpha or CCT delta showed a loss of cell body microtubules, failed to assemble new cilia and died within 2 cell cycles. We also show that loss of CCT subunit activity leads to axoneme shortening and splaying of tips of axonemal microtubules. An epitope-tagged CCT alpha rescued the gene knockout phenotype and localized primarily to the tips of cilia. A mutation in CCT alpha, G346E, at a residue also present in the related protein implicated in the Bardet Biedel Syndrome, BBS6, also caused defects in cilia and impaired CCT alpha localization in cilia. Conclusions/Significance: Our results demonstrate that the CCT subunits are essential and required for ciliary assembly and maintenance of axoneme structure, especially at the tips of cilia.	[Seixas, Cecilia; Cruto, Teresa; Tavares, Alexandra; Soares, Helena] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Seixas, Cecilia; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Soares, Helena] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; University System of Georgia; University of Georgia; Universidade de Lisboa	Seixas, C (corresponding author), CNRS, UMR 5237, Montpellier, France.	mhsoares@fc.ul.pt	Soares, Helena/G-3065-2010; Gaertig, Jacek/F-1553-2010	Soares, Helena/0000-0001-6180-7041; Tavares, Alexandra/0000-0002-5332-3386; Seixas, Ana Cecilia/0000-0002-7364-4320	Fundacao para a Ciencia a Tecnologia [PRAXIS XXI/P/BIA/10097/98, PTDC/BIA-BDE/73163/2006]; NSF [MBC-033965]; IEFP;  [SFRH/BD/5176/2001]	Fundacao para a Ciencia a Tecnologia(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); IEFP; 	This work was supported by Fundacao para a Ciencia a Tecnologia grants PRAXIS XXI/P/BIA/10097/98 and PTDC/BIA-BDE/73163/2006 to HS and NSF grant MBC-033965 to JG. CS received a PhD fellowship SFRH/BD/5176/2001; TC and AT received an IEFP fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH MA, 1995, J CELL SCI, V108, P3541; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; BRUNS P, 2000, BIOLISTIC TRANSFORMA, P501; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; CassidyHanley D, 1997, GENETICS, V146, P135; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; CREUTZ CE, 1994, J BIOL CHEM, V269, P32035; Cyrne L, 1996, FEBS LETT, V383, P277, DOI 10.1016/0014-5793(96)00240-2; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1984, J CELL SCI, V66, P167; DENTLER WL, 1982, CELL MOTIL CYTOSKEL, V2, P549, DOI 10.1002/cm.970020605; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; HAI B, 2000, KNOCKOUT HETEROKARYO, P513; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim SK, 2009, DEV BIOL, V331, P450, DOI 10.1016/j.ydbio.2009.05.239; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; MILLER JM, 1990, J CELL BIOL, V110, P703, DOI 10.1083/jcb.110.3.703; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORIAS E, 1976, EXP CELL RES, V102, P127, DOI 10.1016/0014-4827(76)90307-4; Pappenberger G, 2002, J MOL BIOL, V318, P1367, DOI 10.1016/S0022-2836(02)00190-0; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; PORTMAN RW, 1987, J CELL SCI, V87, P85; Roobol A, 1999, J BIOL CHEM, V274, P2408, DOI 10.1074/jbc.274.4.2408; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seixas C, 2003, EXP CELL RES, V290, P303, DOI 10.1016/S0014-4827(03)00325-2; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; SKRIVER L, 1980, BIOCHEM J, V188, P695, DOI 10.1042/bj1880695; Soares H, 1997, BIOCHEM J, V326, P21, DOI 10.1042/bj3260021; SOARES H, 1994, J BIOL CHEM, V269, P29299; Stephens RE, 1999, CELL MOTIL CYTOSKEL, V44, P274, DOI 10.1002/(SICI)1097-0169(199912)44:4<274::AID-CM5>3.0.CO;2-O; Stephens RE, 1997, MOL BIOL CELL, V8, P2187, DOI 10.1091/mbc.8.11.2187; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Wagner CT, 2004, J BIOL CHEM, V279, P16223, DOI 10.1074/jbc.M310730200; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Williams NE, 2006, EUKARYOT CELL, V5, P555, DOI 10.1128/EC.5.3.555-567.2006; Williams NE, 1997, J CELL SCI, V110, P1665; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069	68	19	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10704	10.1371/journal.pone.0010704	http://dx.doi.org/10.1371/journal.pone.0010704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502701	Green Published, gold, Green Submitted			2022-12-27	WOS:000277776500018
J	de Manzano, O; Cervenka, S; Karabanov, A; Farde, L; Ullen, F				de Manzano, Orjan; Cervenka, Simon; Karabanov, Anke; Farde, Lars; Ullen, Fredrik			Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN BRAIN; VERBAL CREATIVITY; BINDING; CORTEX; PET; TRANSMISSION; AMPHETAMINE; ASSOCIATION; MODULATION	Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic function have previously been associated with psychotic symptoms and a genetic liability to schizophrenia. Scores on divergent thinking tests (Inventiveness battery, Berliner Intelligenz Struktur Test) were correlated with regional D2 receptor densities, as measured by Positron Emission Tomography, and the radioligands [C-11] raclopride and [C-11]FLB 457. The results show a negative correlation between divergent thinking scores and D2 density in the thalamus, also when controlling for age and general cognitive ability. Hence, the results demonstrate that the D2 receptor system, and specifically thalamic function, is important for creative performance, and may be one crucial link between creativity and psychopathology. We suggest that decreased D2 receptor densities in the thalamus lower thalamic gating thresholds, thus increasing thalamocortical information flow. In healthy individuals, who do not suffer from the detrimental effects of psychiatric disease, this may increase performance on divergent thinking tests. In combination with the cognitive functions of higher order cortical networks, this could constitute a basis for the generative and selective processes that underlie real life creativity.	[de Manzano, Orjan; Karabanov, Anke; Ullen, Fredrik] Karolinska Inst, Neuropediat Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [de Manzano, Orjan; Cervenka, Simon; Karabanov, Anke; Farde, Lars; Ullen, Fredrik] Karolinska Inst, Stockholm Brain Inst, Stockholm, Sweden; [Cervenka, Simon; Farde, Lars] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Karabanov, Anke] NINDS, Human Motor Control Unit, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	de Manzano, O (corresponding author), Karolinska Inst, Neuropediat Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	orjan.demanzano@ki.se	Cervenka, Simon/Q-2155-2018	Cervenka, Simon/0000-0001-8103-6977; Karabanov, Anke Ninija/0000-0003-1874-393X; de Manzano, Orjan/0000-0002-4632-1112	Swedish Research Council [2006-4733]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council 2006-4733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aalto S, 2009, EUR J NUCL MED MOL I, V36, P475, DOI 10.1007/s00259-008-0969-9; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Ball D, 1998, NEUROREPORT, V9, P347, DOI 10.1097/00001756-199801260-00031; Batey M, 2008, PERS INDIV DIFFER, V45, P816, DOI 10.1016/j.paid.2008.08.014; BERGSTROM M, 1981, J COMPUT ASSIST TOMO, V5, P136, DOI 10.1097/00004728-198102000-00027; Buchsbaum MS, 2006, SCHIZOPHR RES, V85, P232, DOI 10.1016/j.schres.2006.03.042; Buchsbaum MS, 1996, AM J PSYCHIAT, V153, P191; Burch GS, 2006, EUR J PERSONALITY, V20, P107, DOI 10.1002/per.572; CAMPBELL DT, 1960, PSYCHOL REV, V67, P380, DOI 10.1037/h0040373; Carson SH, 2003, J PERS SOC PSYCHOL, V85, P499, DOI 10.1037/0022-3514.85.3.499; Cervenka S, 2006, BRAIN, V129, P2017, DOI 10.1093/brain/awl163; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Christensen P.R., 1960, ALTERNATE USES; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Dibben CRM, 2009, PSYCHOL MED, V39, P381, DOI 10.1017/S0033291708003887; DORFMAN L, 2007, PERSONALITY INDIVIDU, V44, P1382; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Eysenck H., 1995, GENIUS NATURAL HIST; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; FURNHAM A, 2008, PERSONALITY INDIVIDU, V45; Gilbert AR, 2001, AM J PSYCHIAT, V158, P618, DOI 10.1176/appi.ajp.158.4.618; Glenthoj BY, 2006, BIOL PSYCHIAT, V60, P621, DOI 10.1016/j.biopsych.2006.01.010; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; GUSTAFSSON JE, 1984, INTELLIGENCE, V8, P179, DOI 10.1016/0160-2896(84)90008-4; Hall H, 1996, SYNAPSE, V23, P115, DOI 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jager AO., 1997, TEST BERLINER INTELL; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KARLSSON JL, 1970, HEREDITAS-GENETISK A, V66, P177; KESSLER RM, 1993, BRAIN RES, V609, P237, DOI 10.1016/0006-8993(93)90878-Q; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Kinney DK, 2000, CREATIVITY RES J, V13, P17; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Langer O, 1999, J LABELLED COMPD RAD, V42, P1183; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moises HW, 2001, J NEURAL TRANSM, V108, P115, DOI 10.1007/s007020170102; Montgomery AJ, 2007, J CEREBR BLOOD F MET, V27, P369, DOI 10.1038/sj.jcbfm.9600339; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Okauchi T, 2001, SYNAPSE, V41, P87, DOI 10.1002/syn.1063; Olsson H, 2004, NEUROIMAGE, V22, P794, DOI 10.1016/j.neuroimage.2004.02.002; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; Post F, 1996, BRIT J PSYCHIAT, V168, P545, DOI 10.1192/bjp.168.5.545; Raven J. C., 1998, RAVENS PROGR MATRICE; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; RICHARDS R, 1988, J ABNORM PSYCHOL, V97, P281, DOI 10.1037/0021-843X.97.3.281; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; SANDELL J, 2000, J LABELLED COMPOUNDS, V43; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sternberg R. J., 2002, HDB CREATIVITY; Suhara T, 2002, ARCH GEN PSYCHIAT, V59, P25, DOI 10.1001/archpsyc.59.1.25; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Talvik M, 2006, PSYCHIAT RES-NEUROIM, V148, P165, DOI 10.1016/j.pscychresns.2006.05.009; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Weinberger D, 2001, NEUROPSYCHOPHARMACOL, P833; Yasuno F, 2004, AM J PSYCHIAT, V161, P1016, DOI 10.1176/appi.ajp.161.6.1016	66	75	75	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10670	10.1371/journal.pone.0010670	http://dx.doi.org/10.1371/journal.pone.0010670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	597QK	20498850	Green Published, gold, Green Submitted			2022-12-27	WOS:000277773700013
J	Thorek, DLJ; Tsao, PY; Arora, V; Zhou, LL; Eisenberg, RA; Tsourkas, A				Thorek, Daniel L. J.; Tsao, Patricia Y.; Arora, Vaishali; Zhou, Lanlan; Eisenberg, Robert A.; Tsourkas, Andrew			In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice	PLOS ONE			English	Article							PHASE-II TRIAL; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; DENDRITIC CELLS; RITUXIMAB; DEPLETION; TRACKING; THERAPY; EFFICACY	In Background: B cell depletion immunotherapy has been successfully employed to treat non-Hodgkin's lymphoma. In recent years, increasing attention has been directed towards also using B-cell depletion therapy as a treatment option in autoimmune disorders. However, it appears that the further development of these approaches will depend on a methodology to determine the relation of B-cell depletion to clinical response and how individual patients should be dosed. Thus far, patients have generally been followed by quantification of peripheral blood B cells, but it is not apparent that this measurement accurately reflects systemic B cell dynamics. Methodology/Principal Findings: Cellular imaging of the targeted population in vivo may provide significant insight towards effective therapy and a greater understanding of underlying disease mechanics. Superparamagnetic iron oxide (SPIO) nanoparticles in concert with near infrared (NIR) fluorescent dyes were used to label and track primary C57BL/6 B cells. Following antibody mediated B cell depletion (anti-CD79), NIR-only labeled cells were expeditiously cleared from the circulation and spleen. Interestingly, B cells labeled with both SPIO and NIR were not depleted in the spleen. Conclusions/Significance: Whole body fluorescent tracking of B cells enabled noninvasive, longitudinal imaging of both the distribution and subsequent depletion of B lymphocytes in the spleen. Quantification of depletion revealed a greater than 40% decrease in splenic fluorescent signal-to-background ratio in antibody treated versus control mice. These data suggest that in vivo imaging can be used to follow B cell dynamics, but that the labeling method will need to be carefully chosen. SPIO labeling for tracking purposes, generally thought to be benign, appears to interfere with B cell functions and requires further examination.	[Thorek, Daniel L. J.; Zhou, Lanlan; Tsourkas, Andrew] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Tsao, Patricia Y.; Arora, Vaishali; Eisenberg, Robert A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thorek, DLJ (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/A-1074-2007; Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753	Wyeth-Ayerst Pharmaceuticals; Transdisciplinary Program in Translational Medicine and Therapeutics; Department of Defense Office of the Congressionally Directed Medical [W81XWH-07-1-0457]; Lupus Research Institute	Wyeth-Ayerst Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); Transdisciplinary Program in Translational Medicine and Therapeutics; Department of Defense Office of the Congressionally Directed Medical(United States Department of Defense); Lupus Research Institute	This work was supported in part by Wyeth-Ayerst Pharmaceuticals, the Transdisciplinary Program in Translational Medicine and Therapeutics, Department of Defense Office of the Congressionally Directed Medical Research Program (W81XWH-07-1-0457) and the Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2008, ANN RHEUM DIS, V67, P1724, DOI 10.1136/ard.2007.083162; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Bulte WM, 2005, ACAD RADIOL, V12, pS2; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; De Vita S, 2002, ARTHRITIS RHEUM, V46, P2029, DOI 10.1002/art.10467; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Eisenberg Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P345; Eisenberg R, 2009, J AUTOIMMUN, V32, P223, DOI 10.1016/j.jaut.2009.02.006; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Gordan LN, 2005, J CLIN ONCOL, V23, P1096, DOI 10.1200/JCO.2005.12.171; Grillo-Lopez A. J., 2000, Current Pharmaceutical Biotechnology, V1, P1, DOI 10.2174/1389201003379059; Hainsworth JD, 2000, BLOOD, V95, P3052; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849; Levine TD, 1999, NEUROLOGY, V52, P1701, DOI 10.1212/WNL.52.8.1701; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Li YM, 2008, J IMMUNOL, V181, P2961, DOI 10.4049/jimmunol.181.5.2961; Li YYY, 2006, MOL IMMUNOL, V43, P613, DOI 10.1016/j.molimm.2005.04.010; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MELDER RJ, 1994, J IMMUNOL METHODS, V175, P79, DOI 10.1016/0022-1759(94)90333-6; MERRILL JT, 2008, EFFICACY SAFETY RITU; Millington OR, 2007, INFLAMM RES, V56, P391, DOI 10.1007/s00011-007-7017-2; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pestronk A, 2003, J NEUROL NEUROSUR PS, V74, P485, DOI 10.1136/jnnp.74.4.485; REFF ME, 1994, BLOOD, V83, P435; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Renaud S, 2003, MUSCLE NERVE, V27, P611, DOI 10.1002/mus.10359; Sutter JA, 2008, CLIN IMMUNOL, V126, P282, DOI 10.1016/j.clim.2007.11.012; Tario Joseph D Jr, 2007, Immunol Invest, V36, P861, DOI 10.1080/08820130701712933; Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Valable S, 2007, NEUROIMAGE, V37, pS47, DOI 10.1016/j.neuroimage.2007.05.041; Witzig TE, 2005, J CLIN ONCOL, V23, P1103, DOI 10.1200/JCO.2005.12.052	51	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10655	10.1371/journal.pone.0010655	http://dx.doi.org/10.1371/journal.pone.0010655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498725	gold, Green Published, Green Submitted			2022-12-27	WOS:000277773700007
J	Te, JL; Dozmorov, IM; Guthridge, JM; Nguyen, KL; Cavett, JW; Kelly, JA; Bruner, GR; Harley, JB; Ojwang, JO				Te, Jeannie L.; Dozmorov, Igor M.; Guthridge, Joel M.; Nguyen, Kim L.; Cavett, Joshua W.; Kelly, Jennifer A.; Bruner, Gail R.; Harley, John B.; Ojwang, Joshua O.			Identification of Unique MicroRNA Signature Associated with Lupus Nephritis	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; PERIPHERAL-BLOOD CELLS; ERYTHEMATOSUS PATIENTS; EXPRESSION; ACTIVATION; PATHWAY; PREVALENCE; GENOMICS; DISEASES; PLAYERS	MicroRNAs (miRNA) have emerged as an important new class of modulators of gene expression. In this study we investigated miRNA that are differentially expressed in lupus nephritis. Microarray technology was used to investigate differentially expressed miRNA in peripheral blood mononuclear cells (PBMCs) and Epstein-Barr Virus (EBV)-transformed cell lines obtained from lupus nephritis affected patients and unaffected controls. TaqMan-based stem-loop real-time polymerase chain reaction was used for validation. Microarray analysis of miRNA expressed in both African American (AA) and European American (EA) derived lupus nephritis samples revealed 29 and 50 differentially expressed miRNA, respectively, of 850 tested. There were 18 miRNA that were differentially expressed in both racial groups. When samples from both racial groups and different specimen types were considered, there were 5 primary miRNA that were differentially expressed. We have identified 5 miRNA; hsa-miR-371-5P, hsa-miR-423-5P, hsa-miR-638, hsa-miR-1224-3P and hsa-miR-663 that were differentially expressed in lupus nephritis across different racial groups and all specimen types tested. Hsa-miR371-5P, hsa-miR-1224-3P and hsa-miR-423-5P, are reported here for the first time to be associated with lupus nephritis. Our work establishes EBV-transformed B cell lines as a useful model for the discovery of miRNA as biomarkers for SLE. Based on these findings, we postulate that these differentially expressed miRNA may be potential novel biomarkers for SLE as well as help elucidate pathogenic mechanisms of lupus nephritis. The investigation of miRNA profiles in SLE may lead to the discovery and development of novel methods to diagnosis, treat and prevent SLE.	[Te, Jeannie L.; Dozmorov, Igor M.; Nguyen, Kim L.; Cavett, Joshua W.; Kelly, Jennifer A.; Bruner, Gail R.; Harley, John B.; Ojwang, Joshua O.] Oklahoma Med Res Fdn, Dept Arthrit & Immunol, Oklahoma City, OK 73104 USA; [Guthridge, Joel M.] Oklahoma Med Res Fdn, Dept Clin Immunol, Oklahoma City, OK 73104 USA; [Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Te, JL (corresponding author), Oklahoma Med Res Fdn, Dept Arthrit & Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Joshua-ojwang@omrf.org		Guthridge, Joel/0000-0002-9308-237X; Kelly, Jennifer/0000-0002-3203-2467	National Institutes of Health [0169-04-12-4, NO-1AR62277, PO1-AI 083194, R37-AI 24717, RO1-AR42460, PO1-AR049084, P20 RR020143, R01 AI045050, P30 AR053483, GORDRCC AR053483]; United States Department of Veteran Affairs; Alliance for Lupus Research; Lupus Family Registry and Repository (LFRR); American Cancer Society [IRG-05-066-04]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045050, P01AI083194, R37AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P01AR049084, P30AR053483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veteran Affairs(US Department of Veterans Affairs); Alliance for Lupus Research; Lupus Family Registry and Repository (LFRR); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health (Centers of Biomedical Research Excellence (COBRE) Pilot Grant 0169-04-12-4, NO-1AR62277, PO1-AI 083194, R37-AI 24717, RO1-AR42460, PO1-AR049084, P20 RR020143, R01 AI045050, P30 AR053483, GORDRCC AR053483), the United States Department of Veteran Affairs, the Alliance for Lupus Research, Lupus Family Registry and Repository (LFRR), and the American Cancer Society (IRG-05-066-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; COMPTON LJ, 1984, J IMMUNOL, V133, P213; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; FESSEL WJ, 1974, ARCH INTERN MED, V134, P1027, DOI 10.1001/archinte.134.6.1027; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Mak A, 2007, LUPUS, V16, P28, DOI 10.1177/0961203306074469; MCCARTY DJ, 1995, ARTHRITIS RHEUM, V38, P1260, DOI 10.1002/art.1780380914; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; NOSSENT JC, 1989, ANN RHEUM DIS, V48, P810, DOI 10.1136/ard.48.10.810; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909	30	161	179	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10344	10.1371/journal.pone.0010344	http://dx.doi.org/10.1371/journal.pone.0010344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485490	Green Submitted, Green Published, gold			2022-12-27	WOS:000277563200001
J	Mai, TV; Gunnarsson, I; Lundberg, S; Svenungsson, E; Wramner, L; Fernstrom, A; Syvanen, AC; Lieu, TD; Jacobson, SH; Padyukov, L				Mai Tuyet Vuong; Gunnarsson, Iva; Lundberg, Sigrid; Svenungsson, Elisabet; Wramner, Lars; Fernstrom, Anderson; Syvanen, Ann-Christine; Lieu Thi Do; Jacobson, Stefan H.; Padyukov, Leonid			Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy - No Support of an Overlap	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANTI-C1Q ANTIBODIES; PROMOTER REGION; IRF5; ERYTHEMATOSUS; HAPLOTYPE; CLASSIFICATION; POLYMORPHISMS; ASSOCIATION; POPULATION	Background: IgA nephropathy (IgAN) and nephritis in Systemic Lupus Erythematosus (SLE) are two common forms of glomerulonephritis in which genetic findings are of importance for disease development. We have recently reported an association of IgAN with variants of TGFB1. In several autoimmune diseases, particularly in SLE, IRF5, STAT4 genes and TRAF1-C5 locus have been shown to be important candidate genes. The aim of this study was to compare genetic variants from the TGFB1, IRF5, STAT4 genes and TRAF1-C5 locus with susceptibility to IgAN and lupus nephritis in two Swedish cohorts. Patients and Methods: We genotyped 13 single nucleotide polymorphisms (SNPs) in four genetic loci in 1252 DNA samples from patients with biopsy proven IgAN or with SLE (with and without nephritis) and healthy age-and sex-matched controls from the same population in Sweden. Results: Genotype and allelic frequencies for SNPs from selected genes did not differ significantly between lupus nephritis patients and SLE patients without nephritis. In addition, haplotype analysis for seven selected SNPs did not reveal a difference for the SLE patient groups with and without nephritis. Moreover, none of these SPNs showed a significant difference between IgAN patients and healthy controls. IRF5 and STAT4 variants remained significantly different between SLE cases and healthy controls. In addition, the data did not show an association of TRAF1-C5 polymorphism with susceptibility to SLE in this Swedish population. Conclusion: Our data do not support an overlap in genetic susceptibility between patients with IgAN or SLE and reveal no specific importance of SLE associated SNPs for the presence of lupus nephritis.	[Mai Tuyet Vuong; Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Mai Tuyet Vuong; Jacobson, Stefan H.] Karolinska Inst, Danderyd Hosp, Dept Nephrol, Stockholm, Sweden; [Mai Tuyet Vuong; Lieu Thi Do] Hanoi Med Univ, Dept Internal Med, Hanoi, Vietnam; [Lundberg, Sigrid] Karolinska Univ Hosp, Dept Med, Nephrol Unit, Stockholm, Sweden; [Wramner, Lars] Sahlgrens Univ Hosp, Transplantat Ctr, Gothenburg, Sweden; [Fernstrom, Anderson] Linkoping Univ Hosp, Dept Nephrol, S-58185 Linkoping, Sweden; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Hanoi Medical University; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Linkoping University; Uppsala University	Mai, TV (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	maituyetvuong@gmail.com	Lundberg, Sigrid/AGM-4891-2022; Lundberg, Sigrid/C-8058-2015; Padyukov, Leonid/A-4890-2009	Lundberg, Sigrid/0000-0003-1224-5200; Padyukov, Leonid/0000-0003-2950-5670; Svenungsson, Elisabet/0000-0003-3396-3244	SIDA Secretariat for Research Cooperation [7500730303, 75007342]; Swedish Research Council for Medicine, Sweden	SIDA Secretariat for Research Cooperation; Swedish Research Council for Medicine, Sweden	The support for the project (7500730303 and 75007342) from SIDA Secretariat for Research Cooperation for the bilateral cooperation between Vietnam and Sweden; Swedish Research Council for Medicine, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basile C, 1998, NEPHROL DIAL TRANSPL, V13, P1891; Bhavnani SK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S3; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gunnarsson I, 1997, NEPHROL DIAL TRANSPL, V12, P2263, DOI 10.1093/ndt/12.11.2263; HAN SW, 2009, J RHEUMATOL; HORINO T, LUPUS; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; KURREEMAN FA, 2009, ANN RHEUM DIS; LEE YH, 2008, RHEUMATOL INT; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Maalej A, 2008, SCAND J RHEUMATOL, V37, P414, DOI 10.1080/03009740802256327; Nordmark G, 2009, GENES IMMUN, V10, P68, DOI 10.1038/gene.2008.94; Padyukov L, 2001, IMMUNOGENETICS, V53, P22, DOI 10.1007/s002510000291; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Potlukova E, 2008, SCAND J IMMUNOL, V67, P423, DOI 10.1111/j.1365-3083.2008.02089.x; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; SVENUNGSSON E, 2009, ANN RHEUM DIS; VUONG MT, 2009, NEPHROL DIAL TRANSPL	25	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10559	10.1371/journal.pone.0010559	http://dx.doi.org/10.1371/journal.pone.0010559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479942	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467900015
J	Majumder, S; Ilayaraja, M; Seerapu, HR; Sinha, S; Siamwala, JH; Chatterjee, S				Majumder, Syamantak; Ilayaraja, M.; Seerapu, Himabindu Reddy; Sinha, Swaraj; Siamwala, Jamila H.; Chatterjee, Suvro			Chick Embryo Partial Ischemia Model: A New Approach to Study Ischemia Ex Vivo	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; CREATINE-KINASE ISOENZYME; LIPID-PEROXIDATION; REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; N-ACETYLCYSTEINE; FILAMENT MODEL; NITRIC-OXIDE; EGG-YOLK; HYPOXIA	Background: Ischemia is a pathophysiological condition due to blockade in blood supply to a specific tissue thus damaging the physiological activity of the tissue. Different in vivo models are presently available to study ischemia in heart and other tissues. However, no ex vivo ischemia model has been available to date for routine ischemia research and for faster screening of anti-ischemia drugs. In the present study, we took the opportunity to develop an ex vivo model of partial ischemia using the vascular bed of 4(th) day incubated chick embryo. Methodology/Principal Findings: Ischemia was created in chick embryo by ligating the right vitelline artery using sterile surgical suture. Hypoxia inducible factor-1 alpha (HIF-1 alpha), creatine phospho kinase-MB and reactive oxygen species in animal tissues and cells were measured to confirm ischemia in chick embryo. Additionally, ranolazine, N-acetyl cysteine and trimetazidine were administered as an anti-ischemic drug to validate the present model. Results from the present study depicted that blocking blood flow elevates HIF-1 alpha, lipid peroxidation, peroxynitrite level in ischemic vessels while ranolazine administration partially attenuates ischemia driven HIF-1 alpha expression. Endothelial cell incubated on ischemic blood vessels elucidated a higher level of HIF-1 alpha expression with time while ranolazine treatment reduced HIF-1 alpha in ischemic cells. Incubation of caprine heart strip on chick embryo ischemia model depicted an elevated creatine phospho kinase-MB activity under ischemic condition while histology of the treated heart sections evoked edema and disruption of myofibril structures. Conclusions/Significance: The present study concluded that chick embryo partial ischemia model can be used as a novel ex vivo model of ischemia. Therefore, the present model can be used parallel with the known in vivo ischemia models in understanding the mechanistic insight of ischemia development and in evaluating the activity of anti-ischemic drug.	[Majumder, Syamantak; Ilayaraja, M.; Seerapu, Himabindu Reddy; Sinha, Swaraj; Siamwala, Jamila H.; Chatterjee, Suvro] Anna Univ, Vasc Biol Lab, AU KBC Res Ctr, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai	Majumder, S (corresponding author), Anna Univ, Vasc Biol Lab, AU KBC Res Ctr, Chennai 600025, Tamil Nadu, India.	soovro@yahoo.ca	Siamwala, Jamila/AGN-8667-2022; Muthuramu, Ilayaraja/R-2199-2018	Muthuramu, Ilayaraja/0000-0003-3550-7672; Majumder, Syamantak/0000-0001-8957-9810; Siamwala, Jamila/0000-0001-9482-9183	KB Chandrasekhar- Research Foundation	KB Chandrasekhar- Research Foundation	This work was supported by a grant from KB Chandrasekhar- Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLELY MC, 1990, BRIT J PHARMACOL, V99, P5, DOI 10.1111/j.1476-5381.1990.tb14641.x; ALLELY MC, 1988, BRIT J PHARMACOL, V93, P375, DOI 10.1111/j.1476-5381.1988.tb11444.x; AOKI N, 1988, BRIT J PHARMACOL, V95, P735, DOI 10.1111/j.1476-5381.1988.tb11699.x; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BROMONT C, 1989, STROKE, V20, P918, DOI 10.1161/01.STR.20.7.918; CLARKE B, 1993, BRIT J PHARMACOL, V109, P748, DOI 10.1111/j.1476-5381.1993.tb13637.x; Dittmar M, 2003, STROKE, V34, P2252, DOI 10.1161/01.STR.0000083625.54851.9A; Dittmar MS, 2006, J NEUROSCI METH, V156, P50, DOI 10.1016/j.jneumeth.2006.02.003; FABINYI G, 1977, J NEUROL NEUROSUR PS, V40, P818, DOI 10.1136/jnnp.40.8.818; FUJII DK, 1983, IN VITRO CELL DEV B, V19, P811, DOI 10.1007/BF02618160; GRALINSKI MR, 1994, CARDIOVASC RES, V28, P1231, DOI 10.1093/cvr/28.8.1231; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hartmann C, 2001, WORLD POULTRY SCI J, V57, P13, DOI 10.1079/WPS20010003; Hasenfuss G, 2008, CLIN RES CARDIOL, V97, P222, DOI 10.1007/s00392-007-0612-y; Hauet T, 1998, CRYOBIOLOGY, V37, P231, DOI 10.1006/cryo.1998.2120; Hayashi T, 2008, TRANSPL P, V40, P2139, DOI 10.1016/j.transproceed.2008.07.083; Hogers B, 1999, CARDIOVASC RES, V41, P87, DOI 10.1016/S0008-6363(98)00218-1; Iqbal S, 2002, BRAIN RES, V928, P1, DOI 10.1016/S0006-8993(01)03095-5; KASTE M, 1978, BRIT HEART J, V40, P802; Kaufmann PA, 2000, CORONARY ARTERY DIS, V11, P363, DOI 10.1097/00019501-200006000-00011; KEHRER JP, 1991, ADV EXP MED BIOL, V283, P299; Klawitter PF, 2002, AM J PHYSIOL-HEART C, V283, pH1656, DOI 10.1152/ajpheart.00041.2002; KNUCKEY NW, 1995, STROKE, V26, P305, DOI 10.1161/01.STR.26.2.305; Koksal C, 2003, J SURG RES, V111, P236, DOI 10.1016/S0022-4804(03)00094-5; Kwak KH, 2009, ACTA ANAESTH SCAND, V53, P648, DOI 10.1111/j.1399-6576.2009.01937.x; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Majumder S, 2008, BIOCHEM CELL BIOL, V86, P1, DOI [10.1139/O07-146, 10.1139/o07-146]; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Marshall RC, 2003, AM J PHYSIOL-HEART C, V284, pH654, DOI 10.1152/ajpheart.00594.2002; Matsumura H, 1998, JPN J PHARMACOL, V77, P31, DOI 10.1254/jjp.77.31; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McCormack JG, 1996, CIRCULATION, V93, P135, DOI 10.1161/01.CIR.93.1.135; Miller MJ, 2001, CAN J CARDIOL, V17, P1075; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; OSHINO N, 1975, BIOCHEM J, V146, P53, DOI 10.1042/bj1460053; PULEO PR, 1990, CIRCULATION, V82, P759, DOI 10.1161/01.CIR.82.3.759; SCADUTO RC, 1988, AM J PHYSIOL, V255, pF911, DOI 10.1152/ajprenal.1988.255.5.F911; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; VOS SS, 2003, J EXP BIOL, V206, P1051; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; WIELOCH T, 2003, Patent No. 2003091405; Yada T, 2006, AM J PHYSIOL-HEART C, V291, pH1138, DOI 10.1152/ajpheart.00187.2006; YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10524	10.1371/journal.pone.0010524	http://dx.doi.org/10.1371/journal.pone.0010524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479865	gold, Green Published, Green Submitted			2022-12-27	WOS:000277467800009
J	Balhoff, JP; Dahdul, WM; Kothari, CR; Lapp, H; Lundberg, JG; Mabee, P; Midford, PE; Westerfield, M; Vision, TJ				Balhoff, James P.; Dahdul, Wasila M.; Kothari, Cartik R.; Lapp, Hilmar; Lundberg, John G.; Mabee, Paula; Midford, Peter E.; Westerfield, Monte; Vision, Todd J.			Phenex: Ontological Annotation of Phenotypic Diversity	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OSTARIOPHYSI; SILURIFORMES; GENOMICS	Background: Phenotypic differences among species have long been systematically itemized and described by biologists in the process of investigating phylogenetic relationships and trait evolution. Traditionally, these descriptions have been expressed in natural language within the context of individual journal publications or monographs. As such, this rich store of phenotype data has been largely unavailable for statistical and computational comparisons across studies or integration with other biological knowledge. Methodology/Principal Findings: Here we describe Phenex, a platform-independent desktop application designed to facilitate efficient and consistent annotation of phenotypic similarities and differences using Entity-Quality syntax, drawing on terms from community ontologies for anatomical entities, phenotypic qualities, and taxonomic names. Phenex can be configured to load only those ontologies pertinent to a taxonomic group of interest. The graphical user interface was optimized for evolutionary biologists accustomed to working with lists of taxa, characters, character states, and character-by-taxon matrices. Conclusions/Significance: Annotation of phenotypic data using ontologies and globally unique taxonomic identifiers will allow biologists to integrate phenotypic data from different organisms and studies, leveraging decades of work in systematics and comparative morphology.	[Balhoff, James P.; Dahdul, Wasila M.; Kothari, Cartik R.; Lapp, Hilmar; Midford, Peter E.; Vision, Todd J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.; Kothari, Cartik R.; Vision, Todd J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Dahdul, Wasila M.; Mabee, Paula] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Lundberg, John G.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; University of South Dakota; Drexel University; University of Oregon	Balhoff, JP (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	balhoff@nescent.org	Midford, Peter E./B-5946-2008; Lapp, Hilmar/A-8275-2009; Vision, Todd/B-4867-2010	Midford, Peter E./0000-0001-6512-3296; Mabee, Paula/0000-0002-8455-3213; Balhoff, James/0000-0002-8688-6599; Lapp, Hilmar/0000-0001-9107-0714; Saravanamuthu, Cartik Kothari/0000-0002-0195-950X; Dahdul, Wasila/0000-0003-3162-7490; Vision, Todd/0000-0002-6133-2581	NSF [DBI 0641025]; NIH [HG002659]; National Evolutionary Synthesis Center [NSF EF-0423641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG002659, U41HG002659] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062542] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank NSF (DBI 0641025), http://www.nsf.gov/; NIH (HG002659), http://www.nih.gov/; and the National Evolutionary Synthesis Center (NSF EF-0423641), https://www.nescent.org/, for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, METH MOL B, V316, P67; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; BORNBUSCH AH, 1995, ZOOL J LINN SOC-LOND, V115, P1; Buckup Paulo Andreas, 1998, P123; DAHDUL W, 2010, PLOS ONE IN PRESS; DAHDUL WM, 2010, SYSTEMATIC IN PRESS; DALLWITZ MJ, 1980, TAXON, V29, P41, DOI 10.2307/1219595; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; Hagedorn G., 2005, STRUCTURED DESCRIPTI; Lundberg J.G., 1993, P392; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Maddison WP, 2019, MESQUITE MODULAR SYS; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Prosdocimi F, 2009, EVOL BIOINFORM, V5, P47; Ramirez MJ, 2007, SYST BIOL, V56, P283, DOI 10.1080/10635150701313848; ROYERO R, 1999, STUDIES SYSTEMATICS; Ruttenberg A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S2; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith G.R., 1993, P778; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Toledo-Piza M, 2007, ZOOL J LINN SOC-LOND, V151, P691, DOI 10.1111/j.1096-3642.2007.00355.x; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247	33	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10500	10.1371/journal.pone.0010500	http://dx.doi.org/10.1371/journal.pone.0010500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463926	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400033
J	Foldes, G; Liu, A; Badiger, R; Paul-Clark, M; Moreno, L; Lendvai, Z; Wright, JS; Ali, NN; Harding, SE; Mitchell, JA				Foeldes, Gabor; Liu, Alexander; Badiger, Rekha; Paul-Clark, Mark; Moreno, Laura; Lendvai, Zsuzsanna; Wright, Jamie S.; Ali, Nadire N.; Harding, Sian E.; Mitchell, Jane A.			Innate Immunity in Human Embryonic Stem Cells: Comparison with Adult Human Endothelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; CARDIAC MYOCYTES; TLR4 EXPRESSION; DIFFERENTIATION; MOUSE; PLURIPOTENCY; DEFICIENCY; ACTIVATION; MECHANISMS	Treatment of human disease with human embryonic stem cell (hESC)-derived cells is now close to reality, but little is known of their responses to physiological and pathological insult. The ability of cells to respond via activation of Toll like receptors (TLR) is critical in innate immune sensing in most tissues, but also extends to more general danger sensing, e. g. of oxidative stress, in cardiomyocytes. We used biomarker release and gene-array analysis to compare responses in hESC before and after differentiation, and to those in primary human endothelial cells. The presence of cardiomyocytes and endothelial cells was confirmed in differentiated cultures by immunostaining, FACS-sorting and, for cardiomyocytes, beating activity. Undifferentiated hESC did not respond with CXCL8 release to Gram positive or Gram negative bacteria, or a range of PAMPs (pathogen associated molecular patterns) for TLRs 1-9 (apart from flagellin, an activator of TLR5). Surprisingly, lack of TLR-dependent responses was maintained over 4 months of differentiation of hESC, in cultures which included cardiomyocytes and endothelial cells. In contrast, primary cultures of human aortic endothelial cells (HAEC) demonstrated responses to a broad range of PAMPs. Expression of downstream TLR signalling pathways was demonstrated in hESC, and IL-1 beta, TNF alpha and INF gamma, which bypass the TLRs, stimulated CXCL8 release. NF kappa B pathway expression was also present in hESC and NFkB was able to translocate to the nucleus. Low expression levels of TLRs were detected in hESC, especially TLRs 1 and 4, explaining the lack of response of hESC to the main TLR signals. TLR5 levels were similar between differentiated hESC and HAEC, and siRNA knockdown of TLR5 abolished the response to flagellin. These findings have potential implications for survival and function of grafted hESC-derived cells.	[Foeldes, Gabor; Liu, Alexander; Badiger, Rekha; Paul-Clark, Mark; Moreno, Laura; Wright, Jamie S.; Ali, Nadire N.; Harding, Sian E.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Lendvai, Zsuzsanna] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary	Imperial College London; Semmelweis University	Foldes, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	sian.harding@imperial.ac.uk	Mitchell, Jane A/A-1991-2009; Moreno, Laura/A-9433-2010	Moreno, Laura/0000-0001-9028-2299; Harding, Sian/0000-0002-3651-6354	Wellcome Trust [083429/Z/07/Z]; British Heart Foundation; European Community; BBSRC; Rosetrees Trust; SROP; Geron Corporation; National Centre for the Replacement [G0600373/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); European Community(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust); SROP; Geron Corporation; National Centre for the Replacement	This work was supported by: Wellcome Trust (http://www.wellcome.ac.uk/), British Heart Foundation (http://www.bhf.org.uk/), European Community, NC3Rs (http://www.nc3rs.org.uk/), BBSRC (http://www.bbsrc.ac.uk/), Rosetrees Trust (http://www.rosetreestrust.co.uk/), SROP (http://www.nfu.hu/), and Geron Corporation. A. L. was a recipient of a Wellcome Trust Vacation Scholarship. M. P. C. is a recipient of a Wellcome Trust University Award (083429/Z/07/Z) and R. B. is a recipient of BHF Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Brito-Martins M, 2008, BRIT J PHARMACOL, V153, P751, DOI 10.1038/sj.bjp.0707619; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Harrington LS, 2007, J CARDIOVASC PHARM T, V12, P322, DOI 10.1177/1074248407306217; Kang HB, 2007, STEM CELLS DEV, V16, P615, DOI 10.1089/scd.2007.0014; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim Se-Chan, 2007, BMC Physiology, V7, P5, DOI 10.1186/1472-6793-7-5; Kim YE, 2008, BMB REP, V41, P705, DOI 10.5483/BMBRep.2008.41.10.705; Lee SH, 2009, STEM CELLS, V27, P1604, DOI 10.1002/stem.75; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nourse MB, 2010, ARTERIOSCL THROM VAS, V30, P80, DOI 10.1161/ATVBAHA.109.194233; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Opitz B, 2007, THROMB HAEMOSTASIS, V98, P319, DOI 10.1160/TH06-12-0694; Patel TA, 2007, SHOCK, V28, P434, DOI 10.1097/shk.0b013e31804a55a7; Sivasubramaniyan K, 2008, REGEN MED, V3, P23, DOI 10.2217/17460751.3.1.23; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	24	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10501	10.1371/journal.pone.0010501	http://dx.doi.org/10.1371/journal.pone.0010501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463927	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379400034
J	Martin, AJ; Vazquez-Prokopec, GM; Page, M				Martin, Anthony J.; Vazquez-Prokopec, Gonzalo M.; Page, Michael			First Known Feeding Trace of the Eocene Bottom-Dwelling Fish Notogoneus osculus and Its Paleontological Significance	PLOS ONE			English	Article							GREEN RIVER FORMATION; NEW-ENGLAND; UNDICHNA; FOSSIL; EXAMPLES; TRAILS; LAKES; USA	Background: The Green River Formation (early Eocene, about 42-53 Ma) at and near Fossil Butte National Monument in Wyoming, USA, is world famous for its exquisitely preserved freshwater teleost fish in the former Fossil Lake. Nonetheless, trace fossils attributed to fish interacting with the lake bottom are apparently rare, and have not been associated directly with any fish species. Here we interpret the first known feeding and swimming trace fossil of the teleost Notogoneus osculus Cope (Teleostei: Gonorynchidae), which is also represented as a body fossil in the same stratum. Methodology/Principal Findings: A standard description of the trace fossil, identified as Undichna cf. U. simplicatas, was augmented by high-resolution digital images and spatial and mathematical analyses, which allowed for detailed interpretations of the anatomy, swimming mode, feeding behavior, and body size of the tracemaker. Our analysis indicates that the tracemaker was about 45 cm long; used its caudal, anal, and pelvic fins (the posterior half of its body) to make the swimming traces; and used a ventrally oriented mouth to make overlapping feeding marks. We hypothesize that the tracemaker was an adult Notogoneus osculus. Conclusions/Significance: Our results are the first to link a specific teleost tracemaker with a trace fossil from the Green River Formation, while also interpreting the size and relative age of the tracemaker. The normal feeding and swimming behaviors indicated by the trace fossil indicate temporarily oxygenated benthic conditions in the deepest part of Fossil Lake, counter to most paleoecological interpretations of this deposit. Lastly, our spatial and mathematical analyses significantly update and advance previous approaches to the study of teleost trace fossils.	[Martin, Anthony J.; Vazquez-Prokopec, Gonzalo M.; Page, Michael] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA	Emory University	Martin, AJ (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	geoam@learnlink.emory.edu			Department of Environmental Studies (Emory University)	Department of Environmental Studies (Emory University)	The only funding was internal travel money from the Department of Environmental Studies (Emory University) provided to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON A M, 1976, Palaeontology (Oxford), V19, P397; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; BAINBRIDGE R, 1963, J EXP BIOL, V40, P23; Benner JS, 2008, PALAEOGEOGR PALAEOCL, V260, P375, DOI 10.1016/j.palaeo.2007.12.004; Benner JS, 2009, PALAEOGEOGR PALAEOCL, V272, P212, DOI 10.1016/j.palaeo.2008.10.029; BIAGGI RE, 2002, GEOL SOC AM ABSTR, V34, P557; BOYER BW, 1982, GEOLOGY, V10, P321, DOI 10.1130/0091-7613(1982)10<321:GRLDTP>2.0.CO;2; Buchheim H. P., 1994, CONTRIBUTIONS GEOLOG, V30, P3; Buchheim H.P., 1998, UTAH GEOLOGICAL ASS, P1; BUCHHEIM HP, 2002, GEOL SOC AM ABSTR, V34, P479; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; de Gibert JM, 1999, PALAEONTOLOGY, V42, P409, DOI 10.1111/1475-4983.00079; de Gibert Jordi M., 2001, Ichnos, V8, P15; EDWARDS P, 1976, Contributions to Geology University of Wyoming, V14, P115; FERBER CT, 1995, PALAEOGEOGR PALAEOCL, V117, P185, DOI 10.1016/0031-0182(94)00127-T; Grande L, 2001, T GEOBIOL, V18, P1; GRANDE L, 1982, COPEIA, P523; GRANDE L, 1984, GEOLOGICAL SURVEY WY, V63; Grande L, 2008, J PALEONTOL, V82, P1, DOI 10.1666/0022-3360(2008)82[1:ROTTSF]2.0.CO;2; Grande Lance, 1994, Contributions to Geology University of Wyoming, V30, P33; Loewen Mark A., 1999, Journal of Vertebrate Paleontology, V19, p59A; Lu ZS, 2004, SCI CHINA SER D, V47, P272, DOI 10.1360/02yd0273; Martin Anthony J., 2005, P59; Minter NJ, 2006, PALAEONTOLOGY, V49, P1123, DOI 10.1111/j.1475-4983.2006.00588.x; Morrissey LB, 2004, GEOL J, V39, P337, DOI 10.1002/gj.998; Russ J. C., 2002, IMAGE PROCESSING HDB, V4th, DOI DOI 10.1201/9781420040760; Seilacher A., 2007, TRACE FOSSIL ANAL; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Trewin NH, 2000, PALAEONTOLOGY, V43, P979, DOI 10.1111/1475-4983.00158; Trigub R.M., 2004, FOURIER ANAL APPROXI; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; WARDLE CS, 1995, J EXP BIOL, V198, P1629	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10420	10.1371/journal.pone.0010420	http://dx.doi.org/10.1371/journal.pone.0010420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463969	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400006
J	Choo, YM; Lee, KS; Yoon, HJ; Kim, BY; Sohn, MR; Roh, JY; Je, YH; Kim, NJ; Kim, I; Woo, SD; Sohn, HD; Jin, BR				Choo, Young Moo; Lee, Kwang Sik; Yoon, Hyung Joo; Kim, Bo Yeon; Sohn, Mi Ri; Roh, Jong Yul; Je, Yeon Ho; Kim, Nam Jung; Kim, Iksoo; Woo, Soo Dong; Sohn, Hung Dae; Jin, Byung Rae			Dual Function of a Bee Venom Serine Protease: Prophenoloxidase-Activating Factor in Arthropods and Fibrin(ogen)olytic Enzyme in Mammals	PLOS ONE			English	Article							SNAKE-VENOM; HYMENOPTERA VENOM; PHOSPHOLIPASE A(2); BIOCHEMICAL-CHARACTERIZATION; PRO-PHENOLOXIDASE; BLOOD-COAGULATION; MOLECULAR-CLONING; BOMBYX-MORI; BUMBLEBEE; PURIFICATION	Bee venom contains a variety of peptides and enzymes, including serine proteases. While the presence of serine proteases in bee venom has been demonstrated, the role of these proteins in bee venom has not been elucidated. Furthermore, there is currently no information available regarding the melanization response or the fibrin(ogen)olytic activity of bee venom serine protease, and the molecular mechanism of its action remains unknown. Here we show that bee venom serine protease (Bi-VSP) is a multifunctional enzyme. In insects, Bi-VSP acts as an arthropod prophenoloxidase (proPO)-activating factor (PPAF), thereby triggering the phenoloxidase (PO) cascade. Bi-VSP injected through the stinger induces a lethal melanization response in target insects by modulating the innate immune response. In mammals, Bi-VSP acts similarly to snake venom serine protease, which exhibits fibrin(ogen) olytic activity. Bi-VSP activates prothrombin and directly degrades fibrinogen into fibrin degradation products, defining roles for Bi-VSP as a prothrombin activator, a thrombin-like protease, and a plasmin-like protease. These findings provide a novel view of the mechanism of bee venom in which the bee venom serine protease kills target insects via a melanization strategy and exhibits fibrin(ogen) olytic activity.	[Choo, Young Moo; Lee, Kwang Sik; Kim, Bo Yeon; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Yoon, Hyung Joo; Kim, Nam Jung] Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea; [Roh, Jong Yul; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Iksoo] Chonnam Natl Univ, Dept Agr Biol, Kwangju, South Korea; [Woo, Soo Dong] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea	Dong A University; Seoul National University (SNU); Chonnam National University; Chungbuk National University	Choo, YM (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	brjin@dau.ac.kr			Rural Development Administration [10-29-66]; Ministry of Education, Science and Technology, Republic of Korea	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Agenda Project (10-29-66), the Rural Development Administration, and the BK21 Project, from the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGIOLAS A, 1985, J BIOL CHEM, V260, P1437; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; ASHIDA M, 1983, BIOCHEM BIOPH RES CO, V113, P562, DOI 10.1016/0006-291X(83)91762-X; ASHIDA M, 1990, EUR J BIOCHEM, V188, P507, DOI 10.1111/j.1432-1033.1990.tb15429.x; ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Choo YM, 2008, MOL CELL NEUROSCI, V38, P224, DOI 10.1016/j.mcn.2008.02.011; Choo YM, 2010, COMP BIOCHEM PHYS B, V156, P168, DOI 10.1016/j.cbpb.2010.03.007; DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; GAULDIE J, 1976, EUR J BIOCHEM, V61, P369, DOI 10.1111/j.1432-1033.1976.tb10030.x; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Golden DBK, 2007, IMMUNOL ALLERGY CLIN, V27, P261, DOI 10.1016/j.iac.2007.03.008; Golden DBK, 2009, J ALLERGY CLIN IMMUN, V123, P1371, DOI 10.1016/j.jaci.2009.03.017; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; He JY, 2007, FEBS LETT, V581, P2965, DOI 10.1016/j.febslet.2007.05.047; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; HOFFMAN DR, 1984, ANN ALLERGY, V52, P276; Hoffman DR, 2001, J ALLERGY CLIN IMMUN, V108, P855, DOI 10.1067/mai.2001.119029; Hoffman DR, 1996, J ALLERGY CLIN IMMUN, V97, P812, DOI 10.1016/S0091-6749(96)80159-X; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Je YH, 2001, BIOTECHNOL LETT, V23, P575; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Joseph JS, 2001, HAEMOSTASIS, V31, P234; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Koh YS, 2001, TOXICON, V39, P555, DOI 10.1016/S0041-0101(00)00169-0; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mirshafiey A, 2007, NEUROPHARMACOLOGY, V53, P353, DOI 10.1016/j.neuropharm.2007.05.002; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Ownby CL, 1997, TOXICON, V35, P67, DOI 10.1016/S0041-0101(96)00078-5; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Silva MB, 2003, BIOCHEM J, V369, P129, DOI 10.1042/BJ20020449; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; SPEIJER H, 1986, J BIOL CHEM, V261, P3258; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Winningham KM, 2004, J ALLERGY CLIN IMMUN, V114, P928, DOI 10.1016/j.jaci.2004.07.043; Xin Y, 2009, COMP BIOCHEM PHYS B, V154, P195, DOI 10.1016/j.cbpb.2009.06.003; Yoon HJ, 2002, APPL ENTOMOL ZOOL, V37, P419, DOI 10.1303/aez.2002.419; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	55	73	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10393	10.1371/journal.pone.0010393	http://dx.doi.org/10.1371/journal.pone.0010393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454652	Green Submitted, gold, Green Published			2022-12-27	WOS:000277240300002
J	Morueta-Holme, N; Flojgaard, C; Svenning, JC				Morueta-Holme, Naia; Flojgaard, Camilla; Svenning, Jens-Christian			Climate Change Risks and Conservation Implications for a Threatened Small-Range Mammal Species	PLOS ONE			English	Article							ASSISTED MIGRATION; DISTRIBUTIONS; PREDICTION; DIVERSITY; IMPACTS; DETERMINANTS; EXTINCTION; RESPONSES; PATTERNS; FUTURE	Background: Climate change is already affecting the distributions of many species and may lead to numerous extinctions over the next century. Small-range species are likely to be a special concern, but the extent to which they are sensitive to climate is currently unclear. Species distribution modeling, if carefully implemented, can be used to assess climate sensitivity and potential climate change impacts, even for rare and cryptic species. Methodology/Principal Findings: We used species distribution modeling to assess the climate sensitivity, climate change risks and conservation implications for a threatened small-range mammal species, the Iberian desman (Galemys pyrenaicus), which is a phylogenetically isolated insectivore endemic to south-western Europe. Atlas data on the distribution of G. pyrenaicus was linked to data on climate, topography and human impact using two species distribution modeling algorithms to test hypotheses on the factors that determine the range for this species. Predictive models were developed and projected onto climate scenarios for 2070-2099 to assess climate change risks and conservation possibilities. Mean summer temperature and water balance appeared to be the main factors influencing the distribution of G. pyrenaicus. Climate change was predicted to result in significant reductions of the species' range. However, the severity of these reductions was highly dependent on which predictor was the most important limiting factor. Notably, if mean summer temperature is the main range determinant, G. pyrenaicus is at risk of near total extinction in Spain under the most severe climate change scenario. The range projections for Europe indicate that assisted migration may be a possible long-term conservation strategy for G. pyrenaicus in the face of global warming. Conclusions/Significance: Climate change clearly poses a severe threat to this illustrative endemic species. Our findings confirm that endemic species can be highly vulnerable to a warming climate and highlight the fact that assisted migration has potential as a conservation strategy for species threatened by climate change.	[Morueta-Holme, Naia; Flojgaard, Camilla; Svenning, Jens-Christian] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Flojgaard, Camilla] Aarhus Univ, Natl Environm Res Inst, Dept Wildlife Ecol & Biodivers, Ronde, Denmark	Aarhus University; Aarhus University	Morueta-Holme, N (corresponding author), Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	morueta.holme@biology.au.dk	Svenning, Jens-Christian/C-8977-2012; Morueta-Holme, Naia/J-4952-2013	Svenning, Jens-Christian/0000-0002-3415-0862; Morueta-Holme, Naia/0000-0002-0776-4092; Flojgaard, Camilla/0000-0002-5829-8503	Danish Natural Science Research Council [272-07-0242]	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work received economic support from the Danish Natural Science Research Council (Grant 272-07-0242 to JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; AYMERICH P, 2004, B INFORM SOC ESPANOL, V16, P83; Aymerich P., 2004, HABITATS, V9, P26; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Cabria MT, 2006, GENE, V375, P1, DOI 10.1016/j.gene.2006.01.038; CASTEL E, 2003, HABITATS, V7, P22; *CIESIN CIAT, 2005, POP WORLD VERS 3 GWP; Degerbol M., 1964, Journal of Animal Ecology (Suppl), V33, P71, DOI 10.2307/2431; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Flojgaard C, 2009, J BIOGEOGR, V36, P1152, DOI 10.1111/j.1365-2699.2009.02089.x; GASTON JK, 1994, RARITY; GISBERT J, 2003, VER354 MIN MED AMB; Grayson DK, 2000, J BIOGEOGR, V27, P181, DOI 10.1046/j.1365-2699.2000.00383.x; Grayson DK, 2005, CONSERV BIOL, V19, P557; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; IUCN, 2007, EUR MAMM ASS; IUCN, 2014, IUCN RED LIST THREAT; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; MARRIS E, 2008, CLIMATE CHANGE, V2, P112; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mira A, 2008, MAMM BIOL, V73, P102, DOI 10.1016/j.mambio.2006.11.003; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; NORES C, 1999, SEM CONS MARG MARG G; NORES C, 1992, APROXIMACIO METODOLO; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Palmeirim J.M., 1983, MAMMALIAN SPECIES, V207, P1; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schreuder A., 1940, ARCH NEERLAND ZOOL, V4, P201; Seddon PJ, 2009, CONSERV BIOL, V23, P788, DOI 10.1111/j.1523-1739.2009.01200.x; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Smirnov N G, 2007, Dokl Biol Sci, V414, P219, DOI 10.1134/S0012496607030143; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; SVENNING JC, 2009, IOP C SER EARTH ENV, V8; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Vitt P, 2009, TRENDS ECOL EVOL, V24, P473, DOI 10.1016/j.tree.2009.05.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Willis SG, 2009, CONSERV LETT, V2, P45, DOI 10.1111/j.1755-263X.2008.00043.x	77	105	111	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10360	10.1371/journal.pone.0010360	http://dx.doi.org/10.1371/journal.pone.0010360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454451	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100003
J	Paladino, P; Collins, SE; Mossman, KL				Paladino, Patrick; Collins, Susan E.; Mossman, Karen L.			Cellular Localization of the Herpes Simplex Virus ICP0 Protein Dictates Its Ability to Block IRF3-Mediated Innate Immune Responses	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; EARLY POLYPEPTIDE VMW110; IMMEDIATE-EARLY GENE-1; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSE; TYPE-1 ICP0; STIMULATED GENES; PARTICLE ENTRY; POSTTRANSLATIONAL MODIFICATION	Interferon regulatory factor 3 (IRF3) is important for innate antiviral responses; accordingly, many viruses target and inactivate IRF3. The ability of the Herpes simplex virus type 1 (HSV-1) immediate early protein ICP0 to inhibit IRF3 is controversial and has not been studied solely in the context of a wild type HSV-1 infection. Discrepancies in the literature surround the mechanism by which ICP0 antagonizes the IRF3 pathway, the cellular localization of ICP0 inhibitory activity and the ability of ICP0 to interfere with interferon and interferon-stimulated gene induction. In this study, we set out to investigate the role of ICP0 localization and the requirement of the proteasome during the inhibition of IRF3 activation within the context of an HSV-1 infection. Collectively, the results presented herein demonstrate that incoming wild type HSV-1 activates IRF3 and that de novo produced ICP0 prevents sustained IRF3 activation following its translocation from the nucleus to the cytoplasm. While previous studies implicate the E3 ubiquitin ligase domain of ICP0 in mediating its biological functions, including the inhibition of IRF3, we show that cytoplasmic ICP0 does not require the proteasome for this activity. Instead, proteasome function is required to localize ICP0 to the cytoplasm where it mediates its inhibitory effect independent of E3 ubiquitin ligase activity. The importance of these findings is discussed within the context of an HSV-1 infection.	[Paladino, Patrick; Collins, Susan E.; Mossman, Karen L.] McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University	Paladino, P (corresponding author), McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	mossk@mcmaster.ca	Collins, Susan/AAD-1390-2020		Canadian Institutes for Health Research [FRN 57669]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant from the Canadian Institutes for Health Research (FRN 57669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2001, J VIROL, V75, P7904, DOI 10.1128/JVI.75.17.7904-7912.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BECKER Y, 1977, ANTIMICROB AGENTS CH, V11, P919, DOI 10.1128/AAC.11.5.919; BLAHO JA, 1993, J VIROL, V67, P3891, DOI 10.1128/JVI.67.7.3891-3900.1993; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2008, J VIROL, V82, P10647, DOI 10.1128/JVI.01063-08; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; CAI WZ, 1989, J VIROL, V63, P4579, DOI 10.1128/JVI.63.11.4579-4589.1989; CIUFO DM, 1994, J VIROL, V68, P3267, DOI 10.1128/JVI.68.5.3267-3282.1994; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Davido DJ, 2005, J VIROL, V79, P1232, DOI 10.1128/JVI.79.2.1232-1243.2005; Davido DJ, 2002, J VIROL, V76, P1077, DOI 10.1128/JVI.76.3.1077-1088.2002; DeFilippis V, 2005, J VIROL, V79, P6419, DOI 10.1128/JVI.79.10.6419-6431.2005; Ehlers B, 2007, J VIROL, V81, P8091, DOI 10.1128/JVI.00255-07; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; EVERETT RD, 1991, NUCLEIC ACIDS RES, V19, P6155, DOI 10.1093/nar/19.22.6155; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; EVERETT RD, 1988, J MOL BIOL, V202, P87, DOI 10.1016/0022-2836(88)90521-9; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Everett RD, 2009, J VIROL, V83, P4963, DOI 10.1128/JVI.02593-08; Everett RD, 2009, J VIROL, V83, P4978, DOI 10.1128/JVI.02595-08; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; HAY J, 1977, J ANTIMICROB CHEMOTH, V3, P63, DOI 10.1093/jac/3.suppl_A.63; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kalaravoki M, 2008, J VIROL, V82, P1701, DOI 10.1128/JVI.02157-07; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; KILLINGTON RA, 1977, J GEN VIROL, V37, P297, DOI 10.1099/0022-1317-37-2-297; LEINBACH SS, 1976, BIOCHEMISTRY-US, V15, P426, DOI 10.1021/bi00647a029; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lopez P, 2001, J VIROL, V75, P3832, DOI 10.1128/JVI.75.8.3832-3840.2001; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nicholl MJ, 2000, J GEN VIROL, V81, P2215, DOI 10.1099/0022-1317-81-9-2215; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Noyce RS, 2009, J VIROL, V83, P4013, DOI 10.1128/JVI.02069-08; Ogle WO, 1997, VIROLOGY, V235, P406, DOI 10.1006/viro.1997.8710; PALADINO P, 2009, J INTERFERON CYTOKIN; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Reimer T, 2007, J IMMUNOL, V179, P1166, DOI 10.4049/jimmunol.179.2.1166; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sobol PT, 2006, J VIROL, V80, P218, DOI 10.1128/JVI.80.1.218-225.2006; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Tsitoura E, 2009, J GEN VIROL, V90, P2209, DOI 10.1099/vir.0.012203-0; Van Sant C, 1999, P NATL ACAD SCI USA, V96, P8184, DOI 10.1073/pnas.96.14.8184; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	73	79	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10428	10.1371/journal.pone.0010428	http://dx.doi.org/10.1371/journal.pone.0010428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454685	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100030
J	Olofsson, M; Vallin, A; Jakobsson, S; Wiklund, C				Olofsson, Martin; Vallin, Adrian; Jakobsson, Sven; Wiklund, Christer			Marginal Eyespots on Butterfly Wings Deflect Bird Attacks Under Low Light Intensities with UV Wavelengths	PLOS ONE			English	Article							BICYCLUS-ANYNANA; FEMALE CHOICE; BLUE TITS; ULTRAVIOLET; PREDATION; PATTERNS; LEPIDOPTERA; EVOLUTION; PREY; CUES	Background: Predators preferentially attack vital body parts to avoid prey escape. Consequently, prey adaptations that make predators attack less crucial body parts are expected to evolve. Marginal eyespots on butterfly wings have long been thought to have this deflective, but hitherto undemonstrated function. Methodology/Principal Findings: Here we report that a butterfly, Lopinga achine, with broad-spectrum reflective white scales in its marginal eyespot pupils deceives a generalist avian predator, the blue tit, to attack the marginal eyespots, but only under particular conditions-in our experiments, low light intensities with a prominent UV component. Under high light intensity conditions with a similar UV component, and at low light intensities without UV, blue tits directed attacks towards the butterfly head. Conclusions/Significance: In nature, birds typically forage intensively at early dawn, when the light environment shifts to shorter wavelengths, and the contrast between the eyespot pupils and the background increases. Among butterflies, deflecting attacks is likely to be particularly important at dawn when low ambient temperatures make escape by flight impossible, and when insectivorous birds typically initiate another day's search for food. Our finding that the deflective function of eyespots is highly dependent on the ambient light environment helps explain why previous attempts have provided little support for the deflective role of marginal eyespots, and we hypothesize that the mechanism that we have discovered in our experiments in a laboratory setting may function also in nature when birds forage on resting butterflies under low light intensities.	[Olofsson, Martin; Vallin, Adrian; Jakobsson, Sven; Wiklund, Christer] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Olofsson, M (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	martin.olofsson@zoologi.su.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding: This study was financially supported by the Swedish Research Council to C. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P1345, DOI 10.1098/rspb.1998.0440; BEDNEKOFF PA, 1994, EVOL ECOL, V8, P36, DOI 10.1007/BF01237664; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Blest A. D., 1957, Behaviour, V11, P209, DOI 10.1163/156853956X00048; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; BRAKEFIELD PM, 1992, AVOIDANCE CONCEALMEN, P93; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; CHAI P, 1986, BIOL J LINN SOC, V29, P161, DOI 10.1111/j.1095-8312.1986.tb01772.x; Church SC, 1998, P ROY SOC B-BIOL SCI, V265, P1509, DOI 10.1098/rspb.1998.0465; COOPER WE, 1991, CAN J ZOOL, V69, P757, DOI 10.1139/z91-109; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; de Vries P.J., 1988, Journal of Research on the Lepidoptera, V26, P98; Dennis R.L.H., 1986, Nota Lepidopterologica, V9, P39; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; HUTTO RL, 1981, BEHAV ECOL SOCIOBIOL, V9, P195, DOI 10.1007/BF00302937; Kodandaramaiah U, 2009, ANIM BEHAV, V77, P1415, DOI 10.1016/j.anbehav.2009.02.018; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; Lyytinen A, 2003, OIKOS, V100, P373, DOI 10.1034/j.1600-0706.2003.11935.x; Lyytinen A, 2001, BEHAV ECOL, V12, P65, DOI 10.1093/oxfordjournals.beheco.a000380; Monteiro A, 2008, BIOESSAYS, V30, P358, DOI 10.1002/bies.20733; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; POWELL RA, 1982, AM NAT, V119, P126, DOI 10.1086/283897; RAWLINS J E, 1978, Journal of the Lepidopterists' Society, V32, P145; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Ruxton G. D., 2004, AVOIDING ATTACK; SHAPIRO AM, 1974, AM NAT, V108, P229, DOI 10.1086/282901; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Thery M, 2008, BEHAV ECOL, V19, P627, DOI 10.1093/beheco/arn024; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Vallin A, 2006, BEHAV ECOL SOCIOBIOL, V59, P455, DOI 10.1007/s00265-005-0069-9; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Vallin A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1419, DOI 10.1007/s00265-007-0374-6; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Vlieger L, 2007, BIOL J LINN SOC, V92, P661, DOI 10.1111/j.1095-8312.2007.00863.x; Wall M, 2007, BIOL J LINN SOC, V91, P719, DOI 10.1111/j.1095-8312.2007.00835.x; WOURMS M K, 1985, Journal of the Lepidopterists' Society, V39, P239; WOURMS MK, 1985, EVOLUTION, V39, P845, DOI 10.1111/j.1558-5646.1985.tb00426.x	40	83	85	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10798	10.1371/journal.pone.0010798	http://dx.doi.org/10.1371/journal.pone.0010798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520736	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600025
J	Sartono, E; Lisse, IM; Terveer, EM; van de Sande, PJM; Whittle, H; Fisker, AB; Roth, A; Aaby, P; Yazdanbakhsh, M; Benn, CS				Sartono, Erliyani; Lisse, Ida M.; Terveer, Elisabeth M.; van de Sande, Paula J. M.; Whittle, Hilton; Fisker, Ane B.; Roth, Adam; Aaby, Peter; Yazdanbakhsh, Maria; Benn, Christine S.			Oral Polio Vaccine Influences the Immune Response to BCG Vaccination. A Natural Experiment	PLOS ONE			English	Article							INTERFERON-GAMMA-RECEPTOR; BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSES; MYCOBACTERIAL INFECTION; VITAMIN-A; TUBERCULOSIS; MUTATION; INFANTS; GENE; SUSCEPTIBILITY	Background: Oral polio vaccine (OPV) is recommended to be given at birth together with BCG vaccine. While we were conducting two trials including low-birth-weight (LBW) and normal-birth-weight (NBW) infants in Guinea-Bissau, OPV was not available during some periods and therefore some infants did not receive OPV at birth, but only BCG. We investigated the effect of OPV given simultaneously with BCG at birth on the immune response to BCG vaccine. Methods and Findings: We compared the in vitro and the in vivo response to PPD in the infants who received OPV and BCG with that of infants who received BCG only. At age 6 weeks, the in vitro cytokine response to purified protein derivate (PPD) of M. Tuberculosis was reduced in LBW and NBW infants who had received OPV with BCG. In a pooled analysis receiving OPV with BCG at birth was associated with significantly lower IL-13 (p = 0.041) and IFN-gamma (p = 0.004) and a tendency for lower IL-10 (p = 0.054) in response to PPD. Furthermore, OPV was associated with reduced in vivo response to PPD at age 2 months, the prevalence ratio (PR) of having a PPD reaction being 0.75 (0.58-0.98), p = 0.033, and with a tendency for reduced likelihood of having a BCG scar (0.95 (0.91-1.00), p = 0.057)). Among children with a scar, OPV was associated with reduced scar size, the regression coefficient being -0.24 (-0.43-0.05), p = 0.012. Conclusions: This study is the first to address the consequences for the immune response to BCG of simultaneous administration with OPV. Worryingly, the results indicate that the common practice in low-income countries of administering OPV together with BCG at birth may down-regulate the response to BCG vaccine.	[Sartono, Erliyani; Terveer, Elisabeth M.; van de Sande, Paula J. M.; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Lisse, Ida M.] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Whittle, Hilton] MRC Labs, Fajara, Gambia; [Fisker, Ane B.; Benn, Christine S.] Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen, Denmark; [Roth, Adam] Lund Univ, Dept Med Microbiol, Lund, Sweden; [Aaby, Peter] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; Herlev & Gentofte Hospital; MRC Laboratory Molecular Biology; Statens Serum Institut; Lund University	Sartono, E (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.	E.Sartono@lumc.nl	Fisker, Ane B/E-9283-2019; Yazdanbakhsh, Maria/AAI-3996-2020	Fisker, Ane B/0000-0002-8521-0992; Yazdanbakhsh, Maria/0000-0002-7666-1441; Aaby, Peter/0000-0001-8331-1389	European Commission [ICA4-CT-2002-10053]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the European Commission, INCO-programme (contract no. ICA4-CT-2002-10053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Allende LM, 2001, CLIN DIAGN LAB IMMUN, V8, P133, DOI 10.1128/CDLI.8.1.133-137.2001; Anuradha B, 2008, PEDIATR INFECT DIS J, V27, P325, DOI 10.1097/INF.0b013e31816099e6; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; BOUROS D, 1991, CHEST, V99, P416, DOI 10.1378/chest.99.2.416; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cunningham JA, 2000, INT J TUBERC LUNG D, V4, P791; Diness BR, 2007, AM J CLIN NUTR, V86, P1152, DOI 10.1093/ajcn/86.4.1152; Dogan E, 2005, RENAL FAILURE, V27, P425, DOI 10.1081/JDI-200065379; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Garly ML, 2001, VACCINE, V20, P468, DOI 10.1016/S0264-410X(01)00339-5; GUNTHER J, 1982, EUR J IMMUNOL, V12, P247, DOI 10.1002/eji.1830120315; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Klein NP, 2010, J INFECT DIS, V201, P214, DOI 10.1086/649590; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Marchant A, 1999, J IMMUNOL, V163, P2249; Marchant A, 2001, AM J RESP CELL MOL, V24, P187, DOI 10.1165/ajrcmb.24.2.4274; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Stabell C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004056; Stockinger B, 2004, SEMIN IMMUNOL, V16, P295, DOI 10.1016/j.smim.2004.08.010; Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x	28	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10328	10.1371/journal.pone.0010328	http://dx.doi.org/10.1371/journal.pone.0010328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20502641	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017400003
J	de Breij, A; Dijkshoorn, L; Lagendijk, E; van der Meer, J; Koster, A; Bloemberg, G; Wolterbeek, R; van den Broek, P; Nibbering, P				de Breij, Anna; Dijkshoorn, Lenie; Lagendijk, Ellen; van der Meer, Joke; Koster, Abraham; Bloemberg, Guido; Wolterbeek, Ron; van den Broek, Peterhans; Nibbering, Peter			Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii?	PLOS ONE			English	Article							EPITHELIAL-CELLS; SP NOV.; STRAINS; IDENTIFICATION; HOSPITALS; SURFACES; WIDESPREAD; RESISTANCE; CLONE; PILI	Background: The dramatic increase in antibiotic resistance and the recent manifestation in war trauma patients underscore the threat of Acinetobacter baumannii as a nosocomial pathogen. Despite numerous reports documenting its epidemicity, little is known about the pathogenicity of A. baumannii. The aim of this study was to obtain insight into the factors that might explain the clinical success of A. baumannii. Methodology/Principal Findings: We compared biofilm formation, adherence to and inflammatory cytokine induction by human cells for a large panel of well-described strains of A. baumannii and compared these features to that of other, clinically less relevant Acinetobacter species. Results revealed that biofilm formation and adherence to airway epithelial cells varied widely within the various species, but did not differ among the species. However, airway epithelial cells and cultured human macrophages produced significantly less inflammatory cytokines upon exposure to A. baumannii strains than to strains of A. junii, a species infrequently causing infection. Conclusion/Significance: The induction of a weak inflammatory response may provide a clue to the persistence of A. baumannii in patients.	[de Breij, Anna; Dijkshoorn, Lenie; van den Broek, Peterhans; Nibbering, Peter] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Lagendijk, Ellen] Leiden Univ, Inst Biol, Leiden, Netherlands; [van der Meer, Joke; Koster, Abraham] Leiden Univ, Med Ctr, Sect Elect Microscopy, Dept Mol Cell Biol, Leiden, Netherlands; [Bloemberg, Guido] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Wolterbeek, Ron] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Breij, A (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	a.de_breij@lumc.nl	Bloemberg, Guido/AAC-4914-2020					BEACHEY EH, 1988, AM REV RESPIR DIS, V138, P45; Bresser P, 1997, EUR RESPIR J, V10, P2319, DOI 10.1183/09031936.97.10102319; Chu YW, 1999, J CLIN MICROBIOL, V37, P2962, DOI 10.1128/JCM.37.9.2962-2967.1999; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Da Silva G, 2007, CLIN MICROBIOL INFEC, V13, P190, DOI 10.1111/j.1469-0691.2006.01628.x; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Hoffmann MS, 2010, INFECT CONT HOSP EP, V31, P196, DOI 10.1086/650379; HUGH R, 1978, GLUCOSE NONFERMENTIN, P3; Kapetanovic R, 2007, EXPERT OPIN BIOL TH, V7, P907, DOI 10.1517/14712598.7.6.907; Kim D, 2008, J MICROBIOL, V46, P396, DOI 10.1007/s12275-008-0118-y; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Murray CK, 2009, MIL MED, V174, P598, DOI 10.7205/MILMED-D-03-8008; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2010, INT J SYST EVOL MICR, V60, P896, DOI 10.1099/ijs.0.013656-0; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SEIFERT H, 1993, ZBL BAKT-INT J MED M, V279, P544, DOI 10.1016/S0934-8840(11)80427-5; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; Vaneechoutte M, 1999, RES MICROBIOL, V150, P69, DOI 10.1016/S0923-2508(99)80047-3; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Webster C, 2000, INFECT CONT HOSP EP, V21, P246, DOI 10.1086/503214	33	72	72	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10732	10.1371/journal.pone.0010732	http://dx.doi.org/10.1371/journal.pone.0010732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505779	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017300008
J	Hunt, JH; Wolschin, F; Henshaw, MT; Newman, TC; Toth, AL; Amdam, GV				Hunt, James H.; Wolschin, Florian; Henshaw, Michael T.; Newman, Thomas C.; Toth, Amy L.; Amdam, Gro V.			Differential Gene Expression and Protein Abundance Evince Ontogenetic Bias toward Castes in a Primitively Eusocial Wasp	PLOS ONE			English	Article							HONEY-BEE; PAPER WASP; FLESH FLY; PUPAL DIAPAUSE; OVERWINTERING DIAPAUSE; POLISTES-EXCLAMANS; HSP70 TRANSCRIPTS; JUVENILE-HORMONE; UP-REGULATION; SOCIAL WASPS	Polistes paper wasps are models for understanding conditions that may have characterized the origin of worker and queen castes and, therefore, the origin of paper wasp sociality. Polistes is "primitively eusocial'' by virtue of having context-dependent caste determination and no morphological differences between castes. Even so, Polistes colonies have a temporal pattern in which most female larvae reared by the foundress become workers, and most reared by workers become future-reproductive gynes. This pattern is hypothesized to reflect development onto two pathways, which may utilize mechanisms that regulate diapause in other insects. Using expressed sequence tags (ESTs) for Polistes metricus we selected candidate genes differentially expressed in other insects in three categories: 1) diapause vs. non-diapause phenotypes and/or worker vs. queen differentiation, 2) behavioral subcastes of worker honey bees, and 3) no a priori expectation of a role in worker/gyne development. We also used a non-targeted proteomics screen to test for peptide/protein abundance differences that could reflect larval developmental divergence. We found that foundress-reared larvae (putative worker-destined) and worker-reared larvae (putative gyne-destined) differed in quantitative expression of sixteen genes, twelve of which were associated with caste and/or diapause in other insects, and they also differed in abundance of nine peptides/proteins. Some differentially-expressed genes are involved in diapause regulation in other insects, and other differentially-expressed genes and proteins are involved in the insulin signaling pathway, nutrient metabolism, and caste determination in highly social bees. Differential expression of a gene and a peptide encoding hexameric storage proteins is especially noteworthy. Although not conclusive, our results support hypotheses of 1) larval developmental pathway divergence that can lead to caste bias in adults and 2) nutritional differences as the foundation of the pathway divergence. Finally, the differential expression in Polistes larvae of genes and proteins also differentially expressed during queen vs. worker caste development in honey bees may indicate that regulatory mechanisms of caste outcomes share similarities between primitively eusocial and advanced eusocial Hymenoptera.	[Hunt, James H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Hunt, James H.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Wolschin, Florian; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Wolschin, Florian; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Henshaw, Michael T.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Newman, Thomas C.; Toth, Amy L.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Toth, Amy L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; The National Evolutionary Synthesis Center; Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe; Grand Valley State University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hunt, JH (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	jim_hunt@ncsu.edu	Toth, Amy L/A-9196-2011		US National Science Foundation [0819807, 0803317, 0641431, 0615502]; University of Illinois; National Evolutionary Synthesis Center (NSF) [EF-0905608]; Alexander von Humboldt Foundation; Research Council of Norway [175413, 180504, 185306, 191699]; PEW Foundation [000068-001]; National Institute of Aging (NIA) [P01 AG22500]; Division Of Integrative Organismal Systems [0803317] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); University of Illinois; National Evolutionary Synthesis Center (NSF); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Research Council of Norway(Research Council of Norway); PEW Foundation; National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JHH, MTH, and ALT received support from the US National Science Foundation (0819807, 0803317, 0641431); JHH received additional support from the University of Illinois Sociogenomics Initiative (Gene E. Robinson, PI) and from the National Evolutionary Synthesis Center (NSF # EF-0905608); FW was supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation; and GVA received support from the Research Council of Norway (175413, 180504, 185306 and 191699), the US National Science Foundation (0615502), the PEW Foundation (000068-001), and the National Institute of Aging (NIA P01 AG22500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM S. MASHHOOD, 1958, PROC ZOOL SOC, V11, P113; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; [Anonymous], 1971, INSECT SOC; [Anonymous], 1974, SOCIAL BEHAV BEES; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Batra S. W. T., 1966, Indian Journal of Entomology, V28, P375; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; Cini A, 2009, ANN ZOOL FENN, V46, P423, DOI 10.5735/086.046.0603; CORONA M, 1999, J EXPT BIOL, V202; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Dapporto L, 2005, ANN ZOOL FENN, V42, P135; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Flannagan RD, 1998, P NATL ACAD SCI USA, V95, P5616, DOI 10.1073/pnas.95.10.5616; GADAGKAR R, 1990, P INDIAN AS-ANIM SCI, V99, P141, DOI 10.1007/BF03186384; GADAGKAR R, 1988, PROC R SOC SER B-BIO, V233, P175, DOI 10.1098/rspb.1988.0017; GADAGKAR R, 1991, ECOL ENTOMOL, V16, P435, DOI 10.1111/j.1365-2311.1991.tb00236.x; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gobbi N, 2006, NATURWISSENSCHAFTEN, V93, P487, DOI 10.1007/s00114-006-0140-z; Greene A., 1991, P263; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; Holldobler B., 1990, pi; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; Hunt JH, 1999, BIOTROPICA, V31, P192; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Judd TM, 2010, J INSECT PHYSIOL, V56, P42, DOI 10.1016/j.jinsphys.2009.09.002; Judice CC, 2006, INSECT MOL BIOL, V15, P33, DOI 10.1111/j.1365-2583.2005.00605.x; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Kawamura K, 1999, DEVELOPMENT, V126, P211; Keeping MG, 2002, J INSECT PHYSIOL, V48, P867, DOI 10.1016/S0022-1910(02)00156-7; Kundu HL., 1967, BIRLA I TECHNOL SCI, V1, P152; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Marchal P., 1897, Compte Rendu des Seances de la Societe de Biologie, P557; Matsuura M., 1991, P232; Mead F, 2002, ETHOL ECOL EVOL, V14, P111; Noll Fernando B., 2004, American Museum Novitates, V3467, P1, DOI 10.1206/0003-0082(2004)467<0001:EOCINW>2.0.CO;2; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Pereboom JJM, 2005, P ROY SOC B-BIOL SCI, V272, P1145, DOI 10.1098/rspb.2005.3060; Reeve H.K., 1991, P99; Reeve HK, 2001, MG BEH ECOL, P57; Reeve HK, 1998, P NATL ACAD SCI USA, V95, P13737, DOI 10.1073/pnas.95.23.13737; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; ROSSI AM, 1988, ECOL ENTOMOL, V13, P437, DOI 10.1111/j.1365-2311.1988.tb00376.x; Sim C, 2009, INSECT MOL BIOL, V18, P325, DOI 10.1111/j.1365-2583.2009.00872.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; STRASSMANN JE, 1984, INSECT SOC, V31, P291, DOI 10.1007/BF02223613; SULLIVAN JD, 1984, BEHAV ECOL SOCIOBIOL, V15, P249, DOI 10.1007/BF00292986; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; Sumner S, 2010, P ROY SOC B-BIOL SCI, V277, P1721, DOI 10.1098/rspb.2009.2289; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Toth AL, 2010, P ROY SOC B-BIOL SCI, V277, P2139, DOI 10.1098/rspb.2010.0090; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; WENZEL JW, 1992, INSECT SOC, V39, P31, DOI 10.1007/BF01240529; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Winston M.L., 1991, BIOL HONEY BEE; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0	84	63	64	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10674	10.1371/journal.pone.0010674	http://dx.doi.org/10.1371/journal.pone.0010674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498859	Green Published, gold			2022-12-27	WOS:000277773700017
J	Chao, R; Nevin, L; Agarwal, P; Riemer, J; Bai, XY; Delaney, A; Akana, M; JimenezLopez, N; Bardakjian, T; Schneider, A; Chassaing, N; Schorderet, DF; FitzPatrick, D; Kwok, PY; Ellgaard, L; Gould, DB; Zhang, Y; Malicki, J; Baier, H; Slavotinek, A				Chao, Ryan; Nevin, Linda; Agarwal, Pooja; Riemer, Jan; Bai, Xiaoyang; Delaney, Allen; Akana, Matthew; JimenezLopez, Nelson; Bardakjian, Tanya; Schneider, Adele; Chassaing, Nicolas; Schorderet, Daniel F.; FitzPatrick, David; Kwok, Pui-yan; Ellgaard, Lars; Gould, Douglas B.; Zhang, Yan; Malicki, Jarema; Baier, Herwig; Slavotinek, Anne			A Male with Unilateral Microphthalmia Reveals a Role for TMX3 in Eye Development	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; COPY-NUMBER; CANDIDATE GENES; HEART-DEFECTS; ARRAY-CGH; EXPRESSION; MUTATION; DELETION; PROTEIN; IDENTIFICATION	Anophthalmia and microphthalmia are important birth defects, but their pathogenesis remains incompletely understood. We studied a patient with severe unilateral microphthalmia who had a 2.7 Mb deletion at chromosome 18q22.1 that was inherited from his mother. In-situ hybridization showed that one of the deleted genes, TMX3, was expressed in the retinal neuroepithelium and lens epithelium in the developing murine eye. We re-sequenced TMX3 in 162 patients with anophthalmia or microphthalmia, and found two missense substitutions in unrelated patients: c.116G > A, predicting p.Arg39Gln, in a male with unilateral microphthalmia and retinal coloboma, and c.322G > A, predicting p.Asp108Asn, in a female with unilateral microphthalmia and severe micrognathia. We used two antisense morpholinos targeted against the zebrafish TMX3 orthologue, zgc:110025, to examine the effects of reduced gene expression in eye development. We noted that the morphant larvae resulting from both morpholinos had significantly smaller eye sizes and reduced labeling with islet-1 antibody directed against retinal ganglion cells at 2 days post fertilization. Co-injection of human wild type TMX3 mRNA rescued the small eye phenotype obtained with both morpholinos, whereas co-injection of human TMX3(p.Arg39Gln) mutant mRNA, analogous to the mutation in the patient with microphthalmia and coloboma, did not rescue the small eye phenotype. Our results show that haploinsufficiency for TMX3 results in a small eye phenotype and represents a novel genetic cause of microphthalmia and coloboma. Future experiments to determine if other thioredoxins are important in eye morphogenesis and to clarify the mechanism of function of TMX3 in eye development are warranted.	[Chao, Ryan; JimenezLopez, Nelson; Slavotinek, Anne] Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA; [Nevin, Linda; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Agarwal, Pooja] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Riemer, Jan; Ellgaard, Lars] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bai, Xiaoyang; Akana, Matthew; Kwok, Pui-yan; Gould, Douglas B.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Delaney, Allen] BC Canc Res Ctr, Genome Sci Ctr, Vancouver, BC, Canada; [Akana, Matthew; Kwok, Pui-yan] Univ Calif San Francisco, Dept Dermatol, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bardakjian, Tanya; Schneider, Adele] Albert Einstein Med Ctr, Div Clin Genet, Philadelphia, PA 19141 USA; [Chassaing, Nicolas] Univ Toulouse, Serv Genet Med, Toulouse, France; [Schorderet, Daniel F.] Univ Lausanne, Inst Rech Ophtalmol, Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [FitzPatrick, David] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Zhang, Yan; Malicki, Jarema] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; British Columbia Cancer Agency; University of California System; University of California San Francisco; Yeshiva University; Universite de Toulouse; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Edinburgh; Harvard University; Harvard Medical School	Chao, R (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA.	slavotia@peds.ucsf.edu	Ellgaard, Lars/I-9034-2014; Riemer, Jan/B-3340-2012; Riemer, Jan/AAC-1072-2021; malicki, jarema/G-8611-2014; FitzPatrick, David R/C-7301-2013; Slavotinek, Anne/AAK-6794-2020; Kwok, Pui-Yan/F-7725-2014	Ellgaard, Lars/0000-0002-7018-0137; malicki, jarema/0000-0002-5947-8805; Kwok, Pui-Yan/0000-0002-5087-3059; FitzPatrick, David R./0000-0003-4861-969X; Riemer, Jan/0000-0002-7574-8457	National Institute of Child Health and Development (NICHD) [5R03 HDO49411-02, K08HD053476-01A1]; Sandler Program in Basic Sciences [EY02162]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI) [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD053476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sandler Program in Basic Sciences; National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Anne Slavotinek was generously funded by an R03 grant 5R03 HDO49411-02 from the National Institute of Child Health and Development (NICHD) and a K08 grant K08HD053476-01A1 from the same institution. Doug Gould and Xaioyang Bai were funded by the Sandler Program in Basic Sciences, That Man May See, and the core grant (EY02162). This publication was supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco-Clinical & Translational Science Institute (UCSF-CTSI) Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chatterjee B, 2007, MAMM GENOME, V18, P310, DOI 10.1007/s00335-007-9023-7; Davis-Silberman N, 2005, HUM MOL GENET, V14, P2265, DOI 10.1093/hmg/ddi231; DELANEY A, 2008, CURR PROTOC HUM GENE, pCH8; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Giordano E, 2003, MOL GENET GENOMICS, V268, P692, DOI 10.1007/s00438-002-0792-0; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Haugstetter J, 2007, J BIOL CHEM, V282, P33859, DOI 10.1074/jbc.M706442200; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kantarci S, 2006, AM J MED GENET A, V140A, P17, DOI 10.1002/ajmg.a.31025; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Melloy PG, 1998, DEV BIOL, V193, P77, DOI 10.1006/dbio.1997.8787; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rainger J, 2008, INBORN ERRORS DEV, P94; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Sehgal R, 2008, DEV BIOL, V319, P23, DOI 10.1016/j.ydbio.2008.03.041; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Taylor MR, 2005, GENETICS, V170, P263, DOI 10.1534/genetics.104.036434; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Thisse B, 2004, ZFIN DIRECT DATA SUB; Torres MA, 1996, DEVELOPMENT, V122, P3381; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zayed H, 2010, AM J MED GENET A, V152A, P916, DOI 10.1002/ajmg.a.33341	40	25	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10565	10.1371/journal.pone.0010565	http://dx.doi.org/10.1371/journal.pone.0010565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485507	Green Published, gold, Green Submitted			2022-12-27	WOS:000277563200004
J	Jordao, JF; Ayala-Grosso, CA; Markham, K; Huang, YX; Chopra, R; McLaurin, J; Hynynen, K; Aubert, I				Jordao, Jessica F.; Ayala-Grosso, Carlos A.; Markham, Kelly; Huang, Yuexi; Chopra, Rajiv; McLaurin, JoAnne; Hynynen, Kullervo; Aubert, Isabelle			Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-beta Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							BARRIER; DELIVERY; MICE; IMMUNIZATION; MEMORY; IMMUNOTHERAPY; DISRUPTION; MECHANISMS; DEPOSITION; DEFICITS	Immunotherapy for Alzheimer's disease (AD) relies on antibodies directed against toxic amyloid-beta peptide (A beta), which circulate in the bloodstream and remove A beta from the brain [1,2]. In mouse models of AD, the administration of anti-A beta antibodies directly into the brain, in comparison to the bloodstream, was shown to be more efficient at reducing A beta plaque pathology [3,4]. Therefore, delivering anti-A beta antibodies to the brain of AD patients may also improve treatment efficiency. Transcranial focused ultrasound (FUS) is known to transiently-enhance the permeability of the blood-brain barrier (BBB) [5], allowing intravenously administered therapeutics to enter the brain [6-8]. Our goal was to establish that anti-A beta antibodies delivered to the brain using magnetic resonance imaging-guided FUS (MRIgFUS) [9] can reduce plaque pathology. To test this, TgCRND8 mice [10] received intravenous injections of MRI and FUS contrast agents, as well as anti-A beta antibody, BAM-10. MRIgFUS was then applied transcranially. Within minutes, the MRI contrast agent entered the brain, and BAM-10 was later found bound to A beta plaques in targeted cortical areas. Four days post-treatment, A beta pathology was significantly reduced in TgCRND8 mice. In conclusion, this is the first report to demonstrate that MRIgFUS delivery of anti-A beta antibodies provides the combined advantages of using a low dose of antibody and rapidly reducing plaque pathology.	[Jordao, Jessica F.; Ayala-Grosso, Carlos A.; Markham, Kelly; Huang, Yuexi; Chopra, Rajiv; Hynynen, Kullervo; Aubert, Isabelle] Sunnybrook Res Inst, Toronto, ON, Canada; [Jordao, Jessica F.; McLaurin, JoAnne; Aubert, Isabelle] Univ Toronto, Fac Med, Dept Lab Med & Pathol, Toronto, ON, Canada; [Chopra, Rajiv; Hynynen, Kullervo] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [McLaurin, JoAnne] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ayala-Grosso, Carlos A.] Cent Univ Venezuela, Fac Farm, Unidad Biol Mol, Caracas, Venezuela	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Central Venezuela	Jordao, JF (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	khynynen@sri.utoronto.ca; isabelle.aubert@sri.utoronto.ca	Ayala-Grosso, Carlos/ABD-5221-2020; Chopra, Rajiv/A-8367-2013; Aubert, Isabelle/AAG-4001-2019	Ayala-Grosso, Carlos/0000-0003-3079-1109; Chopra, Rajiv/0000-0003-3605-6076; Aubert, Isabelle/0000-0001-5163-9961	Sunnybrook Research Institute; Ontario Mental Health Foundation; National Institutes of Health [R21/R33 EB000705]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000705, R33EB000705] Funding Source: NIH RePORTER	Sunnybrook Research Institute(University of Toronto); Ontario Mental Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by Sunnybrook Research Institute (IA), Ontario Mental Health Foundation (IA), National Institutes of Health (KH; R21/R33 EB000705 NIH/NIBIB), and Canadian Institutes of Health Research (IA, JM, JFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Braakman N, 2006, J MAGN RESON IMAGING, V24, P530, DOI 10.1002/jmri.20675; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; DaSilva KA, 2009, VACCINE, V27, P1365, DOI 10.1016/j.vaccine.2008.12.044; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Frenkel D, 1998, J NEUROIMMUNOL, V88, P85, DOI 10.1016/S0165-5728(98)00098-8; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; Janus C, 2004, NEUROBIOL AGING, V25, P1213, DOI 10.1016/j.neurobiolaging.2003.11.007; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Opar A, 2008, NAT REV DRUG DISCOV, V7, P717, DOI 10.1038/nrd2676; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2008, J ALZHEIMERS DIS, V15, P555	29	258	268	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10549	10.1371/journal.pone.0010549	http://dx.doi.org/10.1371/journal.pone.0010549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485502	gold, Green Submitted, Green Published			2022-12-27	WOS:000277563200002
J	Forero, MG; Learte, AR; Cartwright, S; Hidalgo, A				Forero, Manuel Guillermo; Learte, Anabel R.; Cartwright, Stephanie; Hidalgo, Alicia			DeadEasy Mito-Glia: Automatic Counting of Mitotic Cells and Glial Cells in Drosophila	PLOS ONE			English	Article								Cell number changes during normal development, and in disease (e.g., neurodegeneration, cancer). Many genes affect cell number, thus functional genetic analysis frequently requires analysis of cell number alterations upon loss of function mutations or in gain of function experiments. Drosophila is a most powerful model organism to investigate the function of genes involved in development or disease in vivo. Image processing and pattern recognition techniques can be used to extract information from microscopy images to quantify automatically distinct cellular features, but these methods are still not very extended in this model organism. Thus cellular quantification is often carried out manually, which is laborious, tedious, error prone or humanly unfeasible. Here, we present DeadEasy Mito-Glia, an image processing method to count automatically the number of mitotic cells labelled with anti-phospho-histone H3 and of glial cells labelled with anti-Repo in Drosophila embryos. This programme belongs to the DeadEasy suite of which we have previously developed versions to count apoptotic cells and neuronal nuclei. Having separate programmes is paramount for accuracy. DeadEasy Mito-Glia is very easy to use, fast, objective and very accurate when counting dividing cells and glial cells labelled with a nuclear marker. Although this method has been validated for Drosophila embryos, we provide an interactive window for biologists to easily extend its application to other nuclear markers and other sample types. DeadEasy MitoGlia is freely available as an ImageJ plug-in, it increases the repertoire of tools for in vivo genetic analysis, and it will be of interest to a broad community of developmental, cancer and neuro-biologists.	[Forero, Manuel Guillermo; Learte, Anabel R.; Cartwright, Stephanie; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Neurodev Grp, Birmingham, W Midlands, England	University of Birmingham	Forero, MG (corresponding author), Univ Birmingham, Sch Biosci, Neurodev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	Wellcome Trust [073228/Z/03/Z]; EMBO YIP; MRC; Biotechnology and Biological Sciences Research Council [BB/H002278/1] Funding Source: researchfish; BBSRC [BB/H002278/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO YIP(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Wellcome Trust Equipment Grant 073228/Z/03/Z and EMBO YIP to A. H. and MRC studentship to A. R. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIGA PSU, 2000, MICRON, P363; ANGARITAJAIMES NC, 2009, CYTOM PART A, P768; Can A, 2003, J MICROSC-OXFORD, V211, P67, DOI 10.1046/j.1365-2818.2003.01195.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CONCHELLO JA, 1995, P 1995 IS T SPIE S E, P138; DIMA A, 2002, IEEE T IM PROC, P790; Falcao AX, 2004, IEEE T PATTERN ANAL, V26, P19, DOI 10.1109/TPAMI.2004.1261076; FORERO MG, 2010, CYTOMETRY A; FORERO MG, 2009, PLOS ONE PUBLIC LIB; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; Guan YQ, 2008, MICROSC RES TECHNIQ, V71, P146, DOI 10.1002/jemt.20536; GUE M, 2005, CYTOMETRY, P18; Harder N, 2007, I S BIOMED IMAGING, P1044, DOI 10.1109/ISBI.2007.357034; Harder N., 2008, WORKSH BIOIM INF BIO; Kervrann C, 2004, J MICROSC-OXFORD, V214, P297, DOI 10.1111/j.0022-2720.2004.01333.x; Li L, 2000, GENE DEV, V14, P147; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; RODENACKER K, 2001, IMAGE ANAL STEREOL, P556; ROERDINK JBT, 1993, J MICROSCOPY; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; VINCENT L, 1992, P SPIE IMAGE ALGEBRA, V3; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wahlby C, 2002, ANAL CELL PATHOL, V24, P101; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wahlby C., 2003, ALGORITHMS APPL DIGI; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10557	10.1371/journal.pone.0010557	http://dx.doi.org/10.1371/journal.pone.0010557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479944	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467900013
J	Collett, GP; Linton, EA; Redman, CWG; Sargent, IL				Collett, Gavin P.; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.			Downregulation of Caveolin-1 Enhances Fusion of Human BeWo Choriocarcinoma Cells	PLOS ONE			English	Article							SYNCYTIAL FUSION; MYOBLAST FUSION; KINASE-ACTIVITY; HUMAN PLACENTA; CANCER CELLS; TROPHOBLAST; DIFFERENTIATION; AKT; EXPRESSION; RECEPTOR	Background: Fusion of placental villous cytotrophoblasts with the overlying syncytiotrophoblast is essential for the maintenance of successful pregnancy, and disturbances in this process have been implicated in pathological conditions such as pre-eclampsia and intra-uterine growth retardation. Caveolin-1 has been shown to be expressed in human villous cytotrophoblast and to be downregulated during fusion into syncytiotrophoblast but it is unclear whether it plays a role in this process. Methodology/Principal Findings: We used RNA interference to determine whether caveolin-1 plays a role in differentiation and fusion in the BeWo choriocarcinoma cell line, a model of villous cytotrophoblast fusion. Assessment of cell fusion by desmosomal protein immunostaining revealed that cells transfected with caveolin-1 siRNA showed significantly enhanced fusion in response to treatment with dibutyryl cyclic AMP compared with cells transfected with a non-silencing control. Furthermore, caveolin-1 knockdown alone was sufficient to promote spontaneous fusion. In addition, biochemical differentiation, assessed by expression of placental alkaline phosphatase, was upregulated in caveolin-1 siRNA-transfected cells, with or without dbcAMP treatment. Assessment of Akt phosphorylation showed that caveolin-1 knockdown resulted in a significant reduction in phosphorylation at Thr(308). Conclusions/Significance: Taken together, these results suggest that caveolin-1 regulates BeWo cell differentiation and fusion, possibly through a mechanism involving modulation of Akt activity.	[Collett, Gavin P.; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Collett, GP (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Gavin.Collett@obs-gyn.ox.ac.uk			Wellcome Trust [GR079862MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant no. GR079862MA (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Byrne S, 2007, IMMUNOBIOLOGY, V212, P39, DOI 10.1016/j.imbio.2006.09.002; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; DOUGLAS GC, 1990, J CELL SCI, V96, P131; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Leitner K, 2001, J HISTOCHEM CYTOCHEM, V49, P1155, DOI 10.1177/002215540104900909; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li WP, 2001, J CELL SCI, V114, P1397; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; Linton EA, 2003, PLACENTA, V24, P745, DOI 10.1016/S0143-4004(03)00106-1; Lyden TW, 2002, PLACENTA, V23, P640, DOI 10.1053/plac.2002.0847; Mayhew TM, 2009, PLACENTA, V30, P565, DOI 10.1016/j.placenta.2009.04.013; MIDGLEY AR, 1963, SCIENCE, V141, P349, DOI 10.1126/science.141.3578.349; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Rote NS, 2004, PLACENTA, V25, P673, DOI 10.1016/j.placenta.2004.02.008; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Xu WP, 2003, CANCER RES, V63, P7777; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006	43	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10529	10.1371/journal.pone.0010529	http://dx.doi.org/10.1371/journal.pone.0010529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463894	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379800016
J	Valladares, R; Sankar, D; Li, N; Williams, E; Lai, KK; Abdelgeliel, AS; Gonzalez, CF; Wasserfall, CH; Larkin, J; Schatz, D; Atkinson, MA; Triplett, EW; Neu, J; Lorca, GL				Valladares, Ricardo; Sankar, Dhyana; Li, Nan; Williams, Emily; Lai, Kin-Kwan; Abdelgeliel, Asmaa Sayed; Gonzalez, Claudio F.; Wasserfall, Clive H.; Larkin, Joseph, III; Schatz, Desmond; Atkinson, Mark A.; Triplett, Eric W.; Neu, Josef; Lorca, Graciela L.			Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats	PLOS ONE			English	Article							TREATMENT PARTIALLY PROTECTS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; COMMENSAL BACTERIA; IFN-GAMMA; PRONE RAT; EXPRESSION; GUT; TRANSCRIPTION; CYCLOOXYGENASE-2	Background: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri isolated from diabetes resistant rats to determine the effect on type 1 diabetes development. Methodology/Principal: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1 diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L. johnsonii fed animals low levels of the pro-inflammatory cytokine IFN gamma were correlated with low levels of iNOS and high levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin. Conclusions: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder.	[Valladares, Ricardo; Williams, Emily; Lai, Kin-Kwan; Abdelgeliel, Asmaa Sayed; Gonzalez, Claudio F.; Larkin, Joseph, III; Triplett, Eric W.; Lorca, Graciela L.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Sankar, Dhyana; Li, Nan; Schatz, Desmond; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL USA; [Wasserfall, Clive H.; Atkinson, Mark A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Valladares, R (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	glorca@ufl.edu	Wasserfall, Clive/ABF-9385-2020; Neu, Josef/AAI-2799-2020; wasserfall, clive/J-9078-2012	Wasserfall, Clive/0000-0002-3522-8932; wasserfall, clive/0000-0002-3522-8932; McMackin, Emily/0000-0003-4570-1743; Larkin, Joseph/0000-0003-2066-6814	Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL)	Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL)(University of Florida)	These studies were supported, in part, by funds from The Brehm Coalition for Type 1 Diabetes Research and Research Innovation Award, Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Belley A, 1999, AM J TROP MED HYG, V60, P10, DOI 10.4269/ajtmh.1999.60.10; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caicedo RA, 2008, PEDIATR RES, V63, P303, DOI 10.1203/PDR.0b013e31815ed662; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Charoenphandhu N, 2007, LIFE SCI, V80, P1729, DOI 10.1016/j.lfs.2007.01.063; Corbett JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1581, DOI 10.1152/ajpcell.1996.270.6.C1581; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; ELLIOTT RB, 1984, DIABETOLOGIA, V26, P297, DOI 10.1007/BF00283653; Gilroy DW, 2000, J MOL MED-JMM, V78, P121, DOI 10.1007/s001090000094; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Gye MC, 2003, INT J ANDROL, V26, P271, DOI 10.1046/j.1365-2605.2003.00423.x; Jiang WL, 2009, J CEREBR BLOOD F MET, V29, P944, DOI 10.1038/jcbfm.2009.18; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kato Y, 2004, FREE RADICAL BIO MED, V37, P1864, DOI 10.1016/j.freeradbiomed.2004.09.007; Klampfer L, 2007, ONCOGENE, V26, P2071, DOI 10.1038/sj.onc.1210015; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; Lai KK, 2009, APPL ENVIRON MICROB, V75, P5018, DOI 10.1128/AEM.02837-08; Luo C, 2002, CELL TISSUE RES, V310, P169, DOI 10.1007/s00441-002-0628-6; Luo C, 2002, ACTA PHYSIOL SCAND, V174, P265, DOI 10.1046/j.1365-201x.2002.00941.x; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Mehta JL, 2006, INT J BIOCHEM CELL B, V38, P794, DOI 10.1016/j.biocel.2005.12.008; Mendez II, 2004, J IMMUNOL, V173, P1327, DOI 10.4049/jimmunol.173.2.1327; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161; Robertson RP, 2006, FREE RADICAL BIO MED, V41, P177, DOI 10.1016/j.freeradbiomed.2005.04.030; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schwartz RF, 2007, DIABETOLOGIA, V50, P220, DOI 10.1007/s00125-006-0526-7; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tam NNC, 2003, AM J PATHOL, V163, P2513, DOI 10.1016/S0002-9440(10)63606-1; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Turler A, 2002, ANN SURG, V236, P56, DOI 10.1097/01.SLA.0000018561.52595.31; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Visser J, 2003, METABOLISM, V52, P333, DOI 10.1053/meta.2003.50052; Visser J, 2009, DIABETOLOGIA, V52, P1445, DOI 10.1007/s00125-009-1370-3; Yan F, 2004, CURR OPIN GASTROEN, V20, P565, DOI 10.1097/00001574-200411000-00011; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	44	178	197	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10507	10.1371/journal.pone.0010507	http://dx.doi.org/10.1371/journal.pone.0010507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463897	gold, Green Submitted, Green Published			2022-12-27	WOS:000277379800003
J	Murphy, HA; Zeyl, CW				Murphy, Helen A.; Zeyl, Clifford W.			Yeast Sex: Surprisingly High Rates of Outcrossing between Asci	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REPRODUCTIVE ISOLATION; POPULATION-STRUCTURE; PARADOXUS; EVOLUTION; GENOMICS	Background: Saccharomyces yeasts are an important model system in many areas of biological research. Very little is known about their ecology and evolution in the wild, but interest in this natural history is growing. Extensive work with lab strains in the last century uncovered the Saccharomyces life cycle. When nutrient limited, a diploid yeast cell will form four haploid spores encased in a protective outer layer called the ascus. Confinement within the ascus is thought to enforce mating between products of the same meiotic division, minimizing outcrossing in this stage of the life cycle. Methodology/Principal Findings: Using a set of S. cerevisiae and S. paradoxus strains isolated from woodlands in North America, we set up trials in which pairs of asci were placed in contact with one another and allowed to germinate. We observed outcrossing in,40% of the trials, and multiple outcrossing events in trials with three asci in contact with each other. When entire populations of densely crowded asci germinated, similar to 10-25% of the resulting colonies were outcrossed. There were differences between the species with S. cerevisiae having an increased tendency to outcross in mass mating conditions. Conclusions/Significance: Our results highlight the potential for random mating between spores in natural strains, even in the presence of asci. If this type of mating does occur in nature and it is between close relatives, then a great deal of mating behavior may be undetectable from genome sequences.	[Murphy, Helen A.; Zeyl, Clifford W.] Wake Forest Univ, Winston Salem, NC 27109 USA	Wake Forest University	Murphy, HA (corresponding author), Wake Forest Univ, Winston Salem, NC 27109 USA.	murphyha@wfu.edu		Murphy, Helen/0000-0002-4363-4543	National Science Foundation [0820969, 0542738]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant# 0820969 awarded to CWZ and National Science Foundation Grant# 0542738 awarded to HAM and CZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BEVAN EA, 1964, MICROBIAL GENETICS B, V21, P5; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GUILLIERMOND A, 1920, YEASTS; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; Joseph-Strauss D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r241; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; LACHANCE MA, 1995, J IND MICROBIOL, V14, P484, DOI 10.1007/BF01573963; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Maclean CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-1; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Murphy HA, 2006, BIOL LETT-UK, V2, P553, DOI 10.1098/rsbl.2006.0534; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; PHAFF H J, 1956, Antonie Van Leeuwenhoek, V22, P117, DOI 10.1007/BF02538319; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Rose MD., 1990, METHODS YEAST GENETI; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Taxis C, 2005, J CELL BIOL, V171, P627, DOI 10.1083/jcb.200507168; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zakharov I. A., 2005, Genetika, V41, P508	32	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10461	10.1371/journal.pone.0010461	http://dx.doi.org/10.1371/journal.pone.0010461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463964	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400013
J	Sethu, S; Pushparaj, PN; Melendez, AJ				Sethu, Swaminathan; Pushparaj, Peter N.; Melendez, Alirio J.			Phospholipase D1 Mediates TNF alpha-Induced Inflammation in a Murine Model of TNF alpha-Induced Peritonitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SERUM INTERLEUKIN-6; PHOSPHATIDIC-ACID; SIGNAL-TRANSDUCTION; HUMAN-DISEASES; KEY ROLE; ACTIVATION; RECEPTOR; GAMMA; IL-6	Background: Tumor Necrosis Factor alpha (TNF alpha) is a pleiotropic cytokine extensively studied for its role in the pathogenesis of a variety of disease conditions, including in inflammatory diseases. We have recently shown that, in vitro, that TNF alpha utilizes PLD1 to mediate the activation of NF kappa B and ERK1/2 in human monocytes. The aim of this study was to investigate the role(s) played by phospholipase D1 (PLD1) in TNF alpha-mediated inflammatory responses in vivo. Methodology/Findings: Studies were performed in vivo using a mouse model of TNF alpha-induced peritonitis. The role of PLD1 was investigated by functional genomics, utilizing a specific siRNA to silence the expression of PLD1. Administration of the siRNA against PLD1 significantly reduced PLD1 levels in vivo. TNF alpha triggers a rapid pyrogenic response, but the in vivo silencing of PLD1 protects mice from the TNFa-induced rise in temperature. Similarly TNF alpha caused an increase in the serum levels of IL-6, MIP-1 alpha and MIP-1 beta: this increase in cytokine/chemokine levels was inhibited in mice where PLD1 had been silenced. We then induced acute peritonitis with TNF alpha. Intraperitoneal injection of TNFa triggered a rapid increase in vascular permeability, and the influx of neutrophils and monocytes into the peritoneal cavity. By contrast, in mice where PLD1 had been silenced, the TNF alpha-triggered increase in vascular permeability and phagocyte influx was substantially reduced. Furthermore, we also show that the TNF alpha-mediated upregulation of the cell adhesion molecules VCAM and ICAM1, in the vascular endothelium, were dependent on PLD1. Conclusions: These novel data demonstrate a critical role for PLD1 in TNF alpha-induced inflammation in vivo and warrant further investigation. Indeed, our results suggest PLD1 as a novel target for treating inflammatory diseases, where TNF alpha play key roles: these include diseases ranging from sepsis to respiratory and autoimmune diseases; all diseases with considerable unmet medical need.	[Sethu, Swaminathan] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Pushparaj, Peter N.; Melendez, Alirio J.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	National University of Singapore; University of Glasgow	Sethu, S (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	a.melendez-romero@clinmed.gla.ac.uk	Sethu, Swaminathan/R-8577-2019; Pushparaj, Peter Natesan/H-9871-2012	Pushparaj, Peter Natesan/0000-0001-7574-1880; Sethu, Swaminathan/0000-0001-9210-2554	Medical Research Council UK [MRC G0700794]; Biomedical Research Council of Singapore [BMRC 06/1/21/19/444]; Medical Research Council [G0700794] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from: the Medical Research Council UK, grant number: MRC G0700794, MRC web site (http://www.mrc.ac.uk/index.htm); and from the Biomedical Research Council of Singapore, grant number BMRC 06/1/21/19/444 BMRC web site ( http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Cadwallader KA, 2004, EUR J BIOCHEM, V271, P2755, DOI 10.1111/j.1432-1033.2004.04204.x; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dana RR, 2000, J BIOL CHEM, V275, P32566, DOI 10.1074/jbc.M005406200; DeVries ME, 1999, SEMIN IMMUNOL, V11, P95, DOI 10.1006/smim.1999.0165; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Gewirtz AT, 1997, J LEUKOCYTE BIOL, V61, P522, DOI 10.1002/jlb.61.4.522; Grisius MM, 1997, J RHEUMATOL, V24, P1089; Hamdi SM, 2008, BBA-MOL CELL BIOL L, V1781, P263, DOI 10.1016/j.bbalip.2008.03.005; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hehlgans T, 2002, BIOL CHEM, V383, P1581, DOI 10.1515/BC.2002.178; Heller M, 1978, Adv Lipid Res, V16, P267; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HOLTKAMP W, 1995, J CLIN GASTROENTEROL, V20, P123, DOI 10.1097/00004836-199503000-00010; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kim H, 2007, CELL BIOL INT, V31, P148, DOI 10.1016/j.cellbi.2006.09.020; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Locati M, 2001, BIOCHEM J, V358, P119, DOI 10.1042/0264-6021:3580119; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Matsumoto K, 1999, CLIN EXP IMMUNOL, V117, P361, DOI 10.1046/j.1365-2249.1999.00975.x; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Melendez AJ, 2001, BLOOD, V98, P3421, DOI 10.1182/blood.V98.12.3421; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Morgan CP, 1997, BIOCHEM J, V325, P581, DOI 10.1042/bj3250581; Murdoch C, 2000, BLOOD, V95, P3032; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; Sethu S, 2008, J IMMUNOL, V180, P6027, DOI 10.4049/jimmunol.180.9.6027; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Singh N, 2006, NAT METHODS, V3, P629, DOI 10.1038/nmeth903; STUART RA, 1995, CLIN EXP RHEUMATOL, V13, P17; Sundgren-Andersson AK, 1998, AM J PHYSIOL-REG I, V275, pR2028, DOI 10.1152/ajpregu.1998.275.6.R2028; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; UR RA, 1999, CURR PHARM DESIGN, V5, P241; vanHensbroek MB, 1996, J INFECT DIS, V174, P1091, DOI 10.1093/infdis/174.5.1091; Wallis RS, 2005, CLIN INFECT DIS, V41, pS194, DOI 10.1086/429996; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; YANG SF, 1967, J BIOL CHEM, V242, P477; ZANETTI G, 1992, J IMMUNOL, V148, P1890	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10506	10.1371/journal.pone.0010506	http://dx.doi.org/10.1371/journal.pone.0010506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463923	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000277379400037
J	Shemon, AN; Heil, GL; Granovsky, AE; Clark, MM; McElheny, D; Chimon, A; Rosner, MR; Koide, S				Shemon, Anne N.; Heil, Gary L.; Granovsky, Alexey E.; Clark, Mathew M.; McElheny, Dan; Chimon, Alexander; Rosner, Marsha R.; Koide, Shohei			Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BOVINE BRAIN; SPERMATOZOA; EXPRESSION; SUGGESTS; SEQUENCE; ROLES; CELLS; RNA	Background: Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We have previously demonstrated that RKIP/Raf interaction is regulated by two mechanisms: phosphorylation of RKIP at Ser-153, and occupation of RKIP's conserved ligand binding domain with a phospholipid (2-dihexanoyl-sn-glycero-3-phosphoethanolamine; DHPE). In addition to phospholipids, other ligands have been reported to bind this domain; however their binding properties remain uncharacterized. Methods/Findings: In this study, we used high-resolution heteronuclear NMR spectroscopy to screen a chemical library and assay a number of potential RKIP ligands for binding to the protein. Surprisingly, many compounds previously postulated as RKIP ligands showed no detectable binding in near-physiological solution conditions even at millimolar concentrations. In contrast, we found three novel ligands for RKIP that specifically bind to the RKIP pocket. Interestingly, unlike the phospholipid, DHPE, these newly identified ligands did not affect RKIP binding to Raf-1 or RKIP phosphorylation. One out of the three ligands displayed off target biological effects, impairing EGF-induced MAPK and metabolic activity. Conclusions/Significance: This work defines the binding properties of RKIP ligands under near physiological conditions, establishing RKIP's affinity for hydrophobic ligands and the importance of bulky aliphatic chains for inhibiting its function. The common structural elements of these compounds defines a minimal requirement for RKIP binding and thus they can be used as lead compounds for future design of RKIP ligands with therapeutic potential.	[Shemon, Anne N.; Granovsky, Alexey E.; Clark, Mathew M.; Chimon, Alexander; Rosner, Marsha R.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Clark, Mathew M.; Rosner, Marsha R.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Heil, Gary L.; McElheny, Dan; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Shemon, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	m-rosner@uchicago.edu	Alex, Granovsky/EUV-7323-2022	Koide, Shohei/0000-0001-5473-4358	National Institutes of Health (NIH) [GM087630, CA112310]; Medical Research Council Australia (NHMRC); NATIONAL CANCER INSTITUTE [R01CA112310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087630] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM087630 and CA112310 (to M. R. R.) and the Medical Research Council Australia (NHMRC) CJ Martin Fellowship (to A.N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; BERNIER I, 1986, BIOCHIM BIOPHYS ACTA, V871, P19, DOI 10.1016/0167-4838(86)90128-7; BERNIER I, 1984, BIOCHIM BIOPHYS ACTA, V790, P174, DOI 10.1016/0167-4838(84)90221-8; BOLLENGIER F, 1988, J NEUROCHEM, V50, P1210, DOI 10.1111/j.1471-4159.1988.tb10594.x; Clark MC, 2006, J BIOMOL NMR, V36, P4, DOI 10.1007/s10858-005-4424-y; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; CORNWALL GA, 1990, BIOL REPROD, V43, P121, DOI 10.1095/biolreprod43.1.121; Creighton T. E., 1993, PROTEINS STRUCTURES; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Marsh D., 1990, CRC HDB LIPID BILAYE; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; PERRY ACF, 1994, BIOCHEM J, V301, P235, DOI 10.1042/bj3010235; SCHOENTGEN F, 1995, FEBS LETT, V369, P22, DOI 10.1016/0014-5793(95)00376-K; SEDDIQI N, 1994, J MOL EVOL, V39, P655, DOI 10.1007/BF00160411; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Vallee BS, 2001, EUR J BIOCHEM, V268, P5831, DOI 10.1046/j.0014-2956.2001.02528.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	36	18	23	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10479	10.1371/journal.pone.0010479	http://dx.doi.org/10.1371/journal.pone.0010479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463977	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400015
J	Cinquin, P; Gondran, C; Giroud, F; Mazabrard, S; Pellissier, A; Boucher, F; Alcaraz, JP; Gorgy, K; Lenouvel, F; Mathe, S; Porcu, P; Cosnier, S				Cinquin, Philippe; Gondran, Chantal; Giroud, Fabien; Mazabrard, Simon; Pellissier, Aymeric; Boucher, Francois; Alcaraz, Jean-Pierre; Gorgy, Karine; Lenouvel, Francois; Mathe, Stephane; Porcu, Paolo; Cosnier, Serge			A Glucose BioFuel Cell Implanted in Rats	PLOS ONE			English	Article							OXIDASE	Powering future generations of implanted medical devices will require cumbersome transcutaneous energy transfer or harvesting energy from the human body. No functional solution that harvests power from the body is currently available, despite attempts to use the Seebeck thermoelectric effect, vibrations or body movements. Glucose fuel cells appear more promising, since they produce electrical energy from glucose and dioxygen, two substrates present in physiological fluids. The most powerful ones, Glucose BioFuel Cells (GBFCs), are based on enzymes electrically wired by redox mediators. However, GBFCs cannot be implanted in animals, mainly because the enzymes they rely on either require low pH or are inhibited by chloride or urate anions, present in the Extra Cellular Fluid (ECF). Here we present the first functional implantable GBFC, working in the retroperitoneal space of freely moving rats. The breakthrough relies on the design of a new family of GBFCs, characterized by an innovative and simple mechanical confinement of various enzymes and redox mediators: enzymes are no longer covalently bound to the surface of the electron collectors, which enables use of a wide variety of enzymes and redox mediators, augments the quantity of active enzymes, and simplifies GBFC construction. Our most efficient GBFC was based on composite graphite discs containing glucose oxidase and ubiquinone at the anode, polyphenol oxidase (PPO) and quinone at the cathode. PPO reduces dioxygen into water, at pH 7 and in the presence of chloride ions and urates at physiological concentrations. This GBFC, with electrodes of 0.133 mL, produced a peak specific power of 24.4 mu W mL(-1), which is better than pacemakers' requirements and paves the way for the development of a new generation of implantable artificial organs, covering a wide range of medical applications.	[Cinquin, Philippe; Boucher, Francois; Alcaraz, Jean-Pierre; Lenouvel, Francois; Porcu, Paolo] Univ Grenoble 1, CNRS, Lab TIMC IMAG, Grenoble, France; [Gondran, Chantal; Giroud, Fabien; Mazabrard, Simon; Pellissier, Aymeric; Gorgy, Karine; Cosnier, Serge] Univ Grenoble 1, CNRS, DCM, Grenoble, France; [Mathe, Stephane] Univ Toulouse 3, Lab Ingn Syst Biol & Procedes, CNRS, Inst Sci Appl Toulouse, F-31062 Toulouse, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier	Cinquin, P (corresponding author), Univ Grenoble 1, CNRS, Lab TIMC IMAG, Grenoble, France.	Philippe.Cinquin@imag.fr; serge.cosnier@ujf-grenoble.fr	Milton, Ross D/J-7164-2012; Cinquin, Philippe/M-5576-2014; ALCARAZ, jean-pierre/M-6821-2014; Ferreira, Fernanda/D-3963-2012; Boucher, François R/M-5937-2014; Cosnier, Serge/M-7712-2013; Cosnier, Serge/AAR-5671-2020	Cinquin, Philippe/0000-0002-2700-1447; ALCARAZ, jean-pierre/0000-0002-5924-9519; Cosnier, Serge/0000-0002-8290-4374; Gondran, Chantal/0000-0003-1021-6748	Universite Joseph Fourier (UJF); Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR); Rhone-Alpes Region EMERGENCE program	Universite Joseph Fourier (UJF); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Rhone-Alpes Region EMERGENCE program(Region Auvergne-Rhone-Alpes)	All co-workers are funded by Universite Joseph Fourier (UJF) and by Centre National de la Recherche Scientifique (CNRS). Part of this project was funded by Agence Nationale de la Recherche (ANR), by a Rhone-Alpes Region EMERGENCE program, and by UJF's subsidiary, Floralis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov P, 2007, ELECTROCHEM SOC INTE, V16, P28; Barriere F, 2006, ELECTROCHIM ACTA, V51, P5187, DOI 10.1016/j.electacta.2006.03.050; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; Coman V, 2008, PHYS CHEM CHEM PHYS, V10, P6093, DOI 10.1039/b808859d; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Davenport A, 2007, LANCET, V370, P2005, DOI 10.1016/S0140-6736(07)61864-9; Deng L, 2008, BIOSENS BIOELECTRON, V24, P329, DOI 10.1016/j.bios.2008.04.006; Dowling RD, 2003, ANN THORAC SURG, V75, pS93, DOI 10.1016/S0003-4975(03)00484-3; DRAKE RF, 1970, T AM SOC ART INT ORG, V16, P199; Habrioux A, 2008, J ELECTROANAL CHEM, V622, P97, DOI 10.1016/j.jelechem.2008.05.011; Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a; KANG JY, 2006, ENCY MED DEVICES INS, P428; Kerzenmacher S, 2008, J POWER SOURCES, V182, P1, DOI 10.1016/j.jpowsour.2008.03.031; Kim SP, 2008, J UROLOGY, V179, P1912, DOI 10.1016/j.juro.2008.01.048; LAMRAOUI H, 2008, DESIGN IMPLEMENTATIO; Liu Y, 2007, ELECTROCHEM COMMUN, V9, P1423, DOI 10.1016/j.elecom.2007.01.055; Mano N, 2008, CHEM COMMUN, P2221, DOI 10.1039/b801786g; Minteer SD, 2007, CURR OPIN BIOTECH, V18, P228, DOI 10.1016/j.copbio.2007.03.007; Ohm OJ, 1997, PACE, V20, P2, DOI 10.1111/j.1540-8159.1997.tb04805.x; SAKAI H, 2009, ENERGY ENV IN PRESS; Shin H, 2007, ELECTROANAL, V19, P638, DOI 10.1002/elan.200603795; Soukharev V, 2004, J AM CHEM SOC, V126, P8368, DOI 10.1021/ja0475510; Togo M, 2008, J POWER SOURCES, V178, P53, DOI 10.1016/j.jpowsour.2007.12.052; Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f; Zayats M, 2008, ELECTROANAL, V20, P583, DOI 10.1002/elan.200704128	25	291	296	3	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10476	10.1371/journal.pone.0010476	http://dx.doi.org/10.1371/journal.pone.0010476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454563	Green Published, gold, Green Submitted			2022-12-27	WOS:000277305300011
J	Lyadova, IV; Tsiganov, EN; Kapina, MA; Shepelkova, GS; Sosunov, VV; Radaeva, TV; Majorov, KB; Shmitova, NS; van den Ham, HJ; Ganusov, VV; De Boer, RJ; Racine, R; Winslow, GM				Lyadova, Irina V.; Tsiganov, Evgeny N.; Kapina, Marina A.; Shepelkova, Galena S.; Sosunov, Vasily V.; Radaeva, Tatiana V.; Majorov, Konstantin B.; Shmitova, Natalya S.; van den Ham, Henk-Jan; Ganusov, Vitaly V.; De Boer, Rob J.; Racine, Rachael; Winslow, Gary M.			In Mice, Tuberculosis Progression Is Associated with Intensive Inflammatory Response and the Accumulation of Gr-1(dim) Cells in the Lungs	PLOS ONE			English	Article							VIRULENT MYCOBACTERIUM-TUBERCULOSIS; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; HOST IMMUNE-RESPONSE; NITRIC-OXIDE; T-LYMPHOCYTES; SUSCEPTIBILITY; INTERLEUKIN-11; INFECTION; RECEPTOR	Background: Infection with Mycobacterium tuberculosis (Mtb) results in different clinical outcomes ranging from asymptomatic containment to rapidly progressing tuberculosis (TB). The mechanisms controlling TB progression in immunologically-competent hosts remain unclear. Methodology/Principal Findings: To address these mechanisms, we analyzed TB progression in a panel of genetically heterogeneous (A/SnxI/St) F2 mice, originating from TB-highly-susceptible I/St and more resistant A/Sn mice. In F2 mice the rates of TB progression differed. In mice that did not reach terminal stage of infection, TB progression did not correlate with lung Mtb loads. Nor was TB progression correlated with lung expression of factors involved in antibacterial immunity, such as iNOS, IFN-gamma, or IL-12p40. The major characteristics of progressing TB was high lung expression of the inflammation-related factors IL-1 beta, IL-6, IL-11 (p < 0.0003); CCL3, CCL4, CXCL2 (p, 0.002); MMP-8 (p < 0.0001). The major predictors of TB progression were high expressions of IL-1b and IL-11. TNF-alpha had both protective and harmful effects. Factors associated with TB progression were expressed mainly by macrophages (F4-80(+) cells) and granulocytes (Gr-1(hi)/Ly-6G(hi) cells). Macrophages and granulocytes from I/St and A/Sn parental strains exhibited intrinsic differences in the expression of inflammatory factors, suggesting that genetically determined peculiarities of phagocytes transcriptional response could account for the peculiarities of gene expression in the infected lungs. Another characteristic feature of progressing TB was the accumulation in the infected lungs of Gr-1(dim) cells that could contribute to TB progression. Conclusions/Significance: In a population of immunocompetent hosts, the outcome of TB depends on quantitatively-and genetically-controlled differences in the intensity of inflammatory responses, rather than being a direct consequence of mycobacterial colonization. Local accumulation of Gr-1(dim) cells is a newly identified feature of progressing TB. High expression of IL-1 beta and IL-11 are potential risk factors for TB progression and possible targets for TB immunomodulation.	[Lyadova, Irina V.; Tsiganov, Evgeny N.; Kapina, Marina A.; Shepelkova, Galena S.; Sosunov, Vasily V.; Radaeva, Tatiana V.; Majorov, Konstantin B.; Shmitova, Natalya S.] Russian Acad Med Sci, Dept Immunol, Cent TB Res Inst, Moscow, Russia; [van den Ham, Henk-Jan; Ganusov, Vitaly V.; De Boer, Rob J.] Univ Utrecht, Dept Theoret Biol & Bioinformat, Utrecht, Netherlands; [Racine, Rachael; Winslow, Gary M.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Ganusov, Vitaly V.] Russian Acad Sci, Siberian Branch, Dept Postgrad Studies, Inst Biophys, Krasnoyarsk, Russia	Russian Academy of Medical Sciences; Utrecht University; State University of New York (SUNY) System; Wadsworth Center; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences	Lyadova, IV (corresponding author), Russian Acad Med Sci, Dept Immunol, Cent TB Res Inst, Moscow, Russia.	ivlyadova@mail.ru	Shepelkova, Galina/F-3059-2017; Lyadova, Irina V/T-7806-2017; van den Ham, HJ/ABF-1071-2021; Majorov, Konstantin Borisovich/AIE-6667-2022; de Boer, Rob/B-6050-2011	Shepelkova, Galina/0000-0001-6854-7932; Lyadova, Irina V/0000-0003-3147-5386; de Boer, Rob/0000-0002-2130-691X; Ganusov, Vitaly/0000-0001-6572-1691; van den Ham, Henk-Jan/0000-0001-8582-5404	National Institutes of Health [1RO1AI078899]; United States Civilian Research and Development Foundation [RUB1-2706-MO-05]; Russian Foundation [07-04-01094]; Marie Curie Incoming International Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Civilian Research and Development Foundation; Russian Foundation(Russian Foundation for Basic Research (RFBR)); Marie Curie Incoming International Fellowship(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant # 1RO1AI078899 (to IL), www.nih.gov; United States Civilian Research and Development Foundation grant # RUB1-2706-MO-05 (to GW and IL), www.crdf.org; Russian Foundation for Basic Research grant # 07-04-01094 (to IL), www.rfbr.ru; Marie Curie Incoming International Fellowship (to VG), http://cordis.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Bellamy RJ, 1998, NOVART FDN SYMP, V217, P3, DOI 10.1002/0470846526.ch2; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAIRO MS, 1994, EXP HEMATOL, V22, P1118; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Chen QS, 2005, J IMMUNOL, V174, P2305, DOI 10.4049/jimmunol.174.4.2305; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Curti A, 2001, BLOOD, V97, P2758, DOI 10.1182/blood.V97.9.2758; Dietrich WF, 2001, GENOME RES, V11, P325, DOI 10.1101/gr.173101; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; HESTDAL K, 1991, J IMMUNOL, V147, P22; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lavebratt C, 1999, J INFECT DIS, V180, P150, DOI 10.1086/314843; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lgssiar A, 2004, EXP BIOL MED, V229, P425, DOI 10.1177/153537020422900511; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003; Mitsos LM, 2003, P NATL ACAD SCI USA, V100, P6610, DOI 10.1073/pnas.1031727100; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Orlova MO, 2006, INFECT IMMUN, V74, P3668, DOI 10.1128/IAI.00196-06; Palmqvist P, 2008, J DENT RES, V87, P558, DOI 10.1177/154405910808700614; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Sanchez F, 2003, INFECT IMMUN, V71, P126, DOI 10.1128/IAI.71.1.126-131.2003; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Schwertschlag US, 1999, LEUKEMIA, V13, P1307, DOI 10.1038/sj.leu.2401514; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; White CA, 2007, J REPROD IMMUNOL, V73, P28, DOI 10.1016/j.jri.2006.05.003; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919	52	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10469	10.1371/journal.pone.0010469	http://dx.doi.org/10.1371/journal.pone.0010469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454613	gold, Green Submitted, Green Published			2022-12-27	WOS:000277305300009
J	Blas, MM; Alva, IE; Carcamo, CP; Cabello, R; Goodreau, SM; Kimball, AM; Kurth, AE				Blas, Magaly M.; Alva, Isaac E.; Carcamo, Cesar P.; Cabello, Robinson; Goodreau, Steven M.; Kimball, Ann M.; Kurth, Ann E.			Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex with Men in Peru	PLOS ONE			English	Article							PREVENTION; INTERNET; REASONS; TRIAL	Background: Although many men who have sex with men (MSM) in Peru are unaware of their HIV status, they are frequent users of the Internet, and can be approached by that medium for promotion of HIV testing. Methods: We conducted an online randomized controlled trial to compare the effect of HIV-testing motivational videos versus standard public health text, both offered through a gay website. The videos were customized for two audiences based on self-identification: either gay or non-gay men. The outcomes evaluated were 'intention to get tested' and 'HIV testing at the clinic.' Findings: In the non-gay identified group, 97 men were randomly assigned to the video-based intervention and 90 to the text-based intervention. Non-gay identified participants randomized to the video-based intervention were more likely to report their intention of getting tested for HIV within the next 30 days (62.5% vs. 15.4%, Relative Risk (RR): 2.77, 95% Confidence Interval (CI): 1.42-5.39). After a mean of 125.5 days of observation (range 42-209 days), 11 participants randomized to the video and none of the participants randomized to text attended our clinic requesting HIV testing (p = 0.001). In the gay-identified group, 142 men were randomized to the video-based intervention and 130 to the text-based intervention. Gay-identified participants randomized to the video were more likely to report intentions of getting an HIV test within 30 days, although not significantly (50% vs. 21.6%, RR: 1.54, 95% CI: 0.74-3.20). At the end of follow up, 8 participants who watched the video and 10 who read the text visited our clinic for HIV testing (Hazard Ratio: 1.07, 95% CI: 0.40-2.85). Conclusion: This study provides some evidence of the efficacy of a video-based online intervention in improving HIV testing among non-gay-identified MSM in Peru. This intervention may be adopted by institutions with websites oriented to motivate HIV testing among similar MSM populations.	[Blas, Magaly M.; Alva, Isaac E.; Carcamo, Cesar P.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Unit Epidemiol HIV & STD, Lima, Peru; [Blas, Magaly M.; Kimball, Ann M.; Kurth, Ann E.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Blas, Magaly M.; Alva, Isaac E.; Cabello, Robinson] NGO Via Libre, Lima, Peru; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Kurth, Ann E.] Univ Washington, Sch Publ Hlth & Community Med, Dept Global Hlth, Seattle, WA 98195 USA; [Kurth, Ann E.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Unit Epidemiol HIV & STD, Lima, Peru.	blasmag@u.washington.edu	Goodreau, Steven/P-2366-2017; Kurth, Ann E/A-1615-2013	Goodreau, Steven/0000-0003-1009-5763	University of Washington; Fogarty International Center/NIH [D43TW007551]; NGO Via Libre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007551] Funding Source: NIH RePORTER	University of Washington(University of Washington); Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NGO Via Libre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by the University of Washington Amauta Health Informatics Research and Training Program, a Fogarty International Center/NIH funded grant (D43TW007551) and the NGO Via Libre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.fic.nih.gov/, http://www.vialibre.org.pe/.	BLAS M, 2007, THESIS U WASHINGTON; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Bull SS, 2004, AIDS CARE, V16, P931, DOI 10.1080/09540120412331292507; Bull SS, 2001, HEALTH EDUC RES, V16, P661, DOI 10.1093/her/16.6.661; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P129; Curioso WH, 2007, PLOS MED, V4, P248, DOI [10.1371/journal.pmed.0040011, 10.1371/jourmal.pmed.0040011]; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Evers KE, 1998, AM J HEALTH PROMOT, V13, P19, DOI 10.4278/0890-1171-13.1.19; Flatley-Brennan P, 1998, COMPUT BIOL MED, V28, P489, DOI 10.1016/S0010-4825(98)00029-8; *GREM CTR COM LUCH, CAMP HAZT PRUEB; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; KUSUNOKI L, 2005, REPORT MONITORING DE; Levine DK, 2005, SEX TRANSM DIS, V32, P139, DOI 10.1097/01.olq.0000149783.67826.4d; LimeSurvey, LIMESURVEY OP SOURC; Mayer R. E., 2001, MULTIMEDIA LEARNING; Mikolajczak J, 2006, AIDS BEHAV, V10, P431, DOI 10.1007/s10461-006-9068-8; MYINT UA, 2008, HLTH PROMOT PRACT, DOI DOI 10.1177/1524839908318830; Nijland N, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.957; ODONNELL L, 1995, SEX TRANSM DIS, V22, P97, DOI 10.1097/00007435-199503000-00004; Orellana ER, 2006, AIDS EDUC PREV, V18, P348, DOI 10.1521/aeap.2006.18.4.348; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; ROSS MW, 2002, CUS, V17, P4; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; *UNAIDS, 2007, AIDS EP UPD; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; 2008, PERU COUNTRY PROGR R; GET TESTED VIA LIBRE; 2008, AIDS ALERT, V23, P18	29	60	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10448	10.1371/journal.pone.0010448	http://dx.doi.org/10.1371/journal.pone.0010448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PW	20454667	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240300021
J	Jones, A; Berkelmans, R				Jones, Alison; Berkelmans, Ray			Potential Costs of Acclimatization to a Warmer Climate: Growth of a Reef Coral with Heat Tolerant vs. Sensitive Symbiont Types	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; BLEACHING EVENT; BUILDING CORALS; ZOOXANTHELLAE; PHOTOSYNTHESIS; ENDOSYMBIONTS; COMMUNITIES; TEMPERATURE; STRESS	One of the principle ways in which reef building corals are likely to cope with a warmer climate is by changing to more thermally tolerant endosymbiotic algae (zooxanthellae) genotypes. It is highly likely that hosting a more heat-tolerant algal genotype will be accompanied by tradeoffs in the physiology of the coral. To better understand one of these tradeoffs, growth was investigated in the Indo-Pacific reef-building coral Acropora millepora in both the laboratory and the field. In the Keppel Islands in the southern Great Barrier Reef this species naturally harbors nrDNA ITS1 thermally sensitive type C2 or thermally tolerant type D zooxanthellae of the genus Symbiodinium and can change dominant type following bleaching. We show that under controlled conditions, corals with type D symbionts grow 29% slower than those with type C2 symbionts. In the field, type D colonies grew 38% slower than C2 colonies. These results demonstrate the magnitude of trade-offs likely to be experienced by this species as they acclimatize to warmer conditions by changing to more thermally tolerant type D zooxanthellae. Irrespective of symbiont genotype, corals were affected to an even greater degree by the stress of a bleaching event which reduced growth by more than 50% for up to 18 months compared to pre-bleaching rates. The processes of symbiont change and acute thermal stress are likely to act in concert on coral growth as reefs acclimatize to more stressful warmer conditions, further compromising their regeneration capacity following climate change.	[Jones, Alison] Cent Queensland Univ, Ctr Environm Management, Rockhampton, Qld 4702, Australia; [Berkelmans, Ray] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Central Queensland University; Australian Institute of Marine Science	Jones, A (corresponding author), Cent Queensland Univ, Ctr Environm Management, Rockhampton, Qld 4702, Australia.	a.jones@cqu.edu.au	Jones, Alison/AAF-5530-2020		Australian Institute of Marine Science; Central Queensland University	Australian Institute of Marine Science; Central Queensland University	This study was made possible by funding from the Australian Institute of Marine Science and Central Queensland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; BERKELMANS R, 2006, P ROYAL SOC LONDON B; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; DAVIES PS, 1984, CORAL REEFS, V2, P181; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Elahi R, 2007, BIOL BULL-US, V212, P20, DOI 10.2307/25066577; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GLADFELTER EH, 1984, CORAL REEFS, V3, P51, DOI 10.1007/BF00306140; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; HUGLY S, 1989, PLANT PHYSIOL, V90, P1134, DOI 10.1104/pp.90.3.1134; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; Jokiel P., 1978, CORAL REEFS RES METH, P529; JONES A, 2009, FLEXIBILITY CORAL AL; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; Jones RJ, 2000, MAR FRESHWATER RES, V51, P63, DOI 10.1071/MF99100; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V313, P349; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1990, ECOSYSTEMS WORLD, V25, P75; Pratchett MS, 2004, CORAL REEFS, V23, P352, DOI 10.1007/s00338-004-0394-x; Ralph PJ, 1999, MAR ECOL PROG SER, V180, P139, DOI 10.3354/meps180139; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sato N, 1996, J PHOTOCH PHOTOBIO B, V36, P333, DOI 10.1016/S1011-1344(96)07389-7; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; TCHERNOV D, 2004, P NATL ACAD SCI USA, P13535; Vago R, 1997, NATURE, V386, P30, DOI 10.1038/386030a0; VANOPPEN MJH, 2004, AUSTRALAS SCI, V25, P41; VANWOESIK R, 1991, ASSESSMENT CORAL REE; VIGH L, 1985, EUR J BIOCHEM, V147, P477; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x; Weinberg S. L., 2002, DATA ANAL BEHAV SCI	50	143	143	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10437	10.1371/journal.pone.0010437	http://dx.doi.org/10.1371/journal.pone.0010437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454653	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300013
J	Lundberg, J; Jonsson, S; Holmin, S				Lundberg, Johan; Jonsson, Stefan; Holmin, Staffan			New Endovascular Method for Transvascular Exit of Arteries and Veins: Developed in Simulator, in Rat and in Rabbit with Full Clinical Integration	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STROMAL CELL TREATMENT; STEM-CELLS; ISLET TRANSPLANTATION; MIGRATION; STROKE	Background: Endovascular technique has benefits vis-a-vis surgical access to organs with less accessible anatomical locations. To minimize surgical risk we propose a novel endovascular technique, to create parenchymal access through endovascular methods. Methodology/Principal Findings: We have developed, manufactured and tested an endovascular catheter with a depth limiting collar and a penetrating tip that is used to perforate vessels, thereby creating a working channel to the extravascular space. Computer simulations and subsequent interventions have been performed ex vivo and in vivo in both small and large animals by testing different prototypes. All tests were designed for testing extravascular hemostasis and absence of thrombo-embolic complications when exiting the vessels from the inside to the extra vascular space. We have deposited prototypes after intervention in vascular walls over a period of 14 days in rat with no impairment on blood flow and no signs of thrombo-embolic complications upon re-exploration (n = 7). We have also incorporated the catheter system with clinically available systems both in an ex vivo simulator setting and in a full scale clinical angiographical setting in rabbit were no bleeding (0%) in any of the interventions performed (n = 40). To prevent hemorrhage during termination of the procedure, a hollow electrolysis detachment-zone leaves the distal tip in the vessel-wall after the intervention. This has also been tested with absolute hemostasis in large animals (n = 6). Conclusions/Significance: We have developed and tested a new system for transvascular tissue access in simulations, ex vivo and in vivo in small and large animals, integrating it with standard clinical catheters and angiographical environment, with absolute hemostasis and without thromboembolic complications. In a clinical setting for stem cell transplantation, local substance administration or tissue sampling, the benefit should be greatest in organs that are difficult or high-risk to access with other techniques, such as the pancreas, the central nervous system (CNS) and the heart.	[Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Lundberg, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	staffan.holmin@karolinska.se		Holmin, Staffan/0000-0002-1628-1615	Swedish Research Council [K2006-73X-20139-01-3]; Karolinska Institutet; Karolinska Institutet Innovations; Swedish Society of Medicine; Strokefonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet Innovations; Swedish Society of Medicine; Strokefonden	This study was supported by grants from the Swedish Research Council (K2006-73X-20139-01-3), Karolinska Institutet funds, Karolinska Institutet Innovations, the Swedish Society of Medicine and Strokefonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale R, 2007, MINIM INVASIV THER, V16, P196, DOI 10.1080/13645700701520578; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Fay J., 1994, INTRO FLUID MECH; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P165, DOI 10.1001/jama.298.2.165; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; John D. B., 1996, THEORY PRACTICE HIST; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; LUNDBERG J, 2009, NEURORADIOLOGY; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Siminiak T, 2005, EUR HEART J, V26, P1188, DOI 10.1093/eurheartj/ehi159; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342	19	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10449	10.1371/journal.pone.0010449	http://dx.doi.org/10.1371/journal.pone.0010449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454668	Green Submitted, gold, Green Published			2022-12-27	WOS:000277240300022
J	Bankapur, A; Zachariah, E; Chidangil, S; Valiathan, M; Mathur, D				Bankapur, Aseefhali; Zachariah, Elsa; Chidangil, Santhosh; Valiathan, Manna; Mathur, Deepak			Raman Tweezers Spectroscopy of Live, Single Red and White Blood Cells	PLOS ONE			English	Article							UV RESONANCE RAMAN; OPTICAL TWEEZERS; LIVING CELLS; MANIPULATION	An optical trap has been combined with a Raman spectrometer to make high-resolution measurements of Raman spectra of optically-immobilized, single, live red (RBC) and white blood cells (WBC) under physiological conditions. Tightly-focused, near infrared wavelength light (1064 nm) is utilized for trapping of single cells and 785 nm light is used for Raman excitation at low levels of incident power (few mW). Raman spectra of RBC recorded using this high-sensitivity, dual-wavelength apparatus has enabled identification of several additional lines; the hitherto-unreported lines originate purely from hemoglobin molecules. Raman spectra of single granulocytes and lymphocytes are interpreted on the basis of standard protein and nucleic acid vibrational spectroscopy data. The richness of the measured spectrum illustrates that Raman studies of live cells in suspension are more informative than conventional micro-Raman studies where the cells are chemically bound to a glass cover slip.	[Bankapur, Aseefhali; Zachariah, Elsa; Chidangil, Santhosh; Mathur, Deepak] Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India; [Valiathan, Manna] Kasturba Med Coll & Hosp, Dept Pathol, Manipal, Karnataka, India; [Mathur, Deepak] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Tata Institute of Fundamental Research (TIFR)	Bankapur, A (corresponding author), Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India.	atmol1@tifr.res.in	Mathur, Deepak/K-5000-2019; Bankapur, Aseefhali/G-8637-2015; Bankapur, Aseefhali/AAN-1484-2020	Mathur, Deepak/0000-0002-2322-6331; Bankapur, Aseefhali/0000-0001-9237-8980; Bankapur, Aseefhali/0000-0001-9237-8980; CHIDANGIL, SANTHOSH/0000-0002-2973-6834	Department of Biotechnology of the Government of India [BT/PR6413/MED/14/802/2005]	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India)	The authors acknowledge the generous support provided by the Department of Biotechnology of the Government of India for this work under grant BT/PR6413/MED/14/802/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; BRUCE A, 2001, MOL BIOL CELL; CALMETTES PP, 1983, P NATL ACAD SCI-BIOL, V80, P7197, DOI 10.1073/pnas.80.23.7197; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chang WT, 2009, J RAMAN SPECTROSC, V40, P1194, DOI 10.1002/jrs.2261; Chen K, 2006, OPT LETT, V31, P2015, DOI 10.1364/OL.31.002015; Creely CM, 2005, OPT COMMUN, V245, P465, DOI 10.1016/j.optcom.2004.10.011; De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943; DEGRUCHY C, 2001, CLIN HAEMATOLOGY MED; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Dharmadhikari JA, 2004, CURR SCI INDIA, V86, P1432; Dharmadhikari JA, 2004, OPT EXPRESS, V12, P1179, DOI 10.1364/OPEX.12.001179; GEBNER R, 2004, CHEMPHYSCHEM, V5, P1159; Gudipati M, 2005, OPT EXPRESS, V13, P1555, DOI 10.1364/OPEX.13.001555; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; Hawi SR, 1996, CANCER LETT, V110, P35, DOI 10.1016/S0304-3835(96)04455-2; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Jess PRT, 2007, J RAMAN SPECTROSC, V38, P1082, DOI 10.1002/jrs.1712; Lapotko DO, 2005, LASER SURG MED, V36, P22, DOI 10.1002/lsm.20119; Li P, 2005, OPT LETT, V30, P156, DOI 10.1364/OL.30.000156; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; MANOHARAN R, 1990, J MICROBIOL METH, V11, P1, DOI 10.1016/0167-7012(90)90042-5; Moritz TJ, 2010, J RAMAN SPECTROSC, V41, P33, DOI 10.1002/jrs.2436; NELSON WH, 1992, APPL SPECTROSC REV, V27, P67, DOI 10.1080/05704929208018270; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Ojeda JF, 2006, OPT EXPRESS, V14, P5385, DOI 10.1364/OE.14.005385; Otto C, 1998, EUR BIOPHYS J BIOPHY, V27, P582, DOI 10.1007/s002490050169; PARKER FS, 1983, APPL INFRARED RAMAN; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Ramanandan G, 2009, OPT EXPRESS, V17, P9614, DOI 10.1364/OE.17.009614; Ramser K, 2004, J BIOMED OPT, V9, P593, DOI 10.1117/1.1689336; Rao S, 2009, BIOPHYS J, V96, P209, DOI 10.1529/biophysj.108.139097; Singh GP, 2005, ANAL CHEM, V77, P2564, DOI 10.1021/ac048359j; Snook RD, 2009, INTEGR BIOL-UK, V1, P43, DOI 10.1039/b815253e; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Wood BR, 2007, ANAL BIOANAL CHEM, V387, P1691, DOI 10.1007/s00216-006-0881-8; Wood BR, 2002, J RAMAN SPECTROSC, V33, P517, DOI 10.1002/jrs.870; WOOD BR, 2001, BIOCHIM BIOPHYS ACTA, V15, P58; Xie CG, 2004, OPT EXPRESS, V12, P6208, DOI 10.1364/OPEX.12.006208; Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249	43	111	114	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10427	10.1371/journal.pone.0010427	http://dx.doi.org/10.1371/journal.pone.0010427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454686	Green Submitted, gold, Green Published			2022-12-27	WOS:000277240100029
J	Blalock, EM; Phelps, JT; Pancani, T; Searcy, JL; Anderson, KL; Gant, JC; Popovic, J; Avdiushko, MG; Cohen, DA; Chen, KC; Porter, NM; Thibault, O				Blalock, Eric M.; Phelps, Jeremiah T.; Pancani, Tristano; Searcy, James L.; Anderson, Katie L.; Gant, John C.; Popovic, Jelena; Avdiushko, Margarita G.; Cohen, Don A.; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier			Effects of Long-Term Pioglitazone Treatment on Peripheral and Central Markers of Aging	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; MILD COGNITIVE IMPAIRMENT; TRANSIENT FOCAL ISCHEMIA; PPAR-GAMMA; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; CALCIUM HOMEOSTASIS	Background: Thiazolidinediones (TZDs) activate peroxisome proliferator-activated receptor gamma (PPAR gamma) and are used clinically to help restore peripheral insulin sensitivity in Type 2 diabetes (T2DM). Interestingly, long-term treatment of mouse models of Alzheimer's disease (AD) with TZDs also has been shown to reduce several well-established brain biomarkers of AD including inflammation, oxidative stress and A beta accumulation. While TZD's actions in AD models help to elucidate the mechanisms underlying their potentially beneficial effects in AD patients, little is known about the functional consequences of TZDs in animal models of normal aging. Because aging is a common risk factor for both AD and T2DM, we investigated whether the TZD, pioglitazone could alter brain aging under non-pathological conditions. Methods and Findings: We used the F344 rat model of aging, and monitored behavioral, electrophysiological, and molecular variables to assess the effects of pioglitazone (PIO-Actos (R) a TZD) on several peripheral (blood and liver) and central (hippocampal) biomarkers of aging. Starting at 3 months or 17 months of age, male rats were treated for 4-5 months with either a control or a PIO-containing diet (final dose approximately 2.3 mg/kg body weight/day). A significant reduction in the Ca2+-dependent afterhyperpolarization was seen in the aged animals, with no significant change in long-term potentiation maintenance or learning and memory performance. Blood insulin levels were unchanged with age, but significantly reduced by PIO. Finally, a combination of microarray analyses on hippocampal tissue and serum-based multiplex cytokine assays revealed that age-dependent inflammatory increases were not reversed by PIO. Conclusions: While current research efforts continue to identify the underlying processes responsible for the progressive decline in cognitive function seen during normal aging, available medical treatments are still very limited. Because TZDs have been shown to have benefits in age-related conditions such as T2DM and AD, our study was aimed at elucidating PIO's potentially beneficial actions in normal aging. Using a clinically-relevant dose and delivery method, long-term PIO treatment was able to blunt several indices of aging but apparently affected neither age-related cognitive decline nor peripheral/central age-related increases in inflammatory signaling.	[Blalock, Eric M.; Phelps, Jeremiah T.; Pancani, Tristano; Searcy, James L.; Anderson, Katie L.; Gant, John C.; Popovic, Jelena; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier] Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Avdiushko, Margarita G.; Cohen, Don A.] Univ Kentucky, Med Ctr, Dept Microbiol & Immunol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Blalock, EM (corresponding author), Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	othibau@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466	Neurosciences Education and Research Foundation [AG029268, AG0033649, NCRR-P20-RR15592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033649, R21AG029268] Funding Source: NIH RePORTER	Neurosciences Education and Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work was provided in part by a gift from the Neurosciences Education and Research Foundation (OT), and research grants AG029268 (OT), AG0033649 (OT) and NCRR-P20-RR15592 (OT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3; Arikawa M, 2004, J CARDIOVASC PHARM, V44, P109, DOI 10.1097/00005344-200407000-00015; Asano M, 1999, BRIT J PHARMACOL, V128, P673, DOI 10.1038/sj.bjp.0702818; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Barnes CA, 1996, LEARN MEMORY, V3, P124, DOI 10.1101/lm.3.2-3.124; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591; Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; BOLSTAD B, 2005, BIOINFORMATICS COMPU; BONINI JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE759, DOI 10.1152/ajpendo.1995.269.4.E759; Boyle PJ, 2002, CLIN THER, V24, P378, DOI 10.1016/S0149-2918(02)85040-8; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Brunton L.B., 2005, GOODMAN GILMANS PHAR, V11th ed; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z; Disterhoft JF, 1996, LIFE SCI, V59, P413, DOI 10.1016/0024-3205(96)00320-7; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Fishel MA, 2005, ARCH NEUROL-CHICAGO, V62, P1539, DOI 10.1001/archneur.62.10.1539; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; GANT JC, 2008, NEUROBIOL AGING; Garcia-Bueno B, 2005, BIOL PSYCHIAT, V57, P885, DOI 10.1016/j.biopsych.2005.01.007; Gemma C, 2004, NEUROREPORT, V15, P2255, DOI 10.1097/00001756-200410050-00023; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; GOODMAN DG, 1979, TOXICOL APPL PHARM, V48, P237, DOI 10.1016/0041-008X(79)90029-2; GRADMAN TJ, 1993, J AM GERIATR SOC, V41, P1305, DOI 10.1111/j.1532-5415.1993.tb06480.x; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Hauner H, 2002, DIABETES-METAB RES, V18, pS10, DOI 10.1002/dmrr.249; Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000; Heneka MT, 1999, J NEUROIMMUNOL, V100, P156, DOI 10.1016/S0165-5728(99)00192-7; HENEKA MT, 2005, BRAIN; Heppner TJ, 2005, PHARMACOLOGY, V73, P15, DOI 10.1159/000081070; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009; Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Ikeda S, 1998, EUR J PHARMACOL, V357, P243, DOI 10.1016/S0014-2999(98)00557-3; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Kruglikov I, 2004, PFLUG ARCH EUR J PHY, V448, P395, DOI 10.1007/s00424-004-1263-8; Lacombe P, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-11; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; LEVIN BE, 1983, AM J PHYSIOL, V245, pR364, DOI 10.1152/ajpregu.1983.245.3.R364; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; MORGENWECK J, 2009, NEUROPHARMACOLOGY; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Nakajima T, 1999, CIRCULATION, V99, P2942, DOI 10.1161/01.CIR.99.22.2942; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Reagan LP, 2002, INT REV NEUROBIOL, V51, P289, DOI 10.1016/S0074-7742(02)51009-6; Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Ryan CM, 2000, DIABETES-METAB RES, V16, P308, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR141>3.0.CO;2-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Song JB, 1997, DIABETES, V46, P659, DOI 10.2337/diabetes.46.4.659; Spanheimer R, 2009, AM J CARDIOL, V104, P234, DOI 10.1016/j.amjcard.2009.03.023; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Storozhevykh TP, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-84; STRANAHAN AM, 2008, NEUROBIOL AGING; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tombaugh GC, 2002, J NEUROSCI, V22, P9932; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061	121	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10405	10.1371/journal.pone.0010405	http://dx.doi.org/10.1371/journal.pone.0010405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454453	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100015
J	Douw, L; de Groot, M; van Dellen, E; Heimans, JJ; Ronner, HE; Stam, CJ; Reijneveld, JC				Douw, Linda; de Groot, Marjolein; van Dellen, Edwin; Heimans, Jan J.; Ronner, Hanneke E.; Stam, Cornelis J.; Reijneveld, Jaap C.			'Functional Connectivity' Is a Sensitive Predictor of Epilepsy Diagnosis after the First Seizure	PLOS ONE			English	Article							GENERALIZED SYNCHRONIZATION; EEG; ABNORMALITIES; MAGNETOENCEPHALOGRAPHY; LIKELIHOOD; DISEASE	Background: Although epilepsy affects almost 1% of the world population, diagnosis of this debilitating disease is still difficult. The EEG is an important tool for epilepsy diagnosis and classification, but the sensitivity of interictal epileptiform discharges (IEDs) on the first EEG is only 30-50%. Here we investigate whether using 'functional connectivity' can improve the diagnostic sensitivity of the first interictal EEG in the diagnosis of epilepsy. Methodology/Principal Findings: Patients were selected from a database with 390 standard EEGs of patients after a first suspected seizure. Patients who were later diagnosed with epilepsy (i.e. >= two seizures) were compared to matched non-epilepsy patients (with a minimum follow-up of one year). The synchronization likelihood (SL) was used as an index of functional connectivity of the EEG, and average SL per patient was calculated in seven frequency bands. In total, 114 patients were selected. Fifty-seven patients were diagnosed with epilepsy (20 had IEDs on their EEG) and 57 matched patients had other diagnoses. Epilepsy patients had significantly higher SL in the theta band than non-epilepsy patients. Furthermore, theta band SL proved to be a significant predictor of a diagnosis of epilepsy. When only those epilepsy patients without IEDs were considered (n = 74), theta band SL could predict diagnosis with specificity of 76% and sensitivity of 62%. Conclusion/Significance: Theta band functional connectivity may be a useful diagnostic tool in diagnosing epilepsy, especially in those patients who do not show IEDs on their first EEG. Our results indicate that epilepsy diagnosis could be improved by using functional connectivity.	[Douw, Linda; de Groot, Marjolein; van Dellen, Edwin; Heimans, Jan J.; Reijneveld, Jaap C.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Douw, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands.	l.douw@vumc.nl	van Dellen, Edwin/AAU-6245-2020; van Dellen, Edwin/AAL-6605-2020; van Dellen, Edwin/ABC-1501-2020	van Dellen, Edwin/0000-0003-1828-5959; van Dellen, Edwin/0000-0003-1828-5959; Douw, Linda/0000-0001-7058-4062; Stam, Cornelis/0000-0001-9163-7274	Dutch Epilepsy Foundation; UCB Pharma	Dutch Epilepsy Foundation; UCB Pharma(UCB Pharma SA)	L. Douw and E. van Dellen have projects sponsored by the Dutch Epilepsy Foundation, while M. de Groot is sponsored by UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2008, BRAIN RES, V1188, P207, DOI 10.1016/j.brainres.2007.10.048; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; BETTUS G, 2008, EPILEPSY RES; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; HORSTMANN MT, 2009, CLIN NEUROPHYSIOL; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mormann F, 2003, EPILEPSY RES, V53, P173, DOI 10.1016/S0920-1211(03)00002-0; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Righi M, 2008, BRAIN TOPOGR, V21, P43, DOI 10.1007/s10548-008-0057-2; ROBIN JJ, 1978, AVIAT SPACE ENVIR MD, V49, P732; Rosso OA, 2009, J NEUROSCI METH, V177, P461, DOI 10.1016/j.jneumeth.2008.10.017; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Zucconi M, 2005, NEUROL SCI, V26, pS199, DOI 10.1007/s10072-005-0487-5	28	82	83	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10839	10.1371/journal.pone.0010839	http://dx.doi.org/10.1371/journal.pone.0010839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520774	Green Published, gold			2022-12-27	WOS:000278221500025
J	Steen, C; Wilczak, N; Hoogduin, JM; Koch, M; De Keyser, J				Steen, Christel; Wilczak, Nadine; Hoogduin, Johannes M.; Koch, Marcus; De Keyser, Jacques			Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SPINAL-CORD; IMMUNOHISTOCHEMICAL LOCALIZATION; GLUTAMATE RECEPTORS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; HUMAN-BRAIN; ASTROCYTES; CELLS; AXONS	Background: Two studies using P-31-magnetic resonance spectroscopy (MRS) reported enhanced phosphocreatine (PCr) levels in normal appearing white matter (NAWM) of subjects with multiple sclerosis (MS), but this finding could not be properly explained. Methodology/Principal Findings: We performed P-31-MRS and H-1-MRS in the NAWM in 36 subjects, including 17 with progressive MS, 9 with benign MS, and 10 healthy controls. Compared to controls, PCr/beta-ATP and PCr/total P-31 ratios were significantly increased in subjects with progressive MS, but not with benign MS. There was no correlation between PCr ratios and the N-acetylaspartate/creatine ratio, suggesting that elevated PCr levels in NAWM were not secondary to axonal loss. In the central nervous system, PCr is degraded by creatine kinase B (CK-B), which in the white matter is confined to astrocytes. In homogenates of NAWM from 10 subjects with progressive MS and 10 controls without central nervous system disease, we measured CK-B levels with an ELISA, and measured its activity with an enzymatic assay kit. Compared to controls, both CK-B levels and activity were decreased in subjects with MS (22.41 versus 46.28 mu g/ml; p = 0.0007, and 2.89 versus 7.76 U/l; p<0.0001). Conclusions/Significance: Our results suggest that PCr metabolism in the NAWM in MS is impaired due to decreased CK-B levels. Our findings raise the possibility that a defective PCr metabolism in astrocytes might contribute to the degeneration of oligodendrocytes and axons in MS.	[Steen, Christel; Wilczak, Nadine; Koch, Marcus; De Keyser, Jacques] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Hoogduin, Johannes M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Hoogduin, Johannes M.] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [De Keyser, Jacques] Vrije Univ Brussel, Dept Neurol, UZ Brussel, Brussels, Belgium	University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Brussel	Steen, C (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	Jacques.DeKeyser@uzbrussel.be	De Keyser, Jacques/AAA-8721-2021; Koch, Marcus/L-9346-2019; De Keyser, Jacques/D-3725-2013; Wilczak, Nadine/G-4422-2011	De Keyser, Jacques/0000-0002-3394-7757; Koch, Marcus/0000-0001-9972-5092; De Keyser, Jacques/0000-0002-3394-7757; 				Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Anderson CM, 2000, GLIA, V32, P1; [Anonymous], [No title captured]; Barnett FH, 2004, NEUROSURGERY, V55, P468, DOI 10.1227/00006123-200408000-00083; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Keyser J, 1999, NEUROLOGY, V53, P1628, DOI 10.1212/WNL.53.8.1628; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Domercq M, 2005, GLIA, V52, P36, DOI 10.1002/glia.20221; Fonseca LL, 2005, GLIA, V51, P286, DOI 10.1002/glia.20209; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Koch M, 2006, J NEUROL, V253, P483, DOI 10.1007/s00415-005-0037-3; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; KUZHIKANDATHIL EV, 1994, J NEUROSCI RES, V39, P70, DOI 10.1002/jnr.490390110; Kuzhikandathil EV, 1999, J NEUROSCI RES, V56, P371, DOI 10.1002/(SICI)1097-4547(19990515)56:4<371::AID-JNR5>3.0.CO;2-W; LANGEMANN H, 1992, EUR NEUROL, V32, P248, DOI 10.1159/000116835; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; MINDERHOUD JM, 1992, ARCH NEUROL-CHICAGO, V49, P161, DOI 10.1001/archneur.1992.00530260063021; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PETROFF OAC, 1988, J NEUROCHEM, V51, P163, DOI 10.1111/j.1471-4159.1988.tb04850.x; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; THOMPSON RJ, 1980, BRAIN RES, V201, P423, DOI 10.1016/0006-8993(80)91046-X; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Xu GY, 2008, NEUROSCIENCE, V153, P1034, DOI 10.1016/j.neuroscience.2008.02.065; YOSHIMINE T, 1983, BRAIN RES, V265, P101, DOI 10.1016/0006-8993(83)91338-0; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	39	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10811	10.1371/journal.pone.0010811	http://dx.doi.org/10.1371/journal.pone.0010811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520825	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034800009
J	He, GX; Xie, YG; Wang, LX; Borgdorff, MW; van der Werf, MJ; Fan, JH; Yan, XL; Li, FB; Zhang, XZ; Zhao, YL; van den Hof, S				He, Guang Xue; Xie, Yan Guang; Wang, Li Xia; Borgdorff, Martien W.; van der Werf, Marieke J.; Fan, Ji Huan; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi; Zhao, Yan Lin; van den Hof, Susan			Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment	PLOS ONE			English	Article							TREATMENT OUTCOMES; CHINA; COUNTRIES	Background: In 2004, an anti-tuberculosis (TB) drug resistance survey in Heilongjiang province, China, enrolled 1574 (79%) new and 421 (21%) retreatment patients. Multi-drug resistant (MDR) TB was detected in 7.2% of new and 30.4% of retreatment patients. All received treatment with standardized first-line drug (FLD) regimens. Methodology/Principal Findings: We report treatment outcomes of the 2004 cohort, and long-term outcomes as assessed in the second half of 2008. The reported cure rate for MDR-TB patients was 83% (94/113) among new and 66% (85/128) among retreatment patients (P<0.001). Ten of the 241 MDR-TB patients died during treatment. Of the remaining 231, 129 (56%) could be traced in 2008. The overall recurrence rates among new and retreatment cases were 46% and 66%, respectively (P=0.03). The overall death rates among new and retreatment cases were 25% and 46%, respectively (P=0.02). Forty percent of the traced new cases and 24% of the retreatment cases were alive and without recurrent TB (P=0.01). Of the 16 patients who failed or defaulted from treatment in 2004, only two patients were not re-diagnosed with TB by 2008. Of the 111 (86%) patients with an initial successful treatment outcome 63 (57%) had developed recurrent TB, 40 (36%) had died, 27 (24%) of them died of TB. The follow-up period of four years precluded follow-up of all patients. In a highly conservative sensitivity analysis in which we assumed that all non-included patients were alive and did not have recurrent TB, the recurrence and death rate were 33% and 21%. Conclusions/Significance: Documentation of cure based on conventional smear microscopy was a poor predictor of long term outcomes. MDR-TB patients in Heilongjiang province in China had high recurrence and death rates four years after treatment with standardized FLD regimens, reinforcing the need for early diagnosis and treatment of MDR-TB, including assessment of treatment outcomes with more sensitive laboratory methods.	[He, Guang Xue; Wang, Li Xia] China Ctr Dis Control & Prevent China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [He, Guang Xue; Borgdorff, Martien W.; van der Werf, Marieke J.; van den Hof, Susan] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Xie, Yan Guang; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi] Heilongjiang Prov Ctr TB Control & Prevent, Harbin, Heilongjiang, Peoples R China; [van der Werf, Marieke J.; van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [Fan, Ji Huan] Peking Union Med Coll, Sch Publ Hlth, Beijing 100021, Peoples R China; [Zhao, Yan Lin] China Ctr Dis Control & Prevent China CDC, Natl TB Reference Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention	He, GX (corresponding author), China Ctr Dis Control & Prevent China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	vandenhofs@kncvtbc.nl		van der Werf, Marieke J./0000-0001-8021-1358	China Global Fund TB Program [07-053, 07-059]; China National Key Project [2008ZX10003-009, 2009ZX10004-714]	China Global Fund TB Program; China National Key Project	Funding: This research project received funding through the China Global Fund TB Program (07-053, 059) and the China National Key Project (2008ZX10003-009, 2009ZX10004-714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Y, 2007, J CHINESE ANTITUBERC, V29, P475; Bonnet M, 2005, INT J TUBERC LUNG D, V9, P1147; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; GAO WW, 2008, J CHINESE ANTITUBERC, V30, P114; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; LI B, 2003, J CHINESE ANTITUBERC, V25, P343; LI Q, 2000, CHINESE J TUBERCULOS, V23, P718; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Ohkado A, 2006, INT J TUBERC LUNG D, V10, P283; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sun ZG, 2008, J CLIN MICROBIOL, V46, P4075, DOI 10.1128/JCM.00822-08; Wang Guo-jie, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P527; WANG SM, 2005, J CHINESE ANTITUBERC, V27, P370; *WHO, 2008, WHOHTMTB2008394; *WHO INT UN TUB LU, 2000, 2 WHO INT UN TUB LUN; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization and International Union against Tuberculosis and Lung Disease, 1997, WHOTB96216; XIE YG, 2005, J CHINESE ANTITUBERC, V30, P395	29	29	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10799	10.1371/journal.pone.0010799	http://dx.doi.org/10.1371/journal.pone.0010799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520720	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600026
J	Nelson, DM; Cann, IKO; Altermann, E; Mackie, RI				Nelson, David M.; Cann, Isaac K. O.; Altermann, Eric; Mackie, Roderick I.			Phylogenetic Evidence for Lateral Gene Transfer in the Intestine of Marine Iguanas	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; RUMEN; GENOME; MICROBIOTA; DIGESTION; LIZARDS; SHEEP; TREES; NOV.	Background: Lateral gene transfer (LGT) appears to promote genotypic and phenotypic variation in microbial communities in a range of environments, including the mammalian intestine. However, the extent and mechanisms of LGT in intestinal microbial communities of non-mammalian hosts remains poorly understood. Methodology/Principal Findings: We sequenced two fosmid inserts obtained from a genomic DNA library derived from an agar-degrading enrichment culture of marine iguana fecal material. The inserts harbored 16S rRNA genes that place the organism from which they originated within Clostridium cluster IV, a well documented group that habitats the mammalian intestinal tract. However, sequence analysis indicates that 52% of the protein-coding genes on the fosmids have top BLASTX hits to bacterial species that are not members of Clostridium cluster IV, and phylogenetic analysis suggests that at least 10 of 44 coding genes on the fosmids may have been transferred from Clostridium cluster XIVa to cluster IV. The fosmids encoded four transposase-encoding genes and an integrase-encoding gene, suggesting their involvement in LGT. In addition, several coding genes likely involved in sugar transport were probably acquired through LGT. Conclusion: Our phylogenetic evidence suggests that LGT may be common among phylogenetically distinct members of the phylum Firmicutes inhabiting the intestinal tract of marine iguanas.	[Nelson, David M.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; [Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Altermann, Eric] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	University System of Maryland; University of Maryland Center for Environmental Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; AgResearch - New Zealand	Nelson, DM (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA.	dmnelson@al.umces.edu; r-mackie@illinois.edu	Nelson, David/AAP-9412-2020; Nelson, David M/D-5596-2009	Nelson, David/0000-0003-2755-5535; Nelson, David M/0000-0003-2755-5535; Altermann, Eric/0000-0003-1376-1549	National Science Foundation [0238422]; Institute for Genomic Biology; United States Department of Agriculture [2008-35107-18664]	National Science Foundation(National Science Foundation (NSF)); Institute for Genomic Biology; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding: Support for this research was provided by National Science Foundation grant #0238422 (R. I. M. and I.K.O.C.), a postdoctoral fellowship from the Institute for Genomic Biology (D.M.N.), and United States Department of Agriculture grant #2008-35107-18664 (D.M.N.). E. A. is a current employee of AgResearch Limited (www.agresearch.co.nz), a New Zealand Crown Research Institute. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; BROWNE J, 1989, VOYAGE BEAGLE C DARW; Carlier JP, 2010, INT J SYST EVOL MICR, V60, P585, DOI 10.1099/ijs.0.016725-0; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gilbert JA, 2008, ISME J, V2, P790, DOI 10.1038/ismej.2008.49; Gophna U., 2009, MICROBE, V4, P549; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lino T, 2007, INT J SYST EVOL MICR, V57, P1840, DOI 10.1099/ijs.0.64717-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Mackie RI, 1997, GASTROINTESTINAL MIC; MACKIE RI, 2008, 4 COMP PHYSL BIOCH M, P193; Nei M., 2000, MOL EVOLUTION PHYLOG; Nesbo CL, 2005, ENVIRON MICROBIOL, V7, P2011, DOI 10.1111/j.1462-2920.2005.00918.x; ORPIN CG, 1985, J APPL BACTERIOL, V58, P585, DOI 10.1111/j.1365-2672.1985.tb01715.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wikelski M, 2000, NATURE, V403, P37, DOI 10.1038/47396; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10785	10.1371/journal.pone.0010785	http://dx.doi.org/10.1371/journal.pone.0010785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520734	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600012
J	Banu, S; Hossain, A; Uddin, MKM; Uddin, MR; Ahmed, T; Khatun, R; Mahmud, AM; Hyder, KA; Lutfor, AB; Karim, MS; Zaman, K; Khan, MAI; Barua, PC; Luby, SP				Banu, Sayera; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Uddin, Muhammad Reaj; Ahmed, Tahmeed; Khatun, Razia; Mahmud, Asif Mujtaba; Hyder, Khurshid Alam; Lutfor, Afzalunnessa Binte; Karim, Md. Sirajul; Zaman, Khalequ; Khan, Md. Ashraful Islam; Barua, Pravat Chandra; Luby, Stephen P.			Pulmonary Tuberculosis and Drug Resistance in Dhaka Central Jail, the Largest Prison in Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; THAI PRISONS; SMEAR; TRANSMISSION; POPULATION; PCR	Background: There are limited data on TB among prison inmates in Bangladesh. The aim of the study was to determine the prevalence of pulmonary tuberculosis (TB), its drug resistance and risk factors in Dhaka Central Jail, the largest prison in Bangladesh. Methods: Cross sectional survey with, active screening of a total number of 11,001 inmates over a period of 2 years. Sputum samples from TB suspects were taken for acid-fast bacilli (AFB) microscopy, culture and drug susceptibility testing. Results: Among 1,781 TB suspects 245 (13.8%) were positive for AFB on microscopy and/or culture. The prevalence rate of sputum-positive pulmonary TB was 2,227/100,000. Fifty three cases (21.6% of 245 cases) were AFB- negative on microscopy but were found positive on culture. Resistance to isoniazid, rifampicin, streptomycin and ethambutol was 11.4%, 0.8%, 22.4% and 6.5% respectively. No multidrug resistance was observed. The main risk factors of TB in prison were exposure to TB patients (adjusted odds ratio 3.16, 95% CI 2.36-4.21), previous imprisonment (1.86, 1.38-2.50), longer duration of stay in prison (17.5 months for TB cases; 1.004, 1.001-1.006) and low body mass index which is less than 18.5 kg/m(2) (5.37, 4.02-7.16). Conclusions: The study results revealed a very high prevalence of TB in the prison population in Dhaka Central Jail. Entry examinations and active symptom screening among inmates are important to control TB transmission inside the prison. Identifying undiagnosed smear-negative TB cases remains a challenge to combat this deadly disease in this difficult setting.	[Banu, Sayera; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Uddin, Muhammad Reaj; Ahmed, Tahmeed; Khatun, Razia; Zaman, Khalequ; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Mahmud, Asif Mujtaba] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh; [Hyder, Khurshid Alam] WHO, Dhaka, Bangladesh; [Lutfor, Afzalunnessa Binte] Sir Salimullah Med Coll, Dept Microbiol, Dhaka, Bangladesh; [Karim, Md. Sirajul] Savar Cantonment, ADMS, Dhaka, Bangladesh; [Khan, Md. Ashraful Islam] Directorate Prisons, Dhaka, Bangladesh; [Barua, Pravat Chandra] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization; Sir Salimullah Medical College	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org		Banu, Sayera/0000-0002-5121-1962	Government of Bangladesh through IHP-HNPRP; International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)	Government of Bangladesh through IHP-HNPRP; International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)	This work was supported by grants from the Government of Bangladesh through IHP-HNPRP and International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The Centre is supported by agencies and countries that share its concern for the health problems of developing countries. The authors gratefully acknowledge these donors for their support and commitment to the Centre's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chaves F, 1997, AM J RESP CRIT CARE, V155, P719, DOI 10.1164/ajrccm.155.2.9032218; CHEVALLAY B, 1983, SCHWEIZ MED WSCHR, V113, P261; Chiang CY, 2002, J FORMOS MED ASSOC, V101, P537; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Coninx R, 1998, BRIT MED J, V316, P1423, DOI 10.1136/bmj.316.7142.1423; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Garcia-Quintanilla A, 2002, J CLIN MICROBIOL, V40, P4646, DOI 10.1128/JCM.40.12.4646-4651.2002; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Munyati SS, 2005, CLIN INFECT DIS, V40, P1818, DOI 10.1086/429912; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pleumpanupat W, 2003, INT J TUBERC LUNG D, V7, P472; Rao N. A., 2004, JPMA Journal of the Pakistan Medical Association, V54, P413; SAHA K, 1989, EUR J CLIN NUTR, V43, P117; Sanchez AR, 2007, CAD SAUDE PUBLICA, V23, P545, DOI 10.1590/S0102-311X2007000300013; Shah S A, 2003, East Mediterr Health J, V9, P667; Sretrirutchai S, 2002, INT J TUBERC LUNG D, V6, P208; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Tueller C, 2005, EUR RESPIR J, V26, P767, DOI 10.1183/09031936.05.00046105; VALWAY SE, 1994, J INFECT DIS, V170, P151, DOI 10.1093/infdis/170.1.151; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108; 2003, INDIAN J ALLERGY AST, V17, P67	25	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2010	5	5							e10759	10.1371/journal.pone.0010759	http://dx.doi.org/10.1371/journal.pone.0010759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VQ	20505826	gold, Green Published, Green Submitted			2022-12-27	WOS:000278017400015
J	Diehnelt, CW; Shah, M; Gupta, N; Belcher, PE; Greving, MP; Stafford, P; Johnston, SA				Diehnelt, Chris W.; Shah, Miti; Gupta, Nidhi; Belcher, Paul E.; Greving, Matthew P.; Stafford, Phillip; Johnston, Stephen Albert			Discovery of High-Affinity Protein Binding Ligands - Backwards	PLOS ONE			English	Article							PHAGE DISPLAY; GENERATION; ANTIBODIES; REAGENTS; PEPTIDES; SPECIFICITY; MICROARRAYS; MOLECULES; LIBRARIES; SELECTION	Background: There is a pressing need for high-affinity protein binding ligands for all proteins in the human and other proteomes. Numerous groups are working to develop protein binding ligands but most approaches develop ligands using the same strategy in which a large library of structured ligands is screened against a protein target to identify a high-affinity ligand for the target. While this methodology generates high-affinity ligands for the target, it is generally an iterative process that can be difficult to adapt for the generation of ligands for large numbers of proteins. Methodology/Principal Findings: We have developed a class of peptide-based protein ligands, called synbodies, which allow this process to be run backwards - i.e. make a synbody and then screen it against a library of proteins to discover the target. By screening a synbody against an array of 8,000 human proteins, we can identify which protein in the library binds the synbody with high affinity. We used this method to develop a high-affinity synbody that specifically binds AKT1 with a K-d<5 nM. It was found that the peptides that compose the synbody bind AKT1 with low micromolar affinity, implying that the affinity and specificity is a product of the bivalent interaction of the synbody with AKT1. We developed a synbody for another protein, ABL1 using the same method. Conclusions/Significance: This method delivered a high-affinity ligand for a target protein in a single discovery step. This is in contrast to other techniques that require subsequent rounds of mutational improvement to yield nanomolar ligands. As this technique is easily scalable, we believe that it could be possible to develop ligands to all the proteins in any proteome using this approach.	[Diehnelt, Chris W.; Shah, Miti; Gupta, Nidhi; Belcher, Paul E.; Stafford, Phillip; Johnston, Stephen Albert] Arizona State Univ, Ctr Innovat Med, Tempe, AZ 85287 USA; [Greving, Matthew P.] Arizona State Univ, Biodesign Inst, Ctr BioOpt Nanotechnol, Tempe, AZ USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Diehnelt, CW (corresponding author), Arizona State Univ, Ctr Innovat Med, Tempe, AZ 85287 USA.	stephen.johnston@asu.edu	Diehnelt, Chris/AAT-9271-2020	Diehnelt, Chris/0000-0003-4565-9338	Arizona Translational Research Initiative Funds	Arizona Translational Research Initiative Funds	The Arizona Translational Research Initiative Funds to S.A.J. and C.W.D supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Blow N, 2007, NATURE, V447, P741, DOI 10.1038/447741a; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; EGLER C, 2009, J MOL RECOGNIT, V5, P5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Gilbreth RN, 2008, J MOL BIOL, V381, P407, DOI 10.1016/j.jmb.2008.06.014; Haab BB, 2006, MOL CELL PROTEOMICS, V5, P1996, DOI 10.1074/mcp.T600020-MCP200; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kijanka G, 2009, J IMMUNOL METHODS, V340, P132, DOI 10.1016/j.jim.2008.10.008; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Oyama T, 2003, CANCER LETT, V202, P219, DOI 10.1016/j.canlet.2003.08.011; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Safsten P, 2006, ANAL BIOCHEM, V353, P181, DOI 10.1016/j.ab.2006.01.041; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Shrivastava A, 2005, PROTEIN ENG DES SEL, V18, P417, DOI 10.1093/protein/gzi049; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uhlen M, 2008, NAT METHODS, V5, P854, DOI 10.1038/nmeth1008-854; Uhlen M, 2007, MOL CELL PROTEOMICS, V6, P1455; Uhlen M, 2009, J MOL RECOGNIT, V22, P57, DOI 10.1002/jmr.891; Vagner J, 2004, BIOORG MED CHEM LETT, V14, P211, DOI 10.1016/j.bmcl.2003.09.079; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735	33	19	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10728	10.1371/journal.pone.0010728	http://dx.doi.org/10.1371/journal.pone.0010728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502719	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400028
J	Tobler, A; Nijhout, HF				Tobler, Alexandra; Nijhout, H. Frederik			A Switch in the Control of Growth of the Wing Imaginal Disks of Manduca sexta	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDES; SILKWORM BOMBYX-MORI; INSECT BODY-SIZE; TOBACCO HORNWORM; JUVENILE-HORMONE; PROTHORACICOTROPIC HORMONE; DROSOPHILA-MELANOGASTER; FAT-BODY; ECDYSTEROID TITER; STATIC ALLOMETRY	Background: Insulin and ecdysone are the key extrinsic regulators of growth for the wing imaginal disks of insects. In vitro tissue culture studies have shown that these two growth regulators act synergistically: either factor alone stimulates only limited growth, but together they stimulate disks to grow at a rate identical to that observed in situ. It is generally thought that insulin signaling links growth to nutrition, and that starvation stops growth because it inhibits insulin secretion. At the end of larval life feeding stops but the disks continue to grow, so at that time disk growth has become uncoupled from nutrition. We sought to determine at exactly what point in development this uncoupling occurs. Methodology: Growth and cell proliferation in the wing imaginal disks and hemolymph carbohydrate concentrations were measured at various stages in the last larval instar under experimental conditions of starvation, ligation, rescue, and hormone treatment. Principal Findings: Here we show that in the last larval instar of M. sexta, the uncoupling of nutrition and growth occurs as the larva passes the critical weight. Before this time, starvation causes a decline in hemolymph glucose and trehalose and a cessation of wing imaginal disks growth, which can be rescued by injections of trehalose. After the critical weight the trehalose response to starvation disappears, and the expression of insulin becomes decoupled from nutrition. After the critical weight the wing disks loose their sensitivity to repression by juvenile hormone, and factors from the abdomen, but not the brain, are required to drive continued growth. Conclusions: During the last larval instar imaginal disk growth becomes decoupled from somatic growth at the time that the endocrine events of metamorphosis are initiated. These regulatory changes ensure that disk growth continues uninterrupted when the nutritive and endocrine signals undergo the drastic changes associated with metamorphosis.	[Tobler, Alexandra; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC USA	Duke University	Tobler, A (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN USA.	hfn@duke.edu			National Science Foundation [IOS-0641144, IOS-0744952]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants IOS-0641144 and IOS-0744952 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BOLLENBACHER WE, 1981, GEN COMP ENDOCR, V44, P302, DOI 10.1016/0016-6480(81)90005-8; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Browder M.H., 2001, Journal of Insect Science (Tucson), V1, pUnpaginated; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; CYMBOROWSKI B, 1982, J INSECT PHYSIOL, V28, P129, DOI 10.1016/0022-1910(82)90120-2; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; DAI JD, 1994, INVERTEBR REPROD DEV, V26, P187, DOI 10.1080/07924259.1994.9672417; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; DOMINICK OS, 1985, J EXP BIOL, V117, P45; DUTKOWSKI AB, 1974, J INSECT PHYSIOL, V20, P743, DOI 10.1016/0022-1910(74)90194-2; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Iwami M, 1996, INSECT BIOCHEM MOLEC, V26, P25, DOI 10.1016/0965-1748(95)00057-7; JESUDASON P, 1990, INSECT BIOCHEM, V20, P593, DOI 10.1016/0020-1790(90)90071-2; KATO Y, 1987, DEVELOPMENT, V100, P227; KIMURAKAWAKAMI M, 1992, GEN COMP ENDOCR, V86, P257, DOI 10.1016/0016-6480(92)90109-W; Kremen C, 1998, J INSECT PHYSIOL, V44, P287, DOI 10.1016/S0022-1910(97)00121-2; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; NAGASAWA H, 1986, P NATL ACAD SCI USA, V83, P5840, DOI 10.1073/pnas.83.16.5840; NIJHOUT F, 1994, INSECT HORMONES, P267; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; NIJHOUT HF, 1975, BIOL BULL-US, V149, P568, DOI 10.2307/1540387; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Smagghe G, 2001, IN VITRO CELL DEV-AN, V37, P90, DOI 10.1290/1071-2690(2001)037<0090:IVAIVE>2.0.CO;2; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; WATSON RD, 1988, MOL CELL ENDOCRINOL, V57, P251, DOI 10.1016/0303-7207(88)90081-0; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	52	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10723	10.1371/journal.pone.0010723	http://dx.doi.org/10.1371/journal.pone.0010723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502707	gold, Green Published, Green Submitted			2022-12-27	WOS:000277845400025
J	Appler, KK; Brown, AN; Stewart, BS; Behr, MJ; Demarest, VL; Wong, SJ; Bernard, KA				Appler, Kim K.; Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Demarest, Valerie L.; Wong, Susan J.; Bernard, Kristen A.			Persistence of West Nile Virus in the Central Nervous System and Periphery of Mice	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; VIREMIC BLOOD-DONORS; NEW-YORK; CEREBROSPINAL-FLUID; FUNCTIONAL OUTCOMES; GOLDEN-HAMSTER; UNITED-STATES; FOLLOW-UP; IN-VIVO; INFECTION	Most acute infections with RNA viruses are transient and subsequently cleared from the host. Recent evidence, however, suggests that the RNA virus, West Nile virus (WNV), not only causes acute disease, but can persist long term in humans and animal models. Our goal in this study was to develop a mouse model of WNV persistence. We inoculated immunocompetent mice subcutaneously (s.c.) with WNV and examined their tissues for infectious virus and WNV RNA for 16 months (mo) post-inoculation (p.i.). Infectious WNV persisted for 1 mo p.i. in all mice and for 4 mo p.i. in 12% of mice, and WNV RNA persisted for up to 6 mo p.i. in 12% of mice. The frequency of persistence was tissue dependent and was in the following order: skin, spinal cord, brain, lymphoid tissues, kidney, and heart. Viral persistence occurred in the face of a robust antibody response and in the presence of inflammation in the brain. Furthermore, persistence in the central nervous system (CNS) and encephalitis were observed even in mice with subclinical infections. Mice were treated at 1 mo p.i. with cyclophosphamide, and active viral replication resulted, suggesting that lymphocytes are functional during viral persistence. In summary, WNV persisted in the CNS and periphery of mice for up to 6 mo p.i. in mice with subclinical infections. These results have implications for WNV-infected humans. In particular, immunosuppressed patients, organ transplantation, and long term sequelae may be impacted by WNV persistence.	[Appler, Kim K.; Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Demarest, Valerie L.; Wong, Susan J.; Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; [Brown, Ashley N.; Stewart, Barbara S.; Behr, Melissa J.; Wong, Susan J.; Bernard, Kristen A.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Appler, KK (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	kbernard@vetmed.wisc.edu		Brown, Ashley/0000-0001-9993-5241	National Institute of Allergy and Infectious Disease, National Institutes of Health [N01-AI25490]; NIH/NIAID (Northeast Biodefense Center) [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025490, U54AI057158] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID (Northeast Biodefense Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract N01-AI25490. The biosafety level-3 (BSL-3) vivarium at the Wadsworth Center was used, which is funded in part as a core facility by NIH/NIAID U54-AI057158 (Northeast Biodefense Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Briese T, 1999, LANCET, V354, P1650; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Cao NJY, 2005, J NEUROL SCI, V236, P73, DOI 10.1016/j.jns.2005.05.007; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; DeSalvo D, 2004, TRANSPLANTATION, V77, P466, DOI 10.1097/01.TP.0000101434.98873.CB; Gottfried K, 2005, SOUTH MED J, V98, P603, DOI 10.1097/01.SMJ.0000155633.43244.AC; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Kauffman EB, 2003, J CLIN MICROBIOL, V41, P3661, DOI 10.1128/JCM.41.8.3661-3667.2003; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lim PY, 2010, VIROLOGY, V400, P93, DOI 10.1016/j.virol.2010.01.029; Loeb M, 2008, ANN INTERN MED, V149, P232, DOI 10.7326/0003-4819-149-4-200808190-00004; MATHUR A, 1986, J GEN VIROL, V67, P381, DOI 10.1099/0022-1317-67-2-381; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Ostlund EN, 2001, EMERG INFECT DIS, V7, P665; Ou Alan C, 2005, J La State Med Soc, V157, P42; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128; Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004; Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003; Xiao SY, 2001, EMERG INFECT DIS, V7, P714	49	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10649	10.1371/journal.pone.0010649	http://dx.doi.org/10.1371/journal.pone.0010649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498839	Green Submitted, gold, Green Published			2022-12-27	WOS:000277771600013
J	Hwang, JH; Voortman, J; Giovannetti, E; Steinberg, SM; Leon, LG; Kim, YT; Funel, N; Park, JK; Kim, MA; Kang, GH; Kim, SW; Del Chiaro, M; Peters, GJ; Giaccone, G				Hwang, Jin-Hyeok; Voortman, Johannes; Giovannetti, Elisa; Steinberg, Seth M.; Leon, Leticia G.; Kim, Yong-Tae; Funel, Niccola; Park, Joo Kyung; Kim, Min A.; Kang, Gyeong Hoon; Kim, Sun-Whe; Del Chiaro, Marco; Peters, Godefridus J.; Giaccone, Giuseppe			Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; HUMAN CHOLANGIOCARCINOMA; DUCTAL ADENOCARCINOMA; PROGNOSTIC MARKERS; ACTIVATED AKT; EXPRESSION; CELLS; GEMCITABINE; SURVIVAL	Background: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. The high risk of recurrence following surgical resection provides the rationale for adjuvant therapy. However, only a subset of patients benefit from adjuvant therapy. Identification of molecular markers to predict treatment outcome is therefore warranted. The aim of the present study was to evaluate whether expression of novel candidate biomarkers, including microRNAs, can predict clinical outcome in PDAC patients treated with adjuvant therapy. Methodology/Principal Findings: Formalin-fixed paraffin embedded specimens from a cohort of 82 resected Korean PDAC cases were analyzed for protein expression by immunohistochemistry and for microRNA expression using quantitative Real-Time PCR. Cox proportional hazards model analysis in the subgroup of patients treated with adjuvant therapy (N = 52) showed that lower than median miR-21 expression was associated with a significantly lower hazard ratio (HR) for death (HR = 0.316; 95% CI = 0.166-0.600; P = 0.0004) and recurrence (HR = 0.521; 95% CI = 0.280-0.967; P = 0.04). MiR-21 expression status emerged as the single most predictive biomarker for treatment outcome among all 27 biological and 9 clinicopathological factors evaluated. No significant association was detected in patients not treated with adjuvant therapy. In an independent validation cohort of 45 frozen PDAC tissues from Italian cases, all treated with adjuvant therapy, lower than median miR-21 expression was confirmed to be correlated with longer overall as well as disease-free survival. Furthermore, transfection with anti-miR-21 enhanced the chemosensitivity of PDAC cells. Conclusions Significance: Low miR-21 expression was associated with benefit from adjuvant treatment in two independent cohorts of PDAC cases, and anti-miR-21 increased anticancer drug activity in vitro. These data provide evidence that miR-21 may allow stratification for adjuvant therapy, and represents a new potential target for therapy in PDAC.	[Hwang, Jin-Hyeok; Voortman, Johannes; Giaccone, Giuseppe] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Hwang, Jin-Hyeok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Hwang, Jin-Hyeok; Kim, Yong-Tae; Park, Joo Kyung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Voortman, Johannes; Giovannetti, Elisa; Leon, Leticia G.; Peters, Godefridus J.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Giovannetti, Elisa] Univ Pisa, Dept Internal Med, Pisa, Italy; [Steinberg, Seth M.] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA; [Funel, Niccola; Del Chiaro, Marco] Hosp Pisa, Div Chirurg Gen & Trapianti Urem & Diabet, Pisa, Italy; [Kim, Min A.; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Sun-Whe] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 151, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Pisa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU)	Hwang, JH (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	giacconeg@mail.nih.gov	giovannetti, elisa/F-4261-2011; Hwang, Jin-Hyeok/J-5735-2012; Kim, Yong-Tae/E-4148-2012; Kim, Sun-Whe/J-2741-2012; Giaccone, Giuseppe/E-8297-2017; Voortman, J/AAO-1289-2020; Kang, Gyeong Hoon/F-1051-2010; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Giaccone, Giuseppe/0000-0002-5023-7562; Kang, Gyeong Hoon/0000-0003-2380-6675; Funel, Niccola/0000-0002-5028-2363; Peters, Godefridus J/0000-0002-5447-2877	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIDSC007202, ZIABC011269] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part funded by the National Institutes of Health, National Cancer Institute intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese JL, 2008, JAMA-J AM MED ASSOC, V299, P1066, DOI 10.1001/jama.299.9.1066; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco C, 2006, CLIN CANCER RES, V12, P7099, DOI 10.1158/1078-0432.CCR-06-0833; Boeck S, 2007, ONCOLOGY-BASEL, V72, P314, DOI 10.1159/000113054; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Chadha KS, 2006, ANN SURG ONCOL, V13, P933, DOI 10.1245/ASO.2006.07.011; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; COX DR, 1972, J R STAT SOC B, V34, P187; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Funel N, 2008, LAB INVEST, V88, P773, DOI 10.1038/labinvest.2008.40; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P937, DOI 10.1001/jama.297.9.937; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hruban RH, 2001, CANCER J, V7, P251; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katz MHG, 2008, CA-CANCER J CLIN, V58, P111, DOI 10.3322/CA.2007.0012; Leon LG, 2008, CHEMMEDCHEM, V3, P1740, DOI 10.1002/cmdc.200800212; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Neoptolemos J, 2009, J CLIN ONCOL, V27; Neuhaus P, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.lba4504; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Salek C, 2009, ANTICANCER RES, V29, P1803; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tonini G, 2007, EXPERT OPIN THER TAR, V11, P1553, DOI 10.1517/14728222.11.12.1553; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Zhang WM, 2008, ELECTROCHEM COMMUN, V10, P519, DOI 10.1016/j.elecom.2008.01.032; Zuckerman DS, 2008, CANCER-AM CANCER SOC, V112, P243, DOI 10.1002/cncr.23174	65	235	251	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10630	10.1371/journal.pone.0010630	http://dx.doi.org/10.1371/journal.pone.0010630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498843	Green Published, Green Submitted, gold			2022-12-27	WOS:000277771600004
J	Reuter, K; Pittelkow, M; Bursy, J; Heine, A; Craan, T; Bremer, E				Reuter, Klaus; Pittelkow, Marco; Bursy, Jan; Heine, Andreas; Craan, Tobias; Bremer, Erhard			Synthesis of 5-Hydroxyectoine from Ectoine: Crystal Structure of the Non-Heme Iron(II) and 2-Oxoglutarate-Dependent Dioxygenase EctD	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; LATERAL GENE-TRANSFER; PROLINE 4-HYDROXYLASE; ESCHERICHIA-COLI; HYDROXYECTOINE; BACTERIA; GROWTH; STABILIZATION; BIOSYNTHESIS; OXYGENASES	As a response to high osmolality, many microorganisms synthesize various types of compatible solutes. These organic osmolytes aid in offsetting the detrimental effects of low water activity on cell physiology. One of these compatible solutes is ectoine. A sub-group of the ectoine producer's enzymatically convert this tetrahydropyrimidine into a hydroxylated derivative, 5-hydroxyectoine. This compound also functions as an effective osmostress protectant and compatible solute but it possesses properties that differ in several aspects from those of ectoine. The enzyme responsible for ectoine hydroxylation (EctD) is a member of the non-heme iron(II)-containing and 2-oxoglutarate-dependent dioxygenases (EC 1.14.11). These enzymes couple the decarboxylation of 2-oxoglutarate with the formation of a high-energy ferryl-oxo intermediate to catalyze the oxidation of the bound organic substrate. We report here the crystal structure of the ectoine hydroxylase EctD from the moderate halophile Virgibacillus salexigens in complex with Fe3+ at a resolution of 1.85 A. Like other non-heme iron(II) and 2-oxoglutarate dependent dioxygenases, the core of the EctD structure consists of a double-stranded beta-helix forming the main portion of the active-site of the enzyme. The positioning of the iron ligand in the active-site of EctD is mediated by an evolutionarily conserved 2-His-1-carboxylate iron-binding motif. The side chains of the three residues forming this iron-binding site protrude into a deep cavity in the EctD structure that also harbours the 2-oxoglutarate co-substrate-binding site. Database searches revealed a widespread occurrence of EctD-type proteins in members of the Bacteria but only in a single representative of the Archaea, the marine crenarchaeon Nitrosopumilus maritimus. The EctD crystal structure reported here can serve as a template to guide further biochemical and structural studies of this biotechnologically interesting enzyme family.	[Reuter, Klaus; Heine, Andreas; Craan, Tobias] Univ Marburg, Dept Pharm, Inst Pharmaceut Chem, Marburg, Germany; [Pittelkow, Marco; Bursy, Jan; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Reuter, K (corresponding author), Univ Marburg, Dept Pharm, Inst Pharmaceut Chem, Marburg, Germany.	reuterk@staff.uni-marburg.de; bremer@staff.uni-marburg.de		Reuter, Klaus/0000-0003-3673-7971	Philipps-University Marburg; Max-Planck-Institute for Terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie; LOEWE Center for Synthetic Microbiology (Marburg); Bundesministerium fur Bildung und Forschung (BMBF) [05ES3XBA/5]	Philipps-University Marburg; Max-Planck-Institute for Terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); LOEWE Center for Synthetic Microbiology (Marburg); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Philipps-University Marburg (to KR and EB), the Max-Planck-Institute for Terrestrial Microbiology (Marburg) (to EB), the Fonds der Chemischen Industrie and the LOEWE Center for Synthetic Microbiology (Marburg) (to EB). The travel costs to the BESSY II synchrotron in Berlin were covered by a grant to AH from the Bundesministerium fur Bildung und Forschung (BMBF support code: 05ES3XBA/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bestvater Thorsten, 2008, Saline Syst, V4, P12, DOI 10.1186/1746-1448-4-12; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P77; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; da Costa M. S., 1998, V61, P117; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Flashman E, 2007, NAT CHEM BIOL, V3, P86, DOI 10.1038/nchembio0207-86; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmetag V, 2009, FEBS J, V276, P3669, DOI 10.1111/j.1742-4658.2009.07085.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JEBBAR M, 1992, J BACTERIOL, V174, P5027, DOI 10.1128/JB.174.15.5027-5035.1992; Jebbar M, 1997, FEMS MICROBIOL LETT, V154, P325, DOI 10.1111/j.1574-6968.1997.tb12663.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kanapathipillai M, 2008, BIOCHEM BIOPH RES CO, V365, P808, DOI 10.1016/j.bbrc.2007.11.074; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lawrence CC, 1996, BIOCHEM J, V313, P185, DOI 10.1042/bj3130185; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; Malin G, 1996, J BACTERIOL, V178, P385, DOI 10.1128/jb.178.2.385-395.1996; Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moghaieb REA, 2006, PLANT CELL ENVIRON, V29, P173, DOI 10.1111/j.1365-3040.2005.01410.x; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Purpero V, 2007, J BIOL INORG CHEM, V12, P587, DOI 10.1007/s00775-007-0231-0; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Sabirova JS, 2008, FEMS MICROBIOL LETT, V285, P89, DOI 10.1111/j.1574-6968.2008.01222.x; Saum SH, 2008, ENVIRON MICROBIOL, V10, P716, DOI 10.1111/j.1462-2920.2007.01494.x; Schiraldi C, 2006, RES MICROBIOL, V157, P693, DOI 10.1016/j.resmic.2006.03.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schnoor M, 2004, BIOCHEM BIOPH RES CO, V322, P867, DOI 10.1016/j.bbrc.2004.07.200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shibasaki T, 1999, APPL ENVIRON MICROB, V65, P4028; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; SYDLIK U, 2009, AM J RESP C IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wei L, 2009, PATHOBIOLOGY, V76, P212, DOI 10.1159/000218338; Welford RWD, 2005, FEBS LETT, V579, P5170, DOI 10.1016/j.febslet.2005.08.033; You Z, 2007, J BIOL CHEM, V282, P36552, DOI 10.1074/jbc.M706358200	75	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10647	10.1371/journal.pone.0010647	http://dx.doi.org/10.1371/journal.pone.0010647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498719	Green Submitted, Green Published, gold			2022-12-27	WOS:000277771600011
J	Olsen, M; Siegelmann-Danieli, N; Siegelmann, HT				Olsen, Megan; Siegelmann-Danieli, Nava; Siegelmann, Hava T.			Dynamic Computational Model Suggests That Cellular Citizenship Is Fundamental for Selective Tumor Apoptosis	PLOS ONE			English	Article							CANCER; THERAPY; CELLS; MORPHOLOGY; HALLMARKS; DEATH	Computational models in the field of cancer research have focused primarily on estimates of biological events based on laboratory generated data. We introduce a novel in-silico technology that takes us to the next level of prediction models and facilitates innovative solutions through the mathematical system. The model's building blocks are cells defined phenotypically as normal or tumor, with biological processes translated into equations describing the life protocols of the cells in a quantitative and stochastic manner. The essentials of communication in a society composed of normal and tumor cells are explored to reveal "protocols" for selective tumor eradication. Results consistently identify "citizenship properties" among cells that are essential for the induction of healing processes in a healthy system invaded by cancer. These properties act via inter-cellular communication protocols that can be optimized to induce tumor eradication along with system recovery. Within the computational systems, the protocols universally succeed in removing a wide variety of tumors defined by proliferation rates, initial volumes, and apoptosis resistant phenotypes; they show high adaptability for biological details and allow incorporation of population heterogeneity. These protocols work as long as at least 32% of cells obey extra-cellular commands and at least 28% of cancer cells report their deaths. This low percentage implies that the protocols are resilient to the suboptimal situations often seen in biological systems. We conclude that our in-silico model is a powerful tool to investigate, to propose, and to exercise logical anti-cancer solutions. Functional results should be confirmed in a biological system and molecular findings should be loaded into the computational model for the next level of directed experiments.	[Olsen, Megan; Siegelmann, Hava T.] Univ Massachusetts, Dept Comp Sci, Amherst, MA 01003 USA; [Siegelmann-Danieli, Nava] CommuniSef Com, Tel Aviv, Israel; [Siegelmann-Danieli, Nava] Maccabi Hlth Serv, Tel Aviv, Israel	University of Massachusetts System; University of Massachusetts Amherst	Olsen, M (corresponding author), Univ Massachusetts, Dept Comp Sci, Amherst, MA 01003 USA.	hava@cs.umass.edu	Olsen, Megan/AAV-6775-2021	Olsen, Megan/0000-0003-0187-997X	Department of Homeland Security; NSF [0501432]	Department of Homeland Security(United States Department of Homeland Security (DHS)); NSF(National Science Foundation (NSF))	This work was partially funded by a Department of Homeland Security Fellowship (http://www.orau.gov/dhsed/), and an NSF grant ECCS 0501432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LH, 2006, BRIT J CANCER, V95, P1136, DOI 10.1038/sj.bjc.6603310; Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Apetoh L, 2008, CANCER RES, V68, P4026, DOI 10.1158/0008-5472.CAN-08-0427; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Eng C, 2009, CANCER RES, V69, P6759, DOI 10.1158/0008-5472.CAN-09-0985; Fuldo S, 2007, EXPERT REV ANTICANC, V7, P1255, DOI 10.1586/14737140.7.9.1255; Galam S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051907; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hess CJ, 2007, J CLIN ONCOL, V25, P1209, DOI 10.1200/JCO.2006.08.4061; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Kim R, 2006, EJSO-EUR J SURG ONC, V32, P269, DOI 10.1016/j.ejso.2005.12.006; McConkey DJ, 2007, ADV EXP MED BIOL, V608, P31; Olsen MM, 2008, ARTIF INTELL, V172, P884, DOI 10.1016/j.artint.2007.10.015; Pert C., 1999, MOL EMOTION SCI MIND; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; PULTACK IF, 2001, CLIN CANCER RES, V7, P1362; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Simpson MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021918; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	26	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10637	10.1371/journal.pone.0010637	http://dx.doi.org/10.1371/journal.pone.0010637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498709	gold, Green Published			2022-12-27	WOS:000277633500021
J	Chiriva-Internati, M; Yu, YF; Mirandola, L; Jenkins, MR; Chapman, C; Cannon, M; Cobos, E; Kast, WM				Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Chapman, Caroline; Cannon, Martin; Cobos, Everardo; Kast, W. Martin			Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; SPERM PROTEIN-17 SP17; DENDRITIC CELLS; MULTIPLE-MYELOMA; SUITABLE TARGET; SELF-ANTIGEN; TH17 CELLS; IN-VIVO; IMMUNOTHERAPY; CPG	Sperm protein (Sp17) is an attractive target for ovarian cancer (OC) vaccines because of its over-expression in primary as well as in metastatic lesions, at all stages of the disease. Our studies suggest that a Sp17-based vaccine can induce an enduring defense against OC development in C57BL/6 mice with ID8 cells, following prophylactic and therapeutic treatments. This is the first time that a mouse counterpart of a cancer testis antigen (Sp17) was shown to be expressed in an OC mouse model, and that vaccination against this antigen significantly controlled tumor growth. Our study shows that the CpG-adjuvated Sp17 vaccine overcomes the issue of immunologic tolerance, the major barrier to the development of effective immunotherapy for OC. Furthermore, this study provides a better understanding of OC biology by showing that Th-17 cells activation and contemporary immunosuppressive T-reg cells inhibition is required for vaccine efficacy. Taken together, these results indicate that prophylactic and therapeutic vaccinations can induce long-standing protection against OC and delay tumor growth, suggesting that this strategy may provide additional treatments of human OC and the prevention of disease onset in women with a family history of OC.	[Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo] Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA; [Chiriva-Internati, Maurizio; Yu, Yuefei; Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo] SW Canc Treatment & Res Ctr, Lubbock, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Dept Obstet & Gynecol, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Laura W Bush Inst Womens Hlth, Amarillo, TX USA; [Jenkins, Marjorie R.] Texas Tech Univ, Hlth Sci Ctr, Ctr Womens Hlth & Gender Based Med, Amarillo, TX USA; [Chapman, Caroline] Univ Nottingham, Div Breast Surg, Nottingham NG7 2RD, England; [Cannon, Martin] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Kast, W. Martin] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Gynecol & Urol, Los Angeles, CA 90033 USA; [Kast, W. Martin] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Nottingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Southern California; University of Southern California; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa	Chiriva-Internati, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA.	maurizio.chiriva@ttuhsc.edu	Chapman, Caroline/B-7503-2012; Mirandola, Leonardo/B-1575-2013	cobos, everardo/0000-0001-5799-0074; Kast, W Martin/0000-0003-2321-3159	Billy and Ruby Power Endowment for Cancer Research; Laura W. Bush Institute for Women's Health; Center for Women's Health; Gender-Based Medicine	Billy and Ruby Power Endowment for Cancer Research; Laura W. Bush Institute for Women's Health; Center for Women's Health; Gender-Based Medicine	This project was supported by the Billy and Ruby Power Endowment for Cancer Research and Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Benatar T, 2008, CANCER IMMUNOL IMMUN, V57, P1757, DOI 10.1007/s00262-008-0502-9; Benencia F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-21; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Cannon MJ, 2009, EXPERT OPIN BIOL TH, V9, P677, DOI 10.1517/14712590902932897; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Chiriva-Internati M, 2003, BLOOD, V102, P3100, DOI 10.1182/blood-2002-11-3580; Chiriva-Internati M, 2002, CANCER-AM CANCER SOC, V94, P2447, DOI 10.1002/cncr.10506; Chiriva-Internati M, 2002, BLOOD, V100, P961, DOI 10.1182/blood-2002-02-0408; Chiriva-Internati M, 2001, EUR J IMMUNOL, V31, P2277, DOI 10.1002/1521-4141(200108)31:8<2277::AID-IMMU2277>3.0.CO;2-Z; Chiriva-Internati M, 2008, J IMMUNOTHER, V31, P693, DOI 10.1097/CJI.0b013e31818283d5; Chiriva-Internati M, 2007, J IMMUNOL METHODS, V321, P86, DOI 10.1016/j.jim.2007.01.010; Coukos G, 2002, BEST PRACT RES CL OB, V16, P597, DOI 10.1053/beog.2002.9305; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dadabayev AR, 2005, AM J HEMATOL, V80, P6, DOI 10.1002/ajh.20415; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Foster T, 2009, GYNECOL ONCOL, V115, P290, DOI 10.1016/j.ygyno.2009.07.026; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Giuntoli RL, 2009, ANTICANCER RES, V29, P2875; Grizzi F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-23; Grizzi F, 2004, J HISTOCHEM CYTOCHEM, V52, P549, DOI 10.1177/002215540405200414; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Holtz DO, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-2; Hwu P, 2002, J IMMUNOTHER, V25, P189, DOI 10.1097/00002371-200205000-00001; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jin B, 2007, IMMUNOLOGY, V122, P15, DOI 10.1111/j.1365-2567.2007.02607.x; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Markiewicz MA, 2004, CANCER INVEST, V22, P417, DOI 10.1081/CNV-200029072; Mendez S, 2003, INFECT IMMUN, V71, P5121, DOI 10.1128/IAI.71.9.5121-5129.2003; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Munn DH, 2009, BLOOD, V114, P1134, DOI 10.1182/blood-2009-06-224246; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; ORAND MG, 1988, DEV BIOL, V129, P231, DOI 10.1016/0012-1606(88)90177-7; Oumouna M, 2005, J VIROL, V79, P2024, DOI 10.1128/JVI.79.4.2024-2032.2005; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Russo A, 2009, CRIT REV ONCOL HEMAT, V69, P28, DOI 10.1016/j.critrevonc.2008.06.003; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Sprent J, 2000, PHILOS T R SOC B, V355, P317, DOI 10.1098/rstb.2000.0568; Straughn JM, 2004, INT J CANCER, V108, P805, DOI 10.1002/ijc.11617; Sun SQ, 2000, SPRINGER SEMIN IMMUN, V22, P77, DOI 10.1007/s002810000028; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Wen Y, 2001, BIOCHEM J, V357, P25, DOI 10.1042/0264-6021:3570025; Zhou H, 2005, BLOOD, V106, P2026, DOI 10.1182/blood-2005-03-0969; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	59	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10471	10.1371/journal.pone.0010471	http://dx.doi.org/10.1371/journal.pone.0010471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485677	Green Submitted, Green Published, gold			2022-12-27	WOS:000277563400001
J	Fraser, ON; Bugnyar, T				Fraser, Orlaith N.; Bugnyar, Thomas			Do Ravens Show Consolation? Responses to Distressed Others	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; POSTCONFLICT 3RD-PARTY AFFILIATION; MACAQUES MACACA-FASCICULARIS; CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; COMMON RAVENS; RECONCILIATION; EMPATHY; INTELLIGENCE; AGGRESSION	Background: Bystander affiliation (post-conflict affiliation from an uninvolved bystander to the conflict victim) may represent an expression of empathy in which the bystander consoles the victim to alleviate the victim's distress ("consolation''). However, alternative hypotheses for the function of bystander affiliation also exist. Determining whether ravens spontaneously offer consolation to distressed partners may not only help us to understand how animals deal with the costs of aggressive conflict, but may also play an important role in the empathy debate. Methodology/Principal findings: This study investigates the post-conflict behavior of ravens, applying the predictive framework for the function of bystander affiliation for the first time in a non-ape species. We found weak evidence for reconciliation (post-conflict affiliation between former opponents), but strong evidence for both bystander affiliation and solicited bystander affiliation (post-conflict affiliation from the victim to a bystander). Bystanders involved in both interactions were likely to share a valuable relationship with the victim. Bystander affiliation offered to the victim was more likely to occur after intense conflicts. Renewed aggression was less likely to occur after the victim solicited affiliation from a bystander. Conclusions/Significance: Our findings suggest that in ravens, bystanders may console victims with whom they share a valuable relationship, thus alleviating the victims' post-conflict distress. Conversely victims may affiliate with bystanders after a conflict in order to reduce the likelihood of renewed aggression. These results stress the importance of relationship quality in determining the occurrence and function of post-conflict interactions, and show that ravens may be sensitive to the emotions of others.	[Fraser, Orlaith N.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Bugnyar, Thomas] Konrad Lorenz Forschungstelle, Grunau, Austria	University of Vienna	Fraser, ON (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	orlaith.fraser@univie.ac.at			European Science Foundation [I-105-G11]; FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [Y366-B17]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	European Science Foundation(European Science Foundation (ESF)European Commission); FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the European Science Foundation (COCOR: I-105-G11; http://www.esf.org) and the FWF (Fonds zur Foerderung der wissenschaftlichen Forschung; START: Y366-B17; http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2002, BEHAV BRAIN SCI, V25, P21, DOI 10.1017/S0140525X02230010; [Anonymous], 2007, LME4 LINEAR MIXED EF; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; ARNOLD K, PRIMATES PE IN PRESS; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 2002, BEHAV BRAIN SCI, V25, P23, DOI 10.1017/S0140525X02250013; AURELI F, 1991, ETHOLOGY, V89, P101; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Boarman W. I., 1999, BIRDS N AM, V476; Bugnyar T, 2007, CURR BIOL, V17, P1804, DOI 10.1016/j.cub.2007.09.048; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cords M., 2000, NATURAL CONFLICT RES, P177; Dall SRX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004530; Dally J, 2006, J ORNITHOL, V147, P154; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; Heinrich B, 2007, SCI AM, V296, P64, DOI 10.1038/scientificamerican0407-64; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Kazem Anahita J. N., 2006, P191; KOSKI SE, EUR J DEV P IN PRESS; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; MARZLUFF JM, 1991, ANIM BEHAV, V42, P755, DOI 10.1016/S0003-3472(05)80121-6; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; *R DEV COR TEAM, 2009, R LANG STAT COMP VIE; Ratcliffe DA., 1997, RAVEN; ROMERO T, J COMP PSCY IN PRESS; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; VONBLOTZHEIM UNG, 1993, HDB VOGEL MITTELEURO, V13, P600; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wascher CAF, 2008, P ROY SOC B-BIOL SCI, V275, P1653, DOI 10.1098/rspb.2008.0146; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; WITTIG RM, MIND CHIMPA IN PRESS; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203	63	89	91	30	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10605	10.1371/journal.pone.0010605	http://dx.doi.org/10.1371/journal.pone.0010605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485685	Green Published, gold			2022-12-27	WOS:000277563400012
J	Funaioli, T; Cavazza, M; Zandomeneghi, M; Pietra, F				Funaioli, Tiziana; Cavazza, Marino; Zandomeneghi, Maurizio; Pietra, Francesco			On the Chiroptical Behavior of Conjugated Multichromophoric Compounds of a New Pseudoaromatic Class: Bicolchicides and Biisocolchicides	PLOS ONE			English	Article							ELECTRONIC CIRCULAR-DICHROISM; OPTICAL-PROPERTIES; CRYSTAL-STRUCTURE; SOLVATION; SPECTRA; MUTAROTATION; ABSORPTION; COLCHICINE; CHARGE	Background: It is well known that, stemming from the mutual interplay between chromophores, circular dichroism (CD) is a powerful technique to deal with structural problems for both the small organic molecule and the biopolymer. However, quantitative interpretations of the spectroscopic and structural terms that give rise to the exciton couplet are usually presented for ideal cases, or a few CD bands only are taken into account, overlooking the role of the solvent medium. Methodology/Principal Findings: Circular dichroism and UV absorption spectra were carried out for colchicide (3) and isocolchicide (6), as well as their coupling products, 10,10'-bicolchicide (2) and 9,9'-biisocolchicide (5), in both hydrogen bonding and non hydrogen bonding solvents, as well as MeCN/H2O mixtures. A dramatic control by the solvent emerged, as even tiny changes in the composition of solvent mixtures, at ca 1 water molar fraction, induced a dramatic modification of their CD bands. A mutarotation phenomenon - long known for isocolchicine (8) - was also observed for 5, and can be attributed to the interconversion between atropisomers (R-a,7S),(R-a,7'S)-5a and (R-a,7S),(S-a,7'S)-5b. Conclusions/Significance: Our data show that with molecules built on two structurally identical moieties which embody both hydrophilic and hydrophobic groups, even tiny changes in the composition of solvent mixtures cause a dramatic modification of the CD bands. Their analysis arrives at a qualitative rationalization of the observed CD couplets from the coupling of high energy transitions, while attempts at a quantitative interpretation of these phenomena through time-dependent density functional theory allowed to reproduce satisfactorily the CD spectrum in the 300-450 nm region only. Failure with higher energies probably reflects currently inadequate specific theoretical treatments of the solvent medium.	[Funaioli, Tiziana; Cavazza, Marino; Zandomeneghi, Maurizio] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy; [Pietra, Francesco] Accademia Lucchese Sci, Lettere, Lucca, Italy; [Pietra, Francesco] Accademia Lucchese Sci, Arti, Lucca, Italy	University of Pisa	Funaioli, T (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	tiziana@dcci.unipi.it			University of Pisa; MIUR-PRIN	University of Pisa; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the University of Pisa and by MIUR-PRIN 2006-2007 (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Berova N, 2007, CHEM SOC REV, V36, P914, DOI 10.1039/b515476f; BRUHN T, 2009, SPECDIS VERSION 1 45; BUSHNELL JE, 2004, XANNEAL VERSION 0 7; Caricato M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2183309; Cavazza M, 2000, TETRAHEDRON LETT, V41, P9129, DOI 10.1016/S0040-4039(00)01631-2; Cavazza M, 1997, SYNTHETIC COMMUN, V27, P3405, DOI 10.1080/00397919708005641; Cramer CJ, 2008, ACCOUNTS CHEM RES, V41, P760, DOI 10.1021/ar800019z; Crawford TD, 2007, J PHYS CHEM A, V111, P12057, DOI 10.1021/jp075046u; DANIELI B, 1985, HELV CHIM ACTA, V68, P2173, DOI 10.1002/hlca.19850680812; DEVOE H, 1965, J CHEM PHYS, V43, P3199, DOI 10.1063/1.1697294; DEVOE H, 1964, J CHEM PHYS, V41, P393, DOI 10.1063/1.1725879; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Florian J, 1999, J PHYS CHEM B, V103, P10282, DOI 10.1021/jp992041r; Frenkel J, 1931, PHYS REV, V37, P17, DOI 10.1103/PhysRev.37.17; GAFFIELD W, 1984, J CHEM SOC CHEM COMM, P610, DOI 10.1039/c39840000610; Gawronski J, 2004, CURR ORG CHEM, V8, P65, DOI 10.2174/1385272043486052; GILBERT K, 2006, STERIC ENERGY MINIMI; Goerigk L, 2009, J PHYS CHEM A, V113, P767, DOI 10.1021/jp807366r; Harada N., 1983, CIRCULAR DICHROIC SP; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Klamt A, 1996, J CHEM PHYS, V105, P9972, DOI 10.1063/1.472829; Kuhne TD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.066401; KUYPER LF, 1991, J PHYS CHEM-US, V95, P6661, DOI 10.1021/j100170a052; LESSINGER L, 1978, ACTA CRYSTALLOGR B, V34, P1556, DOI 10.1107/S056774087800607X; LESSINGER L, 1978, ACTA CRYSTALLOGR B, V34, P578, DOI 10.1107/S0567740878003568; Major DT, 2006, J AM CHEM SOC, V128, P16345, DOI 10.1021/ja066334r; Petrenko T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770706; Pietra F, 2007, J PHYS ORG CHEM, V20, P1102, DOI 10.1002/poc.1263; RAPOPORT H, 1956, J AM CHEM SOC, V78, P2455, DOI 10.1021/ja01592a030; SEMMELHACK MF, 1971, J AM CHEM SOC, V93, P5908, DOI 10.1021/ja00751a062; Superchi S, 2004, CHIRALITY, V16, P422, DOI 10.1002/chir.20056; Venables DS, 1998, J CHEM PHYS, V108, P4935, DOI 10.1063/1.475902; VERACINI CA, 1972, J CHEM SOC CHEM COMM, P1262, DOI 10.1039/c39720001262; ZANDOMENEGHI M, 1979, J PHYS CHEM-US, V83, P2926, DOI 10.1021/j100485a024; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10617	10.1371/journal.pone.0010617	http://dx.doi.org/10.1371/journal.pone.0010617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485544	Green Submitted, gold, Green Published			2022-12-27	WOS:000277563400020
J	Zhang, YY; Yang, SL; Liu, M; Song, CX; Wu, N; Ling, PX; Chu, E; Lin, XK				Zhang, Yuyan; Yang, Shaoli; Liu, Ming; Song, Chunxia; Wu, Ning; Ling, Peixue; Chu, Edward; Lin, Xiukun			Interaction between Thymidylate Synthase and Its Cognate mRNA in Zebrafish Embryos	PLOS ONE			English	Article							BINDING; PROTEIN; AUTOREGULATION; DEGRADATION; EXPRESSION; INDUCTION; MECHANISM; RESIDUES; CANCER; CELLS	Thymidylate synthase (TS), which catalyzes the de novo synthesis of dUMP, is an important target for cancer therapy. In this report, the effects of 5-fluorouracil (5-FU) and ZD1694 on the regulation of TS gene expression were evaluated in zebrafish embryos. Our results revealed that the expression of TS was increased by about six-fold when embryos were treated with 1.0 mu M 5-FU and there was a greater than 10-fold increase in the TS protein level after treatment with 0.4 mu M ZD1694. Northern blot analysis confirmed that expression of TS mRNA was identical in treated or untreated embryos. Gel shift and immunoprecipitation assays revealed that zebrafish TS was specifically bound with its cognate mRNA in vitro and in vivo. We identified a 20 nt RNA sequence, TS:N20, localized to the 5'-UTR of TS mRNA, which corresponded to nt 13-32; TS:N20 bound to the TS protein with an affinity similar to that of the full-length TS mRNA. The MFold program predicted that TS:N20 formed a stable stem-loop structure similar to that of the cis-acting element found in human TS mRNA. Variant RNAs with either a deletion or mutation in the core motif of TS:N20 were unable to bind to the TS protein. In vitro translation experiments, using the rabbit lysate system, confirmed that zebrafish TS mRNA translation was significantly repressed when an excess amount of TS protein was included in the system. Additionally, a TS stability experiment confirmed that treatment of zebrafish embryos with 5-FU could increase the TS stability significantly, and the half life of TS protein was about 2.7 times longer than in untreated embryos. Our study revealed a structural requirement for the interaction of TS RNA with TS protein. These findings also demonstrated that the increase in TS protein induced by 5-FU occurs at the post-transcriptional level and that increased stability and translation efficiency both contributed to the increase in TS protein levels induced by TS inhibitors.	[Zhang, Yuyan; Yang, Shaoli; Liu, Ming; Song, Chunxia; Wu, Ning; Lin, Xiukun] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Chu, Edward] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Zhang, Yuyan; Wu, Ning] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Ling, Peixue] Inst Biopharmaceut Shandong Prov, Jinan, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Yale University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	linxiukun@yahoo.com		Ling, Peixue/0000-0002-2783-7463; Lin, Xiukun/0000-0002-0306-4953	Department of Sci and Technology of Shandong Province [2007GG1005002]; Chinese Academy of Sciences [KSCX2-YW-104, KZCX2-YW-209]	Department of Sci and Technology of Shandong Province; Chinese Academy of Sciences(Chinese Academy of Sciences)	Supported by the Innovative Project of the Department of Sci and Technology of Shandong Province (No#.2007GG1005002). This work was also supported in part by the innovative projects of Chinese Academy of Sciences (No#KSCX2-YW-104 and KZCX2-YW-209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SH, 2004, BBA-PROTEINS PROTEOM, V1696, P15, DOI 10.1016/j.bbapap.2003.09.005; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; CHU E, 1995, MOL CELL BIOL, V15, P179, DOI 10.1128/MCB.15.1.179; CHU E, 1994, J BIOL CHEM, V269, P20289; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; DANBERG PV, 1997, BIOCHIM BIOPHYS ACTA, V473, P73; DOOLEY K, 2002, CURR OPIN GENE DEV, V10, P252; Du CQ, 2006, J BIOCHEM, V139, P913, DOI 10.1093/jb/mvj100; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Ju JF, 1999, P NATL ACAD SCI USA, V96, P3769, DOI 10.1073/pnas.96.7.3769; KEYOMARSI K, 1988, J BIOL CHEM, V263, P14402; Khaladkar M, 2007, NUCLEIC ACIDS RES, V35, pW300, DOI 10.1093/nar/gkm253; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Krarnarova TV, 2008, BBA-BIOENERGETICS, V1777, P747, DOI 10.1016/j.bbabio.2008.05.446; LIN X, 2000, NUCLEIC ACIDS RES, V28, P4622; Lin XK, 2003, NUCLEIC ACIDS RES, V31, P4882, DOI 10.1093/nar/gkg678; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Liu J, 2002, BBA-MOL BASIS DIS, V1587, P174, DOI 10.1016/S0925-4439(02)00080-7; Mathews David H, 2007, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1102s28; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; SWAIN SM, 1989, J CLIN ONCOL, V7, P890, DOI 10.1200/JCO.1989.7.7.890; Tai NW, 2004, FRONT BIOSCI-LANDMRK, V9, P2521, DOI 10.2741/1413; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	28	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10618	10.1371/journal.pone.0010618	http://dx.doi.org/10.1371/journal.pone.0010618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485548	Green Submitted, Green Published, gold			2022-12-27	WOS:000277563400021
J	Mackenzie, G; Ceesay, SJ; Hill, PC; Walther, M; Bojang, KA; Satoguina, J; Enwere, G; D'Alessandro, U; Saha, D; Ikumapayi, UNA; O'Dempsey, T; Mabey, DCW; Corrah, T; Conway, DJ; Adegbola, RA; Greenwood, BM				Mackenzie, Grant; Ceesay, Serign J.; Hill, Philip C.; Walther, Michael; Bojang, Kalifa A.; Satoguina, Judith; Enwere, Godwin; D'Alessandro, Umberto; Saha, Debasish; Ikumapayi, Usman N. A.; O'Dempsey, Tim; Mabey, David C. W.; Corrah, Tumani; Conway, David J.; Adegbola, Richard A.; Greenwood, Brian M.			A Decline in the Incidence of Invasive Non-Typhoidal Salmonella Infection in the Gambia Temporally Associated with a Decline in Malaria Infection	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; WEST-AFRICA; MALAWIAN CHILDREN; KENYAN CHILDREN; BACTEREMIA; COMMUNITY; PNEUMONIA; MORTALITY; EFFICACY; VACCINE	Background: Malaria is a risk factor for invasive non-typhoidal Salmonella (NTS) infection in children. In the last 10 years, indices of malaria infection in The Gambia have fallen substantially. Methods: We compared temporal trends of childhood malaria and NTS infection in two Gambian locations. In Fajara, on the coast, the incidence of NTS infection at three time points between 1979 and 2005 was compared to the percentage of malaria positive outpatient thick blood films and the percentage of admissions associated with malaria over time. In Basse, in the eastern part of the country, the incidence of NTS infection at three time points between 1989 and 2008 was compared to the prevalence of malaria parasitaemia at four time points between 1992 and 2008. Results: The estimated incidence of NTS infection in Fajara fell from 60 (1979-1984) to 10 (2003-05) cases per 100,000 person years. The proportion of outpatients in Fajara with suspected malaria who were parasitaemic fell from 33% (1999) to 6% (2007) while the proportion of admissions associated with malaria fell from 14.5% (1999) to 5% (2007). In Basse, the estimated incidence of NTS infection fell from 105 (1989-1991) to 29 (2008) cases per 100,000 person years while the prevalence of malaria parasitaemia fell from 45% (1992) to 10% (2008). The incidence of pneumococcal bacteraemia in Fajara and Basse did not fall over the study period. Conclusions: These data support an association between malaria and NTS infection. Reductions in malaria infection may be associated with reduced rates of invasive childhood NTS infection.	[Mackenzie, Grant; Ceesay, Serign J.; Walther, Michael; Bojang, Kalifa A.; Satoguina, Judith; Saha, Debasish; Ikumapayi, Usman N. A.; Corrah, Tumani; Conway, David J.; Adegbola, Richard A.] Med Res Council United Kingdom Gambia, Fajara, Gambia; [Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Enwere, Godwin] Program Appropriate Technol Hlth, Meningitis Vaccine Program, Ferney Voltaire, France; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [O'Dempsey, Tim] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Mabey, David C. W.; Greenwood, Brian M.] London Sch Hyg & Trop Med, London WC1, England; [Adegbola, Richard A.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine; University of Otago; Institute of Tropical Medicine (ITM); Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation	Mackenzie, G (corresponding author), Med Res Council United Kingdom Gambia, Fajara, Gambia.	gmackenzie@mrc.gm	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Mabey, David/0000-0002-0031-8276; Bojang, Kalifa/0000-0001-7506-0938; Mackenzie, Grant/0000-0002-4994-2627; Conway, David/0000-0002-8711-3037	Medical Research Council Fajara Clinical Service [MRC(UK)]; URR Salmonella disease epidemiology	Medical Research Council Fajara Clinical Service [MRC(UK)]; URR Salmonella disease epidemiology	Financial support for the studies which contributed data was as follows: Medical Research Council Fajara Clinical Service [MRC(UK)], URR Salmonella disease epidemiology 1989-91 [MRC(UK), United States Agency for International Development] and 2008 (GAVI's PneumoADIP), Hib vaccine trial (World Health Organization, USAID, The United Nations Children's Fund, United Nations Development Programme), Pneumococcal vaccine trial (National Institutes of Health, WHO, PATH, USAID, Wyeth), Insecticide Treated Net evaluation (UNDP, World Bank, WHO), Malaria vaccine trial [MRC(UK)], Malaria prevalence survey 2008 [MRC(UK)]. The authors thank MRC(UK) The Gambia for the administrative and infrastructure support which made possible all the studies which contributed to this report. The funders of the different studies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bojang KA, 1998, VACCINE, V16, P62, DOI 10.1016/S0264-410X(97)00159-X; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; *GAMB BUR STAT, 2002, GAMB MULT IND CLUST; *GAMB BUR STAT, 1998, GAMB MULT IND CLUST; Gambia Bureau of Statistics, 2007, GAMB MULT IND CLUST; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; NESBITT A, 1989, J TROP PEDIATRICS, V35, P35, DOI 10.1093/tropej/35.1.35; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010	24	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10568	10.1371/journal.pone.0010568	http://dx.doi.org/10.1371/journal.pone.0010568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485496	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000277563200005
J	Shimbo, T; Tanemura, A; Yamazaki, T; Tamai, K; Katayama, I; Kaneda, Y				Shimbo, Takashi; Tanemura, Atsushi; Yamazaki, Takehiko; Tamai, Katsuto; Katayama, Ichiro; Kaneda, Yasufumi			Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; BULLOUS PEMPHIGOID ANTIGEN-1; TUMOR-ASSOCIATED ANTIGENS; PHAGE-DISPLAY SELECTION; T-CELLS; AUTOIMMUNE-DISEASE; VITILIGO; GENE; IDENTIFICATION; INTERFERON	Malignant melanoma is one of the most aggressive types of tumor. Because malignant melanoma is difficult to treat once it has metastasized, early detection and treatment are essential. The search for reliable biomarkers of early-stage melanoma, therefore, has received much attention. By using a novel method of screening tumor antigens and their auto-antibodies, we identified bullous pemphigoid antigen 1 (BPAG1) as a melanoma antigen recognized by its auto-antibody. BPAG1 is an auto-antigen in the skin disease bullous pemphigoid (BP) and anti-BPAG1 auto-antibodies are detectable in sera from BP patients and are used for BP diagnosis. However, BPAG1 has been viewed as predominantly a keratinocyte-associated protein and a relationship between BPAG1 expression and melanoma has not been previously reported. In the present study, we show that bpag1 is expressed in the mouse F10 melanoma cell line in vitro and F10 melanoma tumors in vivo and that BPAG1 is expressed in human melanoma cell lines (A375 and G361) and normal human melanocytes. Moreover, the levels of anti-BPAG1 auto-antibodies in the sera of melanoma patients were significantly higher than in the sera of healthy volunteers (p<0.01). Furthermore, anti-BPAG1 auto-antibodies were detected in melanoma patients at both early and advanced stages of disease. Here, we report anti-BPAG1 auto-antibodies as a promising marker for the diagnosis of melanoma, and we discuss the significance of the detection of such auto-antibodies in cancer biology and patients.	[Shimbo, Takashi; Yamazaki, Takehiko; Tamai, Katsuto; Kaneda, Yasufumi] Osaka Univ, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan; [Tanemura, Atsushi; Katayama, Ichiro] Osaka Univ, Dept Dermatol, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University	Shimbo, T (corresponding author), Osaka Univ, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan.	kaneday@gts.med.osaka-u.ac.jp			Biomedical Cluster Kansai; Ministry of Education, Culture, Sports, Science and Technology	Biomedical Cluster Kansai; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the Biomedical Cluster Kansai project, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosserhoff AK, 2006, CLIN CHIM ACTA, V367, P28, DOI 10.1016/j.cca.2005.10.029; Brochez L, 2000, BRIT J DERMATOL, V143, P256, DOI 10.1046/j.1365-2133.2000.03649.x; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BYSTRYN JC, 1989, CLIN DERMATOL, V7, P136, DOI 10.1016/0738-081X(89)90063-1; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Ehlken H, 2004, INT J CANCER, V108, P307, DOI 10.1002/ijc.11537; Forgber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005199; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Ikuta Y, 2005, CLIN CANCER RES, V11, P8079, DOI 10.1158/1078-0432.CCR-05-1074; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y; Kawakami Y, 1997, IMMUNOL RES, V16, P313, DOI 10.1007/BF02786397; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; LABIB RS, 1986, J IMMUNOL, V136, P1231; Lee CW, 2000, BRIT J DERMATOL, V143, P821, DOI 10.1046/j.1365-2133.2000.03838.x; Lee Lewis, 2007, V136, P369; Li G, 2004, CANCER IMMUNOL IMMUN, V53, P139, DOI 10.1007/s00262-003-0471-y; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; MUTASIM DF, 1985, J INVEST DERMATOL, V84, P47, DOI 10.1111/1523-1747.ep12274684; Nakatsura T, 2004, CLIN CANCER RES, V10, P6612, DOI 10.1158/1078-0432.CCR-04-0348; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Ram M, 2007, ANN NY ACAD SCI, V1110, P410, DOI 10.1196/annals.1423.043; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Sun YJ, 2009, J IMMUNOL METHODS, V347, P46, DOI 10.1016/j.jim.2009.06.002; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235	39	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10566	10.1371/journal.pone.0010566	http://dx.doi.org/10.1371/journal.pone.0010566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479946	Green Submitted, gold, Green Published			2022-12-27	WOS:000277467900018
J	Huang, PY; Huang, CT; Tsao, KC; Ye, JJ; Shie, SS; Yang, MY; Leu, HS; Chiang, PC; Weng, YC				Huang, Po-Yen; Huang, Ching-Tai; Tsao, Kuo-Chien; Ye, Jung-Jr; Shie, Shian-Sen; Yang, Ming-Yi; Leu, Hsieh-Shong; Chiang, Ping-Cherng; Weng, Yin-Che			Syndromic Recognition of Influenza A Infection in a Low Prevalence Community Setting	PLOS ONE			English	Article							CLINICAL-DIAGNOSIS; VIRUS	Background: With epidemics of influenza A virus infection, people and medical professionals are all concerned about symptoms or syndromes that may indicate the infection with influenza A virus. Methodology/Principal Findings: A prospective study was performed at a community clinic of a metropolitan area. Throat swab was sampled for 3-6 consecutive adult patients with new episode (< 3 days) of respiratory tract infection every weekday from Dec. 8, 2005 to Mar. 31, 2006. Demographic data, relevant history, symptoms and signs were recorded. Samples were processed with multiplex real time PCR for 9 common respiratory tract pathogens and by virus culture. Throat swab samples were positive for Influenza A virus with multiplex real time PCR system in 12 of 240 patients. The 12 influenza A positive cases were with more clusters and chills than the other 228. Certain symptoms and syndromes increased the likelihood of influenza A virus infection. The syndrome of high fever plus chills plus cough, better with clustering of cases in household or workplace, is with the highest likelihood (positive likelihood ratio 95; 95% CI 12-750). Absence of both cluster and chills provides moderate evidence against the infection (negative likelihood ratio 0.51; 95% CI 0.29-0.90). Conclusions/Significance: Syndromic recognition is not diagnostic but is useful for discriminating between influenza A infection and common cold. In addition to relevant travel history, confirmatory molecular test can be applied to subjects with high likelihood when the disease prevalence is low.	[Huang, Po-Yen; Huang, Ching-Tai; Ye, Jung-Jr; Shie, Shian-Sen; Yang, Ming-Yi; Leu, Hsieh-Shong; Chiang, Ping-Cherng] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med, Div Infect Dis, Tao Yuan, Taiwan; [Huang, Ching-Tai; Leu, Hsieh-Shong] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Dept Biotechnol & Lab Sci, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Weng, Yin-Che] Min Shen Weng Community Clin, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Huang, PY (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Med, Div Infect Dis, Tao Yuan, Taiwan.	chingtaihuang@gmail.com	Chuang, shengHao/C-8217-2012		Chang Gung Memorial Hospital in Taiwan [CMRPG3201S, CMRPG370861, CMRP 350331]; National Science Council of Taiwan [NMRPG370061]	Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from the Chang Gung Memorial Hospital in Taiwan (number CMRPG3201S, CMRPG370861 and CMRP 350331) and from the National Science Council of Taiwan (number NMRPG370061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; *CDC, CDC FLU ACT SURV; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630	11	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10542	10.1371/journal.pone.0010542	http://dx.doi.org/10.1371/journal.pone.0010542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479882	Green Submitted, Green Published, gold			2022-12-27	WOS:000277467800023
J	Hofmann, T; Chubanov, V; Chen, XD; Dietz, AS; Gudermann, T; Montell, C				Hofmann, Thomas; Chubanov, Vladimir; Chen, Xiaodi; Dietz, Anna S.; Gudermann, Thomas; Montell, Craig			Drosophila TRPM Channel Is Essential for the Control of Extracellular Magnesium Levels	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; MG2+ HOMEOSTASIS; SECONDARY HYPOCALCEMIA; RECEPTOR-CELLS; HYPOMAGNESEMIA; IDENTIFICATION; MELANOGASTER; HEMOLYMPH; TRANSPORT; CALCIUM	The TRPM group of cation channels plays diverse roles ranging from sensory signaling to Mg(2+) homeostasis. In most metazoan organisms the TRPM subfamily is comprised of multiple members, including eight in humans. However, the Drosophila TRPM subfamily is unusual in that it consists of a single member. Currently, the functional requirements for this channel have not been reported. Here, we found that the Drosophila TRPM protein was expressed in the fly counterpart of mammalian kidneys, the Malpighian tubules, which function in the removal of electrolytes and toxic components from the hemolymph. We generated mutations in trpm and found that this resulted in shortening of the Malpighian tubules. In contrast to all other Drosophila trp mutations, loss of trpm was essential for viability, as trpm mutations resulted in pupal lethality. Supplementation of the diet with a high concentration of Mg(2+) exacerbated the phenotype, resulting in growth arrest during the larval period. Feeding high Mg(2+) also resulted in elevated Mg(2+) in the hemolymph, but had relatively little effect on cellular Mg(2+). We conclude that loss of Drosophila trpm leads to hypermagnesemia due to a defect in removal of Mg(2+) from the hemolymph. These data provide the first evidence for a role for a Drosophila TRP channel in Mg(2+) homeostasis, and underscore a broad and evolutionarily conserved role for TRPM channels in Mg(2+) homeostasis.	[Hofmann, Thomas; Chen, Xiaodi; Dietz, Anna S.] Univ Marburg, Inst Pharmakol & Toxikol, D-3550 Marburg, Germany; [Chubanov, Vladimir; Gudermann, Thomas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-8000 Munich, Germany; [Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Philipps University Marburg; University of Munich; Johns Hopkins University; Johns Hopkins University	Hofmann, T (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, D-3550 Marburg, Germany.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Chen, Xiaodi/C-9969-2013	Montell, Craig/0000-0001-5637-1482; Chen, Xiaodi/0000-0002-1860-2814	Deutsche Forschungsgemeinschaft; National Eye Institute [EY10852]; National Institute of General Medical Sciences [GM085335]; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. H., X. C. and A. D. were supported by a grant to T. H. from the Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft. V. C. and T. G. were supported by the Deutsche Forschungsgemeinschaft, and C. M. was supported by grants from the National Eye Institute (EY10852) and the National Institute of General Medical Sciences (GM085335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM ME, 1978, BIOCHEM GENET, V16, P101, DOI 10.1007/BF00484387; DIRSCHERL W, 1953, MIKROCHEM MIKROCHIM, V40, P322; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; LEARY NO, 1992, CLIN CHEM, V38, P904; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACK SR, 1978, J PARASITOL, V64, P918, DOI 10.2307/3279531; MacPherson MR, 2005, GENETICS, V169, P1541, DOI 10.1534/genetics.104.035139; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; Quamme GA, 2008, CURR OPIN GASTROEN, V24, P230, DOI 10.1097/MOG.0b013e3282f37b59; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; REICHHART JM, 1998, DROS INFO SERV, V81, P201; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Teramoto T, 2010, PLOS ONE, V5, pA228, DOI 10.1371/journal.pone.0009589; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wessing A, 1999, J INSECT PHYSIOL, V45, P39, DOI 10.1016/S0022-1910(98)00097-3; WESSING A, 1988, EUR J CELL BIOL, V47, P1; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	29	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10519	10.1371/journal.pone.0010519	http://dx.doi.org/10.1371/journal.pone.0010519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463899	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379800013
J	Hinz, A; Hulsik, DL; Forsman, A; Koh, WWL; Belrhali, H; Gorlani, A; de Haard, H; Weiss, RA; Verrips, T; Weissenhorn, W				Hinz, Andreas; Hulsik, David Lutje; Forsman, Anna; Koh, Willie Wee-Lee; Belrhali, Hassan; Gorlani, Andrea; de Haard, Hans; Weiss, Robin A.; Verrips, Theo; Weissenhorn, Winfried			Crystal Structure of the Neutralizing Llama V-HH D7 and Its Mode of HIV-1 gp120 Interaction	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; CD4 BINDING-SITE; PROXIMAL EXTERNAL REGION; FUSION INHIBITOR T-20; ENVELOPE GLYCOPROTEIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE-FUSION; HEAVY-CHAIN; GP41	HIV-1 entry into host cells is mediated by the sequential binding of the envelope glycoprotein gp120 to CD4 and a chemokine receptor. Antibodies binding to epitopes overlapping the CD4-binding site on gp120 are potent inhibitors of HIV entry, such as the llama heavy chain antibody fragment V-HH D7, which has cross-clade neutralizing properties and competes with CD4 and mAb b12 for high affinity binding to gp120. We report the crystal structure of the D7 V-HH at 1.5 angstrom resolution, which reveals the molecular details of the complementarity determining regions (CDR) and substantial flexibility of CDR3 that could facilitate an induced fit interaction with gp120. Structural comparison of CDRs from other CD4 binding site antibodies suggests diverse modes of interaction. Mutational analysis identified CDR3 as a key component of gp120 interaction as determined by surface plasmon resonance. A decrease in affinity is directly coupled to the neutralization efficiency since mutations that decrease gp120 interaction increase the IC50 required for HIV-1 IIIB neutralization. Thus the structural study identifies the long CDR3 of D7 as the key determinant of interaction and HIV-1 neutralization. Furthermore, our data confirm that the structural plasticity of gp120 can accommodate multiple modes of antibody binding within the CD4 binding site.	[Hinz, Andreas; Hulsik, David Lutje; Belrhali, Hassan; Weissenhorn, Winfried] Univ Grenoble 1, CNRS, EMBL, UVHCI,UMI 3265, Grenoble, France; [Hulsik, David Lutje; Gorlani, Andrea; de Haard, Hans; Verrips, Theo] Univ Utrecht, Dept Cellular Architecture & Dynam, Utrecht, Netherlands; [Forsman, Anna; Koh, Willie Wee-Lee; Weiss, Robin A.] UCL, Ctr Med Mol Virol, MRC, Div Infect & Immun, London, England	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Utrecht University; University of London; University College London	Hinz, A (corresponding author), Univ Grenoble 1, CNRS, EMBL, UVHCI,UMI 3265, Grenoble, France.	weissenhorn@embl.fr	gorlani, andrea/C-5678-2014		Bill and Melinda Gates Foundation; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was conducted as part of the Collaboration for AIDS Vaccine Discovery with support from the Bill and Melinda Gates Foundation (to W. W., R. A. W. and T. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAGLEY J, 1994, MOL IMMUNOL, V31, P1149, DOI 10.1016/0161-5890(94)90029-9; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P157; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LESLIE AG, 1992, JNT CCP4 ESF EACMB N, V26; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Litwin V, 1996, J VIROL, V70, P6437, DOI 10.1128/JVI.70.9.6437-6441.1996; Lopes TS, 1996, YEAST, V12, P467, DOI 10.1002/(SICI)1097-0061(199604)12:5<467::AID-YEA933>3.0.CO;2-3; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE JP, 1994, J VIROL, V68, P8350, DOI 10.1128/JVI.68.12.8350-8364.1994; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; PANCERA M, 2009, P NATL ACAD SCI US; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; Prabakaran P, 2006, J MOL BIOL, V357, P82, DOI 10.1016/j.jmb.2005.12.062; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sattentau Q, 2008, CURR OPIN HIV AIDS, V3, P368, DOI 10.1097/COH.0b013e3282f9ae79; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van de Laar T, 2007, BIOTECHNOL BIOENG, V96, P483, DOI 10.1002/bit.21150; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	58	25	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10482	10.1371/journal.pone.0010482	http://dx.doi.org/10.1371/journal.pone.0010482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463957	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400018
J	Mailhot, G; Rabasa-Lhoret, R; Moreau, A; Berthiaume, Y; Levy, E				Mailhot, Genevieve; Rabasa-Lhoret, Remi; Moreau, Alain; Berthiaume, Yves; Levy, Emile			CFTR Depletion Results in Changes in Fatty Acid Composition and Promotes Lipogenesis in Intestinal Caco 2/15 Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; INSULIN-RESISTANCE; BINDING PROTEIN; LIPID-SYNTHESIS; APOLIPOPROTEIN BIOGENESIS; CHOLESTEROL ABSORPTION; KNOCKOUT MICE; ANIMAL-MODEL	Background: Abnormal fatty acid composition (FA) in plasma and tissue lipids frequently occurs in homozygous and even in heterozygous carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. The mechanism(s) underlying these abnormalities remained, however, poorly understood despite the potentially CFTR contributing role. Methodology/Principal Findings: The aim of the present study was to investigate the impact of CFTR depletion on FA uptake, composition and metabolism using the intestinal Caco-2/15 cell line. shRNA-mediated cftr gene silencing induced qualitative and quantitative modifications in FA composition in differentiated enterocytes as determined by gas-liquid chromatography. With the cftr gene disruption, there was a 1,5 fold increase in the total FA amount, largely attributable to monounsaturated and saturated FA compared to controls. The activity of delta-7 desaturase, estimated by the 16: 1(n-7)/16:0, was significantly higher in knockdown cells and consistent with the striking elevation of the n-7 FA family. When incubated with [C-14]-oleic acid, CFTR-depleted cells were capable of quick incorporation and export to the medium concomitantly with the high protein expression of L-FABP known to promote intracellular FA trafficking. Accordingly, lipoprotein vehicles (CM, VLDL, LDL and HDL), isolated from CFTR knockdown cells, exhibited higher levels of radiolabeled FA. Moreover, in the presence of [C-14]-acetate, knockdown cells exhibited enhanced secretion of newly synthesized phospholipids, triglycerides, cholesteryl esters and free FA, thereby suggesting a stimulation of the lipogenic pathway. Conformably, gene expression of SREBP-1c, a key lipogenic transcription factor, was increased while protein expression of the phosphorylated and inactive form of acetylCoA carboxylase was reduced, confirming lipogenesis induction. Finally, CFTR-depleted cells exhibited lower gene expression of transcription factors (PPAR alpha, LXR alpha, LXR beta and RXR alpha). Conclusions/Significance: Collectively, our results indicate that CFTR depletion may disrupt FA homeostasis in intestinal cells through alterations in FA uptake and transport combined with stimulation of lipogenesis that occurs by an LXR/RXR-independent mechanism. These findings exclude a contributing role of CFTR in CF-associated fat malabsorption.	[Mailhot, Genevieve; Moreau, Alain; Levy, Emile] Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada; [Mailhot, Genevieve; Rabasa-Lhoret, Remi; Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Moreau, Alain] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Berthiaume, Yves] CHUM Hotel Dieu, Cyst Fibrosis Clin, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Univ Montreal, CHUM Hotel Dieu, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Univ Montreal, Diabet & Metab Dis Res Grp, Inst Rech Clin, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Mailhot, G (corresponding author), Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada.	emile.levy@recherche-ste-Justine.qc.ca	Berthiaume, Yves/K-7588-2012; Mailhot, Genevieve/AAL-1310-2020; Mailhot, Genevieve/AAB-8928-2020	Mailhot, Genevieve/0000-0002-2673-6492; 	Canadian Institutes of Health Research [82714]; Canadian Cystic Fibrosis Foundation; JA deSeve Research Chair in nutrition	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; JA deSeve Research Chair in nutrition	The current work was supported by research grants from the Canadian Institutes of Health Research (MOP#82714), Canadian Cystic Fibrosis Foundation and JA deSeve Research Chair in nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Turkmani MR, 2008, J LIPID RES, V49, P1946, DOI 10.1194/jlr.M800035-JLR200; Andersson C, 2008, J LIPID RES, V49, P1692, DOI 10.1194/jlr.M700388-JLR200; Bhura-Bandali FN, 2000, J NUTR, V130, P2870, DOI 10.1093/jn/130.12.2870; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; BRASITUS TA, 1985, BIOCHIM BIOPHYS ACTA, V812, P460, DOI 10.1016/0005-2736(85)90321-9; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Russell M, 2006, CELL SIGNAL, V18, P1595, DOI 10.1016/j.cellsig.2006.01.001; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Durieu I, 2007, J CYST FIBROS, V6, P320, DOI 10.1016/j.jcf.2006.12.005; FARRELL PM, 1985, PEDIATR RES, V19, P104, DOI 10.1203/00006450-198501000-00028; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Figueroa V, 2002, AM J CLIN NUTR, V75, P1005, DOI 10.1093/ajcn/75.6.1005; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Grenier E, 2007, AM J PHYSIOL-GASTR L, V293, pG1178, DOI 10.1152/ajpgi.00295.2007; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Iuliano L, 2009, AM J CLIN NUTR, V90, P477, DOI 10.3945/ajcn.2009.27757; Kalivianakis M, 1999, AM J CLIN NUTR, V69, P127; KANG JX, 1992, BIOCHEM J, V285, P725, DOI 10.1042/bj2850725; LEPAGE G, 1989, J LIPID RES, V30, P1483; LEPAGE G, 1986, J LIPID RES, V27, P114; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; LEVY E, 1992, AM J PHYSIOL, V262, pG319, DOI 10.1152/ajpgi.1992.262.2.G319; Li N, 2004, AM J PHYSIOL-GASTR L, V287, pG726, DOI 10.1152/ajpgi.00012.2004; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luxon BA, 2000, BBA-MOL CELL BIOL L, V1487, P309, DOI 10.1016/S1388-1981(00)00104-9; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Marcil V, 2003, J NUTR, V133, P2180, DOI 10.1093/jn/133.7.2180; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Mimoun M, 2009, J NUTR, V139, P2358, DOI 10.3945/jn.109.110999; Montoudis A, 2006, BIOCHEM BIOPH RES CO, V339, P248, DOI 10.1016/j.bbrc.2005.10.202; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ollero M, 2006, METABOLISM, V55, P1192, DOI 10.1016/j.metabol.2006.05.002; Pencharz PB, 2000, CLIN NUTR, V19, P387, DOI 10.1054/clnu.1999.0079; Peretti N, 2005, Nutr Metab (Lond), V2, P11, DOI 10.1186/1743-7075-2-11; Peretti N, 2006, AM J PHYSIOL-GASTR L, V290, pG609, DOI 10.1152/ajpgi.00332.2005; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Ravid Z, 2008, AM J PHYSIOL-GASTR L, V295, pG873, DOI 10.1152/ajpgi.90376.2008; Roulet M, 1997, EUR J PEDIATR, V156, P952, DOI 10.1007/s004310050750; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Werner A, 2004, J LIPID RES, V45, P2277, DOI 10.1194/jlr.M400238-JLR200; Wojtaszewski JFP, 2002, BIOCHEM BIOPH RES CO, V298, P309, DOI 10.1016/S0006-291X(02)02465-8; Xu YQ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-26; ZENTLERMUNRO PL, 1985, GUT, V26, P892, DOI 10.1136/gut.26.9.892; Zoltowska M, 2003, DIABETES, V52, P2539, DOI 10.2337/diabetes.52.10.2539	59	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10446	10.1371/journal.pone.0010446	http://dx.doi.org/10.1371/journal.pone.0010446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463919	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400009
J	Mwagomba, B; Zachariah, R; Massaquoi, M; Misindi, D; Manzi, M; Mandere, BC; Bemelmans, M; Philips, M; Kamoto, K; Schouten, EJ; Harries, AD				Mwagomba, Beatrice; Zachariah, Rony; Massaquoi, Moses; Misindi, Dalitso; Manzi, Marcel; Mandere, Bester C.; Bemelmans, Marielle; Philips, Mit; Kamoto, Kelita; Schouten, Eric J.; Harries, Anthony D.			Mortality Reduction Associated with HIV/AIDS Care and Antiretroviral Treatment in Rural Malawi: Evidence from Registers, Coffin Sales and Funerals	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; ADULT MORTALITY; SOUTH-AFRICA; ADDIS-ABABA; HIV; THERAPY; POPULATION; AIDS; ETHIOPIA; DISTRICT	Background: To report on the trend in all-cause mortality in a rural district of Malawi that has successfully scaled-up HIV/AIDS care including antiretroviral treatment (ART) to its population, through corroborative evidence from a) registered deaths at traditional authorities (TAs), b) coffin sales and c) church funerals. Methods and Findings: Retrospective study in 5 of 12 TAs (covering approximately 50% of the population) during the period 2000-2007. A total of 210 villages, 24 coffin workshops and 23 churches were included. There were a total of 18,473 registered deaths at TAs, 15781 coffins sold, and 2762 church funerals. Between 2000 and 2007, there was a highly significant linear downward trend in death rates, sale of coffins and church funerals (X(2) for linear trend: 338.4 P < 0.0001, 989 P < 0.0001 and 197, P < 0.0001 respectively). Using data from TAs as the most reliable source of data on deaths, overall death rate reduction was 37% (95% Cl:33-40) for the period. The mean annual incremental death rate reduction was 0.52/1000/year. Death rates decreased over time as the percentage of people living with HIV/AIDS enrolled into care and ART increased. Extrapolating these data to the entire district population, an estimated 10,156 (95% Cl: 9786-10259) deaths would have been averted during the 8-year period. Conclusions: Registered deaths at traditional authorities, the sale of coffins and church funerals showed a significant downward trend over a 8-year period which we believe was associated with the scaling up HIV/AIDS care and ART.	[Mwagomba, Beatrice] Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi; [Zachariah, Rony; Manzi, Marcel] Med Sans Frontieres, Med Dept Operat Res, Brussels Operat Ctr, Luxembourg, Luxembourg; [Massaquoi, Moses; Misindi, Dalitso; Bemelmans, Marielle] Med Sans Frontieres, Thyolo, Malawi; [Mandere, Bester C.] Thyolo Dist Assembly, Thyolo, Malawi; [Philips, Mit] Med Sans Frontieres, Anal & Advocacy Unit, Brussels Operat Ctr, Brussels, Belgium; [Kamoto, Kelita; Schouten, Eric J.] Minist Hlth & Populat, Lilongwe, Malawi; [Schouten, Eric J.] Management Sci Hlth, Lilongwe, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine	Mwagomba, B (corresponding author), Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi.	zachariah@internet.lu		zachariah, rony/0000-0002-2915-9328	Medecins Sans Frontieres; EuropeAid; Directorate General of cooperation of the Belgium Government; Children's Investment Fund Foundation; Global Fund for AIDS; Tuberculosis and Malaria; M�decins Sans Fronti�res [09_NAT_ERB_003] Funding Source: researchfish	Medecins Sans Frontieres; EuropeAid; Directorate General of cooperation of the Belgium Government; Children's Investment Fund Foundation; Global Fund for AIDS; Tuberculosis and Malaria; M�decins Sans Fronti�res	The Thyolo district HIV/AIDS program is supported by Medecins Sans Frontieres. The authors are also very grateful to EuropeAid, the Directorate General of cooperation of the Belgium Government, Children's Investment Fund Foundation, the Global Fund for AIDS, Tuberculosis and Malaria, and the World Health Organization for their continuing support for HIV/AIDS activities in Malawi. The authors thank an anonymous donor for his support for operational research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BBC NEWS; Antunes JLF, 2005, INT J EPIDEMIOL, V34, P586, DOI 10.1093/ije/dyi022; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; MAHERS CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; *MIN HLTH POP, 2003, GUID US ANT THER MAL; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *MOHP, 2004, IMM COV DISTR MAL; *MOHP, 2007, HIV SYPH SER NAT HIV; Musila JW, 2002, ECON MODEL, V19, P295, DOI 10.1016/S0264-9993(01)00065-7; *NSO, 2007, POP FIG YEAR THYL DI; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Sanders E, 2003, AIDS, V17, P1209, DOI 10.1097/00002030-200305230-00013; SMITH A, 2009, VITAL REGISTRATION S; Stover J., 2008, SEX TRANSM INFECT S1, V84, P24, DOI DOI 10.1136/STI.2008.029868; Stover J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003729; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	27	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10452	10.1371/journal.pone.0010452	http://dx.doi.org/10.1371/journal.pone.0010452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454611	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000277305300004
J	Cohen, AD; Schaer, DA; Liu, CL; Li, YY; Hirschhorn-Cymmerman, D; Kim, SC; Diab, A; Rizzuto, G; Duan, F; Perales, MA; Merghoub, T; Houghton, AN; Wolchok, JD				Cohen, Adam D.; Schaer, David A.; Liu, Cailian; Li, Yanyun; Hirschhorn-Cymmerman, Daniel; Kim, Soo Chong; Diab, Adi; Rizzuto, Gabrielle; Duan, Fei; Perales, Miguel A.; Merghoub, Taha; Houghton, Alan N.; Wolchok, Jedd D.			Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; TRANSCRIPTION FACTOR FOXP3; IN-VIVO; CUTTING EDGE; ACTIVATION; CD4(+); EXPRESSION; EFFECTOR; LIGAND; SUPPRESSION	In vivo GITR ligation has previously been shown to augment T-cell-mediated anti-tumor immunity, yet the underlying mechanisms of this activity, particularly its in vivo effects on CD4+ foxp3+ regulatory T cells (Tregs), have not been fully elucidated. In order to translate this immunotherapeutic approach to the clinic it is important gain better understanding of its mechanism(s) of action. Utilizing the agonist anti-GITR monoclonal antibody DTA-1, we found that in vivo GITR ligation modulates regulatory T cells (Tregs) directly during induction of melanoma tumor immunity. As a monotherapy, DTA-1 induced regression of small established B16 melanoma tumors. Although DTA-1 did not alter systemic Treg frequencies nor abrogate the intrinsic suppressive activity of Tregs within the tumor-draining lymph node, intra-tumor Treg accumulation was significantly impaired. This resulted in a greater Teff: Treg ratio and enhanced tumor-specific CD8+ T-cell activity. The decreased intra-tumor Treg accumulation was due both to impaired infiltration, coupled with DTA-1-induced loss of foxp3 expression in intra-tumor Tregs. Histological analysis of B16 tumors grown in Foxp3-GFP mice showed that the majority of GFP+ cells had lost Foxp3 expression. These "unstable'' Tregs were absent in IgG-treated tumors and in DTA-1 treated TDLN, demonstrating a tumor-specific effect. Impairment of Treg infiltration was lost if Tregs were GITR(-/-), and the protective effects of DTA-1 were reduced in reconstituted RAG1(-/-) mice if either the Treg or Teff subset were GITR-negative and absent if both were negative. Our results demonstrate that DTA-1 modulates both Teffs and Tregs during effective tumor treatment. The data suggest that DTA-1 prevents intra-tumor Treg accumulation by altering their stability, and as a result of the loss of foxp3 expression, may modify their intra-tumor suppressive capacity. These findings provide further support for the continued development of agonist anti-GITR mAbs as an immunotherapeutic strategy for cancer.	[Cohen, Adam D.; Perales, Miguel A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Schaer, David A.; Liu, Cailian; Li, Yanyun; Hirschhorn-Cymmerman, Daniel; Kim, Soo Chong; Diab, Adi; Rizzuto, Gabrielle; Duan, Fei; Merghoub, Taha; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst Canc Res, Program Immunol, New York, NY USA; [Cohen, Adam D.; Rizzuto, Gabrielle; Duan, Fei; Perales, Miguel A.; Houghton, Alan N.; Wolchok, Jedd D.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Cohen, AD (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	wolchokj@mskcc.org	Cohen, Adam D/F-6729-2012; Merghoub, Taha/ABD-8362-2021; Rizzuto, Gabrielle/GWR-2224-2022	Cohen, Adam/0000-0003-0939-3843; Rizzuto, Gabrielle/0000-0003-3052-0253; Duan, Fei/0000-0002-4659-0144	ASCO Young Investigator Award; Charles A. Dana Foundation; H-C Fellowship; NIH [K08CA127143-01, K08CA10260, K12 CA120121-01]; MSKCC; NIH/NCI [T32 CA09149-30, CA56821, CA47179, CA33049, CA59350]; John D. Proctor Foundation; Damon Runyon-Lilly Clinical Investigator Award [CA56821, CA33049, CA59350]; Damon Runyon-Lilly Foundation; Swim Across America; Lita Annenberg Hazen Foundation; TJ Martell Foundation; Louis & Anne Abrons Foundation; Mr. and Mrs. Quentin J. Kennedy Fund; Mr. William H. Goodwin and Mrs. Alice Goodman Funds; MSKCC Experimental Therapeutics Center; NATIONAL CANCER INSTITUTE [K08CA127143, K12CA120121, P01CA047179, P01CA059350, P01CA033049, T32CA009149, R01CA056821] Funding Source: NIH RePORTER	ASCO Young Investigator Award; Charles A. Dana Foundation; H-C Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John D. Proctor Foundation; Damon Runyon-Lilly Clinical Investigator Award; Damon Runyon-Lilly Foundation; Swim Across America; Lita Annenberg Hazen Foundation; TJ Martell Foundation; Louis & Anne Abrons Foundation; Mr. and Mrs. Quentin J. Kennedy Fund; Mr. William H. Goodwin and Mrs. Alice Goodman Funds; MSKCC Experimental Therapeutics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: ADC (ASCO Young Investigator Award, Charles A. Dana Foundation, H-C Fellowship, and NIH K08CA127143-01). MAP (NIH K08CA10260 and MSKCC Byrne Fund). DAS (NIH Clinical Training for Scholar Grant K12 CA120121-01, NIH/NCI Immunology Training Grant T32 CA09149-30 and John D. Proctor Foundation: Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award). JDW CA56821, CA33049 and CA59350 (Damon Runyon-Lilly Clinical Investigator Award). ANH (NIH/NCI (CA56821, CA47179, CA33049 and CA59350) and Damon Runyon-Lilly Foundation). Additional support provided by Swim Across America, Lita Annenberg Hazen Foundation, TJ Martell Foundation, Louis & Anne Abrons Foundation, Mr. and Mrs. Quentin J. Kennedy Fund, Mr. William H. Goodwin and Mrs. Alice Goodman Funds, and MSKCC Experimental Therapeutics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Igarashi H, 2008, BIOCHEM BIOPH RES CO, V369, P1134, DOI 10.1016/j.bbrc.2008.03.024; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kim HJ, 2006, J IMMUNOL, V176, P3507, DOI 10.4049/jimmunol.176.6.3507; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Muriglan SJ, 2004, J EXP MED, V200, P149, DOI 10.1084/jem.20040116; Nishikawa H, 2008, CANCER RES, V68, P5948, DOI 10.1158/0008-5472.CAN-07-5839; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Suri A, 2004, EUR J IMMUNOL, V34, P447, DOI 10.1002/eji.200324599; Suvas S, 2005, J VIROL, V79, P11935, DOI 10.1128/JVI.79.18.11935-11942.2005; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhou PF, 2007, J IMMUNOL, V179, P7365, DOI 10.4049/jimmunol.179.11.7365; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P5465, DOI 10.1073/pnas.0711350105	49	183	204	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10436	10.1371/journal.pone.0010436	http://dx.doi.org/10.1371/journal.pone.0010436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454651	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240300012
J	Madronal, N; Gruart, A; Sacktor, TC; Delgado-Garcia, JM				Madronal, Noelia; Gruart, Agnes; Sacktor, Todd C.; Delgado-Garcia, Jose M.			PKM zeta Inhibition Reverses Learning-Induced Increases in Hippocampal Synaptic Strength and Memory during Trace Eyeblink Conditioning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; KINASE-M-ZETA; POSTSYNAPTIC AMPA RECEPTORS; CA3-CA1 SYNAPSE; BEHAVING MICE; LATE-PHASE; LTP; MAINTENANCE; CONSOLIDATION; TRANSMISSION	A leading candidate in the process of memory formation is hippocampal long-term potentiation (LTP), a persistent enhancement in synaptic strength evoked by the repetitive activation of excitatory synapses, either by experimental high-frequency stimulation (HFS) or, as recently shown, during actual learning. But are the molecular mechanisms for maintaining synaptic potentiation induced by HFS and by experience the same? Protein kinase Mzeta (PKM zeta), an autonomously active atypical protein kinase C isoform, plays a key role in the maintenance of LTP induced by tetanic stimulation and the storage of long-term memory. To test whether the persistent action of PKM zeta is necessary for the maintenance of synaptic potentiation induced after learning, the effects of ZIP (zeta inhibitory peptide), a PKM zeta inhibitor, on eyeblink-conditioned mice were studied. PKM zeta inhibition in the hippocampus disrupted both the correct retrieval of conditioned responses (CRs) and the experience-dependent persistent increase in synaptic strength observed at CA3-CA1 synapses. In addition, the effects of ZIP on the same associative test were examined when tetanic LTP was induced at the hippocampal CA3-CA1 synapse before conditioning. In this case, PKM zeta inhibition both reversed tetanic LTP and prevented the expected LTP-mediated deleterious effects on eyeblink conditioning. Thus, PKM zeta inhibition in the CA1 area is able to reverse both the expression of trace eyeblink conditioned memories and the underlying changes in CA3-CA1 synaptic strength, as well as the anterograde effects of LTP on associative learning.	[Madronal, Noelia; Gruart, Agnes; Delgado-Garcia, Jose M.] Univ Pablo Olavide, Div Neurociencias, Seville, Spain; [Sacktor, Todd C.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	Universidad Pablo de Olavide; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Madronal, N (corresponding author), Univ Pablo Olavide, Div Neurociencias, Seville, Spain.	jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019		European Community [FP7/2007-201714]; Spanish Ministry of Science and Innovation [BFU2008-00899, BFU2008-03390]; Junta de Andalucia (Spain) [BIO-122, CVI-02487]; Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain); National Institutes of Health (NIH) [MH53576, MH57068]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053576, R01MH057068, R01MH053576, R37MH057068] Funding Source: NIH RePORTER	European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research leading to these results has received funding from the European Community Seventh Framework Program (FP7/2007-201714, DEVANX Project), the Spanish Ministry of Science and Innovation (BFU2008-00899 and BFU2008-03390), the Junta de Andalucia (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain). Dr. Sacktor is supported by National Institutes of Health (NIH) MH53576 and MH57068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Domingo JA, 1997, J NEUROPHYSIOL, V78, P2518, DOI 10.1152/jn.1997.78.5.2518; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	30	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10400	10.1371/journal.pone.0010400	http://dx.doi.org/10.1371/journal.pone.0010400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454458	Green Published, Green Submitted, gold			2022-12-27	WOS:000277240100012
J	Shemesh, H; Arbiv, A; Gersani, M; Ovadia, O; Novoplansky, A				Shemesh, Hagai; Arbiv, Adi; Gersani, Mordechai; Ovadia, Ofer; Novoplansky, Ariel			The Effects of Nutrient Dynamics on Root Patch Choice	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; PLANT BEHAVIOR; HETEROGENEITY; RESPONSES; GROWTH; EXPLOITATION; ENVIRONMENTS; COMPETITION; INHIBITION; ALLOCATION	Plants have been recognized to be capable of allocating more roots to rich patches in the soil. We tested the hypothesis that in addition to their sensitivity to absolute differences in nutrient availability, plants are also responsive to temporal changes in nutrient availability. Different roots of the same Pisum sativum plants were subjected to variable homogeneous and heterogeneous temporally - dynamic and static nutrient regimes. When given a choice, plants not only developed greater root biomasses in richer patches; they discriminately allocated more resources to roots that developed in patches with increasing nutrient levels, even when their other roots developed in richer patches. These results suggest that plants are able to perceive and respond to dynamic environmental changes. This ability might enable plants to increase their performance by responding to both current and anticipated resource availabilities in their immediate proximity.	[Shemesh, Hagai; Arbiv, Adi; Gersani, Mordechai; Ovadia, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Shemesh, Hagai; Arbiv, Adi; Novoplansky, Ariel] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Miterani Dept Desert Ecol, IL-84993 Sede Boqer, Israel	Ben Gurion University; Ben Gurion University	Shemesh, H (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	hagaig@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012	Novoplansky, Ariel/0000-0003-0988-786X; Ovadia, Ofer/0000-0002-4941-4947	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	The study was supported in part by a research grant from the Israel Science Foundation to A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; APHALO PJ, 1995, FUNCT ECOL, V9, P5, DOI 10.2307/2390084; Bilbrough CJ, 1997, ECOLOGY, V78, P231; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Darwin C, 1880, POWER MOVEMENT PLANT; DESBIEZ MO, 1984, PLANTA, V160, P392, DOI 10.1007/BF00429754; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; Dyer AR, 2001, FUNCT ECOL, V15, P85, DOI 10.1046/j.1365-2435.2001.00487.x; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; GERSANI M, 1992, PLANT CELL ENVIRON, V15, P463, DOI 10.1111/j.1365-3040.1992.tb00997.x; Gilroy S, 2008, PLANT TROPISMS, P1; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; INGESTAD T, 1988, PHYSIOL PLANTARUM, V72, P450, DOI 10.1111/j.1399-3054.1988.tb09150.x; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; JONES M, 1987, PROC R SOC SER B-BIO, V232, P1, DOI 10.1098/rspb.1987.0058; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; Larsen KS, 2002, APPL SOIL ECOL, V21, P187, DOI 10.1016/S0929-1393(02)00093-8; LEVINS RICHARD, 1968; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Masi E, 2009, P NATL ACAD SCI USA, V106, P4048, DOI 10.1073/pnas.0804640106; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; NOVOPLANSKY A, 1989, PHYSIOL PLANTARUM, V77, P136, DOI 10.1111/j.1399-3054.1989.tb05989.x; Novoplansky A, 1996, VEGETATIO, V127, P31, DOI 10.1007/BF00054845; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Nyanumba SM, 2007, DEV STRATEGIES PLANT; Owen JP, 2005, PHYSIOL ENTOMOL, V30, P293, DOI 10.1111/j.1365-3032.2005.00461.x; Quilchano C, 2008, ECOL RES, V23, P127, DOI 10.1007/s11284-007-0343-6; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shimansky YP, 2009, BIOL CYBERN, V101, P379, DOI 10.1007/s00422-009-0341-6; Snow R, 1931, P R SOC LOND B-CONTA, V108, P305, DOI 10.1098/rspb.1931.0041; Spieler M, 1997, OECOLOGIA, V109, P184, DOI 10.1007/s004420050073; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Trewavas A, 2009, PLANT CELL ENVIRON, V32, P606, DOI 10.1111/j.1365-3040.2009.01929.x; van Wijk MT, 2003, J ECOL, V91, P664, DOI 10.1046/j.1365-2745.2003.00788.x; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Zar JH, 1999, BIOSTATISTICAL ANAL	48	43	46	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10824	10.1371/journal.pone.0010824	http://dx.doi.org/10.1371/journal.pone.0010824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520811	gold, Green Published			2022-12-27	WOS:000278221500013
J	Kananen, L; Surakka, I; Pirkola, S; Suvisaari, J; Lonnqvist, J; Peltonen, L; Ripatti, S; Hovatta, I				Kananen, Laura; Surakka, Ida; Pirkola, Sami; Suvisaari, Jaana; Lonnqvist, Jouko; Peltonen, Leena; Ripatti, Samuli; Hovatta, Iiris			Childhood Adversities Are Associated with Shorter Telomere Length at Adult Age both in Individuals with an Anxiety Disorder and Controls	PLOS ONE			English	Article							WHITE BLOOD-CELLS; OXIDATIVE STRESS; PSYCHIATRIC-DISORDERS; INSULIN-RESISTANCE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; DNA-DAMAGE; LIFE; HEALTH	Accelerated leukocyte telomere shortening has been previously associated to self-perceived stress and psychiatric disorders, including schizophrenia and mood disorders. We set out to investigate whether telomere length is affected in patients with anxiety disorders in which stress is a known risk factor. We also studied the effects of childhood and recent psychological distress on telomere length. We utilized samples from the nationally representative population-based Health 2000 Survey that was carried out between 2000-2001 in Finland to assess major public health problems and their determinants. We measured the relative telomere length of the peripheral blood cells by quantitative real-time PCR from 321 individuals with DSM-IV anxiety disorder or subthreshold diagnosis and 653 matched controls aged 30-87 years, who all had undergone the Composite International Diagnostic Interview. While telomere length did not differ significantly between cases and controls in the entire cohort, the older half of the anxiety disorder patients (48-87 years) exhibited significantly shorter telomeres than healthy controls of the same age (P = 0.013). Interestingly, shorter telomere length was also associated with a greater number of reported childhood adverse life events, among both the anxiety disorder cases and controls (P = 0.005). Childhood chronic or serious illness was the most significantly associated single event affecting telomere length at the adult age (P = 0.004). Self-reported current psychological distress did not affect telomere length. Our results suggest that childhood stress might lead to accelerated telomere shortening seen at the adult age. This finding has potentially important implications supporting the view that childhood adversities might have a considerable impact on well being later in life.	[Kananen, Laura; Hovatta, Iiris] Univ Helsinki, Res Program Mol Neurol, Fac Med, Helsinki, Finland; [Kananen, Laura; Peltonen, Leena; Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Fac Med, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Pirkola, Sami; Suvisaari, Jaana; Lonnqvist, Jouko; Hovatta, Iiris] Natl Inst Hlth & Welf, Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Pirkola, Sami; Lonnqvist, Jouko] Helsinki Univ Cent Hosp, Dept Psychiat, Helsinki, Finland; [Peltonen, Leena] Broad Inst MIT & Harvard, Cambridge, MA USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Kananen, L (corresponding author), Univ Helsinki, Res Program Mol Neurol, Fac Med, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Hovatta, Iiris/D-6871-2012; Ripatti, Samuli/H-9446-2014	Hovatta, Iiris/0000-0002-5990-7892; Ripatti, Samuli/0000-0002-0504-1202; Kananen, Laura/0000-0003-3742-8927; Surakka, Ida/0000-0002-6669-5541; Suvisaari, Jaana/0000-0001-7167-0990; Pirkola, Sami/0000-0003-0138-3130	Academy of Finland NEURO; Academy Research Fellowship; Biocentrum Helsinki; Sigrid Juselius Foundation; Yrjo and Tuulikki Ilvonen Foundation; LOreal; UNESCO	Academy of Finland NEURO(Academy of Finland); Academy Research Fellowship(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo and Tuulikki Ilvonen Foundation; LOreal; UNESCO	This work was supported by the Academy of Finland NEURO research program and Academy Research Fellowship (http://www.aka.fi), Biocentrum Helsinki (http://www.helsinki.fi/biocentrum), Sigrid Juselius Foundation (http://www.sigridjuselius.fi), Yrjo and Tuulikki Ilvonen Foundation, and LOreal and UNESCO Women in Science Fellowship ( to IH). The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bandelow B, 2004, EUR ARCH PSY CLIN N, V254, P397, DOI 10.1007/s00406-004-0521-2; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; de Oliveira MR, 2007, NEUROTOXICOLOGY, V28, P1191, DOI 10.1016/j.neuro.2007.07.008; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Donner J, 2008, BIOL PSYCHIAT, V64, P672, DOI 10.1016/j.biopsych.2008.06.002; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Goodwin RD, 2005, PSYCHOL MED, V35, P881, DOI 10.1017/S0033291704003265; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Heistaro S., 2008, METHODOLOGY REPORT H; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Heun R, 2000, EUR PSYCHIAT, V15, P173, DOI 10.1016/S0924-9338(00)00228-5; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2008, ANN MED, V40, P92, DOI 10.1080/07853890701747096; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Kao HT, 2008, MOL PSYCHIATR, V13, P118, DOI 10.1038/sj.mp.4002105; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Masood A, 2008, J PHARMACOL EXP THER, V326, P369, DOI 10.1124/jpet.108.137208; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Nakashima H, 2004, HYPERTENS RES, V27, P319, DOI 10.1291/hypres.27.319; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Obana N, 2003, INTERNAL MED, V42, P150, DOI 10.2169/internalmedicine.42.150; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pirkola S, 2005, SOC PSYCH PSYCH EPID, V40, P769, DOI 10.1007/s00127-005-0950-x; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Rammal H, 2008, BRAIN BEHAV IMMUN, V22, P1156, DOI 10.1016/j.bbi.2008.06.005; Richards JB, 2008, ATHEROSCLEROSIS, V200, P271, DOI 10.1016/j.atherosclerosis.2007.12.035; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Yu WY, 2008, J PSYCHIATR NEUROSCI, V33, P244	68	207	207	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10826	10.1371/journal.pone.0010826	http://dx.doi.org/10.1371/journal.pone.0010826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CE	20520834	gold, Green Submitted, Green Published			2022-12-27	WOS:000278034800019
J	Pylkkanen, L; Okano, K				Pylkkaenen, Liina; Okano, Kana			The Nature of Abstract Orthographic Codes: Evidence from Masked Priming and Magnetoencephalography	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; EVENT-RELATED POTENTIALS; LETTER-STRING PERCEPTION; BRAIN POTENTIALS; LEXICAL ACCESS; FORM AREA; TIME-COURSE; FREQUENCY; MASKING; LENGTH	What kind of mental objects are letters? Research on letter perception has mainly focussed on the visual properties of letters, showing that orthographic representations are abstract and size/shape invariant. But given that letters are, by definition, mappings between symbols and sounds, what is the role of sound in orthographic representation? We present two experiments suggesting that letters are fundamentally sound-based representations. To examine the role of sound in orthographic representation, we took advantage of the multiple scripts of Japanese. We show two types of evidence that if a Japanese word is presented in a script it never appears in, this presentation immediately activated the ("actual") visual word form of that lexical item. First, equal amounts of masked repetition priming are observed for full repetition and when the prime appears in an atypical script. Second, visual word form frequency affects neuromagnetic measures already at 100-130 ms whether the word is presented in its conventional script or in a script it never otherwise appears in. This suggests that Japanese orthographic codes are not only shape-invariant, but also script invariant. The finding that two characters belonging to different writing systems can activate the same form representation suggests that sound identity is what determines orthographic identity: as long as two symbols express the same sound, our minds represent them as part of the same character/letter.	[Pylkkaenen, Liina] NYU, Dept Linguist, New York, NY 10003 USA; [Pylkkaenen, Liina] NYU, Dept Psychol, New York, NY 10003 USA; Tufts Univ, Dept Psychol, Medford, MA 02155 USA	New York University; New York University; Tufts University	Pylkkanen, L (corresponding author), NYU, Dept Linguist, Washington Sq, New York, NY 10003 USA.	liina.pylkkanen@nyu.edu			NSF [BCS-0545186]	NSF(National Science Foundation (NSF))	NSF BCS-0545186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S., 2003, NIHONGO NO GOI TOKUS, V7; Assadollahi R, 2003, NEUROREPORT, V14, P1183, DOI 10.1097/00001756-200306110-00016; Bowers JS, 1998, J EXP PSYCHOL HUMAN, V24, P1705, DOI 10.1037/0096-1523.24.6.1705; Chauncey K, 2008, LANG COGNITIVE PROC, V23, P183, DOI 10.1080/01690960701579839; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; DEHAENE S, TRENDS COGNITIVE SCI, V9, P335; Embick D, 2001, COGNITIVE BRAIN RES, V10, P345, DOI 10.1016/S0926-6410(00)00053-7; FERRAND L, 1994, Q J EXP PSYCHOL-A, V47, P365, DOI 10.1080/14640749408401116; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2008, TRENDS COGN SCI, V12, P381, DOI 10.1016/j.tics.2008.06.006; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Longtin CM, 2003, LANG COGNITIVE PROC, V18, P313, DOI 10.1080/01690960244000036; LUKATELA G, 1994, J EXP PSYCHOL GEN, V123, P331, DOI 10.1037/0096-3445.123.4.331; Maurer U., 2008, SINGLE WORD READING, P43; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Monahan PJ, 2008, BRAIN LANG, V106, P65, DOI 10.1016/j.bandl.2008.02.002; PAAP KR, 1984, J EXP PSYCHOL HUMAN, V10, P413, DOI 10.1037/0096-1523.10.3.413; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; PERFETTI CA, 1991, J MEM LANG, V30, P473, DOI 10.1016/0749-596X(91)90017-E; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Rastle K, 2004, PSYCHON B REV, V11, P1090, DOI 10.3758/BF03196742; Rastle K, 2000, LANG COGNITIVE PROC, V15, P507, DOI 10.1080/01690960050119689; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Solomyak O, 2010, J COGNITIVE NEUROSCI, V22, P2042, DOI 10.1162/jocn.2009.21296; Solomyak O, 2009, BRAIN LANG, V108, P191, DOI 10.1016/j.bandl.2008.09.004; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; Zweig E, 2009, LANG COGNITIVE PROC, V24, P412, DOI 10.1080/01690960802180420	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10793	10.1371/journal.pone.0010793	http://dx.doi.org/10.1371/journal.pone.0010793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520833	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034800003
J	Zhao, KY; Wright, M; Kimball, J; Eizenga, G; McClung, A; Kovach, M; Tyagi, W; Ali, ML; Tung, CW; Reynolds, A; Bustamante, CD; McCouch, SR				Zhao, Keyan; Wright, Mark; Kimball, Jennifer; Eizenga, Georgia; McClung, Anna; Kovach, Michael; Tyagi, Wricha; Ali, Md. Liakat; Tung, Chih-Wei; Reynolds, Andy; Bustamante, Carlos D.; McCouch, Susan R.			Genomic Diversity and Introgression in O. sativa Reveal the Impact of Domestication and Breeding on the Rice Genome	PLOS ONE			English	Article							ORYZA-SATIVA; POPULATION-STRUCTURE; NUCLEOTIDE-BINDING; LINKAGE DISEQUILIBRIUM; MAGNAPORTHE-ORYZAE; GENETIC DIVERSITY; GREEN-REVOLUTION; CULTIVATED RICE; AMYLOSE CONTENT; REPEAT PROTEIN	Background: The domestication of Asian rice (Oryza sativa) was a complex process punctuated by episodes of introgressive hybridization among and between subpopulations. Deep genetic divergence between the two main varietal groups (Indica and Japonica) suggests domestication from at least two distinct wild populations. However, genetic uniformity surrounding key domestication genes across divergent subpopulations suggests cultural exchange of genetic material among ancient farmers. Methodology/Principal Findings: In this study, we utilize a novel 1,536 SNP panel genotyped across 395 diverse accessions of O. sativa to study genome-wide patterns of polymorphism, to characterize population structure, and to infer the introgression history of domesticated Asian rice. Our population structure analyses support the existence of five major subpopulations (indica, aus, tropical japonica, temperate japonica and GroupV) consistent with previous analyses. Our introgression analysis shows that most accessions exhibit some degree of admixture, with many individuals within a population sharing the same introgressed segment due to artificial selection. Admixture mapping and association analysis of amylose content and grain length illustrate the potential for dissecting the genetic basis of complex traits in domesticated plant populations. Conclusions/Significance: Genes in these regions control a myriad of traits including plant stature, blast resistance, and amylose content. These analyses highlight the power of population genomics in agricultural systems to identify functionally important regions of the genome and to decipher the role of human-directed breeding in refashioning the genomes of a domesticated species.	[Zhao, Keyan; Wright, Mark; Reynolds, Andy; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Zhao, Keyan; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kimball, Jennifer; Kovach, Michael; Tyagi, Wricha; Tung, Chih-Wei; McCouch, Susan R.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Eizenga, Georgia; McClung, Anna] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Ali, Md. Liakat] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA	Cornell University; Stanford University; Cornell University; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville	Zhao, KY (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	cdbustam@stanford.edu; srm4@cornell.edu		Kimball, Jennifer/0000-0002-1210-8161; Zhao, Keyan/0000-0002-8800-2304; Wright, Mark/0000-0001-8036-1161; Bustamante, Carlos D./0000-0002-4187-7920; TUNG, CHIH-WEI/0000-0001-5337-0177	National Science Foundation [0606461]; University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR	National Science Foundation(National Science Foundation (NSF)); University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR	Funding: This research was funded by National Science Foundation grant #0606461; http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Teresa Hancock and Daniel Wood, supported by this grant through the University of Arkansas at the Rice Research and Extension Center, Stuttgart, AR for their outstanding technical assistance collecting phenotypic information and managing the seed stocks. We thank Weiwei Zhai from Beijing Institute of Genomics for comments and suggestions on the manuscript. We acknowledge the assistance of Melissa Jia in the Genomics Core Facility at the Dale Bumpers National Rice Research Center, Stuttgart, AR for running the grain quality markers. We thank Ken McNally and Jan Leach of the OryzaSNP project for early access to the OryzaSNP data. We are grateful to Lois Swales for help formatting the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; BOLLICH CN, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050038x; BOLLICH CN, 1993, CROP SCI, V33, P877, DOI 10.2135/cropsci1993.0011183X003300040056x; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chang TT, 2002, W CROP SCI, P3; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Falush D, 2003, GENETICS, V164, P1567; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Garris AJ, 2003, GENETICS, V165, P759; Gibbons JW, 2006, CROP SCI, V46, P2317, DOI 10.2135/cropsci2006.03.0173; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Kashiwagi T, 2004, PLANT PHYSIOL, V134, P676, DOI 10.1104/pp.103.029355; KHUSH GS, 2003, IRRI DISCUSSION PAPE, P1; KHUSH GS, 2006, IRRI DISCUSSION PAPE, V46; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Kim SI, 2009, SABRAO J BREED GENET, V41, P25; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu L, 2007, ANTIQUITY, V81, P886, DOI 10.1017/S0003598X00095983; Mackill DJ, 2002, W CROP SCI, P87; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McClung AM, 1997, CROP SCI, V37, P629, DOI 10.2135/cropsci1997.0011183X003700020058x; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moldenhauer KAK, 2007, CROP SCI, V47, P447, DOI 10.2135/cropsci2006.06.0418; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pritchard JK, 2000, GENETICS, V155, P945; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; RASAMIVELONA A, 1995, CROP SCI, V35, P1365, DOI 10.2135/cropsci1995.0011183X003500050017x; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; WANG GL, 1994, GENETICS, V136, P1421; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; WANG ZY, 1989, GENOME, V32, P1113, DOI 10.1139/g89-563; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEIR BS, 1996, GENETIC DATA ANAL, V2, P161; WRIGHT MH, BIOINFORMAT IN PRESS; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yamanaka S, 2004, THEOR APPL GENET, V108, P1200, DOI 10.1007/s00122-003-1564-x; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yano M, 2009, CURR OPIN PLANT BIOL, V12, P103, DOI 10.1016/j.pbi.2009.01.001; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	79	206	216	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10780	10.1371/journal.pone.0010780	http://dx.doi.org/10.1371/journal.pone.0010780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520727	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034600010
J	Bressler, J; Kao, WHL; Pankow, JS; Boerwinkle, E				Bressler, Jan; Kao, W. H. Linda; Pankow, James S.; Boerwinkle, Eric			Risk of Type 2 Diabetes and Obesity Is Differentially Associated with Variation in FTO in Whites and African-Americans in the ARIC Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAT MASS; GENETIC-VARIANTS; POLYMORPHISMS; IGF2BP2; CHINESE; SLC30A8; CDKAL1; REPLICATION; CHOLESTEROL	Single nucleotide polymorphisms (SNPs) in the fat mass and obesity associated (FTO) gene are associated with body mass index (BMI) in populations of European descent. The FTO rs9939609 variant, first detected in a genome-wide association study of diabetes, conferred an increased disease risk that was abolished after adjustment for BMI, suggesting that the association may be due to variation in adiposity. The relationship between diabetes, four previously identified FTO polymorphisms that span a 19.6-kb genomic region, and obesity was therefore evaluated in the biracial population-based Atherosclerosis Risk in Communities Study with the goal of further refining the association by comparing results between the two ethnic groups. The prevalence of diabetes and obesity (BMI >= 30 kg/m(2)) was established at baseline, and diabetes was determined by either self-report, a fasting glucose level >= 126 mg/dL, or non-fasting glucose >= 200 mg/dL. There were 1,004 diabetes cases and 10,038 non-cases in whites, and 670 cases and 2,780 non-cases in African-Americans. Differences in mean BMI were assessed by a general linear model, and multivariable logistic regression was used to predict the risk of diabetes and obesity. For white participants, the FTO rs9939609 A allele was associated with an increased risk of diabetes (odds ratio (OR) = 1.19, p < 0.001) and obesity (OR = 1.22, p < 0.001) under an additive genetic model that was similar for all of the SNPs analyzed. In African-Americans, only the rs1421085 C allele was a determinant of obesity risk (OR = 1.17, p = 0.05), but was found to be protective against diabetes (OR = 0.79, p = 0.03). Adjustment for BMI did not eliminate any of the observed associations with diabetes. Significant statistical interaction between race and the FTO variants suggests that the effect on diabetes susceptibility may be context dependent.	[Bressler, Jan; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Bressler, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA.	Eric.Boerwinkle@uth.tmc.edu		Pankow, James/0000-0001-7076-483X	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055019, N01HC055020, N01HC055021, N01HC055022, N01HC055018, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R41HL055018, R42HL055018] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Song YQ, 2008, OBESITY, V16, P2472, DOI 10.1038/oby.2008.408; STERN MP, 1986, ARTERIOSCLEROSIS, V6, P123, DOI 10.1161/01.ATV.6.2.123; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wing MR, 2009, HUM GENET, V125, P615, DOI 10.1007/s00439-009-0656-3; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; 1998, OBES RES, V51, P209	38	62	63	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10521	10.1371/journal.pone.0010521	http://dx.doi.org/10.1371/journal.pone.0010521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20502638	Green Published, Green Submitted, gold			2022-12-27	WOS:000278017300001
J	Sawai, H; Kim, HL; Kuno, K; Suzuki, S; Gotoh, H; Takada, M; Takahata, N; Satta, Y; Akishinonomiya, F				Sawai, Hiromi; Kim, Hie Lim; Kuno, Kaori; Suzuki, Sayaka; Gotoh, Hideo; Takada, Masaru; Takahata, Naoyuki; Satta, Yoko; Akishinonomiya, Fumihito			The Origin and Genetic Variation of Domestic Chickens with Special Reference to Junglefowls Gallus g. gallus and G. varius	PLOS ONE			English	Article							CONTROL REGION; DNA-SEQUENCES; MODERN HUMANS; GENUS GALLUS; EVOLUTION; BIRDS; DIVERGENCE; GENOME; HYBRIDIZATION; REVEALS	It is postulated that chickens (Gallus gallus domesticus) became domesticated from wild junglefowls in Southeast Asia nearly 10,000 years ago. Based on 19 individual samples covering various chicken breeds, red junglefowl (G. g. gallus), and green junglefowl (G. varius), we address the origin of domestic chickens, the relative roles of ancestral polymorphisms and introgression, and the effects of artificial selection on the domestic chicken genome. DNA sequences from 30 introns at 25 nuclear loci are determined for both diploid chromosomes from a majority of samples. The phylogenetic analysis shows that the DNA sequences of chickens, red and green junglefowls formed reciprocally monophyletic clusters. The Markov chain Monte Carlo simulation further reveals that domestic chickens diverged from red junglefowl 58,000 +/- 16,000 years ago, well before the archeological dating of domestication, and that their common ancestor in turn diverged from green junglefowl 3.6 million years ago. Several shared haplotypes nonetheless found between green junglefowl and chickens are attributed to recent unidirectional introgression of chickens into green junglefowl. Shared haplotypes are more frequently found between red junglefowl and chickens, which are attributed to both introgression and ancestral polymorphisms. Within each chicken breed, there is an excess of homozygosity, but there is no significant reduction in the nucleotide diversity. Phenotypic modifications of chicken breeds as a result of artificial selection appear to stem from ancestral polymorphisms at a limited number of genetic loci.	[Sawai, Hiromi; Kim, Hie Lim; Kuno, Kaori; Suzuki, Sayaka; Satta, Yoko; Akishinonomiya, Fumihito] Grad Univ Adv Studies Sokendai, Hayama Ctr Adv Studies, Kanagawa, Japan; [Gotoh, Hideo] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Takada, Masaru] Res Inst Evolutionary Biol, Setagaya Ku, Tokyo, Japan	Graduate University for Advanced Studies - Japan; National Institute of Agrobiological Sciences - Japan	Sawai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan.	sattayk@soken.ac.jp	Kim, Hie Lim/E-7393-2017	Kim, Hie Lim/0000-0003-3080-9524; Satta, Yoko/0000-0002-5305-493X	Japan Society for Promotion of Science [16107001]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant (no. 16107001) from the Japan Society for Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Avise JC, 1993, MOL MARKERS NATURAL; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Brodkorb P., 1964, Bulletin of the Florida State Museum Biological Sciences, V8, P195; DANFORTH C. H., 1958, JOUR HEREDITY, V49, P167; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dimcheff DE, 2002, MOL PHYLOGENET EVOL, V24, P203, DOI 10.1016/S1055-7903(02)00230-0; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Giuffra E, 2000, GENETICS, V154, P1785; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; HELMBYCHOWSKI KM, 1986, P NATL ACAD SCI USA, V83, P688, DOI 10.1073/pnas.83.3.688; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; JUKES T H, 1969, P21; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komiyama T, 2004, GENE, V333, P91, DOI 10.1016/j.gene.2004.02.035; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; MOREJOHN GV, 1968, EVOLUTION, V22, P576, DOI 10.1111/j.1558-5646.1968.tb03993.x; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; PRAGER EM, 1974, J MOL EVOL, V3, P243, DOI 10.1007/BF01796041; Pritchard JK, 2000, GENETICS, V155, P945; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Rannala B, 2003, GENETICS, V164, P1645; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEINER H, 1945, VEREBUNGFORSCB SOCIA, V20, P236; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Takahata N, 2007, GENETICS, V176, P1, DOI 10.1534/genetics.104.75135; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156	44	66	69	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10639	10.1371/journal.pone.0010639	http://dx.doi.org/10.1371/journal.pone.0010639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502703	Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400003
J	Tian, SB; Haney, RA; Feder, ME				Tian, Sibo; Haney, Robert A.; Feder, Martin E.			Phylogeny Disambiguates the Evolution of Heat-Shock cis-Regulatory Elements in Drosophila	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; MORPHOLOGICAL EVOLUTION; DUPLICATE GENES; HSP26 GENE; IN-VIVO; PROMOTER; SEQUENCE; MELANOGASTER; EXPRESSION	Heat-shock genes have a well-studied control mechanism for their expression that is mediated through cis-regulatory motifs known as heat-shock elements (HSEs). The evolution of important features of this control mechanism has not been investigated in detail, however. Here we exploit the genome sequencing of multiple Drosophila species, combined with a wealth of available information on the structure and function of HSEs in D. melanogaster, to undertake this investigation. We find that in single-copy heat shock genes, entire HSEs have evolved or disappeared 14 times, and the phylogenetic approach bounds the timing and direction of these evolutionary events in relation to speciation. In contrast, in the multicopy gene Hsp70, the number of HSEs is nearly constant across species. HSEs evolve in size, position, and sequence within heat-shock promoters. In turn, functional significance of certain features is implicated by preservation despite this evolutionary change; these features include tail-to-tail arrangements of HSEs, gapped HSEs, and the presence or absence of entire HSEs. The variation among Drosophila species indicates that the cis-regulatory encoding of responsiveness to heat and other stresses is diverse. The broad dimensions of variation uncovered are particularly important as they suggest a substantial challenge for functional studies.	[Tian, Sibo; Haney, Robert A.; Feder, Martin E.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Tian, SB (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	robert.a.haney@gmail.com		Tian, Sibo/0000-0001-5018-4854; Haney, Robert/0000-0002-3742-3395	National Science Foundation [IOB06-41278]	National Science Foundation(National Science Foundation (NSF))	Supported by the National Science Foundation (IOB06-41278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; AMIN J, 1985, MOL CELL BIOL, V5, P197, DOI 10.1128/MCB.5.1.197; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Bauer DC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-220; Besnard G, 2009, MOL BIOL EVOL, V26, P1909, DOI 10.1093/molbev/msp103; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; COHEN RS, 1985, CELL, V43, P737, DOI 10.1016/0092-8674(85)90247-8; Crocker J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000276; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; Fernandes M, 1995, NUCLEIC ACIDS RES, V23, P4799, DOI 10.1093/nar/23.23.4799; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Georgel PT, 2005, BIOCHEM CELL BIOL, V83, P555, DOI 10.1139/O05-060; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Guo LH, 2008, PLANT CELL PHYSIOL, V49, P1306, DOI 10.1093/pcp/pcn105; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Haney RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008486; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jost R, 2007, BIOTECHNIQUES, V43, P206, DOI 10.2144/000112534; Kellett M, 2005, GENOME, V48, P226, DOI [10.1139/g04-113, 10.1139/G04-113]; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000330; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Large AT, 2009, BIOCHEM SOC T, V37, P46, DOI 10.1042/BST0370046; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; LINDQUIST S, 1980, DEV BIOL, V77, P463, DOI 10.1016/0012-1606(80)90488-1; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lis J.T., 1990, STRESS PROTEINS BIOL, P411; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Macario AJL, 2006, J MOL EVOL, V63, P74, DOI 10.1007/s00239-005-6207-1; Matute DR, 2009, EVOLUTION, V63, P595, DOI 10.1111/j.1558-5646.2008.00588.x; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; MESTRIL R, 1985, EMBO J, V4, P2971, DOI 10.1002/j.1460-2075.1985.tb04031.x; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; [ NRC] National Research Council Committee on Defining and Advancing the Conceptual Basis of Biological Sciences in the 21st Century, 2008, ROL THEOR ADV 21 CEN; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Schmid CD, 2004, NUCLEIC ACIDS RES, V32, pD82, DOI 10.1093/nar/gkh122; Singh B, 2009, MOL GENET GENOMICS, V281, P361, DOI 10.1007/s00438-008-0417-3; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Takemori Y, 2009, BIOCHEM J, V424, P253, DOI 10.1042/BJ20090922; THOMAS GH, 1988, EMBO J, V7, P2191, DOI 10.1002/j.1460-2075.1988.tb03058.x; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; Wilczynski B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-82; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; Zhang Zhaolei, 2003, J Biol, V2, P11, DOI 10.1186/1475-4924-2-11; Zhao YM, 2007, MOL CELL BIOCHEM, V306, P1, DOI 10.1007/s11010-007-9547-x	76	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10669	10.1371/journal.pone.0010669	http://dx.doi.org/10.1371/journal.pone.0010669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498853	Green Submitted, Green Published, gold			2022-12-27	WOS:000277773700012
J	Rodriguez-Noriega, E; Gonzalez-Diaz, E; Morfin-Otero, R; Gomez-Abundis, GF; Briseno-Ramirez, J; Perez-Gomez, HR; Lopez-Gatell, H; Alpuche-Aranda, CM; Ramirez, E; Lopez, I; Iguala, M; Chapela, IB; Zavala, EP; Hernandez, M; Stuart, TL; Villarino, ME; Widdowson, MA; Waterman, S; Uyeki, T; Azziz-Baumgartner, E				Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Morfin-Otero, Rayo; Gomez-Abundis, Gerardo F.; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Ramirez, Ernesto; Lopez, Irma; Iguala, Miguel; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Hernandez, Mauricio; Stuart, Tammy L.; Villarino, Margarita Elsa; Widdowson, Marc-Alain; Waterman, Steve; Uyeki, Timothy; Azziz-Baumgartner, Eduardo		Hosp Civil Guadalajara	Hospital Triage System for Adult Patients Using an Influenza-Like Illness Scoring System during the 2009 Pandemic-Mexico	PLOS ONE			English	Article							A H1N1 VIRUS; SURGE CAPACITY; UNITED-STATES; CRITICAL-CARE; PNEUMONIA; DISASTER	Background: Pandemic influenza A (H1N1) virus emerged during 2009. To help clinicians triage adults with acute respiratory illness, a scoring system for influenza-like illness (ILI) was implemented at Hospital Civil de Guadalajara, Mexico. Methods: A medical history, laboratory and radiology results were collected on emergency room (ER) patients with acute respiratory illness to calculate an ILI-score. Patients were evaluated for admission by their ILI-score and clinicians' assessment of risk for developing complications. Nasal and throat swabs were collected from intermediate and high-risk patients for influenza testing by RT-PCR. The disposition and ILI-score of those oseltamivir-treated versus untreated, clinical characteristics of 2009 pandemic influenza A (H1N1) patients versus test-negative patients were compared by Pearson's X(2), Fisher's Exact, and Wilcoxon rank-sum tests. Results: Of 1840 ER patients, 230 were initially hospitalized (mean ILI-score = 15), and the rest were discharged, including 286 ambulatory patients given oseltamivir (median ILI-score = 11), and 1324 untreated (median ILI-score = 5). Fourteen (1%) untreated patients returned, and 3 were hospitalized on oseltamivir (median ILI-score = 19). Of 371 patients tested by RTPCR, 104 (28%) had pandemic influenza and 42 (11%) had seasonal influenza A detected. Twenty (91%) of 22 imaged hospitalized pandemic influenza patients had bilateral infiltrates compared to 23 (38%) of 61 imaged hospital test-negative patients (p<0.001). One patient with confirmed pandemic influenza presented 6 days after symptom onset, required mechanical ventilation, and died. Conclusions: The triaging system that used an ILI-score complimented clinicians' judgment of who needed oseltamivir and inpatient care and helped hospital staff manage a surge in demand for services.	[Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Morfin-Otero, Rayo; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Rodriguez-Noriega, Eduardo; Morfin-Otero, Rayo; Gomez-Abundis, Gerardo F.; Briseno-Ramirez, Jaime; Raul Perez-Gomez, Hector] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Lopez-Gatell, Hugo; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Hernandez, Mauricio] Mexico Minist Hlth, Direcc Gen Epidemiol, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.; Ramirez, Ernesto; Lopez, Irma; Iguala, Miguel] Natl Publ Hlth Lab, Mexico City, DF, Mexico; [Stuart, Tammy L.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Villarino, Margarita Elsa; Widdowson, Marc-Alain; Waterman, Steve; Uyeki, Timothy; Azziz-Baumgartner, Eduardo] US Ctr Dis Control & Prevent, Atlanta, GA USA	Universidad de Guadalajara; Public Health Agency of Canada; Centers for Disease Control & Prevention - USA	Rodriguez-Noriega, E (corresponding author), Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico.	eha9@cdc.gov	Gonzalez-Diaz, Esteban/GVU-0915-2022; Morfín-Otero, Rayo/AAR-8027-2021	Gonzalez-Diaz, Esteban/0000-0002-9743-3739; Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Widdowson, Marc-Alain/0000-0002-0682-6933; RAMIREZ-GONZALEZ, JOSE ERNESTO/0000-0003-0477-2211				Azziz-Baumgartner E, 2009, INFLUENZA OTHER RESP, V3, P189, DOI 10.1111/j.1750-2659.2009.00091.x; *CDC, 2009, INT GUID ANT REC PAT; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *DEP HLTH BRIT INF, 2007, THORAX, V62, pS1; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Hak E, 2004, J INFECT DIS, V189, P450, DOI 10.1086/381165; HANCOCK K, 2009, NEW ENGL J MED, V361, P1; Ho Y-S., 2009, J ENV PROTECTION SCI, V3, P111; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; *PUBL HLTH AG CAN, 2008, CAN INFL PLAN HLTH S; Rubinson L, 2008, CHEST, V133, p32S, DOI 10.1378/chest.07-2691; Schull MJ, 2006, ACAD EMERG MED, V13, P1228, DOI [10.1197/j.aem.2006.04.011, 10.1111/j.1553-2712.2006.tb01653.x]; Singanayagam A, 2009, QJM-INT J MED, V102, P379, DOI 10.1093/qjmed/hcp027; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US DEP HHS, HHS PAND INFL PLA S5; World Health Organization, 2022, PAND INFL PREP RESP; [No title captured]	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10658	10.1371/journal.pone.0010658	http://dx.doi.org/10.1371/journal.pone.0010658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498718	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600019
J	Birky, CW; Adams, J; Gemmel, M; Perry, J				Birky, C. William, Jr.; Adams, Joshua; Gemmel, Marlea; Perry, Julia			Using Population Genetic Theory and DNA Sequences for Species Detection and Identification in Asexual Organisms	PLOS ONE			English	Article							DIVERSIFICATION; DIVERSITY; MODEL	Background: It is widely agreed that species are fundamental units of biology, but there is little agreement on a definition of species or on an operational criterion for delimiting species that is applicable to all organisms. Methodology/Principal Findings: We focus on asexual eukaryotes as the simplest case for investigating species and speciation. We describe a model of speciation in asexual organisms based on basic principles of population and evolutionary genetics. The resulting species are independently evolving populations as described by the evolutionary species concept or the general lineage species concept. Based on this model, we describe a procedure for using gene sequences from small samples of individuals to assign them to the same or different species. Using this method of species delimitation, we demonstrate the existence of species as independent evolutionary units in seven groups of invertebrates, fungi, and protists that reproduce asexually most or all of the time. Conclusions/Significance: This wide evolutionary sampling establishes the general existence of species and speciation in asexual organisms. The method is well suited for measuring species diversity when phenotypic data are insufficient to distinguish species, or are not available, as in DNA barcoding and environmental sequencing. We argue that it is also widely applicable to sexual organisms.	[Birky, C. William, Jr.; Adams, Joshua; Gemmel, Marlea; Perry, Julia] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Birky, C. William, Jr.] Univ Arizona, Grad Interdisciplinary Program Genet, Tucson, AZ USA	University of Arizona; University of Arizona	Birky, CW (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	birky@u.arizona.edu						Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Avise John C., 1994, pi; Barraclough TG, 2003, EVOLUTION, V57, P2166; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Birky CW, 1996, GENETICS, V144, P427; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coyne J.A., 2004, SPECIATION; Darwin C., 1872, P458; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; DONNER J, 1965, ORDNUNG BDELLOIDEA; DONNER J, 1966, ROTIFERS; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Grimsley N, 2010, MOL BIOL EVOL, V27, P47, DOI 10.1093/molbev/msp203; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hall B.G., 2004, PHYLOGENETIC TREES M; Harrison RG, 1998, ENDLESS FORMS, P19; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HIGGS PG, 1992, J MOL EVOL, V35, P454, DOI 10.1007/BF00171824; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P215; HOWARD DJ, 1999, ENDLESS FORMS; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; Melone G, 2005, HYDROBIOLOGIA, V546, P197, DOI 10.1007/s10750-005-4197-z; Nei M, 2000, MOL EVOLUTION PHYLOG; Nei M., 1987, MOL EVOLUTIONARY GEN; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ricci C, 2000, HYDROBIOLOGIA, V418, P73, DOI 10.1023/A:1003840216827; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Scheckenbach F, 2005, AQUAT MICROB ECOL, V38, P239, DOI 10.3354/ame038239; Segers H, 2005, HYDROBIOLOGIA, V546, P141, DOI 10.1007/s10750-005-4111-8; Segers H, 2002, J NAT HIST, V36, P631, DOI 10.1080/002229302317339707; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Templeton A.R., 1989, P3; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; Wiley EO, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P70	52	90	91	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10609	10.1371/journal.pone.0010609	http://dx.doi.org/10.1371/journal.pone.0010609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498705	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500009
J	Goldstone, S; Reyes, C; Gay, G; Courtheoux, T; Dubarry, M; Tournier, S; Gachet, Y				Goldstone, Sherilyn; Reyes, Celine; Gay, Guillaume; Courtheoux, Thibault; Dubarry, Marion; Tournier, Sylvie; Gachet, Yannick			Tip1/CLIP-170 Protein Is Required for Correct Chromosome Poleward Movement in Fission Yeast	PLOS ONE			English	Article							MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; MICROTUBULE ATTACHMENT; DISTINCT MECHANISMS; BINDING PROTEIN; DYNAMICS; CLIP-170; CHECKPOINT; ANAPHASE; KINETOCHORE	The plus-end microtubule binding proteins (+TIPs) play an important role in the regulation of microtubule stability and cell polarity during interphase. In S. pombe, the CLIP-170 like protein Tip1, together with the kinesin Tea2, moves along the microtubules towards their plus ends. Tip1 also requires the EB1 homolog Mal3 to localize to the microtubule tips. Given the requirement for Tip1 for microtubule stability, we have investigated its role during spindle morphogenesis and chromosome movement. Loss of Tip1 affects metaphase plate formation and leads to the activation of the spindle assembly checkpoint. In the absence of Tip1 we also observed the appearance of lagging chromosomes, which do not influence the normal rate of spindle elongation. Our results suggest that S. pombe Tip1/CLIP170 is directly or indirectly required for correct chromosome poleward movement independently of Mal3/EB1.	[Goldstone, Sherilyn; Reyes, Celine; Gay, Guillaume; Courtheoux, Thibault; Dubarry, Marion; Tournier, Sylvie; Gachet, Yannick] Univ Toulouse, CNRS, LBCMCP, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Goldstone, S (corresponding author), Univ Toulouse, CNRS, LBCMCP, Toulouse, France.	tournier@cict.fr; gachet@cict.fr	Gachet, Yannick/AAK-5363-2021	Dubarry, Marion/0000-0001-5648-5770; Gay, Guillaume/0000-0002-5444-5246	Fondation pour la Recherche Medicale; La ligue contre le cancer	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported partially by a post-doctoral fellowship from the Fondation pour la Recherche Medicale. T. C. is supported by a fellowship from La ligue contre le cancer. L'Association de la Recherche sur le Cancer (ARC) provided some part of the microscopy equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2006, CELL CYCLE, V5, P27, DOI 10.4161/cc.5.1.2262; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Courtheoux T, 2007, BIOL CELL, V99, P627, DOI 10.1042/BC20070047; Courtheoux T, 2009, J CELL BIOL, V187, P399, DOI 10.1083/jcb.200902093; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Dzhindzhev NS, 2005, J CELL SCI, V118, P3781, DOI 10.1242/jcs.02504; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Gachet Y, 2006, YEAST, V23, P1015, DOI 10.1002/yea.1410; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Grancell A, 1998, CURR BIOL, V8, pR382, DOI 10.1016/S0960-9822(98)70243-X; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Maekawa H, 2004, DEV CELL, V6, P746, DOI 10.1016/j.devcel.2004.05.017; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pidoux AL, 2000, J CELL SCI, V113, P4177; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Tournier S, 2004, MOL BIOL CELL, V15, P3345, DOI 10.1091/mbc.E04-03-0256; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892; Wuhr M, 2008, CURR BIOL, V18, pR912, DOI 10.1016/j.cub.2008.08.043	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10634	10.1371/journal.pone.0010634	http://dx.doi.org/10.1371/journal.pone.0010634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498706	Green Published, Green Submitted, gold			2022-12-27	WOS:000277633500019
J	Kabir, MM; Dimitri, H; Sanders, P; Antic, R; Nalivaiko, E; Abbott, D; Baumert, M				Kabir, Muammar M.; Dimitri, Hany; Sanders, Prashanthan; Antic, Ral; Nalivaiko, Eugene; Abbott, Derek; Baumert, Mathias			Cardiorespiratory Phase-Coupling Is Reduced in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MYOCARDIAL-INFARCTION; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; TIME-DOMAIN; SYNCHRONIZATION; SYSTEM; RESPIRATION; MODULATION; DYNAMICS	Cardiac and respiratory rhythms reveal transient phases of phase-locking which were proposed to be an important aspect of cardiorespiratory interaction. The aim of this study was to quantify cardio-respiratory phase-locking in obstructive sleep apnea (OSA). We investigated overnight polysomnography data of 248 subjects with suspected OSA. Cardiorespiratory phase-coupling was computed from the R-R intervals of body surface ECG and respiratory rate, calculated from abdominal and thoracic sensors, using Hilbert transform. A significant reduction in phase-coupling was observed in patients with severe OSA compared to patients with no or mild OSA. Cardiorespiratory phase-coupling was also associated with sleep stages and was significantly reduced during rapid-eye-movement (REM) sleep compared to slow-wave (SW) sleep. There was, however, no effect of age and BMI on phase coupling. Our study suggests that the assessment of cardiorespiratory phase coupling may be used as an ECG based screening tool for determining the severity of OSA.	[Kabir, Muammar M.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Ctr Biomed Engn, Adelaide, SA, Australia; [Dimitri, Hany; Sanders, Prashanthan] Univ Adelaide, Cardiovasc Res Ctr, Sch Med, Adelaide, SA, Australia; [Antic, Ral] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Nalivaiko, Eugene] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Baumert, Mathias] Univ Adelaide, Sch Med, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; Royal Adelaide Hospital; University of Newcastle; University of Adelaide	Kabir, MM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Ctr Biomed Engn, Adelaide, SA, Australia.	muammar.kabir@adelaide.edu.au	Baumert, Mathias/A-8324-2008; Kabir, Muammar/C-1210-2010; Abbott, Derek/E-8352-2011; Sanders, Prashanthan/D-7641-2013	Baumert, Mathias/0000-0003-2984-2167; Abbott, Derek/0000-0002-0945-2674; Sanders, Prashanthan/0000-0003-3803-8429; Nalivaiko, Eugene/0000-0002-6449-8181	Australian Research Council [DP0663345]	Australian Research Council(Australian Research Council)	The research was supported by the Australian Research Council (grant #DP0663345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin M, 2004, TEX HEART I J, V31, P132; Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Baumert M, 2008, SLEEP, V31, P959; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bettermann Henrik, 2002, BMC Physiol, V2, P18, DOI 10.1186/1472-6793-2-18; Brandenberger G, 2005, AUTON NEUROSCI-BASIC, V121, P81, DOI 10.1016/j.autneu.2005.06.002; Busetto L, 2005, CHEST, V128, P618, DOI 10.1378/chest.128.2.618; CASOLO GC, 1992, CIRCULATION, V85, P2073, DOI 10.1161/01.CIR.85.6.2073; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Coruzzi P, 2006, CHEST, V130, P1362, DOI 10.1378/chest.130.5.1362; Cysarz D, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-44; FERGUSON KA, 1995, CHEST, V108, P375, DOI 10.1378/chest.108.2.375; Gottesmann C, 1999, PROG NEUROBIOL, V59, P469, DOI 10.1016/S0301-0082(99)00014-3; Guyton A.C., 2006, TXB MED PHYSL, P739; Hamann C, 2009, CHAOS, V19, DOI 10.1063/1.3096415; HAYANO J, 1994, AM J PHYSIOL, V267, pH33, DOI 10.1152/ajpheart.1994.267.1.H33; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hoffmann J, 1996, PACE, V19, P1841, DOI 10.1111/j.1540-8159.1996.tb03237.x; Hoyer D, 2002, MED ENG PHYS, V24, P33, DOI 10.1016/S1350-4533(01)00120-5; Hoyer D, 1997, IEEE ENG MED BIOL, V16, P97, DOI 10.1109/51.637123; Javorka M, 2008, CLIN NEUROPHYSIOL, V119, P1071, DOI 10.1016/j.clinph.2007.12.017; Kenwright DA, 2008, EUR PHYS J B, V65, P425, DOI 10.1140/epjb/e2008-00199-4; Kotani K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051923; Leder U, 2000, Z KARDIOL, V89, P630, DOI 10.1007/s003920070214; Lotric MB, 2000, PHYSICA A, V283, P451, DOI 10.1016/S0378-4371(00)00204-1; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; MEERSMAN RE, 1992, EUR J APPL PHYSL, V64, P434; MOSER M, 1994, CIRCULATION, V90, P1078, DOI 10.1161/01.CIR.90.2.1078; Mrowka R, 2000, INT J BIFURCAT CHAOS, V10, P2479, DOI 10.1142/S0218127400001754; Nalivaiko E, 2007, AM J PHYSIOL-REG I, V292, pR1320, DOI 10.1152/ajpregu.00642.2006; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Narkiewicz K, 2003, ACTA PHYSIOL SCAND, V177, P385, DOI 10.1046/j.1365-201X.2003.01091.x; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Pereda E, 2005, IEEE T BIO-MED ENG, V52, P578, DOI 10.1109/TBME.2005.844022; PIZZUTI GP, 1985, J BIOMED ENG, V7, P247, DOI 10.1016/0141-5425(85)90027-5; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Roche F, 2002, PACE, V25, P1192, DOI 10.1046/j.1460-9592.2002.01192.x; Roche F, 1999, CIRCULATION, V100, P1411, DOI 10.1161/01.CIR.100.13.1411; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Song HS, 2003, APPL PSYCHOPHYS BIOF, V28, P13, DOI 10.1023/A:1022312815649; Stefanovska A, 2000, PHYS REV LETT, V85, P4831, DOI 10.1103/PhysRevLett.85.4831; Toledo E, 2002, MED ENG PHYS, V24, P45, DOI 10.1016/S1350-4533(01)00114-X; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tzeng YC, 2007, AM J PHYSIOL-HEART C, V292, pH1967, DOI 10.1152/ajpheart.01049.2006; Tzeng YC, 2003, EXP PHYSIOL, V88, P775, DOI 10.1113/eph8802606; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Varady P, 2003, IEEE T INSTRUM MEAS, V52, P2, DOI 10.1109/TIM.2003.809095; Wiklund U, 2000, CLIN PHYSIOL, V20, P234; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	55	46	48	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10602	10.1371/journal.pone.0010602	http://dx.doi.org/10.1371/journal.pone.0010602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20485528	Green Published, gold, Green Submitted			2022-12-27	WOS:000277633500007
J	Squarize, CH; Castilho, RM; Bugge, TH; Gutkind, JS				Squarize, Cristiane H.; Castilho, Rogerio M.; Bugge, Thomas H.; Gutkind, J. Silvio			Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; RENAL-ALLOGRAFT REJECTION; CHROMOSOME-10 PTEN; CANCER; SIROLIMUS; TARGET; DISEASE; PROLIFERATION; PHOSPHATASE; MECHANISMS	Background: The management of slow or non-healing ulcerations constitutes an increasing clinical challenge in the developed world because of the ageing of the population and the pandemic rise in type II diabetes. Recent studies suggest that molecular circuitries deployed by tumor cells to promote cancerous growth may also contribute to tissue regeneration. Here, we exploited this emerging information to search for novel molecular targets to accelerate wound healing. Methodology/Principal Findings: We found that the activation of the PI3K-Akt-mTOR pathway, whose aberrant function is a frequent event in human neoplasia, represents an integral component of the normal wound healing process. By the use of genetically defined approaches, including the epithelial-specific ablation of Pten and Tsc1, we show that mTOR activation can dramatically increase epithelial cell proliferation, migration, and cutaneous wound healing, while pharmacological inhibition of mTOR with rapamycin delays wound closure. Conclusions/Significance: Overall, our findings indicate that the transient pharmacologic activation of the PI3K-Akt-mTOR signaling axis may represent a novel clinical intervention strategy to accelerate the healing of debilitating and life-threatening wounds.	[Squarize, Cristiane H.; Castilho, Rogerio M.; Bugge, Thomas H.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Div Oral Pathol Med Radiol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan	Squarize, CH (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA.	sg39v@nih.gov	Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Squarize, Cristiane/0000-0002-6782-3429	NIH, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER	NIH, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of NIH, National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Campistol JM, 2009, TRANSPL INT, V22, P681, DOI 10.1111/j.1432-2277.2009.00858.x; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kaposztas Z, 2008, TRANSPL P, V40, P1744, DOI [10.1016/j.transproceed.2007.11.072, 10.1016/j.transproceed.2008.10.019]; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Knight RJ, 2007, CLIN TRANSPLANT, V21, P460, DOI 10.1111/j.1399-0012.2007.00668.x; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mathew TH, 2006, J CLIN PHARMACOL, V46, P76, DOI 10.1177/0091270005282628; Meikle L, 2005, HUM MOL GENET, V14, P429, DOI 10.1093/hmg/ddi039; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schmid AC, 2004, BIOCHEM SOC T, V32, P348, DOI 10.1042/BST0320348; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Zhao M, 2007, BRIT J PHARMACOL, V152, P1141, DOI 10.1038/sj.bjp.0707503	42	128	134	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10643	10.1371/journal.pone.0010643	http://dx.doi.org/10.1371/journal.pone.0010643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498714	Green Submitted, Green Published, gold			2022-12-27	WOS:000277633500022
J	Massaad, CA; Amin, SK; Hu, LY; Mei, Y; Klann, E; Pautler, RG				Massaad, Cynthia A.; Amin, Samir K.; Hu, Lingyun; Mei, Yuan; Klann, Eric; Pautler, Robia G.			Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AMYLOID-BETA PROTEIN; OXIDATIVE STRESS; MEMORY DEFICITS; DISMUTASE; TAU; PHOSPHORYLATION; BRAIN; OVEREXPRESSION; DYSFUNCTION	Background: Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive decline in cognitive functions and the deposition of aggregated amyloid beta (A beta) into senile plaques and the protein tau into tangles. In addition, a general state of oxidation has long been known to be a major hallmark of the disease. What is not known however, are the mechanisms by which oxidative stress contributes to the pathology of AD. Methodology/Principal Findings: In the current study, we used a mouse model of AD and genetically boosted its ability to quench free radicals of specific mitochondrial origin. We found that such manipulation conferred to the AD mice protection against vascular as well as neuronal deficits that typically affect them. We also found that the vascular deficits are improved via antioxidant modulation of the endothelial nitric oxide synthase, an enzyme primarily responsible for the production of nitric oxide, while neuronal deficits are improved via modulation of the phosphorylation status of the protein tau, which is a neuronal cytoskeletal stabilizer. Conclusions/Significance: These findings directly link free radicals of specific mitochondrial origin to AD-associated vascular and neuronal pathology.	[Massaad, Cynthia A.; Amin, Samir K.; Hu, Lingyun; Mei, Yuan; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Mei, Yuan] Rice Univ, Dept Cognit Sci, Houston, TX USA; [Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA	Baylor College of Medicine; Rice University; New York University	Massaad, CA (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	rpautler@bcm.edu			National Institutes of Health, National Institute on Aging [AG029977]; Wendler Research Fund; National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS034007, NS047384]; Alzheimers Association Investigator Initiated Research [05-15221]; National Institutes of Health, National Heart, Lung and Blood Institute [T32HL07676]; American Health Assistance Foundation, Alzheimer Disease Research [A2008-600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034007, R01NS034007, R37NS034007, R01NS047384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029977] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wendler Research Fund; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Association Investigator Initiated Research(Alzheimer's Association); National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Health Assistance Foundation, Alzheimer Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health, National Institute on Aging Grant AG029977 and The Wendler Research Fund (to R. G. P.), the National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS034007 and NS047384, and Alzheimers Association Investigator Initiated Research Grant 05-15221 (to E. K.); the National Institutes of Health, National Heart, Lung and Blood Institute Grant T32HL07676 and the American Health Assistance Foundation, Alzheimer Disease Research Grant A2008-600 (to C. A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORO G, 2009, NEUROBIOL AGING; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Behl C, 2005, SUB CELL BIOCHEM, V38, P65; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HANSSON O, 2007, NEUROBIOL AGING; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Iadecola C, 2003, ARTERIOSCL THROM VAS, V23, P1951, DOI 10.1161/01.ATV.0000102660.99744.85; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; MONCADA S, 1991, PHARMACOL REV, V43, P109; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Orduna MT, 2009, J PINEAL RES, V46, P262, DOI 10.1111/j.1600-079X.2008.00656.x; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	56	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10561	10.1371/journal.pone.0010561	http://dx.doi.org/10.1371/journal.pone.0010561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479943	gold, Green Published, Green Submitted			2022-12-27	WOS:000277467900016
J	Kelly, DF; Lake, RJ; Middelkoop, TC; Fan, HY; Artavanis-Tsakonas, S; Walz, T				Kelly, Deborah F.; Lake, Robert J.; Middelkoop, Teije C.; Fan, Hua-Ying; Artavanis-Tsakonas, Spyros; Walz, Thomas			Molecular Structure and Dimeric Organization of the Notch Extracellular Domain as Revealed by Electron Microscopy	PLOS ONE			English	Article							EGF REPEATS; PROTEIN; SUPPRESSOR; LOCUS; TILT	Background: The Notch receptor links cell fate decisions of one cell to that of the immediate cellular neighbor. In humans, malfunction of Notch signaling results in diseases and congenital disorders. Structural information is essential for gaining insight into the mechanism of the receptor as well as for potentially interfering with its function for therapeutic purposes. Methodology/Principal Findings: We used the Affinity Grid approach to prepare specimens of the Notch extracellular domain (NECD) of the Drosophila Notch and human Notch1 receptors suitable for analysis by electron microscopy and three-dimensional (3D) image reconstruction. The resulting 3D density maps reveal that the NECD structure is conserved across species. We show that the NECD forms a dimer and adopts different yet defined conformations, and we identify the membrane-proximal region of the receptor and its ligand-binding site. Conclusions/Significance: Our results provide direct and unambiguous evidence that the NECD forms a dimer. Our studies further show that the NECD adopts at least three distinct conformations that are likely related to different functional states of the receptor. These findings open the way to now correlate mutations in the NECD with its oligomeric state and conformation.	[Kelly, Deborah F.; Lake, Robert J.; Middelkoop, Teije C.; Artavanis-Tsakonas, Spyros; Walz, Thomas] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Fan, Hua-Ying] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Program, Philadelphia, PA 19111 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kelly, DF (corresponding author), Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA.	artavanis@hms.harvard.edu; twalz@hms.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Kelly, Deborah/0000-0002-7341-7435; Middelkoop, Teije/0000-0002-0346-6143	National Institutes of Health (NIH) [GM062580, NS26084, CA098402]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084983, P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026084, R01NS026084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants GM062580 (to Stephen C. Harrison) and NS26084 and CA098402 (to Spyros Artavanis-Tsakonas). Thomas Walz is an of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; FOSTER GG, 1975, GENETICS, V81, P99; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hurlbut GD, 2009, P NATL ACAD SCI USA, V106, P2218, DOI 10.1073/pnas.0812024106; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kelly DF, 2008, J MOL BIOL, V382, P423, DOI 10.1016/j.jmb.2008.07.023; Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105; Kelly DF, 2007, P NATL ACAD SCI USA, V104, P9591, DOI 10.1073/pnas.0702887104; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; LI Z, 2009, J ELECTRON MICROSC, V59, P53; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wall JS, 2000, METH MOL B, V148, P589; Wall JS, 1998, METHOD CELL BIOL, V53, P139; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	26	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10532	10.1371/journal.pone.0010532	http://dx.doi.org/10.1371/journal.pone.0010532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479883	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800014
J	Kochin, BF; Yates, AJ; de Roode, JC; Antia, R				Kochin, Beth F.; Yates, Andrew J.; de Roode, Jacobus C.; Antia, Rustom			On the Control of Acute Rodent Malaria Infections by Innate Immunity	PLOS ONE			English	Article							ENDOGENOUS GAMMA-INTERFERON; STAGE PLASMODIUM-CHABAUDI; WITHIN-HOST COMPETITION; ANTIGENIC VARIATION; DYNAMICS; RESPONSES; MODEL; PARASITEMIA; HETEROGENEITY; PHAGOCYTOSIS	Does specific immunity, innate immunity or resource (red blood cell) limitation control the first peak of the blood-stage parasite in acute rodent malaria infections? Since mice deficient in specific immunity exhibit similar initial dynamics as wildtype mice it is generally viewed that the initial control of parasite is due to either limitation of resources (RBC) or innate immune responses. There are conflicting views on the roles of these two mechanisms as there is experimental evidence supporting both these hypotheses. While mathematical models based on RBC limitation are capable of describing the dynamics of primary infections, it was not clear whether a model incorporating the key features of innate immunity would be able to do the same. We examine the conditions under which a model incorporating parasite and innate immunity can describe data from acute Plasmodium chabaudi infections in mice. We find that innate immune response must decay slowly if the parasite density is to fall rather than equilibrate. Further, we show that within this framework the differences in the dynamics of two parasite strains are best ascribed to differences in susceptibility to innate immunity, rather than differences in the strains' growth rates or their propensity to elicit innate immunity. We suggest that further work is required to determine if innate immunity or resource limitation control acute malaria infections in mice.	[Kochin, Beth F.; Yates, Andrew J.; de Roode, Jacobus C.; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Kochin, BF (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	bkochin@emory.edu			National Institutes of Health, NIH [U01-GM070749, R01AI049334]; Fogarty Center; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health (NIH grants U01-GM070749 and R01AI049334), the RAPIDD Program of the Fogarty Center, and the Fannie and John Hertz Foundation provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIA R, 1994, J THEOR BIOL, V168, P141, DOI 10.1006/jtbi.1994.1094; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Barclay VC, 2008, P ROY SOC B-BIOL SCI, V275, P1171, DOI 10.1098/rspb.2007.1713; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; BRINKMANN V, 1984, INFECT IMMUN, V44, P743, DOI 10.1128/IAI.44.3.743-746.1984; Choudhury HR, 2000, INFECT IMMUN, V68, P6127, DOI 10.1128/IAI.68.11.6127-6132.2000; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lamb TJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-68; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; McQueen PG, 2006, AM J TROP MED HYG, V75, P112, DOI 10.4269/ajtmh.2006.75.112; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; STEVENSON MM, 1992, INFECT IMMUN, V60, P1193, DOI 10.1128/IAI.60.3.1193-1201.1992; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Su Z, 2002, J INFECT DIS, V186, P1321, DOI 10.1086/344576; vanderHeyde HC, 1997, EXP PARASITOL, V85, P206, DOI 10.1006/expr.1996.4132; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; YAP GS, 1994, INFECT IMMUN, V62, P3761, DOI 10.1128/IAI.62.9.3761-3765.1994	36	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10444	10.1371/journal.pone.0010444	http://dx.doi.org/10.1371/journal.pone.0010444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463903	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000277379800001
J	Cardarelli, F; Gratton, E				Cardarelli, Francesco; Gratton, Enrico			In Vivo Imaging of Single-Molecule Translocation Through Nuclear Pore Complexes by Pair Correlation Functions	PLOS ONE			English	Article							ARGININE-RICH MOTIF; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; PERMEABILITY; CELLS	Background: Nuclear pore complexes (NPCs) mediate bidirectional transport of proteins, RNAs, and ribonucleoproteins across the double-membrane nuclear envelope. Although there are many studies that look at the traffic in the nucleus and through the nuclear envelope we propose a method to detect the nucleocytoplasmic transport kinetics in an unperturbed cell, with no requirement for specific labeling of isolated molecules and, most important, in the presence of the cell milieu. Methodology: The pair correlation function method (pCF) measures the time a molecule takes to migrate from one location to another within the cell in the presence of many molecules of the same kind. The spatial and temporal correlation among two arbitrary points in the cell provides a local map of molecular transport, and also highlights the presence of barriers to diffusion with millisecond time resolution and spatial resolution limited by diffraction. We use the pair correlation method to monitor a model protein substrate undergoing transport through NPCs in living cells, a biological problem in which single particle tracking (SPT) has given results that cannot be confirmed by traditional single-point FCS measurements because of the lack of spatial resolution. Conclusions: We show that obstacles to molecular flow can be detected and that the pCF algorithm can recognize the heterogeneity of protein intra-compartment diffusion as well as the presence of barriers to transport across NE.	[Cardarelli, Francesco; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Cardarelli, F (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA.	egratton22@yahoo.com			National Institutes of Health (NIH) [P41-RRO3155, P50-GM076516]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from National Institutes of Health (NIH) P41-RRO3155, P50-GM076516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dertinger T, 2008, OPT EXPRESS, V16, P14353, DOI 10.1364/OE.16.014353; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	28	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10475	10.1371/journal.pone.0010475	http://dx.doi.org/10.1371/journal.pone.0010475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454622	gold, Green Published			2022-12-27	WOS:000277240300032
J	Wang, Q; Hall, CL; Al-Adami, MZ; He, QF				Wang, Qiang; Hall, Camille L.; Al-Adami, Mustafa Z.; He, Qingfang			IsiA Is Required for the Formation of Photosystem I Supercomplexes and for Efficient State Transition in Synechocystis PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-BINDING PROTEIN; SYNECHOCOCCUS SP PCC7942; ALGA ANACYSTIS-NIDULANS; SALT-STRESSED CELLS; IRON-DEFICIENCY; CYANOBACTERIAL PHOTOSYNTHESIS; SPECTROSCOPIC PROPERTIES; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; ANTENNA RING	Iron deficiency and other stress conditions strongly impact photosynthetic apparatus in photosynthetic organisms. Two novel chlorophyll (Chl)-containing supercomplexes (F4 and F5) in addition to the photosystem (PS) I trimers (F3) were observed by sucrose gradient ultracentrifugation in Synechocystis PCC 6803 under extensive iron starvation. 77K fluorescence and Western blot analyses of these supercomplexes revealed that they all contained IsiA. The F4 was identified as an IsiA-PSI-PSII supercomplex, while the F5 was assigned as an IsiA-PSI supercomplex. Deletion of isiA resulted in diminishing the PSI trimers (including the PSI trimers in iron-replete cells) and the two novel PSI supercomplexes (F4 and F5), and a significant reduction in the saturated whole-chain electron transport rate. However, the maximum PSII activities remained at levels similar to those of the wild type under various light conditions. The isiA-mutant was defective in state transition and sensitive to high light. The sensitivity of the isiA-mutant to high light was correlated with a higher level of membrane peroxidation. These results demonstrated that IsiA is required for the formation of PSI trimers and other higher complexes, and that IsiA is critical for efficient state transition.	[Wang, Qiang; Hall, Camille L.; Al-Adami, Mustafa Z.; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Wang, Q (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu	He, Qingfang/I-4181-2013		National Science Foundation [MCB0447788]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB0447788. http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrizhiyevskaya EG, 2002, BBA-BIOENERGETICS, V1556, P265, DOI 10.1016/S0005-2728(02)00371-7; Aspinwall CL, 2004, FEBS LETT, V574, P126, DOI 10.1016/j.febslet.2004.08.016; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cadoret JC, 2004, BBA-BIOENERGETICS, V1659, P100, DOI 10.1016/j.bbabio.2004.08.001; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Campbell D, 1996, PLANT PHYSIOL, V111, P1293, DOI 10.1104/pp.111.4.1293; EISENBERGDOMOVICH Y, 1995, J BIOL CHEM, V270, P30181; FERREIRA F, 1994, J APPL PHYCOL, V6, P199, DOI 10.1007/BF02186073; Geiss U, 2001, APPL ENVIRON MICROB, V67, P5247; Geiss U, 2001, FEMS MICROBIOL LETT, V197, P123, DOI 10.1016/S0378-1097(01)00098-2; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Hagemann M, 1999, PHYSIOL PLANTARUM, V105, P670, DOI 10.1034/j.1399-3054.1999.105411.x; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Ivanov AG, 2006, PLANT PHYSIOL, V141, P1436, DOI 10.1104/pp.106.082339; Jeanjean R, 2003, FEBS LETT, V549, P52, DOI 10.1016/S0014-5793(03)00769-5; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Karapetyan NV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1127, DOI 10.1134/S0006297907100100; Karapetyan NV, 2008, PHOTOSYNTH RES, V97, P195, DOI 10.1007/s11120-008-9336-8; Katoh H, 2000, J BACTERIOL, V182, P6523, DOI 10.1128/JB.182.22.6523-6524.2000; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; OQUIST G, 1974, PHYSIOL PLANTARUM, V30, P30, DOI 10.1111/j.1399-3054.1974.tb04987.x; PAKRASI HB, 1985, PLANT PHYSIOL, V79, P290, DOI 10.1104/pp.79.1.290; PAKRASI HB, 1985, P NATL ACAD SCI USA, V82, P6903, DOI 10.1073/pnas.82.20.6903; Pyndiah S, 2007, MOL CELL PROTEOMICS, V6, P193, DOI 10.1074/mcp.M600363-MCP200; Rakhimberdieva MG, 2006, BBA-BIOENERGETICS, P286; RIETHMAN HC, 1988, PLANT PHYSIOL, V88, P497, DOI 10.1104/pp.88.2.497; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Sandstrom S, 2001, PHOTOCHEM PHOTOBIOL, V74, P431, DOI 10.1562/0031-8655(2001)074<0431:CTIGPF>2.0.CO;2; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V890, P134, DOI 10.1016/0005-2728(87)90014-4; Vinnemeier J, 1998, FEMS MICROBIOL LETT, V169, P323, DOI 10.1111/j.1574-6968.1998.tb13336.x; Vinnemeier J, 1999, ARCH MICROBIOL, V172, P377, DOI 10.1007/s002030050774; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yousef N, 2003, ARCH MICROBIOL, V180, P471, DOI 10.1007/s00203-003-0618-4	52	21	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10432	10.1371/journal.pone.0010432	http://dx.doi.org/10.1371/journal.pone.0010432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454661	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240300009
J	Wu, P; Lau, EHY; Cowling, BJ; Leung, CC; Tam, CM; Leung, GM				Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Chi-Chiu; Tam, Cheuk-Ming; Leung, Gabriel M.			The Transmission Dynamics of Tuberculosis in a Recently Developed Chinese City	PLOS ONE			English	Article							EXOGENOUS REINFECTION; HONG-KONG; CHILDHOOD; EPIDEMIOLOGY; ELIMINATION; GENDER; RISKS	Background: Hong Kong is an affluent subtropical city with a well-developed healthcare infrastructure but an intermediate TB burden. Declines in notification rates through the 1960s and 1970s have slowed since the 1980s to the current level of around 82 cases per 100 000 population. We studied the transmission dynamics of TB in Hong Kong to explore the factors underlying recent trends in incidence. Methodology/Principal Findings: We fitted an age-structured compartmental model to TB notifications in Hong Kong between 1968 and 2008. We used the model to quantify the proportion of annual cases due to recent transmission versus endogenous reactivation of latent infection, and to project trends in incidence rates to 2018. The proportion of annual TB notifications attributed to endogenous reactivation increased from 46% to 70% between 1968 and 2008. Age-standardized notification rates were projected to decline to approximately 56 per 100 000 in 2018. Conclusions/Significance: Continued intermediate incidence of TB in Hong Kong is driven primarily by endogenous reactivation of latent infections. Public health interventions which focus on reducing transmission may not lead to substantial reductions in disease burden associated with endogenous reactivation of latent infections in the short- to medium-term. While reductions in transmission with socio-economic development and public health interventions will lead to declines in TB incidence in these regions, a high prevalence of latent infections may hinder substantial declines in burden in the longer term. These findings may therefore have important implications for the burden of TB in developing regions with higher levels of transmission currently.	[Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Chi-Chiu; Tam, Cheuk-Ming] Govt Hong Kong SAR, Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wu, P (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Wu, Peng/0000-0003-1157-9401; Leung, Gabriel/0000-0002-2503-6283	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [09080802]; US National Institute of General Medical Sciences [1 U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (ref: 09080802) and the US National Institute of General Medical Sciences (grant no. 1 U54 GM088558, MIDAS Harvard Center for Communicable Disease Dynamics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD O, 2001, 31 GPE WHO; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CENS STAT DEP, 2008, POP AG GROUP SEX; *CENS STAT DEP, 2008, HONG KONG LIF TABL 1; Chan-Yeung M, 2003, J CLIN MICROBIOL, V41, P2706, DOI 10.1128/JCM.41.6.2706-2708.2003; Chan-Yeung M, 2006, RESPIROLOGY, V11, P442, DOI 10.1111/j.1440-1843.2006.00871.x; Chee CB, 2003, B WORLD HEALTH ORGAN, V81, P217; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; *CTR HLTH PROT, 2000, TUB CONTR HONG KONG; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; *GOV HONG KONG SAR, CENS STAT DEP POP GR; *GOV HONG KONG SAR, HONG KONG TUB CHEST; *GOV HONG KONG SAR, CENS STAT DEP STAT S; *HLTH SERV RES GRO, 2000, SERV TREATM PAT TUB; *HONG KONG TUB CHE, 2007, ANN REP DEP HTLH GOV; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Schooling M, 2004, INT J EPIDEMIOL, V33, P1219, DOI 10.1093/ije/dyh221; Schwander S. K., 2006, REICHMAN HERSHFIELDS, P117; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635 STOP; *UN, 2002, A56326 UN GEN ASS; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354	40	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10468	10.1371/journal.pone.0010468	http://dx.doi.org/10.1371/journal.pone.0010468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454620	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300029
J	Hartbauer, M				Hartbauer, Manfred			Collective Defense of Aphis nerii and Uroleucon hypochoeridis (Homoptera, Aphididae) against Natural Enemies	PLOS ONE			English	Article							APHELINUS-ASYCHIS HYMENOPTERA; SCHIZAPHIS-GRAMINUM HOMOPTERA; ACYRTHOSIPHON-PISUM HARRIS; ALARM PHEROMONE; VIBRATIONAL COMMUNICATION; OVIPOSITION BEHAVIOR; PEA APHID; COLEMANI VIERECK; SOCIAL APHID; SELFISH HERD	The prevalent way aphids accomplish colony defense against natural enemies is a mutualistic relationship with ants or the occurrence of a specialised soldier caste typcial for eusocial aphids, or even both. Despite a group-living life style of those aphid species lacking these defense lines, communal defense against natural predators has not yet been observed there. Individuals of Aphis nerii (Oleander aphid) and Uroleucon hypochoeridis, an aphid species feeding on Hypochoeris radicata (hairy cat's ear), show a behavioral response to visual stimulation in the form of spinning or twitching, which is often accompanied by coordinated kicks executed with hind legs. Interestingly, this behaviour is highly synchronized among members of a colony and repetitive visual stimulation caused strong habituation. Observations of natural aphid colonies revealed that a collective twitching and kicking response (CTKR) was frequently evoked during oviposition attempts of the parasitoid wasp Aphidius colemani and during attacks of aphidophagous larvae. CTKR effectively interrupted oviposition attempts of this parasitoid wasp and even repelled this parasitoid from colonies after evoking consecutive CTKRs. In contrast, solitary feeding A. nerii individuals were not able to successfully repel this parasitoid wasp. In addition, CTKR was also evoked through gentle substrate vibrations. Laser vibrometry of the substrate revealed twitching-associated vibrations that form a train of sharp acceleration peaks in the course of a CTKR. This suggests that visual signals in combination with twitching-related substrate vibrations may play an important role in synchronising defense among members of a colony. In both aphid species collective defense in encounters with different natural enemies was executed in a stereotypical way and was similar to CTKR evoked through visual stimulation. This cooperative defense behavior provides an example of a surprising sociality that can be found in some aphid species that are not expected to be social at all.	Karl Franzens Univ Graz, Dept Zool, Behav Ecol Grp, Graz, Austria	University of Graz	Hartbauer, M (corresponding author), Karl Franzens Univ Graz, Dept Zool, Behav Ecol Grp, Graz, Austria.	manfred.hartbauer@uni-graz.at			Austrian Science Fund [P 21808-B09]; Austrian Science Fund (FWF) [P 21808] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (http://www.fwf.ac.at/, grant P 21808-B09) by contributing to equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2001, P NATL ACAD SCI USA, V98, P12068, DOI 10.1073/pnas.201212698; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; AOKI S, 1978, New Entomologist, V27, P7; Aoki Shigeyuki, 2002, Entomological Science, V5, P55; ARAKAKI N, 1989, J ETHOL, V7, P83, DOI 10.1007/BF02350028; BOYLE H, 1978, P ENTOMOL SOC WASH, V80, P441; CANGIALOSI KR, 1990, BEHAV ECOL SOCIOBIOL, V27, P49; Casas J, 1998, BIOL CONTROL, V11, P147, DOI 10.1006/bcon.1997.0593; Casas J, 2007, P ROY SOC B-BIOL SCI, V274, P1087, DOI 10.1098/rspb.2006.0306; Choe DH, 2006, SOCIOBIOLOGY, V48, P799; Choe JC, 1997, EVOLUTION SOCIAL BEH; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Cocroft RB, 1996, NATURE, V382, P679, DOI 10.1038/382679a0; Cocroft RB, 2005, P ROY SOC B-BIOL SCI, V272, P1023, DOI 10.1098/rspb.2004.3041; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cocroft RB, 2001, AM ZOOL, V41, P1215, DOI 10.1668/0003-1569(2001)041[1215:VCATEO]2.0.CO;2; Cocroft RB, 2002, BEHAV ECOL, V13, P125, DOI 10.1093/beheco/13.1.125; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; CRESPI BJ, 1992, NATURE, V359, P724, DOI 10.1038/359724a0; De Faris AMI, 1999, ENVIRON ENTOMOL, V28, P858, DOI 10.1093/ee/28.5.858; Devetak D., 1979, Bioloski Vestnik, V26, P131; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; Eastop V., 1954, ENTOMOLOGIST, V85, P57; EL-ZIADY S., 1956, Proceedings of the Royal Entomological Society of London, V31, P61; EVANS DL, 1990, INSECT DEFENCES ADAP, pR15; FOSTER WA, 1990, BEHAV ECOL SOCIOBIOL, V27, P421, DOI 10.1007/BF00164069; Foster WA, 1998, ANIM BEHAV, V55, P761, DOI 10.1006/anbe.1997.0664; GARDNER SM, 1984, ECOL ENTOMOL, V9, P149, DOI 10.1111/j.1365-2311.1984.tb00709.x; GERLING D, 1990, J INSECT BEHAV, V3, P501, DOI 10.1007/BF01052014; Gilbert F, 2005, EUR J ENTOMOL, V102, P325, DOI 10.14411/eje.2005.050; Gilbert F.S., 1986, HOVERFLIES; GOGALA M, 1984, Bioloski Vestnik, V32, P19; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HERZIG J., 1937, Zeitschrift fur Angewandte Entomologie, V24, P367; HIGHT S C, 1972, Environmental Entomology, V1, P205; Hodek I., 1996, ECOLOGY COCCINELLIDA; HOFSVANG T, 1986, ENTOMOPHAGA, V31, P261, DOI 10.1007/BF02373335; HOGUE C, 1972, J LEPID SOC, V31, P261; KLINGAUF F, 1967, Z ANGEWANDE ENTOMOLO, V59, P266; KOUAME KL, 1991, OECOLOGIA, V88, P197, DOI 10.1007/BF00320811; KUNKEL H, 1973, Bonner Zoologische Beitraege, V24, P105; KUNKEL H, 1972, BONNER ZOOL BEITR, V2, P161; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P1432; Magal C, 2000, J ACOUST SOC AM, V108, P2412, DOI 10.1121/1.1286098; Markl H., 1983, P332; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MCCONNELL JA, 1990, ENVIRON ENTOMOL, V19, P1798, DOI 10.1093/ee/19.6.1798; MESSING RH, 1995, AGR ECOSYST ENVIRON, V52, P13, DOI 10.1016/0167-8809(94)09002-O; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; NIJVELDT W, 1988, WORLD CROP PESTS APH, P271; PAMILO P, 1984, BEHAV ECOL SOCIOBIOL, V15, P241, DOI 10.1007/BF00292985; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; Potting RPJ, 1999, ENTOMOL EXP APPL, V91, P143, DOI 10.1023/A:1003615914287; PRINCIPI MM, 1984, BIOL CHRYSOPIDAE, P76; PROP N., 1960, ARCH NEERLAND ZOOL, V13, P380; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; ROTHSCHILD M, 1970, J INSECT PHYSIOL, V16, P1141, DOI 10.1016/0022-1910(70)90203-9; RUTH W E, 1975, Entomophaga, V20, P65, DOI 10.1007/BF02373451; SCHUTZE M, 1991, ENTOMOL GEN, V16, P1; Shingleton AW, 2000, P ROY SOC B-BIOL SCI, V267, P1863, DOI 10.1098/rspb.2000.1222; STAMP NE, 1982, ENVIRON ENTOMOL, V11, P100, DOI 10.1093/ee/11.1.100; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Stary P., 1970, BIOL APHID PARASITES; Stern DL, 1996, BIOL REV, V71, P27, DOI 10.1111/j.1469-185X.1996.tb00741.x; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; Vulinec K., 1990, P251; WEISSER WW, 1995, ENTOMOL EXP APPL, V76, P133, DOI 10.1007/BF02383211; WILBERT H, 1967, BIOCONTROL, V12, P127; Williams C. B., 1922, Entomologist London, V55, P173; WINK M, 1991, ENTOMOL GEN, V15, P237	76	32	34	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10417	10.1371/journal.pone.0010417	http://dx.doi.org/10.1371/journal.pone.0010417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454683	gold, Green Published, Green Submitted			2022-12-27	WOS:000277240100023
J	Durr, ML; Mydlarz, WK; Shao, CB; Zahurak, ML; Chuang, AY; Hoque, MO; Westra, WH; Liegeois, NJ; Califano, JA; Sidransky, D; Ha, PK				Durr, Megan L.; Mydlarz, Wojciech K.; Shao, Chunbo; Zahurak, Marianna L.; Chuang, Alice Y.; Hoque, Mohammad O.; Westra, William H.; Liegeois, Nanette J.; Califano, Joseph A.; Sidransky, David; Ha, Patrick K.			Quantitative Methylation Profiles for Multiple Tumor Suppressor Gene Promoters in Salivary Gland Tumors	PLOS ONE			English	Article							ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMA; INDEPENDENT PROGNOSTIC-FACTOR; TISSUE INHIBITOR; PROSTATE-CANCER; BLADDER-CANCER; CLINICAL-SIGNIFICANCE; ABERRANT METHYLATION; LUNG-CANCER; E-CADHERIN	Background: Methylation profiling of tumor suppressor gene (TSGs) promoters is quickly becoming a powerful diagnostic tool for the early detection, prognosis, and even prediction of clinical response to treatment. Few studies address this in salivary gland tumors (SGTs); hence the promoter methylation profile of various TSGs was quantitatively assessed in primary SGT tissue to determine if tumor-specific alterations could be detected. Methodology: DNA isolated from 78 tumor and 17 normal parotid gland specimens was assayed for promoter methylation status of 19 TSGs by fluorescence-based, quantitative methylation-specific PCR (qMSP). The data were utilized in a binary fashion as well as quantitatively (using a methylation quotient) allowing for better profiling and interpretation of results. Principal Findings: The average number of methylation events across the studied genes was highest in salivary duct carcinoma (SDC), with a methylation value of 9.6, compared to the normal 4.5 (p<0.0003). There was a variable frequency and individual methylation quotient detected, depending on the TSG and the tumor type. When comparing normal, benign, and malignant SGTs, there was a statistically significant trend for increasing methylation in APC, Mint 1, PGP9.5, RAR-beta, and Timp3. Conclusions/Significance: Screening promoter methylation profiles in SGTs showed considerable heterogeneity. The methylation status of certain markers was surprisingly high in even normal salivary tissue, confirming the need for such controls. Several TSGs were found to be associated with malignant SGTs, especially SDC. Further study is needed to evaluate the potential use of these associations in the detection, prognosis, and therapeutic outcome of these rare tumors.	[Durr, Megan L.; Mydlarz, Wojciech K.; Shao, Chunbo; Chuang, Alice Y.; Hoque, Mohammad O.; Califano, Joseph A.; Sidransky, David; Ha, Patrick K.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Zahurak, Marianna L.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Westra, William H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Liegeois, Nanette J.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Califano, Joseph A.; Ha, Patrick K.] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Durr, ML (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	pha1@jhmi.edu	Shao, Chunbo/C-5412-2011	Liegeois, Nanette/0000-0001-5002-1799; Hoque, Mohammad Obaidul/0000-0001-6701-9978	National Institute of Dental and Craniofacial Research [K08-DE018463]; Johns Hopkins Clinician Scientist Award; National Cancer Institute SPORE [5P50CA096784-05]; EDRN [U01CA084986]; National Institutes of Health (NIH) [T32DC000027]; NATIONAL CANCER INSTITUTE [U01CA084986, P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE018463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Johns Hopkins Clinician Scientist Award; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EDRN; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Dr. Ha is supported by the Johns Hopkins Clinician Scientist Award and the National Institute of Dental and Craniofacial Research (K08-DE018463). Dr. Sidransky is supported by the National Cancer Institute SPORE (5P50CA096784-05) and EDRN (U01CA084986). Dr. Califano is supported by the National Institute of Dental and Craniofacial Research, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN (U01CA084986). Dr. Mydlarz is supported, in part, by the National Institutes of Health (NIH) T32 training grant (T32DC000027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2005, CLIN CANCER RES, V11, P656; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Augello C, 2006, J CELL PHYSIOL, V207, P654, DOI 10.1002/jcp.20601; Bachman KE, 1999, CANCER RES, V59, P798; Cerilli LA, 1999, HUM PATHOL, V30, P1242, DOI 10.1016/S0046-8177(99)90044-8; Chan AOO, 2003, ONCOGENE, V22, P924, DOI 10.1038/sj.onc.1206123; Chen KM, 2007, ARCH OTOLARYNGOL, V133, P1131, DOI 10.1001/archotol.133.11.1131; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; *CYT SOFTW CORP, 1997, STATXACT 4 WIND VERS; Daa T, 2004, MODERN PATHOL, V17, P1475, DOI 10.1038/modpathol.3800209; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; ElNaggar AK, 1997, AM J SURG PATHOL, V21, P691, DOI 10.1097/00000478-199706000-00009; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2005, J PATHOL, V205, P172, DOI 10.1002/path.1707; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2001, CANCER RES, V61, P3225; *FDN STAT COMP, 2004, R LANG ENV STAT COMP; Fukasawa M, 2006, J HUM GENET, V51, P368, DOI 10.1007/s10038-005-0355-4; Guo XL, 2007, INT J ORAL MAX SURG, V36, P350, DOI 10.1016/j.ijom.2006.11.004; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; Hoque MO, 2008, J UROLOGY, V179, P743, DOI 10.1016/j.juro.2007.09.019; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Johns M E, 1989, Oncology (Williston Park), V3, P85; Johns M E, 1989, Oncology (Williston Park), V3, P47; Kishi M, 2005, ORAL ONCOL, V41, P161, DOI 10.1016/j.oraloncology.2004.08.004; Lalami Y, 2006, CURR OPIN ONCOL, V18, P258, DOI 10.1097/01.cco.0000219255.30220.90; Lee ES, 2008, CLIN CANCER RES, V14, P2664, DOI 10.1158/1078-0432.CCR-07-1232; Li J, 2005, CANCER-AM CANCER SOC, V104, P771, DOI 10.1002/cncr.21215; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Maruya S, 2004, MODERN PATHOL, V17, P637, DOI 10.1038/modpathol.3800104; Maruya S, 2004, J MOL DIAGN, V6, P180, DOI 10.1016/S1525-1578(10)60508-9; Maruya SI, 2003, ORL-J OTO-RHIN-LARYN, V65, P26, DOI 10.1159/000068658; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; Nishimine M, 2003, ONCOL REP, V10, P555; Ogi K, 2002, CLIN CANCER RES, V8, P3164; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Rosenbaum E, 2005, CLIN CANCER RES, V11, P8321, DOI 10.1158/1078-0432.CCR-05-1183; Safar AM, 2005, CLIN CANCER RES, V11, P4400, DOI 10.1158/1078-0432.CCR-04-2378; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; *SAS I INC, 1985, SAS US GUID VERS; Sato N, 2003, CANCER RES, V63, P3735; SPIRO RH, 1974, AM J SURG, V128, P512, DOI 10.1016/0002-9610(74)90265-7; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Uchida D, 2004, BRIT J CANCER, V91, P1131, DOI 10.1038/sj.bjc.6602004; Williams MD, 2006, CLIN CANCER RES, V12, P7353, DOI 10.1158/1078-0432.CCR-06-1272; Zhang CY, 2007, CANCER-AM CANCER SOC, V110, P87, DOI 10.1002/cncr.22758	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10828	10.1371/journal.pone.0010828	http://dx.doi.org/10.1371/journal.pone.0010828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520817	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221500015
J	Fang, SY; Krahe, R; Lozano, G; Han, YH; Chen, W; Post, SM; Zhang, BL; Wilson, CD; Bachinski, LL; Strong, LC; Amos, CI				Fang, Shenying; Krahe, Ralf; Lozano, Guillermina; Han, Younghun; Chen, Wei; Post, Sean M.; Zhang, Baili; Wilson, Charmaine D.; Bachinski, Linda L.; Strong, Louise C.; Amos, Christopher I.			Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; ACCELERATES TUMOR-FORMATION; BREAST-CANCER; P53 MUTATIONS; FAMILIES; ONSET; VARIANTS; SARCOMA; SNP309; HUMANS	Background: Previous studies have shown that MDM2 SNP309 and p53 codon 72 have modifier effects on germline P53 mutations, but those studies relied on case-only studies with small sample sizes. The impact of MDM4 polymorphism on tumor onset in germline mutation carriers has not previously been studied. Methodology/Principal Findings: We analyzed 213 p53 germline mutation carriers including 168(78.9%) affected with cancer and 174 who had genotypic data. We analyzed time to first cancer using Kaplan-Meier and Cox proportional hazards methods, comparing risks according to polymorphism genotypes. For MDM2 SNP309, a significant difference of 9.0 years in the average age of cancer diagnosis was observed between GG/GT and TT carriers (18.6 versus 27.6 years, P = 0.0087). The hazards ratio was 1.58 (P = 0.03) comparing risks among individuals with GG/GT to risk among TT, but this effect was only significant in females (HR = 1.60, P = 0.02). Compared to other genotypes, P53 codon 72 PP homozygotes had a 2.24 times (P = 0.03) higher rate for time to develop cancer. We observed a multiplicative joint effect of MDM2 and p53 codon72 polymorphism on risk. The MDM4 polymorphism had no significant effects. Conclusions/Significance: Our results suggest that the MDM2 SNP309 G allele is associated with cancer risk in p53 germline mutation carriers and accelerates time to cancer onset with a pronounced effect in females. A multiplicative joint effect exists between the MDM2 SNP309 G allele and the p53 codon 72 G allele in the risk of cancer development. Our results further define cancer risk in carriers of germline p53 mutations.	[Fang, Shenying; Han, Younghun; Chen, Wei; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Krahe, Ralf; Lozano, Guillermina; Post, Sean M.; Zhang, Baili; Wilson, Charmaine D.; Bachinski, Linda L.; Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fang, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	camos@mdanderson.org		Fang, Shenying/0000-0002-0604-793X	National Institutes of Health [P01-CA 34936-19A2]; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant P01-CA 34936-19A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Chen XM, 2008, CARCINOGENESIS, V29, P2120, DOI 10.1093/carcin/bgn191; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; GARBER JE, 1991, CANCER RES, V51, P6094; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Jin SK, 2001, J CELL SCI, V114, P4139; Kleihues P, 1997, AM J PATHOL, V150, P1; Kulkarni DA, 2009, CARCINOGENESIS, V30, P1910, DOI 10.1093/carcin/bgp224; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LING DY, 1989, J AM STAT ASSOC, V84, P1074; LUSTBADER ED, 1992, AM J HUM GENET, V51, P344; MALKIN D, 1994, BBA-REV CANCER, V1198, P197, DOI 10.1016/0304-419X(94)90014-0; Marcel V, 2009, J MED GENET, V46, P766, DOI 10.1136/jmg.2009.066704; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Martin AM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e34; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; STRONG LC, 1987, AM J PEDIAT HEMATOL, V9, P99; Xiong XJ, 2009, LEUKEMIA RES, V33, P1454, DOI 10.1016/j.leukres.2009.04.007	23	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10813	10.1371/journal.pone.0010813	http://dx.doi.org/10.1371/journal.pone.0010813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520810	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500010
J	Precht, WF; Aronson, RB; Moody, RM; Kaufman, L				Precht, William F.; Aronson, Richard B.; Moody, Ryan M.; Kaufman, Les			Changing Patterns of Microhabitat Utilization by the Threespot Damselfish, Stegastes planifrons, on Caribbean Reefs	PLOS ONE			English	Article							JAMAICAN CORAL REEFS; REGION-WIDE DECLINES; FLORIDA-KEYS; FISH COMMUNITIES; PROTECTED AREAS; AGE-STRUCTURE; POPULATION; ECOLOGY; SCALE; ZONATION	Background: The threespot damselfish, Stegastes planifrons (Cuvier), is important in mediating interactions among corals, algae, and herbivores on Caribbean coral reefs. The preferred microhabitat of S. planifrons is thickets of the branching staghorn coral Acropora cervicornis. Within the past few decades, mass mortality of A. cervicornis from white-band disease and other factors has rendered this coral a minor ecological component throughout most of its range. Methodology/Principal Findings: Survey data from Jamaica (heavily fished), Florida and the Bahamas (moderately fished), the Cayman Islands (lightly to moderately fished), and Belize (lightly fished) indicate that distributional patterns of S. planifrons are positively correlated with live coral cover and topographic complexity. Our results suggest that species-specific microhabitat preferences and the availability of topographically complex microhabitats are more important than the abundance of predatory fish as proximal controls on S. planifrons distribution and abundance. Conclusions/Significance: The loss of the primary microhabitat of S. planifrons-A. cervicornis-has forced a shift in the distribution and recruitment of these damselfish onto remaining high-structured corals, especially the Montastraea annularis species complex, affecting coral mortality and algal dynamics throughout the Caribbean.	[Precht, William F.] NOAA, Florida Keys Natl Marine Sanctuary, Key Largo, FL USA; [Aronson, Richard B.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Moody, Ryan M.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Kaufman, Les] Boston Univ, Dept Biol, Marine Program, Boston, MA 02215 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Florida Institute of Technology; Dauphin Island Sea Lab; Boston University	Precht, WF (corresponding author), NOAA, Florida Keys Natl Marine Sanctuary, Key Largo, FL USA.	raronson@fit.edu		Aronson, Richard/0000-0003-0383-3844	Northeastern University, Jamaica; Smithsonian Institution; National Geographic Society, Belize; National Geographic Society; Gordon and Betty Moore Foundation	Northeastern University, Jamaica; Smithsonian Institution(Smithsonian Institution); National Geographic Society, Belize(National Geographic Society); National Geographic Society(National Geographic Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	WFP and RBA thank Northeastern University's Three Seas Program for support in Jamaica, and the Smithsonian Institution's Caribbean Coral Reef Ecosystems (CCRE) Program and the National Geographic Society for support in Belize. LK received support from the National Geographic Society and the Marine Management Area Science Program of Conservation International (funded by the Gordon and Betty Moore Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrey CA, 2005, ENVIRON BIOL FISH, V73, P163, DOI 10.1007/s10641-004-5561-y; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 2001, EVOLUTIONARY PALEOECOLOGY, P171; Aronson Richard B., 1994, Atoll Research Bulletin, V421, P1; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Ault JS, 1998, FISH B-NOAA, V96, P395; Baker B, 1999, BIOSCIENCE, V49, P173, DOI 10.2307/1313506; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); BOHNSACK JA, 1982, WASHINGTON SEAGRANT, P258; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Caldow C, 2003, MAR ECOL PROG SER, V265, P185, DOI 10.3354/meps265185; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Ceccarelli DM, 2006, MAR ECOL PROG SER, V309, P255, DOI 10.3354/meps309255; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; CLARKE RD, 1977, MAR BIOL, V40, P277, DOI 10.1007/BF00390882; Eakin CM, 1989, P ASS ISL MAR LAB CA, V22, P35; EBERSOLE JP, 1985, ECOLOGY, V66, P14, DOI 10.2307/1941302; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Friedlander A.M., 2008, 70 NOAA NOS NCCOS; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLADFELTER EH, 1992, ECOLOGICAL STUDIES 2, P14; GLYNN PW, 1990, ECOSYSTEMS WORLD, V25, P365; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; GOREAU TF, 1973, B MAR SCI, V23, P399; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Gutierrez L, 1998, OECOLOGIA, V115, P268, DOI 10.1007/s004420050516; Hardt M.J., 2008, FISH FISH, V10, P1; HARRIS R, 2009, TINY DAMSELFISH MAY; HERNANDEZDELAGA.EA, 1999, THESIS U PUERTO RICO; ITZKOWITZ M, 1979, AM NAT, V114, P585, DOI 10.1086/283504; JACKSON JBC, 1992, AM ZOOL, V32, P719; Kaufman L., 1986, P1; KAUFMAN L, 1981, PALEOBIOLOGY, V7, P527, DOI 10.1017/S0094837300025562; Kaufman L, 1977, P 3 INT COR REEF S, V1, P559; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; KAUFMAN LS, 1979, THESIS J HOPKINS U B; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; KOSLOW JA, 1994, FISH B-NOAA, V92, P737; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Levin PS, 2000, BEHAV ECOL, V11, P565, DOI 10.1093/beheco/11.5.565; Liddell W. D., 1984, SEDIMENTA; LIRMAN D, 1994, J EXP MAR BIOL ECOL, V180, P71, DOI 10.1016/0022-0981(94)90080-9; Lirman D, 1999, B MAR SCI, V65, P235; Lobel PS., 1980, B MAR SCI, V30, P273; Ludwig JA, 1988, STAT ECOLOGY; LUOMA JR, 1996, AUDUBON MAG      NOV, P24; McClanahan Tim R., 2005, P247; MUNRO JL, 1983, ICLARM STUDIES REV, V7, P276; NEELY KL, 2008, THESIS U PROGRAM ECO; OGDEN JC, 1995, PUBL SERV GEOL LUX, V29; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pattengill-Semmens Christy V., 2003, Atoll Research Bulletin, V496, P226; Precht WF, 2006, CONSERV BIOL SER, P40; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Roberts CM, 2003, ORYX, V37, P166, DOI 10.1017/S0030605303000358; ROBERTSON DR, 1981, ECOLOGY, V62, P1162, DOI 10.2307/1937280; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Steneck Robert S., 2005, P110; THOMAS J D, 1991, Invertebrate Taxonomy, V5, P469, DOI 10.1071/IT9910469; Thresher RE, 1980, REEF FISH BEHAV ECOL; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; TOLLER W, 2002, 3 USVI DEP PLANN NAT; Vicente Vance P., 1994, P227; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilkes AA, 2008, SOUTHEAST NAT, V7, P483, DOI 10.1656/1528-7092-7.3.483; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS AH, 1981, ECOLOGY, V62, P1107, DOI 10.2307/1937008; WILLIAMS AH, 1980, AM NAT, V116, P138, DOI 10.1086/283616; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; WOODLEY JD, 1989, ASSESSMENT EC IMPACT	78	39	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10835	10.1371/journal.pone.0010835	http://dx.doi.org/10.1371/journal.pone.0010835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520809	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221500021
J	Nowack, J; Mzilikazi, N; Dausmann, KH				Nowack, Julia; Mzilikazi, Nomakwezi; Dausmann, Kathrin H.			Torpor on Demand: Heterothermy in the Non-Lemur Primate Galago moholi	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; MICROCEBUS-MURINUS; BODY-TEMPERATURE; HIBERNATION; THERMOREGULATION; MADAGASCAR; BATS; METABOLISM; EVOLUTION; SEX	Background: Hibernation and daily torpor are energy-and water-saving adaptations employed to survive unfavourable periods mostly in temperate and arctic environments, but also in tropical and arid climates. Heterothermy has been found in a number of mammalian orders, but within the primates so far it seems to be restricted to one family of Malagasy lemurs. As currently there is no evidence of heterothermy of a primate outside of Madagascar, the aim of our study was to investigate whether small primates from mainland Africa are indeed always homeothermic despite pronounced seasonal changes in weather and food availability. Methodology/Principal Findings: One of the nearest relatives of Malagasy lemurs, the African lesser bushbaby, Galago moholi, which inhabits a highly seasonal habitat with a hot wet-season and a cold dry-season with lower food abundance, was investigated to determine whether it is capable of heterothermy. We measured skin temperature of free-ranging individuals throughout the cool dry season using temperature-sensitive collars as well as metabolic rate in captured individuals. Torpor was employed by 15% of 20 animals. Only one of these animals displayed heterothermy in response to natural availability of food and water, whereas the other animals became torpid without access to food and water. Conclusions/Significance: Our results show that G. moholi are physiologically capable of employing torpor. However they do not use it as a routine behaviour, but only under adverse conditions. This reluctance is presumably a result of conflicting selective pressures for energy savings versus other ecological and evolutionary forces, such as reproduction or territory defence. Our results support the view that heterothermy in primates evolved before the division of African and Malagasy Strepsirhini, with the possible implication that more primate species than previously thought might still have the potential to call upon this possibility, if the situation necessitates it.	[Nowack, Julia; Dausmann, Kathrin H.] Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany; [Mzilikazi, Nomakwezi] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	University of Hamburg; Nelson Mandela University	Nowack, J (corresponding author), Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany.	julia.nowack@uni-hamburg.de	Mzilikazi, Nomakwezi/K-4964-2012; Dausmann, Kathrin/E-9270-2017	Mzilikazi, Nomakwezi/0000-0002-0038-7431	German Academic Exchange Service (DAAD); German Research Foundation (DFG) [DA1013/3-1]; National Research Foundation (NRF) [66025]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); National Research Foundation (NRF)	Funding: This study was supported by the German Academic Exchange Service (DAAD; URL:/www.daad.de), the German Research Foundation (DFG; URL:www.dfg.de) (DA1013/3-1) and the National Research Foundation (NRF; URL:www.nrf.ac.za)(66025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Bartels W, 1998, J COMP PHYSIOL B, V168, P233, DOI 10.1007/s003600050141; Bonaccorso FJ, 1997, J MAMMAL, V78, P1073, DOI 10.2307/1383050; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dausmann K. H., 2008, HYPOMETABOLISM ANIMA, P327; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Dausmann KH, 2005, J THERM BIOL, V30, P195, DOI 10.1016/j.jtherbio.2004.11.003; DAUSMANN KK, 2004, NATURE, V429; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; GEISER F, 1988, PHYSIOL ZOOL, V61, P442, DOI 10.1086/physzool.61.5.30161266; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; GEISER F, 1988, OECOLOGIA, V77, P395, DOI 10.1007/BF00378050; Geiser Fritz, 2004, Australian Mammalogy, V26, P125; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; HELDMAIER G, 2004, RESP PHYSL NEUROBIOL, V141; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; KNOX CM, 1989, S AFR J ZOOL, V24, P89; Kobbe S, 2009, NATURWISSENSCHAFTEN, V96, P1221, DOI 10.1007/s00114-009-0580-3; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Kortner G, 2009, NATURWISSENSCHAFTEN, V96, P525, DOI 10.1007/s00114-008-0492-7; LEWIS SE, 1993, CAN J ZOOL, V71, P1429, DOI 10.1139/z93-197; Lovegrove BG, 1998, J COMP PHYSIOL B, V168, P303, DOI 10.1007/s003600050150; Masters JC, 2007, J BIOGEOGR, V34, P21, DOI 10.1111/j.1365-2699.2006.01569.x; McKechnie A. E., 2006, ACTA ZOOL SINICA, V52, P409; MULLER EF, 1985, FOLIA PRIMATOL, V44, P216, DOI 10.1159/000156215; Mzilikazi N, 2006, FOLIA PRIMATOL, V77, P465, DOI 10.1159/000095392; Ortmann S, 1997, NATURWISSENSCHAFTEN, V84, P28, DOI 10.1007/s001140050344; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; Schmid J, 2000, OECOLOGIA, V123, P175, DOI 10.1007/s004420051003; Schmid J, 2000, J COMP PHYSIOL B, V170, P59, DOI 10.1007/s003600050008; Schulke O, 2007, ACTA ETHOL, V10, P13, DOI 10.1007/s10211-006-0023-5; Turbill C, 2003, J THERM BIOL, V28, P223, DOI 10.1016/S0306-4565(02)00067-0; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120	35	49	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10797	10.1371/journal.pone.0010797	http://dx.doi.org/10.1371/journal.pone.0010797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520735	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000278034600024
J	Susa, M; Iyer, AK; Ryu, K; Choy, E; Hornicek, FJ; Mankin, H; Milane, L; Amiji, MM; Duan, Z				Susa, Michiro; Iyer, Arun K.; Ryu, Keinosuke; Choy, Edwin; Hornicek, Francis J.; Mankin, Henry; Milane, Lara; Amiji, Mansoor M.; Duan, Zhenfeng			Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; OVARIAN-CARCINOMA; CYCLOSPORINE-A; CANCER CELLS; SOLID TUMOR; STEM-CELLS; REVERSAL; DOXORUBICIN; GENE	Background: The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year survival rate from 20% to 70% in the past 30 years. However, for patients who progress after chemotherapy, its effectiveness diminishes due to the emergence of multi-drug resistance (MDR) after prolonged therapy. Methodology/Principal Findings: In order to overcome both the dose-limiting side effects of conventional chemotherapeutic agents and the therapeutic failure resulting from MDR, we designed and evaluated a novel drug delivery system for MDR1 siRNA delivery. Novel biocompatible, lipid-modified dextran-based polymeric nanoparticles were used as the platform for MDR1 siRNA delivery; and the efficacy of combination therapy with this system was evaluated. In this study, multi-drug resistant osteosarcoma cell lines (KHOSR2 and U-2OS(R2)) were treated with the MDR1 siRNA nanocarriers and MDR1 protein (P-gp) expression, drug retention, and immunofluoresence were analyzed. Combination therapy of the MDR1 siRNA loaded nanocarriers with increasing concentrations of doxorubicin was also analyzed. We observed that MDR1 siRNA loaded dextran nanoparticles efficiently suppresses P-gp expression in the drug resistant osteosarcoma cell lines. The results also demonstrated that this approach may be capable of reversing drug resistance by increasing the amount of drug accumulation in MDR cell lines. Conclusions/Significance: Lipid-modified dextran-based polymeric nanoparticles are a promising platform for siRNA delivery. Nanocarriers loaded with MDR1 siRNA are a potential treatment strategy for reversing MDR in osteosarcoma.	[Susa, Michiro; Ryu, Keinosuke; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA USA; [Susa, Michiro; Ryu, Keinosuke; Choy, Edwin; Hornicek, Francis J.; Mankin, Henry; Duan, Zhenfeng] Massachusetts Gen Hosp, Sarcoma Biol Lab, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA USA; [Iyer, Arun K.; Milane, Lara; Amiji, Mansoor M.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Northeastern University	Susa, M (corresponding author), Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA USA.	zduan@partners.org	Duan, Zhenfeng/AAK-5587-2020; Susa, Michiro/L-2291-2013; Amiji, Mansoor M/AAK-1531-2020; Amiji, Mansoor M/A-4365-2014; Iyer, Arun K/G-9072-2017; Iyer, Arun/O-6688-2019	Amiji, Mansoor M/0000-0001-6170-881X; Iyer, Arun K/0000-0002-4428-0222; Iyer, Arun/0000-0002-4428-0222; Choy, Edwin/0000-0001-9896-8084	National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership) [R01-CA119617]; Sarcoma Foundation of America; Gattegno and Wechsler funds; NATIONAL CANCER INSTITUTE [R01CA119617] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sarcoma Foundation of America; Gattegno and Wechsler funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported, in part, by a grant from the National Cancer Institute, National Institutes of Health (Nanotechnology Platform Partnership), R01-CA119617. Dr. Duan is supported, in part, through a grant from Sarcoma Foundation of America. Support has also been provided by the Gattegno and Wechsler funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLAMY WT, 1994, ADV CLIN CHEM, V31, P1, DOI 10.1016/S0065-2423(08)60332-7; BROXTERMAN HJ, 1990, PEZCOLLER FDN S, V1, P309; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Duan ZF, 2004, MOL CANCER THER, V3, P833; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fletcher CDM, 2002, WHO CLASSIFICATION T; FORD JM, 1990, CANCER RES, V50, P1748; Golzio M, 2007, GENE THER, V14, P752, DOI 10.1038/sj.gt.3302920; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HINDENBURG AA, 1987, CANCER RES, V47, P1421; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Kaye SB, 2008, J CLIN ONCOL, V26, P2616, DOI 10.1200/JCO.2008.16.2123; KEIZER HG, 1989, CANCER RES, V49, P2988; KLIMECKI WT, 1994, BLOOD, V83, P2451; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Labroille G, 1998, CYTOMETRY, V32, P86, DOI 10.1002/(SICI)1097-0320(19980601)32:2<86::AID-CYTO3>3.0.CO;2-C; LICHT T, 1994, ANN HEMATOL, V69, P159, DOI 10.1007/BF02215949; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b; MATSUMURA Y, 1986, CANCER RES, V46, P6387; MICKISCH GH, 1991, P NATL ACAD SCI USA, V88, P547, DOI 10.1073/pnas.88.2.547; Minko T, 2000, INT J CANCER, V86, P108, DOI 10.1002/(SICI)1097-0215(20000401)86:1<108::AID-IJC17>3.0.CO;2-8; Minko T, 1999, J CONTROL RELEASE, V59, P133, DOI 10.1016/S0168-3659(98)00186-2; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Pereswetoff-Morath L, 1998, ADV DRUG DELIVER REV, V29, P185, DOI 10.1016/S0169-409X(97)00069-0; Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z; SCHURR E, 1989, CANCER RES, V49, P2729; SCHUURHUIS GJ, 1989, J NATL CANCER I, V81, P1887, DOI 10.1093/jnci/81.24.1887; Schwartz CL, 2007, J CLIN ONCOL, V25, P2057, DOI 10.1200/JCO.2006.07.7776; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; Smeets M, 1997, BRIT J HAEMATOL, V96, P346, DOI 10.1046/j.1365-2141.1997.d01-2024.x; Sonneveld P, 2001, BRIT J HAEMATOL, V115, P895, DOI 10.1046/j.1365-2141.2001.03171.x; SUGAWARA I, 1988, CANCER RES, V48, P1926; Susa M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-399; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G; van Vlerken LE, 2007, PHARM RES-DORDR, V24, P1405, DOI 10.1007/s11095-007-9284-6; VANDERVALK P, 1990, ANN ONCOL, V1, P56; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; Zhang H, 2009, POLYM COMPOSITE, V30, P1243, DOI 10.1002/pc.20684; ZHANG Y, 2003, J POLYM SCI A, V41, P386	48	119	126	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10764	10.1371/journal.pone.0010764	http://dx.doi.org/10.1371/journal.pone.0010764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520719	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600001
J	Hao, GF; Yang, GF				Hao, Ge-Fei; Yang, Guang-Fu			The Role of Phe82 and Phe351 in Auxin-Induced Substrate Perception by TIR1 Ubiquitin Ligase: A Novel Insight from Molecular Dynamics Simulations	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; PARTICLE MESH EWALD; BOX PROTEIN TIR1; AUX/IAA PROTEINS; PLANT-GROWTH; SOLVENT MODELS; FREE-ENERGIES; BINDING; DEGRADATION; ARABIDOPSIS	It is well known that Auxin plays a key role in controlling many aspects of plant growth and development. Crystal structures of Transport inhibitor response 1 (TIR1), a true receptor of auxin, were very recently determined for TIR1 alone and in complexes with auxin and different synthetic analogues and an Auxin/Indole-3-Acetic Acid (Aux/IAA) substrate peptide. However, the dynamic conformational changes of the key residues of TIR1 that take place during the auxin and substrate perception by TIR1 and the detailed mechanism of these changes are still unclear. In the present study, various computational techniques were integrated to uncover the detailed molecular mechanism of the auxin and Aux/IAA perception process; these simulations included molecular dynamics (MD) simulations on complexes and the free enzyme, the molecular mechanics Poisson Boltzmann surface area (MM-PBSA) calculations, normal mode analysis, and hydrogen bond energy (HBE) calculations. The computational simulation results provided a reasonable explanation for the structure-activity relationships of auxin and its synthetic analogues in view of energy. In addition, a more detailed model for auxin and Aux/IAA perception was also proposed, indicating that Phe82 and Phe351 played a pivotal role in Aux/IAA perception. Upon auxin binding, Phe82 underwent conformational changes to accommodate the subsequent binding of Aux/IAA. As a result, auxin enhances the TIR1-Aux/IAA interactions by acting as a "molecular glue''. Besides, Phe351 acts as a "fastener'' to further improve the substrate binding. The structural and mechanistic insights obtained from the present study will provide valuable clues for the future design of promising auxin analogues.	[Hao, Ge-Fei; Yang, Guang-Fu] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China	Central China Normal University	Hao, GF (corresponding author), Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China.	gfyang@mail.ccnu.edu.cn			National Basic Research Program of China [2010CB126103]; NSFC [20925206, 20932005]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	The research was supported in part by the National Basic Research Program of China (No. 2010CB126103) and the NSFC (No. 20925206 and 20932005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bertosa B, 2008, BIOPHYS J, V94, P27, DOI 10.1529/biophysj.107.109025; Callis J, 2005, NATURE, V435, P436, DOI 10.1038/435436b; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2004, AMBER8; COLEMAN TG, 1977, ANN BIOMED ENG, V5, P322, DOI 10.1007/BF02367312; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Henriques R, 2009, CURR OPIN PLANT BIOL, V12, P49, DOI 10.1016/j.pbi.2008.10.009; Hoecker U, 2005, CURR OPIN PLANT BIOL, V8, P469, DOI 10.1016/j.pbi.2005.07.002; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Perrot-Rechenmann C, 2005, VITAM HORM, V72, P203, DOI 10.1016/S0083-6729(04)72006-3; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Taiz L, 2006, PLANT PHYSL ONLINE; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Woodward AW, 2005, PLANT CELL, V17, P2425, DOI 10.1105/tpc.105.036236; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	50	21	23	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2010	5	5							e10742	10.1371/journal.pone.0010742	http://dx.doi.org/10.1371/journal.pone.0010742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600VP	20505777	Green Published, gold, Green Submitted			2022-12-27	WOS:000278017300015
J	Narayanan, S; Silva, R; Peruzzi, G; Alvarez, Y; Simhadri, VR; Debell, K; Coligan, JE; Borrego, F				Narayanan, Sriram; Silva, Rodolfo; Peruzzi, Giovanna; Alvarez, Yelina; Simhadri, Venkateswara R.; Debell, Karen; Coligan, John E.; Borrego, Francisco			Human Th1 Cells That Express CD300a Are Polyfunctional and After Stimulation Up-Regulate the T-Box Transcription Factor Eomesodermin	PLOS ONE			English	Article							RECEPTOR IRP60 CD300A; IFN-GAMMA PRODUCTION; INHIBITORY RECEPTOR; INTERFERON-GAMMA; HELPER LYMPHOCYTES; LEISHMANIA-MAJOR; DENDRITIC CELLS; BET; DIFFERENTIATION; EFFECTOR	Human naive CD4 T cells express low levels of the immunomodulatory receptor CD300a, whereas effector/memory CD4 cells can be either CD300a(+) or CD300a(-). This suggested that CD300a expression could define a specific subset within the effector/memory CD4 T cell subpopulations. In fact, ex vivo analysis of the IFN-gamma producing CD4 T cells showed that they are enriched in the CD300a(+) subset. Moreover, stimulated CD4 T cells producing TNF-alpha and IL-2 besides IFN-gamma (polyfunctional) are predominantly CD300a(+). In addition to producing markedly higher levels of Th1-associated cytokines, the stimulated CD300a(+) CD4 T cells are distinguished by a striking up-regulation of the T-box transcription factor eomesodermin (Eomes), whereas T-bet is up-regulated in both CD300a+ and CD300a(-) activated CD4 T cells to similar levels. The pleiotropic cytokine TGF-beta 1 has a determinant role in dictating the development of this Th1 subset, as its presence inhibits the expression of CD300a and down-regulates the expression of Eomes and IFN-gamma. We conclude that CD300a+ human Th1 cells tend to be polyfunctional and after stimulation up-regulate Eomes.	[Narayanan, Sriram; Silva, Rodolfo; Peruzzi, Giovanna; Alvarez, Yelina; Coligan, John E.] NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD USA; [Simhadri, Venkateswara R.; Debell, Karen; Borrego, Francisco] US FDA, Ctr Biol Evaluat & Res, Lab Mol & Dev Immunol, Div Monoclonal Antibodies, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Narayanan, S (corresponding author), NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD USA.	Francisco.Borrego@fda.hhs.gov		Peruzzi, Giovanna/0000-0002-6517-9107; Narayanan, Sriram/0000-0002-6484-2800; Borrego, Francisco/0000-0002-3105-981X	Food and Drug Administration (FDA); National Institute of Allergy and Infectious Diseases (NIAID)	Food and Drug Administration (FDA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural programs of Food and Drug Administration (FDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Clark GJ, 2007, J LEUKOCYTE BIOL, V82, P1126, DOI 10.1189/jlb.0107035; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Smeltz RB, 2005, IMMUNOLOGY, V114, P484, DOI 10.1111/j.1365-2567.2005.02115.x; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tang J, 2007, J IMMUNOL, V178, P5578, DOI 10.4049/jimmunol.178.9.5578; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	55	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10636	10.1371/journal.pone.0010636	http://dx.doi.org/10.1371/journal.pone.0010636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498708	Green Published, Green Submitted, gold			2022-12-27	WOS:000277633500020
J	Widmann, M; Trodler, P; Pleiss, J				Widmann, Michael; Trodler, Peter; Pleiss, Juergen			The Isoelectric Region of Proteins: A Systematic Analysis	PLOS ONE			English	Article							ION-EXCHANGE CHROMATOGRAPHY; ENGINEERING DATABASE; RETENTION; DESIGN; LIPASE; PURIFICATION; ADSORPTION; FAMILIES; TOOL	Background: Binding of proteins in ion exchange chromatography is dominated by electrostatic interactions and can be tuned by adjusting pH and ionic strength of the solvent. Therefore, the isoelectric region (IER), the pH region of almost zero charge near the pI, has been used to predict the binding properties of proteins. Principal findings: Usually the IER is small and binding and elution is carried out at pH values near to the pI. However, some proteins with an extended IER have been shown to bind and elute far away from its pI. To analyze factors that mediate the size of the IER and to identify proteins with an extended IER, two protein families consisting of more than 7000 proteins were systematically investigated. Most proteins were found to have a small IER and thus are expected to bind or elute near to their pI, while only a small fraction of less than 2% had a large IER. Conclusions: Only four factors, the number of histidines, the pI, the number of titratable amino acids and the ratio of acidic to basic residues, are sufficient to reliably classify proteins by their IER based on their sequence only, and thus to predict their binding and elution behaviour in ion exchange chromatography.	[Widmann, Michael; Trodler, Peter; Pleiss, Juergen] Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany	University of Stuttgart	Widmann, M (corresponding author), Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany.	Juergen.Pleiss@itb.uni-stuttgart.de			German Federal Ministry of Education and Research [PTJ 0313434D]; European Commission [BIOPRODUCTION/NMP-2-CT-2007-026515]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank the German Federal Ministry of Education and Research (PTJ 0313434D) and the European Commission (IP "Sustainable Microbial and Biocatalytic Production of Advanced Functional Materials'', BIOPRODUCTION/NMP-2-CT-2007-026515) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed T, 2006, FLUID PHASE EQUILIBR, V241, P268, DOI 10.1016/j.fluid.2005.12.011; Ahamed T, 2008, J CHROMATOGR A, V1194, P22, DOI 10.1016/j.chroma.2007.11.111; Ahamed T, 2007, J CHROMATOGR A, V1164, P181, DOI 10.1016/j.chroma.2007.07.010; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Fischer M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-495; *GE HEALTHC, HEALTHC G ION EXCH C; Gotte G, 2003, J BIOL CHEM, V278, P46241, DOI 10.1074/jbc.M308470200; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hallgren E, 2000, J CHROMATOGR A, V877, P13, DOI 10.1016/S0021-9673(00)00190-4; Knoll M, 2008, PROTEIN SCI, V17, P1689, DOI 10.1110/ps.035428.108; Malmquist G, 2006, J CHROMATOGR A, V1115, P164, DOI 10.1016/j.chroma.2006.02.097; MELANDER WR, 1989, J CHROMATOGR, V469, P3, DOI 10.1016/S0021-9673(01)96437-4; MITRA CK, 1993, J BIOSCIENCE, V18, P213, DOI 10.1007/BF02703118; Noh H, 2008, BIOMATERIALS, V29, P2033, DOI 10.1016/j.biomaterials.2008.01.017; Palekar AA, 2000, BIOCATAL BIOTRANSFOR, V18, P177, DOI 10.3109/10242420009015244; PATRICKIOS CS, 1995, ANAL BIOCHEM, V231, P82, DOI 10.1006/abio.1995.1506; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROTH CM, 1995, LANGMUIR, V11, P3500, DOI 10.1021/la00009a036; Sheehan D, 1996, Methods Mol Biol, V59, P145; SHEEHAN D, 2001, ENCY LIFE SCI; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Trodler P, 2008, J CHROMATOGR A, V1179, P161, DOI 10.1016/j.chroma.2007.11.108	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10546	10.1371/journal.pone.0010546	http://dx.doi.org/10.1371/journal.pone.0010546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479870	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800025
J	Sun, JS; Hopkins, RC; Jenney, FE; McTernan, PM; Adams, MWW				Sun, Junsong; Hopkins, Robert C.; Jenney, Francis E., Jr.; McTernan, Patrick M.; Adams, Michael W. W.			Heterologous Expression and Maturation of an NADP-Dependent [NiFe]-Hydrogenase: A Key Enzyme in Biofuel Production	PLOS ONE			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; MUTATIONAL ANALYSIS; HYDROGENASE ISOENZYMES; NIFE HYDROGENASE; OPERON; GENES; GENERATION; BIOLOGY; SULFUR	Hydrogen gas is a major biofuel and is metabolized by a wide range of microorganisms. Microbial hydrogen production is catalyzed by hydrogenase, an extremely complex, air-sensitive enzyme that utilizes a binuclear nickel-iron [NiFe] catalytic site. Production and engineering of recombinant [NiFe]-hydrogenases in a genetically-tractable organism, as with metalloprotein complexes in general, has met with limited success due to the elaborate maturation process that is required, primarily in the absence of oxygen, to assemble the catalytic center and functional enzyme. We report here the successful production in Escherichia coli of the recombinant form of a cytoplasmic, NADP-dependent hydrogenase from Pyrococcus furiosus, an anaerobic hyperthermophile. This was achieved using novel expression vectors for the co-expression of thirteen P. furiosus genes (four structural genes encoding the hydrogenase and nine encoding maturation proteins). Remarkably, the native E. coli maturation machinery will also generate a functional hydrogenase when provided with only the genes encoding the hydrogenase subunits and a single protease from P. furiosus. Another novel feature is that their expression was induced by anaerobic conditions, whereby E. coli was grown aerobically and production of recombinant hydrogenase was achieved by simply changing the gas feed from air to an inert gas (N-2). The recombinant enzyme was purified and shown to be functionally similar to the native enzyme purified from P. furiosus. The methodology to generate this key hydrogen-producing enzyme has dramatic implications for the production of hydrogen and NADPH as vehicles for energy storage and transport, for engineering hydrogenase to optimize production and catalysis, as well as for the general production of complex, oxygen-sensitive metalloproteins.	[Sun, Junsong; Hopkins, Robert C.; Jenney, Francis E., Jr.; McTernan, Patrick M.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Sun, JS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022	Jenney, Francis/0000-0002-1667-6924; Adams, Michael/0000-0002-9796-5014	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy [DE-FG02-05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a grant (DE-FG02-05ER15710) from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bascones E, 2000, APPL ENVIRON MICROB, V66, P4292, DOI 10.1128/AEM.66.10.4292-4299.2000; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; Edwards PP, 2007, PHILOS T R SOC A, V365, P1043, DOI 10.1098/rsta.2006.1965; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Esper B, 2006, TRENDS PLANT SCI, V11, P543, DOI 10.1016/j.tplants.2006.09.001; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; HORANYI P, 2006, Patent No. 7582475; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; King PW, 1999, J BACTERIOL, V181, P5250, DOI 10.1128/JB.181.17.5250-5256.1999; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; Ma KS, 2001, METHOD ENZYMOL, V331, P208; Maeda T, 2007, APPL MICROBIOL BIOT, V76, P1035, DOI 10.1007/s00253-007-1086-6; MENON NK, 1993, FEBS LETT, V331, P91, DOI 10.1016/0014-5793(93)80303-C; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; Mertens R, 2003, J MOL CATAL B-ENZYM, V24-5, P39, DOI 10.1016/S1381-1177(03)00071-7; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; OXER MD, 1991, NUCLEIC ACIDS RES, V19, P2889, DOI 10.1093/nar/19.11.2889; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; ROSSMANN R, 1995, EUR J BIOCHEM, V227, P545, DOI 10.1111/j.1432-1033.1995.tb20422.x; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J., 2001, MOL CLONING LAB MANU; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Shirshikova GN, 2009, DOKL BIOCHEM BIOPHYS, V425, P124, DOI 10.1134/S1607672909020185; Sigfusson TI, 2007, PHILOS T R SOC A, V365, P1025, DOI 10.1098/rsta.2006.1960; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456	44	64	72	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10526	10.1371/journal.pone.0010526	http://dx.doi.org/10.1371/journal.pone.0010526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463892	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379800015
J	Matsuo, Y; Kamitani, T				Matsuo, Yasuhiro; Kamitani, Tetsu			Parkinson's Disease-Related Protein, alpha-Synuclein, in Malignant Melanoma	PLOS ONE			English	Article							MART-1; S-100; TYROSINASE; ANTIBODY; LESIONS	Background: Melanoma is the major cause of skin cancer death worldwide. Parkinson's disease is a neurodegenerative disorder that is caused by mutation of alpha-synuclein or other genes. Importantly, epidemiological studies have reported co-occurrence of melanoma and Parkinson's disease, suggesting that these two diseases could share common genetic components. Methodology/Principal Findings: Recently, we found that human melanoma cell lines highly express alpha-synuclein, whereas the protein is undetectable in the non-melanoma cancer cell lines tested. To investigate the expression of alpha-synuclein in human melanoma tissues, we immunostained sections of melanoma, nevus, non-melanocytic cutaneous carcinoma, and normal skin. alpha-Synuclein was positively detected in 86% of the primary and 85% of the metastatic melanoma sections, as well as in 89% of nevus sections. However, alpha-synuclein was undetectable in non-melanocytic cutaneous carcinoma and normal skin. Conclusions/Significance: The Parkinson's disease-related protein, alpha-synuclein, is expressed in both malignant and benign melanocytic lesions, such as melanomas and nevi. Although alpha-synuclein cannot be used to distinguish between malignant and benign melanocytic skin lesions, it might be a useful biomarker for the diagnosis of metastatic melanoma.	[Matsuo, Yasuhiro; Kamitani, Tetsu] Med Coll Georgia, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Matsuo, Y (corresponding author), Med Coll Georgia, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Ctr Canc, Augusta, GA 30912 USA.	tkamitani@mcg.edu	Kamitani, Tetsu/GSI-7613-2022; Matsuo, Yasuhiro/AAT-6220-2021	Matsuo, Yasuhiro/0000-0002-2858-7179; Kamitani, Tetsu/0000-0002-3257-9630	National Institutes of Health [R01 AG024497]; Medical College of Georgia; NATIONAL INSTITUTE ON AGING [R01AG024497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Georgia; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant R01 AG024497 (to T. K.) and Faculty Start-up Fund at the Medical College of Georgia (to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batistatou A, 2009, VIRCHOWS ARCH, V454, P505, DOI 10.1007/s00428-009-0763-5; Clarkson KS, 2001, J CLIN PATHOL, V54, P196, DOI 10.1136/jcp.54.3.196; Cormier JN, 1998, J IMMUNOTHER, V21, P27, DOI 10.1097/00002371-199801000-00003; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Fetsch PA, 1999, CANCER CYTOPATHOL, V87, P37, DOI 10.1002/(SICI)1097-0142(19990225)87:1<37::AID-CNCR7>3.0.CO;2-7; Gao X, 2009, NEUROLOGY, V73, P1286, DOI 10.1212/WNL.0b013e3181bd13a1; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Larson AR, 2009, NAT CLIN PRACT ONCOL, V6, P105, DOI 10.1038/ncponc1296; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Shidham VB, 2001, AM J SURG PATHOL, V25, P1039, DOI 10.1097/00000478-200108000-00008; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Yu LL, 1999, CANCER, V86, P617, DOI 10.1002/(SICI)1097-0142(19990815)86:4<617::AID-CNCR10>3.0.CO;2-S; Zubovits J, 2004, HUM PATHOL, V35, P217, DOI 10.1016/j.humpath.2003.09.019	19	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10481	10.1371/journal.pone.0010481	http://dx.doi.org/10.1371/journal.pone.0010481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463956	gold, Green Published, Green Submitted			2022-12-27	WOS:000277379400017
J	Zhan, Y; Melian, NY; Pantoja, M; Haines, N; Ruohola-Baker, H; Bourque, CW; Rao, Y; Carbonetto, S				Zhan, Yougen; Melian, Nadia Y.; Pantoja, Mario; Haines, Nicola; Ruohola-Baker, Hannele; Bourque, Charles W.; Rao, Yong; Carbonetto, Salvatore			Dystroglycan and Mitochondrial Ribosomal Protein L34 Regulate Differentiation in the Drosophila Eye	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; O-MANNOSYLTRANSFERASE ACTIVITY; GLYCOPROTEIN COMPLEX; NEURONAL MIGRATION; LAMININ; MUSCLE; DISORDERS; POLARITY; MUTANTS; DISEASE	Mutations that diminish the function of the extracellular matrix receptor Dystroglycan (DG) result in muscular dystrophies, with associated neuronal migration defects in the brain and mental retardation e. g. Muscle Eye Brain Disease. To gain insight into the function of DG in the nervous system we initiated a study to examine its contribution to development of the eye of Drosophila melanogaster. Immuno-histochemistry showed that DG is concentrated on the apical surface of photoreceptors (R) cells during specification of cell-fate in the third instar larva and is maintained at this location through early pupal stages. In point mutations that are null for DG we see abortive R cell elongation during differentiation that first appears in the pupa and results in stunted R cells in the adult. Overexpression of DG in R cells results in a small but significant increase in their size. R cell differentiation defects appear at the same stage in a deficiency line Df(2R)Dg(248) that affects Dg and the neighboring mitochondrial ribosomal gene, mRpL34. In the adult, these flies have severely disrupted R cells as well as defects in the lens and ommatidia. Expression of an mRpL34 transgene rescues much of this phenotype. We conclude that DG does not affect neuronal commitment but functions R cell autonomously to regulate neuronal elongation during differentiation in the pupa. We discuss these findings in view of recent work implicating DG as a regulator of cell metabolism and its genetic interaction with mRpL34, a member of a class of mitochondrial genes essential for normal metabolic function.	[Zhan, Yougen; Melian, Nadia Y.; Haines, Nicola; Bourque, Charles W.; Rao, Yong; Carbonetto, Salvatore] McGill Univ, Ctr Res Neurosci, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Pantoja, Mario; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Pantoja, Mario; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	McGill University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zhan, Y (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	sal.carbonetto@mcgill.ca		Bourque, Charles/0000-0002-1594-742X	Canadian Institute for Health Research [82105]; Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis (Canada); Canadian Institute for Health Research Regenerative Medicine Team [82501]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis (Canada); Canadian Institute for Health Research Regenerative Medicine Team(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to S. C. and Y.R. from the Canadian Institute for Health Research (82105); Muscular Dystrophy Association and Amyotrophic Lateral Sclerosis (Canada), as well as a Canadian Institute for Health Research Regenerative Medicine Team Grant (82501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Dekkers LC, 2004, GENE EXPR PATTERNS, V4, P153, DOI 10.1016/j.modgep.2003.09.004; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; DOUVILLE PJ, 1988, J BIOL CHEM, V263, P14964; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gaengel Konstantin, 2008, V420, P277, DOI 10.1007/978-1-59745-583-1_17; Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hino N, 2001, BRAIN DEV-JPN, V23, P97, DOI 10.1016/S0387-7604(01)00189-9; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Liao TSV, 2006, GENETICS, V174, P525, DOI 10.1534/genetics.106.061705; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, P438, DOI 10.1016/S0960-8966(01)00326-1; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Qu Q, 2006, EUR J NEUROSCI, V23, P2877, DOI 10.1111/j.1460-9568.2006.04836.x; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Schneider M, 2008, FLY, V2, P29, DOI 10.4161/fly.5726; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; Stowers RS, 1999, GENETICS, V152, P1631; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Tselykh TV, 2005, EXP CELL RES, V307, P354, DOI 10.1016/j.yexcr.2005.03.037; Voit T, 2002, NEUROMUSCULAR DISORD, V12, P623, DOI 10.1016/S0960-8966(02)00018-4; Walther RF, 2006, NAT PROTOC, V1, P2635, DOI 10.1038/nprot.2006.379; Wawersik S, 2000, Results Probl Cell Differ, V31, P15; XU T, 1993, DEVELOPMENT, V117, P1223; Yatsenko AS, 2007, J BIOL CHEM, V282, P15159, DOI 10.1074/jbc.M608800200; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	50	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10488	10.1371/journal.pone.0010488	http://dx.doi.org/10.1371/journal.pone.0010488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463973	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400024
J	Danelishvili, L; Yamazaki, Y; Selker, J; Bermudez, LE				Danelishvili, Lia; Yamazaki, Yoshitaka; Selker, Jeannie; Bermudez, Luiz E.			Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c Proteins Participate in the Suppression of Macrophage Apoptosis	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; INDUCED CELL-DEATH; PHAGOSOME MATURATION; DEFENSE-MECHANISM; INNATE IMMUNITY; NECROSIS; IDENTIFICATION; INFECTION; AUTOPHAGY; GENE	Background: Inhibition of macrophage apoptosis by Mycobacterium tuberculosis has been proposed as one of the virulence mechanisms whereby the pathogen avoids the host defense. The mechanisms by which M. tuberculosis H37Rv strain suppress apoptosis and escapes human macrophage killing was investigated. Methodology/Principal Findings: The screening of a transposon mutant bank identified several mutants, which, in contrast to the wild-type bacterium, had impaired ability to inhibit apoptosis of macrophages. Among the identified genes, Rv3659c (31G12 mutant) belongs to an operon reminiscent of type IV pili. The Rv3654c and Rv3655c putative proteins in a seven-gene operon are secreted into the macrophage cytoplasm and suppress apoptosis by blocking the extrinsic pathway. The operon is highly expressed when the bacterium is within macrophages, compared to the expression level in the extracellular environment. Rv3654c recognizes the polypyrimidine tract binding Protein-associated Splicing Factor (PSF) and cleaves it, diminishing the availability of caspase-8. While M. tuberculosis inhibits apoptosis by the extrinsic pathway, the pathogen does not appear to affect the intrinsic pathway. Inactivation of the intrinsic pathway by pharmacologic agents afftects M. tuberculosis and induces cell necrosis. Likewise, inactivation of PSF by siRNA significantly decreased the level of caspase-8 in macrophages. Conclusion: While M. tuberculosis inhibits the extrinsic pathway of apoptosis, it appears to activate the intrinsic pathway leading to macrophage necrosis as a potential exit strategy.	[Danelishvili, Lia; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Yamazaki, Yoshitaka] Shinshu Univ, Dept Infect Dis & Lab Med, Sch Med, Matsumoto, Nagano 390, Japan; [Selker, Jeannie] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Bermudez, Luiz E.] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA	Oregon State University; Shinshu University; University of Oregon; Oregon State University	Danelishvili, L (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Luiz.Bermudez@oregonstate.edu		Danelishvili, Lia/0000-0003-1390-3121	Agricultural Experiment Station; National Institute of Allergy and Infectious Diseases [R21-AI064018]; National Institute of Environmental Health Science National Institute of Health [P30 ES00210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Agricultural Experiment Station; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Science National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by an Agricultural Experiment Station grant and by the National Institute of Allergy and Infectious Diseases grant # R21-AI064018. The mass spectrometric sequencing was supported in part by the National Institute of Environmental Health Science National Institute of Health Grant P30 ES00210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cools J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/gcc.10033; Danelishvili L, 2004, FEMS MICROBIOL LETT, V239, P41, DOI 10.1016/j.femsle.2004.08.014; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Duan L, 2002, J IMMUNOL, V169, P5181, DOI 10.4049/jimmunol.169.9.5181; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tamme R, 2000, BIOTECHNIQUES, V28, P895, DOI 10.2144/00285st02; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Ting LM, 1999, J IMMUNOL, V163, P3898; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	33	58	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10474	10.1371/journal.pone.0010474	http://dx.doi.org/10.1371/journal.pone.0010474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454556	Green Submitted, Green Published, gold			2022-12-27	WOS:000277305300010
J	Salas, A; Amigo, J				Salas, Antonio; Amigo, Jorge			A Reduced Number of mtSNPs Saturates Mitochondrial DNA Haplotype Diversity of Worldwide Population Groups	PLOS ONE			English	Article							HUMAN MTDNA; REGION SEQUENCES; GENE FLOW; MUTATIONS; AMERICAN; AFRICAN; SINGLE; GENOME; POLYMORPHISMS; FRAGMENTS	Background: The high levels of variation characterising the mitochondrial DNA (mtDNA) molecule are due ultimately to its high average mutation rate; moreover, mtDNA variation is deeply structured in different populations and ethnic groups. There is growing interest in selecting a reduced number of mtDNA single nucleotide polymorphisms (mtSNPs) that account for the maximum level of discrimination power in a given population. Applications of the selected mtSNP panel range from anthropologic and medical studies to forensic genetic casework. Methodology/Principal Findings: This study proposes a new simulation-based method that explores the ability of different mtSNP panels to yield the maximum levels of discrimination power. The method explores subsets of mtSNPs of different sizes randomly chosen from a preselected panel of mtSNPs based on frequency. More than 2,000 complete genomes representing three main continental human population groups (Africa, Europe, and Asia) and two admixed populations ("African-Americans'' and "Hispanics'') were collected from GenBank and the literature, and were used as training sets. Haplotype diversity was measured for each combination of mtSNP and compared with existing mtSNP panels available in the literature. The data indicates that only a reduced number of mtSNPs ranging from six to 22 are needed to account for 95% of the maximum haplotype diversity of a given population sample. However, only a small proportion of the best mtSNPs are shared between populations, indicating that there is not a perfect set of "universal'' mtSNPs suitable for all population contexts. The discrimination power provided by these mtSNPs is much higher than the power of the mtSNP panels proposed in the literature to date. Some mtSNP combinations also yield high diversity values in admixed populations. Conclusions/Significance: The proposed computational approach for exploring combinations of mtSNPs that optimise the discrimination power of a given set of mtSNPs is more efficient than previous empirical approaches. In contrast to precedent findings, the results seem to indicate that only few mtSNPs are needed to reach high levels of discrimination power in a population, independently of its ancestral background.	[Salas, Antonio; Amigo, Jorge] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Unidade Xenet, Galicia, Spain; [Salas, Antonio; Amigo, Jorge] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Galicia, Spain; [Amigo, Jorge] Univ Santiago de Compostela, Grp Med Xenom, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Amigo Lechuga, Jorge/A-4892-2010	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Amigo Lechuga, Jorge/0000-0002-1362-2605	Fundacion de Investigacion Medica Mutua Madrile [2006/CL370, 2008/CL444]; Xunta de Galicia [2008/XA122]; Fondos Feder; Ministerio de Ciencia e Innovacion [SAF2008-02971]; CESGA	Fundacion de Investigacion Medica Mutua Madrile; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondos Feder(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CESGA	Two grants from Fundacion de Investigacion Medica Mutua Madrile a (2006/CL370 and 2008/CL444), a grant Grupos Emerxentes from Xunta de Galicia (2008/XA122) and "Fondos Feder'', and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971) awarded to A. Salas supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the CESGA for their supercomputing availability and support and Yong-Gang Yao and an anonymous reviewer for critically reading and commenting on the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barros F, 1997, ELECTROPHORESIS, V18, P52, DOI 10.1002/elps.1150180110; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Cerezo M, 2009, ELECTROPHORESIS, V30, P3665, DOI 10.1002/elps.200900294; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; Chinnery PF, 1999, J MED GENET, V36, P425; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2008, TOFORENSICSJ, V1, P4; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mosquera-Miguel A, 2009, FORENSIC SCI INT-GEN, V3, P261, DOI 10.1016/j.fsigen.2009.04.006; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2001, FORENSIC SCI INT, V124, P97, DOI 10.1016/S0379-0738(01)00574-6; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; YAO YG, 2009, AM J HUM GE IN PRESS	53	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10218	10.1371/journal.pone.0010218	http://dx.doi.org/10.1371/journal.pone.0010218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454657	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240300001
J	Chaturvedi, V; Springer, DJ; Behr, MJ; Ramani, R; Li, XJ; Peck, MK; Ren, P; Bopp, DJ; Wood, B; Samsonoff, WA; Butchkoski, CM; Hicks, AC; Stone, WB; Rudd, RJ; Chaturvedi, S				Chaturvedi, Vishnu; Springer, Deborah J.; Behr, Melissa J.; Ramani, Rama; Li, Xiaojiang; Peck, Marcia K.; Ren, Ping; Bopp, Dianna J.; Wood, Britta; Samsonoff, William A.; Butchkoski, Calvin M.; Hicks, Alan C.; Stone, Ward B.; Rudd, Robert J.; Chaturvedi, Sudha			Morphological and Molecular Characterizations of Psychrophilic Fungus Geomyces destructans from New York Bats with White Nose Syndrome (WNS)	PLOS ONE			English	Article							DIVERSITY; INFECTION; PANNORUM; RESPONSES	Background: Massive die-offs of little brown bats (Myotis lucifugus) have been occurring since 2006 in hibernation sites around Albany, New York, and this problem has spread to other States in the Northeastern United States. White cottony fungal growth is seen on the snouts of affected animals, a prominent sign of White Nose Syndrome (WNS). A previous report described the involvement of the fungus Geomyces destructans in WNS, but an identical fungus was recently isolated in France from a bat that was evidently healthy. The fungus has been recovered sparsely despite plentiful availability of afflicted animals. Methodology/Principal Findings: We have investigated 100 bat and environmental samples from eight affected sites in 2008. Our findings provide strong evidence for an etiologic role of G. destructans in bat WNS. (i) Direct smears from bat snouts, Periodic Acid Schiff-stained tissue sections from infected tissues, and scanning electron micrographs of bat tissues all showed fungal structures similar to those of G. destructans. (ii) G. destructans DNA was directly amplified from infected bat tissues, (iii) Isolations of G. destructans in cultures from infected bat tissues showed 100% DNA match with the fungus present in positive tissue samples. (iv) RAPD patterns for all G. destructans cultures isolated from two sites were indistinguishable. (v) The fungal isolates showed psychrophilic growth. (vi) We identified in vitro proteolytic activities suggestive of known fungal pathogenic traits in G. destructans. Conclusions/Significance: Further studies are needed to understand whether G. destructans WNS is a symptom or a trigger for bat mass mortality. The availability of well-characterized G. destructans strains should promote an understanding of bat-fungus relationships, and should aid in the screening of biological and chemical control agents.	[Chaturvedi, Vishnu; Springer, Deborah J.; Ramani, Rama; Li, Xiaojiang; Peck, Marcia K.; Ren, Ping; Chaturvedi, Sudha] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA; [Chaturvedi, Vishnu; Springer, Deborah J.; Ramani, Rama; Chaturvedi, Sudha] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA; [Bopp, Dianna J.] New York State Dept Hlth, Wadsworth Ctr, Bacteriol Lab, Albany, NY USA; [Wood, Britta; Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Rabies Lab, Albany, NY USA; [Butchkoski, Calvin M.] Penn Game Commiss, Harrisburg, PA USA; [Hicks, Alan C.] Bur Wildlife, New York State Dept Environm Conservat, Albany, NY USA; [Stone, Ward B.] New York State Dept Environm Conservat, Wildlife Pathol Unit, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center	Chaturvedi, V (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA.	vishnu@wadsworth.org	Ramani, Rama/AAS-2019-2020	Chaturvedi, Vishnu/0000-0002-3922-9676; Ren, Ping/0000-0002-4022-6667	Clinical Laboratory Reference System of the Wadsworth Center	Clinical Laboratory Reference System of the Wadsworth Center	Funding: This study was supported with funds available as part of the Clinical Laboratory Reference System of the Wadsworth Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baptista-Rosas RC, 2007, ANN NY ACAD SCI, V1111, P35, DOI 10.1196/annals.1406.003; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chaturvedi V, 2002, INFECT IMMUN, V70, P5225, DOI 10.1128/IAI.70.9.5225-5235.2002; CHATURVEDI VP, 1984, SABOURAUDIA, V22, P185; Christen-Zaech S, 2008, J AM ACAD DERMATOL, V58, pS112, DOI 10.1016/j.jaad.2007.04.019; Connell L, 2008, MICROB ECOL, V56, P448, DOI 10.1007/s00248-008-9363-1; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; De Bernardis F, 1999, J CLIN MICROBIOL, V37, P3481, DOI 10.1128/JCM.37.11.3481-3486.1999; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DeBlase A. F., 1965, Journal of Mammalogy, V46, P96, DOI 10.2307/1377821; Dyavaiah Madhu, 2007, BMC Ophthalmol, V7, P1, DOI 10.1186/1471-2415-7-1; Erne JB, 2007, JAVMA-J AM VET MED A, V230, P537, DOI 10.2460/javma.230.4.537; Franco M, 2000, MED MYCOL, V38, P185, DOI 10.1080/714030941; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Gente S, 2006, J IND MICROBIOL BIOT, V33, P1019, DOI 10.1007/s10295-006-0130-3; Gianni C, 2003, MYCOSES, V46, P430, DOI 10.1046/j.1439-0507.2003.00897.x; Gilichinsky D, 2005, FEMS MICROBIOL ECOL, V53, P117, DOI 10.1016/j.femsec.2005.02.003; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; HATTEN BA, 1970, J IMMUNOL, V105, P872; HICKS AC, 2002, HIST STATUS BEHAV HI, P35; Johnson SA, 1998, AM MIDL NAT, V139, P255, DOI 10.1674/0003-0031(1998)139[0255:OWLOIB]2.0.CO;2; Julg B, 2008, J TRAVEL MED, V15, P133, DOI 10.1111/j.1708-8305.2008.00193.x; KELLY T, 2008, NY TIMES; Kerth Gerald, 2003, Acta Ethologica, V5, P107; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Kunz TH, 2003, BAT ECOLOGY, P3; Kurtz CC, 2007, DEV COMP IMMUNOL, V31, P415, DOI 10.1016/j.dci.2006.07.003; Kwon-Chung J.K., 1992, MED MYCOL; Lampo M, 2000, AM J TROP MED HYG, V62, P718, DOI 10.4269/ajtmh.2000.62.718; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Malosso E, 2006, POLAR BIOL, V29, P552, DOI 10.1007/s00300-005-0088-z; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Moller C, 1996, J IND MICROBIOL BIOT, V17, P359, DOI 10.1007/BF01574767; Murtagh GJ, 2002, MYCOL RES, V106, P1277, DOI 10.1017/S0953756202006615; PRICE MF, 1982, SABOURAUDIA, V20, P7; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; Robinson CH, 2001, NEW PHYTOL, V151, P341, DOI 10.1046/j.1469-8137.2001.00177.x; Ruisi Serena, 2007, Reviews in Environmental Science and Bio/Technology, V6, P127, DOI 10.1007/s11157-006-9107-y; Samson R., 2004, INTRO FOOD AIRBORNE; Schmidt SK, 2008, MICROB ECOL, V56, P681, DOI 10.1007/s00248-008-9387-6; SCHOENBORN C, 1970, Mykosen, V13, P253; SCOTT DW, 2000, MULLER KIRKS SMALL A; Symonds EP, 2008, MYCOPATHOLOGIA, V166, P143, DOI 10.1007/s11046-008-9135-y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; TRIMARCHI CV, 1977, J WILDLIFE DIS, V13, P366, DOI 10.7589/0090-3558-13.4.366; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; ZAMORA JRC, 1977, MYCOPATHOLOGIA, V60, P157; Zelenkova Hana, 2006, Acta Dermatovenerol Croat, V14, P21	57	73	75	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10783	10.1371/journal.pone.0010783	http://dx.doi.org/10.1371/journal.pone.0010783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520731	Green Published, Green Submitted, gold			2022-12-27	WOS:000278034600011
J	de Leon, AD; Cronkhite, JT; Katzenstein, ALA; Godwin, JD; Raghu, G; Glazer, CS; Rosenblatt, RL; Girod, CE; Garrity, ER; Xing, C; Garcia, CK				de Leon, Alberto Diaz; Cronkhite, Jennifer T.; Katzenstein, Anna-Luise A.; Godwin, J. David; Raghu, Ganesh; Glazer, Craig S.; Rosenblatt, Randall L.; Girod, Carlos E.; Garrity, Edward R.; Xing, Chao; Garcia, Christine Kim			Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations	PLOS ONE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA COMPONENT; CELLS; HAPLOINSUFFICIENCY; ANTICIPATION; FAMILIES; GENE	Background: Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomerase (TERT) have been described in patients with idiopathic pulmonary fibrosis (IPF). Here we examine the telomere lengths and pulmonary fibrosis phenotype seen in multiple kindreds with heterozygous TERT mutations. Methods and Findings: We have identified 134 individuals with heterozygous TERT mutations from 21 unrelated families. Available medical records, surgical lung biopsies and radiographs were evaluated retrospectively. Genomic DNA isolated from circulating leukocytes has been used to measure telomere lengths with a quantitative PCR assay. We find that telomere lengths of TERT mutation carriers decrease in an age-dependent manner and show progressive shortening with successive generations of mutation inheritance. Family members without TERT mutations have a shorter mean telomere length than normal, demonstrating epigenetic inheritance of shortened telomere lengths in the absence of an inherited TERT mutation. Pulmonary fibrosis is an age-dependent phenotype not seen in mutation carriers less than 40 years of age but found in 60% of men 60 years or older; its development is associated with environmental exposures including cigarette smoking. A radiographic CT pattern of usual interstitial pneumonia (UIP), which is consistent with a diagnosis of IPF, is seen in 74% of cases and a pathologic pattern of UIP is seen in 86% of surgical lung biopsies. Pulmonary fibrosis associated with TERT mutations is progressive and lethal with a mean survival of 3 years after diagnosis. Overall, TERT mutation carriers demonstrate reduced life expectancy, with a mean age of death of 58 and 67 years for males and females, respectively. Conclusions: A subset of pulmonary fibrosis, like dyskeratosis congenita, bone marrow failure, and liver disease, represents a "telomeropathy" caused by germline mutations in telomerase and characterized by short telomere lengths. Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point.	[de Leon, Alberto Diaz; Cronkhite, Jennifer T.; Xing, Chao; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Glazer, Craig S.; Rosenblatt, Randall L.; Girod, Carlos E.; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care Med, Dallas, TX 75390 USA; [Katzenstein, Anna-Luise A.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY USA; [Godwin, J. David] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA; [Raghu, Ganesh] Univ Washington, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Garrity, Edward R.] Univ Chicago, Dept Internal Med, Div Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	de Leon, AD (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	Christine.garcia@utsouthwestern.edu		Xing, Chao/0000-0002-1838-0502	National Institutes of Health [K23RR020632, R01HL093096]; Doris Duke Charitable Foundation; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR020632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grants K23RR020632 and R01HL093096, the Doris Duke Charitable Foundation and the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; ALTER BP, 2007, BLOOD; American Thoracic Society, 2002, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/ajrccm.165.2.ats01; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; ARMANIOS M, 2009, AM J HUM GENET; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GARCIA CK, 2007, NUCL ACIDS RES; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Marciniak RA, 2000, TRENDS GENET, V16, P193, DOI 10.1016/S0168-9525(00)01984-3; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; NORDFJALL K, 2009, EUR J HUM GENET; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; WALNE AJ, 2007, HUM MOL GENET; Wright WE, 1996, DEV GENET, V18, P173; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	34	235	236	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10680	10.1371/journal.pone.0010680	http://dx.doi.org/10.1371/journal.pone.0010680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502709	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400005
J	Paule, B; Bastien, L; Deslandes, E; Cussenot, O; Podgorniak, MP; Allory, Y; Naimi, B; Porcher, R; de La Taille, A; Menashi, S; Calvo, F; Mourah, S				Paule, Bernard; Bastien, Laurence; Deslandes, Emmanuelle; Cussenot, Olivier; Podgorniak, Marie-Pierre; Allory, Yves; Naimi, Benyoussef; Porcher, Raphael; de La Taille, Alexandre; Menashi, Suzanne; Calvo, Fabien; Mourah, Samia			Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas	PLOS ONE			English	Article							ANGIOGENESIS; SORAFENIB; RECEPTORS; EFFICACY; BIOLOGY; PLASMA; TRIAL; VEGF	Background: Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which may improve the knowledge regarding mechanism of action of these treatments. Tyrosine kinase inhibitors (TKI) have proven efficacy in metastatic RCC (mRCC). However, the molecular mechanisms underlying the clinical response to these drugs remain unclear. Methodology/Principal Findings: The present study aimed to identify molecular biomarkers associated with the response to sunitinib, a Tyrosine kinase inhibitor. To evaluate this relationship, primary tumors from 23 metastatic RCC patients treated by sunitinib were analyzed for a panel of 16 biomarkers involved in tumor pathways targeted by sunitinib, using real-time quantitative reverse-transcriptase PCR. Nine of the 23 patients (39%) responded to sunitinib. Among transcripts analyzed, only the levels of vascular endothelial growth factor (VEGF) soluble isoforms (VEGF(121) and VEGF(165)) were associated with the response to sunitinib (P = 0.04 for both). Furthermore, the ratio of VEGF soluble isoforms (VEGF(121)/VEGF(165)) was significantly associated with prognosis (P = 0.02). Conclusions: This preliminary study provides a promising tool that might help in the management of metastatic RCC, and could be extended to other tumors treated by TKI.	[Paule, Bernard; Naimi, Benyoussef; Calvo, Fabien; Mourah, Samia] INSERM, UMRS 940, Paris, France; [Paule, Bernard; Bastien, Laurence; Allory, Yves; de La Taille, Alexandre] Hop Henri Mondor, AP HP, Dept Urol, INSERM,U841Eq07, Creteil, France; [Deslandes, Emmanuelle; Porcher, Raphael] Univ Paris 07, Hop St Louis, AP HP, INSERM,Dept Biostat & Med Data Proc,U717, Paris, France; [Cussenot, Olivier] Hop Tenon, AP HP, Dept Urol, F-75970 Paris, France; [Cussenot, Olivier] CeRePP Natl Grp, Paris, France; [Podgorniak, Marie-Pierre; Calvo, Fabien; Mourah, Samia] Hop St Louis, AP HP, Pharmacol Lab, Paris, France; [Menashi, Suzanne] Univ Paris Est, CNRS, UMR 7149, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Paule, B (corresponding author), INSERM, UMRS 940, Paris, France.	samia.mourah@sls.aphp.fr	de la taille, Alex/ABE-8422-2021	cussenot, olivier/0000-0002-9912-0533; Boutmy, Emmanuelle/0000-0001-9657-9376; calvo, fabien/0000-0002-0298-7633; Porcher, Raphael/0000-0002-5277-4679	Pfizer France	Pfizer France(Pfizer)	This work has been performed with the collaboration of INSERM-U716, Laboratory of Pharmacology of Hopital Saint-Louis and University Paris 7, and the support of Pfizer France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223; Eisen T, 2008, JNCI-J NATL CANCER I, V100, P1454, DOI 10.1093/jnci/djn319; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Loupakis F, 2007, J CLIN ONCOL, V25, P1816, DOI 10.1200/JCO.2006.10.3051; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Rivet J, 2008, CANCER, V112, P433, DOI 10.1002/cncr.23186; Rixe O, 2007, ANN ONCOL, V18, P1117, DOI 10.1093/annonc/mdm184; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tomisawa M, 1999, EUR J CANCER, V35, P133, DOI 10.1016/S0959-8049(98)00278-0; Tsuchiya N, 2001, TOHOKU J EXP MED, V195, P101, DOI 10.1620/tjem.195.101	18	39	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10715	10.1371/journal.pone.0010715	http://dx.doi.org/10.1371/journal.pone.0010715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502715	Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400017
J	Dieterle, MG; Wiest, AE; Plamann, M; McCluskey, K				Dieterle, Michael G.; Wiest, Aric E.; Plamann, Mike; McCluskey, Kevin			Characterization of the Temperature-Sensitive Mutations un-7 and png-1 in Neurospora crassa	PLOS ONE			English	Article							GENOME; CHROMOSOME; CLONING	The model filamentous fungus Neurospora crassa has been studied for over fifty years and many temperature-sensitive mutants have been generated. While most of these have been mapped genetically, many remain anonymous. The mutation in the N. crassa temperature-sensitive lethal mutant un-7 was identified by a complementation based approach as being in the open reading frame designated NCU00651 on linkage group I. Other mutations in this gene have been identified that lead to a temperature-sensitive morphological phenotype called png-1. The mutations underlying un-7 result in a serine to phenylalanine change at position 273 and an isoleucine to valine change at position 390, while the mutation in png-1 was found to result in a serine to leucine change at position 279 although there were other conservative changes in this allele. The overall morphology of the strain carrying the un-7 mutation is compared to strains carrying the png-1 mutation and these mutations are evaluated in the context of other temperature-sensitive mutants in Neurospora.	[Dieterle, Michael G.; Wiest, Aric E.; Plamann, Mike; McCluskey, Kevin] Univ Missouri Kansas City, Sch Biol Sci, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA; [Dieterle, Michael G.] Pembroke Hill Sch, Kansas City, MO USA	University of Missouri System; University of Missouri Kansas City	Dieterle, MG (corresponding author), Univ Missouri Kansas City, Sch Biol Sci, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA.	mccluskeyk@umkc.edu		Dieterle, Michael/0000-0002-3109-6151	US National Science Foundation [0742713]; Direct For Biological Sciences [0742713] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Fungal Genetics Stock Center is supported by the US National Science Foundation grant number 0742713 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; INOUE H, 1970, JPN J GENET, V45, P357, DOI 10.1266/jjg.45.357; Kelkar HS, 2001, GENETICS, V157, P979; Kinney M., 2009, FUNGAL GENETICS REPO, V56, P6; LOO MW, 1981, MOL CELL BIOL, V1, P199, DOI 10.1128/MCB.1.3.199; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McCluskey K., 2007, FUNGAL GENET NEWSL, V54, P9; PERKINS DD, 2002, FUNGAL GENET NEWSL S, V49, P199; Schmidhauser TJ, 1997, FUNGAL GENET BIOL, V21, P323, DOI 10.1006/fgbi.1997.0974; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Videira A, 2009, MICROBIOL-SGM, V155, P3134, DOI 10.1099/mic.0.029710-0; Vogel H.J., 1956, MICROB GENET B, V13, P42; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Wiest A., 2008, FUNGAL GENETICS REPO, V55, P37; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10703	10.1371/journal.pone.0010703	http://dx.doi.org/10.1371/journal.pone.0010703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502699	gold, Green Published, Green Submitted			2022-12-27	WOS:000277776500017
J	Zacchi, LF; Selmecki, AM; Berman, J; Davis, DA				Zacchi, Lucia F.; Selmecki, Anna M.; Berman, Judith; Davis, Dana A.			Low Dosage of Histone H4 Leads to Growth Defects and Morphological Changes in Candida albicans	PLOS ONE			English	Article							MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CELL-CYCLE; DROSOPHILA-MELANOGASTER; WIDESPREAD ANEUPLOIDY; NUCLEOSOME DEPLETION; COLONY MORPHOLOGY; ESCHERICHIA-COLI; FUNGAL PATHOGEN	Chromatin function depends on adequate histone stoichiometry. Alterations in histone dosage affect transcription and chromosome segregation, leading to growth defects and aneuploidies. In the fungal pathogen Candida albicans, aneuploidy formation is associated with antifungal resistance and pathogenesis. Histone modifying enzymes and chromatin remodeling proteins are also required for pathogenesis. However, little is known about the mechanisms that generate aneuploidies or about the epigenetic mechanisms that shape the response of C. albicans to the host environment. Here, we determined the impact of histone H4 deficit in the growth and colony morphology of C. albicans. We found that C. albicans requires at least two of the four alleles that code for histone H4 (HHF1 and HHF22) to grow normally. Strains with only one histone H4 allele show a severe growth defect and unstable colony morphology, and produce faster-growing, morphologically stable suppressors. Segmental or whole chromosomal trisomies that increased wild-type histone H4 copy number were the preferred mechanism of suppression. This is the first study of a core nucleosomal histone in C. albicans, and constitutes the prelude to future, more detailed research on the function of histone H4 in this important fungal pathogen.	[Zacchi, Lucia F.; Berman, Judith; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Selmecki, Anna M.; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zacchi, LF (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	dadavis@umn.edu	Berman, Judith/AAS-5115-2021; Berman, Judith/ABA-8528-2021; Zacchi, Lucia/F-7494-2016; Zacchi, Lucia/N-6484-2019	Berman, Judith/0000-0002-8577-0084; Zacchi, Lucia/0000-0001-6217-1380; Zacchi, Lucia/0000-0001-6217-1380; Selmecki, Anna/0000-0003-3298-2400	Burroughs Wellcome Fund; NIH [R01 AI0624273]; Microbial and Plant Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062427] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microbial and Plant Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund to D. A. D., NIH R01 AI0624273 to J.B. and Microbial and Plant Genomics Institute of MN Integrative Fellowship to A. M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; ASAKURA K, 1991, J GEN MICROBIOL, V137, P2531, DOI 10.1099/00221287-137-11-2531; Au WC, 2008, GENETICS, V179, P263, DOI 10.1534/genetics.108.088518; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; BARTON RC, 1994, J BACTERIOL, V176, P756, DOI 10.1128/jb.176.3.756-763.1994; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Calderone RA., 2002, CANDIDA CANDIDIASIS; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chang CH, 1997, J BIOL CHEM, V272, P23427, DOI 10.1074/jbc.272.37.23427; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; CHOE J, 1985, MOL CELL BIOL, V5, P3261, DOI 10.1128/MCB.5.11.3261; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Davis DA, 2002, GENETICS, V162, P1573; Diogo D, 2009, FUNGAL GENET BIOL, V46, P159, DOI 10.1016/j.fgb.2008.11.005; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DURRIN LK, 1992, MOL CELL BIOL, V12, P1621, DOI 10.1128/MCB.12.4.1621; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; FRETZIN S, 1991, GENE, V107, P341, DOI 10.1016/0378-1119(91)90337-B; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Hanlon SE, 2003, GENETICS, V164, P1333; Hnisz D, 2009, MOL MICROBIOL, V74, P1, DOI 10.1111/j.1365-2958.2009.06772.x; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; IWAGUCHI SI, 1992, J GEN MICROBIOL, V138, P1177, DOI 10.1099/00221287-138-6-1177; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Klar AJS, 2001, GENETICS, V158, P919; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Legrand M, 2004, MOL MICROBIOL, V52, P1451, DOI 10.1111/j.1365-2958.2004.04068.x; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Lu Y, 2008, MOL BIOL CELL, V19, P4260, DOI 10.1091/mbc.E08-02-0173; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MAGEE PT, 1992, J CLIN MICROBIOL, V30, P2674, DOI 10.1128/JCM.30.10.2674-2679.1992; Mao XM, 2006, FEBS LETT, V580, P2615, DOI 10.1016/j.febslet.2006.04.009; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MOORE GD, 1983, GENETICS, V105, P327; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NORRIS D, 1987, MOL CELL BIOL, V7, P3473, DOI 10.1128/MCB.7.10.3473; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V31, P327, DOI 10.1016/S0732-8893(97)00240-X; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; PRUSS D, 1995, BIOESSAYS, V17, P161, DOI 10.1002/bies.950170211; Raman SB, 2006, MOL MICROBIOL, V60, P697, DOI 10.1111/j.1365-2958.2006.05121.x; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; RUSTCHENKO EP, 1994, J BACTERIOL, V176, P3231, DOI 10.1128/jb.176.11.3231-3241.1994; RUSTCHENKOBULGAC EP, 1990, J BACTERIOL, V172, P1276, DOI 10.1128/jb.172.3.1276-1283.1990; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; SAUNDERS MJ, 1990, MOL CELL BIOL, V10, P5721, DOI 10.1128/MCB.10.11.5721; SELLAM A, 2005, MOL MICROBIOL, V55, P1553; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; SMITH MM, 1983, J MOL BIOL, V169, P663, DOI 10.1016/S0022-2836(83)80164-8; Smith MM, 1996, MOL CELL BIOL, V16, P1017; SMITH MM, 1988, J CELL BIOL, V106, P557, DOI 10.1083/jcb.106.3.557; Smith WL, 2002, ANTIMICROB AGENTS CH, V46, P3532, DOI 10.1128/AAC.46.11.3532-3539.2002; SOLL DR, 1988, J CLIN MICROBIOL, V26, P1448, DOI 10.1128/JCM.26.8.1448-1459.1988; SOLL DR, 1987, J CLIN MICROBIOL, V25, P1611, DOI 10.1128/JCM.25.9.1611-1622.1987; SOLL DR, 1989, J CLIN MICROBIOL, V27, P681, DOI 10.1128/JCM.27.4.681-690.1989; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; STEIN G S, 1992, Current Opinion in Cell Biology, V4, P166, DOI 10.1016/0955-0674(92)90028-B; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; SVAREN J, 1993, CURR OPIN GENET DEV, V3, P219, DOI 10.1016/0959-437X(93)90026-L; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Tsui KC, 1997, GENETICS, V145, P647; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Venditti S, 1999, MOL GEN GENET, V262, P367, DOI 10.1007/s004380051095; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WELLS JRE, 1989, HISTONES OTHER BASIC; WICKES B, 1991, INFECT IMMUN, V59, P2480, DOI 10.1128/IAI.59.7.2480-2484.1991; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wu W, 2005, GENETICS, V169, P1311, DOI 10.1534/genetics.104.033167; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	99	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2010	5	5							e10629	10.1371/journal.pone.0010629	http://dx.doi.org/10.1371/journal.pone.0010629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595SN	20498713	gold, Green Published, Green Submitted			2022-12-27	WOS:000277633500017
J	Hu, B; Du, J; Zou, RY; Yuan, YJ				Hu, Bo; Du, Jin; Zou, Rui-yang; Yuan, Ying-jin			An Environment-Sensitive Synthetic Microbial Ecosystem	PLOS ONE			English	Article							COMMUNICATION; BIOLOGY; ANTIBIOTICS; DIVERSITY; GENOMICS; NETWORK; DESIGN; SYSTEM; GENES; VIEW	Microbial ecosystems have been widely used in industrial production, but the inter-relationships of organisms within them haven't been completely clarified due to complex composition and structure of natural microbial ecosystems. So it is challenging for ecologists to get deep insights on how ecosystems function and interplay with surrounding environments. But the recent progresses in synthetic biology show that construction of artificial ecosystems where relationships of species are comparatively clear could help us further uncover the meadow of those tiny societies. By using two quorum-sensing signal transduction circuits, this research designed, simulated and constructed a synthetic ecosystem where various population dynamics formed by changing environmental factors. Coherent experimental data and mathematical simulation in our study show that different antibiotics levels and initial cell densities can result in correlated population dynamics such as extinction, obligatory mutualism, facultative mutualism and commensalism. This synthetic ecosystem provides valuable information for addressing questions in ecology and may act as a chassis for construction of more complex microbial ecosystems.	[Hu, Bo] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Hu, B (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn			National Science Fund of China for Distinguished Young Scholars [20425620]; Key Program Grant [20736006]; National Basic Research Program of China ('973' Program) [2007CB714301]	National Science Fund of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program Grant; National Basic Research Program of China ('973' Program)(National Basic Research Program of China)	The authors are very grateful for BioBrick Foundation for providing biobrick and also thank the financial support from the National Science Fund of China for Distinguished Young Scholars Grant (Project No. 20425620), Key Program Grant (Project No. 20736006), the National Basic Research Program of China ('973' Program: 2007CB714301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Banning NC, 2008, APPL SOIL ECOL, V40, P109, DOI 10.1016/j.apsoil.2008.03.011; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bertin PN, 2008, MICROBIOL-SGM, V154, P347, DOI 10.1099/mic.0.2007/011791-0; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Costanzo SD, 2005, MAR POLLUT BULL, V51, P218, DOI 10.1016/j.marpolbul.2004.10.038; Dunham MJ, 2007, P NATL ACAD SCI USA, V104, P1741, DOI 10.1073/pnas.0611067104; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Foerstner KU, 2006, PHILOS T R SOC B, V361, P519, DOI 10.1098/rstb.2005.1809; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalia VC, 2008, J IND MICROBIOL BIOT, V35, P403, DOI 10.1007/s10295-007-0300-y; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Maru Y, 2009, CENT EUR J BIOL, V4, P1, DOI 10.2478/s11535-008-0063-0; MORAN AC, 2008, ENVIRON TOXICOL CHEM, V3, P1; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paerl HW, 2003, ENVIRON MICROBIOL, V5, P1025, DOI 10.1046/j.1462-2920.2003.00504.x; Pappas KM, 2004, MOL MICROBIOL, V53, P755, DOI 10.1111/j.1365-2958.2004.04212.x; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rittmann BE, 2008, BIOTECHNOL BIOENG, V100, P203, DOI 10.1002/bit.21875; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schmidt TM, 2006, INT MICROBIOL, V9, P217; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Williams HTP, 2008, P NATL ACAD SCI USA, V105, P10432, DOI 10.1073/pnas.0800244105; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	47	40	47	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10619	10.1371/journal.pone.0010619	http://dx.doi.org/10.1371/journal.pone.0010619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485551	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563400022
J	McCormick, MI; Ryen, CA; Munday, PL; Walker, SPW				McCormick, Mark I.; Ryen, Christopher A.; Munday, Philip L.; Walker, Stefan P. W.			Differing Mechanisms Underlie Sexual Size-Dimorphism in Two Populations of a Sex-Changing Fish	PLOS ONE			English	Article							CORAL-REEF FISH; SETTLEMENT-MARKS; MATING SYSTEMS; SOCIAL-CONTROL; GROWTH; EVOLUTION; DENSITY; TEMPERATURE; PERSPECTIVE; PERFORMANCE	Variability in the density of groups within a patchy environment lead to differences in interaction rates, growth dynamics and social organization. In protogynous hermaphrodites there are hypothesised trade-offs among sex-specific growth, reproductive output and mortality. When differences in density lead to changes to social organization the link between growth and the timing of sex-change is predicted to change. The present study explores this prediction by comparing the social organisation and sex-specific growth of two populations of a protogynous tropical wrasse, Halichoeres miniatus, which differ in density. At a low density population a strict harem structure was found, where males maintained a tight monopoly of access and spawning rights to females. In contrast, at a high density population a loosely organised system prevailed, where females could move throughout multiple male territories. Otolith microstructure revealed the species to be annual and deposit an otolith check associated with sex-change. Growth trajectories suggested that individuals that later became males in both populations underwent a growth acceleration at sex-change. Moreover, in the high density population, individuals that later became males were those individuals that had the largest otolith size at hatching and consistently deposited larger increments throughout early larval, juvenile and female life. This study demonstrates that previous growth history and growth rate changes associated with sex change can be responsible for the sexual dimorphism typically found in sex-changing species, and that the relative importance of these may be socially constrained.	[McCormick, Mark I.; Ryen, Christopher A.; Munday, Philip L.; Walker, Stefan P. W.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sch Marine & Trop Biol, Townsville, Qld, Australia	James Cook University	McCormick, MI (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sch Marine & Trop Biol, Townsville, Qld, Australia.	mark.mccormick@jcu.edu.au	Walker, Stefan/A-7238-2010; Munday, Philip L/F-5443-2011; McCormick, Mark I/J-8301-2014	Munday, Philip L/0000-0001-9725-2498; McCormick, Mark I/0000-0001-9289-1645	JCU; Australian Museum; Merit Research Grant; Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561432]	JCU; Australian Museum; Merit Research Grant; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	Research was funded by a JCU Doctoral Research Merit Grant and a Lizard Island Doctoral fellowship (Australian Museum) to S.P.W.W., a Merit Research Grant to M.I.M. and the Australian Research Council Centre of Excellence for Coral Reef Studies (CE0561432; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2001, J FISH BIOL, V59, P183, DOI 10.1111/j.1095-8649.2001.tb02350.x; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Buston PM, 2006, OECOLOGIA, V149, P362, DOI 10.1007/s00442-006-0442-z; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana Steven E., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P73; CHAMBERS RC, 1994, RECENT DEV FISH OTOL, P764; CHARNOV E L, 1982; Choat J. Howard, 2002, P57; Edeline E, 2010, P ROY SOC B-BIOL SCI, V277, P843, DOI 10.1098/rspb.2009.1724; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fey DP, 2006, J FISH BIOL, V69, P794, DOI 10.1111/j.1095-8649.2006.01151.x; FRICKE HW, 1980, ANIM BEHAV, V28, P561, DOI 10.1016/S0003-3472(80)80065-0; Frisch AJ, 2007, HORM BEHAV, V52, P540, DOI 10.1016/j.yhbeh.2007.07.008; Gagliano M, 2007, P R SOC B, V274, P1575, DOI 10.1098/rspb.2007.0242; Gagliano M, 2009, OECOLOGIA, V160, P657, DOI 10.1007/s00442-009-1335-8; Green BS, 2005, MAR ECOL PROG SER, V289, P263, DOI 10.3354/meps289263; Gust N, 2004, CAN J FISH AQUAT SCI, V61, P205, DOI 10.1139/F03-160; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Hoey A.S., 2006, PROC 10 INT CORAL RE, V2006, P420; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Iwasa Y, 1991, BEHAV ECOL, V2, P56, DOI 10.1093/beheco/2.1.56; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; KIMURA S, 1993, JPN J ICHTHYOL, V39, P371, DOI 10.1007/BF02905137; Lindgren B, 2005, J EVOLUTION BIOL, V18, P820, DOI 10.1111/j.1420-9101.2004.00875.x; Lorenzi V, 2006, BEHAV ECOL SOCIOBIOL, V59, P715, DOI 10.1007/s00265-005-0101-0; LUTNESKY MMF, 1994, BEHAV ECOL, V5, P375, DOI 10.1093/beheco/5.4.375; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Munday PL, 2009, CORAL REEFS, V28, P623, DOI 10.1007/s00338-009-0499-3; Munday PL, 2006, P ROY SOC B-BIOL SCI, V273, P2845, DOI 10.1098/rspb.2006.3666; Munday PL, 2004, CAN J FISH AQUAT SCI, V61, P323, DOI 10.1139/F04-057; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; PETERSEN CW, 1990, BEHAVIOUR, V113, P57, DOI 10.1163/156853990X00437; Polo V, 2007, J ANIM ECOL, V76, P866, DOI 10.1111/j.1365-2656.2007.01270.x; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; ROBERTSON DR, 1977, Z TIERPSYCHOL, V45, P298; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; RYEN CA, 2008, SEX SPECIFIC GROWTH; SADOVY Y, 1987, COPEIA, P136, DOI 10.2307/1446046; Sakai Y, 2002, J ETHOL, V20, P101, DOI 10.1007/s10164-002-0060-0; Shapiro D.Y., 1984, P103; SHUSTER SM, 2003, MG BEH ECOL, pR7; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Tibbetts EA, 2008, P ROY SOC B-BIOL SCI, V275, P2201, DOI 10.1098/rspb.2008.0477; Walker SPW, 2007, J FISH BIOL, V71, P1347, DOI 10.1111/j.1095-8649.2007.01595.x; Walker SPW, 2004, MAR ECOL PROG SER, V266, P201, DOI 10.3354/meps266201; Walker SPW, 2009, BIOL LETTERS, V5, P73, DOI 10.1098/rsbl.2008.0555; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; WARNER RR, 1984, AM SCI, V72, P128; WARNER RR, 1980, ECOLOGY, V61, P772, DOI 10.2307/1936747; WARNER RR, 1991, BIOL BULL-US, V181, P199, DOI 10.2307/1542090; WARNER RR, 1988, TRENDS ECOL EVOL, V3, P133, DOI 10.1016/0169-5347(88)90176-0; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259; Wilson DT, 1999, MAR BIOL, V134, P29, DOI 10.1007/s002270050522; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284	59	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2010	5	5							e10616	10.1371/journal.pone.0010616	http://dx.doi.org/10.1371/journal.pone.0010616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UC	20485547	Green Published, gold, Green Accepted			2022-12-27	WOS:000277563400019
J	Charurat, M; Oyegunle, M; Benjamin, R; Habib, A; Eze, E; Ele, P; Ibanga, I; Ajayi, S; Eng, M; Mondal, P; Gebi, U; Iwu, E; Etiebet, MA; Abimiku, A; Dakum, P; Farley, J; Blattner, W				Charurat, Man; Oyegunle, Modupe; Benjamin, Renata; Habib, Abdulrazaq; Eze, Emeka; Ele, Prince; Ibanga, Iquo; Ajayi, Samuel; Eng, Maria; Mondal, Prosanta; Gebi, Usman; Iwu, Emilia; Etiebet, Mary-Ann; Abimiku, Alash'le; Dakum, Patrick; Farley, John; Blattner, William			Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors	PLOS ONE			English	Article							HIV-INFECTED ADULTS; FOLLOW-UP; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; IMPROVE ADHERENCE; INCOME COUNTRIES; LACTIC-ACIDOSIS; 1ST YEAR; STAVUDINE; UGANDA	Background: Substantial resources and patient commitment are required to successfully scale-up antiretroviral therapy (ART) and provide appropriate HIV management in resource-limited settings. We used pharmacy refill records to evaluate risk factors for loss to follow-up (LTFU) and non-adherence to ART in a large treatment cohort in Nigeria. Methods and Findings: We reviewed clinic records of adult patients initiating ART between March 2005 and July 2006 at five health facilities. Patients were classified as LTFU if they did not return > 60 days from their expected visit. Pharmacy refill rates were calculated and used to assess non-adherence. We identified risk factors associated with LTFU and non-adherence using Cox and Generalized Estimating Equation (GEE) regressions, respectively. Of 5,760 patients initiating ART, 26% were LTFU. Female gender (p < 0.001), post-secondary education (p = 0.03), and initiating treatment with zidovudine-containing (p = 0.004) or tenofovir-containing (p = 0.05) regimens were associated with decreased risk of LTFU, while patients with only primary education (p = 0.02) and those with baseline CD4 counts (cell/ml(3)) > 350 and < 100 were at a higher risk of LTFU compared to patients with baseline CD4 counts of 100-200. The adjusted GEE analysis showed that patients aged < 35 years (p = 0.005), who traveled for > 2 hours to the clinic (p = 0.03), had total ART duration of > 6 months (p < 0.001), and CD4 counts > 200 at ART initiation were at a higher risk of non-adherence. Patients who disclosed their HIV status to spouse/family (p = 0.01) and were treated with tenofovir-containing regimens (p < 0.001) were more likely to be adherent. Conclusions: These findings formed the basis for implementing multiple pre-treatment visit preparation that promote disclosure and active community outreaching to support retention and adherence. Expansion of treatment access points of care to communities to diminish travel time may have a positive impact on adherence.	[Charurat, Man; Oyegunle, Modupe; Benjamin, Renata; Eng, Maria; Mondal, Prosanta; Etiebet, Mary-Ann; Abimiku, Alash'le; Dakum, Patrick; Farley, John; Blattner, William] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Habib, Abdulrazaq] Aminu Kano Teaching Hosp, Kano, Nigeria; [Eze, Emeka] Univ Benin, Teaching Hosp, Benin, Edo State, Nigeria; [Ele, Prince] Nnamdi Azikwe Univ, Teaching Hosp, Nnewi, Anambra State, Nigeria; [Ibanga, Iquo] Univ Calabar, Teaching Hosp, Calabar, Cross River Sta, Nigeria; [Ajayi, Samuel] Univ Abuja, Teaching Hosp, Abuja, Federal Capital, Nigeria; [Gebi, Usman; Iwu, Emilia; Etiebet, Mary-Ann; Dakum, Patrick] Inst Human Virol Nigeria, Abuja, Federal Capital, Nigeria; [Iwu, Emilia] Univ Maryland, Sch Nursing, Dept Family & Community Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Benin; University of Calabar; University System of Maryland; University of Maryland Baltimore	Charurat, M (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	mcharurat@ihv.umaryland.edu		Gebi, Usman/0000-0002-1395-4650; Benjamin, Renata/0000-0001-6406-4247	U.S. Centers for Disease Control and Prevention [PS000651]; The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program [D43 TW001041]; International Epidemiologic Database to evaluate AIDS [U01AI069919]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U2GPS000651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program; International Epidemiologic Database to evaluate AIDS; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The AIDS Care and Treatment in Nigeria (ACTION) project is supported by the U.S. Centers for Disease Control and Prevention (Cooperative Agreement No. PS000651). This publication content is solely the responsibility of the authors and does not necessarily represent the official views of the CDC. This on-going project is jointly implemented by the Institute of Human Virology of the University of Maryland School of Medicine, Institute of Human Virology Nigeria, the Nigerian Federal Ministry of Health, and local partner treatment facilities. The U.S. National Institutes of Health's Fogarty AIDS International Training Research Program (AITRP, D43 TW001041) and the International Epidemiologic Database to evaluate AIDS (IeDEA, U01AI069919) provided research training support for this analysis.	[Anonymous], 2008, EP FACT SHEET HIV AI; Bajunirwe Francis, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P139, DOI 10.1177/1545109709332470; Bell DJ, 2007, JAIDS-J ACQ IMM DEF, V45, P560, DOI 10.1097/QAI.0b013e3180decadb; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Cui J, 2009, AM J EPIDEMIOL, V169, P113, DOI 10.1093/aje/kwn292; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; FARLEY J, 2007, ADHERENCE ASSESSMENT; *FMOH, 2005, GUID US ANT DRUGS NI; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Horton NJ, 1999, STAT MED, V18, P213, DOI 10.1002/(SICI)1097-0258(19990130)18:2<213::AID-SIM999>3.0.CO;2-E; Idoko JA, 2007, INT J STD AIDS, V18, P760, DOI 10.1258/095646207782212252; Joly V, 2002, AIDS, V16, P2447, DOI 10.1097/00002030-200212060-00010; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Muyingo SK, 2008, JAIDS-J ACQ IMM DEF, V48, P468, DOI 10.1097/QAI.0b013e31817dc3fd; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Reliquet V, 2001, HIV Med, V2, P92, DOI 10.1046/j.1468-1293.2001.00066.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Scarsella A, 2002, ADV THER, V19, P1, DOI 10.1007/BF02850013; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Unge C, 2009, JAIDS-J ACQ IMM DEF, V50, P397, DOI 10.1097/QAI.0b013e318194618e; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; Vriesendorp R, 2007, EUR J CLIN PHARMACOL, V63, P1115, DOI 10.1007/s00228-007-0369-2; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Williams AB, 2006, JAIDS-J ACQ IMM DEF, V42, P314, DOI 10.1097/01.qai.0000221681.60187.88; World Health Organization, 2006, ANT THER HIV INF AD; Wouters E, 2009, AIDS PATIENT CARE ST, V23, P357, DOI 10.1089/apc.2008.0201	49	98	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10584	10.1371/journal.pone.0010584	http://dx.doi.org/10.1371/journal.pone.0010584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485670	gold, Green Published, Green Submitted			2022-12-27	WOS:000277563200017
J	Handley, MTW; Lian, LY; Haynes, LP; Burgoyne, RD				Handley, Mark T. W.; Lian, Lu-Yun; Haynes, Lee P.; Burgoyne, Robert D.			Structural and Functional Deficits in a Neuronal Calcium Sensor-1 Mutant Identified in a Case of Autistic Spectrum Disorder	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL 4-OH KINASE; CA2+ SIGNAL-TRANSDUCTION; ACCESSORY PROTEIN-LIKE; TRANS-GOLGI NETWORK; BINDING-PROTEINS; NEURITE OUTGROWTH; IL1RAPL1 GENE; PC12 CELLS	Neuronal calcium sensor-1 (NCS-1) is a Ca(2+) sensor protein that has been implicated in the regulation of various aspects of neuronal development and neurotransmission. It exerts its effects through interactions with a range of target proteins one of which is interleukin receptor accessory protein like-1 (IL1RAPL1) protein. Mutations in IL1RAPL1 have recently been associated with autism spectrum disorders and a missense mutation (R102Q) on NCS-1 has been found in one individual with autism. We have examined the effect of this mutation on the structure and function of NCS-1. From use of NMR spectroscopy, it appeared that the R102Q affected the structure of the protein particularly with an increase in the extent of conformational exchange in the C-terminus of the protein. Despite this change NCS-1(R102Q) did not show changes in its affinity for Ca(2+) or binding to IL1RAPL1 and its intracellular localisation was unaffected. Assessment of NCS-1 dynamics indicated that it could rapidly cycle between cytosolic and membrane pools and that the cycling onto the plasma membrane was specifically changed in NCS-1(R102Q) with the loss of a Ca(2+)-dependent component. From these data we speculate that impairment of the normal cycling of NCS-1 by the R102Q mutation could have subtle effects on neuronal signalling and physiology in the developing and adult brain.	[Handley, Mark T. W.; Haynes, Lee P.; Burgoyne, Robert D.] Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Lian, Lu-Yun] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Handley, MTW (corresponding author), Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England.	burgoyne@liv.ac.uk	Burgoyne, Robert/C-6706-2008; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387; Handley, Mark/0000-0001-7200-747X	Wellcome Trust [080796/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number 080796/Z/06/Z) to RDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Aronica E, 2009, NEUROBIOL DIS, V36, P81, DOI 10.1016/j.nbd.2009.06.016; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Bai J, 2004, BIOL PSYCHIAT, V56, P427, DOI 10.1016/j.biopsych.2004.06.022; Bergmann M, 2002, J COMP NEUROL, V449, P231, DOI 10.1002/cne.10302; Bhat SS, 2008, CLIN GENET, V73, P94, DOI 10.1111/j.1399-0004.2007.00920.x; Blasiole B, 2005, J NEUROBIOL, V64, P285, DOI 10.1002/neu.20138; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chen XL, 2001, J PHYSIOL-LONDON, V532, P649, DOI 10.1111/j.1469-7793.2001.0649e.x; COX JA, 1994, J BIOL CHEM, V269, P32807; Dason JS, 2009, J CELL SCI, V122, P4109, DOI 10.1242/jcs.055095; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; GAMBINO F, 2009, EUR J NEUROSCI; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Gao XC, 2008, NEUROSCI LETT, V438, P163, DOI 10.1016/j.neulet.2008.03.084; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Haynes LP, 2007, TRAFFIC, V8, P1080, DOI 10.1111/j.1600-0854.2007.00594.x; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Iketani M, 2009, NEUROSCIENCE, V161, P743, DOI 10.1016/j.neuroscience.2009.04.019; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kawasaki T, 2003, J COMP NEUROL, V460, P465, DOI 10.1002/cne.10649; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Kragelund BB, 2000, J BIOMOL NMR, V16, P85, DOI 10.1023/A:1008383002568; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Nawara M, 2008, AM J MED GENET A, V146A, P3167, DOI 10.1002/ajmg.a.32613; O'Callaghan DW, 2003, J CELL SCI, V116, P4833, DOI 10.1242/jcs.00803; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Petko JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-27; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; Romero-Pozuelo J, 2007, EUR J NEUROSCI, V26, P2428, DOI 10.1111/j.1460-9568.2007.05877.x; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tabolacci E, 2006, AM J MED GENET A, V140A, P482, DOI 10.1002/ajmg.a.31107; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Weiss RA, 2000, EMBO REP, V1, P2, DOI 10.1093/embo-reports/kvd017; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032; Yoshida T, 2008, MOL CELL NEUROSCI, V39, P218, DOI 10.1016/j.mcn.2008.06.013; Zhang Yao-Hua, 2004, Hum Mutat, V24, P273, DOI 10.1002/humu.9269; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x	66	49	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10534	10.1371/journal.pone.0010534	http://dx.doi.org/10.1371/journal.pone.0010534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479890	Green Published, Green Submitted, gold			2022-12-27	WOS:000277467800016
J	Lee, DY; Lee, KS; Lee, HJ; Kim, DH; Noh, YH; Yu, K; Jung, HY; Lee, SH; Lee, JY; Youn, YC; Jeong, Y; Kim, DK; Lee, WB; Kim, SS				Lee, Do Yeon; Lee, Kyu-Sun; Lee, Hyun Jung; Kim, Do Hee; Noh, Yoo Hun; Yu, Kweon; Jung, Hee-Yeon; Lee, Sang Hyung; Lee, Jun Young; Youn, Young Chul; Jeong, Yoonhwa; Kim, Dae Kyong; Lee, Won Bok; Kim, Sung Su			Activation of PERK Signaling Attenuates A beta-Mediated ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; ACCUMULATION; AGGREGATION; INVOLVEMENT; PEPTIDES; CELLS; TRANSDUCERS; DEGRADATION	Alzheimer's disease (AD) is characterized by the deposition of aggregated beta-amyloid (A beta), which triggers a cellular stress response called the unfolded protein response (UPR). The UPR signaling pathway is a cellular defense system for dealing with the accumulation of misfolded proteins but switches to apoptosis when endoplasmic reticulum (ER) stress is prolonged. ER stress is involved in neurodegenerative diseases including AD, but the molecular mechanisms of ER stress-mediated A beta neurotoxicity still remain unknown. Here, we show that treatment of A beta triggers the UPR in the SK-N-SH human neuroblastoma cells. A beta mediated UPR pathway accompanies the activation of protective pathways such as Grp78/Bip and PERK-eIF2 alpha pathway, as well as the apoptotic pathways of the UPR such as CHOP and caspase-4. Knockdown of PERK enhances A beta neurotoxicity through reducing the activation of eIF2 alpha and Grp8/Bip in neurons. Salubrinal, an activator of the eIF2 alpha pathway, significantly increased the Grp78/Bip ER chaperone resulted in attenuating caspase-4 dependent apoptosis in A beta treated neurons. These results indicate that PERK-eIF2 alpha pathway is a potential target for therapeutic applications in neurodegenerative diseases including AD.	[Lee, Do Yeon; Lee, Hyun Jung; Kim, Do Hee; Noh, Yoo Hun; Lee, Won Bok; Kim, Sung Su] Chung Ang Univ, Coll Med, Dept Anat & Cell Biol, Seoul 156756, South Korea; [Lee, Do Yeon; Lee, Kyu-Sun; Yu, Kweon] KRIBB, Aging Res Ctr, Taejon, South Korea; [Jung, Hee-Yeon; Lee, Jun Young] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Lee, Sang Hyung] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Youn, Young Chul] Chung Ang Univ, Coll Med, Dept Neurol, Seoul 156756, South Korea; [Jeong, Yoonhwa] Dankook Univ, Coll Nat Sci, Dept Food Sci & Nutr, Yongin, South Korea; [Kim, Dae Kyong] Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Dankook University; Chung Ang University	Lee, DY (corresponding author), Chung Ang Univ, Coll Med, Dept Anat & Cell Biol, Seoul 156756, South Korea.	sungsu@cau.ac.kr	Jeon, You-Jin/AAR-5061-2020; Lee, Jun-Young/J-5604-2012; Youn, Young Chul/ABA-9938-2021; Jung, Hee Yeon/J-5659-2012; Lee, Sang Hyung/J-5581-2012; Lee, Jun-Young/N-5963-2019	Lee, Jun-Young/0000-0002-5893-3124; Lee, Jun-Young/0000-0002-5893-3124; Youn, Young Chul/0000-0002-2742-1759; Yu, Kweon/0000-0002-4942-2576	Rural Development Administration, Republic of Korea [20100301061075]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (No. 20100301061075), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Gavilan MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashioka S, 2005, NEUROCHEM INT, V47, P369, DOI 10.1016/j.neuint.2005.05.001; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee DY, 2008, EUR J CELL BIOL, V87, P389, DOI 10.1016/j.ejcb.2008.03.003; Lee DY, 2008, FEBS LETT, V582, P4185, DOI 10.1016/j.febslet.2008.11.007; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pereira C, 1999, NEUROBIOL DIS, V6, P209, DOI 10.1006/nbdi.1999.0241; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Yoneda T, 2002, GENE DEV, V16, P1307, DOI 10.1101/gad.1000902; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	49	88	93	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10489	10.1371/journal.pone.0010489	http://dx.doi.org/10.1371/journal.pone.0010489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463975	gold, Green Submitted, Green Published			2022-12-27	WOS:000277379400025
J	Masson, CJ; Plat, J; Mensink, RP; Namiot, A; Kisielewski, W; Namiot, Z; Fullekrug, J; Ehehalt, R; Glatz, JFC; Pelsers, MMAL				Masson, Christiaan J.; Plat, Jogchum; Mensink, Ronald P.; Namiot, Andrzej; Kisielewski, Wojciech; Namiot, Zbigniew; Fuellekrug, Joachim; Ehehalt, Robert; Glatz, Jan F. C.; Pelsers, Maurice M. A. L.			Fatty Acid- and Cholesterol Transporter Protein Expression along the Human Intestinal Tract	PLOS ONE			English	Article							ATP-BINDING CASSETTE; NIEMANN-PICK C1-LIKE-1; ILEAL AUTOTRANSPLANTATION; STEROL TRANSPORTERS; SKELETAL-MUSCLE; PLANT STEROLS; ABSORPTION; METABOLISM; ABCG5; CD36	Protein distribution profiles along the human intestinal tract of transporters involved in the absorption of cholesterol and long-chain fatty acids (LCFA) have been scarcely evaluated. Methodology/Principal Findings: In post-mortem samples from 11 subjects, intestinal transporter distribution profiles were determined via Western Blot. Differences in transporter protein levels were statistically tested using ANOVA and Tukey's Post Hoc comparisons. Levels in all segments were expressed relative to those in duodenum. Except for ABCG5 and FATP4, levels (mean +/- SEM) were the highest in the ileum. For ABCA1, ileal levels (1.80 +/- 0.26) differed significantly from those in duodenum (P = 0.049) and proximal colon (0.92 +/- 0.14; P = 0.029). ABCG8 levels in ileum (1.91 +/- 0.30) differed from those in duodenum (P = 0.041) and distal colon (0.84 +/- 0.22; P = 0.010) and jejunum (1.64 +/- 0.26) tended to be higher than distal colon (0.84 +/- 0.22; P = 0.087). Ileal NPC1L1 levels (2.56 +/- 0.51) differed from duodenum levels (P = 0.019) and from distal colon (1.09 +/- 0.22; P = 0.030). There was also a trend (P = 0.098) for higher jejunal (2.23 +/- 0.37) than duodenal NPC1L1 levels. The levels of ABCG5 did not correlate with those of ABCG8. FAT/CD36 levels in ileum (2.03 +/- 0.42) differed from those in duodenum (P = 0.017), and proximal and distal colon (0.89 +/- 0.13 and 0.97 +/- 0.15 respectively; P = 0.011 and P = 0.014). FABPpm levels in ileum (1.04 +/- 0.13) differed from proximal (0.64 +/- 0.07; P = 0.026) and distal colon (0.66 +/- 0.09; P = 0.037). Conclusions/Significance: The distribution profiles showed a bell-shape pattern along the GI-tract with the highest levels in ileum for ABCA1, ABCG8, NPC1L1, FATCD36 and FABPm, suggesting a prominent role for ileum in transporter-mediated uptake of cholesterol and LCFAs.	[Masson, Christiaan J.; Plat, Jogchum; Mensink, Ronald P.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Namiot, Andrzej] Med Univ Bialystok, Dept Human Anat, Bialystok, Poland; [Kisielewski, Wojciech] Med Univ Bialystok, Dept Clin Pathomorphol, Bialystok, Poland; [Namiot, Zbigniew] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Fuellekrug, Joachim; Ehehalt, Robert] Univ Heidelberg Hosp, Dept Gastroenterol, Heidelberg, Germany; [Glatz, Jan F. C.] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Dept Mol Genet, Maastricht, Netherlands; [Pelsers, Maurice M. A. L.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok; Ruprecht Karls University Heidelberg; Maastricht University; Maastricht University	Masson, CJ (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	maurice.pelsers@gmail.com	Namiot, Andrzej/T-8442-2018; Füllekrug, Joachim/A-6581-2008; Kisielewski, Wojciech/U-2355-2018	Namiot, Andrzej/0000-0002-0678-9458; Kisielewski, Wojciech/0000-0003-1357-2000; Ehehalt, Robert/0000-0003-4252-5801	Medical University of Bialystok [3-13556 L]; Dutch Dairy Association (NZO)	Medical University of Bialystok; Dutch Dairy Association (NZO)	The study was partially funded by grant 3-13556 L by the Medical University of Bialystok and partially by the Dutch Dairy Association (NZO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BECKER GH, 1950, GASTROENTEROLOGY, V14, P80, DOI 10.1016/S0016-5085(50)80113-0; Besnard P, 1996, P NUTR SOC, V55, P19, DOI 10.1079/PNS19960009; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; BOOTH CC, 1961, GUT, V2, P23, DOI 10.1136/gut.2.1.23; BRAND SJ, 1974, BIOCHIM BIOPHYS ACTA, V369, P1, DOI 10.1016/0005-2760(74)90185-4; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; den Bosch HMD, 2008, AM J PHYSIOL-GASTR L, V294, pG1171, DOI 10.1152/ajpgi.00360.2007; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Duan LP, 2006, AM J PHYSIOL-GASTR L, V290, pG269, DOI 10.1152/ajpgi.00172.2005; EDMONDS CJ, 1971, GUT, V12, P356, DOI 10.1136/gut.12.5.356; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Field FJ, 2004, J LIPID RES, V45, P2252, DOI 10.1194/jlr.M400208-JLR200; FLORES CA, 1989, AM J PHYSIOL, V257, pG823, DOI 10.1152/ajpgi.1989.257.5.G823; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; GLATZ JF, PHYSL REV, V90, P367; Glatz JFC, 1997, PROSTAG LEUKOTR ESS, V57, P373, DOI 10.1016/S0952-3278(97)90413-0; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Glatz JFC, 2001, CURR OPIN LIPIDOL, V12, P267, DOI 10.1097/00041433-200106000-00005; Glatz JFC, 1998, ADV EXP MED BIOL, V441, P207; Gogia Atul, 2006, Indian J Med Sci, V60, P72; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grundy Scott M, 2007, Am J Med, V120, pS3, DOI 10.1016/j.amjmed.2007.06.005; GRUNDY SM, 2007, AM J MED, V120, pS9; Gylling H, 2007, TRANSL RES, V149, P310, DOI 10.1016/j.trsl.2006.11.012; Hakala K, 1996, DIGESTION, V57, P83, DOI 10.1159/000201318; HOLLANDER D, 1983, EXP GERONTOL, V18, P287, DOI 10.1016/0531-5565(83)90039-6; Holt PR, 2001, GASTROENTEROL CLIN N, V30, P427, DOI 10.1016/S0889-8553(05)70189-8; Hrabovsky V, 2009, WIEN KLIN WOCHENSCHR, V121, P270, DOI 10.1007/s00508-009-1150-6; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Klett EL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-21; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Lorenzo C, 2006, DIABETES CARE, V29, P625, DOI 10.2337/diacare.29.03.06.dc05-1755; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miettinen TA, 2000, ATHEROSCLEROSIS, V153, P241, DOI 10.1016/S0021-9150(00)00404-4; Miettinen TA, 2000, ARTERIOSCL THROM VAS, V20, P1340, DOI 10.1161/01.ATV.20.5.1340; Montoudis A, 2008, J LIPID RES, V49, P961, DOI 10.1194/jlr.M700363-JLR200; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Pakarinen M, 1997, HEPATOLOGY, V25, P1315, DOI 10.1002/hep.510250602; Pakarinen MP, 1998, LIPIDS, V33, P267, DOI 10.1007/s11745-998-0205-y; Pakarinen MP, 1997, SURGERY, V122, P950, DOI 10.1016/S0039-6060(97)90337-8; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Pelsers MMAL, 2008, SPORTS MED, V38, P387, DOI 10.2165/00007256-200838050-00003; Pelsers MMAL, 1999, BIOCHEM J, V337, P407, DOI 10.1042/0264-6021:3370407; PIHLAJAMAKI J, 2009, METABOLISM; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; SINGLETON AO, 1964, ANN SURG, V159, P690, DOI 10.1097/00000658-196405000-00006; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; STUMP DD, 1993, AM J PHYSIOL, V265, pG894, DOI 10.1152/ajpgi.1993.265.5.G894; SYLVEN C, 1970, SCAND J GASTROENTERO, V5, P57; THOMSON ABR, 1980, AM J PHYSIOL, V239, pG363, DOI 10.1152/ajpgi.1980.239.5.G363; Tomkin GH, 2008, DIABETES CARE, V31, pS241, DOI 10.2337/dc08-s260; TURNER DA, 1958, AM J DIG DIS, V3, P682, DOI 10.1007/BF02231240; Wang Q, 2005, J PHARM SCI-US, V94, P363, DOI 10.1002/jps.20264; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; WEBSTER S G P, 1975, Age and Ageing, V4, P168, DOI 10.1093/ageing/4.3.168; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wodzig KWH, 1997, ANN CLIN BIOCHEM, V34, P263, DOI 10.1177/000456329703400307; Woudstra TD, 2004, LIPIDS, V39, P343, DOI 10.1007/s11745-004-1238-y; Yokoyama S, 2006, J ATHEROSCLER THROMB, V13, P1, DOI 10.5551/jat.13.1	77	35	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10380	10.1371/journal.pone.0010380	http://dx.doi.org/10.1371/journal.pone.0010380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454462	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100007
J	Ibrahim, N; Unwin, DM; Martill, DM; Baidder, L; Zouhri, S				Ibrahim, Nizar; Unwin, David M.; Martill, David M.; Baidder, Lahssen; Zouhri, Samir			A New Pterosaur (Pterodactyloidea: Azhdarchidae) from the Upper Cretaceous of Morocco	PLOS ONE			English	Article							GIANT PTEROSAUR; CHINA; INFORMATION; PHYLOGENY; KAZAKSTAN; DINOSAURS; DEPOSITS; REMAINS; RUSSIA; SAHARA	The Kem Kem beds in South Eastern Morocco contain a rich early Upper (or possibly late Lower) Cretaceous vertebrate assemblage. Fragmentary remains, predominantly teeth and jaw tips, represent several kinds of pterosaur although only one species, the ornithocheirid Coloborhynchus moroccensis, has been named. Here, we describe a new azhdarchid pterosaur, Alanqa saharica nov. gen. nov. sp., based on an almost complete well preserved mandibular symphysis from Aferdou N'Chaft. We assign additional fragmentary jaw remains, some of which have been tentatively identified as azhdarchid and pteranodontid, to this new taxon which is distinguished from other azhdarchids by a remarkably straight, elongate, lance-shaped mandibular symphysis that bears a pronounced dorsal eminence near the posterior end of its dorsal (occlusal) surface. Most remains, including the holotype, represent individuals of approximately three to four meters in wingspan, but a fragment of a large cervical vertebra, that probably also belongs to A. saharica, suggests that wingspans of six meters were achieved in this species. The Kem Kem beds have yielded the most diverse pterosaur assemblage yet reported from Africa and provide the first clear evidence for the presence of azhdarchids in Gondwana at the start of the Late Cretaceous. This, the relatively large size achieved by Alanqa, and the additional evidence of variable jaw morphology in azhdarchids provided by this taxon, indicates a longer and more complex history for this clade than previously suspected.	[Ibrahim, Nizar] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Unwin, David M.] Univ Leicester, Sch Museum Studies, Leicester, Leics, England; [Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Baidder, Lahssen; Zouhri, Samir] Univ Hassan 2, Lab Geosci, Casablanca, Morocco	University College Dublin; University of Leicester; University of Portsmouth; Hassan II University of Casablanca	Ibrahim, N (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	Nizar.Ibrahim@ucd.ie	Zouhri, Samir/T-7894-2019	Zouhri, Samir/0000-0002-3811-9977; BAIDDER, Lahssen/0000-0001-5318-7102; Ibrahim, Nizar/0000-0001-5839-6798; Martill, David/0000-0002-3208-5702	Ad Astra Research Scholarship; University of Portsmouth	Ad Astra Research Scholarship; University of Portsmouth	This research was supported by an Ad Astra Research Scholarship awarded to NI (http://www.ucd.ie/), financial support from the University of Portsmouth to DMM (http://www.port.ac.uk/), contributions from members of the December 2008 expedition to Morocco [Robert Loveridge, Richard Hing, Darren Naish] and a New Blood grant awarded to DMU by Leicester University (http://www.le.ac.uk/ms/contactus/davidunwin.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan Martin, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P19; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Averianov A, 2008, PALEONTOL J+, V42, P634, DOI 10.1134/S0031030108060099; Averianov AO, 2007, PALEONTOL J+, V41, P189, DOI 10.1134/S0031030107020098; Averianov AO, 2004, PALEONTOL J+, V38, P426; Bakhurina Natalia N., 1995, Historical Biology, V10, P197; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Benton MJ, 2000, PALAEOGEOGR PALAEOCL, V157, P227, DOI 10.1016/S0031-0182(99)00167-4; BLACKBEARD M, 2007, J VERT PALEONTOL S, V23, P49; BLACKBURN D, 2002, J VERT PALEONTOL S, V22, pA27; Bogoliubov N. N., 1914, Ann geol miner Novo-Alexandria, V16, P1; BUFFETAUT E, 1994, CR ACAD SCI II, V319, P1563; Buffetaut E, 1997, GEOL MAG, V134, P553, DOI 10.1017/S0016756897007449; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Catuneanu O, 2006, SEDIMENT GEOL, V190, P121, DOI 10.1016/j.sedgeo.2006.05.010; Cavin L, 1999, GEOL MIJNBOUW-N J G, V78, P261, DOI 10.1023/A:1003810123806; Codorniu Laura, 2007, P143; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Dal Sasso Cristiano, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P281; FERRANDINI M, 1985, B SOC GEOL FR, V1, P559; Frey Eberhard, 2006, Oryctos, V6, P19; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P221; Kaup J, 1834, ISIS, V3, P311; Keller JT, 1996, CEPHALALGIA, V16, P3, DOI 10.1046/j.1468-2982.1996.1601003.x; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 1997, J PALEONTOL, V71, P525, DOI 10.1017/S0022336000039548; KELLNER AWA, 2007, SURVEY PTEROSAURS AF, P257; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Knoll Fabien, 2000, Annales de Paleontologie, V86, P157, DOI 10.1016/S0753-3969(00)80006-3; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lavocat R, 1949, CR HEBD ACAD SCI, V7, P125; LAVOCAT R, 1954, NOTES MEM SERV GEOL, V116, P147; LEFRANC JP, 1990, J AFR EARTH SCI, V10, P27, DOI 10.1016/0899-5362(90)90047-I; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Mader Bryn J., 1997, Journal of Vertebrate Paleontology, V17, p62A; Mader Bryn J., 1999, Boletim do Museu Nacional Nova Serie Geologia, V45, P1; Martill David M., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P57; Martill DM, 1999, GEOL MIJNBOUW, V78, P315, DOI 10.1023/A:1003843115145; MARTILL DM, 1998, 3 EUR WORKSH VERT PA, P49; MONTEILLET J, 1982, CR ACAD SCI II, V295, P409; MURRY PA, 1991, J PALEONTOL, V65, P167, DOI 10.1017/S0022336000020291; NESOV LA, 1984, PALEONTOL ZH, P47; Ntamak-Nida M.J., 2006, Africa Geoscience Review, V13, P385; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Owen R., 1859, MONOGRAPHS PALAEONTO, V1859, P1; OWEN R, 1874, MONOGRAPHS PALAEONTO, P1; Padian Kevin, 1993, Journal of Vertebrate Paleontology, V13, p52A; PEREDASUBERBIOL.X, 2003, GEOLOGICAL SOC LONDO, V217, P80; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Plieninger Felix, 1907, Palaeontographica Stuttgart, V53; RECK H, 1931, CENTRALBLATT MINER B, P321; Rodrigues T, 2006, J VERTEBR PALEONTOL, V26, p116A; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; SAYAO JM, 2001, B RES C BRAS PAL RIO, P145; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; SWINTON WE, 1984, B SOC BELG GEOL, V77, P234; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; Unwin D.M., 2007, FOSSILS CRATO FORMAT, P475; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 1997, Historical Biology, V12, P199; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Unwin David M., 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P121; Vullo R, 2009, J VERTEBR PALEONTOL, V29, P277, DOI 10.1080/02724634.2009.10010380; Wang Xiao-Lin, 2003, Vertebrata Palasiatica, V41, P34; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Witton MP, 2009, CRETACEOUS RES, V30, P1293, DOI 10.1016/j.cretres.2009.07.006; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x	77	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10875	10.1371/journal.pone.0010875	http://dx.doi.org/10.1371/journal.pone.0010875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520782	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221500040
J	Gross, DA; Snapp, EL; Silver, DL				Gross, David A.; Snapp, Erik L.; Silver, David L.			Structural Insights into Triglyceride Storage Mediated by Fat Storage-Inducing Transmembrane (FIT) Protein 2	PLOS ONE			English	Article							LIPID DROPLET PROTEINS; MEMBRANE TOPOLOGY; DIACYLGLYCEROL ACYLTRANSFERASE; METABOLISM; FAMILY; FLUORESCENCE; LIPOLYSIS; GENES	Fat storage-Inducing Transmembrane proteins 1 & 2 (FIT1/FITM1 and FIT2/FITM2) belong to a unique family of evolutionarily conserved proteins localized to the endoplasmic reticulum that are involved in triglyceride lipid droplet formation. FIT proteins have been shown to mediate the partitioning of cellular triglyceride into lipid droplets, but not triglyceride biosynthesis. FIT proteins do not share primary sequence homology with known proteins and no structural information is available to inform on the mechanism by which FIT proteins function. Here, we present the experimentally-solved topological models for FIT1 and FIT2 using N-glycosylation site mapping and indirect immunofluorescence techniques. These methods indicate that both proteins have six-transmembrane-domains with both N- and C-termini localized to the cytosol. Utilizing this model for structure-function analysis, we identified and characterized a gain-of-function mutant of FIT2 (FLL(157-9)AAA) in transmembrane domain 4 that markedly augmented the total number and mean size of lipid droplets. Using limited-trypsin proteolysis we determined that the FLL(157-9)AAA mutant has enhanced trypsin cleavage at K86 relative to wild-type FIT2, indicating a conformational change. Taken together, these studies indicate that FIT2 is a 6 transmembrane domain-containing protein whose conformation likely regulates its activity in mediating lipid droplet formation.	[Gross, David A.; Silver, David L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gross, DA (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	david.silver@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Silver, David/0000-0002-7289-9890	NIH, Diabetes Research and Training Center at Einstein [DK020541]; NIH [T32 GM007491]; National Institute of General Medical Sciences and National Institute on Aging [1R01GM086530, 1R21AG032544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288, R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	NIH, Diabetes Research and Training Center at Einstein(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences and National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by a pilot and feasibility grant NIH DK020541 through the Diabetes Research and Training Center at Einstein (to D. L. S.) and an NIH Training Program in Cellular and Molecular Biology and Genetics, T32 GM007491 (to D. A. G.), and grants from National Institute of General Medical Sciences and National Institute on Aging 1R01GM086530 and 1R21AG032544 (to E. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Traini M, 2009, CURR OPIN LIPIDOL, V20, P147, DOI 10.1097/MOL.0b013e32832956c7; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	24	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10796	10.1371/journal.pone.0010796	http://dx.doi.org/10.1371/journal.pone.0010796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520733	gold, Green Published			2022-12-27	WOS:000278034600020
J	Rausenberger, J; Hussong, A; Kircher, S; Kirchenbauer, D; Timmer, J; Nagy, F; Schafer, E; Fleck, C				Rausenberger, Julia; Hussong, Andrea; Kircher, Stefan; Kirchenbauer, Daniel; Timmer, Jens; Nagy, Ferenc; Schaefer, Eberhard; Fleck, Christian			An Integrative Model for Phytochrome B Mediated Photomorphogenesis: From Protein Dynamics to Physiology	PLOS ONE			English	Article							SINAPIS-ALBA L; PLANT PHOTORECEPTORS PHYTOCHROME; GFP FUSION PROTEIN; TRANSGENIC ARABIDOPSIS; SIGNAL-TRANSDUCTION; TERMINAL-DOMAIN; RED-LIGHT; IN-VIVO; IRRADIANCE; SEEDLINGS	Background: Plants have evolved various sophisticated mechanisms to respond and adapt to changes of abiotic factors in their natural environment. Light is one of the most important abiotic environmental factors and it regulates plant growth and development throughout their entire life cycle. To monitor the intensity and spectral composition of the ambient light environment, plants have evolved multiple photoreceptors, including the red/far-red light-sensing phytochromes. Methodology/Principal Findings: We have developed an integrative mathematical model that describes how phytochrome B (phyB), an essential receptor in Arabidopsis thaliana, controls growth. Our model is based on a multiscale approach and connects the mesoscopic intracellular phyB protein dynamics to the macroscopic growth phenotype. To establish reliable and relevant parameters for the model phyB regulated growth we measured: accumulation and degradation, dark reversion kinetics and the dynamic behavior of different nuclear phyB pools using in vivo spectroscopy, western blotting and Fluorescence Recovery After Photobleaching (FRAP) technique, respectively. Conclusions/Significance: The newly developed model predicts that the phyB-containing nuclear bodies (NBs) (i) serve as storage sites for phyB and (ii) control prolonged dark reversion kinetics as well as partial reversibility of phyB Pfr in extended darkness. The predictive power of this mathematical model is further validated by the fact that we are able to formalize a basic photobiological observation, namely that in light-grown seedlings hypocotyl length depends on the total amount of phyB. In addition, we demonstrate that our theoretical predictions are in excellent agreement with quantitative data concerning phyB levels and the corresponding hypocotyl lengths. Hence, we conclude that the integrative model suggested in this study captures the main features of phyB-mediated photomorphogenesis in Arabidopsis.	[Rausenberger, Julia; Fleck, Christian] Univ Freiburg, Ctr Biol Syst Anal, Freiburg, Germany; [Rausenberger, Julia; Hussong, Andrea; Kircher, Stefan; Kirchenbauer, Daniel; Schaefer, Eberhard] Univ Freiburg, Inst Biol 2, D-7800 Freiburg, Germany; [Timmer, Jens; Fleck, Christian] Univ Freiburg, Inst Phys, Freiburg, Germany; [Timmer, Jens; Nagy, Ferenc] Univ Freiburg, Freiburg Inst Adv Studies, Freiburg, Germany; [Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh	Rausenberger, J (corresponding author), ETH, Dept Biosyst Sci & Engn, Basel, Switzerland.	eberhard.schaefer@biologie.uni-freiburg.de; christian.fleck@fdm.uni-freiburg.de	Nagy, Ferenc/D-3532-2015; Fleck, Christian/D-1620-2012	Nagy, Ferenc/0000-0002-6157-9269; Fleck, Christian/0000-0002-6371-4495; Kircher, Stefan/0000-0002-8351-567X	International Graduate School Signal Systems in Plant Model Organisms (DFG) [GRK1305]; Deutsche Forschungsgemeinschaft [SFB 592]; BMBF [0313921]; German Federal and State Governments; Howard Hughes International	International Graduate School Signal Systems in Plant Model Organisms (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); German Federal and State Governments; Howard Hughes International	The work was supported by the International Graduate School Signal Systems in Plant Model Organisms (DFG grant no. GRK1305 for JR), the Deutsche Forschungsgemeinschaft (SFB 592 for AH, SK, ES), BMBF FRISYS 0313921 (for CF and JR), and by the Excellence Initiative of the German Federal and State Governments (for JT and FN). Work in Hungary was supported by a Howard Hughes International Scholar grant to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; BACKMAN G, 1943, WACHSTUM ORG; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; BEGGS CJ, 1980, PLANT PHYSIOL, V66, P615, DOI 10.1104/pp.66.4.615; BRIGGS WR, 2006, PHOTOMORPHOGENESIS P, P223; Cashmoore AR, 2006, PHOTOMORPHOGENESIS P, P199; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; DOWNS R. J., 1957, BOT GAZ, V118, P199, DOI 10.1086/335946; Downson-Day MJ, 1999, PLANT J, V17, P63; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; Gil P, 2000, PLANT J, V22, P135, DOI 10.1046/j.1365-313x.2000.00730.x; Gross J, 1984, TECHNIQUES PHOTOMORP, P131; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Hennig L, 2000, PLANT CELL ENVIRON, V23, P727, DOI 10.1046/j.1365-3040.2000.00587.x; Hirschfeld M, 1998, GENETICS, V149, P523; HOCK B, 1965, PLANTA, V65, P1, DOI 10.1007/BF00385175; Huq E, 2003, PLANT J, V35, P660, DOI 10.1046/j.1365-313X.2003.01836.x; Johnson C. B., 1979, Plant, Cell and Environment, V2, P259, DOI 10.1111/j.1365-3040.1979.tb00077.x; Khan J, 2007, EJC SUPPL, V5, P12, DOI 10.1016/S1359-6349(08)70024-7; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kretsch T, 2000, PLANT J, V22, P177, DOI 10.1046/j.1365-313x.2000.00715.x; KUNKEL T, 1995, J BIOL CHEM, V270, P20193, DOI 10.1074/jbc.270.34.20193; LAGARIAS JC, 1987, PHOTOCHEM PHOTOBIOL, V46, P5, DOI 10.1111/j.1751-1097.1987.tb04729.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Muller TG, 2002, MATH BIOSCI, V177, P147, DOI 10.1016/S0025-5564(01)00098-0; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Quail P.H., 2000, PHOTOMORPHOGENESIS P, P335, DOI [10.1007/1-4020-3811-9_17, DOI 10.1007/1-4020-3811-9_17]; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; QUAIL PH, 1983, ENCY PLANT PHYSL A, V16, P178; Sch_afer E, 2006, PHOTOMORPHOGENESIS P, V3; SCHAFER E, 1974, J MATH BIOL, V1, P9, DOI 10.1007/BF02339485; SCHAFER E, 1975, J MATH BIOL, V2, P41, DOI 10.1007/BF00276015; SCHAFER E, 1976, PHOTOCHEM PHOTOBIOL, V24, P567, DOI 10.1111/j.1751-1097.1976.tb06874.x; SCHAFER E, 2006, PHOTOMORPHOGENESIS P, P13; SCHAFER E, 1977, OPTISCHE STRAHLUNGSQ, P249; SCHMIDT W, 1973, PLANTA, V111, P329, DOI 10.1007/BF00385552; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Ulm R, 2006, PHOTOMORPHOGENESIS P, P279, DOI [10.1007/14020-38119_14, DOI 10.1007/14020-38119_14]; WAGNER D, 1991, PLANT CELL, V3, P1275, DOI 10.1105/tpc.3.12.1275; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437	55	76	79	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10721	10.1371/journal.pone.0010721	http://dx.doi.org/10.1371/journal.pone.0010721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502669	Green Published, Green Submitted, gold			2022-12-27	WOS:000277845400023
J	Sim, S; Dimopoulos, G				Sim, Shuzhen; Dimopoulos, George			Dengue Virus Inhibits Immune Responses in Aedes aegypti Cells	PLOS ONE			English	Article							ANTIVIRAL RESPONSE; TOLL PATHWAY; PROTEIN; EXPRESSION; INSECT; ACTIVATION; BINDING; NS5; IMD	The ability of many viruses to manipulate the host antiviral immune response often results in complex host-pathogen interactions. In order to study the interaction of dengue virus (DENV) with the Aedes aegypti immune response, we have characterized the DENV infection-responsive transcriptome of the immune-competent A. aegypti cell line Aag2. As in mosquitoes, DENV infection transcriptionally activated the cell line Toll pathway and a variety of cellular physiological systems. Most notably, however, DENV infection down-regulated the expression levels of numerous immune signaling molecules and antimicrobial peptides (AMPs). Functional assays showed that transcriptional induction of AMPs from the Toll and IMD pathways in response to bacterial challenge is impaired in DENV-infected cells. In addition, Escherichia coli, a Gram-negative bacteria species, grew better when co-cultured with DENV-infected cells than with uninfected cells, suggesting a decreased production of AMPs from the IMD pathway in virus-infected cells. Pre-stimulation of the cell line with Gram-positive bacteria prior to DENV infection had no effect on DENV titers, while pre-stimulation with Gram-negative bacteria resulted in an increase in DENV titers. These results indicate that DENV is capable of actively suppressing immune responses in the cells it infects, a phenomenon that may have important consequences for virus transmission and insect physiology.	[Sim, Shuzhen; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sim, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	gdimopou@jhsph.edu		Dimopoulos, George/0000-0001-6755-8111	National Institutes of Health/National Institute for Allergy and Infectious Disease [R01AI061576, RO1AI059492, RO1AI078997]; Johns Hopkins School of Public Health; Johns Hopkins Malaria Research Institute; Agency for Science, Technology and Research (A*STAR), Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059492, R01AI061576, R01AI078997] Funding Source: NIH RePORTER	National Institutes of Health/National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins School of Public Health; Johns Hopkins Malaria Research Institute; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health/National Institute for Allergy and Infectious Disease R01AI061576, RO1AI059492, RO1AI078997, the Johns Hopkins School of Public Health, and the Johns Hopkins Malaria Research Institute. SS is supported by the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200; Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nasr NM, 2003, J INVERTEBR PATHOL, V82, P162, DOI 10.1016/S0022-2011(03)00030-2; PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; *WHO, 2009, 117 WHO; Yang IV, 2002, GENOME BIOL, V3; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	36	119	119	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2010	5	5							e10678	10.1371/journal.pone.0010678	http://dx.doi.org/10.1371/journal.pone.0010678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597RA	20502529	Green Submitted, gold, Green Published			2022-12-27	WOS:000277776500002
J	Spicer, E; Suckert, C; Al-Attar, H; Marsden, M				Spicer, Erin; Suckert, Catherine; Al-Attar, Hyder; Marsden, Mungo			Integrin alpha 5 beta 1 Function Is Regulated by XGIPC/kermit2 Mediated Endocytosis during Xenopus laevis Gastrulation	PLOS ONE			English	Article							EMBRYONIC-CELL ADHESION; PDZ DOMAIN PROTEIN; INTERACTING PROTEIN; MESODERM INDUCTION; DNA-REPLICATION; SMALL GTPASE; FIBRONECTIN; RECEPTOR; GIPC; MIGRATION	During Xenopus gastrulation alpha 5 beta 1 integrin function is modulated in a temporally and spatially restricted manner, however, the regulatory mechanisms behind this regulation remain uncharacterized. Here we report that XGIPC/kermit2 binds to the cytoplasmic domain of the alpha 5 subunit and regulates the activity of alpha 5 beta 1 integrin. The interaction of kermit2 with alpha 5 beta 1 is essential for fibronectin (FN) matrix assembly during the early stages of gastrulation. We further demonstrate that kermit2 regulates alpha 5 beta 1 integrin endocytosis downstream of activin signaling. Inhibition of kermit2 function impairs cell migration but not adhesion to FN substrates indicating that integrin recycling is essential for mesoderm cell migration. Furthermore, we find that the alpha 5 beta 1 integrin is colocalized with kermit2 and Rab 21 in embryonic and XTC cells. These data support a model where region specific mesoderm induction acts through kermit2 to regulate the temporally and spatially restricted changes in adhesive properties of the alpha 5 beta 1 integrin through receptor endocytosis.	[Spicer, Erin; Suckert, Catherine; Al-Attar, Hyder; Marsden, Mungo] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spicer, E (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	mmarsden@uwaterloo.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by NSERC Discovery grant to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Booth RA, 2002, J BIOL CHEM, V277, P6719, DOI 10.1074/jbc.M108033200; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; Burke DJ, 2000, CURR OPIN GENET DEV, V10, P26, DOI 10.1016/S0959-437X(99)00040-4; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cohen MW, 2000, J NEUROSCI, V20, P4912; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; DeSimone DW, 2007, METHOD ENZYMOL, V426, P403, DOI 10.1016/S0076-6879(07)26017-3; DESIMONE DW, 1991, METHOD CELL BIOL, V36, P527; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Favre-Bonvin A, 2005, J VIROL, V79, P4229, DOI 10.1128/JVI.79.7.4229-4237.2005; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; GAWANTKA V, 1994, MECH DEVELOP, V47, P199, DOI 10.1016/0925-4773(94)90039-6; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hens MD, 2002, BIOCHEM BIOPH RES CO, V298, P364, DOI 10.1016/S0006-291X(02)02459-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katoh M, 2002, INT J MOL MED, V9, P585; LEE G, 1984, CELL, V36, P729, DOI 10.1016/0092-8674(84)90353-2; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Memmo LM, 1998, J CELL SCI, V111, P425; Na J, 2003, J CELL SCI, V116, P2333, DOI 10.1242/jcs.00445; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; PijuanThompson V, 1997, J BIOL CHEM, V272, P2736, DOI 10.1074/jbc.272.5.2736; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Ramos JW, 1996, J CELL BIOL, V134, P227, DOI 10.1083/jcb.134.1.227; Ramos JW, 1996, DEVELOPMENT, V122, P2873; SAEGUSA J, 2009, J BIOL CHEM; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; SIVE HL, 2000, EARLY DEV XENOPUS LA, V9, P338; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1990, DEVELOPMENT, V108, P229; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Tan C, 2001, DEVELOPMENT, V128, P3665; Tani TT, 2001, J BIOL CHEM, V276, P36535, DOI 10.1074/jbc.M105785200; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; WINKLBAUER R, 1988, DEV BIOL, V130, P175, DOI 10.1016/0012-1606(88)90424-1; Winklbauer R, 1996, DEV BIOL, V177, P413, DOI 10.1006/dbio.1996.0174; WINKLBAUER R, 1990, DEV BIOL, V142, P155, DOI 10.1016/0012-1606(90)90159-G; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007	61	15	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2010	5	5							e10665	10.1371/journal.pone.0010665	http://dx.doi.org/10.1371/journal.pone.0010665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597QK	20498857	gold, Green Submitted, Green Published			2022-12-27	WOS:000277773700009
J	Assies, J; Pouwer, F; Lok, A; Mocking, RJT; Bockting, CLH; Visser, I; Abeling, NGGM; Duran, M; Schene, AH				Assies, Johanna; Pouwer, Francois; Lok, Anja; Mocking, Roel J. T.; Bockting, Claudi L. H.; Visser, Ieke; Abeling, Nico G. G. M.; Duran, Marinus; Schene, Aart H.			Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR MORTALITY; OXIDATIVE STRESS; DISORDER; MOOD; OMEGA-3-FATTY-ACIDS; DESATURASE; BIPOLAR; CORTEX; BLOOD	Background: The polyunsaturated fatty acid (PUFA) composition of (nerve) cell membranes may be involved in the pathophysiology of depression. Studies so far, focussed mainly on omega-3 and omega-6 PUFAs. In the present study, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and PUFAs of the omega-3, -6 and -9 series in plasma and erythrocytes of patients with recurrent major depressive disorder (MDD-R) were compared with controls. Methodology and Principal Findings: We carried out a case-control study. The sample consisted of 137 patients with MDD-R and 65 matched non-depressed controls. In plasma and erythrocytes of patients with MDD-R the concentrations of most of the SFAs and MUFAs, and additionally erythrocyte PUFAs, all with a chain length >20 carbon (C) atoms, were significantly lower than in the controls. In contrast, the concentrations of most of the shorter chain members (<= 18C) of the SFAs and MUFAs were significantly higher in the patients. Estimated activities of several elongases in plasma of patients were significantly altered, whereas delta-9 desaturase activity for C14:0 and C18:0 was significantly higher. Conclusions/Significance: The fatty acid status of patients with MDD-R not only differs with regard to omega-3 and omega-6 PUFAs, but also concerns other fatty acids. These alterations may be due to: differences in diet, changes in synthesizing enzyme activities, higher levels of chronic (oxidative) stress but may also result from adaptive strategies by providing protection against enhanced oxidative stress and production of free radicals.	[Assies, Johanna; Lok, Anja; Mocking, Roel J. T.; Visser, Ieke; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, NL-1105 AZ Amsterdam, Netherlands; [Pouwer, Francois] Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Visser, Ieke] PsyQ Mental Heath Care, Zaandam, Netherlands; [Abeling, Nico G. G. M.; Duran, Marinus] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Tilburg University; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Assies, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.assies@amc.uva.nl	Schene, A.H./H-8085-2014; Mocking, Roel JT/H-8131-2012; Bockting, Claudi L/K-3768-2019	Schene, A.H./0000-0002-1756-3235; Mocking, Roel JT/0000-0003-3543-3810; Bockting, Claudi L/0000-0002-9220-9244; Pouwer, Frans/0000-0002-8172-9818	Health Research Development Counsel (ZonMw); Department Prevention Program; National Foundation for Mental Health (Fonds Psychische Gezondheid)	Health Research Development Counsel (ZonMw)(Netherlands Organization for Health Research and Development); Department Prevention Program; National Foundation for Mental Health (Fonds Psychische Gezondheid)	This study was granted by the Health Research Development Counsel (ZonMw), Department Prevention Program and National Foundation for Mental Health (Fonds Psychische Gezondheid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Bull World Health Organ, V78, P413; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Assies J, 2001, BIOL PSYCHIAT, V49, P510, DOI 10.1016/S0006-3223(00)00986-0; ASSIES J, 2003, PROSTAGLANDINS LEUKO, V70, P151; Astorg P, 2009, PROSTAG LEUKOTR ESS, V81, P265, DOI 10.1016/j.plefa.2009.06.002; BENSACHAR D, 2008, PLOS; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Dacremont G, 1995, J INHERIT METAB DIS, V18, P76, DOI 10.1007/BF00711430; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; First M. D., 1996, USERS GUIDE STRUCTUR; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; JACOBSSON A, 2006, PROGR LIP RES, V45, P15; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kume A, 2008, DIABETES RES CLIN PR, V80, P259, DOI 10.1016/j.diabres.2007.12.014; Liou YA, 2009, PROSTAG LEUKOTR ESS, V80, P201, DOI 10.1016/j.plefa.2009.02.003; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2009, PROSTAG LEUKOTR ESS, V81, P223, DOI 10.1016/j.plefa.2009.05.017; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Severus WE, 2001, HARVARD REV PSYCHIAT, V9, P280, DOI 10.1093/hrp/9.6.280; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sobczak S, 2004, PSYCHOL MED, V34, P103, DOI 10.1017/S0033291703001090; Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Zak A, 2007, TOHOKU J EXP MED, V212, P359, DOI 10.1620/tjem.212.359	41	96	99	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10635	10.1371/journal.pone.0010635	http://dx.doi.org/10.1371/journal.pone.0010635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498721	Green Published, gold, Green Submitted			2022-12-27	WOS:000277771600005
J	Gotz, A; Eylert, E; Eisenreich, W; Goebel, W				Goetz, Andreas; Eylert, Eva; Eisenreich, Wolfgang; Goebel, Werner			Carbon Metabolism of Enterobacterial Human Pathogens Growing in Epithelial Colorectal Adenocarcinoma (Caco-2) Cells	PLOS ONE			English	Article							PHOSPHATE-TRANSPORT-SYSTEM; SHIGELLA-FLEXNERI 2A; ESCHERICHIA-COLI; GENOME SEQUENCE; VIRULENCE; GLUCOSE; INFECTION; MUTANTS; GENE; SUGAR	Analysis of the genome sequences of the major human bacterial pathogens has provided a large amount of information concerning their metabolic potential. However, our knowledge of the actual metabolic pathways and metabolite fluxes occurring in these pathogens under infection conditions is still limited. In this study, we analysed the intracellular carbon metabolism of enteroinvasive Escherichia coli (EIEC HN280 and EIEC 4608-58) and Salmonella enterica Serovar Typhimurium (Stm 14028) replicating in epithelial colorectal adenocarcinoma cells (Caco-2). To this aim, we supplied [U-C-13(6)]glucose to Caco-2 cells infected with the bacterial strains or mutants thereof impaired in the uptake of glucose, mannose and/or glucose 6-phosphate. The C-13-isotopologue patterns of protein-derived amino acids from the bacteria and the host cells were then determined by mass spectrometry. The data showed that EIEC HN280 growing in the cytosol of the host cells, as well as Stm 14028 replicating in the Salmonella-containing vacuole (SCV) utilised glucose, but not glucose 6-phosphate, other phosphorylated carbohydrates, gluconate or fatty acids as major carbon substrates. EIEC 4608-58 used C-3-compound(s) in addition to glucose as carbon source. The labelling patterns reflected strain-dependent carbon flux via glycolysis and/or the Entner-Doudoroff pathway, the pentose phosphate pathway, the TCA cycle and anapleurotic reactions between PEP and oxaloacetate. Mutants of all three strains impaired in the uptake of glucose switched to C-3-substrate(s) accompanied by an increased uptake of amino acids (and possibly also other anabolic monomers) from the host cell. Surprisingly, the metabolism of the host cells, as judged by the efficiency of C-13-incorporation into host cell amino acids, was not significantly affected by the infection with either of these intracellular pathogens.	[Goetz, Andreas; Goebel, Werner] Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany; [Eylert, Eva; Eisenreich, Wolfgang] Tech Univ Munich, Ctr Isotopol Profiling, Lehrstuhl Biochem, D-8046 Garching, Germany; [Goebel, Werner] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany	University of Wurzburg; Technical University of Munich; University of Munich	Gotz, A (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany.	wolfgang.eisenreich@ch.tum.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Goebel, Werner/0000-0003-4851-2083	Deutsche Forschungsgemeinschaft [SPP1316, SFB479, TR34]; Network of Excellence EuroPathoGenomics (NoE EPG); GCWN [1141 W1/4rzburg/Nice]; Franco-German University [ED-31-04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Network of Excellence EuroPathoGenomics (NoE EPG); GCWN; Franco-German University	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP1316, SFB479 and TR34) and the Network of Excellence EuroPathoGenomics (NoE EPG). A.G. was supported by the International DFG Research Training Group 1141 W1/4rzburg/Nice (GCWN) and the Franco-German University (ED-31-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Cersini A, 2003, INFECT IMMUN, V71, P7002, DOI 10.1128/IAI.71.12.7002-7013.2003; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DIETZ GW, 1976, ADV ENZYMOL RAMB, V44, P237; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; ERNI B, 1989, FEMS MICROBIOL LETT, V63, P13, DOI 10.1016/0168-6445(89)90004-1; ERNI B, 1986, J BIOL CHEM, V261, P6398; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; GOTZ A, 2010, MICROBIOLOGY; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; NICOLETTI M, 1988, J CLIN MICROBIOL, V26, P524, DOI 10.1128/JCM.26.3.524-529.1988; Nikel PI, 2009, J BACTERIOL, V191, P5538, DOI 10.1128/JB.00174-09; Noriega FR, 1996, INFECT IMMUN, V64, P3055, DOI 10.1128/IAI.64.8.3055-3061.1996; PAPPENHEIMER JR, 1993, AM J PHYSIOL, V265, pG409, DOI 10.1152/ajpgi.1993.265.3.G409; Porco A, 1997, J BACTERIOL, V179, P1584, DOI 10.1128/jb.179.5.1584-1590.1997; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Romisch-Margl W, 2007, PHYTOCHEMISTRY, V68, P2273, DOI 10.1016/j.phytochem.2007.03.034; Runyen-Janecky LJ, 2002, INFECT IMMUN, V70, P4379, DOI 10.1128/IAI.70.8.4379-4388.2002; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; SANSONETTI PJ, 1982, ANN INST PASTEUR MIC, VA133, P351; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Shaikh AS, 2010, BIOTECHNOL PROGR, V26, P52, DOI 10.1002/btpr.325; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Verhamme DT, 2001, MICROBIOL-SGM, V147, P3345, DOI 10.1099/00221287-147-12-3345; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhao J, 2004, APPL MICROBIOL BIOT, V64, P91, DOI 10.1007/s00253-003-1458-5	51	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2010	5	5							e10586	10.1371/journal.pone.0010586	http://dx.doi.org/10.1371/journal.pone.0010586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594UB	20485672	Green Published, Green Submitted, gold			2022-12-27	WOS:000277563200018
J	Greene, DM; Hsu, DW; Pears, CJ				Greene, David M.; Hsu, Duen-Wei; Pears, Catherine J.			Control of Cyclin C Levels during Development of Dictyostelium	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RNA-POLYMERASE-II; HUMAN CDK8 SUBCOMPLEX; MEDIATOR COMPLEX; OXIDATIVE STRESS; EXPRESSION; DISCOIDEUM; SUBUNITS; PATHWAY; DIFFERENTIATION	Background: Cdk8 and its partner cyclin C form part of the mediator complex which links the basal transcription machinery to regulatory proteins. The pair are required for correct regulation of a subset of genes and have been implicated in control of development in a number of organisms including the social amoeba Dictyostelium discoideum. When feeding, Dictyostelium amoebae are unicellular but upon starvation they aggregate to form a multicellular structure which develops into a fruiting body containing spores. Cells in which the gene encoding Cdk8 has been deleted fail to enter aggregates due to a failure of early gene expression. Principal Findings: We have monitored the expression levels of cyclin C protein during development and find levels decrease after the multicellular mound is formed. This decrease is triggered by extracellular cAMP that, in turn, is working in part through an increase in intracellular cAMP. The loss of cyclin C is coincident with a reduction in the association of Cdk8 with a high molecular weight complex in the nucleus. Overexpression of cyclin C and Cdk8 lead to an increased rate of early development, consistent with the levels being rate limiting. Conclusions: Overall these results show that both cyclin C and Cdk8 are regulated during development in response to extracellular signals and the levels of these proteins are important in controlling the timing of developmental processes. These findings have important implications for the role of these proteins in controlling development, suggesting that they are targets for developmental signals to regulate gene expression.	[Greene, David M.; Hsu, Duen-Wei; Pears, Catherine J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Greene, DM (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	catherine.pears@bioch.ox.ac.uk		Pears, Catherine/0000-0003-1290-8326	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust [081548/Z/06/Z]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	D.G. was the recipient of a Biotechnology and Biological Sciences Research Council (BBSRC) studentship and the work was supported by The Wellcome Trust (Grant ref 081548/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Brabazon ED, 2002, BBA-GENE STRUCT EXPR, V1576, P203, DOI 10.1016/S0167-4781(02)00302-0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Cooper KF, 2002, EUKARYOT CELL, V1, P66, DOI 10.1128/EC.01.1.66-74.2002; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HOPPER NA, 1993, EMBO J, V12, P2459, DOI 10.1002/j.1460-2075.1993.tb05900.x; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Katoch B, 2003, J BIOSCIENCES, V28, P581, DOI 10.1007/BF02703333; Katona RL, 2007, ACTA BIOL HUNG, V58, P133, DOI 10.1556/ABiol.58.2007.1.12; KAY RR, 1989, DEVELOPMENT, V105, P753; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin HHS, 2004, DEV BIOL, V271, P49, DOI 10.1016/j.ydbio.2004.03.020; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Oh C, 2006, ADV EXP MED BIOL, V583, P49; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Plyte SE, 1999, DEVELOPMENT, V126, P325; Strmecki L, 2005, DEV BIOL, V284, P25, DOI 10.1016/j.ydbio.2005.05.011; Strmecki L, 2007, EUKARYOT CELL, V6, P245, DOI 10.1128/EC.00204-06; Takeda K, 2002, DEV GROWTH DIFFER, V44, P213; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Treisman JE, 2001, DEVELOPMENT, V128, P603; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang WM, 2004, DEVELOPMENT, V131, P3147, DOI 10.1242/dev.01187; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10543	10.1371/journal.pone.0010543	http://dx.doi.org/10.1371/journal.pone.0010543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479885	gold, Green Submitted, Green Published			2022-12-27	WOS:000277467800024
J	Kuroshu, RM; Watanabe, J; Sugano, S; Morishita, S; Suzuki, Y; Kasahara, M				Kuroshu, Reginaldo M.; Watanabe, Junichi; Sugano, Sumio; Morishita, Shinichi; Suzuki, Yutaka; Kasahara, Masahiro			Cost-Effective Sequencing of Full-Length cDNA Clones Powered by a De Novo-Reference Hybrid Assembly	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; RNA-SEQ; TRANSCRIPTOME ANALYSIS; GENOME SEQUENCE; EVOLUTION; INSIGHTS; REVEALS; IDENTIFICATION; TECHNOLOGIES; REPERTOIRE	Background: Sequencing full-length cDNA clones is important to determine gene structures including alternative splice forms, and provides valuable resources for experimental analyses to reveal the biological functions of coded proteins. However, previous approaches for sequencing cDNA clones were expensive or time-consuming, and therefore, a fast and efficient sequencing approach was demanded. Methodology: We developed a program, MuSICA 2, that assembles millions of short (36-nucleotide) reads collected from a single flow cell lane of Illumina Genome Analyzer to shotgun-sequence,800 human full-length cDNA clones. MuSICA 2 performs a hybrid assembly in which an external de novo assembler is run first and the result is then improved by reference alignment of shotgun reads. We compared the MuSICA 2 assembly with 200 pooled full-length cDNA clones finished independently by the conventional primer-walking using Sanger sequencers. The exon-intron structure of the coding sequence was correct for more than 95% of the clones with coding sequence annotation when we excluded cDNA clones insufficiently represented in the shotgun library due to PCR failure (42 out of 200 clones excluded), and the nucleotide-level accuracy of coding sequences of those correct clones was over 99.99%. We also applied MuSICA 2 to full-length cDNA clones from Toxoplasma gondii, to confirm that its ability was competent even for non-human species. Conclusions: The entire sequencing and shotgun assembly takes less than 1 week and the consumables cost only, similar to US$3 per clone, demonstrating a significant advantage over previous approaches.	[Kuroshu, Reginaldo M.; Morishita, Shinichi; Kasahara, Masahiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan; [Watanabe, Junichi; Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Morishita, Shinichi] Japan Sci & Technol Agcy, Bioinformat Res & Dev BIRD, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroshu, RM (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan.	ysuzuki@k.u-tokyo.ac.jp; mkasa@cb.k.u-tokyo.ac.jp		Kasahara, Masahiro/0000-0001-8430-1414; Morishita, Shinichi/0000-0002-6201-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan; Bioinformatics Research and Development (BIRD); Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bioinformatics Research and Development (BIRD); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' and "Comparative Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Bioinformatics Research and Development (BIRD), Japan Science and Technology Agency (JST). Computation time was provided in part by T2K Open Supercomputer (Todai Combined Cluster), Information Technology Center, The University of Tokyo and by the Super Computer System, Human Genome Center, Institute of Medical	Andersson B, 1997, DNA SEQUENCE, V7, P63, DOI 10.3109/10425179709020153; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; CLOONAN N, 2008, NAT METHODS; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; DJEBALI S, 2008, NAT METHODS; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Forrest ARR, 2009, RNA BIOL, V6, P107, DOI 10.4161/rna.6.2.7931; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yu W, 1997, GENOME RES, V7, P353, DOI 10.1101/gr.7.4.353; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10517	10.1371/journal.pone.0010517	http://dx.doi.org/10.1371/journal.pone.0010517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479877	Green Published, gold, Green Submitted			2022-12-27	WOS:000277467800006
J	Letzen, BS; Liu, C; Thakor, NV; Gearhart, JD; All, AH; Kerr, CL				Letzen, Brian S.; Liu, Cyndi; Thakor, Nitish V.; Gearhart, John D.; All, Angelo H.; Kerr, Candace L.			MicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CNS; NEUROBLASTOMA; PRECURSORS; MYELINATE; NETWORKS; PATTERNS; RECOVERY; BIOLOGY	Background: Cells of the oligodendrocyte (OL) lineage play a vital role in the production and maintenance of myelin, a multilamellar membrane which allows for saltatory conduction along axons. These cells may provide immense therapeutic potential for lost sensory and motor function in demyelinating conditions, such as spinal cord injury, multiple sclerosis, and transverse myelitis. However, the molecular mechanisms controlling OL differentiation are largely unknown. MicroRNAs (miRNAs) are considered the "micromanagers'' of gene expression with suggestive roles in cellular differentiation and maintenance. Although unique patterns of miRNA expression in various cell lineages have been characterized, this is the first report documenting their expression during oligodendrocyte maturation from human embryonic stem (hES) cells. Here, we performed a global miRNA analysis to reveal and identify characteristic patterns in the multiple stages leading to OL maturation from hES cells including those targeting factors involved in myelin production. Methodology/Principal Findings: We isolated cells from 8 stages of OL differentiation. Total RNA was subjected to miRNA profiling and validations preformed using real-time qRT-PCR. A comparison of miRNAs from our cultured OLs and OL progenitors showed significant similarities with published results from equivalent cells found in the rat and mouse central nervous system. Principal component analysis revealed four main clusters of miRNA expression corresponding to early, mid, and late progenitors, and mature OLs. These results were supported by correlation analyses between adjacent stages. Interestingly, the highest differentially-expressed miRNAs demonstrated a similar pattern of expression throughout all stages of differentiation, suggesting that they potentially regulate a common target or set of targets in this process. The predicted targets of these miRNAs include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, CLDN11, MYTL1, MBOP, MPZL2, and DDR1. Conclusions/Significance: We demonstrate miRNA profiles during distinct stages in oligodendroglial differentiation that may provide key markers of OL maturation. Our results reveal pronounced trends in miRNA expression and their potential mRNA target interactions that could provide valuable insight into the molecular mechanisms of differentiation.	[Letzen, Brian S.; Thakor, Nitish V.; All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Gearhart, John D.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Dept Anim Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [All, Angelo H.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace L.] Johns Hopkins Univ, Dept Gynecol & Obstet, Inst Cell Engn, Baltimore, MD 21205 USA; [Liu, Cyndi; Kerr, Candace L.] Johns Hopkins Univ, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Letzen, BS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	ckerr@jhmi.edu	Thakor, Nitish V/A-5878-2008; Thakor, Nitish/G-9110-2015	Thakor, Nitish/0000-0002-9981-9395	Maryland Stem Cell Research Fund [2008-MSCRFE-0129-00, 2009-MSCRFII-0091-00]	Maryland Stem Cell Research Fund	This work was funded by the Maryland Stem Cell Research Fund (http://www.mscrf.org) Tedco #2008-MSCRFE-0129-00 (Kerr) and 2009-MSCRFII-0091-00 (All). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsky K, 2003, J CELL SCI, V116, P1279, DOI 10.1242/jcs.00302; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Franco-Pons N, 2009, J MOL NEUROSCI, V38, P2, DOI 10.1007/s12031-008-9151-x; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Jakovcevski I, 2005, J NEUROSCI, V25, P10064, DOI 10.1523/JNEUROSCI.2324-05.2005; Jakovcevski I, 2005, GLIA, V49, P480, DOI 10.1002/glia.20134; KAWASEKOGA Y, 2009, DIFFERENT TIMINGS DI; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; KERR C, 2010, INT J NEUROSCIENCE; Kerr DA, 2003, J NEUROSCI, V23, P5131; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; LEHOTZKY A, 2009, GLIA; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; LOAYZAPUCH F, ONCOGENE; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Magnus T, 2005, J CELL MOL MED, V9, P303, DOI 10.1111/j.1582-4934.2005.tb00357.x; MALZKORN B, 2009, BRAIN PATHOLOGY, V9999; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SHI L, 2009, BRAIN RES; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; SHIN D, 2009, ANN NEUROLOGY, V9999; SKALSKY R, BMC GENOMICS, V11, P119; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tan KB, 2006, J NEURO-ONCOL, V80, P235, DOI 10.1007/s11060-006-9184-3; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Van Landeghem FKH, 2002, PEDIATR RES, V51, P129, DOI 10.1203/00006450-200202000-00003; VOORHOEVE P, ADV MOL ONCOLOGY, P17; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yoshikawa Hiroo, 2001, Medical Electron Microscopy, V34, P160, DOI 10.1007/s007950100009; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; ZHI F, EUROPEAN J CANC	60	79	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10480	10.1371/journal.pone.0010480	http://dx.doi.org/10.1371/journal.pone.0010480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463920	Green Published, Green Submitted, gold			2022-12-27	WOS:000277379400016
J	Steitz, J; Barlow, PG; Hossain, J; Kim, E; Okada, K; Kenniston, T; Rea, S; Donis, RO; Gambotto, A				Steitz, Julia; Barlow, Peter G.; Hossain, Jaber; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Donis, Ruben O.; Gambotto, Andrea			A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; CODON OPTIMIZATION; REVERSE GENETICS; HUMAN ADENOVIRUS; DNA VACCINATION; RHESUS-MONKEYS; VIRUS; VECTORS; HUMANS; IMMUNIZATION	Background: In 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an adenovirus-based influenza H1N1 vaccine tested for immunogenicity and efficacy to confer protection in animal model. Methods: We generated two adenovirus(Ad5)-based influenza vaccine candidates encoding the wildtype or a codon-optimized hemagglutinin antigen (HA) from the recently emerged swine influenza isolate A/California/04/2009 (H1N1)pdm. After verification of antigen expression, immunogenicity of the vaccine candidates were tested in a mouse model using dose escalations for subcutaneous immunization. Sera of immunized animals were tested in microneutalization and hemagglutination inhibition assays for the presence of HA-specific antibodies. HA-specific T-cells were measured in IFN gamma Elispot assays. The efficiency of the influenza vaccine candidates were evaluated in a challenge model by measuring viral titer in lung and nasal turbinate 3 days after inoculation of a homologous H1N1 virus. Conclusions/Significance: A single immunization resulted in robust cellular and humoral immune response. Remarkably, the intensity of the immune response was substantially enhanced with codon-optimized antigen, indicating the benefit of manipulating the genetic code of HA antigens in the context of recombinant influenza vaccine design. These results highlight the value of advanced technologies in vaccine development and deployment in response to infections with pandemic potential. Our study emphasizes the potential of an adenoviral-based influenza vaccine platform with the benefits of speed of manufacture and efficacy of a single dose immunization.	[Steitz, Julia; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA; [Barlow, Peter G.; Hossain, Jaber; Donis, Ruben O.] Ctr Dis Control & Prevent, Mol Virol & Vaccines Branch, Influenza Div, Natl Ctr Infect Dis, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Steitz, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	gambottoa@upmc.edu	Barlow, Peter/O-4078-2019	Barlow, Peter/0000-0002-6516-9312; Molodiuc, Veaceslav/0000-0002-3014-4203	National Institutes of Health (NIH) [5R01AI069282-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069282] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant 5R01AI069282-02 (A. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Chen JD, 1996, HUM GENE THER, V7, P1515, DOI 10.1089/hum.1996.7.13-1515; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Gao W, 2003, GENE THER, V10, P1941, DOI 10.1038/sj.gt.3302097; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GREENBERG ME, 2009, N ENGL J MED; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lipatov AS, 2005, J INFECT DIS, V191, P1216, DOI 10.1086/428951; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Mossadegh N, 2004, VIROLOGY, V326, P57, DOI 10.1016/j.virol.2004.04.050; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Ozawa M, 2007, J VIROL, V81, P9556, DOI 10.1128/JVI.01042-07; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Ramakrishna L, 2004, VACCINE, V22, P2586, DOI 10.1016/j.vaccine.2003.12.007; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Ternette N, 2007, VACCINE, V25, P7271, DOI 10.1016/j.vaccine.2007.07.025; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043	34	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10492	10.1371/journal.pone.0010492	http://dx.doi.org/10.1371/journal.pone.0010492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463955	Green Published, gold, Green Accepted			2022-12-27	WOS:000277379400026
J	Vila, B; Jackson, FD; Fortuny, J; Selles, AG; Galobart, A				Vila, Bernat; Jackson, Frankie D.; Fortuny, Josep; Selles, Albert G.; Galobart, Angel			3-D Modelling of Megaloolithid Clutches: Insights about Nest Construction and Dinosaur Behaviour	PLOS ONE			English	Article							SOUTHERN PYRENEES; EGGS; EGGSHELLS; CONDUCTANCE; ARGENTINA; BASIN	Background: Megaloolithid eggs have long been associated with sauropod dinosaurs. Despite their extensive and worldwide fossil record, interpretations of egg size and shape, clutch morphology, and incubation strategy vary. The Pinyes locality in the Upper Cretaceous Tremp Formation in the southern Pyrenees, Catalonia provides new information for addressing these issues. Nine horizons containing Megaloolithus siruguei clutches are exposed near the village of Coll de Nargo. Tectonic deformation in the study area strongly influenced egg size and shape, which could potentially lead to misinterpretation of reproductive biology if 2D and 3D maps are not corrected for bed dip that results from tectonism. Methodology/Findings: Detailed taphonomic study and three-dimensional modelling of fossil eggs show that intact M. siruguei clutches contained 20-28 eggs, which is substantially larger than commonly reported from Europe and India. Linear and grouped eggs occur in three superimposed levels and form an asymmetric, elongate, bowl-shaped profile in lateral view. Computed tomography data support previous interpretations that the eggs hatched within the substrate. Megaloolithid clutch sizes reported from other European and Indian localities are typically less than 15 eggs; however, these clutches often include linear or grouped eggs that resemble those of the larger Pinyes clutches and may reflect preservation of incomplete clutches. Conclusions/Significance: We propose that 25 eggs represent a typical megaloolithid clutch size and smaller egg clusters that display linear or grouped egg arrangements reported at Pinyes and other localities may represent eroded remnants of larger clutches. The similarity of megaloolithid clutch morphology from localities worldwide strongly suggests common reproductive behaviour. The distinct clutch geometry at Pinyes and other localities likely resulted from the asymmetrical, inclined, and laterally compressed titanosaur pes unguals of the female, using the hind foot for scratch-digging during nest excavation.	[Vila, Bernat; Fortuny, Josep; Selles, Albert G.; Galobart, Angel] Campus Univ Autonoma Barcelona, Inst Catala Paleontol, Barcelona, Spain; [Jackson, Frankie D.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Montana State University System; Montana State University Bozeman	Vila, B (corresponding author), Campus Univ Autonoma Barcelona, Inst Catala Paleontol, Barcelona, Spain.	bernat.vila@icp.cat	Selles, Albert G./ACZ-6076-2022; Galobart, Àngel À/H-5024-2011; Fortuny, Josep/L-2523-2014; VILA, BERNAT/AAA-7367-2021	Selles, Albert G./0000-0002-4637-6084; Galobart, Àngel À/0000-0003-1508-4561; Fortuny, Josep/0000-0003-4282-1619; VILA, BERNAT/0000-0002-5935-1732	Ministerio de Ciencia e Innovacion [CGL2008-06533-C03-01]; Departament de Cultura de la Generalitat de Catalunya; Jurassic Foundation; College of Letters and Sciences, Montana State University-Bozeman	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Departament de Cultura de la Generalitat de Catalunya; Jurassic Foundation; College of Letters and Sciences, Montana State University-Bozeman	This research was financially supported by the following organizations: Ministerio de Ciencia e Innovacion (CGL2008-06533-C03-01), Departament de Cultura de la Generalitat de Catalunya, Jurassic Foundation and the College of Letters and Sciences, Montana State University-Bozeman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardevol L, 2000, AAPG BULL, V84, P566; BEETSCHEN JC, 1985, ACT C DIN CHIN FRANC, P113; Bonnan MF, 2005, LIFE O PAST, P346; BORSUKBIALYNICK.M, 1977, PALAEONTOLOGICA POLO, V37, P45; Bravo A.M., 2005, REV ESPANOLA PALEONT, V10, P49; Bravo AM, 2000, 1 INT S DIN EGGS BAB, P15; Bravo Ana Maria, 2003, Palaeovertebrata (Montpellier), V32, P77; BRETON G, 1986, ANN MUS HAVRE, V32, P1; CAMARA P., 1985, ESTUDIOS GEOLGICOS, V41, P391, DOI DOI 10.3989/EGEOL.85415-6720; Carpenter K., 1999, EGGS NESTS BABY DINO; Chiappe L.M., 2000, 1 INT S DIN EGGS BAB, P23; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2004, PALAIOS, V19, P89, DOI 10.1669/0883-1351(2004)019<0089:NSFSSC>2.0.CO;2; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Chiappe LM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P285; Codrea V, 2002, CR PALEVOL, V1, P173, DOI 10.1016/S1631-0683(02)00021-0; Cousin R., 1989, Historical Biology, V2, P157; Cousin R, 2000, 1 INT S DIN EGGS BAB, P31; Cousin Remi, 1994, P56; Cousin Remi, 2004, Bulletin Trimestriel de la Societe Geologique de Normandie et des Amis du Museum du Havre, V89, P1; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; DUGHI R, 1966, CR ACAD SCI D NAT, V262, P2330; DUGHI R, 1958, CR HEBD ACAD SCI, V246, P2271; Elez J., 2000, 1 INT S DIN EGGS BAB, P43; ERBEN HK, 1979, PALEOBIOLOGY, V5, P380, DOI 10.1017/S0094837300016900; Faccio Guillermo, 1994, P47; Feist M., 1983, GEOLOGIE MEDITERRANE, V10, P303, DOI 10.3406/geolm.1983.1273; Fortuny J., 2007, CANTERA PALEONTOLOGI, P181; FOWLER D, MUSEUM ROCKIES OCCAS, V4, P18; FREYTET P, 1965, B SOC ETUDES SCI AUD, V65, P121; GALLUP MR, 1989, GEOL S AM S, V238, P71; Garcia G, 2001, CR ACAD SCI II A, V332, P185, DOI 10.1016/S1251-8050(00)91401-0; Garcia G, 1998, THESIS U MONTPELLIER; Garcia Geraldine, 2003, Palaeovertebrata (Montpellier), V32, P109; Gonzalez-Manteiga W, 2008, TEST-SPAIN, V17, P40, DOI 10.1007/s11749-008-0105-y; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; GRIGORESCU D, 2006, AMEGHINIANA, V43, pR18; Grigorescu Dan, 1994, P75; Hayward J.L., 1989, Journal of Vertebrate Paleontology, V9, P196; HAYWARD JL, HIST BIOL IN PRESS; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Jackson F.D., 2007, THESIS MONTANA STATE; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; KEROURIO P, 1981, COMPTE RENDU SOMMAIR, V1, P25; Lopez-Martinez N, 2000, PALAEOGEOGR PALAEOCL, V160, P153, DOI 10.1016/S0031-0182(00)00063-8; LOPEZMARTINEZ N, 1999, 1 INT S DIN EGGS BAB, P12; Manera de Bianco T, 1996, ASOCIACION PALEONTOL, V4, P59; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Mey P.H.W., 1968, LEIDSE GEOL MEDED, V41, P221; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; Mohabey DM, 2005, LIFE O PAST, P466; Mohabey DM, 1996, CRETACEOUS RES, V17, P183, DOI 10.1006/cres.1996.0014; MOHABEY DM, 1984, J GEOL SOC INDIA, V25, P329; MOHABEY DM, 2000, 1 INT S DIN EGGS BAB, P139; Mohabey DM, 1990, CRETACEOUS EVENT STR; MOLINA MD, 1987, SEDIMENTACION SINTEC, P69; Moratalla J.J., 1994, P37; Mueller-Towe IJ, 2002, PALAEONTOGR ABT A, V267, P119; MUNOZ JA, 1992, THRUST TECTONICS, P235; PEITZ C, 2000, THESIS RF WILHELMS U; Powell Jaime Eduardo, 1992, Acta Zoologica Lilloana, V41, P381; POWELL JE, 1996, AMEHINIANA, V33, P470; PUIGDEFABREGAS C, 1986, TECTONOPHYSICS, V129, P173, DOI 10.1016/0040-1951(86)90251-9; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; Sahni A, 2003, CURR SCI INDIA, V85, P904; Sahni Ashok, 1994, P204; Salgado L, 2009, AMEGHINIANA, V46, P605; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 1998, CR ACAD SCI II A, V327, P67, DOI 10.1016/S1251-8050(98)80020-7; SANZ JL, 1995, NATURE, V376, P731, DOI 10.1038/376731a0; SEYMOUR RS, 1980, AM ZOOL, V20, P437; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Soja Constance M., 2008, American Paleontologist, V16, P21; SRIVASTAVA S, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V193, P219; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Vianey-Liaud M., 2000, 1 INT S DIN EGGS BAB, P165; Vianey-Liaud Monique, 1994, P151; VianeyLiaud M, 1997, J PALEONTOL, V71, P1157, DOI 10.1017/S002233600003609X; Vila B, 2006, ACT 3 JORN INT PAL D, P365; Vila B, 2010, AMEGHINIANA, V47, P79, DOI 10.5710/AMGH.v47i1.3; Vila B, 2010, LETHAIA, V43, P197, DOI 10.1111/j.1502-3931.2009.00183.x; WILLIAMS DLG, 1984, PALAEOGEOGR PALAEOCL, V45, P23, DOI 10.1016/0031-0182(84)90107-X	83	32	33	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10362	10.1371/journal.pone.0010362	http://dx.doi.org/10.1371/journal.pone.0010362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463953	Green Published, gold, Green Submitted			2022-12-27	WOS:000277379400002
J	Aspord, C; Charles, J; Leccia, MT; Laurin, D; Richard, MJ; Chaperot, L; Plumas, J				Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel			A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERFERON-PRODUCING CELLS; INFLUENZA-VIRUS; IN-VITRO; THERAPEUTIC VACCINES; METASTATIC MELANOMA; ANTITUMOR IMMUNITY; TUMOR; ANTIGEN; RESPONSES	Background: The development of effective cancer vaccines still remains a challenge. Despite the crucial role of plasmacytoid dendritic cells (pDCs) in anti-tumor responses, their therapeutic potential has not yet been worked out. We explored the relevance of HLA-A*0201 matched allogeneic pDCs as vectors for immunotherapy. Methods and Findings: Stimulation of PBMC from HLA-A*0201(+) donors by HLA-A*0201 matched allogeneic pDCs pulsed with tumor-derived peptides triggered high levels of antigen-specific and functional cytotoxic T cell responses (up to 98% tetramer(+) CD8 T cells). The pDC vaccine demonstrated strong anti-tumor therapeutic in vivo efficacy as shown by the inhibition of tumor growth in a humanized mouse model. It also elicited highly functional tumor-specific T cells ex-vivo from PBMC and TIL of stage I-IV melanoma patients. Responses against MelA, GP100, tyrosinase and MAGE-3 antigens reached tetramer levels up to 62%, 24%, 85% and 4.3% respectively. pDC vaccine-primed T cells specifically killed patients' own autologous melanoma tumor cells. This semi-allogeneic pDC vaccine was more effective than conventional myeloid DC-based vaccines. Furthermore, the pDC vaccine design endows it with a strong potential for clinical application in cancer treatment. Conclusions: These findings highlight HLA-A*0201 matched allogeneic pDCs as potent inducers of tumor immunity and provide a promising immunotherapeutic strategy to fight cancer.	[Aspord, Caroline; Charles, Julie; Laurin, David; Chaperot, Laurence; Plumas, Joel] Etab Francais Sang Rhone Alpes, R&D Lab, La Tronche, France; [Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel] Univ Grenoble 1, Grenoble, France; [Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel] INSERM, U823, La Tronche, France; [Charles, Julie; Leccia, Marie-Therese; Richard, Marie-Jeanne] CHU Grenoble, Michallon Hosp, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Aspord, C (corresponding author), Etab Francais Sang Rhone Alpes, R&D Lab, La Tronche, France.	carolineaspord@yahoo.com; joel.plumas@wanadoo.fr	Laurin, David/M-7895-2014; Aspord, Caroline/N-3179-2013; chaperot, laurence/N-2927-2013; ASPORD, Caroline/AAU-1805-2020; charles, julie/E-8929-2013; Plumas, Joel/N-2516-2013	Laurin, David/0000-0001-9339-8369; Aspord, Caroline/0000-0002-4979-7044; chaperot, laurence/0000-0002-1479-9410; charles, julie/0000-0003-4667-6009; Leccia, M.Therese/0000-0003-1222-0396	Institut National du Cancer [ACI-63-04, 2004-05]; Etablissement Francais du Sang; National Academy of Medicine [2004-05]	Institut National du Cancer(Institut National du Cancer (INCA) France); Etablissement Francais du Sang; National Academy of Medicine	This work was supported by grants from the Institut National du Cancer (ACI-63-04 and canceropole 2004-05) and Etablissement Francais du Sang. J. Charles was a recipient of grants from the National Academy of Medicine and canceropole 2004-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Aspord C, 2007, EXPERT OPIN DRUG DIS, V2, P949, DOI 10.1517/17460441.2.7.949; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fabre JW, 2001, NAT MED, V7, P649, DOI 10.1038/89008; Fajardo-Moser M, 2008, INT J MED MICROBIOL, V298, P11, DOI 10.1016/j.ijmm.2007.07.003; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gjertsen H A, 1993, Transpl Immunol, V1, P126, DOI 10.1016/0966-3274(93)90005-S; Hartmann E, 2003, CANCER RES, V63, P6478; Holtl L, 2005, CANCER IMMUNOL IMMUN, V54, P663, DOI 10.1007/s00262-004-0629-2; Hus I, 2005, LEUKEMIA, V19, P1621, DOI 10.1038/sj.leu.2403860; Kim R, 2007, IMMUNOLOGY, V121, P149, DOI 10.1111/j.1365-2567.2007.02579.x; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; LUI G, 2009, PLOS ONE IN PRESS; Lui G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007111; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Molenkamp BG, 2008, CLIN CANCER RES, V14, P4532, DOI 10.1158/1078-0432.CCR-07-4711; Molenkamp BG, 2007, CLIN CANCER RES, V13, P2961, DOI 10.1158/1078-0432.CCR-07-0050; Muir G, 2006, BJU INT, V98, P989, DOI 10.1111/j.1464-410X.2006.06421.x; Newton DA, 2000, J IMMUNOTHER, V23, P246, DOI 10.1097/00002371-200003000-00009; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Palucka AK, 2005, J IMMUNOTHER, V28, P158, DOI 10.1097/01.cji.0000154249.74383.17; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Rothenfusser S, 2004, BLOOD, V103, P2162, DOI 10.1182/blood-2003-04-1091; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Santegoets SJAM, 2006, CANCER IMMUNOL IMMUN, V55, P1480, DOI 10.1007/s00262-006-0142-x; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Schettini J, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/106321; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tamir A, 2007, CANCER IMMUNOL IMMUN, V56, P2003, DOI 10.1007/s00262-007-0299-y; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Trefzer U, 2004, INT J CANCER, V110, P730, DOI 10.1002/ijc.20191; Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684; van den Hoorn T, 2008, NAT IMMUNOL, V9, P1208, DOI 10.1038/ni1108-1208; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	55	37	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10458	10.1371/journal.pone.0010458	http://dx.doi.org/10.1371/journal.pone.0010458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454561	Green Submitted, Green Published, gold			2022-12-27	WOS:000277305300007
J	Massignani, M; Canton, I; Sun, T; Hearnden, V; MacNeil, S; Blanazs, A; Armes, SP; Lewis, A; Battaglia, G				Massignani, Marzia; Canton, Irene; Sun, Tao; Hearnden, Vanessa; MacNeil, Sheila; Blanazs, Adam; Armes, Steven P.; Lewis, Andrew; Battaglia, Giuseppe			Enhanced Fluorescence Imaging of Live Cells by Effective Cytosolic Delivery of Probes	PLOS ONE			English	Article							POLYMER VESICLES; GENE-EXPRESSION; LIVING CELLS; MICROSCOPY; SKIN; COPOLYMERS; NANOSCOPY; PROGRESS	Background: Microscopic techniques enable real-space imaging of complex biological events and processes. They have become an essential tool to confirm and complement hypotheses made by biomedical scientists and also allow the re-examination of existing models, hence influencing future investigations. Particularly imaging live cells is crucial for an improved understanding of dynamic biological processes, however hitherto live cell imaging has been limited by the necessity to introduce probes within a cell without altering its physiological and structural integrity. We demonstrate herein that this hurdle can be overcome by effective cytosolic delivery. Principal Findings: We show the delivery within several types of mammalian cells using nanometre-sized biomimetic polymer vesicles (a.k.a. polymersomes) that offer both highly efficient cellular uptake and endolysomal escape capability without any effect on the cellular metabolic activity. Such biocompatible polymersomes can encapsulate various types of probes including cell membrane probes and nucleic acid probes as well as labelled nucleic acids, antibodies and quantum dots. Significance: We show the delivery of sufficient quantities of probes to the cytosol, allowing sustained functional imaging of live cells over time periods of days to weeks. Finally the combination of such effective staining with three-dimensional imaging by confocal laser scanning microscopy allows cell imaging in complex three-dimensional environments under both mono-culture and co-culture conditions. Thus cell migration and proliferation can be studied in models that are much closer to the in vivo situation.	[Massignani, Marzia; Canton, Irene; Hearnden, Vanessa; Battaglia, Giuseppe] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Massignani, Marzia; Sun, Tao; Hearnden, Vanessa; MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield S10 2TN, S Yorkshire, England; [Blanazs, Adam; Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England; [Hearnden, Vanessa] Univ Sheffield, Sch Clin Dent, Dept Oral & Maxillofacial Med & Surg, Sheffield S10 2TN, S Yorkshire, England; [Lewis, Andrew] Biocompatibles UK Ltd, Farnham, Surrey, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Biocompatibles International PLC	Massignani, M (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	g.battaglia@sheffield.ac.uk	Battaglia, Giuseppe/A-2253-2012; Battaglia, Giuseppe/I-2142-2013	Battaglia, Giuseppe/0000-0003-3349-6770; Hearnden, Vanessa/0000-0003-0838-7783; Blanazs, Adam/0000-0001-5956-0860; Canton, Irene/0000-0003-2768-4425; Armes, Steven/0000-0002-8289-6351	Biocompatibles ltd.	Biocompatibles ltd.	The present work was sponsored by Biocompatibles ltd. The funders, Biocompatibles, had no role in study design. However, Prof Lewis (co-author of the paper) from Biocompatibles has been involved in preparation of the manuscript. Some of the data were also reproduced within Biocompatibles laboratories. Prof Andrew Lewis is an employee of the commercial funder. This won't alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AMBROSE E. J., 1961, EXPTL CELL RES SUPPL, V8, P54, DOI 10.1016/0014-4827(61)90340-8; BATTAGLIA G, 2008, RAPID NONTOXIC INTRA; BATTAGLIA G, 2008, POLYMERSOMES NUCL AC; Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2003.04723.x; BRAKENHOFF GJ, 1979, J MICROSC-OXFORD, V117, P219, DOI 10.1111/j.1365-2818.1979.tb01178.x; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COLING D, 2001, CURR PROTOC MOL BIOL; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Du JZ, 2005, J AM CHEM SOC, V127, P12800, DOI 10.1021/ja054755n; Eves P, 2000, BRIT J DERMATOL, V142, P210, DOI 10.1046/j.1365-2133.2000.03287.x; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; HAUGLAND RP, 1999, Patent No. 19920919254; HAUGLAND RP, 1993, Patent No. 5362628; HEARNDEN V, 2008, EUR CELLS MATER, V16, P58; Hearnden V, 2009, PHARM RES-DORDR, V26, P1718, DOI 10.1007/s11095-009-9882-6; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; LANSINGTAYLOR D, 1980, NATURE, V284, P405; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lomas H, 2008, FARADAY DISCUSS, V139, P143, DOI 10.1039/b717431d; Lomas H, 2007, ADV MATER, V19, P4238, DOI 10.1002/adma.200700941; LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; MASSIGNANI M, 2009, IMMUNOPOLYM IN PRESS; Massignani M, 2009, SMALL, V5, P2424, DOI 10.1002/smll.200900578; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Robinson KL, 2002, J MATER CHEM, V12, P890, DOI 10.1039/b200348c; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thompson R.B., 2006, FLUORESCENCE SENSORS; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	41	64	71	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10459	10.1371/journal.pone.0010459	http://dx.doi.org/10.1371/journal.pone.0010459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454666	Green Published, gold, Green Accepted			2022-12-27	WOS:000277240300025
J	Sehlmeyer, S; Wang, LZ; Langel, D; Heckel, DG; Mohagheghi, H; Petschenka, G; Ober, D				Sehlmeyer, Sven; Wang, Linzhu; Langel, Dorothee; Heckel, David G.; Mohagheghi, Hoda; Petschenka, Georg; Ober, Dietrich			Flavin-Dependent Monooxygenases as a Detoxification Mechanism in Insects: New Insights from the Arctiids (Lepidoptera)	PLOS ONE			English	Article							MOTH UTETHEISA-ORNATRIX; PYRROLIZIDINE ALKALOID BIOSYNTHESIS; AMINO-ACID-SEQUENCE; CYTOCHROME-P450 MONOOXYGENASES; HOMOSPERMIDINE SYNTHASE; DEOXYHYPUSINE SYNTHASE; DEFENSE-MECHANISMS; DROSOPHILA-MELANOGASTER; PHALAENOPSIS ORCHIDS; CATALYTIC-PROPERTIES	Insects experience a wide array of chemical pressures from plant allelochemicals and pesticides and have developed several effective counterstrategies to cope with such toxins. Among these, cytochrome P450 monooxygenases are crucial in plant-insect interactions. Flavin-dependent monooxygenases (FMOs) seem not to play a central role in xenobiotic detoxification in insects, in contrast to mammals. However, the previously identified senecionine N-oxygenase of the arctiid moth Tyria jacobaeae (Lepidoptera) indicates that FMOs have been recruited during the adaptation of this insect to plants that accumulate toxic pyrrolizidine alkaloids. Identification of related FMO-like sequences of various arctiids and other Lepidoptera and their combination with expressed sequence tag (EST) data and sequences emerging from the Bombyx mori genome project show that FMOs in Lepidoptera form a gene family with three members (FMO1 to FMO3). Phylogenetic analyses suggest that FMO3 is only distantly related to lepidopteran FMO1 and FMO2 that originated from a more recent gene duplication event. Within the FMO1 gene cluster, an additional gene duplication early in the arctiid lineage provided the basis for the evolution of the highly specific biochemical, physiological, and behavioral adaptations of these butterflies to pyrrolizidine-alkaloid-producing plants. The genes encoding pyrrolizidine-alkaloid-N-oxygenizing enzymes (PNOs) are transcribed in the fat body and the head of the larvae. An N-terminal signal peptide mediates the transport of the soluble proteins into the hemolymph where PNOs efficiently convert pro-toxic pyrrolizidine alkaloids into their non-toxic N-oxide derivatives. Heterologous expression of a PNO of the generalist arctiid Grammia geneura produced an N-oxygenizing enzyme that shows noticeably expanded substrate specificity compared with the related enzyme of the specialist Tyria jacobaeae. The data about the evolution of FMOs within lepidopteran insects and the functional characterization of a further member of this enzyme family shed light on this almost uncharacterized detoxification system in insects.	[Sehlmeyer, Sven; Mohagheghi, Hoda] TU Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany; [Wang, Linzhu; Langel, Dorothee; Ober, Dietrich] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Wang, Linzhu; Langel, Dorothee; Ober, Dietrich] Univ Kiel, Bot Garden, D-2300 Kiel, Germany; [Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Petschenka, Georg] Univ Hamburg, Inst Zool, D-2000 Hamburg, Germany	Braunschweig University of Technology; University of Kiel; University of Kiel; Max Planck Society; University of Hamburg	Sehlmeyer, S (corresponding author), TU Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany.	dober@bot.uni-kiel.de	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSIN M, 1987, DRUG METAB DISPOS, V15, P200; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Anke S, 2008, PLANT PHYSIOL, V148, P751, DOI 10.1104/pp.108.124859; [Anonymous], PHYLIP PHYLOGENY INF; Becker DP, 2006, J MED CHEM, V49, P1125, DOI 10.1021/jm0509501; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berenbaum MR, 1996, AM NAT, V148, pS139, DOI 10.1086/285907; BERGOMAZ R, 1986, Journal of the Lepidopterists' Society, V40, P131; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F; Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CASHMAN JR, 2002, ENZYME SYSTEMS METAB, P67; CASPERS P, 1994, CELL MOL BIOL, V40, P635; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; CONNER WE, 1981, BEHAV ECOL SOCIOBIOL, V9, P227, DOI 10.1007/BF00302942; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; CONNER WE, 1990, J CHEM ECOL, V16, P543, DOI 10.1007/BF01021785; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Feyereisen R., 2005, P1; Frolich C, 2006, PHYTOCHEMISTRY, V67, P1493, DOI 10.1016/j.phytochem.2006.05.031; Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRUBOR VD, 2003, THESIS U MELBOURNE M; Guengerich F, 2002, ENZYME SYSTEMS METAB, P33; Hao D, 2009, GENETICA, V137, P173, DOI 10.1007/s10709-009-9382-y; HARE JF, 1993, OECOLOGIA, V96, P9, DOI 10.1007/BF00318024; Harrison TL, 2001, ARCH INSECT BIOCHEM, V48, P179, DOI 10.1002/arch.1070; Hartmann T, 2000, TOP CURR CHEM, V209, P207; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P1083, DOI 10.1016/j.ibmb.2005.05.011; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hung CF, 1997, INSECT BIOCHEM MOLEC, V27, P377, DOI 10.1016/S0965-1748(97)00009-X; JEAN D, 1989, DEV GENET, V10, P220; KRASNOFF SB, 1989, J CHEM ECOL, V15, P1077, DOI 10.1007/BF01015201; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Michalski C, 2008, J BIOL CHEM, V283, P19219, DOI 10.1074/jbc.M802236200; Narberhaus I, 2005, CHEMOECOLOGY, V15, P121, DOI 10.1007/s00049-005-0302-z; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Nurhayati N, 2009, PHYTOCHEMISTRY, V70, P508, DOI 10.1016/j.phytochem.2009.01.019; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; OVERBY LH, 1995, ARCH BIOCHEM BIOPHYS, V317, P275, DOI 10.1006/abbi.1995.1163; Petersen RA, 2001, INSECT BIOCHEM MOLEC, V31, P679, DOI 10.1016/S0965-1748(00)00174-0; Reina M, 1997, PHYTOCHEMISTRY, V46, P845, DOI 10.1016/S0031-9422(97)00354-3; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scharf ME, 2004, ARCH INSECT BIOCHEM, V57, P28, DOI 10.1002/arch.20012; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schulz Stefan, 2009, P145; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suh JK, 2000, ARCH BIOCHEM BIOPHYS, V381, P317, DOI 10.1006/abbi.2000.1965; Suh JK, 2000, P NATL ACAD SCI USA, V97, P121, DOI 10.1073/pnas.97.1.121; Suh JK, 1999, P NATL ACAD SCI USA, V96, P2687, DOI 10.1073/pnas.96.6.2687; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Zhang M, 2002, ARCH BIOCHEM BIOPHYS, V403, P277, DOI 10.1016/S0003-9861(02)00237-0; ZIEGLER DM, 1977, TRENDS BIOCHEM SCI, V2, P79, DOI 10.1016/0968-0004(77)90042-1; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650; ZIEGLER DM, 1993, ANNU REV PHARMACOL, V33, P179, DOI 10.1146/annurev.pharmtox.33.1.179	72	43	45	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10435	10.1371/journal.pone.0010435	http://dx.doi.org/10.1371/journal.pone.0010435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454663	Green Submitted, gold, Green Published			2022-12-27	WOS:000277240300011
J	Wong, MS; Sun, DS; Chang, HH				Wong, Ming-Show; Sun, Der-Shan; Chang, Hsin-Hou			Bactericidal Performance of Visible-Light Responsive Titania Photocatalyst with Silver Nanostructures	PLOS ONE			English	Article							FERRITE COMPOSITE NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; MAGNETIC CORE; INACTIVATION; SHELL; DISINFECTION; ANTIBIOTICS; RESISTANCE	Background: Titania dioxide (TiO2) photocatalyst is primarily induced by ultraviolet light irradiation. Visible-light responsive anion-doped TiO2 photocatalysts contain higher quantum efficiency under sunlight and can be used safely in indoor settings without exposing to biohazardous ultraviolet light. The antibacterial efficiency, however, remains to be further improved. Methodology/Principal Findings: Using thermal reduction method, here we synthesized silver-nanostructures coated TiO2 thin films that contain a high visible-light responsive antibacterial property. Among our tested titania substrates including TiO2, carbon-doped TiO2 [TiO2 (C)] and nitrogen-doped TiO2 [TiO2 (N)], TiO2 (N) showed the best performance after silver coating. The synergistic antibacterial effect results approximately 5 log reductions of surviving bacteria of Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus and Acinetobacter baumannii. Scanning electron microscope analysis indicated that crystalline silver formed unique wire-like nanostructures on TiO2 (N) substrates, while formed relatively straight and thicker rod-shaped precipitates on the other two titania materials. Conclusion/Significance: Our results suggested that proper forms of silver on various titania materials could further influence the bactericidal property.	[Wong, Ming-Show] Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan; [Wong, Ming-Show; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Hsin-Hou] Tzu Chi Univ, Ctr Vasc Med, Hualien, Taiwan	National Dong Hwa University; National Dong Hwa University; Tzu Chi University; Tzu Chi University	Wong, MS (corresponding author), Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [95-2314-B-320-009-MY3, 95-2120-M-259-003, 96-2221-E-259-010-MY3]; Ministry of Economic Affairs of Taiwan ROC [98-EC-17-A-19-S2-0111]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs of Taiwan ROC(Ministry of Economic Affairs, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. 95-2314-B-320-009-MY3, 95-2120-M-259-003 and 96-2221-E-259-010-MY3, and Ministry of Economic Affairs of Taiwan ROC under grant no. 98-EC-17-A-19-S2-0111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAHI R, 2001, SCIENCE, V269, P293; BERNARD BK, 1990, J TOXICOL ENV HEALTH, V29, P417, DOI 10.1080/15287399009531402; Butkus MA, 2004, APPL ENVIRON MICROB, V70, P2848, DOI 10.1128/AEM.70.5.2848-2853.2004; Chang CW, 2007, J BIOMED SCI, V14, P419, DOI 10.1007/s11373-007-9154-6; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604; Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/S0305-4179(04)90000-9; Elechiguerra J.L., 2005, J NANOBIOTECHNOLOGY, V3, P6, DOI [10.1186/1477-3155-3-6, DOI 10.1186/1477-3155-3-6]; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x; Iroha IR, 2007, SCI RES ESSAYS, V2, P338; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; Kisch H, 2002, CHEMPHYSCHEM, V3, P399, DOI 10.1002/1439-7641(20020517)3:5<399::AID-CPHC399>3.0.CO;2-H; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Matsui Y, 2004, MICROBIOL IMMUNOL, V48, P489, DOI 10.1111/j.1348-0421.2004.tb03541.x; Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panyala NR, 2008, J APPL BIOMED, V6, P117, DOI 10.32725/jab.2008.015; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005; Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007; Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043; Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488; Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021; Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Wong MS, 2008, J MOL CATAL A-CHEM, V279, P20, DOI 10.1016/j.molcata.2007.09.024; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Yang GX, 2004, PLANT PHYSIOL BIOCH, V42, P1, DOI 10.1016/j.plaphy.2003.10.001; Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044; Yao Y, 2008, J BIOMED MATER RES B, V85B, P453, DOI 10.1002/jbm.b.30965	45	48	48	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10394	10.1371/journal.pone.0010394	http://dx.doi.org/10.1371/journal.pone.0010394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454454	gold, Green Submitted, Green Published			2022-12-27	WOS:000277240100010
J	Johns, MC; Eick, AA; Blazes, DL; Lee, SE; Perdue, CL; Lipnick, R; Vest, KG; Russell, KL; DeFraites, RF; Sanchez, JL				Johns, Matthew C.; Eick, Angelia A.; Blazes, David L.; Lee, Seung-eun; Perdue, Christopher L.; Lipnick, Robert; Vest, Kelly G.; Russell, Kevin L.; DeFraites, Robert F.; Sanchez, Jose L.			Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel	PLOS ONE			English	Article							T-CELL RESPONSES; AVIAN INFLUENZA; PREEXISTING IMMUNITY; ANTIBODY-RESPONSES; RISK-FACTORS; A H1N1; LIVE; VIRUS; TRIVALENT; INFECTION	Introduction: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. Materials and Methods: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). Conclusion: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.	[Johns, Matthew C.; Blazes, David L.; Vest, Kelly G.; Russell, Kevin L.; Sanchez, Jose L.] Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA; [Eick, Angelia A.; Lee, Seung-eun] Armed Forces Hlth Surveillance Ctr, Henry M Jackson Fdn Adv Mil Med, Silver Spring, MD USA; [Perdue, Christopher L.; Lipnick, Robert] Armed Forces Hlth Surveillance Ctr, Div Commun Stand & Training, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Johns, MC (corresponding author), Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA.	matthew.c.johns@us.army.mil		Mulvihill, Daniel/0000-0003-2502-5274; Geeves, Michael/0000-0002-9364-8898	US Military; BBSRC [BB/F011784/1] Funding Source: UKRI	US Military; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the baseline funding of the US Military's Defense Health Program for the Armed Forces Health Surveillance Center (AFHSC). No non-government funding was accepted for this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFHSC, 2009, TRI SERV REP EV GUID; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; *CDC, 2010, ADV COMM IMM PRACT P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cohen J, 2010, SCIENCE, V327, P1563, DOI 10.1126/science.327.5973.1563; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; *WHO, 2009, AD HOC POL ADV WORK; WHO, 2009, SUMM REP HIGH LEV CO; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	55	65	66	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10722	10.1371/journal.pone.0010722	http://dx.doi.org/10.1371/journal.pone.0010722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502705	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400024
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; World Health Organization, 2004, POL LAB MAN, V4th; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400031
